Oral	O
treponemes	B-bacteria
are	O
considered	O
to	O
be	O
important	O
in	O
the	O
development	O
and	O
progression	O
of	O
periodontal	O
diseases	O
.	O

We	O
investigated	O
the	O
mechanisms	O
of	O
recognition	O
and	O
activation	O
of	O
human	O
gingival	O
epithelial	O
cells	O
(	O
HGEC	O
)	O
with	O
the	O
oral	O
treponemes	B-bacteria
Treponema	B-bacteria
denticola	I-bacteria
,	O
Treponema	B-bacteria
vincentii	I-bacteria
,	O
and	O
Treponema	B-bacteria
medium	I-bacteria
and	O
their	O
outer	O
membrane	O
extracts	O
(	O
OMEs	O
)	O
.	O

T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
medium	I-bacteria
but	O
not	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
produced	O
interleukin	O
8	O
(	O
IL	O
-	O
8	O
)	O
in	O
an	O
HGEC	O
culture	O
.	O

Further	O
,	O
all	O
three	O
treponemes	B-bacteria
induced	O
IL	O
-	O
8	O
mRNA	O
expression	O
and	O
NF	O
-	O
kappaB	O
activation	O
in	O
HGEC	O
.	O

Among	O
them	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
especially	O
exhibited	O
trypsin	O
-	O
and	O
chymotrypsin	O
-	O
like	O
protease	O
activities	O
,	O
and	O
the	O
addition	O
of	O
chymostatin	O
,	O
a	O
chymotrypsin	O
protease	O
inhibitor	O
,	O
resulted	O
in	O
detectable	O
IL	O
-	O
8	O
production	O
by	O
HGEC	O
cultured	O
with	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

Additionally	O
,	O
IL	O
-	O
8	O
mRNA	O
expression	O
in	O
HGEC	O
cultured	O
with	O
the	O
three	O
treponemes	B-bacteria
and	O
their	O
OMEs	O
was	O
definitely	O
inhibited	O
by	O
the	O
mouse	O
anti	O
-	O
human	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
monoclonal	O
antibody	O
TL2	O
.	O
1	O
.	O

These	O
findings	O
suggest	O
that	O
oral	O
treponemes	B-bacteria
and	O
their	O
OMEs	O
activate	O
HGEC	O
through	O
TLR2	O
.	O

Although	O
bacterial	O
DNA	O
(	O
bDNA	O
)	O
containing	O
unmethylated	O
CpG	O
motifs	O
stimulates	O
innate	O
immune	O
cells	O
through	O
Toll	O
-	O
like	O
receptor	O
9	O
(	O
TLR	O
-	O
9	O
)	O
,	O
its	O
precise	O
role	O
in	O
the	O
pathophysiology	O
of	O
diseases	O
is	O
still	O
equivocal	O
.	O

Here	O
we	O
examined	O
the	O
immunostimulatory	O
effects	O
of	O
DNA	O
extracted	O
from	O
periodontopathogenic	O
bacteria	O
.	O

A	O
major	O
role	O
in	O
the	O
etiology	O
of	O
periodontal	O
diseases	O
has	O
been	O
attributed	O
to	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
.	O

We	O
therefore	O
isolated	O
DNA	O
from	O
these	O
bacteria	O
and	O
stimulated	O
murine	O
macrophages	O
and	O
human	O
gingival	O
fibroblasts	O
(	O
HGF	O
)	O
in	O
vitro	O
.	O

Furthermore	O
,	O
HEK	O
293	O
cells	O
transfected	O
with	O
human	O
TLR	O
-	O
9	O
were	O
also	O
stimulated	O
with	O
these	O
DNA	O
preparations	O
.	O

We	O
observed	O
that	O
DNA	O
from	O
these	O
pathogens	O
stimulates	O
macrophages	O
and	O
gingival	O
fibroblasts	O
to	O
produce	O
tumor	O
necrosis	O
factor	O
alpha	O
and	O
interleukin	O
-	O
6	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Methylation	O
of	O
the	O
CpG	O
motifs	O
abolished	O
the	O
observed	O
effects	O
.	O

Activation	O
of	O
HEK	O
293	O
cells	O
expressing	O
TLR	O
-	O
9	O
which	O
were	O
responsive	O
to	O
bDNA	O
but	O
not	O
to	O
lipopolysaccharide	O
confirmed	O
that	O
immunostimulation	O
was	O
achieved	O
by	O
bDNA	O
.	O

In	O
addition	O
,	O
the	O
examined	O
bDNA	O
differed	O
in	O
the	O
ability	O
to	O
stimulate	O
murine	O
macrophages	O
,	O
HGF	O
,	O
and	O
TLR	O
-	O
9	O
-	O
transfected	O
cells	O
.	O

DNA	O
from	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
elicited	O
a	O
potent	O
cytokine	O
response	O
,	O
while	O
DNA	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
showed	O
lower	O
immunostimulatory	O
activity	O
.	O

Taken	O
together	O
,	O
the	O
results	O
strongly	O
suggest	O
that	O
DNA	O
from	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
possesses	O
immunostimulatory	O
properties	O
in	O
regard	O
to	O
cytokine	O
secretion	O
by	O
macrophages	O
and	O
fibroblasts	O
.	O

These	O
stimulatory	O
effects	O
are	O
due	O
to	O
unmethylated	O
CpG	O
motifs	O
within	O
bDNA	O
and	O
differ	O
between	O
distinct	O
periodontopathogenic	O
bacteria	O
strains	O
.	O

Hence	O
,	O
immunostimulation	O
by	O
DNA	O
from	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
could	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
periodontal	O
diseases	O
.	O

Immunosuppressants	O
play	O
an	O
essential	O
role	O
in	O
transplantation	O
therapy	O
.	O

In	O
view	O
of	O
the	O
side	O
effects	O
,	O
e	O
.	O
g	O
.	O
gingival	O
overgrowth	O
,	O
the	O
present	O
in	O
vitro	O
study	O
was	O
performed	O
in	O
order	O
to	O
investigate	O
the	O
effect	O
of	O
selected	O
immunosuppressants	O
on	O
metabolic	O
activities	O
of	O
gingival	O
fibroblasts	O
.	O

Furthermore	O
,	O
the	O
effect	O
on	O
the	O
growth	O
of	O
six	O
oral	O
microorganisms	O
was	O
investigated	O
.	O

Human	O
gingival	O
fibroblasts	O
were	O
incubated	O
in	O
the	O
presence	O
of	O
azathioprine	O
(	O
Aza	O
)	O
,	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
,	O
tacrolimus	O
(	O
Tac	O
)	O
or	O
mycophenolatmofetil	O
(	O
Myc	O
)	O
.	O

PGE	O
subset	O
2	O
release	O
was	O
determined	O
by	O
means	O
of	O
a	O
specific	O
competitive	O
enzyme	O
immunoassay	O
,	O
using	O
monoclonal	O
antibodies	O
specific	O
for	O
PGE	O
subset	O
2	O
(	O
clone	O
E2R1	O
)	O
.	O

The	O
protein	O
content	O
was	O
measured	O
spectrophotometrically	O
.	O

A	O
redox	O
indicator	O
system	O
was	O
employed	O
to	O
assess	O
the	O
proliferation	O
activity	O
.	O

In	O
an	O
additional	O
trial	O
the	O
growth	O
of	O
six	O
strains	O
of	O
oral	O
bacteria	O
(	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
T14V	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
H1	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
10449	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
DR2001	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
,	O
and	O
M	B-bacteria
.	I-bacteria
micros	I-bacteria
33270	I-bacteria
)	O
in	O
the	O
presence	O
of	O
the	O
immunosuppressants	O
was	O
measured	O
.	O

In	O
comparison	O
with	O
the	O
controls	O
,	O
the	O
PGE	O
subset	O
2	O
release	O
was	O
increased	O
by	O
39	O
.	O
3	O
%	O
following	O
incubation	O
with	O
Aza	O
,	O
and	O
by	O
77	O
.	O
0	O
%	O
with	O
CsA	O
.	O

The	O
protein	O
concentrations	O
(	O
1	O
g	O
immunosuppressant	O
/	O
ml	O
medium	O
)	O
were	O
reduced	O
by	O
26	O
.	O
0	O
%	O
for	O
Aza	O
and	O
17	O
.	O
0	O
%	O
for	O
Myc	O
.	O

Furthermore	O
,	O
a	O
drug	O
-	O
dependent	O
inhibition	O
in	O
the	O
cell	O
proliferation	O
rate	O
was	O
noted	O
after	O
an	O
incubation	O
period	O
of	O
6	O
hours	O
(	O
Aza	O
70	O
.	O
7	O
%	O
,	O
CsA	O
78	O
.	O
2	O
%	O
,	O
Myc	O
69	O
.	O
8	O
%	O
,	O
Tac	O
64	O
.	O
0	O
%	O
)	O
.	O

The	O
most	O
pronounced	O
growth	O
-	O
inhibiting	O
effects	O
were	O
observed	O
for	O
CsA	O
at	O
values	O
ranging	O
from	O
21	O
.	O
0	O
%	O
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
10449	I-bacteria
)	O
to	O
48	O
.	O
6	O
%	O
(	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
T14V	I-bacteria
)	O
growth	O
inhibition	O
.	O

The	O
present	O
study	O
with	O
common	O
immunsuppresants	O
demonstrated	O
both	O
a	O
medication	O
-	O
and	O
dose	O
-	O
dependent	O
alteration	O
in	O
the	O
metabolic	O
activity	O
of	O
gingival	O
fibroblasts	O
.	O

Furthermore	O
,	O
growth	O
-	O
inhibitory	O
effects	O
on	O
the	O
selected	O
bacterial	O
strains	O
could	O
be	O
observed	O
.	O

The	O
in	O
vitro	O
activity	O
of	O
faropenem	O
,	O
an	O
oral	O
penem	O
,	O
was	O
compared	O
with	O
those	O
of	O
penicillin	O
,	O
co	O
-	O
amoxiclav	O
,	O
cefoxitin	O
,	O
clindamycin	O
,	O
erythromycin	O
and	O
metronidazole	O
against	O
106	O
isolates	O
of	O
anaerobic	O
pathogens	O
involved	O
in	O
systemic	O
infections	O
.	O

The	O
organisms	O
tested	O
comprised	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
29	O
)	O
,	O
Prevotella	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
eight	O
)	O
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
(	O
seven	O
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
five	O
)	O
,	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
25	O
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
14	O
)	O
,	O
Peptostreptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
11	O
)	O
,	O
Bacteroides	B-bacteria
ureolyticus	I-bacteria
(	O
five	O
)	O
and	O
Bacteroides	B-bacteria
forsythus	I-bacteria
(	O
two	O
)	O
.	O

The	O
antimicrobial	O
properties	O
of	O
faropenem	O
were	O
investigated	O
by	O
studying	O
MICs	O
,	O
MBCs	O
,	O
time	O
-	O
kill	O
kinetics	O
and	O
post	O
-	O
antibiotic	O
effect	O
(	O
PAE	O
)	O
.	O

faropenem	O
highly	O
active	O
against	O
all	O
the	O
anaerobes	O
tested	O
(	O
MIC	O
(	O
90	O
)	O
<	O
or	O
=	O
0	O
.	O
5	O
mg	O
/	O
L	O
)	O
and	O
was	O
bactericidal	O
against	O
both	O
beta	O
-	O
lactamase	O
-	O
positive	O
and	O
-	O
negative	O
anaerobes	O
,	O
with	O
a	O
maximum	O
bactericidal	O
effect	O
at	O
10	O
x	O
MIC	O
at	O
between	O
12	O
and	O
24	O
h	O
.	O
In	O
addition	O
,	O
faropenem	O
had	O
an	O
in	O
vitro	O
PAE	O
on	O
all	O
the	O
tested	O
isolates	O
and	O
this	O
was	O
not	O
influenced	O
by	O
beta	O
-	O
lactamase	O
production	O
.	O

faropenem	O
be	O
useful	O
for	O
treating	O
infections	O
caused	O
by	O
periodontal	O
bacteria	O
or	O
oral	O
flora	O
.	O

Members	O
of	O
the	O
uncultivated	O
bacterial	O
division	O
TM7	B-bacteria
have	O
been	O
detected	O
in	O
the	O
human	O
mouth	O
,	O
but	O
little	O
information	O
is	O
available	O
regarding	O
their	O
prevalence	O
and	O
diversity	O
at	O
this	O
site	O
.	O

Human	O
subgingival	O
plaque	O
samples	O
from	O
healthy	O
sites	O
and	O
sites	O
exhibiting	O
various	O
stages	O
of	O
periodontal	O
disease	O
were	O
analyzed	O
for	O
the	O
presence	O
of	O
TM7	B-bacteria
bacteria	I-bacteria
.	O

TM7	B-bacteria
ribosomal	O
DNA	O
(	O
rDNA	O
)	O
was	O
found	O
in	O
96	O
%	O
of	O
the	O
samples	O
,	O
and	O
it	O
accounted	O
for	O
approximately	O
0	O
.	O
3	O
%	O
,	O
on	O
average	O
,	O
of	O
all	O
bacterial	O
rDNA	O
in	O
the	O
samples	O
as	O
determined	O
by	O
real	O
-	O
time	O
quantitative	O
PCR	O
.	O

Two	O
new	O
phylotypes	O
of	O
this	O
division	O
were	O
identified	O
,	O
and	O
members	O
of	O
the	O
division	O
were	O
found	O
to	O
exhibit	O
filamentous	O
morphology	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

The	O
abundance	O
of	O
TM7	B-bacteria
rDNA	O
relative	O
to	O
total	O
bacterial	O
rDNA	O
was	O
higher	O
in	O
sites	O
with	O
mild	O
periodontitis	O
(	O
0	O
.	O
54	O
%	O
+	O
/	O
-	O
0	O
.	O
1	O
%	O
)	O
than	O
in	O
either	O
healthy	O
sites	O
(	O
0	O
.	O
21	O
%	O
+	O
/	O
-	O
0	O
.	O
05	O
%	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
or	O
sites	O
with	O
severe	O
periodontitis	O
(	O
0	O
.	O
29	O
%	O
+	O
/	O
-	O
0	O
.	O
06	O
%	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

One	O
division	O
subgroup	O
,	O
the	O
I025	O
phylotype	O
,	O
was	O
detected	O
in	O
1	O
of	O
18	O
healthy	O
samples	O
and	O
38	O
of	O
58	O
disease	O
samples	O
.	O

These	O
data	O
suggest	O
that	O
this	O
phylotype	O
,	O
and	O
the	O
TM7	B-bacteria
bacterial	O
division	O
in	O
general	O
,	O
may	O
play	O
a	O
role	O
in	O
the	O
multifactorial	O
process	O
leading	O
to	O
periodontitis	O
.	O

Dental	O
diseases	O
are	O
among	O
the	O
most	O
prevalent	O
and	O
costly	O
diseases	O
affecting	O
industrialized	O
societies	O
,	O
and	O
yet	O
are	O
highly	O
preventable	O
.	O

The	O
microflora	O
of	O
dental	O
plaque	O
biofilms	O
from	O
diseased	O
sites	O
is	O
distinct	O
from	O
that	O
found	O
in	O
health	O
,	O
although	O
the	O
putative	O
pathogens	O
can	O
often	O
be	O
detected	O
in	O
low	O
numbers	O
at	O
normal	O
sites	O
.	O

In	O
dental	O
caries	O
,	O
there	O
is	O
a	O
shift	O
towards	O
community	O
dominance	O
by	O
acidogenic	O
and	O
acid	O
-	O
tolerant	O
Gram	O
-	O
positive	O
bacteria	O
(	O
e	O
.	O
g	O
.	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
)	O
at	O
the	O
expense	O
of	O
the	O
acid	O
-	O
sensitive	O
species	O
associated	O
with	O
sound	O
enamel	O
.	O

In	O
contrast	O
,	O
the	O
numbers	O
and	O
proportions	O
of	O
obligately	O
anaerobic	O
bacteria	O
,	O
including	O
Gram	O
-	O
negative	O
proteolytic	O
species	O
,	O
increase	O
in	O
periodontal	O
diseases	O
.	O

Modelling	O
studies	O
using	O
defined	O
consortia	O
of	O
oral	O
bacteria	O
grown	O
in	O
planktonic	O
and	O
biofilm	O
systems	O
have	O
been	O
undertaken	O
to	O
identify	O
environmental	O
factors	O
responsible	O
for	O
driving	O
these	O
deleterious	O
shifts	O
in	O
the	O
plaque	O
microflora	O
.	O

Repeated	O
conditions	O
of	O
low	O
pH	O
(	O
rather	O
than	O
sugar	O
availability	O
per	O
se	O
)	O
selected	O
for	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
,	O
while	O
the	O
introduction	O
of	O
novel	O
host	O
proteins	O
and	O
glycoproteins	O
(	O
as	O
occurs	O
during	O
the	O
inflammatory	O
response	O
to	O
plaque	O
)	O
,	O
and	O
the	O
concomitant	O
rise	O
in	O
local	O
pH	O
,	O
enriched	O
for	O
Gram	O
-	O
negative	O
anaerobic	O
and	O
asaccharolytic	O
species	O
.	O

These	O
studies	O
emphasized	O
(	O
a	O
)	O
.	O
significant	O
properties	O
of	O
dental	O
plaque	O
as	O
both	O
a	O
biofilm	O
and	O
a	O
microbial	O
community	O
,	O
and	O
(	O
b	O
)	O
.	O
the	O
dynamic	O
relationship	O
existing	O
between	O
the	O
environment	O
and	O
the	O
composition	O
of	O
the	O
oral	O
microflora	O
.	O

This	O
research	O
resulted	O
in	O
a	O
novel	O
hypothesis	O
(	O
the	O
'	O
ecological	O
plaque	O
hypothesis	O
'	O
)	O
to	O
better	O
describe	O
the	O
relationship	O
between	O
plaque	O
bacteria	O
and	O
the	O
host	O
in	O
health	O
and	O
disease	O
.	O

Implicit	O
in	O
this	O
hypothesis	O
is	O
the	O
concept	O
that	O
disease	O
can	O
be	O
prevented	O
not	O
only	O
by	O
directly	O
inhibiting	O
the	O
putative	O
pathogens	O
,	O
but	O
also	O
by	O
interfering	O
with	O
the	O
environmental	O
factors	O
driving	O
the	O
selection	O
and	O
enrichment	O
of	O
these	O
bacteria	O
.	O

Thus	O
,	O
a	O
more	O
holistic	O
approach	O
can	O
be	O
taken	O
in	O
disease	O
control	O
and	O
management	O
strategies	O
.	O

Sample	O
groups	O
of	O
children	O
(	O
n	O
=	O
50	O
)	O
and	O
adults	O
(	O
n	O
=	O
38	O
)	O
were	O
selected	O
from	O
pools	O
of	O
207	O
children	O
,	O
(	O
11	O
-	O
13	O
-	O
year	O
olds	O
from	O
two	O
primary	O
schools	O
)	O
and	O
94	O
adults	O
(	O
25	O
-	O
44	O
-	O
year	O
olds	O
from	O
four	O
governmental	O
agencies	O
)	O
who	O
were	O
the	O
subjects	O
of	O
an	O
oral	O
health	O
survey	O
among	O
Tibetans	O
living	O
in	O
Lhasa	O
,	O
Tibet	O
Autonomous	O
Region	O
.	O

Mean	O
ages	O
of	O
the	O
study	O
groups	O
of	O
children	O
(	O
38	O
%	O
females	O
)	O
and	O
adults	O
(	O
61	O
%	O
females	O
)	O
were	O
11	O
.	O
6	O
+	O
/	O
-	O
0	O
.	O
9	O
and	O
37	O
.	O
1	O
+	O
/	O
-	O
6	O
.	O
1	O
years	O
,	O
respectively	O
.	O

All	O
had	O
lived	O
in	O
Tibet	O
since	O
birth	O
.	O

Oral	O
rinse	O
samples	O
were	O
selective	O
cultured	O
to	O
isolate	O
,	O
quantify	O
and	O
speciate	O
aerobic	O
and	O
facultatively	O
anaerobic	O
Gram	O
-	O
negative	O
rods	O
(	O
using	O
the	O
API	O
20E	O
kit	O
)	O
and	O
yeasts	O
(	O
using	O
API	O
20C	O
AUX	O
and	O
API	O
ZYM	O
kits	O
)	O
.	O

For	O
children	O
,	O
the	O
isolation	O
rates	O
for	O
oral	O
coliform	B-bacteria
bacteria	I-bacteria
and	O
yeasts	O
were	O
84	O
and	O
14	O
%	O
,	O
respectively	O
,	O
for	O
adults	O
,	O
the	O
respective	O
rates	O
were	O
26	O
and	O
40	O
%	O
.	O

The	O
corresponding	O
quantities	O
of	O
coliforms	B-bacteria
/	O
yeasts	O
for	O
children	O
and	O
adults	O
were	O
0	O
.	O
4	O
+	O
/	O
-	O
1	O
.	O
6	O
x	O
10	O
(	O
3	O
)	O
c	O
.	O
f	O
.	O
u	O
.	O
/	O
15	O
.	O
8	O
+	O
/	O
-	O
72	O
.	O
3	O
and	O
0	O
.	O
2	O
+	O
/	O
-	O
0	O
.	O
6	O
x	O
10	O
(	O
3	O
)	O
c	O
.	O
f	O
.	O
u	O
.	O
/	O
57	O
.	O
2	O
+	O
/	O
-	O
137	O
.	O
5c	O
.	O
f	O
.	O
u	O
.	O
per	O
millilitre	O
oral	O
rinse	O
,	O
respectively	O
.	O

Aerobic	O
and	O
facultatively	O
anaerobic	O
Gram	O
-	O
negative	O
rods	O
and	O
Stenotrophomonas	B-bacteria
maltophilia	I-bacteria
,	O
a	O
free	O
-	O
living	O
saprophytic	O
and	O
ubiquitous	O
bacterial	O
species	O
of	O
wide	O
geographic	O
distribution	O
,	O
were	O
significantly	O
more	O
frequently	O
recovered	O
from	O
the	O
children	O
'	O
s	O
oral	O
rinses	O
.	O

The	O
isolation	O
rates	O
of	O
facultatively	O
anaerobic	O
Gram	O
-	O
negative	O
rods	O
in	O
adults	O
and	O
yeasts	O
in	O
both	O
groups	O
were	O
similar	O
to	O
those	O
found	O
in	O
similar	O
cohorts	O
from	O
southern	O
China	O
in	O
earlier	O
studies	O
.	O

Randomly	O
amplified	O
polymeric	O
DNA	O
analysis	O
showed	O
that	O
the	O
S	B-bacteria
.	I-bacteria
maltophilia	I-bacteria
spp	I-bacteria
.	I-bacteria
isolated	O
from	O
children	O
were	O
of	O
several	O
different	O
clonal	O
types	O
and	O
were	O
school	O
specific	O
.	O

This	O
study	O
shows	O
that	O
the	O
colonisation	O
rate	O
of	O
facultatively	O
anaerobic	O
Gram	O
-	O
negative	O
rods	O
in	O
adults	O
and	O
yeasts	O
in	O
both	O
groups	O
are	O
similar	O
to	O
those	O
in	O
populations	O
living	O
at	O
lower	O
altitudes	O
,	O
the	O
native	O
young	O
,	O
urban	O
Tibetans	O
appear	O
to	O
exhibit	O
a	O
high	O
oral	O
carriage	O
rate	O
of	O
S	B-bacteria
.	I-bacteria
maltophilia	I-bacteria
spp	I-bacteria
.	O

The	O
objectives	O
of	O
the	O
study	O
were	O
to	O
investigate	O
the	O
antimicrobial	O
efficacy	O
,	O
over	O
time	O
,	O
of	O
combining	O
antibacterial	O
agents	O
with	O
a	O
glass	O
ionomer	O
cement	O
(	O
GIC	O
)	O
.	O

This	O
was	O
assessed	O
using	O
an	O
agar	O
diffusion	O
test	O
.	O

Chlorhexidine	O
hydrochloride	O
,	O
cetylpyridinium	O
chloride	O
,	O
cetrimide	O
and	O
benzalkonium	O
chloride	O
were	O
added	O
to	O
Fuji	O
IX	O
GIC	O
at	O
0	O
,	O
1	O
,	O
2	O
and	O
4	O
%	O
w	O
/	O
w	O
.	O

Antibacterial	O
-	O
GIC	O
specimens	O
were	O
placed	O
onto	O
agar	O
plates	O
inoculated	O
with	O
one	O
of	O
six	O
bacterial	O
species	O
(	O
Streptococcis	B-bacteria
,	O
Lactobacillus	B-bacteria
,	O
and	O
Actinomyces	B-bacteria
,	O
two	O
each	O
)	O
and	O
the	O
area	O
of	O
inhibition	O
calculated	O
after	O
24	O
h	O
incubation	O
.	O

The	O
experiment	O
was	O
repeated	O
weekly	O
and	O
at	O
week	O
11	O
the	O
surface	O
of	O
the	O
specimen	O
was	O
abraded	O
prior	O
to	O
replacing	O
on	O
inoculated	O
agar	O
plates	O
.	O

Control	O
specimens	O
of	O
the	O
GIC	O
produced	O
no	O
bacterial	O
inhibition	O
.	O

The	O
antibacterial	O
-	O
GIC	O
combination	O
specimens	O
showed	O
significant	O
inhibition	O
which	O
decreased	O
at	O
different	O
rates	O
over	O
the	O
test	O
period	O
.	O

Resurfacing	O
of	O
the	O
specimens	O
showed	O
a	O
dramatic	O
increase	O
of	O
antibacterial	O
action	O
similar	O
to	O
levels	O
produced	O
on	O
week	O
1	O
.	O

CT	O
-	O
GIC	O
showed	O
the	O
greatest	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
inhibitory	O
effect	O
throughout	O
the	O
experimental	O
period	O
for	O
4	O
out	O
of	O
6	O
test	O
bacteria	O
.	O

The	O
addition	O
of	O
antibacterial	O
agents	O
to	O
Fuji	O
IX	O
creates	O
a	O
GIC	O
material	O
with	O
significant	O
antimicrobial	O
action	O
in	O
vitro	O
which	O
is	O
dependent	O
on	O
concentration	O
and	O
type	O
of	O
antibacterial	O
agent	O
,	O
and	O
appears	O
to	O
be	O
associated	O
primarily	O
with	O
a	O
release	O
of	O
the	O
antibacterial	O
from	O
the	O
surface	O
layer	O
of	O
the	O
specimen	O
.	O

We	O
immunohistologically	O
examined	O
the	O
prevalence	O
and	O
localization	O
of	O
bacteria	O
invading	O
dentinal	O
tubules	O
of	O
the	O
roots	O
of	O
teeth	O
with	O
infected	O
canals	O
.	O

Forty	O
extracted	O
teeth	O
with	O
apical	O
lesions	O
were	O
selected	O
and	O
divided	O
into	O
two	O
groups	O
:	O
a	O
group	O
of	O
untreated	O
teeth	O
and	O
a	O
group	O
of	O
canal	O
-	O
enlarged	O
teeth	O
.	O

The	O
bacteria	O
in	O
the	O
specimens	O
were	O
detected	O
by	O
Brown	O
-	O
Brenn	O
stain	O
and	O
the	O
labeled	O
-	O
streptavidin	O
-	O
biotin	O
method	O
with	O
specific	O
antisera	O
for	O
16	O
-	O
bacteria	O
.	O

Seventy	O
percent	O
of	O
the	O
examined	O
teeth	O
showed	O
bacteria	O
invading	O
the	O
dentinal	O
tubules	O
of	O
the	O
roots	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Eubacterium	B-bacteria
alactolyticum	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
nodatum	I-bacteria
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
,	O
and	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
were	O
abundant	O
.	O

Even	O
in	O
the	O
canal	O
-	O
enlarged	O
group	O
,	O
invasion	O
of	O
bacteria	O
was	O
observed	O
in	O
65	O
%	O
of	O
teeth	O
.	O

This	O
study	O
revealed	O
the	O
actual	O
condition	O
of	O
bacteria	O
in	O
infected	O
root	O
dentin	O
and	O
suggested	O
that	O
the	O
canal	O
-	O
enlargement	O
procedure	O
could	O
not	O
completely	O
remove	O
all	O
the	O
bacteria	O
in	O
the	O
infected	O
dentinal	O
tubules	O
of	O
the	O
root	O
.	O

Mucositis	O
is	O
an	O
acute	O
inflammation	O
of	O
the	O
oral	O
mucosa	O
because	O
of	O
radiotherapy	O
and	O
/	O
or	O
chemotherapy	O
.	O

All	O
patients	O
receiving	O
radiotherapy	O
in	O
the	O
head	O
and	O
neck	O
region	O
develop	O
oral	O
mucositis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
effects	O
of	O
selective	O
oral	O
flora	O
elimination	O
on	O
radiotherapy	O
-	O
induced	O
oral	O
mucositis	O
,	O
in	O
a	O
double	O
-	O
blind	O
,	O
randomised	O
,	O
placebo	O
-	O
controlled	O
trial	O
.	O

Sixty	O
-	O
five	O
patients	O
with	O
a	O
malignant	O
tumour	O
in	O
the	O
head	O
and	O
neck	O
regions	O
to	O
be	O
treated	O
with	O
primary	O
curative	O
or	O
postoperative	O
radiotherapy	O
participated	O
in	O
this	O
study	O
.	O

The	O
patients	O
received	O
either	O
the	O
active	O
lozenges	O
of	O
1	O
g	O
containing	O
polymyxin	O
E	O
2	O
mg	O
,	O
tobramycin	O
1	O
.	O
8	O
mg	O
and	O
amphotericin	O
B	O
10	O
mg	O
(	O
PTA	O
)	O
(	O
33	O
patients	O
)	O
or	O
the	O
placebo	O
lozenges	O
(	O
32	O
patients	O
)	O
,	O
four	O
times	O
daily	O
during	O
the	O
full	O
course	O
of	O
radiotherapy	O
.	O

Mucositis	O
,	O
changes	O
in	O
the	O
oral	O
flora	O
,	O
quality	O
of	O
feeding	O
and	O
changes	O
of	O
total	O
body	O
weight	O
were	O
assessed	O
.	O

Mucositis	O
score	O
did	O
not	O
differ	O
between	O
the	O
groups	O
during	O
the	O
first	O
5	O
weeks	O
of	O
radiotherapy	O
.	O

Nasogastric	O
tube	O
feeding	O
was	O
needed	O
in	O
six	O
patients	O
(	O
19	O
%	O
)	O
of	O
the	O
placebo	O
group	O
and	O
two	O
patients	O
(	O
6	O
%	O
)	O
of	O
the	O
PTA	O
group	O
(	O
P	O
=	O
0	O
.	O
08	O
)	O
.	O

Mean	O
weight	O
loss	O
after	O
5	O
weeks	O
of	O
radiation	O
was	O
less	O
in	O
the	O
PTA	O
group	O
(	O
1	O
.	O
3	O
kg	O
)	O
(	O
s	O
.	O
d	O
.	O

:	O
3	O
.	O
0	O
)	O
than	O
in	O
the	O
placebo	O
group	O
(	O
2	O
.	O
8	O
kg	O
)	O
(	O
s	O
.	O
d	O
.	O
:	O
2	O
.	O
9	O
)	O
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

Colonisation	O
index	O
of	O
Candida	O
species	O
and	O
Gram	O
-	O
negative	O
bacilli	O
was	O
reduced	O
in	O
the	O
PTA	O
group	O
and	O
not	O
in	O
the	O
placebo	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

No	O
effect	O
on	O
other	O
microorganisms	O
was	O
detected	O
.	O

In	O
conclusion	O
,	O
selective	O
oral	O
flora	O
elimination	O
in	O
head	O
and	O
neck	O
irradiation	O
patients	O
does	O
not	O
prevent	O
the	O
development	O
of	O
severe	O
mucositis	O
.	O

Treponema	B-bacteria
have	O
been	O
implicated	O
recently	O
in	O
the	O
pathogenesis	O
of	O
digital	O
dermatitis	O
(	O
DD	O
)	O
and	O
contagious	O
ovine	O
digital	O
dermatitis	O
(	O
CODD	O
)	O
that	O
are	O
infectious	O
diseases	O
of	O
bovine	O
and	O
ovine	O
foot	O
tissues	O
,	O
respectively	O
.	O

Previous	O
analyses	O
of	O
treponemal	O
16S	O
rDNA	O
sequences	O
,	O
PCR	O
-	O
amplified	O
directly	O
from	O
DD	O
or	O
CODD	O
lesions	O
,	O
have	O
suggested	O
relatedness	O
of	O
animal	O
Treponema	B-bacteria
to	O
some	O
human	O
oral	O
Treponema	B-bacteria
species	I-bacteria
isolated	O
from	O
periodontal	O
tissues	O
.	O

In	O
this	O
study	O
a	O
range	O
of	O
adhesion	O
and	O
virulence	O
-	O
related	O
properties	O
of	O
three	O
animal	O
Treponema	B-bacteria
isolates	I-bacteria
have	O
been	O
compared	O
with	O
representative	O
human	O
oral	O
strains	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Treponema	B-bacteria
vincentii	I-bacteria
.	O

In	O
adhesion	O
assays	O
using	O
biotinylated	O
treponemal	O
cells	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
cells	O
bound	O
in	O
consistently	O
higher	O
numbers	O
to	O
fibronectin	O
,	O
laminin	O
,	O
collagen	O
type	O
I	O
,	O
gelatin	O
,	O
keratin	O
and	O
lactoferrin	O
than	O
did	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
or	O
animal	O
Treponema	B-bacteria
isolates	I-bacteria
.	O

However	O
,	O
animal	O
DD	O
strains	O
adhered	O
to	O
fibrinogen	O
at	O
equivalent	O
or	O
greater	O
levels	O
than	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

All	O
Treponema	B-bacteria
strains	I-bacteria
bound	O
to	O
the	O
amino	O
-	O
terminal	O
heparin	O
I	O
/	O
fibrin	O
I	O
domain	O
of	O
fibronectin	O
.	O

16S	O
rDNA	O
sequence	O
analyses	O
placed	O
ovine	O
strain	O
UB1090	B-bacteria
and	O
bovine	O
strain	O
UB1467	B-bacteria
within	O
a	O
cluster	O
that	O
was	O
phylogenetically	O
related	O
to	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
,	O
while	O
ovine	O
strain	O
UB1466	B-bacteria
appeared	O
more	O
closely	O
related	O
to	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

These	O
observations	O
correlated	O
with	O
phenotypic	O
properties	O
.	O

Thus	O
,	O
T	B-bacteria
.	I-bacteria
denticola	B-bacteria
ATCC	I-bacteria
35405	I-bacteria
,	O
GM	B-bacteria
-	I-bacteria
1	I-bacteria
,	O
and	O
Treponema	B-bacteria
UB1466	I-bacteria
had	O
similar	O
outer	O
-	O
membrane	O
protein	O
profiles	O
,	O
produced	O
chymotrypsin	O
-	O
like	O
protease	O
(	O
CTLP	O
)	O
,	O
trypsin	O
-	O
like	O
protease	O
and	O
high	O
levels	O
of	O
proline	O
iminopeptidase	O
,	O
and	O
co	O
-	O
aggregated	O
with	O
human	O
oral	O
bacteria	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Streptococcus	B-bacteria
crista	I-bacteria
.	O

Conversely	O
,	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
ATCC	I-bacteria
35580	I-bacteria
,	O
D2A	B-bacteria
-	I-bacteria
2	I-bacteria
,	O
and	O
animal	O
strains	O
UB1090	B-bacteria
and	O
UB1467	B-bacteria
did	O
not	O
express	O
CTLP	O
or	O
trypsin	O
-	O
like	O
protease	O
and	O
did	O
not	O
co	O
-	O
aggregate	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
crista	I-bacteria
.	O

Taken	O
collectively	O
,	O
these	O
results	O
suggest	O
that	O
human	O
oral	O
-	O
related	O
Treponema	B-bacteria
have	O
broad	O
host	O
specificity	O
and	O
that	O
similar	O
control	O
or	O
preventive	O
strategies	O
might	O
be	O
developed	O
for	O
human	O
and	O
animal	O
Treponema	B-bacteria
-	O
associated	O
infections	O
.	O

Whether	O
micro	O
-	O
organisms	O
can	O
live	O
in	O
periapical	O
endodontic	O
lesions	O
of	O
asymptomatic	O
teeth	O
is	O
under	O
debate	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
visualize	O
and	O
identify	O
micro	O
-	O
organisms	O
within	O
periapical	O
lesions	O
directly	O
,	O
using	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
in	O
combination	O
with	O
epifluorescence	O
and	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
.	O

Thirty	O
-	O
nine	O
periapical	O
lesions	O
were	O
surgically	O
removed	O
,	O
fixed	O
,	O
embedded	O
in	O
cold	O
polymerizing	O
resin	O
and	O
sectioned	O
.	O

The	O
probe	O
EUB	O
338	O
,	O
specific	O
for	O
the	O
domain	O
Bacteria	O
,	O
was	O
used	O
together	O
with	O
a	O
number	O
of	O
species	O
-	O
specific	O
16S	O
rRNA	O
-	O
directed	O
oligonucleotide	O
probes	O
to	O
identify	O
bacteria	O
.	O

To	O
control	O
non	O
-	O
specific	O
binding	O
of	O
EUB	O
338	O
,	O
probe	O
NON	O
338	O
was	O
used	O
.	O

Alternatively	O
,	O
DAPI	O
(	O
4	O
'	O
,	O
6	O
'	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	O
)	O
staining	O
was	O
applied	O
to	O
record	O
prokaryotic	O
and	O
eukaryotic	O
DNA	O
in	O
the	O
specimens	O
.	O

Hybridization	O
with	O
NON	O
338	O
gave	O
no	O
signals	O
despite	O
background	O
fluorescence	O
of	O
the	O
tissue	O
.	O

The	O
eubacterial	O
probe	O
showed	O
bacteria	O
of	O
different	O
morphotypes	O
in	O
50	O
%	O
of	O
the	O
lesions	O
.	O

Rods	B-bacteria
,	O
spirochaetes	B-bacteria
and	O
cocci	B-bacteria
were	O
spread	O
out	O
in	O
areas	O
of	O
the	O
tissue	O
while	O
other	O
parts	O
seemed	O
bacteria	O
-	O
free	O
.	O

Bacteria	O
were	O
also	O
seen	O
to	O
co	O
-	O
aggregate	O
inside	O
the	O
tissue	O
,	O
forming	O
microcolonies	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
and	O
treponemes	B-bacteria
of	O
phylogenetic	O
Group	O
I	O
were	O
detected	O
with	O
specific	O
probes	O
.	O

In	O
addition	O
,	O
colonies	O
with	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
seen	O
in	O
some	O
lesions	O
.	O

A	O
number	O
of	O
morphotypes	O
occurred	O
that	O
could	O
not	O
be	O
identified	O
with	O
the	O
specific	O
probes	O
used	O
,	O
indicating	O
the	O
presence	O
of	O
additional	O
bacterial	O
species	O
.	O

CLSM	O
confirmed	O
that	O
bacteria	O
were	O
located	O
in	O
different	O
layers	O
of	O
the	O
tissue	O
.	O

Accordingly	O
,	O
the	O
FISH	O
technique	O
demonstrated	O
mixed	O
consortia	O
of	O
bacteria	O
consisting	O
of	O
rods	O
,	O
spirochaetes	B-bacteria
and	O
cocci	B-bacteria
in	O
asymptomatic	O
periapical	O
lesions	O
of	O
root	O
-	O
filled	O
teeth	O
.	O

Nearly	O
all	O
infections	O
begin	O
at	O
a	O
mucous	O
membrane	O
site	O
.	O

Also	O
,	O
the	O
human	O
mucous	O
membranes	O
are	O
a	O
reservoir	O
for	O
many	O
pathogenic	O
bacteria	O
found	O
in	O
the	O
environment	O
(	O
that	O
is	O
,	O
pneumococci	B-bacteria
,	O
staphylococci	B-bacteria
,	O
streptococci	B-bacteria
)	O
,	O
some	O
of	O
which	O
are	O
resistant	O
to	O
antibiotics	O
.	O

Clearly	O
,	O
if	O
this	O
human	O
reservoir	O
can	O
be	O
reduced	O
or	O
eliminated	O
,	O
the	O
incidence	O
of	O
disease	O
will	O
be	O
markedly	O
reduced	O
.	O

However	O
,	O
compounds	O
designed	O
to	O
eliminate	O
this	O
reservoir	O
are	O
not	O
available	O
.	O

Towards	O
this	O
goal	O
,	O
we	O
have	O
exploited	O
the	O
highly	O
lethal	O
effects	O
of	O
bacteriophage	O
lytic	O
enzymes	O
(	O
lysins	O
)	O
to	O
specifically	O
destroy	O
disease	O
bacteria	O
on	O
mucous	O
membranes	O
.	O

Such	O
lysins	O
are	O
used	O
by	O
the	O
phage	O
to	O
release	O
their	O
progeny	O
at	O
the	O
end	O
of	O
their	O
replicative	O
cycle	O
.	O

We	O
have	O
identified	O
and	O
purified	O
these	O
enzymes	O
and	O
found	O
that	O
when	O
applied	O
externally	O
to	O
gram	O
-	O
positive	O
bacteria	O
,	O
they	O
are	O
killed	O
seconds	O
after	O
contact	O
.	O

For	O
example	O
,	O
10	O
(	O
7	O
)	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
are	O
reduced	O
to	O
undetectable	O
levels	O
10	O
s	O
after	O
enzyme	O
addition	O
.	O

A	O
feature	O
of	O
these	O
enzymes	O
is	O
their	O
high	O
specificity	O
;	O
that	O
is	O
,	O
streptococcal	O
lysins	O
kill	O
streptococci	B-bacteria
and	O
streptococcal	O
lysins	O
kill	O
pneumococci	B-bacteria
without	O
effects	O
on	O
the	O
normal	O
flora	O
organisms	O
.	O

In	O
vivo	O
,	O
an	O
oral	O
colonization	O
model	O
for	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
and	O
a	O
nasal	O
colonization	O
model	O
for	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
were	O
developed	O
to	O
test	O
the	O
capacity	O
of	O
the	O
lysins	O
to	O
kill	O
organisms	O
on	O
these	O
surfaces	O
.	O

In	O
both	O
cases	O
,	O
when	O
the	O
animals	O
were	O
pre	O
-	O
colonized	O
with	O
their	O
respective	O
bacteria	O
then	O
treated	O
with	O
a	O
small	O
amount	O
of	O
lysin	O
,	O
specific	O
for	O
the	O
colonizing	O
organism	O
,	O
all	O
the	O
animals	O
were	O
found	O
to	O
be	O
free	O
of	O
colonizing	O
bacteria	O
shortly	O
after	O
lysin	O
treatment	O
.	O

Thus	O
,	O
lysins	O
may	O
be	O
added	O
to	O
our	O
armamentarium	O
to	O
control	O
antibiotic	O
-	O
resistant	O
bacteria	O
.	O

To	O
date	O
,	O
there	O
have	O
been	O
relatively	O
few	O
studies	O
addressing	O
the	O
presence	O
and	O
expression	O
of	O
the	O
plasminogen	O
-	O
plasmin	O
system	O
at	O
the	O
site	O
of	O
bacterial	O
infection	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
black	O
-	O
pigmented	O
bacteria	O
on	O
the	O
expression	O
of	O
the	O
plasminogen	O
-	O
plasmin	O
system	O
in	O
human	O
pulp	O
and	O
osteoblastic	O
cells	O
.	O

The	O
supernatants	O
of	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
were	O
used	O
to	O
evaluate	O
tissue	O
-	O
type	O
plasminogen	O
activator	O
(	O
t	O
-	O
PA	O
)	O
and	O
type	O
1	O
plasminogen	O
activator	O
inhibitor	O
(	O
PAI	O
-	O
1	O
)	O
gene	O
expression	O
in	O
human	O
pulp	O
and	O
osteoblastic	O
cells	O
.	O

The	O
levels	O
of	O
mRNA	O
were	O
quantitatively	O
measured	O
by	O
using	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

In	O
this	O
study	O
,	O
black	O
-	O
pigmented	O
bacteria	O
induced	O
not	O
only	O
t	O
-	O
PA	O
but	O
also	O
PAI	O
-	O
1	O
gene	O
expression	O
in	O
human	O
pulp	O
and	O
osteoblastic	O
cells	O
.	O

In	O
addition	O
,	O
the	O
ratio	O
of	O
t	O
-	O
PA	O
to	O
PAI	O
-	O
1	O
was	O
higher	O
in	O
human	O
pulp	O
and	O
osteoblastic	O
cells	O
stimulated	O
by	O
black	O
-	O
pigmented	O
bacteria	O
than	O
in	O
untreated	O
cell	O
cultures	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

A	O
fine	O
balance	O
exists	O
in	O
the	O
expression	O
of	O
components	O
of	O
the	O
plasminogen	O
-	O
plasmin	O
system	O
,	O
whereby	O
tissue	O
homeostasis	O
is	O
maintained	O
.	O

Black	O
-	O
pigmented	O
bacteria	O
activate	O
the	O
activator	O
-	O
inhibitor	O
system	O
in	O
human	O
pulp	O
and	O
osteoblastic	O
cells	O
through	O
unbalance	O
regulation	O
of	O
t	O
-	O
PA	O
and	O
PAI	O
-	O
1	O
,	O
which	O
might	O
result	O
in	O
an	O
uncontrolled	O
degradation	O
of	O
pulpal	O
and	O
periapical	O
tissues	O
.	O

The	O
oral	O
epithelium	O
is	O
continuously	O
exposed	O
to	O
a	O
variety	O
of	O
microbial	O
challenges	O
that	O
can	O
cause	O
infectious	O
diseases	O
such	O
as	O
periodontal	O
disease	O
.	O

Human	O
B	O
Defensin	O
-	O
2	O
(	O
hBD	O
-	O
2	O
)	O
is	O
a	O
cationic	O
antimicrobial	O
peptide	O
with	O
low	O
molecular	O
weight	O
,	O
which	O
is	O
inducible	O
from	O
oral	O
epithelial	O
cells	O
upon	O
either	O
bacterial	O
infection	O
or	O
stimulation	O
with	O
inflammatory	O
cytokines	O
.	O

This	O
peptide	O
has	O
a	O
broad	O
antimicrobial	O
spectrum	O
that	O
includes	O
gram	O
-	O
positive	O
bacteria	O
,	O
gram	O
-	O
negative	O
bacteria	O
,	O
and	O
fungi	O
.	O

Therefore	O
,	O
it	O
is	O
thought	O
that	O
hBD	O
-	O
2	O
plays	O
an	O
important	O
role	O
as	O
one	O
of	O
natural	O
immunities	O
to	O
bacterial	O
infection	O
.	O

However	O
,	O
its	O
activity	O
is	O
inhibited	O
by	O
body	O
fluids	O
such	O
as	O
serum	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
antibacterial	O
activity	O
of	O
synthetic	O
hBD	O
-	O
2	O
against	O
oral	O
bacteria	O
in	O
the	O
presence	O
of	O
saliva	O
or	O
serum	O
.	O

The	O
antibacterial	O
activity	O
of	O
synthetic	O
hBD	O
-	O
2	O
was	O
tested	O
against	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
and	O
Escherichia	B-bacteria
coli	I-bacteria
.	O

Antibacterial	O
broth	O
assay	O
and	O
diffusion	O
assay	O
were	O
performed	O
in	O
vitro	O
.	O

The	O
antibacterial	O
activity	O
of	O
hBD	O
-	O
2	O
was	O
approximately	O
equal	O
to	O
that	O
of	O
minocycline	O
at	O
equimolar	O
concentrations	O
.	O

Furthermore	O
,	O
the	O
activity	O
of	O
hBD	O
-	O
2	O
remained	O
at	O
60	O
%	O
in	O
the	O
presence	O
of	O
80	O
%	O
saliva	O
,	O
whereas	O
no	O
activity	O
remained	O
in	O
the	O
presence	O
of	O
20	O
%	O
serum	O
.	O

Our	O
results	O
suggest	O
the	O
possibility	O
that	O
synthetic	O
hBD	O
-	O
2	O
could	O
be	O
useful	O
to	O
prevent	O
infection	O
by	O
periodontal	O
disease	O
.	O

Viable	O
counts	O
and	O
activities	O
of	O
sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
(	O
SRB	B-bacteria
)	O
and	O
methanogenic	O
bacteria	O
were	O
determined	O
in	O
the	O
oral	O
cavities	O
of	O
eight	O
volunteers	O
.	O

Of	O
these	O
,	O
seven	O
harbored	O
viable	O
SRB	B-bacteria
populations	O
,	O
and	O
six	O
harbored	O
viable	O
methanogenic	O
bacterial	O
populations	O
.	O

Two	O
volunteers	O
classified	O
as	O
type	O
III	O
periodontal	O
patients	O
had	O
both	O
SRB	B-bacteria
and	O
methanogenic	O
bacteria	O
.	O

Six	O
separate	O
sites	O
were	O
sampled	O
:	O
posterior	O
tongue	O
,	O
anterior	O
tongue	O
,	O
mid	O
-	O
buccal	O
mucosa	O
,	O
vestibular	O
mucosa	O
,	O
supragingival	O
plaque	O
,	O
and	O
subgingival	O
plaque	O
.	O

The	O
SRB	B-bacteria
was	O
found	O
in	O
all	O
areas	O
in	O
one	O
volunteer	O
,	O
and	O
it	O
was	O
mostly	O
present	O
in	O
posterior	O
tongue	O
,	O
anterior	O
tongue	O
,	O
supragingival	O
,	O
and	O
subgingival	O
plaques	O
in	O
many	O
volunteers	O
.	O

The	O
methanogenic	O
bacteria	O
were	O
mostly	O
found	O
in	O
supragingival	O
and	O
subgingival	O
plaques	O
.	O

The	O
activities	O
of	O
sulfate	O
reduction	O
and	O
methane	O
production	O
were	O
determined	O
in	O
randomly	O
selected	O
isolates	O
.	O

A	O
clinical	O
procedure	O
was	O
developed	O
to	O
examine	O
the	O
effects	O
of	O
short	O
-	O
term	O
and	O
extended	O
use	O
of	O
a	O
triclosan	O
/	O
copolymer	O
dentifrice	O
and	O
a	O
commercial	O
fluoride	O
dentifrice	O
on	O
oral	O
bacteria	O
,	O
including	O
those	O
producing	O
hydrogen	O
sulfide	O
.	O

Healthy	O
adults	O
volunteered	O
for	O
this	O
double	O
-	O
blind	O
,	O
crossover	O
design	O
clinical	O
study	O
and	O
provided	O
saliva	O
samples	O
for	O
culturing	O
on	O
enriched	O
and	O
indicator	O
media	O
to	O
enumerate	O
all	O
salivary	O
bacteria	O
and	O
those	O
producing	O
hydrogen	O
sulfide	O
(	O
odorigenic	O
)	O
,	O
respectively	O
.	O

Subjects	O
brushed	O
with	O
an	O
assigned	O
dentifrice	O
for	O
7	O
d	O
and	O
were	O
sampled	O
on	O
day	O
8	O
to	O
assess	O
the	O
long	O
-	O
term	O
effects	O
on	O
bacteria	O
.	O

Extended	O
use	O
of	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
resulted	O
in	O
a	O
49	O
%	O
and	O
66	O
%	O
reduction	O
of	O
salivary	O
and	O
odorigenic	O
bacteria	O
,	O
respectively	O
,	O
compared	O
with	O
the	O
fluoride	O
dentifrice	O
.	O

To	O
examine	O
short	O
-	O
term	O
effects	O
,	O
subjects	O
subsequently	O
brushed	O
with	O
their	O
assigned	O
dentifrice	O
and	O
were	O
sampled	O
at	O
2	O
h	O
and	O
4	O
h	O
post	O
-	O
brushing	O
.	O

At	O
2	O
h	O
and	O
4	O
h	O
post	O
-	O
brushing	O
,	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
resulted	O
in	O
a	O
62	O
%	O
and	O
52	O
%	O
decrease	O
for	O
salivary	O
bacteria	O
and	O
79	O
%	O
and	O
72	O
%	O
decrease	O
for	O
odorigenic	O
bacteria	O
,	O
respectively	O
,	O
vs	O
.	O
the	O
fluoride	O
dentifrice	O
.	O

The	O
results	O
indicate	O
a	O
significant	O
decrease	O
of	O
all	O
salivary	O
bacteria	O
and	O
hydrogen	O
sulfide	O
-	O
producing	O
odorigenic	O
bacteria	O
following	O
use	O
of	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
and	O
explain	O
previous	O
results	O
on	O
the	O
efficacy	O
of	O
this	O
dentifrice	O
on	O
oral	O
malodor	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
predominant	O
flora	O
associated	O
with	O
pericoronitis	O
in	O
third	O
molars	O
and	O
to	O
investigate	O
the	O
presence	O
of	O
beta	O
-	O
lactamase	O
-	O
producing	O
strains	O
.	O

The	O
third	O
molars	O
in	O
26	O
adults	O
were	O
evaluated	O
by	O
cultures	O
with	O
nonselective	O
media	O
and	O
with	O
selective	O
media	O
containing	O
amoxicillin	O
,	O
pristinamycin	O
,	O
spiramycin	O
,	O
metronidazole	O
,	O
and	O
spiramycin	O
plus	O
metronidazole	O
.	O

In	O
the	O
majority	O
of	O
cases	O
(	O
19	O
/	O
26	O
)	O
,	O
the	O
flora	O
found	O
in	O
an	O
anaerobic	O
atmosphere	O
predominated	O
.	O

Obligate	O
anaerobes	O
were	O
present	O
in	O
21	O
of	O
the	O
26	O
samples	O
.	O

The	O
bacteria	O
most	O
commonly	O
detected	O
were	O
alpha	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
(	O
26	O
/	O
26	O
)	O
and	O
the	O
genera	O
Prevotella	B-bacteria
(	O
15	O
/	O
26	O
)	O
,	O
Veillonella	B-bacteria
(	O
15	O
/	O
26	O
)	O
,	O
Bacteroides	B-bacteria
(	O
9	O
/	O
26	O
)	O
,	O
and	O
Capnocytophaga	B-bacteria
(	O
9	O
/	O
26	O
)	O
.	O

Amoxicillin	O
and	O
pristinamycin	O
were	O
the	O
most	O
active	O
in	O
reducing	O
the	O
anaerobic	O
cultivable	O
counts	O
.	O

beta	O
-	O
Lactamase	O
-	O
producing	O
strains	O
were	O
detected	O
in	O
9	O
samples	O
and	O
were	O
mostly	O
bacteria	O
of	O
the	O
genera	O
Prevotella	B-bacteria
,	O
Staphylococcus	B-bacteria
,	O
and	O
Bacteroides	B-bacteria
.	O

These	O
results	O
highlight	O
(	O
1	O
)	O
the	O
diversity	O
of	O
the	O
microflora	O
associated	O
with	O
pericoronitis	O
and	O
the	O
importance	O
of	O
the	O
anaerobic	O
flora	O
and	O
(	O
2	O
)	O
the	O
existence	O
of	O
selection	O
pressure	O
related	O
to	O
the	O
use	O
of	O
beta	O
-	O
lactams	O
that	O
may	O
culminate	O
in	O
failure	O
of	O
prescribed	O
penicillins	O
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
screened	O
149	O
subjects	O
and	O
established	O
four	O
groups	O
high	O
or	O
low	O
for	O
salivary	O
killing	O
of	O
oral	O
bacteria	O
,	O
and	O
for	O
aggregation	O
and	O
live	O
and	O
dead	O
adherence	O
of	O
oral	O
bacteria	O
(	O
as	O
a	O
combined	O
factor	O
)	O
.	O

Caries	O
scores	O
were	O
significantly	O
lower	O
in	O
both	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
.	O

In	O
this	O
study	O
we	O
looked	O
at	O
the	O
effects	O
of	O
those	O
differences	O
in	O
salivary	O
function	O
on	O
the	O
quantity	O
and	O
diversity	O
of	O
oral	O
biofilm	O
streptococci	B-bacteria
.	O

Subjects	O
from	O
those	O
four	O
groups	O
were	O
recalled	O
for	O
collection	O
of	O
overnight	O
oral	O
biofilm	O
from	O
buccal	O
upper	O
centra	O
incisors	O
,	O
lingual	O
lower	O
central	O
incisors	O
,	O
buccal	O
upper	O
and	O
lower	O
first	O
molars	O
,	O
and	O
lingual	O
upper	O
and	O
lower	O
first	O
molars	O
.	O

At	O
each	O
site	O
,	O
groups	O
were	O
compared	O
for	O
total	O
biofilm	O
(	O
by	O
DNA	O
concentration	O
)	O
,	O
total	O
streptococci	B-bacteria
(	O
by	O
quantitative	O
PCR	O
)	O
,	O
and	O
streptococcal	B-bacteria
diversity	O
(	O
by	O
Streptococcus	B-bacteria
-	O
specific	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
)	O
.	O

Total	O
biofilm	O
DNA	O
and	O
total	O
streptococci	B-bacteria
were	O
correlated	O
.	O

Both	O
were	O
highest	O
on	O
buccal	O
molar	O
surfaces	O
and	O
lowest	O
on	O
lingual	O
lower	O
central	O
incisors	O
,	O
and	O
both	O
were	O
significantly	O
lower	O
in	O
the	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
(	O
particularly	O
at	O
the	O
buccal	O
molar	O
site	O
)	O
.	O

Fifty	O
distinct	O
bands	O
were	O
observed	O
in	O
denaturing	O
gradient	O
gels	O
.	O

There	O
was	O
great	O
diversity	O
within	O
and	O
between	O
sites	O
.	O

Three	O
major	O
bands	O
were	O
present	O
in	O
almost	O
every	O
person	O
at	O
every	O
site	O
.	O

Densities	O
for	O
two	O
of	O
those	O
bands	O
were	O
significantly	O
lower	O
in	O
both	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
.	O

Other	O
less	O
-	O
prevalent	O
bands	O
also	O
showed	O
the	O
same	O
pattern	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
our	O
caries	O
results	O
in	O
suggesting	O
that	O
differences	O
in	O
salivary	O
function	O
can	O
influence	O
the	O
quantity	O
and	O
composition	O
of	O
streptococci	B-bacteria
in	O
oral	O
biofilms	O
.	O

Dental	O
plaque	O
from	O
76	O
children	O
without	O
amalgam	O
restorations	O
was	O
screened	O
for	O
bacteria	O
resistant	O
to	O
mercuric	O
chloride	O
.	O

Seventy	O
-	O
one	O
per	O
cent	O
of	O
the	O
children	O
harboured	O
mercury	O
-	O
resistant	O
oral	O
bacteria	O
and	O
the	O
median	O
percentage	O
of	O
the	O
total	O
oral	O
microflora	O
resistant	O
to	O
mercuric	O
chloride	O
was	O
0	O
.	O
007	O
%	O
(	O
range	O
0	O
-	O
5	O
.	O
3	O
%	O
)	O
.	O

Eighty	O
-	O
seven	O
mercury	O
-	O
resistant	O
bacteria	O
were	O
isolated	O
and	O
86	O
%	O
of	O
these	O
were	O
streptococci	B-bacteria
with	O
Streptococcus	B-bacteria
mitis	I-bacteria
predominating	O
.	O

Sixty	O
per	O
cent	O
of	O
the	O
mercury	O
-	O
resistant	O
isolates	O
were	O
also	O
resistant	O
to	O
at	O
least	O
one	O
of	O
the	O
four	O
antibiotics	O
tested	O
(	O
penicillin	O
,	O
ampicillin	O
,	O
erythromycin	O
and	O
tetracycline	O
)	O
with	O
resistance	O
to	O
tetracycline	O
(	O
40	O
%	O
of	O
isolates	O
)	O
most	O
frequently	O
encountered	O
.	O

Chronic	O
maxillary	O
sinusitis	O
is	O
a	O
chronic	O
inflammatory	O
condition	O
in	O
which	O
the	O
role	O
of	O
microbial	O
infection	O
remains	O
undefined	O
.	O

Bacteria	O
have	O
been	O
isolated	O
from	O
chronically	O
inflamed	O
sinuses	O
;	O
however	O
,	O
their	O
role	O
in	O
the	O
chronicity	O
of	O
inflammation	O
is	O
unknown	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
bacteria	O
are	O
present	O
in	O
clinical	O
samples	O
from	O
chronic	O
maxillary	O
sinusitis	O
and	O
to	O
assess	O
the	O
diversity	O
of	O
the	O
flora	O
present	O
.	O

Washes	O
and	O
/	O
or	O
tissue	O
samples	O
from	O
endoscopic	O
sinus	O
surgery	O
on	O
11	O
patients	O
with	O
chronic	O
maxillary	O
sinusitis	O
were	O
subjected	O
to	O
PCR	O
amplification	O
of	O
bacterial	O
16S	O
rDNA	O
using	O
three	O
universal	O
primer	O
pairs	O
,	O
followed	O
by	O
cloning	O
and	O
sequencing	O
.	O

The	O
samples	O
were	O
also	O
assessed	O
for	O
the	O
presence	O
of	O
bacteria	O
and	O
fungi	O
by	O
conventional	O
culture	O
methods	O
.	O

Viable	O
bacteria	O
and	O
/	O
or	O
bacterial	O
16S	O
rDNA	O
were	O
detected	O
from	O
maxillary	O
sinus	O
samples	O
of	O
five	O
of	O
the	O
11	O
patients	O
examined	O
(	O
45	O
%	O
)	O
.	O

Three	O
sinus	O
samples	O
were	O
positive	O
by	O
both	O
PCR	O
and	O
culture	O
methods	O
,	O
one	O
was	O
positive	O
only	O
by	O
PCR	O
,	O
and	O
one	O
only	O
by	O
culture	O
.	O

Thirteen	O
bacterial	O
species	O
were	O
identified	O
:	O
Abiotrophia	B-bacteria
defectiva	I-bacteria
,	O
Enterococcus	B-bacteria
avium	I-bacteria
,	O
Eubacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Granulicatella	B-bacteria
elegans	I-bacteria
,	O
Neisseria	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Prevotella	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Serratia	B-bacteria
marcescens	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Stenotrophomonas	B-bacteria
maltophilia	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
/	O
Streptococcus	I-bacteria
oralis	I-bacteria
and	O
Streptococcus	B-bacteria
sp	I-bacteria
.	O

Fungi	O
were	O
not	O
detected	O
.	O

In	O
one	O
patient	O
Streptococcus	B-bacteria
mitis	I-bacteria
/	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
and	O
in	O
another	O
patient	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
were	O
detected	O
from	O
both	O
the	O
sinus	O
and	O
the	O
oral	O
cavity	O
using	O
species	O
-	O
specific	O
PCR	O
primers	O
.	O

These	O
results	O
suggest	O
that	O
both	O
aerobic	O
and	O
anaerobic	O
bacteria	O
can	O
be	O
detected	O
in	O
nearly	O
half	O
of	O
chronic	O
maxillary	O
sinusitis	O
cases	O
.	O

In	O
a	O
previous	O
study	O
we	O
showed	O
that	O
prolonged	O
nasogastric	O
tube	O
feeding	O
is	O
associated	O
with	O
pathogenic	O
oral	O
flora	O
.	O

To	O
reexamine	O
the	O
impact	O
of	O
prolonged	O
nasogastric	O
tube	O
feeding	O
on	O
the	O
oral	O
microbiota	O
and	O
to	O
explore	O
the	O
salivary	O
flow	O
and	O
composition	O
in	O
elderly	O
patients	O
in	O
long	O
-	O
term	O
care	O
.	O

We	O
compared	O
a	O
group	O
of	O
elderly	O
patients	O
fed	O
by	O
nasogastric	O
tube	O
with	O
a	O
control	O
group	O
of	O
elderly	O
patients	O
in	O
long	O
-	O
term	O
care	O
who	O
are	O
fed	O
orally	O
.	O

Bacteriologic	O
studies	O
were	O
performed	O
by	O
culturing	O
samples	O
from	O
the	O
oropharynx	O
.	O

Saliva	O
studies	O
included	O
quantitative	O
and	O
biochemical	O
analysis	O
of	O
basal	O
and	O
stimulated	O
salivary	O
flow	O
.	O

Bacteriologic	O
studies	O
performed	O
in	O
90	O
patients	O
revealed	O
a	O
significantly	O
higher	O
prevalence	O
of	O
gram	O
-	O
negative	O
bacteria	O
in	O
prolonged	O
nasogastric	O
tube	O
feeding	O
patients	O
(	O
73	O
%	O
vs	O
.	O
13	O
%	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

It	O
is	O
emphasized	O
that	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
were	O
commonly	O
and	O
exclusively	O
isolated	O
from	O
the	O
oral	O
flora	O
of	O
the	O
nasogastric	O
-	O
tube	O
fed	O
patients	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
the	O
saliva	O
studies	O
performed	O
on	O
23	O
nasogastric	O
-	O
tube	O
fed	O
and	O
21	O
control	O
patients	O
,	O
basal	O
and	O
stimulated	O
salivary	O
flow	O
was	O
not	O
significantly	O
different	O
in	O
the	O
two	O
groups	O
,	O
however	O
the	O
ratio	O
of	O
stimulated	O
to	O
basal	O
flow	O
was	O
reduced	O
in	O
the	O
nasogastric	O
-	O
tube	O
fed	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Significant	O
differences	O
were	O
also	O
found	O
in	O
the	O
concentrations	O
of	O
sodium	O
,	O
amylase	O
,	O
phosphor	O
and	O
magnesium	O
.	O

Noteworthy	O
was	O
the	O
concentration	O
of	O
uric	O
acid	O
,	O
the	O
main	O
non	O
-	O
enzymatic	O
antioxidant	O
of	O
saliva	O
,	O
which	O
was	O
significantly	O
lower	O
in	O
nasogastric	O
-	O
tube	O
fed	O
patients	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
.	O

These	O
findings	O
suggest	O
that	O
prolonged	O
nasogastric	O
tube	O
feeding	O
is	O
associated	O
with	O
pathologic	O
colonization	O
of	O
the	O
oroparynx	O
and	O
with	O
alterations	O
in	O
the	O
saliva	O
that	O
are	O
related	O
to	O
the	O
risk	O
of	O
aspiration	O
pneumonia	O
.	O

Further	O
research	O
is	O
called	O
for	O
,	O
as	O
well	O
as	O
a	O
thorough	O
revision	O
of	O
the	O
existing	O
oral	O
cleansing	O
procedures	O
in	O
these	O
patients	O
.	O

Lactobacilli	B-bacteria
were	O
considered	O
the	O
prime	O
cariogenic	O
microorganisms	O
until	O
phylogenetic	O
related	O
bacteria	O
,	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
were	O
associated	O
with	O
caries	O
.	O

Today	O
,	O
lactobacilli	B-bacteria
are	O
still	O
considered	O
a	O
factor	O
in	O
determining	O
the	O
predisposition	O
to	O
develop	O
cavities	O
.	O

As	O
a	O
first	O
step	O
in	O
colonization	O
,	O
microorganisms	O
adhere	O
to	O
oral	O
tissues	O
.	O

Based	O
on	O
this	O
fact	O
,	O
the	O
purpose	O
of	O
our	O
study	O
was	O
to	O
determine	O
if	O
there	O
was	O
a	O
statistical	O
association	O
or	O
difference	O
related	O
to	O
the	O
state	O
of	O
oral	O
health	O
with	O
the	O
surface	O
characteristics	O
of	O
lactobacilli	B-bacteria
.	O

Patients	O
were	O
classified	O
as	O
caries	O
-	O
free	O
and	O
caries	O
-	O
active	O
.	O

Interviews	O
were	O
performed	O
to	O
establish	O
the	O
nutritional	O
and	O
oral	O
hygiene	O
habits	O
.	O

The	O
previously	O
reported	O
characteristics	O
of	O
isolated	O
lactobacilli	B-bacteria
'	O
s	O
quantification	O
and	O
association	O
to	O
dental	O
tissues	O
were	O
determined	O
.	O

Although	O
the	O
nutritional	O
habits	O
for	O
caries	O
-	O
free	O
and	O
caries	O
-	O
active	O
patients	O
were	O
similar	O
,	O
the	O
patients	O
'	O
oral	O
hygiene	O
and	O
dental	O
care	O
determined	O
differences	O
in	O
risk	O
indices	O
.	O

The	O
number	O
of	O
lactobacilli	B-bacteria
was	O
statistically	O
lower	O
in	O
saliva	O
of	O
subjects	O
with	O
good	O
oral	O
health	O
.	O

Certain	O
species	O
of	O
lactobacilli	B-bacteria
could	O
not	O
be	O
associated	O
to	O
specific	O
areas	O
of	O
the	O
mouth	O
,	O
although	O
some	O
species	O
could	O
be	O
localized	O
.	O

Lactobacilli	B-bacteria
from	O
caries	O
active	O
(	O
CA	O
)	O
subjects	O
showed	O
a	O
greater	O
ability	O
to	O
adhere	O
to	O
hydrophobic	O
substances	O
,	O
had	O
a	O
greater	O
salt	O
agglutination	O
property	O
,	O
and	O
showed	O
lower	O
production	O
of	O
inhibitory	O
substances	O
.	O

Lactobacilli	B-bacteria
from	O
caries	O
free	O
(	O
CF	O
)	O
subjects	O
were	O
better	O
able	O
to	O
inhibit	O
oral	O
,	O
potentially	O
pathogenic	O
,	O
microorganisms	O
.	O

These	O
studies	O
prove	O
that	O
preliminary	O
differences	O
between	O
oral	O
lactobacilli	B-bacteria
in	O
CF	O
and	O
CA	O
patients	O
exist	O
.	O

Non	O
-	O
specific	O
and	O
specific	O
adhesion	O
mechanisms	O
in	O
bacteria	O
should	O
be	O
further	O
demonstrated	O
.	O

Mucosal	O
immunization	O
should	O
be	O
an	O
excellent	O
method	O
of	O
preventing	O
respiratory	O
infections	O
because	O
the	O
local	O
immunoglobulin	O
A	O
antibodies	O
can	O
neutralize	O
the	O
invading	O
pathogens	O
at	O
the	O
site	O
of	O
entry	O
.	O

Because	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
a	O
normal	O
inhabitant	O
of	O
the	O
human	O
oral	O
cavity	O
,	O
can	O
naturally	O
elicit	O
a	O
mucosal	O
immune	O
response	O
,	O
it	O
has	O
been	O
a	O
prime	O
candidate	O
for	O
investigations	O
as	O
a	O
live	O
oral	O
vaccine	O
vector	O
for	O
immunization	O
against	O
respiratory	O
infections	O
.	O

Antigens	O
from	O
a	O
number	O
of	O
respiratory	O
bacteria	O
,	O
such	O
as	O
Bordetella	B-bacteria
pertussis	I-bacteria
,	O
and	O
one	O
virus	O
have	O
been	O
expressed	O
extracellularly	O
or	O
on	O
the	O
cell	O
surface	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

The	O
antigens	O
expressed	O
were	O
single	O
or	O
multiple	O
proteins	O
from	O
one	O
or	O
more	O
pathogens	O
.	O

The	O
recombinant	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
expressing	O
surface	O
-	O
localized	O
heterologous	O
antigens	O
could	O
colonize	O
and	O
persist	O
in	O
the	O
oral	O
cavity	O
of	O
mice	O
and	O
rats	O
.	O

Oral	O
colonization	O
induced	O
a	O
mucosal	O
immunoglobulin	O
A	O
response	O
and	O
,	O
in	O
some	O
instances	O
,	O
also	O
a	O
systemic	O
immunoglobulin	O
G	O
response	O
to	O
the	O
heterologous	O
antigens	O
.	O

When	O
given	O
parenterally	O
,	O
the	O
heterologous	O
antigens	O
generated	O
a	O
systemic	O
immunoglobulin	O
G	O
response	O
.	O

These	O
findings	O
indicate	O
that	O
antigens	O
expressed	O
by	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
are	O
immunogenic	O
.	O

A	O
new	O
approach	O
to	O
the	O
use	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
as	O
a	O
vaccine	O
vector	O
is	O
to	O
modulate	O
immune	O
responses	O
by	O
co	O
-	O
expressing	O
cytokines	O
with	O
the	O
antigen	O
.	O

The	O
ability	O
to	O
express	O
antigens	O
from	O
respiratory	O
pathogens	O
and	O
induce	O
immune	O
responses	O
during	O
oral	O
colonization	O
suggests	O
that	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
may	O
be	O
developed	O
into	O
a	O
live	O
vector	O
for	O
oral	O
immunization	O
against	O
respiratory	O
infections	O
.	O

The	O
major	O
challenge	O
ahead	O
is	O
to	O
find	O
ways	O
to	O
achieve	O
a	O
high	O
level	O
of	O
immune	O
response	O
following	O
oral	O
colonization	O
.	O

Chavez	O
de	O
Paz	O
LE	O
,	O
Dahlen	O
G	O
,	O
Molander	O
A	O
,	O
Moller	O
A	O
,	O
Bergenholtz	O
G	O
.	O
Bacteria	O
recovered	O
from	O
teeth	O
with	O
apical	O
periodontitis	O
after	O
antimicrobial	O
endodontic	O
treatment	O
.	O

International	O
Endodontic	O
Journal	O
,	O
36	O
,	O
500	O
-	O
508	O
,	O
2003	O
.	O

To	O
determine	O
whether	O
there	O
is	O
a	O
pattern	O
for	O
certain	O
bacteria	O
to	O
remain	O
after	O
chemo	O
-	O
mechanical	O
treatment	O
of	O
root	O
canals	O
in	O
teeth	O
with	O
apical	O
periodontitis	O
.	O

Consecutive	O
root	O
-	O
canal	O
samples	O
of	O
200	O
teeth	O
receiving	O
root	O
-	O
canal	O
treatment	O
,	O
referred	O
from	O
general	O
practitioners	O
and	O
endodontic	O
specialists	O
for	O
analyses	O
of	O
cultivable	O
microbes	O
,	O
were	O
studied	O
prospectively	O
.	O

To	O
be	O
included	O
,	O
samples	O
had	O
to	O
be	O
taken	O
at	O
a	O
treatment	O
session	O
subsequent	O
to	O
the	O
one	O
at	O
which	O
endodontic	O
therapy	O
was	O
initiated	O
.	O

All	O
samples	O
were	O
from	O
teeth	O
that	O
either	O
presented	O
with	O
clinical	O
or	O
radiographic	O
evidence	O
of	O
apical	O
periodontitis	O
or	O
both	O
.	O

Bacteriological	O
findings	O
were	O
linked	O
to	O
clinical	O
and	O
radiographic	O
parameters	O
including	O
status	O
of	O
the	O
root	O
canal	O
prior	O
to	O
treatment	O
,	O
namely	O
,	O
vital	O
pulp	O
,	O
necrotic	O
pulp	O
or	O
root	O
filled	O
.	O

A	O
total	O
of	O
248	O
strains	O
were	O
isolated	O
from	O
107	O
teeth	O
giving	O
bacterial	O
growth	O
.	O

Gram	O
-	O
positives	O
predominated	O
(	O
85	O
%	O
)	O
.	O

Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
22	O
%	O
)	O
,	O
nonmutans	B-bacteria
streptococci	I-bacteria
(	O
18	O
%	O
)	O
,	O
and	O
Enterococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
12	O
%	O
)	O
were	O
the	O
most	O
common	O
isolates	O
.	O

Gram	O
-	O
negative	O
anaerobes	O
were	O
relatively	O
sporadic	O
.	O

Large	O
radiographic	O
bone	O
lesions	O
,	O
persistent	O
pain	O
and	O
use	O
of	O
intracanal	O
calcium	O
hydroxide	O
dressing	O
correlated	O
with	O
bacterial	O
presence	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Once	O
established	O
,	O
nonmutans	B-bacteria
streptococci	I-bacteria
,	O
enterococci	B-bacteria
and	O
lactobacilli	B-bacteria
appear	O
to	O
survive	O
commonly	O
following	O
root	O
-	O
canal	O
treatment	O
of	O
teeth	O
with	O
clinical	O
and	O
radiographical	O
signs	O
of	O
apical	O
periodontitis	O
.	O

Oral	O
streptococci	B-bacteria
are	O
present	O
in	O
large	O
numbers	O
in	O
dental	O
plaque	O
and	O
several	O
types	O
interact	O
with	O
the	O
enamel	O
salivary	O
pellicle	O
to	O
form	O
a	O
biofilm	O
on	O
tooth	O
surfaces	O
.	O

The	O
respective	O
affinity	O
of	O
individual	O
streptococci	B-bacteria
for	O
salivary	O
components	O
has	O
an	O
influence	O
on	O
the	O
etiologic	O
properties	O
of	O
oral	O
biofilm	O
in	O
the	O
development	O
of	O
dental	O
caries	O
.	O

We	O
studied	O
real	O
-	O
time	O
biospecific	O
interactions	O
between	O
oral	O
streptococci	B-bacteria
and	O
salivary	O
components	O
utilizing	O
biosensor	O
technology	O
to	O
analyze	O
surface	O
plasmon	O
resonance	O
.	O

Streptococcus	B-bacteria
sanguis	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
showed	O
significant	O
responses	O
for	O
binding	O
to	O
salivary	O
components	O
,	O
in	O
comparison	O
with	O
other	O
bacteria	O
.	O

Further	O
,	O
the	O
association	O
rates	O
(	O
4	O
.	O
1	O
x	O
10	O
-	O
11	O
/	O
bacterium	O
)	O
and	O
dissociation	O
rate	O
(	O
5	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
9	O
x	O
10	O
-	O
3	O
Second	O
(	O
s	O
)	O
-	O
1	O
)	O
were	O
higher	O
for	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
than	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
2	O
.	O
4	O
x	O
10	O
-	O
11	O
and	O
2	O
.	O
9	O
+	O
/	O
-	O
0	O
.	O
8	O
x	O
10	O
-	O
3	O
)	O
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
(	O
1	O
.	O
3	O
x	O
10	O
-	O
11	O
and	O
3	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
3	O
x	O
10	O
-	O
3	O
)	O
.	O

However	O
,	O
the	O
association	O
equilibrium	O
constants	O
(	O
8	O
.	O
2	O
S	O
/	O
bacterium	O
)	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
2	O
times	O
higher	O
in	O
than	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
(	O
3	O
.	O
8	O
)	O
and	O
slightly	O
higher	O
than	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
(	O
7	O
.	O
2	O
)	O
.	O

These	O
findings	O
may	O
provide	O
useful	O
information	O
regarding	O
the	O
mechanism	O
of	O
early	O
biofilm	O
formation	O
by	O
streptococci	B-bacteria
on	O
the	O
tooth	O
surface	O
.	O

This	O
article	O
describes	O
the	O
microbiology	O
,	O
diagnosis	O
,	O
and	O
management	O
of	O
human	O
and	O
animal	O
bite	O
wound	O
infections	O
.	O

Various	O
organisms	O
can	O
be	O
recovered	O
from	O
bite	O
wounds	O
that	O
generally	O
result	O
from	O
aerobic	O
and	O
anaerobic	O
microbial	O
flora	O
of	O
the	O
oral	O
cavity	O
of	O
the	O
biting	O
animal	O
,	O
rather	O
than	O
the	O
victim	O
'	O
s	O
own	O
skin	O
flora	O
.	O

The	O
role	O
of	O
anaerobes	O
in	O
bite	O
wound	O
infections	O
has	O
been	O
increasingly	O
appreciated	O
.	O

Anaerobes	O
were	O
isolated	O
from	O
more	O
than	O
two	O
thirds	O
of	O
human	O
and	O
animal	O
bite	O
wound	O
infections	O
,	O
especially	O
those	O
associated	O
with	O
abscess	O
formation	O
.	O

This	O
article	O
describes	O
several	O
of	O
the	O
organisms	O
found	O
in	O
the	O
bites	O
of	O
various	O
species	O
.	O

In	O
addition	O
to	O
local	O
wound	O
infection	O
,	O
other	O
complications	O
may	O
occur	O
,	O
including	O
lymphangitis	O
,	O
local	O
abscess	O
,	O
septic	O
arthritis	O
,	O
tenosynovitis	O
,	O
and	O
osteomyelitis	O
.	O

Rare	O
complications	O
include	O
endocarditis	O
,	O
meningitis	O
,	O
brain	O
abscess	O
,	O
and	O
sepsis	O
with	O
disseminated	O
intravascular	O
coagulation	O
,	O
especially	O
in	O
immunocompromised	O
individuals	O
.	O

Wound	O
management	O
includes	O
the	O
administration	O
of	O
proper	O
local	O
care	O
and	O
the	O
use	O
of	O
proper	O
antimicrobial	O
agents	O
when	O
needed	O
.	O

The	O
mucosal	O
secretory	O
proteins	O
,	O
such	O
as	O
the	O
salivary	O
proteins	O
,	O
play	O
a	O
key	O
role	O
in	O
the	O
acquisition	O
and	O
regulation	O
of	O
the	O
mucosal	O
microflora	O
.	O

Most	O
notably	O
,	O
some	O
microorganisms	O
utilize	O
the	O
host	O
'	O
s	O
secretory	O
proteins	O
to	O
adhere	O
to	O
the	O
mucosa	O
;	O
a	O
first	O
step	O
in	O
colonization	O
and	O
infection	O
.	O

The	O
secretory	O
proteins	O
also	O
influence	O
colonization	O
by	O
affecting	O
the	O
binding	O
among	O
microorganisms	O
,	O
a	O
process	O
denoted	O
as	O
coadherence	O
.	O

Previously	O
we	O
reported	O
that	O
acute	O
stressors	O
cause	O
specific	O
changes	O
in	O
saliva	O
composition	O
.	O

The	O
present	O
study	O
investigated	O
to	O
what	O
extent	O
these	O
changes	O
influence	O
saliva	O
-	O
mediated	O
microbial	O
adherence	O
and	O
coadherence	O
(	O
ex	O
vivo	O
)	O
.	O

Thirty	O
-	O
two	O
male	O
undergraduates	O
provided	O
unstimulated	O
saliva	O
before	O
and	O
during	O
a	O
control	O
condition	O
and	O
two	O
stressors	O
:	O
A	O
memory	O
test	O
and	O
a	O
surgery	O
video	O
presentation	O
.	O

We	O
used	O
saliva	O
-	O
coated	O
microplates	O
to	O
test	O
the	O
adherence	O
of	O
bacteria	O
for	O
which	O
the	O
oral	O
cavity	O
is	O
either	O
a	O
natural	O
reservoir	O
(	O
eg	O
,	O
viridans	B-bacteria
streptococci	I-bacteria
)	O
or	O
a	O
portal	O
of	O
entry	O
(	O
eg	O
,	O
Helicobacter	B-bacteria
pylori	I-bacteria
)	O
.	O

We	O
also	O
tested	O
the	O
saliva	O
-	O
mediated	O
co	O
-	O
adherence	O
between	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
the	O
yeast	O
Candida	O
albicans	O
.	O

Correlation	O
analyses	O
were	O
performed	O
to	O
determine	O
the	O
relationships	O
between	O
changes	O
in	O
microbial	O
adherence	O
and	O
the	O
concentrations	O
of	O
potential	O
salivary	O
ligands	O
,	O
viz	O
.	O

cystatin	O
S	O
,	O
the	O
mucins	O
MUC5B	O
and	O
MUC7	O
,	O
S	O
-	O
IgA	O
,	O
lactoferrin	O
,	O
alpha	O
-	O
amylase	O
,	O
and	O
total	O
salivary	O
protein	O
.	O

During	O
the	O
memory	O
test	O
,	O
saliva	O
-	O
mediated	O
adhesion	O
of	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
increased	O
,	O
whereas	O
the	O
coadherence	O
of	O
C	O
.	O
albicans	O
with	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
decreased	O
.	O

During	O
the	O
surgical	O
video	O
presentation	O
the	O
saliva	O
-	O
mediated	O
adherence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
increased	O
.	O

These	O
changes	O
were	O
independent	O
of	O
salivary	O
flow	O
rate	O
,	O
but	O
correlated	O
with	O
specific	O
changes	O
in	O
salivary	O
protein	O
composition	O
.	O

The	O
results	O
show	O
that	O
even	O
moderate	O
stressors	O
,	O
by	O
altering	O
the	O
activity	O
of	O
the	O
mucosal	O
secretory	O
glands	O
,	O
may	O
affect	O
microbial	O
colonization	O
processes	O
such	O
as	O
adherence	O
and	O
coadherence	O
.	O

This	O
study	O
hereby	O
presents	O
a	O
mechanism	O
by	O
which	O
stress	O
may	O
affect	O
the	O
mucosal	O
microflora	O
and	O
susceptibility	O
to	O
infectious	O
disease	O
.	O

The	O
accurate	O
classification	O
of	O
oral	O
Actinomyces	B-bacteria
isolates	I-bacteria
as	O
one	O
species	O
is	O
difficult	O
.	O

Out	O
of	O
18	O
Actinomyces	B-bacteria
isolates	I-bacteria
forming	O
red	O
colonies	O
on	O
brain	O
heart	O
blood	O
agar	O
,	O
12	O
could	O
be	O
straightforwardly	O
assigned	O
as	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
by	O
biochemical	O
,	O
morphological	O
,	O
and	O
chemotaxonomic	O
characteristics	O
.	O

For	O
the	O
remaining	O
six	O
isolates	O
,	O
the	O
results	O
of	O
the	O
different	O
identification	O
methods	O
were	O
inconsistent	O
.	O

By	O
sequencing	O
a	O
16S	O
ribosomal	O
DNA	O
fragment	O
by	O
a	O
rapid	O
mass	O
spectrometric	O
method	O
,	O
all	O
isolates	O
could	O
be	O
identified	O
unambiguously	O
as	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
.	O

This	O
result	O
proves	O
the	O
importance	O
of	O
red	O
colony	O
pigmentation	O
on	O
brain	O
heart	O
blood	O
agar	O
together	O
with	O
the	O
characteristic	O
cell	O
morphology	O
for	O
unequivocal	O
assignment	O
of	O
oral	O
Actinomyces	B-bacteria
isolates	I-bacteria
to	O
the	O
species	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
.	O

The	O
oral	O
cavity	O
is	O
a	O
reservoir	O
for	O
colonization	O
and	O
infection	O
of	O
systemic	O
organs	O
by	O
pathogenic	O
bacteria	O
.	O

It	O
is	O
understood	O
that	O
aging	O
,	O
tooth	O
eruption	O
,	O
hormonal	O
changes	O
,	O
active	O
disease	O
,	O
oral	O
hygiene	O
,	O
and	O
other	O
factors	O
have	O
an	O
influence	O
on	O
biofilm	O
formation	O
and	O
bacterial	O
accumulation	O
in	O
the	O
oral	O
cavity	O
.	O

To	O
understand	O
the	O
influence	O
of	O
systemic	O
health	O
care	O
on	O
microfloral	O
changes	O
,	O
we	O
conducted	O
epidemiological	O
studies	O
of	O
nursing	O
home	O
residents	O
in	O
an	O
attempt	O
to	O
elucidate	O
the	O
relationship	O
between	O
underlying	O
systemic	O
diseases	O
and	O
the	O
isolation	O
frequency	O
of	O
oral	O
opportunistic	O
pathogens	O
.	O

The	O
prevalence	O
of	O
bacteria	O
and	O
fungi	O
causing	O
pneumonia	O
in	O
association	O
with	O
oral	O
biofilm	O
bacteria	O
were	O
determined	O
using	O
detection	O
culture	O
plates	O
.	O

The	O
influences	O
of	O
gender	O
,	O
age	O
,	O
denture	O
-	O
wearing	O
status	O
,	O
number	O
of	O
teeth	O
,	O
and	O
bedridden	O
status	O
in	O
the	O
patients	O
residing	O
in	O
nursing	O
homes	O
were	O
then	O
analyzed	O
.	O

The	O
isolation	O
frequency	O
rates	O
of	O
Candida	O
albicans	O
,	O
Pseudomonadaceae	B-bacteria
,	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
some	O
strains	O
of	O
Enterobacteriaceae	B-bacteria
in	O
plaque	O
samples	O
,	O
as	O
well	O
as	O
C	O
.	O
albicans	O
and	O
Xanthomonas	B-bacteria
maltophilia	I-bacteria
in	O
samples	O
from	O
the	O
pharynx	O
,	O
were	O
significantly	O
higher	O
in	O
those	O
requiring	O
systemic	O
care	O
(	O
mean	O
age	O
83	O
.	O
9	O
years	O
)	O
than	O
in	O
those	O
who	O
did	O
not	O
require	O
such	O
care	O
(	O
mean	O
71	O
.	O
0	O
years	O
)	O
.	O

In	O
particular	O
,	O
the	O
frequencies	O
of	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
C	O
.	O
albicans	O
,	O
and	O
Serratia	B-bacteria
marcescens	I-bacteria
in	O
plaque	O
were	O
significantly	O
higher	O
in	O
those	O
who	O
were	O
bedridden	O
.	O

Furthermore	O
,	O
the	O
isolation	O
of	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
and	O
/	O
or	O
C	O
.	O
albicans	O
in	O
plaque	O
was	O
significantly	O
associated	O
with	O
heart	O
disease	O
.	O

The	O
coexistence	O
of	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
C	O
.	O
albicans	O
in	O
elderly	O
with	O
10	O
-	O
19	O
teeth	O
is	O
a	O
potential	O
indicator	O
of	O
high	O
risk	O
for	O
pneumonia	O
and	O
heart	O
disease	O
.	O

Therefore	O
,	O
attention	O
to	O
oral	O
hygiene	O
and	O
professional	O
care	O
for	O
removing	O
the	O
indicators	O
may	O
diminish	O
the	O
occurrence	O
of	O
systemic	O
disease	O
in	O
the	O
elderly	O
requiring	O
systemic	O
care	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
oral	O
status	O
of	O
children	O
suffering	O
from	O
end	O
-	O
stage	O
renal	O
disease	O
(	O
ESRD	O
)	O
with	O
the	O
aim	O
of	O
determining	O
the	O
causes	O
of	O
low	O
caries	O
prevalence	O
in	O
this	O
population	O
(	O
using	O
the	O
CRT	O
bacteria	O
and	O
buffer	O
test	O
)	O
,	O
and	O
compared	O
results	O
with	O
a	O
control	O
group	O
(	O
n	O
=	O
38	O
)	O
.	O

In	O
the	O
study	O
group	O
,	O
there	O
were	O
38	O
children	O
(	O
aged	O
4	O
-	O
17	O
years	O
)	O
who	O
were	O
being	O
treated	O
in	O
pediatric	O
nephrology	O
units	O
at	O
three	O
different	O
hospitals	O
in	O
Izmir	O
,	O
Turkey	O
.	O

The	O
study	O
and	O
control	O
groups	O
did	O
not	O
significantly	O
differ	O
in	O
daily	O
tooth	O
brushing	O
frequency	O
and	O
periodic	O
dental	O
check	O
-	O
up	O
frequency	O
.	O

Severe	O
enamel	O
hypoplasia	O
was	O
present	O
in	O
the	O
study	O
group	O
.	O

Dmft	O
,	O
DMFT	O
,	O
gingival	O
and	O
plaque	O
indices	O
were	O
compared	O
statistically	O
in	O
mixed	O
dentition	O
stage	O
with	O
the	O
control	O
group	O
and	O
dmft	O
and	O
gingival	O
status	O
showed	O
a	O
statistically	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
differences	O
among	O
groups	O
for	O
DMFT	O
and	O
plaque	O
indices	O
were	O
not	O
statistically	O
significant	O
.	O

In	O
the	O
study	O
group	O
,	O
high	O
salivary	O
buffer	O
capacity	O
was	O
found	O
in	O
89	O
.	O
5	O
%	O
of	O
patients	O
.	O

Salivary	O
levels	O
of	O
cariogenic	O
streptococcus	B-bacteria
mutans	I-bacteria
and	O
lactobacilli	B-bacteria
in	O
the	O
study	O
group	O
were	O
significantly	O
lower	O
than	O
in	O
the	O
control	O
group	O
.	O

In	O
conclusion	O
,	O
probably	O
due	O
to	O
increased	O
concentrations	O
of	O
antibacterial	O
chemicals	O
such	O
as	O
urea	O
in	O
the	O
saliva	O
of	O
children	O
with	O
ESRD	O
,	O
decreased	O
levels	O
of	O
cariogenic	O
microorganisms	O
were	O
detected	O
.	O

Therefore	O
,	O
although	O
dental	O
treatment	O
need	O
is	O
not	O
high	O
,	O
these	O
children	O
should	O
receive	O
dental	O
health	O
education	O
,	O
including	O
oral	O
hygiene	O
instruction	O
,	O
in	O
order	O
to	O
improve	O
their	O
overall	O
oral	O
health	O
.	O

It	O
has	O
been	O
suggested	O
that	O
between	O
3	O
%	O
and	O
13	O
%	O
of	O
the	O
cerebral	O
abscesses	O
(	O
CA	O
)	O
are	O
presumably	O
associated	O
to	O
oral	O
infections	O
or	O
dental	O
procedures	O
.	O

Determine	O
the	O
prevalence	O
of	O
CA	O
of	O
oral	O
origin	O
,	O
discussing	O
their	O
clinical	O
and	O
microbiological	O
characteristics	O
.	O

Retrospectively	O
,	O
54	O
cases	O
of	O
CA	O
diagnosed	O
in	O
3	O
hospitals	O
of	O
Galicia	O
between	O
2001	O
and	O
2002	O
were	O
reviewed	O
.	O

A	O
presumed	O
oral	O
portal	O
of	O
entry	O
was	O
recorded	O
in	O
6	O
patients	O
(	O
11	O
.	O
1	O
%	O
)	O
;	O
4	O
cases	O
were	O
associated	O
to	O
oral	O
infections	O
and	O
the	O
remaining	O
2	O
had	O
received	O
dental	O
treatment	O
in	O
the	O
months	O
prior	O
to	O
the	O
onset	O
of	O
symptoms	O
.	O

Half	O
of	O
the	O
patients	O
showed	O
irrelevant	O
medical	O
record	O
,	O
2	O
had	O
had	O
previous	O
extracranial	O
abscesses	O
and	O
1	O
presented	O
a	O
type	O
A	O
immunoglobulin	O
deficiency	O
.	O

In	O
4	O
cases	O
,	O
the	O
microbiological	O
analysis	O
was	O
positive	O
and	O
typical	O
oral	O
bacteria	O
(	O
Streptococcus	B-bacteria
viridans	I-bacteria
and	O
Peptostreptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
were	O
identified	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
a	O
significant	O
number	O
of	O
CA	O
are	O
probably	O
of	O
oral	O
origin	O
.	O

In	O
consequence	O
,	O
to	O
maintain	O
a	O
good	O
oral	O
health	O
status	O
is	O
important	O
and	O
specific	O
prophylactic	O
measures	O
before	O
any	O
dental	O
procedure	O
should	O
be	O
applied	O
,	O
especially	O
in	O
patients	O
with	O
risk	O
recognized	O
factors	O
.	O

Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
are	O
early	O
colonizing	O
inhabitants	O
in	O
the	O
mouth	O
.	O

As	O
part	O
of	O
studies	O
on	O
penicillin	O
resistance	O
among	O
oral	O
indigenous	O
anaerobic	O
microbiota	O
in	O
childhood	O
,	O
the	O
aim	O
of	O
the	O
present	O
longitudinal	O
study	O
was	O
to	O
examine	O
the	O
emergence	O
of	O
resistant	O
strains	O
in	O
Veillonella	B-bacteria
populations	O
.	O

Altogether	O
305	O
Veillonella	B-bacteria
isolates	I-bacteria
from	O
saliva	O
of	O
49	O
healthy	O
infants	O
followed	O
from	O
2	O
to	O
24	O
months	O
of	O
age	O
were	O
examined	O
for	O
their	O
in	O
vitro	O
susceptibility	O
to	O
penicillin	O
G	O
and	O
,	O
further	O
,	O
20	O
penicillin	O
-	O
resistant	O
isolates	O
representing	O
5	O
MIC	O
categories	O
to	O
ampicillin	O
,	O
amoxicillin	O
,	O
amoxicillin	O
/	O
clavulanate	O
,	O
cefoxitin	O
,	O
and	O
beta	O
-	O
lactamase	O
production	O
.	O

In	O
infants	O
positive	O
for	O
oral	O
Veillonella	B-bacteria
,	O
the	O
recovery	O
rate	O
of	O
penicillin	O
-	O
resistant	O
(	O
MIC	O
>	O
/	O
=	O
2	O
microg	O
/	O
ml	O
)	O
strains	O
increased	O
with	O
age	O
up	O
to	O
68	O
%	O
,	O
however	O
,	O
most	O
infants	O
simultaneously	O
harbored	O
penicillin	O
-	O
susceptible	O
strains	O
.	O

During	O
the	O
follow	O
-	O
up	O
,	O
the	O
MIC	O
(	O
50	O
)	O
increased	O
from	O
0	O
.	O
5	O
microg	O
/	O
ml	O
to	O
2	O
microg	O
/	O
ml	O
.	O

In	O
addition	O
to	O
penicillin	O
G	O
,	O
8	O
/	O
20	O
strains	O
also	O
showed	O
reduced	O
susceptibility	O
to	O
ampicillin	O
and	O
/	O
or	O
amoxicillin	O
but	O
none	O
produced	O
beta	O
-	O
lactamase	O
.	O

Our	O
study	O
suggests	O
other	O
mechanisms	O
than	O
enzymatic	O
degradation	O
of	O
beta	O
-	O
lactam	O
ring	O
for	O
resistance	O
of	O
oral	O
Veillonella	B-bacteria
to	O
penicillin	O
.	O

The	O
complete	O
2	O
,	O
343	O
,	O
479	O
-	O
bp	O
genome	O
sequence	O
of	O
the	O
gram	O
-	O
negative	O
,	O
pathogenic	O
oral	O
bacterium	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
strain	I-bacteria
W83	I-bacteria
,	O
a	O
major	O
contributor	O
to	O
periodontal	O
disease	O
,	O
was	O
determined	O
.	O

Whole	O
-	O
genome	O
comparative	O
analysis	O
with	O
other	O
available	O
complete	O
genome	O
sequences	O
confirms	O
the	O
close	O
relationship	O
between	O
the	O
Cytophaga	B-bacteria
-	I-bacteria
Flavobacteria	I-bacteria
-	I-bacteria
Bacteroides	I-bacteria
(	O
CFB	B-bacteria
)	O
phylum	O
and	O
the	O
green	O
-	O
sulfur	O
bacteria	O
.	O

Within	O
the	O
CFB	B-bacteria
phyla	I-bacteria
,	O
the	O
genomes	O
most	O
similar	O
to	O
that	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
are	O
those	O
of	O
Bacteroides	B-bacteria
thetaiotaomicron	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
fragilis	I-bacteria
.	O

Outside	O
of	O
the	O
CFB	B-bacteria
phyla	I-bacteria
the	O
most	O
similar	O
genome	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
is	O
that	O
of	O
Chlorobium	B-bacteria
tepidum	I-bacteria
,	O
supporting	O
the	O
previous	O
phylogenetic	O
studies	O
that	O
indicated	O
that	O
the	O
Chlorobia	B-bacteria
and	O
CFB	B-bacteria
phyla	I-bacteria
are	O
related	O
,	O
albeit	O
distantly	O
.	O

Genome	O
analysis	O
of	O
strain	O
W83	O
reveals	O
a	O
range	O
of	O
pathways	O
and	O
virulence	O
determinants	O
that	O
relate	O
to	O
the	O
novel	O
biology	O
of	O
this	O
oral	O
pathogen	O
.	O

Among	O
these	O
determinants	O
are	O
at	O
least	O
six	O
putative	O
hemagglutinin	O
-	O
like	O
genes	O
and	O
36	O
previously	O
unidentified	O
peptidases	O
.	O

Genome	O
analysis	O
also	O
reveals	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
metabolize	O
a	O
range	O
of	O
amino	O
acids	O
and	O
generate	O
a	O
number	O
of	O
metabolic	O
end	O
products	O
that	O
are	O
toxic	O
to	O
the	O
human	O
host	O
or	O
human	O
gingival	O
tissue	O
and	O
contribute	O
to	O
the	O
development	O
of	O
periodontal	O
disease	O
.	O

It	O
has	O
recently	O
been	O
shown	O
that	O
human	O
salivary	O
glands	O
constitutively	O
express	O
CD14	O
,	O
an	O
important	O
molecule	O
in	O
innate	O
immunity	O
,	O
and	O
that	O
a	O
soluble	O
form	O
of	O
CD14	O
is	O
secreted	O
in	O
saliva	O
.	O

The	O
concentration	O
of	O
CD14	O
in	O
parotid	O
(	O
a	O
serous	O
gland	O
)	O
saliva	O
was	O
comparable	O
to	O
that	O
in	O
normal	O
serum	O
and	O
10	O
-	O
fold	O
the	O
amount	O
in	O
whole	O
saliva	O
,	O
although	O
the	O
physiological	O
function	O
of	O
saliva	O
CD14	O
remained	O
unclear	O
.	O

Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
is	O
a	O
periodontopathic	O
bacterium	O
and	O
is	O
able	O
to	O
invade	O
oral	O
epithelial	O
cells	O
.	O

The	O
present	O
study	O
showed	O
that	O
upon	O
exposure	O
to	O
live	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
for	O
2	O
h	O
,	O
human	O
oral	O
epithelial	O
HSC	O
-	O
2	O
cells	O
produced	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
for	O
a	O
further	O
24	O
h	O
and	O
whole	O
saliva	O
augmented	O
the	O
production	O
induced	O
by	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
.	O

Parotid	O
saliva	O
showed	O
a	O
more	O
pronounced	O
effect	O
on	O
the	O
production	O
of	O
IL	O
-	O
8	O
than	O
whole	O
saliva	O
.	O

Neither	O
saliva	O
preparation	O
itself	O
had	O
IL	O
-	O
8	O
-	O
inducing	O
activity	O
.	O

Parotid	O
saliva	O
exhibited	O
antibacterial	O
activity	O
against	O
a	O
low	O
concentration	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
,	O
but	O
recombinant	O
CD14	O
did	O
not	O
show	O
the	O
activity	O
.	O

The	O
internalization	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
into	O
HSC	O
-	O
2	O
cells	O
was	O
inhibited	O
by	O
cytochalasin	O
B	O
,	O
indicating	O
that	O
the	O
process	O
was	O
actin	O
dependent	O
,	O
and	O
depletion	O
of	O
CD14	O
from	O
parotid	O
saliva	O
inhibited	O
the	O
invasion	O
and	O
,	O
as	O
a	O
consequence	O
,	O
inhibited	O
production	O
of	O
IL	O
-	O
8	O
.	O

Furthermore	O
,	O
human	O
recombinant	O
CD14	O
augmented	O
invasion	O
and	O
IL	O
-	O
8	O
production	O
.	O

These	O
results	O
suggest	O
that	O
saliva	O
CD14	O
promoted	O
the	O
invasion	O
of	O
oral	O
epithelial	O
cells	O
by	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
consequently	O
augmented	O
the	O
production	O
of	O
IL	O
-	O
8	O
,	O
playing	O
an	O
important	O
role	O
in	O
innate	O
immunity	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
in	O
vitro	O
activities	O
of	O
human	O
beta	O
-	O
defensin	O
3	O
(	O
hBD	O
-	O
3	O
)	O
alone	O
or	O
combined	O
with	O
lysozyme	O
,	O
metronidazole	O
,	O
amoxicillin	O
,	O
and	O
chlorhexidine	O
were	O
investigated	O
with	O
the	O
oral	O
bacteria	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

hBD	O
-	O
3	O
showed	O
bactericidal	O
activity	O
against	O
all	O
of	O
the	O
bacterial	O
species	O
tested	O
.	O

The	O
bactericidal	O
effect	O
was	O
enhanced	O
when	O
the	O
peptide	O
was	O
used	O
in	O
combination	O
with	O
the	O
antimicrobial	O
agents	O
mentioned	O
above	O
.	O

Cysteine	O
proteinases	O
(	O
gingipains	O
)	O
from	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
are	O
considered	O
key	O
virulence	O
factors	O
of	O
severe	O
periodontitis	O
and	O
host	O
immune	O
evasion	O
.	O

Since	O
expression	O
of	O
intercellular	O
adhesion	O
molecule	O
-	O
1	O
(	O
ICAM	O
-	O
1	O
)	O
on	O
gingival	O
epithelium	O
is	O
indispensable	O
in	O
polymorphonuclear	O
leukocyte	O
(	O
PMN	O
)	O
migration	O
at	O
the	O
site	O
of	O
periodontitis	O
,	O
we	O
examined	O
the	O
effects	O
of	O
gingipains	O
on	O
the	O
expression	O
of	O
ICAM	O
-	O
1	O
on	O
human	O
oral	O
epithelial	O
cell	O
lines	O
(	O
KB	O
and	O
HSC	O
-	O
2	O
)	O
by	O
flow	O
cytometry	O
and	O
Western	O
blotting	O
.	O

We	O
found	O
that	O
three	O
purified	O
forms	O
of	O
gingipains	O
efficiently	O
reduced	O
ICAM	O
-	O
1	O
expression	O
on	O
the	O
cells	O
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
.	O

Gingipains	O
reduced	O
the	O
expression	O
on	O
fixed	O
cells	O
and	O
degraded	O
the	O
ICAM	O
-	O
1	O
in	O
the	O
cell	O
membranes	O
,	O
indicating	O
that	O
the	O
reduction	O
resulted	O
from	O
direct	O
proteolysis	O
.	O

They	O
then	O
disturbed	O
the	O
ICAM	O
-	O
1	O
-	O
dependent	O
adhesion	O
of	O
PMNs	O
to	O
the	O
cells	O
.	O

These	O
results	O
indicate	O
that	O
gingipains	O
cleave	O
ICAM	O
-	O
1	O
on	O
oral	O
epithelial	O
cells	O
,	O
consequently	O
disrupting	O
PMN	O
-	O
oral	O
epithelial	O
cell	O
interaction	O
,	O
and	O
are	O
involved	O
in	O
immune	O
evasion	O
by	O
the	O
bacterium	O
in	O
periodontal	O
tissues	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
describe	O
a	O
16S	O
rDNA	O
-	O
based	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
nPCR	O
)	O
assay	O
to	O
investigate	O
the	O
occurrence	O
of	O
Campylobacter	B-bacteria
gracilis	I-bacteria
in	O
oral	O
infections	O
.	O

Samples	O
were	O
collected	O
from	O
ten	O
infected	O
root	O
canals	O
,	O
ten	O
cases	O
of	O
acute	O
periradicular	O
abscesses	O
and	O
eight	O
cases	O
of	O
adult	O
marginal	O
periodontitis	O
.	O

DNA	O
extracted	O
from	O
the	O
samples	O
was	O
initially	O
amplified	O
using	O
universal	O
16S	O
rDNA	O
primers	O
.	O

A	O
second	O
round	O
of	O
amplification	O
used	O
the	O
first	O
PCR	O
products	O
to	O
detect	O
C	B-bacteria
.	I-bacteria
gracilis	I-bacteria
using	O
oligonucleotide	O
primers	O
designed	O
from	O
species	O
-	O
specific	O
16S	O
rDNA	O
signature	O
sequences	O
.	O

The	O
nPCR	O
assay	O
used	O
in	O
this	O
study	O
showed	O
a	O
detection	O
limit	O
of	O
10	O
C	B-bacteria
.	I-bacteria
gracilis	I-bacteria
cells	O
and	O
no	O
cross	O
-	O
reactivity	O
was	O
observed	O
with	O
nontarget	O
bacteria	O
.	O

C	B-bacteria
.	I-bacteria
gracilis	I-bacteria
was	O
detected	O
in	O
the	O
three	O
types	O
of	O
oral	O
infections	O
investigated	O
-	O
4	O
/	O
10	O
infected	O
root	O
canals	O
;	O
2	O
/	O
10	O
acute	O
periradicular	O
abscesses	O
;	O
and	O
1	O
/	O
8	O
subgingival	O
specimens	O
from	O
adult	O
periodontitis	O
.	O

The	O
method	O
proposed	O
in	O
this	O
study	O
showed	O
both	O
high	O
sensitivity	O
and	O
high	O
specificity	O
to	O
directly	O
detect	O
C	B-bacteria
.	I-bacteria
gracilis	I-bacteria
in	O
samples	O
from	O
root	O
canal	O
infections	O
,	O
abscesses	O
,	O
and	O
subgingival	O
plaque	O
.	O

Our	O
findings	O
confirmed	O
that	O
C	B-bacteria
.	I-bacteria
gracilis	I-bacteria
may	O
be	O
a	O
member	O
of	O
the	O
microbiota	O
associated	O
with	O
distinct	O
oral	O
infections	O
,	O
and	O
its	O
specific	O
role	O
in	O
such	O
diseases	O
requires	O
further	O
clarification	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
perform	O
a	O
quantitative	O
and	O
qualitative	O
analysis	O
of	O
oral	O
carriage	O
of	O
staphylococci	B-bacteria
in	O
a	O
range	O
of	O
oral	O
specimens	O
from	O
patients	O
admitted	O
to	O
a	O
regional	O
burns	O
unit	O
.	O

The	O
study	O
recruited	O
28	O
patients	O
and	O
reasons	O
for	O
admittance	O
were	O
:	O
burns	O
(	O
46	O
%	O
)	O
,	O
skin	O
grafting	O
(	O
39	O
%	O
)	O
,	O
lacerations	O
(	O
7	O
%	O
)	O
,	O
scalding	O
(	O
4	O
%	O
)	O
and	O
necrotizing	O
fasciitis	O
(	O
4	O
%	O
)	O
.	O

No	O
patient	O
had	O
smoke	O
inhalation	O
injuries	O
or	O
trauma	O
to	O
the	O
oro	O
-	O
pharynx	O
.	O

There	O
were	O
five	O
patients	O
from	O
whom	O
methicillin	B-bacteria
-	I-bacteria
sensitive	I-bacteria
S	I-bacteria
.	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
could	O
be	O
detected	O
in	O
oral	O
specimens	O
.	O

For	O
three	O
patients	O
only	O
the	O
wound	O
and	O
oral	O
specimens	O
were	O
positive	O
for	O
MRSA	B-bacteria
.	O

In	O
one	O
patient	O
only	O
the	O
oral	O
specimens	O
were	O
positive	O
for	O
MRSA	B-bacteria
.	O

There	O
were	O
five	O
patients	O
from	O
whom	O
methicillin	B-bacteria
-	I-bacteria
sensitive	I-bacteria
S	I-bacteria
.	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
could	O
be	O
detected	O
in	O
the	O
oral	O
specimens	O
.	O

In	O
one	O
patient	O
only	O
the	O
oral	O
specimens	O
were	O
positive	O
for	O
MSSA	B-bacteria
.	O

Staphylococci	B-bacteria
could	O
be	O
recovered	O
from	O
the	O
dental	O
plaque	O
,	O
denture	O
and	O
toothbrush	O
specimens	O
with	O
a	O
mean	O
count	O
of	O
1	O
.	O
1	O
x	O
10	O
(	O
4	O
)	O
cfu	O
/	O
mL	O
(	O
range	O
20	O
-	O
5	O
.	O
3	O
x	O
10	O
(	O
4	O
)	O
)	O
,	O
5	O
.	O
4	O
x	O
10	O
(	O
3	O
)	O
(	O
range	O
40	O
-	O
2	O
.	O
1	O
x	O
10	O
(	O
4	O
)	O
)	O
and	O
264	O
cfu	O
/	O
mL	O
(	O
range	O
20	O
-	O
500	O
)	O
,	O
respectively	O
.	O

Both	O
MSSA	B-bacteria
and	O
MRSA	B-bacteria
could	O
be	O
recovered	O
from	O
these	O
specimen	O
types	O
.	O

In	O
one	O
patient	O
only	O
the	O
toothbrush	O
was	O
positive	O
for	O
MRSA	B-bacteria
and	O
all	O
other	O
oral	O
specimens	O
were	O
negative	O
.	O

This	O
study	O
suggests	O
that	O
staphylococci	B-bacteria
are	O
not	O
infrequent	O
colonizers	O
of	O
the	O
oral	O
cavity	O
,	O
and	O
that	O
this	O
site	O
may	O
serve	O
as	O
a	O
potential	O
reservoir	O
for	O
transmission	O
to	O
other	O
body	O
sites	O
.	O

The	O
prevalence	O
of	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
in	O
healthy	O
4	O
-	O
and	O
6	O
-	O
year	O
-	O
old	O
children	O
who	O
had	O
not	O
received	O
antibiotics	O
during	O
the	O
3	O
months	O
prior	O
to	O
sampling	O
was	O
investigated	O
.	O

Of	O
the	O
47	O
children	O
sampled	O
,	O
46	O
harboured	O
tetracycline	O
-	O
resistant	O
bacteria	O
.	O

The	O
median	O
proportion	O
of	O
cultivable	O
anaerobic	O
and	O
aerobic	O
oral	O
bacteria	O
resistant	O
to	O
tetracycline	O
was	O
1	O
.	O
1	O
%	O
and	O
the	O
MIC50	O
of	O
these	O
was	O
64	O
microg	O
ml	O
(	O
-	O
1	O
)	O
.	O

The	O
majority	O
(	O
56	O
%	O
)	O
of	O
tetracycline	O
-	O
resistant	O
bacteria	O
were	O
resistant	O
to	O
at	O
least	O
one	O
other	O
antibiotic	O
,	O
usually	O
erythromycin	O
.	O

The	O
most	O
commonly	O
identified	O
tetracycline	O
-	O
resistant	O
bacteria	O
were	O
the	O
oral	O
streptococci	B-bacteria
(	O
65	O
%	O
)	O
,	O
the	O
next	O
most	O
prevalent	O
groups	O
were	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
10	O
%	O
)	O
and	O
Neisseria	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
9	O
%	O
)	O
.	O

The	O
most	O
frequently	O
identified	O
tetracycline	O
resistance	O
determinant	O
was	O
tet	O
(	O
M	O
)	O
.	O

The	O
results	O
of	O
this	O
study	O
have	O
shown	O
that	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
were	O
widespread	O
amongst	O
the	O
children	O
studied	O
.	O

Naturally	O
occurring	O
antimicrobial	O
peptides	O
have	O
emerged	O
as	O
alternative	O
classes	O
of	O
antimicrobials	O
.	O

In	O
general	O
,	O
these	O
antimicrobial	O
peptides	O
exhibit	O
selectivity	O
for	O
prokaryotes	O
and	O
minimize	O
the	O
problems	O
of	O
engendering	O
microbial	O
resistance	O
.	O

As	O
an	O
alternative	O
method	O
to	O
search	O
for	O
more	O
effective	O
broad	O
-	O
spectrum	O
peptide	O
antimicrobials	O
,	O
investigators	O
have	O
developed	O
peptide	O
libraries	O
by	O
using	O
synthetic	O
combinatorial	O
technology	O
.	O

A	O
novel	O
decapeptide	O
,	O
KKVVFKVKFK	O
(	O
KSL	O
)	O
,	O
has	O
been	O
identified	O
that	O
shows	O
a	O
broad	O
range	O
of	O
antibacterial	O
activity	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
efficacy	O
of	O
this	O
antimicrobial	O
peptide	O
in	O
killing	O
selected	O
strains	O
of	O
oral	O
pathogens	O
and	O
resident	O
saliva	O
bacteria	O
collected	O
from	O
human	O
subjects	O
.	O

Cytotoxic	O
activity	O
of	O
KSL	O
against	O
mammalian	O
cells	O
and	O
the	O
structural	O
features	O
of	O
this	O
decapeptide	O
were	O
also	O
investigated	O
,	O
the	O
latter	O
by	O
using	O
two	O
-	O
dimensional	O
NMR	O
in	O
aqueous	O
and	O
DMSO	O
solutions	O
.	O

MICs	O
of	O
KSL	O
for	O
the	O
majority	O
of	O
oral	O
bacteria	O
tested	O
in	O
vitro	O
ranged	O
from	O
3	O
to	O
100	O
microg	O
ml	O
(	O
-	O
1	O
)	O
.	O

Minimal	O
bactericidal	O
concentrations	O
of	O
KSL	O
were	O
,	O
in	O
general	O
,	O
within	O
one	O
to	O
two	O
dilutions	O
of	O
the	O
MICs	O
.	O

KSL	O
exhibited	O
an	O
ED	O
(	O
99	O
)	O
(	O
the	O
dose	O
at	O
which	O
99	O
%	O
killing	O
was	O
observed	O
after	O
15	O
min	O
at	O
37	O
degrees	O
C	O
)	O
of	O
6	O
.	O
25	O
microg	O
ml	O
(	O
-	O
1	O
)	O
against	O
selected	O
strains	O
of	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

In	O
addition	O
,	O
KSL	O
damaged	O
bacterial	O
cell	O
membranes	O
and	O
caused	O
1	O
.	O
05	O
log	O
units	O
reduction	O
of	O
viability	O
counts	O
of	O
saliva	O
bacteria	O
.	O

In	O
vitro	O
toxicity	O
studies	O
showed	O
that	O
KSL	O
,	O
at	O
concentrations	O
up	O
to	O
1	O
mg	O
ml	O
(	O
-	O
1	O
)	O
,	O
did	O
not	O
induce	O
cell	O
death	O
or	O
compromise	O
the	O
membrane	O
integrity	O
of	O
human	O
gingival	O
fibroblasts	O
.	O

NMR	O
studies	O
suggest	O
that	O
KSL	O
adopts	O
an	O
alpha	O
-	O
helical	O
structure	O
in	O
DMSO	O
solution	O
,	O
which	O
mimics	O
the	O
polar	O
aprotic	O
membrane	O
environment	O
,	O
whereas	O
it	O
remains	O
unstructured	O
in	O
aqueous	O
medium	O
.	O

This	O
study	O
shows	O
that	O
KSL	O
may	O
be	O
a	O
useful	O
antimicrobial	O
agent	O
for	O
inhibiting	O
the	O
growth	O
of	O
oral	O
bacteria	O
that	O
are	O
associated	O
with	O
caries	O
development	O
and	O
early	O
plaque	O
formation	O
.	O

Microbial	O
interactions	O
with	O
host	O
molecules	O
,	O
and	O
programmed	O
responses	O
to	O
host	O
environmental	O
stimuli	O
,	O
are	O
critical	O
for	O
colonization	O
and	O
initiation	O
of	O
pathogenesis	O
.	O

Bacteria	O
of	O
the	O
genus	O
Streptococcus	B-bacteria
are	O
primary	O
colonizers	O
of	O
the	O
human	O
mouth	O
.	O

They	O
express	O
multiple	O
cell	O
-	O
surface	O
adhesins	O
that	O
bind	O
salivary	O
components	O
and	O
other	O
oral	O
bacteria	O
and	O
enable	O
the	O
development	O
of	O
polymicrobial	O
biofilms	O
associated	O
with	O
tooth	O
decay	O
and	O
periodontal	O
disease	O
.	O

However	O
,	O
the	O
mechanisms	O
by	O
which	O
streptococci	B-bacteria
invade	O
dentine	O
to	O
infect	O
the	O
tooth	O
pulp	O
and	O
periapical	O
tissues	O
are	O
poorly	O
understood	O
.	O

Here	O
we	O
show	O
that	O
production	O
of	O
the	O
antigen	O
I	O
/	O
II	O
(	O
AgI	O
/	O
II	O
)	O
family	O
polypeptide	O
adhesin	O
and	O
invasin	O
SspA	O
in	O
Streptococcus	B-bacteria
gordonii	I-bacteria
is	O
specifically	O
upregulated	O
in	O
response	O
to	O
a	O
collagen	O
type	O
I	O
signal	O
,	O
minimally	O
the	O
tri	O
-	O
peptide	O
Gly	O
-	O
Pro	O
-	O
Xaa	O
(	O
where	O
Xaa	O
is	O
hydroxyproline	O
or	O
alanine	O
)	O
.	O

Increased	O
AgI	O
/	O
II	O
polypeptide	O
expression	O
promotes	O
bacterial	O
adhesion	O
and	O
extended	O
growth	O
of	O
streptococcal	O
cell	O
chains	O
along	O
collagen	O
type	O
I	O
fibrils	O
that	O
are	O
characteristically	O
found	O
within	O
dentinal	O
tubules	O
.	O

These	O
observations	O
define	O
a	O
new	O
model	O
of	O
host	O
matrix	O
signal	O
-	O
induced	O
tissue	O
penetration	O
by	O
bacteria	O
and	O
open	O
the	O
way	O
for	O
novel	O
therapy	O
opportunities	O
for	O
oral	O
invasive	O
diseases	O
.	O

Oral	O
epithelium	O
may	O
play	O
a	O
regulatory	O
role	O
in	O
local	O
immune	O
responses	O
when	O
interacting	O
with	O
bacteria	O
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
investigate	O
the	O
effects	O
of	O
selected	O
bacterial	O
pathogens	O
found	O
in	O
periodontal	O
and	O
endodontic	O
infections	O
on	O
oral	O
epithelial	O
cells	O
.	O

Expression	O
of	O
cell	O
surface	O
molecules	O
(	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
Class	O
II	O
,	O
CD54	O
,	O
CD70	O
,	O
CD80	O
and	O
CD86	O
)	O
and	O
secretion	O
of	O
inflammatory	O
cytokines	O
(	O
interleukin	O
(	O
IL	O
)	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
and	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-	O
alpha	O
)	O
in	O
response	O
to	O
selected	O
bacterial	O
challenge	O
were	O
examined	O
on	O
an	O
immortalized	O
oral	O
epithelial	O
cell	O
line	O
,	O
HOK	O
-	O
18A	O
and	O
a	O
skin	O
epithelial	O
cell	O
line	O
,	O
HaCaT	O
.	O

Actinomyces	B-bacteria
viscosus	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
lipopolysaccharide	O
(	O
LPS	O
)	O
or	O
primary	O
human	O
periradicular	O
exudate	O
from	O
a	O
granuloma	O
were	O
co	O
-	O
cultured	O
with	O
epithelial	O
cells	O
for	O
4	O
or	O
24	O
h	O
.	O
Subsequently	O
,	O
cell	O
surface	O
expression	O
of	O
MHC	O
Class	O
II	O
,	O
CD54	O
,	O
CD70	O
,	O
CD80	O
and	O
CD86	O
,	O
along	O
with	O
pro	O
-	O
inflammatory	O
cytokine	O
levels	O
were	O
determined	O
using	O
flow	O
cytometry	O
,	O
ELISA	O
and	O
RT	O
-	O
PCR	O
.	O

Results	O
indicated	O
that	O
the	O
selected	O
oral	O
bacteria	O
have	O
greater	O
effects	O
on	O
oral	O
versus	O
skin	O
epithelial	O
cells	O
.	O

F	I-bacteria
.	I-bacteria
nucleatum	I-bacteria
increased	O
MHC	O
Class	O
II	O
and	O
CD54	O
(	O
ICAM	O
-	O
1	O
)	O
cell	O
surface	O
expression	O
on	O
HOK	O
-	O
18A	O
and	O
HaCaT	O
cells	O
.	O

A	O
.	O
israelii	O
also	O
had	O
enhancing	O
effects	O
on	O
the	O
expression	O
of	O
CD54	O
and	O
MHC	O
Class	O
II	O
.	O

A	B-bacteria
.	I-bacteria
israelii	I-bacteria
and	O
LPS	O
induced	O
a	O
2	O
.	O
8	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
4	O
.	O
4	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
005	O
)	O
TNF	O
-	O
alpha	O
secretion	O
,	O
respectively	O
,	O
while	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
LPS	O
induced	O
a	O
10	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
0004	O
)	O
and	O
6	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
IL	O
-	O
1beta	O
secretion	O
,	O
respectively	O
by	O
HOK	O
-	O
18A	O
.	O

Interestingly	O
,	O
CD70	O
,	O
CD80	O
,	O
and	O
CD86	O
were	O
generally	O
decreased	O
upon	O
bacteria	O
and	O
LPS	O
challenge	O
on	O
HOK	O
-	O
18A	O
.	O

The	O
effects	O
of	O
increased	O
MHC	O
Class	O
II	O
and	O
decreased	O
CD70	O
were	O
also	O
evident	O
with	O
challenge	O
of	O
human	O
periradicular	O
exudate	O
on	O
HOK	O
-	O
18A	O
.	O

The	O
implications	O
of	O
the	O
study	O
are	O
unique	O
in	O
that	O
oral	O
epithelial	O
cells	O
may	O
play	O
both	O
activating	O
and	O
inhibitory	O
roles	O
in	O
the	O
host	O
immune	O
response	O
towards	O
infection	O
by	O
oral	O
bacteria	O
.	O

We	O
introduce	O
a	O
concept	O
of	O
'	O
dormancy	O
'	O
where	O
the	O
differential	O
expression	O
of	O
key	O
cell	O
surface	O
antigens	O
on	O
oral	O
epithelial	O
cells	O
may	O
keep	O
the	O
recruited	O
immune	O
effector	O
cells	O
in	O
a	O
state	O
of	O
unresponsiveness	O
,	O
thus	O
contributing	O
to	O
the	O
long	O
term	O
quiescent	O
period	O
observed	O
in	O
many	O
periodontal	O
and	O
endodontic	O
lesions	O
.	O

Human	O
beta	O
-	O
defensin	O
-	O
2	O
,	O
and	O
-	O
3	O
(	O
hBD	O
-	O
2	O
,	O
-	O
3	O
)	O
are	O
small	O
inducible	O
antimicrobial	O
peptides	O
involved	O
in	O
host	O
defense	O
.	O

Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
a	O
gram	O
-	O
negative	O
facultative	O
anaerobe	O
,	O
is	O
frequently	O
associated	O
with	O
oral	O
disease	O
in	O
humans	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
strain	O
JP2	B-bacteria
,	O
was	O
examined	O
for	O
its	O
ability	O
to	O
modulate	O
hBD	O
-	O
2	O
and	O
-	O
3	O
gene	O
expression	O
in	O
normal	O
human	O
oral	O
epithelial	O
cells	O
(	O
NHOECs	O
)	O
and	O
in	O
OKF6	O
/	O
Tert	O
cells	O
,	O
an	O
immortalized	O
cell	O
line	O
derived	O
from	O
human	O
oral	O
epithelial	O
cells	O
.	O

Stimulation	O
of	O
both	O
cell	O
types	O
by	O
live	O
bacteria	O
,	O
at	O
a	O
minimal	O
bacteria	O
/	O
cell	O
ratio	O
of	O
500	O
:	O
1	O
,	O
resulted	O
in	O
increased	O
hBD	O
-	O
3	O
gene	O
expression	O
.	O

This	O
was	O
not	O
evinced	O
for	O
hBD	O
-	O
2	O
in	O
either	O
cell	O
type	O
with	O
live	O
bacteria	O
,	O
even	O
at	O
bacteria	O
/	O
cell	O
ratios	O
exceeding	O
500	O
:	O
1	O
.	O

The	O
increased	O
hBD	O
-	O
3	O
gene	O
expression	O
was	O
dependent	O
upon	O
viable	O
bacteria	O
,	O
and	O
not	O
their	O
lipopolysaccharides	O
(	O
LPS	O
)	O
,	O
since	O
heat	O
-	O
killed	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
did	O
not	O
induce	O
hBD	O
-	O
3	O
transcript	O
expression	O
.	O

The	O
overall	O
similarity	O
between	O
results	O
obtained	O
in	O
OKF6	O
/	O
Tert	O
cells	O
and	O
NHOECs	O
suggest	O
that	O
the	O
OKF6	O
/	O
Tert	O
cell	O
line	O
may	O
be	O
a	O
useful	O
tool	O
in	O
the	O
study	O
of	O
beta	O
-	O
defensin	O
expression	O
in	O
oral	O
epithelium	O
.	O

The	O
in	O
vitro	O
activity	O
of	O
Melaleuca	O
alternifolia	O
(	O
tea	O
tree	O
)	O
oil	O
against	O
161	O
isolates	O
of	O
oral	O
bacteria	O
from	O
15	O
genera	O
was	O
determined	O
.	O

Minimum	O
inhibitory	O
concentrations	O
(	O
MIC	O
)	O
and	O
minimum	O
bactericidal	O
concentrations	O
(	O
MBC	O
)	O
ranged	O
from	O
0	O
.	O
003	O
to	O
2	O
.	O
0	O
%	O
(	O
v	O
/	O
v	O
)	O
.	O

MIC90	O
values	O
were	O
1	O
.	O
0	O
%	O
(	O
v	O
/	O
v	O
)	O
for	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
and	O
0	O
.	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
for	O
Prevotella	B-bacteria
spp	I-bacteria
.	O

Isolates	O
of	O
Porphyromonas	B-bacteria
,	O
Prevotella	B-bacteria
and	O
Veillonella	B-bacteria
had	O
the	O
lowest	O
MICs	O
and	O
MBCs	O
,	O
and	O
isolates	O
of	O
Streptococcus	B-bacteria
,	O
Fusobacterium	B-bacteria
and	O
Lactobacillus	B-bacteria
had	O
the	O
highest	O
.	O

Time	O
kill	O
studies	O
with	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
showed	O
that	O
treatment	O
with	O
>	O
or	O
=	O
0	O
.	O
5	O
%	O
tea	O
tree	O
oil	O
caused	O
decreases	O
in	O
viability	O
of	O
>	O
3	O
log	O
colony	O
forming	O
units	O
/	O
ml	O
after	O
only	O
30	O
s	O
,	O
and	O
viable	O
organisms	O
were	O
not	O
detected	O
after	O
5	O
min	O
.	O

These	O
studies	O
indicate	O
that	O
a	O
range	O
of	O
oral	O
bacteria	O
are	O
susceptible	O
to	O
tea	O
tree	O
oil	O
,	O
suggesting	O
that	O
tea	O
tree	O
oil	O
may	O
be	O
of	O
use	O
in	O
oral	O
healthcare	O
products	O
and	O
in	O
the	O
maintenance	O
of	O
oral	O
hygiene	O
.	O

Bacterial	O
effects	O
on	O
in	O
vitro	O
mineralization	O
of	O
human	O
periodontal	O
fibroblasts	O
(	O
HPF	O
)	O
have	O
not	O
yet	O
been	O
examined	O
in	O
great	O
detail	O
.	O

In	O
our	O
study	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
soluble	O
extracts	O
of	O
the	O
periodontopathic	O
bacteria	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Bacteroides	B-bacteria
forsythus	I-bacteria
and	O
,	O
Treponema	B-bacteria
denticola	I-bacteria
on	O
cell	O
proliferation	O
,	O
mineralization	O
,	O
as	O
well	O
as	O
on	O
osteoblastic	O
markers	O
present	O
in	O
HPF	O
cultured	O
in	O
vitro	O
,	O
such	O
as	O
alkaline	O
phosphatase	O
(	O
ALP	O
)	O
activity	O
and	O
collagen	O
content	O
.	O

Periodontal	O
fibroblasts	O
stimulated	O
by	O
B	O
-	O
glycerophosphate	O
,	O
ascorbic	O
acid	O
and	O
dexamethasone	O
(	O
BAD	O
)	O
or	O
by	O
dexamethasone	O
and	O
ascorbic	O
acid	O
(	O
DA	O
)	O
were	O
compared	O
to	O
unstimulated	O
cells	O
.	O

During	O
the	O
cultivation	O
period	O
,	O
the	O
stimulation	O
of	O
HPF	O
by	O
combined	O
dexamethasone	O
and	O
ascorbic	O
acid	O
(	O
DA	O
)	O
had	O
a	O
strong	O
inductive	O
effect	O
on	O
proliferation	O
,	O
ALP	O
activity	O
and	O
collagen	O
formation	O
.	O

The	O
extracts	O
obtained	O
from	O
the	O
periodontal	O
pathogens	O
had	O
a	O
suppressing	O
effect	O
on	O
the	O
proliferation	O
rate	O
of	O
HPF	O
.	O

The	O
extracts	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
B	B-bacteria
.	I-bacteria
forsythus	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
caused	O
a	O
decrease	O
in	O
ALP	O
activity	O
within	O
24	O
h	O
of	O
application	O
.	O

While	O
extracts	O
obtained	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
forsythus	I-bacteria
induced	O
a	O
reduction	O
in	O
collagen	O
content	O
in	O
BAD	O
-	O
and	O
DA	O
-	O
stimulated	O
HPF	O
cells	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
extracts	O
led	O
to	O
an	O
increase	O
in	O
collagen	O
.	O

Our	O
data	O
suggest	O
that	O
specific	O
periodontopathic	O
bacteria	O
may	O
suppress	O
tissue	O
regeneration	O
in	O
vivo	O
not	O
only	O
by	O
activating	O
host	O
defense	O
mechanisms	O
but	O
also	O
directly	O
via	O
a	O
suppression	O
of	O
growth	O
and	O
differentiation	O
of	O
HPF	O
and	O
a	O
reduction	O
in	O
the	O
extracellular	O
collagen	O
matrix	O
.	O

For	O
the	O
process	O
of	O
pocket	O
formation	O
,	O
not	O
even	O
the	O
direct	O
influence	O
of	O
viable	O
bacteria	O
seems	O
to	O
be	O
necessary	O
.	O

Additionally	O
,	O
long	O
-	O
distance	O
effects	O
of	O
bacteria	O
harboured	O
in	O
periodontal	O
pockets	O
or	O
in	O
root	O
canals	O
may	O
be	O
of	O
importance	O
.	O

Six	O
strains	O
of	O
anaerobic	O
,	O
Gram	O
-	O
negative	O
coccobacilli	O
isolated	O
from	O
the	O
root	O
canals	O
of	O
patients	O
with	O
endodontic	O
infections	O
(	O
five	O
strains	O
)	O
and	O
from	O
a	O
deep	O
periodontal	O
pocket	O
(	O
one	O
strain	O
)	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genetic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
.	O

Following	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
,	O
they	O
were	O
found	O
to	O
be	O
most	O
closely	O
related	O
to	O
Dialister	B-bacteria
pneumosintes	I-bacteria
,	O
with	O
93	O
%	O
sequence	O
similarity	O
between	O
the	O
two	O
taxa	O
.	O

A	O
novel	O
species	O
,	O
Dialister	B-bacteria
invisus	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
.	O

Biochemically	O
,	O
the	O
species	O
is	O
largely	O
unreactive	O
and	O
is	O
asaccharolytic	O
,	O
with	O
only	O
traces	O
of	O
acetate	O
and	O
propionate	O
detected	O
as	O
metabolic	O
end	O
-	O
products	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
D	O
.	O
invisus	O
strains	O
is	O
45	O
-	O
46	O
mol	O
%	O
.	O

The	O
type	O
strain	O
is	O
E7	O
.	O
25	O
(	O
T	O
)	O
(	O
=	O
CCUG	B-bacteria
47026	I-bacteria
(	O
T	O
)	O
=	O
DSM	B-bacteria
15470	I-bacteria
(	O
T	O
)	O
)	O
.	O

To	O
investigate	O
whether	O
human	O
breast	O
milk	O
contains	O
potentially	O
probiotic	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
and	O
therefore	O
,	O
whether	O
it	O
can	O
be	O
considered	O
a	O
synbiotic	O
food	O
.	O

Study	O
design	O
Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
were	O
isolated	O
from	O
milk	O
,	O
mammary	O
areola	O
,	O
and	O
breast	O
skin	O
of	O
eight	O
healthy	O
mothers	O
and	O
oral	O
swabs	O
and	O
feces	O
of	O
their	O
respective	O
breast	O
-	O
fed	O
infants	O
.	O

Some	O
isolates	O
(	O
178	O
from	O
each	O
mother	O
and	O
newborn	O
pair	O
)	O
were	O
randomly	O
selected	O
and	O
submitted	O
to	O
randomly	O
amplified	O
polymorphic	O
DNA	O
(	O
RAPD	O
)	O
polymerase	O
chain	O
reaction	O
analysis	O
,	O
and	O
those	O
that	O
displayed	O
identical	O
RAPD	O
patterns	O
were	O
identified	O
by	O
16S	O
rDNA	O
sequencing	O
.	O

Within	O
each	O
mother	O
and	O
newborn	O
pair	O
,	O
some	O
rod	O
-	O
shaped	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
isolated	O
from	O
mammary	O
areola	O
,	O
breast	O
milk	O
,	O
and	O
infant	O
oral	O
swabs	O
and	O
feces	O
displayed	O
identical	O
RAPD	O
profiles	O
.	O

All	O
of	O
them	O
,	O
independently	O
from	O
the	O
mother	O
and	O
child	O
pair	O
,	O
were	O
identified	O
as	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
.	O

Similarly	O
,	O
among	O
coccoid	B-bacteria
lactic	I-bacteria
acid	I-bacteria
bacteria	I-bacteria
from	O
these	O
different	O
sources	O
,	O
some	O
shared	O
an	O
identical	O
RAPD	O
pattern	O
and	O
were	O
identified	O
as	O
Enterococcus	B-bacteria
faecium	I-bacteria
.	O

In	O
contrast	O
,	O
none	O
of	O
the	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
isolated	O
from	O
breast	O
skin	O
shared	O
RAPD	O
profiles	O
with	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
of	O
the	O
other	O
sources	O
.	O

Breast	O
-	O
feeding	O
can	O
be	O
a	O
significant	O
source	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
to	O
the	O
infant	O
gut	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
present	O
in	O
milk	O
may	O
have	O
an	O
endogenous	O
origin	O
and	O
may	O
not	O
be	O
the	O
result	O
of	O
contamination	O
from	O
the	O
surrounding	O
breast	O
skin	O
.	O

To	O
analyze	O
the	O
relationship	O
between	O
Helicobacter	B-bacteria
pylori	I-bacteria
(	O
Hp	B-bacteria
)	O
in	O
oral	O
cavity	O
and	O
the	O
Hp	B-bacteria
infection	O
in	O
stomach	O
.	O

102	O
patients	O
with	O
gastric	O
Hp	B-bacteria
infection	O
and	O
periodontitis	O
were	O
enrolled	O
in	O
this	O
study	O
.	O

DNA	O
was	O
extracted	O
from	O
subgingival	O
plaques	O
,	O
mouthwashes	O
and	O
stomach	O
mucosa	O
samples	O
by	O
using	O
the	O
glass	O
-	O
milk	O
(	O
SiO2	O
)	O
purification	O
method	O
.	O

To	O
identify	O
the	O
presence	O
of	O
Hp	B-bacteria
in	O
these	O
samples	O
,	O
PCR	O
(	O
polymerase	O
chain	O
reaction	O
)	O
was	O
carried	O
out	O
,	O
and	O
two	O
pairs	O
of	O
oligonucleotide	O
primer	O
were	O
used	O
to	O
amplify	O
a	O
portion	O
of	O
gene	O
urease	O
C	O
and	O
gene	O
cag	O
A	O
of	O
Hp	B-bacteria
.	O

The	O
rate	O
of	O
Hp	B-bacteria
detected	O
in	O
oral	O
cavity	O
was	O
significantly	O
higher	O
in	O
patients	O
with	O
positive	O
Hp	B-bacteria
in	O
stomach	O
(	O
43	O
.	O
1	O
%	O
,	O
n	O
=	O
58	O
)	O
than	O
in	O
those	O
with	O
negative	O
Hp	B-bacteria
in	O
stomach	O
(	O
22	O
.	O
7	O
%	O
,	O
n	O
=	O
44	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

After	O
the	O
treatment	O
for	O
gastric	O
Hp	B-bacteria
infection	O
for	O
4	O
weeks	O
,	O
the	O
eradication	O
rate	O
of	O
Hp	B-bacteria
in	O
stomach	O
was	O
lower	O
,	O
but	O
only	O
slightly	O
in	O
patients	O
with	O
positive	O
oral	O
Hp	B-bacteria
(	O
16	O
/	O
25	O
,	O
64	O
%	O
)	O
than	O
in	O
those	O
with	O
negative	O
oral	O
Hp	B-bacteria
(	O
24	O
/	O
33	O
,	O
72	O
.	O
7	O
%	O
)	O
.	O

However	O
,	O
this	O
difference	O
became	O
apparent	O
(	O
36	O
.	O
0	O
%	O
vs	O
63	O
.	O
6	O
%	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
after	O
one	O
year	O
of	O
the	O
treatment	O
.	O

The	O
effectiveness	O
of	O
the	O
eradication	O
therapy	O
for	O
gastric	O
Hp	B-bacteria
infection	O
is	O
affected	O
by	O
the	O
presence	O
of	O
Hp	B-bacteria
in	O
oral	O
cavity	O
.	O

Oral	O
colonization	O
of	O
Hp	B-bacteria
may	O
imply	O
that	O
there	O
is	O
a	O
risk	O
of	O
the	O
relapses	O
of	O
gastric	O
and	O
duodenal	O
Hp	B-bacteria
infection	O
and	O
ulcer	O
after	O
the	O
antibiotics	O
treatment	O
for	O
the	O
eradication	O
of	O
Hp	B-bacteria
.	O

The	O
feasibility	O
of	O
recovering	O
and	O
genotypically	O
comparing	O
oral	O
bacteria	O
from	O
bitemarks	O
for	O
forensic	O
purposes	O
was	O
assessed	O
experimentally	O
.	O

Volunteers	O
firmly	O
bit	O
their	O
own	O
upper	O
arms	O
and	O
bitemarks	O
were	O
sampled	O
at	O
intervals	O
to	O
recover	O
viable	O
Streptococcus	B-bacteria
isolates	I-bacteria
.	O

The	O
recoverability	O
of	O
bacteria	O
decreased	O
over	O
time	O
but	O
an	O
average	O
of	O
more	O
than	O
one	O
thousand	O
viable	O
organisms	O
was	O
recovered	O
24	O
hrs	O
after	O
biting	O
,	O
provided	O
the	O
site	O
remained	O
relatively	O
undisturbed	O
.	O

Physical	O
exertion	O
,	O
manual	O
rubbing	O
and	O
application	O
of	O
moisturizing	O
lotion	O
all	O
decreased	O
bacterial	O
recoverability	O
compared	O
to	O
controls	O
.	O

Streptococci	B-bacteria
could	O
also	O
be	O
recovered	O
from	O
bites	O
inflicted	O
on	O
various	O
fabrics	O
.	O

Genomic	O
profiles	O
(	O
DNA	O
`	O
`	O
fingerprints	O
'	O
'	O
)	O
of	O
bacteria	O
recovered	O
from	O
bitemarks	O
could	O
be	O
identified	O
exclusively	O
with	O
those	O
from	O
the	O
teeth	O
of	O
the	O
individual	O
responsible	O
.	O

These	O
findings	O
suggest	O
that	O
a	O
bacterial	O
genotyping	O
approach	O
to	O
bitemark	O
analysis	O
could	O
have	O
forensic	O
application	O
in	O
situations	O
where	O
the	O
perpetrator	O
'	O
s	O
DNA	O
can	O
not	O
be	O
recovered	O
from	O
an	O
oral	O
contact	O
site	O
.	O

The	O
innate	O
immune	O
response	O
is	O
critical	O
for	O
the	O
epithelial	O
antimicrobial	O
barrier	O
.	O

The	O
human	O
beta	O
-	O
defensins	O
are	O
small	O
,	O
cationic	O
antimicrobial	O
peptides	O
that	O
are	O
made	O
by	O
epithelial	O
cells	O
and	O
that	O
play	O
a	O
role	O
in	O
mucosal	O
and	O
skin	O
defenses	O
.	O

Human	O
beta	O
-	O
defensin	O
1	O
(	O
hBD	O
-	O
1	O
)	O
is	O
expressed	O
constitutively	O
in	O
epithelial	O
tissues	O
,	O
whereas	O
hBD	O
-	O
2	O
and	O
hBD	O
-	O
3	O
are	O
expressed	O
in	O
response	O
to	O
bacterial	O
stimuli	O
or	O
inflammation	O
.	O

Previous	O
studies	O
showed	O
that	O
hBD	O
-	O
2	O
was	O
induced	O
by	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
cell	O
wall	O
extract	O
without	O
the	O
involvement	O
of	O
the	O
NF	O
-	O
kappaB	O
transcription	O
factors	O
,	O
which	O
typically	O
are	O
associated	O
with	O
innate	O
immunity	O
and	O
inflammation	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
characterize	O
signaling	O
pathways	O
involved	O
in	O
hBD	O
-	O
2	O
induction	O
in	O
response	O
to	O
commensal	O
and	O
pathogenic	O
bacteria	O
.	O

Cultured	O
human	O
oral	O
and	O
foreskin	O
keratinocytes	O
were	O
treated	O
separately	O
with	O
inhibitors	O
of	O
NF	O
-	O
kappaB	O
,	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
,	O
and	O
p38	O
and	O
then	O
stimulated	O
with	O
oral	O
commensal	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
oral	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
skin	O
commensal	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
,	O
or	O
skin	O
pathogen	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
.	O

Different	O
bacteria	O
induced	O
different	O
levels	O
of	O
hBD	O
-	O
2	O
and	O
in	O
response	O
to	O
the	O
various	O
inhibitors	O
tested	O
,	O
although	O
certain	O
common	O
patterns	O
were	O
observed	O
for	O
commensal	O
-	O
and	O
pathogen	O
-	O
stimulated	O
cells	O
.	O

hBD	O
-	O
2	O
induction	O
by	O
all	O
bacteria	O
tested	O
was	O
partially	O
or	O
completely	O
blocked	O
by	O
inhibitors	O
of	O
the	O
JNK	O
and	O
p38	O
pathways	O
.	O

However	O
,	O
in	O
addition	O
,	O
hBD	O
-	O
2	O
induction	O
by	O
pathogenic	O
bacteria	O
in	O
both	O
oral	O
and	O
foreskin	O
keratinocytes	O
was	O
blocked	O
by	O
inhibitors	O
of	O
NF	O
-	O
kappaB	O
.	O

The	O
results	O
indicate	O
that	O
commensal	O
and	O
pathogenic	O
bacteria	O
utilize	O
different	O
pathways	O
in	O
hBD	O
-	O
2	O
induction	O
and	O
suggest	O
that	O
epithelial	O
cells	O
from	O
different	O
body	O
sites	O
have	O
common	O
signaling	O
mechanisms	O
to	O
distinguish	O
between	O
commensal	O
and	O
pathogenic	O
bacteria	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
organisms	O
are	O
occasionally	O
isolated	O
from	O
the	O
blood	O
of	O
patients	O
with	O
infective	O
endocarditis	O
,	O
though	O
the	O
mechanisms	O
of	O
invasion	O
and	O
survival	O
remain	O
to	O
be	O
elucidated	O
.	O

Two	O
of	O
four	O
blood	O
isolates	O
from	O
patients	O
with	O
bacteremia	O
or	O
infective	O
endocarditis	O
(	O
strains	O
TW295	B-bacteria
and	O
TW871	B-bacteria
)	O
were	O
serologically	O
untypeable	O
by	O
immunodiffusion	O
testing	O
,	O
which	O
was	O
due	O
to	O
a	O
lack	O
of	O
the	O
glucose	O
side	O
chain	O
of	O
the	O
serotype	O
-	O
specific	O
polysaccharide	O
antigen	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Immunodiffusion	O
analyses	O
using	O
antisera	O
against	O
these	O
strains	O
demonstrated	O
that	O
2	O
of	O
100	O
isolates	O
from	O
100	O
subjects	O
showed	O
a	O
positive	O
reaction	O
,	O
while	O
further	O
analysis	O
of	O
2500	O
isolates	O
from	O
50	O
subjects	O
revealed	O
that	O
all	O
50	O
isolates	O
from	O
a	O
single	O
subject	O
were	O
not	O
reactive	O
with	O
anti	O
-	O
c	O
,	O
-	O
e	O
,	O
and	O
-	O
f	O
antisera	O
,	O
though	O
they	O
were	O
reactive	O
with	O
anti	O
-	O
TW295	O
and	O
-	O
TW871	O
antisera	O
.	O

The	O
oral	O
isolates	O
showed	O
biological	O
properties	O
similar	O
to	O
those	O
of	O
the	O
reference	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strain	I-bacteria
MT8148	I-bacteria
,	O
including	O
high	O
levels	O
of	O
sucrose	O
-	O
dependent	O
adhesion	O
and	O
cellular	O
hydrophobicity	O
,	O
along	O
with	O
expression	O
of	O
glucosyltransferases	O
and	O
a	O
protein	O
antigen	O
,	O
PA	O
.	O
We	O
designated	O
these	O
organisms	O
serotype	O
k	O
.	O
A	O
glucose	O
side	O
chain	O
-	O
defective	O
mutant	O
strain	O
was	O
then	O
constructed	O
by	O
insertional	O
inactivation	O
of	O
the	O
gluA	O
gene	O
of	O
strain	O
MT8148	B-bacteria
,	O
which	O
showed	O
biological	O
properties	O
similar	O
to	O
those	O
of	O
serotype	O
k	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Serotype	O
k	O
oral	O
isolates	O
were	O
less	O
susceptible	O
to	O
phagocytosis	O
,	O
as	O
were	O
the	O
gluA	O
-	O
inactivated	O
mutant	O
of	O
strain	O
MT8148	B-bacteria
and	O
blood	O
isolates	O
.	O

These	O
results	O
indicate	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
serotype	I-bacteria
k	I-bacteria
strains	I-bacteria
are	O
present	O
in	O
the	O
oral	O
cavity	O
in	O
humans	O
and	O
may	O
be	O
able	O
to	O
survive	O
longer	O
in	O
blood	O
owing	O
to	O
their	O
low	O
susceptibility	O
to	O
phagocytosis	O
.	O

A	O
retrospective	O
analysis	O
of	O
laboratory	O
data	O
to	O
investigate	O
the	O
isolation	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
from	O
the	O
oral	O
cavity	O
and	O
facial	O
area	O
in	O
specimens	O
submitted	O
to	O
a	O
regional	O
diagnostic	O
oral	O
microbiology	O
laboratory	O
.	O

A	O
hand	O
search	O
of	O
laboratory	O
records	O
for	O
a	O
three	O
-	O
year	O
period	O
(	O
1998	O
-	O
2000	O
)	O
was	O
performed	O
for	O
specimens	O
submitted	O
to	O
the	O
regional	O
diagnostic	O
oral	O
microbiology	O
laboratory	O
based	O
at	O
Glasgow	O
Dental	O
Hospital	O
and	O
School	O
.	O

Data	O
were	O
collected	O
from	O
forms	O
where	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
was	O
isolated	O
.	O

These	O
data	O
included	O
demographics	O
,	O
referral	O
source	O
,	O
specimen	O
type	O
,	O
methicillin	O
susceptibility	O
and	O
clinical	O
details	O
.	O

For	O
the	O
period	O
1998	O
-	O
2000	O
,	O
there	O
were	O
5	O
,	O
005	O
specimens	O
submitted	O
to	O
the	O
laboratory	O
.	O

S	B-bacteria
.	I-bacteria
aureus	I-bacteria
was	O
isolated	O
from	O
1	O
,	O
017	O
specimens	O
,	O
of	O
which	O
967	O
(	O
95	O
%	O
)	O
were	O
sensitive	O
to	O
methicillin	O
(	O
MSSA	B-bacteria
)	O
and	O
50	O
(	O
5	O
%	O
)	O
were	O
resistant	O
to	O
methicillin	O
(	O
MRSA	B-bacteria
)	O
.	O

The	O
1	O
,	O
017	O
specimens	O
were	O
provided	O
from	O
615	O
patients	O
.	O

MRSA	B-bacteria
was	O
isolated	O
from	O
37	O
(	O
6	O
%	O
)	O
of	O
patients	O
.	O

There	O
was	O
an	O
increasing	O
incidence	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
with	O
age	O
,	O
particularly	O
in	O
the	O
>	O
70	O
years	O
age	O
group	O
.	O

The	O
most	O
common	O
specimen	O
from	O
which	O
MSSA	B-bacteria
was	O
isolated	O
was	O
an	O
oral	O
rinse	O
(	O
38	O
%	O
)	O
whilst	O
for	O
MRSA	B-bacteria
isolates	I-bacteria
this	O
was	O
a	O
tongue	O
swab	O
(	O
28	O
%	O
)	O
.	O

The	O
clinical	O
condition	O
most	O
commonly	O
reported	O
for	O
MSSA	B-bacteria
isolates	I-bacteria
was	O
angular	O
cheilitis	O
(	O
22	O
%	O
)	O
.	O

Erythema	O
,	O
swelling	O
,	O
pain	O
or	O
burning	O
of	O
the	O
oral	O
mucosa	O
was	O
the	O
clinical	O
condition	O
most	O
commonly	O
reported	O
for	O
MRSA	B-bacteria
isolates	I-bacteria
(	O
16	O
%	O
)	O
.	O

Patients	O
from	O
whom	O
the	O
MSSA	B-bacteria
isolates	I-bacteria
were	O
recovered	O
were	O
most	O
commonly	O
(	O
55	O
%	O
)	O
seen	O
in	O
the	O
oral	O
medicine	O
clinic	O
at	O
the	O
dental	O
hospital	O
,	O
whilst	O
patients	O
with	O
MRSA	B-bacteria
were	O
more	O
commonly	O
seen	O
in	O
primary	O
care	O
settings	O
such	O
as	O
nursing	O
homes	O
,	O
hospices	O
and	O
general	O
dental	O
practice	O
(	O
51	O
%	O
)	O
.	O

In	O
line	O
with	O
more	O
recent	O
surveys	O
,	O
this	O
retrospective	O
study	O
suggests	O
that	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
may	O
be	O
a	O
more	O
frequent	O
isolate	O
from	O
the	O
oral	O
cavity	O
than	O
hitherto	O
suspected	O
.	O

A	O
small	O
proportion	O
of	O
the	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
isolates	I-bacteria
were	O
MRSA	B-bacteria
.	O

There	O
were	O
insufficient	O
data	O
available	O
to	O
determine	O
whether	O
the	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
isolates	I-bacteria
were	O
colonising	O
or	O
infecting	O
the	O
oral	O
cavity	O
.	O

However	O
,	O
the	O
role	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
several	O
diseases	O
of	O
the	O
oral	O
mucosa	O
merits	O
further	O
investigation	O
.	O

Calcific	O
aortic	O
stenosis	O
is	O
a	O
major	O
public	O
health	O
problem	O
in	O
the	O
United	O
States	O
.	O

The	O
mechanism	O
of	O
calcification	O
remains	O
unclear	O
.	O

The	O
hypothesis	O
that	O
low	O
grade	O
chronic	O
or	O
recurrent	O
bacterial	O
endocarditis	O
with	O
specific	O
calcifiable	O
bacteria	O
is	O
a	O
cause	O
of	O
calcification	O
of	O
the	O
aortic	O
valves	O
was	O
investigated	O
using	O
an	O
animal	O
model	O
.	O

Such	O
bacteria	O
are	O
typically	O
present	O
as	O
part	O
of	O
the	O
normal	O
human	O
oral	O
flora	O
.	O

Forty	O
New	O
Zealand	O
white	O
rabbits	O
were	O
divided	O
into	O
four	O
groups	O
:	O
group	O
1	O
,	O
control	O
(	O
1	O
ml	O
of	O
normal	O
saline	O
)	O
;	O
group	O
2	O
,	O
Corynebacterium	B-bacteria
matruchotti	I-bacteria
100	O
,	O
000	O
colonies	O
;	O
group	O
3	O
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
II	I-bacteria
10	I-bacteria
colonies	O
;	O
and	O
group	O
4	O
,	O
C	B-bacteria
matruchotti	I-bacteria
100	O
,	O
000	O
colonies	O
plus	O
S	B-bacteria
sanguis	I-bacteria
II	I-bacteria
10	O
colonies	O
.	O

Animals	O
were	O
inoculated	O
with	O
bacteria	O
through	O
a	O
flexible	O
catheter	O
placed	O
through	O
the	O
aortic	O
valve	O
through	O
a	O
right	O
carotid	O
cut	O
down	O
.	O

Inoculations	O
were	O
repeated	O
every	O
3	O
days	O
the	O
first	O
2	O
weeks	O
and	O
then	O
twice	O
a	O
week	O
thereafter	O
.	O

At	O
postmortem	O
examination	O
the	O
aortic	O
valves	O
were	O
harvested	O
,	O
embedded	O
in	O
paraffin	O
,	O
and	O
stained	O
with	O
von	O
Kossa	O
stain	O
.	O

They	O
were	O
also	O
examined	O
by	O
scanning	O
and	O
transmission	O
electron	O
micrography	O
.	O

Group	O
4	O
had	O
93	O
.	O
3	O
%	O
large	O
calcifications	O
(	O
confluent	O
calcium	O
densities	O
that	O
are	O
easily	O
recognized	O
with	O
minimal	O
magnification	O
)	O
and	O
6	O
.	O
6	O
%	O
small	O
microcalcifications	O
(	O
dustlike	O
microscopic	O
particles	O
requiring	O
a	O
compound	O
microscope	O
to	O
appreciate	O
)	O
of	O
the	O
aortic	O
valves	O
.	O

Group	O
3	O
exhibited	O
large	O
calcification	O
in	O
20	O
%	O
and	O
small	O
in	O
40	O
%	O
of	O
the	O
aortic	O
valves	O
.	O

Group	O
1	O
and	O
group	O
2	O
had	O
no	O
evidence	O
of	O
calcification	O
.	O

These	O
results	O
suggest	O
that	O
recurrent	O
low	O
-	O
grade	O
endocarditis	O
from	O
calcifying	O
oral	O
bacteria	O
,	O
particularly	O
when	O
occurring	O
with	O
synergistic	O
strains	O
,	O
may	O
be	O
one	O
cause	O
of	O
calcific	O
aortic	O
stenosis	O
.	O

Some	O
oral	O
anaerobes	O
from	O
the	O
Streptococcus	B-bacteria
milleri	I-bacteria
strain	I-bacteria
group	O
were	O
found	O
to	O
secrete	O
human	O
specific	O
hemolytic	O
toxin	O
,	O
which	O
was	O
detected	O
when	O
bacteria	O
were	O
cultured	O
in	O
Todd	O
-	O
Hewitt	O
broth	O
and	O
Brain	O
Heart	O
Infusion	O
broth	O
.	O

The	O
toxin	O
elicited	O
by	O
the	O
Streptococcus	B-bacteria
intermedius	I-bacteria
strain	I-bacteria
was	O
partially	O
fractionated	O
by	O
ammonium	O
sulfate	O
precipitation	O
.	O

Preincubation	O
with	O
glutathione	O
or	O
cysteine	O
showed	O
significant	O
inhibiting	O
effects	O
;	O
however	O
,	O
no	O
effects	O
were	O
seen	O
with	O
dithiothreitol	O
or	O
beta	O
-	O
mercaptoethanol	O
,	O
and	O
cholesterol	O
was	O
a	O
weak	O
inhibitor	O
.	O

Five	O
kinds	O
of	O
protease	O
inhibitor	O
had	O
no	O
effect	O
on	O
the	O
hemolytic	O
activity	O
,	O
and	O
rabbit	O
preimmune	O
and	O
immune	O
sera	O
against	O
the	O
bacterial	O
cells	O
showed	O
weak	O
inhibition	O
at	O
a	O
similar	O
level	O
.	O

Digestion	O
with	O
trypsin	O
,	O
chymotrypsin	O
,	O
proteinase	O
-	O
K	O
,	O
subtilisin	O
and	O
pronase	O
-	O
P	O
brought	O
about	O
a	O
rise	O
in	O
activity	O
,	O
followed	O
by	O
a	O
decrease	O
during	O
long	O
-	O
term	O
incubation	O
.	O

Other	O
enzymes	O
tested	O
showed	O
no	O
effects	O
.	O

Further	O
,	O
the	O
presence	O
of	O
the	O
intermedilysin	O
gene	O
in	O
the	O
portion	O
with	O
hemolytic	O
activity	O
was	O
not	O
identified	O
by	O
polymerase	O
chain	O
reaction	O
.	O

The	O
authors	O
studied	O
the	O
bacterial	O
flora	O
of	O
the	O
dog	O
oral	O
cavity	O
and	O
of	O
bite	O
wounds	O
,	O
Aerobic	O
bacteria	O
were	O
isolated	O
from	O
mouth	O
swabs	O
of	O
16	O
normal	O
and	O
5	O
rabid	O
dogs	O
as	O
well	O
as	O
from	O
infected	O
dog	O
-	O
bite	O
wounds	O
from	O
18	O
patients	O
.	O

A	O
total	O
of	O
20	O
different	O
microbial	O
species	O
were	O
recovered	O
from	O
mouth	O
swab	O
cultures	O
.	O

The	O
most	O
frequently	O
isolated	O
organisms	O
were	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
ssp	I-bacteria
pneumoniae	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Citrobacter	B-bacteria
freundii	I-bacteria
,	O
Enterobacter	B-bacteria
cloacae	I-bacteria
,	O
Acinetobacter	B-bacteria
calcoaceticus	I-bacteria
,	O
and	O
Pasteurella	B-bacteria
species	I-bacteria
.	O

There	O
were	O
no	O
differences	O
in	O
the	O
aerobic	O
bacterial	O
flora	O
between	O
rabid	O
and	O
nonrabid	O
dogs	O
.	O

From	O
the	O
cultures	O
of	O
the	O
bite	O
wound	O
swabs	O
,	O
the	O
authors	O
found	O
that	O
almost	O
all	O
of	O
the	O
organisms	O
identified	O
were	O
part	O
of	O
the	O
normal	O
oral	O
flora	O
of	O
the	O
dog	O
.	O

One	O
or	O
more	O
aerobic	O
bacteria	O
were	O
isolated	O
from	O
the	O
infected	O
dog	O
-	O
bite	O
wounds	O
.	O

Two	O
patients	O
had	O
four	O
,	O
3	O
had	O
three	O
,	O
4	O
had	O
two	O
,	O
and	O
6	O
had	O
one	O
of	O
the	O
nine	O
organisms	O
in	O
their	O
wounds	O
.	O

The	O
predominant	O
species	O
of	O
bacteria	O
involved	O
in	O
infection	O
of	O
bite	O
wounds	O
were	O
,	O
as	O
follows	O
:	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Pasteurella	B-bacteria
multocida	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
Moraxella	B-bacteria
species	I-bacteria
,	O
Pasteurella	B-bacteria
canis	I-bacteria
,	O
and	O
Enterobacter	B-bacteria
cloacae	I-bacteria
.	O

However	O
,	O
three	O
wound	O
cultures	O
had	O
no	O
aerobic	O
bacterial	O
growth	O
.	O

The	O
results	O
of	O
this	O
study	O
show	O
that	O
the	O
infected	O
bite	O
wounds	O
may	O
contain	O
a	O
mixed	O
bacterial	O
flora	O
that	O
colonize	O
human	O
skin	O
and	O
the	O
oral	O
cavity	O
of	O
dogs	O
.	O

Oral	O
streptococci	B-bacteria
are	O
primary	O
colonisers	O
of	O
the	O
tooth	O
surface	O
and	O
are	O
abundant	O
in	O
dental	O
plaque	O
biofilms	O
.	O

Bacteria	O
growing	O
in	O
these	O
relatively	O
dense	O
,	O
surface	O
-	O
associated	O
communities	O
are	O
phenotypically	O
quite	O
distinct	O
from	O
their	O
planktonic	O
counterparts	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
develop	O
a	O
method	O
to	O
investigate	O
biofilm	O
-	O
specific	O
surface	O
protein	O
expression	O
by	O
Streptococcus	B-bacteria
sanguis	I-bacteria
to	O
help	O
provide	O
a	O
better	O
understanding	O
of	O
the	O
critical	O
events	O
in	O
plaque	O
development	O
.	O

Biofilm	O
cells	O
were	O
grown	O
on	O
the	O
surface	O
of	O
glass	O
beads	O
in	O
a	O
biofilm	O
device	O
fed	O
with	O
mucin	O
-	O
containing	O
artificial	O
saliva	O
.	O

Planktonic	O
cells	O
were	O
grown	O
in	O
continuous	O
culture	O
at	O
approximately	O
the	O
same	O
growth	O
rate	O
.	O

Surface	O
hydrophobicity	O
of	O
biofilm	O
and	O
planktonic	O
cells	O
was	O
determined	O
by	O
hexadecane	O
partitioning	O
,	O
and	O
expression	O
of	O
streptococcal	B-bacteria
fibronectin	O
adhesin	O
CshA	O
was	O
determined	O
in	O
ELISA	O
using	O
specific	O
antiserum	O
.	O

Antisera	O
raised	O
to	O
glutaraldehyde	O
-	O
fixed	O
whole	O
biofilm	O
or	O
planktonic	O
grown	O
cells	O
were	O
used	O
to	O
screen	O
an	O
expression	O
library	O
of	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
genomic	O
DNA	O
,	O
and	O
isolated	O
clones	O
were	O
sequenced	O
.	O

Phenotypic	O
analysis	O
of	O
biofilm	O
and	O
planktonic	O
cells	O
confirmed	O
that	O
mode	O
of	O
growth	O
affected	O
surface	O
properties	O
of	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
.	O

Thus	O
,	O
hydrophobicity	O
and	O
CshA	O
expression	O
was	O
significantly	O
elevated	O
in	O
biofilm	O
cells	O
.	O

Library	O
screening	O
with	O
biofilm	O
antiserum	O
yielded	O
32	O
recombinant	O
clones	O
representing	O
21	O
different	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
proteins	O
involved	O
in	O
adhesion	O
and	O
colonisation	O
,	O
carbohydrate	O
utilisation	O
or	O
bacterial	O
metabolism	O
.	O

In	O
differential	O
analysis	O
of	O
four	O
selected	O
Escherichia	B-bacteria
coli	I-bacteria
clones	O
,	O
biofilm	O
antiserum	O
reacted	O
five	O
times	O
stronger	O
than	O
planktonic	O
antiserum	O
with	O
cell	O
-	O
free	O
extracts	O
of	O
clones	O
encoding	O
homologues	O
of	O
CshA	O
and	O
Cna	O
collagen	O
adhesin	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
suggesting	O
that	O
these	O
surface	O
proteins	O
are	O
up	O
-	O
regulated	O
in	O
biofilm	O
cells	O
.	O

In	O
contrast	O
,	O
both	O
antisera	O
reacted	O
equally	O
strongly	O
with	O
cell	O
-	O
free	O
extracts	O
of	O
the	O
remaining	O
two	O
clones	O
(	O
encoding	O
dihydrofolate	O
synthase	O
and	O
an	O
unknown	O
protein	O
)	O
.	O

The	O
method	O
described	O
represents	O
a	O
useful	O
means	O
for	O
determining	O
bacterial	O
protein	O
expression	O
in	O
biofilms	O
based	O
on	O
a	O
combination	O
of	O
molecular	O
and	O
immunological	O
techniques	O
.	O

Surface	O
expression	O
of	O
putative	O
fibronectin	O
and	O
collagen	O
adhesins	O
was	O
up	O
-	O
regulated	O
in	O
biofilm	O
cells	O
.	O

Human	O
beta	O
-	O
defensins	O
2	O
and	O
3	O
(	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
)	O
are	O
inducible	O
peptides	O
present	O
at	O
sites	O
of	O
infection	O
in	O
the	O
oral	O
cavity	O
.	O

A	O
few	O
studies	O
have	O
reported	O
broad	O
-	O
spectrum	O
antimicrobial	O
activity	O
for	O
both	O
peptides	O
.	O

However	O
,	O
no	O
comprehensive	O
study	O
has	O
thoroughly	O
investigated	O
their	O
potential	O
against	O
oral	O
pathogens	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
effectiveness	O
of	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
against	O
a	O
collection	O
of	O
oral	O
organisms	O
(	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Candida	O
tropicalis	O
,	O
Candida	O
parapsilosis	O
,	O
Candida	O
krusei	O
,	O
Candida	O
glabrata	O
,	O
and	O
Candida	O
albicans	O
)	O
.	O

Radial	O
diffusion	O
assays	O
were	O
used	O
to	O
test	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
activities	O
against	O
at	O
least	O
three	O
strains	O
of	O
each	O
species	O
.	O

There	O
was	O
significant	O
variability	O
in	O
MICs	O
,	O
which	O
was	O
strain	O
specific	O
rather	O
than	O
species	O
specific	O
.	O

MICs	O
ranged	O
from	O
3	O
.	O
9	O
to	O
>	O
250	O
micro	O
g	O
/	O
ml	O
for	O
HBD	O
-	O
2	O
and	O
from	O
1	O
.	O
4	O
to	O
>	O
250	O
micro	O
g	O
/	O
ml	O
for	O
HBD	O
-	O
3	O
.	O

HBD	O
-	O
3	O
demonstrated	O
greater	O
antimicrobial	O
activity	O
and	O
was	O
effective	O
against	O
a	O
broader	O
array	O
of	O
organisms	O
.	O

Overall	O
,	O
aerobes	O
were	O
100	O
%	O
susceptible	O
to	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
,	O
whereas	O
only	O
21	O
.	O
4	O
and	O
50	O
%	O
of	O
the	O
anaerobes	O
were	O
susceptible	O
to	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
,	O
respectively	O
.	O

HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
also	O
demonstrated	O
strain	O
-	O
specific	O
activity	O
against	O
the	O
Candida	O
species	O
evaluated	O
.	O

Interestingly	O
,	O
an	O
association	O
between	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
activities	O
was	O
noted	O
.	O

This	O
suggests	O
that	O
the	O
two	O
peptides	O
may	O
have	O
similar	O
mechanisms	O
yet	O
utilize	O
distinct	O
pathways	O
.	O

The	O
lack	O
of	O
activity	O
against	O
specific	O
anaerobic	O
strains	O
and	O
Candida	O
warrants	O
further	O
investigation	O
of	O
the	O
potential	O
resistance	O
mechanisms	O
of	O
these	O
organisms	O
.	O

Finally	O
,	O
the	O
significant	O
variability	O
between	O
strains	O
underlies	O
the	O
importance	O
of	O
testing	O
multiple	O
strains	O
when	O
evaluating	O
activities	O
of	O
antimicrobial	O
peptides	O
.	O

To	O
compare	O
the	O
protective	O
activity	O
of	O
liver	O
injury	O
induced	O
by	O
D	O
-	O
galactosamine	O
(	O
GalN	O
)	O
between	O
Huangqin	O
-	O
Tang	O
and	O
their	O
metabolites	O
by	O
human	O
intestinal	O
bacteria	O
(	O
HIB	O
)	O
.	O

The	O
liver	O
injuries	O
in	O
conventional	O
and	O
pseudo	O
-	O
germfree	O
mice	O
were	O
induced	O
by	O
GalN	O
.	O

After	O
oral	O
administration	O
of	O
Huangqin	O
-	O
Tang	O
and	O
their	O
metabolites	O
mixtures	O
by	O
HIB	O
,	O
the	O
serum	O
transaminase	O
(	O
ALT	O
and	O
AST	O
)	O
activities	O
were	O
detected	O
.	O

In	O
conventional	O
mice	O
,	O
large	O
and	O
medium	O
doses	O
(	O
20	O
and	O
10	O
g	O
.	O
kg	O
-	O
1	O
)	O
of	O
Huangqin	O
-	O
Tang	O
decoction	O
significantly	O
reduced	O
the	O
increase	O
of	O
serum	O
ALT	O
activity	O
after	O
18	O
h	O
GalN	O
treatment	O
.	O

In	O
pseudo	O
-	O
germfree	O
mice	O
,	O
metabolites	O
significantly	O
reduced	O
the	O
ALT	O
levels	O
.	O

However	O
,	O
Huangqing	O
-	O
Tang	O
did	O
n	O
'	O
t	O
affect	O
the	O
ALT	O
levels	O
in	O
this	O
kind	O
of	O
mice	O
.	O

To	O
all	O
of	O
the	O
animals	O
,	O
AST	O
levels	O
remained	O
the	O
same	O
after	O
oral	O
Huangqin	O
-	O
tang	O
or	O
their	O
metabolites	O
.	O

The	O
metabolism	O
by	O
intestinal	O
bacteria	O
plays	O
a	O
role	O
in	O
pharmacological	O
effects	O
of	O
constituents	O
of	O
Chinese	O
herbal	O
medicine	O
.	O

The	O
metabolites	O
of	O
the	O
constituents	O
by	O
intestinal	O
bacteria	O
were	O
the	O
real	O
active	O
components	O
in	O
vivo	O
.	O

Oral	O
streptococci	B-bacteria
are	O
major	O
constituents	O
of	O
dental	O
plaque	O
,	O
and	O
their	O
prevalence	O
is	O
implicated	O
in	O
various	O
pathologies	O
.	O

Therefore	O
,	O
accurate	O
identification	O
of	O
oral	O
streptococci	B-bacteria
would	O
be	O
valuable	O
for	O
studies	O
of	O
cariogenic	O
plaque	O
and	O
for	O
diagnostic	O
use	O
in	O
infective	O
endocarditis	O
.	O

Many	O
oral	O
streptococci	B-bacteria
possess	O
glucosyltransferase	O
enzymes	O
that	O
synthesize	O
glucan	O
,	O
which	O
is	O
an	O
obligate	O
component	O
of	O
dental	O
plaque	O
.	O

We	O
established	O
a	O
rapid	O
and	O
precise	O
method	O
to	O
identify	O
oral	O
streptococci	B-bacteria
by	O
PCR	O
using	O
the	O
species	O
-	O
specific	O
region	O
from	O
the	O
glucosyltransferase	O
gene	O
.	O

With	O
the	O
species	O
-	O
specific	O
primers	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
could	O
be	O
successfully	O
distinguished	O
.	O

Further	O
,	O
we	O
developed	O
a	O
simple	O
method	O
to	O
extract	O
the	O
bacterial	O
DNA	O
from	O
saliva	O
.	O

Using	O
the	O
resultant	O
DNA	O
as	O
a	O
template	O
,	O
the	O
proposed	O
PCR	O
detection	O
was	O
performed	O
.	O

Their	O
distribution	O
was	O
in	O
accord	O
with	O
results	O
of	O
conventional	O
biochemical	O
tests	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
present	O
PCR	O
method	O
is	O
useful	O
for	O
the	O
analysis	O
of	O
oral	O
streptococci	B-bacteria
and	O
can	O
be	O
successfully	O
used	O
in	O
clinical	O
applications	O
to	O
identify	O
pathogenic	O
bacteria	O
associated	O
with	O
oral	O
infectious	O
disease	O
and	O
/	O
or	O
endocarditis	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
a	O
gram	O
-	O
negative	O
anaerobe	O
ubiquitous	O
to	O
the	O
oral	O
cavity	O
.	O

It	O
is	O
associated	O
with	O
periodontal	O
disease	O
.	O

It	O
is	O
also	O
associated	O
with	O
preterm	O
birth	O
and	O
has	O
been	O
isolated	O
from	O
the	O
amniotic	O
fluid	O
,	O
placenta	O
,	O
and	O
chorioamnionic	O
membranes	O
of	O
women	O
delivering	O
prematurely	O
.	O

Periodontal	O
disease	O
is	O
a	O
newly	O
recognized	O
risk	O
factor	O
for	O
preterm	O
birth	O
.	O

This	O
study	O
examined	O
the	O
possible	O
mechanism	O
underlying	O
the	O
link	O
between	O
these	O
two	O
diseases	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strains	I-bacteria
isolated	O
from	O
amniotic	O
fluids	O
and	O
placentas	O
along	O
with	O
those	O
isolated	O
from	O
orally	O
related	O
sources	O
invaded	O
both	O
epithelial	O
and	O
endothelial	O
cells	O
.	O

The	O
invasive	O
ability	O
may	O
enable	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
colonize	O
and	O
infect	O
the	O
pregnant	O
uterus	O
.	O

Transient	O
bacteremia	O
caused	O
by	O
periodontal	O
infection	O
may	O
facilitate	O
bacterial	O
transmission	O
from	O
the	O
oral	O
cavity	O
to	O
the	O
uterus	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
intravenously	O
injected	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
into	O
pregnant	O
CF	O
-	O
1	O
mice	O
.	O

The	O
injection	O
resulted	O
in	O
premature	O
delivery	O
,	O
stillbirths	O
,	O
and	O
nonsustained	O
live	O
births	O
.	O

The	O
bacterial	O
infection	O
was	O
restricted	O
inside	O
the	O
uterus	O
,	O
without	O
spreading	O
systemically	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
first	O
detected	O
in	O
the	O
blood	O
vessels	O
in	O
murine	O
placentas	O
.	O

Invasion	O
of	O
the	O
endothelial	O
cells	O
lining	O
the	O
blood	O
vessels	O
was	O
observed	O
.	O

The	O
bacteria	O
then	O
crossed	O
the	O
endothelium	O
,	O
proliferated	O
in	O
surrounding	O
tissues	O
,	O
and	O
finally	O
spread	O
to	O
the	O
amniotic	O
fluid	O
.	O

The	O
pattern	O
of	O
infection	O
paralleled	O
that	O
in	O
humans	O
.	O

This	O
study	O
represents	O
the	O
first	O
evidence	O
that	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
may	O
be	O
transmitted	O
hematogenously	O
to	O
the	O
placenta	O
and	O
cause	O
adverse	O
pregnancy	O
outcomes	O
.	O

The	O
results	O
strengthen	O
the	O
link	O
between	O
periodontal	O
disease	O
and	O
preterm	O
birth	O
.	O

Our	O
study	O
also	O
indicates	O
that	O
invasion	O
may	O
be	O
an	O
important	O
virulence	O
mechanism	O
for	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
infect	O
the	O
placenta	O
.	O

We	O
examined	O
the	O
antimicrobial	O
effects	O
of	O
human	O
beta	O
-	O
defensin	O
-	O
2	O
(	O
hBD	O
-	O
2	O
)	O
on	O
17	O
species	O
of	O
oral	O
streptococci	B-bacteria
to	O
investigate	O
the	O
involvement	O
of	O
antimicrobial	O
peptide	O
activity	O
in	O
oral	O
microflora	O
development	O
and	O
the	O
clinical	O
use	O
of	O
the	O
antimicrobial	O
peptide	O
for	O
oral	O
microflora	O
control	O
.	O

Oral	O
streptococci	B-bacteria
exhibit	O
diverse	O
levels	O
of	O
susceptibility	O
to	O
human	O
beta	O
-	O
defensin	O
-	O
2	O
(	O
hBD	O
-	O
2	O
)	O
.	O

Two	O
major	O
cariogenic	O
bacterial	O
species	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
were	O
found	O
to	O
be	O
susceptible	O
to	O
the	O
peptide	O
,	O
indicating	O
that	O
it	O
is	O
a	O
potential	O
therapeutic	O
agent	O
for	O
preventing	O
dental	O
caries	O
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
exhibited	O
the	O
lowest	O
susceptibility	O
to	O
the	O
peptide	O
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
is	O
a	O
major	O
indigenous	O
bacterium	O
in	O
the	O
oral	O
microflora	O
,	O
and	O
our	O
results	O
suggest	O
that	O
it	O
might	O
possess	O
a	O
certain	O
resistance	O
mechanism	O
against	O
hBD	O
-	O
2	O
.	O

To	O
study	O
dynamic	O
relation	O
between	O
periodontal	O
pathogens	O
and	O
cariogenic	O
bacteria	O
under	O
analogous	O
oral	O
environment	O
.	O

Eight	O
periodontopathic	O
and	O
cariogenic	O
bacteria	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
Aa	B-bacteria
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
Fn	B-bacteria
)	O
,	O
Provotella	B-bacteria
intermedium	I-bacteria
(	O
Pi	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
Sm	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
(	O
Ss	B-bacteria
)	O
,	O
Actinomyces	B-bacteria
viscosus	I-bacteria
(	O
Av	B-bacteria
)	O
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
(	O
La	B-bacteria
)	O
were	O
used	O
.	O

These	O
eight	O
strains	O
were	O
cultured	O
in	O
modified	O
chemostat	O
under	O
analogous	O
oral	O
environment	O
which	O
contained	O
600	O
ml	O
modified	O
BM	O
medium	O
supplemented	O
with	O
2	O
.	O
5	O
g	O
/	O
L	O
porcine	O
gastric	O
mucin	O
,	O
respectively	O
.	O

After	O
1	O
,	O
24	O
,	O
48	O
and	O
96	O
h	O
,	O
optical	O
sectioning	O
of	O
plaque	O
biofilms	O
on	O
removable	O
and	O
replaceable	O
hydroxyapatite	O
disks	O
was	O
analyzed	O
by	O
the	O
combination	O
of	O
live	O
bacterial	O
Gram	O
fluorescence	O
staining	O
and	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Biofilm	O
thickness	O
and	O
reconstruction	O
of	O
the	O
three	O
-	O
dimensional	O
architecture	O
of	O
plaque	O
biofilms	O
were	O
made	O
.	O

Biofilm	O
thickness	O
increased	O
significantly	O
with	O
time	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Biofilms	O
of	O
Aa	B-bacteria
were	O
thinner	O
than	O
those	O
of	O
Ss	O
and	O
eight	O
-	O
specie	O
biofilms	O
were	O
thicker	O
than	O
those	O
formed	O
by	O
Ss	B-bacteria
and	O
Aa	B-bacteria
per	O
time	O
point	O
.	O

Three	O
-	O
dimensional	O
images	O
showed	O
periodontal	O
pathogens	O
mainly	O
occurred	O
in	O
cariogenic	O
bacterial	O
complex	O
or	O
on	O
the	O
biofilm	O
surface	O
.	O

Gram	O
-	O
positive	O
cariogenic	O
species	O
initially	O
predominated	O
in	O
artificial	O
plaque	O
,	O
followed	O
by	O
the	O
increasing	O
proportions	O
of	O
Gram	O
-	O
negative	O
periodontal	O
pathogens	O
.	O

The	O
relation	O
between	O
microecological	O
balance	O
among	O
bacteria	O
and	O
diseases	O
is	O
worthy	O
of	O
further	O
studies	O
.	O

It	O
is	O
difficult	O
to	O
permanently	O
change	O
the	O
composition	O
of	O
the	O
complex	O
intestinal	O
microflora	O
of	O
the	O
adult	O
.	O

Orally	O
administered	O
probiotic	O
bacteria	O
produce	O
only	O
temporary	O
colonization	O
of	O
the	O
intestine	O
in	O
patients	O
with	O
a	O
fully	O
developed	O
gut	O
microflora	O
.	O

The	O
gastrointestinal	O
tract	O
of	O
a	O
healthy	O
fetus	O
is	O
sterile	O
.	O

During	O
the	O
birth	O
process	O
and	O
rapidly	O
thereafter	O
,	O
microbes	O
from	O
the	O
mother	O
and	O
the	O
surrounding	O
environment	O
colonize	O
the	O
gastrointestinal	O
tract	O
until	O
a	O
dense	O
,	O
complex	O
microflora	O
develops	O
.	O

Probiotic	O
bacteria	O
have	O
been	O
shown	O
to	O
beneficially	O
influence	O
the	O
intestinal	O
and	O
systemic	O
immune	O
system	O
and	O
mediate	O
protection	O
against	O
nosocomial	O
infections	O
affecting	O
the	O
neonate	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
oral	O
administration	O
of	O
the	O
probiotic	O
micro	O
-	O
organism	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
strain	I-bacteria
GG	I-bacteria
(	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
)	O
to	O
the	O
pregnant	O
woman	O
leads	O
to	O
colonization	O
of	O
the	O
newborn	O
infant	O
.	O

The	O
authors	O
identified	O
six	O
women	O
who	O
were	O
taking	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
during	O
late	O
pregnancy	O
.	O

None	O
of	O
the	O
children	O
received	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
after	O
birth	O
,	O
and	O
their	O
mothers	O
discontinued	O
its	O
consumption	O
at	O
the	O
time	O
of	O
delivery	O
.	O

L	B-bacteria
.	I-bacteria
GG	I-bacteria
concentration	O
in	O
fecal	O
samples	O
was	O
determined	O
by	O
colony	O
morphology	O
and	O
molecular	O
analysis	O
.	O

In	O
all	O
four	O
children	O
delivered	O
vaginally	O
and	O
in	O
one	O
of	O
two	O
children	O
delivered	O
by	O
cesarean	O
section	O
,	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
was	O
present	O
in	O
fecal	O
samples	O
at	O
1	O
and	O
6	O
months	O
of	O
age	O
.	O

Three	O
children	O
remained	O
colonized	O
for	O
at	O
least	O
12	O
months	O
,	O
and	O
in	O
two	O
children	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
was	O
detected	O
in	O
fecal	O
samples	O
at	O
24	O
months	O
of	O
age	O
.	O

Three	O
mothers	O
were	O
tested	O
1	O
month	O
post	O
partum	O
and	O
no	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
was	O
present	O
in	O
fecal	O
samples	O
.	O

No	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
was	O
found	O
in	O
one	O
of	O
these	O
women	O
24	O
months	O
post	O
partum	O
.	O

There	O
was	O
no	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
detectable	O
in	O
stools	O
of	O
the	O
siblings	O
of	O
two	O
children	O
at	O
the	O
2	O
-	O
year	O
and	O
3	O
-	O
years	O
after	O
birth	O
of	O
the	O
index	O
child	O
.	O

L	B-bacteria
.	I-bacteria
GG	I-bacteria
was	O
not	O
isolated	O
from	O
the	O
stools	O
of	O
children	O
whose	O
mothers	O
were	O
not	O
taking	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
.	O

Temporary	O
colonization	O
of	O
an	O
infant	O
with	O
L	B-bacteria
.	I-bacteria
GG	I-bacteria
may	O
be	O
possible	O
by	O
colonizing	O
the	O
pregnant	O
mother	O
before	O
delivery	O
.	O

Colonization	O
is	O
stable	O
for	O
as	O
long	O
as	O
6	O
months	O
,	O
and	O
in	O
unexplained	O
circumstances	O
may	O
persist	O
for	O
as	O
long	O
as	O
24	O
months	O
.	O

Peculiarities	O
of	O
quantitative	O
and	O
qualitative	O
composition	O
of	O
microbiocenosis	O
of	O
the	O
oral	O
cavity	O
in	O
healthy	O
children	O
and	O
children	O
with	O
chronic	O
aphthous	O
recurrent	O
stomatitis	O
have	O
been	O
studied	O
.	O

Strains	O
of	O
microorganisms	O
(	O
n	O
=	O
259	O
)	O
have	O
been	O
isolated	O
and	O
identified	O
.	O

The	O
results	O
obtained	O
showed	O
that	O
the	O
studied	O
biotope	O
is	O
characterised	O
by	O
a	O
wide	O
spectrum	O
of	O
isolated	O
microflora	O
.	O

The	O
growth	O
of	O
microorganism	O
association	O
is	O
observed	O
in	O
all	O
the	O
studied	O
samples	O
.	O

The	O
analysis	O
of	O
genus	O
and	O
species	O
composition	O
of	O
microbiocenosis	O
of	O
the	O
mucous	O
membrane	O
indicated	O
that	O
streptococci	B-bacteria
,	O
neiserii	B-bacteria
,	O
corynebacteria	B-bacteria
,	O
enterococci	B-bacteria
,	O
lactobacilli	B-bacteria
,	O
epidermal	B-bacteria
staphylococci	I-bacteria
and	O
candidas	O
were	O
distinguished	O
as	O
to	O
isolation	O
frequency	O
among	O
the	O
isolated	O
strains	O
.	O

These	O
bacteria	O
were	O
isolated	O
from	O
oral	O
cavity	O
of	O
healthy	O
and	O
sick	O
children	O
,	O
but	O
their	O
quantity	O
in	O
1	O
mm2	O
of	O
sick	O
children	O
mucosa	O
prevailed	O
,	O
except	O
for	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
their	O
quantity	O
was	O
far	O
less	O
.	O

Golden	O
staphylococci	B-bacteria
,	O
escherichia	B-bacteria
,	O
klebsiella	B-bacteria
,	O
clostridia	B-bacteria
,	O
hemophilic	B-bacteria
rods	I-bacteria
and	O
campylobacteria	B-bacteria
were	O
isolated	O
from	O
sick	O
children	O
only	O
.	O

Microflora	O
of	O
oral	O
cavity	O
of	O
people	O
of	O
45	O
-	O
65	O
years	O
with	O
removable	O
denture	O
and	O
children	O
with	O
acute	O
herpetic	O
stomatitis	O
,	O
its	O
dependence	O
upon	O
the	O
degree	O
of	O
local	O
immunity	O
,	O
presence	O
and	O
severity	O
of	O
inflammatory	O
process	O
have	O
been	O
studied	O
.	O

Percentage	O
of	O
leucocyte	O
subpopulations	O
activity	O
of	O
bactericide	O
enzymes	O
of	O
granulocytes	O
,	O
average	O
anticolonization	O
ratio	O
,	O
correlation	O
of	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
,	O
degree	O
of	O
colonization	O
with	O
Candida	O
fungi	O
have	O
been	O
determined	O
is	O
smear	O
-	O
simprints	O
of	O
mucous	O
membrane	O
.	O

The	O
intensity	O
of	O
growth	O
of	O
optional	O
anaerobic	O
microorganisms	O
has	O
been	O
investigated	O
in	O
bacteriological	O
studies	O
of	O
material	O
taken	O
from	O
mucous	O
membrane	O
.	O

Their	O
identification	O
has	O
been	O
performed	O
using	O
morphological	O
-	O
cultural	O
and	O
biochemical	O
indices	O
.	O

Significant	O
changes	O
in	O
microbiocenosis	O
of	O
oral	O
cavity	O
such	O
as	O
disappearance	O
of	O
autochthonous	O
microflora	O
,	O
appearance	O
and	O
intensive	O
growth	O
of	O
pathogenic	O
and	O
opportunistic	O
microorganisms	O
are	O
to	O
be	O
observed	O
in	O
conditions	O
of	O
decrease	O
of	O
non	O
-	O
specific	O
resistance	O
and	O
presence	O
of	O
inflammatory	O
process	O
in	O
persons	O
with	O
removable	O
denture	O
and	O
acute	O
herpetic	O
stomatitis	O
.	O

Cranberry	O
juice	O
is	O
known	O
to	O
inhibit	O
bacterial	O
adhesion	O
.	O

We	O
examined	O
the	O
inhibitory	O
effect	O
of	O
cranberry	O
juice	O
on	O
the	O
adhesion	O
of	O
oral	O
streptococci	B-bacteria
strains	I-bacteria
labeled	O
with	O
[	O
3H	O
]	O
-	O
thymidine	O
to	O
saliva	O
-	O
coated	O
hydroxyapatite	O
beads	O
(	O
s	O
-	O
HA	O
)	O
.	O

When	O
the	O
bacterial	O
cells	O
were	O
momentarily	O
exposed	O
to	O
cranberry	O
juice	O
,	O
their	O
adherence	O
to	O
s	O
-	O
HA	O
decreased	O
significantly	O
compared	O
with	O
the	O
control	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Their	O
hydrophobicity	O
also	O
decreased	O
dependently	O
with	O
the	O
concentration	O
of	O
cranberry	O
juice	O
.	O

We	O
also	O
evaluated	O
the	O
inhibitory	O
effect	O
of	O
cranberry	O
juice	O
on	O
biofilm	O
formation	O
.	O

By	O
using	O
a	O
microplate	O
system	O
,	O
we	O
found	O
that	O
the	O
high	O
molecular	O
mass	O
constituents	O
of	O
cranberry	O
juice	O
inhibited	O
the	O
biofilm	O
formation	O
of	O
the	O
tested	O
streptococci	B-bacteria
.	O

The	O
inhibitory	O
activity	O
was	O
related	O
to	O
the	O
reduction	O
of	O
the	O
hydrophobicity	O
.	O

The	O
present	O
findings	O
suggest	O
that	O
cranberry	O
juice	O
component	O
(	O
s	O
)	O
can	O
inhibit	O
colonization	O
by	O
oral	O
streptococci	B-bacteria
to	O
the	O
tooth	O
surface	O
and	O
can	O
thus	O
slow	O
development	O
of	O
dental	O
plaque	O
.	O

To	O
investigate	O
the	O
effect	O
of	O
triclosan	O
exposure	O
on	O
the	O
antimicrobial	O
susceptibilities	O
of	O
numerically	O
important	O
dental	O
bacteria	O
.	O

A	O
gradient	O
plate	O
technique	O
was	O
used	O
to	O
expose	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
,	O
Neisseria	B-bacteria
subflava	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Veillonella	B-bacteria
dispar	I-bacteria
repeatedly	O
to	O
escalating	O
,	O
sublethal	O
concentrations	O
of	O
triclosan	O
.	O

Escherichia	B-bacteria
coli	I-bacteria
ATCC	I-bacteria
8739	I-bacteria
was	O
included	O
as	O
an	O
organism	O
showing	O
the	O
triclosan	O
resistance	O
development	O
trait	O
.	O

MIC	O
values	O
towards	O
chlorhexidine	O
,	O
metronidazole	O
and	O
tetracycline	O
were	O
determined	O
before	O
and	O
after	O
biocide	O
exposure	O
.	O

N	B-bacteria
.	I-bacteria
subflava	I-bacteria
,	O
Pr	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
Po	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
highly	O
susceptible	O
to	O
triclosan	O
(	O
MIC	O
range	O
0	O
.	O
1	O
-	O
3	O
.	O
9	O
mg	O
/	O
L	O
)	O
,	O
whereas	O
the	O
lactobacillus	B-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
less	O
susceptible	O
(	O
MIC	O
range	O
15	O
.	O
6	O
-	O
20	O
.	O
8	O
mg	O
/	O
L	O
)	O
.	O

Triclosan	O
exposure	O
resulted	O
in	O
a	O
highly	O
significant	O
(	O
approximately	O
400	O
-	O
fold	O
)	O
reduction	O
in	O
triclosan	O
susceptibility	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
for	O
the	O
positive	O
control	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
although	O
its	O
MICs	O
towards	O
chlorhexidine	O
,	O
metronidazole	O
and	O
tetracycline	O
were	O
not	O
significantly	O
altered	O
.	O

Minor	O
(	O
approximately	O
two	O
-	O
fold	O
)	O
decreases	O
in	O
triclosan	O
susceptibility	O
(	O
MIC	O
)	O
occurred	O
for	O
Pr	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
and	O
in	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
(	O
MBC	O
)	O
.	O

Mean	O
changes	O
in	O
susceptibilities	O
(	O
MIC	O
and	O
MBC	O
)	O
of	O
the	O
oral	O
species	O
to	O
chlorhexidine	O
,	O
metronidazole	O
and	O
tetracycline	O
did	O
not	O
exceed	O
two	O
-	O
fold	O
,	O
although	O
chlorhexidine	O
MBCs	O
for	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
were	O
markedly	O
,	O
but	O
transiently	O
,	O
increased	O
.	O

These	O
data	O
fail	O
to	O
demonstrate	O
biologically	O
significant	O
drug	O
resistance	O
in	O
triclosan	O
-	O
exposed	O
bacteria	O
and	O
suggest	O
that	O
markedly	O
decreased	O
triclosan	O
susceptibility	O
,	O
although	O
confirmed	O
for	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
is	O
not	O
a	O
universal	O
phenomenon	O
.	O

Other	O
bacteria	O
possibly	O
possess	O
more	O
susceptible	O
targets	O
than	O
FabI	O
that	O
are	O
highly	O
conserved	O
,	O
which	O
may	O
govern	O
triclosan	O
activity	O
.	O

Previously	O
,	O
we	O
screened	O
149	O
subjects	O
and	O
established	O
four	O
groups	O
high	O
or	O
low	O
for	O
salivary	O
killing	O
of	O
oral	O
bacteria	O
,	O
and	O
for	O
aggregation	O
and	O
live	O
and	O
dead	O
adherence	O
of	O
oral	O
bacteria	O
(	O
as	O
a	O
combined	O
factor	O
)	O
.	O

Caries	O
scores	O
were	O
significantly	O
lower	O
in	O
both	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
.	O

Subsequently	O
,	O
we	O
found	O
that	O
supragingival	O
total	O
biofilm	O
DNA	O
,	O
total	O
streptococci	B-bacteria
and	O
two	O
major	O
streptococcal	O
rRNA	O
variants	O
also	O
were	O
significantly	O
lower	O
in	O
the	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
.	O

In	O
this	O
study	O
,	O
we	O
looked	O
at	O
the	O
effects	O
of	O
those	O
differences	O
in	O
salivary	O
function	O
on	O
three	O
periodontal	O
pathogens	O
.	O

Quantitative	O
PCR	O
was	O
used	O
to	O
determine	O
levels	O
of	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythensis	I-bacteria
(	O
formerly	O
Bacteroides	B-bacteria
forsythus	I-bacteria
)	O
in	O
stored	O
DNA	O
extracts	O
of	O
overnight	O
supragingival	O
biofilm	O
collected	O
from	O
buccal	O
upper	O
central	O
incisors	O
(	O
UC	O
)	O
,	O
lingual	O
lower	O
central	O
incisors	O
(	O
LC	O
)	O
and	O
buccal	O
upper	O
and	O
lower	O
first	O
molars	O
(	O
BM	O
)	O
and	O
lingual	O
upper	O
and	O
lower	O
first	O
molars	O
(	O
LM	O
)	O
of	O
subjects	O
in	O
the	O
four	O
groups	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
almost	O
completely	O
absent	O
from	O
these	O
samples	O
.	O

T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
was	O
found	O
in	O
11	O
of	O
35	O
persons	O
at	O
the	O
buccal	O
molar	O
site	O
.	O

Only	O
two	O
of	O
those	O
subjects	O
were	O
in	O
the	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
,	O
and	O
that	O
difference	O
was	O
statistically	O
significant	O
.	O

The	O
mean	O
quantity	O
of	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
also	O
was	O
significantly	O
lower	O
in	O
the	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
.	O

The	O
difference	O
between	O
the	O
Low	O
and	O
High	O
Aggregation	O
-	O
Adherence	O
groups	O
might	O
reflect	O
direct	O
interactions	O
of	O
salivary	O
proteins	O
with	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
.	O

Alternatively	O
,	O
the	O
higher	O
levels	O
of	O
total	O
biofilm	O
and	O
total	O
streptococci	B-bacteria
seen	O
in	O
the	O
Low	O
Aggregation	O
-	O
Adherence	O
groups	O
might	O
create	O
a	O
favourable	O
environment	O
for	O
early	O
secondary	O
colonization	O
of	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
.	O

The	O
incidence	O
of	O
oral	O
candidosis	O
has	O
increased	O
in	O
recent	O
years	O
,	O
largely	O
as	O
a	O
result	O
of	O
the	O
emergence	O
of	O
human	O
immunodeficiency	O
virus	O
infection	O
and	O
the	O
more	O
widespread	O
use	O
of	O
immunosuppressive	O
chemotherapy	O
.	O

This	O
development	O
has	O
been	O
associated	O
with	O
a	O
need	O
for	O
more	O
reliable	O
methods	O
for	O
the	O
detection	O
of	O
Candida	O
.	O

The	O
present	O
study	O
assessed	O
the	O
performance	O
of	O
a	O
real	O
-	O
time	O
PCR	O
and	O
two	O
block	O
-	O
based	O
PCRs	O
for	O
the	O
detection	O
of	O
Candida	O
in	O
193	O
concentrated	O
oral	O
rinse	O
culture	O
(	O
CRC	O
)	O
specimens	O
.	O

A	O
total	O
of	O
102	O
CRC	O
specimens	O
were	O
positive	O
by	O
culture	O
for	O
Candida	O
;	O
and	O
96	O
,	O
90	O
,	O
and	O
75	O
of	O
these	O
were	O
also	O
positive	O
by	O
real	O
-	O
time	O
,	O
N18	O
-	O
specific	O
,	O
and	O
internal	O
transcribed	O
spacer	O
(	O
ITS	O
)	O
-	O
specific	O
PCRs	O
,	O
respectively	O
.	O

The	O
five	O
false	O
-	O
negative	O
results	O
by	O
the	O
real	O
-	O
time	O
PCR	O
were	O
all	O
non	O
-	O
Candida	O
albicans	O
positive	O
by	O
culture	O
.	O

Of	O
the	O
91	O
culture	O
-	O
negative	O
CRC	O
specimens	O
,	O
20	O
,	O
41	O
,	O
and	O
44	O
were	O
positive	O
by	O
the	O
real	O
-	O
time	O
PCR	O
and	O
the	O
N18	O
-	O
and	O
ITS	O
-	O
specific	O
PCRs	O
,	O
respectively	O
.	O

All	O
three	O
PCRs	O
detected	O
fungal	O
DNA	O
in	O
8	O
culture	O
-	O
negative	O
CRC	O
specimens	O
,	O
with	O
a	O
further	O
30	O
being	O
positive	O
by	O
two	O
of	O
the	O
three	O
PCRs	O
.	O

A	O
total	O
of	O
32	O
CRC	O
specimens	O
were	O
Candida	O
free	O
by	O
all	O
methods	O
.	O

In	O
summary	O
,	O
a	O
real	O
-	O
time	O
PCR	O
that	O
provides	O
a	O
sensitive	O
,	O
specific	O
,	O
and	O
rapid	O
alternative	O
technique	O
for	O
detection	O
of	O
Candida	O
in	O
the	O
mouth	O
is	O
described	O
.	O

The	O
mouths	O
of	O
three	O
human	O
infants	O
were	O
examined	O
from	O
birth	O
to	O
age	O
2	O
years	O
to	O
detect	O
colonization	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
and	I-bacteria
2	I-bacteria
.	O

These	O
bacteria	O
did	O
not	O
colonize	O
until	O
after	O
tooth	O
eruption	O
.	O

The	O
diversity	O
of	O
posteruption	O
isolates	O
was	O
determined	O
by	O
ribotyping	O
.	O

Using	O
immunoblotting	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
we	O
determined	O
the	O
reactivity	O
of	O
secretory	O
immunoglobulin	O
A	O
(	O
SIgA	O
)	O
antibodies	O
in	O
saliva	O
samples	O
collected	O
from	O
each	O
infant	O
before	O
and	O
after	O
colonization	O
against	O
cell	O
wall	O
proteins	O
from	O
their	O
own	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
strains	I-bacteria
and	O
carbohydrates	O
from	O
standard	O
A	B-bacteria
.		I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
and	I-bacteria
2	I-bacteria
strains	I-bacteria
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
and	I-bacteria
2	I-bacteria
carbohydrate	O
-	O
reactive	O
SIgA	O
antibodies	O
were	O
not	O
detected	O
in	O
any	O
saliva	O
sample	O
.	O

However	O
,	O
SIgA	O
antibodies	O
reactive	O
with	O
cell	O
wall	O
proteins	O
were	O
present	O
in	O
saliva	O
before	O
these	O
bacteria	O
colonized	O
the	O
mouth	O
.	O

These	O
antibodies	O
could	O
be	O
almost	O
completely	O
removed	O
by	O
absorption	O
with	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
,	O
a	O
species	O
known	O
to	O
colonize	O
the	O
human	O
mouth	O
shortly	O
after	O
birth	O
.	O

However	O
,	O
after	O
colonization	O
by	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
and	I-bacteria
2	I-bacteria
,	O
specific	O
antibodies	O
were	O
induced	O
that	O
could	O
not	O
be	O
removed	O
by	O
absorption	O
with	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
.	O

Cluster	O
analysis	O
of	O
the	O
patterns	O
of	O
reactivity	O
of	O
postcolonization	O
salivary	O
antibodies	O
from	O
each	O
infant	O
with	O
antigens	O
from	O
their	O
own	O
strains	O
showed	O
that	O
not	O
only	O
could	O
these	O
antibodies	O
discriminate	O
among	O
strains	O
but	O
antibodies	O
in	O
saliva	O
samples	O
collected	O
at	O
different	O
times	O
showed	O
different	O
reactivity	O
patterns	O
.	O

Overall	O
,	O
these	O
data	O
suggest	O
that	O
,	O
although	O
much	O
of	O
the	O
salivary	O
SIgA	O
antibodies	O
reactive	O
with	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
and	I-bacteria
2	I-bacteria
are	O
directed	O
against	O
genus	O
-	O
specific	O
or	O
more	O
broadly	O
cross	O
-	O
reactive	O
antigens	O
,	O
species	O
,	O
genospecies	O
,	O
and	O
possibly	O
strain	O
-	O
specific	O
antibodies	O
are	O
induced	O
in	O
response	O
to	O
colonization	O
.	O

Hydrolytic	O
degradation	O
by	O
-	O
products	O
associated	O
with	O
the	O
constitutive	O
monomers	O
2	O
,	O
2	O
-	O
bis	O
[	O
4	O
-	O
(	O
2	O
-	O
hydroxy	O
-	O
3	O
-	O
methacryloxypropoxy	O
)	O
phenyl	O
]	O
propane	O
(	O
bis	O
-	O
GMA	O
)	O
,	O
bisphenol	O
A	O
polyethylene	O
glycol	O
diether	O
dimethacrylate	O
(	O
bis	O
-	O
EMA	O
)	O
,	O
and	O
triethylene	O
glycol	O
dimethacrylate	O
(	O
TEDGMA	O
)	O
used	O
in	O
dental	O
restorative	O
composites	O
include	O
bis	O
-	O
hydroxy	O
-	O
propoxyphenyl	O
propane	O
(	O
bis	O
-	O
HPPP	O
)	O
,	O
ethoxylated	O
bisphenol	O
A	O
(	O
E	O
-	O
bisPA	O
)	O
,	O
methacrylic	O
acid	O
(	O
MA	O
)	O
,	O
and	O
triethylene	O
glycol	O
(	O
TEG	O
)	O
.	O

These	O
products	O
are	O
generated	O
from	O
the	O
interaction	O
of	O
human	O
salivary	O
esterases	O
with	O
the	O
composites	O
.	O

Recent	O
findings	O
have	O
indicated	O
that	O
TEGDMA	O
has	O
the	O
ability	O
to	O
modulate	O
oral	O
bacteria	O
but	O
it	O
is	O
unclear	O
which	O
components	O
of	O
TEGDMA	O
are	O
related	O
to	O
the	O
observed	O
effects	O
.	O

The	O
objective	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
influence	O
of	O
TEGDMA	O
derived	O
degradation	O
products	O
MA	O
and	O
TEG	O
on	O
the	O
growth	O
of	O
three	O
strains	O
of	O
oral	O
bacteria	O
:	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
NG8	I-bacteria
and	O
JH1005	B-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
AT2	I-bacteria
.	O

Bacterial	O
growth	O
rates	O
were	O
measured	O
at	O
37	O
degrees	O
C	O
,	O
and	O
pH	O
values	O
of	O
5	O
.	O
5	O
(	O
representative	O
of	O
cariogenic	O
state	O
)	O
or	O
7	O
.	O
0	O
at	O
concentrations	O
of	O
0	O
-	O
50mmol	O
/	O
l	O
for	O
MA	O
(	O
Sigma	O
,	O
US	O
)	O
and	O
0	O
-	O
100mmol	O
/	O
l	O
for	O
TEG	O
(	O
Sigma	O
,	O
US	O
)	O
.	O

It	O
was	O
found	O
that	O
at	O
pH	O
5	O
.	O
5	O
TEG	O
significantly	O
stimulated	O
the	O
growth	O
of	O
both	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
concentration	O
range	O
of	O
0	O
.	O
5	O
-	O
10	O
.	O
0mmol	O
/	O
l	O
and	O
stimulated	O
the	O
growth	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
AT2	I-bacteria
for	O
the	O
entire	O
concentration	O
range	O
tested	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

TEG	O
(	O
above	O
50mmol	O
/	O
1	O
)	O
did	O
not	O
significantly	O
affect	O
the	O
doubling	O
times	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
at	O
pH	O
of	O
7	O
.	O
0	O
and	O
it	O
inhibited	O
the	O
growth	O
of	O
both	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
above	O
50mmol	O
/	O
l	O
at	O
the	O
same	O
pH	O
value	O
.	O

At	O
pH	O
5	O
.	O
5	O
MA	O
inhibited	O
the	O
growth	O
of	O
all	O
three	O
strains	O
with	O
increasing	O
concentration	O
.	O

At	O
neutral	O
pH	O
,	O
the	O
growth	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
NG8	I-bacteria
strain	I-bacteria
was	O
significantly	O
reduced	O
by	O
MA	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
above	O
10mmol	O
/	O
l	O
.	O

In	O
summary	O
,	O
these	O
results	O
indicate	O
that	O
TEG	O
and	O
MA	O
modulate	O
the	O
growth	O
rate	O
of	O
important	O
oral	O
bacteria	O
in	O
a	O
concentration	O
and	O
pH	O
dependent	O
manner	O
.	O

Two	O
bacterial	O
strains	O
,	O
EHS11	B-bacteria
(	O
T	O
)	O
and	O
EPSA11	B-bacteria
(	O
T	O
)	O
,	O
which	O
were	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
,	O
were	O
characterized	O
in	O
terms	O
of	O
phenotypic	O
and	O
biochemical	O
characteristics	O
,	O
cellular	O
fatty	O
acid	O
profiles	O
and	O
phylogenetic	O
position	O
based	O
on	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
showed	O
that	O
each	O
of	O
the	O
isolates	O
belonged	O
to	O
a	O
novel	O
species	O
of	O
the	O
genus	O
Prevotella	B-bacteria
.	O

Strain	O
EHS11	B-bacteria
(	O
T	O
)	O
was	O
related	O
to	O
Prevotella	B-bacteria
loescheii	I-bacteria
(	O
about	O
95	O
%	O
similarity	O
)	O
,	O
whereas	O
strain	O
EPSA11	B-bacteria
(	O
T	O
)	O
was	O
related	O
to	O
Prevotella	B-bacteria
oris	I-bacteria
(	O
about	O
94	O
%	O
similarity	O
)	O
.	O

Both	O
strains	O
were	O
obligately	O
anaerobic	O
,	O
non	O
-	O
pigmented	O
,	O
non	O
-	O
spore	O
-	O
forming	O
,	O
non	O
-	O
motile	O
,	O
Gram	O
-	O
negative	O
rods	O
.	O

The	O
cellular	O
fatty	O
acid	O
composition	O
of	O
strain	O
EPSA11	B-bacteria
(	O
T	O
)	O
was	O
very	O
similar	O
to	O
that	O
of	O
P	B-bacteria
.	I-bacteria
oris	I-bacteria
JCM	I-bacteria
8540	I-bacteria
(	O
T	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
cellular	O
fatty	O
acid	O
composition	O
of	O
strain	O
EHS11	B-bacteria
(	O
T	O
)	O
was	O
significantly	O
different	O
from	O
those	O
of	O
other	O
Prevotella	B-bacteria
species	I-bacteria
.	O

The	O
predominant	O
fatty	O
acids	O
in	O
strain	O
EHS11	B-bacteria
(	O
T	O
)	O
are	O
C	O
(	O
18	O
:	O
1	O
)	O
omega9c	O
,	O
C	O
(	O
16	O
:	O
0	O
)	O
and	O
C	O
(	O
16	O
:	O
0	O
)	O
3	O
-	O
OH	O
,	O
whereas	O
other	O
Prevotella	B-bacteria
species	I-bacteria
,	O
except	O
for	O
P	B-bacteria
.	I-bacteria
loescheii	I-bacteria
JCM	I-bacteria
8530	I-bacteria
(	O
T	O
)	O
,	O
possess	O
anteiso	O
-	O
C	O
(	O
15	O
:	O
0	O
)	O
,	O
iso	O
-	O
C	O
(	O
17	O
:	O
0	O
)	O
3	O
-	O
OH	O
and	O
C	O
(	O
18	O
:	O
1	O
)	O
omega9c	O
.	O

The	O
predominant	O
fatty	O
acids	O
in	O
P	B-bacteria
.	I-bacteria
loescheii	I-bacteria
JCM	I-bacteria
8530	I-bacteria
(	O
T	O
)	O
are	O
anteiso	O
-	O
C	O
(	O
15	O
:	O
0	O
)	O
,	O
C	O
(	O
16	O
:	O
0	O
)	O
and	O
C	O
(	O
18	O
:	O
1	O
)	O
omega9c	O
.	O

DNA	O
-	O
DNA	O
hybridization	O
experiments	O
revealed	O
a	O
genomic	O
distinction	O
of	O
strains	O
EHS11	B-bacteria
(	O
T	O
)	O
and	O
EPSA11	B-bacteria
(	O
T	O
)	O
from	O
P	B-bacteria
.	I-bacteria
loescheii	I-bacteria
JCM	I-bacteria
8530	I-bacteria
(	O
T	O
)	O
and	O
P	B-bacteria
.	I-bacteria
oris	I-bacteria
JCM	I-bacteria
8540	I-bacteria
(	O
T	O
)	O
.	O

On	O
the	O
basis	O
of	O
these	O
data	O
,	O
two	O
novel	O
Prevotella	B-bacteria
species	I-bacteria
are	O
proposed	O
:	O
Prevotella	B-bacteria
shahii	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
and	O
Prevotella	B-bacteria
salivae	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	O

The	O
type	O
strains	O
of	O
P	B-bacteria
.	I-bacteria
shahii	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
salivae	I-bacteria
are	O
EHS11	B-bacteria
(	O
T	O
)	O
(	O
=	O
JCM	B-bacteria
12083	I-bacteria
(	O
T	O
)	O
=	O
DSM	B-bacteria
15611	I-bacteria
(	O
T	O
)	O
)	O
and	O
EPSA11	B-bacteria
(	O
T	O
)	O
(	O
=	O
JCM	B-bacteria
12084	I-bacteria
(	O
T	O
)	O
=	O
DSM	B-bacteria
15606	I-bacteria
(	O
T	O
)	O
)	O
,	O
respectively	O
.	O

Terminal	O
RFLP	O
(	O
T	O
-	O
RFLP	O
)	O
analysis	O
was	O
used	O
to	O
investigate	O
changes	O
in	O
the	O
oral	O
microbiota	O
in	O
saliva	O
and	O
subgingival	O
plaque	O
samples	O
from	O
one	O
patient	O
with	O
aggressive	O
periodontitis	O
(	O
subject	O
A	O
)	O
and	O
two	O
patients	O
with	O
chronic	O
periodontitis	O
(	O
subjects	O
B	O
and	O
C	O
)	O
before	O
and	O
3	O
months	O
after	O
periodontal	O
treatment	O
.	O

Substantial	O
changes	O
in	O
the	O
T	O
-	O
RFLP	O
patterns	O
of	O
subgingival	O
plaque	O
samples	O
of	O
subjects	O
B	O
and	O
C	O
were	O
noted	O
after	O
3	O
months	O
of	O
improved	O
oral	O
hygiene	O
and	O
full	O
-	O
mouth	O
supra	O
-	O
and	O
subgingival	O
scaling	O
and	O
root	O
planing	O
.	O

However	O
,	O
there	O
was	O
little	O
change	O
in	O
the	O
subgingival	O
microbiota	O
of	O
subject	O
A	O
.	O

Although	O
the	O
proportions	O
of	O
terminal	O
restriction	O
fragments	O
(	O
T	O
-	O
RFs	O
)	O
larger	O
than	O
1000	O
bp	O
were	O
notable	O
in	O
the	O
T	O
-	O
RFLP	O
patterns	O
generated	O
after	O
digestion	O
with	O
HhaI	O
of	O
the	O
samples	O
from	O
two	O
subjects	O
before	O
treatment	O
(	O
subject	O
B	O
,	O
35	O
.	O
5	O
%	O
;	O
subject	O
C	O
,	O
29	O
.	O
6	O
%	O
)	O
,	O
the	O
proportions	O
of	O
these	O
T	O
-	O
RFs	O
were	O
significantly	O
reduced	O
or	O
not	O
detected	O
after	O
treatment	O
(	O
subject	O
B	O
,	O
none	O
;	O
subject	O
C	O
,	O
4	O
.	O
1	O
%	O
)	O
.	O

Real	O
-	O
time	O
PCR	O
showed	O
a	O
significant	O
change	O
in	O
the	O
proportions	O
of	O
target	O
bacteria	O
in	O
subgingival	O
plaque	O
samples	O
of	O
subject	O
B	O
.	O

After	O
3	O
months	O
,	O
the	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
population	O
was	O
markedly	O
reduced	O
(	O
3	O
.	O
1	O
x	O
10	O
(	O
-	O
3	O
)	O
%	O
)	O
,	O
whereas	O
the	O
proportion	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
before	O
treatment	O
was	O
7	O
.	O
6	O
%	O
.	O

The	O
proportions	O
of	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Treponema	B-bacteria
socranskii	I-bacteria
were	O
also	O
markedly	O
diminished	O
after	O
treatment	O
.	O

Similarly	O
,	O
the	O
proportion	O
of	O
the	O
T	O
-	O
RF	O
presumed	O
to	O
represent	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
5	O
.	O
9	O
%	O
and	O
became	O
undetectable	O
after	O
3	O
months	O
.	O

Analysis	O
of	O
16S	O
rRNA	O
gene	O
clone	O
libraries	O
from	O
subgingival	O
plaque	O
samples	O
of	O
subject	O
B	O
before	O
and	O
after	O
treatment	O
showed	O
a	O
notable	O
change	O
in	O
the	O
subgingival	O
microbiota	O
.	O

These	O
results	O
were	O
in	O
agreement	O
with	O
the	O
T	O
-	O
RFLP	O
analysis	O
data	O
and	O
showed	O
that	O
the	O
T	O
-	O
RFs	O
larger	O
than	O
1000	O
bp	O
represent	O
Peptostreptococcus	B-bacteria
species	I-bacteria
.	O

Our	O
results	O
indicate	O
that	O
T	O
-	O
RFLP	O
analysis	O
is	O
useful	O
for	O
evaluation	O
of	O
the	O
effects	O
of	O
medical	O
treatment	O
of	O
periodontitis	O
.	O

Once	O
established	O
,	O
early	O
-	O
colonizing	O
bacterial	O
species	O
tend	O
to	O
persist	O
in	O
the	O
mouth	O
.	O

To	O
obtain	O
detailed	O
information	O
on	O
the	O
population	O
dynamics	O
of	O
early	O
-	O
colonizing	O
oral	O
anaerobes	O
,	O
we	O
examined	O
the	O
clonal	O
diversity	O
and	O
persistence	O
of	O
clones	O
among	O
oral	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
populations	O
during	O
the	O
first	O
2	O
yrs	O
of	O
life	O
.	O

Consecutive	O
salivary	O
samples	O
from	O
12	O
infants	O
,	O
collected	O
at	O
2	O
,	O
6	O
,	O
12	O
,	O
18	O
,	O
and	O
24	O
mos	O
of	O
age	O
,	O
yielded	O
a	O
total	O
of	O
546	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
isolates	I-bacteria
for	O
clonal	O
typing	O
with	O
arbitrarily	O
primed	O
PCR	O
(	O
AP	O
-	O
PCR	O
)	O
.	O

Up	O
to	O
7	O
AP	O
-	O
PCR	O
types	O
were	O
simultaneously	O
detected	O
in	O
each	O
sample	O
.	O

In	O
11	O
out	O
of	O
the	O
12	O
infants	O
examined	O
,	O
AP	O
-	O
PCR	O
types	O
persisted	O
for	O
up	O
to	O
1	O
yr	O
.	O
Strain	O
turnover	O
rate	O
was	O
high	O
during	O
the	O
first	O
year	O
of	O
life	O
,	O
but	O
then	O
the	O
occurrence	O
of	O
persistent	O
clones	O
increased	O
.	O

This	O
study	O
indicates	O
a	O
wide	O
genetic	O
diversity	O
within	O
the	O
species	O
and	O
provides	O
evidence	O
for	O
the	O
increasing	O
persistence	O
of	O
F	O
.	O
nucleatum	O
clones	O
in	O
the	O
oral	O
cavity	O
with	O
age	O
.	O

Colonization	O
of	O
the	O
tooth	O
surface	O
by	O
actinomyces	B-bacteria
and	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
involves	O
the	O
attachment	O
of	O
these	O
bacteria	O
to	O
adsorbed	O
salivary	O
components	O
of	O
the	O
acquired	O
enamel	O
pellicle	O
.	O

The	O
hypothesis	O
that	O
this	O
attachment	O
depends	O
on	O
specific	O
adhesins	O
has	O
now	O
been	O
assessed	O
from	O
the	O
binding	O
of	O
bacteria	O
with	O
well	O
-	O
defined	O
adhesive	O
properties	O
to	O
blots	O
of	O
SDS	O
-	O
PAGE	O
-	O
separated	O
parotid	O
and	O
submandibular	O
-	O
sublingual	O
(	O
SM	O
-	O
SL	O
)	O
saliva	O
.	O

Streptococcus	B-bacteria
sanguis	I-bacteria
and	O
type	B-bacteria
2	I-bacteria
fimbriated	I-bacteria
Actinomyces	I-bacteria
naeslundii	I-bacteria
,	O
which	O
bound	O
terminal	O
sialic	O
acid	O
and	O
Galbeta1	O
-	O
3GalNAc	O
,	O
respectively	O
,	O
recognized	O
only	O
a	O
few	O
SM	O
-	O
SL	O
salivary	O
components	O
,	O
primarily	O
MG2	O
.	O

In	O
contrast	O
,	O
type	O
1	O
fimbriated	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
which	O
bound	O
purified	O
proline	O
-	O
rich	O
proteins	O
(	O
PRPs	O
)	O
,	O
recognized	O
several	O
other	O
components	O
from	O
both	O
SM	O
-	O
SL	O
and	O
parotid	O
saliva	O
.	O

Significantly	O
,	O
bacteria	O
that	O
lacked	O
PRP	O
-	O
binding	O
and	O
the	O
lectin	O
-	O
like	O
activities	O
detected	O
by	O
binding	O
to	O
MG2	O
failed	O
to	O
bind	O
any	O
immobilized	O
salivary	O
component	O
.	O

These	O
findings	O
suggest	O
the	O
involvement	O
of	O
specific	O
adhesins	O
in	O
bacterial	O
recognition	O
of	O
many	O
adsorbed	O
salivary	O
proteins	O
and	O
glycoproteins	O
.	O

The	O
oral	O
environment	O
contains	O
many	O
different	O
types	O
of	O
microorganisms	O
,	O
including	O
both	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
cocci	O
,	O
bacilli	O
,	O
and	O
spirochetes	O
.	O

From	O
the	O
ecological	O
point	O
of	O
view	O
,	O
the	O
oral	O
cavity	O
is	O
a	O
perfect	O
niche	O
for	O
certain	O
bacteria	O
such	O
as	O
lactobacilli	B-bacteria
because	O
they	O
interact	O
,	O
forming	O
different	O
types	O
of	O
communities	O
.	O

Lactobacilli	B-bacteria
have	O
been	O
associated	O
with	O
the	O
generation	O
of	O
caries	O
in	O
some	O
reports	O
,	O
secondary	O
to	O
the	O
cariogenic	O
Streptococcus	B-bacteria
.	O

In	O
previous	O
papers	O
,	O
the	O
isolation	O
and	O
identification	O
of	O
145	O
strains	O
from	O
healthy	O
subjects	O
and	O
from	O
subjects	O
with	O
active	O
caries	O
were	O
performed	O
.	O

Strains	O
were	O
characterized	O
by	O
their	O
surface	O
properties	O
and	O
also	O
by	O
the	O
production	O
of	O
inhibitory	O
substances	O
.	O

From	O
all	O
the	O
strains	O
,	O
one	O
isolated	O
from	O
the	O
teeth	O
of	O
healthy	O
patients	O
and	O
another	O
from	O
a	O
patient	O
with	O
caries	O
,	O
sharing	O
some	O
surface	O
properties	O
,	O
were	O
selected	O
for	O
further	O
study	O
of	O
their	O
adhesion	O
properties	O
in	O
an	O
experimental	O
model	O
by	O
using	O
hydroxylapatite	O
beads	O
.	O

Adhesion	O
is	O
the	O
first	O
step	O
in	O
the	O
association	O
of	O
microorganisms	O
with	O
surfaces	O
or	O
mucous	O
membranes	O
.	O

The	O
first	O
approach	O
is	O
a	O
nonspecific	O
interaction	O
of	O
both	O
surfaces	O
;	O
later	O
some	O
other	O
types	O
of	O
interactions	O
can	O
occur	O
,	O
involving	O
more	O
specific	O
mediators	O
of	O
adhesions	O
.	O

Many	O
different	O
assays	O
are	O
available	O
to	O
study	O
the	O
adhesion	O
phenomenon	O
;	O
some	O
of	O
them	O
use	O
predictive	O
characteristics	O
,	O
and	O
others	O
use	O
experimental	O
models	O
resembling	O
the	O
in	O
vivo	O
situation	O
.	O

Two	O
model	O
systems	O
predominate	O
.	O

The	O
most	O
widely	O
used	O
has	O
been	O
saliva	O
-	O
coated	O
hydroxylapatite	O
or	O
hydroxylapatite	O
coated	O
with	O
buffers	O
,	O
proteins	O
,	O
and	O
other	O
substances	O
.	O

In	O
an	O
attempt	O
to	O
increase	O
knowledge	O
of	O
the	O
mechanisms	O
of	O
adhesion	O
of	O
oral	O
lactobacilli	B-bacteria
with	O
hard	O
surfaces	O
,	O
this	O
chapter	O
describes	O
an	O
experimental	O
model	O
for	O
studing	O
the	O
adhesion	O
between	O
lactobacilli	B-bacteria
and	O
hard	O
tissues	O
represented	O
by	O
hydroxylapatite	O
,	O
the	O
component	O
most	O
abundant	O
in	O
the	O
teeth	O
.	O

The	O
following	O
steps	O
were	O
performed	O
:	O
1	O
.	O
Obtaining	O
the	O
microorganisms	O
.	O
2	O
.	O
Preparation	O
of	O
the	O
hydroxylapatite	O
beads	O
.	O

3	O
.	O
Adhesion	O
assay	O
.	O
Commensal	O
microflora	O
(	O
normal	O
microflora	O
,	O
indigenous	O
microbiota	O
)	O
consists	O
of	O
those	O
micro	O
-	O
organisms	O
,	O
which	O
are	O
present	O
on	O
body	O
surfaces	O
covered	O
by	O
epithelial	O
cells	O
and	O
are	O
exposed	O
to	O
the	O
external	O
environment	O
(	O
gastrointestinal	O
and	O
respiratory	O
tract	O
,	O
vagina	O
,	O
skin	O
,	O
etc	O
.	O
)	O
.	O

The	O
number	O
of	O
bacteria	O
colonising	O
mucosal	O
and	O
skin	O
surfaces	O
exceeds	O
the	O
number	O
of	O
cells	O
forming	O
human	O
body	O
.	O

Commensal	O
bacteria	O
co	O
-	O
evolved	O
with	O
their	O
hosts	O
,	O
however	O
,	O
under	O
specific	O
conditions	O
they	O
are	O
able	O
to	O
overcome	O
protective	O
host	O
responses	O
and	O
exert	O
pathologic	O
effects	O
.	O

Resident	O
bacteria	O
form	O
complex	O
ecosystems	O
,	O
whose	O
diversity	O
is	O
enormous	O
.	O

The	O
most	O
abundant	O
microflora	O
is	O
present	O
in	O
the	O
distal	O
parts	O
of	O
the	O
gut	O
;	O
the	O
majority	O
of	O
the	O
intestinal	O
bacteria	O
are	O
Gram	O
-	O
negative	O
anaerobes	O
.	O

More	O
than	O
50	O
%	O
of	O
intestinal	O
bacteria	O
can	O
not	O
be	O
cultured	O
by	O
conventional	O
microbiological	O
techniques	O
.	O

Molecular	O
biological	O
methods	O
help	O
in	O
analysing	O
the	O
structural	O
and	O
functional	O
complexity	O
of	O
the	O
microflora	O
and	O
in	O
identifying	O
its	O
components	O
.	O

Resident	O
microflora	O
contains	O
a	O
number	O
of	O
components	O
able	O
to	O
activate	O
innate	O
and	O
adaptive	O
immunity	O
.	O

Unlimited	O
immune	O
activation	O
in	O
response	O
to	O
signals	O
from	O
commensal	O
bacteria	O
could	O
pose	O
the	O
risk	O
of	O
inflammation	O
;	O
immune	O
responses	O
to	O
mucosal	O
microbiota	O
therefore	O
require	O
a	O
precise	O
regulatory	O
control	O
.	O

The	O
mucosal	O
immune	O
system	O
has	O
developed	O
specialised	O
regulatory	O
,	O
anti	O
-	O
inflammatory	O
mechanisms	O
for	O
eliminating	O
or	O
tolerating	O
non	O
-	O
dangerous	O
,	O
food	O
and	O
airborne	O
antigens	O
and	O
commensal	O
micro	O
-	O
organisms	O
(	O
oral	O
,	O
mucosal	O
tolerance	O
)	O
.	O

However	O
,	O
at	O
the	O
same	O
time	O
the	O
mucosal	O
immune	O
system	O
must	O
provide	O
local	O
defense	O
mechanisms	O
against	O
environmental	O
threats	O
(	O
e	O
.	O
g	O
.	O
invading	O
pathogens	O
)	O
.	O

This	O
important	O
requirement	O
is	O
fulfilled	O
by	O
several	O
mechanisms	O
of	O
mucosal	O
immunity	O
:	O
strongly	O
developed	O
innate	O
defense	O
mechanisms	O
ensuring	O
appropriate	O
function	O
of	O
the	O
mucosal	O
barrier	O
,	O
existence	O
of	O
unique	O
types	O
of	O
lymphocytes	O
and	O
their	O
products	O
,	O
transport	O
of	O
polymeric	O
immunoglobulins	O
through	O
epithelial	O
cells	O
into	O
secretions	O
(	O
sIgA	O
)	O
and	O
migration	O
and	O
homing	O
of	O
cells	O
originating	O
from	O
the	O
mucosal	O
organised	O
tissues	O
in	O
mucosae	O
and	O
exocrine	O
glands	O
.	O

The	O
important	O
role	O
of	O
commensal	O
bacteria	O
in	O
development	O
of	O
optimally	O
functioning	O
mucosal	O
immune	O
system	O
was	O
demonstrated	O
in	O
germ	O
-	O
free	O
animals	O
(	O
using	O
gnotobiological	O
techniques	O
)	O
.	O

Involvement	O
of	O
commensal	O
microflora	O
and	O
its	O
components	O
with	O
strong	O
immunoactivating	O
properties	O
(	O
e	O
.	O
g	O
.	O
LPS	O
,	O
peptidoglycans	O
,	O
superantigens	O
,	O
bacterial	O
DNA	O
,	O
Hsp	O
)	O
in	O
etiopathogenetic	O
mechanism	O
of	O
various	O
complex	O
,	O
multifactorial	O
and	O
multigenic	O
diseases	O
,	O
including	O
inflammatory	O
bowel	O
diseases	O
,	O
periodontal	O
disease	O
,	O
rheumatoid	O
arthritis	O
,	O
atherosclerosis	O
,	O
allergy	O
,	O
multiorgan	O
failure	O
,	O
colon	O
cancer	O
has	O
been	O
recently	O
suggested	O
.	O

Animal	O
models	O
of	O
human	O
diseases	O
reared	O
in	O
defined	O
gnotobiotic	O
conditions	O
are	O
helping	O
to	O
elucidate	O
the	O
aetiology	O
of	O
these	O
frequent	O
disorders	O
.	O

An	O
improved	O
understanding	O
of	O
commensal	O
bacteria	O
-	O
host	O
interactions	O
employing	O
germ	O
-	O
free	O
animal	O
models	O
with	O
selective	O
colonisation	O
strategies	O
combined	O
with	O
modern	O
molecular	O
techniques	O
could	O
bring	O
new	O
insights	O
into	O
the	O
mechanisms	O
of	O
mucosal	O
immunity	O
and	O
also	O
into	O
pathogenetic	O
mechanisms	O
of	O
several	O
infectious	O
,	O
inflammatory	O
,	O
autoimmune	O
and	O
neoplastic	O
diseases	O
.	O

Regulation	O
of	O
microflora	O
composition	O
(	O
e	O
.	O
g	O
.	O
by	O
probiotics	O
and	O
prebiotics	O
)	O
offers	O
the	O
possibility	O
to	O
influence	O
the	O
development	O
of	O
mucosal	O
and	O
systemic	O
immunity	O
but	O
it	O
can	O
play	O
a	O
role	O
also	O
in	O
prevention	O
and	O
treatment	O
of	O
some	O
diseases	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
sampling	O
methods	O
for	O
recovery	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
and	O
lactobacilli	B-bacteria
(	O
LB	B-bacteria
)	O
in	O
children	O
9	O
to	O
36	O
months	O
of	O
age	O
.	O

Tongue	O
and	O
plaque	O
specimens	O
collected	O
on	O
cotton	O
swabs	O
and	O
stimulated	O
saliva	O
were	O
diluted	O
and	O
plated	O
on	O
selective	O
and	O
nonselective	O
media	O
.	O

Tongue	O
specimens	O
on	O
a	O
swab	O
and	O
mouth	O
mirror	O
were	O
inoculated	O
directly	O
on	O
selective	O
agar	O
media	O
(	O
MS	B-bacteria
only	O
)	O
.	O

Sampling	O
methods	O
were	O
compared	O
by	O
frequency	O
of	O
recovery	O
of	O
MS	B-bacteria
or	O
LB	B-bacteria
,	O
correlation	O
of	O
microbial	O
counts	O
with	O
dmfs	O
scores	O
,	O
and	O
potential	O
of	O
specific	O
microbial	O
counts	O
to	O
predict	O
caries	O
presence	O
or	O
absence	O
.	O

The	O
mean	O
dmfs	O
score	O
of	O
87	O
subjects	O
was	O
6	O
.	O
3	O
;	O
48	O
subjects	O
were	O
caries	O
free	O
.	O

Levels	O
of	O
MS	B-bacteria
and	O
LB	B-bacteria
were	O
consistently	O
higher	O
in	O
plaque	O
than	O
in	O
other	O
sampling	O
techniques	O
(	O
P	O
<	O
.	O
001	O
)	O
,	O
and	O
frequencies	O
of	O
recovery	O
of	O
MS	B-bacteria
were	O
highest	O
in	O
plaque	O
(	O
P	O
<	O
.	O
041	O
)	O
and	O
tongue	O
(	O
P	O
<	O
.	O
006	O
)	O
.	O

Frequency	O
of	O
LB	B-bacteria
recovery	O
did	O
not	O
differ	O
significantly	O
between	O
sampling	O
methods	O
.	O

Counts	O
of	O
MS	B-bacteria
or	O
LB	B-bacteria
in	O
total	O
subjects	O
and	O
subjects	O
aged	O
9	O
to	O
24	O
months	O
correlated	O
positively	O
with	O
dmfs	O
scores	O
(	O
P	O
<	O
.	O
028	O
)	O
.	O

Threshold	O
levels	O
of	O
MS	B-bacteria
which	O
were	O
predictive	O
of	O
presence	O
of	O
caries	O
were	O
:	O
(	O
1	O
)	O
plaque	O
=	O
>	O
2x10	O
(	O
5	O
)	O
;	O
(	O
2	O
)	O
tongue	O
=	O
>	O
10	O
(	O
4	O
)	O
;	O
(	O
3	O
)	O
saliva	O
=	O
>	O
10	O
(	O
5	O
)	O
;	O
(	O
4	O
)	O
mirror	O
=	O
>	O
50	O
;	O
and	O
(	O
5	O
)	O
swab	O
=	O
>	O
50	O
.	O

Comparable	O
levels	O
of	O
LB	B-bacteria
were	O
:	O
plaque	O
,	O
>	O
10	O
(	O
3	O
)	O
;	O
tongue	O
,	O
>	O
10	O
(	O
2	O
)	O
and	O
saliva	O
,	O
>	O
10	O
(	O
3	O
)	O
.	O

Specificities	O
associated	O
with	O
these	O
predictions	O
were	O
higher	O
than	O
sensitivities	O
for	O
all	O
sampling	O
methods	O
.	O

(	O
1	O
)	O
All	O
sampling	O
methods	O
were	O
adequate	O
for	O
microbial	O
risk	O
assessment	O
tests	O
in	O
children	O
under	O
3	O
years	O
of	O
age	O
;	O
(	O
2	O
)	O
MS	B-bacteria
was	O
a	O
stronger	O
indicator	O
of	O
caries	O
status	O
than	O
LB	B-bacteria
.	O

Recent	O
studies	O
suggest	O
that	O
normal	O
human	O
oral	O
keratinocytes	O
(	O
NHOKs	O
)	O
can	O
be	O
infected	O
by	O
HIV	O
-	O
1	O
,	O
and	O
alcohol	O
can	O
enhance	O
HIV	O
infection	O
and	O
replication	O
in	O
lymphocytes	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
possibility	O
that	O
alcohol	O
might	O
facilitate	O
HIV	O
-	O
1	O
infection	O
of	O
NHOKs	O
by	O
up	O
-	O
regulating	O
cell	O
surface	O
expression	O
of	O
the	O
coreceptor	O
,	O
CXCR4	O
.	O

Alcohol	O
enhanced	O
in	O
vitro	O
infection	O
of	O
NHOKs	O
by	O
CXCR4	O
-	O
tropic	O
strains	O
of	O
HIV	O
-	O
1	O
as	O
indicated	O
by	O
synthesis	O
of	O
viral	O
reverse	O
transcripts	O
and	O
production	O
of	O
p24gag	O
protein	O
.	O

Alcohol	O
had	O
no	O
effect	O
on	O
CXCR4	O
gene	O
expression	O
or	O
on	O
total	O
cellular	O
complements	O
of	O
CXCR4	O
protein	O
.	O

However	O
,	O
alcohol	O
did	O
enhance	O
the	O
fraction	O
of	O
total	O
CXCR4	O
expressed	O
on	O
the	O
cell	O
surface	O
relative	O
to	O
intracellular	O
stores	O
.	O

Alcohol	O
-	O
induced	O
up	O
-	O
regulation	O
of	O
cell	O
surface	O
CXCR4	O
expression	O
and	O
HIV	O
-	O
1	O
infectivity	O
could	O
be	O
blocked	O
by	O
SDF	O
-	O
1alpha	O
-	O
mediated	O
internalization	O
.	O

These	O
data	O
suggest	O
that	O
alcohol	O
may	O
influence	O
oral	O
HIV	O
transmission	O
by	O
altering	O
the	O
cellular	O
compartmentalization	O
of	O
CXCR4	O
in	O
cells	O
of	O
the	O
oral	O
cavity	O
.	O

To	O
observe	O
the	O
dynamic	O
changes	O
of	O
oral	O
microflora	O
early	O
colonized	O
in	O
infants	O
.	O

The	O
oral	O
swab	O
samples	O
for	O
the	O
study	O
were	O
taken	O
in	O
1	O
day	O
,	O
1	O
,	O
3	O
,	O
6	O
,	O
9	O
,	O
12	O
months	O
after	O
birth	O
from	O
12	O
healthy	O
neonates	O
.	O

By	O
choosing	O
suitable	O
diluted	O
concentration	O
,	O
the	O
samples	O
were	O
incubated	O
aerobically	O
,	O
facultative	O
anaerobically	O
and	O
anaerobically	O
.	O

The	O
strains	O
were	O
identified	O
by	O
observing	O
colony	O
characteristics	O
,	O
Gram	O
staining	O
and	O
biochemical	O
tests	O
.	O

S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
was	O
the	O
most	O
frequent	O
microflora	O
,	O
followed	O
by	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
occurred	O
in	O
oral	O
cavity	O
after	O
tooth	O
eruption	O
.	O

Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
can	O
be	O
detected	O
in	O
oral	O
cavity	O
of	O
1	O
-	O
month	O
-	O
old	O
babies	O
,	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
was	O
isolated	O
from	O
8	O
.	O
3	O
%	O
infants	O
of	O
more	O
than	O
3	O
months	O
old	O
.	O

L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
maintained	O
the	O
lower	O
prevalence	O
in	O
oral	O
cavity	O
of	O
babies	O
.	O

Leptotrichia	B-bacteria
buccalis	I-bacteria
and	O
Capnocytophaga	B-bacteria
spp	I-bacteria
.	I-bacteria
occurred	O
in	O
oral	O
cavity	O
of	O
some	O
dentate	O
infants	O
.	O

S	B-bacteria
.	I-bacteria
solivarius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
are	O
predominant	O
species	O
in	O
oral	O
cavity	O
of	O
the	O
infants	O
,	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
is	O
the	O
first	O
and	O
the	O
most	O
anaerobic	O
species	O
appeared	O
in	O
oral	O
cavity	O
of	O
healthy	O
babies	O
.	O

A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
is	O
the	O
first	O
actinomyces	B-bacteria
detected	O
in	O
oral	O
cavity	O
.	O

With	O
the	O
increasing	O
months	O
,	O
kind	O
and	O
amount	O
of	O
microflora	O
increase	O
dramatically	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
effect	O
of	O
ozonated	O
water	O
on	O
oral	O
microorganisms	O
and	O
dental	O
plaque	O
.	O

Almost	O
no	O
microorganisms	O
were	O
detected	O
after	O
being	O
treated	O
with	O
ozonated	O
water	O
(	O
4	O
mg	O
/	O
l	O
)	O
for	O
10	O
s	O
.	O
To	O
estimate	O
the	O
ozonated	O
water	O
-	O
treated	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
bacterial	O
cells	O
were	O
stained	O
with	O
LIVE	O
/	O
DEAD	O
BacLight	O
Bacterial	O
Viability	O
Kit	O
.	O

Fluorescence	O
microscopic	O
analysis	O
revealed	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
cells	O
were	O
killed	O
instantaneously	O
in	O
ozonated	O
water	O
.	O

Some	O
breakage	O
of	O
ozonated	O
water	O
-	O
treated	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
found	O
by	O
electron	O
microscopy	O
.	O

When	O
the	O
experimental	O
dental	O
plaque	O
was	O
exposed	O
to	O
ozonated	O
water	O
,	O
the	O
number	O
of	O
viable	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
remarkably	O
decreased	O
.	O

Ozonated	O
water	O
strongly	O
inhibited	O
the	O
accumulation	O
of	O
experimental	O
dental	O
plaque	O
in	O
vitro	O
.	O

After	O
the	O
dental	O
plaque	O
samples	O
from	O
human	O
subjects	O
were	O
exposed	O
to	O
ozonated	O
water	O
in	O
vitro	O
,	O
almost	O
no	O
viable	O
bacterial	O
cells	O
were	O
detected	O
.	O

These	O
results	O
suggest	O
that	O
ozonated	O
water	O
should	O
be	O
useful	O
in	O
reducing	O
the	O
infections	O
caused	O
by	O
oral	O
microorganisms	O
in	O
dental	O
plaque	O
.	O

Dental	O
plaque	O
is	O
composed	O
of	O
a	O
biofilm	O
community	O
of	O
microorganisms	O
on	O
teeth	O
that	O
coats	O
the	O
oral	O
cavity	O
,	O
including	O
attaching	O
to	O
the	O
teeth	O
,	O
and	O
provides	O
a	O
protective	O
reservoir	O
for	O
oral	O
microbial	O
pathogens	O
,	O
which	O
are	O
the	O
primary	O
cause	O
of	O
persistent	O
and	O
chronic	O
infectious	O
diseases	O
.	O

Oral	O
streptococci	B-bacteria
are	O
pioneering	O
organisms	O
that	O
play	O
an	O
important	O
role	O
in	O
biofilm	O
formation	O
on	O
tooth	O
surfaces	O
as	O
well	O
as	O
being	O
primary	O
causative	O
agents	O
of	O
dental	O
caries	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
clarify	O
the	O
role	O
of	O
the	O
E2f1	O
gene	O
in	O
susceptibility	O
to	O
dry	O
mouth	O
and	O
bacterial	O
adherence	O
of	O
oral	O
streptococci	B-bacteria
to	O
tooth	O
surfaces	O
in	O
animal	O
model	O
experiments	O
.	O

A	O
mutation	O
of	O
the	O
E2f1	O
gene	O
in	O
mice	O
is	O
known	O
to	O
cause	O
enhanced	O
T	O
-	O
lymphocyte	O
proliferation	O
,	O
leading	O
to	O
testicular	O
atrophy	O
,	O
splenomegaly	O
,	O
salivary	O
gland	O
dysplasia	O
,	O
and	O
other	O
systemic	O
and	O
organ	O
-	O
specific	O
autoimmunity	O
.	O

We	O
found	O
a	O
decreased	O
volume	O
of	O
saliva	O
production	O
and	O
protein	O
production	O
rate	O
,	O
along	O
with	O
increased	O
amylase	O
activity	O
,	O
IgA	O
concentration	O
,	O
and	O
mucin	O
1	O
concentration	O
in	O
E2F	O
-	O
1	O
(	O
-	O
/	O
-	O
)	O
mice	O
as	O
compared	O
with	O
the	O
control	O
C57BL	O
/	O
6	O
mice	O
.	O

Further	O
,	O
we	O
quantified	O
the	O
recolonization	O
of	O
oral	O
streptococci	B-bacteria
in	O
E2F	O
-	O
1	O
(	O
-	O
/	O
-	O
)	O
mice	O
and	O
found	O
that	O
a	O
higher	O
number	O
of	O
some	O
oral	O
streptococci	B-bacteria
were	O
colonized	O
on	O
the	O
teeth	O
of	O
these	O
mice	O
.	O

In	O
particular	O
,	O
following	O
oral	O
ingestion	O
of	O
1	O
%	O
sucrose	O
in	O
water	O
,	O
the	O
colonization	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
increased	O
in	O
comparison	O
with	O
other	O
streptococci	B-bacteria
.	O

Our	O
results	O
suggest	O
that	O
the	O
E2f1	O
gene	O
may	O
affect	O
susceptibility	O
for	O
oral	O
biofilm	O
formation	O
by	O
streptococci	B-bacteria
in	O
humans	O
with	O
dry	O
mouth	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
is	O
an	O
important	O
gastrointestinal	O
pathogen	O
associated	O
with	O
gastritis	O
,	O
peptic	O
ulcers	O
,	O
and	O
an	O
increased	O
risk	O
of	O
gastric	O
carcinoma	O
.	O

The	O
oral	O
cavity	O
has	O
been	O
indicated	O
as	O
a	O
possible	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
reservoir	O
,	O
and	O
may	O
therefore	O
be	O
involved	O
in	O
the	O
reinfection	O
of	O
the	O
stomach	O
which	O
sometimes	O
follows	O
treatment	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
as	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
the	O
oral	O
cavity	O
of	O
periodontitis	O
patients	O
testing	O
positive	O
for	O
this	O
bacterium	O
in	O
the	O
stomach	O
.	O

Thirty	O
adult	O
patients	O
with	O
alterations	O
of	O
the	O
superior	O
digestive	O
tract	O
,	O
testing	O
urease	O
positive	O
after	O
endoscopy	O
and	O
biopsy	O
,	O
were	O
selected	O
.	O

A	O
full	O
-	O
mouth	O
periodontal	O
examination	O
was	O
performed	O
in	O
every	O
patient	O
and	O
the	O
subjects	O
were	O
allocated	O
to	O
two	O
groups	O
:	O
gingivitis	O
(	O
15	O
patients	O
)	O
and	O
chronic	O
periodontitis	O
(	O
15	O
patients	O
)	O
.	O

plaque	O
and	O
saliva	O
samples	O
collected	O
from	O
each	O
patient	O
were	O
stored	O
in	O
0	O
.	O
5	O
ml	O
of	O
TE	O
buffer	O
.	O

DNA	O
was	O
extracted	O
from	O
the	O
samples	O
by	O
the	O
boiling	O
method	O
and	O
was	O
evaluated	O
for	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
using	O
the	O
PCR	O
method	O
.	O

JW	O
22	O
/	O
23	O
primers	O
were	O
used	O
.	O

The	O
DNA	O
of	O
ATCC	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
43629	I-bacteria
(	O
positive	O
control	O
)	O
and	O
water	O
(	O
negative	O
control	O
)	O
were	O
used	O
for	O
controlling	O
the	O
reactions	O
.	O

Of	O
the	O
30	O
evaluated	O
patients	O
,	O
13	O
(	O
43	O
.	O
3	O
%	O
)	O
harbored	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
mouth	O
.	O

The	O
bacterium	O
was	O
not	O
found	O
on	O
the	O
dorsum	O
of	O
the	O
tongue	O
of	O
any	O
patient	O
,	O
but	O
was	O
found	O
in	O
saliva	O
in	O
three	O
patients	O
(	O
10	O
%	O
)	O
,	O
in	O
the	O
supragingival	O
plaque	O
in	O
six	O
patients	O
(	O
20	O
%	O
)	O
,	O
and	O
in	O
the	O
subgingival	O
plaque	O
in	O
eight	O
patients	O
(	O
26	O
.	O
6	O
%	O
)	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
similar	O
in	O
the	O
gingivitis	O
and	O
chronic	O
periodontitis	O
groups	O
.	O

In	O
conclusion	O
,	O
a	O
high	O
percentage	O
of	O
patients	O
harbored	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
mouth	O
.	O

The	O
bacterium	O
was	O
detected	O
in	O
saliva	O
,	O
supragingival	O
and	O
subgingival	O
plaque	O
,	O
suggesting	O
that	O
these	O
sites	O
may	O
be	O
considered	O
reservoirs	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
urease	O
-	O
positive	O
patients	O
.	O

The	O
comparative	O
in	O
vitro	O
activities	O
of	O
11	O
iodonium	O
salt	O
compounds	O
,	O
0	O
.	O
12	O
%	O
chlorhexidine	O
,	O
and	O
four	O
antimicrobial	O
agents	O
against	O
322	O
anaerobic	O
and	O
fastidious	O
potential	O
dental	O
and	O
periodontal	O
bacterial	O
pathogens	O
were	O
studied	O
.	O

Iodonium	O
salts	O
3	O
,	O
4	O
,	O
5	O
,	O
9	O
,	O
and	O
10	O
had	O
in	O
vitro	O
activities	O
comparable	O
to	O
that	O
of	O
chlorhexidine	O
against	O
most	O
isolates	O
.	O

These	O
compounds	O
may	O
be	O
suitable	O
for	O
incorporation	O
into	O
an	O
oral	O
mouthwash	O
.	O

To	O
evaluate	O
the	O
relationship	O
between	O
oral	O
bacteria	O
species	O
detection	O
and	O
volatile	O
sulphide	O
compounds	O
(	O
VSC	O
)	O
concentration	O
in	O
the	O
elderly	O
.	O

Cross	O
-	O
sectional	O
microbiological	O
and	O
clinical	O
VSC	O
examination	O
of	O
elderly	O
.	O

Sixty	O
-	O
seven	O
elderly	O
people	O
aged	O
75	O
,	O
who	O
were	O
functionally	O
independent	O
and	O
dentate	O
.	O

VSC	O
(	O
H2S	O
and	O
CH3SH	O
)	O
concentrations	O
in	O
the	O
mouth	O
air	O
of	O
subjects	O
were	O
measured	O
using	O
portable	O
gas	O
chromatography	O
.	O

Oral	O
bacteria	O
samples	O
were	O
taken	O
from	O
dental	O
plaque	O
and	O
identification	O
of	O
bacteria	O
species	O
was	O
accomplished	O
using	O
standard	O
methods	O
.	O

Fewer	O
than	O
20	O
%	O
of	O
subjects	O
showed	O
more	O
than	O
10	O
ng	O
/	O
10	O
ml	O
of	O
H2S	O
(	O
severe	O
odour	O
level	O
)	O
.	O

The	O
detection	O
rate	O
of	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
was	O
significantly	O
higher	O
in	O
elderly	O
people	O
with	O
more	O
than	O
10	O
ng	O
/	O
10	O
ml	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
levels	O
.	O

Fusobacterium	B-bacteria
had	O
a	O
tendency	O
to	O
be	O
found	O
in	O
those	O
with	O
more	O
than	O
10	O
ng	O
/	O
10	O
ml	O
,	O
but	O
a	O
significant	O
relation	O
was	O
not	O
found	O
.	O

The	O
results	O
suggest	O
that	O
Fusobacterium	B-bacteria
and	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
may	O
be	O
involved	O
in	O
the	O
production	O
of	O
H2S	O
in	O
the	O
oral	O
cavity	O
of	O
elderly	O
people	O
.	O

Microbial	O
communities	O
within	O
the	O
human	O
oral	O
cavity	O
are	O
dynamic	O
associations	O
of	O
more	O
than	O
500	O
bacterial	O
species	O
that	O
form	O
biofilms	O
on	O
the	O
soft	O
and	O
hard	O
tissues	O
of	O
the	O
mouth	O
.	O

Understanding	O
the	O
development	O
and	O
spatial	O
organization	O
of	O
oral	O
biofilms	O
has	O
been	O
facilitated	O
by	O
the	O
use	O
of	O
in	O
vitro	O
models	O
.	O

We	O
used	O
a	O
saliva	O
-	O
conditioned	O
flow	O
cell	O
,	O
with	O
saliva	O
as	O
the	O
sole	O
nutritional	O
source	O
,	O
as	O
a	O
model	O
to	O
examine	O
the	O
development	O
of	O
multispecies	O
biofilm	O
communities	O
from	O
an	O
inoculum	O
containing	O
the	O
coaggregation	O
partners	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Veillonella	B-bacteria
atypica	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Biofilms	O
inoculated	O
with	O
individual	O
species	O
in	O
a	O
sequential	O
order	O
were	O
compared	O
with	O
biofilms	O
inoculated	O
with	O
coaggregates	O
of	O
the	O
four	O
species	O
.	O

Our	O
results	O
indicated	O
that	O
flow	O
cells	O
inoculated	O
sequentially	O
produced	O
biofilms	O
with	O
larger	O
biovolumes	O
compared	O
to	O
those	O
biofilms	O
inoculated	O
with	O
coaggregates	O
.	O

Individual	O
-	O
species	O
biovolumes	O
within	O
the	O
four	O
-	O
species	O
communities	O
also	O
differed	O
between	O
the	O
two	O
modes	O
of	O
inoculation	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
with	O
genus	O
-	O
and	O
species	O
-	O
specific	O
probes	O
revealed	O
that	O
the	O
majority	O
of	O
cells	O
in	O
both	O
sequentially	O
and	O
coaggregate	O
-	O
inoculated	O
biofilms	O
were	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
regardless	O
of	O
the	O
inoculation	O
order	O
.	O

However	O
,	O
the	O
representation	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
and	O
V	B-bacteria
.	I-bacteria
atypica	I-bacteria
was	O
significantly	O
higher	O
in	O
biofilms	O
inoculated	O
with	O
coaggregates	O
compared	O
to	O
sequentially	O
inoculated	O
biofilms	O
.	O

Thus	O
,	O
these	O
results	O
indicate	O
that	O
the	O
development	O
of	O
multispecies	O
biofilm	O
communities	O
is	O
influenced	O
by	O
coaggregations	O
preformed	O
in	O
planktonic	O
phase	O
.	O

Coaggregating	O
bacteria	O
such	O
as	O
certain	O
streptococci	B-bacteria
are	O
especially	O
adapted	O
to	O
primary	O
colonization	O
of	O
saliva	O
-	O
conditioned	O
surfaces	O
independent	O
of	O
the	O
mode	O
of	O
inoculation	O
and	O
order	O
of	O
addition	O
in	O
the	O
multispecies	O
inoculum	O
.	O

Preformed	O
coaggregations	O
favor	O
other	O
bacterial	O
strains	O
and	O
may	O
facilitate	O
symbiotic	O
relationships	O
.	O

To	O
isolate	O
bacteriophages	O
lytic	O
for	O
oral	O
pathogens	O
from	O
human	O
saliva	O
,	O
dental	O
plaque	O
and	O
mature	O
biofilms	O
constituted	O
from	O
saliva	O
-	O
derived	O
bacteria	O
.	O

Saliva	O
and	O
dental	O
plaque	O
samples	O
from	O
healthy	O
volunteers	O
and	O
from	O
patients	O
with	O
gingivitis	O
and	O
periodontitis	O
were	O
examined	O
for	O
the	O
presence	O
of	O
lytic	O
bacteriophages	O
using	O
a	O
panel	O
of	O
oral	O
pathogens	O
and	O
bacteria	O
isolated	O
from	O
the	O
samples	O
.	O

Samples	O
were	O
also	O
enriched	O
for	O
bacteriophage	O
using	O
static	O
culture	O
techniques	O
and	O
mature	O
biofilms	O
.	O

A	O
limited	O
number	O
of	O
samples	O
contained	O
bacteriophage	O
particles	O
that	O
were	O
visualized	O
using	O
electron	O
microscopy	O
.	O

Cultures	O
yielded	O
phage	O
infecting	O
non	O
-	O
oral	O
bacteria	O
(	O
Proteus	B-bacteria
mirabilis	I-bacteria
)	O
but	O
no	O
bacteriophage	O
specific	O
for	O
recognized	O
oral	O
pathogens	O
were	O
found	O
.	O

Some	O
micro	O
-	O
organisms	O
from	O
the	O
oral	O
microflora	O
elaborated	O
antibacterial	O
substances	O
that	O
inhibited	O
growth	O
of	O
other	O
residents	O
of	O
the	O
oral	O
cavity	O
.	O

Unlike	O
other	O
ecosystems	O
,	O
the	O
composition	O
of	O
the	O
oral	O
cavity	O
does	O
not	O
appear	O
to	O
be	O
heavily	O
influenced	O
by	O
interactions	O
between	O
bacteriophages	O
and	O
their	O
hosts	O
.	O

Bacteriophage	O
for	O
control	O
of	O
oral	O
infections	O
may	O
need	O
to	O
be	O
obtained	O
from	O
other	O
sources	O
.	O

Antibacterial	O
substances	O
derived	O
from	O
some	O
members	O
of	O
the	O
oral	O
microflora	O
warrant	O
investigation	O
as	O
potential	O
antibiotics	O
.	O

Mercury	O
-	O
resistant	O
bacteria	O
isolated	O
from	O
the	O
oral	O
cavities	O
of	O
children	O
carried	O
one	O
of	O
two	O
types	O
of	O
merA	O
gene	O
that	O
appear	O
to	O
have	O
evolved	O
from	O
a	O
common	O
ancestor	O
.	O

Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
a	O
few	O
other	O
species	O
had	O
merA	O
genes	O
that	O
were	O
very	O
similar	O
to	O
merA	O
of	O
Bacillus	B-bacteria
cereus	I-bacteria
strain	I-bacteria
RC607	I-bacteria
.	O

Unlike	O
the	O
B	B-bacteria
.	I-bacteria
cereus	I-bacteria
RC607	I-bacteria
merA	O
gene	O
,	O
however	O
,	O
the	O
streptococcal	O
merA	O
genes	O
were	O
not	O
carried	O
on	O
Tn5084	O
-	O
like	O
transposons	O
.	O

Instead	O
,	O
comparisons	O
with	O
microbial	O
genomic	O
sequences	O
suggest	O
the	O
merA	O
gene	O
is	O
located	O
on	O
a	O
novel	O
type	O
II	O
transposon	O
.	O

Coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	B-bacteria
and	O
Streptococcus	B-bacteria
parasanguis	I-bacteria
had	O
identical	O
merA	O
genes	O
that	O
represent	O
a	O
new	O
merA	O
variant	O
.	O

The	O
alanine	O
-	O
rich	O
repeating	O
region	O
(	O
A	O
-	O
region	O
)	O
in	O
the	O
surface	O
protein	O
antigen	O
(	O
PAc	O
)	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
has	O
received	O
much	O
attention	O
as	O
an	O
antigenic	O
component	O
for	O
vaccines	O
against	O
dental	O
caries	O
.	O

The	O
PAc	O
(	O
residue	O
361	O
-	O
386	O
)	O
peptide	O
in	O
the	O
A	O
-	O
region	O
possesses	O
a	O
multiple	O
binding	O
motif	O
(	O
L	O
-	O
-	O
V	O
-	O
K	O
-	O
-	O
A	O
)	O
to	O
various	O
HLA	O
-	O
DR	O
molecules	O
and	O
a	O
B	O
-	O
cell	O
core	O
epitope	O
(	O
-	O
Y	O
-	O
-	O
-	O
L	O
-	O
-	O
Y	O
-	O
-	O
-	O
-	O
)	O
that	O
recognizes	O
the	O
inhibiting	O
antibody	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
immunogenicity	O
of	O
the	O
PAc	O
(	O
361	O
-	O
386	O
)	O
peptide	O
in	O
humans	O
and	O
regulators	O
of	O
induction	O
of	O
the	O
anti	O
-	O
PAc	O
(	O
361	O
-	O
386	O
)	O
peptide	O
IgA	O
antibody	O
(	O
aPPA	O
)	O
in	O
saliva	O
.	O

The	O
PAc	O
(	O
361	O
-	O
386	O
)	O
peptide	O
was	O
confirmed	O
as	O
an	O
ideal	O
peptide	O
antigen	O
for	O
induction	O
of	O
the	O
inhibiting	O
antibody	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
151	O
healthy	O
human	O
subjects	O
(	O
36	O
.	O
6	O
+	O
/	O
-	O
12	O
.	O
6	O
years	O
old	O
)	O
by	O
quantitative	O
analyses	O
of	O
oral	O
bacteria	O
and	O
ELISA	O
,	O
as	O
the	O
aPPA	O
titre	O
in	O
human	O
saliva	O
decreased	O
significantly	O
in	O
an	O
age	O
-	O
dependent	O
manner	O
.	O

Homozygous	O
DRB1	O
*	O
0405	O
and	O
1502	O
,	O
and	O
heterozygous	O
DRB1	O
*	O
0405	O
/	O
1502	O
showed	O
a	O
negative	O
association	O
with	O
production	O
of	O
aPPA	O
and	O
tended	O
to	O
reduce	O
the	O
number	O
of	O
total	O
streptococci	B-bacteria
in	O
saliva	O
.	O

In	O
contrast	O
,	O
the	O
DRB1	O
*	O
1501	O
allele	O
was	O
significantly	O
correlated	O
with	O
a	O
high	O
level	O
of	O
induction	O
of	O
the	O
antibodies	O
,	O
and	O
also	O
tended	O
to	O
reduce	O
lactobacilli	B-bacteria
and	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Further	O
,	O
peptide	O
immunogenicity	O
was	O
confirmed	O
in	O
NOD	O
-	O
SCID	O
mice	O
grafted	O
with	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
interplay	O
between	O
regulators	O
such	O
as	O
age	O
,	O
DRB1	O
genotype	O
,	O
cytokines	O
,	O
and	O
peptide	O
immunogenicity	O
may	O
provide	O
a	O
potential	O
means	O
for	O
developing	O
a	O
vaccine	O
useful	O
for	O
the	O
prevention	O
of	O
dental	O
caries	O
as	O
well	O
as	O
their	O
diagnosis	O
.	O

Oral	O
streptococci	B-bacteria
play	O
a	O
large	O
role	O
in	O
dental	O
biofilm	O
formation	O
,	O
and	O
several	O
types	O
interact	O
as	O
early	O
colonizers	O
with	O
the	O
enamel	O
salivary	O
pellicle	O
to	O
form	O
the	O
primary	O
biofilm	O
,	O
as	O
well	O
as	O
to	O
incorporate	O
other	O
bacteria	O
on	O
tooth	O
surfaces	O
.	O

Interactions	O
of	O
surface	O
molecules	O
of	O
individual	O
streptococci	B-bacteria
with	O
the	O
salivary	O
pellicle	O
on	O
the	O
tooth	O
surface	O
have	O
an	O
influence	O
on	O
the	O
etiological	O
properties	O
of	O
an	O
oral	O
biofilm	O
.	O

To	O
elucidate	O
the	O
molecular	O
interactions	O
of	O
streptococci	B-bacteria
with	O
salivary	O
components	O
,	O
binding	O
between	O
surface	O
protein	O
(	O
SspB	O
and	O
PAg	O
)	O
peptides	O
of	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
were	O
investigated	O
by	O
utilizing	O
BIAcore	O
biosensor	O
technology	O
.	O

The	O
analogous	O
peptide	O
[	O
change	O
of	O
T	O
at	O
position	O
400	O
to	O
K	O
in	O
SspB	O
(	O
390	O
-	O
402	O
)	O
,	O
resulting	O
in	O
the	O
SspB	O
(	O
390	O
-	O
T400K	O
-	O
402	O
)	O
peptide	O
]	O
from	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
showed	O
the	O
greatest	O
response	O
for	O
binding	O
to	O
salivary	O
components	O
and	O
inhibited	O
the	O
binding	O
of	O
Streptococcus	B-bacteria
sanguis	I-bacteria
by	O
more	O
than	O
50	O
%	O
in	O
a	O
competitive	O
inhibition	O
assay	O
in	O
a	O
comparison	O
with	O
other	O
SspB	O
and	O
PAg	O
peptides	O
.	O

This	O
peptide	O
also	O
bound	O
to	O
the	O
high	O
-	O
molecular	O
-	O
weight	O
protein	O
complex	O
of	O
salivary	O
components	O
and	O
the	O
agglutinin	O
(	O
gp340	O
/	O
DMBT1	O
)	O
peptide	O
(	O
scavenger	O
receptor	O
cysteine	O
-	O
rich	O
domain	O
peptide	O
2	O
[	O
SRCRP	O
2	O
]	O
)	O
.	O

In	O
addition	O
,	O
the	O
SspB	O
(	O
390	O
-	O
T400K	O
-	O
402	O
)	O
peptide	O
was	O
visualized	O
by	O
two	O
surface	O
positive	O
charges	O
in	O
connection	O
with	O
the	O
positively	O
charged	O
residues	O
,	O
in	O
which	O
lysine	O
was	O
a	O
key	O
residue	O
for	O
binding	O
.	O

Therefore	O
,	O
the	O
region	O
containing	O
lysine	O
may	O
have	O
binding	O
activity	O
in	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
and	O
the	O
SRCRP	O
2	O
region	O
may	O
function	O
as	O
a	O
receptor	O
for	O
the	O
binding	O
.	O

These	O
findings	O
may	O
provide	O
useful	O
information	O
regarding	O
the	O
molecular	O
mechanism	O
of	O
early	O
biofilm	O
formation	O
by	O
streptococci	B-bacteria
on	O
tooth	O
surfaces	O
.	O

Dental	O
plaque	O
samples	O
from	O
40	O
children	O
were	O
screened	O
for	O
the	O
presence	O
of	O
bacteria	O
resistant	O
to	O
amoxicillin	O
.	O

Fifteen	O
children	O
had	O
used	O
amoxicillin	O
and	O
25	O
had	O
not	O
used	O
any	O
antibiotic	O
in	O
the	O
3	O
months	O
prior	O
to	O
sample	O
collection	O
.	O

All	O
(	O
100	O
%	O
)	O
of	O
the	O
children	O
harbored	O
amoxicillin	O
-	O
resistant	O
oral	O
bacteria	O
.	O

The	O
median	O
percentage	O
of	O
the	O
total	O
cultivable	O
oral	O
microbiota	O
resistant	O
to	O
amoxicillin	O
was	O
2	O
.	O
4	O
%	O
(	O
range	O
,	O
0	O
.	O
1	O
to	O
14	O
.	O
3	O
%	O
)	O
in	O
children	O
without	O
amoxicillin	O
use	O
and	O
10	O
.	O
9	O
%	O
(	O
range	O
,	O
0	O
.	O
8	O
to	O
97	O
.	O
3	O
%	O
)	O
in	O
children	O
with	O
amoxicillin	O
use	O
,	O
with	O
the	O
latter	O
value	O
being	O
significantly	O
higher	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

A	O
total	O
of	O
224	O
amoxicillin	O
-	O
resistant	O
bacteria	O
were	O
isolated	O
and	O
comprised	O
three	O
main	O
genera	O
:	O
Haemophilus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Veillonella	B-bacteria
spp	I-bacteria
.	O

The	O
biodiversity	O
of	O
the	O
amoxicillin	O
-	O
resistant	O
microbiota	O
was	O
similar	O
among	O
the	O
isolates	O
from	O
children	O
with	O
and	O
without	O
previous	O
antibiotic	O
use	O
.	O

The	O
amoxicillin	O
MIC	O
at	O
which	O
90	O
%	O
of	O
the	O
isolates	O
were	O
inhibited	O
for	O
isolates	O
from	O
children	O
who	O
had	O
used	O
amoxicillin	O
in	O
the	O
previous	O
3	O
months	O
was	O
higher	O
(	O
64	O
mg	O
liter	O
(	O
-	O
1	O
)	O
)	O
than	O
that	O
obtained	O
for	O
the	O
isolates	O
from	O
subjects	O
who	O
had	O
not	O
used	O
antibiotics	O
(	O
16	O
mg	O
liter	O
(	O
-	O
1	O
)	O
)	O
.	O

The	O
majority	O
of	O
the	O
amoxicillin	O
-	O
resistant	O
isolates	O
(	O
65	O
%	O
)	O
were	O
also	O
resistant	O
to	O
at	O
least	O
one	O
of	O
the	O
three	O
antibiotics	O
tested	O
(	O
penicillin	O
,	O
erythromycin	O
,	O
and	O
tetracycline	O
)	O
,	O
with	O
resistance	O
to	O
penicillin	O
(	O
51	O
%	O
of	O
isolates	O
)	O
being	O
the	O
most	O
frequently	O
encountered	O
.	O

However	O
,	O
significantly	O
more	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
of	O
the	O
amoxicillin	O
-	O
resistant	O
isolates	O
from	O
subjects	O
with	O
previous	O
amoxicillin	O
use	O
were	O
also	O
resistant	O
to	O
erythromycin	O
.	O

This	O
study	O
has	O
demonstrated	O
that	O
a	O
diverse	O
collection	O
of	O
amoxicillin	O
-	O
resistant	O
bacteria	O
is	O
present	O
in	O
the	O
oral	O
cavity	O
and	O
that	O
the	O
number	O
,	O
proportions	O
,	O
MICs	O
,	O
and	O
resistance	O
to	O
erythromycin	O
can	O
significantly	O
increase	O
with	O
amoxicillin	O
use	O
.	O

Motile	O
bacteria	O
often	O
use	O
sophisticated	O
chemotaxis	O
signaling	O
systems	O
to	O
direct	O
their	O
movements	O
.	O

In	O
general	O
,	O
bacterial	O
chemotactic	O
signal	O
transduction	O
pathways	O
have	O
three	O
basic	O
elements	O
:	O
(	O
1	O
)	O
signal	O
reception	O
by	O
bacterial	O
chemoreceptors	O
located	O
on	O
the	O
membrane	O
;	O
(	O
2	O
)	O
signal	O
transduction	O
to	O
relay	O
the	O
signals	O
from	O
membrane	O
receptors	O
to	O
the	O
motor	O
;	O
and	O
(	O
3	O
)	O
signal	O
adaptation	O
to	O
desensitize	O
the	O
initial	O
signal	O
input	O
.	O

The	O
chemotaxis	O
proteins	O
involved	O
in	O
these	O
signal	O
transduction	O
pathways	O
have	O
been	O
identified	O
and	O
extensively	O
studied	O
,	O
especially	O
in	O
the	O
enterobacteria	B-bacteria
Escherichia	B-bacteria
coli	I-bacteria
and	O
Salmonella	B-bacteria
enterica	I-bacteria
serovar	I-bacteria
typhimurium	I-bacteria
.	O

Chemotaxis	O
-	O
guided	O
bacterial	O
movements	O
enable	O
bacteria	O
to	O
adapt	O
better	O
to	O
their	O
natural	O
habitats	O
via	O
moving	O
toward	O
favorable	O
conditions	O
and	O
away	O
from	O
hostile	O
surroundings	O
.	O

A	O
variety	O
of	O
oral	O
microbes	O
exhibits	O
motility	O
and	O
chemotaxis	O
,	O
behaviors	O
that	O
may	O
play	O
important	O
roles	O
in	O
bacterial	O
survival	O
and	O
pathogenesis	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
innate	O
immune	O
response	O
is	O
of	O
pivotal	O
importance	O
in	O
defending	O
the	O
mucosal	O
barriers	O
of	O
the	O
body	O
against	O
pathogenic	O
attack	O
.	O

The	O
list	O
of	O
proteins	O
that	O
contribute	O
to	O
this	O
defense	O
mechanism	O
is	O
constantly	O
being	O
updated	O
.	O

In	O
this	O
review	O
we	O
introduce	O
a	O
novel	O
family	O
of	O
secreted	O
proteins	O
,	O
palate	O
,	O
lung	O
,	O
and	O
nasal	O
epithelium	O
clones	O
(	O
PLUNCs	O
)	O
,	O
that	O
are	O
expressed	O
in	O
the	O
mouth	O
,	O
nose	O
and	O
upper	O
airways	O
of	O
humans	O
,	O
mice	O
,	O
rats	O
and	O
cows	O
.	O

In	O
humans	O
,	O
PLUNC	O
genes	O
are	O
located	O
in	O
a	O
compact	O
cluster	O
on	O
chromosome	O
20	O
,	O
with	O
similar	O
loci	O
being	O
found	O
in	O
synteneic	O
locations	O
in	O
other	O
species	O
.	O

The	O
protein	O
products	O
of	O
this	O
gene	O
cluster	O
are	O
predicted	O
to	O
be	O
structural	O
homologues	O
of	O
the	O
human	O
lipopolysaccharide	O
binding	O
proteins	O
,	O
lipopolysaccharide	O
binding	O
-	O
protein	O
(	O
LBP	O
)	O
and	O
bacterial	O
permeability	O
-	O
increasing	O
protein	O
(	O
BPI	O
)	O
,	O
which	O
are	O
known	O
mediators	O
of	O
host	O
defense	O
against	O
Gram	O
-	O
negative	O
bacteria	O
.	O

On	O
the	O
basis	O
of	O
these	O
observations	O
we	O
outline	O
why	O
we	O
believe	O
PLUNC	O
proteins	O
mediate	O
host	O
defense	O
functions	O
in	O
the	O
oral	O
,	O
nasal	O
and	O
respiratory	O
epithelia	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
relationship	O
between	O
oral	O
bacterial	O
colonization	O
and	O
oral	O
motor	O
dysfunction	O
.	O

Oral	O
motor	O
dysfunction	O
(	O
swallowing	O
and	O
speech	O
disorders	O
)	O
and	O
detection	O
of	O
oral	O
bacterial	O
species	O
from	O
dental	O
plaque	O
in	O
55	O
elderly	O
persons	O
who	O
had	O
remained	O
hospitalized	O
for	O
more	O
than	O
3	O
months	O
were	O
investigated	O
and	O
statistically	O
analyzed	O
.	O

The	O
detection	O
rates	O
of	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
,	O
and	O
Stenotrophomonas	B-bacteria
maltophilia	I-bacteria
were	O
significantly	O
higher	O
in	O
subjects	O
with	O
than	O
in	O
those	O
without	O
a	O
swallowing	O
disorder	O
.	O

A	O
similar	O
result	O
was	O
found	O
with	O
regard	O
to	O
the	O
presence	O
of	O
a	O
speech	O
disorder	O
.	O

About	O
half	O
of	O
subjects	O
who	O
had	O
oral	O
motor	O
dysfunction	O
and	O
hypoalbuminemia	O
had	O
colonization	O
by	O
MRSA	B-bacteria
and	O
/	O
or	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

These	O
results	O
suggest	O
that	O
the	O
combination	O
of	O
oral	O
motor	O
dysfunction	O
and	O
hypoalbminemia	O
elevated	O
the	O
risk	O
of	O
opportunistic	O
microorganisms	O
colonization	O
in	O
the	O
oral	O
cavity	O
of	O
elderly	O
patients	O
hospitalized	O
over	O
the	O
long	O
term	O
.	O

Clinical	O
studies	O
have	O
demonstrated	O
the	O
considerable	O
effects	O
of	O
chlorhexidine	O
on	O
dental	O
plaque	O
and	O
oral	O
microbiota	O
as	O
well	O
as	O
improvements	O
in	O
indices	O
of	O
oral	O
health	O
.	O

This	O
investigation	O
examined	O
the	O
efficacy	O
of	O
lower	O
concentrations	O
of	O
chlorhexidine	O
.	O

Mouthrinses	O
with	O
0	O
.	O
03	O
%	O
,	O
0	O
.	O
06	O
%	O
,	O
0	O
.	O
12	O
%	O
chlorhexidine	O
and	O
a	O
control	O
rinse	O
without	O
chlorhexidine	O
were	O
examined	O
.	O

Alamar	O
blue	O
,	O
an	O
oxidation	O
-	O
reduction	O
dye	O
with	O
fluorescent	O
end	O
-	O
points	O
proportional	O
to	O
bacterial	O
viability	O
,	O
was	O
used	O
to	O
determine	O
bacterial	O
viability	O
.	O

Further	O
clinical	O
studies	O
examined	O
the	O
effects	O
of	O
these	O
rinses	O
on	O
salivary	O
bacteria	O
and	O
on	O
bacteria	O
producing	O
hydrogen	O
sulfide	O
(	O
H	O
(	O
2	O
)	O
S	O
)	O
and	O
implicated	O
in	O
halitosis	O
.	O

In	O
laboratory	O
tests	O
,	O
a	O
significant	O
dose	O
-	O
dependent	O
effect	O
was	O
observed	O
with	O
Actinomyces	B-bacteria
viscosus	I-bacteria
as	O
a	O
model	O
system	O
using	O
the	O
Alamar	O
blue	O
procedure	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Clinical	O
studies	O
examined	O
the	O
effects	O
1	O
.	O
5	O
h	O
and	O
3	O
h	O
post	O
-	O
treatment	O
on	O
salivary	O
bacteria	O
and	O
bacteria	O
producing	O
H	O
(	O
2	O
)	O
S	O
.	O

The	O
first	O
study	O
compared	O
the	O
control	O
rinse	O
with	O
the	O
0	O
.	O
03	O
%	O
and	O
0	O
.	O
06	O
%	O
chlorhexidine	O
rinses	O
;	O
a	O
second	O
study	O
compared	O
the	O
effects	O
of	O
the	O
control	O
rinse	O
and	O
the	O
0	O
.	O
06	O
%	O
and	O
0	O
.	O
12	O
%	O
chlorhexidine	O
mouthrinses	O
.	O

In	O
both	O
studies	O
,	O
chlorhexidine	O
rinses	O
demonstrated	O
significant	O
dose	O
-	O
dependent	O
effects	O
post	O
-	O
treatment	O
on	O
salivary	O
bacteria	O
vs	O
.	O
the	O
control	O
rinse	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Significant	O
decreases	O
in	O
H	O
(	O
2	O
)	O
S	O
-	O
producing	O
bacteria	O
were	O
noted	O
with	O
these	O
chlorhexidine	O
rinses	O
vs	O
.	O
the	O
control	O
rinse	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
results	O
highlight	O
the	O
dose	O
-	O
dependent	O
relationships	O
noted	O
in	O
laboratory	O
and	O
clinical	O
tests	O
which	O
have	O
potential	O
implications	O
for	O
the	O
use	O
of	O
lower	O
doses	O
of	O
chlorhexidine	O
to	O
inhibit	O
oral	O
bacteria	O
,	O
including	O
those	O
implicated	O
in	O
halitosis	O
.	O

Four	O
oral	O
bacterial	O
strains	O
,	O
of	O
which	O
two	O
are	O
considered	O
aciduric	O
and	O
two	O
are	O
considered	O
acid	O
-	O
sensitive	O
,	O
were	O
grown	O
under	O
glucose	O
-	O
limiting	O
conditions	O
in	O
chemostats	O
to	O
determine	O
whether	O
their	O
membrane	O
fatty	O
acid	O
profiles	O
were	O
altered	O
in	O
response	O
to	O
environmental	O
acidification	O
.	O

Streptococcus	B-bacteria
gordonii	I-bacteria
DL1	I-bacteria
,	O
as	O
well	O
as	O
the	O
aciduric	O
strains	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
57	I-bacteria
.	I-bacteria
I	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
4646	I-bacteria
increased	O
the	O
levels	O
of	O
mono	O
-	O
unsaturated	O
membrane	O
fatty	O
acids	O
.	O

The	O
non	O
-	O
aciduric	O
strain	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
10904	I-bacteria
did	O
not	O
alter	O
its	O
membrane	O
composition	O
in	O
response	O
to	O
pH	O
values	O
examined	O
here	O
.	O

Thus	O
,	O
in	O
response	O
to	O
low	O
pH	O
,	O
aciduric	O
oral	O
bacteria	O
alter	O
their	O
membrane	O
composition	O
to	O
contain	O
increased	O
levels	O
of	O
long	O
-	O
chained	O
,	O
mono	O
-	O
unsaturated	O
fatty	O
acids	O
.	O

This	O
suggests	O
that	O
membrane	O
fatty	O
acid	O
adaptation	O
is	O
a	O
common	O
mechanism	O
utilized	O
by	O
bacteria	O
to	O
withstand	O
environmental	O
stress	O
.	O

Fourteen	O
strains	O
of	O
Gram	O
-	O
negative	O
,	O
anaerobic	O
,	O
fluoroquinolone	O
-	O
resistant	O
,	O
non	O
-	O
sporulating	O
rods	O
were	O
isolated	O
from	O
various	O
infections	O
in	O
cats	O
and	O
dogs	O
,	O
as	O
well	O
as	O
from	O
wounds	O
in	O
humans	O
after	O
cat	O
-	O
or	O
dog	O
-	O
bites	O
.	O

These	O
strains	O
were	O
characterized	O
by	O
sequencing	O
of	O
the	O
16S	O
-	O
23S	O
rDNA	O
internal	O
transcribed	O
spacer	O
(	O
ITS	O
)	O
regions	O
,	O
16S	O
rDNA	O
,	O
DNA	O
-	O
DNA	O
hybridization	O
,	O
phylogenetic	O
analysis	O
,	O
and	O
phenotypic	O
tests	O
.	O

The	O
results	O
indicate	O
that	O
the	O
novel	O
strains	O
belong	O
to	O
a	O
distinct	O
species	O
,	O
closely	O
related	O
to	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

The	O
species	O
Fusobacterium	B-bacteria
canifelinum	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
is	O
proposed	O
,	O
with	O
strain	O
ATCC	B-bacteria
BAA	I-bacteria
689T	I-bacteria
as	O
the	O
type	O
strain	O
.	O

The	O
control	O
of	O
oral	O
malodor	O
is	O
well	O
-	O
recognized	O
in	O
efforts	O
to	O
improve	O
oral	O
health	O
.	O

Antimicrobial	O
formulations	O
can	O
mitigate	O
oral	O
malodor	O
,	O
however	O
,	O
procedures	O
to	O
assess	O
effects	O
on	O
oral	O
bacteria	O
including	O
those	O
implicated	O
in	O
halitosis	O
are	O
unavailable	O
.	O

This	O
investigation	O
examined	O
the	O
antimicrobial	O
effects	O
of	O
a	O
new	O
liquid	O
triclosan	O
/	O
copolymer	O
dentifrice	O
(	O
test	O
)	O
formulation	O
that	O
demonstrated	O
significant	O
inhibition	O
of	O
oral	O
malodor	O
in	O
previous	O
organoleptic	O
clinical	O
studies	O
.	O

Procedures	O
compared	O
antimicrobial	O
effects	O
of	O
the	O
test	O
and	O
control	O
formulations	O
on	O
a	O
range	O
of	O
oral	O
micro	O
-	O
organisms	O
including	O
members	O
implicated	O
in	O
halitosis	O
,	O
substantive	O
antimicrobial	O
effects	O
of	O
formulations	O
with	O
hydroxyapatite	O
as	O
a	O
surrogate	O
for	O
human	O
teeth	O
and	O
ex	O
vivo	O
effects	O
on	O
oral	O
bacteria	O
from	O
human	O
volunteers	O
.	O

With	O
Actinomyces	B-bacteria
viscosus	I-bacteria
,	O
as	O
a	O
model	O
system	O
,	O
the	O
test	O
formulation	O
demonstrated	O
a	O
dose	O
-	O
dependent	O
effect	O
.	O

At	O
these	O
concentrations	O
the	O
test	O
formulation	O
provided	O
significant	O
antimicrobial	O
effects	O
on	O
13	O
strains	O
of	O
oral	O
bacteria	O
including	O
those	O
implicated	O
in	O
bad	O
breath	O
at	O
selected	O
posttreatment	O
time	O
points	O
.	O

Treatment	O
of	O
hydroxyapatite	O
by	O
the	O
test	O
dentifrice	O
resulted	O
in	O
a	O
significant	O
and	O
substantive	O
antimicrobial	O
effect	O
vs	O
.	O
controls	O
.	O

Oral	O
bacteria	O
from	O
subjects	O
treated	O
ex	O
vivo	O
with	O
the	O
test	O
dentifrice	O
resulted	O
in	O
significant	O
reductions	O
in	O
cultivable	O
oral	O
bacteria	O
and	O
odorigenic	O
bacteria	O
producing	O
hydrogen	O
sulfide	O
.	O

In	O
summary	O
,	O
microbiological	O
methods	O
adapted	O
to	O
study	O
odorigenic	O
bacteria	O
demonstrate	O
the	O
significant	O
antimicrobial	O
effects	O
of	O
the	O
test	O
(	O
triclosan	O
/	O
copolymer	O
)	O
dentifrice	O
with	O
laboratory	O
and	O
clinical	O
strains	O
of	O
oral	O
bacteria	O
implicated	O
in	O
bad	O
breath	O
.	O

A	O
range	O
of	O
opportunistic	O
pathogens	O
have	O
been	O
associated	O
with	O
dental	O
unit	O
water	O
systems	O
(	O
DUWS	O
)	O
,	O
particularly	O
in	O
the	O
biofilms	O
that	O
can	O
line	O
the	O
tubing	O
.	O

This	O
study	O
therefore	O
aimed	O
to	O
assess	O
the	O
microbiology	O
of	O
DUWS	O
and	O
biofilms	O
in	O
general	O
dental	O
practices	O
across	O
seven	O
European	O
countries	O
,	O
including	O
the	O
United	O
Kingdom	O
(	O
UK	O
)	O
,	O
Ireland	O
(	O
IRL	O
)	O
,	O
Greece	O
(	O
GR	O
)	O
,	O
Spain	O
(	O
ES	O
)	O
,	O
Germany	O
(	O
D	O
)	O
,	O
Denmark	O
(	O
DK	O
)	O
and	O
the	O
Netherlands	O
(	O
NL	O
)	O
.	O

Water	O
supplied	O
by	O
51	O
%	O
of	O
237	O
dental	O
unit	O
water	O
lines	O
exceeded	O
current	O
American	O
Dental	O
Association	O
recommendations	O
of	O
<	O
or	O
=	O
200	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
ml	O
(	O
-	O
1	O
)	O
.	O

Microbiological	O
loading	O
of	O
the	O
source	O
waters	O
was	O
between	O
0	O
(	O
Denmark	O
,	O
the	O
Netherlands	O
and	O
Spain	O
)	O
and	O
4	O
.	O
67	O
(	O
IRL	O
)	O
log	O
CFU	O
ml	O
(	O
-	O
1	O
)	O
;	O
water	O
line	O
samples	O
from	O
the	O
DUWS	O
ranged	O
from	O
1	O
.	O
52	O
(	O
ES	O
)	O
to	O
2	O
.	O
79	O
(	O
GR	O
)	O
log	O
CFU	O
ml	O
(	O
-	O
1	O
)	O
;	O
and	O
biofilm	O
counts	O
ranged	O
from	O
1	O
.	O
49	O
(	O
GR	O
)	O
to	O
3	O
.	O
22	O
(	O
DK	O
)	O
log	O
CFU	O
.	O
cm	O
(	O
-	O
2	O
)	O
.	O

Opportunistic	O
pathogens	O
such	O
as	O
legionellae	O
(	O
DK	O
and	O
ES	O
)	O
,	O
including	O
Legionella	B-bacteria
pneumophila	I-bacteria
SG1	I-bacteria
(	O
DK	O
and	O
GR	O
)	O
,	O
and	O
Mycobacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
DK	O
,	O
NL	O
,	O
GR	O
,	O
D	O
and	O
ES	O
)	O
were	O
recovered	O
occasionally	O
.	O

Presumptive	O
oral	O
streptococci	B-bacteria
(	O
ES	O
and	O
NL	O
)	O
,	O
oral	O
anaerobes	O
(	O
GR	O
)	O
,	O
Candida	O
spp	O
.	O
(	O
UK	O
,	O
NL	O
and	O
ES	O
)	O
and	O
blood	O
(	O
GR	O
and	O
IRL	O
)	O
were	O
detected	O
at	O
relatively	O
low	O
frequencies	O
,	O
but	O
their	O
presence	O
indicated	O
a	O
failure	O
of	O
the	O
3	O
-	O
in	O
-	O
1	O
antiretraction	O
valve	O
,	O
leading	O
to	O
back	O
siphonage	O
of	O
oral	O
fluids	O
into	O
the	O
water	O
and	O
biofilm	O
phase	O
.	O

These	O
findings	O
confirm	O
that	O
a	O
substantial	O
proportion	O
of	O
DUWS	O
have	O
high	O
levels	O
of	O
microbial	O
contamination	O
,	O
irrespective	O
of	O
country	O
,	O
type	O
of	O
equipment	O
and	O
source	O
water	O
.	O

The	O
study	O
emphasizes	O
the	O
need	O
for	O
effective	O
mechanisms	O
to	O
reduce	O
the	O
microbial	O
burden	O
within	O
DUWS	O
,	O
and	O
highlights	O
the	O
risk	O
of	O
occupational	O
exposure	O
and	O
cross	O
-	O
infection	O
in	O
general	O
dental	O
practice	O
.	O

We	O
investigated	O
the	O
involvement	O
of	O
oral	O
epithelial	O
cells	O
via	O
two	O
cytokines	O
(	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
alpha	O
)	O
and	O
one	O
chemokine	O
(	O
IL	O
-	O
8	O
)	O
in	O
local	O
defences	O
against	O
live	O
yeast	O
(	O
Candida	O
albicans	O
)	O
and	O
bacteria	O
(	O
Streptococcus	B-bacteria
salivarius	I-bacteria
)	O
using	O
an	O
engineered	O
human	O
oral	O
mucosa	O
model	O
.	O

We	O
report	O
that	O
the	O
yeast	O
changed	O
from	O
the	O
blastospore	O
to	O
the	O
hyphal	O
form	O
and	O
induced	O
significant	O
tissue	O
disorganization	O
at	O
later	O
contact	O
periods	O
(	O
24	O
and	O
48	O
h	O
)	O
compared	O
to	O
the	O
bacteria	O
.	O

However	O
,	O
this	O
effect	O
did	O
not	O
reduce	O
the	O
viability	O
or	O
total	O
number	O
of	O
epithelial	O
cells	O
.	O

Gene	O
activation	O
analyses	O
revealed	O
that	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
TNF	O
-	O
alpha	O
mRNA	O
levels	O
rose	O
in	O
tissues	O
in	O
contact	O
with	O
live	O
C	O
.	O
albicans	O
or	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
.	O

Gene	O
activation	O
was	O
followed	O
by	O
an	O
upregulation	O
of	O
protein	O
secretion	O
.	O

IL	O
-	O
6	O
levels	O
were	O
higher	O
after	O
contact	O
with	O
C	O
.	O
albicans	O
than	O
with	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
.	O

IL	O
-	O
8	O
levels	O
after	O
contact	O
with	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
were	O
higher	O
than	O
with	O
C	O
.	O
albicans	O
.	O

Our	O
study	O
suggests	O
that	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
is	O
more	O
efficient	O
at	O
inducing	O
proinflammatory	O
mediator	O
release	O
than	O
C	O
.	O
albicans	O
.	O

These	O
results	O
provide	O
additional	O
evidence	O
for	O
the	O
contribution	O
of	O
oral	O
epithelial	O
cells	O
to	O
the	O
inflammatory	O
response	O
against	O
fungi	O
and	O
bacteria	O
.	O

Controversy	O
exists	O
concerning	O
the	O
association	O
between	O
oral	O
bacteria	O
and	O
infection	O
of	O
hemodialysis	O
(	O
HD	O
)	O
shunts	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
extent	O
to	O
which	O
oral	O
bacteria	O
are	O
associated	O
with	O
vascular	O
access	O
site	O
infections	O
in	O
a	O
group	O
of	O
HD	O
patients	O
.	O

STUDY	O
Microbial	O
blood	O
culture	O
data	O
for	O
87	O
HD	O
patients	O
were	O
collected	O
:	O
53	O
via	O
chart	O
review	O
(	O
retrospective	O
)	O
,	O
and	O
34	O
with	O
newly	O
suspected	O
vascular	O
access	O
infections	O
(	O
prospective	O
)	O
.	O

The	O
primary	O
outcome	O
was	O
the	O
nature	O
(	O
i	O
.	O
e	O
.	O
,	O
species	O
)	O
of	O
the	O
bacteria	O
recovered	O
from	O
blood	O
cultures	O
of	O
subjects	O
with	O
vascular	O
access	O
infection	O
,	O
specifically	O
those	O
bacteria	O
considered	O
to	O
be	O
oral	O
flora	O
.	O

The	O
predominant	O
bacteria	O
reported	O
to	O
cause	O
HD	O
vascular	O
access	O
infections	O
were	O
Staphylococcus	B-bacteria
(	O
48	O
.	O
6	O
%	O
)	O
and	O
Enterococcus	B-bacteria
(	O
17	O
.	O
6	O
%	O
)	O
species	O
.	O

Most	O
infections	O
occurred	O
in	O
hemodialysis	O
catheters	O
(	O
89	O
%	O
)	O
compared	O
with	O
AV	O
grafts	O
(	O
11	O
%	O
)	O
and	O
AV	O
fistulas	O
(	O
0	O
%	O
)	O
.	O

The	O
subclavian	O
venous	O
access	O
(	O
41	O
%	O
)	O
and	O
the	O
internal	O
jugular	O
venous	O
access	O
(	O
38	O
.	O
9	O
%	O
)	O
were	O
more	O
commonly	O
infected	O
than	O
other	O
sites	O
.	O

None	O
of	O
the	O
bacteria	O
identified	O
by	O
blood	O
cultures	O
were	O
considered	O
to	O
be	O
oral	O
flora	O
.	O

The	O
results	O
suggest	O
that	O
oral	O
bacteria	O
rarely	O
,	O
if	O
ever	O
,	O
cause	O
vascular	O
access	O
infections	O
in	O
hemodialysis	O
patients	O
.	O

It	O
is	O
not	O
well	O
known	O
how	O
periodontopathic	O
bacteria	O
colonize	O
in	O
the	O
oral	O
cavity	O
during	O
childhood	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
distribution	O
of	O
periodontopathic	O
bacteria	O
in	O
oral	O
cavities	O
of	O
children	O
and	O
their	O
parents	O
and	O
the	O
relationship	O
between	O
the	O
bacterial	O
findings	O
and	O
clinical	O
parameters	O
.	O

Fifty	O
-	O
six	O
children	O
(	O
mean	O
age	O
:	O
8	O
.	O
3	O
+	O
/	O
-	O
3	O
.	O
5	O
,	O
range	O
:	O
1	O
-	O
15	O
years	O
)	O
,	O
including	O
15	O
with	O
deciduous	O
dentition	O
,	O
26	O
with	O
mixed	O
dentition	O
and	O
15	O
with	O
permanent	O
dentition	O
,	O
and	O
their	O
parents	O
participated	O
in	O
this	O
study	O
.	O

Whole	O
saliva	O
and	O
dental	O
plaque	O
of	O
the	O
children	O
and	O
whole	O
saliva	O
of	O
their	O
parents	O
were	O
collected	O
for	O
detection	O
of	O
seven	O
species	O
of	O
periodontopathic	O
bacteria	O
(	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
(	O
Bacteroides	B-bacteria
forsythus	I-bacteria
)	O
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
using	O
the	O
polymerase	O
chain	O
reaction	O
method	O
.	O

Clinical	O
parameters	O
including	O
simplified	O
Oral	O
Hygiene	O
Index	O
and	O
Papillary	O
-	O
Marginal	O
-	O
Attachment	O
Index	O
were	O
recorded	O
for	O
the	O
children	O
and	O
their	O
accompanied	O
parents	O
.	O

The	O
detection	O
frequencies	O
of	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
the	O
oral	O
cavities	O
of	O
children	O
were	O
42	O
.	O
9	O
%	O
,	O
94	O
.	O
6	O
%	O
,	O
42	O
.	O
9	O
%	O
,	O
48	O
.	O
2	O
%	O
,	O
1	O
.	O
8	O
%	O
and	O
8	O
.	O
9	O
%	O
,	O
respectively	O
.	O

T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
detected	O
more	O
frequently	O
in	O
the	O
saliva	O
of	O
parents	O
(	O
54	O
.	O
8	O
%	O
,	O
54	O
.	O
8	O
%	O
,	O
88	O
.	O
1	O
%	O
,	O
respectively	O
)	O
than	O
in	O
the	O
saliva	O
of	O
children	O
(	O
25	O
.	O
5	O
%	O
,	O
7	O
.	O
3	O
%	O
,	O
41	O
.	O
8	O
%	O
,	O
respectively	O
)	O
.	O

Different	O
detection	O
frequencies	O
of	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
were	O
found	O
among	O
the	O
oral	O
cavities	O
of	O
children	O
with	O
deciduous	O
,	O
mixed	O
and	O
permanent	O
dentitions	O
.	O

In	O
mixed	O
dentition	O
,	O
females	O
harbored	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
more	O
frequently	O
than	O
males	O
did	O
.	O

Children	O
who	O
harbored	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
showed	O
high	O
scores	O
for	O
oral	O
debris	O
measurement	O
by	O
simplified	O
Oral	O
Hygiene	O
Index	O
.	O

T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
were	O
detected	O
more	O
frequently	O
in	O
children	O
whose	O
parents	O
were	O
positive	O
for	O
these	O
pathogens	O
than	O
in	O
children	O
whose	O
parents	O
were	O
negative	O
.	O

High	O
plaque	O
retention	O
seems	O
to	O
promote	O
the	O
colonization	O
of	O
periodontal	O
pathogens	O
in	O
the	O
oral	O
cavities	O
of	O
children	O
.	O

T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
were	O
detected	O
more	O
frequently	O
in	O
the	O
oral	O
cavities	O
of	O
children	O
whose	O
parents	O
already	O
harbored	O
these	O
bacteria	O
.	O

Familial	O
transmission	O
of	O
these	O
bacteria	O
is	O
suggested	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
isolate	O
and	O
identify	O
alkali	O
-	O
resistant	O
bacteria	O
from	O
the	O
dentin	O
of	O
infected	O
root	O
canals	O
.	O

Bacteria	O
from	O
homogenized	O
dentin	O
powder	O
made	O
up	O
from	O
infected	O
root	O
canal	O
walls	O
from	O
human	O
teeth	O
were	O
cultured	O
on	O
buffer	O
-	O
enriched	O
Brain	O
Heart	O
Infusion	O
agar	O
supplemented	O
with	O
4	O
%	O
sheep	O
blood	O
(	O
BHI	O
-	O
blood	O
agar	O
)	O
,	O
adjusted	O
to	O
pH	O
7	O
.	O
0	O
,	O
9	O
.	O
0	O
or	O
10	O
.	O
0	O
.	O

Incubation	O
took	O
place	O
for	O
7	O
days	O
at	O
37	O
degrees	O
C	O
in	O
an	O
anaerobic	O
glove	O
box	O
.	O

Bacterial	O
strains	O
selected	O
according	O
to	O
colony	O
and	O
morphology	O
were	O
subcultured	O
in	O
buffer	O
-	O
enriched	O
BHI	O
broth	O
adjusted	O
to	O
pH	O
9	O
.	O
0	O
,	O
10	O
.	O
0	O
or	O
11	O
.	O
0	O
to	O
confirm	O
their	O
growth	O
as	O
alkali	O
-	O
resistant	O
bacteria	O
.	O

Polymerase	O
chain	O
reaction	O
amplification	O
using	O
specific	O
primer	O
sets	O
and	O
16S	O
rDNA	O
sequence	O
analysis	O
was	O
performed	O
for	O
identification	O
of	O
alkali	O
-	O
resistant	O
isolates	O
.	O

In	O
the	O
present	O
study	O
,	O
37	O
teeth	O
extracted	O
from	O
37	O
patients	O
were	O
used	O
for	O
preparation	O
of	O
the	O
dentin	O
powder	O
samples	O
.	O

Bacteria	O
were	O
detected	O
in	O
25	O
samples	O
when	O
standard	O
BHI	O
-	O
blood	O
agars	O
(	O
pH	O
7	O
.	O
0	O
)	O
were	O
used	O
.	O

Of	O
these	O
,	O
29	O
strains	O
from	O
15	O
samples	O
were	O
alkali	O
resistant	O
,	O
25	O
strains	O
growing	O
at	O
pH	O
9	O
.	O
0	O
and	O
4	O
at	O
pH	O
10	O
.	O
0	O
.	O

The	O
alkali	O
-	O
resistant	O
strains	O
included	O
Enterococcus	B-bacteria
faecium	I-bacteria
(	O
10	O
strains	O
)	O
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
(	O
2	O
strains	O
)	O
,	O
Enterobacter	B-bacteria
cancerogenus	I-bacteria
(	O
1	O
strains	O
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
1	O
strains	O
)	O
,	O
Klebsiella	B-bacteria
ornithinolytica	I-bacteria
(	O
2	O
strains	O
)	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
(	O
2	O
strains	O
)	O
,	O
Streptococcus	B-bacteria
anginosus	I-bacteria
(	O
2	O
strains	O
)	O
,	O
Streptococcus	B-bacteria
constellatus	I-bacteria
(	O
3	O
strains	O
)	O
,	O
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
(	O
2	O
strains	O
)	O
.	O

Three	O
strains	O
were	O
also	O
identified	O
as	O
bacteria	O
of	O
genus	O
Firmicutes	B-bacteria
or	O
Staphylococcus	B-bacteria
at	O
the	O
genus	O
level	O
.	O

The	O
present	O
study	O
showed	O
that	O
many	O
bacterial	O
species	O
in	O
infected	O
root	O
canal	O
dentin	O
were	O
alkali	O
-	O
resistant	O
at	O
pH	O
9	O
.	O
0	O
and	O
/	O
or	O
pH	O
10	O
.	O
0	O
,	O
and	O
belonged	O
mainly	O
to	O
the	O
genus	O
Enterococcus	B-bacteria
.	O

oral	O
treponemes	B-bacteria
are	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
disease	O
.	O

We	O
have	O
previously	O
shown	O
that	O
Treponema	B-bacteria
denticola	I-bacteria
ATCC	I-bacteria
type	I-bacteria
strains	I-bacteria
and	O
strain	O
GM	O
-	O
1	O
are	O
resistant	O
to	O
killing	O
by	O
human	O
beta	O
-	O
defensins	O
(	O
hbetaD	O
)	O
-	O
1	O
and	O
-	O
2	O
.	O

We	O
hypothesize	O
that	O
resistance	O
to	O
beta	O
-	O
defensins	O
is	O
a	O
common	O
feature	O
of	O
oral	O
treponemes	B-bacteria
,	O
which	O
allows	O
colonization	O
and	O
persistence	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
additional	O
isolates	O
of	O
T	O
.	O
denticola	O
,	O
as	O
well	O
as	O
six	O
other	O
species	O
of	O
treponemes	B-bacteria
,	O
for	O
resistance	O
to	O
hbetaD	O
-	O
1	O
,	O
-	O
2	O
and	O
-	O
3	O
.	O

We	O
also	O
examined	O
the	O
four	O
ATCC	B-bacteria
strains	I-bacteria
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
strain	O
GM	B-bacteria
-	I-bacteria
1	I-bacteria
for	O
resistance	O
to	O
hbetaD	O
-	O
3	O
.	O

Resistance	O
was	O
determined	O
by	O
motility	O
and	O
Blue	O
assays	O
for	O
metabolic	O
activity	O
.	O

All	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
strains	I-bacteria
tested	O
were	O
resistant	O
to	O
hbetaD	O
-	O
1	O
,	O
-	O
2	O
and	O
-	O
3	O
,	O
with	O
the	O
exception	O
of	O
strain	O
Ambigua	O
,	O
which	O
was	O
sensitive	O
to	O
hbetaD	O
-	O
2	O
and	O
-	O
3	O
.	O

All	O
other	O
treponemes	B-bacteria
except	O
Treponema	B-bacteria
vincentii	I-bacteria
were	O
resistant	O
to	O
hbetaD	O
-	O
1	O
.	O

Treponema	B-bacteria
pectinovorum	I-bacteria
sensitive	O
to	O
hbetaD	O
-	O
2	O
,	O
while	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
pectinovorum	I-bacteria
and	O
Treponema	B-bacteria
maltophilum	I-bacteria
were	O
sensitive	O
to	O
hbetaD	O
-	O
3	O
.	O

Escherichia	B-bacteria
coli	I-bacteria
was	O
used	O
as	O
a	O
control	O
organism	O
and	O
was	O
killed	O
by	O
all	O
three	O
defensins	O
.	O

Resistance	O
to	O
the	O
constitutively	O
expressed	O
hbetaD	O
-	O
1	O
may	O
assist	O
treponemes	B-bacteria
in	O
initial	O
colonization	O
of	O
epithelial	O
surfaces	O
,	O
while	O
resistance	O
to	O
the	O
inducible	O
hbetaD	O
-	O
2	O
and	O
-	O
3	O
would	O
allow	O
some	O
treponemes	B-bacteria
to	O
survive	O
in	O
active	O
periodontal	O
lesions	O
.	O

Dental	O
caries	O
prevention	O
programs	O
using	O
chlorhexidine	O
(	O
CHX	O
)	O
have	O
been	O
proposed	O
,	O
but	O
CHX	O
'	O
s	O
effect	O
in	O
reducing	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
)	O
appears	O
to	O
last	O
for	O
only	O
a	O
few	O
months	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
attempt	O
to	O
eradicate	O
mutans	B-bacteria
streptococci	I-bacteria
from	O
the	O
oral	O
cavity	O
using	O
intensive	O
professional	O
mechanical	O
tooth	O
cleaning	O
(	O
PMTC	O
)	O
and	O
topical	O
application	O
of	O
CHX	O
in	O
custom	O
-	O
made	O
trays	O
.	O

Seven	O
adult	O
dentate	O
subjects	O
participated	O
in	O
this	O
study	O
(	O
mean	O
age	O
53	O
.	O
7	O
+	O
/	O
-	O
5	O
.	O
6	O
,	O
age	O
range	O
46	O
to	O
62	O
,	O
mean	O
DMFT	O
,	O
9	O
.	O
1	O
+	O
/	O
-	O
4	O
.	O
2	O
)	O
.	O

For	O
each	O
subject	O
,	O
PMTC	O
was	O
carried	O
out	O
eight	O
times	O
within	O
ten	O
days	O
.	O

After	O
each	O
PMTC	O
,	O
1	O
%	O
CHX	O
was	O
applied	O
twice	O
to	O
the	O
tooth	O
surface	O
using	O
custom	O
-	O
made	O
trays	O
.	O

In	O
addition	O
,	O
as	O
home	O
treatment	O
,	O
subjects	O
were	O
required	O
to	O
carry	O
out	O
tooth	O
brushing	O
three	O
times	O
a	O
day	O
,	O
and	O
apply	O
0	O
.	O
2	O
%	O
CHX	O
in	O
custom	O
trays	O
after	O
brushing	O
in	O
the	O
morning	O
and	O
evening	O
.	O

In	O
addition	O
,	O
subjects	O
rinsed	O
with	O
0	O
.	O
2	O
%	O
CHX	O
solution	O
after	O
lunch	O
.	O

Salivary	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
were	O
evaluated	O
using	O
Dentocult	O
-	O
SM	O
at	O
baseline	O
and	O
on	O
days	O
9	O
,	O
20	O
,	O
70	O
,	O
120	O
.	O

Mutans	B-bacteria
streptococci	I-bacteria
were	O
eradicated	O
by	O
day	O
120	O
from	O
4	O
of	O
the	O
7	O
seven	O
subjects	O
participating	O
in	O
this	O
study	O
.	O

Those	O
3	O
subjects	O
still	O
harboring	O
mutans	B-bacteria
streptococci	I-bacteria
exhibited	O
deep	O
periodontal	O
pocketing	O
.	O

Eradication	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
from	O
the	O
oral	O
cavity	O
is	O
feasible	O
using	O
a	O
combination	O
of	O
CHX	O
application	O
in	O
custom	O
-	O
made	O
trays	O
and	O
intensive	O
PMTC	O
.	O

During	O
investigation	O
of	O
adhesive	O
properties	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
it	O
was	O
found	O
out	O
that	O
11	O
strains	O
adhered	O
to	O
buccal	O
intestinal	O
and	O
vaginal	O
epithelium	O
of	O
human	O
.	O

The	O
highest	O
adhesive	O
activity	O
was	O
detected	O
in	O
enterococci	B-bacteria
(	O
adhesive	O
index	O
7	O
.	O
75	O
-	O
14	O
.	O
26	O
)	O
,	O
lower	O
one	O
-	O
-	O
in	O
streptococci	B-bacteria
(	O
6	O
.	O
40	O
-	O
9	O
.	O
16	O
)	O
.	O

In	O
lactobacilli	B-bacteria
adhesive	O
properties	O
manifested	O
in	O
different	O
ways	O
:	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
strains	I-bacteria
adhered	O
more	O
often	O
to	O
buccal	O
epithelium	O
(	O
2	O
.	O
58	O
-	O
4	O
.	O
60	O
)	O
and	O
rarely	O
-	O
-	O
to	O
intestinal	O
and	O
vaginal	O
.	O

L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
manifested	O
high	O
adhesive	O
activity	O
(	O
8	O
.	O
03	O
-	O
9	O
.	O
69	O
)	O
to	O
buccal	O
epithelium	O
and	O
lower	O
one	O
-	O
-	O
to	O
the	O
rest	O
of	O
epithelium	O
types	O
.	O

Monosaccharide	O
composition	O
of	O
glycocalix	O
of	O
6	O
strains	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
was	O
studied	O
to	O
understand	O
the	O
adhesion	O
mechanism	O
.	O

It	O
was	O
shown	O
that	O
surface	O
structures	O
of	O
this	O
microorganism	O
interact	O
with	O
plant	O
lectins	O
,	O
specific	O
to	O
certain	O
monosaccharides	O
.	O

Nosocomial	O
pneumonia	O
remains	O
a	O
common	O
complication	O
in	O
patients	O
undergoing	O
endotracheal	O
intubation	O
.	O

This	O
study	O
examined	O
the	O
transport	O
of	O
bacteria	O
into	O
the	O
trachea	O
during	O
endotracheal	O
intubation	O
,	O
and	O
evaluated	O
the	O
effects	O
of	O
gargling	O
with	O
povidone	O
-	O
iodine	O
on	O
bacterial	O
contamination	O
of	O
the	O
tip	O
of	O
the	O
intubation	O
tube	O
.	O

In	O
the	O
gargling	O
group	O
,	O
patients	O
gargled	O
with	O
25	O
mL	O
of	O
povidone	O
-	O
iodine	O
(	O
2	O
.	O
5	O
mg	O
.	O
mL	O
(	O
-	O
1	O
)	O
)	O
.	O

In	O
the	O
control	O
group	O
,	O
patients	O
gargled	O
with	O
25	O
mL	O
of	O
tap	O
water	O
.	O

Before	O
tracheal	O
intubation	O
,	O
microorganisms	O
were	O
obtained	O
from	O
the	O
posterior	O
wall	O
of	O
the	O
patient	O
'	O
s	O
pharynx	O
using	O
sterile	O
cotton	O
swabs	O
.	O

After	O
anesthesia	O
,	O
all	O
patients	O
were	O
extubated	O
and	O
bacteria	O
contaminating	O
the	O
tip	O
of	O
the	O
tracheal	O
tube	O
were	O
sampled	O
and	O
cultured	O
.	O

Before	O
orotracheal	O
intubation	O
,	O
all	O
19	O
patients	O
who	O
gargled	O
with	O
tap	O
water	O
(	O
control	O
group	O
)	O
had	O
bacterial	O
colonization	O
on	O
the	O
posterior	O
walls	O
of	O
the	O
pharynx	O
.	O

This	O
group	O
included	O
five	O
patients	O
who	O
had	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
in	O
their	O
nasal	O
cavity	O
preoperatively	O
and	O
MRSA	B-bacteria
was	O
also	O
detected	O
in	O
the	O
pharynx	O
of	O
four	O
patients	O
.	O

Bacterial	O
colonization	O
was	O
observed	O
in	O
all	O
19	O
patients	O
who	O
gargled	O
with	O
povidone	O
-	O
iodine	O
(	O
gargling	O
group	O
)	O
and	O
four	O
patients	O
carried	O
MRSA	B-bacteria
in	O
their	O
nasal	O
cavity	O
,	O
although	O
no	O
MRSA	B-bacteria
was	O
detected	O
in	O
the	O
pharynx	O
.	O

In	O
the	O
control	O
group	O
,	O
all	O
the	O
patients	O
had	O
bacterial	O
colonization	O
at	O
the	O
tip	O
of	O
the	O
tube	O
after	O
extubation	O
.	O

Additionally	O
,	O
MRSA	B-bacteria
was	O
detected	O
in	O
two	O
of	O
the	O
four	O
patients	O
.	O

In	O
the	O
gargling	O
group	O
,	O
povidone	O
-	O
iodine	O
eradicated	O
general	O
bacteria	O
and	O
MRSA	B-bacteria
colonies	O
in	O
the	O
pharynx	O
before	O
intubation	O
and	O
at	O
the	O
tip	O
of	O
the	O
tube	O
after	O
extubation	O
.	O

Gargling	O
with	O
povidone	O
-	O
iodine	O
before	O
oral	O
intubation	O
reduces	O
the	O
transport	O
of	O
bacteria	O
into	O
the	O
trachea	O
.	O

Previous	O
analysis	O
of	O
the	O
microbiology	O
of	O
advanced	O
caries	O
by	O
culture	O
and	O
real	O
-	O
time	O
PCR	O
emphasized	O
the	O
high	O
incidence	O
and	O
abundance	O
of	O
gram	O
-	O
negative	O
anaerobic	O
species	O
,	O
particularly	O
Prevotella	O
-	O
like	O
bacteria	O
.	O

The	O
diversity	O
of	O
Prevotella	O
-	O
like	O
bacteria	O
was	O
further	O
explored	O
by	O
analyzing	O
pooled	O
bacterial	O
DNA	O
from	O
lesions	O
of	O
carious	O
dentine	O
.	O

This	O
was	O
achieved	O
by	O
amplification	O
of	O
a	O
region	O
of	O
the	O
16S	O
ribosomal	O
DNA	O
with	O
a	O
Prevotella	B-bacteria
genus	O
-	O
specific	O
forward	O
primer	O
and	O
a	O
universal	O
bacterial	O
reverse	O
primer	O
,	O
followed	O
by	O
cloning	O
and	O
sequencing	O
.	O

Cultured	O
Prevotella	B-bacteria
species	I-bacteria
commonly	O
associated	O
with	O
oral	O
tissues	O
constituted	O
only	O
12	O
%	O
of	O
the	O
Prevotella	B-bacteria
clones	O
isolated	O
from	O
advanced	O
carious	O
lesions	O
.	O

The	O
remaining	O
88	O
%	O
consisted	O
of	O
a	O
diverse	O
range	O
of	O
phylotypes	O
.	O

These	O
included	O
five	O
clusters	O
of	O
previously	O
recognized	O
but	O
uncultured	O
oral	O
Prevotella	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
a	O
major	O
cluster	O
containing	O
Prevotella	O
-	O
like	O
bacteria	O
most	O
closely	O
related	O
to	O
uncharacterized	O
rumen	O
bacteria	O
.	O

Cluster	O
-	O
specific	O
primers	O
were	O
designed	O
,	O
and	O
the	O
numbers	O
of	O
bacteria	O
within	O
clusters	O
were	O
quantified	O
by	O
real	O
-	O
time	O
PCR	O
,	O
confirming	O
the	O
abundance	O
of	O
these	O
organisms	O
.	O

The	O
data	O
indicated	O
that	O
advanced	O
dental	O
caries	O
provides	O
a	O
unique	O
environment	O
for	O
a	O
complex	O
array	O
of	O
novel	O
and	O
uncultured	O
Prevotella	B-bacteria
and	O
Prevotella	O
-	O
like	O
bacteria	O
which	O
,	O
in	O
some	O
cases	O
,	O
may	O
dominate	O
the	O
diverse	O
polymicrobial	O
community	O
associated	O
with	O
the	O
disease	O
.	O

To	O
compare	O
five	O
different	O
commercial	O
mouth	O
rinses	O
with	O
chlorhexidine	O
(	O
CHX	O
)	O
with	O
respect	O
to	O
their	O
anti	O
-	O
halitosis	O
effect	O
and	O
anti	O
-	O
microbial	O
activity	O
on	O
salivary	O
bacterial	O
counts	O
,	O
following	O
a	O
standardised	O
research	O
protocol	O
.	O

And	O
secondly	O
,	O
to	O
validate	O
the	O
study	O
model	O
proposed	O
in	O
the	O
evaluation	O
of	O
patients	O
suffering	O
from	O
halitosis	O
.	O

PATIENTS	O
AND	O
Ten	O
volunteers	O
,	O
with	O
a	O
healthy	O
oral	O
status	O
,	O
were	O
enrolled	O
in	O
a	O
double	O
-	O
blind	O
,	O
cross	O
-	O
over	O
design	O
,	O
using	O
sterile	O
saline	O
as	O
negative	O
control	O
and	O
five	O
CHX	O
-	O
containing	O
mouth	O
rinses	O
:	O
0	O
.	O
12	O
%	O
CHX	O
alone	O
(	O
CHX	O
+	O
NO	O
)	O
,	O
plus	O
alcohol	O
(	O
CHX	O
+	O
ALC	O
)	O
,	O
plus	O
0	O
.	O
05	O
%	O
cetylpiridinium	O
chloride	O
(	O
CHX	O
+	O
CPC	O
)	O
,	O
plus	O
sodium	O
fluoride	O
(	O
CHX	O
+	O
NaF	O
)	O
,	O
and	O
0	O
.	O
05	O
%	O
CHX	O
plus	O
0	O
.	O
05	O
%	O
CPC	O
,	O
plus	O
0	O
.	O
14	O
%	O
zinc	O
lactate	O
(	O
CHX	O
+	O
Zn	O
)	O
.	O

The	O
levels	O
of	O
whole	O
-	O
mouth	O
volatile	O
sulphur	O
compounds	O
(	O
VSCs	O
)	O
were	O
measured	O
by	O
means	O
of	O
a	O
sulphide	O
monitor	O
at	O
baseline	O
,	O
1	O
and	O
5	O
h	O
after	O
rinsing	O
with	O
the	O
assigned	O
product	O
.	O

Baseline	O
measurements	O
also	O
included	O
an	O
organoleptic	O
assessment	O
and	O
the	O
recording	O
of	O
the	O
tongue	O
-	O
coating	O
index	O
.	O

Aerobic	O
and	O
anaerobic	O
salivary	O
bacterial	O
counts	O
were	O
also	O
obtained	O
by	O
collecting	O
unstimulated	O
saliva	O
samples	O
at	O
the	O
same	O
evaluation	O
times	O
,	O
and	O
processed	O
by	O
culturing	O
techniques	O
.	O

Analysis	O
of	O
variance	O
was	O
used	O
to	O
evaluate	O
whether	O
significant	O
differences	O
existed	O
among	O
groups	O
,	O
at	O
each	O
evaluation	O
point	O
,	O
or	O
in	O
changes	O
between	O
evaluations	O
.	O

No	O
significant	O
differences	O
were	O
detected	O
at	O
baseline	O
,	O
with	O
VSC	O
levels	O
ranging	O
between	O
190	O
and	O
227	O
parts	O
per	O
billion	O
(	O
p	O
.	O
p	O
.	O
b	O
.	O
)	O

After	O
rinsing	O
,	O
VSC	O
levels	O
were	O
reduced	O
with	O
all	O
products	O
(	O
except	O
saline	O
)	O
,	O
after	O
1	O
h	O
.	O
Significant	O
differences	O
at	O
1	O
h	O
were	O
detected	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
,	O
corresponding	O
to	O
a	O
lower	O
amount	O
of	O
p	O
.	O
p	O
.	O
b	O
.	O

(	O
109	O
)	O
in	O
(	O
CHX	O
+	O
Zn	O
)	O
as	O
compared	O
with	O
the	O
other	O
groups	O
(	O
except	O
CHX	O
+	O
NO	O
)	O
.	O

At	O
5	O
h	O
,	O
VSC	O
levels	O
were	O
lower	O
for	O
CHX	O
+	O
CPC	O
and	O
CHX	O
+	O
Zn	O
(	O
155	O
and	O
169	O
,	O
respectively	O
)	O
,	O
while	O
the	O
other	O
groups	O
showed	O
levels	O
higher	O
than	O
220	O
p	O
.	O
p	O
.	O
b	O
.	O

With	O
respect	O
to	O
aerobic	O
salivary	O
bacterial	O
counts	O
,	O
CHX	O
+	O
CPC	O
demonstrated	O
the	O
lowest	O
percentage	O
of	O
survival	O
(	O
6	O
%	O
after	O
1	O
h	O
and	O
18	O
%	O
after	O
5	O
h	O
)	O
.	O

For	O
anaerobic	O
bacterial	O
counts	O
,	O
again	O
CHX	O
+	O
CPC	O
demonstrated	O
the	O
lowest	O
percentage	O
of	O
survival	O
(	O
10	O
%	O
at	O
1	O
h	O
and	O
23	O
%	O
at	O
5	O
h	O
)	O
,	O
together	O
with	O
CHX	O
+	O
ALC	O
(	O
18	O
%	O
of	O
survival	O
at	O
5	O
h	O
)	O
.	O

However	O
,	O
salivary	O
counts	O
and	O
VSCs	O
were	O
only	O
significantly	O
correlated	O
at	O
baseline	O
,	O
but	O
not	O
after	O
treatment	O
.	O

Important	O
differences	O
can	O
be	O
expected	O
from	O
different	O
CHX	O
formulations	O
,	O
in	O
relation	O
to	O
both	O
their	O
anti	O
-	O
halitosis	O
effect	O
and	O
anti	O
-	O
microbial	O
activity	O
in	O
saliva	O
.	O

Formulations	O
that	O
combine	O
CHX	O
and	O
CPC	O
achieved	O
the	O
best	O
results	O
,	O
and	O
a	O
formulation	O
combining	O
CHX	O
with	O
NaF	O
resulted	O
in	O
the	O
poorest	O
.	O

Glucansucrases	O
of	O
oral	O
streptococci	B-bacteria
and	O
Leuconostoc	B-bacteria
mesenteroides	I-bacteria
have	O
a	O
common	O
pattern	O
of	O
structural	O
organization	O
and	O
characteristically	O
contain	O
a	O
domain	O
with	O
a	O
series	O
of	O
tandem	O
amino	O
acid	O
repeats	O
in	O
which	O
certain	O
residues	O
are	O
highly	O
conserved	O
,	O
particularly	O
aromatic	O
amino	O
acids	O
and	O
glycine	O
.	O

In	O
some	O
glucosyltransferases	O
(	O
GTFs	O
)	O
the	O
repeat	O
region	O
has	O
been	O
identified	O
as	O
a	O
glucan	O
binding	O
domain	O
(	O
GBD	O
)	O
.	O

Such	O
GBDs	O
are	O
also	O
found	O
in	O
several	O
glucan	O
binding	O
proteins	O
(	O
GBP	O
)	O
of	O
oral	O
streptococci	B-bacteria
that	O
do	O
not	O
have	O
glucansucrase	O
activity	O
.	O

Alignment	O
of	O
the	O
amino	O
acid	O
sequences	O
of	O
20	O
glucansucrases	O
and	O
GBP	O
showed	O
the	O
widespread	O
conservation	O
of	O
the	O
33	O
-	O
residue	O
A	O
repeat	O
first	O
identified	O
in	O
GtfI	O
of	O
Streptococcus	B-bacteria
downei	I-bacteria
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
individual	O
highly	O
conserved	O
residues	O
in	O
recombinant	O
GBD	O
of	O
GtfI	O
demonstrated	O
the	O
importance	O
of	O
the	O
first	O
tryptophan	O
and	O
the	O
tyrosine	O
-	O
phenylalanine	O
pair	O
in	O
the	O
binding	O
of	O
dextran	O
,	O
as	O
well	O
as	O
the	O
essential	O
contribution	O
of	O
a	O
basic	O
residue	O
(	O
arginine	O
or	O
lysine	O
)	O
.	O

A	O
microplate	O
binding	O
assay	O
was	O
developed	O
to	O
measure	O
the	O
binding	O
affinity	O
of	O
recombinant	O
GBDs	O
.	O

GBD	O
of	O
GtfI	O
was	O
shown	O
to	O
be	O
capable	O
of	O
binding	O
glucans	O
with	O
predominantly	O
alpha	O
-	O
1	O
,	O
3	O
or	O
alpha	O
-	O
1	O
,	O
6	O
links	O
,	O
as	O
well	O
as	O
alternating	O
alpha	O
-	O
1	O
,	O
3	O
and	O
alpha	O
-	O
1	O
,	O
6	O
links	O
(	O
alternan	O
)	O
.	O

Western	O
blot	O
experiments	O
using	O
biotinylated	O
dextran	O
or	O
alternan	O
as	O
probes	O
demonstrated	O
a	O
difference	O
between	O
the	O
binding	O
of	O
streptococcal	O
GTF	O
and	O
GBP	O
and	O
that	O
of	O
Leuconostoc	B-bacteria
glucansucrases	I-bacteria
.	O

Experimental	O
data	O
and	O
bioinformatics	O
analysis	O
showed	O
that	O
the	O
A	O
repeat	O
motif	O
is	O
distinct	O
from	O
the	O
20	O
-	O
residue	O
CW	O
motif	O
,	O
which	O
also	O
has	O
conserved	O
aromatic	O
amino	O
acids	O
and	O
glycine	O
and	O
which	O
occurs	O
in	O
the	O
choline	O
-	O
binding	O
proteins	O
of	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
and	O
other	O
organisms	O
.	O

Because	O
oral	O
infections	O
are	O
common	O
,	O
the	O
physician	O
must	O
understand	O
the	O
underlying	O
etiology	O
,	O
pathogeny	O
,	O
and	O
other	O
variables	O
that	O
determine	O
how	O
these	O
processes	O
evolve	O
in	O
order	O
to	O
choose	O
the	O
most	O
appropriate	O
antibiotic	O
drug	O
.	O

The	O
special	O
characteristics	O
of	O
the	O
oral	O
cavity	O
determine	O
the	O
make	O
-	O
up	O
of	O
the	O
microflora	O
that	O
lives	O
there	O
.	O

Different	O
anaerobic	O
species	O
belonging	O
to	O
the	O
Peptostreptococcus	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Gemella	B-bacteria
,	O
and	O
Porphyromonas	B-bacteria
genera	I-bacteria
are	O
of	O
particular	O
interest	O
,	O
as	O
are	O
the	O
aerobic	O
species	O
Streptococcus	B-bacteria
,	O
Staphylococcus	B-bacteria
,	O
and	O
Corynebacterium	B-bacteria
.	O

Each	O
of	O
these	O
microorganisms	O
occupies	O
a	O
different	O
microniche	O
within	O
the	O
oral	O
cavity	O
,	O
and	O
the	O
prevailing	O
balance	O
is	O
upset	O
when	O
conditions	O
become	O
modified	O
as	O
a	O
result	O
of	O
illness	O
or	O
due	O
to	O
dental	O
interventions	O
such	O
as	O
tooth	O
extraction	O
or	O
tooth	O
scaling	O
and	O
polishing	O
.	O

Pathogenic	O
or	O
opportunistic	O
bacteria	O
(	O
Actinomyces	B-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
species	I-bacteria
,	O
etc	O
.	O
)	O
can	O
develop	O
in	O
these	O
conditions	O
,	O
as	O
can	O
yeasts	O
(	O
Candida	O
sp	O
.	O
,	O
Histoplasma	O
capsulatum	O
)	O
,	O
virus	O
(	O
herpes	O
simplex	O
,	O
papilomavirus	O
)	O
,	O
and	O
parasites	O
(	O
Entamoeba	O
gingivalis	O
,	O
Trichomonas	O
tenax	O
)	O
.	O

When	O
infection	O
occurs	O
,	O
the	O
patients	O
s	O
immune	O
system	O
reacts	O
by	O
means	O
of	O
inborn	O
immunity	O
(	O
non	O
-	O
specific	O
)	O
and	O
acquired	O
immunity	O
(	O
specific	O
)	O
.	O

Empirical	O
treatment	O
is	O
administered	O
that	O
should	O
be	O
based	O
on	O
etiological	O
data	O
and	O
on	O
the	O
antimicrobial	O
sensitivity	O
of	O
the	O
pathogen	O
that	O
is	O
causing	O
the	O
infection	O
.	O

However	O
,	O
oral	O
microflora	O
sensitivity	O
to	O
different	O
antibiotics	O
is	O
currently	O
declining	O
and	O
there	O
is	O
a	O
noticeable	O
trend	O
towards	O
resistances	O
.	O

As	O
a	O
consequence	O
of	O
all	O
this	O
,	O
the	O
treatment	O
of	O
oral	O
infections	O
must	O
also	O
aim	O
to	O
restore	O
the	O
ecological	O
balance	O
of	O
the	O
oral	O
cavity	O
and	O
to	O
minimize	O
the	O
emergence	O
of	O
resistance	O
in	O
the	O
microorganisms	O
present	O
in	O
the	O
mouth	O
.	O

Hence	O
,	O
epidemiological	O
oral	O
pathogen	O
sensitivity	O
studies	O
must	O
be	O
conducted	O
,	O
fostering	O
the	O
administration	O
of	O
appropriate	O
antibiotics	O
at	O
proper	O
doses	O
and	O
keeping	O
specialists	O
abreast	O
of	O
the	O
latest	O
trends	O
.	O

In	O
recent	O
decades	O
,	O
oral	O
infections	O
comprise	O
one	O
of	O
the	O
most	O
common	O
pathologies	O
in	O
the	O
general	O
population	O
,	O
due	O
in	O
large	O
part	O
to	O
infectious	O
complications	O
associated	O
with	O
poor	O
oral	O
hygiene	O
.	O

This	O
in	O
turn	O
,	O
translates	O
into	O
an	O
increased	O
need	O
and	O
demand	O
for	O
dental	O
care	O
,	O
while	O
at	O
the	O
same	O
time	O
,	O
it	O
requires	O
that	O
the	O
professional	O
accurately	O
understand	O
the	O
etiological	O
factors	O
involved	O
,	O
as	O
well	O
as	O
the	O
pathogeny	O
and	O
different	O
variables	O
that	O
determine	O
the	O
specificity	O
of	O
these	O
kinds	O
of	O
infections	O
,	O
so	O
as	O
to	O
be	O
able	O
to	O
choose	O
the	O
appropriate	O
antimicrobial	O
drugs	O
for	O
proper	O
treatment	O
.	O

Halitosis	O
refers	O
to	O
the	O
condition	O
of	O
offensive	O
mouth	O
odour	O
.	O

More	O
than	O
90	O
%	O
of	O
cases	O
of	O
halitosis	O
originate	O
from	O
the	O
oral	O
cavity	O
.	O

The	O
implicated	O
bacteria	O
(	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythensis	I-bacteria
)	O
are	O
located	O
in	O
stagnant	O
areas	O
in	O
the	O
oral	O
cavity	O
,	O
such	O
as	O
the	O
dorsal	O
surface	O
of	O
tongue	O
,	O
periodontal	O
pockets	O
,	O
and	O
interproximal	O
areas	O
.	O

These	O
bacteria	O
proteolyse	O
the	O
amino	O
acids	O
releasing	O
volatile	O
sulphur	O
compounds	O
.	O

The	O
management	O
of	O
halitosis	O
involves	O
determining	O
and	O
eliminating	O
the	O
causes	O
,	O
which	O
includes	O
identifying	O
any	O
contributory	O
factors	O
,	O
because	O
certain	O
medical	O
conditions	O
are	O
also	O
associated	O
with	O
characteristic	O
smells	O
.	O

Professional	O
advice	O
should	O
be	O
given	O
on	O
oral	O
hygiene	O
and	O
diet	O
,	O
and	O
treatments	O
should	O
include	O
dental	O
scaling	O
,	O
and	O
root	O
planing	O
of	O
the	O
associated	O
periodontal	O
pockets	O
to	O
reduce	O
the	O
bacterial	O
loading	O
.	O

In	O
addition	O
to	O
the	O
normal	O
oral	O
hygiene	O
practice	O
,	O
tongue	O
cleaning	O
and	O
use	O
of	O
mouthwash	O
are	O
advocated	O
.	O

This	O
paper	O
discusses	O
the	O
common	O
aetiological	O
factors	O
,	O
classification	O
of	O
oral	O
halitosis	O
,	O
and	O
its	O
treatment	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
is	O
a	O
gram	O
-	O
negative	O
,	O
microaerophilic	O
rod	O
-	O
shaped	O
bacteria	O
that	O
lives	O
beneath	O
the	O
gastric	O
mucous	O
layer	O
,	O
on	O
the	O
surface	O
of	O
epithelial	O
cells	O
.	O

Stomach	O
infection	O
with	O
this	O
organism	O
causes	O
inflammation	O
of	O
the	O
gastric	O
mucosa	O
,	O
which	O
can	O
lead	O
to	O
gastritis	O
,	O
duodenal	O
or	O
gastric	O
ulcer	O
and	O
even	O
in	O
rare	O
cases	O
to	O
gastric	O
carcinoma	O
or	O
MALT	O
lymphoma	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
world	O
'	O
s	O
population	O
is	O
believed	O
to	O
be	O
infected	O
with	O
H	O
.	O
pylori	O
.	O

Most	O
infections	O
is	O
probably	O
acquired	O
in	O
childhood	O
,	O
but	O
the	O
exact	O
route	O
of	O
transmission	O
is	O
unknown	O
.	O

It	O
has	O
been	O
speculated	O
that	O
dental	O
plaque	O
might	O
harbour	O
Helicobacter	B-bacteria
pylori	I-bacteria
and	O
,	O
therefore	O
,	O
might	O
be	O
a	O
source	O
of	O
gastric	O
infection	O
.	O

In	O
order	O
to	O
address	O
this	O
issue	O
we	O
studied	O
the	O
relationships	O
between	O
oral	O
and	O
gastric	O
infections	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
100	O
subjects	O
.	O

Gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
determined	O
by	O
(	O
13	O
)	O
C	O
-	O
urea	O
breath	O
test	O
(	O
UBT	O
)	O
and	O
the	O
presence	O
of	O
the	O
bacteria	O
in	O
oral	O
cavity	O
was	O
monitored	O
by	O
the	O
culture	O
from	O
the	O
saliva	O
and	O
from	O
dental	O
plaque	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
in	O
the	O
stomach	O
in	O
51	O
%	O
of	O
studied	O
individuals	O
,	O
while	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
in	O
54	O
%	O
(	O
in	O
saliva	O
)	O
and	O
in	O
48	O
.	O
3	O
%	O
(	O
in	O
gingival	O
pockets	O
)	O
,	O
the	O
difference	O
was	O
not	O
statistical	O
significant	O
(	O
p	O
=	O
NS	O
)	O
.	O

Interestingly	O
,	O
anti	O
-	O
Hp	O
IgA	O
was	O
found	O
in	O
84	O
%	O
of	O
studied	O
individuals	O
.	O

No	O
relationship	O
was	O
found	O
between	O
the	O
presence	O
of	O
the	O
bacteria	O
in	O
the	O
oral	O
cavity	O
and	O
the	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
gastric	O
infection	O
.	O

54	O
.	O
9	O
%	O
of	O
subjects	O
with	O
stomach	O
infection	O
showed	O
concomitant	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
saliva	O
.	O

52	O
.	O
3	O
%	O
of	O
examined	O
subjects	O
with	O
negative	O
UBT	O
-	O
test	O
revealed	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
culture	O
from	O
the	O
saliva	O
.	O

The	O
X	O
(	O
2	O
)	O
value	O
of	O
relationship	O
between	O
UBT	O
and	O
culture	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
saliva	O
was	O
0	O
.	O
029	O
(	O
p	O
=	O
0	O
.	O
9	O
)	O
.	O

Similarly	O
,	O
no	O
relationship	O
was	O
found	O
between	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
and	O
in	O
the	O
dental	O
plaque	O
(	O
X2	O
=	O
0	O
.	O
6	O
)	O
;	O
p	O
=	O
0	O
.	O
4	O
)	O
.	O

As	O
expected	O
,	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
dental	O
plaque	O
was	O
significantly	O
correlated	O
with	O
the	O
presence	O
of	O
bacteria	O
in	O
the	O
saliva	O
(	O
X2	O
=	O
18	O
.	O
4	O
;	O
p	O
=	O
0	O
.	O
0002	O
)	O
.	O

We	O
also	O
compared	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
saliva	O
of	O
patients	O
with	O
and	O
without	O
teeth	O
.	O

The	O
cultured	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
in	O
63	O
.	O
7	O
%	O
of	O
patients	O
without	O
teeth	O
and	O
in	O
52	O
.	O
9	O
%	O
of	O
patients	O
with	O
teeth	O
.	O

This	O
indicates	O
that	O
the	O
presence	O
of	O
teeth	O
does	O
not	O
seem	O
to	O
affect	O
the	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
saliva	O
.	O

We	O
conclude	O
that	O
oral	O
activity	O
contamination	O
with	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
occurs	O
at	O
similar	O
degree	O
to	O
that	O
in	O
the	O
stomach	O
.	O

However	O
,	O
there	O
was	O
no	O
significant	O
correlation	O
between	O
the	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
and	O
in	O
the	O
oral	O
cavity	O
indicating	O
that	O
other	O
factors	O
,	O
like	O
susceptibility	O
to	O
infection	O
due	O
to	O
acid	O
environment	O
in	O
the	O
stomach	O
may	O
be	O
the	O
major	O
factor	O
in	O
gastric	O
infection	O
with	O
that	O
bacteria	O
,	O
while	O
oral	O
cavity	O
may	O
serve	O
only	O
as	O
transient	O
food	O
-	O
related	O
contamination	O
without	O
clear	O
relation	O
to	O
gastric	O
infection	O
.	O

Prevotella	B-bacteria
species	I-bacteria
are	O
a	O
major	O
component	O
of	O
the	O
oral	O
microflora	O
and	O
some	O
have	O
been	O
implicated	O
in	O
various	O
forms	O
of	O
periodontal	O
disease	O
.	O

Despite	O
the	O
importance	O
of	O
understanding	O
the	O
prevalence	O
of	O
these	O
organisms	O
in	O
the	O
oral	O
microflora	O
,	O
no	O
rapid	O
,	O
simultaneous	O
detection	O
system	O
for	O
these	O
species	O
has	O
been	O
reported	O
.	O

This	O
study	O
developed	O
a	O
multiplex	O
polymerase	O
chain	O
reaction	O
assay	O
for	O
the	O
simultaneous	O
detection	O
of	O
four	O
oral	O
black	O
-	O
pigmented	O
Prevotella	B-bacteria
species	I-bacteria
in	O
various	O
oral	O
specimens	O
.	O

This	O
assay	O
will	O
be	O
useful	O
for	O
determining	O
the	O
prevalence	O
of	O
these	O
organisms	O
in	O
the	O
oral	O
ecosystem	O
.	O

Furthermore	O
,	O
this	O
assay	O
system	O
should	O
prove	O
a	O
useful	O
tool	O
for	O
analyzing	O
the	O
role	O
of	O
black	O
-	O
pigmented	O
Prevotella	B-bacteria
species	I-bacteria
in	O
the	O
mouth	O
.	O

Previously	O
,	O
we	O
used	O
in	O
situ	O
hybridization	O
and	O
confocal	O
microscopy	O
to	O
detect	O
the	O
periodontal	O
pathogens	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythensis	I-bacteria
within	O
buccal	O
epithelial	O
cells	O
taken	O
directly	O
from	O
the	O
mouth	O
.	O

This	O
study	O
tested	O
the	O
hypothesis	O
that	O
the	O
intracellular	O
flora	O
of	O
buccal	O
cells	O
is	O
polymicrobial	O
.	O

Mixtures	O
containing	O
a	O
red	O
fluorescent	O
universal	O
probe	O
paired	O
with	O
green	O
fluorescent	O
versions	O
of	O
either	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
-	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
-	O
,	O
or	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
-	O
specific	O
probes	O
were	O
hybridized	O
with	O
buccal	O
cells	O
collected	O
from	O
each	O
of	O
38	O
healthy	O
humans	O
.	O

We	O
verified	O
co	O
-	O
localization	O
of	O
probe	O
pairs	O
within	O
cells	O
by	O
generating	O
three	O
-	O
dimensional	O
reconstructions	O
.	O

Intracellular	O
bacteria	O
were	O
detected	O
in	O
every	O
subject	O
.	O

Each	O
cell	O
that	O
was	O
labeled	O
with	O
a	O
species	O
-	O
specific	O
probe	O
also	O
contained	O
bacteria	O
recognized	O
only	O
by	O
the	O
universal	O
probe	O
.	O

Bacteria	O
labeled	O
with	O
specific	O
probes	O
often	O
occupied	O
smaller	O
regions	O
within	O
larger	O
masses	O
of	O
bacteria	O
.	O

Those	O
findings	O
suggest	O
that	O
future	O
studies	O
of	O
invasion	O
by	O
oral	O
bacteria	O
may	O
need	O
to	O
include	O
microbial	O
consortia	O
.	O

Induction	O
of	O
resistance	O
of	O
oral	O
anaerobes	O
to	O
the	O
effects	O
of	O
human	O
beta	O
-	O
defensin	O
1	O
(	O
hbetaD	O
-	O
1	O
)	O
to	O
hbetaD	O
-	O
4	O
was	O
investigated	O
by	O
pretreating	O
cells	O
with	O
either	O
sublethal	O
levels	O
of	O
defensins	O
or	O
environmental	O
factors	O
,	O
followed	O
by	O
a	O
challenge	O
with	O
lethal	O
levels	O
of	O
defensins	O
.	O

Cultures	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
were	O
(	O
i	O
)	O
pretreated	O
with	O
defensins	O
at	O
1	O
ng	O
/	O
ml	O
,	O
(	O
ii	O
)	O
heated	O
to	O
42	O
degrees	O
C	O
(	O
heat	O
stress	O
)	O
,	O
(	O
iii	O
)	O
exposed	O
to	O
normal	O
atmosphere	O
(	O
oxidative	O
stress	O
)	O
,	O
or	O
(	O
iv	O
)	O
exposed	O
to	O
1	O
mM	O
hydrogen	O
peroxide	O
(	O
peroxide	O
stress	O
)	O
.	O

Samples	O
(	O
10	O
microl	O
)	O
were	O
distributed	O
among	O
the	O
wells	O
of	O
sterile	O
384	O
-	O
well	O
plates	O
containing	O
hbetaD	O
-	O
1	O
to	O
-	O
4	O
(	O
100	O
microg	O
/	O
ml	O
)	O
.	O

Plates	O
were	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
36	O
h	O
in	O

an	O
anaerobe	O
chamber	O
.	O

Growth	O
inhibition	O
was	O
determined	O
by	O
a	O
system	O
that	O
measures	O
the	O
total	O
nucleic	O
acid	O
of	O
a	O
sample	O
with	O
a	O
DNA	O
binding	O
dye	O
.	O

The	O
MICs	O
of	O
the	O
four	O
defensins	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
3	O
to	O
12	O
microg	O
/	O
ml	O
.	O

We	O
found	O
that	O
sublethal	O
levels	O
of	O
the	O
defensins	O
and	O
heat	O
and	O
peroxide	O
stress	O
,	O
but	O
not	O
oxidative	O
stress	O
,	O
induced	O
resistance	O
to	O
100	O
microg	O
of	O
defensin	O
per	O
ml	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Resistance	O
induced	O
by	O
sublethal	O
levels	O
of	O
hbetaD	O
-	O
2	O
lasted	O
90	O
min	O
,	O
and	O
the	O
resistance	O
induced	O
by	O
each	O
defensin	O
was	O
effective	O
against	O
the	O
other	O
three	O
.	O

Multiple	O
strains	O
exposed	O
to	O
hbetaD	O
-	O
2	O
all	O
evidenced	O
resistance	O
induction	O
.	O

Defensin	O
resistance	O
is	O
vital	O
to	O
the	O
pathogenic	O
potential	O
of	O
several	O
human	O
pathogens	O
.	O

This	O
is	O
the	O
first	O
report	O
describing	O
the	O
induction	O
of	O
defensin	O
resistance	O
in	O
the	O
oral	O
periodontal	O
pathogen	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Such	O
resistance	O
may	O
have	O
an	O
effect	O
on	O
the	O
ability	O
of	O
oral	O
pathogens	O
to	O
persist	O
in	O
the	O
mouth	O
and	O
to	O
withstand	O
innate	O
human	O
immunity	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
has	O
been	O
recognized	O
as	O
an	O
important	O
etiological	O
agent	O
in	O
human	O
dental	O
caries	O
.	O

Some	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
also	O
produce	O
bacteriocins	O
.	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
demonstrate	O
that	O
bacteriocin	O
production	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
GS5	I-bacteria
and	O
BM71	B-bacteria
was	O
mediated	O
by	O
quorum	O
sensing	O
,	O
which	O
is	O
dependent	O
on	O
a	O
competence	O
-	O
stimulating	O
peptide	O
(	O
CSP	O
)	O
signaling	O
system	O
encoded	O
by	O
the	O
com	O
genes	O
.	O

We	O
also	O
demonstrated	O
that	O
interactions	O
with	O
some	O
other	O
oral	O
streptococci	B-bacteria
interfered	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
bacteriocin	O
production	O
both	O
in	O
broth	O
and	O
in	O
biofilms	O
.	O

The	O
inhibition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
bacteriocin	O
production	O
by	O
oral	O
bacteria	O
was	O
stronger	O
in	O
biofilms	O
than	O
in	O
broth	O
.	O

Using	O
transposon	O
Tn916	O
mutagenesis	O
,	O
we	O
identified	O
a	O
gene	O
(	O
sgc	O
;	O
named	O
for	O
Streptococcus	B-bacteria
gordonii	I-bacteria
challisin	I-bacteria
)	O
responsible	O
for	O
the	O
inhibition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
bacteriocin	O
production	O
by	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
Challis	O
.	O

Interruption	O
of	O
the	O
sgc	O
gene	O
in	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
Challis	O
resulted	O
in	O
attenuated	O
inhibition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
bacteriocin	O
production	O
.	O

The	O
supernatant	O
fluids	O
from	O
the	O
sgc	O
mutant	O
did	O
not	O
inactivate	O
the	O
exogenous	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
CSP	O
as	O
did	O
those	O
from	O
the	O
parent	O
strain	O
Challis	O
.	O

S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
Challis	O
did	O
not	O
inactivate	O
bacteriocin	O
produced	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
GS5	I-bacteria
.	O

Because	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
uses	O
quorum	O
sensing	O
to	O
regulate	O
virulence	O
,	O
strategies	O
designed	O
to	O
interfere	O
with	O
these	O
signaling	O
systems	O
may	O
have	O
broad	O
applicability	O
for	O
biological	O
control	O
of	O
this	O
caries	O
-	O
causing	O
organism	O
.	O

Direct	O
person	O
-	O
to	O
-	O
person	O
transmission	O
of	O
periodontal	O
bacteria	O
through	O
saliva	O
has	O
recently	O
been	O
widely	O
reported	O
and	O
dental	O
units	O
have	O
been	O
demonstrated	O
to	O
retract	O
saliva	O
from	O
patients	O
under	O
treatment	O
and	O
to	O
release	O
it	O
into	O
the	O
mouths	O
of	O
subjects	O
undergoing	O
the	O
next	O
operation	O
.	O

In	O
this	O
study	O
the	O
presence	O
of	O
a	O
group	O
of	O
periodontal	O
pathogenic	O
bacteria	O
inside	O
waterlines	O
in	O
dental	O
units	O
was	O
investigated	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
based	O
methods	O
.	O

Briefly	O
,	O
18	O
dental	O
units	O
of	O
three	O
different	O
manufacturers	O
were	O
studied	O
.	O

Dental	O
units	O
were	O
divided	O
into	O
two	O
groups	O
according	O
to	O
their	O
prevalent	O
use	O
in	O
routine	O
practice	O
.	O

The	O
first	O
group	O
consisted	O
of	O
nine	O
dental	O
units	O
characterized	O
by	O
the	O
frequent	O
use	O
of	O
high	O
-	O
speed	O
dental	O
hand	O
-	O
pieces	O
directly	O
inside	O
the	O
mouth	O
and	O
in	O
contact	O
with	O
patients	O
'	O
saliva	O
.	O

The	O
second	O
group	O
,	O
as	O
a	O
control	O
,	O
consisted	O
of	O
nine	O
dental	O
units	O
where	O
high	O
-	O
speed	O
dental	O
hand	O
-	O
pieces	O
were	O
not	O
in	O
use	O
.	O

A	O
one	O
cm	O
section	O
of	O
the	O
waterline	O
tubing	O
connected	O
to	O
the	O
high	O
-	O
speed	O
hand	O
-	O
piece	O
was	O
removed	O
from	O
each	O
dental	O
unit	O
to	O
evaluate	O
the	O
presence	O
of	O
DNA	O
of	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Bacteroides	B-bacteria
forsythus	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

Two	O
specimens	O
were	O
positive	O
for	O
Prevotella	B-bacteria
intermedia	I-bacteria
DNA	O
.	O

All	O
the	O
positive	O
results	O
were	O
from	O
samples	O
obtained	O
from	O
dental	O
units	O
categorised	O
in	O
the	O
first	O
group	O
.	O

These	O
findings	O
clearly	O
suggest	O
that	O
dental	O
units	O
have	O
the	O
potential	O
to	O
transmit	O
periodontal	O
pathogens	O
.	O

Manufacturers	O
should	O
be	O
invited	O
to	O
design	O
dental	O
units	O
that	O
incorporate	O
automated	O
devices	O
to	O
disinfect	O
DUWLs	O
between	O
patients	O
with	O
minimal	O
effort	O
by	O
dental	O
staff	O
.	O

The	O
aim	O
of	O
this	O
investigation	O
was	O
to	O
evaluate	O
the	O
prevalence	O
of	O
Candida	O
and	O
Enterobacteriaceae	B-bacteria
in	O
a	O
group	O
of	O
adolescents	O
during	O
fixed	O
orthodontic	O
appliance	O
(	O
FOA	O
)	O
therapy	O
.	O

The	O
experimental	O
group	O
was	O
recruited	O
from	O
a	O
larger	O
sample	O
of	O
orthodontic	O
patients	O
who	O
were	O
clinically	O
examined	O
once	O
to	O
obtain	O
baseline	O
data	O
before	O
active	O
treatment	O
.	O

The	O
group	O
comprised	O
27	O
subjects	O
;	O
13	O
males	O
,	O
14	O
females	O
(	O
mean	O
age	O
15	O
.	O
5	O
+	O
/	O
-	O
2	O
.	O
3	O
years	O
)	O
.	O

Thereafter	O
,	O
the	O
experimental	O
group	O
was	O
examined	O
three	O
times	O
during	O
a	O
3	O
month	O
follow	O
-	O
up	O
period	O
after	O
insertion	O
of	O
the	O
FOA	O
.	O

The	O
whole	O
mouth	O
plaque	O
score	O
was	O
obtained	O
,	O
and	O
the	O
oral	O
cavity	O
was	O
then	O
sampled	O
for	O
Candida	O
species	O
and	O
Enterobacteriaceae	B-bacteria
using	O
three	O
different	O
microbiological	O
culture	O
techniques	O
,	O
namely	O
the	O
oral	O
rinse	O
,	O
pooled	O
plaque	O
and	O
the	O
imprint	O
culture	O
.	O
A	O
significant	O
increase	O
in	O
candidal	O
numbers	O
was	O
observed	O
after	O
FOA	O
insertion	O
when	O
the	O
imprint	O
technique	O
was	O
used	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
although	O
the	O
overall	O
candidal	O
prevalence	O
rates	O
obtained	O
using	O
the	O
oral	O
rinse	O
and	O
pooled	O
plaque	O
techniques	O
did	O
not	O
demonstrate	O
such	O
a	O
change	O
.	O

The	O
predominant	O
Candida	O
species	O
isolated	O
was	O
C	O
.	O
albicans	O
and	O
the	O
number	O
of	O
coliform	B-bacteria
carriers	O
significantly	O
increased	O
after	O
the	O
insertion	O
of	O
a	O
FOA	O
,	O
as	O
detected	O
by	O
the	O
oral	O
rinse	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
the	O
pooled	O
plaque	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
techniques	O
.	O

In	O
total	O
,	O
eight	O
coliform	B-bacteria
species	I-bacteria
were	O
isolated	O
following	O
FOA	O
therapy	O
compared	O
with	O
the	O
three	O
species	O
isolated	O
before	O
insertion	O
of	O
the	O
appliance	O
.	O

The	O
results	O
also	O
revealed	O
a	O
significant	O
increase	O
in	O
plaque	O
index	O
due	O
to	O
the	O
introduction	O
of	O
a	O
FOA	O
.	O

Taken	O
together	O
,	O
these	O
data	O
imply	O
that	O
insertion	O
of	O
a	O
FOA	O
is	O
likely	O
to	O
promote	O
oral	O
carriage	O
of	O
Candida	O
and	O
coliform	B-bacteria
species	I-bacteria
.	O

Furthermore	O
,	O
it	O
appears	O
that	O
routine	O
oral	O
hygiene	O
instruction	O
and	O
information	O
on	O
appliance	O
hygiene	O
given	O
to	O
these	O
patients	O
may	O
not	O
necessarily	O
reduce	O
plaque	O
accumulation	O
and	O
possible	O
attendant	O
effects	O
.	O

Further	O
work	O
with	O
a	O
larger	O
cohort	O
is	O
required	O
to	O
confirm	O
these	O
findings	O
.	O

Cecropin	O
-	O
XJ	O
belongs	O
to	O
cecropin	O
-	O
B	O
,	O
which	O
is	O
the	O
most	O
potent	O
antibacterial	O
peptide	O
found	O
naturally	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
cecropin	O
-	O
XJ	O
on	O
growth	O
and	O
adherence	O
of	O
oral	O
cariogenic	O
bacteria	O
.	O

Four	O
oral	O
cariogenic	O
bacteria	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Actinomyces	B-bacteria
viscosus	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
)	O
were	O
chosen	O
for	O
this	O
experiment	O
.	O

The	O
minimal	O
inhibitory	O
concentrations	O
(	O
MICs	O
)	O
and	O
reductive	O
percent	O
of	O
bacterial	O
growth	O
were	O
used	O
to	O
assay	O
the	O
antibacterial	O
activity	O
of	O
cecropin	O
-	O
XJ	O
.	O

Mammalian	O
cytotoxicity	O
of	O
cecropin	O
-	O
XJ	O
was	O
tested	O
with	O
human	O
periodontal	O
membrane	O
fibroblasts	O
by	O
tetrazolium	O
(	O
MTT	O
)	O
colorimetric	O
assay	O
.	O

The	O
bacterial	O
morphological	O
changes	O
induced	O
by	O
cecropin	O
-	O
XJ	O
were	O
examined	O
on	O
scanning	O
electron	O
microscope	O
(	O
SEM	O
)	O
.	O

The	O
influence	O
of	O
cecropin	O
-	O
XJ	O
on	O
bacterial	O
adhesion	O
to	O
saliva	O
-	O
coated	O
hydroxyapatite	O
(	O
S	O
-	O
HA	O
)	O
was	O
measured	O
by	O
scintillation	O
counting	O
.	O

The	O
MICs	O
of	O
cecropin	O
-	O
XJ	O
for	O
inhibition	O
of	O
the	O
growth	O
of	O
four	O
bacteria	O
ranged	O
from	O
4	O
.	O
0	O
to	O
42	O
.	O
8	O
micromol	O
/	O
L	O
with	O
the	O
highest	O
susceptible	O
to	O
A	O
.	O
naeslundii	O
and	O
the	O
lowest	O
susceptible	O
to	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

At	O
pH	O
6	O
.	O
8	O
,	O
5	O
.	O
5	O
and	O
8	O
.	O
2	O
,	O
1	O
/	O
2	O
MIC	O
of	O
cecropin	O
-	O
XJ	O
reduced	O
the	O
number	O
of	O
viable	O
bacteria	O
by	O
40	O
.	O
9	O
%	O
,	O
67	O
.	O
8	O
%	O
and	O
32	O
.	O
8	O
%	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
by	O
28	O
.	O
1	O
%	O
,	O
57	O
.	O
2	O
%	O
and	O
37	O
.	O
9	O
%	O
for	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

The	O
activities	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
increased	O
at	O
pH	O
5	O
.	O
5	O
compared	O
with	O
pH	O
6	O
.	O
8	O
(	O
P	O
<	O
0	O
.	O
01	O
,	O
respectively	O
)	O
.	O

In	O
present	O
of	O
50	O
%	O
saliva	O
,	O
1	O
/	O
2	O
MIC	O
of	O
the	O
peptide	O
decreased	O
the	O
direct	O
count	O
of	O
viable	O
cells	O
by	O
29	O
.	O
2	O
%	O
and	O
14	O
.	O
4	O
%	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
,	O
respectively	O
(	O
P	O
<	O
0	O
.	O
01	O
and	O
P	O
>	O
0	O
.	O
05	O
,	O
respectively	O
)	O
,	O
whereas	O
almost	O
no	O
reduction	O
counts	O
were	O
detected	O
in	O
the	O
presence	O
of	O
20	O
%	O
serum	O
for	O
both	O
bacteria	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
respectively	O
)	O
.	O

Mammalian	O
cytotoxicity	O
of	O
cecropin	O
-	O
XJ	O
from	O
1	O
.	O
0	O
to	O
100	O
micromol	O
/	O
L	O
exhibited	O
no	O
cytotoxicity	O
against	O
human	O
periodontal	O
membrane	O
fibroblasts	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Bacterial	O
morphological	O
changes	O
induced	O
by	O
MIC	O
of	O
cecropin	O
-	O
XJ	O
examined	O
on	O
SEM	O
showed	O
cell	O
surface	O
disruption	O
.	O

Furthermore	O
,	O
the	O
ability	O
of	O
A	O
.	O
naeslundii	O
adhesion	O
to	O
S	O
-	O
HA	O
decreased	O
significantly	O
with	O
MIC	O
of	O
cecropin	O
-	O
XJ	O
for	O
10	O
and	O
20	O
minutes	O
(	O
P	O
=	O
0	O
.	O
001	O
and	O
0	O
.	O
000	O
,	O
respectively	O
)	O
,	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
to	O
S	O
-	O
HA	O
decreased	O
significantly	O
with	O
MIC	O
of	O
cecropin	O
-	O
XJ	O
for	O
20	O
minutes	O
(	O
P	O
=	O
0	O
.	O
000	O
,	O
respectively	O
)	O
.	O

Cecropin	O
-	O
XJ	O
exhibited	O
bactericidal	O
action	O
against	O
cariogenic	O
pathogens	O
,	O
and	O
the	O
antibacterial	O
activity	O
enhanced	O
in	O
the	O
acid	O
environment	O
.	O

The	O
results	O
also	O
demonstrate	O
that	O
cecropin	O
-	O
XJ	O
prevents	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
actinomyces	B-bacteria
adsorption	O
to	O
S	O
-	O
HA	O
.	O

These	O
findings	O
suggest	O
that	O
Cecropin	O
-	O
XJ	O
may	O
have	O
potential	O
to	O
prevent	O
caries	O
.	O

It	O
is	O
hypothesized	O
that	O
the	O
enterosalivary	O
nitrate	O
circulation	O
encourages	O
nitrate	O
reducing	O
bacteria	O
to	O
reside	O
within	O
the	O
oral	O
cavity	O
.	O

Nitrite	O
production	O
may	O
then	O
limit	O
the	O
growth	O
of	O
acidogenic	O
bacteria	O
as	O
a	O
result	O
of	O
the	O
production	O
of	O
antimicrobial	O
oxides	O
of	O
nitrogen	O
,	O
including	O
nitric	O
oxide	O
.	O

This	O
study	O
was	O
carried	O
out	O
with	O
10	O
subjects	O
to	O
characterize	O
oral	O
nitrate	O
reduction	O
and	O
identify	O
the	O
bacteria	O
responsible	O
.	O

Nitrate	O
reduction	O
varied	O
between	O
individuals	O
(	O
mean	O
85	O
.	O
4	O
+	O
/	O
-	O
15	O
.	O
9	O
nmol	O
nitrite	O
min	O
(	O
-	O
1	O
)	O
with	O
10	O
ml	O
1	O
mm	O
KNO	O
(	O
3	O
)	O
mouth	O
wash	O
)	O
and	O
was	O
found	O
to	O
be	O
concentrated	O
at	O
the	O
rear	O
of	O
the	O
tongue	O
dorsal	O
surface	O
.	O

Nitrate	O
reductase	O
positive	O
isolates	O
identified	O
,	O
using	O
16S	O
rDNA	O
sequencing	O
,	O
from	O
the	O
tongue	O
comprised	O
Veillonella	B-bacteria
atypica	I-bacteria
(	O
34	O
%	O
)	O
,	O
Veillonella	B-bacteria
dispar	I-bacteria
(	O
24	O
%	O
)	O
,	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
(	O
21	O
%	O
)	O
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
(	O
2	O
%	O
)	O
,	O
Rothia	B-bacteria
mucilaginosa	I-bacteria
(	O
10	O
%	O
)	O
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
(	O
3	O
%	O
)	O
and	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
(	O
5	O
%	O
)	O
.	O

Nitrite	O
production	O
rates	O
,	O
using	O
intact	O
and	O
permeabilized	O
cells	O
,	O
of	O
the	O
major	O
tongue	O
nitrate	O
reducers	O
were	O
determined	O
in	O
the	O
presence	O
of	O
methyl	O
and	O
benzyl	O
viologen	O
.	O

Under	O
anaerobic	O
conditions	O
in	O
the	O
presence	O
of	O
nitrate	O
,	O
rates	O
in	O
decreasing	O
order	O
were	O
:	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
>	O
R	B-bacteria
.	I-bacteria
mucilaginosa	I-bacteria
>	O
R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
>	O
V	B-bacteria
.	I-bacteria
dispar	I-bacteria
>	O
V	B-bacteria
.	I-bacteria
atypica	I-bacteria
.	O

In	O
conclusion	O
,	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
found	O
to	O
be	O
the	O
most	O
prevalent	O
taxa	O
isolated	O
and	O
thus	O
may	O
make	O
a	O
major	O
contribution	O
to	O
nitrate	O
reduction	O
in	O
the	O
oral	O
cavity	O
.	O

Bone	O
necrosis	O
secondary	O
to	O
radiation	O
was	O
previously	O
attributed	O
to	O
trauma	O
of	O
devitalized	O
bone	O
and	O
microbiological	O
sepsis	O
.	O

However	O
,	O
conventional	O
microbiological	O
technique	O
has	O
failed	O
to	O
demonstrate	O
microorganisms	O
throughout	O
osteoradionecrotic	O
bone	O
,	O
claimed	O
to	O
be	O
hypoxic	O
,	O
hypovascular	O
and	O
hypocellular	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
such	O
bone	O
for	O
bacteria	O
using	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Compared	O
to	O
standard	O
culture	O
methods	O
this	O
technique	O
enables	O
the	O
investigation	O
of	O
a	O
vast	O
number	O
of	O
bacteria	O
in	O
a	O
fairly	O
short	O
time	O
.	O

Twelve	O
deep	O
medullary	O
specimens	O
from	O
resected	O
radionecrotic	O
mandibles	O
were	O
studied	O
.	O

A	O
multitude	O
of	O
bacterial	O
species	O
were	O
detected	O
,	O
most	O
of	O
them	O
anaerobic	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
the	O
most	O
predominant	O
organism	O
,	O
followed	O
by	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
subspecies	I-bacteria
polymorphum	I-bacteria
.	O

All	O
samples	O
contained	O
Actinomyces	B-bacteria
,	O
Prevotella	B-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

The	O
results	O
of	O
this	O
study	O
indicate	O
that	O
bacteria	O
,	O
particularly	O
anaerobes	O
,	O
may	O
play	O
a	O
more	O
fundamental	O
role	O
in	O
the	O
pathophysiology	O
of	O
osteoradionecrosis	O
than	O
being	O
merely	O
surface	O
contaminants	O
.	O

Glycoproteins	O
display	O
carbohydrate	O
facets	O
that	O
serve	O
as	O
adhesion	O
receptors	O
for	O
cells	O
including	O
leukocytes	O
and	O
bacterial	O
cells	O
.	O

Our	O
aim	O
was	O
to	O
understand	O
the	O
role	O
of	O
the	O
specialized	O
carbohydrate	O
motifs	O
carried	O
by	O
highly	O
glycosylated	O
human	O
salivary	O
proteins	O
in	O
regulating	O
the	O
oral	O
ecology	O
.	O

To	O
date	O
,	O
our	O
structural	O
studies	O
suggest	O
that	O
these	O
molecules	O
display	O
a	O
wide	O
array	O
of	O
oligosaccharide	O
structures	O
,	O
including	O
many	O
species	O
with	O
highly	O
charged	O
and	O
/	O
or	O
fucosylated	O
termini	O
.	O

Here	O
,	O
we	O
used	O
an	O
immunoblot	O
approach	O
to	O
gain	O
additional	O
information	O
about	O
the	O
nature	O
of	O
these	O
oligosaccharides	O
.	O

The	O
results	O
showed	O
that	O
MG1	O
and	O
the	O
salivary	O
agglutinin	O
express	O
the	O
MECA	O
-	O
79	O
epitope	O
,	O
an	O
unusual	O
sulfated	O
carbohydrate	O
structure	O
that	O
belongs	O
to	O
an	O
important	O
class	O
of	O
high	O
-	O
affinity	O
(	O
endothelial	O
)	O
L	O
-	O
selectin	O
ligands	O
.	O

Unexpectedly	O
,	O
we	O
discovered	O
that	O
in	O
many	O
women	O
the	O
expression	O
of	O
this	O
epitope	O
is	O
hormonally	O
regulated	O
.	O

Additional	O
experiments	O
revealed	O
that	O
MG1	O
,	O
MG2	O
,	O
and	O
the	O
salivary	O
agglutinin	O
also	O
present	O
Lewis	O
blood	O
group	O
antigens	O
,	O
the	O
exact	O
repertoire	O
varying	O
on	O
an	O
individual	O
basis	O
.	O

In	O
parallel	O
,	O
we	O
explored	O
the	O
functions	O
of	O
these	O
carbohydrate	O
motifs	O
.	O

Using	O
an	O
assay	O
that	O
detects	O
L	O
-	O
selectin	O
ligands	O
,	O
we	O
found	O
that	O
the	O
subset	O
of	O
MECA	O
-	O
79	O
-	O
reactive	O
oligosaccharides	O
displayed	O
on	O
salivary	O
molecules	O
specifically	O
bind	O
an	O
L	O
-	O
selectin	O
/	O
Fc	O
chimera	O
.	O

In	O
contrast	O
,	O
the	O
Lewis	O
blood	O
group	O
structures	O
are	O
receptors	O
for	O
many	O
strains	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
,	O
an	O
organism	O
that	O
is	O
implicated	O
in	O
the	O
development	O
of	O
gastric	O
ulcers	O
and	O
cancer	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
MG1	O
,	O
MG2	O
,	O
and	O
the	O
salivary	O
agglutinin	O
play	O
important	O
roles	O
in	O
governing	O
leukocyte	O
and	O
bacterial	O
adhesion	O
.	O

Our	O
findings	O
suggest	O
novel	O
strategies	O
,	O
based	O
on	O
the	O
relevant	O
carbohydrate	O
structures	O
,	O
for	O
promoting	O
or	O
inhibiting	O
these	O
processes	O
.	O

Expression	O
of	O
the	O
phosphorylcholine	O
(	O
PC	O
)	O
epitope	O
was	O
examined	O
in	O
48	O
viridans	B-bacteria
streptococcal	I-bacteria
strains	I-bacteria
,	O
including	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
R36a	I-bacteria
as	O
the	O
positive	O
control	O
,	O
and	O
their	O
immunogenicity	O
to	O
induce	O
an	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
-	O
cross	O
-	O
reactive	O
response	O
was	O
evaluated	O
in	O
mice	O
.	O

Thirteen	O
strains	O
were	O
found	O
to	O
express	O
the	O
PC	O
epitope	O
,	O
while	O
no	O
obvious	O
association	O
was	O
found	O
between	O
the	O
taxonomic	O
categories	O
and	O
PC	O
expression	O
.	O

Serum	O
antibody	O
responses	O
to	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
cells	O
were	O
induced	O
in	O
mice	O
by	O
intraperitoneal	O
injection	O
of	O
the	O
PC	O
-	O
positive	O
,	O
but	O
not	O
PC	O
-	O
negative	O
,	O
strains	O
.	O

The	O
cross	O
-	O
reactive	O
antibodies	O
induced	O
by	O
non	O
-	O
pneumococcal	O
oral	O
streptococci	B-bacteria
were	O
readily	O
inhibited	O
by	O
free	O
hapten	O
PC	O
.	O

IgM	O
was	O
the	O
sole	O
isotype	O
of	O
the	O
anti	O
-	O
pneumococcal	O
and	O
anti	O
-	O
PC	O
antibodies	O
,	O
and	O
the	O
phenomenon	O
of	O
immunological	O
memory	O
was	O
not	O
observed	O
.	O

Since	O
the	O
anti	O
-	O
PC	O
antibody	O
is	O
critically	O
important	O
for	O
resistance	O
against	O
pneumococcal	O
infection	O
in	O
mice	O
,	O
the	O
present	O
results	O
indicate	O
the	O
possibility	O
that	O
PC	O
-	O
expressing	O
oral	O
commensal	O
bacteria	O
have	O
a	O
significant	O
influence	O
on	O
the	O
hosts	O
'	O
responsiveness	O
to	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
.	O

Antifungal	O
prophylactic	O
therapy	O
in	O
oncology	O
patients	O
has	O
favors	O
the	O
emergence	O
of	O
diverse	O
species	O
of	O
Candida	O
.	O

In	O
the	O
present	O
study	O
32	O
clinic	O
isolates	O
of	O
Candida	O
spp	O
.	O
,	O
recovered	O
from	O
oral	O
cavity	O
,	O
were	O
evaluated	O
testing	O
their	O
susceptibility	O
to	O
diverse	O
antifungals	O
by	O
means	O
of	O
the	O
microdilution	O
method	O
according	O
with	O
the	O
document	O
M	O
-	O
27A	O
of	O
the	O
National	O
Committee	O
for	O
Clinical	O
Laboratory	O
Standards	O
(	O
NCCLS	O
)	O
.	O

The	O
response	O
to	O
antifungals	O
was	O
then	O
compared	O
with	O
SSCP	O
patterns	O
of	O
the	O
gene	O
ERG11	O
,	O
hoping	O
to	O
find	O
mutations	O
in	O
this	O
gene	O
linked	O
to	O
resistance	O
to	O
the	O
azole	O
antifungals	O
from	O
samples	O
of	O
clinical	O
origin	O
.	O

Three	O
SSCP	O
genotypes	O
with	O
diverse	O
response	O
to	O
different	O
antifungals	O
were	O
found	O
.	O

This	O
study	O
suggested	O
that	O
a	O
link	O
of	O
mutations	O
in	O
the	O
ERG11	O
gene	O
of	O
Candida	O
albicans	O
and	O
antifungal	O
resistance	O
was	O
not	O
supported	O
by	O
this	O
data	O
.	O

In	O
addition	O
,	O
the	O
isolates	O
were	O
also	O
classified	O
by	O
conventional	O
methods	O
and	O
their	O
genetic	O
diversity	O
evaluated	O
by	O
means	O
of	O
SSCP	O
analysis	O
and	O
evaluation	O
of	O
their	O
ITS2	O
regions	O
,	O
identifying	O
eight	O
SSCP	O
genotypes	O
.	O

This	O
technique	O
has	O
the	O
potential	O
to	O
be	O
a	O
more	O
sensitive	O
method	O
for	O
taxonomic	O
classification	O
.	O

To	O
validate	O
perfused	O
,	O
inline	O
,	O
filter	O
-	O
based	O
fermentation	O
systems	O
(	O
multiple	O
Sorbarod	O
devices	O
,	O
MSD	O
)	O
for	O
their	O
ability	O
to	O
maintain	O
stable	O
oral	O
bacterial	O
communities	O
.	O

MSD	O
enable	O
replicate	O
(	O
n	O
=	O
5	O
)	O
microcosm	O
biofilms	O
(	O
BF	O
)	O
to	O
be	O
established	O
and	O
sampled	O
,	O
together	O
with	O
their	O
perfusates	O
(	O
PA	O
,	O
cells	O
in	O
eluted	O
medium	O
)	O
.	O

Fresh	O
saliva	O
from	O
human	O
volunteers	O
was	O
used	O
to	O
inoculate	O
MSD	O
,	O
incubated	O
in	O
an	O
anaerobic	O
cabinet	O
and	O
perfused	O
with	O
artificial	O
saliva	O
at	O
7	O
ml	O
h	O
(	O
-	O
1	O
)	O
.	O

BF	O
within	O
Sorbarod	O
filters	O
and	O
cells	O
eluted	O
in	O
the	O
PA	O
were	O
analysed	O
at	O
24	O
-	O
h	O
intervals	O
by	O
differential	O
bacteriological	O
culture	O
and	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
(	O
CKB	O
,	O
40	O
oral	O
species	O
)	O
.	O

Dynamic	O
stability	O
was	O
apparent	O
after	O
2	O
-	O
3	O
days	O
within	O
both	O
BF	O
and	O
PA	O
as	O
evidenced	O
by	O
culture	O
,	O
CKB	O
data	O
and	O
pH	O
measurements	O
.	O

BF	O
harboured	O
large	O
numbers	O
of	O
anaerobic	O
species	O
and	O
facultative	O
anaerobes	O
[	O
ca	O
10	O
-	O
11	O
log10	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
filter	O
]	O
comprising	O
considerable	O
numbers	O
of	O
streptococci	B-bacteria
and	O
Gram	O
-	O
negative	O
species	O
.	O

PA	O
contained	O
ca	O
9	O
-	O
10	O
log	O
(	O
10	O
)	O
CFU	O
ml	O
(	O
-	O
1	O
)	O
suggesting	O
an	O
apparent	O
mean	O
growth	O
rate	O
of	O
0	O
.	O
1	O
h	O
(	O
-	O
1	O
)	O
for	O
the	O
BF	O
,	O
as	O
a	O
whole	O
corresponding	O
to	O
a	O
mean	O
generation	O
time	O
of	O
10	O
h	O
.	O
CKB	O
analysis	O
revealed	O
considerable	O
bacterial	O
diversity	O
within	O
the	O
respective	O
MSD	O
.	O

Inter	O
-	O
individual	O
variations	O
in	O
the	O
relative	O
species	O
abundance	O
of	O
inocula	O
was	O
broadly	O
reproduced	O
in	O
the	O
MSD	O
(	O
BF	O
and	O
PA	O
)	O
,	O
although	O
considerable	O
variation	O
was	O
apparent	O
between	O
triplicate	O
models	O
established	O
using	O
saliva	O
from	O
one	O
saliva	O
donor	O
or	O
from	O
three	O
individual	O
donors	O
.	O

The	O
dominance	O
of	O
Gram	O
-	O
negative	O
species	O
,	O
indicated	O
by	O
culture	O
was	O
supported	O
by	O
CKB	O
analysis	O
(	O
major	O
species	O
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
)	O
.	O

Data	O
obtained	O
from	O
the	O
various	O
analytical	O
approaches	O
showed	O
a	O
high	O
degree	O
of	O
congruence	O
.	O

The	O
MSD	O
enables	O
the	O
maintenance	O
of	O
complex	O
,	O
stable	O
salivary	O
microcosms	O
and	O
represents	O
a	O
simple	O
,	O
reproducible	O
tool	O
for	O
modelling	O
individual	O
oral	O
bacterial	O
ecosystems	O
.	O

This	O
study	O
demonstrates	O
the	O
utility	O
of	O
the	O
MSD	O
for	O
studying	O
the	O
micro	O
-	O
ecology	O
of	O
the	O
oral	O
cavity	O
.	O

The	O
main	O
cause	O
of	O
acute	O
diverticulitis	O
is	O
the	O
abnormal	O
accumulation	O
of	O
fecal	O
bacteria	O
within	O
the	O
diverticular	O
lumen	O
,	O
leading	O
to	O
a	O
balancing	O
between	O
normal	O
probiotic	O
microflora	O
and	O
pathogenic	O
species	O
;	O
Gram	O
negative	O
Entero	O
-	O
bacteriaceae	O
,	O
mainly	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
Proteus	B-bacteria
spp	I-bacteria
,	O
are	O
the	O
genders	O
that	O
usually	O
cause	O
the	O
disease	O
-	O
related	O
symptoms	O
,	O
due	O
to	O
their	O
ability	O
to	O
adhere	O
to	O
intestinal	O
mucosa	O
.	O

The	O
intestine	O
is	O
well	O
known	O
as	O
the	O
largest	O
human	O
lymphoepithelial	O
organ	O
and	O
daily	O
produces	O
more	O
antibodies	O
,	O
mainly	O
secretory	O
IgAs	O
,	O
than	O
do	O
all	O
other	O
lymphoid	O
tissues	O
.	O

IgAs	O
have	O
different	O
immune	O
and	O
anti	O
-	O
inflammatory	O
properties	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
verify	O
the	O
efficacy	O
of	O
an	O
oral	O
immunostimulant	O
highly	O
-	O
purified	O
,	O
polymicrobial	O
lysate	O
in	O
the	O
prevention	O
of	O
recurrent	O
attacks	O
of	O
diverticulitis	O
and	O
in	O
the	O
improvement	O
of	O
symptoms	O
.	O

The	O
study	O
was	O
carried	O
out	O
on	O
83	O
consecutive	O
patients	O
suffering	O
from	O
recurrent	O
symptomatic	O
acute	O
diverticulitis	O
and	O
with	O
at	O
least	O
2	O
attacks	O
in	O
the	O
previous	O
year	O
;	O
patients	O
were	O
randomly	O
assigned	O
to	O
receive	O
(	O
group	O
A	O
)	O
an	O
oral	O
polybacterial	O
lysate	O
suspension	O
or	O
to	O
a	O
no	O
-	O
treatment	O
clinical	O
follow	O
-	O
up	O
as	O
controls	O
(	O
group	O
B	O
)	O
.	O

A	O
total	O
of	O
76	O
patients	O
(	O
41	O
in	O
group	O
A	O
and	O
35	O
in	O
group	O
B	O
)	O
terminated	O
the	O
study	O
period	O
.	O

the	O
sums	O
of	O
the	O
scores	O
for	O
symptoms	O
,	O
reported	O
on	O
day	O
schedules	O
,	O
were	O
calculated	O
and	O
examined	O
by	O
means	O
of	O
ANOVA	O
statistical	O
analysis	O
.	O

Statistical	O
differences	O
between	O
group	O
A	O
vs	O
group	O
B	O
were	O
recorded	O
after	O
1	O
month	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
3	O
months	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
of	O
treatment	O
with	O
the	O
oral	O
polybacterial	O
lysate	O
suspension	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
administration	O
of	O
an	O
oral	O
enterovaccine	O
for	O
the	O
prophylaxis	O
of	O
recurrent	O
diverticulitis	O
is	O
effective	O
and	O
well	O
tolerated	O
,	O
probably	O
due	O
to	O
a	O
direct	O
stimulation	O
of	O
IgA	O
-	O
mediated	O
mucosal	O
defences	O
.	O

We	O
studied	O
the	O
pheno	O
-	O
and	O
genotypes	O
of	O
an	O
oral	O
Granulicatella	B-bacteria
elegans	I-bacteria
strain	I-bacteria
in	O
comparison	O
with	O
those	O
of	O
a	O
blood	O
-	O
derived	O
isolate	O
which	O
caused	O
infective	O
endocarditis	O
.	O

The	O
two	O
isolates	O
exhibited	O
identical	O
biochemical	O
characteristics	O
and	O
had	O
the	O
same	O
drug	O
MICs	O
.	O

Their	O
genotypes	O
were	O
indistinguishable	O
,	O
indicating	O
that	O
these	O
were	O
from	O
the	O
same	O
clone	O
.	O

The	O
transmission	O
of	O
G	B-bacteria
.	I-bacteria
elegans	I-bacteria
from	O
the	O
oral	O
cavity	O
thus	O
should	O
be	O
noted	O
as	O
a	O
possible	O
cause	O
of	O
infective	O
endocarditis	O
.	O

It	O
is	O
well	O
-	O
known	O
that	O
some	O
periodontopathic	O
bacteria	O
,	O
especially	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
formerly	O
Bacteroides	B-bacteria
forsythus	I-bacteria
or	O
Tan	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
actively	O
produce	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
,	O
such	O
as	O
H2S	O
and	O
CH3SH	O
.	O

We	O
previously	O
reported	O
a	O
qualitative	O
relationship	O
between	O
periodontopathic	O
bacteria	O
and	O
VSCs	O
;	O
however	O
,	O
a	O
quantitative	O
analysis	O
of	O
periodontopathic	O
bacteria	O
in	O
oral	O
specimens	O
is	O
required	O
for	O
further	O
characterization	O
of	O
the	O
relationship	O
between	O
oral	O
bacteria	O
and	O
VSCs	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
a	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
method	O
for	O
the	O
quantitative	O
analysis	O
of	O
VSC	O
-	O
producing	O
bacteria	O
in	O
oral	O
specimens	O
.	O

Specimens	O
were	O
collected	O
from	O
22	O
patients	O
who	O
visited	O
the	O
Preventive	O
Dentistry	O
and	O
Breath	O
Odor	O
Clinic	O
of	O
Kyushu	O
Dental	O
College	O
.	O

A	O
real	O
-	O
time	O
PCR	O
assay	O
using	O
the	O
TaqMan	O
system	O
,	O
based	O
on	O
the	O
5	O
'	O
-	O
3	O
'	O
exonuclease	O
activity	O
of	O
Taq	O
polymerase	O
,	O
was	O
employed	O
for	O
the	O
quantitative	O
analysis	O
of	O
periodontopathic	O
bacteria	O
that	O
produce	O
VSCs	O
.	O

Using	O
real	O
-	O
time	O
PCR	O
,	O
we	O
performed	O
a	O
quantitative	O
analysis	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
Tan	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
in	O
the	O
saliva	O
,	O
on	O
the	O
tongue	O
coat	O
,	O
and	O
in	O
the	O
subgingival	O
plaque	O
of	O
patients	O
with	O
oral	O
malodor	O
.	O

Real	O
-	O
time	O
PCR	O
using	O
the	O
TaqMan	O
system	O
can	O
be	O
used	O
for	O
the	O
quantitative	O
analysis	O
of	O
VSC	O
-	O
producing	O
oral	O
bacteria	O
.	O

To	O
evaluate	O
the	O
efficacy	O
of	O
antimicrobial	O
therapy	O
in	O
oral	O
odontogenic	O
infections	O
using	O
estimated	O
pharmacokinetic	O
/	O
pharmacodynamic	O
parameters	O
or	O
efficacy	O
indices	O
,	O
and	O
to	O
compare	O
pharmacokinetic	O
/	O
pharmacodynamic	O
breakpoints	O
with	O
National	O
Committee	O
for	O
Clinical	O
Laboratory	O
Standards	O
'	O
(	O
NCCLS	O
)	O
breakpoints	O
.	O

Retrospective	O
literature	O
search	O
to	O
obtain	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
values	O
,	O
pharmacokinetic	O
parameters	O
of	O
antimicrobials	O
and	O
NCCLS	O
breakpoints	O
.	O

Pharmacokinetic	O
simulations	O
were	O
carried	O
out	O
using	O
WinNonlin	O
software	O
(	O
Pharsight	O
Corporation	O
,	O
Mountain	O
View	O
,	O
CA	O
,	O
USA	O
)	O
.	O

For	O
antimicrobials	O
with	O
time	O
-	O
dependent	O
activity	O
,	O
the	O
time	O
that	O
the	O
plasma	O
drug	O
concentration	O
exceeds	O
the	O
MIC	O
as	O
the	O
percentage	O
of	O
dose	O
interval	O
at	O
steady	O
state	O
was	O
calculated	O
.	O

For	O
antimicrobials	O
with	O
concentration	O
-	O
dependent	O
activity	O
,	O
the	O
total	O
area	O
under	O
the	O
plasma	O
concentration	O
-	O
time	O
curve	O
over	O
24	O
hours	O
at	O
steady	O
state	O
divided	O
by	O
the	O
MIC	O
was	O
calculated	O
.	O

Pharmacokinetic	O
/	O
pharmacodynamic	O
breakpoints	O
were	O
calculated	O
according	O
to	O
these	O
parameters	O
.	O

Only	O
amoxicillin	O
/	O
clavulanic	O
acid	O
and	O
clindamycin	O
showed	O
adequate	O
efficacy	O
indices	O
against	O
the	O
most	O
commonly	O
isolated	O
bacteria	O
in	O
odontogenic	O
infections	O
.	O

Metronidazole	O
reached	O
good	O
indices	O
against	O
anaerobes	O
only	O
.	O

Pharmacokinetic	O
/	O
pharmacodynamic	O
susceptibility	O
breakpoints	O
do	O
not	O
coincide	O
exactly	O
with	O
NCCLS	O
breakpoints	O
.	O

Owing	O
to	O
the	O
scarcity	O
of	O
double	O
-	O
blind	O
,	O
clinical	O
trials	O
on	O
the	O
use	O
of	O
antimicrobials	O
in	O
endodontics	O
,	O
this	O
study	O
may	O
be	O
useful	O
in	O
determining	O
the	O
best	O
antimicrobial	O
treatment	O
in	O
these	O
infections	O
.	O

However	O
,	O
as	O
we	O
have	O
not	O
used	O
concentration	O
data	O
in	O
infected	O
tissue	O
to	O
determine	O
pharmacokinetic	O
/	O
pharmacodynamic	O
indices	O
,	O
it	O
would	O
be	O
necessary	O
to	O
design	O
clinical	O
trials	O
in	O
order	O
to	O
confirm	O
these	O
results	O
.	O

Apoptosis	O
is	O
critical	O
in	O
the	O
pathogenesis	O
of	O
several	O
infectious	O
diseases	O
.	O

The	O
induction	O
of	O
apoptosis	O
was	O
assessed	O
in	O
mouse	O
lymph	O
node	O
cells	O
by	O
four	O
bacteria	O
recovered	O
from	O
infected	O
human	O
dental	O
pulp	O
:	O
Gemella	B-bacteria
morbillorum	I-bacteria
,	O
Clostridium	B-bacteria
butyricum	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Bifidobacterium	B-bacteria
adolescentis	I-bacteria
.	O

Smaller	O
lymph	O
nodes	O
and	O
smaller	O
numbers	O
of	O
cells	O
were	O
observed	O
after	O
experimental	O
dental	O
pulp	O
infection	O
with	O
C	B-bacteria
.	I-bacteria
butyricum	I-bacteria
,	O
suggesting	O
that	O
this	O
bacterium	O
induces	O
cell	O
death	O
.	O

Apoptosis	O
was	O
evaluated	O
by	O
determination	O
of	O
cell	O
ploidy	O
and	O
detection	O
of	O
DNA	O
degradation	O
in	O
cells	O
cultured	O
with	O
killed	O
bacteria	O
.	O

Paraformaldehyde	O
-	O
killed	O
C	B-bacteria
.	I-bacteria
butyricum	I-bacteria
and	O
heat	O
-	O
killed	O
G	B-bacteria
.	I-bacteria
morbillorum	I-bacteria
induced	O
substantial	O
cell	O
death	O
,	O
while	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
induced	O
cell	O
death	O
at	O
lower	O
levels	O
.	O

No	O
bacterial	O
preparations	O
induced	O
apoptosis	O
in	O
cells	O
from	O
mice	O
genetically	O
deficient	O
for	O
tumour	O
necrosis	O
factor	O
receptor	O
p55	O
(	O
TNFRp55	O
)	O
,	O
implicating	O
this	O
receptor	O
directly	O
or	O
indirectly	O
as	O
a	O
mediator	O
in	O
the	O
process	O
.	O

It	O
was	O
concluded	O
that	O
apoptosis	O
may	O
be	O
induced	O
during	O
periapical	O
lesions	O
of	O
pulpal	O
origin	O
.	O

The	O
objective	O
of	O
this	O
randomized	O
,	O
crossover	O
study	O
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
a	O
newly	O
designed	O
manual	O
toothbrush	O
(	O
Colgate	O
360	O
degrees	O
)	O
to	O
two	O
commercially	O
available	O
manual	O
toothbrushes	O
(	O
Oral	O
-	O
B	O
Indicator	O
and	O
Oral	O
-	O
B	O
CrossAction	O
)	O
and	O
a	O
battery	O
-	O
powered	O
toothbrush	O
(	O
Crest	O
SpinBrush	O
PRO	O
)	O
for	O
their	O
ability	O
to	O
reduce	O
hydrogen	O
-	O
sulfide	O
-	O
forming	O
bacteria	O
on	O
the	O
tongue	O
.	O

After	O
a	O
washout	O
period	O
,	O
subjects	O
arrived	O
at	O
the	O
clinical	O
site	O
for	O
baseline	O
sampling	O
without	O
performing	O
dental	O
hygiene	O
,	O
eating	O
,	O
or	O
drinking	O
.	O

Subjects	O
sampled	O
the	O
left	O
side	O
of	O
their	O
tongue	O
with	O
a	O
cotton	O
swab	O
.	O

Subjects	O
brushed	O
for	O
1	O
minute	O
with	O
the	O
assigned	O
test	O
toothbrush	O
and	O
regular	O
fluoride	O
toothpaste	O
.	O

Those	O
using	O
the	O
Colgate	O
360	O
degrees	O
toothbrush	O
were	O
instructed	O
to	O
clean	O
their	O
tongue	O
with	O
the	O
implement	O
on	O
the	O
back	O
of	O
the	O
brush	O
head	O
for	O
10	O
seconds	O
.	O

After	O
2	O
hours	O
,	O
the	O
subjects	O
returned	O
to	O
the	O
clinical	O
site	O
having	O
refrained	O
from	O
dental	O
hygiene	O
,	O
eating	O
,	O
and	O
drinking	O
for	O
posttreatment	O
sampling	O
,	O
this	O
time	O
sampling	O
the	O
right	O
side	O
of	O
their	O
tongue	O
.	O

After	O
a	O
minimum	O
2	O
-	O
day	O
washout	O
period	O
,	O
subjects	O
repeated	O
the	O
same	O
regimen	O
using	O
the	O
other	O
toothbrushes	O
.	O

Collected	O
tongue	O
samples	O
were	O
dispersed	O
in	O
sterile	O
water	O
,	O
serially	O
diluted	O
in	O
sterile	O
phosphate	O
-	O
buffered	O
saline	O
,	O
and	O
plated	O
in	O
duplicate	O
onto	O
lead	O
acetate	O
agar	O
.	O

When	O
plated	O
on	O
this	O
medium	O
,	O
bacteria	O
that	O
produce	O
hydrogen	O
sulfide	O
appear	O
as	O
dark	O
-	O
pigmented	O
colonies	O
.	O

After	O
72	O
hours	O
of	O
incubation	O
,	O
the	O
dark	O
colonies	O
were	O
counted	O
,	O
expressed	O
as	O
log	O
colony	O
-	O
forming	O
units	O
/	O
mL	O
,	O
and	O
reduction	O
from	O
baseline	O
was	O
calculated	O
.	O

Thirty	O
-	O
one	O
adult	O
men	O
and	O
women	O
completed	O
the	O
clinical	O
study	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
baseline	O
hydrogen	O
-	O
sulfide	O
-	O
forming	O
bacteria	O
levels	O
.	O

Posttreatment	O
,	O
the	O
log	O
reduction	O
of	O
bacteria	O
was	O
0	O
.	O
80	O
,	O
0	O
.	O
41	O
,	O
0	O
.	O
33	O
,	O
and	O
0	O
.	O
44	O
for	O
the	O
Colgate	O
360	O
degrees	O
,	O
Oral	O
-	O
B	O
Indicator	O
,	O
Crest	O
SpinBrush	O
PRO	O
,	O
and	O
Oral	O
-	O
B	O
CrossAction	O
,	O
respectively	O
.	O

Statistical	O
analysis	O
indicated	O
that	O
the	O
Colgate	O
360	O
toothbrush	O
was	O
statistically	O
significantly	O
better	O
(	O
P	O
<	O
.	O
05	O
)	O
than	O
the	O
3	O
commercial	O
toothbrushes	O
in	O
reducing	O
the	O
levels	O
of	O
hydrogen	O
-	O
sulfide	O
-	O
forming	O
bacteria	O
on	O
the	O
tongue	O
.	O

We	O
have	O
found	O
that	O
broadband	O
light	O
(	O
380	O
to	O
520	O
nm	O
)	O
rapidly	O
and	O
selectively	O
kills	O
oral	O
black	O
-	O
pigmented	O
bacteria	O
(	O
BPB	O
)	O
in	O
pure	O
cultures	O
and	O
in	O
dental	O
plaque	O
samples	O
obtained	O
from	O
human	O
subjects	O
with	O
chronic	O
periodontitis	O
.	O

We	O
hypothesize	O
that	O
this	O
killing	O
effect	O
is	O
a	O
result	O
of	O
light	O
excitation	O
of	O
their	O
endogenous	O
porphyrins	O
.	O

Cultures	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
were	O
killed	O
by	O
4	O
.	O
2	O
J	O
/	O
cm2	O
,	O
whereas	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
required	O
21	O
J	O
/	O
cm2	O
.	O

Exposure	O
to	O
light	O
with	O
a	O
fluence	O
of	O
42	O
J	O
/	O
cm2	O
produced	O
99	O
%	O
killing	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

High	O
-	O
performance	O
liquid	O
chromatography	O
demonstrated	O
the	O
presence	O
of	O
various	O
amounts	O
of	O
different	O
porphyrin	O
molecules	O
in	O
BPB	O
.	O

The	O
amounts	O
of	O
endogenous	O
porphyrin	O
in	O
BPB	O
were	O
267	O
(	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
)	O
,	O
47	O
(	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
)	O
,	O
41	O
(	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
)	O
,	O
and	O
2	O
.	O
2	O
(	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
ng	O
/	O
mg	O
.	O

Analysis	O
of	O
bacteria	O
in	O
dental	O
plaque	O
samples	O
by	O
DNA	O
-	O
DNA	O
hybridization	O
for	O
40	O
taxa	O
before	O
and	O
after	O
phototherapy	O
showed	O
that	O
the	O
growth	O
of	O
the	O
four	O
BPB	O
was	O
decreased	O
by	O
2	O
and	O
3	O
times	O
after	O
irradiation	O
at	O
energy	O
fluences	O
of	O
4	O
.	O
2	O
and	O
21	O
J	O
/	O
cm2	O
,	O
respectively	O
,	O
whereas	O
the	O
growth	O
of	O
the	O
remaining	O
36	O
microorganisms	O
was	O
decreased	O
by	O
1	O
.	O
5	O
times	O
at	O
both	O
energy	O
fluences	O
.	O

The	O
present	O
study	O
suggests	O
that	O
intraoral	O
light	O
exposure	O
may	O
be	O
used	O
to	O
control	O
BPB	O
growth	O
and	O
possibly	O
benefit	O
patients	O
with	O
periodontal	O
disease	O
.	O

Autologous	O
stem	O
cell	O
transplantation	O
has	O
augmented	O
treatment	O
successes	O
.	O

However	O
,	O
high	O
-	O
dose	O
chemotherapy	O
is	O
still	O
accompanied	O
by	O
dose	O
-	O
limiting	O
toxicities	O
,	O
for	O
example	O
,	O
severe	O
mucositis	O
.	O

Mucosal	O
lesions	O
serve	O
as	O
portals	O
of	O
entry	O
for	O
infections	O
.	O

In	O
order	O
to	O
reduce	O
the	O
oral	O
microbial	O
burden	O
,	O
we	O
prospectively	O
evaluated	O
the	O
microbiological	O
impact	O
of	O
a	O
complex	O
regimen	O
of	O
mouth	O
rinses	O
consisting	O
of	O
concomitantly	O
applied	O
polyene	O
antifungals	O
,	O
povidone	O
-	O
iodine	O
,	O
chlorhexidine	O
,	O
sage	O
tea	O
,	O
and	O
prophylactic	O
ciprofloxacin	O
and	O
fluconazole	O
.	O

A	O
total	O
of	O
15	O
patients	O
were	O
enrolled	O
into	O
this	O
longitudinal	O
evaluation	O
.	O

Colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
were	O
quantitated	O
from	O
saliva	O
,	O
buccal	O
and	O
palatinal	O
swabs	O
during	O
high	O
-	O
dose	O
chemotherapy	O
and	O
autologous	O
stem	O
cell	O
transplantation	O
.	O

The	O
number	O
of	O
CFU	O
did	O
not	O
show	O
any	O
significant	O
changes	O
after	O
initiation	O
of	O
the	O
mouth	O
rinses	O
and	O
the	O
prophylactic	O
antibiotics	O
.	O

The	O
median	O
CFU	O
count	O
was	O
268	O
x	O
10	O
(	O
6	O
)	O
/	O
ml	O
saliva	O
before	O
chemotherapy	O
and	O
decreased	O
after	O
initiation	O
of	O
intravenous	O
antibiotics	O
only	O
.	O

Neither	O
prophylactic	O
nor	O
therapeutic	O
antifungals	O
significantly	O
reduced	O
the	O
number	O
of	O
cultures	O
positive	O
for	O
yeasts	O
.	O

Since	O
90	O
%	O
of	O
our	O
patients	O
had	O
febrile	O
neutropenia	O
at	O
some	O
time	O
point	O
during	O
the	O
observation	O
period	O
,	O
the	O
approach	O
evaluated	O
can	O
not	O
be	O
recommended	O
as	O
prophylaxis	O
of	O
febrile	O
neutropenia	O
as	O
such	O
.	O

Two	O
studies	O
were	O
conducted	O
to	O
determine	O
the	O
antimicrobial	O
effect	O
of	O
rinsing	O
with	O
an	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
12	O
h	O
after	O
a	O
single	O
rinse	O
and	O
12	O
h	O
after	O
2	O
weeks	O
of	O
twice	O
daily	O
rinsing	O
,	O
during	O
the	O
daytime	O
and	O
overnight	O
.	O

These	O
studies	O
utilized	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
controlled	O
crossover	O
design	O
.	O

Following	O
baseline	O
sampling	O
of	O
bacteria	O
from	O
supragingival	O
plaque	O
and	O
the	O
dorsum	O
of	O
the	O
tongue	O
,	O
subjects	O
began	O
twice	O
-	O
daily	O
rinsing	O
with	O
either	O
an	O
essential	O
oil	O
mouth	O
rinse	O
containing	O
0	O
.	O
09	O
%	O
zinc	O
chloride	O
(	O
Tartar	O
Control	O
Listerine	O
Antiseptic	O
)	O
or	O
a	O
negative	O
control	O
rinse	O
.	O

Bacterial	O
sampling	O
was	O
repeated	O
12	O
h	O
after	O
the	O
first	O
rinse	O
,	O
and	O
again	O
12	O
h	O
after	O
the	O
final	O
rinse	O
14	O
days	O
later	O
.	O

The	O
sampling	O
schedule	O
was	O
adjusted	O
according	O
to	O
whether	O
the	O
study	O
was	O
investigating	O
daytime	O
or	O
overnight	O
activity	O
.	O

Samples	O
were	O
plated	O
on	O
Schaedlers	O
medium	O
(	O
total	O
anaerobes	O
)	O
,	O
Schaedlers	O
Nalidixic	O
/	O
Vancomycin	O
medium	O
(	O
Gram	O
-	O
negative	O
anaerobes	O
)	O
,	O
and	O
OOPS	O
medium	O
(	O
volatile	O
sulphur	O
compound	O
(	O
VSC	O
)	O
-	O
producing	O
organisms	O
)	O
.	O

Inter	O
-	O
group	O
log10	O
transformed	O
colony	O
-	O
forming	O
units	O
/	O
ml	O
counts	O
from	O
samples	O
of	O
supragingival	O
plaque	O
and	O
tongue	O
swabs	O
on	O
each	O
of	O
the	O
three	O
media	O
were	O
compared	O
by	O
analysis	O
of	O
covariance	O
.	O

The	O
mean	O
bacterial	O
counts	O
in	O
subjects	O
using	O
the	O
essential	O
oil	O
mouth	O
rinse	O
were	O
significantly	O
lower	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
005	O
)	O
than	O
mean	O
counts	O
in	O
subjects	O
using	O
the	O
control	O
rinse	O
in	O
all	O
the	O
comparisons	O
,	O
i	O
.	O
e	O
.	O
,	O
tongue	O
and	O
supragingival	O
plaque	O
samples	O
on	O
each	O
of	O
three	O
media	O
at	O
two	O
sampling	O
periods	O
in	O
the	O
daytime	O
and	O
overnight	O
study	O
,	O
respectively	O
.	O

Mean	O
bacterial	O
count	O
percent	O
reductions	O
for	O
plaque	O
samples	O
ranged	O
from	O
56	O
.	O
3	O
to	O
95	O
.	O
3	O
;	O
percent	O
reductions	O
for	O
tongue	O
samples	O
ranged	O
from	O
61	O
.	O
1	O
to	O
96	O
.	O
1	O
.	O

There	O
was	O
a	O
trend	O
to	O
higher	O
reductions	O
after	O
14	O
days	O
'	O
rinsing	O
than	O
after	O
the	O
initial	O
rinse	O
.	O

Rinsing	O
with	O
the	O
essential	O
oil	O
mouth	O
rinse	O
can	O
have	O
long	O
-	O
lasting	O
effects	O
in	O
reducing	O
anaerobic	O
bacteria	O
overall	O
as	O
well	O
as	O
Gram	O
-	O
negative	O
anaerobes	O
and	O
VSC	O
-	O
producing	O
bacteria	O
.	O

The	O
significant	O
reductions	O
in	O
numbers	O
of	O
these	O
bacteria	O
produced	O
by	O
the	O
essential	O
oil	O
mouth	O
rinse	O
,	O
both	O
in	O
plaque	O
and	O
on	O
the	O
dorsum	O
of	O
the	O
tongue	O
,	O
can	O
play	O
a	O
key	O
role	O
in	O
explaining	O
the	O
essential	O
oil	O
mouth	O
rinse	O
'	O
s	O
effectiveness	O
in	O
reducing	O
supragingival	O
plaque	O
and	O
gingivitis	O
as	O
well	O
as	O
its	O
effectiveness	O
in	O
controlling	O
intrinsic	O
oral	O
malodor	O
over	O
prolonged	O
periods	O
.	O

Psychological	O
stress	O
is	O
known	O
to	O
increase	O
the	O
circulating	O
levels	O
of	O
the	O
catecholamine	O
hormones	O
noradrenaline	O
and	O
adrenaline	O
,	O
which	O
have	O
been	O
shown	O
to	O
influence	O
the	O
growth	O
of	O
a	O
large	O
number	O
of	O
bacterial	O
species	O
by	O
acting	O
in	O
a	O
siderophore	O
-	O
like	O
manner	O
or	O
by	O
inducing	O
the	O
production	O
of	O
novel	O
autoinducers	O
of	O
growth	O
.	O

As	O
we	O
have	O
previously	O
demonstrated	O
that	O
periodontal	O
organisms	O
display	O
differing	O
growth	O
responses	O
to	O
noradrenaline	O
and	O
adrenaline	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
these	O
growth	O
effects	O
were	O
based	O
upon	O
either	O
siderophore	O
-	O
like	O
or	O
autoinducer	O
mechanisms	O
.	O

Initial	O
inocula	O
of	O
43	O
microbial	O
organisms	O
normally	O
found	O
within	O
the	O
subgingival	O
biofilm	O
were	O
established	O
under	O
anaerobic	O
conditions	O
(	O
35	O
degrees	O
C	O
)	O
.	O

Each	O
strain	O
was	O
re	O
-	O
inoculated	O
into	O
a	O
serum	O
-	O
based	O
minimal	O
medium	O
and	O
growth	O
was	O
assessed	O
by	O
optical	O
density	O
(	O
OD	O
(	O
600	O
nm	O
)	O
)	O
with	O
test	O
and	O
control	O
cultures	O
performed	O
in	O
triplicate	O
.	O

Test	O
cultures	O
were	O
supplemented	O
with	O
either	O
50	O
mum	O
ferric	O
nitrate	O
or	O
a	O
previously	O
described	O
Escherichia	B-bacteria
coli	I-bacteria
autoinducer	O
of	O
growth	O
.	O

Significant	O
growth	O
effects	O
for	O
supplementation	O
with	O
ferric	O
nitrate	O
(	O
13	O
species	O
responding	O
positively	O
)	O
and	O
E	B-bacteria
.	I-bacteria
coli	O
autoinducer	O
(	O
24	O
species	O
responding	O
positively	O
)	O
were	O
observed	O
,	O
with	O
differences	O
in	O
growth	O
response	O
within	O
bacterial	O
species	O
and	O
within	O
microbial	O
complexes	O
.	O

When	O
data	O
for	O
all	O
organisms	O
were	O
compared	O
with	O
published	O
responses	O
to	O
catecholamines	O
there	O
were	O
only	O
weak	O
correlations	O
with	O
Fe	O
(	O
r	O
=	O
0	O
.	O
28	O
)	O
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
autoinducer	O
(	O
r	O
=	O
0	O
.	O
34	O
)	O
responses	O
.	O

However	O
,	O
large	O
positive	O
responses	O
(	O
>	O
25	O
%	O
increase	O
)	O
to	O
free	O
Fe	O
and	O
/	O
or	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
autoinducer	O
were	O
significantly	O
more	O
prevalent	O
in	O
the	O
group	O
of	O
organisms	O
(	O
n	O
=	O
12	O
)	O
known	O
to	O
exhibit	O
similar	O
responses	O
to	O
catecholamine	O
hormones	O
(	O
P	O
<	O
0	O
.	O
01	O
;	O
chi2	O
=	O
4	O
.	O
56	O
)	O
.	O

The	O
results	O
support	O
the	O
view	O
that	O
catecholamines	O
may	O
exert	O
their	O
effects	O
on	O
subgingival	O
organisms	O
by	O
initiating	O
autoinducer	O
production	O
,	O
or	O
simply	O
by	O
acting	O
in	O
a	O
siderophore	O
-	O
like	O
manner	O
,	O
scavenging	O
bound	O
iron	O
from	O
the	O
local	O
environment	O
.	O

It	O
is	O
possible	O
that	O
autoinducer	O
mechanisms	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
response	O
of	O
oral	O
microorganisms	O
to	O
stress	O
hormones	O
,	O
thereby	O
contributing	O
to	O
the	O
clinical	O
course	O
of	O
stress	O
-	O
associated	O
periodontal	O
diseases	O
.	O

We	O
isolated	O
bacteria	O
from	O
periodontal	O
sites	O
and	O
mixed	O
saliva	O
in	O
eight	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
and	O
surveyed	O
them	O
to	O
determine	O
whether	O
they	O
produced	O
heat	O
shock	O
proteins	O
(	O
HSPs	O
)	O
and	O
superantigen	O
.	O

Cultivable	O
bacterial	O
compositions	O
from	O
periodontal	O
sites	O
and	O
saliva	O
were	O
examined	O
by	O
anaerobic	O
culture	O
using	O
blood	O
agar	O
plates	O
.	O

Gram	O
-	O
negative	O
anaerobic	O
rods	O
such	O
as	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Capnocytophaga	B-bacteria
species	I-bacteria
were	O
predominant	O
in	O
the	O
isolates	O
from	O
the	O
subgingival	O
plaque	O
samples	O
.	O

The	O
Streptococcus	B-bacteria
mitis	I-bacteria
group	O
was	O
the	O
most	O
common	O
type	O
isolated	O
from	O
the	O
saliva	O
samples	O
.	O

To	O
detect	O
the	O
production	O
of	O
HSPs	O
,	O
Western	O
blot	O
analyses	O
were	O
performed	O
using	O
a	O
polyclonal	O
rabbit	O
antibody	O
to	O
Escherichia	B-bacteria
coli	I-bacteria
DnaK	O
and	O
a	O
monoclonal	O
antibody	O
to	O
Helicobacter	B-bacteria
pylori	I-bacteria
Gro	O
-	O
EL	O
.	O

Sonic	O
extracts	O
of	O
27	O
of	O
the	O
strains	O
(	O
79	O
.	O
4	O
%	O
)	O
reacted	O
with	O
the	O
antibody	O
against	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
DnaK	O
.	O

Nine	O
of	O
these	O
34	O
strains	O
(	O
26	O
.	O
5	O
%	O
)	O
were	O
found	O
to	O
produce	O
HSPs	O
that	O
reacted	O
with	O
antibody	O
to	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
Gro	O
-	O
EL	O
.	O

A	O
total	O
of	O
54	O
isolates	O
were	O
examined	O
for	O
superantigen	O
activity	O
against	O
human	O
peripheral	O
leukocytes	O
.	O

Twenty	O
-	O
five	O
gram	O
-	O
negative	O
clinical	O
strains	O
isolated	O
from	O
chronic	O
periodontitis	O
lesions	O
and	O
20	O
ATCC	B-bacteria
strains	I-bacteria
of	O
microorganisms	O
were	O
also	O
examined	O
.	O

We	O
could	O
not	O
detect	O
any	O
superantigen	O
activity	O
in	O
500x	O
diluted	O
supernatant	O
of	O
the	O
strains	O
isolated	O
from	O
the	O
eight	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
.	O

The	O
present	O
study	O
indicates	O
that	O
the	O
anaerobic	O
strains	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
these	O
patients	O
produce	O
HSPs	O
,	O
the	O
production	O
being	O
related	O
to	O
Bechet	O
'	O
s	O
disease	O
.	O

Peptidoglycan	O
recognition	O
proteins	O
(	O
PGRPs	O
)	O
,	O
a	O
novel	O
family	O
of	O
pattern	O
recognition	O
molecules	O
(	O
PRMs	O
)	O
in	O
innate	O
immunity	O
conserved	O
from	O
insects	O
to	O
mammals	O
,	O
recognize	O
bacterial	O
cell	O
wall	O
peptidoglycan	O
(	O
PGN	O
)	O
and	O
are	O
suggested	O
to	O
act	O
as	O
anti	O
-	O
bacterial	O
factors	O
.	O

In	O
humans	O
,	O
four	O
kinds	O
of	O
PGRPs	O
(	O
PGRP	O
-	O
L	O
,	O
-	O
Ialpha	O
,	O
-	O
Ibeta	O
and	O
-	O
S	O
)	O
have	O
been	O
cloned	O
and	O
all	O
four	O
human	O
PGRPs	O
bind	O
PGN	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
possible	O
regulation	O
of	O
the	O
expression	O
of	O
PGRPs	O
in	O
oral	O
epithelial	O
cells	O
upon	O
stimulation	O
with	O
chemically	O
synthesized	O
pathogen	O
-	O
associated	O
molecular	O
patterns	O
(	O
PAMPs	O
)	O
in	O
bacterial	O
cell	O
surface	O
components	O
:	O
Escherichia	O
coli	O
-	O
type	O
tryacyl	O
lipopeptide	O
(	O
Pam3CSSNA	O
)	O
,	O
E	O
.	O
coli	O
-	O
type	O
lipid	O
A	O
(	O
LA	O
-	O
15	O
-	O
PP	O
)	O
,	O
diaminopimelic	O
acid	O
containing	O
desmuramyl	O
peptide	O
(	O
gamma	O
-	O
D	O
-	O
glutamyl	O
-	O
meso	O
-	O
DAP	O
;	O
iE	O
-	O
DAP	O
)	O
,	O
and	O
muramyldipeptide	O
(	O
MDP	O
)	O
.	O

These	O
synthetic	O
PAMPs	O
markedly	O
upregulated	O
the	O
mRNA	O
expression	O
of	O
the	O
four	O
PGRPs	O
and	O
cell	O
surface	O
expression	O
of	O
PGRP	O
-	O
Ialpha	O
and	O
-	O
Ibeta	O
,	O
but	O
did	O
not	O
induce	O
either	O
mRNA	O
expression	O
or	O
secretion	O
of	O
inflammatory	O
cytokines	O
,	O
in	O
oral	O
epithelial	O
cells	O
.	O

Suppression	O
of	O
the	O
expression	O
of	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
2	O
,	O
TLR4	O
,	O
nucleotide	O
-	O
binding	O
oligomerization	O
domain	O
(	O
NOD	O
)	O
1	O
and	O
NOD2	O
by	O
RNA	O
interference	O
specifically	O
inhibited	O
the	O
upregulation	O
of	O
PGRP	O
mRNA	O
expression	O
induced	O
by	O
Pam3CSSNA	O
,	O
LA	O
-	O
15	O
-	O
PP	O
,	O
iE	O
-	O
DAP	O
and	O
MDP	O
respectively	O
.	O

These	O
PAMPs	O
definitely	O
activated	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
in	O
the	O
epithelial	O
cells	O
,	O
and	O
suppression	O
of	O
NF	O
-	O
kappaB	O
activation	O
clearly	O
prevented	O
the	O
induction	O
of	O
PGRP	O
mRNA	O
expression	O
induced	O
by	O
these	O
PAMPs	O
in	O
the	O
cells	O
.	O

These	O
findings	O
suggested	O
that	O
bacterial	O
PAMPs	O
induced	O
the	O
expression	O
of	O
PGRPs	O
,	O
but	O
not	O
proinflammatory	O
cytokines	O
,	O
in	O
oral	O
epithelial	O
cells	O
,	O
and	O
the	O
PGRPs	O
might	O
be	O
involved	O
in	O
host	O
defence	O
against	O
bacterial	O
invasion	O
without	O
accompanying	O
inflammatory	O
responses	O
.	O

oral	O
treponemes	B-bacteria
are	O
well	O
-	O
known	O
as	O
causative	O
agents	O
of	O
periodontal	O
disease	O
;	O
however	O
,	O
the	O
details	O
have	O
not	O
been	O
fully	O
clarified	O
.	O

Here	O
,	O
we	O
examined	O
the	O
effects	O
of	O
Treponema	B-bacteria
medium	I-bacteria
glycoconjugate	O
on	O
the	O
activation	O
of	O
human	O
gingival	O
fibroblasts	O
using	O
phenol	O
-	O
water	O
extracts	O
from	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
subsp	I-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

The	O
phenol	O
-	O
water	O
extracts	O
activated	O
human	O
gingival	O
fibroblasts	O
to	O
mediate	O
IL	O
-	O
8	O
production	O
,	O
as	O
well	O
as	O
IL	O
-	O
8	O
mRNA	O
expression	O
,	O
phosphorylation	O
of	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
,	O
and	O
expression	O
of	O
intercellular	O
adhesion	O
molecule	O
-	O
1	O
.	O

T	B-bacteria
.	I-bacteria
medium	I-bacteria
glycoconjugate	O
exhibited	O
no	O
activation	O
of	O
human	O
gingival	O
fibroblasts	O
,	O
while	O
phenol	O
-	O
water	O
extract	O
-	O
induced	O
activation	O
of	O
human	O
gingival	O
fibroblasts	O
was	O
clearly	O
inhibited	O
by	O
T	B-bacteria
.	I-bacteria
medium	I-bacteria
glycoconjugate	O
.	O

Furthermore	O
,	O
binding	O
of	O
biotinylated	O
phenol	O
-	O
water	O
extracts	O
to	O
CD14	O
in	O
the	O
presence	O
of	O
LPS	O
-	O
binding	O
protein	O
was	O
blocked	O
with	O
T	B-bacteria
.	I-bacteria
medium	I-bacteria
glycoconjugate	O
.	O

These	O
results	O
suggest	O
that	O
T	B-bacteria
.	I-bacteria
medium	I-bacteria
glycoconjugate	O
has	O
an	O
inhibitory	O
effect	O
on	O
host	O
cell	O
activation	O
by	O
periodontopathic	O
bacteria	O
caused	O
by	O
binding	O
to	O
CD14	O
-	O
and	O
LPS	O
-	O
binding	O
protein	O
.	O

Enterococcus	B-bacteria
faecalis	I-bacteria
is	O
consistently	O
associated	O
with	O
recurrent	O
root	O
canal	O
infections	O
.	O

Only	O
low	O
concentrations	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
in	O
the	O
human	O
mouth	O
have	O
been	O
demonstrated	O
by	O
culture	O
techniques	O
.	O

Quantitative	O
detection	O
strategies	O
more	O
sensitive	O
than	O
culturing	O
,	O
such	O
as	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
,	O
could	O
provide	O
more	O
illuminating	O
data	O
.	O

Thirty	O
outpatients	O
attending	O
the	O
University	O
of	O
Michigan	O
Graduate	O
Endodontic	O
Clinic	O
for	O
endodontic	O
treatment	O
provided	O
oral	O
rinse	O
samples	O
that	O
were	O
analysed	O
for	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
using	O
qPCR	O
and	O
microbiological	O
culturing	O
.	O

A	O
SYBR	O
Green	O
I	O
qPCR	O
protocol	O
was	O
developed	O
for	O
the	O
quantifiable	O
detection	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
and	O
total	O
bacteria	O
in	O
oral	O
rinse	O
samples	O
using	O
primers	O
designed	O
to	O
target	O
the	O
16S	O
rRNA	O
gene	O
.	O

Annealing	O
temperature	O
and	O
primer	O
,	O
magnesium	O
ion	O
,	O
and	O
dimethyl	O
sulfoxide	O
concentrations	O
were	O
investigated	O
for	O
optimisation	O
of	O
the	O
protocol	O
;	O
a	O
minimum	O
sensitivity	O
limit	O
of	O
23	O
rRNA	O
copies	O
(	O
an	O
estimated	O
six	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
cells	O
)	O
was	O
established	O
for	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
in	O
pure	O
culture	O
,	O
and	O
104	O
rRNA	O
copies	O
(	O
an	O
estimated	O
26	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
cells	O
)	O
in	O
mixed	O
culture	O
.	O

In	O
qPCR	O
assays	O
,	O
based	O
on	O
extrapolation	O
from	O
estimated	O
rRNA	O
gene	O
copy	O
numbers	O
,	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
comprised	O
0	O
.	O
0006	O
-	O
0	O
.	O
0047	O
%	O
of	O
a	O
total	O
bacteria	O
load	O
that	O
ranged	O
from	O
5	O
.	O
92	O
x	O
10	O
(	O
5	O
)	O
to	O
5	O
.	O
69	O
x	O
10	O
(	O
7	O
)	O
cells	O
/	O
ml	O
of	O
oral	O
rinse	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
detected	O
in	O
five	O
(	O
17	O
%	O
)	O
samples	O
in	O
concentrations	O
from	O
114	O
to	O
490	O
cells	O
/	O
ml	O
.	O

In	O
parallel	O
culture	O
assays	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
were	O
detected	O
in	O
only	O
two	O
samples	O
(	O
7	O
%	O
)	O
of	O
the	O
five	O
identified	O
by	O
qPCR	O
and	O
in	O
concentrations	O
30	O
and	O
240	O
CFU	O
/	O
ml	O
.	O

qPCR	O
reported	O
a	O
higher	O
incidence	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
in	O
oral	O
rinse	O
samples	O
than	O
culture	O
techniques	O
and	O
afforded	O
greater	O
sensitivity	O
.	O

The	O
application	O
of	O
molecular	O
,	O
mainly	O
16S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
-	O
based	O
approaches	O
enables	O
researchers	O
to	O
bypass	O
the	O
cultivation	O
step	O
and	O
has	O
proven	O
its	O
usefulness	O
in	O
studying	O
the	O
microbial	O
composition	O
in	O
a	O
variety	O
of	O
ecosystems	O
,	O
including	O
the	O
human	O
oral	O
cavity	O
.	O

In	O
this	O
mini	O
-	O
review	O
,	O
we	O
describe	O
the	O
impact	O
of	O
these	O
culture	O
-	O
independent	O
approaches	O
on	O
our	O
knowledge	O
of	O
the	O
ecology	O
of	O
the	O
human	O
oral	O
cavity	O
and	O
provide	O
directions	O
for	O
future	O
studies	O
that	O
should	O
emphasize	O
the	O
role	O
of	O
specific	O
strains	O
,	O
species	O
and	O
groups	O
of	O
microbes	O
in	O
periodontal	O
disease	O
.	O

Recent	O
findings	O
are	O
summarized	O
to	O
elucidate	O
the	O
relationship	O
between	O
periodontal	O
disease	O
and	O
human	O
oral	O
microbiota	O
,	O
including	O
as	O
-	O
yet	O
-	O
to	O
-	O
be	O
-	O
cultured	O
organisms	O
.	O

The	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
method	O
was	O
developed	O
to	O
detect	O
and	O
quantify	O
periodontopathic	O
bacteria	O
,	O
such	O
as	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
(	O
formerly	O
Bacteroides	B-bacteria
forsythus	I-bacteria
)	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

The	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
allowed	O
enumeration	O
of	O
large	O
numbers	O
of	O
species	O
in	O
very	O
large	O
numbers	O
of	O
samples	O
.	O

16S	O
rRNA	O
gene	O
clone	O
library	O
analysis	O
revealed	O
the	O
diversity	O
of	O
human	O
oral	O
microbiota	O
and	O
the	O
existence	O
of	O
as	O
-	O
yet	O
-	O
to	O
-	O
be	O
-	O
cultured	O
organisms	O
that	O
are	O
presumed	O
periodontal	O
pathogens	O
.	O

In	O
addition	O
,	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
T	O
-	O
RFLP	O
)	O
analysis	O
was	O
applied	O
for	O
assessment	O
of	O
diversity	O
of	O
human	O
oral	O
microbiota	O
.	O

Culture	O
-	O
independent	O
approaches	O
are	O
useful	O
for	O
studying	O
the	O
microbial	O
ecology	O
in	O
the	O
human	O
oral	O
cavity	O
and	O
should	O
be	O
useful	O
in	O
the	O
future	O
to	O
elucidate	O
the	O
etiology	O
of	O
periodontal	O
disease	O
.	O

The	O
description	O
of	O
the	O
new	O
species	O
Cardiobacterium	B-bacteria
valvarum	I-bacteria
prompted	O
a	O
search	O
for	O
additional	O
strains	O
of	O
the	O
organism	O
.	O

Here	O
we	O
report	O
characterization	O
of	O
four	O
oral	O
Cardiobacterium	B-bacteria
strains	I-bacteria
from	O
the	O
Culture	O
Collection	O
of	O
the	O
University	O
of	O
Goteborg	O
.	O

The	O
16S	O
rRNA	O
gene	O
sequences	O
of	O
the	O
organisms	O
exhibited	O
99	O
.	O
6	O
%	O
to	O
99	O
.	O
3	O
%	O
homology	O
with	O
Cardiobacterium	B-bacteria
valvarum	I-bacteria
.	O

The	O
cellular	O
fatty	O
acid	O
profiles	O
,	O
electrophoretic	O
patterns	O
of	O
whole	O
-	O
cell	O
proteins	O
,	O
growth	O
rate	O
and	O
nutritional	O
requirement	O
,	O
colonial	O
and	O
cellular	O
morphology	O
,	O
and	O
biochemical	O
reactions	O
were	O
also	O
similar	O
to	O
those	O
of	O
C	B-bacteria
.	I-bacteria
valvarum	I-bacteria
.	O

These	O
results	O
thus	O
classify	O
these	O
organisms	O
as	O
oral	O
strains	O
of	O
C	B-bacteria
.	I-bacteria
valvarum	I-bacteria
.	O

All	O
strains	O
were	O
susceptible	O
to	O
many	O
antibiotics	O
tested	O
.	O

The	O
description	O
of	O
the	O
species	O
was	O
emended	O
.	O

C	B-bacteria
.	I-bacteria
valvarum	I-bacteria
is	O
a	O
rare	O
cause	O
of	O
endocarditis	O
,	O
and	O
its	O
relationship	O
with	O
periodontal	O
diseases	O
may	O
need	O
investigation	O
.	O

Oral	O
Campylobacter	B-bacteria
species	I-bacteria
are	O
rarely	O
reported	O
to	O
cause	O
extraoral	O
infections	O
.	O

Here	O
we	O
present	O
three	O
cases	O
of	O
extraoral	O
abscess	O
caused	O
by	O
an	O
oral	O
Campylobacter	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
a	O
Streptococcus	B-bacteria
sp	I-bacteria
.	O

The	O
Campylobacter	B-bacteria
species	I-bacteria
were	O
all	O
isolated	O
anaerobically	O
and	O
identified	O
by	O
sequencing	O
analysis	O
of	O
the	O
16S	O
rRNA	O
gene	O
.	O

The	O
cases	O
included	O
a	O
breast	O
abscess	O
caused	O
by	O
Campylobacter	B-bacteria
rectus	I-bacteria
and	O
a	O
non	O
-	O
group	O
A	O
beta	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococcus	I-bacteria
in	O
a	O
patient	O
with	O
lymphoma	O
,	O
a	O
liver	O
abscess	O
caused	O
by	O
Campylobacter	B-bacteria
curvus	I-bacteria
and	O
an	O
alpha	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococcus	I-bacteria
in	O
a	O
patient	O
with	O
complicated	O
ovarian	O
cancer	O
,	O
and	O
a	O
postobstructive	O
bronchial	O
abscess	O
caused	O
by	O
C	B-bacteria
.	I-bacteria
curvus	I-bacteria
and	O
group	O
C	O
beta	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
Streptococcus	I-bacteria
constellatus	I-bacteria
in	O
a	O
patient	O
with	O
lung	O
cancer	O
.	O

The	O
abscesses	O
were	O
drained	O
or	O
resected	O
,	O
and	O
the	O
patients	O
were	O
treated	O
with	O
antibiotics	O
with	O
full	O
resolution	O
of	O
the	O
lesions	O
.	O

The	O
C	B-bacteria
.	I-bacteria
curvus	I-bacteria
cases	O
are	O
likely	O
the	O
first	O
reported	O
infections	O
by	O
this	O
organism	O
,	O
and	O
the	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
case	O
represents	O
the	O
second	O
such	O
reported	O
extraoral	O
infection	O
.	O

This	O
paper	O
describes	O
some	O
of	O
the	O
work	O
done	O
in	O
the	O
author	O
'	O
s	O
laboratory	O
over	O
the	O
past	O
35	O
years	O
.	O

The	O
research	O
covers	O
the	O
following	O
areas	O
:	O
the	O
physiology	O
of	O
oral	O
streptococci	B-bacteria
and	O
their	O
interactions	O
;	O
the	O
physiology	O
of	O
some	O
Gram	O
-	O
negative	O
anaerobes	O
and	O
their	O
interactions	O
in	O
relation	O
to	O
periodontal	O
diseases	O
;	O
preventing	O
the	O
major	O
dental	O
diseases	O
;	O
and	O
the	O
future	O
of	O
oral	O
microbiology	O
.	O

Antimicrobial	O
peptides	O
are	O
one	O
of	O
the	O
factors	O
involved	O
in	O
innate	O
immunity	O
.	O

The	O
susceptibility	O
of	O
periodontopathogenic	O
and	O
cariogenic	O
bacteria	O
to	O
the	O
major	O
antimicrobial	O
peptides	O
produced	O
by	O
epithelia	O
was	O
investigated	O
.	O

Synthetic	O
antimicrobial	O
peptides	O
of	O
human	O
beta	O
-	O
defensin	O
-	O
1	O
(	O
hBD1	O
)	O
,	O
hBD2	O
,	O
hBD3	O
and	O
LL37	O
(	O
CAP18	O
)	O
were	O
evaluated	O
for	O
their	O
antimicrobial	O
activity	O
against	O
oral	O
bacteria	O
.	O

They	O
included	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
20	O
strains	O
)	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
6	O
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
7	O
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
7	O
)	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
5	O
)	O
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
(	O
5	O
)	O
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
(	O
5	O
)	O
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
(	O
4	O
)	O
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
(	O
2	O
)	O
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
(	O
1	O
)	O
.	O

Although	O
the	O
four	O
peptides	O
had	O
bactericidal	O
activity	O
against	O
all	O
bacteria	O
tested	O
,	O
the	O
degree	O
of	O
antibacterial	O
activity	O
was	O
variable	O
against	O
the	O
different	O
strains	O
and	O
species	O
.	O

The	O
antibacterial	O
activity	O
of	O
hBD1	O
was	O
lower	O
than	O
that	O
of	O
the	O
other	O
peptides	O
.	O

Among	O
the	O
bacteria	O
tested	O
in	O
this	O
study	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
highly	O
susceptible	O
to	O
hBD3	O
and	O
LL37	O
,	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
highly	O
susceptible	O
to	O
hBD3	O
.	O

We	O
measured	O
the	O
Zeta	O
-	O
potential	O
,	O
representing	O
the	O
net	O
charge	O
of	O
whole	O
bacteria	O
,	O
to	O
study	O
the	O
relationship	O
between	O
susceptibility	O
to	O
cationic	O
peptide	O
and	O
the	O
net	O
charge	O
of	O
the	O
bacteria	O
.	O

Although	O
we	O
found	O
some	O
correlation	O
in	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
strains	I-bacteria
,	O
we	O
did	O
not	O
find	O
a	O
definite	O
correlation	O
with	O
all	O
the	O
bacterial	O
species	O
.	O

These	O
results	O
indicate	O
that	O
beta	O
-	O
defensins	O
and	O
LL37	O
have	O
versatile	O
antibacterial	O
activity	O
against	O
oral	O
bacteria	O
.	O

Transcriptional	O
profiling	O
,	O
bioinformatics	O
,	O
statistical	O
and	O
ontology	O
tools	O
were	O
used	O
to	O
uncover	O
and	O
dissect	O
genes	O
and	O
pathways	O
of	O
human	O
gingival	O
epithelial	O
cells	O
that	O
are	O
modulated	O
upon	O
interaction	O
with	O
the	O
periodontal	O
pathogens	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

Consistent	O
with	O
their	O
biological	O
and	O
clinical	O
differences	O
,	O
the	O
common	O
core	O
transcriptional	O
response	O
of	O
epithelial	O
cells	O
to	O
both	O
organisms	O
was	O
very	O
limited	O
,	O
and	O
organism	O
-	O
specific	O
responses	O
predominated	O
.	O

A	O
large	O
number	O
of	O
differentially	O
regulated	O
genes	O
linked	O
to	O
the	O
P53	O
apoptotic	O
network	O
were	O
found	O
with	O
both	O
organisms	O
,	O
which	O
was	O
consistent	O
with	O
the	O
pro	O
-	O
apoptotic	O
phenotype	O
observed	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
anti	O
-	O
apoptotic	O
phenotype	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Furthermore	O
,	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
the	O
induction	O
of	O
apoptosis	O
did	O
not	O
appear	O
to	O
be	O
Fas	O
-	O
or	O
TNF	O
(	O
alpha	O
)	O
-	O
mediated	O
.	O

Linkage	O
of	O
specific	O
bacterial	O
components	O
to	O
host	O
pathways	O
and	O
networks	O
provided	O
additional	O
insight	O
into	O
the	O
pathogenic	O
process	O
.	O

Comparison	O
of	O
the	O
transcriptional	O
responses	O
of	O
epithelial	O
cells	O
challenged	O
with	O
parental	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
with	O
a	O
mutant	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
deficient	O
in	O
production	O
of	O
major	O
fimbriae	O
,	O
which	O
are	O
required	O
for	O
optimal	O
invasion	O
,	O
showed	O
major	O
expression	O
differences	O
that	O
reverberated	O
throughout	O
the	O
host	O
cell	O
transcriptome	O
.	O

In	O
contrast	O
,	O
gene	O
ORF859	O
in	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
which	O
may	O
play	O
a	O
role	O
in	O
intracellular	O
homeostasis	O
,	O
had	O
a	O
more	O
subtle	O
effect	O
on	O
the	O
transcriptome	O
.	O

These	O
studies	O
help	O
unravel	O
the	O
complex	O
and	O
dynamic	O
interactions	O
between	O
host	O
epithelial	O
cells	O
and	O
endogenous	O
bacteria	O
that	O
can	O
cause	O
opportunistic	O
infections	O
.	O

Garlic	O
(	O
Allium	O
sativum	O
)	O
has	O
long	O
been	O
known	O
to	O
have	O
antibacterial	O
,	O
antifungal	O
and	O
antiviral	O
properties	O
but	O
there	O
are	O
few	O
data	O
on	O
its	O
effects	O
against	O
oral	O
bacterial	O
species	O
particularly	O
putative	O
periodontal	O
pathogens	O
or	O
their	O
enzymes	O
.	O

Filter	O
sterilised	O
,	O
aqueous	O
extract	O
of	O
garlic	O
was	O
tested	O
for	O
ability	O
to	O
inhibit	O
the	O
growth	O
of	O
a	O
range	O
of	O
oral	O
species	O
and	O
to	O
inhibit	O
the	O
trypsin	O
-	O
like	O
and	O
total	O
protease	O
activity	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
garlic	O
extract	O
(	O
57	O
.	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
,	O
containing	O
220	O
microg	O
/	O
ml	O
allicin	O
)	O
inhibited	O
the	O
growth	O
and	O
killed	O
most	O
of	O
the	O
organisms	O
tested	O
.	O

In	O
general	O
,	O
the	O
minimal	O
inhibitory	O
and	O
minimum	O
bactericidal	O
concentrations	O
for	O
the	O
Gram	O
-	O
negative	O
strains	O
(	O
garlic	O
MIC	O
range	O
35	O
.	O
7	O
-	O
1	O
.	O
1	O
mg	O
/	O
ml	O
;	O
allicin	O
mean	O
MIC	O
4	O
.	O
1	O
microg	O
/	O
ml	O
;	O
mean	O
MBC	O
7	O
.	O
9	O
microg	O
/	O
ml	O
)	O
were	O
lower	O
than	O
those	O
for	O
the	O
Gram	O
-	O
positive	O
strains	O
tested	O
(	O
garlic	O
MIC	O
range	O
142	O
.	O
7	O
-	O
35	O
.	O
7	O
mg	O
/	O
ml	O
;	O
allicin	O
mean	O
MIC	O
27	O
.	O
5	O
microg	O
/	O
ml	O
;	O
mean	O
MBC	O
91	O
.	O
9	O
microg	O
/	O
ml	O
)	O
.	O

Also	O
,	O
of	O
the	O
organisms	O
tested	O
,	O
the	O
putative	O
periodontal	O
pathogens	O
had	O
among	O
the	O
lowest	O
MICs	O
(	O
17	O
.	O
8	O
-	O
1	O
.	O
1	O
mg	O
/	O
ml	O
garlic	O
)	O
and	O
MBCs	O
(	O
35	O
.	O
7	O
-	O
1	O
.	O
1	O
mg	O
/	O
ml	O
garlic	O
)	O
.	O

Time	O
-	O
kill	O
curves	O
for	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
ginigvalis	I-bacteria
,	O
showed	O
that	O
killing	O
of	O
the	O
latter	O
started	O
almost	O
immediately	O
,	O
whereas	O
there	O
was	O
a	O
delay	O
before	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
killed	O
.	O

The	O
garlic	O
extract	O
also	O
inhibited	O
the	O
trypsin	O
-	O
like	O
and	O
total	O
protease	O
activity	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
by	O
92	O
.	O
7	O
%	O
and	O
94	O
.	O
88	O
%	O
,	O
respectively	O
.	O

These	O
data	O
indicate	O
that	O
garlic	O
extract	O
inhibits	O
the	O
growth	O
of	O
oral	O
pathogens	O
and	O
certain	O
proteases	O
and	O
so	O
may	O
have	O
therapeutic	O
value	O
,	O
particularly	O
for	O
periodontitis	O
.	O

The	O
aims	O
of	O
this	O
study	O
are	O
to	O
describe	O
the	O
relationships	O
between	O
IgG	O
antibodies	O
to	O
17	O
oral	O
organisms	O
and	O
atherosclerosis	O
as	O
indexed	O
by	O
carotid	O
intima	O
-	O
medial	O
wall	O
thickness	O
(	O
IMT	O
)	O
and	O
to	O
evaluate	O
the	O
role	O
of	O
smoking	O
.	O

Our	O
study	O
is	O
based	O
on	O
a	O
subset	O
of	O
participants	O
in	O
the	O
Atherosclerosis	O
Risk	O
in	O
Communities	O
(	O
ARIC	O
)	O
Study	O
,	O
who	O
received	O
a	O
complete	O
periodontal	O
examination	O
during	O
visit	O
4	O
(	O
1996	O
-	O
1998	O
)	O
.	O

The	O
outcome	O
was	O
mean	O
carotid	O
IMT	O
>	O
/	O
=	O
1mm	O
assessed	O
by	O
B	O
-	O
mode	O
ultrasound	O
.	O

The	O
exposures	O
were	O
serum	O
IgG	O
antibody	O
levels	O
against	O
17	O
periodontal	O
organisms	O
using	O
a	O
whole	O
bacterial	O
checkerboard	O
immunoblotting	O
technique	O
.	O

Evaluation	O
of	O
all	O
17	O
antibodies	O
indicated	O
that	O
antibody	O
to	O
Campylobacter	B-bacteria
rectus	I-bacteria
resulted	O
in	O
the	O
best	O
-	O
fitting	O
model	O
(	O
OR	O
=	O
2	O
.	O
3	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
83	O
-	O
2	O
.	O
84	O
)	O
and	O
individuals	O
with	O
both	O
high	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
and	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
titers	O
had	O
almost	O
twice	O
the	O
prevalence	O
of	O
IMT	O
>	O
/	O
=	O
1mm	O
than	O
those	O
with	O
only	O
a	O
high	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
antibody	O
(	O
8	O
.	O
3	O
%	O
versus	O
16	O
.	O
3	O
%	O
)	O
.	O

Stratification	O
by	O
smoking	O
indicated	O
that	O
all	O
microbial	O
models	O
significant	O
for	O
smokers	O
were	O
also	O
significant	O
for	O
never	O
smokers	O
except	O
for	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
p	O
=	O
0	O
.	O
08	O
)	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
report	O
a	O
relationship	O
between	O
IgG	O
antibody	O
reactive	O
to	O
oral	O
organisms	O
and	O
subclinical	O
atherosclerosis	O
with	O
significant	O
relationships	O
evident	O
in	O
both	O
ever	O
and	O
never	O
smokers	O
.	O

To	O
detect	O
enterococci	B-bacteria
,	O
enteric	O
bacteria	O
and	O
yeast	O
species	O
from	O
the	O
canals	O
of	O
teeth	O
with	O
primary	O
endodontic	O
infections	O
before	O
and	O
after	O
canal	O
preparation	O
and	O
to	O
test	O
the	O
antibiotic	O
susceptibility	O
of	O
enterococcal	B-bacteria
strains	I-bacteria
isolated	O
from	O
infected	O
root	O
canals	O
.	O

Twenty	O
-	O
five	O
single	O
-	O
rooted	O
teeth	O
with	O
pulp	O
necrosis	O
,	O
intact	O
pulp	O
chambers	O
and	O
periradicular	O
lesions	O
were	O
selected	O
for	O
study	O
.	O

Samples	O
were	O
collected	O
from	O
canals	O
before	O
and	O
after	O
instrumentation	O
.	O

Amongst	O
isolated	O
microorganisms	O
from	O
infected	O
root	O
canals	O
only	O
enterococci	B-bacteria
,	O
enteric	O
bacteria	O
and	O
yeasts	O
were	O
identified	O
by	O
biochemical	O
tests	O
.	O

The	O
in	O
vitro	O
antimicrobial	O
susceptibility	O
of	O
isolated	O
enterococci	B-bacteria
strains	I-bacteria
was	O
evaluated	O
by	O
the	O
Etest	O
system	O
.	O

Microorganisms	O
were	O
isolated	O
from	O
92	O
%	O
of	O
the	O
samples	O
following	O
intracoronal	O
access	O
,	O
22	O
%	O
were	O
enterococci	B-bacteria
,	O
enteric	O
bacteria	O
or	O
yeast	O
species	O
.	O

After	O
biomechanical	O
preparation	O
,	O
these	O
species	O
were	O
no	O
longer	O
detected	O
.	O

After	O
7	O
days	O
without	O
intracanal	O
dressing	O
,	O
100	O
%	O
of	O
the	O
canals	O
contained	O
microorganisms	O
,	O
52	O
%	O
of	O
which	O
were	O
target	O
species	O
.	O

However	O
,	O
after	O
using	O
paramonochlorophenol	O
[	O
PRP	O
(	O
2	O
.	O
0	O
g	O
)	O
,	O
Rinosoro	O
and	O
polyethylene	O
glycol	O
(	O
400	O
equal	O
parts	O
up	O
to	O
100	O
mL	O
)	O
]	O
as	O
an	O
intracanal	O
dressing	O
for	O
7	O
days	O
,	O
enteric	O
bacteria	O
and	O
yeasts	O
were	O
not	O
detected	O
;	O
only	O
enterococci	B-bacteria
were	O
still	O
present	O
.	O

All	O
strains	O
of	O
enterococci	B-bacteria
were	O
susceptible	O
to	O
ampicillin	O
,	O
but	O
exhibited	O
variable	O
susceptibility	O
to	O
rifampin	O
and	O
ciprofloxacin	O
.	O

Enterococci	B-bacteria
,	O
enteric	O
bacteria	O
and	O
yeasts	O
were	O
present	O
in	O
primary	O
endodontic	O
infections	O
.	O

Enterococci	B-bacteria
,	O
particularly	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
were	O
resistant	O
to	O
removal	O
by	O
root	O
canal	O
preparation	O
followed	O
by	O
intracanal	O
dressing	O
.	O

To	O
inquire	O
into	O
the	O
effect	O
of	O
different	O
of	O
Nidus	O
Vespae	O
extract	O
(	O
NVE	O
)	O
on	O
growth	O
and	O
acid	O
production	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
and	O
Actinomyces	B-bacteria
viscosus	I-bacteria
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
ATCC	I-bacteria
10556	I-bacteria
and	O
Actinomyces	B-bacteria
viscosus	I-bacteria
ATCC	I-bacteria
19246	I-bacteria
were	O
chosen	O
as	O
the	O
experimental	O
bacteria	O
.	O

Four	O
extracts	O
of	O
Nidus	O
Vespae	O
were	O
prepared	O
and	O
then	O
the	O
effects	O
of	O
these	O
Nidus	O
Vespae	O
extracts	O
on	O
the	O
acid	O
production	O
were	O
determined	O
.	O

All	O
of	O
Nidus	O
Vespae	O
extracts	O
could	O
inhibit	O
the	O
growth	O
the	O
of	O
the	O
three	O
strains	O
,	O
and	O
NVE1	O
,	O
NVE3	O
,	O
NVE4	O
could	O
inhibit	O
the	O
acid	O
production	O
of	O
the	O
three	O
strains	O
,	O
NVE2	O
could	O
inhibit	O
the	O
acid	O
production	O
of	O
Actinomyces	B-bacteria
viscosus	I-bacteria
.	O

Four	O
extracts	O
of	O
Nidus	O
Vespae	O
could	O
inhibit	O
the	O
acid	O
production	O
of	O
three	O
bacteria	O
strains	O
.	O

Noninvasive	O
in	O
situ	O
detection	O
of	O
suspected	O
cariogenic	O
bacterial	O
species	O
within	O
dental	O
biofilms	O
could	O
facilitate	O
monitoring	O
of	O
the	O
dynamic	O
change	O
of	O
oral	O
microbial	O
flora	O
and	O
assist	O
in	O
the	O
assessment	O
of	O
the	O
treatment	O
efficacy	O
of	O
therapeutic	O
agents	O
.	O

In	O
this	O
study	O
,	O
we	O
explore	O
the	O
possibility	O
to	O
use	O
three	O
well	O
-	O
characterized	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
to	O
identify	O
these	O
three	O
important	O
members	O
of	O
the	O
oral	O
microbial	O
community	O
in	O
the	O
complex	O
environment	O
of	O
oral	O
biofilms	O
.	O

These	O
MAbs	O
,	O
which	O
were	O
conjugated	O
to	O
different	O
fluorescent	O
labels	O
and	O
visualized	O
with	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
,	O
proved	O
to	O
be	O
an	O
useful	O
tool	O
to	O
identify	O
the	O
three	O
species	O
of	O
interest	O
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
,	O
and	O
L	B-bacteria
.	I-bacteria
casei	I-bacteria
)	O
under	O
various	O
experimental	O
conditions	O
including	O
in	O
vitro	O
and	O
in	O
vivo	O
derived	O
oral	O
biofilms	O
.	O

Manifold	O
addition	O
of	O
the	O
MAbs	O
on	O
consecutive	O
days	O
did	O
not	O
alter	O
the	O
biofilm	O
structure	O
thus	O
allowing	O
monitoring	O
of	O
the	O
same	O
biofilm	O
over	O
extended	O
time	O
periods	O
.	O

Using	O
this	O
MAb	O
-	O
based	O
method	O
the	O
effect	O
of	O
sucrose	O
challenge	O
on	O
the	O
biofilm	O
composition	O
and	O
the	O
distribution	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
,	O
and	O
L	B-bacteria
.	I-bacteria
casei	I-bacteria
were	O
examined	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
found	O
to	O
be	O
the	O
predominant	O
species	O
under	O
the	O
various	O
biofilm	O
conditions	O
tested	O
.	O

These	O
studies	O
indicate	O
that	O
MAbs	O
based	O
bacterial	O
detection	O
with	O
CLSM	O
is	O
a	O
versatile	O
tool	O
which	O
permits	O
new	O
insights	O
into	O
the	O
ecology	O
of	O
oral	O
biofilm	O
development	O
.	O

To	O
investigate	O
the	O
microbial	O
contents	O
presented	O
on	O
the	O
surface	O
of	O
mucosa	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
who	O
accepted	O
radiotherapy	O
,	O
and	O
to	O
provide	O
the	O
evidences	O
of	O
controlling	O
post	O
-	O
radiotherapeutic	O
infections	O
.	O

32	O
patients	O
(	O
19	O
males	O
and	O
13	O
females	O
)	O
aged	O
from	O
37	O
-	O
72	O
received	O
radiotherapy	O
after	O
oral	O
squamous	O
cell	O
carcinomas	O
operation	O
were	O
selected	O
.	O

Samples	O
of	O
saliva	O
were	O
obtained	O
from	O
the	O
radiated	O
center	O
and	O
opposite	O
mucosa	O
before	O
and	O
after	O
radiotherapy	O
.	O

The	O
detective	O
amount	O
,	O
detective	O
ratio	O
and	O
constituent	O
ratio	O
were	O
analysed	O
by	O
cultivation	O
and	O
identification	O
.	O

Streptococci	B-bacteria
,	O
Candida	O
albicans	O
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
significantly	O
increased	O
on	O
both	O
sides	O
of	O
the	O
oral	O
mucosa	O
while	O
Neisseria	B-bacteria
and	O
Actinobacillus	B-bacteria
decreased	O
on	O
radiated	O
region	O
after	O
the	O
radiotherapy	O
.	O

Radiotherapy	O
has	O
great	O
effects	O
on	O
oral	O
bacteria	O
and	O
pathogenic	O
organism	O
may	O
play	O
a	O
role	O
in	O
post	O
-	O
radiotherapy	O
infections	O
.	O

It	O
is	O
necessary	O
to	O
do	O
bacteria	O
culture	O
and	O
choose	O
sensitive	O
antibiotics	O
regularly	O
for	O
post	O
-	O
radiotherapeutic	O
patients	O
.	O

This	O
review	O
describes	O
current	O
knowledge	O
on	O
probiotic	O
bacteriotherapy	O
from	O
the	O
oral	O
health	O
perspective	O
.	O

Recent	O
experimental	O
studies	O
and	O
results	O
from	O
randomized	O
controlled	O
trials	O
have	O
shown	O
that	O
certain	O
gut	O
bacteria	O
,	O
in	O
particular	O
species	O
of	O
Lactobacillus	B-bacteria
and	O
Bifidobacterium	B-bacteria
,	O
may	O
exert	O
beneficial	O
effects	O
in	O
the	O
oral	O
cavity	O
by	O
inhibiting	O
cariogenic	O
streptococci	B-bacteria
and	O
Candida	O
sp	O
.	O

Probiotics	O
have	O
been	O
successfully	O
used	O
to	O
control	O
gastro	O
-	O
intestinal	O
diseases	O
.	O

They	O
also	O
appear	O
to	O
alleviate	O
symptoms	O
of	O
allergy	O
and	O
diseases	O
with	O
immunological	O
pathology	O
.	O

The	O
mechanisms	O
of	O
probiotic	O
action	O
appear	O
to	O
link	O
with	O
colonization	O
resistance	O
and	O
immune	O
modulation	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
can	O
produce	O
different	O
antimicrobial	O
components	O
such	O
as	O
organic	O
acids	O
,	O
hydrogen	O
peroxide	O
,	O
carbon	O
peroxide	O
,	O
diacetyl	O
,	O
low	O
molecular	O
weight	O
antimicrobial	O
substances	O
,	O
bacteriocins	O
,	O
and	O
adhesion	O
inhibitors	O
,	O
which	O
also	O
affect	O
oral	O
microflora	O
.	O

However	O
,	O
data	O
is	O
still	O
sparse	O
on	O
the	O
probiotic	O
action	O
in	O
the	O
oral	O
cavity	O
.	O

More	O
information	O
is	O
needed	O
on	O
the	O
colonization	O
of	O
probiotics	O
in	O
the	O
mouth	O
and	O
their	O
possible	O
effect	O
on	O
and	O
within	O
oral	O
biofilms	O
.	O

There	O
is	O
every	O
reason	O
to	O
believe	O
that	O
the	O
putative	O
probiotic	O
mechanisms	O
of	O
action	O
are	O
the	O
same	O
in	O
the	O
mouth	O
as	O
they	O
are	O
in	O
other	O
parts	O
of	O
the	O
gastrointestinal	O
tract	O
.	O

Because	O
of	O
the	O
increasing	O
global	O
problem	O
with	O
antimicrobial	O
drug	O
resistance	O
,	O
the	O
concept	O
of	O
probiotic	O
therapy	O
is	O
interesting	O
and	O
pertinent	O
,	O
and	O
merits	O
further	O
research	O
in	O
the	O
fields	O
of	O
oral	O
medicine	O
and	O
dentistry	O
.	O

Zinc	O
is	O
used	O
in	O
oral	O
care	O
products	O
as	O
an	O
antiplaque	O
/	O
antigingivitis	O
agent	O
.	O

Our	O
objective	O
was	O
to	O
assess	O
the	O
antimicrobial	O
actions	O
of	O
zinc	O
against	O
oral	O
anaerobes	O
associated	O
with	O
gingivitis	O
,	O
specifically	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
with	O
focus	O
on	O
catabolism	O
and	O
oxidative	O
metabolism	O
.	O

The	O
oral	O
anaerobes	O
were	O
grown	O
in	O
complex	O
medium	O
in	O
an	O
anaerobic	O
chamber	O
,	O
harvested	O
by	O
centrifugation	O
and	O
used	O
directly	O
for	O
experiments	O
with	O
suspensions	O
.	O

Biofilm	O
growth	O
involved	O
super	O
-	O
infection	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
of	O
an	O
initial	O
biofilm	O
formed	O
by	O
Streptococcus	B-bacteria
sanguis	I-bacteria
.	O

Zn	O
(	O
2	O
+	O
)	O
inhibited	O
catabolism	O
of	O
glutamate	O
,	O
glutamyl	O
-	O
glutamate	O
,	O
glucose	O
and	O
fructose	O
by	O
F	O
.	O
nucleatum	O
cells	O
in	O
suspensions	O
with	O
ID	O
(	O
50	O
)	O
values	O
,	O
respectively	O
,	O
of	O
0	O
.	O
05	O
,	O
0	O
.	O
005	O
,	O
0	O
.	O
01	O
and	O
0	O
.	O
01	O
mM	O
.	O

The	O
ID	O
(	O
50	O
)	O
value	O
for	O
inhibition	O
of	O
glutamate	O
catabolism	O
by	O
biofilms	O
was	O
0	O
.	O
10	O
mM	O
.	O

Inhibition	O
of	O
glutamate	O
catabolism	O
could	O
be	O
related	O
to	O
inhibition	O
of	O
substrate	O
uptake	O
and	O
of	O
2	O
-	O
oxoglutarate	O
reductase	O
.	O

Zn	O
(	O
2	O
+	O
)	O
also	O
inhibited	O
catabolism	O
of	O
aspartate	O
or	O
aspartyl	O
-	O
aspartate	O
by	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
with	O
ID	O
(	O
50	O
)	O
values	O
of	O
0	O
.	O
07	O
and	O
about	O
0	O
.	O
03	O
mM	O
,	O
respectively	O
.	O

Respiration	O
of	O
intact	O
cells	O
of	O
F	O
.	O
nucleatum	O
and	O
NADH	O
oxidase	O
in	O
cell	O
extracts	O
were	O
sensitive	O
to	O
zinc	O
with	O
ID	O
(	O
50	O
)	O
values	O
,	O
respectively	O
,	O
of	O
about	O
1	O
.	O
0	O
and	O
1	O
.	O
4	O
mM	O
.	O

Zinc	O
also	O
inhibited	O
production	O
of	O
hydrogen	O
peroxide	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
ID	O
(	O
50	O
)	O
=	O
ca	O
.	O
0	O
.	O
04	O
mM	O
.	O
)	O

but	O
at	O
high	O
concentrations	O
acted	O
to	O
potentiate	O
and	O
enhance	O
peroxide	O
killing	O
of	O
the	O
anaerobe	O
.	O

Zn	O
(	O
2	O
+	O
)	O
is	O
a	O
potent	O
inhibitor	O
of	O
catabolism	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
including	O
catabolism	O
of	O
peptides	O
,	O
which	O
can	O
be	O
degraded	O
to	O
yield	O
inflammatory	O
metabolic	O
end	O
products	O
.	O

Zn	O
(	O
2	O
+	O
)	O
also	O
inhibits	O
O	O
(	O
2	O
)	O
metabolism	O
of	O
F	O
.	O
nucleatum	O
by	O
about	O
50	O
%	O
and	O
hydrogen	O
peroxide	O
production	O
nearly	O
completely	O
but	O
also	O
enhances	O
killing	O
by	O
peroxide	O
added	O
to	O
cells	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
assess	O
levels	O
of	O
occurrence	O
and	O
number	O
of	O
aerobic	O
bacteria	O
hemolysing	O
and	O
non	O
-	O
hemolysing	O
,	O
anaerobic	O
bacteria	O
,	O
streptococci	B-bacteria
hemolysing	O
and	O
non	O
-	O
hemolysing	O
,	O
staphylococci	B-bacteria
,	O
and	O
bacteria	O
responsible	O
for	O
tooth	O
decay	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
on	O
oral	O
cavity	O
in	O
children	O
and	O
adults	O
.	O

The	O
results	O
obtained	O
indicate	O
the	O
difference	O
of	O
the	O
level	O
of	O
occurrence	O
of	O
,	O
aerobic	O
bacteria	O
hemolysing	O
and	O
non	O
-	O
hemolysing	O
,	O
anaerobic	O
bacteria	O
,	O
streptococci	B-bacteria
hemolysing	O
and	O
non	O
-	O
hemolysing	O
,	O
staphylococci	B-bacteria
,	O
and	O
bacteria	O
responsible	O
for	O
tooth	O
decay	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
was	O
not	O
statistically	O
significant	O
in	O
either	O
group	O
.	O

The	O
counts	O
and	O
average	O
values	O
of	O
the	O
counts	O
for	O
aerobic	O
bacteria	O
non	O
-	O
hemolysing	O
,	O
anaerobic	O
bacteria	O
,	O
streptococci	B-bacteria
hemolysing	O
and	O
non	O
-	O
hemolysing	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
turned	O
out	O
to	O
be	O
statistically	O
significantly	O
larger	O
in	O
adults	O
than	O
in	O
children	O
.	O

However	O
for	O
aerobic	O
bacteria	O
hemolysing	O
,	O
staphylococci	B-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
the	O
difference	O
of	O
the	O
counts	O
was	O
not	O
statistically	O
significant	O
in	O
either	O
group	O
.	O

The	O
comparative	O
in	O
vitro	O
potency	O
of	O
XRP2868	O
,	O
a	O
new	O
oral	O
semisynthetic	O
streptogramin	O
antibiotic	O
,	O
was	O
evaluated	O
against	O
gram	O
-	O
positive	O
bacteria	O
.	O

XRP2868	O
inhibited	O
all	O
staphylococci	B-bacteria
at	O
<	O
or	O
=	O
1	O
microg	O
/	O
ml	O
and	O
all	O
non	O
-	O
pneumococcal	O
streptococci	I-bacteria
at	O
<	O
or	O
=	O
0	O
.	O
25	O
microg	O
/	O
ml	O
and	O
was	O
fourfold	O
more	O
potent	O
than	O
quinupristin	O
-	O
dalfopristin	O
against	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Enterococcus	B-bacteria
faecium	I-bacteria
.	O

The	O
purpose	O
of	O
the	O
present	O
investigation	O
was	O
to	O
determine	O
if	O
the	O
salivary	O
counts	O
of	O
40	O
common	O
oral	O
bacteria	O
in	O
subjects	O
with	O
an	O
oral	O
squamous	O
cell	O
carcinoma	O
(	O
OSCC	O
)	O
lesion	O
would	O
differ	O
from	O
those	O
found	O
in	O
cancer	O
-	O
free	O
(	O
OSCC	O
-	O
free	O
)	O
controls	O
.	O

Unstimulated	O
saliva	O
samples	O
were	O
collected	O
from	O
229	O
OSCC	O
-	O
free	O
and	O
45	O
OSCC	O
subjects	O
and	O
evaluated	O
for	O
their	O
content	O
of	O
40	O
common	O
oral	O
bacteria	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

DNA	O
counts	O
per	O
ml	O
saliva	O
were	O
determined	O
for	O
each	O
species	O
,	O
averaged	O
across	O
subjects	O
in	O
the	O
2	O
subject	O
groups	O
,	O
and	O
significance	O
of	O
differences	O
between	O
groups	O
determined	O
using	O
the	O
Mann	O
-	O
Whitney	O
test	O
and	O
adjusted	O
for	O
multiple	O
comparisons	O
.	O

Diagnostic	O
sensitivity	O
and	O
specificity	O
in	O
detection	O
of	O
OSCC	O
by	O
levels	O
of	O
salivary	O
organisms	O
were	O
computed	O
and	O
comparisons	O
made	O
separately	O
between	O
a	O
non	O
-	O
matched	O
group	O
of	O
45	O
OSCC	O
subjects	O
and	O
229	O
controls	O
and	O
a	O
group	O
of	O
45	O
OSCC	O
subjects	O
and	O
45	O
controls	O
matched	O
by	O
age	O
,	O
gender	O
and	O
smoking	O
history	O
.	O

Counts	O
of	O
3	O
of	O
the	O
40	O
species	O
tested	O
,	O
Capnocytophaga	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
were	O
elevated	O
in	O
the	O
saliva	O
of	O
individuals	O
with	O
OSCC	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

When	O
tested	O
as	O
diagnostic	O
markers	O
the	O
3	O
species	O
were	O
found	O
to	O
predict	O
80	O
%	O
of	O
cancer	O
cases	O
(	O
sensitivity	O
)	O
while	O
excluding	O
83	O
%	O
of	O
controls	O
(	O
specificity	O
)	O
in	O
the	O
non	O
-	O
matched	O
group	O
.	O

Diagnostic	O
sensitivity	O
and	O
specificity	O
in	O
the	O
matched	O
group	O
were	O
80	O
%	O
and	O
82	O
%	O
respectively	O
.	O

High	O
salivary	O
counts	O
of	O
C	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
may	O
be	O
diagnostic	O
indicators	O
of	O
OSCC	O
.	O

Heat	O
shock	O
proteins	O
(	O
HSP	O
)	O
are	O
released	O
by	O
cells	O
in	O
response	O
to	O
stress	O
signals	O
.	O

It	O
is	O
hypothesized	O
that	O
pathogenic	O
bacteria	O
stimulate	O
the	O
cells	O
in	O
the	O
periodontium	O
to	O
up	O
-	O
regulate	O
the	O
expression	O
of	O
HSP60	O
,	O
which	O
would	O
stimulate	O
macrophages	O
,	O
and	O
possibly	O
other	O
cells	O
,	O
to	O
produce	O
proinflammatory	O
cytokines	O
.	O

We	O
sought	O
to	O
determine	O
whether	O
oral	O
keratinocytes	O
responded	O
to	O
recombinant	O
human	O
HSP60	O
and	O
to	O
identify	O
the	O
signalling	O
pathways	O
involved	O
.	O

In	O
addition	O
,	O
whether	O
oral	O
keratinocytes	O
are	O
a	O
source	O
of	O
endogenous	O
HSP60	O
was	O
also	O
investigated	O
.	O

RT	O
-	O
PCR	O
revealed	O
that	O
rhHSP60	O
induced	O
expression	O
of	O
the	O
IL	O
-	O
1beta	O
gene	O
in	O
the	O
Human	O
Oral	O
Keratinocyte	O
(	O
HOK	O
-	O
16B	O
)	O
cell	O
line	O
and	O
it	O
was	O
highest	O
at	O
the	O
lowest	O
concentration	O
used	O
(	O
0	O
.	O
1	O
microg	O
/	O
ml	O
)	O
.	O

These	O
responses	O
were	O
mediated	O
via	O
activation	O
of	O
p44	O
/	O
42	O
MAP	O
-	O
kinases	O
and	O
to	O
a	O
lesser	O
extend	O
the	O
MAP	O
-	O
kinase	O
SAP	O
/	O
JNK	O
.	O

Similar	O
data	O
was	O
obtained	O
from	O
analysis	O
of	O
intracellular	O
signalling	O
pathways	O
in	O
HOK	O
-	O
16B	O
cells	O
by	O
rhHSP70	O
and	O
LPS	O
(	O
from	O
both	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
the	O
oral	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
.	O

However	O
,	O
there	O
was	O
little	O
activation	O
of	O
p38	O
by	O
rhHSP60	O
.	O

Blocking	O
of	O
the	O
p44	O
/	O
42	O
pathway	O
decreased	O
HSP60	O
-	O
induced	O
IL	O
-	O
1beta	O
gene	O
expression	O
and	O
protein	O
secretion	O
.	O

In	O
addition	O
,	O
we	O
discovered	O
that	O
self	O
-	O
HSP60	O
proteins	O
were	O
constitutively	O
secreted	O
by	O
HOK	O
-	O
16B	O
cells	O
.	O

Secretion	O
of	O
self	O
-	O
HSP60	O
was	O
up	O
-	O
regulated	O
in	O
cells	O
treated	O
with	O
LPS	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
but	O
down	O
-	O
regulated	O
with	O
LPS	O
from	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

To	O
summarize	O
,	O
oral	O
keratinocytes	O
respond	O
to	O
exogenous	O
HSP60	O
by	O
triggering	O
expression	O
of	O
the	O
inflammatory	O
cytokine	O
IL	O
-	O
1beta	O
through	O
activation	O
of	O
p44	O
/	O
42	O
MAP	O
kinase	O
.	O

Oral	O
keratinocytes	O
are	O
also	O
a	O
source	O
for	O
self	O
-	O
HSP60	O
and	O
the	O
secretion	O
of	O
this	O
protein	O
may	O
be	O
differentially	O
modified	O
by	O
LPS	O
from	O
different	O
bacterial	O
species	O
.	O

These	O
results	O
highlight	O
the	O
importance	O
of	O
oral	O
keratinocytes	O
and	O
HSPs	O
in	O
the	O
development	O
of	O
an	O
immune	O
response	O
against	O
bacterial	O
infection	O
.	O

Endodontic	O
infections	O
have	O
been	O
traditionally	O
studied	O
by	O
culture	O
methods	O
,	O
but	O
recent	O
reports	O
showing	O
that	O
over	O
50	O
%	O
of	O
the	O
oral	O
microbiota	O
is	O
still	O
uncultivable	O
(	O
B	O
.	O
J	O
.	O
Paster	O
et	O
al	O
.	O
,	O
J	O
.	O
Bacteriol	O
.	O
183	O
:	O
3770	O
-	O
3783	O
,	O
2001	O
)	O
raise	O
the	O
possibility	O
that	O
many	O
endodontic	O
pathogens	O
remain	O
unknown	O
.	O

This	O
study	O
intended	O
to	O
investigate	O
the	O
prevalence	O
of	O
several	O
uncultivated	O
oral	O
phylotypes	O
,	O
as	O
well	O
as	O
newly	O
named	O
species	O
in	O
primary	O
or	O
persistent	O
endodontic	O
infections	O
associated	O
with	O
chronic	O
periradicular	O
diseases	O
.	O

Samples	O
were	O
taken	O
from	O
the	O
root	O
canals	O
of	O
21	O
untreated	O
teeth	O
and	O
22	O
root	O
-	O
filled	O
teeth	O
,	O
all	O
of	O
them	O
with	O
radiographic	O
evidence	O
of	O
periradicular	O
bone	O
destruction	O
.	O

Genomic	O
DNA	O
was	O
isolated	O
directly	O
from	O
each	O
sample	O
,	O
and	O
16S	O
rRNA	O
gene	O
-	O
based	O
nested	O
or	O
heminested	O
PCR	O
assays	O
were	O
used	O
to	O
determine	O
the	O
presence	O
of	O
13	O
species	O
or	O
phylotypes	O
of	O
bacteria	O
.	O

Species	O
-	O
specific	O
primers	O
had	O
already	O
been	O
validated	O
in	O
the	O
literature	O
or	O
were	O
developed	O
by	O
aligning	O
closely	O
related	O
16S	O
rRNA	O
gene	O
sequences	O
.	O

Species	O
specificity	O
for	O
each	O
primer	O
pair	O
was	O
confirmed	O
by	O
running	O
PCRs	O
against	O
a	O
panel	O
of	O
several	O
oral	O
bacteria	O
and	O
by	O
sequencing	O
DNA	O
from	O
representative	O
positive	O
samples	O
.	O

All	O
species	O
or	O
phylotypes	O
were	O
detected	O
in	O
at	O
least	O
one	O
case	O
of	O
primary	O
infections	O
.	O

The	O
most	O
prevalent	O
species	O
or	O
phylotypes	O
found	O
in	O
primary	O
infections	O
were	O
Dialister	B-bacteria
invisus	I-bacteria
(	O
81	O
%	O
)	O
,	O
Synergistes	B-bacteria
oral	I-bacteria
clone	I-bacteria
BA121	I-bacteria
(	O
33	O
%	O
)	O
,	O
and	O
Olsenella	B-bacteria
uli	I-bacteria
(	O
33	O
%	O
)	O
.	O

Of	O
the	O
target	O
bacteria	O
,	O
only	O
these	O
three	O
species	O
were	O
detected	O
in	O
persistent	O
infections	O
.	O

Detection	O
of	O
uncultivated	O
phylotypes	O
and	O
newly	O
named	O
species	O
in	O
infected	O
root	O
canals	O
suggests	O
that	O
there	O
are	O
previously	O
unrecognized	O
bacteria	O
that	O
may	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
periradicular	O
diseases	O
.	O

Diverse	O
methylotrophic	O
bacteria	O
were	O
isolated	O
from	O
the	O
tongue	O
,	O
and	O
supra	O
-	O
and	O
subgingival	O
plaque	O
in	O
the	O
mouths	O
of	O
volunteers	O
and	O
patients	O
with	O
periodontitis	O
.	O

One	O
-	O
carbon	O
compounds	O
such	O
as	O
dimethylsulfide	O
in	O
the	O
mouth	O
are	O
likely	O
to	O
be	O
used	O
as	O
growth	O
substrates	O
for	O
these	O
organisms	O
.	O

Methylotrophic	O
strains	O
of	O
Bacillus	B-bacteria
,	O
Brevibacterium	B-bacteria
casei	I-bacteria
,	O
Hyphomicrobium	B-bacteria
sulfonivorans	I-bacteria
,	O
Methylobacterium	B-bacteria
,	O
Micrococcus	B-bacteria
luteus	I-bacteria
and	O
Variovorax	B-bacteria
paradoxus	I-bacteria
were	O
characterized	O
physiologically	O
and	O
by	O
their	O
16S	O
rRNA	O
gene	O
sequences	O
.	O

The	O
type	O
strain	O
of	O
B	B-bacteria
.	I-bacteria
casei	I-bacteria
was	O
shown	O
to	O
be	O
methylotrophic	O
.	O

Enzymes	O
of	O
methylotrophic	O
metabolism	O
were	O
characterized	O
in	O
some	O
strains	O
,	O
and	O
activities	O
consistent	O
with	O
growth	O
using	O
known	O
pathways	O
of	O
C1	O
-	O
compound	O
metabolism	O
demonstrated	O
.	O

Genomic	O
DNA	O
from	O
18	O
tongue	O
and	O
dental	O
plaque	O
samples	O
from	O
nine	O
volunteers	O
was	O
amplified	O
by	O
the	O
polymerase	O
chain	O
reaction	O
using	O
primers	O
for	O
the	O
16S	O
rRNA	O
gene	O
of	O
Methylobacterium	O
and	O
the	O
mxaF	O
gene	O
of	O
methanol	O
dehydrogenase	O
.	O

MxaF	O
was	O
detected	O
in	O
all	O
nine	O
volunteers	O
,	O
and	O
Methylobacterium	B-bacteria
was	O
detected	O
in	O
seven	O
.	O

Methylotrophic	O
activity	O
is	O
thus	O
a	O
feature	O
of	O
the	O
oral	O
bacterial	O
community	O
.	O

Recent	O
studies	O
have	O
suggested	O
that	O
infectious	O
organisms	O
play	O
a	O
role	O
in	O
vascular	O
diseases	O
.	O

In	O
this	O
study	O
,	O
to	O
explore	O
a	O
possible	O
link	O
between	O
oral	O
infection	O
and	O
Buerger	O
disease	O
,	O
we	O
investigated	O
whether	O
oral	O
(	O
periodontal	O
)	O
bacteria	O
were	O
present	O
in	O
occluded	O
arteries	O
removed	O
from	O
patients	O
with	O
characteristic	O
Buerger	O
disease	O
.	O

Fourteen	O
male	O
patients	O
with	O
a	O
smoking	O
history	O
who	O
had	O
developed	O
characteristics	O
of	O
Buerger	O
disease	O
before	O
the	O
age	O
of	O
50	O
years	O
were	O
included	O
in	O
this	O
study	O
.	O

Occluded	O
arteries	O
,	O
including	O
superficial	O
femoral	O
(	O
n	O
=	O
4	O
)	O
,	O
popliteal	O
(	O
n	O
=	O
2	O
)	O
,	O
anterior	O
tibial	O
(	O
n	O
=	O
4	O
)	O
,	O
and	O
posterior	O
tibial	O
(	O
n	O
=	O
4	O
)	O
arteries	O
,	O
were	O
removed	O
and	O
studied	O
.	O

A	O
periodontist	O
performed	O
a	O
periodontal	O
examination	O
on	O
each	O
patient	O
and	O
collected	O
dental	O
plaque	O
and	O
saliva	O
samples	O
from	O
them	O
at	O
the	O
same	O
time	O
.	O

The	O
polymerase	O
chain	O
reaction	O
method	O
was	O
applied	O
to	O
detect	O
whether	O
seven	O
species	O
of	O
periodontal	O
bacteria	O
-	O
-	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Prevotella	B-bacteria
nigrescens	I-bacteria
-	O
-	O
were	O
present	O
in	O
the	O
occluded	O
arteries	O
and	O
oral	O
samples	O
.	O

In	O
addition	O
,	O
arterial	O
specimens	O
from	O
seven	O
control	O
patients	O
were	O
examined	O
by	O
polymerase	O
chain	O
reaction	O
analysis	O
.	O

DNA	O
of	O
oral	O
bacteria	O
was	O
detected	O
in	O
13	O
of	O
14	O
arterial	O
samples	O
and	O
all	O
oral	O
samples	O
of	O
patients	O
with	O
Buerger	O
disease	O
.	O

Treponema	B-bacteria
denticola	I-bacteria
was	O
found	O
in	O
12	O
arterial	O
and	O
all	O
oral	O
samples	O
.	O

Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
nigrescens	I-bacteria
were	O
found	O
in	O
14	O
%	O
to	O
43	O
%	O
of	O
the	O
arterial	O
samples	O
and	O
71	O
%	O
to	O
100	O
%	O
of	O
the	O
oral	O
samples	O
.	O

A	O
pathologic	O
examination	O
revealed	O
that	O
arterial	O
specimens	O
showed	O
the	O
characteristics	O
of	O
an	O
intermediate	O
-	O
chronic	O
-	O
stage	O
or	O
chronic	O
-	O
stage	O
lesion	O
of	O
Buerger	O
disease	O
.	O

All	O
14	O
patients	O
with	O
Buerger	O
disease	O
had	O
moderate	O
to	O
severe	O
periodontitis	O
.	O

None	O
of	O
the	O
control	O
arterial	O
samples	O
was	O
positive	O
for	O
periodontal	O
bacteria	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
identify	O
oral	O
microorganisms	O
in	O
the	O
lesions	O
of	O
Buerger	O
disease	O
.	O

Our	O
findings	O
suggest	O
a	O
possible	O
etiologic	O
link	O
between	O
Buerger	O
disease	O
and	O
chronic	O
infections	O
such	O
as	O
oral	O
bacterial	O
infections	O
.	O

Eleven	O
strains	O
of	O
anaerobic	O
Gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
two	O
homogeneous	O
groups	O
,	O
designated	O
E2	O
and	O
E4	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
revealed	O
that	O
members	O
of	O
both	O
groups	O
belonged	O
to	O
the	O
genus	O
Prevotella	B-bacteria
but	O
were	O
distinct	O
from	O
any	O
species	O
with	O
validly	O
published	O
names	O
.	O

This	O
distinction	O
was	O
confirmed	O
by	O
DNA	O
-	O
DNA	O
hybridization	O
and	O
phenotypic	O
tests	O
.	O

Two	O
novel	O
species	O
are	O
therefore	O
proposed	O
:	O
Prevotella	B-bacteria
marshii	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
(	O
group	O
E2	O
)	O
and	O
Prevotella	B-bacteria
baroniae	I-bacteria
(	O
group	O
E4	O
)	O
.	O

Both	O
species	O
are	O
saccharolytic	O
;	O
the	O
end	O
-	O
products	O
of	O
fermentation	O
for	O
P	O
.	O
marshii	O
are	O
acetic	O
,	O
propionic	O
and	O
succinic	O
acids	O
,	O
while	O
P	B-bacteria
.	I-bacteria
baroniae	I-bacteria
produces	O
acetic	O
and	O
succinic	O
acids	O
with	O
minor	O
amounts	O
of	O
isovaleric	O
and	O
isobutyric	O
acids	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
the	O
type	O
strain	O
of	O
Prevotella	B-bacteria
marshii	I-bacteria
is	O
51	O
mol	O
%	O
and	O
that	O
of	O
Prevotella	B-bacteria
baroniae	I-bacteria
is	O
52	O
mol	O
%	O
.	O

The	O
type	O
strain	O
for	O
P	B-bacteria
.	I-bacteria
marshii	I-bacteria
is	O
E9	B-bacteria
.	I-bacteria
34	I-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
16973	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
50419	I-bacteria
(	O
T	O
)	O
)	O
and	O
that	O
for	O
P	B-bacteria
.	I-bacteria
baroniae	I-bacteria
is	O
E9	B-bacteria
.	I-bacteria
33	I-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
16972	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
50418	I-bacteria
(	O
T	O
)	O
)	O
.	O

Timely	O
initiation	O
of	O
antibiotic	O
therapy	O
is	O
crucial	O
for	O
severe	O
infection	O
.	O

Appropriate	O
antibiotic	O
therapy	O
is	O
often	O
delayed	O
for	O
nosocomial	O
infections	O
caused	O
by	O
antibiotic	O
-	O
resistant	O
bacteria	O
.	O

The	O
relationship	O
between	O
knowledge	O
of	O
colonization	O
caused	O
by	O
antibiotic	O
-	O
resistant	O
gram	O
-	O
negative	O
bacteria	O
(	O
ABR	O
-	O
GNB	O
)	O
and	O
rate	O
of	O
appropriate	O
initial	O
antibiotic	O
therapy	O
for	O
subsequent	O
bacteremia	O
was	O
evaluated	O
.	O

Retrospective	O
cohort	O
study	O
.	O

Fifty	O
-	O
four	O
-	O
bed	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
of	O
a	O
university	O
hospital	O
.	O

In	O
this	O
unit	O
,	O
colonization	O
surveillance	O
is	O
performed	O
through	O
routine	O
site	O
-	O
specific	O
surveillance	O
cultures	O
(	O
urine	O
,	O
mouth	O
,	O
trachea	O
,	O
and	O
anus	O
)	O
.	O

Additional	O
cultures	O
are	O
performed	O
when	O
presumed	O
clinically	O
relevant	O
.	O

ICU	O
patients	O
with	O
nosocomial	O
bacteremia	O
caused	O
by	O
ABR	O
-	O
GNB	O
.	O

Infectious	O
and	O
microbiological	O
characteristics	O
and	O
rates	O
of	O
appropriate	O
antibiotic	O
therapy	O
were	O
compared	O
between	O
patients	O
with	O
and	O
without	O
colonization	O
prior	O
to	O
bacteremia	O
.	O

Prior	O
colonization	O
was	O
defined	O
as	O
the	O
presence	O
(	O
detected	O
>	O
or	O
=	O
2	O
days	O
before	O
the	O
onset	O
of	O
bacteremia	O
)	O
of	O
the	O
same	O
ABR	O
-	O
GNB	O
in	O
colonization	O
and	O
subsequent	O
blood	O
cultures	O
.	O

During	O
the	O
study	O
period	O
,	O
157	O
episodes	O
of	O
bacteremia	O
caused	O
by	O
ABR	O
-	O
GNB	O
were	O
suitable	O
for	O
evaluation	O
.	O

One	O
hundred	O
seventeen	O
episodes	O
of	O
bacteremia	O
(	O
74	O
.	O
5	O
%	O
)	O
were	O
preceded	O
by	O
colonization	O
.	O

Appropriate	O
empiric	O
antibiotic	O
therapy	O
(	O
started	O
within	O
24	O
hours	O
)	O
was	O
administered	O
for	O
74	O
.	O
4	O
%	O
of	O
these	O
episodes	O
versus	O
55	O
.	O
0	O
%	O
of	O
the	O
episodes	O
that	O
occurred	O
without	O
prior	O
colonization	O
.	O

Appropriate	O
therapy	O
was	O
administered	O
within	O
48	O
hours	O
for	O
all	O
episodes	O
preceded	O
by	O
colonization	O
versus	O
90	O
.	O
0	O
%	O
of	O
episodes	O
without	O
prior	O
colonization	O
.	O

Knowledge	O
of	O
colonization	O
status	O
prior	O
to	O
infection	O
is	O
associated	O
with	O
higher	O
rates	O
of	O
appropriate	O
therapy	O
for	O
patients	O
with	O
bacteremia	O
caused	O
by	O
ABR	O
-	O
GNB	O
.	O

To	O
investigate	O
the	O
maintenance	O
of	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
and	O
the	O
genes	O
encoding	O
tetracycline	O
resistance	O
in	O
these	O
bacteria	O
in	O
children	O
(	O
aged	O
4	O
-	O
-	O
6	O
years	O
)	O
over	O
a	O
period	O
of	O
12	O
months	O
.	O

Plaque	O
and	O
saliva	O
samples	O
were	O
taken	O
from	O
26	O
children	O
.	O

Tetracycline	O
-	O
resistant	O
bacteria	O
were	O
isolated	O
and	O
identified	O
.	O

The	O
types	O
of	O
resistance	O
genes	O
and	O
their	O
genetic	O
locations	O
were	O
also	O
determined	O
.	O

Fifteen	O
out	O
of	O
18	O
children	O
harboured	O
tetracycline	O
-	O
resistant	O
(	O
defined	O
as	O
having	O
a	O
MIC	O
>	O
or	O
=	O
8	O
mg	O
/	O
L	O
)	O
oral	O
bacteria	O
at	O
all	O
three	O
time	O
points	O
.	O

The	O
median	O
percentage	O
of	O
tetracycline	O
-	O
resistant	O
bacteria	O
at	O
0	O
,	O
6	O
and	O
12	O
months	O
was	O
1	O
.	O
37	O
,	O
1	O
.	O
37	O
and	O
0	O
.	O
85	O
%	O
,	O
respectively	O
;	O
these	O
were	O
not	O
significantly	O
different	O
.	O

The	O
MIC	O
(	O
50	O
)	O
of	O
the	O
group	O
was	O
64	O
mg	O
/	O
L	O
at	O
all	O
three	O
time	O
points	O
compared	O
with	O
the	O
MIC	O
(	O
90	O
)	O
,	O
which	O
was	O
64	O
mg	O
/	O
L	O
at	O
0	O
months	O
,	O
and	O
128	O
mg	O
/	O
L	O
at	O
6	O
and	O
12	O
months	O
.	O

The	O
most	O
prevalent	O
resistant	O
species	O
were	O
streptococci	B-bacteria
(	O
68	O
%	O
)	O
,	O
which	O
were	O
isolated	O
at	O
all	O
three	O
time	O
points	O
in	O
13	O
children	O
.	O

The	O
most	O
prevalent	O
gene	O
encoding	O
tetracycline	O
resistance	O
was	O
tet	O
(	O
M	O
)	O
and	O
this	O
was	O
found	O
in	O
different	O
species	O
at	O
all	O
three	O
time	O
points	O
.	O

For	O
the	O
first	O
time	O
,	O
tet	O
(	O
32	O
)	O
was	O
found	O
in	O
Streptococcus	B-bacteria
parasanguinis	I-bacteria
and	O
Eubacterium	B-bacteria
saburreum	I-bacteria
.	O

PCR	O
and	O
Southern	O
-	O
blot	O
analysis	O
(	O
on	O
isolates	O
from	O
three	O
of	O
the	O
children	O
)	O
showed	O
that	O
the	O
tet	O
(	O
M	O
)	O
gene	O
was	O
located	O
on	O
a	O
Tn916	O
-	O
like	O
element	O
and	O
could	O
be	O
detected	O
at	O
all	O
three	O
time	O
points	O
,	O
in	O
four	O
different	O
genera	O
,	O
Streptococcus	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Neisseria	B-bacteria
.	O

The	O
results	O
of	O
this	O
study	O
show	O
that	O
tetracycline	O
-	O
resistant	O
bacteria	O
and	O
tet	O
(	O
M	O
)	O
are	O
maintained	O
within	O
the	O
indigenous	O
oral	O
microbiota	O
of	O
children	O
,	O
even	O
though	O
they	O
are	O
unlikely	O
to	O
have	O
been	O
directly	O
exposed	O
to	O
tetracycline	O
.	O

The	O
presence	O
and	O
maturity	O
of	O
the	O
salivary	O
pellicle	O
influences	O
microbial	O
adhesion	O
and	O
its	O
tenacity	O
in	O
the	O
oral	O
cavity	O
,	O
posing	O
a	O
challenge	O
to	O
different	O
plaque	O
-	O
control	O
systems	O
.	O

Some	O
plaque	O
-	O
control	O
systems	O
rely	O
on	O
surface	O
-	O
tension	O
forces	O
arising	O
from	O
passing	O
microbubbles	O
sprayed	O
over	O
the	O
pellicle	O
.	O

Passage	O
of	O
such	O
bubbles	O
is	O
accompanied	O
by	O
a	O
high	O
fluid	O
flow	O
,	O
but	O
systematic	O
studies	O
are	O
lacking	O
on	O
the	O
contribution	O
of	O
fluid	O
flow	O
vs	O
.	O
microbubbles	O
towards	O
plaque	O
removal	O
.	O

Therefore	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
detachment	O
efficacy	O
of	O
laminar	O
fluid	O
flow	O
(	O
wall	O
shear	O
rates	O
11	O
,	O
000	O
-	O
16	O
,	O
000	O
s	O
(	O
-	O
1	O
)	O
)	O
,	O
with	O
and	O
without	O
microbubbles	O
,	O
towards	O
the	O
detachment	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
-	I-bacteria
J1	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
J22	I-bacteria
,	O
and	O
their	O
coadhering	O
aggregates	O
,	O
from	O
salivary	O
pellicles	O
formed	O
over	O
2	O
h	O
or	O
16	O
h	O
from	O
reconstituted	O
human	O
whole	O
saliva	O
.	O

Microbubbles	O
in	O
a	O
fluid	O
flow	O
were	O
more	O
efficient	O
at	O
inducing	O
single	O
bacterial	O
detachment	O
,	O
resulting	O
in	O
almost	O
complete	O
(	O
97	O
%	O
)	O
removal	O
for	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
J22	I-bacteria
and	O
a	O
15	O
-	O
fold	O
increase	O
in	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
-	I-bacteria
J1	I-bacteria
removal	O
as	O
compared	O
to	O
the	O
detachment	O
caused	O
by	O
fluid	O
flow	O
alone	O
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
was	O
more	O
difficult	O
to	O
remove	O
and	O
apparently	O
formed	O
the	O
strongest	O
bonds	O
with	O
high	O
-	O
molecular	O
-	O
weight	O
proteins	O
in	O
16	O
-	O
h	O
pellicles	O
.	O

The	O
detachment	O
of	O
coaggregates	O
after	O
2	O
min	O
left	O
a	O
substantial	O
amount	O
of	O
adhered	O
bacterial	O
mass	O
,	O
including	O
more	O
than	O
60	O
%	O
of	O
singly	O
attached	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
on	O
the	O
pellicle	O
surface	O
,	O
providing	O
nucleation	O
sites	O
for	O
the	O
de	O
novo	O
adhesion	O
of	O
coadhering	O
streptococci	B-bacteria
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
identify	O
hydrogen	O
sulfide	O
(	O
H2S	O
)	O
-	O
producing	O
bacteria	O
among	O
tongue	O
biofilm	O
microflora	O
and	O
to	O
investigate	O
the	O
relationship	O
between	O
bacterial	O
flora	O
and	O
H2S	O
levels	O
in	O
mouth	O
air	O
.	O

Oral	O
malodour	O
levels	O
in	O
10	O
subjects	O
(	O
age	O
21	O
-	O
56	O
years	O
)	O
were	O
assessed	O
by	O
gas	O
chromatography	O
,	O
and	O
Breathtron	O
and	O
organoleptic	O
scores	O
.	O

Based	O
on	O
these	O
assessments	O
,	O
subjects	O
were	O
divided	O
into	O
two	O
groups	O
:	O
an	O
odour	O
group	O
and	O
a	O
no	O
/	O
low	O
odour	O
group	O
.	O

Tongue	O
coatings	O
were	O
sampled	O
and	O
spread	O
onto	O
Fastidious	O
Anaerobe	O
Agar	O
plates	O
containing	O
0	O
.	O
05	O
%	O
cysteine	O
,	O
0	O
.	O
12	O
%	O
glutathione	O
and	O
0	O
.	O
02	O
%	O
lead	O
acetate	O
,	O
and	O
were	O
then	O
incubated	O
anaerobically	O
at	O
37	O
degrees	O
C	O
for	O
2	O
weeks	O
.	O

Bacteria	O
forming	O
black	O
or	O
grey	O
colonies	O
were	O
selected	O
as	O
H2S	O
-	O
producing	O
phenotypes	O
.	O

The	O
numbers	O
of	O
total	O
bacteria	O
(	O
P	O
<	O
0	O
.	O
005	O
)	O
and	O
H2S	O
-	O
producing	O
bacteria	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
odour	O
group	O
were	O
significantly	O
larger	O
than	O
those	O
in	O
the	O
no	O
/	O
low	O
odour	O
group	O
.	O

Bacteria	O
forming	O
black	O
or	O
grey	O
colonies	O
(	O
126	O
isolates	O
from	O
the	O
odour	O
group	O
;	O
242	O
isolates	O
from	O
the	O
no	O
/	O
low	O
odour	O
group	O
)	O
were	O
subcultured	O
,	O
confirmed	O
as	O
producing	O
H2S	O
and	O
identified	O
according	O
to	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

Species	O
of	O
Veillonella	B-bacteria
(	O
38	O
.	O
1	O
%	O
in	O
odour	O
group	O
;	O
46	O
.	O
3	O
%	O
in	O
no	O
/	O
low	O
odour	O
group	O
)	O
,	O
Actinomyces	B-bacteria
(	O
25	O
.	O
4	O
%	O
;	O
17	O
.	O
7	O
%	O
)	O
and	O
Prevotella	B-bacteria
(	O
10	O
.	O
3	O
%	O
;	O
7	O
.	O
8	O
%	O
)	O
were	O
the	O
predominant	O
H2S	O
-	O
producing	O
bacteria	O
in	O
both	O
the	O
odour	O
and	O
no	O
/	O
low	O
odour	O
groups	O
.	O

These	O
results	O
suggest	O
that	O
an	O
increase	O
in	O
the	O
number	O
of	O
H2S	O
-	O
producing	O
bacteria	O
in	O
the	O
tongue	O
biofilm	O
is	O
responsible	O
for	O
oral	O
malodour	O
,	O
although	O
the	O
bacterial	O
composition	O
of	O
tongue	O
biofilm	O
was	O
similar	O
between	O
the	O
two	O
groups	O
.	O

Thorough	O
examination	O
of	O
114	O
young	O
men	O
of	O
pre	O
-	O
constriction	O
military	O
training	O
age	O
disclosed	O
that	O
possibility	O
of	O
oral	O
cavity	O
pathology	O
development	O
is	O
mainly	O
determined	O
by	O
the	O
indices	O
DMFT	O
,	O
PMA	O
,	O
OHI	O
-	O
S	O
and	O
the	O
following	O
parameters	O
of	O
mixed	O
saliva	O
-	O
-	O
basic	O
salivary	O
flow	O
,	O
pH	O
and	O
Lactobacillus	B-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
amounts	O
.	O

The	O
degree	O
of	O
these	O
factors	O
changes	O
expressed	O
in	O
scores	O
identifies	O
groups	O
of	O
low	O
,	O
medium	O
and	O
high	O
probability	O
of	O
stomatologic	O
pathology	O
development	O
and	O
basing	O
on	O
this	O
to	O
individualize	O
curative	O
and	O
preventive	O
measures	O
.	O

The	O
accumulation	O
of	O
microorganisms	O
in	O
dental	O
plaque	O
is	O
related	O
to	O
the	O
etiology	O
of	O
caries	O
and	O
periodontal	O
disease	O
,	O
with	O
a	O
high	O
prevalence	O
worldwide	O
.	O

The	O
prophylactic	O
measures	O
include	O
the	O
use	O
of	O
chemical	O
agents	O
as	O
NaF	O
and	O
chlorhexidine	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
are	O
members	O
of	O
the	O
normal	O
microbiota	O
of	O
the	O
oral	O
cavity	O
being	O
discussed	O
with	O
regard	O
to	O
their	O
beneficial	O
or	O
detrimental	O
effect	O
in	O
this	O
environment	O
.	O

The	O
present	O
study	O
was	O
performed	O
to	O
determine	O
the	O
growth	O
of	O
some	O
species	O
of	O
Lactobacillus	B-bacteria
at	O
different	O
concentrations	O
of	O
NaF	O
and	O
chlorhexidine	O
.	O

The	O
strains	O
were	O
isolated	O
from	O
both	O
caries	O
-	O
free	O
and	O
caries	O
patients	O
.	O

Their	O
growth	O
parameters	O
were	O
evaluated	O
by	O
the	O
application	O
of	O
the	O
Gompertz	O
model	O
to	O
the	O
experimental	O
data	O
of	O
optical	O
density	O
as	O
a	O
measurement	O
of	O
growth	O
.	O

The	O
degree	O
of	O
inhibition	O
of	O
the	O
growth	O
of	O
all	O
of	O
the	O
lactobacilli	B-bacteria
studied	O
was	O
different	O
,	O
depending	O
on	O
each	O
particular	O
strain	O
.	O

NaF	O
at	O
1	O
mmol	O
x	O
L	O
(	O
-	O
1	O
)	O
inhibited	O
between	O
5	O
%	O
and	O
46	O
%	O
,	O
at	O
5	O
mmol	O
x	O
L	O
(	O
-	O
1	O
)	O
between	O
13	O
%	O
and	O
65	O
%	O
,	O
and	O
at	O
20	O
mmol	O
x	O
L	O
(	O
-	O
1	O
)	O
between	O
57	O
%	O
and	O
84	O
%	O
.	O

CHX	O
at	O
higher	O
concentrations	O
(	O
197	O
and	O
98	O
mmol	O
x	O
L	O
(	O
-	O
1	O
)	O
showed	O
a	O
complete	O
inhibition	O
of	O
some	O
of	O
the	O
strains	O
.	O

The	O
significance	O
of	O
the	O
results	O
was	O
evaluated	O
by	O
the	O
application	O
of	O
a	O
multivariate	O
analysis	O
and	O
also	O
compared	O
with	O
the	O
inhibition	O
of	O
pathogenic	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
with	O
lactobacilli	B-bacteria
strains	I-bacteria
from	O
collection	O
cultures	O
.	O

The	O
presence	O
of	O
selected	O
bacteria	O
(	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
in	O
infected	O
root	O
canals	O
was	O
studied	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
assays	O
,	O
and	O
the	O
association	O
of	O
bacteria	O
with	O
clinical	O
signs	O
of	O
endodontic	O
disease	O
was	O
assessed	O
.	O

The	O
null	O
hypothesis	O
,	O
that	O
no	O
difference	O
could	O
be	O
observed	O
between	O
clinical	O
signs	O
of	O
apical	O
periodontitis	O
and	O
a	O
specific	O
bacterial	O
strain	O
,	O
was	O
tested	O
.	O

Microbial	O
samples	O
were	O
obtained	O
from	O
62	O
teeth	O
in	O
54	O
patients	O
with	O
endodontic	O
disease	O
.	O

For	O
each	O
tooth	O
,	O
clinical	O
data	O
including	O
patient	O
symptoms	O
were	O
collected	O
.	O

Teeth	O
were	O
categorized	O
by	O
diagnosis	O
as	O
having	O
acute	O
apical	O
periodontitis	O
(	O
AAP	O
,	O
teeth	O
with	O
clinical	O
symptoms	O
but	O
no	O
periapical	O
radiolucency	O
,	O
n	O
=	O
22	O
)	O
,	O
chronic	O
apical	O
periodontitis	O
(	O
CAP	O
,	O
teeth	O
with	O
radiolucency	O
but	O
no	O
clinical	O
symptoms	O
,	O
n	O
=	O
15	O
)	O
or	O
exacerbated	O
apical	O
periodontitis	O
(	O
EAP	O
,	O
teeth	O
with	O
symptoms	O
and	O
radiolucency	O
,	O
n	O
=	O
25	O
)	O
.	O

Seventy	O
-	O
one	O
percent	O
of	O
cases	O
were	O
primary	O
endodontic	O
infections	O
,	O
and	O
29	O
%	O
were	O
recurrent	O
(	O
'	O
secondary	O
'	O
)	O
endodontic	O
infections	O
(	O
failing	O
cases	O
)	O
.	O

PCR	O
assays	O
were	O
used	O
to	O
detect	O
the	O
presence	O
of	O
the	O
selected	O
bacteria	O
.	O

T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
were	O
each	O
detected	O
in	O
15	O
of	O
62	O
samples	O
(	O
24	O
%	O
)	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
8	O
samples	O
(	O
13	O
%	O
)	O
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
in	O
5	O
samples	O
(	O
8	O
%	O
)	O
,	O
and	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
in	O
4	O
samples	O
(	O
7	O
%	O
)	O
.	O

T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
detected	O
in	O
56	O
%	O
of	O
teeth	O
with	O
EAP	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
found	O
in	O
60	O
%	O
of	O
teeth	O
with	O
CAP	O
and	O
in	O
72	O
%	O
of	O
teeth	O
with	O
secondary	O
infection	O
.	O

Statistical	O
analysis	O
demonstrated	O
an	O
association	O
of	O
CAP	O
and	O
secondary	O
endodontic	O
infection	O
with	O
the	O
presence	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
.	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

EAP	O
was	O
associated	O
with	O
the	O
presence	O
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
associated	O
with	O
symptomatic	O
endodontic	O
disease	O
in	O
the	O
presence	O
of	O
apical	O
bone	O
resorption	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
associated	O
with	O
treatment	O
failures	O
.	O

We	O
suggest	O
that	O
these	O
species	O
may	O
play	O
critical	O
roles	O
in	O
endodontic	O
pathology	O
.	O

Until	O
today	O
,	O
human	O
stomach	O
is	O
the	O
only	O
recognized	O
habitat	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
.	O

However	O
,	O
recruitment	O
of	O
DNA	O
-	O
based	O
methods	O
has	O
made	O
possible	O
the	O
detection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
water	O
and	O
oral	O
cavity	O
,	O
thus	O
suggesting	O
fecal	O
-	O
oral	O
and	O
oral	O
-	O
oral	O
routes	O
for	O
transmission	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
yeast	O
has	O
been	O
proposed	O
as	O
a	O
common	O
vector	O
for	O
transmission	O
of	O
H	B-bacteria
pylori	I-bacteria
.	O

Thus	O
designed	O
primers	O
were	O
recruited	O
to	O
target	O
16S	O
rDNA	O
and	O
cagA	O
genes	O
in	O
the	O
oral	O
yeasts	O
by	O
PCR	O
.	O

MATERIALS	O
AND	O
Eighteen	O
yeasts	O
were	O
examined	O
microscopically	O
for	O
the	O
presence	O
of	O
bacterial	O
-	O
like	O
bodies	O
.	O

DNAs	O
were	O
extracted	O
from	O
oral	O
yeasts	O
using	O
phenol	O
-	O
chloroform	O
method	O
.	O

Amplification	O
conditions	O
were	O
optimized	O
as	O
33	O
cycles	O
and	O
annealing	O
temperatures	O
of	O
63	O
degrees	O
C	O
for	O
16S	O
rDNA	O
and	O
51	O
degrees	O
C	O
and	O
52	O
degrees	O
C	O
for	O
cagA	O
gene	O
which	O
was	O
targeted	O
in	O
two	O
steps	O
.	O

DNAs	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
and	O
Saccharomyces	O
cerevisiae	O
were	O
used	O
as	O
controls	O
.	O

Polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
products	O
of	O
two	O
genes	O
from	O
one	O
yeast	O
and	O
from	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
were	O
cloned	O
in	O
pCAP	O
and	O
subsequently	O
subcloned	O
in	O
pSK	O
+	O
and	O
were	O
sequenced	O
.	O

Bacterial	O
-	O
like	O
bodies	O
were	O
observed	O
in	O
all	O
oral	O
yeasts	O
.	O

The	O
amplified	O
products	O
of	O
16S	O
rDNA	O
from	O
all	O
oral	O
yeasts	O
were	O
homologous	O
in	O
size	O
with	O
those	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Fifteen	O
out	O
of	O
eighteen	O
(	O
83	O
%	O
)	O
yeasts	O
contained	O
cagA	O
gene	O
,	O
homologous	O
to	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

CagA	O
was	O
not	O
amplified	O
from	O
three	O
yeasts	O
and	O
S	B-bacteria
.	I-bacteria
cerevisiae	I-bacteria
.	O

Analysis	O
of	O
the	O
sequenced	O
products	O
of	O
16S	O
rDNA	O
and	O
cagA	O
from	O
one	O
oral	O
yeast	O
showed	O
98	O
%	O
homology	O
with	O
those	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
inside	O
the	O
yeast	O
was	O
indicated	O
by	O
light	O
microscopy	O
and	O
PCR	O
.	O

It	O
appears	O
that	O
yeasts	O
,	O
which	O
are	O
abundant	O
in	O
nature	O
and	O
thrive	O
the	O
mucosal	O
surfaces	O
of	O
human	O
,	O
might	O
serve	O
as	O
reservoirs	O
and	O
vehicles	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

The	O
functions	O
of	O
epithelial	O
cells	O
are	O
more	O
than	O
a	O
physical	O
selective	O
barrier	O
for	O
protection	O
from	O
mucosal	O
pathogens	O
.	O

The	O
epithelial	O
response	O
regulated	O
by	O
host	O
-	O
microorganism	O
interaction	O
may	O
change	O
due	O
to	O
histological	O
and	O
physiological	O
differences	O
between	O
sterile	O
and	O
nonsterile	O
sites	O
.	O

In	O
this	O
study	O
we	O
examined	O
the	O
presence	O
of	O
a	O
difference	O
between	O
bactericidal	O
capacities	O
of	O
urinary	O
and	O
oral	O
epithelial	O
cells	O
against	O
different	O
strains	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
.	O

Oral	O
epithelial	O
cells	O
were	O
collected	O
from	O
unstimulated	O
saliva	O
and	O
uroepithelial	O
cells	O
were	O
collected	O
from	O
urine	O
of	O
eight	O
healthy	O
volunteers	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
K12	I-bacteria
and	I-bacteria
O75	I-bacteria
strains	I-bacteria
and	O
epithelial	O
cells	O
were	O
prepared	O
for	O
the	O
experiment	O
,	O
added	O
to	O
microplates	O
and	O
incubated	O
for	O
one	O
hour	O
.	O

The	O
growth	O
of	O
bacteria	O
was	O
detected	O
by	O
the	O
quantitative	O
colony	O
counting	O
method	O
.	O

Antibacterial	O
effects	O
of	O
the	O
oral	O
and	O
urinary	O
epithelial	O
cells	O
against	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
K12	I-bacteria
and	I-bacteria
O75	I-bacteria
strains	I-bacteria
were	O
49	O
.	O
8	O
%	O
,	O
34	O
.	O
7	O
%	O
,	O
45	O
.	O
7	O
%	O
and	O
29	O
.	O
2	O
%	O
,	O
respectively	O
.	O

As	O
a	O
result	O
,	O
it	O
was	O
detected	O
that	O
the	O
antibacterial	O
activity	O
of	O
oral	O
epithelial	O
cells	O
to	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
K12	I-bacteria
and	I-bacteria
O75	I-bacteria
were	O
higher	O
than	O
urinary	O
epithelial	O
cells	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
relationship	O
between	O
the	O
number	O
of	O
polymorphonuclear	O
leukocytes	O
(	O
PMNL	O
)	O
and	O
the	O
number	O
of	O
selected	O
bacteria	O
in	O
human	O
oral	O
cavity	O
.	O

Sixty	O
one	O
healthy	O
people	O
(	O
periodontal	O
index	O
of	O
Russel	O
'	O
s	O
did	O
not	O
exceed	O
0	O
.	O
2	O
)	O
,	O
aged	O
22	O
-	O
26	O
were	O
investigated	O
.	O

PMNL	O
were	O
isolated	O
by	O
rinsing	O
oral	O
cavity	O
with	O
isotonic	O
,	O
buffered	O
NaCl	O
solution	O
.	O

Nonstimulated	O
whole	O
saliva	O
was	O
bacteriologically	O
examined	O
.	O

The	O
number	O
of	O
PMNL	O
,	O
which	O
was	O
obtained	O
from	O
mouth	O
of	O
examined	O
people	O
was	O
between	O
100	O
,	O
000	O
and	O
4	O
,	O
200	O
,	O
000	O
in	O
100	O
mL	O
of	O
rinsings	O
.	O

Usually	O
,	O
i	O
.	O
e	O
.	O
in	O
34	O
%	O
of	O
cases	O
,	O
the	O
number	O
was	O
between	O
500	O
,	O
000	O
-	O
1	O
,	O
000	O
,	O
000	O
.	O

Streptococci	B-bacteria
were	O
isolated	O
from	O
all	O
tested	O
people	O
and	O
their	O
number	O
was	O
the	O
biggest	O
.	O

Almost	O
in	O
all	O
cases	O
there	O
were	O
isolated	O
cariogenic	O
bacteria	O
-	O
-	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
95	O
%	O
)	O
and	O
lactobacilli	B-bacteria
(	O
93	O
%	O
)	O
.	O

Haemophili	B-bacteria
,	O
staphylococci	B-bacteria
,	O
including	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
were	O
found	O
relatively	O
often	O
(	O
in	O
86	O
%	O
,	O
86	O
%	O
and	O
52	O
%	O
respectively	O
)	O
.	O

Gram	O
-	O
negative	O
enteric	O
rods	O
were	O
rarely	O
isolated	O
(	O
33	O
%	O
)	O
and	O
were	O
the	O
least	O
numerous	O
group	O
of	O
all	O
.	O

It	O
has	O
been	O
stated	O
,	O
that	O
there	O
is	O
a	O
comparatively	O
strong	O
negative	O
correlation	O
between	O
the	O
number	O
of	O
PMNL	O
in	O
oral	O
cavity	O
and	O
the	O
number	O
of	O
streptococci	B-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
55	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
haemophili	B-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
564	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
staphylococci	B-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
538	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
lactobacilli	B-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
407	O
;	O
p	O
=	O
0	O
.	O
0017	O
)	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
483	O
;	O
p	O
=	O
0	O
.	O
0002	O
)	O
.	O

The	O
results	O
suggest	O
that	O
PMNL	O
are	O
one	O
of	O
the	O
factors	O
controlling	O
the	O
number	O
of	O
some	O
bacteria	O
in	O
human	O
oral	O
cavity	O
.	O

To	O
examine	O
the	O
isolation	O
frequency	O
and	O
the	O
carriage	O
of	O
yeasts	O
,	O
Enterobacteriaceae	B-bacteria
,	O
Staphylococcus	B-bacteria
and	O
Enterococcus	B-bacteria
species	I-bacteria
in	O
oral	O
samples	O
from	O
elderly	O
Greeks	O
living	O
alone	O
or	O
in	O
institutions	O
.	O

Ageing	O
may	O
promote	O
changes	O
in	O
the	O
oral	O
ecosystem	O
,	O
which	O
lead	O
to	O
colonisation	O
of	O
the	O
mouth	O
by	O
microbes	O
found	O
less	O
commonly	O
or	O
only	O
transiently	O
in	O
younger	O
subjects	O
.	O

Previous	O
studies	O
indicate	O
a	O
geographical	O
variation	O
in	O
the	O
isolation	O
frequency	O
of	O
such	O
bacteria	O
in	O
elderly	O
populations	O
.	O

Medical	O
and	O
dental	O
records	O
were	O
obtained	O
from	O
66	O
attenders	O
at	O
elderly	O
people	O
'	O
s	O
day	O
centres	O
(	O
EPDC	O
)	O
,	O
and	O
82	O
residents	O
of	O
elderly	O
people	O
'	O
s	O
homes	O
(	O
EPH	O
)	O
,	O
66	O
-	O
95	O
years	O
old	O
.	O

Mucosa	O
smear	O
samples	O
were	O
cultured	O
on	O
appropriate	O
media	O
for	O
enumeration	O
of	O
the	O
above	O
species	O
.	O

Microbial	O
identification	O
was	O
performed	O
by	O
conventional	O
microbiological	O
tests	O
.	O

The	O
results	O
were	O
analysed	O
using	O
the	O
Multiple	O
Correspondence	O
Analysis	O
(	O
MCA	O
)	O
,	O
ANOVA	O
and	O
other	O
traditional	O
statistical	O
tests	O
.	O

No	O
statistically	O
significant	O
association	O
was	O
found	O
between	O
the	O
place	O
of	O
residence	O
and	O
the	O
wearing	O
of	O
dentures	O
.	O

The	O
isolation	O
frequencies	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Enterococcus	B-bacteria
and	O
Enterobacteriaceae	B-bacteria
species	I-bacteria
were	O
21	O
.	O
6	O
,	O
20	O
.	O
3	O
and	O
7	O
.	O
4	O
%	O
respectively	O
.	O

MCA	O
,	O
and	O
further	O
statistical	O
analysis	O
,	O
revealed	O
that	O
the	O
place	O
of	O
residence	O
affected	O
the	O
isolation	O
frequency	O
of	O
years	O
(	O
54	O
.	O
9	O
%	O
in	O
EPH	O
vs	O
.	O
37	O
.	O
9	O
%	O
in	O
EPDC	O
)	O
.	O

Moreover	O
,	O
ANOVA	O
showed	O
that	O
living	O
in	O
EPH	O
increased	O
the	O
carriage	O
of	O
yeasts	O
.	O

Elderly	O
Greeks	O
exhibit	O
a	O
moderate	O
to	O
high	O
oral	O
carriage	O
of	O
transient	O
bacteria	O
compared	O
with	O
other	O
elderly	O
populations	O
.	O

Living	O
in	O
EPH	O
seems	O
to	O
increase	O
both	O
the	O
isolation	O
frequency	O
and	O
carriage	O
of	O
yeasts	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
antimicrobial	O
effect	O
of	O
essential	O
oil	O
-	O
containing	O
oral	O
strips	O
on	O
different	O
species	O
of	O
the	O
oral	O
microbiota	O
.	O

Saliva	O
samples	O
were	O
collected	O
from	O
20	O
subjects	O
with	O
good	O
oral	O
health	O
,	O
diluted	O
and	O
plated	O
onto	O
blood	O
agar	O
medium	O
.	O

The	O
subjects	O
were	O
asked	O
to	O
place	O
the	O
strip	O
(	O
Listerine	O
PocketPaks	O
)	O
on	O
the	O
tongue	O
allowing	O
it	O
to	O
dissolve	O
.	O

After	O
30	O
minutes	O
,	O
new	O
saliva	O
samples	O
were	O
collected	O
again	O
and	O
the	O
plates	O
with	O
the	O
samples	O
were	O
incubated	O
under	O
anaerobic	O
conditions	O
at	O
37	O
degrees	O
C	O
for	O
seven	O
days	O
.	O

Colony	O
counts	O
(	O
CFU	O
/	O
mL	O
)	O
were	O
determined	O
for	O
each	O
sample	O
.	O

The	O
colonies	O
on	O
the	O
plates	O
were	O
washed	O
with	O
1	O
mL	O
of	O
TE	O
buffer	O
,	O
and	O
the	O
bacterial	O
suspensions	O
were	O
processed	O
for	O
the	O
identification	O
of	O
24	O
species	O
by	O
DNA	O
probes	O
and	O
the	O
Checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
method	O
.	O

Differences	O
in	O
total	O
counts	O
,	O
prevalence	O
,	O
and	O
levels	O
of	O
the	O
species	O
evaluated	O
before	O
and	O
after	O
placement	O
of	O
the	O
strips	O
were	O
determined	O
by	O
Wilcoxon	O
sign	O
rank	O
and	O
Chi	O
-	O
square	O
tests	O
.	O

A	O
modest	O
increase	O
in	O
the	O
total	O
bacterial	O
number	O
in	O
saliva	O
from	O
1	O
.	O
4	O
x	O
10	O
(	O
8	O
)	O
to	O
1	O
.	O
7	O
x	O
10	O
(	O
8	O
)	O
bacterial	O
cells	O
was	O
observed	O
30	O
minutes	O
after	O
the	O
strip	O
placement	O
,	O
although	O
this	O
change	O
was	O
not	O
significant	O
(	O
p	O
=	O
0	O
.	O
632	O
)	O
.	O

Most	O
of	O
the	O
species	O
reduced	O
in	O
frequency	O
and	O
/	O
or	O
levels	O
,	O
including	O
the	O
pathogens	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
,	O
Fusobacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
noxia	I-bacteria
,	O
as	O
well	O
as	O
the	O
beneficial	O
species	O
A	B-bacteria
.	I-bacteria
meyeri	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
georgia	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
gerencseriae	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
after	O
strip	O
placement	O
.	O

In	O
contrast	O
,	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
,	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
and	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
presented	O
an	O
increase	O
in	O
prevalence	O
and	O
/	O
or	O
levels	O
.	O

These	O
changes	O
were	O
not	O
statistically	O
significant	O
after	O
adjusting	O
for	O
multiple	O
comparisons	O
(	O
p	O
>	O
0	O
.	O
0022	O
)	O
.	O

The	O
use	O
of	O
the	O
essential	O
oil	O
-	O
containing	O
oral	O
strips	O
resulted	O
in	O
a	O
short	O
-	O
term	O
small	O
increase	O
in	O
the	O
total	O
number	O
of	O
salivary	O
microorganisms	O
.	O

In	O
addition	O
,	O
a	O
not	O
significant	O
decrease	O
of	O
certain	O
periodontopathogens	O
,	O
and	O
an	O
increase	O
in	O
species	O
compatible	O
with	O
oral	O
health	O
were	O
observed	O
.	O

To	O
analyse	O
the	O
microbial	O
flora	O
in	O
specific	O
sites	O
in	O
20	O
dentate	O
(	O
>	O
or	O
=	O
16	O
teeth	O
)	O
subjects	O
with	O
hyposalivation	O
due	O
to	O
medicines	O
or	O
of	O
unknown	O
origin	O
and	O
in	O
20	O
controls	O
matched	O
according	O
to	O
age	O
,	O
sex	O
and	O
number	O
of	O
teeth	O
.	O

The	O
microbial	O
samples	O
were	O
analysed	O
for	O
the	O
following	O
micro	O
-	O
organisms	O
:	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
associated	O
with	O
the	O
development	O
of	O
caries	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
/	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
associated	O
with	O
plaque	O
accumulation	O
and	O
gingivitis	O
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
frequently	O
found	O
in	O
elevated	O
numbers	O
in	O
periodontitis	O
sites	O
and	O
Candida	O
albicans	O
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
enterics	B-bacteria
and	O
enterococci	B-bacteria
,	O
associated	O
with	O
mucosal	O
infections	O
.	O

The	O
total	O
microbial	O
count	O
was	O
also	O
registered	O
,	O
together	O
with	O
the	O
total	O
number	O
of	O
streptococci	B-bacteria
,	O
associated	O
with	O
good	O
oral	O
health	O
.	O

In	O
the	O
hyposalivation	O
group	O
,	O
the	O
mean	O
age	O
was	O
54	O
+	O
/	O
-	O
8	O
years	O
and	O
the	O
mean	O
number	O
of	O
teeth	O
25	O
+	O
/	O
-	O
3	O
.	O

The	O
unstimulated	O
secretion	O
rate	O
was	O
0	O
.	O
04	O
+	O
/	O
-	O
0	O
.	O
04	O
mL	O
/	O
min	O
and	O
the	O
stimulated	O
secretion	O
rate	O
0	O
.	O
98	O
+	O
/	O
-	O
0	O
.	O
51	O
mL	O
/	O
min	O
.	O

Compared	O
with	O
the	O
controls	O
,	O
the	O
hyposalivation	O
group	O
tended	O
to	O
harbour	O
a	O
lower	O
number	O
and	O
proportion	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
on	O
the	O
tongue	O
,	O
and	O
an	O
increased	O
number	O
of	O
enterococci	B-bacteria
in	O
the	O
vestibular	O
region	O
.	O

In	O
the	O
supragingival	O
plaque	O
,	O
the	O
numbers	O
of	O
Strepococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
significantly	O
increased	O
and	O
the	O
number	O
of	O
C	O
.	O
albicans	O
tended	O
to	O
be	O
increased	O
.	O

The	O
results	O
indicate	O
that	O
subjects	O
with	O
hyposalivation	O
due	O
to	O
medicines	O
or	O
of	O
unknown	O
origin	O
have	O
a	O
supragingival	O
plaque	O
associated	O
with	O
the	O
development	O
of	O
caries	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
a	O
periodontopathic	O
bacterium	O
,	O
is	O
known	O
to	O
invade	O
oral	O
epithelial	O
cells	O
in	O
periodontal	O
lesions	O
,	O
although	O
the	O
mechanism	O
is	O
unclear	O
.	O

In	O
the	O
present	O
study	O
,	O
goat	O
polyclonal	O
anti	O
-	O
intercellular	O
adhesion	O
molecule	O
1	O
(	O
anti	O
-	O
ICAM	O
-	O
1	O
)	O
antibody	O
inhibited	O
the	O
invasion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
into	O
KB	O
cells	O
(	O
human	O
oral	O
epithelial	O
cells	O
)	O
.	O

Further	O
,	O
the	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
fimbria	O
,	O
a	O
pathogenic	O
adhesion	O
molecule	O
,	O
bound	O
to	O
recombinant	O
human	O
ICAM	O
-	O
1	O
,	O
as	O
shown	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
also	O
found	O
to	O
colocalize	O
with	O
ICAM	O
-	O
1	O
on	O
KB	O
cells	O
,	O
as	O
seen	O
with	O
an	O
immunofluorescence	O
microscope	O
,	O
and	O
the	O
knockdown	O
of	O
ICAM	O
-	O
1	O
in	O
KB	O
cells	O
resulted	O
in	O
the	O
inhibition	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
by	O
RNA	O
interference	O
.	O

In	O
addition	O
,	O
methyl	O
-	O
beta	O
-	O
cyclodextrin	O
,	O
a	O
cholesterol	O
-	O
binding	O
agent	O
,	O
inhibited	O
the	O
colocalization	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
with	O
ICAM	O
-	O
1	O
and	O
invasion	O
by	O
the	O
microorganism	O
.	O

The	O
colocalization	O
of	O
caveolin	O
-	O
1	O
,	O
a	O
caveolar	O
marker	O
protein	O
,	O
on	O
KB	O
cells	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
also	O
shown	O
,	O
and	O
the	O
knockdown	O
of	O
caveolin	O
-	O
1	O
in	O
KB	O
cells	O
caused	O
a	O
reduced	O
level	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
.	O

These	O
results	O
suggest	O
that	O
ICAM	O
-	O
1	O
and	O
caveolae	O
are	O
required	O
for	O
the	O
invasion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
into	O
human	O
oral	O
epithelial	O
cells	O
,	O
and	O
these	O
molecules	O
appear	O
to	O
be	O
associated	O
with	O
the	O
primary	O
stages	O
of	O
the	O
development	O
and	O
progression	O
of	O
chronic	O
periodontitis	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
bv	I-bacteria
.	I-bacteria
1	I-bacteria
is	O
a	O
pioneer	O
colonizer	O
of	O
the	O
human	O
oral	O
cavity	O
.	O

Studies	O
of	O
its	O
population	O
dynamics	O
within	O
parents	O
and	O
their	O
infants	O
and	O
within	O
neonates	O
have	O
shown	O
extensive	O
diversity	O
within	O
and	O
between	O
subjects	O
.	O

We	O
examined	O
the	O
genetic	O
diversity	O
and	O
clonal	O
turnover	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
bv	I-bacteria
.	I-bacteria
1	I-bacteria
isolated	O
from	O
the	O
cheeks	O
,	O
tongue	O
,	O
and	O
primary	O
incisors	O
of	O
four	O
infants	O
from	O
birth	O
to	O
1	O
year	O
of	O
age	O
.	O

In	O
addition	O
,	O
we	O
compared	O
the	O
clonotypes	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
bv	I-bacteria
.	I-bacteria
1	I-bacteria
isolated	O
from	O
their	O
mothers	O
'	O
saliva	O
collected	O
in	O
parallel	O
to	O
determine	O
whether	O
the	O
mother	O
was	O
the	O
origin	O
of	O
the	O
clones	O
colonizing	O
her	O
infant	O
.	O

Of	O
859	O
isolates	O
obtained	O
from	O
the	O
infants	O
,	O
568	O
were	O
unique	O
clones	O
.	O

Each	O
of	O
the	O
surfaces	O
examined	O
,	O
whether	O
shedding	O
or	O
nonshedding	O
,	O
displayed	O
the	O
same	O
degree	O
of	O
diversity	O
.	O

Among	O
the	O
four	O
infants	O
it	O
was	O
rare	O
to	O
detect	O
the	O
same	O
clone	O
colonizing	O
more	O
than	O
one	O
surface	O
at	O
a	O
given	O
visit	O
.	O

There	O
was	O
little	O
evidence	O
for	O
persistence	O
of	O
clones	O
,	O
but	O
when	O
clones	O
were	O
isolated	O
on	O
multiple	O
visits	O
they	O
were	O
not	O
always	O
found	O
on	O
the	O
same	O
surface	O
.	O

A	O
similar	O
degree	O
of	O
clonal	O
diversity	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
bv	I-bacteria
.	I-bacteria
1	I-bacteria
was	O
observed	O
in	O
the	O
mothers	O
'	O
saliva	O
as	O
in	O
their	O
infants	O
'	O
mouths	O
.	O

Clones	O
common	O
to	O
both	O
infant	O
and	O
mothers	O
'	O
saliva	O
were	O
found	O
infrequently	O
suggesting	O
that	O
this	O
is	O
not	O
the	O
origin	O
of	O
the	O
infants	O
'	O
clones	O
.	O

It	O
is	O
unclear	O
whether	O
mucosal	O
immunity	O
exerts	O
the	O
environmental	O
pressure	O
driving	O
the	O
genetic	O
diversity	O
and	O
clonal	O
turnover	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
bv	I-bacteria
.	I-bacteria
1	I-bacteria
,	O
which	O
may	O
be	O
mechanisms	O
employed	O
by	O
this	O
bacterium	O
to	O
evade	O
immune	O
elimination	O
.	O

Bacteriocins	O
are	O
bacteriocidal	O
proteinaceous	O
molecules	O
produced	O
by	O
the	O
Gram	O
-	O
positive	O
bacteria	O
not	O
active	O
against	O
the	O
produced	O
strain	O
.	O

Many	O
investigations	O
have	O
revealed	O
that	O
certain	O
bacteria	O
using	O
antibacterial	O
or	O
the	O
inhibitory	O
substance	O
inhibit	O
some	O
other	O
bacteria	O
.	O

A	O
study	O
was	O
conducted	O
in	O
a	O
group	O
of	O
60	O
children	O
to	O
ascertain	O
whether	O
any	O
correlation	O
exists	O
between	O
the	O
proportion	O
of	O
salivary	O
bacteria	O
inhibiting	O
and	O
stimulating	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
the	O
oral	O
health	O
indices	O
(	O
DMFT	O
,	O
deft	O
and	O
Community	O
Periodontal	O
Index	O
of	O
Treatment	O
Needs	O
)	O
.	O

A	O
definite	O
inverse	O
correlation	O
was	O
observed	O
between	O
the	O
percentage	O
of	O
salivary	O
inhibiting	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
untreated	O
carious	O
teeth	O
(	O
UCT	O
)	O
.	O

Postoperative	O
maxillary	O
cyst	O
(	O
POMC	O
)	O
is	O
known	O
to	O
occur	O
as	O
a	O
delayed	O
complication	O
of	O
radical	O
maxillary	O
sinus	O
surgery	O
,	O
such	O
as	O
Caldwell	O
-	O
Luc	O
surgery	O
.	O

The	O
cyst	O
gradually	O
expands	O
with	O
no	O
symptoms	O
over	O
a	O
period	O
of	O
years	O
,	O
and	O
then	O
occasionally	O
causes	O
swelling	O
and	O
pain	O
in	O
the	O
buccal	O
region	O
and	O
/	O
or	O
the	O
mucogingival	O
fold	O
.	O

It	O
is	O
probable	O
that	O
bacterial	O
infection	O
affects	O
the	O
progression	O
of	O
POMC	O
symptoms	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
determine	O
the	O
bacterial	O
density	O
and	O
to	O
examine	O
the	O
presence	O
of	O
20	O
oral	O
bacteria	O
in	O
POMC	O
fluids	O
.	O

POMC	O
fluids	O
(	O
4	O
purulent	O
,	O
2	O
mucous	O
and	O
4	O
serous	O
)	O
were	O
sampled	O
from	O
10	O
subjects	O
(	O
aged	O
43	O
-	O
77	O
years	O
)	O
.	O

Bacterial	O
quantification	O
and	O
detection	O
were	O
performed	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
nested	O
PCR	O
based	O
on	O
bacterial	O
16S	O
rRNA	O
genes	O
,	O
respectively	O
.	O

Bacterial	O
DNA	O
was	O
detected	O
in	O
all	O
samples	O
and	O
the	O
average	O
concentrations	O
of	O
bacterial	O
DNA	O
were	O
5	O
.	O
9	O
(	O
purulent	O
)	O
,	O
0	O
.	O
5	O
(	O
mucous	O
)	O
,	O
and	O
0	O
.	O
7	O
(	O
serous	O
)	O
ng	O
/	O
mg	O
of	O
sample	O
.	O

Twelve	O
bacterial	O
species	O
,	O
including	O
anginosus	B-bacteria
streptococci	I-bacteria
,	O
known	O
to	O
be	O
associated	O
with	O
abscess	O
formation	O
,	O
were	O
detected	O
in	O
the	O
purulent	O
fluids	O
,	O
while	O
two	O
and	O
five	O
species	O
were	O
detected	O
in	O
the	O
mucous	O
and	O
serous	O
fluids	O
,	O
respectively	O
.	O

Purulent	O
fluids	O
contained	O
numerous	O
bacteria	O
of	O
various	O
types	O
,	O
thus	O
suggesting	O
that	O
oral	O
bacteria	O
may	O
cause	O
symptoms	O
such	O
as	O
pain	O
in	O
POMC	O
with	O
purulent	O
fluids	O
.	O

Mucous	O
and	O
serous	O
fluids	O
also	O
contained	O
bacteria	O
,	O
although	O
their	O
numbers	O
were	O
small	O
,	O
thus	O
suggesting	O
an	O
association	O
between	O
bacteria	O
and	O
progression	O
of	O
POMC	O
.	O

Lactobacilli	B-bacteria
are	O
known	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
maintenance	O
of	O
health	O
by	O
stimulating	O
natural	O
immunity	O
and	O
contributing	O
to	O
the	O
balance	O
of	O
microflora	O
.	O

However	O
,	O
their	O
role	O
in	O
chronic	O
periodontitis	O
is	O
unclear	O
.	O

We	O
aimed	O
to	O
identify	O
oral	O
lactobacilli	B-bacteria
in	O
chronic	O
periodontitis	O
and	O
periodontally	O
healthy	O
subjects	O
,	O
and	O
to	O
determine	O
their	O
antimicrobial	O
activity	O
against	O
putative	O
oral	O
pathogens	O
.	O

A	O
total	O
of	O
238	O
Lactobacillus	B-bacteria
isolates	I-bacteria
from	O
the	O
saliva	O
and	O
subgingival	O
sites	O
of	O
20	O
chronic	O
periodontitis	O
and	O
15	O
healthy	O
subjects	O
were	O
collected	O
.	O

In	O
all	O
,	O
115	O
strains	O
were	O
identified	O
using	O
rapid	O
amplified	O
ribosomal	O
DNA	O
restriction	O
analysis	O
.	O

Antimicrobial	O
activity	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
was	O
assessed	O
.	O

Lactobacilli	B-bacteria
belonging	O
to	O
10	O
species	O
were	O
identified	O
.	O

The	O
most	O
prevalent	O
strains	O
in	O
healthy	O
persons	O
were	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
and	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
and	O
in	O
chronic	O
periodontitis	O
patients	O
,	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
.	O

Obligately	O
homofermentatives	O
,	O
particularly	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
,	O
were	O
less	O
prevalent	O
in	O
chronic	O
periodontitis	O
patients	O
compared	O
with	O
healthy	O
subjects	O
(	O
8	O
%	O
vs	O
.	O
64	O
%	O
for	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
,	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Sixty	O
-	O
nine	O
percent	O
of	O
tested	O
lactobacilli	B-bacteria
inhibited	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
88	O
%	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
82	O
%	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
65	O
%	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
.	O

The	O
strongest	O
antimicrobial	O
activity	O
was	O
associated	O
with	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
.	O

The	O
strains	O
from	O
periodontally	O
healthy	O
patients	O
showed	O
a	O
lower	O
antimicrobial	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
than	O
the	O
strains	O
from	O
chronic	O
periodontitis	O
patients	O
.	O

The	O
composition	O
of	O
oral	O
lactoflora	O
in	O
chronic	O
periodontitis	O
and	O
healthy	O
subjects	O
differs	O
,	O
with	O
a	O
higher	O
prevalence	O
of	O
homofermentative	O
lactobacilli	B-bacteria
,	O
particularly	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
,	O
in	O
the	O
latter	O
group	O
.	O

Both	O
homo	O
-	O
and	O
heterofermentative	O
oral	O
lactobacilli	B-bacteria
suppress	O
the	O
growth	O
of	O
periodontal	O
pathogens	O
,	O
but	O
the	O
antimicrobial	O
properties	O
are	O
strain	O
,	O
species	O
and	O
origin	O
specific	O
.	O

Recent	O
evidence	O
from	O
molecular	O
genetic	O
studies	O
has	O
revealed	O
that	O
oral	O
Treponema	B-bacteria
species	I-bacteria
are	O
involved	O
in	O
infections	O
of	O
endodontic	O
origin	O
.	O

This	O
study	O
assessed	O
the	O
occurrence	O
of	O
two	O
newly	O
named	O
oral	O
treponemes	B-bacteria
-	O
Treponema	B-bacteria
parvum	I-bacteria
and	O
Treponema	B-bacteria
putidum	I-bacteria
-	O
in	O
primary	O
endodontic	O
infections	O
using	O
a	O
culture	O
-	O
independent	O
identification	O
technique	O
.	O

Genomic	O
DNA	O
was	O
isolated	O
directly	O
from	O
clinical	O
samples	O
,	O
and	O
a	O
16S	O
rRNA	O
gene	O
-	O
based	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
assay	O
was	O
used	O
to	O
determine	O
the	O
presence	O
of	O
T	B-bacteria
.	I-bacteria
parvum	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
putidum	I-bacteria
.	O

Species	O
-	O
specific	O
primer	O
pairs	O
were	O
developed	O
by	O
aligning	O
closely	O
related	O
16S	O
rRNA	O
gene	O
sequences	O
.	O

The	O
specificity	O
for	O
each	O
primer	O
pair	O
was	O
validated	O
by	O
running	O
PCR	O
against	O
a	O
panel	O
of	O
oral	O
bacteria	O
and	O
by	O
sequence	O
analysis	O
of	O
PCR	O
products	O
from	O
positive	O
clinical	O
samples	O
.	O

T	B-bacteria
.	I-bacteria
parvum	I-bacteria
was	O
detected	O
in	O
52	O
%	O
of	O
the	O
root	O
canals	O
associated	O
with	O
chronic	O
apical	O
periodontitis	O
,	O
in	O
20	O
%	O
of	O
the	O
cases	O
diagnosed	O
as	O
acute	O
apical	O
periodontitis	O
,	O
and	O
in	O
no	O
abscessed	O
case	O
.	O

In	O
general	O
,	O
T	B-bacteria
.	I-bacteria
parvum	I-bacteria
was	O
detected	O
in	O
26	O
%	O
of	O
the	O
samples	O
from	O
primary	O
endodontic	O
infections	O
.	O

T	B-bacteria
.	I-bacteria
putidum	I-bacteria
was	O
found	O
in	O
only	O
one	O
case	O
of	O
acute	O
apical	O
periodontitis	O
(	O
2	O
%	O
of	O
the	O
total	O
number	O
of	O
cases	O
investigated	O
)	O
.	O

The	O
devised	O
nested	O
PCR	O
protocol	O
was	O
able	O
to	O
identify	O
both	O
T	B-bacteria
.	I-bacteria
parvum	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
putidum	I-bacteria
directly	O
in	O
clinical	O
samples	O
and	O
demonstrated	O
that	O
these	O
two	O
treponemes	B-bacteria
can	O
take	O
part	O
in	O
endodontic	O
infections	O
.	O

This	O
study	O
assessed	O
,	O
for	O
forensic	O
purposes	O
,	O
the	O
feasibility	O
of	O
genotypically	O
matching	O
oral	O
streptococci	B-bacteria
recovered	O
from	O
recent	O
human	O
bite	O
marks	O
with	O
those	O
from	O
the	O
teeth	O
of	O
the	O
biter	O
.	O

Streptococci	B-bacteria
were	O
isolated	O
from	O
the	O
incisors	O
of	O
eight	O
volunteers	O
.	O

Arbitrarily	O
primed	O
PCR	O
(	O
AP	O
-	O
PCR	O
)	O
distinguished	O
106	O
streptococcal	O
genotypes	O
among	O
the	O
participants	O
,	O
each	O
harbouring	O
at	O
least	O
eight	O
distinct	O
strains	O
.	O

In	O
a	O
crime	O
simulation	O
,	O
a	O
sample	O
from	O
an	O
experimental	O
bite	O
mark	O
was	O
analysed	O
by	O
an	O
experimenter	O
unaware	O
of	O
its	O
origin	O
.	O

The	O
bacteria	O
were	O
unambiguously	O
matched	O
to	O
the	O
biter	O
by	O
comparing	O
the	O
amplicon	O
profiles	O
with	O
those	O
from	O
the	O
eight	O
participants	O
.	O

In	O
contrast	O
,	O
bacteria	O
from	O
an	O
additional	O
bite	O
mark	O
(	O
not	O
generated	O
by	O
one	O
of	O
the	O
original	O
participants	O
)	O
could	O
not	O
be	O
matched	O
to	O
any	O
of	O
the	O
eight	O
participants	O
.	O

Between	O
20	O
and	O
78	O
%	O
of	O
catalogued	O
bacterial	O
genotypes	O
were	O
recovered	O
12	O
months	O
later	O
from	O
each	O
participant	O
.	O

Throughout	O
the	O
study	O
period	O
,	O
none	O
of	O
the	O
bacterial	O
genotypes	O
were	O
shared	O
between	O
participants	O
.	O

Streptococci	B-bacteria
isolated	O
from	O
recent	O
bite	O
marks	O
can	O
be	O
catalogued	O
by	O
AP	O
-	O
PCR	O
and	O
matched	O
to	O
the	O
teeth	O
responsible	O
for	O
the	O
bite	O
.	O

The	O
study	O
provides	O
'	O
proof	O
of	O
concept	O
'	O
that	O
genotypic	O
analysis	O
of	O
streptococci	B-bacteria
from	O
bite	O
marks	O
may	O
provide	O
valuable	O
forensic	O
evidence	O
in	O
situations	O
where	O
the	O
perpetrator	O
'	O
s	O
DNA	O
can	O
not	O
be	O
recovered	O
.	O

We	O
have	O
shown	O
that	O
buccal	O
epithelial	O
cells	O
(	O
BEC	O
)	O
from	O
humans	O
can	O
contain	O
a	O
polymicrobial	O
intracellular	O
flora	O
.	O

Members	O
of	O
that	O
flora	O
can	O
induce	O
proinflammatory	O
responses	O
.	O

However	O
,	O
our	O
subjects	O
all	O
had	O
healthy	O
oral	O
mucosa	O
.	O

This	O
might	O
reflect	O
tolerance	O
of	O
bacterial	O
invasion	O
by	O
live	O
BEC	O
.	O

Alternatively	O
,	O
inflammation	O
might	O
not	O
occur	O
if	O
invaded	O
cells	O
were	O
mostly	O
dead	O
,	O
and	O
thus	O
unable	O
to	O
mount	O
a	O
response	O
.	O

This	O
study	O
addressed	O
that	O
issue	O
,	O
by	O
determining	O
the	O
vital	O
status	O
of	O
BEC	O
and	O
the	O
bacteria	O
associated	O
with	O
them	O
.	O

Initial	O
experiments	O
indicated	O
that	O
BEC	O
were	O
anomalously	O
permeable	O
to	O
the	O
DNA	O
stain	O
propidium	O
iodide	O
.	O

We	O
used	O
that	O
property	O
to	O
develop	O
a	O
protocol	O
that	O
combined	O
the	O
DNA	O
stains	O
SYTO	O
9	O
and	O
propidium	O
iodide	O
(	O
indicators	O
of	O
bacterial	O
viability	O
)	O
with	O
the	O
esterase	O
substrate	O
calcein	O
blue	O
AM	O
(	O
an	O
indicator	O
of	O
BEC	O
viability	O
)	O
,	O
and	O
Annexin	O
V	O
Alexa	O
Fluor	O
647	O
conjugate	O
(	O
an	O
apoptosis	O
marker	O
)	O
.	O

That	O
protocol	O
was	O
applied	O
to	O
BEC	O
collected	O
from	O
36	O
human	O
subjects	O
.	O

On	O
average	O
,	O
70	O
%	O
of	O
BEC	O
displayed	O
calcein	O
blue	O
staining	O
,	O
with	O
no	O
binding	O
of	O
Annexin	O
V	O
,	O
25	O
%	O
showed	O
signs	O
of	O
apoptosis	O
,	O
and	O
5	O
%	O
did	O
not	O
stain	O
with	O
calcein	O
blue	O
.	O

The	O
mean	O
percent	O
of	O
BEC	O
with	O
live	O
cell	O
-	O
associated	O
bacteria	O
was	O
29	O
%	O
.	O

Collectively	O
,	O
25	O
%	O
of	O
total	O
BEC	O
displayed	O
calcein	O
blue	O
staining	O
and	O
live	O
(	O
SYTO	O
9	O
stained	O
)	O
bacteria	O
.	O

Only	O
1	O
%	O
of	O
total	O
BEC	O
were	O
negative	O
for	O
calcein	O
blue	O
and	O
associated	O
with	O
live	O
bacteria	O
.	O

Our	O
findings	O
suggest	O
that	O
live	O
BEC	O
are	O
tolerant	O
of	O
bacterial	O
invasion	O
.	O

This	O
may	O
be	O
due	O
to	O
complex	O
interactions	O
between	O
members	O
of	O
the	O
polymicrobial	O
flora	O
and	O
their	O
host	O
BEC	O
.	O

To	O
measure	O
antibacterial	O
action	O
of	O
photoactivated	O
disinfection	O
(	O
PAD	O
)	O
on	O
endodontic	O
bacteria	O
in	O
planktonic	O
suspension	O
and	O
root	O
canals	O
.	O

Four	O
bacteria	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Streptococcus	B-bacteria
intermedius	I-bacteria
,	O
were	O
tested	O
in	O
suspension	O
.	O

After	O
mixing	O
equal	O
volumes	O
of	O
Tolonium	O
chloride	O
and	O
bacterial	O
suspension	O
for	O
60s	O
,	O
each	O
200	O
microL	O
of	O
concentration	O
(	O
>	O
10	O
(	O
6	O
)	O
cfu	O
mL	O
(	O
-	O
1	O
)	O
)	O
was	O
irradiated	O
with	O
light	O
at	O
633	O
+	O
/	O
-	O
2	O
nm	O
.	O

Each	O
energy	O
dose	O
/	O
Tolonium	O
chloride	O
concentration	O
combination	O
was	O
tested	O
eight	O
times	O
,	O
with	O
controls	O
.	O

Prepared	O
root	O
canals	O
in	O
Training	O
Blocs	O
and	O
extracted	O
human	O
teeth	O
were	O
inoculated	O
with	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
followed	O
by	O
10	O
mg	O
L	O
(	O
-	O
1	O
)	O
Tolonium	O
chloride	O
or	O
saline	O
.	O

Bacteria	O
in	O
canals	O
were	O
sampled	O
before	O
and	O
after	O
light	O
irradiation	O
.	O

Student	O
t	O
-	O
test	O
assessed	O
significance	O
of	O
changes	O
in	O
viable	O
bacteria	O
produced	O
by	O
treatment	O
of	O
either	O
light	O
or	O
Tolonium	O
chloride	O
alone	O
and	O
light	O
/	O
Tolonium	O
chloride	O
combinations	O
.	O

In	O
suspension	O
,	O
reductions	O
in	O
bacteria	O
were	O
highly	O
significant	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
for	O
light	O
/	O
Tolonium	O
chloride	O
combinations	O
compared	O
to	O
light	O
or	O
Tolonium	O
chloride	O
alone	O
.	O

Maximum	O
mean	O
log	O
reductions	O
of	O
1	O
.	O
14	O
(	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
)	O
,	O
2	O
.	O
48	O
(	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
)	O
,	O
2	O
.	O
81	O
(	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
)	O
and	O
6	O
.	O
73	O
(	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
)	O
were	O
at	O
4	O
.	O
8	O
J	O
/	O
20	O
mg	O
L	O
(	O
-	O
1	O
)	O
.	O

Antibacterial	O
action	O
was	O
increased	O
by	O
energy	O
dose	O
increase	O
(	O
not	O
always	O
significantly	O
)	O
,	O
but	O
not	O
by	O
Tolonium	O
chloride	O
concentration	O
.	O

In	O
control	O
canals	O
mean	O
log	O
reductions	O
of	O
0	O
.	O
42	O
(	O
Blocs	O
)	O
and	O
0	O
.	O
38	O
(	O
teeth	O
)	O
from	O
initial	O
levels	O
were	O
not	O
significant	O
.	O

PAD	O
mean	O
log	O
reductions	O
of	O
2	O
.	O
40	O
(	O
Blocs	O
)	O
and	O
2	O
.	O
01	O
(	O
teeth	O
)	O
were	O
highly	O
significant	O
.	O

Changes	O
for	O
PAD	O
/	O
energy	O
dose	O
combinations	O
were	O
not	O
significant	O
.	O

PAD	O
killed	O
endodontic	O
bacteria	O
at	O
statistically	O
significant	O
levels	O
compared	O
to	O
controls	O
.	O

Kills	O
varied	O
with	O
bacterial	O
species	O
.	O

The	O
purposes	O
of	O
the	O
study	O
presented	O
are	O
to	O
identify	O
the	O
microbial	O
content	O
of	O
the	O
collected	O
bone	O
debris	O
and	O
to	O
determine	O
the	O
antibacterial	O
efficiency	O
of	O
chlorhexidine	O
mouth	O
rinse	O
in	O
reducing	O
the	O
microbial	O
content	O
of	O
the	O
collected	O
bone	O
debris	O
.	O

Twenty	O
-	O
five	O
patients	O
who	O
had	O
asymptomatic	O
fully	O
impacted	O
mandibular	O
third	O
molars	O
bilaterally	O
underwent	O
surgical	O
removal	O
for	O
prophylactic	O
and	O
orthodontic	O
considerations	O
.	O

Immediately	O
before	O
surgery	O
all	O
patients	O
rinsed	O
with	O
10	O
mL	O
of	O
their	O
assigned	O
solution	O
(	O
chlorhexidine	O
or	O
sterile	O
saline	O
)	O
for	O
2	O
minutes	O
.	O

Before	O
surgical	O
removal	O
of	O
the	O
teeth	O
,	O
bone	O
debris	O
was	O
collected	O
with	O
a	O
stringent	O
aspiration	O
protocol	O
from	O
the	O
ramus	O
by	O
bone	O
filter	O
.	O

The	O
microbial	O
content	O
of	O
the	O
bone	O
debris	O
was	O
assessed	O
and	O
the	O
bacterial	O
levels	O
between	O
the	O
2	O
groups	O
were	O
compared	O
statistically	O
.	O

All	O
samples	O
from	O
both	O
groups	O
(	O
chlorhexidine	O
or	O
sterile	O
saline	O
)	O
yielded	O
viable	O
microorganisms	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
mean	O
/	O
median	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
g	O
values	O
of	O
both	O
group	O
samples	O
,	O
for	O
aerobes	O
(	O
Streptococcus	B-bacteria
salivarius	I-bacteria
)	O
and	O
anaerobes	O
(	O
Bacteroides	B-bacteria
,	O
Peptococcus	B-bacteria
,	O
Peptostreptococcus	B-bacteria
,	O
and	O
Veillonella	B-bacteria
species	I-bacteria
)	O
.	O

With	O
regard	O
to	O
total	O
microorganisms	O
,	O
the	O
mean	O
CFU	O
/	O
g	O
derived	O
from	O
the	O
chlorhexidine	O
group	O
samples	O
were	O
1	O
.	O
5	O
x	O
10	O
(	O
8	O
)	O
CFU	O
/	O
g	O
per	O
bone	O
sample	O
compared	O
with	O
1	O
.	O
5	O
x	O
10	O
(	O
9	O
)	O
CFU	O
/	O
g	O
for	O
the	O
sterile	O
saline	O
control	O
group	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Although	O
chlorhexidine	O
rinsing	O
immediately	O
before	O
surgery	O
reduced	O
the	O
levels	O
of	O
total	O
microorganisms	O
when	O
compared	O
with	O
stringent	O
aspiration	O
protocol	O
alone	O
,	O
it	O
has	O
not	O
been	O
found	O
effective	O
on	O
aerobic	O
Streptococcus	B-bacteria
salivarius	I-bacteria
and	O
,	O
importantly	O
,	O
on	O
anaerobes	O
.	O

The	O
reduced	O
bacterial	O
levels	O
may	O
still	O
carry	O
high	O
infectious	O
risk	O
and	O
may	O
lead	O
to	O
failure	O
in	O
autogenous	O
grafting	O
procedures	O
in	O
oral	O
surgery	O
.	O

Rheumatoid	O
arthritis	O
(	O
RA	O
)	O
and	O
adult	O
periodontitis	O
share	O
common	O
pathogenetic	O
mechanisms	O
and	O
immunologic	O
and	O
pathological	O
findings	O
.	O

One	O
oral	O
pathogen	O
strongly	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
disease	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
possesses	O
a	O
unique	O
microbial	O
enzyme	O
,	O
peptidylarginine	O
deiminase	O
(	O
PAD	O
)	O
,	O
the	O
human	O
equivalent	O
of	O
which	O
has	O
been	O
identified	O
as	O
a	O
susceptibility	O
factor	O
for	O
RA	O
.	O

We	O
suggest	O
that	O
individuals	O
predisposed	O
to	O
periodontal	O
infection	O
are	O
exposed	O
to	O
antigens	O
generated	O
by	O
PAD	O
,	O
with	O
de	O
-	O
iminated	O
fibrin	O
as	O
a	O
likely	O
candidate	O
,	O
which	O
become	O
systemic	O
immunogens	O
and	O
lead	O
to	O
intraarticular	O
inflammation	O
.	O

PAD	O
engendered	O
antigens	O
lead	O
to	O
production	O
of	O
rheumatoid	O
factor	O
-	O
containing	O
immune	O
complexes	O
and	O
provoke	O
local	O
inflammation	O
,	O
both	O
in	O
gingiva	O
and	O
synovium	O
via	O
Fc	O
and	O
C5a	O
receptors	O
.	O

To	O
assess	O
antimicrobial	O
activities	O
of	O
aqueous	O
crude	O
khat	O
(	O
Catha	O
edulis	O
)	O
extracts	O
against	O
a	O
panel	O
of	O
oral	O
microorganisms	O
and	O
to	O
test	O
their	O
ability	O
to	O
modify	O
bacterial	O
resistance	O
to	O
tetracycline	O
and	O
penicillin	O
in	O
vitro	O
.	O

Lyophilized	O
aqueous	O
extracts	O
were	O
prepared	O
from	O
three	O
khat	O
cultivars	O
.	O

The	O
agar	O
dilution	O
method	O
of	O
the	O
NCCLS	O
was	O
used	O
to	O
test	O
the	O
extracts	O
,	O
at	O
concentrations	O
of	O
20	O
-	O
1	O
.	O
25	O
mg	O
/	O
ml	O
,	O
against	O
33	O
oral	O
strains	O
.	O

MIC	O
was	O
defined	O
as	O
the	O
lowest	O
concentration	O
at	O
which	O
there	O
was	O
no	O
visible	O
growth	O
.	O

Slight	O
growth	O
was	O
defined	O
as	O
marked	O
growth	O
reduction	O
(	O
MGR	O
)	O
.	O

The	O
E	O
-	O
test	O
was	O
used	O
to	O
determine	O
the	O
MICs	O
of	O
tetracycline	O
and	O
penicillin	O
-	O
G	O
for	O
three	O
resistant	O
strains	O
in	O
absence	O
and	O
presence	O
of	O
a	O
sub	O
-	O
MIC	O
of	O
the	O
khat	O
extracts	O
(	O
5mg	O
/	O
ml	O
)	O
.	O

Eighteen	O
strains	O
(	O
55	O
%	O
)	O
were	O
sensitive	O
to	O
the	O
extracts	O
(	O
MICs	O
5	O
-	O
20	O
mg	O
/	O
ml	O
)	O
.	O

Most	O
of	O
these	O
were	O
periodontal	O
pathogens	O
with	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythensis	I-bacteria
being	O
the	O
most	O
susceptible	O
(	O
MIC	O
5	O
-	O
10mg	O
/	O
ml	O
)	O
.	O

Veillonella	B-bacteria
parvula	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
and	O
some	O
streptococci	B-bacteria
were	O
not	O
sensitive	O
.	O

Except	O
for	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
that	O
showed	O
MGR	O
at	O
1mg	O
/	O
ml	O
,	O
cariogenic	O
species	O
were	O
neither	O
sensitive	O
.	O

The	O
extracts	O
were	O
active	O
against	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
(	O
MIC	O
10	O
-	O
20	O
mg	O
/	O
ml	O
)	O
but	O
not	O
against	O
Candida	O
albicans	O
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

The	O
presence	O
of	O
the	O
khat	O
extracts	O
at	O
a	O
sub	O
-	O
MIC	O
resulted	O
in	O
a	O
2	O
-	O
4	O
-	O
fold	O
potentiation	O
of	O
the	O
tested	O
antibiotics	O
against	O
the	O
resistant	O
strains	O
.	O

Khat	O
has	O
water	O
-	O
soluble	O
constituents	O
possessing	O
selective	O
antibacterial	O
activity	O
against	O
oral	O
bacteria	O
.	O

There	O
is	O
preliminary	O
evidence	O
for	O
presence	O
of	O
an	O
antibiotic	O
resistance	O
-	O
modifying	O
component	O
.	O

Further	O
investigation	O
is	O
needed	O
to	O
identify	O
the	O
active	O
components	O
and	O
assess	O
their	O
clinical	O
relevance	O
.	O

We	O
analyzed	O
the	O
distribution	O
of	O
10	O
periodontal	O
bacteria	O
species	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Capnocytophaga	B-bacteria
ochracea	I-bacteria
,	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
in	O
children	O
,	O
and	O
then	O
compared	O
their	O
distribution	O
in	O
those	O
children	O
and	O
their	O
mothers	O
,	O
with	O
special	O
attention	O
given	O
to	O
three	O
of	O
the	O
species	O
known	O
as	O
the	O
red	O
complex	O
(	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
)	O
whose	O
presence	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
conditions	O
related	O
to	O
periodontal	O
diseases	O
.	O

One	O
hundred	O
thirteen	O
pairs	O
of	O
children	O
and	O
their	O
mothers	O
were	O
randomly	O
selected	O
from	O
patients	O
treated	O
at	O
the	O
Pedodontic	O
Clinic	O
of	O
Osaka	O
University	O
Dental	O
Hospital	O
.	O

Saliva	O
samples	O
were	O
taken	O
at	O
the	O
second	O
visit	O
prior	O
to	O
receiving	O
professional	O
tooth	O
brushing	O
instruction	O
.	O

Genomic	O
DNA	O
was	O
extracted	O
from	O
each	O
saliva	O
sample	O
,	O
followed	O
by	O
a	O
polymerase	O
chain	O
reaction	O
assay	O
with	O
species	O
-	O
specific	O
sets	O
of	O
primers	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
was	O
the	O
most	O
frequently	O
detected	O
species	O
in	O
the	O
mothers	O
,	O
followed	O
by	O
C	B-bacteria
.	I-bacteria
sputigena	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
while	O
C	B-bacteria
.	I-bacteria
sputigena	I-bacteria
had	O
the	O
highest	O
detection	O
rate	O
,	O
followed	O
by	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
in	O
the	O
children	O
.	O

The	O
detection	O
rate	O
of	O
the	O
red	O
complex	O
species	O
in	O
children	O
whose	O
mothers	O
possessed	O
the	O
same	O
species	O
was	O
significantly	O
higher	O
than	O
in	O
those	O
whose	O
mothers	O
did	O
not	O
possess	O
them	O
.	O

Our	O
results	O
indicate	O
a	O
correlation	O
between	O
the	O
presence	O
of	O
periodontal	O
bacteria	O
in	O
children	O
and	O
their	O
mothers	O
,	O
while	O
the	O
presence	O
of	O
red	O
complex	O
bacteria	O
in	O
children	O
was	O
highly	O
associated	O
with	O
that	O
in	O
their	O
mothers	O
.	O

Bacteria	O
were	O
isolated	O
from	O
the	O
dental	O
plaques	O
of	O
nine	O
dogs	O
and	O
a	O
sample	O
of	O
pooled	O
saliva	O
from	O
five	O
other	O
dogs	O
and	O
were	O
then	O
identified	O
by	O
comparative	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

Among	O
339	O
isolates	O
,	O
84	O
different	O
phylotypes	O
belonging	O
to	O
37	O
genera	O
were	O
identified	O
.	O

Approximately	O
half	O
of	O
the	O
phylotypes	O
were	O
identified	O
to	O
the	O
species	O
level	O
,	O
and	O
28	O
%	O
of	O
these	O
were	O
considered	O
members	O
of	O
the	O
indigenous	O
oral	O
microbiota	O
of	O
humans	O
.	O

The	O
16S	O
rRNA	O
gene	O
sequences	O
of	O
the	O
remaining	O
44	O
phylotypes	O
were	O
not	O
represented	O
in	O
GenBank	O
,	O
and	O
most	O
of	O
these	O
phylotypes	O
were	O
tentatively	O
identified	O
as	O
candidate	O
new	O
species	O
.	O

The	O
genera	O
most	O
frequently	O
isolated	O
from	O
saliva	O
were	O
Actinomyces	B-bacteria
(	O
26	O
%	O
)	O
,	O
Streptococcus	B-bacteria
(	O
18	O
%	O
)	O
,	O
and	O
Granulicatella	B-bacteria
(	O
17	O
%	O
)	O
.	O

The	O
genera	O
most	O
frequently	O
isolated	O
from	O
plaque	O
were	O
Porphyromonas	B-bacteria
(	O
20	O
%	O
)	O
,	O
Actinomyces	B-bacteria
(	O
12	O
%	O
)	O
,	O
and	O
Neisseria	B-bacteria
(	O
10	O
%	O
)	O
.	O

A	O
comparison	O
of	O
the	O
DNA	O
sequences	O
from	O
this	O
study	O
with	O
sequences	O
of	O
the	O
human	O
microbiota	O
available	O
in	O
GenBank	O
showed	O
that	O
,	O
on	O
average	O
,	O
canine	O
and	O
human	O
microbiotas	O
differed	O
by	O
almost	O
7	O
%	O
in	O
the	O
16S	O
rRNA	O
gene	O
.	O

In	O
conclusion	O
,	O
this	O
study	O
has	O
shown	O
that	O
the	O
cultivable	O
oral	O
microbiotas	O
of	O
dogs	O
and	O
humans	O
show	O
significant	O
differences	O
.	O

More	O
than	O
700	O
bacterial	O
species	O
or	O
phylotypes	O
,	O
of	O
which	O
over	O
50	O
%	O
have	O
not	O
been	O
cultivated	O
,	O
have	O
been	O
detected	O
in	O
the	O
oral	O
cavity	O
.	O

Our	O
purposes	O
were	O
(	O
i	O
)	O
to	O
utilize	O
culture	O
-	O
independent	O
molecular	O
techniques	O
to	O
extend	O
our	O
knowledge	O
on	O
the	O
breadth	O
of	O
bacterial	O
diversity	O
in	O
the	O
healthy	O
human	O
oral	O
cavity	O
,	O
including	O
not	O
-	O
yet	O
-	O
cultivated	O
bacteria	O
species	O
,	O
and	O
(	O
ii	O
)	O
to	O
determine	O
the	O
site	O
and	O
subject	O
specificity	O
of	O
bacterial	O
colonization	O
.	O

Nine	O
sites	O
from	O
five	O
clinically	O
healthy	O
subjects	O
were	O
analyzed	O
.	O

Sites	O
included	O
tongue	O
dorsum	O
,	O
lateral	O
sides	O
of	O
tongue	O
,	O
buccal	O
epithelium	O
,	O
hard	O
palate	O
,	O
soft	O
palate	O
,	O
supragingival	O
plaque	O
of	O
tooth	O
surfaces	O
,	O
subgingival	O
plaque	O
,	O
maxillary	O
anterior	O
vestibule	O
,	O
and	O
tonsils	O
.	O

16S	O
rRNA	O
genes	O
from	O
sample	O
DNA	O
were	O
amplified	O
,	O
cloned	O
,	O
and	O
transformed	O
into	O
Escherichia	B-bacteria
coli	I-bacteria
.	O

Sequences	O
of	O
16S	O
rRNA	O
genes	O
were	O
used	O
to	O
determine	O
species	O
identity	O
or	O
closest	O
relatives	O
.	O

In	O
2	O
,	O
589	O
clones	O
,	O
141	O
predominant	O
species	O
were	O
detected	O
,	O
of	O
which	O
over	O
60	O
%	O
have	O
not	O
been	O
cultivated	O
.	O

Thirteen	O
new	O
phylotypes	O
were	O
identified	O
.	O

Species	O
common	O
to	O
all	O
sites	O
belonged	O
to	O
the	O
genera	O
Gemella	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
and	O
Veillonella	B-bacteria
.	O

While	O
some	O
species	O
were	O
subject	O
specific	O
and	O
detected	O
in	O
most	O
sites	O
,	O
other	O
species	O
were	O
site	O
specific	O
.	O

Most	O
sites	O
possessed	O
20	O
to	O
30	O
different	O
predominant	O
species	O
,	O
and	O
the	O
number	O
of	O
predominant	O
species	O
from	O
all	O
nine	O
sites	O
per	O
individual	O
ranged	O
from	O
34	O
to	O
72	O
.	O

Species	O
typically	O
associated	O
with	O
periodontitis	O
and	O
caries	O
were	O
not	O
detected	O
.	O

There	O
is	O
a	O
distinctive	O
predominant	O
bacterial	O
flora	O
of	O
the	O
healthy	O
oral	O
cavity	O
that	O
is	O
highly	O
diverse	O
and	O
site	O
and	O
subject	O
specific	O
.	O

It	O
is	O
important	O
to	O
fully	O
define	O
the	O
human	O
microflora	O
of	O
the	O
healthy	O
oral	O
cavity	O
before	O
we	O
can	O
understand	O
the	O
role	O
of	O
bacteria	O
in	O
oral	O
disease	O
.	O

Oral	O
malodour	O
is	O
considered	O
to	O
be	O
caused	O
by	O
the	O
proteolytic	O
activity	O
of	O
anaerobic	O
Gram	O
-	O
negative	O
oral	O
bacteria	O
.	O

In	O
a	O
previous	O
study	O
,	O
it	O
was	O
shown	O
that	O
these	O
bacteria	O
were	O
susceptible	O
to	O
blue	O
light	O
(	O
wavelengths	O
of	O
400	O
-	O
500	O
nm	O
)	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
blue	O
light	O
on	O
malodour	O
production	O
by	O
mixed	O
oral	O
microflora	O
was	O
tested	O
in	O
a	O
salivary	O
incubation	O
assay	O
.	O

Whole	O
saliva	O
samples	O
were	O
exposed	O
to	O
a	O
xenon	O
light	O
source	O
for	O
30	O
,	O
60	O
,	O
120	O
and	O
240	O
s	O
,	O
equivalent	O
to	O
fluences	O
of	O
34	O
,	O
68	O
,	O
137	O
and	O
274	O
J	O
cm	O
(	O
-	O
2	O
)	O
,	O
respectively	O
.	O

Malodour	O
was	O
scored	O
by	O
two	O
judges	O
.	O

The	O
levels	O
of	O
volatile	O
sulfide	O
compounds	O
(	O
VSC	O
)	O
were	O
measured	O
using	O
a	O
sulfide	O
monitor	O
(	O
Halimeter	O
)	O
,	O
the	O
microbial	O
population	O
was	O
assessed	O
using	O
viable	O
counts	O
and	O
microscopy	O
,	O
salivary	O
protein	O
degradation	O
was	O
followed	O
by	O
SDS	O
-	O
PAGE	O
densitometry	O
and	O
VSC	O
-	O
producing	O
bacteria	O
were	O
demonstrated	O
using	O
a	O
differential	O
agar	O
.	O

The	O
results	O
showed	O
that	O
the	O
exposure	O
of	O
mixed	O
salivary	O
microflora	O
to	O
blue	O
light	O
caused	O
a	O
reduction	O
in	O
malodour	O
production	O
concomitant	O
with	O
a	O
selective	O
inhibitory	O
effect	O
on	O
the	O
population	O
of	O
Gram	O
-	O
negative	O
oral	O
bacteria	O
.	O

These	O
results	O
suggest	O
that	O
light	O
exposure	O
might	O
have	O
clinical	O
applications	O
for	O
the	O
treatment	O
of	O
oral	O
malodour	O
.	O

Current	O
treatment	O
options	O
in	O
patients	O
with	O
primary	O
and	O
secondary	O
hyperoxaluria	O
are	O
limited	O
and	O
do	O
not	O
always	O
lead	O
to	O
sufficient	O
reduction	O
in	O
urinary	O
oxalate	O
excretion	O
.	O

Intestinal	O
oxalate	O
degrading	O
bacteria	O
are	O
capable	O
of	O
degrading	O
oxalate	O
to	O
CO	O
(	O
2	O
)	O
and	O
formate	O
,	O
the	O
latter	O
being	O
further	O
metabolized	O
and	O
excreted	O
via	O
the	O
feces	O
.	O

It	O
is	O
speculated	O
,	O
that	O
both	O
endogenously	O
produced	O
,	O
as	O
well	O
as	O
dietary	O
oxalate	O
can	O
be	O
significantly	O
removed	O
via	O
the	O
intestinal	O
tract	O
.	O

Oxalobacter	B-bacteria
formigenes	I-bacteria
,	O
an	O
obligate	O
anaerobic	O
microbe	O
normally	O
found	O
in	O
the	O
intestinal	O
tract	O
has	O
one	O
oxalate	O
degrading	O
enzyme	O
,	O
oxalyl	O
-	O
CoA	O
decarboxylase	O
,	O
which	O
is	O
also	O
found	O
in	O
Bifidobacterium	B-bacteria
lactis	I-bacteria
.	O

Other	O
bacteria	O
with	O
possible	O
oxalate	O
degrading	O
potency	O
are	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
as	O
well	O
as	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Eubacterium	B-bacteria
lentum	I-bacteria
.	O

However	O
,	O
specific	O
therapeutic	O
studies	O
on	O
humans	O
are	O
scarce	O
and	O
,	O
except	O
for	O
Oxalobacter	B-bacteria
,	O
data	O
are	O
not	O
congruent	O
.	O

We	O
found	O
the	O
oral	O
application	O
of	O
Oxalobacter	B-bacteria
successful	O
in	O
patients	O
with	O
primary	O
hyperoxaluria	O
.	O

However	O
,	O
long	O
-	O
term	O
post	O
-	O
treatment	O
follow	O
-	O
up	O
of	O
1	O
-	O
2	O
years	O
showed	O
that	O
constant	O
intestinal	O
colonization	O
is	O
not	O
achieved	O
in	O
most	O
patients	O
.	O

In	O
one	O
patient	O
with	O
constant	O
colonization	O
,	O
urinary	O
oxalate	O
excretion	O
normalized	O
over	O
time	O
.	O

Short	O
-	O
term	O
studies	O
with	O
other	O
bacteria	O
such	O
as	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
did	O
not	O
show	O
a	O
specific	O
reduction	O
in	O
urinary	O
oxalate	O
excretion	O
.	O

O	O
.	O
formigenes	O
might	O
be	O
a	O
promising	O
new	O
therapeutic	O
tool	O
in	O
patients	O
with	O
primary	O
and	O
secondary	O
hyperoxaluria	O
.	O

A	O
novel	O
mouthrinse	O
(	O
IND	O
61	O
,	O
164	O
)	O
containing	O
essential	O
oils	O
and	O
extracts	O
from	O
four	O
plant	O
species	O
(	O
Melaleuca	O
alternifolia	O
,	O
Leptospermum	O
scoparium	O
,	O
Calendula	O
officinalis	O
and	O
Camellia	O
sinensis	O
)	O
were	O
tested	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
safety	O
,	O
palatability	O
and	O
preliminary	O
efficacy	O
of	O
the	O
rinse	O
.	O

Fifteen	O
subjects	O
completed	O
the	O
Phase	O
I	O
safety	O
study	O
.	O

Seventeen	O
subjects	O
completed	O
the	O
Phase	O
II	O
randomized	O
placebo	O
-	O
controlled	O
study	O
.	O

Plaque	O
was	O
collected	O
,	O
gingival	O
and	O
plaque	O
indices	O
were	O
recorded	O
(	O
baseline	O
,	O
6	O
weeks	O
,	O
and	O
12	O
weeks	O
)	O
.	O

The	O
relative	O
abundance	O
of	O
two	O
periodontal	O
pathogens	O
(	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tanerella	B-bacteria
forsythensis	I-bacteria
)	O
was	O
determined	O
utilizing	O
digoxigenin	O
-	O
labeled	O
DNA	O
probes	O
.	O

ANCOVA	O
was	O
used	O
at	O
the	O
p	O
=	O
0	O
.	O
05	O
level	O
of	O
significance	O
.	O

Two	O
subjects	O
reported	O
a	O
minor	O
adverse	O
event	O
.	O

One	O
subject	O
withdrew	O
from	O
the	O
study	O
.	O

Several	O
subjects	O
objected	O
to	O
the	O
taste	O
of	O
the	O
test	O
rinse	O
but	O
continued	O
treatment	O
.	O

Differences	O
between	O
gingival	O
index	O
,	O
plaque	O
index	O
or	O
relative	O
abundance	O
of	O
either	O
bacterial	O
species	O
did	O
not	O
reach	O
statistical	O
significance	O
when	O
comparing	O
nine	O
placebo	O
subjects	O
with	O
eight	O
test	O
rinse	O
subjects	O
.	O

Subjects	O
exposed	O
to	O
the	O
test	O
rinse	O
experienced	O
no	O
abnormal	O
oral	O
lesions	O
,	O
altered	O
vital	O
signs	O
,	O
changes	O
in	O
liver	O
,	O
kidney	O
,	O
or	O
bone	O
marrow	O
function	O
.	O

Larger	O
scale	O
studies	O
would	O
be	O
necessary	O
to	O
determine	O
the	O
efficacy	O
and	O
oral	O
health	O
benefits	O
of	O
the	O
test	O
rinse	O
.	O

Human	O
dental	O
plaque	O
is	O
thought	O
to	O
contribute	O
to	O
disease	O
,	O
not	O
only	O
in	O
the	O
oral	O
cavity	O
but	O
also	O
at	O
other	O
body	O
sites	O
.	O

To	O
investigate	O
the	O
pathogenicity	O
of	O
dental	O
plaque	O
in	O
tissues	O
remote	O
from	O
the	O
mouth	O
,	O
we	O
examined	O
the	O
ability	O
of	O
human	O
supragingival	O
dental	O
plaque	O
to	O
induce	O
infective	O
endocarditis	O
(	O
IE	O
)	O
in	O
rats	O
.	O

In	O
total	O
,	O
15	O
out	O
of	O
27	O
catheterized	O
rats	O
survived	O
after	O
intravenous	O
injections	O
with	O
human	O
supragingival	O
dental	O
plaque	O
suspensions	O
containing	O
3	O
x	O
10	O
(	O
6	O
)	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
of	O
bacterial	O
cells	O
.	O

In	O
surviving	O
rats	O
,	O
infected	O
vegetations	O
were	O
formed	O
in	O
all	O
except	O
one	O
rat	O
.	O

The	O
microbial	O
composition	O
of	O
the	O
infected	O
vegetations	O
was	O
different	O
from	O
that	O
of	O
the	O
respective	O
dental	O
plaque	O
inocula	O
,	O
with	O
Streptococcus	B-bacteria
oralis	I-bacteria
comprising	O
the	O
majority	O
of	O
the	O
isolates	O
.	O

In	O
rats	O
affected	O
with	O
endocarditis	O
,	O
the	O
aortic	O
sinus	O
was	O
filled	O
with	O
fibrinous	O
vegetation	O
containing	O
bacteria	O
.	O

Inflammatory	O
cells	O
infiltrated	O
the	O
aortic	O
valve	O
,	O
the	O
aorta	O
adjacent	O
to	O
the	O
valve	O
,	O
and	O
the	O
cardiac	O
muscles	O
.	O

The	O
inoculation	O
of	O
catheterized	O
rats	O
with	O
a	O
cell	O
suspension	O
of	O
S	O
.	O
oralis	O
isolate	O
(	O
5	O
x	O
10	O
(	O
6	O
)	O
CFU	O
)	O
was	O
not	O
lethal	O
but	O
capable	O
of	O
inducing	O
endocarditis	O
in	O
all	O
animals	O
.	O

The	O
results	O
suggest	O
that	O
if	O
dental	O
plaque	O
were	O
introduced	O
into	O
the	O
bloodstream	O
,	O
it	O
could	O
serve	O
as	O
a	O
potent	O
source	O
of	O
bacteria	O
causing	O
IE	O
in	O
humans	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
)	O
is	O
an	O
important	O
gastrointestinal	O
pathogen	O
associated	O
with	O
gastritis	O
as	O
well	O
as	O
gastric	O
or	O
duodenal	O
ulcers	O
and	O
gastric	O
cancer	O
.	O

The	O
oral	O
cavity	O
has	O
been	O
considered	O
as	O
a	O
potential	O
reservoir	O
for	O
the	O
gastric	O
infection	O
and	O
reinfection	O
.	O

The	O
objective	O
of	O
our	O
studies	O
was	O
to	O
evaluate	O
the	O
influence	O
of	O
oral	O
H	O
.	O
pylori	O
for	O
the	O
stomach	O
infection	O
and	O
the	O
release	O
of	O
gut	O
hormones	O
affecting	O
food	O
intake	O
such	O
as	O
ghrelin	O
and	O
gastric	O
secretion	O
such	O
as	O
gastrin	O
.	O

Additionally	O
,	O
the	O
contribution	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
periodontal	O
disease	O
has	O
been	O
examined	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
stomach	O
was	O
assessed	O
by	O
(	O
13	O
)	O
C	O
-	O
Urease	O
Breath	O
Test	O
and	O
presence	O
of	O
the	O
bacteria	O
in	O
oral	O
cavity	O
by	O
culture	O
.	O

The	O
periodontal	O
status	O
was	O
measured	O
by	O
pockets	O
depth	O
with	O
the	O
periodontal	O
probe	O
.	O

We	O
estimated	O
the	O
serum	O
level	O
of	O
IgG	O
anti	O
-	O
H	O
.	O
pylori	O
,	O
anti	O
-	O
VacA	O
,	O
anti	O
-	O
CagA	O
,	O
ghrelin	O
,	O
gastrin	O
,	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
8	O
in	O
blood	O
and	O
the	O
level	O
of	O
IgA	O
anti	O
-	O
H	O
.	O
pylori	O
in	O
saliva	O
.	O

The	O
presence	O
of	O
H	O
.	O
pylori	O
in	O
oral	O
cavity	O
was	O
detected	O
in	O
54	O
.	O
1	O
%	O
of	O
examined	O
individuals	O
,	O
whereas	O
the	O
H	O
.	O
pylori	O
gastric	O
infection	O
in	O
tested	O
group	O
was	O
found	O
in	O
51	O
%	O
cases	O
.	O

However	O
,	O
the	O
correlation	O
analysis	O
between	O
those	O
two	O
groups	O
of	O
patients	O
involving	O
together	O
about	O
100	O
subjects	O
showed	O
that	O
within	O
the	O
group	O
of	O
patients	O
with	O
positive	O
gastric	O
H	O
.	O
pylori	O
infection	O
only	O
45	O
.	O
1	O
%	O
did	O
not	O
show	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
saliva	O
and	O
43	O
.	O
1	O
%	O
showed	O
no	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
supragingival	O
plaque	O
.	O

In	O
line	O
of	O
these	O
findings	O
patients	O
who	O
did	O
not	O
have	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
,	O
53	O
.	O
2	O
%	O
showed	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
saliva	O
and	O
42	O
.	O
9	O
%	O
in	O
supragingival	O
plaques	O
.	O

Serum	O
level	O
of	O
ghrelin	O
and	O
gastrin	O
in	O
subjects	O
with	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
inoculation	O
but	O
without	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
were	O
not	O
significantly	O
different	O
from	O
those	O
without	O
the	O
presence	O
of	O
this	O
germ	O
in	O
oral	O
cavity	O
.	O

In	O
contrast	O
,	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
resulted	O
in	O
significant	O
reduction	O
in	O
serum	O
ghrelin	O
levels	O
and	O
significant	O
elevation	O
of	O
gastrin	O
as	O
compared	O
to	O
those	O
who	O
were	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
negative	O
.	O

We	O
concluded	O
that	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
alone	O
does	O
not	O
seem	O
to	O
serve	O
as	O
bacterium	O
sanctuary	O
for	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
and	O
,	O
unlike	O
gastric	O
infection	O
,	O
it	O
fails	O
to	O
affect	O
serum	O
levels	O
of	O
hormones	O
stimulating	O
appetitive	O
behaviour	O
such	O
as	O
ghrelin	O
and	O
gastric	O
acid	O
secretion	O
such	O
as	O
gastrin	O
.	O

The	O
aim	O
of	O
this	O
prospective	O
study	O
was	O
to	O
evaluate	O
the	O
long	O
term	O
change	O
in	O
oral	O
pathogens	O
following	O
radiation	O
therapy	O
.	O

Twenty	O
-	O
two	O
patients	O
with	O
planned	O
radiation	O
therapy	O
(	O
>	O
30	O
Gy	O
)	O
of	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
were	O
included	O
.	O

Before	O
radiation	O
therapy	O
,	O
after	O
3	O
,	O
6	O
,	O
and	O
12	O
months	O
samples	O
from	O
the	O
deepest	O
periodontal	O
pocket	O
were	O
drawn	O
.	O

Five	O
major	O
periodontal	O
pathogens	O
were	O
studied	O
using	O
DNA	O
probes	O
(	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Bacteriodes	B-bacteria
forsythus	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
.	O

Stimulated	O
saliva	O
was	O
sampled	O
for	O
the	O
microbiologic	O
study	O
of	O
caries	O
pathogens	O
(	O
streptococci	B-bacteria
and	O
lactobacilli	B-bacteria
)	O
.	O

Plaque	O
index	O
and	O
decayed	O
,	O
missing	O
,	O
filled	O
tooth	O
surfaces	O
(	O
DMF	O
-	O
S	O
)	O
were	O
recorded	O
.	O

A	O
normalisation	O
of	O
the	O
caries	O
bacteria	O
is	O
not	O
found	O
correlating	O
to	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
affected	O
teeth	O
(	O
DMF	O
-	O
S	O
)	O
from	O
80	O
.	O
7	O
to	O
88	O
.	O
5	O
after	O
12	O
months	O
.	O

The	O
plaque	O
index	O
remained	O
unchanged	O
.	O

The	O
incidence	O
of	O
periodontal	O
pathogens	O
did	O
not	O
significantly	O
change	O
during	O
the	O
follow	O
up	O
.	O

In	O
contrast	O
to	O
radiation	O
caries	O
there	O
seems	O
to	O
be	O
no	O
microbiological	O
evidence	O
for	O
`	O
`	O
radiation	O
periodontitis	O
'	O
'	O
.	O

Despite	O
of	O
the	O
intensive	O
oral	O
hygiene	O
no	O
reduction	O
of	O
the	O
high	O
number	O
of	O
caries	O
pathogens	O
is	O
found	O
,	O
which	O
leads	O
to	O
a	O
high	O
risk	O
of	O
tooth	O
decay	O
even	O
12	O
months	O
after	O
radiation	O
.	O

To	O
evaluate	O
the	O
number	O
of	O
bacteria	O
extruded	O
apically	O
from	O
extracted	O
teeth	O
ex	O
vivo	O
after	O
canal	O
instrumentation	O
using	O
the	O
two	O
engine	O
-	O
driven	O
techniques	O
utilizing	O
nickel	O
-	O
titanium	O
instruments	O
(	O
ProTaper	O
and	O
System	O
GT	O
)	O
.	O

Forty	O
extracted	O
single	O
-	O
rooted	O
human	O
mandibular	O
premolar	O
teeth	O
were	O
used	O
.	O

Access	O
cavities	O
were	O
prepared	O
and	O
root	O
canals	O
were	O
then	O
contaminated	O
with	O
a	O
suspension	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
dried	O
.	O

The	O
contaminated	O
roots	O
were	O
divided	O
into	O
two	O
experimental	O
groups	O
of	O
15	O
teeth	O
each	O
and	O
one	O
control	O
group	O
of	O
10	O
teeth	O
.	O

Group	O
1	O
,	O
ProTaper	O
group	O
:	O
the	O
root	O
canals	O
were	O
instrumented	O
using	O
ProTaper	O
instruments	O
.	O

Group	O
2	O
,	O
System	O
GT	O
group	O
:	O
the	O
root	O
canals	O
were	O
instrumented	O
using	O
System	O
GT	O
instruments	O
.	O

Group	O
3	O
,	O
control	O
group	O
:	O
no	O
instrumentation	O
was	O
attempted	O
.	O

Bacteria	O
extruded	O
from	O
the	O
apical	O
foramen	O
during	O
instrumentation	O
were	O
collected	O
into	O
vials	O
.	O

The	O
microbiological	O
samples	O
from	O
the	O
vials	O
were	O
incubated	O
in	O
culture	O
media	O
for	O
24	O
h	O
.	O
Colonies	O
of	O
bacteria	O
were	O
counted	O
and	O
the	O
results	O
were	O
given	O
as	O
number	O
of	O
colony	O
-	O
forming	O
units	O
.	O

The	O
data	O
obtained	O
were	O
analysed	O
using	O
the	O
Kruskal	O
-	O
Wallis	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
and	O
Mann	O
-	O
Whitney	O
U	O
-	O
tests	O
,	O
with	O
alpha	O
=	O
0	O
.	O
05	O
as	O
the	O
level	O
for	O
statistical	O
significance	O
.	O

There	O
was	O
no	O
significant	O
difference	O
as	O
to	O
the	O
number	O
of	O
extruded	O
bacteria	O
between	O
the	O
ProTaper	O
and	O
System	O
GT	O
engine	O
-	O
driven	O
systems	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Both	O
engine	O
-	O
driven	O
nickel	O
-	O
titanium	O
systems	O
extruded	O
bacteria	O
through	O
the	O
apical	O
foramen	O
.	O

This	O
study	O
was	O
conducted	O
to	O
determine	O
the	O
component	O
that	O
causes	O
the	O
disease	O
in	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
,	O
which	O
shows	O
great	O
resemblance	O
to	O
periodontitis	O
in	O
a	O
pathologic	O
context	O
.	O

Within	O
this	O
study	O
,	O
the	O
pathogen	O
-	O
specific	O
IgG	O
levels	O
formed	O
against	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
FDC	I-bacteria
381	I-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
ATCC	I-bacteria
25845	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
,	O
Bacteroides	B-bacteria
forsythus	I-bacteria
ATCC	I-bacteria
43047	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
25611	I-bacteria
oral	O
bacteria	O
were	O
researched	O
from	O
the	O
blood	O
serum	O
samples	O
of	O
30	O
RA	O
patients	O
and	O
20	O
healthy	O
controls	O
with	O
the	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
method	O
.	O

The	O
IgG	O
levels	O
of	O
P	B-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
melaninogenica	I-bacteria
,	O
and	O
B	B-bacteria
forsythus	I-bacteria
were	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
RA	O
patients	O
when	O
compared	O
with	O
those	O
of	O
the	O
controls	O
.	O

Of	O
the	O
other	O
bacteria	O
antibodies	O
,	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
was	O
not	O
found	O
at	O
greater	O
levels	O
in	O
RA	O
serum	O
samples	O
in	O
comparison	O
with	O
the	O
healthy	O
samples	O
.	O

The	O
antibodies	O
formed	O
against	O
P	B-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
melaninogenica	I-bacteria
,	O
and	O
B	B-bacteria
forsythus	I-bacteria
could	O
be	O
important	O
to	O
the	O
etiopathogenesis	O
of	O
RA	O
.	O

A	O
significant	O
proportion	O
of	O
oral	O
bacteria	O
are	O
unable	O
to	O
undergo	O
cultivation	O
by	O
existing	O
techniques	O
.	O

In	O
this	O
regard	O
,	O
the	O
microbiota	O
from	O
root	O
canals	O
still	O
requires	O
complementary	O
characterization	O
.	O

The	O
present	O
study	O
aimed	O
at	O
the	O
identification	O
of	O
bacteria	O
by	O
sequence	O
analysis	O
of	O
16S	O
rDNA	O
clone	O
libraries	O
from	O
seven	O
endodontically	O
infected	O
teeth	O
.	O

Samples	O
were	O
collected	O
from	O
the	O
root	O
canals	O
,	O
subjected	O
to	O
the	O
PCR	O
with	O
universal	O
16S	O
rDNA	O
primers	O
,	O
cloned	O
and	O
partially	O
sequenced	O
.	O

Clones	O
were	O
clustered	O
into	O
groups	O
of	O
closely	O
related	O
sequences	O
(	O
phylotypes	O
)	O
and	O
identification	O
to	O
the	O
species	O
level	O
was	O
performed	O
by	O
comparative	O
analysis	O
with	O
the	O
GenBank	O
,	O
EMBL	O
and	O
DDBJ	O
databases	O
,	O
according	O
to	O
a	O
98	O
%	O
minimum	O
identity	O
.	O

All	O
samples	O
were	O
positive	O
for	O
bacteria	O
and	O
the	O
number	O
of	O
phylotypes	O
detected	O
per	O
subject	O
varied	O
from	O
two	O
to	O
14	O
.	O

The	O
majority	O
of	O
taxa	O
(	O
65	O
.	O
2	O
%	O
)	O
belonged	O
to	O
the	O
phylum	O
Firmicutes	B-bacteria
of	O
the	O
Gram	O
-	O
positive	O
bacteria	O
,	O
followed	O
by	O
Proteobacteria	B-bacteria
(	O
10	O
.	O
9	O
%	O
)	O
,	O
Spirochaetes	B-bacteria
(	O
4	O
.	O
3	O
%	O
)	O
,	O
Bacteroidetes	B-bacteria
(	O
6	O
.	O
5	O
%	O
)	O
,	O
Actinobacteria	B-bacteria
(	O
2	O
.	O
2	O
%	O
)	O
and	O
Deferribacteres	B-bacteria
(	O
2	O
.	O
2	O
%	O
)	O
.	O

A	O
total	O
of	O
46	O
distinct	O
taxonomic	O
units	O
was	O
identified	O
.	O

Four	O
clones	O
with	O
low	O
similarity	O
to	O
sequences	O
previously	O
deposited	O
in	O
the	O
databases	O
were	O
sequenced	O
to	O
nearly	O
full	O
extent	O
and	O
were	O
classified	O
taxonomically	O
as	O
novel	O
representatives	O
of	O
the	O
order	O
Clostridiales	B-bacteria
,	O
including	O
a	O
putative	O
novel	O
species	O
of	O
Mogibacterium	B-bacteria
.	O

The	O
identification	O
of	O
novel	O
phylotypes	O
associated	O
with	O
endodontic	O
infections	O
suggests	O
that	O
the	O
endodontium	O
may	O
still	O
harbour	O
a	O
relevant	O
proportion	O
of	O
uncharacterized	O
taxa	O
.	O

An	O
evaluation	O
is	O
made	O
of	O
bacterial	O
species	O
and	O
susceptibility	O
to	O
various	O
antibiotics	O
used	O
in	O
application	O
to	O
odontogenic	O
infections	O
of	O
periapical	O
location	O
and	O
in	O
pericoronitis	O
of	O
the	O
lower	O
third	O
molar	O
,	O
with	O
the	O
aim	O
of	O
optimizing	O
the	O
antibiotherapy	O
of	O
such	O
infections	O
and	O
thus	O
preventing	O
unnecessary	O
side	O
effects	O
and	O
over	O
-	O
treatment	O
.	O

Sixty	O
-	O
four	O
patients	O
with	O
odontogenic	O
infection	O
were	O
selected	O
on	O
the	O
basis	O
of	O
a	O
series	O
of	O
inclusion	O
and	O
exclusion	O
criteria	O
.	O

Samples	O
were	O
collected	O
from	O
lesions	O
under	O
maximally	O
aseptic	O
conditions	O
,	O
avoiding	O
oral	O
saprophytic	O
contamination	O
.	O

The	O
samples	O
were	O
cultured	O
and	O
incubated	O
under	O
aerobic	O
and	O
anaerobic	O
conditions	O
,	O
followed	O
by	O
bacteriological	O
identification	O
and	O
antibiotic	O
susceptibility	O
testing	O
.	O

A	O
total	O
of	O
184	O
bacterial	O
strains	O
were	O
isolated	O
and	O
identified	O
,	O
comprising	O
grampositive	O
facultative	O
anaerobes	O
(	O
68	O
%	O
)	O
,	O
gramnegative	O
strict	O
anaerobes	O
(	O
30	O
%	O
)	O
and	O
grampositive	O
facultative	O
anaerobes	O
(	O
2	O
%	O
)	O
.	O

Regardless	O
of	O
the	O
origin	O
of	O
the	O
odontogenic	O
infection	O
,	O
the	O
causal	O
bacteria	O
yielded	O
the	O
best	O
results	O
in	O
terms	O
of	O
increased	O
sensitivity	O
and	O
lesser	O
resistance	O
with	O
amoxicillin	O
/	O
clavulanate	O
and	O
amoxicillin	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

There	O
are	O
increasingly	O
numerous	O
reports	O
in	O
the	O
literature	O
of	O
growing	O
bacterial	O
resistance	O
to	O
antibiotics	O
in	O
infectious	O
processes	O
affecting	O
non	O
-	O
buccodental	O
territories	O
.	O

This	O
same	O
tendency	O
has	O
not	O
been	O
observed	O
in	O
relation	O
to	O
oral	O
infections	O
,	O
though	O
important	O
resistance	O
has	O
been	O
documented	O
for	O
certain	O
concrete	O
antibiotics	O
.	O

According	O
to	O
our	O
results	O
,	O
the	O
common	O
-	O
use	O
antibiotics	O
with	O
the	O
greatest	O
sensitivity	O
and	O
lowest	O
resistance	O
were	O
shown	O
to	O
be	O
amoxicillin	O
/	O
clavulanate	O
followed	O
by	O
amoxicillin	O
alone	O
.	O

In	O
various	O
immunopathologic	O
conditions	O
,	O
bacterial	O
flora	O
induce	O
an	O
immune	O
response	O
which	O
results	O
in	O
inflammatory	O
manifestations	O
,	O
e	O
.	O
g	O
.	O
periapical	O
granuloma	O
.	O

Dendritic	O
cells	O
provide	O
the	O
main	O
orchestration	O
of	O
specific	O
immune	O
responses	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
test	O
the	O
capacity	O
of	O
distinct	O
oral	O
bacterial	O
antigens	O
(	O
prepared	O
from	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
,	O
and	O
Bacteroides	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
to	O
prime	O
human	O
dendritic	O
cells	O
for	O
stimulation	O
of	O
the	O
T	O
-	O
lymphocyte	O
response	O
.	O

To	O
assess	O
the	O
T	O
-	O
lymphocyte	O
response	O
,	O
the	O
expression	O
of	O
CD25	O
,	O
CD69	O
,	O
intracellular	O
interferon	O
gamma	O
(	O
cIFN	O
-	O
gamma	O
)	O
,	O
and	O
intracellular	O
interleukin	O
4	O
(	O
cIL	O
-	O
4	O
)	O
was	O
determined	O
.	O

Dendritic	O
cells	O
were	O
prepared	O
from	O
leukocyte	O
buffy	O
coat	O
from	O
healthy	O
blood	O
donors	O
.	O

Monocytes	O
were	O
stimulated	O
with	O
IL	O
-	O
4	O
and	O
GM	O
-	O
CSF	O
and	O
dendritic	O
cells	O
activated	O
with	O
bacterial	O
lysates	O
.	O

Cell	O
suspensions	O
contained	O
up	O
to	O
90	O
%	O
dendritic	O
cells	O
,	O
which	O
represented	O
2	O
-	O
12	O
%	O
of	O
the	O
initial	O
number	O
of	O
mononuclear	O
cells	O
.	O

Lymphocyte	O
subsets	O
that	O
developed	O
in	O
lymphocyte	O
cultures	O
after	O
1	O
week	O
of	O
stimulation	O
were	O
analyzed	O
by	O
flow	O
cytometry	O
.	O

Dendritic	O
cells	O
,	O
primed	O
with	O
antigens	O
of	O
Bacteroides	B-bacteria
fragilis	I-bacteria
have	O
shown	O
significantly	O
higher	O
activation	O
and	O
expression	O
of	O
intercellular	O
IFN	O
-	O
gamma	O
by	O
T	O
lymphocytes	O
compared	O
to	O
negative	O
controls	O
.	O

The	O
dendritic	O
cells	O
primed	O
with	O
antigens	O
of	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
had	O
no	O
effect	O
on	O
T	O
-	O
lymphocyte	O
activation	O
or	O
cytokine	O
production	O
;	O
instead	O
they	O
induced	O
differentiation	O
of	O
T	O
lymphocytes	O
into	O
CD25bright	O
cells	O
(	O
regulatory	O
T	O
cells	O
)	O
with	O
a	O
potentially	O
inhibitory	O
effect	O
on	O
immune	O
response	O
.	O

Dendritic	O
cells	O
primed	O
with	O
antigens	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
induced	O
increased	O
expression	O
of	O
cIL	O
-	O
4	O
.	O

We	O
conclude	O
that	O
commensal	O
oral	O
bacteria	O
antigens	O
prepared	O
from	O
B	B-bacteria
.	I-bacteria
fragilis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
prime	O
human	O
dendritic	O
cells	O
to	O
induce	O
Th1	O
,	O
Th2	O
,	O
and	O
T	O
(	O
reg	O
)	O
differentiation	O
,	O
respectively	O
.	O

This	O
may	O
advance	O
our	O
understanding	O
of	O
immunopathologic	O
manifestations	O
in	O
the	O
oral	O
cavity	O
and	O
offer	O
new	O
possibilities	O
for	O
redirecting	O
immune	O
responses	O
in	O
mucosal	O
vaccination	O
.	O

To	O
establish	O
whether	O
an	O
intra	O
-	O
oral	O
lubricating	O
device	O
for	O
dry	O
mouth	O
alters	O
the	O
oral	O
environment	O
.	O

A	O
single	O
-	O
blind	O
randomized	O
cross	O
-	O
over	O
study	O
.	O

Twenty	O
-	O
nine	O
dentate	O
subjects	O
from	O
the	O
Sjogren	O
'	O
s	O
syndrome	O
clinic	O
attended	O
on	O
five	O
occasions	O
at	O
4	O
-	O
week	O
intervals	O
.	O

They	O
were	O
randomized	O
,	O
having	O
the	O
device	O
fitted	O
on	O
either	O
the	O
second	O
or	O
the	O
fourth	O
visit	O
for	O
the	O
experimental	O
period	O
,	O
whilst	O
using	O
their	O
preferred	O
method	O
of	O
lubrication	O
throughout	O
the	O
rest	O
of	O
the	O
study	O
.	O

The	O
preferred	O
methods	O
of	O
lubrication	O
were	O
either	O
water	O
(	O
group	O
1	O
,	O
n	O
=	O
10	O
)	O
or	O
saliva	O
substitute	O
(	O
group	O
2	O
,	O
n	O
=	O
9	O
)	O
or	O
sugar	O
-	O
free	O
chewing	O
gum	O
(	O
group	O
3	O
,	O
n	O
=	O
10	O
)	O
.	O

At	O
each	O
visit	O
microbiological	O
,	O
unstimulated	O
and	O
stimulated	O
saliva	O
samples	O
were	O
collected	O
.	O

Dry	O
mouth	O
score	O
,	O
speech	O
test	O
and	O
periodontal	O
indices	O
were	O
recorded	O
.	O

The	O
water	O
lubrication	O
group	O
(	O
1	O
)	O
had	O
a	O
resting	O
salivary	O
flow	O
greater	O
than	O
lubrication	O
groups	O
(	O
2	O
and	O
3	O
)	O
by	O
post	O
-	O
ANOVA	O
contrasts	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
postdevice	O
data	O
also	O
demonstrated	O
a	O
salivary	O
flow	O
greater	O
than	O
lubrication	O
group	O
(	O
3	O
)	O
by	O
post	O
-	O
ANOVA	O
contrasts	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
epithelial	O
cell	O
count	O
using	O
the	O
Spearman	O
correlation	O
was	O
high	O
,	O
possibly	O
reflecting	O
increased	O
viscosity	O
of	O
the	O
saliva	O
(	O
P	O
=	O
0	O
.	O
044	O
)	O
.	O

The	O
speech	O
test	O
indicated	O
that	O
the	O
experimental	O
subjects	O
had	O
difficulty	O
in	O
speaking	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
.	O

This	O
was	O
slightly	O
easier	O
postdevice	O
wear	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
(	O
P	O
=	O
0	O
.	O
009	O
)	O
and	O
Lactobacillus	B-bacteria
(	O
P	O
=	O
0	O
.	O
058	O
)	O
increased	O
in	O
the	O
salivary	O
after	O
wearing	O
the	O
device	O
.	O

Salivary	O
flow	O
rate	O
,	O
Candida	O
albicans	O
,	O
oral	O
dryness	O
,	O
speaking	O
and	O
periodontal	O
indices	O
were	O
unchanged	O
.	O

The	O
oral	O
environment	O
was	O
altered	O
by	O
wearing	O
a	O
lubricating	O
device	O
with	O
an	O
increase	O
in	O
the	O
numbers	O
of	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
.	O

Clinical	O
dryness	O
and	O
speech	O
test	O
correlated	O
with	O
the	O
mean	O
whole	O
salivary	O
flow	O
suggesting	O
a	O
screening	O
method	O
for	O
xerostomia	O
.	O

Ecological	O
studies	O
indicate	O
that	O
most	O
Lactobacillus	B-bacteria
species	I-bacteria
found	O
in	O
the	O
human	O
gastrointestinal	O
tract	O
are	O
likely	O
to	O
be	O
transient	O
(	O
allochthonous	O
)	O
,	O
originating	O
from	O
either	O
the	O
oral	O
cavity	O
or	O
food	O
.	O

In	O
order	O
to	O
investigate	O
if	O
oral	O
lactobacilli	B-bacteria
constitute	O
a	O
part	O
of	O
the	O
faecal	O
Lactobacillus	B-bacteria
biota	I-bacteria
,	O
the	O
Lactobacillus	B-bacteria
biota	I-bacteria
of	O
saliva	O
and	O
faeces	O
of	O
three	O
human	O
subjects	O
were	O
investigated	O
and	O
compared	O
at	O
two	O
time	O
-	O
points	O
in	O
a	O
3	O
-	O
months	O
interval	O
.	O

Bacteriological	O
culture	O
,	O
performed	O
by	O
incubation	O
under	O
standard	O
(	O
37	O
degrees	O
C	O
,	O
anaerobic	O
)	O
and	O
alternative	O
(	O
30	O
degrees	O
C	O
,	O
microaerobic	O
)	O
conditions	O
,	O
as	O
well	O
as	O
PCR	O
-	O
DGGE	O
with	O
group	O
-	O
specific	O
primers	O
were	O
used	O
to	O
characterize	O
the	O
predominant	O
lactobacilli	B-bacteria
.	O

Cell	O
counts	O
varied	O
among	O
the	O
subjects	O
and	O
over	O
time	O
,	O
reaching	O
up	O
to	O
10	O
(	O
7	O
)	O
CFU	O
/	O
ml	O
in	O
saliva	O
and	O
5	O
x	O
10	O
(	O
6	O
)	O
CFU	O
/	O
g	O
in	O
faecal	O
samples	O
.	O

The	O
species	O
composition	O
of	O
the	O
Lactobacillus	B-bacteria
biota	I-bacteria
of	O
human	O
saliva	O
and	O
faeces	O
was	O
found	O
to	O
be	O
subject	O
-	O
specific	O
and	O
fluctuated	O
to	O
some	O
degree	O
,	O
but	O
the	O
species	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
,	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
and	O
Lactobacillus	B-bacteria
vaginalis	I-bacteria
were	O
detected	O
at	O
both	O
time	O
-	O
points	O
in	O
saliva	O
and	O
faecal	O
samples	O
of	O
individual	O
subjects	O
.	O

RAPD	O
-	O
PCR	O
analysis	O
indicated	O
that	O
several	O
strains	O
of	O
these	O
species	O
were	O
present	O
both	O
in	O
the	O
oral	O
cavity	O
and	O
in	O
the	O
faecal	O
samples	O
of	O
the	O
same	O
subject	O
.	O

Oral	O
isolates	O
of	O
the	O
species	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
vaginalis	I-bacteria
showing	O
identical	O
RAPD	O
types	O
were	O
found	O
to	O
persist	O
over	O
time	O
,	O
suggesting	O
that	O
these	O
species	O
are	O
autochthonous	O
to	O
the	O
oral	O
cavity	O
.	O

Our	O
results	O
together	O
with	O
recent	O
published	O
data	O
give	O
strong	O
evidence	O
that	O
some	O
lactobacilli	B-bacteria
found	O
in	O
human	O
faeces	O
are	O
allochthonous	O
to	O
the	O
intestine	O
and	O
originate	O
from	O
the	O
oral	O
cavity	O
.	O

There	O
are	O
conflicting	O
data	O
on	O
the	O
occurrence	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
endodontic	O
patients	O
.	O

This	O
study	O
investigated	O
the	O
prevalence	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
in	O
multi	O
-	O
site	O
oral	O
samples	O
(	O
n	O
=	O
136	O
)	O
from	O
41	O
endodontic	O
patients	O
using	O
culture	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

Additionally	O
,	O
culturable	O
strains	O
were	O
investigated	O
for	O
virulence	O
traits	O
.	O

Overall	O
,	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
detected	O
in	O
at	O
least	O
one	O
tongue	O
,	O
oral	O
rinse	O
,	O
or	O
gingival	O
sulcus	O
sample	O
in	O
68	O
%	O
of	O
patients	O
and	O
in	O
the	O
root	O
canals	O
only	O
in	O
5	O
%	O
of	O
patients	O
.	O

In	O
21	O
patients	O
from	O
whom	O
samples	O
were	O
obtained	O
from	O
all	O
four	O
sites	O
,	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
detected	O
in	O
more	O
tongue	O
than	O
gingival	O
sulcus	O
,	O
oral	O
rinse	O
,	O
and	O
root	O
canal	O
samples	O
(	O
43	O
,	O
14	O
,	O
10	O
,	O
and	O
10	O
%	O
,	O
respectively	O
;	O
p	O
=	O
0	O
.	O
0148	O
,	O
chi	O
(	O
2	O
)	O
)	O
,	O
and	O
in	O
proportionally	O
greater	O
numbers	O
of	O
patients	O
with	O
gingivitis	O
/	O
periodontitis	O
compared	O
to	O
healthy	O
periodontium	O
(	O
73	O
%	O
versus	O
20	O
%	O
;	O
p	O
=	O
0	O
.	O
03	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
.	O

PCR	O
was	O
more	O
sensitive	O
than	O
culture	O
in	O
detecting	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
in	O
oral	O
samples	O
(	O
32	O
%	O
and	O
4	O
%	O
,	O
respectively	O
;	O
p	O
<	O
0	O
.	O
0001	O
,	O
McNemar	O
'	O
s	O
test	O
)	O
.	O

Multiple	O
virulence	O
traits	O
were	O
identified	O
in	O
culturable	O
strains	O
.	O

The	O
oral	O
health	O
of	O
dependent	O
residents	O
at	O
special	O
facilities	O
has	O
often	O
been	O
reported	O
as	O
being	O
poor	O
,	O
but	O
it	O
is	O
difficult	O
to	O
relate	O
oral	O
health	O
to	O
general	O
health	O
and	O
define	O
the	O
need	O
for	O
oral	O
health	O
care	O
.	O

Microbiological	O
analyses	O
of	O
the	O
oral	O
flora	O
have	O
been	O
suggested	O
as	O
a	O
suitable	O
method	O
for	O
evaluating	O
oral	O
health	O
in	O
this	O
group	O
of	O
patients	O
.	O

A	O
study	O
was	O
performed	O
at	O
a	O
nursing	O
facility	O
where	O
33	O
individuals	O
participated	O
.	O

The	O
aim	O
was	O
to	O
describe	O
their	O
oral	O
flora	O
in	O
relation	O
to	O
other	O
health	O
variables	O
and	O
to	O
classify	O
the	O
residents	O
on	O
different	O
risk	O
levels	O
.	O

An	O
oral	O
examination	O
of	O
the	O
residents	O
was	O
made	O
at	O
the	O
facility	O
,	O
together	O
with	O
a	O
3	O
-	O
day	O
food	O
record	O
and	O
an	O
oral	O
microbiological	O
analysis	O
.	O

The	O
analysis	O
classified	O
the	O
residents	O
in	O
different	O
categories	O
according	O
to	O
both	O
acid	O
-	O
producing	O
bacteria	O
and	O
the	O
flora	O
correlated	O
with	O
a	O
reduction	O
in	O
general	O
health	O
.	O

The	O
categories	O
were	O
based	O
on	O
previous	O
studies	O
conducted	O
at	O
the	O
Department	O
of	O
Microbiology	O
(	O
Faculty	O
of	O
Odontology	O
in	O
Goteborg	O
)	O
.	O

The	O
present	O
study	O
revealed	O
that	O
the	O
level	O
for	O
acid	O
-	O
producing	O
bacteria	O
was	O
high	O
in	O
12	O
individuals	O
and	O
the	O
micriobial	O
level	O
according	O
to	O
decreased	O
general	O
health	O
was	O
high	O
in	O
seven	O
individuals	O
.	O

A	O
high	O
level	O
of	O
acid	O
-	O
producing	O
bacteria	O
was	O
related	O
to	O
functional	O
impairment	O
,	O
which	O
was	O
in	O
turn	O
related	O
to	O
nutritional	O
problems	O
and	O
help	O
with	O
oral	O
hygiene	O
.	O

The	O
microbial	O
level	O
according	O
to	O
the	O
reduction	O
in	O
general	O
health	O
did	O
not	O
significantly	O
correlate	O
with	O
other	O
variables	O
.	O

To	O
date	O
,	O
it	O
appears	O
that	O
the	O
dentists	O
'	O
war	O
against	O
dental	O
caries	O
has	O
no	O
end	O
in	O
sight	O
due	O
to	O
the	O
fact	O
that	O
dentists	O
lack	O
any	O
genuine	O
offensive	O
firepower	O
.	O

Make	O
no	O
mistake	O
,	O
the	O
defense	O
has	O
drastically	O
improved	O
as	O
dentists	O
have	O
shifted	O
the	O
focus	O
more	O
toward	O
the	O
preventive	O
aspects	O
of	O
dental	O
care	O
.	O

But	O
defense	O
by	O
itself	O
can	O
not	O
defeat	O
the	O
enemy	O
;	O
at	O
best	O
,	O
it	O
can	O
maintain	O
the	O
status	O
quo	O
.	O

In	O
order	O
to	O
defeat	O
the	O
enemy	O
,	O
one	O
must	O
study	O
and	O
understand	O
the	O
enemy	O
,	O
to	O
know	O
its	O
strengths	O
and	O
weaknesses	O
,	O
and	O
to	O
strike	O
at	O
those	O
points	O
of	O
vulnerability	O
.	O

The	O
aim	O
of	O
this	O
research	O
is	O
to	O
identify	O
and	O
characterize	O
genes	O
that	O
are	O
responsible	O
for	O
observed	O
virulence	O
factors	O
in	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
which	O
is	O
the	O
primary	O
pathogen	O
involved	O
in	O
the	O
development	O
of	O
dental	O
caries	O
.	O

Once	O
there	O
is	O
a	O
more	O
defined	O
understanding	O
of	O
the	O
many	O
virulence	O
factors	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
there	O
will	O
be	O
a	O
much	O
more	O
valuable	O
insight	O
into	O
its	O
role	O
in	O
the	O
ecology	O
of	O
the	O
oral	O
cavity	O
.	O

Eventually	O
,	O
this	O
knowledge	O
could	O
enable	O
dentists	O
to	O
convert	O
the	O
bacterial	O
`	O
`	O
weaponry	O
'	O
'	O
into	O
its	O
own	O
arsenal	O
,	O
which	O
could	O
then	O
be	O
innovatively	O
employed	O
as	O
preventive	O
,	O
diagnostic	O
,	O
and	O
therapeutic	O
agents	O
to	O
treat	O
oral	O
bacterial	O
-	O
related	O
diseases	O
.	O

Our	O
study	O
aimed	O
to	O
evaluate	O
the	O
oral	O
cavity	O
as	O
a	O
reservoir	O
from	O
where	O
Helicobacter	B-bacteria
pylori	I-bacteria
may	O
be	O
transmitted	O
.	O

Histology	O
and	O
PCR	O
amplification	O
were	O
performed	O
.	O

Eighty	O
-	O
four	O
percent	O
of	O
the	O
stomach	O
biopsies	O
tested	O
positive	O
;	O
however	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
detected	O
in	O
dental	O
samples	O
,	O
indicating	O
the	O
absence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
within	O
the	O
oral	O
cavity	O
.	O

The	O
genus	O
Lactobacillus	B-bacteria
has	O
been	O
associated	O
with	O
dental	O
caries	O
in	O
humans	O
,	O
although	O
it	O
is	O
seldom	O
speciated	O
due	O
to	O
lack	O
of	O
simple	O
and	O
nonlaborious	O
identification	O
methods	O
.	O

A	O
considerable	O
heterogeneity	O
among	O
Lactobacillus	B-bacteria
species	I-bacteria
has	O
been	O
demonstrated	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
develop	O
simple	O
methods	O
combining	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
of	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
-	O
amplified	O
16S	O
rRNA	O
(	O
16S	O
rRNA	O
gene	O
PCR	O
-	O
RFLP	O
)	O
and	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
for	O
the	O
identification	O
of	O
13	O
reference	O
strains	O
of	O
Lactobacillus	B-bacteria
.	O

The	O
16S	O
rRNA	O
gene	O
sequences	O
were	O
amplified	O
by	O
PCR	O
using	O
universal	O
primers	O
and	O
digestion	O
of	O
PCR	O
products	O
with	O
the	O
restriction	O
endonucleases	O
,	O
HpaII	O
and	O
HaeIII	O
.	O

The	O
16S	O
rRNA	O
gene	O
PCR	O
-	O
RFLP	O
is	O
reproducible	O
and	O
has	O
been	O
proved	O
to	O
be	O
useful	O
for	O
differentiating	O
Lactobacillus	B-bacteria
strains	I-bacteria
to	O
species	O
level	O
.	O

Seventy	O
-	O
seven	O
Lactobacillus	B-bacteria
isolates	I-bacteria
from	O
a	O
Thai	O
population	O
were	O
used	O
to	O
show	O
the	O
applicability	O
of	O
the	O
identification	O
test	O
.	O

PCR	O
-	O
RFLP	O
alone	O
had	O
limitations	O
,	O
because	O
the	O
RFLP	O
patterns	O
of	O
Lactobacillus	B-bacteria
casei	I-bacteria
and	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
and	O
of	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
and	O
Lactobacillus	B-bacteria
crispatus	I-bacteria
showed	O
similar	O
patterns	O
;	O
however	O
,	O
these	O
could	O
be	O
differentiated	O
by	O
SDS	O
-	O
PAGE	O
.	O

Of	O
the	O
77	O
isolates	O
,	O
38	O
were	O
identified	O
as	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
,	O
25	O
as	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
,	O
5	O
as	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
5	O
as	O
L	B-bacteria
.	I-bacteria
casei	I-bacteria
,	O
3	O
as	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
and	O
1	O
as	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
.	O

16S	O
rRNA	O
gene	O
PCR	O
-	O
RFLP	O
,	O
using	O
HpaII	O
and	O
HaeIII	O
,	O
together	O
with	O
SDS	O
-	O
PAGE	O
protein	O
profiles	O
could	O
be	O
an	O
alternative	O
method	O
for	O
the	O
identification	O
of	O
oral	O
Lactobacillus	B-bacteria
strains	I-bacteria
to	O
species	O
level	O
,	O
and	O
may	O
be	O
applicable	O
for	O
large	O
-	O
scale	O
studies	O
on	O
the	O
association	O
of	O
Lactobacillus	B-bacteria
to	O
dental	O
caries	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
use	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
and	O
the	O
16S	O
rRNA	O
gene	O
clone	O
library	O
to	O
investigate	O
the	O
diversity	O
of	O
the	O
microbiota	O
associated	O
with	O
asymptomatic	O
and	O
symptomatic	O
endodontic	O
infections	O
and	O
to	O
compare	O
the	O
bacterial	O
community	O
structure	O
in	O
these	O
two	O
clinical	O
conditions	O
.	O

Samples	O
were	O
taken	O
from	O
asymptomatic	O
endodontic	O
infections	O
associated	O
with	O
chronic	O
periradicular	O
lesions	O
and	O
from	O
symptomatic	O
infections	O
clinically	O
diagnosed	O
as	O
acute	O
abscesses	O
.	O

16S	O
rRNA	O
genes	O
from	O
DNA	O
isolated	O
from	O
clinical	O
samples	O
were	O
used	O
to	O
construct	O
clone	O
libraries	O
or	O
were	O
subjected	O
to	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
.	O

Sequence	O
analysis	O
of	O
186	O
clones	O
revealed	O
42	O
taxa	O
;	O
23	O
(	O
55	O
%	O
)	O
were	O
uncultivated	O
phylotypes	O
,	O
of	O
which	O
seven	O
were	O
unique	O
to	O
endodontic	O
infections	O
.	O

Clone	O
sequencing	O
and	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
revealed	O
that	O
the	O
most	O
commonly	O
detected	O
taxa	O
were	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
including	O
terminal	O
restriction	O
fragment	O
types	O
1	O
and	O
2	O
)	O
,	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
/	O
Peptostreptococcus	I-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
AJ062	I-bacteria
/	O
BS044	B-bacteria
/	O
FG014	B-bacteria
,	O
Prevotella	B-bacteria
species	I-bacteria
,	O
Dialister	B-bacteria
species	I-bacteria
,	O
Mogibacterium	B-bacteria
species	I-bacteria
,	O
Lachnospiraceae	B-bacteria
oral	I-bacteria
clone	I-bacteria
55A	I-bacteria
-	I-bacteria
34	I-bacteria
,	O
Filifactor	B-bacteria
alocis	I-bacteria
,	O
Megasphaera	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
CS025	I-bacteria
/	I-bacteria
BS073	I-bacteria
,	O
and	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
BP1	I-bacteria
-	I-bacteria
85	I-bacteria
/	O
Veillonella	B-bacteria
dispar	I-bacteria
/	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
.	O

Bacteroides	B-bacteria
-	I-bacteria
like	I-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
X083	I-bacteria
/	O
Bacteroidales	B-bacteria
oral	I-bacteria
clone	I-bacteria
MCE7	I-bacteria
_	I-bacteria
20	I-bacteria
and	O
Dialister	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
BS016	I-bacteria
/	I-bacteria
MCE7	I-bacteria
_	I-bacteria
134	I-bacteria
were	O
detected	O
only	O
in	O
asymptomatic	O
teeth	O
.	O

On	O
the	O
other	O
hand	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
terminal	O
restriction	O
fragment	O
type	O
2	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Dialister	B-bacteria
pneumosintes	I-bacteria
,	O
and	O
some	O
phylotypes	O
were	O
exclusively	O
detected	O
in	O
symptomatic	O
samples	O
.	O

Bacterial	O
profiles	O
of	O
symptomatic	O
endodontic	O
infections	O
generated	O
by	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
were	O
clearly	O
different	O
from	O
those	O
of	O
asymptomatic	O
infections	O
.	O

Overall	O
,	O
the	O
average	O
number	O
of	O
terminal	O
restriction	O
fragments	O
in	O
symptomatic	O
samples	O
was	O
significantly	O
larger	O
than	O
in	O
asymptomatic	O
samples	O
.	O

Molecular	O
analysis	O
of	O
the	O
microbiota	O
associated	O
with	O
symptomatic	O
or	O
asymptomatic	O
endodontic	O
infections	O
indicates	O
that	O
the	O
endodontic	O
bacterial	O
diversity	O
is	O
greater	O
than	O
previously	O
described	O
by	O
culture	O
methods	O
and	O
that	O
the	O
structure	O
of	O
the	O
microbiota	O
differ	O
significantly	O
between	O
asymptomatic	O
and	O
symptomatic	O
infections	O
.	O

Lactobacillus	B-bacteria
rhamnosus	I-bacteria
GG	I-bacteria
(	O
LGG	B-bacteria
)	O
is	O
one	O
of	O
the	O
most	O
widely	O
studied	O
probiotic	O
bacterial	O
strain	O
.	O

The	O
benefits	O
of	O
LGG	B-bacteria
treatment	O
in	O
gastrointestinal	O
disorders	O
are	O
well	O
documented	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
whether	O
LGG	B-bacteria
can	O
be	O
detected	O
in	O
the	O
oral	O
cavity	O
after	O
discontinuation	O
of	O
administration	O
of	O
a	O
product	O
prepared	O
with	O
this	O
bacterium	O
.	O

56	O
volunteers	O
consumed	O
Gefilus	O
juice	O
(	O
Valio	O
Ltd	O
,	O
Helsinki	O
,	O
Finland	O
)	O
containing	O
LGG	B-bacteria
during	O
a	O
14	O
-	O
day	O
trial	O
period	O
.	O

Saliva	O
samples	O
were	O
collected	O
and	O
cultured	O
onto	O
MRS	O
agar	O
after	O
a	O
clearance	O
period	O
and	O
then	O
daily	O
after	O
a	O
2	O
-	O
week	O
intervention	O
period	O
for	O
as	O
long	O
as	O
LGG	B-bacteria
was	O
found	O
.	O

LGG	B-bacteria
-	O
like	O
colonies	O
were	O
analyzed	O
in	O
saliva	O
samples	O
,	O
identified	O
by	O
characteristic	O
colony	O
morphology	O
,	O
a	O
lactose	O
fermentation	O
test	O
,	O
and	O
PCR	O
with	O
specific	O
primers	O
.	O

LGG	B-bacteria
was	O
not	O
able	O
to	O
colonize	O
the	O
oral	O
cavity	O
.	O

It	O
could	O
only	O
be	O
temporarily	O
detected	O
.	O

In	O
one	O
female	O
subject	O
,	O
however	O
,	O
whose	O
medical	O
history	O
revealed	O
use	O
of	O
LGG	B-bacteria
in	O
childhood	O
,	O
the	O
bacterium	O
was	O
detected	O
in	O
all	O
saliva	O
samples	O
taken	O
up	O
to	O
5	O
months	O
.	O

(	O
She	O
was	O
excluded	O
from	O
the	O
intervention	O
trial	O
)	O
.	O

Permanent	O
colonization	O
of	O
LGG	B-bacteria
in	O
the	O
oral	O
cavity	O
is	O
improbable	O
but	O
seems	O
possible	O
in	O
individual	O
cases	O
.	O

In	O
order	O
to	O
estimate	O
the	O
clinical	O
efficacy	O
of	O
a	O
povidone	O
-	O
iodine	O
oral	O
antiseptic	O
(	O
PVP	O
-	O
I	O
)	O
on	O
oral	O
bacterial	O
infectious	O
diseases	O
,	O
we	O
studied	O
the	O
effect	O
of	O
oral	O
organic	O
matter	O
on	O
the	O
in	O
vitro	O
killing	O
activity	O
of	O
PVP	O
-	O
I	O
.	O

In	O
addition	O
,	O
we	O
compared	O
the	O
in	O
vitro	O
short	O
-	O
time	O
killing	O
activity	O
of	O
PVP	O
-	O
I	O
with	O
those	O
of	O
other	O
oral	O
antiseptics	O
using	O
mouth	O
-	O
washing	O
and	O
gargling	O
samples	O
collected	O
from	O
healthy	O
volunteers	O
.	O

When	O
any	O
of	O
the	O
mouth	O
-	O
washing	O
and	O
gargling	O
samples	O
was	O
used	O
,	O
the	O
standard	O
(	O
0	O
.	O
23	O
-	O
0	O
.	O
47	O
%	O
)	O
or	O
lower	O
concentrations	O
of	O
PVP	O
-	O
I	O
killed	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
including	O
multidrug	O
-	O
resistant	O
strains	O
,	O
within	O
15	O
-	O
60	O
s	O
in	O
the	O
presence	O
of	O
oral	O
organic	O
matter	O
.	O

0	O
.	O
02	O
%	O
benzethonium	O
chloride	O
(	O
BEC	O
)	O
and	O
0	O
.	O
002	O
%	O
chlorhexidine	O
gluconate	O
(	O
CHG	O
)	O
did	O
not	O
show	O
effects	O
against	O
MRSA	B-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
including	O
multidrug	O
-	O
resistant	O
strains	O
)	O
in	O
mouth	O
-	O
washing	O
and	O
gargling	O
samples	O
even	O
after	O
60	O
s	O
.	O
The	O
above	O
-	O
mentioned	O
results	O
show	O
that	O
the	O
in	O
vitro	O
killing	O
activity	O
of	O
the	O
standard	O
concentration	O
of	O
PVP	O
-	O
I	O
was	O
hardly	O
affected	O
by	O
the	O
oral	O
organic	O
matter	O
and	O
that	O
a	O
mouth	O
-	O
washing	O
or	O
gargling	O
solution	O
containing	O
PVP	O
-	O
I	O
has	O
a	O
stronger	O
bactericidal	O
activity	O
than	O
BEC	O
and	O
CHG	O
.	O

Although	O
mouth	O
-	O
washing	O
and	O
gargling	O
samples	O
were	O
obtained	O
from	O
healthy	O
individuals	O
in	O
this	O
study	O
,	O
PVP	O
-	O
I	O
may	O
be	O
used	O
for	O
protection	O
against	O
infections	O
in	O
patients	O
with	O
various	O
diseases	O
,	O
if	O
proper	O
concentrations	O
and	O
usage	O
are	O
encouraged	O
.	O

A	O
total	O
of	O
8	O
strains	O
of	O
6	O
bacterial	O
species	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
ATCC33277	I-bacteria
and	I-bacteria
TDC286	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
ATCC29523	I-bacteria
and	I-bacteria
JP2	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
No	I-bacteria
.	I-bacteria
2	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
ATCC43937	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
ATCC25611	I-bacteria
and	O
Streptococcus	B-bacteria
anginosus	I-bacteria
ATCC33397	I-bacteria
,	O
were	O
treated	O
with	O
povidone	O
-	O
iodine	O
(	O
PVP	O
-	O
I	O
)	O
gargle	O
(	O
PVP	O
-	O
I	O
:	O
0	O
.	O
47	O
and	O
0	O
.	O
23	O
%	O
w	O
/	O
v	O
)	O
or	O
chlorhexidine	O
gluconate	O
(	O
CHG	O
)	O
gargle	O
(	O
CHG	O
:	O
0	O
.	O
002	O
%	O
w	O
/	O
v	O
)	O
for	O
15	O
,	O
30	O
or	O
60	O
s	O
,	O
after	O
which	O
they	O
were	O
inoculated	O
into	O
various	O
media	O
,	O
cultured	O
and	O
counted	O
for	O
residual	O
bacteria	O
.	O

At	O
both	O
concentrations	O
,	O
PVP	O
-	O
I	O
gargle	O
reduced	O
the	O
viable	O
cell	O
count	O
of	O
all	O
8	O
bacterial	O
strains	O
to	O
below	O
the	O
measurable	O
limit	O
within	O
15	O
s	O
.	O
By	O
contrast	O
,	O
there	O
were	O
more	O
than	O
1	O
,	O
000	O
viable	O
colonies	O
60	O
s	O
following	O
treatment	O
with	O
the	O
CHG	O
gargle	O
.	O

The	O
results	O
demonstrate	O
that	O
povidone	O
-	O
iodine	O
gargle	O
has	O
rapid	O
bactericidal	O
activity	O
against	O
the	O
causative	O
bacteria	O
of	O
periodontal	O
disease	O
.	O

An	O
evaluation	O
on	O
the	O
applicability	O
of	O
Mitis	B-bacteria
Salivarius	I-bacteria
agar	O
(	O
MS	B-bacteria
)	O
medium	O
,	O
commonly	O
used	O
for	O
the	O
detection	O
of	O
oral	O
streptococci	B-bacteria
in	O
human	O
and	O
animals	O
,	O
to	O
dog	O
specimens	O
and	O
the	O
development	O
of	O
a	O
new	O
selective	O
medium	O
for	O
isolating	O
streptococci	B-bacteria
from	O
the	O
canine	O
oral	O
cavity	O
are	O
described	O
.	O

Oral	O
samples	O
from	O
dogs	O
were	O
cultured	O
on	O
MS	B-bacteria
medium	O
under	O
anaerobic	O
conditions	O
.	O

The	O
predominant	O
facultative	O
anaerobic	O
bacteria	O
on	O
MS	B-bacteria
plates	O
were	O
gram	O
-	O
negative	O
rods	O
.	O

Selectivity	O
of	O
streptococci	B-bacteria
on	O
MS	B-bacteria
medium	O
was	O
21	O
.	O
2	O
%	O
.	O

A	O
new	O
selective	O
medium	O
,	O
designated	O
MS	O
-	O
CAN	O
-	O
AE	O
,	O
was	O
developed	O
for	O
the	O
isolation	O
of	O
streptococci	B-bacteria
from	O
the	O
canine	O
oral	O
cavity	O
.	O

The	O
average	O
growth	O
recovery	O
of	O
laboratory	O
and	O
clinically	O
isolated	O
strains	O
of	O
streptococci	B-bacteria
on	O
MS	O
-	O
CAN	O
-	O
AE	O
medium	O
was	O
84	O
.	O
1	O
%	O
of	O
that	O
on	O
MS	B-bacteria
medium	O
.	O

Gram	O
-	O
positive	O
rods	O
and	O
gram	O
-	O
negative	O
rods	O
and	O
cocci	O
rarely	O
grew	O
on	O
the	O
MS	O
-	O
CAN	O
-	O
AE	O
.	O

The	O
selectivity	O
of	O
MS	O
-	O
CAN	O
-	O
AE	O
was	O
95	O
.	O
0	O
%	O
for	O
clinical	O
samples	O
.	O

MS	O
-	O
CAN	O
-	O
AE	O
medium	O
will	O
be	O
helpful	O
for	O
investigations	O
of	O
streptococci	B-bacteria
in	O
the	O
canine	O
oral	O
cavity	O
.	O

To	O
study	O
the	O
inhibition	O
of	O
compound	O
lightyellow	O
sophora	O
root	O
collutory	O
on	O
oral	O
bacteria	O
.	O

The	O
standard	O
strains	O
of	O
common	O
oral	O
bacteria	O
were	O
cultured	O
and	O
proliferated	O
by	O
corresponding	O
media	O
in	O
vitro	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
,	O
MIC	O
(	O
50	O
)	O
,	O
MIC	O
(	O
90	O
)	O
of	O
compound	O
lightyellow	O
sophora	O
root	O
collutory	O
were	O
determined	O
.	O

The	O
bacteriostatic	O
effects	O
were	O
determined	O
by	O
the	O
plating	O
method	O
.	O

The	O
MIC	O
of	O
compound	O
lightyellow	O
sophora	O
root	O
collutory	O
were	O
lower	O
than	O
the	O
stock	O
solution	O
concentration	O
.	O

It	O
was	O
showed	O
that	O
compound	O
lightyellow	O
sophora	O
root	O
collutory	O
had	O
the	O
same	O
effect	O
as	O
tea	O
polyphenol	O
on	O
oral	O
bacteria	O
.	O

To	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
compound	O
lightyellow	O
sophora	O
root	O
collutory	O
inhibited	O
the	O
bacteria	O
growth	O
more	O
obviously	O
than	O
tea	O
polyphenol	O
.	O

The	O
result	O
showed	O
that	O
there	O
was	O
no	O
remarkable	O
difference	O
between	O
the	O
compound	O
lightyellow	O
sophora	O
root	O
collutory	O
and	O
tea	O
polyphenol	O
by	O
the	O
plating	O
method	O
.	O

Compound	O
lightyellow	O
sophora	O
root	O
collutory	O
can	O
inhibit	O
the	O
oral	O
bacteria	O
growth	O
obviously	O
.	O

To	O
determine	O
whether	O
dosing	O
with	O
bacteriocin	O
-	O
producing	O
Streptococcus	B-bacteria
salivarius	I-bacteria
following	O
an	O
antimicrobial	O
mouthwash	O
effects	O
a	O
change	O
in	O
oral	O
malodour	O
parameters	O
and	O
in	O
the	O
composition	O
of	O
the	O
oral	O
microbiota	O
of	O
subjects	O
with	O
halitosis	O
.	O

Twenty	O
-	O
three	O
subjects	O
with	O
halitosis	O
undertook	O
a	O
3	O
-	O
day	O
regimen	O
of	O
chlorhexidine	O
(	O
CHX	O
)	O
mouth	O
rinsing	O
,	O
followed	O
at	O
intervals	O
by	O
the	O
use	O
of	O
lozenges	O
containing	O
either	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
or	O
placebo	O
.	O

Assessment	O
of	O
the	O
subjects	O
'	O
volatile	O
sulphur	O
compound	O
(	O
VSC	O
)	O
levels	O
1	O
week	O
after	O
treatment	O
initiation	O
showed	O
that	O
85	O
%	O
of	O
the	O
K12	O
-	O
treated	O
group	O
and	O
30	O
%	O
of	O
the	O
placebo	O
group	O
had	O
substantial	O
(	O
>	O
100	O
ppb	O
)	O
reductions	O
.	O

The	O
bacterial	O
composition	O
of	O
the	O
saliva	O
was	O
monitored	O
by	O
culture	O
and	O
PCR	O
-	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
PCR	O
-	O
DGGE	O
)	O
.	O

Changes	O
in	O
the	O
PCR	O
-	O
DGGE	O
profiles	O
occurred	O
in	O
most	O
subjects	O
following	O
K12	B-bacteria
treatment	O
.	O

In	O
vitro	O
testing	O
showed	O
that	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
suppressed	O
the	O
growth	O
of	O
black	O
-	O
pigmented	O
bacteria	O
in	O
saliva	O
samples	O
and	O
also	O
in	O
various	O
reference	O
strains	O
of	O
bacteria	O
implicated	O
in	O
halitosis	O
.	O

Administration	O
of	O
bacteriocin	O
-	O
producing	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
after	O
an	O
oral	O
antimicrobial	O
mouthwash	O
reduces	O
oral	O
VSC	O
levels	O
.	O

The	O
outcome	O
of	O
this	O
preliminary	O
study	O
indicates	O
that	O
the	O
replacement	O
of	O
bacteria	O
implicated	O
in	O
halitosis	O
by	O
colonization	O
with	O
competitive	O
bacteria	O
such	O
as	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
may	O
provide	O
an	O
effective	O
strategy	O
to	O
reduce	O
the	O
severity	O
of	O
halitosis	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
)	O
infection	O
spreads	O
from	O
person	O
-	O
to	O
-	O
person	O
,	O
however	O
the	O
precise	O
mode	O
of	O
transmission	O
(	O
oral	O
-	O
oral	O
,	O
fecal	O
-	O
oral	O
or	O
gastro	O
-	O
gastric	O
)	O
is	O
hitherto	O
not	O
known	O
.	O

Gaining	O
understanding	O
into	O
the	O
spread	O
of	O
the	O
bacterium	O
might	O
be	O
useful	O
in	O
identifying	O
high	O
-	O
risk	O
populations	O
,	O
especially	O
in	O
areas	O
that	O
have	O
high	O
rates	O
of	O
gastric	O
malignancies	O
or	O
peptic	O
ulcer	O
.	O

In	O
this	O
review	O
,	O
the	O
authors	O
analyze	O
the	O
aspects	O
concerning	O
the	O
plausibility	O
for	O
the	O
fecal	O
-	O
oral	O
route	O
on	O
the	O
basis	O
of	O
the	O
available	O
data	O
.	O

Since	O
the	O
discovery	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
)	O
,	O
much	O
progress	O
has	O
been	O
made	O
worldwide	O
in	O
the	O
field	O
of	O
its	O
epidemiology	O
.	O

In	O
spite	O
of	O
these	O
advancements	O
,	O
many	O
aspects	O
of	O
epidemiology	O
still	O
remain	O
unclear	O
,	O
particularly	O
among	O
populations	O
with	O
low	O
socio	O
-	O
economic	O
status	O
.	O

The	O
present	O
study	O
was	O
designed	O
to	O
elucidate	O
the	O
different	O
routes	O
of	O
transmission	O
of	O
H	B-bacteria
.		I-bacteria
pylori	I-bacteria
in	O
the	O
Hyderabad	O
(	O
South	O
India	O
)	O
population	O
and	O
to	O
investigate	O
the	O
impact	O
of	O
certain	O
factors	O
,	O
such	O
as	O
age	O
,	O
gender	O
,	O
and	O
lifestyle	O
.	O

Samples	O
used	O
for	O
the	O
study	O
included	O
saliva	O
and	O
biopsy	O
samples	O
of	O
400	O
symptomatic	O
subjects	O
from	O
Hyderabad	O
,	O
India	O
.	O

The	O
patients	O
were	O
retrospectively	O
grouped	O
,	O
based	O
on	O
histopathology	O
of	O
the	O
biopsy	O
and	O
16S	O
rRNA	O
amplification	O
of	O
both	O
saliva	O
and	O
biopsy	O
as	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
positive	O
and	O
negative	O
.	O

This	O
study	O
showed	O
that	O
the	O
prevalence	O
of	O
H	O
.	O
pylori	O
in	O
both	O
saliva	O
and	O
biopsy	O
samples	O
increased	O
with	O
age	O
.	O

In	O
addition	O
,	O
the	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
found	O
more	O
commonly	O
in	O
the	O
saliva	O
and	O
biopsy	O
samples	O
among	O
males	O
(	O
64	O
percent	O
and	O
60	O
percent	O
,	O
respectively	O
)	O
than	O
females	O
(	O
53	O
.	O
3	O
percent	O
and	O
64	O
percent	O
,	O
respectively	O
)	O
.	O

Similarly	O
,	O
71	O
.	O
6	O
percent	O
and	O
73	O
.	O
5	O
percent	O
of	O
those	O
who	O
consumed	O
municipal	O
water	O
acquired	O
H	O
.	O
pylori	O
(	O
which	O
were	O
respectively	O
found	O
in	O
their	O
saliva	O
and	O
biopsy	O
samples	O
)	O
compared	O
to	O
a	O
lesser	O
proportion	O
(	O
12	O
.	O
6	O
percent	O
and	O
12	O
.	O
6	O
percent	O
,	O
respectively	O
)	O
of	O
those	O
who	O
consumed	O
boiled	O
or	O
filtered	O
water	O
.	O

The	O
study	O
also	O
found	O
that	O
subjects	O
who	O
preferred	O
home	O
-	O
cooked	O
food	O
(	O
57	O
.	O
1	O
percent	O
and	O
57	O
.	O
7	O
percent	O
)	O
showed	O
a	O
lower	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
saliva	O
and	O
biopsy	O
samples	O
,	O
respectively	O
,	O
compared	O
to	O
those	O
(	O
80	O
percent	O
and	O
88	O
percent	O
)	O
who	O
frequently	O
ate	O
out	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
suggest	O
that	O
besides	O
the	O
oral	O
-	O
oral	O
route	O
,	O
the	O
transmission	O
of	O
H	O
.	O
pylori	O
also	O
takes	O
place	O
through	O
the	O
consumption	O
of	O
food	O
prepared	O
under	O
unhygienic	O
conditions	O
.	O

Consumption	O
of	O
municipal	O
tap	O
water	O
also	O
has	O
a	O
high	O
impact	O
in	O
the	O
transmission	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Bacterial	O
invasion	O
of	O
host	O
epithelial	O
cells	O
plays	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
diseases	O
;	O
however	O
,	O
the	O
interactions	O
between	O
subgingival	O
species	O
and	O
the	O
gingival	O
crevice	O
cells	O
are	O
not	O
fully	O
understood	O
.	O

This	O
study	O
determined	O
the	O
prevalence	O
of	O
a	O
group	O
of	O
oral	O
bacterial	O
species	O
on	O
or	O
in	O
epithelial	O
cells	O
derived	O
from	O
periodontal	O
pockets	O
and	O
the	O
gingival	O
crevice	O
of	O
subjects	O
with	O
periodontitis	O
.	O

Samples	O
of	O
epithelial	O
cells	O
were	O
obtained	O
from	O
120	O
sites	O
with	O
periodontal	O
pockets	O
>	O
or	O
=	O
4	O
mm	O
and	O
92	O
periodontally	O
healthy	O
sites	O
from	O
49	O
patients	O
(	O
mean	O
age	O
46	O
.	O
3	O
+	O
/	O
-	O
1	O
.	O
4	O
years	O
;	O
43	O
%	O
males	O
)	O
with	O
chronic	O
periodontitis	O
.	O

Bacteria	O
in	O
or	O
on	O
epithelial	O
cells	O
were	O
separated	O
from	O
unattached	O
bacteria	O
by	O
Percoll	O
density	O
-	O
gradient	O
centrifugation	O
.	O

The	O
presence	O
and	O
levels	O
of	O
33	O
oral	O
species	O
were	O
determined	O
in	O
epithelial	O
cell	O
samples	O
by	O
whole	O
genomic	O
DNA	O
probes	O
and	O
the	O
checkerboard	O
method	O
.	O

The	O
most	O
frequently	O
detected	O
species	O
were	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
42	O
%	O
)	O
,	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
38	O
%	O
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
37	O
%	O
)	O
,	O
Streptococcus	B-bacteria
intermedius	I-bacteria
(	O
36	O
%	O
)	O
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
(	O
35	O
%	O
)	O
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
(	O
35	O
%	O
)	O
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
(	O
34	O
%	O
)	O
.	O

Species	O
of	O
Actinomyces	B-bacteria
were	O
found	O
in	O
low	O
prevalence	O
and	O
levels	O
.	O

The	O
data	O
indicated	O
that	O
there	O
were	O
more	O
micro	O
-	O
organisms	O
on	O
or	O
in	O
epithelial	O
cells	O
obtained	O
from	O
periodontal	O
pockets	O
than	O
from	O
healthy	O
sulci	O
;	O
however	O
,	O
no	O
significant	O
differences	O
regarding	O
the	O
percentage	O
and	O
level	O
of	O
any	O
specific	O
species	O
were	O
found	O
between	O
these	O
sites	O
.	O

Veillonella	B-bacteria
parvula	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
tended	O
to	O
be	O
more	O
prevalent	O
in	O
sites	O
without	O
disease	O
.	O

These	O
findings	O
demonstrated	O
that	O
a	O
wide	O
range	O
of	O
oral	O
species	O
may	O
be	O
detected	O
on	O
or	O
in	O
crevicular	O
epithelial	O
cells	O
from	O
sites	O
with	O
periodontitis	O
and	O
from	O
periodontally	O
healthy	O
sulci	O
.	O

Seven	O
strains	O
of	O
anaerobic	O
Gram	O
-	O
positive	O
cocci	O
isolated	O
from	O
human	O
oral	O
sites	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
revealed	O
that	O
the	O
strains	O
constituted	O
a	O
homogeneous	O
group	O
that	O
was	O
distinct	O
from	O
species	O
with	O
validly	O
published	O
names	O
,	O
but	O
related	O
to	O
Peptostreptococcus	B-bacteria
anaerobius	I-bacteria
.	O

All	O
oral	O
strains	O
tested	O
belonged	O
to	O
this	O
group	O
,	O
whereas	O
all	O
non	O
-	O
oral	O
strains	O
studied	O
were	O
confirmed	O
as	O
P	B-bacteria
.	I-bacteria
anaerobius	I-bacteria
.	O

A	O
novel	O
species	O
,	O
Peptostreptococcus	B-bacteria
stomatis	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
to	O
accommodate	O
these	O
oral	O
strains	O
.	O

P	B-bacteria
.	I-bacteria
stomatis	I-bacteria
is	O
weakly	O
saccharolytic	O
and	O
produces	O
acetic	O
,	O
butyric	O
,	O
isobutyric	O
,	O
isovaleric	O
and	O
isocaproic	O
acids	O
as	O
end	O
products	O
of	O
fermentation	O
.	O

The	O
type	O
strain	O
of	O
P	B-bacteria
.	I-bacteria
stomatis	I-bacteria
is	O
W2278T	B-bacteria
(	O
=	O
DSM	B-bacteria
17678T	I-bacteria
=	O
CCUG	B-bacteria
51858T	I-bacteria
)	O
;	O
the	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
this	O
strain	O
is	O
36	O
mol	O
%	O
.	O

Intrauterine	O
infection	O
is	O
a	O
recognized	O
cause	O
of	O
preterm	O
birth	O
.	O

The	O
infectious	O
organisms	O
are	O
believed	O
to	O
originate	O
primarily	O
from	O
the	O
vaginal	O
tract	O
and	O
secondarily	O
from	O
other	O
parts	O
of	O
the	O
body	O
.	O

It	O
is	O
plausible	O
that	O
microbes	O
in	O
the	O
oral	O
cavity	O
can	O
be	O
transmitted	O
to	O
the	O
pregnant	O
uterus	O
.	O

However	O
,	O
direct	O
evidence	O
supporting	O
such	O
a	O
transmission	O
is	O
lacking	O
.	O

In	O
this	O
study	O
,	O
amniotic	O
fluids	O
of	O
34	O
pregnant	O
women	O
were	O
examined	O
by	O
PCR	O
using	O
16S	O
and	O
23S	O
rRNA	O
universally	O
conserved	O
primers	O
.	O

Bacterial	O
DNA	O
was	O
amplified	O
from	O
the	O
only	O
patient	O
with	O
clinical	O
intrauterine	O
infection	O
and	O
histologic	O
necrotizing	O
acute	O
and	O
chronic	O
chorioamnionitis	O
.	O

One	O
strain	O
,	O
Bergeyella	B-bacteria
sp	I-bacteria
.	I-bacteria
clone	I-bacteria
AF14	I-bacteria
,	O
was	O
detected	O
and	O
was	O
99	O
.	O
7	O
%	O
identical	O
to	O
a	O
previously	O
reported	O
uncultivated	O
oral	O
Bergeyella	B-bacteria
strain	I-bacteria
,	O
clone	B-bacteria
AK152	I-bacteria
,	O
at	O
the	O
16S	O
rRNA	O
level	O
.	O

The	O
same	O
strain	O
was	O
detected	O
in	O
the	O
subgingival	O
plaque	O
of	O
the	O
patient	O
but	O
not	O
in	O
her	O
vaginal	O
tract	O
.	O

The	O
16S	O
-	O
23S	O
rRNA	O
sequence	O
of	O
clone	O
AF14	O
matched	O
exactly	O
with	O
the	O
sequences	O
amplified	O
from	O
the	O
patient	O
'	O
s	O
subgingival	O
plaque	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
Bergeyella	B-bacteria
strain	I-bacteria
identified	O
in	O
the	O
patient	O
'	O
s	O
intrauterine	O
infection	O
originated	O
from	O
the	O
oral	O
cavity	O
.	O

This	O
is	O
the	O
first	O
direct	O
evidence	O
of	O
oral	O
-	O
utero	O
microbial	O
transmission	O
.	O

The	O
patient	O
'	O
s	O
periodontal	O
health	O
during	O
pregnancy	O
was	O
unclear	O
.	O

She	O
did	O
not	O
have	O
detectable	O
periodontal	O
disease	O
during	O
postpartum	O
examination	O
.	O

Bergeyella	B-bacteria
spp	I-bacteria
.	I-bacteria
had	O
not	O
been	O
previously	O
associated	O
with	O
preterm	O
birth	O
and	O
were	O
detected	O
in	O
subgingival	O
plaque	O
of	O
women	O
without	O
clinical	O
levels	O
of	O
intrauterine	O
infection	O
.	O

Uncultivated	O
species	O
may	O
be	O
overlooked	O
opportunistic	O
pathogens	O
in	O
preterm	O
birth	O
.	O

This	O
study	O
sheds	O
new	O
light	O
on	O
the	O
implication	O
of	O
oral	O
bacteria	O
in	O
preterm	O
birth	O
.	O

The	O
initial	O
microbial	O
colonization	O
of	O
tooth	O
surfaces	O
is	O
a	O
repeatable	O
and	O
selective	O
process	O
,	O
with	O
certain	O
bacterial	O
species	O
predominating	O
in	O
the	O
nascent	O
biofilm	O
.	O

Characterization	O
of	O
the	O
initial	O
microflora	O
is	O
the	O
first	O
step	O
in	O
understanding	O
interactions	O
among	O
community	O
members	O
that	O
shape	O
ensuing	O
biofilm	O
development	O
.	O

Using	O
molecular	O
methods	O
and	O
a	O
retrievable	O
enamel	O
chip	O
model	O
,	O
we	O
characterized	O
the	O
microbial	O
diversity	O
of	O
early	O
dental	O
biofilms	O
in	O
three	O
subjects	O
.	O

A	O
total	O
of	O
531	O
16S	O
rRNA	O
gene	O
sequences	O
were	O
analyzed	O
,	O
and	O
97	O
distinct	O
phylotypes	O
were	O
identified	O
.	O

Microbial	O
community	O
composition	O
was	O
shown	O
to	O
be	O
statistically	O
different	O
among	O
subjects	O
.	O

In	O
all	O
subjects	O
,	O
however	O
,	O
4	O
-	O
h	O
and	O
8	O
-	O
h	O
communities	O
were	O
dominated	O
by	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
belonging	O
to	O
the	O
Streptococcus	B-bacteria
oralis	I-bacteria
/	O
Streptococcus	B-bacteria
mitis	I-bacteria
group	O
.	O

Other	O
frequently	O
observed	O
genera	O
(	O
comprising	O
at	O
least	O
5	O
%	O
of	O
clone	O
sequences	O
in	O
at	O
least	O
one	O
of	O
the	O
six	O
clone	O
libraries	O
)	O
were	O
Actinomyces	B-bacteria
,	O
Gemella	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Rothia	B-bacteria
,	O
and	O
Veillonella	B-bacteria
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
confirmed	O
that	O
the	O
proportion	O
of	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
sequences	O
in	O
the	O
clone	O
libraries	O
coincided	O
with	O
the	O
proportion	O
of	O
streptococcus	B-bacteria
probe	O
-	O
positive	O
organisms	O
on	O
the	O
chip	O
.	O

FISH	O
also	O
revealed	O
that	O
,	O
in	O
the	O
undisturbed	O
plaque	O
,	O
not	O
only	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
but	O
also	O
the	O
rarer	O
Prevotella	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
usually	O
seen	O
in	O
small	O
multigeneric	O
clusters	O
of	O
cells	O
.	O

This	O
study	O
shows	O
that	O
the	O
initial	O
dental	O
plaque	O
community	O
of	O
each	O
subject	O
is	O
unique	O
in	O
terms	O
of	O
diversity	O
and	O
composition	O
.	O

Repetitive	O
and	O
distinctive	O
community	O
composition	O
within	O
subjects	O
suggests	O
that	O
the	O
spatiotemporal	O
interactions	O
and	O
ecological	O
shifts	O
that	O
accompany	O
biofilm	O
maturation	O
also	O
occur	O
in	O
a	O
subject	O
-	O
dependent	O
manner	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
is	O
a	O
prominent	O
member	O
of	O
the	O
oral	O
microbiota	O
and	O
has	O
excellent	O
potential	O
for	O
use	O
as	O
a	O
probiotic	O
targeting	O
the	O
oral	O
cavity	O
.	O

In	O
this	O
report	O
we	O
document	O
safety	O
data	O
relating	O
to	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
,	O
including	O
assessment	O
of	O
its	O
antibiogram	O
,	O
metabolic	O
profiles	O
,	O
and	O
virulence	O
determinants	O
,	O
and	O
we	O
examine	O
the	O
microbial	O
composition	O
of	O
saliva	O
following	O
the	O
dosing	O
of	O
subjects	O
with	O
K12	B-bacteria
.	O

Ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
is	O
the	O
most	O
frequently	O
occurring	O
nosocomial	O
infection	O
associated	O
with	O
increased	O
morbidity	O
and	O
mortality	O
.	O

Although	O
oral	O
decontamination	O
with	O
antibiotics	O
reduces	O
incidences	O
of	O
VAP	O
,	O
it	O
is	O
not	O
recommended	O
because	O
of	O
potential	O
selection	O
of	O
antibiotic	O
-	O
resistant	O
pathogens	O
.	O

We	O
hypothesized	O
that	O
oral	O
decontamination	O
with	O
either	O
chlorhexidine	O
(	O
CHX	O
,	O
2	O
%	O
)	O
or	O
CHX	O
/	O
colistin	O
(	O
CHX	O
/	O
COL	O
,	O
2	O
%	O
/	O
2	O
%	O
)	O
would	O
reduce	O
and	O
postpone	O
development	O
of	O
VAP	O
,	O
and	O
oral	O
and	O
endotracheal	O
colonization	O
.	O

To	O
determine	O
the	O
effect	O
of	O
oral	O
decontamination	O
with	O
CHX	O
or	O
CHX	O
/	O
COL	O
on	O
VAP	O
incidence	O
and	O
time	O
to	O
development	O
of	O
VAP	O
.	O

Consecutive	O
patients	O
needing	O
mechanical	O
ventilation	O
for	O
48	O
h	O
or	O
more	O
were	O
enrolled	O
in	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
with	O
three	O
arms	O
:	O
CHX	O
,	O
CHX	O
/	O
COL	O
,	O
and	O
placebo	O
(	O
PLAC	O
)	O
.	O

Trial	O
medication	O
was	O
applied	O
every	O
6	O
h	O
into	O
the	O
buccal	O
cavity	O
.	O

Oropharyngeal	O
swabs	O
were	O
obtained	O
daily	O
and	O
quantitatively	O
analyzed	O
for	O
gram	O
-	O
positive	O
and	O
gram	O
-	O
negative	O
microorganisms	O
.	O

Endotracheal	O
colonization	O
was	O
monitored	O
twice	O
weekly	O
.	O

Of	O
385	O
patients	O
included	O
,	O
130	O
received	O
PLAC	O
,	O
127	O
CHX	O
and	O
128	O
CHX	O
/	O
COL	O
.	O

Baseline	O
characteristics	O
were	O
comparable	O
.	O

The	O
daily	O
risk	O
of	O
VAP	O
was	O
reduced	O
in	O
both	O
treatment	O
groups	O
compared	O
with	O
PLAC	O
:	O
65	O
%	O
(	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
0	O
.	O
352	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
,	O
0	O
.	O
160	O
,	O
0	O
.	O

791	O
;	O
p	O
=	O
0	O
.	O
012	O
)	O
for	O
CHX	O
and	O
55	O
%	O
(	O
HR	O
=	O
0	O
.	O
454	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
224	O
,	O
0	O
.	O

925	O
;	O
p	O
=	O
0	O
.	O
030	O
)	O
for	O
CHX	O
/	O
COL	O
.	O

CHX	O
/	O
COL	O
provided	O
significant	O
reduction	O
in	O
oropharyngeal	O
colonization	O
with	O
both	O
gram	O
-	O
negative	O
and	O
gram	O
-	O
positive	O
microorganisms	O
,	O
whereas	O
CHX	O
mostly	O
affected	O
gram	O
-	O
positive	O
microorganisms	O
.	O

Endotracheal	O
colonization	O
was	O
reduced	O
for	O
CHX	O
/	O
COL	O
patients	O
and	O
to	O
a	O
lesser	O
extent	O
for	O
CHX	O
patients	O
.	O

No	O
differences	O
in	O
duration	O
of	O
mechanical	O
ventilation	O
,	O
intensive	O
care	O
unit	O
stay	O
,	O
or	O
intensive	O
care	O
unit	O
survival	O
could	O
be	O
demonstrated	O
.	O

Topical	O
oral	O
decontamination	O
with	O
CHX	O
or	O
CHX	O
/	O
COL	O
reduces	O
the	O
incidence	O
of	O
VAP	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
eight	O
aerobic	O
and	O
anaerobic	O
oral	O
commensal	O
bacterial	O
species	O
on	O
in	O
vitro	O
Candida	O
albicans	O
biofilm	O
development	O
.	O

A	O
single	O
isolate	O
of	O
C	O
.	O
albicans	O
2560	O
g	O
,	O
and	O
eight	O
different	O
species	O
of	O
oral	O
bacteria	O
comprising	O
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
intermedius	I-bacteria
were	O
studied	O
using	O
an	O
in	O
vitro	O
biofilm	O
assay	O
.	O

Biofilm	O
formation	O
was	O
quantified	O
in	O
terms	O
of	O
the	O
ability	O
of	O
Candida	O
to	O
grow	O
on	O
polystyrene	O
plastic	O
surfaces	O
co	O
-	O
cultured	O
with	O
the	O
foregoing	O
bacteria	O
.	O

A	O
viable	O
cell	O
count	O
was	O
used	O
to	O
quantify	O
the	O
sessile	O
yeast	O
growth	O
and	O
scanning	O
electron	O
microscopy	O
was	O
employed	O
to	O
confirm	O
and	O
visualize	O
biofilm	O
formation	O
.	O

Co	O
-	O
culture	O
with	O
differing	O
concentrations	O
of	O
bacteria	O
had	O
variable	O
effects	O
on	O
Candida	O
biofilm	O
formation	O
.	O

Co	O
-	O
culture	O
with	O
the	O
highest	O
concentrations	O
of	O
each	O
of	O
the	O
foregoing	O
bacteria	O
resulted	O
in	O
a	O
consistent	O
reduction	O
in	O
the	O
yeast	O
counts	O
in	O
the	O
candidal	O
biofilm	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
except	O
for	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
co	O
-	O
cultures	O
.	O

Further	O
,	O
on	O
regression	O
analysis	O
a	O
significant	O
negative	O
correlation	O
between	O
the	O
co	O
-	O
culture	O
concentration	O
of	O
either	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
viable	O
yeast	O
counts	O
in	O
the	O
biofilm	O
was	O
noted	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
although	O
this	O
was	O
not	O
evident	O
for	O
the	O
other	O
bacterial	O
species	O
.	O

Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
,	O
quantitative	O
and	O
qualitative	O
nature	O
of	O
the	O
bacteria	O
modulate	O
C	O
.	O
albicans	O
biofilm	O
formation	O
in	O
mixed	O
species	O
environments	O
such	O
as	O
the	O
oral	O
cavity	O
.	O

We	O
investigated	O
cellular	O
and	O
humoral	O
immune	O
responses	O
to	O
oral	O
biofilm	O
bacteria	O
,	O
including	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
anginosus	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
in	O
NOD	O
/	O
SCID	O
mice	O
immunized	O
with	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
hu	O
-	O
PBMC	O
-	O
NOD	O
/	O
SCID	O
mice	O
)	O
to	O
explore	O
the	O
pathogenicity	O
of	O
each	O
of	O
those	O
organisms	O
in	O
dental	O
and	O
oral	O
inflammatory	O
diseases	O
.	O

hu	O
-	O
PBMC	O
-	O
NOD	O
/	O
SCID	O
mice	O
were	O
immunized	O
by	O
intraperitoneal	O
injections	O
with	O
the	O
whole	O
cells	O
of	O
the	O
streptococci	B-bacteria
once	O
a	O
week	O
for	O
3	O
weeks	O
.	O

FACS	O
analyses	O
were	O
used	O
to	O
determine	O
the	O
percentages	O
of	O
various	O
hu	O
-	O
T	O
cell	O
types	O
,	O
as	O
well	O
as	O
intracellular	O
cytokine	O
production	O
of	O
interleukin	O
-	O
4	O
and	O
interferon	O
-	O
gamma	O
.	O

Serum	O
IgG	O
and	O
IgM	O
antibody	O
levels	O
in	O
response	O
to	O
the	O
streptococci	B-bacteria
were	O
also	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
induced	O
a	O
significant	O
amount	O
of	O
the	O
proinflammatory	O
cytokine	O
interferon	O
-	O
gamma	O
in	O
CD4	O
(	O
+	O
)	O
and	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
in	O
comparison	O
with	O
the	O
other	O
streptococci	B-bacteria
.	O

However	O
,	O
there	O
was	O
no	O
significant	O
differences	O
between	O
the	O
streptococci	B-bacteria
in	O
interleukin	O
-	O
4	O
production	O
by	O
CD4	O
(	O
+	O
)	O
and	O
CD8	O
(	O
+	O
)	O
T	O
cells	O
after	O
inoculation	O
.	O

Further	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
significantly	O
induced	O
human	O
anti	O
-	O
S	O
.	O
mutans	O
IgG	O
,	O
IgG	O
(	O
1	O
)	O
,	O
IgG	O
(	O
2	O
)	O
,	O
and	O
IgM	O
antibodies	O
in	O
comparison	O
with	O
the	O
other	O
organisms	O
.	O

In	O
conclusion	O
,	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
up	O
-	O
regulated	O
Th1	O
and	O
Tc1	O
cells	O
,	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
led	O
to	O
increasing	O
levels	O
of	O
their	O
antibodies	O
,	O
which	O
was	O
associated	O
with	O
the	O
induction	O
of	O
Th2	O
cells	O
.	O

These	O
results	O
may	O
contribute	O
to	O
a	O
better	O
understanding	O
of	O
human	O
lymphocyte	O
interactions	O
to	O
biofilm	O
bacteria	O
,	O
along	O
with	O
their	O
impact	O
on	O
dental	O
and	O
mucosal	O
inflammatory	O
diseases	O
,	O
as	O
well	O
as	O
endocarditis	O
.	O

Oropharyngeal	O
candidiasis	O
is	O
emerging	O
as	O
a	O
serious	O
health	O
problem	O
in	O
the	O
elderly	O
as	O
well	O
as	O
other	O
chronically	O
immunosuppressed	O
patient	O
populations	O
.	O

Several	O
approaches	O
have	O
been	O
used	O
to	O
study	O
the	O
interactions	O
between	O
Candida	O
and	O
the	O
oral	O
mucosa	O
in	O
vitro	O
.	O

Recently	O
,	O
three	O
-	O
dimensional	O
organotypic	O
systems	O
of	O
the	O
oral	O
mucosa	O
have	O
been	O
developed	O
,	O
which	O
provide	O
an	O
organizational	O
complexity	O
that	O
is	O
between	O
the	O
culture	O
of	O
single	O
cell	O
types	O
and	O
organ	O
cultures	O
in	O
vivo	O
.	O

In	O
this	O
report	O
we	O
describe	O
the	O
development	O
of	O
a	O
novel	O
three	O
-	O
dimensional	O
system	O
of	O
the	O
human	O
oral	O
mucosa	O
based	O
on	O
an	O
immortalized	O
oral	O
keratinocyte	O
cell	O
line	O
.	O

Unlike	O
the	O
commercially	O
available	O
cell	O
line	O
systems	O
,	O
this	O
system	O
also	O
contains	O
a	O
connective	O
tissue	O
cell	O
component	O
,	O
which	O
ensures	O
the	O
quality	O
and	O
resemblance	O
of	O
the	O
tissue	O
model	O
to	O
the	O
human	O
oral	O
masticatory	O
mucosa	O
and	O
submucosa	O
.	O

Using	O
a	O
panel	O
of	O
Candida	O
albicans	O
strains	O
with	O
variable	O
virulence	O
in	O
vivo	O
,	O
we	O
showed	O
that	O
the	O
extent	O
of	O
tissue	O
damage	O
,	O
fungal	O
invasion	O
and	O
host	O
inflammatory	O
response	O
in	O
this	O
system	O
was	O
proportional	O
to	O
the	O
well	O
-	O
documented	O
in	O
vivo	O
virulence	O
potential	O
of	O
these	O
strains	O
.	O

Therefore	O
,	O
this	O
investigation	O
has	O
added	O
another	O
useful	O
tool	O
in	O
the	O
study	O
of	O
host	O
pathogen	O
interactions	O
in	O
oral	O
candidiasis	O
.	O

To	O
examine	O
the	O
efficacy	O
of	O
the	O
multiple	O
Sorbarod	O
device	O
(	O
MSD	O
)	O
for	O
the	O
reproduction	O
of	O
inter	O
-	O
individual	O
variations	O
in	O
oral	O
microbiotas	O
.	O

The	O
MSD	O
supports	O
sessile	O
growth	O
on	O
parallel	O
cellulose	O
filters	O
,	O
perfused	O
with	O
artificial	O
saliva	O
.	O

This	O
enables	O
biofilms	O
(	O
BF	O
)	O
to	O
be	O
grown	O
and	O
sampled	O
,	O
together	O
with	O
released	O
cells	O
in	O
eluted	O
medium	O
(	O
perfusates	O
,	O
PAs	O
)	O
.	O

Two	O
sets	O
of	O
triplicate	O
MSDs	O
were	O
established	O
.	O

One	O
set	O
was	O
inoculated	O
using	O
fresh	O
saliva	O
from	O
three	O
separate	O
volunteers	O
;	O
the	O
second	O
set	O
was	O
inoculated	O
from	O
one	O
saliva	O
donor	O
.	O

Both	O
were	O
incubated	O
in	O
an	O
anaerobic	O
cabinet	O
.	O

BF	O
and	O
PA	O
were	O
analysed	O
at	O
24	O
-	O
h	O
intervals	O
by	O
PCR	O
-	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
of	O
16S	O
rDNA	O
.	O

Hierarchical	O
dendrograms	O
were	O
constructed	O
in	O
order	O
to	O
sort	O
community	O
fingerprints	O
over	O
time	O
,	O
based	O
on	O
community	O
relatedness	O
.	O

The	O
MSD	O
supported	O
complex	O
oral	O
communities	O
,	O
as	O
evidenced	O
by	O
DGGE	O
(	O
>	O
20	O
distinct	O
DGGE	O
bands	O
)	O
and	O
confocal	O
scanning	O
laser	O
microscopy	O
.	O

DGGE	O
band	O
sequencing	O
revealed	O
bacteriological	O
diversity	O
and	O
a	O
high	O
incidence	O
of	O
anaerobic	O
species	O
,	O
including	O
Prevotella	B-bacteria
sp	I-bacteria
.	O

Dendrograms	O
demonstrated	O
marked	O
inter	O
-	O
individual	O
variation	O
in	O
the	O
relative	O
species	O
abundance	O
within	O
salivary	O
inocula	O
from	O
different	O
volunteers	O
(	O
DV	O
)	O
and	O
each	O
associated	O
MSD	O
(	O
all	O
>	O
45	O
%	O
,	O
majority	O
c	O
.	O
85	O
%	O
concordance	O
)	O
.	O

Less	O
variation	O
was	O
shown	O
between	O
triplicate	O
models	O
established	O
using	O
saliva	O
from	O
a	O
single	O
volunteer	O
(	O
SV	O
)	O
(	O
all	O
>	O
58	O
%	O
;	O
majority	O
c	O
.	O
95	O
%	O
concordance	O
)	O
.	O

PAs	O
clustered	O
together	O
with	O
the	O
associated	O
biofilms	O
and	O
inocula	O
in	O
the	O
majority	O
of	O
cases	O
for	O
the	O
DV	O
MSDs	O
whilst	O
SV	O
MSD	O
community	O
profiles	O
clustered	O
between	O
replicate	O
MSDs	O
.	O

Data	O
indicate	O
that	O
marked	O
inter	O
-	O
individual	O
variations	O
in	O
human	O
salivary	O
composition	O
can	O
be	O
partially	O
replicated	O
in	O
individualized	O
MSD	O
microcosms	O
.	O
This	O
study	O
demonstrates	O
the	O
in	O
vitro	O
reproduction	O
of	O
individual	O
oral	O
microbiotas	O
and	O
suggests	O
that	O
taking	O
inter	O
-	O
individual	O
variability	O
into	O
account	O
will	O
increase	O
the	O
relevance	O
of	O
microcosm	O
studies	O
.	O

Triclosan	O
(	O
TCS	O
)	O
exposure	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
selects	O
for	O
tolerant	O
clones	O
,	O
mutated	O
in	O
their	O
enoyl	O
-	O
acyl	O
carrier	O
protein	O
reductase	O
(	O
FabI	O
)	O
.	O

It	O
has	O
been	O
inferred	O
that	O
this	O
phenomenon	O
is	O
widespread	O
amongst	O
bacterial	O
genera	O
and	O
might	O
be	O
associated	O
with	O
resistance	O
to	O
third	O
party	O
agents	O
.	O

Ex	O
-	O
situ	O
,	O
low	O
passage	O
isolates	O
of	O
enteric	O
,	O
human	O
axilla	O
,	O
human	O
oral	O
origin	O
and	O
bacteria	O
isolated	O
from	O
a	O
domestic	O
drain	O
,	O
together	O
with	O
selected	O
type	O
cultures	O
were	O
exposed	O
to	O
escalating	O
concentrations	O
of	O
TCS	O
over	O
10	O
passages	O
using	O
a	O
gradient	O
plate	O
technique	O
.	O

One	O
fresh	O
faecal	O
isolate	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
was	O
included	O
as	O
a	O
positive	O
control	O
.	O

TCS	O
susceptibility	O
was	O
determined	O
for	O
all	O
strains	O
before	O
and	O
after	O
exposure	O
,	O
whilst	O
enteric	O
isolates	O
were	O
additionally	O
assessed	O
for	O
susceptibility	O
towards	O
chlorhexidine	O
,	O
tetracycline	O
,	O
chloramphenicol	O
,	O
nalidixic	O
acid	O
and	O
ciprofloxacin	O
,	O
and	O
the	O
oral	O
isolates	O
towards	O
chlorhexidine	O
,	O
tetracycline	O
and	O
metronidazole	O
.	O

Triclosan	O
exposure	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
markedly	O
decreased	O
TCS	O
susceptibility	O
.	O

TCS	O
susceptibility	O
also	O
decreased	O
for	O
Klebsiella	B-bacteria
oxytoca	I-bacteria
,	O
Aranicola	B-bacteria
proteolyticus	I-bacteria
and	O
Stenotrophomonas	B-bacteria
maltophilia	I-bacteria
.	O

Susceptibility	O
of	O
the	O
remaining	O
35	O
strains	O
to	O
TCS	O
and	O
the	O
other	O
test	O
agents	O
remained	O
unchanged	O
.	O

These	O
data	O
suggest	O
that	O
selection	O
for	O
high	O
level	O
resistance	O
by	O
TCS	O
exposure	O
is	O
not	O
widespread	O
and	O
appears	O
to	O
be	O
confined	O
to	O
certain	O
enteric	O
bacteria	O
,	O
especially	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

Change	O
in	O
TCS	O
susceptibility	O
did	O
not	O
affect	O
susceptibility	O
towards	O
chemically	O
unrelated	O
antimicrobials	O
.	O

Acquired	O
high	O
-	O
level	O
TCS	O
resistance	O
is	O
not	O
a	O
widespread	O
phenomenon	O
.	O

The	O
present	O
study	O
aimed	O
to	O
evaluate	O
if	O
the	O
oral	O
cavity	O
of	O
chronic	O
periodontitis	O
patients	O
can	O
harbor	O
Helicobacter	B-bacteria
pylori	I-bacteria
after	O
systemic	O
eradication	O
therapy	O
.	O

Samples	O
of	O
30	O
patients	O
(	O
15	O
with	O
gingivitis	O
and	O
15	O
with	O
chronic	O
periodontitis	O
)	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
were	O
evaluated	O
.	O

Samples	O
were	O
collected	O
3	O
months	O
after	O
triple	O
systemic	O
antibiotic	O
therapy	O
from	O
saliva	O
,	O
microbiota	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
,	O
supra	O
-	O
and	O
sub	O
-	O
gingival	O
plaque	O
as	O
well	O
as	O
gastric	O
biopsies	O
.	O

DNA	O
of	O
each	O
sample	O
was	O
extracted	O
by	O
the	O
boiling	O
method	O
and	O
used	O
as	O
a	O
template	O
in	O
polymerase	O
chain	O
reaction	O
with	O
the	O
primers	O
JW22	O
/	O
23	O
.	O

Eighteen	O
patients	O
(	O
60	O
%	O
)	O
harboured	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
mouths	O
.	O

Five	O
patients	O
(	O
16	O
.	O
6	O
%	O
)	O
were	O
positive	O
in	O
saliva	O
,	O
two	O
(	O
6	O
.	O
6	O
%	O
)	O
on	O
the	O
dorsum	O
of	O
the	O
tongue	O
,	O
nine	O
(	O
30	O
%	O
)	O
in	O
supra	O
-	O
gingival	O
plaque	O
,	O
14	O
(	O
46	O
.	O
6	O
%	O
)	O
in	O
sub	O
-	O
gingival	O
plaque	O
and	O
three	O
(	O
10	O
%	O
)	O
in	O
the	O
stomach	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
between	O
study	O
groups	O
.	O

Eradication	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
after	O
therapy	O
was	O
more	O
effective	O
for	O
the	O
stomach	O
than	O
for	O
the	O
mouth	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Mouths	O
of	O
patients	O
with	O
gingivitis	O
or	O
with	O
chronic	O
periodontitis	O
,	O
who	O
are	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
stomachs	O
,	O
may	O
be	O
considered	O
as	O
reservoirs	O
of	O
these	O
bacteria	O
.	O

To	O
study	O
the	O
role	O
of	O
fibrinogen	O
molecule	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
diseases	O
.	O

An	O
in	O
vitro	O
cell	O
culture	O
model	O
was	O
used	O
.	O

Methyl	O
-	O
(	O
3	O
)	O
H	O
Thymidine	O
radiolabeled	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	I-bacteria
Pg	I-bacteria
)	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
were	O
examined	O
for	O
their	O
ability	O
to	O
adhere	O
to	O
and	O
invade	O
the	O
confluent	O
monolayers	O
of	O
human	O
oral	O
epithelial	O
KB	O
cells	O
with	O
or	O
without	O
exogenous	O
human	O
fibrinogens	O
by	O
scintillation	O
spectrometry	O
.	O

The	O
addition	O
of	O
exogenous	O
fibrinogens	O
made	O
more	O
amount	O
of	O
and	O
higher	O
ratios	O
of	O
adhesive	O
and	O
invasive	O
Pg	B-bacteria
,	O
in	O
contrast	O
to	O
the	O
group	O
without	O
exogenous	O
fibrinogen	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

At	O
different	O
concentrations	O
of	O
exogenous	O
fibrinogen	O
,	O
the	O
amount	O
and	O
ratios	O
of	O
adhesive	O
and	O
invasive	O
Pg	B-bacteria
varied	O
significantly	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
007	O
)	O
.	O

The	O
higher	O
concentrations	O
of	O
exogenous	O
fibrinogen	O
was	O
added	O
,	O
the	O
greater	O
amount	O
and	O
ratios	O
of	O
adhesive	O
and	O
invasive	O
Pg	B-bacteria
were	O
found	O
.	O

Fibrinogen	O
promotes	O
the	O
adherence	O
of	O
Pg	B-bacteria
to	O
human	O
oral	O
epithelial	O
cells	O
and	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
diseases	O
.	O

(	O
1	O
)	O
To	O
investigate	O
the	O
prevalence	O
of	O
oral	B-bacteria
streptococci	I-bacteria
(	O
OS	B-bacteria
)	O
and	O
biological	O
indicators	O
of	O
water	O
contamination	O
by	O
oral	O
fluids	O
in	O
water	O
from	O
dental	O
unit	O
water	O
lines	O
(	O
DUWs	O
)	O
by	O
detection	O
and	O
quantification	O
and	O
of	O
saprophytes	O
indigenous	O
to	O
the	O
oral	O
cavity	O
.	O

(	O
2	O
)	O
To	O
test	O
whether	O
measurement	O
of	O
the	O
total	O
cultivable	O
mesophilic	O
flora	O
(	O
TCF	O
)	O
,	O
the	O
parameter	O
commonly	O
used	O
to	O
monitor	O
water	O
quality	O
in	O
DUWs	O
,	O
is	O
an	O
effective	O
predictor	O
for	O
OS	B-bacteria
contamination	O
.	O

Survey	O
of	O
21	O
dental	O
units	O
equipped	O
with	O
antiretraction	O
devices	O
.	O

Water	O
samples	O
were	O
collected	O
from	O
air	O
-	O
water	O
syringes	O
,	O
cup	O
fillers	O
,	O
tap	O
water	O
,	O
and	O
before	O
and	O
during	O
the	O
working	O
day	O
.	O

Units	O
were	O
from	O
7	O
public	O
dental	O
offices	O
selected	O
for	O
convenience	O
from	O
among	O
those	O
in	O
proximity	O
of	O
the	O
microbiological	O
laboratory	O
.	O

For	O
detection	O
of	O
OS	B-bacteria
,	O
samples	O
were	O
plated	O
on	O
an	O
enriched	O
medium	O
,	O
to	O
revitalize	O
the	O
organisms	O
.	O

Colonies	O
were	O
subcultured	O
on	O
a	O
selective	O
medium	O
and	O
biochemically	O
identified	O
(	O
lower	O
detection	O
limit	O
,	O
1	O
cfu	O
/	O
mL	O
)	O
.	O

For	O
measurement	O
of	O
the	O
TCF	O
,	O
samples	O
were	O
plated	O
on	O
a	O
nutrient	O
-	O
poor	O
medium	O
.	O

Cultures	O
with	O
colony	O
counts	O
greater	O
than	O
200	O
cfu	O
/	O
mL	O
were	O
considered	O
to	O
be	O
TCF	O
positive	O
.	O

The	O
sensitivity	O
and	O
specificity	O
of	O
TCF	O
positivity	O
in	O
predicting	O
OS	B-bacteria
detection	O
was	O
calculated	O
.	O

Prevalence	O
rates	O
for	O
OS	B-bacteria
contamination	O
and	O
for	O
TCF	O
positivity	O
were	O
,	O
respectively	O
,	O
34	O
.	O
4	O
%	O
(	O
11	O
of	O
32	O
samples	O
)	O
and	O
25	O
.	O
0	O
%	O
(	O
8	O
of	O
32	O
samples	O
)	O
for	O
syringes	O
,	O
27	O
.	O
8	O
%	O
(	O
10	O
of	O
36	O
samples	O
)	O
and	O
8	O
.	O
3	O
%	O
(	O
3	O
of	O
36	O
samples	O
)	O
for	O
cup	O
fillers	O
,	O
and	O
0	O
.	O
0	O
%	O
(	O
0	O
of	O
7	O
samples	O
)	O
for	O
tap	O
water	O
.	O

OS	B-bacteria
contamination	O
levels	O
ranged	O
from	O
1	O
to	O
6	O
cfu	O
/	O
mL	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
found	O
between	O
samples	O
obtained	O
before	O
and	O
during	O
the	O
working	O
day	O
.	O

TCF	O
positivity	O
did	O
not	O
predict	O
OS	B-bacteria
contamination	O
effectively	O
,	O
because	O
of	O
low	O
sensitivity	O
.	O

Given	O
the	O
absence	O
of	O
OS	B-bacteria
in	O
tap	O
water	O
,	O
the	O
reported	O
prevalence	O
of	O
OS	B-bacteria
contamination	O
suggests	O
that	O
oral	O
fluids	O
are	O
aspirated	O
during	O
dental	O
therapy	O
with	O
relatively	O
high	O
frequency	O
and	O
that	O
DUWs	O
can	O
potentially	O
expose	O
successive	O
patients	O
to	O
bloodborne	O
cross	O
-	O
infections	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
prevalence	O
of	O
oral	O
bacteria	O
on	O
the	O
dorsum	O
of	O
the	O
tongue	O
.	O

In	O
addition	O
,	O
the	O
relationship	O
between	O
the	O
number	O
of	O
teeth	O
and	O
the	O
microflora	O
present	O
on	O
the	O
coating	O
of	O
the	O
tongue	O
in	O
a	O
population	O
of	O
85	O
-	O
year	O
-	O
old	O
people	O
was	O
assessed	O
.	O

Two	O
hundred	O
and	O
five	O
individuals	O
(	O
89	O
males	O
,	O
116	O
females	O
)	O
from	O
the	O
same	O
geographical	O
area	O
who	O
were	O
85	O
years	O
of	O
age	O
were	O
examined	O
.	O

Five	O
periodontopathic	O
bacteria	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
and	O
one	O
cariogenic	O
bacterium	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
)	O
were	O
analysed	O
using	O
a	O
polymerase	O
chain	O
reaction	O
assay	O
of	O
tongue	O
samples	O
from	O
the	O
population	O
.	O

Periodontal	O
bacteria	O
-	O
positive	O
individuals	O
have	O
more	O
teeth	O
than	O
that	O
of	O
periodontal	O
bacteria	O
-	O
negative	O
people	O
.	O

Between	O
the	O
periodontal	O
bacteria	O
-	O
positive	O
and	O
-	O
negative	O
individuals	O
,	O
there	O
were	O
significant	O
differences	O
in	O
the	O
mean	O
number	O
of	O
teeth	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
p	O
=	O
0	O
.	O
002	O
)	O
,	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
(	O
p	O
=	O
0	O
.	O
005	O
)	O
,	O
while	O
there	O
were	O
no	O
significant	O
differences	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
p	O
=	O
0	O
.	O
998	O
)	O
or	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
p	O
=	O
0	O
.	O
147	O
)	O
.	O

A	O
wide	O
range	O
of	O
species	O
,	O
including	O
anaerobes	O
,	O
was	O
detected	O
in	O
85	O
-	O
year	O
-	O
old	O
subjects	O
.	O

It	O
was	O
found	O
that	O
the	O
detection	O
of	O
periodontal	O
bacteria	O
on	O
the	O
tongue	O
coating	O
increased	O
with	O
the	O
number	O
of	O
teeth	O
.	O

There	O
was	O
a	O
positive	O
relationship	O
between	O
the	O
tooth	O
number	O
and	O
periodontopathic	O
bacteria	O
,	O
except	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

These	O
results	O
suggest	O
that	O
tongue	O
care	O
is	O
essential	O
for	O
preventing	O
oral	O
disease	O
and	O
needs	O
to	O
be	O
part	O
of	O
any	O
oral	O
care	O
programme	O
in	O
elderly	O
people	O
.	O

The	O
aim	O
of	O
this	O
work	O
is	O
to	O
emphasize	O
that	O
particular	O
stains	O
on	O
the	O
third	O
cervical	O
of	O
the	O
buccal	O
and	O
lingual	O
surfaces	O
in	O
mixed	O
dentition	O
,	O
called	O
`	O
`	O
black	O
stain	O
.	O
'	O
'	O

Previous	O
research	O
showed	O
the	O
microbiological	O
etiology	O
of	O
this	O
discoloration	O
by	O
chromogen	O
bacterias	O
.	O

Our	O
study	O
shows	O
bacteria	O
spp	O
involved	O
in	O
stains	O
by	O
means	O
of	O
PCR	O
process	O
and	O
electrophoresis	O
gel	O
on	O
the	O
agarose	O
medium	O
.	O

Sample	O
was	O
formed	O
by	O
100	O
subject	O
with	O
black	O
stain	O
and	O
100	O
control	O
subjects	O
stain	O
-	O
free	O
.	O

A	O
statistical	O
analysis	O
(	O
SPSS	O
10	O
.	O
0	O
)	O
using	O
X2	O
was	O
performed	O
in	O
this	O
study	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
were	O
not	O
involved	O
in	O
both	O
in	O
black	O
stain	O
subjects	O
and	O
in	O
the	O
control	O
.	O

On	O
the	O
contrary	O
,	O
Actinomyces	B-bacteria
could	O
be	O
involved	O
in	O
the	O
pigmentation	O
process	O
.	O

Antimicrobial	O
peptides	O
are	O
components	O
of	O
the	O
innate	O
immunity	O
that	O
play	O
an	O
important	O
role	O
in	O
systemic	O
and	O
oral	O
health	O
.	O

The	O
antibacterial	O
activity	O
of	O
the	O
amphibian	O
-	O
derived	O
K4	O
-	O
S4	O
(	O
1	O
-	O
15	O
)	O
a	O
antimicrobial	O
peptide	O
was	O
tested	O
against	O
oral	O
pathogens	O
associated	O
with	O
caries	O
and	O
periodontitis	O
and	O
compared	O
with	O
the	O
activities	O
of	O
the	O
human	O
-	O
derived	O
antimicrobial	O
peptides	O
LL	O
-	O
37	O
and	O
dhvar4a	O
.	O

Growth	O
inhibition	O
of	O
planktonic	O
bacteria	O
was	O
tested	O
using	O
standard	O
microdilution	O
assays	O
.	O

Live	O
/	O
Dead	O
staining	O
followed	O
by	O
confocal	O
scanning	O
laser	O
microscopy	O
(	O
CSLM	O
)	O
was	O
used	O
to	O
determine	O
the	O
bactericidal	O
effect	O
of	O
K4	O
-	O
S4	O
(	O
1	O
-	O
15	O
)	O
a	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
attached	O
to	O
a	O
glass	O
surface	O
or	O
grown	O
as	O
biofilm	O
.	O

The	O
cariogenic	O
species	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
and	O
Actinomyces	B-bacteria
viscosus	I-bacteria
were	O
resistant	O
to	O
LL	O
-	O
37	O
found	O
in	O
the	O
oral	O
cavity	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
the	O
species	O
most	O
resistant	O
to	O
the	O
three	O
tested	O
peptides	O
.	O

K4	O
-	O
S4	O
(	O
1	O
-	O
15	O
)	O
a	O
demonstrated	O
the	O
highest	O
activity	O
against	O
the	O
tested	O
planktonic	O
bacteria	O
.	O

In	O
addition	O
,	O
K4	O
-	O
S4	O
(	O
1	O
-	O
15	O
)	O
a	O
was	O
bactericidal	O
to	O
surface	O
-	O
attached	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
as	O
well	O
as	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
grown	O
in	O
vitro	O
.	O

However	O
,	O
surface	O
attachment	O
increased	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
resistance	O
to	O
the	O
antimicrobial	O
peptide	O
.	O

Our	O
results	O
support	O
growing	O
evidence	O
suggesting	O
the	O
use	O
of	O
antimicrobial	O
peptides	O
for	O
prevention	O
and	O
treatment	O
of	O
oral	O
disease	O
.	O

To	O
isolate	O
and	O
characterise	O
Streptococcus	B-bacteria
mutans	I-bacteria
from	O
Irish	O
saliva	O
samples	O
and	O
to	O
assess	O
their	O
sensitivity	O
to	O
a	O
food	O
-	O
grade	O
preparation	O
of	O
the	O
lantibiotic	O
,	O
lacticin	O
3147	O
,	O
produced	O
by	O
Lactococcus	B-bacteria
lactis	I-bacteria
DPC3147	I-bacteria
.	O

Saliva	O
samples	O
collected	O
from	O
children	O
with	O
varying	O
oral	O
health	O
status	O
were	O
screened	O
on	O
Mitis	O
Salivarius	O
agar	O
for	O
the	O
presence	O
of	O
pathogenic	O
streptococci	B-bacteria
.	O

Following	O
selective	O
plating	O
,	O
16S	O
rDNA	O
sequencing	O
and	O
Pulsed	O
Field	O
Gel	O
Electrophoresis	O
(	O
PFGE	O
)	O
,	O
15	O
distinct	O
strains	O
of	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
identified	O
.	O

These	O
were	O
grouped	O
according	O
to	O
their	O
relative	O
sensitivity	O
to	O
lacticin	O
3147	O
which	O
ranged	O
from	O
0	O
.	O
78	O
to	O
6	O
.	O
25	O
%	O
;	O
relative	O
to	O
a	O
sensitive	O
indicator	O
strain	O
,	O
Lactococcus	B-bacteria
lactis	I-bacteria
ssp	I-bacteria
.	I-bacteria
lactis	I-bacteria
HP	I-bacteria
.	O

Inhibition	O
of	O
indicator	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
from	O
sensitive	O
,	O
intermediate	O
and	O
tolerant	O
groupings	O
were	O
assessed	O
in	O
microtitre	O
plate	O
assays	O
with	O
increasing	O
concentrations	O
of	O
lacticin	O
3147	O
.	O

The	O
concentration	O
of	O
lacticin	O
3147	O
required	O
to	O
give	O
50	O
%	O
growth	O
inhibition	O
correlated	O
with	O
their	O
relative	O
sensitivities	O
(	O
as	O
assayed	O
by	O
well	O
diffusion	O
methodology	O
)	O
and	O
ranged	O
from	O
1280	O
to	O
5120	O
AU	O
ml	O
(	O
-	O
1	O
)	O
.	O

Concentrated	O
preparations	O
of	O
lacticin	O
3147	O
caused	O
a	O
rapid	O
killing	O
of	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
in	O
broth	O
.	O

Moreover	O
,	O
in	O
human	O
saliva	O
deliberately	O
spiked	O
with	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
the	O
pathogenic	O
was	O
eliminated	O
(	O
initial	O
inoculum	O
of	O
10	O
(	O
5	O
)	O
)	O
in	O
the	O
presence	O
of	O
40	O
,	O
000	O
AU	O
ml	O
(	O
-	O
1	O
)	O
of	O
lacticin	O
3147	O
.	O

Furthermore	O
,	O
a	O
food	O
-	O
grade	O
lacticin	O
3147	O
spray	O
dried	O
powder	O
ingredient	O
was	O
assessed	O
for	O
the	O
inhibition	O
of	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
human	O
saliva	O
,	O
spiked	O
with	O
a	O
strain	O
of	O
intermediate	O
sensitivity	O
,	O
resulting	O
in	O
up	O
to	O
a	O
4	O
-	O
log	O
reduction	O
in	O
counts	O
after	O
20	O
min	O
.	O

A	O
food	O
grade	O
preparation	O
of	O
lacticin	O
3147	O
was	O
effective	O
in	O
the	O
inhibition	O
of	O
oral	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
inhibition	O
of	O
oral	O
streptococci	B-bacteria
by	O
food	O
grade	O
preparations	O
of	O
lacticin	O
3147	O
may	O
offer	O
novel	O
opportunities	O
for	O
the	O
development	O
of	O
lacticin	O
3147	O
as	O
an	O
anti	O
-	O
cariogenic	O
agent	O
particularly	O
in	O
the	O
area	O
of	O
functional	O
foods	O
for	O
the	O
improvement	O
of	O
oral	O
health	O
.	O

Streptococci	B-bacteria
are	O
the	O
primary	O
component	O
of	O
the	O
multispecies	O
oral	O
biofilm	O
known	O
as	O
supragingival	O
dental	O
plaque	O
;	O
they	O
grow	O
by	O
fermentation	O
of	O
sugars	O
to	O
organic	O
acids	O
,	O
e	O
.	O
g	O
.	O
,	O
lactic	O
acid	O
.	O

Veillonellae	O
,	O
a	O
ubiquitous	O
component	O
of	O
early	O
plaque	O
,	O
are	O
unable	O
to	O
use	O
sugars	O
;	O
they	O
ferment	O
organic	O
acids	O
,	O
such	O
as	O
lactate	O
,	O
to	O
a	O
mixture	O
of	O
shorter	O
-	O
chain	O
-	O
length	O
acids	O
,	O
CO	O
(	O
2	O
)	O
,	O
and	O
hydrogen	O
.	O

Certain	O
veillonellae	B-bacteria
bind	O
to	O
(	O
coaggregate	O
with	O
)	O
streptococci	B-bacteria
in	O
vitro	O
.	O

We	O
show	O
that	O
,	O
between	O
4	O
and	O
8	O
hours	O
into	O
plaque	O
development	O
,	O
the	O
dominant	O
strains	O
of	O
Veillonella	B-bacteria
change	O
in	O
their	O
phenotypic	O
characteristics	O
(	O
coaggregation	O
and	O
antibody	O
reactivity	O
)	O
as	O
well	O
as	O
in	O
their	O
genotypic	O
characteristics	O
(	O
16S	O
RNA	O
gene	O
sequences	O
as	O
well	O
as	O
strain	O
level	O
fingerprint	O
patterns	O
)	O
.	O

This	O
succession	O
is	O
coordinated	O
with	O
the	O
development	O
of	O
mixed	O
-	O
species	O
bacterial	O
colonies	O
.	O

Changes	O
in	O
community	O
structure	O
can	O
occur	O
very	O
rapidly	O
in	O
natural	O
biofilm	O
development	O
,	O
and	O
we	O
suggest	O
that	O
this	O
process	O
may	O
influence	O
evolution	O
within	O
this	O
ecosystem	O
.	O

Epithelial	O
cells	O
(	O
EC	O
)	O
have	O
an	O
important	O
role	O
in	O
the	O
constitution	O
of	O
both	O
innate	O
and	O
acquired	O
immune	O
responses	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
alterations	O
of	O
bactericidal	O
effects	O
and	O
cytokine	O
production	O
patterns	O
of	O
human	O
oral	O
epithelial	O
cells	O
(	O
OEC	O
)	O
against	O
different	O
doses	O
of	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
.	O

For	O
this	O
purpose	O
,	O
OEC	O
have	O
been	O
stimulated	O
with	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
with	O
an	O
effector	O
/	O
target	O
(	O
E	O
/	O
T	O
)	O
cell	O
ratio	O
of	O
1	O
/	O
1	O
,	O
1	O
/	O
100	O
,	O
1	O
/	O
1	O
.	O
000	O
and	O
1	O
/	O
10	O
.	O
000	O
,	O
and	O
bactericidal	O
effects	O
and	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
IL	O
-	O
10	O
levels	O
were	O
detected	O
in	O
the	O
first	O
and	O
sixth	O
hours	O
of	O
incubation	O
.	O

The	O
mean	O
rates	O
of	O
bactericidal	O
effect	O
detected	O
in	O
the	O
first	O
and	O
sixth	O
hours	O
were	O
38	O
.	O
7	O
%	O
and	O
54	O
.	O
5	O
%	O
,	O
respectively	O
.	O

The	O
bactericidal	O
effects	O
observed	O
at	O
1	O
/	O
1	O
E	O
/	O
T	O
cell	O
ratio	O
in	O
the	O
first	O
hour	O
,	O
and	O
at	O
1	O
/	O
1	O
and	O
1	O
/	O
100	O
E	O
/	O
T	O
cell	O
ratio	O
in	O
the	O
the	O
sixth	O
hour	O
were	O
found	O
significantly	O
higher	O
then	O
the	O
other	O
cells	O
ratios	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Time	O
-	O
and	O
dose	O
-	O
depended	O
differences	O
were	O
detected	O
in	O
the	O
cytokine	O
responses	O
of	O
OEC	O
for	O
different	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
concentrations	O
.	O

IL	O
-	O
6	O
levels	O
produced	O
by	O
stimulated	O
OEC	O
were	O
found	O
higher	O
,	O
and	O
IL	O
-	O
8	O
levels	O
were	O
found	O
lower	O
then	O
the	O
levels	O
which	O
were	O
produced	O
by	O
unstimulated	O
OEC	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
in	O
the	O
first	O
hour	O
,	O
while	O
there	O
were	O
no	O
change	O
in	O
IL	O
-	O
10	O
levels	O
after	O
stimulation	O
with	O
different	O
bacterial	O
concentrations	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

At	O
the	O
sixth	O
hour	O
there	O
were	O
no	O
differences	O
in	O
the	O
IL	O
-	O
6	O
levels	O
produced	O
by	O
stimulated	O
and	O
unstimulated	O
cells	O
,	O
while	O
the	O
levels	O
of	O
IL	O
-	O
8	O
produced	O
by	O
stimulated	O
cells	O
were	O
found	O
lower	O
then	O
the	O
levels	O
produced	O
by	O
unstimulated	O
cells	O
in	O
the	O
E	O
/	O
T	O
cell	O
ratio	O
of	O
1	O
/	O
100	O
,	O
1	O
/	O
1000	O
and	O
1	O
/	O
10	O
.	O
000	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
p	O
<	O
0	O
.	O
01	O
,	O
p	O
<	O
0	O
.	O
01	O
,	O
respectively	O
)	O
.	O

Nevertheless	O
IL	O
-	O
10	O
levels	O
in	O
the	O
E	O
/	O
T	O
cell	O
ratio	O
of	O
1	O
/	O
100	O
and	O
1	O
/	O
1	O
.	O
000	O
were	O
statistically	O
higher	O
then	O
the	O
levels	O
produced	O
by	O
unstimulated	O
cells	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

As	O
a	O
result	O
OEC	O
stimulated	O
with	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
showed	O
dose	O
dependent	O
manner	O
in	O
bactericidal	O
effect	O
and	O
cytokine	O
production	O
.	O

It	O
is	O
suggested	O
that	O
epithelial	O
cells	O
stimulation	O
with	O
different	O
doses	O
of	O
antigen	O
contributed	O
to	O
the	O
immune	O
system	O
activation	O
or	O
tolerance	O
.	O

Benzimidazoles	O
are	O
widely	O
used	O
as	O
proton	O
-	O
pump	O
inhibitors	O
to	O
control	O
stomach	O
hyperacidity	O
and	O
have	O
been	O
found	O
also	O
to	O
have	O
antimicrobial	O
actions	O
against	O
Helicobacter	B-bacteria
pylori	I-bacteria
and	O
oral	O
streptococci	B-bacteria
.	O

Our	O
primary	O
aim	O
was	O
to	O
determine	O
if	O
they	O
are	O
active	O
also	O
against	O
oral	O
anaerobes	O
associated	O
with	O
gingivitis	O
.	O

Our	O
major	O
focus	O
was	O
on	O
catabolism	O
because	O
it	O
leads	O
to	O
production	O
of	O
inflammatory	O
metabolites	O
such	O
as	O
butyrate	O
and	O
ammonia	O
.	O

The	O
benzimidazoles	O
are	O
effective	O
in	O
the	O
protonated	O
form	O
at	O
acid	O
pH	O
values	O
and	O
cause	O
irreversible	O
inhibition	O
of	O
enzymes	O
associated	O
with	O
formation	O
of	O
drug	O
-	O
target	O
disulfide	O
bonds	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
ATCC	I-bacteria
25611	I-bacteria
were	O
grown	O
anaerobically	O
in	O
suspension	O
cultures	O
,	O
harvested	O
,	O
washed	O
and	O
exposed	O
to	O
the	O
benzimidazole	O
lansoprazole	O
at	O
pH	O
values	O
of	O
4	O
or	O
5	O
before	O
being	O
washed	O
and	O
used	O
for	O
standard	O
assays	O
to	O
detect	O
inhibition	O
of	O
catabolic	O
functions	O
,	O
uptake	O
of	O
the	O
agent	O
and	O
lethality	O
.	O

Lansoprazole	O
was	O
found	O
to	O
be	O
a	O
bacteriostatic	O
,	O
multi	O
-	O
target	O
antimicrobial	O
against	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
under	O
anaerobic	O
conditions	O
inhibitory	O
for	O
amino	O
acid	O
fermentation	O
and	O
also	O
for	O
glycolysis	O
of	O
glucose	O
or	O
fructose	O
.	O

ID	O
(	O
50	O
)	O
values	O
for	O
fermentation	O
of	O
amino	O
acids	O
and	O
dipeptides	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ranged	O
from	O
0	O
.	O
05	O
mM	O
for	O
lysine	O
to	O
0	O
.	O
25	O
mM	O
for	O
serine	O
.	O

Fructose	O
catabolism	O
was	O
highly	O
sensitive	O
with	O
an	O
ID	O
(	O
50	O
)	O
value	O
of	O
0	O
.	O
03	O
mM	O
apparently	O
related	O
to	O
high	O
sensitivity	O
of	O
the	O
phosphoenolpyruvate	O
:	O
fructose	O
phosphotransferase	O
system	O
,	O
while	O
the	O
ID	O
(	O
50	O
)	O
for	O
glucose	O
catabolism	O
by	O
intact	O
cells	O
was	O
some	O
0	O
.	O
07	O
mM	O
.	O

Fermentation	O
of	O
aspartate	O
or	O
aspartylaspartate	O
by	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
was	O
found	O
to	O
be	O
lansoprazole	O
-	O
sensitive	O
with	O
ID	O
(	O
50	O
)	O
values	O
of	O
about	O
0	O
.	O
18	O
and	O
0	O
.	O
20	O
mM	O
,	O
respectively	O
.	O

Catabolism	O
of	O
amino	O
acids	O
,	O
dipeptides	O
and	O
sugars	O
by	O
oral	O
anaerobes	O
associated	O
with	O
gingivitis	O
are	O
sensitive	O
to	O
the	O
inhibitory	O
actions	O
of	O
lansoprazole	O
.	O

Thus	O
,	O
catabolic	O
pathways	O
are	O
potential	O
targets	O
for	O
use	O
of	O
benzimidazoles	O
against	O
bacteria	O
involved	O
in	O
gingivitis	O
.	O

Most	O
infections	O
of	O
the	O
oral	O
cavity	O
,	O
including	O
the	O
major	O
dental	O
diseases	O
caries	O
and	O
periodontitis	O
,	O
are	O
opportunistic	O
in	O
nature	O
.	O

They	O
are	O
caused	O
or	O
maintained	O
by	O
microorganisms	O
of	O
the	O
resident	O
or	O
transient	O
flora	O
normally	O
present	O
in	O
low	O
numbers	O
and	O
not	O
pathogenic	O
,	O
but	O
in	O
certain	O
circumstances	O
develop	O
infections	O
.	O

Mucosal	O
infections	O
have	O
some	O
degree	O
of	O
specificity	O
[	O
e	O
.	O
g	O
.	O

Candida	O
spp	O
.	O
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
and	O
enterics	B-bacteria
]	O
and	O
a	O
microbiological	O
test	O
can	O
be	O
interpreted	O
accurately	O
for	O
clinical	O
diagnosis	O
and	O
choice	O
of	O
treatment	O
.	O

Subepithelial	O
or	O
deep	O
infections	O
,	O
however	O
,	O
include	O
a	O
number	O
of	O
species	O
from	O
the	O
resident	O
flora	O
,	O
mainly	O
anaerobes	O
whose	O
role	O
in	O
the	O
infections	O
is	O
difficult	O
to	O
interpret	O
.	O

However	O
,	O
microbiological	O
tests	O
and	O
the	O
presence	O
of	O
certain	O
bacterial	O
species	O
could	O
be	O
used	O
for	O
treatment	O
control	O
,	O
risk	O
-	O
evaluation	O
and	O
even	O
for	O
patient	O
motivation	O
in	O
the	O
prevention	O
of	O
these	O
diseases	O
.	O

Microbiological	O
diagnosis	O
can	O
be	O
used	O
in	O
general	O
practice	O
for	O
several	O
purposes	O
and	O
in	O
various	O
situations	O
that	O
can	O
be	O
of	O
great	O
value	O
for	O
the	O
dental	O
patient	O
.	O

Carbohydrate	O
antigen	O
detection	O
,	O
nucleic	O
acid	O
probe	O
detection	O
,	O
and	O
bacterial	O
culture	O
are	O
commonly	O
used	O
to	O
confirm	O
group	B-bacteria
A	I-bacteria
streptococcus	I-bacteria
(	O
GAS	B-bacteria
)	O
pharyngitis	O
.	O

Compared	O
to	O
standard	O
throat	O
swab	O
specimens	O
,	O
the	O
sensitivities	O
of	O
these	O
tests	O
with	O
mouth	O
specimens	O
are	O
poor	O
.	O

When	O
testing	O
for	O
GAS	B-bacteria
pharyngitis	O
,	O
the	O
throat	O
remains	O
the	O
optimum	O
site	O
for	O
sampling	O
.	O

Tetracycline	O
resistance	O
is	O
commonly	O
found	O
in	O
endodontic	O
bacteria	O
.	O

One	O
of	O
the	O
most	O
common	O
tetracycline	O
-	O
resistance	O
genes	O
is	O
tet	O
(	O
M	O
)	O
,	O
which	O
is	O
often	O
encoded	O
on	O
the	O
broad	O
-	O
host	O
-	O
range	O
conjugative	O
transposon	O
Tn916	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
whether	O
tet	O
(	O
M	O
)	O
was	O
present	O
in	O
bacteria	O
isolated	O
from	O
endodontic	O
patients	O
at	O
the	O
Eastman	O
Dental	O
Institute	O
and	O
whether	O
this	O
gene	O
was	O
carried	O
on	O
the	O
transferable	O
conjugative	O
transposon	O
Tn916	O
.	O

The	O
cultivable	O
microflora	O
isolated	O
from	O
15	O
endodontic	O
patients	O
was	O
screened	O
for	O
resistance	O
to	O
tetracycline	O
.	O

Polymerase	O
chain	O
reactions	O
for	O
tet	O
(	O
M	O
)	O
and	O
for	O
unique	O
regions	O
of	O
Tn916	O
were	O
carried	O
out	O
on	O
the	O
DNA	O
of	O
all	O
tetracycline	O
-	O
resistant	O
bacteria	O
.	O

Filter	O
-	O
mating	O
experiments	O
were	O
used	O
to	O
see	O
if	O
transfer	O
of	O
any	O
Tn916	O
-	O
like	O
elements	O
could	O
occur	O
.	O

Eight	O
out	O
of	O
15	O
tetracycline	O
-	O
resistant	O
bacteria	O
isolated	O
were	O
shown	O
to	O
possess	O
tet	O
(	O
M	O
)	O
.	O

Furthermore	O
,	O
four	O
of	O
these	O
eight	O
were	O
shown	O
to	O
possess	O
the	O
Tn916	O
-	O
unique	O
regions	O
linked	O
to	O
the	O
tet	O
(	O
M	O
)	O
gene	O
.	O

Transfer	O
experiments	O
demonstrated	O
that	O
a	O
Neisseria	B-bacteria
sp	I-bacteria
.	I-bacteria
donor	O
could	O
transfer	O
an	O
extremely	O
unstable	O
Tn916	O
-	O
like	O
element	O
to	O
Enterococcus	B-bacteria
faecalis	I-bacteria
.	O

The	O
tet	O
(	O
M	O
)	O
gene	O
is	O
present	O
in	O
the	O
majority	O
of	O
tetracycline	O
-	O
resistant	O
bacteria	O
isolated	O
in	O
this	O
study	O
and	O
the	O
conjugative	O
transposon	O
Tn916	O
has	O
been	O
shown	O
to	O
be	O
responsible	O
for	O
the	O
support	O
and	O
transfer	O
of	O
this	O
gene	O
in	O
some	O
of	O
the	O
bacteria	O
isolated	O
.	O

Opportunistic	O
infections	O
in	O
the	O
oral	O
cavity	O
of	O
the	O
elderly	O
may	O
increase	O
the	O
incidence	O
of	O
systemic	O
disease	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
differences	O
in	O
the	O
oral	O
bacterial	O
flora	O
between	O
dependent	O
elderly	O
(	O
inpatients	O
)	O
and	O
independent	O
elderly	O
(	O
community	O
-	O
dwelling	O
residents	O
)	O
.	O

After	O
multiple	O
variables	O
were	O
taken	O
into	O
account	O
,	O
inpatients	O
had	O
significantly	O
lower	O
detection	O
rates	O
than	O
community	O
-	O
dwelling	O
residents	O
for	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
Neisseria	B-bacteria
(	O
p	O
0	O
.	O
004	O
)	O
,	O
and	O
higher	O
detection	O
rates	O
for	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
(	O
p	O
0	O
.	O
024	O
)	O
,	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
(	O
p	O
0	O
.	O
011	O
)	O
and	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
p	O
0	O
.	O
005	O
)	O
.	O

Among	O
inpatients	O
,	O
the	O
requirement	O
for	O
a	O
high	O
degree	O
of	O
care	O
was	O
related	O
negatively	O
to	O
detection	O
of	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
,	O
but	O
was	O
related	O
significantly	O
to	O
detection	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
p	O
0	O
.	O
018	O
)	O
or	O
MRSA	B-bacteria
(	O
p	O
0	O
.	O
004	O
)	O
.	O

Tube	O
-	O
fed	O
inpatients	O
had	O
a	O
significantly	O
lower	O
detection	O
rate	O
for	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
(	O
p	O
0	O
.	O
041	O
)	O
and	O
a	O
higher	O
detection	O
rate	O
for	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
p	O
0	O
.	O
004	O
)	O
than	O
those	O
who	O
did	O
not	O
require	O
tube	O
feeding	O
.	O

Inpatients	O
with	O
a	O
history	O
of	O
antibiotic	O
use	O
had	O
a	O
significantly	O
lower	O
detection	O
rate	O
for	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
(	O
p	O
0	O
.	O
049	O
)	O
and	O
a	O
higher	O
detection	O
rate	O
for	O
MRSA	B-bacteria
(	O
p	O
0	O
.	O
007	O
)	O
than	O
those	O
without	O
a	O
history	O
of	O
antibiotic	O
use	O
.	O

The	O
detection	O
rates	O
for	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
or	O
MRSA	B-bacteria
in	O
inpatients	O
without	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
were	O
higher	O
than	O
in	O
inpatients	O
with	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
after	O
controlling	O
for	O
age	O
and	O
gender	O
(	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
,	O
p	O
0	O
.	O
006	O
;	O
MRSA	B-bacteria
,	O
p	O
0	O
.	O
001	O
)	O
.	O

Overall	O
,	O
detection	O
of	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
had	O
an	O
inverse	O
correlation	O
with	O
the	O
detection	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
and	O
MRSA	B-bacteria
in	O
the	O
oral	O
cavity	O
and	O
is	O
likely	O
to	O
be	O
an	O
indicator	O
of	O
pathogenic	O
bacterial	O
infection	O
.	O

Peptidoglycans	O
(	O
PGNs	O
)	O
are	O
ubiquitous	O
constituents	O
of	O
bacterial	O
cell	O
walls	O
and	O
exhibit	O
various	O
immunobiological	O
activities	O
.	O

Two	O
types	O
of	O
minimum	O
essential	O
PGN	O
structures	O
for	O
immunobiological	O
activities	O
were	O
chemically	O
synthesized	O
and	O
designated	O
as	O
muramyldipeptide	O
;	O
N	O
-	O
acetylmuramyl	O
-	O
L	O
-	O
alanyl	O
-	O
D	O
-	O
isoglutamine	O
(	O
MDP	O
)	O
and	O
gamma	O
-	O
D	O
-	O
glutamyl	O
-	O
meso	O
-	O
diaminopimelic	O
acid	O
(	O
iE	O
-	O
DAP	O
)	O
,	O
which	O
are	O
common	O
constituents	O
of	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
,	O
as	O
well	O
as	O
most	O
Gram	O
-	O
negative	O
and	O
some	O
Gram	O
-	O
positive	O
bacteria	O
,	O
respectively	O
.	O

Recently	O
,	O
intracellular	O
receptors	O
for	O
MDP	O
and	O
iE	O
-	O
DAP	O
have	O
been	O
demonstrated	O
to	O
be	O
nucleotide	O
-	O
binding	O
oligomerization	O
domain	O
(	O
NOD	O
)	O
1	O
and	O
NOD2	O
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
chemically	O
synthesized	O
meso	O
-	O
DAP	O
itself	O
activated	O
human	O
epithelial	O
cells	O
from	O
various	O
tissues	O
,	O
through	O
NOD1	O
to	O
generate	O
antibacterial	O
factors	O
,	O
PGN	O
recognition	O
proteins	O
and	O
beta	O
-	O
defensin	O
2	O
,	O
and	O
cytokines	O
in	O
specified	O
cases	O
,	O
although	O
the	O
activities	O
of	O
meso	O
-	O
DAP	O
were	O
generally	O
weaker	O
than	O
those	O
of	O
known	O
NOD	O
agonists	O
.	O

However	O
,	O
stereoisomers	O
of	O
meso	O
-	O
DAP	O
,	O
LL	O
-	O
DAP	O
,	O
and	O
DD	O
-	O
DAP	O
were	O
only	O
slightly	O
activated	O
or	O
remained	O
inactive	O
,	O
respectively	O
.	O

Synthetic	O
meso	O
-	O
lanthionine	O
,	O
which	O
is	O
another	O
diamino	O
-	O
type	O
amino	O
acid	O
specific	O
to	O
PGN	O
of	O
the	O
specified	O
Gram	O
-	O
negative	O
bacteria	O
,	O
was	O
also	O
recognized	O
by	O
NOD1	O
.	O

In	O
human	O
monocytic	O
cells	O
,	O
in	O
the	O
presence	O
of	O
cytochalasin	O
D	O
meso	O
-	O
DAP	O
induced	O
slightly	O
but	O
significantly	O
increased	O
production	O
of	O
cytokines	O
,	O
although	O
the	O
cells	O
did	O
not	O
respond	O
to	O
meso	O
-	O
DAP	O
in	O
the	O
absent	O
of	O
cytochalasin	O
D	O
.	O
Our	O
findings	O
suggest	O
that	O
NOD1	O
is	O
a	O
special	O
sentinel	O
molecule	O
,	O
especially	O
in	O
the	O
epithelial	O
barrier	O
,	O
allowing	O
the	O
intracellular	O
detection	O
of	O
bacteria	O
through	O
recognizing	O
meso	O
-	O
DAP	O
or	O
comparable	O
moiety	O
of	O
PGN	O
from	O
specified	O
bacteria	O
in	O
cooperation	O
with	O
NOD2	O
,	O
thereby	O
playing	O
a	O
key	O
role	O
in	O
innate	O
immunity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
serum	O
antibody	O
responses	O
to	O
periodontal	O
pathogens	O
after	O
single	O
-	O
visit	O
full	O
-	O
mouth	O
ultrasonic	O
debridement	O
and	O
quadrant	O
-	O
wise	O
therapy	O
.	O

Thirty	O
-	O
six	O
subjects	O
with	O
chronic	O
periodontitis	O
were	O
randomized	O
into	O
three	O
groups	O
:	O
quadrant	O
-	O
wise	O
debridement	O
in	O
four	O
visits	O
,	O
one	O
-	O
visit	O
full	O
-	O
mouth	O
debridement	O
with	O
water	O
and	O
with	O
povidone	O
iodine	O
.	O

Blood	O
samples	O
were	O
collected	O
before	O
and	O
immediately	O
after	O
treatment	O
and	O
1	O
,	O
3	O
and	O
6	O
months	O
post	O
-	O
therapy	O
.	O

Serum	O
antibody	O
titres	O
and	O
avidity	O
to	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
were	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
and	O
thiocyanate	O
ELISA	O
,	O
respectively	O
.	O

IgG	O
titres	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
significantly	O
decreased	O
at	O
1	O
,	O
3	O
and	O
6	O
months	O
in	O
full	O
-	O
mouth	O
debridement	O
with	O
water	O
group	O
,	O
while	O
significant	O
reductions	O
were	O
seen	O
only	O
at	O
3	O
and	O
6	O
months	O
after	O
quadrant	O
-	O
wise	O
debridement	O
.	O

Both	O
full	O
-	O
mouth	O
groups	O
showed	O
significant	O
reduction	O
in	O
IgG	O
titres	O
to	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
at	O
3	O
and	O
6	O
months	O
.	O

Significant	O
increases	O
in	O
antibody	O
avidity	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
were	O
noted	O
3	O
months	O
following	O
full	O
-	O
mouth	O
debridement	O
with	O
povidone	O
.	O

Both	O
full	O
-	O
mouth	O
and	O
quadrant	O
treatments	O
generally	O
resulted	O
in	O
a	O
decrease	O
in	O
antibody	O
titres	O
and	O
increase	O
in	O
antibody	O
avidity	O
.	O

Full	O
-	O
mouth	O
debridement	O
induced	O
an	O
earlier	O
reduction	O
of	O
IgG	O
titre	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
than	O
quadrant	O
-	O
wise	O
therapy	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
oral	O
cavity	O
condition	O
,	O
identify	O
microorganisms	O
and	O
evaluate	O
interrelation	O
between	O
protozoans	O
,	O
bacteria	O
and	O
fungi	O
occurring	O
in	O
mouths	O
of	O
insuline	O
treated	O
diabetics	O
.	O

30	O
men	O
and	O
women	O
,	O
25	O
-	O
60	O
years	O
old	O
,	O
were	O
clinically	O
assessed	O
for	O
their	O
oral	O
cavity	O
condition	O
including	O
pH	O
range	O
.	O

Fifteen	O
of	O
them	O
were	O
the	O
insuline	O
treated	O
diabetics	O
.	O

Swabs	O
taken	O
of	O
different	O
sites	O
of	O
periodontium	O
,	O
dental	O
plaques	O
and	O
dental	O
pockets	O
collected	O
from	O
each	O
patients	O
were	O
used	O
for	O
detection	O
and	O
identification	O
of	O
protozoans	O
,	O
bacteria	O
and	O
fungi	O
.	O

Mucosal	O
inflammation	O
,	O
dental	O
caries	O
,	O
loose	O
teeth	O
,	O
periodontitis	O
were	O
observed	O
in	O
the	O
diabetic	O
patients	O
,	O
whereas	O
the	O
oral	O
cavities	O
were	O
generally	O
in	O
better	O
condition	O
in	O
the	O
control	O
patients	O
.	O

Prevalence	O
of	O
the	O
protozoan	O
parasites	O
Entamoeba	O
gingivalis	O
and	O
Trichomonas	O
tenax	O
was	O
higher	O
in	O
the	O
control	O
patients	O
than	O
in	O
the	O
diabetics	O
(	O
26	O
.	O
6	O
%	O
and	O
13	O
.	O
3	O
%	O
,	O
respectively	O
)	O
.	O

Fecal	O
bacteria	O
Enterococcus	B-bacteria
fecalis	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
occurred	O
with	O
significantly	O
higher	O
frequency	O
in	O
the	O
insuline	O
treated	O
patients	O
(	O
60	O
%	O
)	O
than	O
in	O
the	O
control	O
(	O
6	O
.	O
6	O
%	O
)	O
.	O

Various	O
Candida	O
albicans	O
strains	O
were	O
more	O
often	O
found	O
in	O
the	O
diabetic	O
(	O
53	O
.	O
2	O
%	O
)	O
than	O
in	O
the	O
control	O
patients	O
(	O
13	O
.	O
3	O
%	O
)	O
.	O

The	O
results	O
of	O
our	O
studies	O
show	O
a	O
clear	O
interrelation	O
between	O
alteration	O
of	O
oral	O
health	O
and	O
the	O
occurrence	O
of	O
microorganisms	O
in	O
the	O
insuline	O
treated	O
diabetics	O
.	O

Metabolic	O
disease	O
that	O
causes	O
serious	O
multi	O
-	O
organ	O
disturbances	O
as	O
well	O
as	O
insulinotherapy	O
are	O
the	O
very	O
important	O
factors	O
changing	O
oral	O
cavity	O
ecology	O
of	O
the	O
persons	O
with	O
diabetes	O
mellitus	O
;	O
decresed	O
pH	O
(	O
the	O
average	O
5	O
.	O
5	O
)	O
may	O
inhibit	O
development	O
of	O
infection	O
with	O
protozoans	O
in	O
the	O
oral	O
cavity	O
of	O
these	O
patients	O
and	O
favour	O
subclinical	O
infections	O
with	O
other	O
microorganisms	O
.	O

Thus	O
,	O
in	O
the	O
insuline	O
treated	O
diabetics	O
,	O
examination	O
of	O
mouths	O
with	O
regard	O
to	O
the	O
occurrence	O
of	O
opportunistic	O
fecal	O
bacteria	O
and	O
fungi	O
,	O
particularly	O
before	O
a	O
therapy	O
with	O
antibiotics	O
is	O
strongly	O
recommended	O
.	O

Alcohol	O
is	O
a	O
well	O
documented	O
risk	O
factor	O
for	O
upper	O
digestive	O
tract	O
cancers	O
.	O

It	O
has	O
been	O
shown	O
that	O
acetaldehyde	O
,	O
the	O
first	O
metabolite	O
of	O
ethanol	O
is	O
carcinogenic	O
.	O

The	O
role	O
of	O
microbes	O
in	O
the	O
production	O
of	O
acetaldehyde	O
to	O
the	O
oral	O
cavity	O
has	O
previously	O
been	O
described	O
in	O
several	O
studies	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
aim	O
was	O
to	O
investigate	O
the	O
capability	O
of	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
of	O
normal	O
oral	O
flora	O
to	O
produce	O
acetaldehyde	O
in	O
vitro	O
during	O
ethanol	O
incubation	O
.	O

Furthermore	O
,	O
the	O
aim	O
was	O
to	O
measure	O
the	O
alcohol	O
dehydrogenase	O
(	O
ADH	O
)	O
activity	O
of	O
the	O
bacteria	O
.	O

Eight	O
clinical	O
strains	O
and	O
eight	O
American	O
Type	O
Culture	O
Collection	O
(	O
ATCC	O
)	O
strains	O
of	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
were	O
selected	O
for	O
the	O
study	O
.	O

Bacterial	O
suspensions	O
were	O
incubated	O
in	O
two	O
different	O
ethanol	O
concentrations	O
,	O
11	O
mM	O
and	O
1100	O
mM	O
and	O
the	O
acetaldehyde	O
was	O
measured	O
by	O
gas	O
chromatography	O
.	O

ADH	O
-	O
activity	O
was	O
measured	O
by	O
using	O
a	O
sensitive	O
spectroscopy	O
.	O

The	O
results	O
show	O
significant	O
differences	O
between	O
the	O
bacterial	O
strains	O
regarding	O
acetaldehyde	O
production	O
capability	O
and	O
the	O
detected	O
ADH	O
-	O
activity	O
.	O

In	O
particular	O
,	O
clinical	O
strain	O
of	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
both	O
clinical	O
and	O
culture	O
collection	O
strains	O
of	O
Streptococcus	B-bacteria
intermedius	I-bacteria
and	O
culture	O
collection	O
strain	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
produced	O
high	O
amounts	O
of	O
acetaldehyde	O
in	O
11	O
mM	O
and	O
1100	O
mM	O
ethanol	O
incubation	O
.	O

All	O
these	O
four	O
bacterial	O
strains	O
also	O
showed	O
significant	O
ADH	O
-	O
enzyme	O
activity	O
.	O

Twelve	O
other	O
strains	O
were	O
found	O
to	O
be	O
low	O
acetaldehyde	O
producers	O
.	O

Consequently	O
,	O
our	O
study	O
shows	O
that	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
may	O
play	O
a	O
role	O
in	O
metabolizing	O
ethanol	O
to	O
carcinogenic	O
acetaldehyde	O
in	O
the	O
mouth	O
.	O

The	O
observation	O
supports	O
the	O
concept	O
of	O
a	O
novel	O
mechanism	O
in	O
the	O
pathogenesis	O
of	O
oral	O
cancer	O
.	O

Twelve	O
out	O
of	O
96	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
isolated	O
from	O
oral	O
samples	O
harbored	O
tetracycline	O
resistance	O
genes	O
.	O

The	O
most	O
common	O
resistance	O
gene	O
was	O
tet	O
(	O
M	O
)	O
.	O

A	O
tet	O
(	O
M	O
)	O
-	O
positive	O
Veillonella	B-bacteria
dispar	I-bacteria
strain	I-bacteria
was	O
shown	O
to	O
transfer	O
a	O
Tn916	O
-	O
like	O
element	O
to	O
four	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
by	O
conjugation	O
at	O
a	O
frequency	O
of	O
5	O
.	O
2	O
x	O
10	O
(	O
-	O
6	O
)	O
to	O
4	O
.	O
5	O
x	O
10	O
(	O
-	O
5	O
)	O
per	O
recipient	O
.	O

At	O
this	O
time	O
in	O
the	O
USA	O
there	O
are	O
no	O
antimicrobials	O
with	O
specific	O
indications	O
for	O
oral	O
infections	O
,	O
and	O
many	O
of	O
those	O
currently	O
used	O
have	O
limited	O
efficacy	O
against	O
oral	O
anaerobic	O
strains	O
.	O

We	O
tested	O
the	O
activity	O
of	O
azithromycin	O
against	O
a	O
broad	O
range	O
of	O
anaerobic	O
oral	O
pathogens	O
and	O
,	O
at	O
pH	O
8	O
,	O
found	O
it	O
to	O
be	O
effective	O
against	O
98	O
%	O
of	O
strains	O
,	O
including	O
all	O
fusobacteria	B-bacteria
and	O
beta	O
-	O
lactamase	O
-	O
producing	O
strains	O
of	O
Prevotella	B-bacteria
spp	I-bacteria
.	O

All	O
strains	O
of	O
Eikenella	B-bacteria
corrodens	I-bacteria
were	O
also	O
susceptible	O
to	O
azithromycin	O
but	O
resistant	O
to	O
erythromycin	O
,	O
clindamycin	O
,	O
metronidazole	O
and	O
cefalexin	O
.	O

Other	O
comparator	O
agents	O
were	O
penicillin	O
,	O
amoxicillin	O
/	O
clavulanic	O
acid	O
,	O
tetracycline	O
,	O
levofloxacin	O
and	O
ciprofloxacin	O
.	O

Minimum	O
inhibitory	O
concentrations	O
obtained	O
on	O
agar	O
adjusted	O
to	O
pH	O
8	O
were	O
generally	O
one	O
dilution	O
lower	O
than	O
those	O
obtained	O
on	O
agar	O
at	O
pH	O
7	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
is	O
common	O
in	O
people	O
.	O

However	O
,	O
the	O
existence	O
of	O
extra	O
gastric	O
reservoirs	O
and	O
transmission	O
routes	O
remain	O
controversial	O
in	O
the	O
field	O
.	O

Because	O
the	O
oral	O
cavity	O
has	O
been	O
proposed	O
as	O
a	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
a	O
study	O
was	O
carried	O
out	O
to	O
determine	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dental	O
plaque	O
and	O
saliva	O
.	O

The	O
results	O
were	O
asociated	O
with	O
those	O
obtained	O
in	O
the	O
gastric	O
biopsy	O
.	O

Ninety	O
-	O
seven	O
dyspeptic	O
and	O
fifty	O
asymptomatic	O
patients	O
were	O
studied	O
and	O
samples	O
taken	O
for	O
biopsy	O
,	O
dental	O
plaque	O
and	O
saliva	O
.	O

The	O
gastric	O
biopsies	O
were	O
evaluated	O
using	O
microbiology	O
and	O
histology	O
methods	O
.	O

Cultures	O
and	O
urease	O
tests	O
were	O
carried	O
out	O
on	O
the	O
oral	O
cavity	O
samples	O
and	O
included	O
pretreatment	O
methods	O
using	O
urea	O
and	O
HCl	O
.	O

The	O
frequency	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
for	O
all	O
the	O
patients	O
evaluated	O
was	O
75	O
.	O
5	O
%	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
isolated	O
in	O
saliva	O
or	O
dental	O
plaque	O
in	O
any	O
of	O
the	O
two	O
groups	O
studied	O
with	O
or	O
without	O
sample	O
pretreatment	O
.	O

The	O
urease	O
test	O
in	O
dental	O
plaque	O
was	O
positive	O
in	O
99	O
.	O
3	O
%	O
of	O
the	O
patients	O
and	O
89	O
.	O
8	O
%	O
in	O
saliva	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
between	O
the	O
infection	O
prevalence	O
by	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dyspeptic	O
or	O
not	O
dyspeptic	O
patients	O
.	O

The	O
obtained	O
results	O
suggest	O
that	O
the	O
methodology	O
used	O
for	O
the	O
detection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
is	O
not	O
sufficiently	O
sensitive	O
for	O
the	O
determination	O
of	O
the	O
microorganism	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
bacterial	O
division	O
Synergistes	B-bacteria
represents	O
a	O
poorly	O
characterized	O
phylotype	O
of	O
which	O
only	O
a	O
few	O
isolates	O
have	O
been	O
cultured	O
,	O
primarily	O
from	O
natural	O
environments	O
.	O

Recent	O
detection	O
of	O
Synergistes	O
-	O
like	O
sequence	O
types	O
in	O
periodontal	O
pockets	O
and	O
caries	O
lesions	O
of	O
humans	O
prompted	O
us	O
to	O
search	O
the	O
R	O
.	O
M	O
.	O
Alden	O
culture	O
collection	O
(	O
Santa	O
Monica	O
,	O
Calif	O
.	O
)	O
for	O
biochemically	O
unidentifiable	O
,	O
slow	O
-	O
growing	O
,	O
obligately	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
.	O

Here	O
we	O
report	O
on	O
five	O
clinical	O
isolates	O
cultured	O
from	O
peritoneal	O
fluid	O
and	O
two	O
isolates	O
from	O
soft	O
-	O
tissue	O
infections	O
that	O
together	O
constitute	O
three	O
separate	O
evolutionary	O
lineages	O
within	O
the	O
phylogenetic	O
radiation	O
of	O
the	O
division	O
Synergistes	B-bacteria
.	O

One	O
of	O
these	O
clusters	O
was	O
formed	O
by	O
the	O
peritoneal	O
isolates	O
and	O
had	O
an	O
85	O
%	O
similarity	O
to	O
Synergistes	B-bacteria
jonesii	I-bacteria
,	O
the	O
first	O
described	O
Synergistes	B-bacteria
species	I-bacteria
,	O
which	O
was	O
isolated	O
from	O
the	O
rumen	O
of	O
a	O
goat	O
.	O

The	O
isolates	O
from	O
soft	O
-	O
tissue	O
infections	O
,	O
on	O
the	O
other	O
hand	O
,	O
formed	O
two	O
distinct	O
lineages	O
moderately	O
related	O
to	O
each	O
other	O
with	O
a	O
similarity	O
of	O
approximately	O
78	O
%	O
.	O

In	O
addition	O
,	O
by	O
using	O
a	O
newly	O
designed	O
16S	O
rRNA	O
gene	O
-	O
based	O
PCR	O
assay	O
with	O
intended	O
target	O
specificity	O
for	O
Synergistes	B-bacteria
,	O
we	O
found	O
that	O
the	O
dominant	O
phylotype	O
from	O
a	O
fecal	O
sample	O
was	O
nearly	O
identical	O
to	O
that	O
of	O
the	O
strains	O
obtained	O
from	O
peritonitis	O
.	O

Conversely	O
,	O
sequence	O
types	O
detected	O
in	O
periodontal	O
pockets	O
formed	O
a	O
separate	O
cluster	O
that	O
shared	O
a	O
similarity	O
of	O
only	O
80	O
%	O
with	O
the	O
soft	O
-	O
tissue	O
isolates	O
.	O

These	O
findings	O
suggest	O
a	O
high	O
diversity	O
of	O
medically	O
important	O
Synergistes	B-bacteria
clades	O
that	O
apparently	O
are	O
unique	O
to	O
individual	O
ecological	O
niches	O
in	O
the	O
human	O
body	O
.	O

In	O
conclusion	O
,	O
we	O
now	O
have	O
available	O
the	O
first	O
characterized	O
human	O
isolates	O
of	O
the	O
division	O
Synergistes	B-bacteria
which	O
are	O
colonizing	O
,	O
and	O
probably	O
infecting	O
,	O
several	O
sites	O
in	O
the	O
human	O
body	O
.	O

Malodour	O
has	O
been	O
correlated	O
with	O
the	O
concentration	O
of	O
volatile	O
sulphur	O
compounds	O
produced	O
in	O
the	O
oral	O
cavity	O
by	O
metabolic	O
activity	O
of	O
bacteria	O
colonizing	O
the	O
periodontal	O
sites	O
and	O
the	O
dorsum	O
of	O
the	O
tongue	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
detect	O
malodour	O
in	O
mouth	O
air	O
organoleptically	O
and	O
using	O
a	O
portable	O
sulphide	O
monitor	O
and	O
to	O
correlate	O
it	O
with	O
the	O
clinical	O
parameters	O
,	O
halitosis	O
linked	O
toxins	O
and	O
BANA	O
,	O
using	O
tongue	O
and	O
subgingival	O
plaque	O
samples	O
.	O

The	O
halitosis	O
grading	O
is	O
also	O
correlated	O
with	O
the	O
microbial	O
colonies	O
of	O
the	O
subgingival	O
plaque	O
sample	O
.	O

20	O
patients	O
with	O
chronic	O
periodontitis	O
with	O
5	O
-	O
7	O
mm	O
pocket	O
depth	O
,	O
radiographic	O
evidence	O
of	O
bone	O
loss	O
and	O
presence	O
of	O
oral	O
malodour	O
participated	O
in	O
this	O
study	O
.	O

Assessment	O
of	O
mouth	O
air	O
was	O
done	O
organoleptically	O
and	O
by	O
using	O
a	O
portable	O
sulphide	O
monitor	O
.	O

The	O
clinical	O
parameter	O
,	O
plaque	O
index	O
(	O
PI	O
)	O
,	O
gingival	O
index	O
(	O
GI	O
)	O
,	O
gingival	O
bleeding	O
index	O
(	O
BI	O
)	O
,	O
were	O
obtained	O
from	O
all	O
the	O
areas	O
.	O

Samples	O
for	O
BANA	O
and	O
to	O
detect	O
halitosis	O
linked	O
toxins	O
were	O
taken	O
from	O
the	O
dorsal	O
surface	O
of	O
the	O
tongue	O
and	O
periodontal	O
pockets	O
ranging	O
5	O
-	O
7	O
mm	O
.	O

Halitosis	O
related	O
microbial	O
colonies	O
were	O
identified	O
using	O
anaerobic	O
culturing	O
from	O
the	O
subgingival	O
plaque	O
.	O

The	O
scores	O
of	O
PI	O
,	O
GI	O
,	O
BI	O
and	O
sample	O
that	O
tested	O
positive	O
for	O
halitosis	O
linked	O
toxins	O
and	O
with	O
the	O
halitosis	O
grading	O
were	O
not	O
significant	O
.	O

The	O
presence	O
of	O
tongue	O
coating	O
and	O
the	O
halitosis	O
grading	O
and	O
toxin	O
levels	O
were	O
significant	O
.	O

BANA	O
has	O
shown	O
to	O
be	O
non	O
contributory	O
due	O
to	O
technical	O
problems	O
.	O

Anaerobic	O
culture	O
has	O
shown	O
to	O
identify	O
Streptococcus	B-bacteria
,	O
Bacteroides	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Porphyromonas	B-bacteria
and	O
Prevotella	B-bacteria
colonies	O
.	O

The	O
results	O
confirmed	O
that	O
there	O
was	O
no	O
correlation	O
between	O
the	O
clinical	O
parameters	O
,	O
halitosis	O
linked	O
toxins	O
and	O
halitosis	O
grading	O
.	O

The	O
microbial	O
colonies	O
have	O
shown	O
to	O
correlate	O
with	O
the	O
presence	O
of	O
oral	O
malodour	O
.	O

The	O
degree	O
of	O
adhesion	O
and	O
colonization	O
was	O
studied	O
among	O
27	O
patients	O
with	O
generalized	O
paradontitis	O
of	O
moderate	O
severity	O
and	O
in	O
remission	O
stage	O
.	O

All	O
these	O
patients	O
had	O
different	O
material	O
teeth	O
prostheses	O
.	O

12	O
patients	O
had	O
acrylic	O
plastic	O
`	O
`	O
Ftorax	O
'	O
'	O
material	O
prostheses	O
and	O
15	O
of	O
them	O
polypropylenes	O
prostheses	O
.	O

Prostheses	O
prepared	O
from	O
acryl	O
plastic	O
were	O
intensively	O
colonized	O
by	O
stable	O
microflora	O
of	O
oral	O
cavity	O
,	O
as	O
well	O
as	O
by	O
paradontopathogens	O
,	O
whereas	O
usage	O
of	O
polypropylenes	O
prostheses	O
is	O
rather	O
effective	O
for	O
patients	O
with	O
paradontitis	O
,	O
because	O
it	O
is	O
followed	O
by	O
partial	O
recovery	O
of	O
stable	O
microflora	O
and	O
lack	O
of	O
secretion	O
of	O
parodontopathogenic	O
types	O
,	O
such	O
as	O
actynomycetes	B-bacteria
,	O
prevotellae	B-bacteria
,	O
fusobacteria	B-bacteria
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
assess	O
the	O
anatomical	O
spaces	O
and	O
causative	O
micro	O
-	O
organisms	O
responsible	O
for	O
deep	O
fascial	O
space	O
head	O
and	O
neck	O
infections	O
and	O
evaluate	O
the	O
resistance	O
of	O
antibiotics	O
used	O
in	O
the	O
treatment	O
of	O
these	O
infections	O
.	O

A	O
6	O
-	O
year	O
retrospective	O
study	O
evaluated	O
hospital	O
records	O
of	O
103	O
patients	O
.	O

All	O
patients	O
in	O
this	O
study	O
underwent	O
surgical	O
incision	O
and	O
drainage	O
,	O
received	O
IV	O
antibiotics	O
,	O
and	O
had	O
culture	O
and	O
sensitivity	O
performed	O
.	O

Patient	O
demographics	O
reviewed	O
were	O
gender	O
,	O
age	O
,	O
involved	O
fascial	O
space	O
(	O
s	O
)	O
,	O
micro	O
-	O
organisms	O
identified	O
and	O
antibiotic	O
resistance	O
from	O
culture	O
and	O
sensitivity	O
testing	O
.	O

There	O
were	O
56	O
male	O
(	O
54	O
%	O
)	O
and	O
47	O
(	O
46	O
%	O
)	O
female	O
patients	O
.	O

The	O
submandibular	O
space	O
was	O
the	O
most	O
frequent	O
location	O
for	O
a	O
single	O
space	O
abscess	O
(	O
30	O
%	O
)	O
,	O
followed	O
by	O
the	O
buccal	O
space	O
(	O
27	O
.	O
5	O
%	O
)	O
and	O
the	O
lateral	O
pharyngeal	O
space	O
(	O
12	O
.	O
5	O
%	O
)	O
.	O

Sixty	O
-	O
three	O
patients	O
presented	O
with	O
multiple	O
space	O
involvement	O
,	O
totaling	O
142	O
spaces	O
involved	O
.	O

A	O
total	O
of	O
269	O
bacterial	O
strains	O
were	O
isolated	O
from	O
103	O
patients	O
.	O

The	O
bacteria	O
were	O
found	O
to	O
be	O
63	O
.	O
5	O
%	O
gram	O
-	O
positive	O
.	O

Gram	O
-	O
positive	O
cocci	O
were	O
isolated	O
57	O
.	O
7	O
%	O
of	O
specimens	O
and	O
gram	O
-	O
negative	O
rods	O
were	O
isolated	O
in	O
33	O
%	O
of	O
cultures	O
.	O

There	O
were	O
178	O
aerobes	O
(	O
65	O
.	O
7	O
%	O
)	O
and	O
91	O
anaerobes	O
(	O
34	O
.	O
3	O
%	O
)	O
isolated	O
.	O

The	O
most	O
common	O
bacteria	O
isolated	O
were	O
Viridans	B-bacteria
streptococci	I-bacteria
,	O
Provetella	B-bacteria
,	O
Staphylococci	B-bacteria
,	O
and	O
Peptostreptococcus	B-bacteria
.	O

culture	O
and	O
sensitivity	O
testing	O
were	O
reviewed	O
on	O
101	O
patients	O
.	O

Patients	O
who	O
underwent	O
surgical	O
incision	O
and	O
drainage	O
in	O
the	O
operating	O
room	O
had	O
a	O
tendency	O
for	O
involvement	O
of	O
multiple	O
space	O
abscesses	O
with	O
the	O
submandibular	O
space	O
,	O
submental	O
,	O
and	O
lateral	O
pharyngeal	O
spaces	O
effected	O
most	O
frequently	O
.	O

culture	O
and	O
sensitivity	O
testing	O
commonly	O
showed	O
greater	O
growth	O
in	O
aerobes	O
(	O
65	O
.	O
7	O
%	O
)	O
than	O
in	O
anaerobes	O
.	O

Gram	O
positive	O
cocci	O
and	O
gram	O
negative	O
rods	O
had	O
the	O
greatest	O
growth	O
percentage	O
in	O
cultures	O
.	O

The	O
aim	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
30	O
%	O
ethanolic	O
extract	O
of	O
Bulgarian	O
propolis	O
on	O
94	O
clinical	O
anaerobic	O
strains	O
.	O

The	O
strains	O
were	O
tested	O
by	O
both	O
agar	O
-	O
well	O
diffusion	O
(	O
wells	O
,	O
7	O
mm	O
diameter	O
)	O
and	O
disk	O
-	O
diffusion	O
methods	O
.	O

Only	O
15	O
%	O
of	O
Clostridium	B-bacteria
-	O
,	O
3	O
.	O
3	O
%	O
of	O
other	O
Gram	O
-	O
positive	O
-	O
and	O
9	O
.	O
1	O
%	O
of	O
Gram	O
-	O
negative	O
anaerobic	O
strains	O
were	O
not	O
inhibited	O
by	O
30	O
microL	O
propolis	O
extract	O
per	O
well	O
.	O

Propolis	O
extract	O
was	O
more	O
active	O
than	O
the	O
ethanol	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

By	O
30	O
microL	O
extract	O
per	O
well	O
,	O
mean	O
inhibitory	O
diameters	O
of	O
the	O
clostridia	B-bacteria
,	O
other	O
Gram	O
-	O
positive	O
-	O
and	O
Gram	O
-	O
negative	O
anaerobes	O
were	O
11	O
.	O
5	O
,	O
13	O
.	O
1	O
,	O
and	O
11	O
.	O
3	O
mm	O
,	O
and	O
those	O
by	O
90	O
microL	O
were	O
16	O
,	O
18	O
.	O
1	O
and	O
15	O
.	O
4	O
mm	O
,	O
respectively	O
.	O

Mean	O
inhibitory	O
diameters	O
of	O
all	O
strains	O
by	O
30	O
and	O
90	O
microL	O
ethanol	O
were	O
only	O
8	O
.	O
4	O
and	O
9	O
.	O
5	O
mm	O
.	O

By	O
30	O
microL	O
propolis	O
extract	O
per	O
well	O
,	O
inhibitory	O
diameters	O
of	O
15	O
mm	O
or	O
more	O
were	O
more	O
common	O
in	O
Gram	O
-	O
positive	O
(	O
32	O
%	O
)	O
than	O
in	O
Gram	O
-	O
negative	O
bacteria	O
(	O
13	O
.	O
6	O
%	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Moist	O
propolis	O
disks	O
inhibited	O
more	O
strains	O
(	O
89	O
.	O
4	O
%	O
)	O
than	O
dried	O
disks	O
(	O
68	O
.	O
1	O
%	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Most	O
(	O
81	O
.	O
8	O
%	O
)	O
Bacteroides	B-bacteria
fragilis	I-bacteria
group	I-bacteria
strains	I-bacteria
and	O
75	O
%	O
of	O
clostridial	B-bacteria
strains	I-bacteria
were	O
inhibited	O
by	O
moist	O
EEP	O
disks	O
.	O

Bulgarian	O
propolis	O
was	O
active	O
against	O
most	O
anaerobic	O
strains	O
of	O
different	O
genera	O
.	O

In	O
addition	O
to	O
oral	O
pathogens	O
,	O
an	O
activity	O
of	O
propolis	O
against	O
Clostridium	B-bacteria
,	O
Bacteroides	B-bacteria
and	O
Propionibacterium	B-bacteria
species	I-bacteria
was	O
observed	O
.	O

The	O
results	O
could	O
motivate	O
a	O
higher	O
medical	O
interest	O
and	O
further	O
trials	O
for	O
evaluating	O
the	O
use	O
of	O
bee	O
glue	O
for	O
prophylaxis	O
or	O
treatment	O
of	O
some	O
anaerobic	O
infections	O
such	O
as	O
oral	O
,	O
skin	O
and	O
wound	O
diseases	O
.	O

Most	O
probiotic	O
products	O
are	O
consumed	O
orally	O
and	O
hence	O
it	O
is	O
feasible	O
that	O
the	O
bacteria	O
in	O
these	O
products	O
may	O
also	O
attach	O
to	O
oral	O
surfaces	O
;	O
however	O
,	O
the	O
effects	O
of	O
these	O
bacteria	O
on	O
the	O
oral	O
ecosystem	O
are	O
mostly	O
unknown	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
oral	O
colonization	O
potential	O
of	O
different	O
probiotic	O
,	O
dairy	O
,	O
and	O
fecal	O
Lactobacillus	B-bacteria
and	O
Bifidobacterium	B-bacteria
strains	I-bacteria
in	O
vitro	O
.	O

The	O
binding	O
of	O
17	O
Lactobacillus	B-bacteria
and	O
seven	O
Bifidobacterium	B-bacteria
strains	I-bacteria
to	O
hydroxyapatite	O
and	O
microtitre	O
wells	O
coated	O
with	O
human	O
saliva	O
was	O
tested	O
.	O

Binding	O
of	O
selected	O
strains	O
to	O
human	O
buccal	O
epithelial	O
cells	O
and	O
co	O
-	O
adherence	O
with	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
were	O
also	O
investigated	O
.	O

In	O
addition	O
,	O
the	O
survival	O
in	O
sterilized	O
human	O
whole	O
saliva	O
was	O
examined	O
.	O

There	O
was	O
a	O
large	O
variation	O
in	O
binding	O
to	O
saliva	O
-	O
coated	O
surfaces	O
and	O
buccal	O
epithelial	O
cells	O
but	O
all	O
strains	O
survived	O
in	O
saliva	O
.	O

The	O
binding	O
pattern	O
of	O
the	O
probiotics	O
did	O
not	O
differ	O
from	O
the	O
binding	O
of	O
the	O
fecal	O
strains	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
altered	O
the	O
binding	O
of	O
both	O
the	O
low	O
-	O
binding	O
bifidobacteria	B-bacteria
and	O
the	O
high	O
-	O
binding	O
lactobacilli	B-bacteria
.	O

The	O
differences	O
in	O
binding	O
in	O
vitro	O
may	O
indicate	O
that	O
there	O
are	O
also	O
differences	O
in	O
the	O
persistence	O
of	O
the	O
different	O
probiotic	O
strains	O
in	O
the	O
oral	O
cavity	O
in	O
vivo	O
.	O

Colonization	O
of	O
Candida	O
albicans	O
on	O
oral	O
surfaces	O
can	O
serve	O
as	O
a	O
reservoir	O
for	O
disseminated	O
infections	O
,	O
such	O
as	O
aspiration	O
pneumonia	O
and	O
gastrointestinal	O
infection	O
,	O
particularly	O
in	O
the	O
immunocompromised	O
host	O
.	O

Therefore	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
salivary	O
and	O
serum	O
pellicles	O
on	O
C	O
.	O
albicans	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
Lactobacillus	B-bacteria
and	O
Actinomyces	B-bacteria
colonization	O
on	O
type	O
I	O
collagen	O
,	O
a	O
major	O
organic	O
component	O
of	O
periodontal	O
ligaments	O
.	O

The	O
colonization	O
potential	O
of	O
two	O
isolates	O
each	O
of	O
C	O
.	O
albicans	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
and	O
a	O
single	O
isolate	O
each	O
of	O
Lactobacillus	B-bacteria
and	O
Actinomyces	B-bacteria
to	O
uncoated	O
(	O
control	O
)	O
,	O
saliva	O
-	O
coated	O
or	O
serum	O
-	O
coated	O
type	O
I	O
collagen	O
plates	O
(	O
surface	O
area	O
143	O
mm	O
(	O
2	O
)	O
,	O
Cell	O
Disk	O
;	O
Sumitomo	O
,	O
Tokyo	O
,	O
Japan	O
)	O
was	O
examined	O
using	O
a	O
bioluminescent	O
adenosine	O
triphosphate	O
assay	O
based	O
on	O
firefly	O
luciferase	O
-	O
luciferin	O
system	O
.	O

The	O
results	O
revealed	O
that	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
a	O
saliva	O
pellicle	O
was	O
significantly	O
more	O
effective	O
in	O
promoting	O
bacterial	O
colonization	O
compared	O
with	O
the	O
pellicle	O
-	O
free	O
collagen	O
disc	O
,	O
and	O
the	O
serum	O
-	O
coated	O
sample	O
significantly	O
inhibited	O
the	O
colonization	O
of	O
streptococci	B-bacteria
(	O
anova	O
;	O
P	O
<	O
0b01	O
)	O
.	O

In	O
contrast	O
,	O
in	O
the	O
case	O
of	O
C	O
.	O
albicans	O
,	O
Lactobacillus	B-bacteria
and	O
Actinomyces	B-bacteria
isolates	I-bacteria
,	O
a	O
serum	O
pellicle	O
was	O
significantly	O
more	O
effective	O
in	O
promoting	O
the	O
colonization	O
,	O
followed	O
by	O
saliva	O
pellicle	O
and	O
uncoated	O
specimen	O
(	O
anova	O
;	O
P	O
<	O
0b01	O
)	O
.	O

These	O
results	O
suggested	O
that	O
crevicular	O
fluid	O
rich	O
in	O
seruminous	O
components	O
would	O
promote	O
the	O
colonization	O
of	O
Candida	O
,	O
Lactobacillus	B-bacteria
and	O
Actinomyces	B-bacteria
on	O
type	O
I	O
collagen	O
as	O
opposed	O
to	O
streptococci	B-bacteria
which	O
showed	O
greater	O
avidity	O
to	O
saliva	O
-	O
coated	O
collagen	O
.	O

This	O
study	O
investigated	O
the	O
antibacterial	O
effect	O
of	O
electrolyzed	O
water	O
on	O
oral	O
bacteria	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Tap	O
water	O
was	O
electrolyzed	O
in	O
a	O
water	O
vessel	O
using	O
platinum	O
cell	O
technology	O
.	O

The	O
electrolyzed	O
tap	O
water	O
(	O
called	O
Puri	O
-	O
water	O
)	O
was	O
put	O
in	O
contact	O
with	O
five	O
major	O
periodontopathogens	O
or	O
toothbrushes	O
contaminated	O
with	O
these	O
bacteria	O
for	O
30	O
sec	O
.	O

In	O
addition	O
,	O
Puri	O
-	O
water	O
was	O
used	O
as	O
a	O
mouthwash	O
for	O
30	O
sec	O
in	O
16	O
subjects	O
and	O
the	O
antibacterial	O
effect	O
on	O
salivary	O
bacteria	O
was	O
evaluated	O
.	O

Puri	O
-	O
water	O
significantly	O
reduced	O
the	O
growth	O
of	O
all	O
periodontopathogens	O
in	O
culture	O
and	O
on	O
toothbrushes	O
,	O
and	O
that	O
of	O
aerobic	O
and	O
anaerobic	O
bacteria	O
in	O
saliva	O
,	O
when	O
compared	O
to	O
the	O
effect	O
of	O
tap	O
water	O
.	O

It	O
also	O
significantly	O
reduced	O
mutans	B-bacteria
streptococci	I-bacteria
growing	O
on	O
mitis	O
salivarius	O
-	O
bacitracin	O
agar	O
.	O

Our	O
results	O
demonstrate	O
that	O
the	O
electrolyzed	O
tap	O
water	O
is	O
effective	O
as	O
a	O
mouthwash	O
and	O
for	O
toothbrush	O
disinfection	O
.	O

Anaerobic	O
infections	O
are	O
common	O
and	O
can	O
cause	O
diseases	O
associated	O
with	O
severe	O
morbidity	O
,	O
but	O
are	O
easily	O
overlooked	O
in	O
clinical	O
settings	O
.	O

Both	O
the	O
relatively	O
small	O
number	O
of	O
infections	O
due	O
to	O
exogenous	O
anaerobes	O
and	O
the	O
much	O
larger	O
number	O
of	O
infections	O
involving	O
anaerobic	O
species	O
that	O
are	O
originally	O
members	O
of	O
the	O
normal	O
flora	O
,	O
may	O
lead	O
to	O
a	O
life	O
-	O
threatening	O
situation	O
unless	O
appropriate	O
treatment	O
is	O
instituted	O
.	O

Special	O
laboratory	O
procedures	O
are	O
needed	O
for	O
the	O
isolation	O
,	O
identification	O
and	O
susceptibility	O
testing	O
of	O
this	O
diverse	O
group	O
of	O
bacteria	O
.	O

Since	O
many	O
anaerobes	O
grow	O
more	O
slowly	O
than	O
the	O
facultative	O
or	O
aerobic	O
bacteria	O
,	O
and	O
particularly	O
since	O
clinical	O
specimens	O
yielding	O
anaerobic	O
bacteria	O
commonly	O
contain	O
several	O
organisms	O
and	O
often	O
very	O
complex	O
mixtures	O
of	O
aerobic	O
and	O
anaerobic	O
bacteria	O
,	O
considerable	O
time	O
may	O
elapse	O
before	O
the	O
laboratory	O
is	O
able	O
to	O
provide	O
a	O
final	O
report	O
.	O

Species	O
definition	O
based	O
on	O
phenotypic	O
features	O
is	O
often	O
time	O
-	O
consuming	O
and	O
is	O
not	O
always	O
easy	O
to	O
carry	O
out	O
.	O

Molecular	O
genetic	O
methods	O
may	O
help	O
in	O
the	O
everyday	O
clinical	O
microbiological	O
practice	O
in	O
laboratories	O
dealing	O
with	O
the	O
diagnostics	O
of	O
anaerobic	O
infections	O
.	O

Methods	O
have	O
been	O
introduced	O
for	O
species	O
diagnostics	O
,	O
such	O
as	O
16S	O
rRNA	O
PCR	O
-	O
RFLP	O
profile	O
determination	O
,	O
which	O
can	O
help	O
to	O
distinguish	O
species	O
of	O
Bacteroides	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
etc	O
.	O
that	O
are	O
otherwise	O
difficult	O
to	O
differentiate	O
.	O

The	O
use	O
of	O
DNA	O
-	O
DNA	O
hybridization	O
and	O
the	O
sequencing	O
of	O
special	O
regions	O
of	O
the	O
16S	O
rRNA	O
have	O
revealed	O
fundamental	O
taxonomic	O
changes	O
among	O
anaerobic	O
bacteria	O
.	O

Some	O
anaerobic	O
bacteria	O
are	O
extremely	O
slow	O
growing	O
or	O
not	O
cultivatable	O
at	O
all	O
.	O

To	O
detect	O
them	O
in	O
special	O
infections	O
involving	O
flora	O
changes	O
due	O
to	O
oral	O
malignancy	O
or	O
periodontitis	O
,	O
for	O
instance	O
,	O
a	O
PCR	O
-	O
based	O
hybridization	O
technique	O
is	O
used	O
.	O

Molecular	O
methods	O
have	O
demonstrated	O
the	O
spread	O
of	O
specific	O
resistance	O
genes	O
among	O
the	O
most	O
important	O
anaerobic	O
bacteria	O
,	O
the	O
members	O
of	O
the	O
Bacteroides	B-bacteria
genus	I-bacteria
.	O

Their	O
detection	O
and	O
investigation	O
of	O
the	O
IS	O
elements	O
involved	O
in	O
their	O
expression	O
may	O
facilitate	O
following	O
of	O
the	O
spread	O
of	O
antibiotic	O
resistance	O
among	O
anaerobic	O
bacteria	O
involved	O
in	O
infections	O
and	O
in	O
the	O
normal	O
flora	O
members	O
.	O

Molecular	O
methods	O
(	O
a	O
search	O
for	O
toxin	O
genes	O
and	O
ribotyping	O
)	O
may	O
promote	O
a	O
better	O
understanding	O
of	O
the	O
pathogenic	O
features	O
of	O
some	O
anaerobic	O
infections	O
,	O
such	O
as	O
the	O
nosocomial	O
diarrhoea	O
caused	O
by	O
C	O
.	O
difficile	O
and	O
its	O
spread	O
in	O
the	O
hospital	O
environment	O
and	O
the	O
community	O
.	O

The	O
investigation	O
of	O
toxin	O
production	O
at	O
a	O
molecular	O
level	O
helps	O
in	O
the	O
detection	O
of	O
new	O
toxin	O
types	O
.	O

This	O
mini	O
-	O
review	O
surveys	O
some	O
of	O
the	O
results	O
obtained	O
by	O
our	O
group	O
and	O
others	O
using	O
molecular	O
genetic	O
methods	O
in	O
anaerobic	O
diagnostics	O
.	O

Bacillus	B-bacteria
thuringiensis	I-bacteria
is	O
the	O
most	O
widely	O
applied	O
biological	O
insecticide	O
and	O
is	O
used	O
to	O
manage	O
insects	O
that	O
affect	O
forestry	O
and	O
agriculture	O
and	O
transmit	O
human	O
and	O
animal	O
pathogens	O
.	O

This	O
ubiquitous	O
spore	O
-	O
forming	O
bacterium	O
kills	O
insect	O
larvae	O
largely	O
through	O
the	O
action	O
of	O
insecticidal	O
crystal	O
proteins	O
and	O
is	O
commonly	O
deployed	O
as	O
a	O
direct	O
bacterial	O
spray	O
.	O

Moreover	O
,	O
plants	O
engineered	O
with	O
the	O
cry	O
genes	O
encoding	O
the	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
crystal	O
proteins	O
are	O
the	O
most	O
widely	O
cultivated	O
transgenic	O
crops	O
.	O

For	O
decades	O
,	O
the	O
mechanism	O
of	O
insect	O
killing	O
has	O
been	O
assumed	O
to	O
be	O
toxin	O
-	O
mediated	O
lysis	O
of	O
the	O
gut	O
epithelial	O
cells	O
,	O
which	O
leads	O
to	O
starvation	O
,	O
or	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
septicemia	O
.	O

Here	O
,	O
we	O
report	O
that	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
does	O
not	O
kill	O
larvae	O
of	O
the	O
gypsy	O
moth	O
in	O
the	O
absence	O
of	O
indigenous	O
midgut	O
bacteria	O
.	O

Elimination	O
of	O
the	O
gut	O
microbial	O
community	O
by	O
oral	O
administration	O
of	O
antibiotics	O
abolished	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
insecticidal	O
activity	O
,	O
and	O
reestablishment	O
of	O
an	O
Enterobacter	B-bacteria
sp	I-bacteria
.	I-bacteria
that	O
normally	O
resides	O
in	O
the	O
midgut	O
microbial	O
community	O
restored	O
B	O
.	O
thuringiensis	O
-	O
mediated	O
killing	O
.	O

Escherichia	B-bacteria
coli	I-bacteria
engineered	O
to	O
produce	O
the	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
insecticidal	O
toxin	O
killed	O
gypsy	O
moth	O
larvae	O
irrespective	O
of	O
the	O
presence	O
of	O
other	O
bacteria	O
in	O
the	O
midgut	O
.	O

However	O
,	O
when	O
the	O
engineered	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
was	O
heat	O
-	O
killed	O
and	O
then	O
fed	O
to	O
the	O
larvae	O
,	O
the	O
larvae	O
did	O
not	O
die	O
in	O
the	O
absence	O
of	O
the	O
indigenous	O
midgut	O
bacteria	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
the	O
Enterobacter	B-bacteria
sp	I-bacteria
.	I-bacteria
achieved	O
high	O
populations	O
in	O
hemolymph	O
,	O
in	O
contrast	O
to	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
,	O
which	O
appeared	O
to	O
die	O
in	O
hemolymph	O
.	O

Our	O
results	O
demonstrate	O
that	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
-	O
induced	O
mortality	O
depends	O
on	O
enteric	O
bacteria	O
.	O

In	O
this	O
investigation	O
,	O
the	O
urine	O
samples	O
obtained	O
in	O
a	O
single	O
oral	O
-	O
dose	O
pharmacokinetic	O
study	O
were	O
examined	O
for	O
their	O
bactericidal	O
activity	O
against	O
a	O
range	O
of	O
relevant	O
urinary	O
tract	O
pathogens	O
.	O

Six	O
healthy	O
volunteers	O
received	O
a	O
single	O
oral	O
dose	O
of	O
ten	O
oral	O
antibiotics	O
available	O
in	O
Croatia	O
.	O

Urine	O
samples	O
were	O
taken	O
every	O
2	O
h	O
during	O
the	O
whole	O
dosing	O
interval	O
of	O
the	O
particular	O
antibiotic	O
.	O

The	O
urinary	O
bactericidal	O
activity	O
was	O
tested	O
by	O
determination	O
of	O
urinary	O
bactericidal	O
titers	O
.	O

All	O
antibiotics	O
showed	O
a	O
significant	O
urinary	O
bactericidal	O
activity	O
against	O
non	O
-	O
extended	O
spectrum	O
beta	O
-	O
lactamase	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
Proteus	B-bacteria
mirabilis	I-bacteria
.	O

Fluoroquinolones	O
displayed	O
high	O
and	O
persisting	O
levels	O
of	O
urinary	O
bactericidal	O
activity	O
against	O
all	O
gram	O
-	O
negative	O
bacteria	O
and	O
Staphylococcus	B-bacteria
saprophyticus	I-bacteria
.	O

Average	O
urinary	O
bactericidal	O
activity	O
can	O
be	O
predicted	O
from	O
in	O
vitro	O
susceptibility	O
testing	O
,	O
but	O
we	O
expect	O
that	O
there	O
will	O
be	O
patients	O
with	O
a	O
low	O
level	O
of	O
urinary	O
bactericidal	O
activity	O
.	O

The	O
authors	O
compared	O
the	O
in	O
vivo	O
antimicrobial	O
effects	O
on	O
microorganisms	O
from	O
dental	O
plaque	O
,	O
saliva	O
and	O
the	O
tongue	O
in	O
subjects	O
who	O
used	O
a	O
triclosan	O
/	O
copolymer	O
dentifrice	O
and	O
a	O
fluoride	O
dentifrice	O
(	O
control	O
)	O
.	O

The	O
authors	O
assigned	O
15	O
subjects	O
randomly	O
to	O
the	O
control	O
dentifrice	O
or	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
for	O
twice	O
-	O
daily	O
use	O
for	O
one	O
week	O
.	O

They	O
collected	O
samples	O
of	O
plaque	O
,	O
saliva	O
and	O
tongue	O
scrapings	O
six	O
and	O
12	O
hours	O
after	O
the	O
final	O
brushing	O
.	O

They	O
analyzed	O
colony	O
-	O
forming	O
units	O
of	O
Veillonella	B-bacteria
species	I-bacteria
,	O
Fusobacteria	B-bacteria
species	I-bacteria
,	O
total	O
cultivable	O
anaerobes	O
and	O
hydrogen	O
sulfide	O
(	O
H	O
(	O
2	O
)	O
S	O
)	O
-	O
producing	O
bacteria	O
.	O

A	O
one	O
-	O
week	O
washout	O
followed	O
.	O

The	O
authors	O
repeated	O
the	O
protocol	O
with	O
the	O
second	O
dentifrice	O
.	O

The	O
results	O
showed	O
no	O
differences	O
at	O
baseline	O
.	O

Significant	O
reductions	O
(	O
88	O
to	O
96	O
percent	O
)	O
in	O
oral	O
anaerobic	O
bacteria	O
were	O
observed	O
in	O
the	O
triclosan	O
/	O
copolymer	O
group	O
six	O
and	O
12	O
hours	O
after	O
brushing	O
compared	O
with	O
the	O
control	O
group	O
(	O
P	O
=	O
.	O
001	O
)	O
.	O

Fusobacteria	B-bacteria
decreased	O
by	O
77	O
to	O
92	O
percent	O
and	O
Veillonella	B-bacteria
decreased	O
by	O
84	O
to	O
89	O
percent	O
six	O
and	O
12	O
hours	O
after	O
brushing	O
in	O
the	O
triclosan	O
/	O
copolymer	O
group	O
versus	O
the	O
control	O
group	O
.	O

The	O
triclosan	O
/	O
copolymer	O
group	O
also	O
demonstrated	O
a	O
significant	O
decrease	O
in	O
H	O
(	O
2	O
)	O
S	O
-	O
producing	O
bacteria	O
six	O
and	O
12	O
hours	O
after	O
brushing	O
(	O
74	O
to	O
85	O
percent	O
)	O
(	O
P	O
=	O
.	O
001	O
)	O
.	O

Brushing	O
with	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
resulted	O
in	O
significant	O
reductions	O
in	O
microorganisms	O
from	O
the	O
three	O
sites	O
compared	O
with	O
the	O
control	O
dentifrice	O
.	O

:	O
The	O
triclosan	O
/	O
copolymer	O
dentifrice	O
produced	O
sustained	O
effects	O
on	O
oral	O
bacteria	O
for	O
12	O
hours	O
.	O

To	O
determine	O
antibacterial	O
activity	O
of	O
chewing	O
mastic	O
gum	O
against	O
the	O
salivary	O
levels	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
total	O
number	O
of	O
viable	O
bacteria	O
,	O
and	O
lactobacilli	B-bacteria
in	O
patients	O
undergoing	O
therapy	O
with	O
fixed	O
orthodontic	O
appliances	O
.	O

In	O
this	O
study	O
,	O
the	O
levels	O
of	O
S	B-bacteria
mutans	I-bacteria
,	O
lactobacilli	B-bacteria
,	O
and	O
total	O
cultivated	O
bacteria	O
were	O
measured	O
before	O
and	O
after	O
chewing	O
mastic	O
gum	O
.	O

The	O
antibacterial	O
effects	O
of	O
chewing	O
mastic	O
gum	O
against	O
these	O
microorganisms	O
in	O
saliva	O
were	O
compared	O
with	O
a	O
placebo	O
gum	O
.	O

The	O
counts	O
for	O
orthodontically	O
treated	O
patients	O
were	O
evaluated	O
before	O
chewing	O
gum	O
;	O
just	O
after	O
chewing	O
gum	O
;	O
and	O
after	O
45	O
,	O
75	O
,	O
105	O
,	O
and	O
135	O
minutes	O
.	O

Saliva	O
samples	O
taken	O
from	O
the	O
patients	O
were	O
inoculated	O
onto	O
trypticase	O
-	O
yeast	O
-	O
cystine	O
-	O
bacitracin	O
agar	O
for	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
onto	O
Rogosa	O
agar	O
for	O
lactobacilli	B-bacteria
.	O

The	O
agar	O
plates	O
were	O
incubated	O
for	O
48	O
hours	O
anaerobically	O
at	O
37	O
degrees	O
C	O
.	O
The	O
total	O
number	O
of	O
viable	O
bacteria	O
was	O
then	O
counted	O
.	O

Just	O
after	O
chewing	O
the	O
mastic	O
gum	O
for	O
15	O
minutes	O
,	O
a	O
significant	O
decrease	O
of	O
total	O
bacteria	O
and	O
S	B-bacteria
mutans	I-bacteria
was	O
observed	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

The	O
reduction	O
in	O
lactobacilli	B-bacteria
was	O
not	O
significant	O
at	O
later	O
first	O
stage	O
(	O
P	O
>	O
.	O
05	O
)	O
.	O

However	O
,	O
at	O
the	O
end	O
of	O
135	O
minutes	O
,	O
there	O
were	O
significantly	O
fewer	O
S	B-bacteria
mutans	I-bacteria
(	O
P	O
<	O
.	O
001	O
)	O
,	O
total	O
viable	O
bacteria	O
(	O
P	O
<	O
.	O
001	O
)	O
,	O
and	O
lactobacilli	B-bacteria
(	O
P	O
<	O
.	O
001	O
)	O
in	O
the	O
oral	O
cavity	O
after	O
chewing	O
mastic	O
gum	O
than	O
after	O
chewing	O
paraffin	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

The	O
results	O
show	O
that	O
chewing	O
mastic	O
gum	O
decreased	O
the	O
total	O
viable	O
bacteria	O
,	O
S	B-bacteria
mutans	I-bacteria
,	O
and	O
lactobacilli	B-bacteria
in	O
saliva	O
in	O
orthodontically	O
treated	O
patients	O
with	O
fixed	O
appliances	O
.	O

Chewing	O
mastic	O
gum	O
might	O
be	O
useful	O
in	O
preventing	O
caries	O
lesions	O
.	O

The	O
mode	O
of	O
acquisition	O
of	O
gastric	O
Helicobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
infection	O
in	O
dogs	O
has	O
not	O
been	O
determined	O
.	O

It	O
is	O
suspected	O
that	O
oral	O
-	O
oral	O
and	O
faecal	O
-	O
oral	O
transmission	O
may	O
be	O
involved	O
.	O

The	O
present	O
study	O
sought	O
to	O
determine	O
if	O
Helicobacter	B-bacteria
spp	I-bacteria
.	O

DNA	O
is	O
present	O
in	O
the	O
oral	O
cavity	O
of	O
healthy	O
and	O
vomiting	O
dogs	O
.	O

Thirty	O
-	O
eight	O
pet	O
dogs	O
(	O
27	O
vomiting	O
and	O
11	O
clinically	O
healthy	O
)	O
were	O
studied	O
.	O

The	O
presence	O
of	O
Helicobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
determined	O
by	O
single	O
and	O
nested	O
PCR	O
evaluation	O
of	O
DNA	O
extracted	O
from	O
saliva	O
,	O
dental	O
plaque	O
and	O
gastric	O
biopsy	O
samples	O
.	O

Helicobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
DNA	O
was	O
detected	O
by	O
nested	O
PCR	O
in	O
36	O
(	O
94	O
.	O
7	O
%	O
)	O
gastric	O
biopsies	O
,	O
17	O
(	O
44	O
.	O
7	O
%	O
)	O
dental	O
plaque	O
and	O
19	O
(	O
50	O
%	O
)	O
saliva	O
samples	O
out	O
of	O
the	O
38	O
dogs	O
examined	O
.	O

Overall	O
27	O
(	O
71	O
.	O
1	O
%	O
)	O
dogs	O
screened	O
by	O
nested	O
PCR	O
were	O
found	O
to	O
harbour	O
Helicobacter	B-bacteria
spp	I-bacteria
.	O

DNA	O
in	O
the	O
oral	O
cavity	O
(	O
dental	O
plaque	O
and	O
/	O
or	O
saliva	O
)	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
prevalence	O
of	O
Helicobacter	B-bacteria
spp	I-bacteria
.	O

DNA	O
in	O
the	O
oral	O
cavity	O
of	O
vomiting	O
and	O
healthy	O
dogs	O
,	O
and	O
the	O
time	O
from	O
vomiting	O
to	O
oral	O
sampling	O
did	O
not	O
have	O
significant	O
impact	O
.	O

This	O
study	O
confirms	O
the	O
high	O
prevalence	O
of	O
gastric	O
Helicobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
infection	O
in	O
dogs	O
,	O
and	O
reveals	O
that	O
Helicobacter	B-bacteria
spp	I-bacteria
.	O

DNA	O
is	O
detectable	O
in	O
the	O
oral	O
cavity	O
of	O
over	O
70	O
%	O
of	O
dogs	O
.	O

These	O
findings	O
support	O
the	O
possibility	O
of	O
oral	O
-	O
oral	O
transmission	O
between	O
dogs	O
and	O
that	O
the	O
canine	O
oral	O
cavity	O
may	O
act	O
as	O
source	O
of	O
non	B-bacteria
-	I-bacteria
pylori	I-bacteria
Helicobacter	I-bacteria
spp	I-bacteria
.	I-bacteria
infection	O
fors	O
humans	O
.	O

There	O
are	O
numerous	O
studies	O
suggesting	O
that	O
inflammation	O
of	O
the	O
oral	O
cavity	O
caused	O
by	O
bacteria	O
or	O
fungi	O
is	O
accompanied	O
by	O
gastric	O
inflammation	O
.	O

This	O
is	O
particularly	O
relevant	O
in	O
patients	O
using	O
complete	O
dentures	O
.	O

Since	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
can	O
be	O
easily	O
discovered	O
by	O
bacteria	O
culture	O
and	O
that	O
in	O
the	O
stomach	O
by	O
(	O
13	O
)	O
C	O
urea	O
breath	O
test	O
(	O
UBT	O
)	O
and	O
histology	O
of	O
gastric	O
endoscopic	O
biopsy	O
samples	O
it	O
is	O
reasonably	O
to	O
state	O
that	O
the	O
majority	O
of	O
the	O
patients	O
show	O
the	O
presence	O
of	O
bacterium	O
in	O
oral	O
cavity	O
and	O
active	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
.	O

When	O
comparing	O
,	O
however	O
,	O
the	O
bacteria	O
culture	O
originating	O
from	O
the	O
oral	O
mucosa	O
to	O
those	O
from	O
the	O
gastric	O
mucosa	O
,	O
employing	O
molecular	O
biology	O
examination	O
,	O
such	O
as	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
we	O
found	O
that	O
the	O
oral	O
bacteria	O
and	O
those	O
originating	O
from	O
stomach	O
are	O
completely	O
different	O
,	O
suggesting	O
that	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
may	O
be	O
present	O
only	O
transiently	O
in	O
oral	O
cavity	O
and	O
does	O
not	O
play	O
major	O
role	O
in	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
.	O

Thus	O
,	O
oral	O
cavity	O
does	O
not	O
serve	O
as	O
bacterial	O
reservoir	O
to	O
infect	O
gastric	O
mucosa	O
.	O

Most	O
important	O
finding	O
of	O
our	O
study	O
is	O
that	O
patients	O
with	O
recognized	O
inflammation	O
in	O
the	O
oral	O
cavity	O
in	O
the	O
form	O
of	O
stomatitis	O
prothetica	O
hyperplasica	O
both	O
fibrosa	O
as	O
well	O
as	O
papillaris	O
showed	O
in	O
nearly	O
100	O
%	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
,	O
usually	O
without	O
the	O
presence	O
of	O
the	O
same	O
bacterium	O
in	O
the	O
oral	O
cavity	O
,	O
suggesting	O
that	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
affects	O
oral	O
mucosa	O
at	O
distance	O
by	O
some	O
,	O
as	O
yet	O
,	O
unknown	O
mechanism	O
.	O

To	O
assess	O
caries	O
risk	O
and	O
check	O
the	O
presence	O
of	O
four	O
commonly	O
found	O
oral	O
cariogenic	O
bacteria	O
in	O
`	O
`	O
8020	O
'	O
'	O
achievers	O
.	O

Initial	O
report	O
based	O
on	O
Japan	O
'	O
s	O
newly	O
implemented	O
`	O
`	O
8020	O
'	O
'	O
campaign	O
,	O
which	O
aims	O
to	O
promote	O
health	O
and	O
awareness	O
in	O
older	O
people	O
.	O

Simply	O
stated	O
,	O
the	O
goal	O
is	O
,	O
at	O
80	O
years	O
,	O
to	O
maintain	O
20	O
teeth	O
.	O

Healthy	O
community	O
-	O
dwelling	O
elderly	O
individuals	O
of	O
Okayama	O
Prefecture	O
,	O
Japan	O
.	O

One	O
hundred	O
sixty	O
individuals	O
aged	O
80	O
and	O
older	O
with	O
20	O
of	O
their	O
own	O
natural	O
teeth	O
.	O

General	O
and	O
oral	O
health	O
conditions	O
,	O
caries	O
risk	O
assessment	O
using	O
the	O
Cariostat	O
method	O
,	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
detection	O
of	O
four	O
oral	O
cariogenic	O
bacteria	O
.	O

The	O
participants	O
had	O
an	O
average	O
of	O
24	O
.	O
7	O
teeth	O
,	O
of	O
which	O
12	O
.	O
1	O
were	O
sound	O
,	O
12	O
.	O
2	O
were	O
treated	O
,	O
and	O
0	O
.	O
4	O
were	O
untreated	O
.	O

Based	O
on	O
Cariostat	O
scores	O
,	O
64	O
.	O
4	O
%	O
had	O
low	O
caries	O
risk	O
.	O

Using	O
PCR	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
,	O
and	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
were	O
detected	O
in	O
51	O
.	O
3	O
%	O
,	O
23	O
.	O
1	O
%	O
,	O
40	O
%	O
,	O
and	O
25	O
%	O
of	O
the	O
participants	O
,	O
respectively	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
P	O
<	O
.	O
001	O
)	O
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
(	O
P	O
=	O
.	O
002	O
)	O
,	O
L	B-bacteria
.	I-bacteria
casei	I-bacteria
(	O
P	O
<	O
.	O
001	O
)	O
,	O
and	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
(	O
P	O
=	O
.	O
001	O
)	O
deoxyribonucleic	O
acid	O
band	O
was	O
detected	O
more	O
in	O
participants	O
with	O
high	O
caries	O
risk	O
scores	O
.	O

Participants	O
with	O
low	O
caries	O
risk	O
scores	O
had	O
low	O
prevalence	O
of	O
cariogenic	O
bacteria	O
,	O
20	O
or	O
more	O
sound	O
teeth	O
,	O
and	O
fewer	O
missing	O
teeth	O
.	O

Incorporating	O
caries	O
risk	O
assessment	O
,	O
using	O
the	O
Cariostat	O
and	O
PCR	O
analysis	O
,	O
in	O
the	O
`	O
`	O
8020	O
'	O
'	O
campaign	O
in	O
health	O
systems	O
worldwide	O
will	O
contribute	O
to	O
a	O
better	O
life	O
for	O
the	O
aging	O
society	O
,	O
initiate	O
research	O
interest	O
regarding	O
the	O
program	O
,	O
and	O
improve	O
current	O
health	O
policies	O
.	O

A	O
variety	O
of	O
oxalate	O
-	O
degrading	O
bacteria	O
including	O
Oxalobacter	B-bacteria
formigenes	I-bacteria
and	O
some	O
species	O
of	O
Bifidobacterium	B-bacteria
are	O
known	O
to	O
colonize	O
the	O
human	O
intestinal	O
tract	O
.	O

Oral	O
lactosucrose	O
supplementation	O
promotes	O
the	O
growth	O
of	O
Bifidobacterium	B-bacteria
in	O
the	O
human	O
intestine	O
.	O

Therefore	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
oral	O
lactosucrose	O
supplementation	O
on	O
enteric	O
oxalate	O
-	O
degrading	O
bacteria	O
in	O
twelve	O
healthy	O
men	O
(	O
age	O
ranging	O
from	O
25	O
to	O
39	O
years	O
)	O
.	O

Lactosucrose	O
was	O
orally	O
administered	O
10	O
g	O
daily	O
for	O
2	O
weeks	O
without	O
restriction	O
of	O
dietary	O
intake	O
.	O

The	O
total	O
number	O
of	O
oxalate	O
-	O
degrading	O
bacteria	O
in	O
feces	O
and	O
the	O
24	O
-	O
hour	O
urinary	O
excretion	O
of	O
oxalate	O
were	O
examined	O
before	O
and	O
after	O
lactosucrose	O
supplementation	O
.	O

The	O
total	O
number	O
of	O
oxalate	O
degrading	O
-	O
bacteria	O
was	O
significantly	O
increased	O
by	O
lactosucrose	O
supplementation	O
(	O
9	O
.	O
20	O
+	O
/	O
-	O
0	O
.	O
44	O
versus	O
9	O
.	O
77	O
+	O
/	O
-	O
0	O
.	O
46	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
although	O
there	O
was	O
no	O
significant	O
change	O
in	O
the	O
urinary	O
oxalate	O
excretion	O
.	O

The	O
oxalate	O
degrading	O
-	O
bacteria	O
isolated	O
from	O
feces	O
was	O
biochemically	O
identified	O
as	O
Bifidobacterium	B-bacteria
adolescentis	I-bacteria
.	O

In	O
conclusion	O
,	O
oral	O
supplementation	O
of	O
10	O
g	O
lactosucrose	O
daily	O
for	O
2	O
weeks	O
was	O
effective	O
in	O
multiplying	O
oxalate	O
-	O
degrading	O
bacteria	O
,	O
but	O
not	O
in	O
reducing	O
urinary	O
oxalate	O
excretion	O
under	O
free	O
non	O
-	O
restricted	O
dietary	O
intake	O
.	O

In	O
addition	O
,	O
it	O
was	O
suggested	O
that	O
various	O
species	O
of	O
Bifidobacterium	B-bacteria
were	O
related	O
to	O
degradation	O
of	O
oxalate	O
in	O
the	O
human	O
intestine	O
.	O

The	O
purpose	O
of	O
the	O
study	O
was	O
to	O
explore	O
the	O
physiological	O
and	O
antigenic	O
diversity	O
of	O
a	O
large	O
number	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
isolates	I-bacteria
in	O
order	O
to	O
begin	O
to	O
determine	O
whether	O
these	O
properties	O
contribute	O
to	O
species	O
persistence	O
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
was	O
collected	O
from	O
four	O
infants	O
from	O
birth	O
to	O
the	O
first	O
year	O
of	O
age	O
.	O

At	O
each	O
of	O
eight	O
to	O
nine	O
visits	O
,	O
60	O
isolates	O
each	O
were	O
obtained	O
from	O
the	O
cheeks	O
,	O
tongue	O
and	O
incisors	O
(	O
once	O
erupted	O
)	O
yielding	O
4440	O
in	O
total	O
.	O

These	O
were	O
tested	O
for	O
production	O
of	O
neuraminidase	O
,	O
beta1	O
-	O
N	O
-	O
acetylglucosaminidase	O
,	O
beta1	O
-	O
N	O
-	O
acetylgalactosaminidase	O
,	O
IgA1	O
protease	O
and	O
amylase	O
-	O
binding	O
.	O

Antigenic	O
diversity	O
was	O
examined	O
by	O
ELISA	O
and	O
Western	O
immunoblotting	O
using	O
antisera	O
raised	O
against	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
NCTC	I-bacteria
12261	I-bacteria
(	O
T	O
)	O
and	O
SK145	B-bacteria
.	O

Three	O
thousand	O
three	O
hundred	O
and	O
thirty	O
(	O
75	O
%	O
)	O
of	O
the	O
isolates	O
were	O
identified	O
as	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
and	O
3144	B-bacteria
(	O
94	O
.	O
4	O
%	O
)	O
could	O
be	O
divided	O
into	O
four	O
large	O
phenotypic	O
groups	O
based	O
on	O
glycosidase	O
production	O
.	O

Fifty	O
-	O
four	O
percent	O
of	O
the	O
isolates	O
produced	O
IgA1	O
protease	O
,	O
but	O
production	O
was	O
disproportionate	O
among	O
the	O
phenotypes	O
.	O

Between	O
one	O
-	O
third	O
and	O
one	O
-	O
half	O
of	O
the	O
strains	O
of	O
each	O
phenotype	O
bound	O
salivary	O
alpha	O
-	O
amylase	O
.	O

Antisera	O
against	O
strains	O
NCTC	B-bacteria
12261	I-bacteria
(	O
T	O
)	O
and	O
SK145	B-bacteria
displayed	O
different	O
patterns	O
of	O
reactivity	O
with	O
randomly	O
selected	O
representatives	O
of	O
the	O
four	O
phenotypes	O
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
is	O
physiologically	O
and	O
antigenically	O
diverse	O
,	O
properties	O
which	O
could	O
aid	O
strains	O
in	O
avoiding	O
host	O
immunity	O
and	O
promote	O
re	O
-	O
colonization	O
of	O
a	O
habitat	O
or	O
transfer	O
to	O
a	O
new	O
habitat	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
plays	O
a	O
significant	O
role	O
in	O
gastric	O
disease	O
.	O

However	O
,	O
the	O
presence	O
of	O
this	O
bacterium	O
in	O
the	O
oral	O
cavity	O
remains	O
controversial	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
detect	O
and	O
quantify	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
29	O
different	O
sites	O
of	O
the	O
oral	O
cavity	O
in	O
non	O
-	O
dyspeptic	O
subjects	O
by	O
means	O
of	O
real	O
-	O
time	O
polymerase	O
chain	O
reactions	O
(	O
PCR	O
)	O
.	O

Ten	O
subjects	O
without	O
gastric	O
symptoms	O
were	O
studied	O
.	O

Samples	O
from	O
unstimulated	O
saliva	O
,	O
three	O
sites	O
of	O
the	O
tongue	O
,	O
oral	O
mucosa	O
,	O
and	O
12	O
sites	O
of	O
both	O
supragingival	O
and	O
subgingival	O
plaque	O
were	O
collected	O
from	O
each	O
subject	O
.	O

DNA	O
was	O
extracted	O
from	O
the	O
oral	O
samples	O
and	O
analysed	O
for	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
real	O
-	O
time	O
PCR	O
(	O
LightCycler	O
)	O
using	O
JW23	O
/	O
22	O
primers	O
which	O
targeted	O
the	O
16S	O
rRNA	O
gene	O
.	O

DNA	O
from	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
DSM	I-bacteria
4867	I-bacteria
was	O
used	O
as	O
a	O
positive	O
control	O
.	O

Amplification	O
efficiency	O
for	O
the	O
LightCycler	O
2	O
.	O
0	O
runs	O
ranged	O
from	O
1	O
.	O
8	O
to	O
2	O
.	O
4	O
.	O

Melting	O
curve	O
analysis	O
identified	O
all	O
the	O
positive	O
control	O
capillaries	O
,	O
which	O
contained	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
reference	O
DNA	O
,	O
as	O
a	O
single	O
and	O
narrow	O
peak	O
at	O
a	O
melting	O
temperature	O
between	O
84	O
.	O
5	O
and	O
84	O
.	O
9	O
degrees	O
C	O
.	O
All	O
the	O
negative	O
control	O
capillaries	O
with	O
no	O
template	O
control	O
and	O
the	O
29	O
oral	O
samples	O
from	O
each	O
subject	O
showed	O
either	O
no	O
melting	O
peaks	O
or	O
broad	O
melting	O
peaks	O
below	O
80	O
degrees	O
C	O
,	O
which	O
were	O
considered	O
as	O
primer	O
dimers	O
.	O

Therefore	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
detected	O
from	O
any	O
of	O
the	O
290	O
oral	O
samples	O
.	O

As	O
a	O
conclusion	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
seems	O
not	O
to	O
be	O
permanently	O
present	O
in	O
the	O
oral	O
cavity	O
of	O
a	O
non	O
-	O
dyspeptic	O
population	O
.	O

The	O
oral	O
streptococci	B-bacteria
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
are	O
common	O
aetiological	O
agents	O
of	O
infective	O
endocarditis	O
,	O
and	O
their	O
ability	O
to	O
adhere	O
to	O
and	O
induce	O
the	O
aggregation	O
of	O
platelets	O
is	O
thought	O
to	O
be	O
a	O
virulence	O
trait	O
.	O

The	O
platelet	O
glycoprotein	O
GPIbalpha	O
has	O
been	O
implicated	O
as	O
the	O
adhesion	O
receptor	O
for	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
but	O
it	O
is	O
not	O
known	O
if	O
this	O
is	O
the	O
case	O
for	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
and	O
other	O
species	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
GPIbalpha	O
-	O
interactive	O
capability	O
of	O
a	O
range	O
of	O
oral	O
streptococci	B-bacteria
and	O
to	O
determine	O
the	O
relationship	O
between	O
this	O
capability	O
and	O
their	O
ability	O
to	O
interact	O
with	O
the	O
salivary	O
constituents	O
that	O
they	O
would	O
encounter	O
in	O
their	O
normal	O
habitat	O
.	O

All	O
platelet	O
-	O
adhesive	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
strains	I-bacteria
and	O
most	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
strains	I-bacteria
adhered	O
in	O
a	O
GPIbalpha	O
-	O
dependent	O
manner	O
,	O
but	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
cristatus	I-bacteria
,	O
Streptococcus	B-bacteria
parasanguinis	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
had	O
no	O
direct	O
affinity	O
for	O
platelets	O
.	O

Those	O
strains	O
that	O
were	O
able	O
to	O
bind	O
GPIbalpha	O
also	O
bound	O
to	O
the	O
low	O
-	O
molecular	O
-	O
weight	O
submandibular	O
salivary	O
mucin	O
,	O
MG2	O
,	O
and	O
this	O
interaction	O
was	O
sialic	O
acid	O
-	O
dependent	O
.	O

The	O
data	O
suggest	O
that	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
may	O
be	O
efficient	O
colonizers	O
of	O
platelet	O
vegetations	O
because	O
of	O
their	O
adaptation	O
to	O
recognize	O
sialylated	O
salivary	O
mucins	O
.	O

In	O
contrast	O
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
does	O
not	O
interact	O
with	O
platelets	O
and	O
so	O
is	O
likely	O
to	O
colonize	O
vegetations	O
through	O
an	O
as	O
yet	O
unidentified	O
mechanism	O
.	O

Halitosis	O
can	O
be	O
a	O
crippling	O
social	O
problem	O
,	O
and	O
standard	O
dental	O
treatments	O
and	O
mouthwashes	O
often	O
provide	O
only	O
temporary	O
relief	O
.	O

The	O
mouth	O
is	O
home	O
to	O
hundreds	O
of	O
bacterial	O
species	O
that	O
produce	O
several	O
fetid	O
substances	O
as	O
a	O
result	O
of	O
protein	O
degradation	O
.	O

Volatile	O
sulfur	O
compound	O
(	O
VSC	O
)	O
-	O
producing	O
bacteria	O
colonizing	O
the	O
lingual	O
dorsum	O
have	O
recently	O
been	O
implicated	O
in	O
the	O
generation	O
of	O
halitosis	O
.	O

Detection	O
of	O
VSCs	O
,	O
such	O
as	O
methylmercaptan	O
and	O
hydrogen	O
sulfite	O
,	O
via	O
organoleptic	O
and	O
objective	O
methods	O
,	O
can	O
aid	O
in	O
the	O
identification	O
of	O
their	O
source	O
.	O

Following	O
comprehensive	O
evaluation	O
for	O
possible	O
causes	O
,	O
most	O
halitosis	O
in	O
patients	O
seen	O
in	O
an	O
ENT	O
practice	O
can	O
be	O
localized	O
to	O
the	O
tongue	O
.	O

We	O
review	O
methods	O
of	O
diagnosis	O
and	O
treatment	O
of	O
oral	O
malodor	O
from	O
the	O
overgrowth	O
of	O
proteolytic	O
,	O
anaerobic	O
,	O
gram	O
-	O
negative	O
bacteria	O
on	O
the	O
crevices	O
of	O
the	O
lingual	O
dorsum	O
.	O

Bacteriologic	O
analysis	O
of	O
biofilm	O
and	O
scraped	O
specimens	O
obtained	O
from	O
the	O
lingual	O
dorsum	O
and	O
other	O
oral	O
sites	O
,	O
primarily	O
gingival	O
pockets	O
and	O
tonsillar	O
crypts	O
,	O
can	O
identify	O
VSC	O
-	O
producing	O
bacteria	O
.	O

Porphyromonas	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Actinobacillus	B-bacteria
,	O
and	O
Fusobacterium	B-bacteria
species	I-bacteria
are	O
the	O
most	O
common	O
organisms	O
identified	O
.	O

Halitosis	O
is	O
an	O
oral	O
phenomenon	O
,	O
with	O
almost	O
no	O
cases	O
originating	O
distal	O
to	O
the	O
tonsils	O
.	O

Halitosis	O
arising	O
from	O
the	O
lingual	O
dorsum	O
secondary	O
to	O
overpopulated	O
VSC	O
-	O
producing	O
bacteria	O
can	O
be	O
successfully	O
managed	O
with	O
a	O
combination	O
of	O
mechanical	O
cleansing	O
using	O
tongue	O
brushes	O
or	O
scrapes	O
and	O
chemical	O
solutions	O
containing	O
essential	O
oils	O
,	O
zinc	O
chloride	O
,	O
and	O
cetylpyridinium	O
chloride	O
.	O

The	O
hygiene	O
hypothesis	O
contends	O
that	O
fewer	O
opportunities	O
for	O
infection	O
have	O
led	O
to	O
increases	O
in	O
the	O
prevalences	O
of	O
asthma	O
and	O
other	O
allergic	O
diseases	O
.	O

This	O
study	O
evaluated	O
the	O
association	O
between	O
asthma	O
,	O
wheeze	O
,	O
and	O
hay	O
fever	O
and	O
antibodies	O
to	O
2	O
oral	O
bacteria	O
associated	O
with	O
periodontal	O
disease	O
.	O

Data	O
were	O
obtained	O
from	O
the	O
Third	O
National	O
Health	O
and	O
Nutrition	O
Examination	O
Survey	O
.	O

Serum	O
levels	O
of	O
IgG	O
antibodies	O
to	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
were	O
quantified	O
by	O
enzyme	O
-	O
linked	O
immunoassays	O
in	O
9385	O
subjects	O
age	O
12	O
years	O
and	O
older	O
.	O

The	O
outcomes	O
were	O
current	O
asthma	O
,	O
wheeze	O
,	O
and	O
hay	O
fever	O
.	O

Odds	O
ratios	O
(	O
ORs	O
)	O
representing	O
a	O
1	O
-	O
log	O
-	O
unit	O
increase	O
in	O
IgG	O
concentrations	O
were	O
estimated	O
with	O
logistic	O
regression	O
.	O

ORs	O
were	O
adjusted	O
for	O
8	O
confounders	O
and	O
weighted	O
to	O
represent	O
the	O
US	O
population	O
.	O

For	O
each	O
disease	O
outcome	O
,	O
geometric	O
mean	O
antibody	O
concentrations	O
were	O
higher	O
in	O
persons	O
without	O
the	O
disease	O
outcome	O
than	O
with	O
the	O
disease	O
outcome	O
.	O

For	O
a	O
1	O
-	O
log	O
-	O
unit	O
increase	O
in	O
P	B-bacteria
gingivalis	I-bacteria
antibody	O
concentration	O
,	O
adjusted	O
ORs	O
were	O
0	O
.	O
41	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
20	O
-	O
0	O
.	O
87	O
)	O
for	O
asthma	O
,	O
0	O
.	O
43	O
(	O
0	O
.	O
23	O
-	O
0	O
.	O
78	O
)	O
for	O
wheeze	O
,	O
and	O
0	O
.	O
45	O
(	O
0	O
.	O
23	O
-	O
0	O
.	O
93	O
)	O
for	O
hay	O
fever	O
.	O

For	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
those	O
ORs	O
were	O
0	O
.	O
56	O
(	O
0	O
.	O
19	O
-	O
1	O
.	O
72	O
)	O
,	O
0	O
.	O
39	O
(	O
0	O
.	O
17	O
-	O
0	O
.	O
86	O
)	O
,	O
and	O
0	O
.	O
48	O
(	O
0	O
.	O
23	O
-	O
1	O
.	O
03	O
)	O
,	O
respectively	O
.	O

Consistent	O
with	O
the	O
hygiene	O
hypothesis	O
,	O
higher	O
concentrations	O
of	O
IgG	O
antibodies	O
to	O
P	B-bacteria
gingivalis	I-bacteria
were	O
significantly	O
associated	O
with	O
lower	O
prevalences	O
of	O
asthma	O
,	O
wheeze	O
,	O
and	O
hay	O
fever	O
,	O
and	O
higher	O
concentrations	O
of	O
IgG	O
antibodies	O
to	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
were	O
significantly	O
associated	O
with	O
a	O
lower	O
prevalence	O
of	O
wheeze	O
.	O

Colonization	O
of	O
the	O
oral	O
cavity	O
by	O
bacteria	O
and	O
other	O
microbes	O
might	O
play	O
a	O
protective	O
role	O
in	O
the	O
etiology	O
of	O
allergic	O
disease	O
.	O

Aortic	O
aneurysms	O
are	O
common	O
vascular	O
conditions	O
that	O
cause	O
considerable	O
morbidity	O
and	O
mortality	O
.	O

Understanding	O
of	O
the	O
mechanisms	O
involved	O
in	O
the	O
pathogenesis	O
of	O
the	O
condition	O
remains	O
limited	O
.	O

Recently	O
,	O
infection	O
has	O
been	O
suggested	O
as	O
possible	O
contributor	O
in	O
the	O
development	O
of	O
the	O
disease	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
aortic	O
aneurysms	O
for	O
the	O
presence	O
of	O
bacterial	O
DNA	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
targeting	O
the	O
16S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
gene	O
,	O
followed	O
by	O
cloning	O
and	O
sequencing	O
.	O

Universal	O
eubacterial	O
primers	O
were	O
used	O
to	O
amplify	O
16S	O
rRNA	O
bacterial	O
genes	O
in	O
10	O
specimens	O
from	O
arterial	O
walls	O
of	O
aortic	O
aneurysms	O
.	O

Subsequently	O
,	O
PCR	O
amplicons	O
were	O
cloned	O
into	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
sequencing	O
of	O
the	O
cloned	O
inserts	O
was	O
used	O
to	O
determine	O
species	O
identity	O
or	O
closest	O
relatives	O
by	O
comparison	O
with	O
known	O
sequences	O
in	O
GenBank	O
.	O

Sequences	O
of	O
Stenotrophomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
including	O
S	B-bacteria
.	I-bacteria
maltophilia	I-bacteria
(	O
formerly	O
Pseudomonas	B-bacteria
homology	I-bacteria
group	I-bacteria
V	I-bacteria
)	O
were	O
detected	O
in	O
six	O
aneurysm	O
samples	O
.	O

Propionibacterium	B-bacteria
acnes	I-bacteria
was	O
identified	O
in	O
five	O
samples	O
,	O
and	O
Brevundimonas	B-bacteria
diminuta	I-bacteria
(	O
formerly	O
P	B-bacteria
.	I-bacteria
diminuta	I-bacteria
)	O
in	O
four	O
samples	O
.	O

Other	O
species	O
previously	O
assigned	O
to	O
the	O
Pseudomonas	B-bacteria
genus	I-bacteria
such	O
as	O
Comamonas	B-bacteria
testosteroni	I-bacteria
,	O
Delftia	B-bacteria
acidovorans	I-bacteria
,	O
Burkholderia	B-bacteria
cepacia	I-bacteria
,	O
Herbaspirillum	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
and	O
Acidovorax	B-bacteria
sp	I-bacteria
.	I-bacteria
were	O
also	O
detected	O
.	O

Some	O
clones	O
fell	O
into	O
other	O
environmental	O
species	O
,	O
including	O
Methylobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
Bradyrhizobium	B-bacteria
elkanii	I-bacteria
,	O
and	O
others	O
represented	O
bacteria	O
that	O
have	O
not	O
yet	O
been	O
cultivated	O
.	O

DNA	O
sequences	O
from	O
oral	O
bacteria	O
,	O
including	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Leptotrichia	B-bacteria
buccalis	I-bacteria
were	O
detected	O
.	O

Sequences	O
from	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
and	O
Lactobacillus	B-bacteria
delbrueckii	I-bacteria
,	O
which	O
are	O
commonly	O
found	O
in	O
both	O
mouth	O
and	O
gastrointestinal	O
tract	O
,	O
were	O
also	O
detected	O
.	O

Additional	O
species	O
included	O
Dermacoccus	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Corynebacterium	B-bacteria
vitaeruminis	I-bacteria
.	O

A	O
wide	O
variety	O
of	O
bacteria	O
,	O
including	O
oral	O
bacteria	O
,	O
was	O
found	O
to	O
colonize	O
aortic	O
aneurysms	O
and	O
may	O
play	O
a	O
role	O
in	O
their	O
development	O
.	O

Several	O
of	O
these	O
microorganisms	O
have	O
not	O
yet	O
been	O
cultivated	O
.	O

Although	O
Chlamydophila	B-bacteria
pneumoniae	I-bacteria
has	O
been	O
detected	O
in	O
aneurysmal	O
walls	O
,	O
its	O
exact	O
role	O
in	O
the	O
condition	O
remains	O
inconclusive	O
.	O

Overall	O
,	O
there	O
is	O
scarce	O
information	O
about	O
the	O
role	O
of	O
microorganisms	O
in	O
aneurysmal	O
disease	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
molecular	O
genetics	O
to	O
detect	O
a	O
diversity	O
of	O
bacteria	O
in	O
arterial	O
walls	O
of	O
aortic	O
aneurysms	O
.	O

The	O
presence	O
of	O
multiple	O
microorganisms	O
in	O
aneurysmal	O
disease	O
may	O
have	O
implications	O
for	O
chemoprophylaxis	O
and	O
antibiotic	O
treatment	O
if	O
directed	O
only	O
at	O
C	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
.	O

We	O
have	O
already	O
reported	O
that	O
chitosan	O
inhibited	O
the	O
growth	O
of	O
cariogenic	O
bacteria	O
in	O
vitro	O
.	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
whether	O
chewing	O
gum	O
,	O
containing	O
chitosan	O
,	O
can	O
effectively	O
suppressed	O
the	O
growth	O
of	O
oral	O
bacteria	O
(	O
total	O
bacteria	O
,	O
total	O
Streptococci	B-bacteria
,	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
)	O
in	O
saliva	O
.	O

Fifty	O
healthy	O
subjects	O
,	O
ranging	O
in	O
age	O
from	O
19	O
to	O
32	O
years	O
,	O
were	O
recruited	O
from	O
among	O
the	O
staff	O
and	O
students	O
of	O
Nagasaki	O
University	O
School	O
of	O
Dentistry	O
.	O

For	O
the	O
slab	O
of	O
gum	O
study	O
,	O
the	O
subjects	O
chewed	O
gum	O
for	O
5	O
min	O
and	O
then	O
rested	O
for	O
5	O
min	O
.	O

Each	O
subject	O
chewed	O
a	O
total	O
of	O
eight	O
pieces	O
of	O
gum	O
,	O
which	O
was	O
either	O
supplemented	O
with	O
or	O
without	O
chitosan	O
,	O
for	O
a	O
total	O
of	O
80	O
min	O
.	O

Two	O
different	O
types	O
of	O
gums	O
were	O
examined	O
with	O
at	O
least	O
1	O
week	O
as	O
a	O
rest	O
period	O
in	O
between	O
treatments	O
.	O

This	O
in	O
vivo	O
study	O
was	O
carried	O
out	O
by	O
the	O
double	O
blind	O
comparison	O
test	O
.	O

The	O
amount	O
of	O
oral	O
bacteria	O
was	O
found	O
to	O
significantly	O
decrease	O
in	O
the	O
chitosan	O
group	O
.	O

Especially	O
,	O
the	O
number	O
of	O
MS	B-bacteria
were	O
maintained	O
at	O
about	O
a	O
20	O
%	O
level	O
in	O
comparison	O
to	O
that	O
before	O
gum	O
chewing	O
,	O
even	O
at	O
1h	O
after	O
gum	O
chewing	O
.	O

These	O
findings	O
suggest	O
that	O
a	O
supplementation	O
of	O
chitosan	O
to	O
gum	O
is	O
an	O
effective	O
method	O
for	O
controlling	O
the	O
number	O
of	O
cariogenic	O
bacteria	O
in	O
situations	O
where	O
it	O
is	O
difficult	O
to	O
brush	O
one	O
'	O
s	O
teeth	O
,	O
such	O
as	O
when	O
an	O
individual	O
is	O
away	O
from	O
home	O
all	O
day	O
or	O
participating	O
in	O
outdoor	O
training	O
.	O

This	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
impact	O
of	O
haematopoietic	O
stem	O
cell	O
transplantation	O
(	O
HSCT	O
)	O
on	O
Helicobacter	B-bacteria
pylori	I-bacteria
colonization	O
of	O
the	O
oral	O
mucosa	O
by	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
nested	O
-	O
PCR	O
)	O
.	O

Forty	O
six	O
consecutive	O
patients	O
submitted	O
to	O
HSCT	O
and	O
46	O
healthy	O
volunteers	O
were	O
included	O
in	O
the	O
study	O
.	O

Oral	O
swabs	O
were	O
taken	O
from	O
the	O
oral	O
mucosa	O
of	O
the	O
patients	O
and	O
control	O
group	O
.	O

The	O
medical	O
records	O
of	O
the	O
patients	O
were	O
reviewed	O
and	O
the	O
following	O
information	O
was	O
retrieved	O
:	O
gender	O
and	O
age	O
of	O
the	O
patient	O
,	O
donor	O
gender	O
,	O
primary	O
disease	O
,	O
stem	O
cell	O
source	O
(	O
bone	O
marrow	O
or	O
blood	O
stem	O
cells	O
)	O
,	O
leukocyte	O
,	O
neutrophil	O
and	O
platelet	O
counts	O
,	O
and	O
chronic	O
graft	O
versus	O
host	O
disease	O
(	O
cGVHD	O
)	O
of	O
salivary	O
glands	O
.	O

The	O
results	O
demonstrated	O
an	O
increased	O
frequency	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
mucosa	O
of	O
HSCT	O
patients	O
compared	O
to	O
controls	O
(	O
rho	O
=	O
0	O
.	O
002	O
)	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
mucosa	O
was	O
not	O
related	O
to	O
the	O
severity	O
of	O
cGVHD	O
.	O

The	O
median	O
counts	O
of	O
platelet	O
/	O
mm3	O
,	O
leukocytes	O
/	O
mm3	O
and	O
neutrophils	O
/	O
mm3	O
in	O
the	O
group	O
of	O
HSCT	O
patients	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
were	O
not	O
statistically	O
different	O
from	O
those	O
of	O
the	O
patients	O
negative	O
for	O
it	O
.	O

In	O
conclusion	O
,	O
the	O
present	O
study	O
shows	O
increased	O
frequency	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
mucosa	O
of	O
HSCT	O
patients	O
compared	O
to	O
non	O
-	O
transplanted	O
healthy	O
volunteers	O
.	O

Salivary	O
nitrate	O
is	O
positively	O
correlated	O
with	O
plasma	O
nitrate	O
and	O
its	O
level	O
is	O
9	O
times	O
the	O
plasma	O
level	O
after	O
nitrate	O
loading	O
.	O

Nitrate	O
in	O
saliva	O
is	O
known	O
to	O
be	O
reduced	O
to	O
nitrite	O
by	O
oral	O
bacteria	O
.	O

Nitrate	O
and	O
nitrite	O
levels	O
in	O
saliva	O
are	O
3	O
-	O
5	O
times	O
those	O
in	O
serum	O
in	O
physiological	O
conditions	O
respectively	O
in	O
our	O
previous	O
study	O
.	O

The	O
biological	O
functions	O
of	O
high	O
salivary	O
nitrate	O
and	O
nitrite	O
are	O
still	O
not	O
well	O
understood	O
.	O

The	O
aim	O
of	O
this	O
in	O
vitro	O
study	O
was	O
to	O
investigate	O
the	O
antimicrobial	O
effects	O
of	O
nitrate	O
and	O
nitrite	O
on	O
main	O
oral	O
pathogens	O
under	O
acidic	O
conditions	O
.	O

Six	O
common	O
oral	O
pathogens	O
including	O
Streptococcus	B-bacteria
mutans	I-bacteria
NCTC	I-bacteria
10449	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
ATCC	I-bacteria
4646	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
,	O
Capnocytophaga	B-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33624	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
10953	I-bacteria
,	O
and	O
Candida	O
albicans	O
ATCC	O
10231	O
were	O
cultured	O
in	O
liquid	O
medium	O
.	O

Sodium	O
nitrate	O
or	O
sodium	O
nitrite	O
was	O
added	O
to	O
the	O
medium	O
to	O
final	O
concentrations	O
of	O
0	O
,	O
0	O
.	O
5	O
,	O
1	O
,	O
2	O
,	O
and	O
10	O
mmol	O
/	O
L	O
.	O

All	O
of	O
the	O
microorganisms	O
were	O
incubated	O
for	O
24	O
to	O
48	O
hours	O
.	O

The	O
optical	O
densities	O
(	O
OD	O
)	O
of	O
cell	O
suspensions	O
were	O
determined	O
and	O
the	O
cultures	O
were	O
transferred	O
to	O
solid	O
nutrient	O
broth	O
medium	O
to	O
observe	O
the	O
minimum	O
inhibitory	O
concentration	O
and	O
minimum	O
bactericidal	O
/	O
fungicidal	O
concentration	O
for	O
the	O
six	O
tested	O
pathogens	O
.	O

Nitrite	O
at	O
concentrations	O
of	O
0	O
.	O
5	O
to	O
10	O
mmol	O
/	O
L	O
had	O
an	O
inhibitory	O
effect	O
on	O
all	O
tested	O
organisms	O
at	O
low	O
pH	O
values	O
.	O

The	O
antimicrobial	O
effect	O
of	O
nitrite	O
increased	O
with	O
the	O
acidity	O
of	O
the	O
medium	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
NCTC	I-bacteria
10449	I-bacteria
was	O
highly	O
sensitive	O
to	O
nitrite	O
at	O
low	O
pH	O
values	O
.	O

Lactobacillus	B-bacteria
acidophilus	I-bacteria
ATCC	I-bacteria
4646	I-bacteria
and	O
Candida	O
albicans	O
ATCC	B-bacteria
10231	I-bacteria
were	O
relatively	O
resistant	O
to	O
acidified	O
nitrite	O
.	O

Nitrate	O
at	O
the	O
given	O
concentrations	O
and	O
under	O
acidic	O
conditions	O
had	O
no	O
inhibitory	O
effect	O
on	O
the	O
growth	O
of	O
any	O
of	O
the	O
tested	O
pathogens	O
.	O

Nitrite	O
,	O
at	O
a	O
concentration	O
equal	O
to	O
that	O
in	O
human	O
saliva	O
,	O
is	O
both	O
cytocidal	O
and	O
cytostatic	O
to	O
six	O
principal	O
oral	O
pathogens	O
in	O
vitro	O
,	O
whereas	O
nitrate	O
at	O
a	O
similar	O
concentration	O
has	O
no	O
antimicrobial	O
effect	O
on	O
these	O
organisms	O
.	O

As	O
the	O
result	O
of	O
the	O
study	O
of	O
stomatological	O
status	O
indices	O
in	O
children	O
with	O
gastroduodenal	O
pathology	O
associated	O
with	O
Helicobacter	B-bacteria
pylori	I-bacteria
it	O
was	O
established	O
that	O
caries	O
incidence	O
in	O
children	O
did	O
not	O
depend	O
upon	O
contamination	O
while	O
caries	O
prevalence	O
in	O
examined	O
children	O
unlike	O
caries	O
incidence	O
was	O
associated	O
with	O
HP	O
-	O
status	O
of	O
the	O
oral	O
cavity	O
.	O

Patients	O
with	O
concomitant	O
gastroduodenal	O
pathology	O
had	O
frequently	O
periodontal	O
disease	O
(	O
PD	O
)	O
.	O

In	O
children	O
with	O
chronic	O
antral	O
gastritis	O
associated	O
with	O
Helicobacter	B-bacteria
pylori	I-bacteria
clinical	O
manifestations	O
were	O
poor	O
and	O
tended	O
towards	O
inflammatory	O
process	O
chronicity	O
.	O

All	O
the	O
patients	O
had	O
chronic	O
catarrhal	O
gingivitis	O
.	O

In	O
children	O
with	O
Helicobacter	B-bacteria
pylori	I-bacteria
associated	O
pathology	O
of	O
GIT	O
it	O
proceeded	O
with	O
100	O
%	O
contamination	O
of	O
gingival	O
mucous	O
membrane	O
by	O
Helicobacter	B-bacteria
pylori	I-bacteria
as	O
shown	O
by	O
bacterioscopic	O
study	O
.	O

For	O
nearly	O
a	O
century	O
,	O
lactobacilli	B-bacteria
(	O
LB	B-bacteria
)	O
in	O
the	O
oral	O
cavity	O
have	O
been	O
generally	O
associated	O
with	O
dental	O
caries	O
.	O

Here	O
,	O
we	O
characterized	O
the	O
LB	B-bacteria
isolated	O
from	O
the	O
saliva	O
of	O
6	O
women	O
with	O
active	O
caries	O
using	O
genetic	O
-	O
based	O
taxonomical	O
identification	O
methods	O
.	O

From	O
each	O
subject	O
,	O
30	O
isolates	O
growing	O
on	O
Rogosa	O
medium	O
and	O
presumed	O
to	O
be	O
LB	B-bacteria
were	O
analyzed	O
.	O

Of	O
the	O
180	O
isolates	O
,	O
176	O
were	O
further	O
characterized	O
by	O
biotyping	O
,	O
DNA	O
melting	O
points	O
,	O
DNA	O
chromosomal	O
fingerprinting	O
,	O
genotyping	O
,	O
and	O
phylogenetic	O
cluster	O
assessment	O
.	O

We	O
found	O
a	O
total	O
of	O
30	O
unique	O
genotypes	O
of	O
LB	B-bacteria
in	O
the	O
saliva	O
of	O
caries	O
-	O
active	O
women	O
,	O
with	O
each	O
woman	O
harboring	O
between	O
2	O
and	O
8	O
distinct	O
genotypes	O
.	O

Although	O
Lactobacillus	B-bacteria
vaginalis	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
,	O
and	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
were	O
found	O
in	O
4	O
of	O
6	O
of	O
the	O
subjects	O
,	O
results	O
from	O
other	O
studies	O
using	O
comparable	O
methods	O
show	O
an	O
entirely	O
different	O
array	O
of	O
LB	B-bacteria
associated	O
with	O
caries	O
.	O

These	O
collective	O
observations	O
lead	O
us	O
to	O
surmise	O
that	O
LB	B-bacteria
associated	O
with	O
dental	O
caries	O
are	O
likely	O
exogenous	O
and	O
opportunistic	O
colonizers	O
,	O
arising	O
from	O
food	O
or	O
other	O
reservoirs	O
outside	O
the	O
oral	O
cavity	O
.	O

In	O
this	O
longitudinal	O
study	O
,	O
patients	O
with	O
fixed	O
orthodontic	O
appliances	O
served	O
as	O
models	O
to	O
determine	O
whether	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
total	O
streptococci	B-bacteria
increased	O
after	O
treatment	O
,	O
and	O
whether	O
treatment	O
affected	O
bacterial	O
invasion	O
into	O
the	O
adjacent	O
buccal	O
epithelial	O
cells	O
(	O
BEC	O
)	O
.	O

Supragingival	O
plaque	O
,	O
subgingival	O
plaque	O
,	O
and	O
BEC	O
were	O
collected	O
from	O
27	O
patients	O
before	O
and	O
at	O
least	O
4	O
weeks	O
after	O
placement	O
of	O
orthodontic	O
fixed	O
appliances	O
.	O

Total	O
sample	O
DNA	O
was	O
determined	O
,	O
and	O
bacteria	O
were	O
assayed	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
.	O

The	O
BEC	O
were	O
also	O
examined	O
by	O
confocal	O
microscopy	O
after	O
fluorescent	O
in	O
-	O
situ	O
hybridization	O
to	O
visually	O
detect	O
the	O
presence	O
of	O
each	O
species	O
bacteria	O
in	O
BEC	O
.	O

Total	O
DNA	O
in	O
supragingival	O
and	O
subgingival	O
plaque	O
increased	O
after	O
appliance	O
placement	O
(	O
P	O
=	O
.	O
005	O
)	O
.	O

There	O
was	O
also	O
a	O
significant	O
increase	O
in	O
supragingival	O
streptococci	B-bacteria
(	O
P	O
=	O
.	O
0002	O
)	O
.	O

By	O
confocal	O
microscopy	O
,	O
a	O
trend	O
toward	O
fewer	O
buccal	O
cells	O
recovered	O
was	O
found	O
after	O
appliance	O
placement	O
,	O
and	O
there	O
was	O
a	O
significant	O
increase	O
in	O
the	O
percentage	O
of	O
buccal	O
cells	O
containing	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
P	O
=	O
.	O
0058	O
)	O
.	O

Appliance	O
placement	O
appeared	O
to	O
increase	O
buccal	O
cell	O
susceptibility	O
to	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
invasion	O
.	O

This	O
might	O
be	O
due	O
to	O
physical	O
trauma	O
or	O
to	O
leaching	O
of	O
metals	O
from	O
the	O
appliances	O
.	O

High	O
level	O
of	O
hydrogen	O
peroxide	O
was	O
produced	O
by	O
S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
,	O
a	O
novel	O
oral	O
streptococcus	B-bacteria
isolated	O
from	O
human	O
oral	O
cavity	O
previously	O
in	O
our	O
laboratory	O
.	O

To	O
characterize	O
the	O
hydrogen	O
peroxide	O
production	O
by	O
S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
,	O
hydrogen	O
peroxide	O
yields	O
at	O
different	O
growth	O
phases	O
and	O
from	O
different	O
substrates	O
were	O
assayed	O
.	O

The	O
results	O
turned	O
out	O
that	O
hydrogen	O
peroxide	O
production	O
started	O
at	O
the	O
beginning	O
of	O
logarithmic	O
phase	O
,	O
and	O
reached	O
the	O
maximal	O
yield	O
at	O
the	O
early	O
stationary	O
phase	O
.	O

Peptone	O
and	O
yeast	O
extract	O
could	O
be	O
the	O
main	O
substrates	O
for	O
hydrogen	O
peroxide	O
production	O
.	O

Moreover	O
,	O
lactate	O
,	O
as	O
a	O
fermentative	O
product	O
of	O
glucose	O
,	O
can	O
be	O
another	O
substrate	O
for	O
hydrogen	O
peroxide	O
production	O
.	O

Furthermore	O
three	O
oxidases	O
activities	O
possibly	O
associated	O
with	O
H2O2	O
production	O
were	O
assayed	O
,	O
and	O
both	O
activities	O
of	O
lactate	O
oxidase	O
and	O
NADH	O
oxidase	O
were	O
detected	O
under	O
aerobic	O
condition	O
,	O
while	O
pyruvate	O
oxidase	O
activity	O
was	O
not	O
detected	O
in	O
the	O
permeabilized	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
,	O
implying	O
that	O
S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
could	O
mainly	O
rely	O
on	O
the	O
two	O
enzymes	O
activities	O
for	O
H2O2	O
production	O
.	O

There	O
is	O
increasing	O
prevalence	O
of	O
root	O
caries	O
.	O

We	O
hypothesized	O
different	O
biofilms	O
will	O
cause	O
varying	O
demineralization	O
in	O
cementum	O
.	O

This	O
study	O
investigated	O
the	O
extent	O
of	O
demineralization	O
of	O
cementum	O
by	O
oral	O
biofilm	O
formed	O
from	O
three	O
major	O
cariogenic	O
microorganisms	O
:	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
and	O
Actinomyces	B-bacteria
israelii	I-bacteria
.	O

Sound	O
cementum	O
tooth	O
blocks	O
were	O
incubated	O
with	O
mono	O
-	O
,	O
bi	O
-	O
,	O
and	O
tri	O
-	O
species	O
combinations	O
of	O
the	O
bacteria	O
under	O
investigation	O
.	O

MATERIALS	O
AND	O
The	O
matrix	O
(	O
amide	O
I	O
)	O
and	O
phosphate	O
content	O
of	O
the	O
lesions	O
was	O
analyzed	O
by	O
Fourier	O
-	O
transform	O
infrared	O
spectroscopy	O
(	O
FTIR	O
)	O
,	O
and	O
calcium	O
and	O
phosphorus	O
levels	O
were	O
analyzed	O
by	O
scanning	O
electron	O
microscopy	O
and	O
energy	O
-	O
dispersive	O
spectroscopy	O
(	O
SEM	O
-	O
EDX	O
)	O
.	O

The	O
log	O
[	O
amide	O
I	O
:	O
HPO	O
(	O
4	O
)	O
(	O
2	O
-	O
)	O
absorbance	O
]	O
values	O
showed	O
that	O
A	B-bacteria
.	I-bacteria
israelii	I-bacteria
mono	O
-	O
culture	O
caused	O
significantly	O
more	O
demineralization	O
than	O
the	O
other	O
bacterial	O
cultures	O
.	O

log	O
[	O
Ca	O
:	O
P	O
]	O
showed	O
that	O
all	O
carious	O
lesions	O
were	O
confined	O
to	O
the	O
cementum	O
.	O

Oral	O
biofilm	O
arising	O
from	O
bacterial	O
species	O
A	B-bacteria
.	I-bacteria
israelii	I-bacteria
alone	O
was	O
the	O
most	O
cariogenic	O
of	O
those	O
tested	O
and	O
produced	O
the	O
most	O
demineralization	O
in	O
incipient	O
carious	O
lesions	O
in	O
cementum	O
.	O

It	O
is	O
thought	O
that	O
the	O
incidence	O
and	O
severity	O
of	O
cancer	O
chemotherapy	O
-	O
associated	O
mucositis	O
is	O
caused	O
in	O
part	O
by	O
changes	O
in	O
the	O
oral	O
bacterial	O
microflora	O
.	O

This	O
systematic	O
review	O
examined	O
the	O
role	O
of	O
oral	O
bacterial	O
microflora	O
changes	O
in	O
the	O
development	O
of	O
oral	O
mucositis	O
during	O
chemotherapy	O
.	O

Thirteen	O
prospective	O
clinical	O
trials	O
were	O
identified	O
,	O
involving	O
300	O
patients	O
with	O
13	O
different	O
cancer	O
diagnoses	O
.	O

There	O
was	O
great	O
variability	O
in	O
patient	O
populations	O
,	O
bacterial	O
sample	O
collection	O
methodology	O
,	O
and	O
oral	O
sample	O
sites	O
.	O

No	O
clear	O
pattern	O
regarding	O
qualitative	O
and	O
quantitative	O
oral	O
flora	O
changes	O
emerged	O
among	O
these	O
studies	O
.	O

The	O
most	O
frequent	O
Gram	O
-	O
negative	O
species	O
isolated	O
during	O
chemotherapy	O
were	O
from	O
the	O
Enterobacteriaceae	B-bacteria
family	I-bacteria
,	O
Pseudomonas	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

The	O
most	O
common	O
Gram	O
-	O
positive	O
species	O
isolated	O
were	O
Staphylococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
Streptococcus	B-bacteria
sp	I-bacteria
.	O

Five	O
studies	O
assessed	O
the	O
role	O
of	O
oral	O
flora	O
changes	O
in	O
the	O
genesis	O
of	O
oral	O
mucosal	O
changes	O
,	O
with	O
no	O
consensus	O
among	O
them	O
.	O

More	O
detailed	O
studies	O
are	O
required	O
to	O
understand	O
the	O
relationship	O
between	O
chemotherapy	O
,	O
alterations	O
in	O
the	O
nature	O
and	O
magnitude	O
of	O
the	O
oral	O
microflora	O
,	O
and	O
the	O
presence	O
of	O
mucositis	O
.	O

To	O
investigate	O
the	O
presence	O
of	O
oral	O
bacterial	O
DNAs	O
in	O
serum	O
and	O
synovial	O
fluid	O
(	O
SF	O
)	O
of	O
patients	O
with	O
active	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
and	O
psoriatic	O
arthritis	O
(	O
PsA	O
)	O
.	O

Serum	O
and	O
SF	O
samples	O
from	O
16	O
RA	O
patients	O
,	O
14	O
PsA	O
patients	O
,	O
and	O
9	O
osteoarthritis	O
(	O
controls	O
)	O
patients	O
were	O
extracted	O
for	O
oral	O
bacterial	O
DNA	O
.	O

This	O
was	O
used	O
in	O
a	O
checkerboard	O
DNA	O
-	O
DNA	O
-	O
hybridization	O
set	O
up	O
,	O
to	O
identify	O
40	O
different	O
bacteria	O
.	O

Mean	O
number	O
+	O
/	O
-	O
standard	O
deviation	O
(	O
SD	O
)	O
of	O
oral	O
bacterial	O
species	O
in	O
sera	O
were	O
6	O
.	O
2	O
(	O
3	O
.	O
2	O
)	O
in	O
the	O
RA	O
group	O
(	O
p	O
=	O
0	O
.	O
004	O
)	O
and	O
5	O
.	O
4	O
(	O
2	O
.	O
7	O
)	O
in	O
the	O
PsA	O
group	O
(	O
p	O
=	O
0	O
.	O
009	O
)	O
compared	O
to	O
2	O
.	O
1	O
(	O
1	O
.	O
7	O
)	O
in	O
the	O
controls	O
.	O

Periodontitis	O
associated	O
species	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Prevotella	B-bacteria
nigrescens	I-bacteria
were	O
exclusively	O
detected	O
in	O
RA	O
and	O
PsA	O
.	O

Mean	O
number	O
(	O
+	O
/	O
-	O
SD	O
)	O
of	O
oral	O
bacterial	O
species	O
in	O
SF	O
were	O
14	O
.	O
0	O
(	O
6	O
.	O
8	O
)	O
in	O
the	O
RA	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
19	O
.	O
4	O
(	O
7	O
.	O
1	O
)	O
in	O
the	O
PsA	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
compared	O
to	O
4	O
.	O
0	O
(	O
1	O
.	O
7	O
)	O
in	O
controls	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
were	O
exclusively	O
identified	O
in	O
RA	O
and	O
PsA	O
SF	O
.	O

Higher	O
means	O
of	O
DNAs	O
were	O
found	O
in	O
RA	O
SF	O
compared	O
to	O
RA	O
serum	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
in	O
PsA	O
SF	O
compared	O
to	O
PsA	O
serum	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Higher	O
concentrations	O
of	O
bacterial	O
DNAs	O
were	O
found	O
in	O
RA	O
and	O
PsA	O
compared	O
to	O
controls	O
.	O

Higher	O
variety	O
and	O
concentrations	O
of	O
oral	O
bacterial	O
DNAs	O
were	O
found	O
in	O
SF	O
compared	O
to	O
serum	O
of	O
RA	O
and	O
PsA	O
patients	O
.	O

These	O
findings	O
indicate	O
that	O
synovial	O
inflammation	O
in	O
RA	O
and	O
PsA	O
may	O
favor	O
trapping	O
of	O
oral	O
bacterial	O
DNAs	O
,	O
suggesting	O
a	O
perpetuating	O
effect	O
of	O
oral	O
pathogens	O
in	O
joint	O
disease	O
.	O

Nitroethane	O
inhibits	O
the	O
growth	O
of	O
certain	O
zoonotic	O
pathogens	O
such	O
as	O
Campylobacter	B-bacteria
and	O
Salmonella	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
foodborne	O
pathogens	O
estimated	O
to	O
cause	O
millions	O
of	O
human	O
infections	O
each	O
year	O
,	O
and	O
enhances	O
the	O
Salmonella	B-bacteria
-	O
and	O
Escherichia	B-bacteria
coli	I-bacteria
-	O
killing	O
effect	O
of	O
an	O
experimental	O
chlorate	O
product	O
being	O
developed	O
as	O
a	O
feed	O
additive	O
to	O
kill	O
these	O
bacteria	O
immediately	O
pre	O
-	O
harvest	O
.	O

Limited	O
studies	O
have	O
shown	O
that	O
nitroethane	O
inhibits	O
ruminal	O
methane	O
production	O
,	O
which	O
represents	O
a	O
loss	O
of	O
2	O
-	O
12	O
%	O
of	O
the	O
host	O
'	O
s	O
gross	O
energy	O
intake	O
and	O
contributes	O
to	O
global	O
warming	O
and	O
destruction	O
of	O
the	O
ozone	O
layer	O
.	O

The	O
present	O
study	O
was	O
conducted	O
to	O
assess	O
the	O
effects	O
of	O
14	O
-	O
day	O
oral	O
nitroethane	O
administration	O
,	O
0	O
(	O
0X	O
)	O
,	O
80	O
(	O
1X	O
)	O
or	O
160	O
(	O
2X	O
)	O
mg	O
nitroethane	O
/	O
kg	O
body	O
weight	O
per	O
day	O
on	O
ruminal	O
and	O
fecal	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
Campylobacter	B-bacteria
,	O
ruminal	O
and	O
fecal	O
methane	O
-	O
producing	O
and	O
nitroethane	O
-	O
reducing	O
activity	O
,	O
whole	O
animal	O
methane	O
emissions	O
,	O
and	O
ruminal	O
and	O
fecal	O
fermentation	O
balance	O
in	O
Holstein	O
steers	O
(	O
n	O
=	O
6	O
per	O
treatment	O
)	O
averaging	O
403	O
+	O
/	O
-	O
26	O
(	O
SD	O
)	O
kg	O
BW	O
.	O

An	O
experimental	O
chlorate	O
product	O
was	O
fed	O
the	O
day	O
following	O
the	O
last	O
nitroethane	O
administration	O
to	O
determine	O
effects	O
on	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
Campylobacter	B-bacteria
.	O

The	O
experimental	O
chlorate	O
product	O
decreased	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
fecal	O
,	O
but	O
not	O
ruminal	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
E	O
.	O
coli	O
concentrations	O
by	O
1000	O
-	O
and	O
10	O
-	O
fold	O
by	O
24	O
and	O
48	O
h	O
,	O
respectively	O
,	O
after	O
chlorate	O
feeding	O
when	O
compared	O
to	O
pre	O
-	O
treatment	O
concentrations	O
(	O
>	O
5	O
.	O
7	O
log	O
(	O
10	O
)	O
colony	O
forming	O
units	O
/	O
g	O
)	O
.	O

No	O
effects	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
of	O
nitroethane	O
or	O
the	O
experimental	O
chlorate	O
product	O
were	O
observed	O
on	O
fecal	O
Campylobacter	B-bacteria
concentrations	O
;	O
Campylobacter	B-bacteria
were	O
not	O
recovered	O
from	O
ruminal	O
contents	O
.	O

Nitroethane	O
treatment	O
decreased	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
ruminal	O
(	O
8	O
.	O
46	O
,	O
7	O
.	O
91	O
and	O
4	O
.	O
74	O
+	O
/	O
-	O
0	O
.	O
78	O
micromol	O
/	O
g	O
/	O
h	O
)	O
and	O
fecal	O
(	O
3	O
.	O
90	O
,	O
1	O
.	O
36	O
and	O
1	O
.	O
38	O
+	O
/	O
-	O
0	O
.	O
50	O
micromol	O
/	O
g	O
/	O
h	O
)	O
methane	O
-	O
producing	O
activity	O
for	O
treatments	O
0X	O
,	O
1X	O
and	O
2X	O
,	O
respectively	O
.	O

Administration	O
of	O
nitroethane	O
increased	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
nitroethane	O
-	O
reducing	O
activity	O
in	O
ruminal	O
,	O
but	O
not	O
fecal	O
samples	O
.	O

Day	O
of	O
study	O
affected	O
ruminal	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
but	O
not	O
fecal	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
methane	O
-	O
producing	O
and	O
nitroethane	O
-	O
reducing	O
activities	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
;	O
treatment	O
by	O
day	O
interactions	O
were	O
not	O
observed	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Ruminal	O
accumulations	O
of	O
acetate	O
decreased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
2X	O
-	O
treated	O
steers	O
when	O
compared	O
with	O
0X	O
-	O
and	O
1X	O
-	O
treated	O
steers	O
,	O
but	O
no	O
effect	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
of	O
nitroethane	O
was	O
observed	O
on	O
propionate	O
,	O
butyrate	O
or	O
the	O
acetate	O
to	O
propionate	O
ratio	O
.	O

Whole	O
animal	O
methane	O
emissions	O
,	O
expressed	O
as	O
L	O
/	O
day	O
or	O
as	O
a	O
proportion	O
of	O
gross	O
energy	O
intake	O
(	O
%	O
GEI	O
)	O
,	O
were	O
unaffected	O
by	O
nitroethane	O
treatment	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
,	O
and	O
were	O
not	O
correlated	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
with	O
ruminal	O
methane	O
-	O
producing	O
activity	O
.	O

These	O
results	O
demonstrate	O
that	O
oral	O
nitroethane	O
administration	O
reduces	O
ruminal	O
methane	O
-	O
producing	O
activity	O
but	O
suggest	O
that	O
a	O
microbial	O
adaptation	O
,	O
likely	O
due	O
to	O
an	O
in	O
situ	O
enrichment	O
of	O
ruminal	O
nitroethane	O
-	O
reducing	O
bacteria	O
,	O
may	O
cause	O
depletion	O
of	O
nitroethane	O
,	O
at	O
least	O
at	O
the	O
1X	O
administration	O
dose	O
,	O
to	O
concentrations	O
too	O
low	O
to	O
be	O
effective	O
.	O

Further	O
research	O
is	O
warranted	O
to	O
determine	O
if	O
the	O
optimization	O
of	O
dosage	O
of	O
nitroethane	O
or	O
related	O
nitrocompouds	O
can	O
maintain	O
the	O
enteropathogen	O
control	O
and	O
anti	O
-	O
methanogen	O
effect	O
in	O
fed	O
steers	O
.	O

Involvement	O
of	O
the	O
oral	O
mucosa	O
can	O
occur	O
in	O
lepromatous	O
leprosy	O
;	O
however	O
,	O
lesions	O
in	O
the	O
oral	O
mucosa	O
of	O
paucibacillary	O
patients	O
have	O
not	O
been	O
previously	O
observed	O
.	O

The	O
objective	O
of	O
this	O
study	O
is	O
to	O
determine	O
whether	O
clinical	O
and	O
subclinical	O
lesions	O
exist	O
in	O
oral	O
mucosa	O
in	O
nontreated	O
paucibacillary	O
leprosy	O
patients	O
,	O
using	O
clinical	O
and	O
histopathological	O
examination	O
.	O

A	O
clinical	O
and	O
histopathological	O
study	O
involving	O
30	O
untreated	O
paucibacillary	O
leprosy	O
patients	O
was	O
conducted	O
.	O

All	O
patients	O
underwent	O
biopsies	O
of	O
the	O
buccal	O
mucosa	O
,	O
soft	O
palate	O
,	O
and	O
tongue	O
.	O

When	O
acid	O
-	O
fast	O
bacilli	O
in	O
association	O
with	O
inflammatory	O
infiltrate	O
,	O
granulomatous	O
or	O
not	O
,	O
were	O
encountered	O
,	O
it	O
was	O
considered	O
`	O
`	O
specific	O
'	O
'	O
involvement	O
of	O
the	O
oral	O
mucosa	O
;	O
and	O
`	O
`	O
nonspecific	O
'	O
'	O
involvement	O
when	O
the	O
bacilli	O
were	O
not	O
encountered	O
.	O

Eight	O
nonspecific	O
chronic	O
inflammatory	O
reactions	O
and	O
1	O
granulomatous	O
inflammatory	O
process	O
without	O
acid	O
-	O
fast	O
bacilli	O
were	O
detected	O
.	O

Paucibacillary	O
leprosy	O
patients	O
do	O
not	O
exhibit	O
specific	O
,	O
clinical	O
or	O
subclinical	O
,	O
involvement	O
in	O
the	O
oral	O
mucosa	O
;	O
nonspecific	O
alterations	O
occur	O
even	O
in	O
the	O
absence	O
of	O
signs	O
and	O
symptoms	O
.	O

The	O
bactericidal	O
efficacy	O
of	O
diode	O
lasers	O
has	O
already	O
been	O
demonstrated	O
in	O
vitro	O
.	O

We	O
investigated	O
the	O
reduction	O
of	O
aerobe	O
bacteria	O
-	O
colonizing	O
rough	O
titanium	O
samples	O
in	O
biofilms	O
intraorally	O
grown	O
-	O
by	O
diode	O
lasers	O
of	O
different	O
wave	O
lengths	O
.	O

Twenty	O
-	O
two	O
volunteers	O
participated	O
in	O
the	O
trial	O
.	O

They	O
were	O
fitted	O
for	O
10	O
days	O
with	O
custom	O
-	O
made	O
intraoral	O
plastic	O
splints	O
carrying	O
titanium	O
sleeves	O
.	O

A	O
part	O
of	O
the	O
sleeves	O
was	O
then	O
irradiated	O
with	O
diode	O
lasers	O
in	O
different	O
modes	O
.	O

The	O
other	O
part	O
remained	O
non	O
-	O
irradiated	O
and	O
served	O
as	O
control	O
.	O

Directly	O
after	O
irradiation	O
,	O
the	O
sleeves	O
were	O
swabbed	O
and	O
the	O
gained	O
bacteria	O
were	O
first	O
examined	O
microscopically	O
and	O
then	O
were	O
cultured	O
under	O
aerobic	O
conditions	O
.	O

The	O
bacteria	O
in	O
the	O
controls	O
and	O
in	O
the	O
treated	O
samples	O
were	O
quantified	O
.	O

A	O
comparison	O
with	O
the	O
controls	O
revealed	O
a	O
marked	O
overall	O
reduction	O
of	O
bacterial	O
colonization	O
in	O
all	O
irradiated	O
sleeves	O
.	O

Continuous	O
irradiation	O
for	O
20	O
s	O
reduced	O
bacteria	O
counts	O
by	O
99	O
.	O
67	O
%	O
at	O
810	O
nm	O
and	O
99	O
.	O
58	O
%	O
at	O
980	O
nm	O
.	O

Repeating	O
the	O
20	O
s	O
exposure	O
five	O
times	O
reduced	O
counts	O
by	O
99	O
.	O
98	O
%	O
at	O
810	O
nm	O
and	O
by	O
99	O
.	O
39	O
%	O
at	O
980	O
nm	O
.	O

A	O
98	O
.	O
86	O
%	O
reduction	O
was	O
seen	O
after	O
irradiation	O
in	O
pulsed	O
mode	O
.	O

A	O
further	O
analysis	O
in	O
respect	O
of	O
different	O
isolated	O
bacteria	O
revealed	O
that	O
the	O
streptococci	B-bacteria
group	O
was	O
reduced	O
by	O
99	O
.	O
29	O
-	O
99	O
.	O
99	O
%	O
,	O
while	O
the	O
staphylococci	B-bacteria
group	O
was	O
reduced	O
to	O
a	O
lesser	O
extent	O
in	O
the	O
range	O
94	O
.	O
67	O
-	O
99	O
.	O
99	O
%	O
.	O

The	O
results	O
are	O
of	O
clinical	O
relevance	O
.	O

In	O
comparison	O
with	O
the	O
mean	O
bacterial	O
counts	O
of	O
the	O
untreated	O
samples	O
,	O
all	O
irradiation	O
programs	O
studied	O
in	O
this	O
investigation	O
reduced	O
mean	O
bacterial	O
colonization	O
in	O
a	O
biofilm	O
on	O
intraoral	O
rough	O
titanium	O
surfaces	O
by	O
more	O
than	O
98	O
%	O
.	O

The	O
actual	O
extent	O
of	O
reduction	O
was	O
dependent	O
on	O
the	O
bacteria	O
species	O
as	O
well	O
as	O
on	O
the	O
irradiation	O
mode	O
.	O

Under	O
physiological	O
conditions	O
,	O
matrix	O
metalloproteinases	O
(	O
MMPs	O
)	O
are	O
involved	O
in	O
the	O
remodeling	O
and	O
turnover	O
of	O
periodontal	O
tissue	O
and	O
their	O
activity	O
is	O
tightly	O
regulated	O
by	O
tissue	O
inhibitors	O
of	O
metalloproteinases	O
(	O
TIMPs	O
)	O
.	O

Disturbances	O
in	O
the	O
balance	O
between	O
MMPs	O
and	O
TIMPs	O
may	O
result	O
in	O
excessive	O
tissue	O
destruction	O
.	O

We	O
previously	O
used	O
an	O
engineered	O
human	O
oral	O
mucosa	O
(	O
EHOM	O
)	O
model	O
to	O
demonstrate	O
that	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
a	O
major	O
etiological	O
agent	O
of	O
periodontitis	O
,	O
infiltrates	O
connective	O
tissue	O
and	O
induces	O
significant	O
loss	O
of	O
attachment	O
of	O
the	O
stratified	O
epithelium	O
from	O
the	O
basement	O
membrane	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
the	O
expression	O
and	O
production	O
of	O
MMP	O
-	O
2	O
,	O
MMP	O
-	O
9	O
,	O
TIMP	O
-	O
1	O
,	O
and	O
TIMP	O
-	O
2	O
by	O
oral	O
fibroblasts	O
and	O
epithelial	O
cells	O
.	O

The	O
EHOM	O
model	O
was	O
infected	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
or	O
its	O
derivative	O
gingipain	O
-	O
null	O
mutant	O
(	O
KDP128	O
)	O
for	O
different	O
periods	O
of	O
time	O
.	O

MMP	O
and	O
TIMP	O
mRNA	O
expression	O
was	O
evaluated	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
analysis	O
,	O
while	O
protein	O
secretion	O
into	O
the	O
culture	O
medium	O
was	O
assessed	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
significantly	O
up	O
-	O
regulated	O
MMP	O
-	O
2	O
and	O
MMP	O
-	O
9	O
mRNA	O
expression	O
by	O
oral	O
epithelial	O
cells	O
.	O

This	O
MMP	O
gene	O
activation	O
was	O
paralleled	O
by	O
TIMP	O
-	O
2	O
gene	O
activation	O
.	O

However	O
,	O
only	O
MMP	O
-	O
9	O
mRNA	O
expression	O
was	O
significantly	O
enhanced	O
by	O
the	O
gingipain	O
-	O
null	O
mutant	O
.	O

At	O
8	O
and	O
24	O
h	O
post	O
-	O
infection	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
increased	O
significantly	O
the	O
MMP	O
-	O
9	O
protein	O
level	O
compared	O
to	O
the	O
uninfected	O
EHOM	O
model	O
.	O

The	O
present	O
study	O
reports	O
the	O
ability	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
to	O
regulate	O
MMP	O
and	O
TIMP	O
production	O
by	O
oral	O
cells	O
,	O
a	O
phenomenon	O
that	O
may	O
contribute	O
to	O
tissue	O
destruction	O
.	O

Nail	O
biting	O
is	O
a	O
common	O
oral	O
habit	O
in	O
children	O
and	O
young	O
adults	O
.	O

However	O
,	O
its	O
effect	O
on	O
the	O
oral	O
carriage	O
of	O
Enterobacteriaceae	B-bacteria
is	O
unclear	O
.	O

The	O
purpose	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
differences	O
in	O
prevalence	O
of	O
Enterobacteriaceae	B-bacteria
in	O
saliva	O
samples	O
from	O
subjects	O
with	O
and	O
without	O
a	O
nail	O
-	O
biting	O
habit	O
.	O

Saliva	O
samples	O
were	O
taken	O
from	O
25	O
subjects	O
who	O
were	O
nail	O
-	O
biters	O
and	O
34	O
subjects	O
with	O
no	O
oral	O
habit	O
.	O

The	O
mean	O
chronological	O
age	O
for	O
all	O
subjects	O
was	O
13	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
9	O
years	O
.	O

The	O
saliva	O
samples	O
were	O
studied	O
microbiologically	O
.	O

A	O
Pearson	O
chi	O
-	O
squared	O
test	O
was	O
performed	O
to	O
compare	O
the	O
prevalence	O
of	O
Enterobacteriaceae	B-bacteria
in	O
the	O
saliva	O
samples	O
of	O
the	O
subjects	O
with	O
and	O
without	O
nail	O
-	O
biting	O
habits	O
.	O

Statistically	O
significant	O
differences	O
were	O
found	O
in	O
the	O
prevalence	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
total	O
Enterobacteriaceae	B-bacteria
between	O
both	O
groups	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
Enterobacter	B-bacteria
aerogenes	I-bacteria
,	O
Enterobacter	B-bacteria
cloacae	I-bacteria
and	O
Enterobacter	B-bacteria
gergoviae	I-bacteria
were	O
found	O
in	O
the	O
saliva	O
samples	O
of	O
19	O
of	O
the	O
25	O
nail	O
-	O
biting	O
subjects	O
(	O
76	O
%	O
)	O
,	O
whereas	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
aerogenes	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
cloacae	I-bacteria
were	O
detected	O
in	O
the	O
saliva	O
samples	O
of	O
only	O
nine	O
of	O
the	O
34	O
subjects	O
who	O
were	O
not	O
nail	O
-	O
biters	O
(	O
26	O
.	O
5	O
%	O
)	O
.	O

According	O
to	O
the	O
results	O
of	O
the	O
present	O
study	O
,	O
the	O
Enterobacteriaceae	B-bacteria
were	O
more	O
prevalent	O
in	O
the	O
oral	O
cavities	O
of	O
children	O
with	O
nail	O
-	O
biting	O
habits	O
than	O
in	O
children	O
with	O
no	O
oral	O
habit	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
eradication	O
from	O
the	O
oral	O
cavity	O
is	O
more	O
difficult	O
than	O
from	O
the	O
stomach	O
.	O

Thus	O
,	O
if	O
the	O
bacterium	O
survives	O
the	O
antibacterial	O
therapy	O
in	O
the	O
oral	O
cavity	O
,	O
it	O
would	O
be	O
able	O
to	O
re	O
-	O
infect	O
the	O
stomach	O
within	O
a	O
few	O
weeks	O
.	O

Since	O
oral	O
health	O
status	O
could	O
correspond	O
to	O
oral	O
infection	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
determine	O
whether	O
oral	O
health	O
and	O
oral	O
hygiene	O
practices	O
affect	O
the	O
efficacy	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
eradication	O
from	O
the	O
stomach	O
.	O

The	O
study	O
was	O
performed	O
in	O
137	O
patients	O
with	O
peptic	O
ulcer	O
who	O
had	O
undergone	O
a	O
7	O
-	O
day	O
course	O
of	O
eradication	O
treatment	O
with	O
one	O
of	O
two	O
sets	O
of	O
drugs	O
:	O
1	O
,	O
omeprazole	O
,	O
amoxicillin	O
,	O
and	O
tinidazole	O
or	O
2	O
,	O
omeprazole	O
,	O
clarithromycin	O
,	O
and	O
tinidazole	O
.	O

The	O
efficacy	O
of	O
H	O
.	O
pylori	O
eradication	O
from	O
the	O
stomach	O
was	O
evaluated	O
at	O
the	O
second	O
gastroscopy	O
4	O
weeks	O
after	O
cessation	O
of	O
eradication	O
therapy	O
by	O
means	O
of	O
two	O
methods	O
:	O
rapid	O
urease	O
test	O
and	O
histology	O
.	O

The	O
examination	O
of	O
natural	O
dentition	O
and	O
prosthetic	O
restorations	O
as	O
well	O
as	O
the	O
assessment	O
of	O
hygienic	O
procedures	O
referring	O
to	O
natural	O
dentition	O
and	O
dentures	O
accompanied	O
the	O
second	O
gastroscopy	O
.	O

No	O
association	O
was	O
found	O
between	O
the	O
efficacy	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
eradication	O
from	O
the	O
stomach	O
and	O
the	O
number	O
of	O
natural	O
teeth	O
,	O
decayed	O
teeth	O
,	O
use	O
of	O
dentures	O
,	O
debris	O
index	O
,	O
or	O
periodontal	O
index	O
.	O

However	O
,	O
an	O
association	O
between	O
eradication	O
success	O
and	O
some	O
oral	O
hygiene	O
procedures	O
were	O
noted	O
.	O

Unexpectedly	O
,	O
in	O
patients	O
treated	O
with	O
omeprazole	O
,	O
amoxicillin	O
and	O
tinidazole	O
,	O
the	O
removal	O
of	O
dental	O
prosthesis	O
for	O
the	O
night	O
and	O
brushing	O
the	O
natural	O
teeth	O
twice	O
a	O
day	O
or	O
more	O
reduced	O
the	O
efficacy	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
eradication	O
from	O
the	O
stomach	O
.	O

Oral	O
health	O
and	O
oral	O
hygiene	O
practices	O
seem	O
unlikely	O
to	O
increase	O
the	O
efficacy	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
eradication	O
from	O
the	O
stomach	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
)	O
is	O
an	O
important	O
pathogen	O
in	O
gastritis	O
,	O
peptic	O
ulcer	O
and	O
possibly	O
gastric	O
cancer	O
,	O
but	O
several	O
questions	O
remain	O
unanswered	O
.	O

Particularly	O
how	O
the	O
organism	O
is	O
transmitted	O
and	O
what	O
is	O
the	O
relationship	O
between	O
oral	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
and	O
the	O
gastric	O
infection	O
.	O

Accordingly	O
,	O
we	O
aimed	O
to	O
characterize	O
the	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
and	O
to	O
evaluate	O
its	O
relationship	O
to	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
.	O

Out	O
of	O
total	O
100	O
screened	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
female	O
subjects	O
(	O
40	O
to	O
85	O
y	O
)	O
,	O
49	O
patients	O
(	O
pts	O
)	O
,	O
who	O
had	O
positive	O
C	O
-	O
urea	O
breath	O
test	O
(	O
UBT	O
)	O
and	O
dyspeptic	O
symptoms	O
,	O
agreed	O
for	O
1	O
week	O
regimen	O
of	O
triple	O
anti	O
-	O
H	O
.	O
pylori	O
therapy	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
was	O
assessed	O
using	O
bacterial	O
culture	O
from	O
saliva	O
and	O
gingival	O
pockets	O
.	O

Gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
estimated	O
using	O
capsulated	O
C	O
-	O
urea	O
breath	O
test	O
and	O
plasma	O
anti	O
-	O
H	O
.	O
pylori	O
IgG	O
and	O
saliva	O
IgA	O
antibodies	O
.	O

In	O
addition	O
,	O
plasma	O
gastrin	O
,	O
ghrelin	O
,	O
and	O
pepsinogen	O
I	O
were	O
measured	O
by	O
radioimmunoassay	O
.	O

In	O
selected	O
patients	O
,	O
gastroscopy	O
was	O
additionally	O
performed	O
and	O
gastric	O
biopsy	O
samples	O
were	O
taken	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
random	O
amplification	O
of	O
polymorphic	O
DNA	O
genetic	O
profiling	O
.	O

The	O
triple	O
therapy	O
resulted	O
in	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
eradication	O
in	O
79	O
%	O
pts	O
,	O
along	O
with	O
significant	O
decrease	O
of	O
plasma	O
gastrin	O
combined	O
with	O
an	O
increase	O
in	O
plasma	O
ghrelin	O
and	O
pepsinogen	O
I	O
(	O
PgI	O
)	O
levels	O
and	O
a	O
marked	O
alleviation	O
of	O
dyspeptic	O
symptoms	O
.	O

In	O
contrast	O
to	O
gastric	O
effects	O
,	O
the	O
eradication	O
therapy	O
failed	O
to	O
cause	O
any	O
changes	O
in	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
.	O

Moreover	O
no	O
relationship	O
was	O
observed	O
between	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
and	O
the	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
eradication	O
.	O

In	O
line	O
with	O
these	O
findings	O
,	O
no	O
relationship	O
between	O
gastric	O
and	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
using	O
genetic	O
profiling	O
by	O
random	O
amplification	O
of	O
polymorphic	O
DNA	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
detected	O
both	O
in	O
the	O
oral	O
cavity	O
and	O
the	O
stomach	O
but	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
had	O
no	O
relation	O
to	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
and	O
remained	O
unaffected	O
by	O
eradication	O
of	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Structure	O
of	O
bacterial	O
microflora	O
of	O
periodontal	O
pocket	O
using	O
classical	O
cultural	O
and	O
molecular	O
genetic	O
methods	O
(	O
PCR	O
and	O
RT	O
-	O
PCR	O
assays	O
)	O
was	O
studied	O
in	O
patients	O
with	O
chronic	O
generalized	O
severe	O
or	O
intermediate	O
periodontitis	O
in	O
acute	O
phase	O
and	O
in	O
healthy	O
subjects	O
.	O

Structure	O
of	O
viral	O
and	O
fungal	O
microflora	O
using	O
PCR	O
or	O
ELISA	O
assays	O
was	O
studied	O
also	O
.	O

Markers	O
of	O
Gram	O
-	O
negative	O
bacteria	O
(	O
B	B-bacteria
.	I-bacteria
forsithus	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomicetemcommitans	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
were	O
detected	O
with	O
different	O
rates	O
.	O

Rate	O
of	O
detection	O
of	O
pigment	O
-	O
forming	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
significantly	O
higher	O
when	O
PCR	O
assay	O
was	O
used	O
compared	O
with	O
traditional	O
bacteriologic	O
method	O
.	O

Detection	O
rate	O
of	O
Candida	O
albicans	O
DNA	O
in	O
tooth	O
-	O
gingival	O
fluid	O
was	O
virtually	O
not	O
different	O
from	O
one	O
when	O
cultural	O
method	O
was	O
used	O
.	O

PCR	O
assay	O
is	O
recommended	O
as	O
laboratory	O
method	O
for	O
detection	O
of	O
DNA	O
of	O
microorganisms	O
associated	O
with	O
inflammatory	O
diseases	O
of	O
oral	O
mucosa	O
and	O
periodontium	O
.	O

Trauma	O
intensive	O
care	O
unit	O
(	O
TICU	O
)	O
patients	O
requiring	O
mechanical	O
respiratory	O
support	O
frequently	O
develop	O
ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
.	O

Oral	O
and	O
oropharyngeal	O
bacteria	O
are	O
believed	O
to	O
be	O
responsible	O
for	O
many	O
cases	O
of	O
VAP	O
,	O
but	O
definitive	O
evidence	O
of	O
this	O
relationship	O
is	O
lacking	O
.	O

Earlier	O
studies	O
used	O
conventional	O
culture	O
-	O
based	O
methods	O
for	O
identification	O
of	O
bacterial	O
pathogens	O
,	O
but	O
these	O
methods	O
are	O
insufficient	O
,	O
as	O
some	O
bacteria	O
may	O
be	O
uncultivable	O
or	O
difficult	O
to	O
grow	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
use	O
a	O
culture	O
-	O
independent	O
molecular	O
approach	O
to	O
analyze	O
and	O
compare	O
the	O
bacterial	O
species	O
colonizing	O
the	O
oral	O
cavity	O
and	O
the	O
lungs	O
of	O
TICU	O
patients	O
who	O
developed	O
VAP	O
.	O

Bacterial	O
samples	O
were	O
acquired	O
from	O
the	O
dorsal	O
tongue	O
and	O
bronchoalveolar	O
lavage	O
fluid	O
of	O
16	O
patients	O
.	O

Bacterial	O
DNA	O
was	O
extracted	O
,	O
and	O
the	O
16S	O
rRNA	O
genes	O
were	O
PCR	O
amplified	O
,	O
cloned	O
into	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
and	O
sequenced	O
.	O

The	O
sequencing	O
data	O
revealed	O
the	O
following	O
:	O
(	O
i	O
)	O
a	O
wide	O
diversity	O
of	O
bacterial	O
species	O
in	O
both	O
the	O
oral	O
and	O
pulmonary	O
sites	O
,	O
some	O
of	O
them	O
novel	O
;	O
(	O
ii	O
)	O
known	O
and	O
putative	O
respiratory	O
pathogens	O
colonizing	O
both	O
the	O
oral	O
cavity	O
and	O
lungs	O
of	O
14	O
patients	O
;	O
and	O
(	O
iii	O
)	O
a	O
number	O
of	O
bacterial	O
pathogens	O
(	O
e	O
.	O
g	O
.	O
,	O
Dialister	B-bacteria
pneumosintes	I-bacteria
,	O
Haemophilus	B-bacteria
segnis	I-bacteria
,	O
Gemella	B-bacteria
morbillorum	I-bacteria
,	O
and	O
Pseudomonas	B-bacteria
fluorescens	I-bacteria
)	O
in	O
lung	O
samples	O
that	O
had	O
not	O
been	O
reported	O
previously	O
at	O
this	O
site	O
when	O
culture	O
-	O
based	O
methods	O
were	O
used	O
.	O

Our	O
data	O
indicate	O
that	O
the	O
dorsal	O
surface	O
of	O
the	O
tongue	O
serves	O
as	O
a	O
potential	O
reservoir	O
for	O
bacterial	O
species	O
involved	O
in	O
VAP	O
.	O

Furthermore	O
,	O
it	O
is	O
clear	O
that	O
the	O
diversity	O
of	O
bacterial	O
pathogens	O
for	O
VAP	O
is	O
far	O
more	O
complex	O
than	O
the	O
current	O
literature	O
suggests	O
.	O

The	O
aim	O
of	O
this	O
cross	O
-	O
sectional	O
study	O
was	O
to	O
evaluate	O
the	O
periodontal	O
status	O
and	O
oral	O
microbiological	O
patterns	O
of	O
a	O
population	O
with	O
end	O
-	O
stage	O
renal	O
disease	O
(	O
ESRD	O
)	O
,	O
undergoing	O
haemodialysis	O
(	O
HD	O
)	O
.	O

This	O
was	O
a	O
cross	O
-	O
sectional	O
study	O
,	O
involving	O
52	O
patients	O
from	O
the	O
Nephrology	O
Department	O
and	O
52	O
matched	O
control	O
subjects	O
.	O

The	O
subjects	O
had	O
a	O
periodontal	O
clinical	O
examination	O
;	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
and	O
analysed	O
using	O
a	O
semiquantitative	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
test	O
to	O
detect	O
Porphyromas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

Subgingival	O
plaque	O
and	O
saliva	O
samples	O
were	O
studied	O
for	O
Candida	O
and	O
Enterobacteriaceae	B-bacteria
.	O

Most	O
of	O
the	O
104	O
subjects	O
had	O
some	O
degree	O
of	O
loss	O
of	O
periodontal	O
attachment	O
(	O
LPA	O
)	O
>	O
or	O
=	O
3	O
mm	O
[	O
11	O
(	O
10	O
.	O
5	O
%	O
)	O
had	O
severe	O
LPA	O
;	O
16	O
(	O
15	O
.	O
4	O
%	O
)	O
moderate	O
LPA	O
;	O
and	O
64	O
(	O
61	O
.	O
5	O
%	O
)	O
mild	O
LPA	O
]	O
.	O

Only	O
13	O
subjects	O
(	O
12	O
.	O
5	O
%	O
)	O
presented	O
good	O
periodontal	O
health	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
found	O
between	O
the	O
HD	O
patients	O
and	O
the	O
control	O
group	O
regarding	O
bleeding	O
index	O
,	O
number	O
of	O
teeth	O
,	O
or	O
percentage	O
of	O
LPA	O
>	O
or	O
=	O
3	O
mm	O
.	O

However	O
,	O
a	O
statistically	O
significant	O
difference	O
was	O
seen	O
in	O
the	O
degree	O
of	O
oral	O
hygiene	O
.	O

On	O
the	O
basis	O
of	O
the	O
findings	O
presented	O
here	O
,	O
we	O
can	O
not	O
associate	O
ESRD	O
with	O
more	O
severe	O
periodontal	O
destruction	O
.	O

Although	O
HD	O
patients	O
presented	O
a	O
higher	O
number	O
of	O
periodontopathic	O
microorganisms	O
than	O
the	O
matched	O
controls	O
,	O
a	O
prolonged	O
duration	O
of	O
HD	O
did	O
not	O
bear	O
a	O
statistically	O
significant	O
relationship	O
with	O
the	O
percentage	O
of	O
sites	O
with	O
LPA	O
>	O
or	O
=	O
3	O
mm	O
,	O
specific	O
microbiota	O
or	O
composition	O
of	O
biofilm	O
.	O

To	O
study	O
the	O
short	O
-	O
term	O
microbiological	O
changes	O
following	O
full	O
-	O
mouth	O
compared	O
with	O
quadrant	O
wise	O
scaling	O
and	O
root	O
planing	O
(	O
FMRP	O
and	O
QRP	O
)	O
as	O
well	O
as	O
long	O
-	O
term	O
effects	O
.	O

Twenty	O
patients	O
with	O
chronic	O
periodontitis	O
were	O
randomized	O
into	O
a	O
test	O
group	O
treated	O
in	O
two	O
sessions	O
with	O
subgingival	O
scaling	O
and	O
root	O
planing	O
within	O
24	O
h	O
(	O
FMRP	O
)	O
and	O
a	O
control	O
group	O
treated	O
quadrant	O
by	O
quadrant	O
in	O
four	O
sessions	O
at	O
intervals	O
of	O
one	O
week	O
(	O
QRP	O
)	O
.	O

Microbiological	O
samples	O
were	O
taken	O
in	O
the	O
two	O
deepest	O
pockets	O
of	O
the	O
maxillary	O
right	O
quadrant	O
immediately	O
before	O
treatment	O
and	O
after	O
1	O
day	O
,	O
1	O
,	O
2	O
,	O
4	O
,	O
8	O
,	O
12	O
,	O
and	O
24	O
weeks	O
.	O

The	O
samples	O
were	O
evaluated	O
by	O
real	O
-	O
time	O
PCR	O
for	O
quantification	O
of	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
.	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
as	O
well	O
as	O
for	O
total	O
bacterial	O
counts	O
(	O
TBC	O
)	O
.	O

Treatment	O
resulted	O
in	O
a	O
TBC	O
median	O
log	O
reduction	O
of	O
0	O
.	O
75	O
(	O
FMRP	O
)	O
and	O
0	O
.	O
72	O
(	O
QRP	O
)	O
.	O

There	O
were	O
no	O
differences	O
between	O
groups	O
either	O
for	O
the	O
short	O
term	O
(	O
1	O
day	O
-	O
4	O
weeks	O
)	O
(	O
analysis	O
of	O
variance	O
:	O
p	O
=	O
0	O
.	O
3150	O
)	O
or	O
for	O
long	O
term	O
(	O
4	O
-	O
24	O
weeks	O
)	O
(	O
analysis	O
of	O
variance	O
:	O
p	O
=	O
0	O
.	O
9671	O
)	O
.	O

Likewise	O
,	O
no	O
differences	O
were	O
detected	O
for	O
selected	O
target	O
bacteria	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
showed	O
similar	O
microbiological	O
outcomes	O
following	O
both	O
treatment	O
modalities	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
lactobacilli	B-bacteria
from	O
the	O
human	O
oral	O
cavity	O
as	O
a	O
potential	O
source	O
of	O
probiotic	O
strains	O
.	O

Samples	O
were	O
collected	O
from	O
four	O
different	O
locations	O
within	O
the	O
oral	O
cavity	O
:	O
surface	O
of	O
healthy	O
tooth	O
,	O
oral	O
mucous	O
membrane	O
,	O
surface	O
of	O
tooth	O
decay	O
and	O
deep	O
tooth	O
decay	O
.	O

On	O
the	O
basis	O
of	O
morphological	O
and	O
biochemical	O
properties	O
eight	O
categories	O
were	O
formed	O
and	O
26	O
isolates	O
were	O
selected	O
for	O
further	O
characterization	O
.	O

The	O
isolates	O
were	O
determined	O
as	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
using	O
primers	O
specific	O
for	O
16S	O
rDNA	O
.	O

Sequencing	O
of	O
16S	O
rDNA	O
genes	O
and	O
repetitive	O
sequence	O
-	O
based	O
polymerase	O
chain	O
reactions	O
were	O
used	O
for	O
determination	O
to	O
species	O
and	O
subspecies	O
levels	O
.	O

Predominant	O
species	O
were	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
,	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
and	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
subsp	I-bacteria
.	I-bacteria
paracasei	I-bacteria
,	O
while	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Lactobacillus	B-bacteria
cellobiosus	I-bacteria
,	O
Lactobacillus	B-bacteria
delbrueckii	I-bacteria
subsp	I-bacteria
.	I-bacteria
lactis	I-bacteria
and	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
were	O
also	O
present	O
.	O

The	O
isolates	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
,	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
BGHO36	I-bacteria
and	I-bacteria
BGHO64	I-bacteria
,	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
BGHO89	I-bacteria
and	O
Lactobacillus	B-bacteria
delbrueckii	I-bacteria
subsp	I-bacteria
.	I-bacteria
lactis	I-bacteria
BGHO99	I-bacteria
exhibited	O
antagonistic	O
action	O
on	O
the	O
growth	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Micrococcus	B-bacteria
flavus	I-bacteria
,	O
Salmonella	B-bacteria
enteritidis	I-bacteria
,	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
but	O
not	O
on	O
growth	O
of	O
Candida	O
albicans	O
.	O

Moreover	O
,	O
the	O
isolates	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
BGHO89	I-bacteria
were	O
tolerant	O
to	O
low	O
pH	O
and	O
high	O
concentration	O
of	O
bile	O
salts	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
imply	O
that	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
BGHO89	I-bacteria
might	O
be	O
subjects	O
for	O
additional	O
investigation	O
as	O
potential	O
probiotic	O
strains	O
.	O

The	O
bacteriocin	O
producer	O
Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
is	O
used	O
as	O
a	O
probiotic	O
targeting	O
the	O
oral	O
cavity	O
,	O
so	O
our	O
study	O
aimed	O
to	O
assess	O
whether	O
its	O
dispersal	O
and	O
persistence	O
could	O
be	O
monitored	O
using	O
real	O
-	O
time	O
quantitative	O
polymerase	O
chain	O
reaction	O
.	O

To	O
this	O
end	O
,	O
we	O
designed	O
polymerase	O
chain	O
reaction	O
primers	O
and	O
a	O
hybridization	O
probe	O
specifically	O
targeting	O
salA	O
,	O
which	O
encodes	O
for	O
the	O
prepropeptide	O
of	O
salivaricin	O
A	O
.	O

Using	O
a	O
single	O
individual	O
as	O
our	O
subject	O
,	O
we	O
administered	O
four	O
lozenges	O
of	O
K12	B-bacteria
Throat	O
Guard	O
per	O
day	O
over	O
3	O
days	O
,	O
then	O
measured	O
salA	O
gene	O
levels	O
for	O
16	O
different	O
oral	O
sites	O
at	O
six	O
different	O
intervals	O
over	O
35	O
days	O
.	O

Four	O
samples	O
each	O
from	O
gingival	O
sulci	O
and	O
from	O
teeth	O
all	O
remained	O
negative	O
.	O

In	O
contrast	O
,	O
in	O
saliva	O
and	O
at	O
all	O
mucosal	O
membranes	O
K12	B-bacteria
was	O
detected	O
,	O
but	O
with	O
varying	O
amounts	O
and	O
time	O
profiles	O
.	O

Relatively	O
high	O
salA	O
gene	O
copy	O
numbers	O
,	O
calibrated	O
on	O
the	O
basis	O
of	O
colony	O
-	O
forming	O
units	O
,	O
were	O
seen	O
on	O
the	O
tongue	O
(	O
maximum	O
4	O
.	O
6	O
x	O
10	O
(	O
4	O
)	O
/	O
swab	O
at	O
day	O
4	O
)	O
,	O
in	O
stimulated	O
saliva	O
(	O
2	O
.	O
4	O
x	O
10	O
(	O
4	O
)	O
/	O
ml	O
,	O
day	O
4	O
)	O
and	O
on	O
buccal	O
membranes	O
(	O
1	O
.	O
3	O
x	O
10	O
(	O
4	O
)	O
/	O
swab	O
,	O
day	O
8	O
)	O
.	O

K12	B-bacteria
was	O
present	O
on	O
both	O
sides	O
of	O
the	O
pharynx	O
but	O
asymmetrically	O
in	O
both	O
quantity	O
and	O
duration	O
.	O

In	O
conclusion	O
,	O
we	O
have	O
developed	O
a	O
real	O
-	O
time	O
quantitative	O
-	O
polymerase	O
chain	O
reaction	O
for	O
counting	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
at	O
various	O
sites	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
the	O
individual	O
studied	O
,	O
K12	B-bacteria
could	O
be	O
detected	O
at	O
the	O
mucosal	O
membranes	O
for	O
as	O
long	O
as	O
3	O
weeks	O
,	O
but	O
with	O
steadily	O
decreasing	O
numbers	O
after	O
day	O
8	O
.	O

Thus	O
,	O
K12	B-bacteria
may	O
have	O
the	O
potential	O
to	O
control	O
oral	O
bacterial	O
infections	O
only	O
when	O
the	O
uptake	O
is	O
repeated	O
frequently	O
.	O

The	O
ability	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
to	O
promote	O
coagulation	O
prompted	O
the	O
hypothesis	O
that	O
pro	O
-	O
inflammatory	O
cytokines	O
induced	O
by	O
oral	O
streptococci	B-bacteria
might	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
viridans	O
endocarditis	O
.	O

We	O
used	O
supernatant	O
fluids	O
from	O
peripheral	O
blood	O
mononuclear	O
monocyte	O
(	O
PBMC	O
)	O
cultures	O
,	O
stimulated	O
for	O
just	O
4	O
-	O
6	O
hrs	O
with	O
representative	O
streptococcal	B-bacteria
isolates	I-bacteria
,	O
to	O
study	O
cytokines	O
that	O
promoted	O
endothelial	O
tissue	O
factor	O
(	O
TF	O
)	O
activity	O
.	O

Neutralizing	O
antibodies	O
demonstrated	O
that	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
was	O
a	O
major	O
early	O
endothelial	O
TF	O
inducer	O
,	O
and	O
that	O
recombinant	O
IL	O
-	O
1beta	O
was	O
comparable	O
with	O
the	O
supernatant	O
fluid	O
in	O
activity	O
.	O

IL	O
-	O
1beta	O
-	O
rich	O
supernatant	O
fluids	O
from	O
oral	O
streptococci	B-bacteria
-	O
stimulated	O
or	O
lipopolysaccharide	O
-	O
stimulated	O
PBMC	O
cultures	O
up	O
-	O
regulated	O
the	O
expression	O
of	O
endothelial	O
ICAM	O
-	O
1	O
and	O
E	O
-	O
selectin	O
.	O

These	O
molecules	O
could	O
help	O
trap	O
TF	O
-	O
producing	O
monocytes	O
or	O
dendritic	O
cells	O
bearing	O
streptococci	B-bacteria
at	O
the	O
site	O
.	O

Thus	O
,	O
the	O
rapid	O
IL	O
-	O
1beta	O
-	O
inducing	O
capacity	O
of	O
oral	O
streptococci	B-bacteria
could	O
facilitate	O
the	O
early	O
deposition	O
of	O
bacteria	O
in	O
fibrin	O
clots	O
and	O
promote	O
endocarditis	O
.	O

We	O
evaluated	O
the	O
effects	O
of	O
special	O
oral	O
care	O
using	O
a	O
toothbrush	O
with	O
combined	O
irrigation	O
and	O
suctioning	O
functions	O
,	O
along	O
with	O
povidone	O
-	O
iodine	O
to	O
treat	O
oral	O
bacteria	O
and	O
mucositis	O
,	O
in	O
esophageal	O
cancer	O
patients	O
undergoing	O
chemoradiotherapy	O
.	O

In	O
the	O
special	O
care	O
group	O
,	O
oral	O
hygiene	O
was	O
performed	O
3	O
days	O
a	O
week	O
after	O
dinner	O
.	O

Bacteria	O
in	O
saliva	O
and	O
plague	O
samples	O
were	O
measured	O
at	O
various	O
sampling	O
points	O
after	O
chemoradiotherapy	O
.	O

The	O
incidence	O
of	O
mucositis	O
was	O
significantly	O
reduced	O
in	O
the	O
special	O
care	O
group	O
in	O
comparison	O
with	O
the	O
control	O
group	O
.	O

Total	O
streptococci	B-bacteria
were	O
significantly	O
decreased	O
in	O
the	O
opportunistic	O
pathogens	O
-	O
positive	O
and	O
lower	O
-	O
level	O
mutans	B-bacteria
streptococci	I-bacteria
control	O
group	O
during	O
chemoradiotherapy	O
,	O
but	O
they	O
were	O
not	O
reduced	O
in	O
the	O
opportunistic	O
pathogens	O
-	O
negative	O
and	O
higher	O
-	O
level	O
mutans	B-bacteria
streptococci	I-bacteria
control	O
groups	O
or	O
in	O
the	O
special	O
care	O
group	O
.	O

Our	O
results	O
showed	O
that	O
a	O
special	O
oral	O
care	O
regimen	O
enabled	O
the	O
total	O
population	O
of	O
streptococci	B-bacteria
microflora	O
to	O
remain	O
stable	O
,	O
was	O
negatively	O
correlated	O
with	O
opportunistic	O
pathogens	O
and	O
positively	O
correlated	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
infection	O
,	O
and	O
prevented	O
the	O
development	O
of	O
mucositis	O
.	O

A	O
significant	O
amount	O
of	O
evidence	O
has	O
been	O
accumulated	O
to	O
show	O
that	O
Toll	O
-	O
like	O
receptors	O
(	O
TLRs	O
)	O
function	O
as	O
sensors	O
for	O
microbial	O
invasion	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
how	O
signalling	O
triggered	O
by	O
TLRs	O
leads	O
to	O
the	O
phagocytosis	O
of	O
pathogens	O
.	O

This	O
study	O
was	O
designed	O
to	O
determine	O
whether	O
stimulation	O
of	O
TLR2	O
mainly	O
with	O
the	O
lipopeptide	O
FSL	O
-	O
1	O
plays	O
a	O
role	O
in	O
the	O
phagocytosis	O
of	O
pathogens	O
by	O
macrophages	O
.	O

FSL	O
-	O
1	O
enhanced	O
the	O
phagocytosis	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
to	O
a	O
markedly	O
greater	O
extent	O
than	O
it	O
did	O
that	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
but	O
did	O
not	O
enhance	O
the	O
phagocytosis	O
of	O
latex	O
beads	O
.	O

FSL	O
-	O
1	O
stimulation	O
resulted	O
in	O
enhanced	O
phagocytosis	O
of	O
bacteria	O
by	O
macrophages	O
from	O
TLR2	O
(	O
+	O
/	O
+	O
)	O
mice	O
but	O
not	O
by	O
those	O
from	O
TLR2	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Chinese	O
hamster	O
ovary	O
cells	O
stably	O
expressing	O
TLR2	O
failed	O
to	O
phagocytose	O
these	O
bacteria	O
,	O
but	O
the	O
cells	O
expressing	O
CD14	O
did	O
.	O

FSL	O
-	O
1	O
induced	O
upregulation	O
of	O
the	O
expression	O
of	O
phagocytic	O
receptors	O
,	O
including	O
MSR1	O
,	O
CD36	O
,	O
DC	O
-	O
SIGN	O
and	O
Dectin	O
-	O
1	O
in	O
THP	O
-	O
1	O
cells	O
.	O

Human	O
embryonic	O
kidney	O
293	O
cells	O
transfected	O
with	O
DC	O
-	O
SIGN	O
and	O
MSR1	O
phagocytosed	O
these	O
bacteria	O
.	O

These	O
results	O
suggest	O
that	O
the	O
FSL	O
-	O
1	O
-	O
induced	O
enhancement	O
of	O
phagocytosis	O
of	O
bacteria	O
by	O
macrophages	O
may	O
be	O
explained	O
partly	O
by	O
the	O
upregulation	O
of	O
scavenger	O
receptors	O
and	O
the	O
C	O
-	O
type	O
lectins	O
through	O
TLR2	O
-	O
mediated	O
signalling	O
pathways	O
,	O
and	O
that	O
TLR2	O
by	O
itself	O
does	O
not	O
function	O
as	O
a	O
phagocytic	O
receptor	O
.	O

The	O
efficacy	O
of	O
a	O
novel	O
synthetic	O
antimicrobial	O
peptide	O
(	O
WLBU2	O
)	O
was	O
evaluated	O
against	O
three	O
oral	O
microorganisms	O
(	O
grown	O
planktonically	O
)	O
:	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

WLBU2	O
killed	O
all	O
three	O
species	O
,	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
being	O
the	O
most	O
susceptible	O
.	O

WLBU2	O
also	O
reduced	O
the	O
bacterial	O
burden	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
biofilms	O
.	O

Recently	O
,	O
the	O
clinical	O
additive	O
value	O
of	O
a	O
highly	O
concentrated	O
chlorhexidine	O
(	O
CHX	O
)	O
varnish	O
,	O
when	O
applied	O
subgingivally	O
as	O
an	O
adjunct	O
to	O
scaling	O
and	O
root	O
planing	O
,	O
was	O
described	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
microbiological	O
impact	O
of	O
a	O
treatment	O
strategy	O
for	O
chronic	O
periodontitis	O
based	O
on	O
a	O
combination	O
of	O
same	O
-	O
day	O
full	O
-	O
mouth	O
root	O
planing	O
and	O
subgingival	O
CHX	O
varnish	O
administration	O
.	O

A	O
randomized	O
,	O
controlled	O
,	O
single	O
-	O
blind	O
,	O
parallel	O
trial	O
was	O
conducted	O
on	O
33	O
non	O
-	O
smoking	O
chronic	O
periodontitis	O
patients	O
.	O

The	O
control	O
group	O
received	O
oral	O
hygiene	O
instructions	O
and	O
same	O
-	O
day	O
full	O
-	O
mouth	O
root	O
planing	O
.	O

The	O
test	O
group	O
received	O
the	O
same	O
instructions	O
and	O
treatment	O
;	O
however	O
,	O
all	O
pockets	O
also	O
were	O
disinfected	O
using	O
a	O
supersaturated	O
CHX	O
varnish	O
.	O

Subgingival	O
plaque	O
samples	O
were	O
collected	O
from	O
the	O
deepest	O
site	O
per	O
quadrant	O
in	O
each	O
patient	O
at	O
baseline	O
and	O
after	O
1	O
,	O
3	O
,	O
and	O
6	O
months	O
.	O

Pooled	O
sample	O
analysis	O
was	O
performed	O
using	O
a	O
multiplex	O
polymerase	O
chain	O
reaction	O
-	O
based	O
method	O
for	O
the	O
identification	O
of	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
Aa	B-bacteria
)	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
(	O
Tf	B-bacteria
)	O
,	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
Td	B-bacteria
)	O
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
Pi	B-bacteria
)	O
.	O

In	O
terms	O
of	O
detection	O
frequency	O
and	O
bacterial	O
levels	O
,	O
significant	O
,	O
mainly	O
temporary	O
,	O
reductions	O
from	O
baseline	O
were	O
found	O
in	O
both	O
groups	O
.	O

When	O
a	O
comparison	O
was	O
made	O
between	O
the	O
control	O
and	O
the	O
test	O
group	O
,	O
significant	O
differences	O
in	O
the	O
detection	O
frequency	O
of	O
Tf	B-bacteria
(	O
P	O
=	O
0	O
.	O
024	O
)	O
and	O
Td	B-bacteria
(	O
P	O
=	O
0	O
.	O
024	O
)	O
,	O
which	O
favored	O
the	O
test	O
group	O
,	O
were	O
found	O
at	O
1	O
month	O
.	O

A	O
similar	O
phenomenon	O
was	O
seen	O
for	O
Td	B-bacteria
(	O
P	O
=	O
0	O
.	O
031	O
)	O
based	O
on	O
bacterial	O
levels	O
.	O

An	O
important	O
trend	O
toward	O
lower	O
Tf	O
levels	O
in	O
the	O
test	O
group	O
also	O
was	O
found	O
at	O
1	O
month	O
(	O
P	O
=	O
0	O
.	O
052	O
)	O
.	O

Compared	O
to	O
baseline	O
levels	O
,	O
microbiological	O
benefits	O
in	O
the	O
test	O
group	O
seemed	O
to	O
be	O
maintained	O
,	O
at	O
least	O
in	O
part	O
,	O
over	O
a	O
6	O
-	O
month	O
period	O
.	O

In	O
contrast	O
,	O
all	O
microbial	O
levels	O
had	O
relapsed	O
in	O
the	O
control	O
group	O
at	O
study	O
termination	O
.	O

The	O
microbiological	O
results	O
of	O
the	O
present	O
study	O
promote	O
the	O
subgingival	O
administration	O
of	O
a	O
highly	O
concentrated	O
CHX	O
varnish	O
as	O
an	O
adjunct	O
to	O
same	O
-	O
day	O
full	O
-	O
mouth	O
root	O
planing	O
.	O

By	O
using	O
fluorescence	O
microscopy	O
,	O
fluorescently	O
labeled	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
W50	I-bacteria
was	O
shown	O
to	O
adhere	O
to	O
oral	O
epithelial	O
(	O
KB	O
)	O
cells	O
as	O
discrete	O
cells	O
or	O
small	O
cell	O
aggregates	O
,	O
whereas	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
bound	O
as	O
large	O
cell	O
aggregates	O
.	O

Flow	O
cytometric	O
analysis	O
showed	O
that	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
W50	I-bacteria
there	O
was	O
a	O
logarithmic	O
relationship	O
between	O
the	O
bacterial	O
cell	O
ratio	O
(	O
BCR	O
)	O
,	O
that	O
is	O
the	O
number	O
of	O
bacterial	O
cells	O
to	O
KB	O
cells	O
,	O
and	O
the	O
percentage	O
of	O
KB	O
cells	O
with	O
W50	B-bacteria
cells	O
attached	O
.	O

This	O
percentage	O
of	O
KB	O
cells	O
with	O
W50	B-bacteria
attached	O
reached	O
a	O
plateau	O
of	O
approximately	O
84	O
%	O
cells	O
at	O
a	O
BCR	O
of	O
500	O
:	O
1	O
.	O

In	O
contrast	O
,	O
a	O
quadratic	O
relationship	O
was	O
observed	O
between	O
BCR	O
and	O
the	O
percentage	O
of	O
KB	O
cells	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
attached	O
,	O
reaching	O
a	O
maximum	O
of	O
47	O
%	O
at	O
a	O
BCR	O
of	O
100	O
:	O
1	O
but	O
decreasing	O
to	O
7	O
%	O
at	O
a	O
BCR	O
of	O
1	O
,	O
000	O
:	O
1	O
.	O

The	O
lower	O
binding	O
of	O
ATCC	B-bacteria
33277	I-bacteria
at	O
high	O
cell	O
concentrations	O
was	O
attributed	O
to	O
autoaggregation	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
W50	I-bacteria
cells	O
treated	O
with	O
an	O
inhibitor	O
(	O
Nalpha	O
-	O
p	O
-	O
tosyl	O
-	O
L	O
-	O
lysine	O
chloromethyl	O
ketone	O
[	O
TLCK	O
]	O
)	O
of	O
its	O
RgpA	O
-	O
Kgp	O
proteinase	O
-	O
adhesin	O
complex	O
exhibited	O
significantly	O
reduced	O
binding	O
to	O
KB	O
cells	O
than	O
to	O
untreated	O
cells	O
,	O
suggesting	O
a	O
role	O
for	O
proteinase	O
activity	O
in	O
binding	O
to	O
KB	O
cells	O
.	O

Competitive	O
inhibition	O
with	O
purified	O
proteinase	O
-	O
active	O
and	O
TLCK	O
-	O
inactivated	O
RgpA	O
-	O
Kgp	O
complex	O
significantly	O
decreased	O
the	O
adherence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
W50	I-bacteria
cells	O
to	O
KB	O
cells	O
.	O

Furthermore	O
,	O
isogenic	O
mutants	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
W50	I-bacteria
lacking	O
the	O
kgp	O
gene	O
product	O
,	O
but	O
not	O
the	O
rgpA	O
or	O
rgpB	O
gene	O
products	O
,	O
exhibited	O
significantly	O
decreased	O
adherence	O
to	O
KB	O
cells	O
compared	O
to	O
the	O
wild	O
type	O
.	O

To	O
investigate	O
the	O
molecular	O
effects	O
of	O
the	O
periodontopathogens	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
FN	B-bacteria
)	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
PG	B-bacteria
)	O
on	O
the	O
oral	O
epithelium	O
,	O
the	O
H400	O
oral	O
epithelial	O
cell	O
line	O
was	O
cultured	O
in	O
the	O
presence	O
of	O
non	O
-	O
viable	O
bacteria	O
.	O

Following	O
confirmation	O
of	O
the	O
presence	O
of	O
transcripts	O
for	O
the	O
bacterial	O
pattern	O
recognition	O
receptors	O
in	O
H400	O
cells	O
,	O
Toll	O
-	O
like	O
receptors	O
-	O
2	O
,	O
-	O
4	O
and	O
-	O
9	O
,	O
and	O
components	O
of	O
the	O
NF	O
-	O
kappaB	O
signalling	O
pathway	O
,	O
immunocytochemical	O
analyses	O
were	O
performed	O
showing	O
that	O
NF	O
-	O
kappaB	O
was	O
activated	O
within	O
1	O
h	O
of	O
exposure	O
to	O
both	O
periodontopathogens	O
.	O

A	O
significantly	O
greater	O
number	O
of	O
NF	O
-	O
kappaB	O
nuclear	O
translocations	O
were	O
apparent	O
following	O
H400	O
cell	O
exposure	O
to	O
FN	B-bacteria
as	O
compared	O
with	O
PG	B-bacteria
.	O

Gene	O
expression	O
analyses	O
indicated	O
that	O
transcripts	O
known	O
to	O
be	O
regulated	O
by	O
the	O
NF	O
-	O
kappaB	O
pathway	O
,	O
including	O
cytokines	O
/	O
chemokines	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
8	O
,	O
MCP	O
-	O
1	O
/	O
CCL2	O
and	O
GM	O
-	O
CSF	O
,	O
were	O
up	O
-	O
regulated	O
following	O
4	O
and	O
24	O
h	O
of	O
exposure	O
to	O
both	O
periodontopathogens	O
.	O

In	O
addition	O
,	O
H400	O
periodontopathogen	O
exposure	O
resulted	O
in	O
differential	O
regulation	O
of	O
transcripts	O
for	O
several	O
cytokeratin	O
gene	O
family	O
members	O
.	O

Consistent	O
with	O
the	O
immunocytochemical	O
data	O
,	O
microarray	O
results	O
indicated	O
that	O
FN	B-bacteria
induced	O
a	O
greater	O
number	O
of	O
gene	O
expression	O
changes	O
than	O
PG	B-bacteria
following	O
24	O
h	O
of	O
exposure	O
,	O
609	O
and	O
409	O
genes	O
,	O
respectively	O
.	O

Ninety	O
-	O
one	O
genes	O
were	O
commonly	O
differentially	O
expressed	O
by	O
both	O
periodontopathogens	O
and	O
represented	O
biological	O
processes	O
commonly	O
associated	O
with	O
periodontitis	O
.	O

Gene	O
expression	O
analyses	O
by	O
reserve	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
of	O
molecules	O
identified	O
from	O
the	O
microarray	O
data	O
sets	O
,	O
including	O
Heme	O
oxygenase	O
-	O
1	O
,	O
lysyl	O
oxidase	O
,	O
SOD2	O
,	O
CCL20	O
and	O
calprotectin	O
components	O
,	O
confirmed	O
their	O
differential	O
expression	O
profiles	O
induced	O
by	O
the	O
two	O
periodontopathogens	O
.	O

FN	B-bacteria
and	O
PG	B-bacteria
have	O
clearly	O
different	O
molecular	O
effects	O
on	O
oral	O
epithelial	O
cells	O
,	O
potentially	O
highlighting	O
the	O
importance	O
of	O
the	O
composition	O
of	O
the	O
plaque	O
biofilm	O
in	O
periodontitis	O
pathogenesis	O
.	O

In	O
2002	O
we	O
investigated	O
an	O
outbreak	O
comprising	O
231	O
patients	O
in	O
Norway	O
,	O
caused	O
by	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
linked	O
to	O
the	O
use	O
of	O
contaminated	O
mouth	O
swabs	O
called	O
Dent	O
-	O
O	O
-	O
Sept	O
.	O

Here	O
we	O
describe	O
the	O
extent	O
of	O
contamination	O
of	O
the	O
swabs	O
,	O
and	O
identify	O
critical	O
points	O
in	O
the	O
production	O
process	O
that	O
made	O
the	O
contamination	O
possible	O
,	O
in	O
order	O
to	O
prevent	O
future	O
outbreaks	O
.	O

Environmental	O
investigation	O
with	O
microbiological	O
examination	O
of	O
production	O
,	O
ingredients	O
and	O
product	O
,	O
molecular	O
typing	O
of	O
bacteria	O
and	O
a	O
system	O
audit	O
of	O
production	O
.	O

Of	O
the	O
1565	O
swabs	O
examined	O
from	O
149	O
different	O
production	O
batches	O
the	O
outbreak	O
strain	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
was	O
detected	O
in	O
76	O
swabs	O
from	O
12	O
batches	O
produced	O
in	O
2001	O
and	O
2002	O
.	O

In	O
total	O
more	O
than	O
250	O
swabs	O
were	O
contaminated	O
with	O
one	O
or	O
more	O
microbial	O
species	O
.	O

P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
was	O
detected	O
from	O
different	O
spots	O
along	O
the	O
production	O
line	O
.	O

The	O
audit	O
revealed	O
serious	O
breeches	O
of	O
production	O
regulations	O
.	O

Health	O
care	O
institutions	O
reported	O
non	O
-	O
proper	O
use	O
of	O
the	O
swabs	O
and	O
weaknesses	O
in	O
their	O
purchasing	O
systems	O
.	O

Biofilm	O
formation	O
in	O
the	O
wet	O
part	O
of	O
the	O
production	O
is	O
the	O
most	O
plausible	O
explanation	O
for	O
the	O
continuous	O
contamination	O
of	O
the	O
swabs	O
with	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
over	O
a	O
period	O
of	O
at	O
least	O
30	O
weeks	O
.	O

When	O
not	O
abiding	O
to	O
production	O
regulations	O
fatal	O
consequences	O
for	O
the	O
users	O
may	O
ensue	O
.	O

For	O
the	O
most	O
vulnerable	O
patient	O
groups	O
only	O
documented	O
quality	O
-	O
controlled	O
,	O
high	O
-	O
level	O
disinfected	O
products	O
and	O
items	O
should	O
be	O
used	O
in	O
the	O
oropharynx	O
.	O

The	O
DNA	O
sequence	O
flanking	O
a	O
tet	O
(	O
W	O
)	O
gene	O
in	O
an	O
oral	O
Rothia	B-bacteria
sp	I-bacteria
.	I-bacteria
was	O
determined	O
.	O

The	O
gene	O
was	O
linked	O
to	O
two	O
different	O
transposases	O
,	O
and	O
these	O
were	O
flanked	O
by	O
two	O
almost	O
identical	O
mef	O
(	O
macrolide	O
efflux	O
)	O
genes	O
.	O

This	O
structure	O
was	O
found	O
in	O
4	O
out	O
of	O
20	O
tet	O
(	O
W	O
)	O
-	O
containing	O
oral	O
bacteria	O
investigated	O
.	O

Uncaria	O
tomentosa	O
is	O
considered	O
a	O
medicinal	O
plant	O
used	O
over	O
centuries	O
by	O
the	O
peruvian	O
population	O
as	O
an	O
alternative	O
treatment	O
for	O
several	O
diseases	O
.	O

Many	O
microorganisms	O
usually	O
inhabit	O
the	O
human	O
oral	O
cavity	O
and	O
under	O
certain	O
conditions	O
can	O
become	O
etiologic	O
agents	O
of	O
diseases	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
antimicrobial	O
activity	O
of	O
different	O
concentrations	O
of	O
Uncaria	O
tomentosa	O
on	O
different	O
strains	O
of	O
microorganisms	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
.	O

Micropulverized	O
Uncaria	O
tomentosa	O
was	O
tested	O
in	O
vitro	O
to	O
determine	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
on	O
selected	O
microbial	O
strains	O
.	O

The	O
tested	O
strains	O
were	O
oral	O
clinical	O
isolates	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Candida	O
albicans	O
,	O
Enterobacteriaceae	B-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

The	O
tested	O
concentrations	O
of	O
Uncaria	O
tomentosa	O
ranged	O
from	O
0	O
.	O
25	O
-	O
5	O
%	O
in	O
Mueller	O
-	O
Hinton	O
agar	O
.	O

Three	O
percent	O
Uncaria	O
tomentosa	O
inhibited	O
8	O
%	O
of	O
Enterobacteriaceae	B-bacteria
isolates	I-bacteria
,	O
52	O
%	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
96	O
%	O
of	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	O

The	O
tested	O
concentrations	O
did	O
not	O
present	O
inhibitory	O
effect	O
on	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
and	O
C	O
.	O
albicans	O
.	O

It	O
could	O
be	O
concluded	O
that	O
micropulverized	O
Uncaria	O
tomentosa	O
presented	O
antimicrobial	O
activity	O
on	O
Enterobacteriaceae	B-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
isolates	I-bacteria
.	O

In	O
addition	O
to	O
saliva	O
,	O
other	O
oral	O
components	O
such	O
as	O
gingival	O
crevicular	O
fluid	O
,	O
epithelial	O
cells	O
,	O
bacteria	O
,	O
breath	O
,	O
and	O
dental	O
plaque	O
have	O
diagnostic	O
potential	O
.	O

For	O
oral	O
diseases	O
such	O
as	O
caries	O
and	O
periodontal	O
disease	O
,	O
visual	O
diagnosis	O
is	O
usually	O
adequate	O
,	O
but	O
objective	O
diagnostic	O
tests	O
with	O
predictive	O
value	O
are	O
desired	O
.	O

Therefore	O
,	O
prediction	O
models	O
like	O
the	O
Cariogram	O
have	O
been	O
developed	O
that	O
also	O
include	O
oral	O
aspects	O
such	O
as	O
saliva	O
secretion	O
,	O
buffering	O
capacity	O
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
for	O
the	O
prediction	O
of	O
caries	O
.	O

Correlation	O
studies	O
on	O
salivary	O
components	O
and	O
caries	O
have	O
not	O
been	O
conclusive	O
,	O
but	O
correlation	O
studies	O
on	O
functional	O
aspects	O
,	O
such	O
as	O
saliva	O
-	O
induced	O
bacterial	O
aggregation	O
and	O
caries	O
,	O
look	O
promising	O
.	O

Modern	O
proteomic	O
techniques	O
make	O
it	O
possible	O
to	O
study	O
simultaneously	O
the	O
many	O
salivary	O
components	O
involved	O
in	O
these	O
functions	O
.	O

Neutrophils	O
,	O
monocytes	O
,	O
and	O
dendritic	O
cells	O
(	O
DC	O
)	O
are	O
phenotypically	O
and	O
functionally	O
related	O
phagocytes	O
whose	O
presence	O
in	O
infected	O
tissues	O
is	O
critical	O
to	O
host	O
survival	O
.	O

Their	O
overlapping	O
expression	O
pattern	O
of	O
surface	O
molecules	O
,	O
the	O
differentiation	O
capacity	O
of	O
monocytes	O
,	O
and	O
the	O
presence	O
of	O
monocyte	O
subsets	O
underscores	O
the	O
complexity	O
of	O
understanding	O
the	O
role	O
of	O
these	O
cells	O
during	O
infection	O
.	O

In	O
this	O
study	O
we	O
use	O
five	O
-	O
to	O
seven	O
-	O
color	O
flow	O
cytometry	O
to	O
assess	O
the	O
phenotype	O
and	O
function	O
of	O
monocytes	O
recruited	O
to	O
Peyer	O
'	O
s	O
patches	O
(	O
PP	O
)	O
and	O
mesenteric	O
lymph	O
nodes	O
(	O
MLN	O
)	O
after	O
oral	O
Salmonella	B-bacteria
infection	O
of	O
mice	O
.	O

The	O
data	O
show	O
that	O
CD68	O
(	O
high	O
)	O
Gr	O
-	O
1	O
(	O
int	O
)	O
(	O
intermediate	O
)	O
monocytes	O
,	O
along	O
with	O
CD68	O
(	O
int	O
)	O
Gr	O
-	O
1	O
(	O
high	O
)	O
neutrophils	O
,	O
rapidly	O
accumulate	O
in	O
PP	O
and	O
MLN	O
.	O

The	O
monocytes	O
have	O
increased	O
MHC	O
-	O
II	O
and	O
costimulatory	O
molecule	O
expression	O
and	O
,	O
in	O
contrast	O
to	O
neutrophils	O
and	O
DC	O
,	O
produce	O
inducible	O
NO	O
synthase	O
.	O

Although	O
neutrophils	O
and	O
monocytes	O
from	O
infected	O
mice	O
produce	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
1beta	O
upon	O
ex	O
vivo	O
culture	O
,	O
DC	O
do	O
not	O
.	O

In	O
addition	O
,	O
although	O
recruited	O
monocytes	O
internalize	O
Salmonella	B-bacteria
in	O
vitro	O
and	O
in	O
vivo	O
they	O
did	O
not	O
induce	O
the	O
proliferation	O
of	O
OT	O
-	O
II	O
CD4	O
(	O
+	O
)	O
T	O
cells	O
after	O
coincubation	O
with	O
Salmonella	B-bacteria
expressing	O
OVA	O
despite	O
their	O
ability	O
to	O
activate	O
OT	O
-	O
II	O
cells	O
when	O
pulsed	O
with	O
the	O
OVA	O
(	O
323	O
-	O
339	O
)	O
peptide	O
.	O

We	O
also	O
show	O
that	O
recruited	O
monocytes	O
enter	O
the	O
PP	O
of	O
infected	O
mice	O
independently	O
of	O
the	O
mucosal	O
address	O
in	O
cell	O
adhesion	O
molecule	O
-	O
1	O
(	O
MAdCAM	O
-	O
1	O
)	O
.	O

Finally	O
,	O
recruited	O
but	O
not	O
resident	O
monocytes	O
increase	O
in	O
the	O
blood	O
of	O
orally	O
infected	O
mice	O
,	O
and	O
MHC	O
-	O
II	O
up	O
-	O
regulation	O
,	O
but	O
not	O
TNF	O
-	O
alpha	O
or	O
iNOS	O
production	O
,	O
occur	O
already	O
in	O
the	O
blood	O
.	O

These	O
studies	O
are	O
the	O
first	O
to	O
describe	O
the	O
accumulation	O
and	O
function	O
of	O
monocyte	O
subsets	O
in	O
the	O
blood	O
and	O
GALT	O
during	O
oral	O
Salmonella	B-bacteria
infection	O
.	O

Cystic	O
fibrosis	O
(	O
CF	O
)	O
patients	O
who	O
are	O
chronically	O
infected	O
with	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
make	O
serum	O
antibodies	O
to	O
bacterial	O
surface	O
LPS	O
as	O
well	O
as	O
other	O
pseudomonas	B-bacteria
antigens	O
.	O

This	O
study	O
investigated	O
the	O
feasibility	O
of	O
using	O
oral	O
fluid	O
samples	O
for	O
the	O
detection	O
of	O
pseudomonas	B-bacteria
antibodies	O
in	O
CF	O
patients	O
and	O
compared	O
these	O
results	O
with	O
corresponding	O
serum	O
antibodies	O
.	O

Most	O
strains	O
of	O
P	O
.	O
aeruginosa	O
produce	O
two	O
forms	O
of	O
LPS	O
molecule	O
,	O
termed	O
A	O
-	O
band	O
(	O
described	O
as	O
a	O
common	O
antigen	O
)	O
and	O
B	O
-	O
band	O
(	O
O	O
-	O
serotype	O
-	O
specific	O
antigen	O
)	O
,	O
apparently	O
bound	O
to	O
a	O
common	O
core	O
oligosaccharide	O
moiety	O
.	O

A	O
-	O
band	O
LPS	O
was	O
demonstrated	O
in	O
45	O
out	O
of	O
49	O
clinical	O
isolates	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
by	O
SDS	O
-	O
PAGE	O
and	O
immunoblotting	O
with	O
a	O
specific	O
antibody	O
.	O

Oral	O
fluids	O
were	O
collected	O
from	O
17	O
adult	O
CF	O
patients	O
,	O
all	O
of	O
whom	O
were	O
sputum	O
culture	O
positive	O
for	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
13	O
also	O
provided	O
serum	O
samples	O
)	O
,	O
11	O
primary	O
ciliary	O
dyskinesia	O
(	O
PCD	O
)	O
patients	O
and	O
37	O
healthy	O
volunteers	O
.	O

Antibodies	O
to	O
A	O
-	O
band	O
LPS	O
were	O
detected	O
by	O
immunoblotting	O
in	O
all	O
of	O
the	O
CF	O
patients	O
'	O
oral	O
fluids	O
but	O
10	O
of	O
the	O
volunteer	O
samples	O
gave	O
weak	O
reactions	O
with	O
immunoblotting	O
.	O

Six	O
of	O
the	O
PCD	O
patients	O
gave	O
a	O
weak	O
reaction	O
with	O
A	O
-	O
band	O
antibodies	O
and	O
only	O
one	O
demonstrated	O
antibodies	O
to	O
core	O
LPS	O
.	O

In	O
a	O
quantitative	O
ELISA	O
,	O
15	O
of	O
the	O
17	O
CF	O
patients	O
'	O
oral	O
fluids	O
were	O
shown	O
to	O
contain	O
antibodies	O
to	O
A	O
-	O
band	O
LPS	O
,	O
whilst	O
none	O
of	O
the	O
volunteer	O
samples	O
contained	O
antibodies	O
to	O
A	O
-	O
band	O
LPS	O
.	O

All	O
serum	O
samples	O
from	O
the	O
CF	O
patients	O
were	O
positive	O
by	O
both	O
methods	O
.	O

Thus	O
this	O
is	O
a	O
sensitive	O
procedure	O
for	O
the	O
detection	O
of	O
antibodies	O
to	O
A	O
-	O
band	O
LPS	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
in	O
oral	O
fluid	O
and	O
serum	O
from	O
patients	O
with	O
CF	O
.	O

Interactions	O
between	O
oral	O
bacteria	O
and	O
gingival	O
epithelial	O
cells	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
diseases	O
.	O

This	O
study	O
used	O
in	O
situ	O
hybridization	O
with	O
16	O
rRNA	O
probes	O
and	O
confocal	O
microscopy	O
to	O
detect	O
the	O
periodontal	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
within	O
epithelial	O
cells	O
from	O
periodontal	O
pockets	O
,	O
gingival	O
crevice	O
,	O
and	O
buccal	O
mucosa	O
collected	O
from	O
subjects	O
with	O
chronic	O
periodontitis	O
(	O
n	O
=	O
14	O
)	O
and	O
good	O
periodontal	O
health	O
(	O
n	O
=	O
8	O
)	O
.	O

Each	O
green	O
fluorescent	O
species	O
-	O
specific	O
and	O
universal	O
probe	O
was	O
hybridized	O
with	O
all	O
58	O
epithelial	O
samples	O
from	O
the	O
22	O
patients	O
.	O

The	O
samples	O
were	O
observed	O
by	O
confocal	O
microscopy	O
to	O
confirm	O
the	O
intracellular	O
localization	O
of	O
oral	O
species	O
of	O
bacteria	O
.	O

The	O
mean	O
frequency	O
of	O
detection	O
and	O
number	O
of	O
intracellular	O
bacteria	O
per	O
epithelial	O
cell	O
were	O
computed	O
for	O
each	O
sample	O
.	O

The	O
frequency	O
of	O
cells	O
with	O
internalized	O
bacteria	O
was	O
higher	O
in	O
samples	O
from	O
the	O
gingival	O
crevice	O
than	O
in	O
samples	O
from	O
the	O
oral	O
mucosa	O
.	O

Epithelial	O
cells	O
from	O
all	O
subjects	O
harbored	O
intracellular	O
bacteria	O
;	O
however	O
,	O
patients	O
with	O
periodontitis	O
presented	O
significantly	O
higher	O
counts	O
of	O
bacteria	O
per	O
cell	O
than	O
periodontally	O
healthy	O
individuals	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Periodontal	O
pathogens	O
showed	O
a	O
trend	O
to	O
be	O
detected	O
in	O
higher	O
numbers	O
in	O
epithelial	O
cells	O
from	O
periodontitis	O
patients	O
.	O

In	O
particular	O
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
significantly	O
more	O
prevalent	O
in	O
periodontal	O
pocket	O
cells	O
than	O
healthy	O
sulci	O
and	O
buccal	O
cell	O
samples	O
in	O
the	O
periodontitis	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Those	O
findings	O
indicate	O
that	O
crevicular	O
and	O
buccal	O
cells	O
present	O
internalized	O
bacteria	O
,	O
regardless	O
of	O
periodontal	O
status	O
.	O

However	O
,	O
higher	O
bacterial	O
loads	O
are	O
detected	O
in	O
cells	O
from	O
subjects	O
with	O
periodontitis	O
.	O

Clinical	O
,	O
epidemiological	O
and	O
microbiological	O
examinations	O
of	O
adult	O
patients	O
with	O
periodontal	O
disease	O
.	O

The	O
study	O
of	O
population	O
consisted	O
of	O
21	O
subjects	O
(	O
13	O
female	O
and	O
8	O
male	O
)	O
aged	O
38	O
-	O
58	O
years	O
,	O
treated	O
in	O
the	O
Outpatient	O
Department	O
of	O
Periodontology	O
.	O

Dental	O
examinations	O
were	O
performed	O
at	O
an	O
artificial	O
light	O
and	O
using	O
a	O
WHO	O
periodontometer	O
,	O
a	O
mirror	O
and	O
a	O
probe	O
.	O

Periodontal	O
status	O
was	O
assessed	O
by	O
determination	O
of	O
the	O
probing	O
pocket	O
depth	O
(	O
CPI	O
)	O
,	O
gingival	O
state	O
(	O
GSBI	O
according	O
to	O
Muhlemann	O
and	O
Son	O
)	O
,	O
and	O
oral	O
hygiene	O
index	O
(	O
according	O
to	O
Silness	O
and	O
Loe	O
)	O
.	O

Material	O
for	O
microbiological	O
examination	O
was	O
collected	O
from	O
subgingival	O
and	O
supragingival	O
plaques	O
of	O
each	O
patient	O
.	O

Additionally	O
,	O
pus	O
was	O
obtained	O
from	O
8	O
patients	O
and	O
periodontal	O
pocket	O
fluid	O
from	O
2	O
patients	O
.	O

The	O
samples	O
were	O
examined	O
for	O
the	O
presence	O
of	O
aerobic	O
and	O
anaerobic	O
bacteria	O
and	O
Candida	O
yeasts	O
.	O

Standard	O
procedures	O
were	O
used	O
for	O
culture	O
and	O
identification	O
of	O
bacteria	O
and	O
fungi	O
.	O

Candida	O
yeasts	O
were	O
not	O
isolated	O
from	O
adults	O
with	O
periodontal	O
disease	O
.	O

In	O
19	O
/	O
21	O
patients	O
,	O
cultures	O
of	O
both	O
aerobic	O
and	O
anaerobic	O
bacteria	O
from	O
subgingival	O
and	O
supragingival	O
plaque	O
samples	O
were	O
positive	O
.	O

A	O
total	O
of	O
42	O
bacterial	O
strains	O
were	O
isolated	O
from	O
subgingival	O
plaques	O
,	O
of	O
which	O
24	O
(	O
57	O
.	O
1	O
%	O
)	O
belonged	O
to	O
7	O
anaerobic	O
species	O
and	O
18	O
(	O
42	O
.	O
9	O
%	O
)	O
to	O
12	O
aerobic	O
species	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

There	O
were	O
more	O
aerobic	O
(	O
33	O
/	O
53	O
;	O
62	O
.	O
3	O
%	O
)	O
than	O
anaerobic	O
bacteria	O
(	O
20	O
/	O
53	O
;	O
37	O
.	O
7	O
%	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
supragingival	O
plaques	O
.	O

Anaerobes	O
were	O
isolated	O
more	O
frequently	O
than	O
aerobes	O
from	O
the	O
abscess	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

1	O
)	O
In	O
adult	O
patients	O
with	O
periodontal	O
disease	O
,	O
Gram	O
-	O
positive	O
anaerobes	O
,	O
including	O
Peptostreptococcus	B-bacteria
,	O
were	O
the	O
predominant	O
bacteria	O
in	O
the	O
subgingival	O
plaque	O
.	O

2	O
)	O
While	O
in	O
the	O
supragingival	O
plaque	O
,	O
Gram	O
-	O
positive	O
aerobic	O
cocci	O
(	O
Streptococcus	B-bacteria
and	O
Staphylococcus	B-bacteria
)	O
were	O
predominant	O
.	O

Determination	O
of	O
bacterial	O
composition	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
removable	O
dentures	O
and	O
with	O
own	O
dentition	O
(	O
without	O
dentures	O
)	O
.	O

Bacteriological	O
investigations	O
were	O
performed	O
in	O
55	O
patients	O
from	O
the	O
department	O
of	O
internal	O
medicine	O
(	O
32	O
diabetic	O
patients	O
)	O
and	O
40	O
patients	O
treated	O
in	O
surgical	O
department	O
(	O
25	O
patients	O
with	O
malignancy	O
)	O
.	O

Palate	O
mucosa	O
and	O
tongue	O
dorsa	O
swabs	O
were	O
collected	O
from	O
two	O
groups	O
of	O
patients	O
,	O
and	O
additionally	O
swabs	O
from	O
mucosal	O
part	O
of	O
denture	O
surfaces	O
in	O
prosthetic	O
patients	O
.	O

Cultures	O
in	O
oxygenic	O
and	O
microaerophilic	O
(	O
5	O
%	O
CO2	O
)	O
conditions	O
were	O
conducted	O
on	O
solid	O
non	O
-	O
selective	O
and	O
selective	O
media	O
as	O
well	O
as	O
media	O
enriched	O
with	O
5	O
%	O
sheep	O
blood	O
.	O

Standard	O
procedures	O
of	O
bacterial	O
culture	O
and	O
identification	O
were	O
applied	O
.	O

Among	O
95	O
of	O
examined	O
patients	O
,	O
57	O
(	O
60	O
.	O
0	O
%	O
)	O
with	O
removable	O
dentures	O
and	O
38	O
(	O
40	O
.	O
0	O
%	O
)	O
had	O
their	O
own	O
dentition	O
.	O

As	O
far	O
as	O
prosthetic	O
patients	O
were	O
concerned	O
,	O
the	O
rate	O
of	O
bacterial	O
isolations	O
from	O
palate	O
,	O
tongue	O
dorsa	O
and	O
denture	O
plaque	O
swabs	O
were	O
generally	O
comparable	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
;	O
in	O
number	O
and	O
species	O
compositions	O
.	O

Statistically	O
significant	O
differences	O
were	O
observed	O
in	O
the	O
bacterial	O
composition	O
of	O
denture	O
plaques	O
,	O
palate	O
and	O
tongue	O
dorsa	O
in	O
patients	O
with	O
and	O
without	O
abdominal	O
cancers	O
.	O

Patients	O
without	O
cancer	O
did	O
not	O
reveal	O
staphylococci	B-bacteria
and	O
enteric	O
bacteria	O
in	O
the	O
samples	O
from	O
a	O
various	O
sites	O
of	O
their	O
oral	O
cavities	O
.	O

These	O
bacteria	O
were	O
most	O
common	O
in	O
cancer	O
patients	O
.	O

Similar	O
(	O
in	O
number	O
and	O
species	O
)	O
composition	O
of	O
bacteria	O
occurred	O
in	O
palate	O
and	O
tongue	O
swabs	O
in	O
patients	O
without	O
dentures	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
incidence	O
rate	O
of	O
aerobic	O
bacteria	O
in	O
denture	O
plaques	O
and	O
palatal	O
mucosa	O
of	O
patients	O
with	O
(	O
37	O
/	O
57	O
;	O
64	O
.	O
9	O
%	O
)	O
and	O
without	O
(	O
20	O
/	O
57	O
;	O
35	O
.	O
1	O
%	O
)	O
denture	O
associated	O
stomatitis	O
were	O
comparable	O
(	O
except	O
for	O
Neisseria	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
.	O

1	O
)	O
Generally	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
species	O
composition	O
of	O
bacteria	O
isolated	O
from	O
the	O
hard	O
palate	O
and	O
tongue	O
dorsa	O
in	O
patients	O
with	O
and	O
without	O
removable	O
dentures	O
.	O

2	O
)	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Gram	O
-	O
negative	O
enteric	O
bacilli	O
were	O
isolated	O
more	O
often	O
from	O
denture	O
plaque	O
,	O
palate	O
and	O
tongue	O
dorsa	O
of	O
cancer	O
patients	O
than	O
from	O
patients	O
without	O
cancer	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

3	O
)	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
isolated	O
more	O
frequently	O
from	O
denture	O
plaques	O
of	O
diabetic	O
patients	O
compared	O
with	O
non	O
-	O
diabetic	O
patients	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

4	O
)	O
No	O
significant	O
differences	O
observed	O
in	O
isolation	O
frequencies	O
(	O
%	O
)	O
of	O
aerobic	O
bacteria	O
in	O
denture	O
plaques	O
and	O
palatal	O
mucosa	O
of	O
patients	O
with	O
and	O
without	O
denture	O
associated	O
stomatitis	O
.	O

To	O
evaluate	O
the	O
hypothesis	O
that	O
food	O
-	O
borne	O
viable	O
Enterococcus	B-bacteria
faecalis	I-bacteria
cells	O
could	O
enter	O
the	O
root	O
canal	O
space	O
via	O
coronal	O
leakage	O
.	O

In	O
a	O
simulated	O
oral	O
environment	O
under	O
mastication	O
the	O
capacity	O
of	O
a	O
calcium	O
sulphate	O
-	O
based	O
temporary	O
filling	O
material	O
(	O
Cavit	O
W	O
)	O
to	O
prevent	O
leakage	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
from	O
a	O
cheese	O
through	O
the	O
endodontic	O
access	O
cavity	O
into	O
the	O
pulp	O
chamber	O
was	O
assessed	O
.	O

Standardized	O
class	O
I	O
access	O
cavities	O
were	O
prepared	O
in	O
human	O
maxillary	O
molars	O
.	O

These	O
were	O
filled	O
with	O
Cavit	O
of	O
either	O
2	O
or	O
4	O
mm	O
thickness	O
(	O
n	O
=	O
16	O
,	O
each	O
)	O
.	O

Empty	O
access	O
cavities	O
served	O
as	O
positive	O
,	O
teeth	O
filled	O
with	O
a	O
light	O
-	O
curing	O
composite	O
material	O
acted	O
as	O
negative	O
controls	O
(	O
n	O
=	O
8	O
,	O
each	O
)	O
.	O

A	O
cheese	O
containing	O
viable	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
cells	O
was	O
placed	O
on	O
the	O
occlusal	O
aspects	O
of	O
test	O
and	O
control	O
teeth	O
,	O
which	O
were	O
subsequently	O
subjected	O
to	O
680	O
mastication	O
loads	O
per	O
day	O
for	O
1	O
week	O
in	O
a	O
masticator	O
device	O
perfused	O
with	O
artificial	O
saliva	O
at	O
37	O
degrees	O
C	O
.	O
Leakage	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
from	O
the	O
cheese	O
into	O
the	O
pulp	O
chamber	O
was	O
assessed	O
by	O
culture	O
on	O
a	O
kanamycin	O
aesculin	O
azide	O
agar	O
and	O
compared	O
between	O
groups	O
using	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

All	O
of	O
the	O
positive	O
controls	O
showed	O
pure	O
growth	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
.	O

In	O
addition	O
,	O
one	O
of	O
the	O
negative	O
control	O
teeth	O
leaked	O
.	O

The	O
4	O
mm	O
application	O
of	O
Cavit	O
prevented	O
leakage	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
significantly	O
better	O
than	O
the	O
corresponding	O
2	O
mm	O
application	O
:	O
1	O
of	O
16	O
specimens	O
compared	O
with	O
6	O
of	O
16	O
specimens	O
had	O
leakage	O
,	O
respectively	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
current	O
results	O
substantiate	O
the	O
suspicion	O
that	O
food	O
-	O
derived	O
microbiota	O
could	O
enter	O
the	O
necrotic	O
root	O
canal	O
system	O
via	O
microleakage	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluated	O
the	O
prevalence	O
rate	O
of	O
oral	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
(	O
VGS	B-bacteria
)	O
and	O
their	O
susceptibilities	O
to	O
some	O
antibiotics	O
in	O
healthy	O
children	O
.	O

Samples	O
of	O
pharyngeal	O
swabs	O
and	O
supragingival	O
dental	O
plaques	O
for	O
microbiological	O
studies	O
were	O
collected	O
from	O
206	O
healthy	O
children	O
,	O
aged	O
4	O
-	O
18	O
years	O
.	O

Additionally	O
,	O
75	O
samples	O
of	O
carious	O
lesions	O
from	O
children	O
with	O
dental	O
caries	O
were	O
included	O
.	O

The	O
streptococci	B-bacteria
were	O
isolated	O
and	O
identified	O
using	O
standard	O
methods	O
and	O
commercial	O
identification	O
kits	O
.	O

For	O
performance	O
of	O
antibacterial	O
susceptibility	O
testing	O
of	O
VGS	B-bacteria
strains	I-bacteria
disk	O
diffusion	O
and	O
/	O
or	O
breakpoints	O
procedures	O
were	O
used	O
according	O
to	O
NCCLS	O
standards	O
and	O
criteria	O
.	O

A	O
total	O
of	O
425	O
VGS	B-bacteria
strains	I-bacteria
were	O
tested	O
against	O
penicillin	O
,	O
ampicillin	O
,	O
erythromycin	O
,	O
clindamycin	O
,	O
tetracycline	O
,	O
doxycycline	O
,	O
ciprofloxacin	O
and	O
vancomycin	O
.	O

A	O
total	O
of	O
239	O
VGS	B-bacteria
strains	I-bacteria
belonging	O
to	O
8	O
species	O
from	O
pharyngeal	O
swabs	O
of	O
192	O
(	O
93	O
.	O
2	O
%	O
)	O
children	O
were	O
isolated	O
.	O

VGS	B-bacteria
strains	I-bacteria
from	O
supragingival	O
plaques	O
were	O
isolated	O
in	O
149	O
(	O
72	O
.	O
3	O
%	O
)	O
healthy	O
children	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
from	O
carious	O
lesions	O
in	O
37	O
(	O
49	O
.	O
3	O
%	O
)	O
children	O
with	O
dental	O
caries	O
.	O

VGS	B-bacteria
strains	I-bacteria
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
species	I-bacteria
were	O
isolated	O
most	O
frequently	O
from	O
4	O
-	O
5	O
year	O
old	O
as	O
compared	O
to	O
12	O
and	O
18	O
year	O
old	O
children	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
while	O
S	B-bacteria
.	I-bacteria
vestibularis	I-bacteria
strains	I-bacteria
isolated	O
most	O
often	O
in	O
12	O
year	O
old	O
ones	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Among	O
425	O
VGS	B-bacteria
strains	I-bacteria
,	O
high	O
level	O
of	O
penicillin	O
resistance	O
(	O
MIC	O
>	O
or	O
=	O
2	O
.	O
0	O
mg	O
/	O
L	O
)	O
was	O
shown	O
in	O
71	O
(	O
16	O
.	O
7	O
%	O
)	O
strains	O
,	O
33	O
(	O
46	O
.	O
5	O
%	O
)	O
of	O
them	O
belonged	O
to	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
species	I-bacteria
.	O

VGS	B-bacteria
strains	I-bacteria
were	O
also	O
resistant	O
to	O
erythromycin	O
(	O
23	O
.	O
5	O
%	O
)	O
,	O
clindamycin	O
(	O
23	O
.	O
1	O
%	O
)	O
,	O
tetracyclines	O
(	O
T	O
-	O
52	O
%	O
,	O
DOX	O
-	O
16	O
%	O
)	O
,	O
gentamycin	O
(	O
25	O
.	O
9	O
%	O
)	O
and	O
ciprofloxacin	O
(	O
55	O
.	O
2	O
%	O
)	O
.	O

All	O
VGS	B-bacteria
strains	I-bacteria
were	O
vancomycin	O
-	O
susceptible	O
.	O

1	O
.	O
In	O
the	O
oral	O
cavities	O
of	O
healthy	O
children	O
,	O
approximately	O
98	O
%	O
of	O
streptococci	B-bacteria
belonged	O
to	O
two	O
VGS	B-bacteria
groups	O
,	O
i	O
.	O
e	O
.	O
mitis	B-bacteria
and	I-bacteria
salivarius	I-bacteria
groups	I-bacteria
.	O

Streptococci	B-bacteria
of	I-bacteria
mutans	I-bacteria
and	I-bacteria
anginosus	I-bacteria
groups	I-bacteria
were	O
isolated	O
sporadically	O
(	O
2	O
%	O
)	O
.	O

2	O
.	O

We	O
observed	O
difference	O
in	O
susceptibility	O
to	O
penicillin	O
and	O
other	O
antibiotics	O
between	O
the	O
various	O
species	O
of	O
viridans	B-bacteria
groups	I-bacteria
streptococci	I-bacteria
.	O

Mitis	I-bacteria
group	I-bacteria
strains	I-bacteria
(	O
except	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
)	O
were	O
more	O
frequently	O
penicillin	O
-	O
resistant	O
(	O
23	O
%	O
)	O
in	O
comparison	O
to	O
salivarius	O
group	O
of	O
VGS	B-bacteria
strains	I-bacteria
(	O
9	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
.	O

Respiratory	O
infection	O
is	O
a	O
major	O
cause	O
of	O
death	O
in	O
the	O
elderly	O
.	O

We	O
have	O
evaluated	O
the	O
role	O
of	O
professional	O
oral	O
health	O
care	O
(	O
POHC	O
)	O
by	O
dental	O
hygienists	O
in	O
reducing	O
respiratory	O
infections	O
in	O
elderly	O
persons	O
requiring	O
nursing	O
care	O
.	O

Two	O
populations	O
of	O
elderly	O
persons	O
,	O
one	O
receiving	O
POHC	O
and	O
one	O
not	O
,	O
were	O
examined	O
to	O
determine	O
numbers	O
of	O
microorganisms	O
,	O
potent	O
pathogens	O
of	O
respiratory	O
infection	O
,	O
enzymatic	O
activity	O
in	O
saliva	O
,	O
fevers	O
,	O
prevalence	O
of	O
fatal	O
aspiration	O
pneumonia	O
and	O
prevalence	O
of	O
influenza	O
.	O

In	O
the	O
first	O
population	O
,	O
we	O
found	O
a	O
high	O
prevalence	O
of	O
potent	O
respiratory	O
pathogens	O
such	O
as	O
Staphylococcus	B-bacteria
species	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Candida	O
albicans	O
.	O

Patients	O
who	O
received	O
POHC	O
showed	O
a	O
lower	O
prevalence	O
for	O
these	O
pathogens	O
than	O
those	O
who	O
did	O
not	O
.	O

The	O
ratio	O
of	O
fatal	O
aspiration	O
pneumonia	O
in	O
POHC	O
patients	O
was	O
significantly	O
lower	O
than	O
that	O
in	O
patients	O
without	O
POHC	O
(	O
non	O
-	O
POHC	O
)	O
over	O
a	O
24	O
-	O
month	O
period	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
prevalence	O
of	O
a	O
fever	O
of	O
37	O
.	O
8	O
degrees	O
C	O
or	O
more	O
in	O
POHC	O
patients	O
was	O
significantly	O
lower	O
than	O
that	O
in	O
the	O
non	O
-	O
POHC	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
the	O
second	O
study	O
population	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
POHC	O
on	O
infection	O
with	O
influenza	O
over	O
a	O
6	O
-	O
month	O
period	O
.	O

In	O
the	O
POHC	O
group	O
,	O
neuraminidase	O
and	O
trypsin	O
-	O
like	O
protease	O
activities	O
decreased	O
,	O
and	O
one	O
of	O
98	O
patients	O
was	O
diagnosed	O
with	O
influenza	O
;	O
whereas	O
,	O
in	O
the	O
non	O
-	O
POHC	O
group	O
,	O
nine	O
of	O
92	O
patients	O
were	O
diagnosed	O
with	O
influenza	O
.	O

The	O
relative	O
risk	O
of	O
developing	O
influenza	O
while	O
under	O
POHC	O
was	O
0	O
.	O
1	O
(	O
95	O
%	O
CI	O
0	O
.	O
01	O
-	O
0	O
.	O
81	O
,	O
P	O
=	O
0	O
.	O
008	O
)	O
.	O

These	O
results	O
suggest	O
that	O
POHC	O
by	O
dental	O
hygienists	O
is	O
effective	O
in	O
preventing	O
respiratory	O
infections	O
in	O
elderly	O
persons	O
requiring	O
nursing	O
care	O
.	O

A	O
total	O
of	O
270	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
(	O
VS	B-bacteria
)	O
isolated	O
from	O
healthy	O
children	O
,	O
identified	O
to	O
the	O
species	O
level	O
,	O
were	O
tested	O
for	O
their	O
susceptibilities	O
to	O
penicillin	O
,	O
imipenem	O
,	O
erythromycin	O
,	O
and	O
vancomycin	O
.	O

A	O
total	O
of	O
270	O
isolates	O
and	O
1	O
,	O
080	O
organism	O
-	O
antibiotic	O
combinations	O
were	O
evaluated	O
.	O

The	O
overall	O
susceptibility	O
rates	O
of	O
all	O
isolates	O
obtained	O
by	O
the	O
Etest	O
(	O
ET	O
)	O
versus	O
agar	O
dilution	O
(	O
AD	O
)	O
were	O
60	O
.	O
4	O
%	O
versus	O
61	O
.	O
8	O
%	O
for	O
penicillin	O
,	O
63	O
.	O
8	O
%	O
versus	O
63	O
.	O
9	O
%	O
for	O
erythromycin	O
,	O
90	O
.	O
6	O
%	O
versus	O
96	O
%	O
for	O
vancomycin	O
,	O
and	O
99	O
.	O
1	O
%	O
versus	O
96	O
.	O
0	O
%	O
for	O
imipenem	O
,	O
respectively	O
.	O

Major	O
discrepancies	O
occurred	O
in	O
the	O
testing	O
of	O
the	O
susceptibility	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
to	O
vancomycin	O
,	O
with	O
59	O
.	O
5	O
%	O
(	O
ET	O
)	O
versus	O
100	O
%	O
(	O
AD	O
)	O
,	O
followed	O
by	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
with	O
84	O
.	O
1	O
%	O
versus	O
100	O
%	O
;	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
with	O
82	O
.	O
1	O
%	O
versus	O
96	O
.	O
4	O
%	O
;	O
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
with	O
90	O
%	O
versus	O
100	O
%	O
,	O
respectively	O
.	O

There	O
were	O
also	O
differences	O
in	O
the	O
rates	O
of	O
susceptibility	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
66	O
.	O
5	O
%	O
(	O
ET	O
)	O
versus	O
85	O
.	O
1	O
%	O
(	O
AD	O
)	O
,	O
and	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
,	O
82	O
.	O
9	O
%	O
versus	O
72	O
.	O
1	O
%	O
,	O
respectively	O
,	O
to	O
penicillin	O
.	O

General	O
agreement	O
between	O
the	O
results	O
of	O
ET	O
and	O
AD	O
was	O
obtained	O
for	O
973	O
organism	O
-	O
antibiotic	O
combinations	O
out	O
of	O
1	O
,	O
080	O
antibiotic	O
combinations	O
,	O
i	O
.	O
e	O
.	O
,	O
90	O
.	O
1	O
%	O
.	O

Very	O
major	O
errors	O
were	O
found	O
for	O
6	O
.	O
8	O
%	O
of	O
isolates	O
,	O
and	O
major	O
errors	O
were	O
found	O
for	O
3	O
.	O
2	O
%	O
of	O
isolates	O
;	O
the	O
minor	O
errors	O
were	O
negligible	O
.	O

Agreement	O
between	O
the	O
results	O
of	O
the	O
two	O
methods	O
was	O
98	O
.	O
7	O
%	O
for	O
penicillin	O
,	O
94	O
.	O
6	O
%	O
for	O
vancomycin	O
,	O
96	O
.	O
9	O
%	O
for	O
imipenem	O
,	O
and	O
99	O
.	O
9	O
%	O
for	O
erythromycin	O
.	O

The	O
highest	O
rate	O
of	O
very	O
major	O
errors	O
was	O
for	O
vancomycin	O
,	O
at	O
5	O
.	O
4	O
%	O
.	O

The	O
ET	O
appears	O
to	O
be	O
as	O
efficient	O
as	O
AD	O
for	O
susceptibility	O
testing	O
of	O
VS	O
,	O
except	O
for	O
vancomycin	O
,	O
where	O
very	O
major	O
errors	O
in	O
the	O
results	O
were	O
relatively	O
high	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
influence	O
of	O
oral	O
hygiene	O
instruction	O
(	O
OHI	O
)	O
on	O
oral	O
hygiene	O
status	O
and	O
on	O
the	O
reduction	O
of	O
inducing	O
bacteria	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
in	O
30	O
subjects	O
(	O
12	O
males	O
and	O
18	O
females	O
)	O
with	O
an	O
age	O
range	O
from	O
10	O
to	O
14	O
years	O
.	O

The	O
patients	O
were	O
instructed	O
on	O
how	O
to	O
carry	O
out	O
effective	O
oral	O
hygiene	O
close	O
to	O
brackets	O
and	O
ligatures	O
,	O
and	O
in	O
the	O
use	O
of	O
dental	O
floss	O
for	O
cleaning	O
spaces	O
around	O
brackets	O
,	O
between	O
the	O
teeth	O
and	O
under	O
archwires	O
.	O

The	O
plaque	O
index	O
(	O
PI	O
)	O
was	O
used	O
to	O
measure	O
oral	O
hygiene	O
status	O
,	O
and	O
the	O
level	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
determined	O
using	O
the	O
colour	O
reaction	O
time	O
test	O
before	O
and	O
after	O
1	O
month	O
of	O
OHI	O
.	O

Statistical	O
analysis	O
included	O
a	O
Student	O
'	O
s	O
t	O
-	O
test	O
and	O
chi	O
-	O
square	O
test	O
.	O

The	O
results	O
showed	O
that	O
OHI	O
significantly	O
improved	O
oral	O
hygiene	O
.	O

The	O
percentage	O
of	O
patients	O
with	O
a	O
PI	O
exceeding	O
1	O
decreased	O
from	O
23	O
.	O
3	O
to	O
10	O
per	O
cent	O
and	O
for	O
those	O
with	O
a	O
PI	O
below	O
0	O
.	O
1	O
it	O
increased	O
from	O
20	O
to	O
60	O
per	O
cent	O
.	O

The	O
level	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
not	O
reduced	O
.	O

The	O
percentage	O
of	O
subjects	O
with	O
excessive	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
above	O
10	O
(	O
6	O
)	O
bacteria	O
in	O
1	O
ml	O
of	O
saliva	O
)	O
decreased	O
after	O
OHI	O
but	O
only	O
from	O
73	O
.	O
3	O
to	O
70	O
per	O
cent	O
.	O

For	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
a	O
level	O
above	O
10	O
(	O
5	O
)	O
of	O
bacteria	O
in	O
1	O
ml	O
of	O
saliva	O
was	O
found	O
for	O
all	O
subjects	O
at	O
both	O
time	O
points	O
.	O

Patients	O
with	O
fixed	O
appliances	O
,	O
trained	O
in	O
scrupulous	O
tooth	O
cleaning	O
,	O
remain	O
at	O
risk	O
of	O
developing	O
caries	O
and	O
should	O
be	O
carefully	O
monitored	O
.	O

Effect	O
of	O
Bactisporin	O
-	O
-	O
a	O
probiotic	O
,	O
containing	O
spores	O
of	O
aerobic	O
Bacillus	B-bacteria
subtilis	I-bacteria
3H	I-bacteria
bacterium	I-bacteria
-	O
-	O
for	O
complex	O
treatment	O
of	O
patients	O
with	O
nosocomial	O
urinary	O
tract	O
infections	O
was	O
studied	O
.	O

68	O
Cultures	O
of	O
different	O
species	O
of	O
conditionally	O
pathogenic	O
bacteria	O
were	O
isolated	O
from	O
urine	O
of	O
the	O
patients	O
.	O

Susceptibility	O
of	O
the	O
isolated	O
cultures	O
to	O
antibiotics	O
before	O
and	O
after	O
application	O
of	O
B	B-bacteria
.	I-bacteria
subtilis	I-bacteria
3H	I-bacteria
metabolites	O
was	O
determined	O
.	O

The	O
metabolites	O
were	O
accumulated	O
on	O
potato	O
-	O
glucose	O
agar	O
(	O
PGA	O
)	O
while	O
bacterium	O
was	O
cultivated	O
on	O
kapron	O
membranes	O
placed	O
on	O
surface	O
of	O
the	O
medium	O
.	O

Influence	O
of	O
obtained	O
metabolites	O
on	O
isolated	O
strains	O
was	O
assessed	O
by	O
cultivation	O
of	O
each	O
strain	O
in	O
metabolites	O
-	O
rich	O
PGA	O
during	O
24	O
h	O
.	O
Metabolites	O
of	O
B	B-bacteria
.	I-bacteria
subtilis	I-bacteria
led	O
to	O
decrease	O
in	O
resistance	O
of	O
isolated	O
uropathogenic	O
microflora	O
to	O
antibiotics	O
.	O

Use	O
of	O
Bactisporin	O
in	O
complex	O
treatment	O
of	O
nosocomial	O
urinary	O
tract	O
infections	O
resulted	O
in	O
accelerated	O
elimination	O
of	O
causative	O
microorganism	O
.	O

To	O
investigate	O
the	O
association	O
of	O
recurrent	O
aphthous	O
ulcer	O
(	O
RAU	O
)	O
with	O
Helicobacter	B-bacteria
pylori	I-bacteria
(	O
Hp	B-bacteria
)	O
infection	O
and	O
digestive	O
diseases	O
.	O

Saliva	O
samples	O
were	O
collected	O
from	O
82	O
patients	O
with	O
RAU	O
and	O
74	O
healthy	O
volunteers	O
for	O
Hp	B-bacteria
detection	O
with	O
PCR	O
.	O

The	O
positivity	O
rates	O
of	O
HP	B-bacteria
differed	O
significantly	O
between	O
RAU	O
patients	O
and	O
healthy	O
volunteers	O
(	O
43	O
.	O
9	O
%	O
vs	O
16	O
.	O
2	O
%	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

In	O
the	O
82	O
RAU	O
patients	O
,	O
22	O
(	O
26	O
.	O
82	O
%	O
)	O
were	O
identified	O
to	O
have	O
gastritis	O
and	O
peptic	O
ulcer	O
,	O
whereas	O
only	O
7	O
out	O
of	O
the	O
74	O
healthy	O
volunteers	O
(	O
10	O
.	O
45	O
%	O
)	O
had	O
such	O
digestive	O
diseases	O
,	O
showing	O
significant	O
difference	O
between	O
them	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Hp	B-bacteria
might	O
in	O
some	O
way	O
associate	O
with	O
RAU	O
,	O
which	O
in	O
turn	O
is	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
digestive	O
diseases	O
.	O

Wine	O
contains	O
a	O
number	O
of	O
biologically	O
active	O
compounds	O
with	O
beneficial	O
effects	O
on	O
human	O
health	O
.	O

The	O
antibacterial	O
action	O
of	O
commercial	O
red	O
and	O
white	O
wines	O
against	O
oral	O
streptococci	B-bacteria
responsible	O
for	O
caries	O
development	O
and	O
against	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
responsible	O
for	O
pharyngitis	O
was	O
studied	O
.	O

Its	O
postcontact	O
effect	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
also	O
studied	O
.	O

Both	O
wines	O
displayed	O
activity	O
.	O

The	O
compounds	O
responsible	O
for	O
such	O
activities	O
were	O
succinic	O
,	O
malic	O
,	O
lactic	O
,	O
tartaric	O
,	O
citric	O
,	O
and	O
acetic	O
acid	O
.	O

The	O
synthetic	O
mixtures	O
of	O
the	O
organic	O
acids	O
tested	O
at	O
the	O
concentrations	O
found	O
in	O
wine	O
had	O
greater	O
antibacterial	O
activity	O
than	O
the	O
beverages	O
,	O
indicating	O
that	O
in	O
wine	O
they	O
are	O
inhibited	O
by	O
other	O
components	O
.	O

Wine	O
polyphenols	O
displayed	O
no	O
activity	O
against	O
oral	O
streptococci	B-bacteria
or	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
.	O

Findings	O
show	O
that	O
wine	O
is	O
active	O
against	O
oral	O
streptococci	B-bacteria
and	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
and	O
suggest	O
that	O
it	O
enhances	O
oral	O
health	O
.	O

Patients	O
undergoing	O
allogeneic	O
stem	O
cell	O
transplantation	O
are	O
at	O
high	O
risk	O
for	O
infection	O
with	O
a	O
variety	O
of	O
pathogens	O
during	O
different	O
phases	O
of	O
the	O
procedure	O
.	O

Human	O
infections	O
due	O
to	O
Bartonella	B-bacteria
spp	I-bacteria
.	I-bacteria
are	O
viewed	O
as	O
emerging	O
diseases	O
typical	O
in	O
,	O
although	O
not	O
exclusive	O
to	O
,	O
immunosuppressed	O
patients	O
,	O
in	O
particular	O
those	O
with	O
AIDS	O
,	O
organ	O
transplants	O
and	O
haematological	O
malignancies	O
.	O

We	O
describe	O
four	O
patients	O
,	O
three	O
children	O
and	O
one	O
adult	O
,	O
who	O
developed	O
vegetating	O
papillomatous	O
lesions	O
exclusively	O
on	O
the	O
oral	O
mucosae	O
.	O

They	O
shared	O
a	O
history	O
of	O
haematological	O
malignancy	O
and	O
allogeneic	O
bone	O
marrow	O
/	O
stem	O
cell	O
transplantation	O
,	O
and	O
later	O
developed	O
chronic	O
graft	O
-	O
versus	O
-	O
host	O
disease	O
,	O
also	O
involving	O
the	O
oral	O
mucosae	O
.	O

Histopathologically	O
,	O
the	O
vegetating	O
lesions	O
were	O
characterized	O
by	O
a	O
diffuse	O
neoangiogenesis	O
,	O
granulation	O
-	O
like	O
tissue	O
,	O
and	O
a	O
mixed	O
cell	O
infiltrate	O
predominantly	O
composed	O
of	O
neutrophils	O
.	O

Gram	O
-	O
negative	O
bacteria	O
were	O
found	O
in	O
the	O
endothelial	O
cells	O
of	O
the	O
vessels	O
in	O
the	O
deeper	O
portion	O
of	O
the	O
corium	O
by	O
electron	O
microscopy	O
.	O

In	O
three	O
cases	O
,	O
DNA	O
of	O
B	B-bacteria
.	I-bacteria
henselae	I-bacteria
was	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
and	O
confirmed	O
by	O
sequencing	O
of	O
the	O
PCR	O
products	O
.	O

All	O
the	O
lesions	O
healed	O
after	O
systemic	O
antibiotic	O
therapy	O
,	O
although	O
some	O
recurred	O
after	O
months	O
,	O
and	O
regressed	O
again	O
after	O
systemic	O
antibiotic	O
treatment	O
associated	O
with	O
conservative	O
surgical	O
excision	O
.	O

The	O
paper	O
describes	O
an	O
optimized	O
technique	O
for	O
DNA	O
isolation	O
from	O
the	O
Streptococcus	B-bacteria
mutans	I-bacteria
cultures	O
and	O
from	O
the	O
clinical	O
samples	O
including	O
proteinase	O
K	O
treatment	O
and	O
detergent	O
lysis	O
,	O
followed	O
by	O
sorbent	O
-	O
based	O
enrichment	O
.	O

This	O
technique	O
was	O
employed	O
for	O
isolating	O
DNA	O
from	O
the	O
periodontal	O
bacteria	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
Bacteroides	B-bacteria
forsythus	I-bacteria
.	O

A	O
multiplex	O
PCR	O
technique	O
was	O
adapted	O
for	O
large	O
-	O
scale	O
studies	O
of	O
clinical	O
samples	O
.	O

An	O
original	O
PCR	O
method	O
was	O
developed	O
for	O
the	O
semiquantitative	O
detection	O
of	O
Str	O
.	O

mutans	O
,	O
showing	O
the	O
sensitivity	O
of	O
100	O
genome	O
copies	O
per	O
reaction	O
.	O

Extensive	O
studies	O
of	O
approximately	O
2	O
,	O
000	O
individuals	O
have	O
demonstrated	O
that	O
these	O
methods	O
are	O
applicable	O
to	O
the	O
study	O
of	O
the	O
dental	O
and	O
gingival	O
microflora	O
in	O
the	O
biological	O
sample	O
from	O
the	O
oral	O
cavity	O
of	O
persons	O
with	O
dental	O
diseases	O
from	O
various	O
age	O
groups	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
aerobic	O
and	O
anaerobic	O
microbiology	O
of	O
acute	O
maxillary	O
sinusitis	O
of	O
odontogenic	O
origin	O
presenting	O
with	O
periodontal	O
infection	O
in	O
children	O
.	O

Aspirates	O
of	O
18	O
acutely	O
infected	O
maxillary	O
sinuses	O
that	O
were	O
associated	O
with	O
odontogenic	O
infection	O
in	O
children	O
who	O
presented	O
with	O
periorbital	O
cellulitis	O
were	O
processed	O
for	O
aerobic	O
and	O
anaerobic	O
bacteria	O
.	O

A	O
total	O
of	O
54	O
isolates	O
were	O
recovered	O
(	O
3	O
.	O
0	O
per	O
specimen	O
)	O
:	O
13	O
aerobic	O
and	O
facultative	O
(	O
0	O
.	O
7	O
per	O
specimen	O
)	O
and	O
41	O
anaerobic	O
(	O
2	O
.	O
3	O
per	O
specimen	O
)	O
.	O

The	O
number	O
of	O
isolates	O
per	O
specimen	O
varied	O
from	O
1	O
to	O
4	O
.	O

Aerobic	O
and	O
facultative	O
organisms	O
alone	O
were	O
recovered	O
in	O
2	O
specimens	O
(	O
11	O
%	O
)	O
,	O
anaerobes	O
only	O
in	O
7	O
(	O
39	O
%	O
)	O
,	O
and	O
mixed	O
aerobic	O
and	O
anaerobic	O
bacteria	O
in	O
9	O
(	O
50	O
%	O
)	O
.	O

The	O
predominant	O
aerobic	O
and	O
facultative	O
organisms	O
were	O
alpha	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
(	O
4	O
)	O
,	O
microaerophilic	B-bacteria
streptococci	I-bacteria
(	O
3	O
)	O
,	O
and	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
(	O
2	O
each	O
)	O
.	O

The	O
predominant	O
anaerobic	O
bacteria	O
were	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
(	O
17	O
)	O
,	O
Peptostreptococcus	B-bacteria
spp	I-bacteria
(	O
11	O
)	O
,	O
Fusobacterium	B-bacteria
spp	I-bacteria
(	O
8	O
)	O
,	O
and	O
Propionibacterium	B-bacteria
acnes	I-bacteria
(	O
2	O
)	O
.	O

Twelve	O
beta	O
-	O
lactamase	O
-	O
producing	O
bacteria	O
were	O
recovered	O
from	O
9	O
specimens	O
(	O
50	O
%	O
)	O
.	O

This	O
study	O
demonstrates	O
the	O
unique	O
aerobic	O
and	O
anaerobic	O
microbiological	O
features	O
of	O
acute	O
maxillary	O
sinusitis	O
of	O
odontogenic	O
origin	O
presenting	O
with	O
periorbital	O
cellulitis	O
in	O
children	O
.	O

Oral	O
epithelia	O
are	O
constantly	O
exposed	O
to	O
non	O
-	O
pathogenic	O
(	O
commensal	O
)	O
bacteria	O
,	O
but	O
generally	O
remain	O
healthy	O
and	O
uninflamed	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
an	O
oral	O
commensal	O
bacterium	O
,	O
strongly	O
induces	O
human	O
beta	O
-	O
defensin	O
-	O
2	O
(	O
hBD2	O
)	O
,	O
an	O
antimicrobial	O
and	O
immunomodulatory	O
peptide	O
,	O
in	O
gingival	O
epithelial	O
cells	O
(	O
GECs	O
)	O
.	O

hBD2	O
is	O
also	O
expressed	O
in	O
normal	O
oral	O
tissue	O
leading	O
to	O
the	O
hypothesis	O
that	O
oral	O
epithelia	O
are	O
in	O
an	O
activated	O
state	O
with	O
respect	O
to	O
innate	O
immune	O
responses	O
under	O
normal	O
in	O
vivo	O
conditions	O
.	O

In	O
order	O
to	O
test	O
this	O
hypothesis	O
,	O
global	O
gene	O
expression	O
was	O
evaluated	O
in	O
GECs	O
in	O
response	O
to	O
stimulation	O
by	O
an	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
cell	O
wall	O
(	O
FnCW	O
)	O
preparation	O
and	O
to	O
hBD2	O
peptide	O
.	O

FnCW	O
treatment	O
altered	O
829	O
genes	O
,	O
while	O
hBD2	O
altered	O
209	O
genes	O
(	O
P	O
<	O
0	O
.	O
005	O
,	O
ANOVA	O
)	O
.	O

Many	O
induced	O
genes	O
were	O
associated	O
with	O
the	O
gene	O
ontology	O
categories	O
of	O
immune	O
responses	O
and	O
defence	O
responses	O
.	O

Consistent	O
with	O
the	O
hypothesis	O
,	O
similar	O
responses	O
were	O
activated	O
by	O
commensal	O
bacteria	O
and	O
hBD2	O
.	O

These	O
responses	O
included	O
up	O
-	O
regulation	O
of	O
common	O
antimicrobial	O
effectors	O
and	O
chemokines	O
,	O
and	O
down	O
-	O
regulation	O
of	O
proliferation	O
markers	O
.	O

In	O
addition	O
,	O
FnCW	O
up	O
-	O
regulated	O
multiple	O
protease	O
inhibitors	O
,	O
and	O
suppressed	O
NF	O
-	O
kappaB	O
function	O
and	O
the	O
ubiquitin	O
/	O
proteasome	O
system	O
.	O

These	O
global	O
changes	O
may	O
protect	O
the	O
tissue	O
from	O
inflammatory	O
damage	O
.	O

Both	O
FnCW	O
and	O
hBD2	O
also	O
up	O
-	O
regulated	O
genes	O
that	O
may	O
enhance	O
the	O
epithelial	O
barrier	O
.	O

The	O
findings	O
suggest	O
that	O
both	O
commensal	O
bacteria	O
and	O
hBD2	O
activate	O
protective	O
responses	O
of	O
GECs	O
and	O
play	O
an	O
important	O
role	O
in	O
immune	O
modulation	O
in	O
the	O
oral	O
cavity	O
.	O

Antagonistic	O
abilities	O
may	O
confer	O
ecological	O
advantages	O
for	O
micro	O
-	O
organisms	O
in	O
competitive	O
ecosystems	O
.	O

However	O
,	O
reports	O
regarding	O
this	O
phenomenon	O
in	O
Eikenella	B-bacteria
corrodens	I-bacteria
are	O
not	O
available	O
.	O

Nineteen	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
strains	I-bacteria
,	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
human	O
beings	O
without	O
periodontal	O
disease	O
(	O
n	O
=	O
5	O
)	O
and	O
with	O
aggressive	O
(	O
n	O
=	O
9	O
)	O
and	O
chronic	O
(	O
n	O
=	O
5	O
)	O
periodontitis	O
,	O
as	O
well	O
as	O
a	O
reference	O
strain	O
(	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
ATCC23834	I-bacteria
)	O
,	O
were	O
evaluated	O
for	O
antagonistic	O
activity	O
.	O

The	O
following	O
indicators	O
were	O
used	O
:	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
FDC381	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
ATCC25611	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
ATCC12102	I-bacteria
,	O
Eubacterium	B-bacteria
lentum	I-bacteria
ATCC25559	I-bacteria
,	O
Peptostreptococcus	B-bacteria
anaerobius	I-bacteria
ATCC27337	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
FDCY4	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ATCC10953	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
ATCC10557	I-bacteria
,	O
Streptococcus	B-bacteria
uberis	I-bacteria
ATCC9927	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
IM	I-bacteria
/	I-bacteria
UFRJ	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
ATCC33591	I-bacteria
and	O
Candida	O
albicans	O
ATCC18804	O
.	O

All	O
the	O
strains	O
showed	O
antagonism	O
against	O
at	O
least	O
one	O
of	O
the	O
indicator	O
strains	O
.	O

This	O
phenomenon	O
was	O
more	O
frequently	O
observed	O
for	O
strains	O
isolated	O
from	O
patients	O
with	O
chronic	O
periodontitis	O
(	O
36	O
.	O
4	O
%	O
)	O
,	O
than	O
those	O
from	O
healthy	O
subjects	O
(	O
20	O
.	O
6	O
%	O
)	O
and	O
those	O
with	O
aggressive	O
periodontitis	O
(	O
10	O
.	O
8	O
%	O
)	O
.	O

The	O
heterogeneous	O
antagonistic	O
spectrum	O
exhibited	O
by	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
isolates	I-bacteria
suggests	O
their	O
ability	O
to	O
produce	O
more	O
than	O
one	O
antagonistic	O
substance	O
,	O
whose	O
ecological	O
relevance	O
is	O
yet	O
to	O
be	O
demonstrated	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
antagonistic	O
compound	O
production	O
by	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
and	O
its	O
relationships	O
with	O
the	O
clinical	O
status	O
of	O
the	O
patients	O
.	O

Strong	O
epidemiological	O
,	O
genetic	O
and	O
biochemical	O
evidence	O
indicates	O
that	O
local	O
acetaldehyde	O
exposure	O
is	O
a	O
major	O
factor	O
behind	O
gastrointestinal	O
cancers	O
especially	O
associated	O
with	O
alcohol	O
drinking	O
and	O
smoking	O
.	O

Thus	O
,	O
reducing	O
the	O
exposure	O
to	O
carcinogenic	O
acetaldehyde	O
either	O
by	O
decreasing	O
the	O
production	O
or	O
by	O
eliminating	O
acetaldehyde	O
locally	O
might	O
offer	O
a	O
preventive	O
strategy	O
against	O
acetaldehyde	O
-	O
induced	O
gastrointestinal	O
cancers	O
.	O

Thiol	O
products	O
,	O
such	O
as	O
the	O
amino	O
acid	O
cysteine	O
,	O
are	O
known	O
to	O
be	O
able	O
to	O
protect	O
against	O
acetaldehyde	O
toxicity	O
.	O

Cysteine	O
is	O
able	O
to	O
bind	O
acetaldehyde	O
efficiently	O
by	O
forming	O
a	O
stable	O
thiazolidine	O
-	O
carboxylic	O
acid	O
compound	O
.	O

Special	O
cysteine	O
preparations	O
(	O
such	O
as	O
lozenge	O
and	O
chewing	O
gum	O
)	O
have	O
already	O
been	O
developed	O
to	O
bind	O
smoking	O
and	O
alcohol	O
drinking	O
derived	O
acetaldehyde	O
from	O
the	O
oral	O
cavity	O
.	O

Most	O
importantly	O
,	O
these	O
type	O
of	O
drug	O
formulations	O
offer	O
a	O
novel	O
method	O
for	O
intervention	O
studies	O
aimed	O
to	O
resolve	O
the	O
eventual	O
role	O
of	O
acetaldehyde	O
in	O
the	O
pathogenesis	O
of	O
upper	O
digestive	O
tract	O
cancers	O
.	O

Acetaldehyde	O
exposure	O
could	O
also	O
be	O
influenced	O
by	O
modifying	O
the	O
acetaldehyde	O
producing	O
microbiota	O
.	O

With	O
regard	O
to	O
the	O
upper	O
digestive	O
tract	O
,	O
acetaldehyde	O
production	O
from	O
ingested	O
ethanol	O
could	O
be	O
significantly	O
reduced	O
by	O
using	O
an	O
antiseptic	O
mouthwash	O
,	O
chlorhexidine	O
.	O

In	O
the	O
large	O
intestine	O
acetaldehyde	O
production	O
could	O
be	O
markedly	O
decreased	O
either	O
by	O
reducing	O
the	O
Gram	O
-	O
negative	O
microbes	O
by	O
ciprofloxacin	O
antibiotic	O
or	O
by	O
lowering	O
the	O
intraluminal	O
pH	O
by	O
lactulose	O
.	O

Enterococci	B-bacteria
are	O
rarely	O
found	O
in	O
the	O
healthy	O
human	O
oral	O
cavity	O
,	O
yet	O
they	O
are	O
strongly	O
associated	O
with	O
filled	O
root	O
canals	O
.	O

The	O
origin	O
of	O
these	O
enterococci	B-bacteria
remains	O
unknown	O
.	O

Our	O
hypothesis	O
is	O
that	O
they	O
are	O
transient	O
food	O
-	O
born	O
colonizers	O
under	O
healthy	O
conditions	O
.	O

This	O
pilot	O
study	O
reinvestigated	O
the	O
prevalence	O
of	O
enterococci	B-bacteria
in	O
the	O
oral	O
cavity	O
of	O
healthy	O
volunteers	O
,	O
screened	O
cheese	O
samples	O
for	O
enterococci	B-bacteria
and	O
investigated	O
colonization	O
of	O
the	O
oral	O
cavity	O
after	O
ingestion	O
of	O
an	O
enterocci	O
-	O
positive	O
cheese	O
.	O

Concentrated	O
oral	O
rinse	O
samples	O
were	O
collected	O
from	O
a	O
cohort	O
of	O
50	O
dental	O
students	O
and	O
proved	O
negative	O
for	O
viable	O
enterococci	B-bacteria
.	O

Twenty	O
cheese	O
samples	O
were	O
obtained	O
from	O
local	O
supermarkets	O
.	O

Enterococci	B-bacteria
were	O
cultured	O
and	O
identified	O
using	O
standard	O
methods	O
.	O

Viable	O
enterococci	B-bacteria
were	O
detected	O
in	O
one	O
of	O
five	O
specimens	O
of	O
Swiss	O
Tilsiter	O
,	O
three	O
of	O
five	O
samples	O
of	O
French	O
soft	O
cheese	O
,	O
one	O
of	O
five	O
Mozzarella	O
samples	O
and	O
one	O
of	O
five	O
Feta	O
samples	O
.	O

Eight	O
volunteers	O
from	O
the	O
cohort	O
consumed	O
10	O
g	O
of	O
a	O
cheese	O
with	O
high	O
Enterococcus	B-bacteria
faecalis	I-bacteria
load	O
.	O

Oral	O
rinse	O
samples	O
were	O
collected	O
before	O
and	O
1	O
,	O
10	O
and	O
100	O
min	O
after	O
cheese	O
ingestion	O
.	O

One	O
minute	O
after	O
ingestion	O
,	O
a	O
median	O
of	O
5	O
,	O
480	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
colony	O
-	O
forming	O
units	O
was	O
recovered	O
from	O
the	O
oral	O
rinse	O
samples	O
.	O

Bacterial	O
counts	O
were	O
reduced	O
after	O
10	O
min	O
,	O
had	O
dropped	O
after	O
100	O
min	O
to	O
levels	O
that	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
005	O
)	O
different	O
from	O
the	O
1	O
-	O
min	O
and	O
10	O
-	O
min	O
scores	O
and	O
were	O
below	O
the	O
detection	O
limit	O
after	O
1	O
week	O
.	O

These	O
findings	O
suggest	O
that	O
colonization	O
of	O
the	O
healthy	O
oral	O
cavity	O
by	O
enterococci	B-bacteria
is	O
transitional	O
,	O
but	O
at	O
the	O
same	O
time	O
add	O
weight	O
to	O
our	O
hypothesis	O
that	O
enterococcal	O
root	O
canal	O
infections	O
could	O
be	O
food	O
-	O
borne	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
current	O
antimicrobial	O
susceptibility	O
of	O
the	O
principle	O
anaerobic	O
pathogens	O
involved	O
in	O
dentoalveolar	O
infection	O
,	O
to	O
13	O
oral	O
antibiotics	O
,	O
and	O
to	O
assess	O
the	O
value	O
of	O
each	O
antibiotic	O
in	O
the	O
management	O
of	O
the	O
infection	O
.	O

A	O
total	O
of	O
800	O
isolates	O
from	O
patients	O
with	O
dentoalveolar	O
infection	O
(	O
Prevotella	B-bacteria
species	I-bacteria
,	O
Fusobacterium	B-bacteria
species	I-bacteria
,	O
Porphyromonas	B-bacteria
species	I-bacteria
and	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
)	O
were	O
tested	O
for	O
their	O
susceptibility	O
to	O
amoxicillin	O
,	O
amoxicillin	O
/	O
clavulanate	O
,	O
cefaclor	O
,	O
cefuroxime	O
,	O
cefcapene	O
,	O
cefdinir	O
,	O
erythromycin	O
,	O
azithromycin	O
,	O
telithromycin	O
,	O
minocycline	O
,	O
levofloxacin	O
,	O
clindamycin	O
,	O
and	O
metronidazole	O
using	O
an	O
agar	O
dilution	O
method	O
.	O

Although	O
the	O
majority	O
of	O
Fusobacterium	B-bacteria
strains	I-bacteria
were	O
resistant	O
to	O
erythromycin	O
,	O
azithromycin	O
,	O
and	O
telithromycin	O
,	O
the	O
remaining	O
antibiotics	O
demonstrated	O
a	O
high	O
level	O
of	O
antimicrobial	O
activity	O
.	O

P	B-bacteria
.	I-bacteria
micros	I-bacteria
and	O
Porphyromonas	B-bacteria
species	I-bacteria
exhibited	O
high	O
susceptibility	O
to	O
all	O
antibiotics	O
tested	O
in	O
this	O
study	O
.	O

In	O
the	O
case	O
of	O
Prevotella	B-bacteria
species	I-bacteria
,	O
resistance	O
to	O
amoxicillin	O
occurred	O
in	O
34	O
%	O
of	O
isolates	O
and	O
all	O
of	O
these	O
resistant	O
strains	O
were	O
found	O
to	O
produce	O
beta	O
-	O
lactamase	O
.	O

Susceptibility	O
of	O
Prevotella	B-bacteria
strains	I-bacteria
to	O
cefaclor	O
,	O
cefuroxime	O
,	O
cefcapene	O
,	O
cefdinir	O
,	O
erythromycin	O
,	O
azithromycin	O
,	O
and	O
minocycline	O
was	O
found	O
to	O
correlate	O
with	O
amoxicillin	O
susceptibility	O
.	O

Amoxicillin	O
/	O
clavulanate	O
,	O
telithromycin	O
,	O
clindamycin	O
,	O
and	O
metronidazole	O
exhibited	O
high	O
antimicrobial	O
activity	O
even	O
against	O
amoxicillin	O
-	O
resistant	O
strains	O
of	O
Prevotella	B-bacteria
species	I-bacteria
.	O

Amoxicillin	O
would	O
still	O
be	O
advocated	O
therefore	O
as	O
being	O
a	O
suitable	O
first	O
-	O
line	O
agent	O
,	O
while	O
reduced	O
susceptibility	O
of	O
Prevotella	B-bacteria
strains	I-bacteria
remains	O
a	O
matter	O
of	O
concern	O
with	O
penicillins	O
.	O

Amoxicillin	O
/	O
clavulanate	O
,	O
clindamycin	O
,	O
and	O
metronidazole	O
are	O
useful	O
alternatives	O
in	O
combating	O
the	O
anaerobic	O
bacteria	O
involved	O
in	O
dentoalveolar	O
infection	O
.	O

To	O
determine	O
the	O
distribution	O
of	O
pathogens	O
on	O
cattle	O
hides	O
at	O
the	O
feedlot	O
,	O
samples	O
were	O
collected	O
from	O
six	O
hide	O
surface	O
locations	O
(	O
back	O
,	O
flank	O
,	O
hock	O
,	O
neck	O
,	O
perineum	O
,	O
and	O
ventrum	O
)	O
,	O
the	O
oral	O
cavity	O
,	O
the	O
rectal	O
-	O
anal	O
junction	O
,	O
and	O
the	O
feces	O
of	O
feedlot	O
cattle	O
and	O
subjected	O
to	O
Escherichia	B-bacteria
coli	I-bacteria
0157	I-bacteria
detection	O
via	O
culture	O
methods	O
and	O
to	O
Salmonella	B-bacteria
detection	O
via	O
PCR	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
0157	I-bacteria
was	O
isolated	O
from	O
one	O
or	O
more	O
of	O
the	O
sampling	O
locations	O
from	O
31	O
(	O
42	O
.	O
5	O
%	O
)	O
of	O
the	O
73	O
animals	O
sampled	O
.	O

Location	O
-	O
specific	O
prevalence	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
0157	I-bacteria
was	O
5	O
%	O
for	O
back	O
samples	O
,	O
5	O
%	O
for	O
flank	O
samples	O
,	O
12	O
%	O
for	O
hock	O
samples	O
,	O
7	O
%	O
for	O
neck	O
samples	O
,	O
12	O
%	O
for	O
perineum	O
samples	O
,	O
8	O
%	O
for	O
ventrum	O
samples	O
,	O
1	O
%	O
for	O
oral	O
cavity	O
samples	O
,	O
4	O
%	O
for	O
rectal	O
-	O
anal	O
junction	O
swabs	O
,	O
and	O
23	O
%	O
for	O
fecal	O
grab	O
samples	O
.	O

Salmonella	B-bacteria
was	O
isolated	O
from	O
one	O
or	O
more	O
of	O
these	O
sample	O
locations	O
from	O
100	O
%	O
(	O
50	O
of	O
50	O
samples	O
)	O
of	O
all	O
animals	O
sampled	O
.	O

Location	O
-	O
specific	O
prevalence	O
of	O
Salmonella	B-bacteria
was	O
76	O
%	O
for	O
back	O
samples	O
,	O
74	O
%	O
for	O
flank	O
samples	O
,	O
94	O
%	O
for	O
hock	O
samples	O
,	O
76	O
%	O
for	O
neck	O
samples	O
,	O
88	O
%	O
for	O
perineum	O
samples	O
,	O
86	O
%	O
for	O
ventrum	O
samples	O
,	O
94	O
%	O
for	O
oral	O
cavity	O
samples	O
,	O
64	O
%	O
for	O
rectal	O
-	O
anal	O
junction	O
swabs	O
,	O
and	O
50	O
%	O
for	O
fecal	O
grab	O
samples	O
.	O

The	O
sampling	O
locations	O
that	O
maximized	O
the	O
likelihood	O
of	O
finding	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
0157	I-bacteria
and	O
Salmonella	B-bacteria
(	O
84	O
and	O
96	O
%	O
,	O
respectively	O
)	O
if	O
the	O
animal	O
was	O
positive	O
at	O
one	O
sampling	O
location	O
or	O
more	O
were	O
the	O
hock	O
,	O
perineum	O
,	O
and	O
fecal	O
grab	O
.	O

These	O
data	O
suggest	O
that	O
the	O
use	O
of	O
multiple	O
sample	O
locations	O
is	O
useful	O
when	O
isolating	O
these	O
pathogens	O
from	O
feedlot	O
cattle	O
.	O

Focusing	O
on	O
one	O
sampling	O
location	O
may	O
underestimate	O
the	O
prevalence	O
.	O

Enhanced	O
delivery	O
of	O
bifidobacteria	B-bacteria
and	O
fecal	O
changes	O
were	O
compared	O
following	O
multiple	O
oral	O
administrations	O
of	O
protected	O
bifidobacteria	O
-	O
loaded	O
alginate	O
poly	O
-	O
l	O
-	O
lysine	O
microparticles	O
(	O
bap	O
-	O
microparticles	O
)	O
and	O
unprotected	O
bifidobacteria	B-bacteria
cultures	O
over	O
a	O
period	O
of	O
1	O
month	O
to	O
healthy	O
human	O
volunteers	O
as	O
preliminary	O
in	O
vivo	O
studies	O
.	O

When	O
bap	O
-	O
microparticles	O
were	O
orally	O
administered	O
,	O
enhanced	O
delivery	O
of	O
bifidobacteria	B-bacteria
was	O
achieved	O
.	O

The	O
viability	O
of	O
the	O
bifidobacteria	B-bacteria
was	O
significantly	O
increased	O
approximately	O
11	O
.	O
5	O
-	O
30	O
times	O
(	O
1	O
.	O
06	O
-	O
1	O
.	O
48	O
log	O
cycles	O
)	O
during	O
the	O
ingestion	O
period	O
when	O
compared	O
with	O
the	O
bifidobacteria	B-bacteria
culture	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

However	O
,	O
other	O
gut	O
microflora	O
such	O
as	O
bifidobacteria	B-bacteria
,	O
enterobacteriaceae	B-bacteria
,	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
and	O
staphylococci	B-bacteria
in	O
feces	O
were	O
not	O
significantly	O
different	O
between	O
the	O
two	O
groups	O
.	O

Encapsulated	O
bifidobacteria	B-bacteria
resulted	O
in	O
more	O
frequent	O
defecation	O
and	O
decreased	O
fecal	O
viscosity	O
.	O

The	O
`	O
`	O
Synergistes	B-bacteria
'	O
'	O
group	O
of	O
organisms	O
are	O
a	O
phylogenetic	O
cluster	O
of	O
Gram	O
-	O
negative	O
anaerobes	O
related	O
to	O
Synergistes	B-bacteria
jonesii	I-bacteria
,	O
sufficiently	O
distinct	O
from	O
all	O
other	O
phyla	O
to	O
be	O
considered	O
a	O
distinct	O
phylum	O
or	O
Division	O
.	O

They	O
are	O
widely	O
distributed	O
in	O
nature	O
although	O
normally	O
only	O
a	O
minor	O
constituent	O
of	O
the	O
bacterial	O
community	O
in	O
each	O
habitat	O
.	O

They	O
have	O
evolved	O
to	O
adapt	O
to	O
each	O
habitat	O
,	O
and	O
therefore	O
exhibit	O
a	O
wide	O
range	O
of	O
physiological	O
and	O
biochemical	O
characteristics	O
,	O
although	O
all	O
cultivable	O
taxa	O
so	O
far	O
studied	O
have	O
the	O
ability	O
to	O
degrade	O
amino	O
acids	O
.	O

They	O
are	O
found	O
in	O
the	O
human	O
mouth	O
where	O
they	O
appear	O
to	O
be	O
more	O
numerous	O
in	O
tooth	O
and	O
gum	O
disease	O
than	O
health	O
.	O

They	O
have	O
also	O
been	O
found	O
in	O
the	O
human	O
gut	O
and	O
soft	O
tissue	O
infections	O
.	O

Their	O
role	O
in	O
human	O
disease	O
has	O
yet	O
to	O
be	O
established	O
but	O
improved	O
knowledge	O
of	O
the	O
characteristics	O
that	O
enable	O
their	O
identification	O
should	O
increase	O
the	O
likelihood	O
of	O
their	O
recognition	O
when	O
present	O
at	O
diseased	O
sites	O
.	O

An	O
in	O
vitro	O
plaque	O
model	O
based	O
on	O
the	O
use	O
of	O
human	O
salivary	O
bacteria	O
and	O
tooth	O
-	O
like	O
surfaces	O
was	O
previously	O
developed	O
for	O
studying	O
the	O
formation	O
of	O
oral	O
biofilm	O
and	O
its	O
use	O
for	O
pre	O
-	O
clinical	O
testing	O
of	O
candidate	O
antimicrobial	O
or	O
antiplaque	O
agents	O
.	O

In	O
this	O
study	O
,	O
a	O
quantitative	O
Taqman	O
PCR	O
assay	O
(	O
QPCR	O
)	O
was	O
developed	O
to	O
compare	O
the	O
bacterial	O
compositions	O
of	O
in	O
vitro	O
biofilms	O
to	O
parent	O
saliva	O
samples	O
,	O
and	O
to	O
determine	O
the	O
relative	O
contributions	O
of	O
different	O
species	O
in	O
the	O
formation	O
of	O
the	O
oral	O
biofilm	O
.	O

In	O
addition	O
,	O
the	O
growth	O
inhibition	O
of	O
saliva	O
-	O
derived	O
plaque	O
was	O
evaluated	O
by	O
chlorhexidine	O
.	O

With	O
this	O
assay	O
,	O
which	O
consisted	O
of	O
primer	O
/	O
probe	O
sets	O
targeting	O
either	O
16S	O
rDNA	O
sequences	O
present	O
in	O
public	O
databases	O
or	O
cloned	O
ribosomal	O
intergenic	O
spacer	O
region	O
(	O
ISR	O
)	O
sequences	O
,	O
15	O
oral	O
bacteria	O
derived	O
from	O
saliva	O
as	O
well	O
as	O
those	O
that	O
were	O
responsible	O
for	O
biofilm	O
formation	O
in	O
an	O
in	O
vitro	O
plaque	O
model	O
were	O
rapidly	O
identified	O
and	O
quantified	O
.	O

Among	O
the	O
target	O
organisms	O
were	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Micromonas	B-bacteria
micros	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
and	O
Veillonella	B-bacteria
parvula	I-bacteria
.	O

Primer	O
and	O
probe	O
sets	O
developed	O
were	O
both	O
sensitive	O
and	O
specific	O
.	O

The	O
relative	O
profiles	O
of	O
a	O
number	O
of	O
bacteria	O
in	O
45	O
-	O
h	O
-	O
old	O
biofilms	O
were	O
determined	O
and	O
,	O
when	O
compared	O
to	O
saliva	O
samples	O
,	O
it	O
was	O
found	O
that	O
most	O
of	O
the	O
bacteria	O
identified	O
in	O
saliva	O
also	O
populated	O
the	O
in	O
vitro	O
plaque	O
,	O
including	O
some	O
anaerobes	O
.	O

Brief	O
exposure	O
of	O
biofilms	O
to	O
chlorhexidine	O
resulted	O
in	O
significant	O
losses	O
in	O
viability	O
.	O

This	O
new	O
broad	O
spectrum	O
QPCR	O
assay	O
in	O
combination	O
with	O
the	O
in	O
vitro	O
plaque	O
model	O
will	O
be	O
of	O
significant	O
value	O
in	O
the	O
quantitative	O
study	O
of	O
the	O
microbial	O
composition	O
of	O
human	O
saliva	O
,	O
saliva	O
-	O
derived	O
plaque	O
,	O
and	O
pre	O
-	O
clinical	O
evaluation	O
of	O
potential	O
antimicrobial	O
and	O
antiplaque	O
molecules	O
.	O

Sutures	O
used	O
in	O
oral	O
surgery	O
should	O
avoid	O
or	O
limit	O
bacterial	O
adhesion	O
and	O
proliferation	O
to	O
those	O
parts	O
exposed	O
to	O
oral	O
fluids	O
.	O

Hence	O
,	O
microbial	O
colonization	O
on	O
various	O
intraoral	O
suture	O
materials	O
from	O
patients	O
undergoing	O
dental	O
surgery	O
was	O
compared	O
.	O

PATIENTS	O
AND	O
During	O
dentoalveolar	O
surgery	O
,	O
various	O
suture	O
materials	O
were	O
used	O
in	O
60	O
patients	O
,	O
who	O
were	O
randomly	O
divided	O
into	O
5	O
groups	O
of	O
12	O
.	O

In	O
each	O
group	O
,	O
silk	O
was	O
placed	O
intraorally	O
in	O
association	O
with	O
a	O
different	O
type	O
of	O
suture	O
(	O
ie	O
,	O
Supramid	O
,	O
Synthofil	O
,	O
Ethibond	O
Excel	O
,	O
Ti	O
-	O
cron	O
,	O
Monocryl	O
)	O
at	O
the	O
same	O
site	O
to	O
compare	O
microbial	O
colonization	O
intraindividually	O
.	O

Eight	O
days	O
postoperatively	O
,	O
the	O
sutures	O
were	O
removed	O
,	O
and	O
adhered	O
micro	O
-	O
organisms	O
were	O
isolated	O
,	O
counted	O
,	O
and	O
identified	O
through	O
enzymatic	O
activities	O
and	O
fermentation	O
of	O
sugars	O
.	O

In	O
all	O
60	O
patients	O
,	O
silk	O
sutures	O
exhibited	O
the	O
smallest	O
affinity	O
toward	O
the	O
adhesion	O
of	O
bacteria	O
compared	O
with	O
considerable	O
proliferation	O
with	O
nonresorbable	O
multifilament	O
sutures	O
(	O
Supramid	O
,	O
Synthofil	O
,	O
Ethibond	O
Excel	O
,	O
Ti	O
-	O
cron	O
)	O
.	O

On	O
the	O
contrary	O
,	O
the	O
microbial	O
load	O
was	O
significantly	O
lower	O
when	O
absorbable	O
monofilament	O
Monocryl	O
was	O
used	O
.	O

A	O
greater	O
quantity	O
of	O
bacteria	O
was	O
found	O
on	O
nonresorbable	O
sutures	O
than	O
on	O
absorbable	O
ones	O
,	O
and	O
nearly	O
2	O
times	O
more	O
facultative	O
anaerobic	O
bacteria	O
were	O
isolated	O
in	O
total	O
.	O

Our	O
results	O
show	O
that	O
bacteria	O
adhere	O
with	O
different	O
affinity	O
to	O
various	O
types	O
of	O
suture	O
materials	O
.	O

Absorbable	O
silk	O
and	O
Monocryl	O
exhibited	O
the	O
smallest	O
number	O
of	O
adherent	O
bacteria	O
.	O

Colonization	O
by	O
pathogens	O
on	O
sutures	O
leads	O
to	O
the	O
recommendation	O
that	O
sutures	O
should	O
be	O
removed	O
as	O
early	O
as	O
possible	O
after	O
surgery	O
is	O
performed	O
,	O
to	O
eliminate	O
or	O
to	O
limit	O
the	O
reservoir	O
for	O
oral	O
pathogens	O
.	O

This	O
recommendation	O
is	O
dependent	O
on	O
whether	O
the	O
suture	O
is	O
absorbable	O
.	O

The	O
objective	O
of	O
this	O
trial	O
was	O
to	O
measure	O
the	O
antimicrobial	O
effects	O
of	O
a	O
minocycline	O
HCl	O
microsphere	O
(	O
MM	O
)	O
local	O
drug	O
-	O
delivery	O
system	O
when	O
used	O
as	O
an	O
adjunct	O
to	O
scaling	O
and	O
root	O
planing	O
(	O
SRP	O
)	O
.	O

DNA	O
probe	O
analysis	O
for	O
40	O
bacteria	O
was	O
used	O
to	O
evaluate	O
the	O
oral	O
bacteria	O
of	O
127	O
subjects	O
with	O
moderate	O
to	O
advanced	O
chronic	O
periodontitis	O
.	O

Subjects	O
were	O
randomly	O
assigned	O
to	O
either	O
SRP	O
alone	O
(	O
N	O
=	O
65	O
)	O
or	O
MM	O
+	O
SRP	O
(	O
N	O
=	O
62	O
)	O
.	O

The	O
primary	O
endpoints	O
of	O
this	O
study	O
were	O
changes	O
in	O
numbers	O
and	O
proportions	O
of	O
the	O
red	B-bacteria
-	I-bacteria
complex	I-bacteria
bacteria	I-bacteria
(	O
RCB	B-bacteria
)	O
and	O
the	O
sum	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
formally	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
relative	O
to	O
40	O
oral	O
bacteria	O
at	O
each	O
test	O
site	O
from	O
baseline	O
to	O
day	O
30	O
.	O

Numbers	O
of	O
RCB	B-bacteria
from	O
the	O
five	O
test	O
sites	O
were	O
averaged	O
to	O
provide	O
a	O
value	O
for	O
each	O
subject	O
.	O

MM	O
+	O
SRP	O
reduced	O
the	O
proportion	O
of	O
RCB	B-bacteria
by	O
6	O
.	O
49	O
%	O
and	O
the	O
numbers	O
by	O
9	O
.	O
4	O
x	O
10	O
(	O
5	O
)	O
.	O

The	O
reduction	O
in	O
RCB	B-bacteria
proportions	O
and	O
numbers	O
by	O
SRP	O
alone	O
(	O
5	O
.	O
03	O
%	O
and	O
5	O
.	O
1	O
x	O
10	O
(	O
5	O
)	O
,	O
respectively	O
)	O
was	O
significantly	O
less	O
.	O

In	O
addition	O
,	O
MM	O
+	O
SRP	O
reduced	O
probing	O
depth	O
by	O
1	O
.	O
38	O
mm	O
(	O
compared	O
to	O
1	O
.	O
01	O
mm	O
by	O
SRP	O
alone	O
)	O
,	O
bleeding	O
on	O
probing	O
was	O
reduced	O
by	O
25	O
.	O
2	O
%	O
(	O
compared	O
to	O
13	O
.	O
8	O
%	O
by	O
SRP	O
alone	O
)	O
,	O
and	O
a	O
clinical	O
attachment	O
level	O
gain	O
of	O
1	O
.	O
16	O
mm	O
(	O
compared	O
to	O
0	O
.	O
80	O
mm	O
by	O
SRP	O
alone	O
)	O
was	O
achieved	O
.	O

These	O
observations	O
support	O
the	O
hypothesis	O
that	O
RCBs	B-bacteria
are	O
responsible	O
for	O
periodontal	O
disease	O
and	O
that	O
local	O
antimicrobial	O
therapy	O
using	O
MM	O
+	O
SRP	O
effectively	O
reduces	O
numbers	O
of	O
RCBs	B-bacteria
and	O
their	O
proportions	O
to	O
a	O
greater	O
extent	O
than	O
SRP	O
alone	O
.	O

The	O
authors	O
examined	O
the	O
tongue	O
bacteria	O
associated	O
with	O
oral	O
halitosis	O
(	O
bad	O
breath	O
originating	O
from	O
the	O
oral	O
cavity	O
)	O
,	O
focusing	O
on	O
noncultivable	O
bacteria	O
-	O
bacteria	O
that	O
can	O
not	O
be	O
identified	O
by	O
bacterial	O
culture	O
techniques	O
.	O

The	O
authors	O
took	O
samples	O
from	O
the	O
dorsal	O
tongue	O
surface	O
of	O
eight	O
adult	O
subjects	O
with	O
halitosis	O
and	O
five	O
control	O
subjects	O
who	O
did	O
not	O
have	O
halitosis	O
.	O

They	O
identified	O
the	O
bacteria	O
in	O
these	O
samples	O
by	O
using	O
both	O
anaerobic	O
culture	O
and	O
direct	O
amplification	O
of	O
16S	O
ribosomal	O
DNA	O
,	O
a	O
method	O
that	O
can	O
identify	O
both	O
cultivable	O
and	O
noncultivable	O
microorganisms	O
.	O

They	O
analyzed	O
the	O
resulting	O
microbiological	O
data	O
using	O
chi	O
(	O
2	O
)	O
and	O
correlation	O
coefficient	O
tests	O
.	O

Clinical	O
measures	O
of	O
halitosis	O
were	O
correlated	O
highly	O
with	O
each	O
other	O
and	O
with	O
tongue	O
coating	O
scores	O
.	O

Of	O
4	O
,	O
088	O
isolates	O
and	O
phylotypes	O
identified	O
from	O
the	O
13	O
subjects	O
,	O
32	O
species	O
including	O
13	O
noncultivable	O
species	O
were	O
found	O
only	O
in	O
subjects	O
with	O
halitosis	O
.	O

Solobacterium	B-bacteria
moorei	I-bacteria
was	O
present	O
in	O
all	O
subjects	O
with	O
halitosis	O
but	O
not	O
in	O
any	O
control	O
subjects	O
.	O

Subjects	O
with	O
halitosis	O
harbor	O
some	O
bacterial	O
species	O
on	O
their	O
dorsal	O
tongue	O
surfaces	O
that	O
are	O
distinct	O
from	O
bacterial	O
species	O
found	O
in	O
control	O
subjects	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
hypothesis	O
that	O
halitosis	O
has	O
a	O
microbial	O
etiology	O
.	O

Like	O
other	O
oral	O
diseases	O
with	O
microbial	O
etiology	O
,	O
halitosis	O
may	O
be	O
amenable	O
to	O
specific	O
and	O
nonspecific	O
antimicrobial	O
therapy	O
targeted	O
toward	O
the	O
bacteria	O
associated	O
with	O
it	O
.	O

Because	O
of	O
its	O
excellent	O
osteogenic	O
potential	O
,	O
autogenous	O
bone	O
is	O
the	O
preferred	O
grafting	O
material	O
for	O
dental	O
procedures	O
;	O
however	O
,	O
bone	O
collected	O
in	O
osseous	O
coagulum	O
traps	O
is	O
subject	O
to	O
contamination	O
by	O
oral	O
bacteria	O
.	O

This	O
study	O
assessed	O
bacterial	O
contamination	O
of	O
osseous	O
coagulum	O
and	O
tested	O
treatments	O
for	O
reducing	O
contamination	O
.	O

Fifty	O
bone	O
samples	O
from	O
patients	O
undergoing	O
implant	O
osteotomy	O
procedures	O
were	O
collected	O
in	O
osseous	O
coagulum	O
traps	O
,	O
divided	O
into	O
groups	O
of	O
10	O
,	O
and	O
rinsed	O
with	O
normal	O
saline	O
,	O
0	O
.	O
12	O
%	O
chlorhexidine	O
,	O
or	O
50	O
mg	O
/	O
mL	O
tetracycline	O
.	O

Twenty	O
control	O
samples	O
received	O
no	O
treatment	O
.	O

The	O
bone	O
samples	O
were	O
plated	O
in	O
triplicate	O
on	O
selective	O
and	O
differential	O
media	O
to	O
assay	O
aerobic	O
and	O
anaerobic	O
bacteria	O
and	O
potential	O
bacterial	O
pathogens	O
,	O
including	O
staphylococci	B-bacteria
,	O
streptococci	B-bacteria
,	O
enterics	B-bacteria
,	O
and	O
black	O
-	O
pigmented	O
bacteria	O
(	O
BPB	O
)	O
.	O

Inoculations	O
were	O
performed	O
with	O
an	O
Autoplate	O
4000	O
,	O
and	O
plates	O
were	O
incubated	O
at	O
37	O
degrees	O
C	O
either	O
aerobically	O
or	O
in	O
a	O
Coy	O
anaerobic	O
chamber	O
.	O

Bacteria	O
were	O
isolated	O
from	O
all	O
samples	O
.	O

In	O
control	O
samples	O
,	O
the	O
mean	O
colony	O
-	O
forming	O
units	O
(	O
cfu	O
)	O
per	O
milliliter	O
of	O
suspended	O
osseous	O
coagulum	O
was	O
6	O
.	O
5	O
x	O
10	O
(	O
4	O
)	O
+	O
/	O
-	O
9	O
.	O
6	O
x	O
10	O
(	O
4	O
)	O
in	O
aerobic	O
cultures	O
and	O
4	O
.	O
8	O
x	O
10	O
(	O
4	O
)	O
+	O
/	O
-	O
6	O
.	O
9	O
x	O
10	O
(	O
4	O
)	O
in	O
anaerobic	O
cultures	O
.	O

Viridans	B-bacteria
streptococci	I-bacteria
were	O
isolated	O
from	O
46	O
samples	O
,	O
with	O
a	O
mean	O
of	O
2	O
.	O
9	O
x	O
10	O
(	O
4	O
)	O
+	O
/	O
-	O
4	O
.	O
1	O
x	O
10	O
(	O
4	O
)	O
cfu	O
/	O
mL	O
.	O

Enterics	O
were	O
in	O
16	O
samples	O
with	O
cfu	O
ranging	O
from	O
200	O
cfu	O
/	O
mL	O
to	O
3	O
.	O
4	O
x	O
10	O
(	O
4	O
)	O
cfu	O
/	O
mL	O
.	O

Mannitol	O
nonfermenting	B-bacteria
staphylococci	I-bacteria
were	O
found	O
in	O
one	O
sample	O
at	O
106	O
cfu	O
/	O
mL	O
.	O

BPB	O
were	O
not	O
isolated	O
.	O

A	O
Mann	O
-	O
Whitney	O
U	O
test	O
with	O
significance	O
set	O
at	O
P	O
=	O
.	O
05	O
determined	O
that	O
the	O
only	O
statistically	O
significant	O
reductions	O
in	O
bacterial	O
numbers	O
occurred	O
in	O
tetracycline	O
-	O
treated	O
samples	O
of	O
anaerobic	O
bacteria	O
(	O
5	O
-	O
fold	O
decrease	O
,	O
P	O
=	O
.	O
02	O
)	O
and	O
aerobic	O
bacteria	O
(	O
6	O
-	O
fold	O
decrease	O
,	O
P	O
=	O
.	O
01	O
)	O
.	O

Tetracycline	O
treatments	O
effected	O
a	O
7	O
-	O
fold	O
decrease	O
in	O
streptococci	B-bacteria
,	O
but	O
the	O
difference	O
was	O
not	O
significant	O
(	O
P	O
=	O
.	O
07	O
)	O
.	O

These	O
data	O
indicate	O
significant	O
bacterial	O
contamination	O
of	O
bone	O
collected	O
in	O
osseous	O
coagulum	O
traps	O
and	O
justify	O
further	O
research	O
into	O
methods	O
for	O
eliminating	O
that	O
contamination	O
.	O

Primary	O
infection	O
of	O
oral	O
epithelial	O
cells	O
by	O
HIV	O
-	O
1	O
,	O
if	O
it	O
occurs	O
,	O
could	O
promote	O
systemic	O
infection	O
.	O

Most	O
primary	O
systemic	O
infections	O
are	O
associated	O
with	O
R5	O
-	O
type	O
HIV	O
-	O
1	O
targeting	O
the	O
R5	O
-	O
specific	O
coreceptor	O
CCR5	O
,	O
which	O
is	O
not	O
usually	O
expressed	O
on	O
oral	O
keratinocytes	O
.	O

Because	O
coinfection	O
with	O
other	O
microbes	O
has	O
been	O
suggested	O
to	O
modulate	O
cellular	O
infection	O
by	O
HIV	O
-	O
1	O
,	O
we	O
hypothesized	O
that	O
oral	O
keratinocytes	O
may	O
up	O
-	O
regulate	O
CCR5	O
in	O
response	O
to	O
the	O
oral	O
endogenous	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
by	O
cysteine	O
-	O
protease	O
(	O
gingipains	O
)	O
activation	O
of	O
the	O
protease	O
-	O
activated	O
receptors	O
(	O
PARs	O
)	O
or	O
LPS	O
signaling	O
through	O
the	O
TLRs	O
.	O

The	O
OKF6	O
/	O
TERT	O
-	O
2	O
-	O
immortalized	O
normal	O
human	O
oral	O
keratinocyte	O
line	O
expressed	O
CXCR4	O
,	O
whereas	O
CCR5	O
was	O
not	O
detectable	O
.	O

When	O
exposed	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
,	O
TERT	O
-	O
2	O
cells	O
induced	O
greater	O
time	O
-	O
dependent	O
expression	O
of	O
CCR5	O
-	O
specific	O
mRNA	O
and	O
surface	O
coreceptors	O
than	O
CXCR4	O
.	O

By	O
comparing	O
arg	O
-	O
(	O
Rgp	O
)	O
and	O
lys	O
-	O
gingipain	O
(	O
Kgp	O
)	O
mutants	O
,	O
a	O
mutant	O
deficient	O
in	O
both	O
proteases	O
,	O
and	O
the	O
action	O
of	O
trypsin	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
Rgp	O
was	O
strongly	O
suggested	O
to	O
cleave	O
PAR	O
-	O
1	O
and	O
PAR	O
-	O
2	O
to	O
up	O
-	O
regulate	O
CCR5	O
.	O

CCR5	O
was	O
also	O
slightly	O
up	O
-	O
regulated	O
by	O
an	O
isogenic	O
gingipain	O
-	O
deficient	O
mutant	O
,	O
suggesting	O
the	O
presence	O
of	O
a	O
nongingipain	O
-	O
mediated	O
mechanism	O
.	O

Purified	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
also	O
up	O
-	O
regulated	O
CCR5	O
.	O

Blocking	O
TLR2	O
and	O
TLR4	O
receptors	O
with	O
Abs	O
attenuated	O
induction	O
of	O
CCR5	O
,	O
suggesting	O
LPS	O
signaling	O
through	O
TLRs	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
therefore	O
,	O
selectively	O
up	O
-	O
regulated	O
CCR5	O
by	O
two	O
independent	O
signaling	O
pathways	O
,	O
Rgp	O
acting	O
on	O
PAR	O
-	O
1	O
and	O
PAR	O
-	O
2	O
,	O
and	O
LPS	O
on	O
TLR2	O
and	O
TLR4	O
.	O

By	O
inducing	O
CCR5	O
expression	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
coinfection	O
could	O
promote	O
selective	O
R5	O
-	O
type	O
HIV	O
-	O
1	O
infection	O
of	O
oral	O
keratinocytes	O
.	O

To	O
assess	O
the	O
effectiveness	O
of	O
0	O
.	O
2	O
%	O
chlorhexidine	O
gluconate	O
mouth	O
rinse	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
lactobacilli	B-bacteria
in	O
orthodontic	O
patients	O
with	O
fixed	O
appliances	O
.	O

Twenty	O
patients	O
,	O
aged	O
13	O
-	O
18	O
,	O
with	O
fixed	O
orthodontic	O
appliances	O
participated	O
in	O
the	O
study	O
.	O

The	O
levels	O
of	O
S	B-bacteria
mutans	I-bacteria
and	O
lactobacilli	B-bacteria
in	O
saliva	O
samples	O
were	O
evaluated	O
at	O
four	O
stages	O
:	O
at	O
the	O
beginning	O
of	O
the	O
orthodontic	O
treatment	O
,	O
at	O
least	O
2	O
weeks	O
after	O
the	O
bonding	O
of	O
brackets	O
,	O
1	O
week	O
after	O
the	O
introduction	O
of	O
0	O
.	O
2	O
%	O
chlorhexidine	O
gluconate	O
mouth	O
rinse	O
,	O
and	O
at	O
the	O
fourth	O
week	O
.	O

The	O
changes	O
in	O
S	B-bacteria
mutans	I-bacteria
and	O
lactobacilli	B-bacteria
levels	O
were	O
analyzed	O
via	O
Wilcoxon	O
test	O
.	O

Increases	O
in	O
bacterial	O
levels	O
of	O
S	B-bacteria
mutans	I-bacteria
and	O
lactobacilli	B-bacteria
were	O
detected	O
after	O
the	O
orthodontic	O
appliances	O
were	O
bonded	O
.	O

A	O
significant	O
decrease	O
in	O
S	B-bacteria
mutans	I-bacteria
levels	O
was	O
observed	O
1	O
week	O
after	O
the	O
introduction	O
of	O
chlorhexidine	O
mouth	O
rinse	O
.	O

An	O
0	O
.	O
2	O
%	O
chlorhexidine	O
gluconate	O
mouth	O
rinse	O
decreased	O
S	B-bacteria
mutans	I-bacteria
levels	O
,	O
but	O
had	O
no	O
effect	O
on	O
lactobacilli	B-bacteria
levels	O
.	O

This	O
paper	O
aims	O
to	O
critically	O
review	O
current	O
knowledge	O
about	O
the	O
key	O
factors	O
involved	O
in	O
oral	O
colonization	O
of	O
the	O
cariogenic	O
group	O
of	O
bacteria	O
,	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
in	O
young	O
children	O
.	O

MS	B-bacteria
,	O
consisting	O
mainly	O
of	O
the	O
species	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
are	O
commonly	O
cultured	O
from	O
the	O
mouths	O
of	O
infants	O
,	O
with	O
prevalence	O
of	O
infection	O
ranging	O
from	O
around	O
30	O
per	O
cent	O
in	O
3	O
month	O
old	O
predentate	O
children	O
to	O
over	O
80	O
per	O
cent	O
in	O
24	O
month	O
old	O
children	O
with	O
primary	O
teeth	O
.	O

MS	B-bacteria
is	O
usually	O
transmitted	O
to	O
children	O
through	O
their	O
mothers	O
,	O
and	O
the	O
risk	O
of	O
transmission	O
increases	O
with	O
high	O
maternal	O
salivary	O
levels	O
of	O
MS	B-bacteria
and	O
frequent	O
inoculation	O
.	O

Factors	O
that	O
affect	O
the	O
colonization	O
of	O
MS	B-bacteria
may	O
be	O
divided	O
into	O
bacterial	O
virulence	O
,	O
host	O
-	O
related	O
and	O
environmental	O
factors	O
.	O

Complex	O
interaction	O
among	O
these	O
factors	O
determine	O
the	O
success	O
and	O
timing	O
of	O
MS	B-bacteria
colonization	O
in	O
the	O
child	O
.	O

As	O
clinical	O
studies	O
have	O
shown	O
that	O
caries	O
risk	O
is	O
correlated	O
with	O
age	O
at	O
which	O
initial	O
MS	B-bacteria
colonization	O
occurred	O
,	O
strategies	O
for	O
the	O
prevention	O
of	O
dental	O
caries	O
should	O
include	O
timely	O
control	O
of	O
colonization	O
of	O
the	O
cariogenic	O
bacteria	O
in	O
the	O
mouths	O
of	O
young	O
children	O
.	O

Oral	O
administration	O
of	O
artificial	O
cell	O
microcapsules	O
has	O
been	O
proposed	O
for	O
various	O
therapy	O
procedures	O
using	O
biologically	O
active	O
materials	O
.	O

Recently	O
we	O
have	O
designed	O
novel	O
APPPA	O
microcapsules	O
using	O
alginate	O
,	O
poly	O
-	O
L	O
-	O
lysine	O
,	O
pectin	O
,	O
poly	O
-	O
L	O
-	O
lysine	O
and	O
alginate	O
that	O
have	O
shown	O
superior	O
oral	O
delivery	O
features	O
.	O

This	O
article	O
investigates	O
,	O
in	O
-	O
vitro	O
using	O
a	O
computer	O
controlled	O
dynamic	O
gastrointestinal	O
(	O
GI	O
)	O
model	O
,	O
effects	O
of	O
APPPA	O
microcapsules	O
on	O
health	O
of	O
gastrointestinal	O
(	O
GI	O
)	O
microbial	O
flora	O
.	O

The	O
impact	O
of	O
APPPA	O
microcapsules	O
on	O
GI	O
bacterial	O
population	O
,	O
total	O
anaerobes	O
,	O
total	O
aerobes	O
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
Staphylococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
has	O
been	O
analyzed	O
.	O

In	O
addition	O
,	O
the	O
effects	O
of	O
microcapsules	O
on	O
GI	O
microbial	O
extracellular	O
enzymatic	O
activities	O
have	O
been	O
investigated	O
.	O

Result	O
shows	O
the	O
altered	O
activities	O
of	O
microbial	O
flora	O
and	O
enzymes	O
due	O
to	O
the	O
use	O
of	O
APPPA	O
microcapsule	O
.	O

The	O
most	O
disparity	O
is	O
observed	O
in	O
the	O
colon	O
ascendans	O
microbial	O
activities	O
.	O

This	O
study	O
would	O
have	O
significant	O
impact	O
on	O
future	O
microcapsule	O
design	O
.	O

However	O
,	O
further	O
in	O
-	O
vivo	O
studies	O
are	O
required	O
.	O

The	O
inhibitory	O
role	O
of	O
TNF	O
-	O
alpha	O
on	O
survival	O
of	O
naive	O
and	O
IL	O
-	O
2	O
treated	O
NK	O
cells	O
has	O
been	O
demonstrated	O
in	O
the	O
past	O
.	O

However	O
,	O
its	O
effect	O
on	O
the	O
function	O
of	O
these	O
cells	O
against	O
tumor	O
cells	O
,	O
in	O
particular	O
against	O
oral	O
tumors	O
has	O
not	O
been	O
established	O
.	O

We	O
investigated	O
the	O
significance	O
of	O
secreted	O
TNF	O
-	O
alpha	O
in	O
death	O
and	O
functional	O
loss	O
of	O
splenocytes	O
and	O
NK	O
cells	O
in	O
ex	O
-	O
vivo	O
cultures	O
with	O
oral	O
tumors	O
.	O

Oral	O
tumors	O
trigger	O
potent	O
secretion	O
of	O
TNF	O
-	O
alpha	O
by	O
human	O
and	O
murine	O
immune	O
effectors	O
.	O

Absence	O
of	O
TNF	O
-	O
alpha	O
increases	O
the	O
cytotoxic	O
activity	O
and	O
secretion	O
of	O
IFN	O
-	O
gamma	O
by	O
IL	O
-	O
2	O
treated	O
splenocytes	O
and	O
NK	O
cells	O
in	O
co	O
-	O
cultures	O
with	O
MOK	O
L2D1	O
+	O
/	O
p53	O
-	O
/	O
-	O
oral	O
tumor	O
cells	O
.	O

IL	O
-	O
2	O
treated	O
splenocytes	O
and	O
NK	O
cells	O
from	O
TNF	O
-	O
alpha	O
-	O
/	O
-	O
mice	O
survive	O
and	O
proliferate	O
more	O
when	O
compared	O
to	O
cells	O
from	O
TNF	O
-	O
alpha	O
+	O
/	O
+	O
mice	O
.	O

Cell	O
death	O
induced	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
an	O
oral	O
bacteria	O
,	O
in	O
TNF	O
-	O
alpha	O
-	O
/	O
-	O
splenocytes	O
are	O
considerably	O
lower	O
than	O
that	O
induced	O
in	O
TNF	O
-	O
alpha	O
+	O
/	O
+	O
splenocytes	O
where	O
potent	O
release	O
of	O
TNF	O
-	O
alpha	O
is	O
reproducibly	O
observed	O
.	O

Addition	O
of	O
exogenous	O
rTNF	O
-	O
alpha	O
to	O
IL	O
-	O
2	O
treated	O
splenocytes	O
and	O
NK	O
cells	O
decreased	O
survival	O
and	O
function	O
of	O
splenocytes	O
and	O
NK	O
cells	O
obtained	O
from	O
TNF	O
-	O
alpha	O
-	O
/	O
-	O
mice	O
against	O
oral	O
tumors	O
.	O

These	O
findings	O
suggest	O
that	O
potent	O
induction	O
of	O
TNF	O
-	O
alpha	O
during	O
interaction	O
of	O
immune	O
effectors	O
with	O
oral	O
tumors	O
and	O
/	O
or	O
oral	O
bacteria	O
is	O
an	O
important	O
factor	O
in	O
decreasing	O
the	O
function	O
and	O
survival	O
of	O
cytotoxic	O
immune	O
effectors	O
.	O

Strategies	O
to	O
neutralize	O
TNF	O
-	O
alpha	O
may	O
be	O
beneficial	O
in	O
the	O
treatment	O
of	O
oral	O
cancers	O
.	O

Probiotics	O
have	O
been	O
extensively	O
studied	O
for	O
their	O
health	O
-	O
promoting	O
effects	O
.	O

The	O
main	O
field	O
of	O
research	O
has	O
been	O
in	O
the	O
gastrointestinal	O
tract	O
.	O

However	O
,	O
in	O
the	O
past	O
few	O
years	O
probiotics	O
have	O
also	O
been	O
investigated	O
in	O
the	O
oral	O
health	O
perspective	O
,	O
which	O
is	O
the	O
topic	O
of	O
the	O
present	O
review	O
.	O

We	O
discuss	O
the	O
mechanisms	O
of	O
bacterial	O
adhesion	O
,	O
potential	O
of	O
probiotics	O
in	O
oral	O
cavity	O
colonization	O
,	O
interspecies	O
interactions	O
,	O
and	O
possible	O
effects	O
on	O
immunomodulation	O
,	O
and	O
means	O
of	O
probiotic	O
administration	O
.	O

We	O
suggest	O
that	O
probiotic	O
treatment	O
of	O
diseases	O
other	O
than	O
dental	O
caries	O
and	O
periodontal	O
disease	O
should	O
also	O
be	O
systematically	O
investigated	O
.	O

In	O
general	O
,	O
hardly	O
any	O
randomized	O
controlled	O
trials	O
have	O
been	O
conducted	O
in	O
this	O
area	O
and	O
the	O
studies	O
on	O
probiotics	O
vs	O
oral	O
health	O
are	O
still	O
in	O
their	O
cradle	O
.	O

Hence	O
,	O
much	O
more	O
investigations	O
are	O
called	O
for	O
before	O
any	O
evidence	O
-	O
based	O
conclusions	O
can	O
be	O
drawn	O
:	O
if	O
or	O
not	O
probiotic	O
therapy	O
can	O
be	O
recommended	O
for	O
oral	O
health	O
purposes	O
.	O

Assessment	O
of	O
the	O
presence	O
of	O
probiotic	O
bacteria	O
in	O
feces	O
after	O
oral	O
ingestion	O
.	O

Probiotic	O
bacteria	O
are	O
said	O
to	O
have	O
beneficial	O
effects	O
on	O
the	O
host	O
.	O

As	O
a	O
precondition	O
for	O
any	O
effect	O
,	O
probiotic	O
strains	O
must	O
survive	O
passage	O
through	O
the	O
gastrointestinal	O
tract	O
.	O

The	O
feces	O
of	O
seven	O
volunteers	O
were	O
analyzed	O
for	O
the	O
presence	O
of	O
probiotic	O
strains	O
after	O
one	O
week	O
'	O
s	O
oral	O
ingestion	O
of	O
each	O
of	O
six	O
commercially	O
available	O
products	O
:	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
Nissle	I-bacteria
0	O
.	O
5	O
-	O
5	O
x	O
10	O
(	O
9	O
)	O
cells	O
(	O
Mutaflor	O
)	O
,	O
Enterococcus	B-bacteria
faecium	I-bacteria
SF	I-bacteria
68	I-bacteria
7	O
.	O
5	O
x	O
10	O
(	O
7	O
)	O
cells	O
(	O
Bioflorin	O
)	O
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
and	O
Bifidobacterium	B-bacteria
infantis	I-bacteria
both	O
1	O
x	O
10	O
(	O
9	O
)	O
cells	O
(	O
Infloran	O
)	O
,	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
and	O
Bifidobacterium	B-bacteria
longum	I-bacteria
both	O
1	O
x	O
10	O
(	O
8	O
)	O
cells	O
(	O
Omniflora	O
)	O
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
rhamnosus	I-bacteria
1	O
x	O
10	O
(	O
9	O
)	O
cells	O
(	O
Antibiophilus	O
)	O
,	O
and	O
yoghurt	O
enriched	O
with	O
Lactobacillus	B-bacteria
casei	I-bacteria
Immunitas	O
1	O
x	O
10	O
(	O
10	O
)	O
cells	O
(	O
Actimel	O
)	O
.	O

Ten	O
colonies	O
were	O
selected	O
from	O
each	O
stool	O
sample	O
,	O
and	O
DNA	O
was	O
extracted	O
and	O
typed	O
using	O
random	O
amplification	O
of	O
polymorphic	O
DNA	O
(	O
RAPD	O
)	O
.	O

Typing	O
patterns	O
of	O
the	O
ingested	O
probiotics	O
and	O
the	O
fecal	O
isolates	O
were	O
compared	O
.	O

Fingerprints	O
identical	O
to	O
the	O
ingested	O
probiotic	O
strains	O
were	O
recovered	O
from	O
fecal	O
samples	O
of	O
4	O
/	O
7	O
volunteers	O
after	O
one	O
week	O
of	O
Mutaflor	O
,	O
from	O
4	O
/	O
6	O
after	O
taking	O
Bioflorin	O
,	O
and	O
from	O
1	O
/	O
6	O
after	O
Infloran	O
.	O

Cultivation	O
of	O
strains	O
of	O
the	O
same	O
species	O
from	O
fecal	O
specimens	O
was	O
negative	O
after	O
consumption	O
of	O
Antibiophilus	O
,	O
Omniflora	O
and	O
Actimel	O
.	O

After	O
oral	O
consumption	O
of	O
probiotics	O
,	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
enterococci	B-bacteria
could	O
be	O
detected	O
in	O
stool	O
samples	O
(	O
57	O
%	O
and	O
67	O
%	O
,	O
respectively	O
)	O
.	O

In	O
contrast	O
,	O
with	O
only	O
one	O
exception	O
,	O
ingested	O
lactobacilli	B-bacteria
and	O
bifidobacteria	B-bacteria
could	O
not	O
be	O
detected	O
in	O
human	O
feces	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
susceptibility	O
of	O
nonperiodontopathic	O
and	O
periodontopathic	O
bacteria	O
to	O
major	O
defense	O
mechanisms	O
for	O
bacterial	O
clearance	O
in	O
gingival	O
sulcus	O
.	O

Twenty	O
strains	O
of	O
13	O
oral	O
bacterial	O
species	O
were	O
studied	O
for	O
their	O
susceptibility	O
to	O
phagocytosis	O
by	O
human	O
neutrophils	O
and	O
to	O
the	O
antimicrobial	O
peptides	O
LL	O
-	O
37	O
and	O
human	O
beta	O
defensin	O
-	O
3	O
.	O

The	O
minimum	O
inhibitory	O
concentrations	O
of	O
LL	O
-	O
37	O
and	O
human	O
beta	O
defensin	O
-	O
3	O
were	O
determined	O
by	O
a	O
liquid	O
dilution	O
assay	O
,	O
and	O
susceptibility	O
to	O
phagocytosis	O
was	O
examined	O
by	O
a	O
flow	O
cytometric	O
phagocytosis	O
assay	O
.	O

The	O
minimum	O
inhibitory	O
concentrations	O
of	O
LL	O
-	O
37	O
and	O
human	O
beta	O
defensin	O
-	O
3	O
varied	O
greatly	O
,	O
depending	O
on	O
the	O
strain	O
and	O
species	O
.	O

Although	O
a	O
significant	O
difference	O
between	O
the	O
non	O
-	O
and	O
periodontopathic	O
groups	O
was	O
not	O
observed	O
,	O
the	O
red	O
-	O
complex	O
bacteria	O
were	O
more	O
resistant	O
to	O
LL	O
-	O
37	O
than	O
the	O
others	O
(	O
p	O
=	O
0	O
.	O
004	O
)	O
.	O

The	O
susceptibility	O
of	O
oral	O
bacteria	O
to	O
phagocytosis	O
was	O
quite	O
variable	O
,	O
depending	O
on	O
the	O
species	O
but	O
not	O
on	O
the	O
strains	O
.	O

The	O
periodontopathic	O
bacteria	O
,	O
especially	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
the	O
red	O
-	O
complex	O
triad	O
,	O
were	O
more	O
resistant	O
to	O
phagocytosis	O
than	O
were	O
the	O
nonperiodontopathic	O
bacteria	O
(	O
p	O
=	O
0	O
.	O
0003	O
)	O
.	O

In	O
addition	O
,	O
bacteria	O
resistant	O
both	O
to	O
antimicrobial	O
peptides	O
and	O
to	O
phagocytosis	O
were	O
more	O
common	O
in	O
the	O
periodontopathic	O
group	O
.	O

Our	O
results	O
indicate	O
that	O
immune	O
evasion	O
may	O
contribute	O
to	O
the	O
pathogenicity	O
of	O
some	O
periodontopathic	O
bacteria	O
.	O

Antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
are	O
naturally	O
occurring	O
,	O
broad	O
-	O
spectrum	O
antimicrobial	O
agents	O
that	O
have	O
recently	O
been	O
examined	O
for	O
their	O
utility	O
as	O
therapeutic	O
antibiotics	O
.	O

Unfortunately	O
,	O
they	O
are	O
expensive	O
to	O
produce	O
and	O
are	O
often	O
sensitive	O
to	O
protease	O
digestion	O
.	O

To	O
address	O
this	O
problem	O
,	O
we	O
have	O
examined	O
the	O
activity	O
of	O
a	O
peptide	O
mimetic	O
whose	O
design	O
was	O
based	O
on	O
the	O
structure	O
of	O
magainin	O
,	O
exhibiting	O
its	O
amphiphilic	O
structure	O
.	O

We	O
demonstrate	O
that	O
this	O
compound	O
,	O
meta	O
-	O
phenylene	O
ethynylene	O
(	O
mPE	O
)	O
,	O
exhibits	O
antimicrobial	O
activity	O
at	O
nanomolar	O
concentrations	O
against	O
a	O
variety	O
of	O
bacterial	O
and	O
Candida	O
species	O
found	O
in	O
oral	O
infections	O
.	O

Since	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
an	O
etiological	O
agent	O
of	O
dental	O
caries	O
,	O
colonizes	O
the	O
tooth	O
surface	O
and	O
forms	O
a	O
biofilm	O
,	O
we	O
quantified	O
the	O
activity	O
of	O
this	O
compound	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
growing	O
under	O
conditions	O
that	O
favor	O
biofilm	O
formation	O
.	O

Our	O
results	O
indicate	O
that	O
mPE	O
can	O
prevent	O
the	O
formation	O
of	O
a	O
biofilm	O
at	O
nanomolar	O
concentrations	O
.	O

Incubation	O
with	O
5	O
nM	O
mPE	O
prevents	O
further	O
growth	O
of	O
the	O
biofilm	O
,	O
and	O
100	O
nM	O
mPE	O
reduces	O
viable	O
bacteria	O
in	O
the	O
biofilm	O
by	O
3	O
logs	O
.	O

Structure	O
-	O
function	O
analyses	O
suggest	O
that	O
mPE	O
inhibits	O
the	O
bioactivity	O
of	O
lipopolysaccharide	O
and	O
binds	O
DNA	O
at	O
equimolar	O
ratios	O
,	O
suggesting	O
that	O
it	O
may	O
act	O
both	O
as	O
a	O
membrane	O
-	O
active	O
molecule	O
,	O
similar	O
to	O
magainin	O
,	O
and	O
as	O
an	O
intracellular	O
antibiotic	O
,	O
similar	O
to	O
other	O
AMPs	O
.	O

We	O
conclude	O
that	O
mPE	O
and	O
similar	O
molecules	O
display	O
great	O
potential	O
for	O
development	O
as	O
therapeutic	O
antimicrobials	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
exhibits	O
extensive	O
genotypic	O
diversity	O
,	O
but	O
the	O
role	O
of	O
this	O
variation	O
is	O
poorly	O
understood	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
the	O
number	O
and	O
distribution	O
of	O
genotypes	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
isolated	O
from	O
caries	O
-	O
active	O
and	O
caries	O
-	O
free	O
children	O
and	O
to	O
evaluate	O
some	O
of	O
their	O
phenotypic	O
traits	O
.	O

Stimulated	O
saliva	O
,	O
tongue	O
surface	O
and	O
biofilms	O
over	O
sound	O
and	O
carious	O
teeth	O
surfaces	O
were	O
sampled	O
from	O
10	O
caries	O
-	O
free	O
and	O
11	O
caries	O
-	O
active	O
children	O
aged	O
5	O
-	O
8	O
years	O
.	O

A	O
total	O
of	O
339	O
isolates	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
genotyped	O
by	O
arbitrarily	O
primed	O
polymerase	O
chain	O
reaction	O
using	O
OPA2	O
primer	O
.	O

One	O
isolate	O
from	O
each	O
genotype	O
was	O
tested	O
for	O
its	O
acid	O
susceptibility	O
and	O
its	O
ability	O
to	O
form	O
a	O
biofilm	O
.	O

Fifty	O
-	O
one	O
distinct	O
genotypes	O
were	O
determined	O
,	O
one	O
to	O
three	O
genotypes	O
in	O
each	O
oral	O
sample	O
.	O

A	O
single	O
genotype	O
was	O
detected	O
in	O
seven	O
children	O
,	O
whereas	O
the	O
remaining	O
14	O
children	O
exhibited	O
two	O
to	O
seven	O
genotypes	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
number	O
of	O
genotypes	O
detected	O
in	O
caries	O
-	O
free	O
and	O
caries	O
-	O
active	O
children	O
.	O

No	O
correlation	O
was	O
observed	O
between	O
the	O
number	O
of	O
genotypes	O
and	O
the	O
mutans	B-bacteria
streptococci	I-bacteria
salivary	O
levels	O
.	O

Five	O
of	O
the	O
six	O
high	O
biofilm	O
-	O
forming	O
genotypes	O
were	O
obtained	O
from	O
caries	O
-	O
active	O
children	O
,	O
although	O
the	O
differences	O
in	O
biofilm	O
formation	O
between	O
isolates	O
from	O
caries	O
-	O
free	O
and	O
caries	O
-	O
active	O
children	O
were	O
not	O
statistically	O
significant	O
.	O

Genotypes	O
with	O
low	O
susceptibility	O
to	O
acid	O
challenge	O
were	O
statistically	O
more	O
frequent	O
among	O
isolates	O
from	O
caries	O
-	O
active	O
children	O
than	O
among	O
those	O
from	O
caries	O
-	O
free	O
children	O
.	O

The	O
present	O
data	O
suggested	O
that	O
there	O
were	O
differences	O
in	O
the	O
distribution	O
of	O
genotypes	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
according	O
to	O
the	O
oral	O
site	O
and	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
populations	O
differ	O
in	O
their	O
acid	O
susceptibility	O
and	O
ability	O
to	O
form	O
biofilms	O
,	O
factors	O
allowing	O
their	O
colonization	O
of	O
sucrose	O
-	O
rich	O
environments	O
.	O

Autoinducer	O
-	O
2	O
(	O
AI	O
-	O
2	O
)	O
is	O
a	O
widespread	O
communication	O
-	O
signal	O
molecule	O
that	O
allows	O
bacteria	O
to	O
sense	O
and	O
react	O
to	O
environmental	O
factors	O
.	O

In	O
some	O
streptococci	B-bacteria
AI	O
-	O
2	O
is	O
reported	O
to	O
be	O
involved	O
in	O
virulence	O
expression	O
and	O
biofilm	O
formation	O
.	O

It	O
has	O
earlier	O
been	O
shown	O
that	O
the	O
alga	O
Delisea	O
pulchra	O
produces	O
bromated	O
furanones	O
,	O
which	O
prevent	O
bacterial	O
colonization	O
of	O
the	O
algae	O
.	O

We	O
have	O
previously	O
published	O
a	O
novel	O
and	O
simple	O
synthesis	O
of	O
(	O
Z	O
)	O
-	O
5	O
-	O
bromomethylene	O
-	O
2	O
(	O
5H	O
)	O
-	O
furanone	O
.	O

In	O
this	O
study	O
we	O
showed	O
that	O
our	O
synthesized	O
furanone	O
inhibited	O
biofilm	O
formation	O
and	O
bioluminescence	O
induction	O
by	O
Streptococcus	B-bacteria
anginosus	I-bacteria
,	O
Streptococcus	B-bacteria
intermedius	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
as	O
well	O
as	O
bioluminescence	O
induction	O
by	O
Vibrio	B-bacteria
harveyi	I-bacteria
BB152	I-bacteria
.	O

We	O
suggest	O
that	O
the	O
effect	O
is	O
linked	O
to	O
interference	O
with	O
the	O
AI	O
-	O
2	O
signaling	O
pathway	O
because	O
adding	O
furanone	O
to	O
the	O
medium	O
had	O
no	O
effect	O
on	O
the	O
ability	O
of	O
the	O
AI	O
-	O
2	O
-	O
defective	O
S	O
.	O
anginosus	O
luxS	O
and	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
luxS	O
mutants	O
to	O
form	O
biofilms	O
.	O

Biofilms	O
are	O
complex	O
aggregations	O
of	O
microorganisms	O
attached	O
to	O
a	O
surface	O
.	O

The	O
formation	O
of	O
biofilms	O
might	O
facilitate	O
certain	O
survival	O
and	O
virulence	O
characteristics	O
under	O
some	O
situations	O
.	O

This	O
study	O
tested	O
the	O
hypothesis	O
that	O
the	O
ability	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
to	O
form	O
biofilms	O
is	O
related	O
to	O
the	O
source	O
of	O
the	O
strains	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
strains	I-bacteria
recovered	O
from	O
root	O
canals	O
(	O
n	O
=	O
33	O
)	O
,	O
the	O
oral	O
cavity	O
(	O
n	O
=	O
21	O
)	O
,	O
and	O
non	O
-	O
oral	O
/	O
non	O
-	O
endodontic	O
sources	O
(	O
n	O
=	O
16	O
)	O
were	O
studied	O
.	O

Biofilms	O
were	O
grown	O
in	O
tryptic	O
soy	O
broth	O
in	O
96	O
-	O
well	O
plates	O
for	O
24	O
hours	O
at	O
37	O
degrees	O
C	O
,	O
fixed	O
with	O
Bouin	O
'	O
s	O
fixative	O
,	O
and	O
stained	O
with	O
1	O
%	O
crystal	O
violet	O
.	O

Optical	O
density	O
at	O
570	O
nm	O
(	O
OD	O
(	O
570	O
)	O
)	O
was	O
measured	O
by	O
using	O
a	O
microtiter	O
plate	O
reader	O
.	O

Experiments	O
were	O
performed	O
in	O
quadruplicate	O
on	O
three	O
occasions	O
and	O
mean	O
OD	O
(	O
570	O
)	O
readings	O
determined	O
for	O
each	O
strain	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
groups	O
(	O
p	O
=	O
0	O
.	O
066	O
,	O
Kruskal	O
-	O
Wallis	O
)	O
.	O

Within	O
the	O
root	O
canal	O
and	O
oral	O
isolates	O
there	O
were	O
no	O
significant	O
associations	O
between	O
biofilm	O
formation	O
and	O
the	O
presence	O
of	O
the	O
virulence	O
determinants	O
asa	O
,	O
cylA	O
,	O
esp	O
,	O
and	O
gelE	O
.	O

Salivary	O
occurrence	O
of	O
periodontopathic	O
bacteria	O
is	O
of	O
interest	O
especially	O
in	O
children	O
as	O
a	O
risk	O
indicator	O
for	O
the	O
transmission	O
,	O
development	O
and	O
control	O
of	O
periodontal	O
disease	O
.	O

We	O
assessed	O
the	O
prevalence	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
as	O
microbial	O
complexes	O
in	O
the	O
saliva	O
of	O
children	O
with	O
mixed	O
dentition	O
and	O
healthy	O
gingiva	O
.	O

Paraffin	O
-	O
stimulated	O
saliva	O
samples	O
were	O
collected	O
from	O
41	O
children	O
(	O
22	O
boys	O
and	O
19	O
girls	O
)	O
,	O
aged	O
6	O
-	O
13	O
years	O
old	O
.	O

Gingival	O
health	O
was	O
determined	O
during	O
the	O
initial	O
screening	O
exam	O
.	O

The	O
test	O
bacteria	O
were	O
identified	O
using	O
a	O
16S	O
rRNA	O
-	O
based	O
PCR	O
analysis	O
.	O

P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
was	O
the	O
most	O
frequent	O
species	O
(	O
80	O
%	O
)	O
,	O
followed	O
by	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
(	O
32	O
%	O
)	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
24	O
%	O
)	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
12	O
%	O
)	O
.	O

P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
were	O
not	O
detected	O
.	O

P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
was	O
also	O
common	O
species	O
in	O
combinations	O
.	O

Paired	O
and	O
triple	O
bacterial	O
combinations	O
were	O
found	O
in	O
24	O
%	O
and	O
20	O
%	O
of	O
all	O
children	O
,	O
respectively	O
.	O

There	O
was	O
no	O
positive	O
association	O
between	O
bacterial	O
combinations	O
in	O
colonization	O
and	O
subject	O
'	O
s	O
gender	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
Fisher	O
exact	O
test	O
)	O
.	O

The	O
salivary	O
presence	O
of	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
but	O
not	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
can	O
occur	O
in	O
childhood	O
without	O
clinical	O
signs	O
of	O
gingival	O
disease	O
.	O

Thus	O
,	O
the	O
possible	O
risk	O
of	O
bacterial	O
transmissions	O
through	O
saliva	O
and	O
,	O
the	O
need	O
to	O
screen	O
for	O
periodontal	O
pathogens	O
should	O
be	O
considered	O
before	O
mixed	O
dentition	O
.	O

To	O
evaluate	O
our	O
hypothesis	O
that	O
non	O
-	O
pathogenic	O
bacterial	O
flora	O
inhibit	O
later	O
colonization	O
with	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
in	O
extremely	O
low	O
birth	O
weight	O
(	O
ELBW	O
)	O
infants	O
,	O
we	O
performed	O
a	O
retrospective	O
investigation	O
of	O
the	O
association	O
between	O
non	O
-	O
pathogenic	O
bacterial	O
flora	O
and	O
later	O
inhibition	O
of	O
colonization	O
by	O
MRSA	B-bacteria
in	O
ELBW	O
infants	O
.	O

A	O
total	O
of	O
110	O
preterm	O
infants	O
with	O
birth	O
weight	O
<	O
1	O
,	O
000	O
g	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
of	O
Nagano	O
Children	O
'	O
s	O
Hospital	O
from	O
January	O
1997	O
to	O
December	O
2003	O
were	O
analyzed	O
retrospectively	O
with	O
regard	O
to	O
colonization	O
by	O
MRSA	B-bacteria
during	O
hospitalization	O
.	O

We	O
investigated	O
the	O
incidence	O
of	O
MRSA	B-bacteria
colonization	O
in	O
56	O
infants	O
with	O
non	O
-	O
pathogenic	O
bacterial	O
flora	O
in	O
the	O
oral	O
cavity	O
during	O
the	O
first	O
week	O
after	O
birth	O
and	O
compared	O
them	O
with	O
54	O
infants	O
lacking	O
non	O
-	O
pathogenic	O
bacteria	O
.	O

Incidence	O
rate	O
of	O
colonization	O
by	O
MRSA	B-bacteria
at	O
postnatal	O
week	O
6	O
was	O
significantly	O
lower	O
in	O
infants	O
with	O
non	O
-	O
pathogenic	O
bacterial	O
flora	O
in	O
the	O
oral	O
cavity	O
(	O
32	O
.	O
1	O
%	O
)	O
than	O
in	O
infants	O
without	O
such	O
bacteria	O
during	O
the	O
first	O
week	O
of	O
life	O
(	O
77	O
.	O
8	O
%	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
present	O
results	O
suggest	O
an	O
important	O
role	O
for	O
non	O
-	O
pathogenic	O
bacterial	O
flora	O
in	O
the	O
oral	O
cavity	O
during	O
early	O
life	O
in	O
prevention	O
of	O
later	O
MRSA	B-bacteria
colonization	O
in	O
ELBW	O
infants	O
.	O

Flavors	O
and	O
natural	O
botanic	O
extracts	O
are	O
often	O
used	O
in	O
chewing	O
gum	O
and	O
compressed	O
mints	O
for	O
breath	O
freshening	O
and	O
relief	O
of	O
oral	O
malodor	O
.	O

The	O
oral	O
malodor	O
is	O
a	O
result	O
of	O
bacterial	O
putrification	O
of	O
proteinaceous	O
materials	O
from	O
food	O
or	O
saliva	O
.	O

In	O
this	O
study	O
,	O
magnolia	O
bark	O
extract	O
(	O
MBE	O
)	O
and	O
its	O
two	O
main	O
components	O
,	O
magnolol	O
and	O
honokiol	O
,	O
were	O
evaluated	O
by	O
the	O
minimum	O
inhibition	O
concentration	O
(	O
MIC	O
)	O
test	O
.	O

The	O
inhibitory	O
effect	O
of	O
MBE	O
mint	O
was	O
further	O
evaluated	O
by	O
a	O
kill	O
-	O
time	O
assay	O
study	O
.	O

In	O
addition	O
,	O
an	O
in	O
vivo	O
study	O
was	O
performed	O
on	O
nine	O
healthy	O
volunteers	O
postlunch	O
.	O

Saliva	O
samples	O
were	O
taken	O
before	O
and	O
after	O
subjects	O
consumed	O
mints	O
and	O
gum	O
,	O
with	O
and	O
without	O
MBE	O
.	O

Listerine	O
mouthwash	O
was	O
included	O
as	O
a	O
positive	O
control	O
.	O

The	O
testing	O
results	O
indicated	O
that	O
MBE	O
and	O
its	O
two	O
main	O
constituents	O
demonstrated	O
a	O
strong	O
germ	O
-	O
kill	O
effect	O
against	O
bacteria	O
responsible	O
for	O
halitosis	O
and	O
also	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
bacteria	O
involved	O
in	O
dental	O
caries	O
formation	O
.	O

The	O
MIC	O
of	O
magnolol	O
,	O
honokiol	O
,	O
and	O
MBE	O
on	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
ranged	O
from	O
8	O
to	O
31	O
microg	O
/	O
mL	O
.	O

Kill	O
-	O
time	O
assay	O
results	O
indicated	O
that	O
mints	O
containing	O
0	O
.	O
2	O
%	O
MBE	O
reduced	O
more	O
than	O
99	O
.	O
9	O
%	O
of	O
three	O
oral	O
bacteria	O
within	O
5	O
min	O
of	O
treatment	O
.	O

The	O
in	O
vivo	O
study	O
demonstrated	O
that	O
MBE	O
containing	O
mints	O
reduced	O
total	O
salivary	O
bacteria	O
by	O
61	O
.	O
6	O
%	O
at	O
30	O
min	O
and	O
33	O
.	O
8	O
%	O
at	O
60	O
min	O
postconsumption	O
.	O

In	O
comparison	O
,	O
the	O
flavorless	O
mint	O
reduced	O
total	O
salivary	O
bacteria	O
by	O
3	O
.	O
6	O
%	O
at	O
30	O
min	O
and	O
increased	O
total	O
bacteria	O
by	O
47	O
.	O
9	O
%	O
at	O
60	O
min	O
.	O

The	O
MBE	O
containing	O
chewing	O
gum	O
reduced	O
total	O
salivary	O
bacteria	O
by	O
43	O
.	O
0	O
%	O
at	O
40	O
min	O
,	O
while	O
placebo	O
gum	O
reduced	O
total	O
salivary	O
bacteria	O
by	O
18	O
.	O
0	O
%	O
.	O

In	O
conclusion	O
,	O
MBE	O
demonstrated	O
a	O
significant	O
antibacterial	O
activity	O
against	O
organisms	O
responsible	O
for	O
oral	O
malodor	O
and	O
can	O
be	O
incorporated	O
in	O
compressed	O
mints	O
and	O
chewing	O
gum	O
for	O
improved	O
breath	O
-	O
freshening	O
benefits	O
.	O

The	O
mechanisms	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
by	O
bacteria	O
in	O
the	O
oral	O
cavity	O
are	O
still	O
not	O
clearly	O
defined	O
but	O
salivary	O
streptococci	B-bacteria
have	O
been	O
reported	O
to	O
generate	O
NO	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
clarify	O
the	O
mechanism	O
of	O
nitrite	O
metabolism	O
and	O
generation	O
of	O
NO	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
a	O
major	O
pathogen	O
of	O
dental	O
caries	O
.	O

We	O
searched	O
the	O
genomic	O
database	O
of	O
oral	O
pathogens	O
for	O
nitrite	O
reductase	O
and	O
used	O
a	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
to	O
clone	O
the	O
nirJ	O
gene	O
from	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
GS5	I-bacteria
.	O

His	O
-	O
tagged	O
recombinant	O
NirJ	O
protein	O
was	O
expressed	O
in	O
Escherichia	B-bacteria
coli	I-bacteria
BL21	I-bacteria
and	O
characterized	O
.	O

We	O
constructed	O
a	O
nirJ	O
gene	O
-	O
disrupted	O
mutant	O
strain	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
DeltanirJ	O
)	O
to	O
analyze	O
the	O
physiological	O
significance	O
of	O
nirJ	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
generates	O
NO	O
from	O
nitrite	O
,	O
probably	O
as	O
a	O
result	O
of	O
the	O
possession	O
of	O
nitrite	O
reductase	O
.	O

We	O
cloned	O
the	O
nirJ	O
gene	O
from	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
GS5	I-bacteria
by	O
PCR	O
.	O

The	O
recombinant	O
NirJ	O
protein	O
catalyzed	O
the	O
reduction	O
of	O
nitrite	O
with	O
a	O
K	O
(	O
m	O
)	O
value	O
of	O
3	O
.	O
37	O
microM	O
and	O
a	O
specific	O
activity	O
of	O
2	O
.	O
5	O
micromol	O
/	O
min	O
/	O
mg	O
of	O
protein	O
at	O
37	O
degrees	O
C	O
.	O
Biochemical	O
analysis	O
revealed	O
that	O
the	O
nitrite	O
-	O
reducing	O
activity	O
of	O
the	O
mutant	O
(	O
DeltanirJ	O
)	O
strain	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
wild	O
-	O
type	O
strain	O
.	O

The	O
growth	O
of	O
the	O
mutant	O
strain	O
,	O
but	O
not	O
of	O
the	O
wild	O
-	O
type	O
strain	O
,	O
was	O
strongly	O
suppressed	O
by	O
the	O
presence	O
of	O
physiological	O
levels	O
of	O
nitrite	O
(	O
approximately	O
0	O
.	O
2	O
mM	O
)	O
in	O
saliva	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
elimination	O
of	O
nitrite	O
and	O
/	O
or	O
the	O
generation	O
of	O
NO	O
are	O
important	O
for	O
the	O
survival	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

Elimination	O
of	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
is	O
of	O
critical	O
importance	O
in	O
oral	O
and	O
maxillofacial	O
surgery	O
because	O
control	O
is	O
very	O
difficult	O
once	O
infection	O
of	O
an	O
oral	O
tumor	O
or	O
oral	O
wound	O
with	O
MRSA	B-bacteria
is	O
established	O
.	O

We	O
retrospectively	O
investigated	O
the	O
risk	O
factors	O
for	O
acquiring	O
MRSA	B-bacteria
in	O
518	O
patients	O
with	O
oral	O
cancer	O
among	O
1	O
,	O
877	O
inpatients	O
in	O
our	O
department	O
between	O
1984	O
and	O
2005	O
.	O

The	O
patients	O
with	O
oral	O
cancer	O
demonstrated	O
a	O
high	O
rate	O
of	O
MRSA	B-bacteria
colonization	O
and	O
infection	O
(	O
77	O
.	O
8	O
%	O
)	O
relative	O
to	O
the	O
population	O
as	O
a	O
whole	O
with	O
MRSA	B-bacteria
isolated	O
percentage	O
in	O
our	O
department	O
after	O
1991	O
.	O

The	O
risk	O
factors	O
for	O
MRSA	B-bacteria
in	O
oral	O
cancer	O
patients	O
are	O
also	O
related	O
to	O
systemic	O
diseases	O
and	O
physiological	O
and	O
iatrogenic	O
conditions	O
,	O
including	O
cerebrovascular	O
diseases	O
(	O
77	O
.	O
8	O
%	O
)	O
,	O
peripheral	O
arterial	O
catheterization	O
(	O
69	O
.	O
2	O
%	O
)	O
,	O
diabetes	O
(	O
50	O
.	O
0	O
%	O
)	O
,	O
tracheotomy	O
(	O
50	O
.	O
0	O
%	O
)	O
,	O
renal	O
failure	O
(	O
50	O
.	O
0	O
%	O
)	O
,	O
long	O
-	O
term	O
broad	O
-	O
spectrum	O
antibiotic	O
use	O
(	O
45	O
.	O
7	O
%	O
)	O
,	O
and	O
malnutrition	O
(	O
43	O
.	O
3	O
%	O
)	O
.	O

However	O
,	O
the	O
highest	O
risk	O
of	O
MRSA	B-bacteria
seems	O
to	O
be	O
related	O
to	O
poor	O
hygienic	O
care	O
.	O

Beginning	O
in	O
1999	O
,	O
we	O
implemented	O
a	O
strategy	O
for	O
reducing	O
infection	O
by	O
MRSA	B-bacteria
that	O
included	O
nasal	O
mupirocin	O
ointment	O
for	O
patients	O
at	O
high	O
risk	O
of	O
MRSA	B-bacteria
;	O
since	O
then	O
,	O
the	O
detection	O
rate	O
has	O
decreased	O
.	O

We	O
suggest	O
that	O
the	O
administration	O
of	O
nasal	O
mupirocin	O
ointment	O
and	O
provision	O
of	O
scrupulous	O
hygienic	O
care	O
for	O
high	O
-	O
risk	O
patients	O
are	O
useful	O
and	O
effective	O
measures	O
for	O
decreasing	O
the	O
incidence	O
of	O
MRSA	B-bacteria
infection	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
is	O
the	O
etiologic	O
agent	O
of	O
dental	O
caries	O
and	O
is	O
a	O
causative	O
agent	O
of	O
infective	O
endocarditis	O
.	O

While	O
the	O
mechanisms	O
by	O
which	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
cells	O
colonize	O
heart	O
tissue	O
is	O
not	O
clear	O
,	O
it	O
is	O
thought	O
that	O
bacterial	O
binding	O
to	O
extracellular	O
matrix	O
and	O
blood	O
components	O
is	O
crucial	O
in	O
the	O
development	O
of	O
endocarditis	O
.	O

Previously	O
,	O
we	O
have	O
demonstrated	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
cells	O
have	O
the	O
capacity	O
to	O
bind	O
and	O
activate	O
plasminogen	O
to	O
plasmin	O
.	O

Here	O
we	O
report	O
the	O
first	O
cloning	O
and	O
characterization	O
of	O
an	O
alpha	O
-	O
enolase	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
that	O
binds	O
plasminogen	O
.	O

The	O
functional	O
identity	O
of	O
the	O
purified	O
recombinant	O
alpha	O
-	O
enolase	O
protein	O
was	O
confirmed	O
by	O
its	O
ability	O
to	O
catalyze	O
the	O
conversion	O
of	O
2	O
-	O
phosphoglycerate	O
to	O
phosphoenolpyruvate	O
.	O

The	O
protein	O
exhibited	O
a	O
Km	O
of	O
9	O
.	O
5	O
mM	O
and	O
a	O
Vmax	O
of	O
31	O
.	O
0	O
mM	O
/	O
min	O
/	O
mg	O
.	O

The	O
alpha	O
-	O
enolase	O
protein	O
was	O
localized	O
in	O
the	O
cytoplasmic	O
,	O
cell	O
wall	O
and	O
extracellular	O
fractions	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Binding	O
studies	O
using	O
an	O
immunoblot	O
analysis	O
revealed	O
that	O
human	O
plasminogen	O
binds	O
to	O
the	O
enolase	O
enzyme	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

These	O
findings	O
identify	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
alpha	O
-	O
enolase	O
as	O
a	O
binding	O
molecule	O
used	O
by	O
this	O
oral	O
pathogen	O
to	O
interact	O
with	O
the	O
blood	O
component	O
,	O
plasminogen	O
.	O

Further	O
studies	O
of	O
this	O
interaction	O
may	O
be	O
critical	O
to	O
understand	O
the	O
pathogenesis	O
of	O
endocarditis	O
caused	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Plasma	O
and	O
salivary	O
amoxicillin	O
(	O
AMO	O
)	O
concentrations	O
were	O
quantified	O
following	O
a	O
single	O
oral	O
dose	O
(	O
875	O
mg	O
)	O
of	O
two	O
formulations	O
of	O
AMO	O
(	O
Amoxicillin	O
-	O
EMS	O
Sigma	O
Pharma	O
and	O
Amoxil	O
BD	O
875	O
mg	O
)	O
.	O

In	O
addition	O
,	O
the	O
effect	O
of	O
amoxicillin	O
against	O
oral	O
microorganisms	O
was	O
accessed	O
.	O

The	O
open	O
,	O
randomized	O
,	O
two	O
-	O
period	O
crossover	O
study	O
was	O
carried	O
out	O
in	O
20	O
volunteers	O
.	O

Saliva	O
and	O
blood	O
samples	O
were	O
collected	O
at	O
0	O
,	O
0	O
.	O
5	O
,	O
1	O
,	O
2	O
,	O
4	O
,	O
8	O
and	O
12	O
h	O
after	O
drug	O
administration	O
,	O
and	O
quantified	O
using	O
HPLC	O
-	O
ESI	O
-	O
MS	O
and	O
HPLC	O
,	O
respectively	O
.	O

Streptococci	B-bacteria
counts	O
,	O
anaerobe	O
counts	O
and	O
total	O
microorganism	O
counts	O
were	O
obtained	O
.	O

No	O
differences	O
were	O
observed	O
between	O
formulations	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
in	O
the	O
plasma	O
and	O
salivary	O
AMO	O
concentrations	O
and	O
the	O
pharmacokinetic	O
parameters	O
(	O
C	O
(	O
max	O
)	O
,	O
t	O
(	O
max	O
)	O
,	O
AUC	O
(	O
0	O
-	O
8	O
)	O
,	O
and	O
AUC	O
(	O
0	O
-	O
infinity	O
)	O
)	O
also	O
showed	O
no	O
statistically	O
significant	O
differences	O
between	O
formulations	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

Microorganism	O
counts	O
for	O
the	O
two	O
formulations	O
at	O
all	O
sampling	O
times	O
did	O
not	O
differ	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
but	O
all	O
microorganism	O
counts	O
at	O
60	O
min	O
post	O
-	O
dose	O
showed	O
a	O
significant	O
decrease	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Amoxicillin	O
was	O
effective	O
in	O
reducing	O
oral	O
microorganism	O
levels	O
up	O
to	O
12	O
h	O
post	O
-	O
dose	O
.	O

Oral	O
epithelium	O
is	O
a	O
stratified	O
squamous	O
epithelium	O
that	O
functions	O
as	O
the	O
barrier	O
between	O
the	O
outside	O
environment	O
and	O
the	O
host	O
.	O

In	O
the	O
oral	O
cavity	O
,	O
epithelial	O
tissues	O
are	O
constantly	O
exposed	O
to	O
a	O
variety	O
of	O
bacteria	O
,	O
but	O
most	O
individuals	O
maintain	O
healthy	O
homeostasis	O
.	O

Epithelial	O
cells	O
contribute	O
to	O
the	O
innate	O
host	O
response	O
,	O
and	O
antimicrobial	O
peptide	O
expression	O
in	O
all	O
human	O
epithelia	O
,	O
including	O
oral	O
epithelia	O
,	O
is	O
an	O
important	O
part	O
of	O
this	O
epithelial	O
function	O
.	O

These	O
antimicrobial	O
peptides	O
have	O
a	O
broad	O
spectrum	O
of	O
activity	O
against	O
both	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
bacteria	O
as	O
well	O
as	O
against	O
yeast	O
and	O
viruses	O
.	O

In	O
humans	O
these	O
antimicrobial	O
peptides	O
include	O
defensins	O
and	O
a	O
cathelicidin	O
family	O
member	O
LL	O
-	O
37	O
in	O
skin	O
and	O
oral	O
mucosa	O
and	O
other	O
epithelia	O
.	O

The	O
human	O
defensins	O
include	O
the	O
alpha	O
-	O
defensins	O
of	O
intestinal	O
and	O
neutrophil	O
origin	O
,	O
and	O
the	O
beta	O
-	O
defensins	O
of	O
skin	O
and	O
oral	O
mucosa	O
and	O
other	O
epithelia	O
.	O

Present	O
studies	O
have	O
identified	O
specific	O
signaling	O
routes	O
that	O
pathogens	O
and	O
commensals	O
take	O
in	O
stimulating	O
these	O
innate	O
immune	O
responses	O
,	O
and	O
this	O
may	O
open	O
the	O
way	O
for	O
development	O
of	O
new	O
therapeutic	O
agents	O
for	O
periodontal	O
diseases	O
.	O

A	O
recent	O
study	O
indicated	O
that	O
Neisseria	B-bacteria
subflava	I-bacteria
,	O
one	O
of	O
the	O
commensal	O
Neisseria	B-bacteria
species	I-bacteria
,	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
emergence	O
of	O
Neisseria	B-bacteria
gonorrhoeae	I-bacteria
strains	I-bacteria
with	O
chromosomally	O
mediated	O
resistance	O
to	O
penicillin	O
or	O
cephalosporin	O
by	O
the	O
horizontal	O
genetic	O
exchange	O
of	O
penA	O
genes	O
encoding	O
the	O
target	O
site	O
for	O
penicillin	O
or	O
cephalosporin	O
.	O

The	O
present	O
investigation	O
examined	O
the	O
antimicrobial	O
susceptibility	O
of	O
45	O
isolates	O
of	O
N	B-bacteria
.	I-bacteria
subflava	I-bacteria
from	O
the	O
oral	O
cavities	O
of	O
Japanese	O
men	O
and	O
women	O
to	O
various	O
agents	O
used	O
for	O
the	O
treatment	O
of	O
gonococcal	O
infections	O
.	O

Of	O
the	O
45	O
isolates	O
,	O
40	O
(	O
88	O
.	O
9	O
%	O
)	O
and	O
4	O
(	O
8	O
.	O
8	O
%	O
)	O
were	O
intermediately	O
resistant	O
and	O
resistant	O
to	O
penicillin	O
,	O
respectively	O
,	O
with	O
the	O
minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
(	O
50	O
)	O
and	O
MIC	O
(	O
90	O
)	O
of	O
penicillin	O
being	O
0	O
.	O
5	O
mg	O
/	O
l	O
and	O
1	O
mg	O
/	O
l	O
,	O
respectively	O
.	O

Of	O
the	O
45	O
isolates	O
,	O
13	O
(	O
28	O
.	O
9	O
%	O
)	O
and	O
14	O
(	O
31	O
.	O
1	O
%	O
)	O
were	O
resistant	O
to	O
tetracycline	O
and	O
ciprofloxacin	O
,	O
respectively	O
,	O
and	O
3	O
(	O
6	O
.	O
7	O
%	O
)	O
showed	O
reduced	O
susceptibility	O
to	O
cefixime	O
(	O
although	O
the	O
susceptibility	O
category	O
was	O
not	O
determined	O
)	O
.	O

These	O
results	O
indicate	O
that	O
several	O
isolates	O
of	O
N	B-bacteria
.	I-bacteria
subflava	I-bacteria
have	O
acquired	O
resistance	O
or	O
intermediate	O
resistance	O
to	O
various	O
antimicrobial	O
agents	O
,	O
including	O
penicillin	O
,	O
cephalosporin	O
,	O
tetracycline	O
,	O
and	O
ciprofloxacin	O
.	O

The	O
present	O
study	O
may	O
thus	O
confirm	O
that	O
N	O
.	O
subflava	O
may	O
be	O
involved	O
in	O
the	O
emergence	O
of	O
N	B-bacteria
.	I-bacteria
gonorrhoeae	I-bacteria
strains	I-bacteria
with	O
either	O
intermediate	O
or	O
total	O
resistance	O
to	O
penicillin	O
or	O
cephalosporin	O
by	O
the	O
horizontal	O
genetic	O
exchange	O
of	O
the	O
penA	O
gene	O
.	O

Granulicatella	B-bacteria
elegans	I-bacteria
is	O
a	O
member	O
of	O
normal	O
human	O
oral	O
flora	O
and	O
is	O
thought	O
to	O
be	O
a	O
potent	O
pathogen	O
in	O
endocarditis	O
,	O
especially	O
so	O
-	O
called	O
`	O
`	O
culture	O
-	O
negative	O
'	O
'	O
endocarditis	O
.	O

To	O
elucidate	O
the	O
pathogenicity	O
of	O
this	O
microorganism	O
in	O
inflammatory	O
diseases	O
,	O
the	O
effect	O
of	O
the	O
extracellular	O
products	O
of	O
this	O
bacteria	O
on	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
was	O
examined	O
.	O

Culture	O
supernatants	O
produced	O
by	O
oral	O
isolates	O
of	O
G	B-bacteria
.	I-bacteria
elegans	I-bacteria
strongly	O
inhibited	O
the	O
proliferation	O
of	O
PBMC	O
stimulated	O
by	O
the	O
T	O
-	O
cell	O
mitogens	O
phytohemagglutinin	O
-	O
P	O
,	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
,	O
concanavalin	O
A	O
,	O
and	O
staphylococcal	O
enterotoxin	O
B	O
.	O
Purification	O
of	O
the	O
active	O
extracellular	O
product	O
revealed	O
that	O
a	O
fraction	O
containing	O
proteins	O
of	O
approximately	O
47	O
kDa	O
showing	O
arginine	O
deiminase	O
activity	O
contributed	O
to	O
the	O
inhibition	O
of	O
PBMC	O
proliferation	O
.	O

In	O
order	O
to	O
characterize	O
the	O
bacterial	O
microbiota	O
present	O
within	O
oral	O
cancerous	O
lesions	O
,	O
tumorous	O
and	O
non	O
-	O
tumorous	O
mucosal	O
tissue	O
specimens	O
(	O
approx	O
.	O

1	O
cm	O
(	O
3	O
)	O
)	O
were	O
harvested	O
from	O
ten	O
oral	O
squamous	O
cell	O
carcinoma	O
(	O
OSCC	O
)	O
patients	O
at	O
the	O
time	O
of	O
surgery	O
.	O

Any	O
microbial	O
contamination	O
on	O
the	O
surface	O
of	O
the	O
specimens	O
was	O
eliminated	O
by	O
immersion	O
in	O
Betadine	O
and	O
washing	O
with	O
PBS	O
.	O

Bacteria	O
were	O
visualized	O
within	O
sections	O
of	O
the	O
OSCC	O
by	O
performing	O
fluorescent	O
in	O
situ	O
hybridization	O
with	O
the	O
universal	O
oligonucleotide	O
probe	O
,	O
EUB338	O
.	O

DNA	O
was	O
extracted	O
from	O
each	O
aseptically	O
macerated	O
tissue	O
specimen	O
using	O
a	O
commercial	O
kit	O
.	O

This	O
was	O
then	O
used	O
as	O
template	O
for	O
PCR	O
with	O
three	O
sets	O
of	O
primers	O
,	O
targeting	O
the	O
16S	O
rRNA	O
genes	O
of	O
Spirochaetes	B-bacteria
,	O
Bacteroidetes	B-bacteria
and	O
the	O
domain	O
Bacteria	O
.	O

PCR	O
products	O
were	O
differentiated	O
by	O
TA	O
cloning	O
and	O
bacterial	O
species	O
were	O
identified	O
by	O
partial	O
sequencing	O
of	O
the	O
16S	O
rRNA	O
gene	O
fragments	O
.	O

A	O
total	O
of	O
70	O
distinct	O
taxa	O
was	O
detected	O
:	O
52	O
different	O
phylotypes	O
isolated	O
from	O
the	O
tumorous	O
tissues	O
,	O
and	O
37	O
taxa	O
from	O
within	O
the	O
non	O
-	O
tumorous	O
specimens	O
.	O

Differences	O
between	O
the	O
composition	O
of	O
the	O
microbiotas	O
within	O
the	O
tumorous	O
and	O
non	O
-	O
tumorous	O
mucosae	O
were	O
apparent	O
,	O
possibly	O
indicating	O
selective	O
growth	O
of	O
bacteria	O
within	O
carcinoma	O
tissue	O
.	O

Most	O
taxa	O
isolated	O
from	O
within	O
the	O
tumour	O
tissue	O
represented	O
saccharolytic	O
and	O
aciduric	O
species	O
.	O

Whether	O
the	O
presence	O
of	O
these	O
bacteria	O
within	O
the	O
mucosa	O
has	O
any	O
bearing	O
on	O
the	O
carcinogenic	O
process	O
is	O
a	O
concept	O
worthy	O
of	O
further	O
investigation	O
.	O

Three	O
strains	O
of	O
anaerobic	O
Gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
human	O
oral	O
sites	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
revealed	O
the	O
strains	O
to	O
constitute	O
a	O
novel	O
group	O
within	O
the	O
genus	O
Prevotella	B-bacteria
,	O
most	O
closely	O
related	O
to	O
Prevotella	B-bacteria
oris	I-bacteria
and	O
Prevotella	B-bacteria
salivae	I-bacteria
.	O

A	O
novel	O
species	O
,	O
Prevotella	B-bacteria
maculosa	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
to	O
accommodate	O
these	O
strains	O
.	O

Prevotella	B-bacteria
maculosa	I-bacteria
is	O
saccharolytic	O
and	O
produces	O
acetic	O
and	O
succinic	O
acids	O
as	O
end	O
products	O
of	O
fermentation	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
the	O
type	O
strain	O
is	O
48	O
mol	O
%	O
.	O

The	O
type	O
strain	O
of	O
Prevotella	B-bacteria
maculosa	I-bacteria
is	O
W1609	B-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
19339	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
54766	I-bacteria
(	O
T	O
)	O
)	O
.	O

Periodontitis	O
is	O
a	O
common	O
oral	O
disease	O
produced	O
by	O
bacterial	O
species	O
that	O
reside	O
in	O
the	O
subgingival	O
plaque	O
.	O

These	O
microorganisms	O
have	O
been	O
associated	O
to	O
atherosclerosis	O
and	O
it	O
is	O
suggested	O
that	O
periodontitis	O
is	O
a	O
cardiovascular	O
risk	O
factor	O
.	O

To	O
isolate	O
periodontal	O
bacteria	O
from	O
blood	O
and	O
atheroma	O
samples	O
,	O
from	O
patients	O
with	O
atherosclerosis	O
and	O
periodontitis	O
.	O

Twelve	O
patients	O
with	O
periodontitis	O
and	O
a	O
clinical	O
diagnosis	O
of	O
atherosclerosis	O
and	O
12	O
patients	O
with	O
periodontitis	O
but	O
without	O
atherosclerosis	O
were	O
studied	O
.	O

Blood	O
samples	O
were	O
obtained	O
immediately	O
before	O
and	O
after	O
scaling	O
and	O
root	O
planing	O
.	O

The	O
samples	O
were	O
incubated	O
in	O
aerobic	O
and	O
anaerobic	O
conditions	O
.	O

One	O
week	O
after	O
scaling	O
,	O
atheromatous	O
plaques	O
were	O
obtained	O
during	O
endarterectomy	O
in	O
the	O
12	O
patients	O
with	O
atherosclerosis	O
.	O

These	O
were	O
homogenized	O
and	O
cultured	O
for	O
aerobic	O
and	O
anaerobic	O
bacteria	O
.	O

Microorganisms	O
were	O
identified	O
by	O
means	O
ofPCR	O
.	O

Five	O
patients	O
with	O
and	O
two	O
without	O
atherosclerosis	O
,	O
had	O
bacteremia	O
after	O
scaling	O
and	O
root	O
planing	O
.	O

Bacterial	O
species	O
isolated	O
from	O
blood	O
samples	O
were	O
the	O
same	O
found	O
in	O
periodontic	O
pockets	O
.	O

Four	O
atheromatous	O
plaques	O
of	O
patients	O
with	O
bacteremia	O
yielded	O
positive	O
cultures	O
.	O

The	O
isolated	O
bacteria	O
were	O
the	O
same	O
found	O
in	O
blood	O
samples	O
and	O
periodontal	O
pockets	O
.	O

Bacteremia	O
occurred	O
in	O
seven	O
of	O
24	O
patients	O
after	O
scaling	O
and	O
root	O
planing	O
.	O

In	O
four	O
patients	O
,	O
the	O
same	O
species	O
found	O
in	O
periodontic	O
pockets	O
and	O
blood	O
cultures	O
were	O
detected	O
in	O
atherosclerotic	O
plaques	O
obtained	O
one	O
week	O
after	O
the	O
dental	O
procedure	O
.	O

To	O
investigate	O
a	O
possible	O
peroral	O
route	O
of	O
infective	O
endocarditis	O
(	O
IE	O
)	O
,	O
the	O
occurrence	O
of	O
staphylococci	B-bacteria
in	O
the	O
oral	O
cavity	O
was	O
examined	O
using	O
saliva	O
and	O
supragingival	O
plaque	O
specimens	O
from	O
56	O
systemically	O
and	O
periodontally	O
healthy	O
adults	O
aged	O
22	O
-	O
43	O
years	O
old	O
(	O
27	O
.	O
1	O
+	O
/	O
-	O
5	O
.	O
3	O
)	O
.	O

Nine	O
Staphylococcus	B-bacteria
species	I-bacteria
and	O
334	O
isolates	O
were	O
identified	O
.	O

In	O
saliva	O
,	O
the	O
total	O
occurrence	O
rate	O
was	O
83	O
.	O
9	O
%	O
and	O
the	O
total	O
number	O
of	O
bacteria	O
was	O
10	O
(	O
2	O
)	O
-	O
10	O
(	O
4	O
)	O
c	O
.	O
f	O
.	O
u	O
.	O

ml	O
(	O
-	O
1	O
)	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
the	O
most	O
frequent	O
species	O
(	O
46	O
.	O
4	O
%	O
)	O
,	O
followed	O
by	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
(	O
41	O
.	O
1	O
%	O
)	O
and	O
others	O
(	O
Staphylococcus	B-bacteria
hominis	I-bacteria
,	O
Staphylococcus	B-bacteria
warneri	I-bacteria
,	O
Staphylococcus	B-bacteria
intermedius	I-bacteria
,	O
Staphylococcus	B-bacteria
capitis	I-bacteria
,	O
Staphylococcus	B-bacteria
haemolyticus	I-bacteria
,	O
Staphylococcus	B-bacteria
lugdunensis	I-bacteria
and	O
Staphylococcus	B-bacteria
gallinarum	I-bacteria
,	O
isolation	O
frequencies	O
ranging	O
in	O
order	O
from	O
12	O
.	O
5	O
to	O
1	O
.	O
8	O
%	O
)	O
.	O

A	O
similar	O
isolation	O
tendency	O
was	O
observed	O
in	O
supragingival	O
plaque	O
,	O
with	O
a	O
total	O
occurrence	O
rate	O
of	O
73	O
.	O
2	O
%	O
and	O
amounts	O
of	O
bacteria	O
ranging	O
from	O
10	O
(	O
2	O
)	O
to	O
10	O
(	O
5	O
)	O
c	O
.	O
f	O
.	O
u	O
.	O
g	O
(	O
-	O
1	O
)	O
.	O

Four	O
common	O
Staphylococcus	B-bacteria
species	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
lugdunensis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
hominis	I-bacteria
)	O
were	O
isolated	O
from	O
nasal	O
swab	O
samples	O
taken	O
from	O
the	O
oral	O
staphylococci	O
-	O
positive	O
subjects	O
.	O

Genotyping	O
of	O
all	O
18	O
combinations	O
of	O
oral	O
-	O
and	O
nasal	O
-	O
derived	O
isolates	O
by	O
PFGE	O
indicated	O
that	O
identical	O
clones	O
or	O
close	O
relatives	O
were	O
commonly	O
distributed	O
in	O
these	O
two	O
cavities	O
.	O

Since	O
the	O
provision	O
of	O
micro	O
-	O
organisms	O
from	O
the	O
nasal	O
cavity	O
was	O
shown	O
and	O
occurrence	O
rates	O
in	O
the	O
oral	O
cavity	O
were	O
adequate	O
,	O
these	O
results	O
suggest	O
a	O
possible	O
peroral	O
route	O
of	O
staphylococcal	B-bacteria
IE	O
,	O
as	O
in	O
cases	O
of	O
viridans	B-bacteria
streptococcal	I-bacteria
IE	O
.	O

Triterpene	O
acids	O
(	O
ursolic	O
,	O
oleanoic	O
,	O
gypsogenic	O
,	O
and	O
sumaresinolic	O
acids	O
)	O
isolated	O
from	O
Miconia	O
species	O
,	O
along	O
with	O
a	O
mixture	O
of	O
ursolic	O
and	O
oleanolic	O
acids	O
and	O
a	O
mixture	O
of	O
maslinic	O
and	O
2	O
-	O
a	O
-	O
hydroxyursolic	O
acids	O
,	O
as	O
well	O
as	O
ursolic	O
acid	O
derivatives	O
were	O
evaluated	O
against	O
the	O
following	O
microorganisms	O
:	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
which	O
are	O
potentially	O
responsible	O
for	O
the	O
formation	O
of	O
dental	O
caries	O
in	O
humans	O
.	O

The	O
microdilution	O
method	O
was	O
used	O
for	O
the	O
determination	O
of	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
during	O
the	O
evaluation	O
of	O
the	O
antibacterial	O
activity	O
.	O

All	O
the	O
isolated	O
compounds	O
,	O
mixtures	O
,	O
and	O
semi	O
-	O
synthetic	O
derivatives	O
displayed	O
activity	O
against	O
all	O
the	O
tested	O
bacteria	O
,	O
showing	O
that	O
they	O
are	O
promising	O
antiplaque	O
and	O
anticaries	O
agents	O
.	O

Ursolic	O
and	O
oleanolic	O
acids	O
displayed	O
the	O
most	O
intense	O
antibacterial	O
effect	O
,	O
with	O
MIC	O
values	O
ranging	O
from	O
30	O
microg	O
/	O
mL	O
to	O
80	O
microg	O
/	O
mL	O
.	O

The	O
MIC	O
values	O
of	O
ursolic	O
acid	O
derivatives	O
,	O
as	O
well	O
as	O
those	O
obtained	O
for	O
the	O
mixture	O
of	O
ursolic	O
and	O
oleanolic	O
acids	O
showed	O
that	O
these	O
compounds	O
do	O
not	O
have	O
higher	O
antibacterial	O
activity	O
when	O
compared	O
with	O
the	O
activity	O
observed	O
with	O
either	O
ursolic	O
acid	O
or	O
oleanolic	O
acid	O
alone	O
.	O

With	O
regard	O
to	O
the	O
structure	O
-	O
activity	O
relationship	O
of	O
triterpene	O
acids	O
and	O
derivatives	O
,	O
it	O
is	O
suggested	O
that	O
both	O
hydroxy	O
and	O
carboxy	O
groups	O
present	O
in	O
the	O
triterpenes	O
are	O
important	O
for	O
their	O
antibacterial	O
activity	O
against	O
oral	O
pathogens	O
.	O

Extracts	O
or	O
alkaloids	O
isolated	O
from	O
Mahonia	O
aquifolium	O
exhibit	O
antimicrobial	O
activity	O
against	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
,	O
fungi	O
,	O
and	O
protozoa	O
.	O

In	O
this	O
study	O
the	O
bacteriostatic	O
and	O
bacteriocidal	O
activities	O
of	O
a	O
M	O
.	O
aquifolium	O
extract	O
and	O
two	O
of	O
its	O
major	O
alkaloids	O
,	O
berberine	O
chloride	O
and	O
oxyacanthine	O
sulphate	O
,	O
were	O
tested	O
in	O
vitro	O
against	O
nine	O
different	O
oral	O
bacteria	O
.	O

Minimum	O
inhibitory	O
concentrations	O
were	O
in	O
the	O
range	O
from	O
<	O
or	O
=	O
0	O
.	O
0031	O
%	O
to	O
0	O
.	O
1993	O
%	O
for	O
the	O
M	O
.	O
aquifolium	O
extract	O
,	O
from	O
0	O
.	O
002	O
%	O
to	O
>	O
0	O
.	O
125	O
%	O
for	O
berberine	O
chloride	O
,	O
and	O
from	O
0	O
.	O
0156	O
%	O
to	O
>	O
0	O
.	O
0625	O
%	O
for	O
oxyacanthine	O
sulphate	O
.	O

The	O
values	O
for	O
the	O
minimum	O
bactericidal	O
concentrations	O
were	O
in	O
the	O
same	O
range	O
,	O
indicating	O
that	O
the	O
test	O
substances	O
most	O
probably	O
acted	O
in	O
a	O
bactericidal	O
manner	O
.	O

The	O
most	O
susceptible	O
bacterium	O
against	O
all	O
three	O
test	O
substances	O
was	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
oral	O
epithelium	O
functions	O
as	O
a	O
mechanical	O
and	O
protective	O
barrier	O
to	O
resist	O
bacterial	O
infection	O
.	O

beta	O
-	O
Defensins	O
are	O
a	O
group	O
of	O
antimicrobial	O
peptides	O
mainly	O
produced	O
by	O
epithelial	O
cells	O
of	O
many	O
organs	O
including	O
skin	O
,	O
lung	O
,	O
kidney	O
,	O
pancreas	O
,	O
uterus	O
,	O
eye	O
,	O
and	O
nasal	O
and	O
oral	O
mucosa	O
.	O

This	O
review	O
focuses	O
on	O
beta	O
-	O
defensins	O
(	O
BDs	O
)	O
in	O
oral	O
epithelia	O
and	O
discusses	O
their	O
importance	O
in	O
oral	O
epithelial	O
health	O
and	O
disease	O
.	O

BDs	O
exhibit	O
antimicrobial	O
activity	O
against	O
oral	O
microbes	O
including	O
periodontitis	O
-	O
related	O
bacteria	O
,	O
Candida	O
,	O
and	O
papilloma	O
virus	O
.	O

Alterative	O
expression	O
of	O
BDs	O
was	O
observed	O
in	O
oral	O
epithelial	O
diseases	O
,	O
including	O
oral	O
inflammatory	O
lesions	O
with	O
and	O
without	O
microbial	O
infection	O
and	O
oral	O
cancer	O
.	O

BDs	O
may	O
be	O
useful	O
in	O
the	O
treatment	O
of	O
oral	O
infectious	O
diseases	O
,	O
ulcerative	O
lesions	O
,	O
and	O
cancer	O
.	O

BDs	O
play	O
an	O
important	O
role	O
in	O
protection	O
against	O
oral	O
microbes	O
and	O
may	O
be	O
used	O
in	O
clinical	O
applications	O
.	O

Probiotics	O
are	O
living	O
micro	O
-	O
organisms	O
added	O
to	O
food	O
which	O
beneficially	O
affect	O
the	O
host	O
by	O
improving	O
its	O
intestinal	O
microbial	O
balance	O
.	O

This	O
paper	O
aims	O
to	O
present	O
a	O
general	O
background	O
on	O
probiotics	O
and	O
its	O
health	O
effects	O
in	O
children	O
,	O
and	O
to	O
examine	O
the	O
evidence	O
for	O
oral	O
colonization	O
and	O
the	O
possible	O
impact	O
on	O
oral	O
health	O
in	O
children	O
and	O
young	O
adults	O
.	O

For	O
delivery	O
and	O
general	O
health	O
effects	O
,	O
recent	O
systematic	O
reviews	O
,	O
meta	O
-	O
analyses	O
,	O
and	O
other	O
relevant	O
papers	O
were	O
used	O
.	O

Concerning	O
oral	O
installation	O
and	O
oral	O
effects	O
,	O
a	O
broad	O
search	O
for	O
publications	O
in	O
English	O
was	O
conducted	O
through	O
February	O
2007	O
in	O
PubMed	O
.	O

Studies	O
describing	O
an	O
installation	O
or	O
intervention	O
trial	O
in	O
humans	O
with	O
a	O
controlled	O
design	O
and	O
an	O
oral	O
endpoint	O
measure	O
were	O
considered	O
.	O

Fourteen	O
papers	O
with	O
dental	O
focus	O
were	O
identified	O
,	O
of	O
which	O
two	O
were	O
narrative	O
reviews	O
.	O

Only	O
one	O
study	O
of	O
dental	O
interest	O
was	O
conducted	O
in	O
children	O
.	O

Four	O
papers	O
dealt	O
with	O
oral	O
installation	O
of	O
probiotic	O
bacteria	O
,	O
and	O
although	O
detectable	O
levels	O
were	O
found	O
in	O
saliva	O
shortly	O
after	O
intake	O
,	O
the	O
studies	O
failed	O
to	O
demonstrate	O
a	O
long	O
-	O
term	O
installation	O
.	O

Seven	O
papers	O
evaluated	O
the	O
effect	O
of	O
lactobacilli	B-bacteria
-	O
or	O
bifidobacteria	B-bacteria
-	O
derived	O
probiotics	O
on	O
the	O
salivary	O
levels	O
of	O
caries	O
-	O
associated	O
bacteria	O
in	O
placebo	O
-	O
controlled	O
designs	O
.	O

All	O
but	O
one	O
reported	O
a	O
hampering	O
effect	O
on	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
/	O
or	O
yeast	O
.	O

The	O
single	O
study	O
carried	O
out	O
in	O
early	O
childhood	O
reported	O
a	O
significant	O
caries	O
reduction	O
in	O
3	O
-	O
to	O
4	O
-	O
year	O
-	O
old	O
children	O
after	O
7	O
months	O
of	O
daily	O
consumption	O
of	O
probiotic	O
milk	O
.	O

Bacteriotheraphy	O
in	O
the	O
form	O
of	O
probiotic	O
bacteria	O
with	O
an	O
inhibitory	O
effect	O
on	O
oral	O
pathogens	O
is	O
a	O
promising	O
concept	O
,	O
especially	O
in	O
childhood	O
,	O
but	O
this	O
may	O
not	O
necessarily	O
lead	O
to	O
improved	O
oral	O
health	O
.	O

Further	O
placebo	O
controlled	O
trials	O
that	O
assess	O
carefully	O
selected	O
and	O
defined	O
probiotic	O
strains	O
using	O
standardized	O
outcomes	O
are	O
needed	O
before	O
any	O
clinical	O
recommendations	O
can	O
be	O
made	O
.	O

To	O
investigate	O
prospectively	O
the	O
qualitative	O
and	O
quantitative	O
changes	O
in	O
oral	O
carriage	O
of	O
yeasts	O
and	O
coliforms	B-bacteria
in	O
southern	O
Chinese	O
people	O
suffering	O
from	O
stroke	O
.	O

In	O
56	O
elderly	O
people	O
suffering	O
from	O
stroke	O
in	O
a	O
rehabilitation	O
unit	O
of	O
a	O
general	O
medical	O
hospital	O
in	O
Hong	O
Kong	O
,	O
oral	O
microbiological	O
sampling	O
using	O
a	O
combined	O
imprint	O
culture	O
,	O
oral	O
rinse	O
approach	O
and	O
clinical	O
assessment	O
was	O
made	O
during	O
the	O
acute	O
stroke	O
phase	O
,	O
on	O
hospital	O
discharge	O
and	O
6	O
months	O
later	O
.	O

The	O
oral	O
carriage	O
of	O
yeasts	O
increased	O
significantly	O
during	O
acute	O
stroke	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
whereas	O
coliform	B-bacteria
carriage	O
did	O
not	O
.	O

A	O
reduction	O
in	O
oral	O
carriage	O
of	O
yeasts	O
was	O
found	O
on	O
hospital	O
discharge	O
and	O
6	O
months	O
later	O
and	O
in	O
coliforms	B-bacteria
at	O
the	O
6	O
-	O
month	O
assessment	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Candida	O
albicans	O
and	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
were	O
the	O
predominant	O
yeast	O
and	O
coliform	B-bacteria
respectively	O
.	O

Stroke	O
-	O
related	O
difficulty	O
in	O
tooth	O
brushing	O
and	O
denture	O
wearing	O
were	O
associated	O
with	O
higher	O
oral	O
yeast	O
carriage	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

We	O
also	O
report	O
here	O
for	O
the	O
first	O
time	O
that	O
the	O
use	O
of	O
aspirin	O
was	O
associated	O
with	O
lower	O
oral	O
yeast	O
carriage	O
in	O
people	O
suffering	O
from	O
stroke	O
.	O

Oral	O
yeast	O
carriage	O
was	O
closely	O
linked	O
to	O
the	O
level	O
of	O
stroke	O
-	O
related	O
functional	O
disability	O
that	O
improved	O
over	O
time	O
but	O
had	O
not	O
totally	O
resolved	O
6	O
months	O
after	O
hospital	O
discharge	O
.	O

The	O
oral	O
reservoir	O
of	O
yeasts	O
and	O
coliforms	B-bacteria
in	O
people	O
suffering	O
from	O
stroke	O
is	O
noteworthy	O
by	O
care	O
providers	O
as	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
may	O
cause	O
aspiration	O
pneumonia	O
.	O

Proton	O
pump	O
inhibitors	O
(	O
PPI	O
)	O
used	O
to	O
suppress	O
acid	O
secretion	O
in	O
the	O
stomach	O
are	O
among	O
the	O
most	O
widely	O
prescribed	O
medications	O
.	O

There	O
is	O
emerging	O
evidence	O
of	O
proton	O
secretion	O
elsewhere	O
in	O
the	O
aerodigestive	O
tract	O
,	O
and	O
acidic	O
microenvironments	O
are	O
integral	O
to	O
oral	O
flora	O
such	O
as	O
Lactobacillus	B-bacteria
.	O

The	O
hypothesis	O
of	O
this	O
study	O
is	O
that	O
the	O
growth	O
rate	O
and	O
morphology	O
of	O
oral	O
Lactobacillus	B-bacteria
strains	I-bacteria
are	O
effected	O
by	O
PPIs	O
.	O

Nineteen	O
different	O
strains	O
of	O
Lactobacilli	B-bacteria
were	O
inoculated	O
in	O
microtiter	O
plates	O
at	O
pH	O
of	O
4	O
.	O
5	O
to	O
6	O
.	O
5	O
and	O
exposed	O
to	O
twofold	O
dilutions	O
of	O
pantoprazole	O
at	O
a	O
range	O
of	O
2	O
.	O
5	O
mg	O
/	O
mL	O
to	O
2	O
.	O
5	O
microg	O
/	O
mL	O
.	O

Bacterial	O
growth	O
was	O
monitored	O
,	O
and	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
the	O
drug	O
was	O
determined	O
for	O
the	O
strains	O
most	O
sensitive	O
to	O
pantoprazole	O
.	O

In	O
the	O
unexposed	O
(	O
control	O
)	O
group	O
,	O
nine	O
Lactobacilli	B-bacteria
strains	I-bacteria
were	O
affected	O
by	O
pH	O
changes	O
from	O
6	O
.	O
5	O
to	O
4	O
.	O
5	O
.	O

In	O
the	O
group	O
exposed	O
to	O
pantoprazole	O
,	O
9	O
of	O
the	O
19	O
Lactobacilli	B-bacteria
strains	I-bacteria
were	O
found	O
to	O
have	O
an	O
MIC	O
below	O
625	O
microg	O
/	O
mL	O
,	O
with	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
14917	I-bacteria
being	O
the	O
most	O
sensitive	O
(	O
MIC	O
=	O
20	O
microg	O
/	O
mL	O
)	O
.	O

In	O
some	O
strains	O
,	O
such	O
as	O
L	B-bacteria
.	I-bacteria
s	I-bacteria
.	I-bacteria
salivarius	I-bacteria
11741	I-bacteria
,	O
Gram	O
-	O
staining	O
revealed	O
conformational	O
changes	O
in	O
the	O
bacteria	O
when	O
grown	O
in	O
the	O
presence	O
of	O
pantoprazole	O
.	O

Growth	O
rates	O
and	O
morphology	O
of	O
oral	O
Lactobacillus	B-bacteria
are	O
affected	O
by	O
the	O
pH	O
of	O
the	O
environment	O
.	O

Pantoprazole	O
at	O
supraphysiologic	O
doses	O
further	O
affects	O
growth	O
rates	O
and	O
conformation	O
in	O
some	O
strains	O
.	O

The	O
balance	O
of	O
oral	O
flora	O
and	O
upper	O
digestive	O
tract	O
homeostasis	O
may	O
be	O
affected	O
by	O
unexpected	O
targets	O
of	O
PPI	O
pharmacotherapy	O
,	O
with	O
possible	O
unanticipated	O
consequences	O
.	O
(	O
i	O
)	O
To	O
assess	O
the	O
pattern	O
of	O
early	O
bacterial	O
colonization	O
on	O
titanium	O
oral	O
implants	O
after	O
installation	O
,	O
at	O
12	O
weeks	O
and	O
at	O
12	O
months	O
,	O
(	O
ii	O
)	O
to	O
compare	O
the	O
microbiota	O
at	O
submucosal	O
implant	O
sites	O
and	O
adjacent	O
subgingival	O
tooth	O
sites	O
and	O
(	O
iii	O
)	O
to	O
assess	O
whether	O
or	O
not	O
early	O
colonization	O
was	O
predictive	O
of	O
12	O
-	O
month	O
colonization	O
patterns	O
.	O

Submucosal	O
/	O
subgingival	O
plaque	O
samples	O
from	O
17	O
titanium	O
oral	O
implants	O
and	O
adjacent	O
teeth	O
were	O
analyzed	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
30	O
min	O
,	O
12	O
weeks	O
and	O
12	O
months	O
after	O
implant	O
installation	O
.	O

At	O
12	O
months	O
,	O
none	O
of	O
the	O
inserted	O
implants	O
had	O
been	O
lost	O
or	O
presented	O
with	O
signs	O
of	O
peri	O
-	O
implantitis	O
.	O

The	O
distribution	O
of	O
sites	O
at	O
implants	O
and	O
teeth	O
with	O
bleeding	O
on	O
probing	O
varied	O
between	O
2	O
%	O
and	O
11	O
%	O
.	O

Probing	O
pocket	O
depths	O
<	O
or	O
=	O
3	O
mm	O
were	O
found	O
at	O
75	O
%	O
of	O
implant	O
sites	O
.	O

At	O
12	O
months	O
,	O
the	O
sum	O
of	O
the	O
bacterial	O
counts	O
of	O
40	O
species	O
was	O
statistically	O
significantly	O
higher	O
at	O
tooth	O
compared	O
with	O
implant	O
sites	O
(	O
mean	O
difference	O
:	O
34	O
.	O
4	O
x	O
10	O
(	O
5	O
)	O
,	O
95	O
%	O
confidence	O
interval	O
-	O
0	O
.	O
4	O
to	O
69	O
.	O
4	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

At	O
12	O
months	O
,	O
higher	O
individual	O
bacterial	O
counts	O
at	O
tooth	O
sites	O
were	O
found	O
for	O
7	O
/	O
40	O
species	O
compared	O
with	O
implant	O
sites	O
.	O

Detection	O
or	O
lack	O
of	O
detection	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
at	O
implant	O
sites	O
at	O
12	O
weeks	O
resulted	O
in	O
the	O
highest	O
positive	O
(	O
e	O
.	O
g	O
.	O
80	O
%	O
)	O
and	O
negative	O
(	O
e	O
.	O
g	O
.	O
90	O
%	O
)	O
predictive	O
values	O
,	O
respectively	O
.	O

Between	O
12	O
weeks	O
and	O
12	O
months	O
,	O
the	O
prevalence	O
of	O
Tannerella	B-bacteria
forsythia	I-bacteria
increased	O
statistically	O
significantly	O
at	O
implant	O
sites	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Lack	O
of	O
detection	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
at	O
12	O
weeks	O
yielded	O
a	O
negative	O
predictive	O
value	O
of	O
93	O
.	O
1	O
%	O
of	O
this	O
microorganism	O
being	O
undetectable	O
at	O
implant	O
sites	O
at	O
12	O
months	O
.	O

Within	O
the	O
limits	O
of	O
this	O
study	O
,	O
the	O
findings	O
showed	O
(	O
i	O
)	O
a	O
few	O
differences	O
in	O
the	O
prevalence	O
of	O
bacterial	O
species	O
between	O
implant	O
and	O
adjacent	O
tooth	O
sites	O
at	O
12	O
months	O
and	O
(	O
ii	O
)	O
high	O
positive	O
and	O
negative	O
predictive	O
values	O
for	O
selected	O
bacterial	O
species	O
.	O

To	O
determine	O
the	O
effectiveness	O
of	O
oral	O
decontamination	O
with	O
2	O
%	O
chlorhexidine	O
solution	O
for	O
the	O
prevention	O
of	O
ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
.	O

Randomized	O
controlled	O
trial	O
and	O
meta	O
-	O
analysis	O
.	O

A	O
tertiary	O
care	O
university	O
hospital	O
in	O
Bangkok	O
,	O
Thailand	O
.	O

Adult	O
patients	O
who	O
received	O
mechanical	O
ventilation	O
and	O
who	O
were	O
hospitalized	O
in	O
intensive	O
care	O
units	O
and	O
general	O
medical	O
wards	O
.	O

The	O
patients	O
were	O
randomized	O
to	O
receive	O
oral	O
decontamination	O
with	O
2	O
%	O
chlorhexidine	O
solution	O
or	O
normal	O
saline	O
solution	O
4	O
times	O
per	O
day	O
until	O
their	O
endotracheal	O
tubes	O
were	O
removed	O
.	O

The	O
outcome	O
measures	O
were	O
the	O
development	O
of	O
VAP	O
and	O
oropharyngeal	O
colonization	O
with	O
gram	O
-	O
negative	O
bacilli	O
.	O

Meta	O
-	O
analysis	O
was	O
performed	O
by	O
combining	O
the	O
results	O
of	O
the	O
present	O
study	O
with	O
those	O
from	O
another	O
randomized	O
controlled	O
trial	O
that	O
also	O
used	O
a	O
2	O
%	O
chlorhexidine	O
formulation	O
for	O
oral	O
decontamination	O
.	O

The	O
characteristics	O
of	O
the	O
patients	O
in	O
the	O
chlorhexidine	O
group	O
(	O
n	O
=	O
102	O
)	O
and	O
the	O
normal	O
saline	O
group	O
(	O
n	O
=	O
105	O
)	O
were	O
not	O
significantly	O
different	O
.	O

The	O
incidence	O
of	O
VAP	O
in	O
the	O
chlorhexidine	O
group	O
was	O
4	O
.	O
9	O
%	O
(	O
5	O
of	O
102	O
)	O
,	O
and	O
the	O
incidence	O
in	O
the	O
normal	O
saline	O
group	O
was	O
11	O
.	O
4	O
%	O
(	O
12	O
of	O
105	O
)	O
(	O
P	O
=	O
.	O
08	O
)	O
.	O

The	O
rate	O
of	O
VAP	O
in	O
the	O
chlorhexidine	O
group	O
was	O
7	O
episodes	O
per	O
1	O
,	O
000	O
ventilator	O
-	O
days	O
,	O
and	O
the	O
rate	O
in	O
the	O
normal	O
saline	O
group	O
was	O
21	O
episodes	O
per	O
1	O
,	O
000	O
ventilator	O
-	O
days	O
(	O
P	O
=	O
.	O
04	O
)	O
.	O

Irritation	O
of	O
the	O
oral	O
mucosa	O
was	O
observed	O
in	O
10	O
(	O
9	O
.	O
8	O
%	O
)	O
of	O
the	O
patients	O
in	O
the	O
chlorhexidine	O
group	O
and	O
in	O
1	O
(	O
0	O
.	O
9	O
%	O
)	O
of	O
the	O
patients	O
in	O
the	O
normal	O
saline	O
group	O
(	O
P	O
=	O
.	O
001	O
)	O
.	O

Oropharyngeal	O
colonization	O
with	O
gram	O
-	O
negative	O
bacilli	O
was	O
either	O
reduced	O
or	O
delayed	O
in	O
the	O
chlorhexidine	O
group	O
.	O

Overall	O
mortality	O
of	O
the	O
patients	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
groups	O
.	O

Meta	O
-	O
analysis	O
of	O
2	O
randomized	O
controlled	O
trials	O
revealed	O
an	O
overall	O
relative	O
risk	O
of	O
VAP	O
for	O
patients	O
in	O
the	O
chlorhexidine	O
group	O
of	O
0	O
.	O
53	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
31	O
-	O
0	O
.	O
90	O
;	O
P	O
=	O
.	O
02	O
)	O
.	O

Oral	O
decontamination	O
with	O
2	O
%	O
chlorhexidine	O
solution	O
is	O
an	O
effective	O
and	O
safe	O
method	O
for	O
preventing	O
VAP	O
in	O
patients	O
who	O
receive	O
mechanical	O
ventilation	O
.	O

Oral	O
microbes	O
that	O
colonize	O
in	O
the	O
mouths	O
of	O
humans	O
contribute	O
to	O
disease	O
susceptibility	O
,	O
but	O
it	O
is	O
unclear	O
if	O
host	O
genetic	O
factors	O
mediate	O
colonization	O
.	O

We	O
therefore	O
tested	O
the	O
hypothesis	O
that	O
the	O
levels	O
at	O
which	O
oral	O
microbes	O
colonize	O
in	O
the	O
mouth	O
are	O
heritable	O
.	O

Dental	O
plaque	O
biofilms	O
were	O
sampled	O
from	O
intact	O
tooth	O
surfaces	O
of	O
118	O
caries	O
-	O
free	O
twins	O
.	O

An	O
additional	O
86	O
caries	O
-	O
active	O
twins	O
were	O
sampled	O
for	O
plaque	O
from	O
carious	O
lesions	O
and	O
intact	O
tooth	O
surfaces	O
.	O

Using	O
a	O
reverse	O
capture	O
checkerboard	O
assay	O
the	O
relative	O
abundance	O
of	O
82	O
bacterial	O
species	O
was	O
determined	O
.	O

An	O
integrative	O
computational	O
predictive	O
model	O
determined	O
microbial	O
abundance	O
patterns	O
of	O
microbial	O
species	O
in	O
caries	O
-	O
free	O
twins	O
as	O
compared	O
to	O
caries	O
-	O
active	O
twins	O
.	O

Heritability	O
estimates	O
were	O
calculated	O
for	O
the	O
relative	O
microbial	O
abundance	O
levels	O
of	O
the	O
microbial	O
species	O
in	O
both	O
groups	O
.	O

The	O
levels	O
of	O
10	O
species	O
were	O
significantly	O
different	O
in	O
healthy	O
individuals	O
than	O
in	O
caries	O
-	O
active	O
individuals	O
,	O
including	O
,	O
A	B-bacteria
.	I-bacteria
defectiva	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
parasanguinis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
/	I-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
clone	I-bacteria
CH016	I-bacteria
,	O
G	B-bacteria
.	I-bacteria
morbillorum	I-bacteria
and	O
G	B-bacteria
.	I-bacteria
haemolysans	I-bacteria
.	O

Moderate	O
to	O
high	O
heritability	O
estimates	O
were	O
found	O
for	O
these	O
species	O
(	O
h	O
(	O
2	O
)	O
=	O
56	O
%	O
-	O
80	O
%	O
,	O
p	O
<	O
.	O
0001	O
)	O
.	O

Similarity	O
of	O
the	O
overall	O
oral	O
microbial	O
flora	O
was	O
also	O
evident	O
in	O
caries	O
-	O
free	O
twins	O
from	O
multivariate	O
distance	O
matrix	O
regression	O
analysis	O
.	O

It	O
appears	O
that	O
genetic	O
and	O
/	O
or	O
familial	O
factors	O
significantly	O
contribute	O
to	O
the	O
colonization	O
of	O
oral	O
beneficial	O
species	O
in	O
twins	O
.	O

To	O
identify	O
the	O
predictors	O
of	O
early	O
childhood	O
caries	O
and	O
urgent	O
dental	O
treatment	O
need	O
among	O
primarily	O
African	O
-	O
American	O
children	O
in	O
child	O
care	O
centers	O
in	O
the	O
Delta	O
region	O
of	O
Mississippi	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
replicate	O
predictors	O
of	O
caries	O
and	O
urgent	O
dental	O
treatment	O
needs	O
that	O
were	O
identified	O
in	O
an	O
earlier	O
study	O
conducted	O
in	O
Delta	O
child	O
care	O
centers	O
and	O
to	O
assess	O
additional	O
caries	O
risk	O
factors	O
not	O
collected	O
in	O
the	O
original	O
study	O
.	O

Children	O
in	O
19	O
child	O
care	O
centers	O
were	O
examined	O
by	O
the	O
dentists	O
,	O
and	O
the	O
parents	O
provided	O
data	O
on	O
oral	O
health	O
practices	O
,	O
oral	O
health	O
history	O
,	O
and	O
on	O
children	O
'	O
s	O
oral	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
QOL	O
)	O
.	O

The	O
dentists	O
also	O
assessed	O
visible	O
plaque	O
and	O
tested	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Predictors	O
of	O
caries	O
and	O
treatment	O
need	O
among	O
children	O
24	O
to	O
71	O
months	O
of	O
age	O
were	O
examined	O
using	O
logistic	O
regression	O
.	O

Two	O
parent	O
predictors	O
of	O
caries	O
identified	O
in	O
the	O
earlier	O
study	O
(	O
parent	O
flossing	O
and	O
soft	O
/	O
sugary	O
drink	O
consumption	O
)	O
were	O
not	O
predictive	O
in	O
the	O
current	O
study	O
.	O

Parent	O
history	O
of	O
abscess	O
continued	O
to	O
predict	O
their	O
child	O
'	O
s	O
urgent	O
need	O
for	O
treatment	O
.	O

Young	O
children	O
'	O
s	O
level	O
of	O
salivary	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
maxillary	O
incisor	O
visible	O
plaque	O
,	O
and	O
parents	O
'	O
reports	O
of	O
child	O
oral	O
health	O
-	O
related	O
QOL	O
measures	O
predicted	O
the	O
presence	O
of	O
both	O
caries	O
and	O
urgent	O
treatment	O
need	O
.	O

Some	O
expected	O
predictors	O
,	O
such	O
as	O
frequency	O
of	O
child	O
'	O
s	O
toothbrushing	O
,	O
were	O
not	O
predictive	O
of	O
caries	O
.	O

Parental	O
abscess	O
and	O
parent	O
'	O
s	O
report	O
of	O
the	O
child	O
'	O
s	O
oral	O
health	O
-	O
related	O
OOL	O
are	O
risk	O
indicators	O
for	O
poor	O
oral	O
health	O
outcomes	O
that	O
could	O
be	O
used	O
by	O
nondental	O
personnel	O
to	O
identify	O
young	O
children	O
in	O
need	O
of	O
early	O
preventive	O
intervention	O
and	O
dental	O
referral	O

Even	O
though	O
animal	O
models	O
have	O
limitations	O
,	O
they	O
are	O
often	O
superior	O
to	O
in	O
vitro	O
or	O
clinical	O
studies	O
in	O
addressing	O
mechanistic	O
questions	O
and	O
serve	O
as	O
an	O
essential	O
link	O
between	O
hypotheses	O
and	O
human	O
patients	O
.	O

Periodontal	O
disease	O
can	O
be	O
viewed	O
as	O
a	O
process	O
that	O
involves	O
four	O
major	O
stages	O
:	O
bacterial	O
colonization	O
,	O
invasion	O
,	O
induction	O
of	O
a	O
destructive	O
host	O
response	O
in	O
connective	O
tissue	O
and	O
a	O
repair	O
process	O
that	O
reduces	O
the	O
extent	O
of	O
tissue	O
breakdown	O
.	O

Animal	O
studies	O
should	O
be	O
evaluated	O
in	O
terms	O
of	O
their	O
capacity	O
to	O
test	O
specific	O
hypotheses	O
rather	O
than	O
their	O
fidelity	O
to	O
all	O
aspects	O
of	O
periodontal	O
disease	O
initiation	O
and	O
progression	O
.	O

Thus	O
,	O
each	O
of	O
the	O
models	O
described	O
below	O
can	O
be	O
adapted	O
to	O
test	O
discrete	O
components	O
of	O
these	O
four	O
major	O
steps	O
,	O
but	O
not	O
all	O
of	O
them	O
.	O

This	O
review	O
describes	O
five	O
different	O
animal	O
models	O
that	O
are	O
appropriate	O
for	O
examining	O
components	O
of	O
host	O
-	O
bacteria	O
interactions	O
that	O
can	O
lead	O
to	O
breakdown	O
of	O
hard	O
and	O
soft	O
connective	O
tissue	O
or	O
conditions	O
that	O
limit	O
its	O
repair	O
as	O
follows	O
:	O
the	O
mouse	O
calvarial	O
model	O
,	O
murine	O
oral	O
gavage	O
models	O
with	O
or	O
without	O
adoptive	O
transfer	O
of	O
human	O
lymphocytes	O
,	O
rat	O
ligature	O
model	O
and	O
rat	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
feeding	O
model	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
causes	O
dental	O
caries	O
and	O
infective	O
endocarditis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
genomic	O
diversity	O
among	O
serotype	O
c	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
laboratory	O
and	O
clinical	O
strains	O
and	O
to	O
characterize	O
the	O
genetic	O
events	O
involved	O
.	O

A	O
genome	O
-	O
based	O
approach	O
using	O
PFGE	O
coupled	O
with	O
Southern	O
hybridization	O
was	O
employed	O
to	O
examine	O
a	O
total	O
of	O
58	O
serotype	O
c	O
oral	O
and	O
blood	O
isolates	O
and	O
seven	O
laboratory	O
strains	O
and	O
to	O
compare	O
them	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
UA159	I-bacteria
.	O

No	O
significant	O
differences	O
were	O
found	O
in	O
the	O
phenotypic	O
characteristics	O
of	O
the	O
strains	O
tested	O
,	O
except	O
that	O
some	O
of	O
the	O
strains	O
exhibited	O
smooth	O
rather	O
than	O
rough	O
colony	O
morphology	O
.	O

In	O
contrast	O
,	O
PFGE	O
profiles	O
of	O
clinical	O
isolates	O
,	O
from	O
either	O
diseased	O
or	O
healthy	O
subjects	O
,	O
exhibited	O
diverse	O
patterns	O
,	O
suggesting	O
that	O
recombination	O
or	O
point	O
mutations	O
occurred	O
frequently	O
in	O
vivo	O
.	O

Diverse	O
PFGE	O
patterns	O
,	O
with	O
various	O
lengths	O
of	O
insertions	O
and	O
deletions	O
,	O
could	O
be	O
detected	O
even	O
within	O
a	O
localized	O
chromosomal	O
region	O
between	O
rRNA	O
operons	O
.	O

Comparative	O
analysis	O
using	O
Southern	O
hybridization	O
with	O
specific	O
markers	O
revealed	O
that	O
a	O
large	O
chromosomal	O
inversion	O
had	O
also	O
occurred	O
between	O
rrn	O
operons	O
in	O
25	O
strains	O
.	O

To	O
analyse	O
the	O
microbial	O
flora	O
in	O
specific	O
oral	O
sites	O
in	O
13	O
dentate	O
subjects	O
,	O
6	O
-	O
8	O
months	O
after	O
completed	O
radiation	O
therapy	O
(	O
RT	O
group	O
)	O
and	O
in	O
13	O
matched	O
controls	O
.	O

The	O
microflora	O
on	O
the	O
tongue	O
,	O
buccal	O
mucosa	O
,	O
vestibulum	O
,	O
supragingival	O
plaque	O
and	O
subgingival	O
region	O
was	O
analysed	O
using	O
duplicate	O
sampling	O
and	O
cultivation	O
technique	O
.	O

A	O
clinical	O
examination	O
was	O
also	O
performed	O
.	O

Candida	O
albicans	O
was	O
found	O
in	O
one	O
or	O
more	O
sites	O
in	O
54	O
%	O
of	O
the	O
RT	O
subjects	O
and	O
in	O
15	O
%	O
of	O
the	O
controls	O
.	O

In	O
three	O
RT	O
subjects	O
,	O
C	O
.	O
albicans	O
was	O
found	O
at	O
all	O
four	O
sites	O
analysed	O
.	O

An	O
unexpected	O
finding	O
was	O
that	O
enterococci	B-bacteria
were	O
found	O
in	O
all	O
RT	O
subjects	O
and	O
in	O
high	O
number	O
in	O
38	O
%	O
.	O

None	O
of	O
the	O
controls	O
harboured	O
enterococci	B-bacteria
.	O

In	O
supragingival	O
plaque	O
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
detected	O
in	O
92	O
%	O
of	O
the	O
RT	O
subjects	O
and	O
the	O
number	O
and	O
proportion	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
extremely	O
high	O
compared	O
with	O
the	O
controls	O
.	O

Mutans	B-bacteria
streptococci	I-bacteria
were	O
detected	O
in	O
high	O
numbers	O
in	O
31	O
%	O
of	O
the	O
RT	O
subjects	O
,	O
while	O
they	O
were	O
not	O
detected	O
in	O
23	O
%	O
.	O

The	O
microbial	O
results	O
explain	O
why	O
some	O
RT	O
subjects	O
have	O
an	O
increased	O
susceptibility	O
to	O
oral	O
diseases	O
and	O
stress	O
that	O
site	O
-	O
specific	O
microbial	O
analysis	O
is	O
an	O
important	O
diagnostic	O
tool	O
when	O
planning	O
oral	O
health	O
preventive	O
care	O
for	O
RT	O
subjects	O
.	O

Although	O
Streptococcus	B-bacteria
mutans	I-bacteria
has	O
been	O
implicated	O
as	O
a	O
major	O
etiological	O
agent	O
of	O
dental	O
caries	O
,	O
our	O
cross	O
-	O
sectional	O
preliminary	O
study	O
indicated	O
that	O
10	O
%	O
of	O
subjects	O
with	O
rampant	O
caries	O
in	O
permanent	O
teeth	O
do	O
not	O
have	O
detectable	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Our	O
aims	O
were	O
to	O
use	O
molecular	O
methods	O
to	O
detect	O
all	O
bacterial	O
species	O
associated	O
with	O
caries	O
in	O
primary	O
and	O
permanent	O
teeth	O
and	O
to	O
determine	O
the	O
bacterial	O
profiles	O
associated	O
with	O
different	O
disease	O
states	O
.	O

Plaque	O
was	O
collected	O
from	O
39	O
healthy	O
controls	O
and	O
from	O
intact	O
enamel	O
and	O
white	O
-	O
spot	O
lesions	O
,	O
dentin	O
lesions	O
,	O
and	O
deep	O
-	O
dentin	O
lesions	O
in	O
each	O
of	O
51	O
subjects	O
with	O
severe	O
caries	O
.	O

16S	O
rRNA	O
genes	O
were	O
PCR	O
amplified	O
,	O
cloned	O
,	O
and	O
sequenced	O
to	O
determine	O
species	O
identities	O
.	O

In	O
a	O
reverse	O
-	O
capture	O
checkerboard	O
assay	O
,	O
243	O
samples	O
were	O
analyzed	O
for	O
110	O
prevalent	O
bacterial	O
species	O
.	O

A	O
sequencing	O
analysis	O
of	O
1	O
,	O
285	O
16S	O
rRNA	O
clones	O
detected	O
197	O
bacterial	O
species	O
/	O
phylotypes	O
,	O
of	O
which	O
50	O
%	O
were	O
not	O
cultivable	O
.	O

Twenty	O
-	O
two	O
new	O
phylotypes	O
were	O
identified	O
.	O

PROC	O
MIXED	O
tests	O
revealed	O
health	O
-	O
and	O
disease	O
-	O
associated	O
species	O
.	O

In	O
subjects	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
additional	O
species	O
,	O
e	O
.	O
g	O
.	O
,	O
species	O
of	O
the	O
genera	O
Atopobium	B-bacteria
,	O
Propionibacterium	B-bacteria
,	O
and	O
Lactobacillus	B-bacteria
,	O
were	O
present	O
at	O
significantly	O
higher	O
levels	O
than	O
those	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
,	O
and	O
low	O
-	O
pH	O
non	O
-	O
S	O
.	O
mutans	B-bacteria
streptococci	I-bacteria
were	O
predominant	O
in	O
subjects	O
with	O
no	O
detectable	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
non	O
-	O
S	O
.	O
mutans	B-bacteria
streptococci	I-bacteria
were	O
predominant	O
in	O
white	O
-	O
spot	O
lesions	O
,	O
while	O
known	O
acid	O
producers	O
were	O
found	O
at	O
their	O
highest	O
levels	O
later	O
in	O
disease	O
.	O

Bacterial	O
profiles	O
change	O
with	O
disease	O
states	O
and	O
differ	O
between	O
primary	O
and	O
secondary	O
dentitions	O
.	O

Bacterial	O
species	O
other	O
than	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
e	O
.	O
g	O
.	O
,	O
species	O
of	O
the	O
genera	O
Veillonella	B-bacteria
,	O
Lactobacillus	B-bacteria
,	O
Bifidobacterium	B-bacteria
,	O
and	O
Propionibacterium	B-bacteria
,	O
low	O
-	O
pH	O
non	B-bacteria
-	I-bacteria
S	I-bacteria
.	I-bacteria
mutans	I-bacteria
streptococci	I-bacteria
,	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Atopobium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
likely	O
play	O
important	O
roles	O
in	O
caries	O
progression	O
.	O

Bacteria	O
of	O
the	O
genus	O
Capnocytophaga	B-bacteria
form	O
part	O
of	O
the	O
resident	O
oral	O
flora	O
in	O
children	O
and	O
adults	O
.	O

They	O
are	O
recognized	O
as	O
opportunistic	O
pathogens	O
of	O
various	O
extra	O
-	O
oral	O
infections	O
.	O

The	O
significance	O
of	O
individual	O
species	O
in	O
periodontal	O
and	O
extra	O
-	O
oral	O
diseases	O
is	O
unclear	O
,	O
due	O
to	O
the	O
inability	O
of	O
conventional	O
phenotypic	O
tests	O
to	O
identify	O
clinical	O
isolates	O
to	O
species	O
level	O
.	O

Aiming	O
at	O
a	O
clear	O
distinction	O
between	O
species	O
,	O
we	O
undertook	O
a	O
phylogenetic	O
study	O
of	O
a	O
collection	O
of	O
102	O
Capnocytophaga	B-bacteria
strains	I-bacteria
including	O
62	O
oral	O
isolates	O
from	O
children	O
and	O
40	O
reference	O
strains	O
from	O
oral	O
and	O
extra	O
-	O
oral	O
infections	O
representing	O
the	O
five	O
known	O
,	O
human	O
,	O
oral	O
Capnocytophaga	B-bacteria
species	I-bacteria
.	O

The	O
phylogeny	O
was	O
estimated	O
on	O
the	O
basis	O
of	O
multilocus	O
enzyme	O
electrophoresis	O
(	O
MLEE	O
)	O
of	O
12	O
intracellular	O
,	O
housekeeping	O
enzymes	O
and	O
by	O
partial	O
16S	O
rRNA	O
gene	O
sequencing	O
,	O
and	O
was	O
compared	O
to	O
phenotypic	O
characteristics	O
.	O

The	O
clustering	O
profiles	O
in	O
the	O
MLEE	O
and	O
sequence	O
-	O
based	O
dendrograms	O
were	O
concordant	O
and	O
allowed	O
identification	O
of	O
isolates	O
to	O
species	O
level	O
,	O
based	O
on	O
co	O
-	O
clustering	O
with	O
reference	O
strains	O
.	O

The	O
study	O
confirmed	O
Capnocytophaga	B-bacteria
ochracea	I-bacteria
and	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
as	O
separate	O
species	O
,	O
and	O
underlined	O
the	O
problems	O
of	O
distinguishing	O
between	O
them	O
by	O
conventional	O
phenotypic	O
tests	O
.	O

The	O
presence	O
of	O
two	O
distinct	O
clusters	O
of	O
oral	O
isolates	O
from	O
children	O
indicated	O
the	O
existence	O
of	O
novel	O
species	O
,	O
supported	O
by	O
analysis	O
of	O
near	O
-	O
full	O
-	O
length	O
16S	O
rRNA	O
gene	O
sequences	O
and	O
by	O
DNA	O
-	O
DNA	O
hybridization	O
results	O
.	O

One	O
cluster	O
of	O
weakly	O
saccharolytic	O
isolates	O
without	O
the	O
ability	O
to	O
ferment	O
sucrose	O
is	O
proposed	O
as	O
Capnocytophaga	B-bacteria
leadbetteri	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
(	O
type	O
strain	O
AHN8855	B-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
51857	I-bacteria
(	O
T	O
)	O
=	O
NCTC	B-bacteria
13375	I-bacteria
(	O
T	O
)	O
)	O
.	O

Another	O
cluster	O
not	O
phenotypically	O
distinguishable	O
from	O
C	B-bacteria
.	I-bacteria
ochracea	I-bacteria
and	O
C	B-bacteria
.	I-bacteria
sputigena	I-bacteria
is	O
designated	O
Capnocytophaga	B-bacteria
genospecies	I-bacteria
AHN8471	I-bacteria
(	O
represented	O
by	O
strain	O
AHN8471	B-bacteria
=	O
CCUG	B-bacteria
51856	I-bacteria
=	O
NCTC	B-bacteria
13374	I-bacteria
)	O
.	O

The	O
roles	O
of	O
the	O
'	O
classical	O
'	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
as	O
colonizers	O
of	O
oral	O
cavities	O
of	O
man	O
and	O
animals	O
,	O
in	O
development	O
of	O
intra	O
-	O
oral	O
infections	O
and	O
as	O
agents	O
of	O
actinomycosis	O
have	O
been	O
well	O
documented	O
.	O

This	O
mini	O
-	O
review	O
focuses	O
on	O
perceptions	O
of	O
human	O
colonization	O
and	O
infection	O
that	O
have	O
emerged	O
in	O
the	O
past	O
decade	O
,	O
largely	O
as	O
a	O
result	O
of	O
advances	O
in	O
classification	O
,	O
identification	O
and	O
direct	O
detection	O
from	O
clinical	O
material	O
.	O

Arguably	O
,	O
of	O
the	O
greatest	O
importance	O
is	O
the	O
recognition	O
of	O
actinomycosis	O
as	O
a	O
major	O
factor	O
and	O
indicator	O
of	O
poor	O
prognosis	O
in	O
both	O
infected	O
osteoradionecrosis	O
and	O
bisphosphonate	O
-	O
associated	O
osteonecrosis	O
of	O
the	O
jaws	O
.	O

Among	O
recently	O
described	O
species	O
,	O
Actinomyces	B-bacteria
graevenitzii	I-bacteria
has	O
been	O
isolated	O
almost	O
exclusively	O
from	O
oral	O
and	O
respiratory	O
sites	O
and	O
may	O
be	O
a	O
causative	O
agent	O
of	O
actinomycosis	O
.	O

Conversely	O
,	O
several	O
other	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
are	O
isolated	O
commonly	O
from	O
superficial	O
soft	O
tissue	O
infections	O
.	O

Members	O
of	O
the	O
genus	O
Actinobaculum	B-bacteria
,	O
which	O
is	O
closely	O
related	O
to	O
Actinomyces	B-bacteria
,	O
are	O
strongly	O
associated	O
with	O
urosepsis	O
.	O

Isolation	O
and	O
identification	O
of	O
Actinomyces	B-bacteria
and	O
related	O
genera	O
by	O
conventional	O
methods	O
remain	O
difficult	O
.	O

Diagnosis	O
is	O
commonly	O
belated	O
and	O
based	O
solely	O
upon	O
histological	O
findings	O
.	O

Development	O
of	O
direct	O
detection	O
methods	O
may	O
aid	O
patient	O
management	O
and	O
further	O
elucidate	O
clinical	O
associations	O
.	O

A	O
microscopic	O
method	O
for	O
noninvasively	O
visualizing	O
the	O
action	O
of	O
an	O
antimicrobial	O
agent	O
inside	O
a	O
biofilm	O
was	O
developed	O
and	O
applied	O
to	O
describe	O
spatial	O
and	O
temporal	O
patterns	O
of	O
mouthrinse	O
activity	O
on	O
model	O
oral	O
biofilms	O
.	O

Three	O
species	O
biofilms	O
of	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
were	O
grown	O
in	O
glass	O
capillary	O
flow	O
cells	O
.	O

Bacterial	O
cells	O
were	O
stained	O
with	O
the	O
fluorogenic	O
esterase	O
substrate	O
Calcien	O
AM	O
(	O
CAM	O
)	O
.	O

Loss	O
of	O
green	O
fluorescence	O
upon	O
exposure	O
to	O
an	O
antimicrobial	O
formulation	O
was	O
subsequently	O
imaged	O
by	O
time	O
-	O
lapse	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

When	O
an	O
antimicrobial	O
mouthrinse	O
containing	O
chlorhexidine	O
digluconate	O
was	O
administered	O
,	O
a	O
gradual	O
loss	O
of	O
green	O
fluorescence	O
was	O
observed	O
that	O
began	O
at	O
the	O
periphery	O
of	O
cell	O
clusters	O
where	O
they	O
adjoined	O
the	O
flowing	O
bulk	O
fluid	O
and	O
progressed	O
inward	O
over	O
a	O
time	O
period	O
of	O
several	O
minutes	O
.	O

Image	O
analysis	O
was	O
performed	O
to	O
quantify	O
a	O
penetration	O
velocity	O
of	O
4	O
mum	O
/	O
min	O
.	O

An	O
enzyme	O
-	O
based	O
antimicrobial	O
formulation	O
led	O
to	O
a	O
gradual	O
,	O
continually	O
slowing	O
loss	O
of	O
fluorescence	O
in	O
a	O
pattern	O
that	O
was	O
qualitatively	O
different	O
from	O
the	O
behavior	O
observed	O
with	O
chlorhexidine	O
.	O

Ethanol	O
at	O
11	O
.	O
6	O
%	O
had	O
little	O
effect	O
on	O
the	O
biofilm	O
.	O

None	O
of	O
these	O
treatments	O
resulted	O
in	O
the	O
removal	O
of	O
biomass	O
from	O
the	O
biofilm	O
.	O

Most	O
methods	O
to	O
measure	O
or	O
visualize	O
antimicrobial	O
action	O
in	O
biofilms	O
are	O
destructive	O
.	O

Spatial	O
information	O
is	O
important	O
because	O
biofilms	O
are	O
known	O
for	O
their	O
structural	O
and	O
physiological	O
heterogeneity	O
.	O

The	O
CAM	O
staining	O
technique	O
has	O
the	O
potential	O
to	O
provide	O
information	O
about	O
the	O
rate	O
of	O
antimicrobial	O
penetration	O
,	O
the	O
presence	O
of	O
tolerant	O
subpopulations	O
,	O
and	O
the	O
extent	O
of	O
biomass	O
removal	O
effected	O
by	O
a	O
treatment	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
whether	O
wild	O
-	O
thyme	O
(	O
Thymus	O
serpyllum	O
)	O
hydrosol	O
had	O
a	O
preserving	O
effect	O
against	O
spoilage	O
of	O
freshwater	O
fish	O
.	O

Sensorial	O
characteristics	O
,	O
chemical	O
freshness	O
indicator	O
contents	O
,	O
and	O
microbial	O
counts	O
(	O
total	O
aerobes	O
,	O
psychrotrophics	O
,	O
Enterobacteriaceae	B-bacteria
,	O
fecal	B-bacteria
coliform	I-bacteria
bacteria	I-bacteria
,	O
Aeromonas	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
of	O
whole	O
ungutted	O
and	O
gutted	O
Transcaucasian	O
barb	O
(	O
Capoeta	O
capoeta	O
capoeta	O
Guldenstaedt	O
,	O
1772	O
)	O
stored	O
on	O
ice	O
produced	O
from	O
wild	O
-	O
thyme	O
hydrosol	O
and	O
tap	O
water	O
at	O
4	O
degrees	O
C	O
for	O
20	O
days	O
were	O
compared	O
.	O

The	O
results	O
did	O
not	O
reveal	O
any	O
significant	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
differences	O
in	O
the	O
microbial	O
counts	O
,	O
sensorial	O
characteristics	O
,	O
pH	O
,	O
and	O
total	O
volatile	O
basic	O
nitrogen	O
values	O
between	O
gutted	O
and	O
ungutted	O
groups	O
.	O

Sensory	O
evaluation	O
and	O
microbiological	O
and	O
chemical	O
analyses	O
indicated	O
that	O
the	O
storage	O
of	O
the	O
fish	O
on	O
ice	O
produced	O
from	O
wild	O
-	O
thyme	O
hydrosol	O
had	O
a	O
significant	O
increase	O
in	O
shelf	O
life	O
by	O
at	O
least	O
15	O
to	O
20	O
days	O
.	O

Frequent	O
occurrence	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
in	O
the	O
human	O
gastrointestinal	O
tract	O
and	O
its	O
persistence	O
due	O
to	O
unsuccessful	O
antimicrobial	O
therapy	O
might	O
be	O
related	O
to	O
a	O
stage	O
in	O
the	O
life	O
cycle	O
of	O
H	O
.	O
pylori	O
in	O
which	O
the	O
bacterium	O
establishes	O
itself	O
as	O
an	O
intracellular	O
symbiont	O
in	O
yeast	O
.	O

In	O
this	O
study	O
,	O
occurrence	O
of	O
non	O
-	O
culturable	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
yeast	O
was	O
assessed	O
by	O
targeting	O
vacuolating	O
cytotoxin	O
A	O
(	O
vacA	O
s1s2	O
)	O
and	O
ureAB	O
genes	O
in	O
the	O
total	O
DNAs	O
of	O
yeasts	O
.	O

DNAs	O
were	O
extracted	O
from	O
13	O
oral	O
yeasts	O
in	O
which	O
bacterium	O
-	O
like	O
bodies	O
,	O
suspected	O
to	O
be	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
were	O
observed	O
microscopically	O
.	O

Primers	O
were	O
recruited	O
to	O
amplify	O
vacA	O
s1s2	O
and	O
ureAB	O
genes	O
.	O

DNAs	O
from	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
used	O
as	O
controls	O
.	O

The	O
amplicons	O
from	O
one	O
yeast	O
and	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
were	O
sequenced	O
.	O

Yeasts	O
were	O
identified	O
as	O
Candida	O
albicans	O
.	O

Fragments	O
of	O
vacA	O
s1s2	O
and	O
ureAB	O
genes	O
were	O
amplified	O
from	O
13	O
yeasts	O
.	O

The	O
size	O
of	O
PCR	O
products	O
was	O
286	O
bp	O
for	O
vacA	O
s1s2	O
gene	O
and	O
406	O
bp	O
for	O
ureAB	O
gene	O
.	O

Similar	O
bands	O
were	O
obtained	O
from	O
the	O
control	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
and	O
the	O
results	O
for	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
negative	O
.	O

The	O
data	O
from	O
sequencing	O
of	O
PCR	O
products	O
showed	O
about	O
98	O
%	O
homology	O
between	O
the	O
genes	O
amplified	O
from	O
yeast	O
and	O
those	O
from	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

The	O
results	O
of	O
this	O
study	O
showed	O
the	O
intracellular	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
yeast	O
.	O

This	O
endosymbiotic	O
relationship	O
might	O
explain	O
the	O
persistence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
,	O
the	O
consequence	O
of	O
which	O
could	O
be	O
reinoculation	O
of	O
the	O
stomach	O
by	O
the	O
bacterium	O
and	O
spread	O
of	O
infection	O
among	O
human	O
populations	O
.	O

Type	O
1	O
diabetes	O
mellitus	O
(	O
T1DM	O
)	O
is	O
an	O
auto	O
-	O
immune	O
disease	O
while	O
oral	O
administrating	O
its	O
autoantigens	O
could	O
be	O
a	O
treatment	O
of	O
T1DM	O
.	O

To	O
express	O
human	O
insulin	O
gene	O
(	O
ins	O
)	O
in	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
for	O
oral	O
vaccine	O
,	O
ins	O
gene	O
was	O
replaced	O
by	O
LAB	B-bacteria
bias	O
codon	O
and	O
an	O
8	O
-	O
amino	O
-	O
acid	O
-	O
residue	O
linker	O
peptide	O
forming	O
a	O
beta	O
-	O
turn	O
was	O
designed	O
to	O
link	O
insulin	O
chain	O
A	O
and	O
B	O
.	O

After	O
synthesized	O
by	O
primer	O
annealing	O
method	O
,	O
the	O
whole	O
ins	O
gene	O
was	O
fused	O
with	O
signal	O
peptide	O
sequence	O
SP	O
(	O
Usp45	O
)	O
,	O
subcloned	O
into	O
a	O
LAB	B-bacteria
secretory	O
expressive	O
vector	O
pSW501	O
and	O
then	O
introduced	O
to	O
Lactococcus	B-bacteria
lactis	I-bacteria
(	I-bacteria
L	I-bacteria
.	I-bacteria
lactis	I-bacteria
)	I-bacteria
MG1363	I-bacteria
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
(	I-bacteria
Lb	I-bacteria
.	I-bacteria
casei	I-bacteria
)	I-bacteria
ATCC27092	I-bacteria
respectively	O
.	O

Western	O
blot	O
showed	O
that	O
the	O
expression	O
product	O
(	O
SP	O
(	O
Usp45	O
)	O
-	O
INS	O
protein	O
)	O
targeted	O
mainly	O
at	O
the	O
cell	O
wall	O
while	O
little	O
was	O
found	O
in	O
cytoplasm	O
or	O
supernatant	O
.	O

The	O
highest	O
expression	O
level	O
emerged	O
in	O
exponential	O
phase	O
when	O
the	O
optical	O
density	O
at	O
600nm	O
of	O
the	O
culture	O
was	O
0	O
.	O
4	O
.	O

The	O
culture	O
of	O
the	O
recombinant	O
strain	O
Lb	B-bacteria
.	I-bacteria
casei	I-bacteria
/	O
pSW501	B-bacteria
was	O
administered	O
to	O
non	O
-	O
obese	O
diabetic	O
(	O
NOD	O
)	O
mice	O
orally	O
.	O

ELISA	O
and	O
Western	O
blot	O
results	O
showed	O
that	O
the	O
recombinant	O
strain	O
could	O
induce	O
SP	O
(	O
Usp45	O
)	O
-	O
INS	O
-	O
specific	O
antibodies	O
and	O
raise	O
IL	O
-	O
4	O
level	O
(	O
38	O
.	O
583	O
+	O
/	O
-	O
2	O
.	O
083	O
pg	O
/	O
mL	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
mice	O
'	O
s	O
sera	O
.	O

Expression	O
of	O
insulin	O
in	O
the	O
food	O
-	O
grade	O
vehicle	O
LAB	B-bacteria
could	O
induce	O
oral	O
immune	O
tolerance	O
in	O
NOD	O
mice	O
and	O
protect	O
it	O
from	O
pancreas	O
injury	O
,	O
suggesting	O
it	O
might	O
be	O
a	O
new	O
way	O
to	O
the	O
treatment	O
of	O
T1DM	O
.	O

The	O
incorporation	O
of	O
antibacterial	O
agents	O
into	O
adhesive	O
systems	O
has	O
been	O
proposed	O
to	O
eliminate	O
residual	O
bacteria	O
from	O
dentine	O
.	O

This	O
study	O
used	O
the	O
agar	O
diffusion	O
method	O
to	O
evaluate	O
the	O
antibacterial	O
activity	O
of	O
Clearfil	O
Protect	O
Bond	O
(	O
CPB	O
)	O
,	O
Clearfil	O
SE	O
Bond	O
(	O
CSEB	O
)	O
,	O
Clearfil	O
Tri	O
-	O
S	O
Bond	O
(	O
C3SB	O
)	O
and	O
Xeno	O
-	O
III	O
(	O
XIII	O
)	O
self	O
-	O
etching	O
adhesive	O
systems	O
,	O
with	O
or	O
without	O
light	O
-	O
activation	O
,	O
against	O
cariogenic	O
bacteria	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
human	O
dentine	O
on	O
the	O
antibacterial	O
activity	O
of	O
these	O
materials	O
.	O

An	O
aliquot	O
of	O
10	O
microl	O
per	O
material	O
(	O
and	O
individual	O
components	O
)	O
were	O
pipetted	O
onto	O
paper	O
and	O
dentine	O
discs	O
distributed	O
in	O
Petri	O
dishes	O
containing	O
bacterial	O
culture	O
in	O
BHI	O
agar	O
.	O

Positive	O
control	O
was	O
0	O
.	O
2	O
%	O
chlorhexidine	O
digluconate	O
(	O
CHX	O
)	O
.	O

After	O
incubation	O
,	O
the	O
adhesive	O
components	O
of	O
CPB	O
and	O
CSEB	O
,	O
liquid	O
A	O
of	O
XIII	O
and	O
C3SB	O
did	O
not	O
present	O
antibacterial	O
activity	O
when	O
applied	O
to	O
paper	O
discs	O
.	O

The	O
non	O
-	O
light	O
-	O
activated	O
CPB	O
primer	O
+	O
adhesive	O
promoted	O
the	O
greatest	O
inhibition	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
whereas	O
with	O
light	O
-	O
activation	O
,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
primer	O
+	O
adhesive	O
and	O
primer	O
alone	O
.	O

For	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
CPB	O
primer	O
presented	O
the	O
greatest	O
antibacterial	O
activity	O
in	O
both	O
light	O
-	O
activation	O
conditions	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Regarding	O
the	O
dentine	O
discs	O
,	O
only	O
CHX	O
promoted	O
an	O
inhibitory	O
effect	O
,	O
though	O
less	O
intense	O
than	O
on	O
paper	O
discs	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

CHX	O
presented	O
greater	O
antibacterial	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
than	O
against	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Light	O
-	O
activation	O
significantly	O
reduced	O
the	O
antibacterial	O
activity	O
of	O
the	O
self	O
-	O
etching	O
adhesive	O
systems	O
;	O
MDPB	O
incorporation	O
contributed	O
to	O
the	O
effect	O
of	O
adhesive	O
systems	O
against	O
cariogenic	O
bacteria	O
;	O
the	O
components	O
eluted	O
from	O
the	O
adhesive	O
systems	O
were	O
not	O
capable	O
to	O
diffuse	O
through	O
400	O
microm	O
-	O
thick	O
dentine	O
disc	O
to	O
exert	O
their	O
antibacterial	O
activity	O
against	O
cariogenic	O
bacteria	O
.	O

Cathelicidins	O
are	O
antimicrobial	O
peptides	O
found	O
in	O
epithelial	O
and	O
mucosal	O
tissues	O
as	O
well	O
as	O
the	O
secondary	O
granules	O
of	O
neutrophils	O
.	O

SMAP29	O
,	O
a	O
sheep	O
cathelicidin	O
,	O
has	O
differential	O
antimicrobial	O
properties	O
against	O
various	O
pathogens	O
,	O
including	O
periodontal	O
organisms	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
antimicrobial	O
properties	O
and	O
cytotoxicity	O
of	O
SMAP29	O
,	O
SMAP28	O
,	O
and	O
three	O
congeners	O
(	O
SMAP18A	O
,	O
SMAP18D	O
,	O
and	O
SMAP14A	O
)	O
.	O

The	O
peptides	O
at	O
concentrations	O
ranging	O
from	O
0	O
.	O
25	O
to	O
250	O
microg	O
/	O
ml	O
were	O
tested	O
for	O
their	O
activity	O
against	O
multiple	O
strains	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
using	O
a	O
radial	O
diffusion	O
assay	O
.	O

Cytotoxicity	O
of	O
keratinocytes	O
was	O
evaluated	O
by	O
measuring	O
lactate	O
dehydrogenase	O
release	O
after	O
incubation	O
with	O
the	O
individual	O
peptides	O
.	O

SMAP28	O
,	O
thought	O
to	O
be	O
the	O
biologically	O
active	O
peptide	O
,	O
was	O
the	O
most	O
potent	O
antimicrobial	O
(	O
range	O
of	O
minimum	O
inhibitory	O
concentrations	O
0	O
.	O
06	O
-	O
7	O
.	O
03	O
microg	O
/	O
ml	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
;	O
however	O
,	O
the	O
activity	O
of	O
SMAP28	O
and	O
SMAP29	O
was	O
strongly	O
associated	O
(	O
r	O
=	O
0	O
.	O
933	O
)	O
.	O

The	O
congeners	O
also	O
demonstrated	O
antimicrobial	O
activity	O
against	O
the	O
bacteria	O
tested	O
(	O
range	O
of	O
minimum	O
inhibitory	O
concnetrations	O
0	O
.	O
21	O
-	O
79	O
microg	O
/	O
ml	O
)	O
.	O

Overall	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
the	O
most	O
susceptible	O
organism	O
,	O
while	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
the	O
least	O
susceptible	O
.	O

Keratinocyte	O
cytotoxicity	O
was	O
dependent	O
on	O
peptide	O
length	O
and	O
dose	O
.	O

SMAP28	O
was	O
the	O
most	O
cytotoxic	O
,	O
while	O
SMAP14A	O
was	O
the	O
least	O
cytotoxic	O
.	O

The	O
antimicrobial	O
activities	O
against	O
oral	O
microorganisms	O
and	O
the	O
minimal	O
toxicity	O
seen	O
in	O
this	O
study	O
suggest	O
that	O
the	O
congeners	O
of	O
SMAP29	O
may	O
serve	O
as	O
an	O
alternative	O
to	O
traditional	O
antibiotics	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
periodontal	O
and	O
other	O
oral	O
diseases	O
.	O

Intestinal	O
lactobacilli	B-bacteria
have	O
been	O
successfully	O
used	O
as	O
probiotics	O
to	O
treat	O
gastrointestinal	O
disorders	O
,	O
but	O
only	O
limited	O
data	O
are	O
available	O
for	O
the	O
probiotic	O
properties	O
of	O
oral	O
lactobacilli	B-bacteria
to	O
combat	O
oral	O
diseases	O
.	O

We	O
aimed	O
to	O
characterize	O
oral	O
lactobacilli	B-bacteria
for	O
their	O
potential	O
probiotic	O
properties	O
according	O
to	O
the	O
international	O
guidelines	O
for	O
the	O
evaluation	O
of	O
probiotics	O
,	O
and	O
to	O
select	O
potential	O
probiotic	O
strains	O
for	O
oral	O
health	O
.	O

The	O
study	O
included	O
67	O
salivary	O
and	O
subgingival	O
lactobacilli	B-bacteria
of	O
10	O
species	O
,	O
isolated	O
from	O
healthy	O
humans	O
.	O

All	O
strains	O
were	O
identified	O
using	O
amplified	O
ribosomal	O
DNA	O
restriction	O
analysis	O
,	O
tested	O
for	O
antimicrobial	O
activity	O
against	O
oral	O
pathogens	O
,	O
tolerance	O
of	O
low	O
pH	O
and	O
bile	O
content	O
.	O

Thereafter	O
,	O
the	O
lysozyme	O
tolerance	O
and	O
antibiotic	O
susceptibility	O
of	O
22	O
potential	O
probiotic	O
strains	O
were	O
assessed	O
.	O

The	O
majority	O
of	O
strains	O
suppressed	O
the	O
growth	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
but	O
none	O
inhibited	O
Candida	O
albicans	O
.	O

The	O
lowest	O
pH	O
tolerated	O
by	O
lactobacilli	B-bacteria
following	O
4	O
h	O
of	O
incubation	O
was	O
pH	O
2	O
.	O
5	O
,	O
but	O
none	O
of	O
the	O
strains	O
grew	O
at	O
this	O
pH	O
.	O

All	O
strains	O
tolerated	O
a	O
high	O
concentration	O
of	O
lysozyme	O
(	O
10	O
mg	O
/	O
ml	O
)	O
and	O
half	O
of	O
the	O
strains	O
tolerated	O
a	O
high	O
concentration	O
of	O
human	O
bile	O
[	O
5	O
%	O
volume	O
/	O
volume	O
(	O
V	O
/	O
V	O
)	O
]	O
.	O

Four	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
and	O
two	O
Lactobacillus	B-bacteria
oris	I-bacteria
strains	I-bacteria
expressed	O
resistance	O
to	O
tetracycline	O
and	O
/	O
or	O
doxycycline	O
.	O

Strains	O
of	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
,	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
expressed	O
both	O
high	O
antimicrobial	O
activity	O
and	O
high	O
tolerance	O
of	O
environmental	O
stress	O
.	O

The	O
absence	O
of	O
transferable	O
antibiotic	O
-	O
resistance	O
genes	O
in	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
strains	I-bacteria
remains	O
to	O
be	O
confirmed	O
.	O

These	O
results	O
suggest	O
a	O
potential	O
for	O
oral	O
lactobacilli	B-bacteria
to	O
be	O
used	O
as	O
probiotics	O
for	O
oral	O
health	O
.	O

It	O
is	O
unclear	O
when	O
the	O
initial	O
colonization	O
by	O
periodontal	O
pathogens	O
occurs	O
in	O
the	O
oral	O
cavity	O
.	O

Therefore	O
,	O
we	O
report	O
here	O
the	O
association	O
between	O
specific	O
age	O
groups	O
and	O
the	O
time	O
when	O
the	O
initial	O
colonization	O
by	O
periodontal	O
pathogens	O
occurs	O
in	O
the	O
oral	O
cavity	O
in	O
such	O
groups	O
.	O

Findings	O
are	O
based	O
on	O
an	O
epidemiological	O
analysis	O
of	O
the	O
prevalence	O
of	O
five	O
periodontal	O
pathogens	O
in	O
the	O
oral	O
cavities	O
of	O
a	O
wide	O
range	O
of	O
age	O
populations	O
,	O
from	O
newborn	O
to	O
elderly	O
,	O
who	O
were	O
randomly	O
selected	O
in	O
a	O
geographic	O
region	O
of	O
Brazil	O
.	O

These	O
periodontal	O
pathogens	O
include	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
were	O
analyzed	O
in	O
the	O
bacterial	O
samples	O
isolated	O
from	O
gingival	O
sulcus	O
,	O
the	O
dorsum	O
of	O
the	O
tongue	O
,	O
and	O
cheek	O
mucosa	O
of	O
diverse	O
age	O
groups	O
,	O
using	O
a	O
bacterial	O
DNA	O
-	O
specific	O
PCR	O
method	O
.	O

Results	O
indicated	O
that	O
there	O
are	O
distinct	O
age	O
-	O
related	O
groups	O
where	O
initial	O
colonization	O
by	O
the	O
five	O
periodontal	O
pathogens	O
examined	O
in	O
this	O
study	O
can	O
be	O
detected	O
and	O
that	O
the	O
presence	O
of	O
teeth	O
is	O
a	O
permissive	O
factor	O
for	O
colonization	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
.	O

Although	O
it	O
remains	O
unclear	O
exactly	O
how	O
or	O
when	O
target	O
pathogens	O
colonize	O
healthy	O
subjects	O
,	O
an	O
understanding	O
of	O
age	O
-	O
related	O
groups	O
does	O
provide	O
a	O
potentially	O
useful	O
tool	O
in	O
the	O
early	O
detection	O
and	O
prevention	O
of	O
periodontitis	O
in	O
healthy	O
individuals	O
.	O

To	O
assess	O
the	O
level	O
of	O
antibiotic	O
resistance	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
in	O
the	O
oral	O
flora	O
of	O
children	O
with	O
a	O
history	O
of	O
rheumatic	O
fever	O
,	O
receiving	O
long	O
-	O
term	O
monthly	O
intramuscular	O
benzathine	O
penicillin	O
G	O
prophylaxis	O
.	O

PATIENTS	O
AND	O
Oral	O
swabs	O
from	O
patients	O
receiving	O
monthly	O
penicillin	O
G	O
prophylaxis	O
for	O
rheumatic	O
fever	O
were	O
cultured	O
and	O
tested	O
for	O
viridans	B-bacteria
streptococci	I-bacteria
.	O

The	O
E	O
-	O
test	O
was	O
used	O
to	O
test	O
susceptibility	O
to	O
penicillin	O
G	O
,	O
clindamycin	O
,	O
clarithromycin	O
and	O
rifampin	O
.	O

Findings	O
were	O
compared	O
with	O
samples	O
from	O
healthy	O
children	O
who	O
had	O
not	O
been	O
exposed	O
to	O
antibiotic	O
treatment	O
for	O
at	O
least	O
2	O
months	O
.	O

Twenty	O
-	O
six	O
patients	O
and	O
20	O
control	O
children	O
were	O
included	O
in	O
the	O
study	O
.	O

Duration	O
of	O
intramuscular	O
antibiotic	O
treatment	O
ranged	O
from	O
5	O
months	O
to	O
13	O
.	O
5	O
years	O
.	O

Sixty	O
isolates	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
species	I-bacteria
were	O
obtained	O
,	O
with	O
a	O
similar	O
distribution	O
in	O
the	O
two	O
groups	O
.	O

Intermediate	O
resistance	O
to	O
penicillin	O
(	O
MIC	O
0	O
.	O
25	O
-	O
2	O
mg	O
/	O
L	O
)	O
was	O
documented	O
in	O
10	O
of	O
the	O
32	O
isolates	O
(	O
31	O
.	O
2	O
%	O
)	O
in	O
the	O
study	O
group	O
,	O
and	O
high	O
resistance	O
in	O
none	O
,	O
compared	O
to	O
seven	O
of	O
28	O
isolates	O
(	O
25	O
%	O
)	O
with	O
intermediate	O
or	O
high	O
resistance	O
in	O
the	O
control	O
group	O
(	O
p	O
=	O
NS	O
)	O
.	O

All	O
isolates	O
in	O
the	O
study	O
group	O
and	O
all	O
but	O
one	O
in	O
the	O
control	O
group	O
were	O
susceptible	O
to	O
clindamycin	O
,	O
and	O
all	O
isolates	O
from	O
both	O
groups	O
were	O
susceptible	O
to	O
rifampin	O
.	O

One	O
isolate	O
(	O
3	O
.	O
1	O
%	O
)	O
in	O
the	O
study	O
group	O
and	O
two	O
(	O
7	O
.	O
1	O
%	O
)	O
in	O
the	O
control	O
group	O
were	O
resistant	O
to	O
clarithromycin	O
.	O

Monthly	O
Intramuscular	O
penicillin	O
prophylaxis	O
has	O
no	O
effect	O
on	O
the	O
antibiotic	O
susceptibility	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
in	O
oral	O
flora	O
in	O
children	O
with	O
a	O
history	O
of	O
rheumatic	O
fever	O
,	O
receiving	O
secondary	O
prophylaxis	O
after	O
rheumatic	O
fever	O
,	O
regardless	O
of	O
the	O
duration	O
of	O
treatment	O
.	O

A	O
broad	O
variety	O
of	O
microbes	O
are	O
present	O
in	O
atherosclerotic	O
plaques	O
and	O
chronic	O
bacterial	O
infection	O
increases	O
the	O
risk	O
of	O
atherosclerosis	O
by	O
mechanisms	O
that	O
have	O
remained	O
vague	O
.	O

One	O
possible	O
mechanism	O
is	O
that	O
bacteria	O
or	O
bacterial	O
products	O
activate	O
plaque	O
mast	O
cells	O
that	O
are	O
known	O
to	O
participate	O
in	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
.	O

Here	O
,	O
we	O
show	O
by	O
real	O
-	O
time	O
PCR	O
analysis	O
and	O
ELISA	O
that	O
Chlamydia	B-bacteria
pneumoniae	I-bacteria
(	O
Cpn	B-bacteria
)	O
and	O
a	O
periodontal	O
pathogen	O
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
Aa	B-bacteria
)	O
,	O
both	O
induce	O
a	O
time	O
and	O
concentration	O
-	O
dependent	O
expression	O
and	O
secretion	O
of	O
interleukin	O
8	O
(	O
IL	O
-	O
8	O
)	O
,	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
and	O
monocyte	O
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
)	O
by	O
cultured	O
human	O
peripheral	O
blood	O
-	O
derived	O
mast	O
cells	O
,	O
but	O
not	O
anti	O
-	O
inflammatory	O
molecules	O
,	O
such	O
as	O
IL	O
-	O
10	O
or	O
transforming	O
growth	O
factor	O
beta	O
1	O
(	O
TGF	O
-	O
beta	O
1	O
)	O
.	O

The	O
IL	O
-	O
8	O
and	O
MCP	O
-	O
1	O
responses	O
were	O
immediate	O
,	O
whereas	O
the	O
onset	O
of	O
TNF	O
-	O
alpha	O
secretion	O
was	O
delayed	O
.	O

The	O
Cpn	O
-	O
mediated	O
pro	O
-	O
inflammatory	O
effect	O
was	O
attenuated	O
when	O
the	O
bacteria	O
were	O
inactivated	O
by	O
UV	O
-	O
treatment	O
.	O

Human	O
monocyte	O
-	O
derived	O
macrophages	O
that	O
were	O
pre	O
-	O
infected	O
with	O
Cpn	O
also	O
induced	O
a	O
significant	O
pro	O
-	O
inflammatory	O
response	O
in	O
human	O
mast	O
cells	O
,	O
both	O
in	O
cocultures	O
and	O
when	O
preconditioned	O
media	O
from	O
Cpn	O
-	O
infected	O
macrophages	O
were	O
used	O
.	O

Intranasal	O
and	O
intravenous	O
administration	O
of	O
live	O
Cpn	B-bacteria
and	O
Aa	B-bacteria
,	O
respectively	O
induced	O
an	O
accumulation	O
of	O
activated	O
mast	O
cells	O
in	O
the	O
aortic	O
sinus	O
of	O
apolipoprotein	O
E	O
-	O
deficient	O
mice	O
,	O
however	O
,	O
with	O
varying	O
responses	O
in	O
the	O
systemic	O
levels	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
TNF	O
-	O
alpha	O
.	O

Pro	O
-	O
atherogenic	O
Cpn	B-bacteria
and	O
Aa	B-bacteria
induce	O
a	O
pro	O
-	O
inflammatory	O
response	O
in	O
cultured	O
human	O
connective	O
tissue	O
-	O
type	O
mast	O
cells	O
and	O
activation	O
of	O
mouse	O
aortic	O
mast	O
cells	O
in	O
vivo	O
.	O

Plasminogen	O
binding	O
by	O
bacteria	O
is	O
a	O
virulence	O
factor	O
important	O
for	O
the	O
entry	O
and	O
dissemination	O
of	O
bacteria	O
in	O
the	O
body	O
.	O

A	O
wide	O
variety	O
of	O
bacteria	O
bind	O
plasminogen	O
,	O
including	O
both	O
organisms	O
causing	O
disease	O
and	O
components	O
of	O
the	O
normal	O
oral	O
flora	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
characteristics	O
of	O
plasminogen	O
binding	O
by	O
six	O
clinical	O
isolates	O
of	O
oral	O
streptococci	B-bacteria
from	O
both	O
dental	O
plaque	O
and	O
inflammatory	O
lesions	O
.	O

All	O
the	O
strains	O
bound	O
plasminogen	O
with	O
approximately	O
the	O
same	O
affinity	O
,	O
and	O
binding	O
was	O
specific	O
and	O
lysine	O
-	O
dependent	O
as	O
evidenced	O
by	O
its	O
inhibition	O
by	O
epsilon	O
-	O
aminocaproic	O
acid	O
.	O

All	O
of	O
the	O
test	O
strains	O
were	O
capable	O
of	O
activating	O
bound	O
plasminogen	O
to	O
plasmin	O
without	O
the	O
addition	O
of	O
a	O
plasminogen	O
activator	O
,	O
and	O
subsequent	O
analysis	O
revealed	O
the	O
presence	O
of	O
streptokinase	O
in	O
all	O
strains	O
.	O

However	O
,	O
the	O
streptococci	B-bacteria
exhibited	O
fibrinolytic	O
activity	O
only	O
in	O
the	O
presence	O
of	O
plasminogen	O
and	O
this	O
could	O
be	O
inhibited	O
by	O
the	O
addition	O
of	O
epsilon	O
-	O
aminocaproic	O
acid	O
.	O

SDS	O
-	O
PAGE	O
and	O
2D	O
gel	O
electrophoresis	O
coupled	O
with	O
plasminogen	O
ligand	O
blotting	O
showed	O
that	O
only	O
a	O
subset	O
of	O
the	O
total	O
proteins	O
(	O
2	O
-	O
15	O
)	O
were	O
involved	O
in	O
the	O
binding	O
of	O
plasminogen	O
.	O

Partial	O
identification	O
of	O
the	O
binding	O
proteins	O
revealed	O
that	O
four	O
glycolytic	O
enzymes	O
,	O
enolase	O
,	O
phosphoglycerate	O
kinase	O
,	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
and	O
phosphoglycerate	O
mutase	O
,	O
were	O
predominant	O
in	O
binding	O
plasminogen	O
.	O

The	O
binding	O
of	O
plasminogen	O
by	O
bacteria	O
from	O
pus	O
did	O
not	O
differ	O
from	O
that	O
of	O
the	O
strains	O
from	O
supragingival	O
plaque	O
.	O

The	O
findings	O
illustrate	O
how	O
apparently	O
innocuous	O
commensal	O
bacteria	O
are	O
capable	O
of	O
utilizing	O
a	O
mechanism	O
that	O
is	O
generally	O
regarded	O
as	O
being	O
of	O
importance	O
to	O
pathogenicity	O
and	O
suggest	O
an	O
additional	O
role	O
of	O
plasminogen	O
binding	O
.	O

Coaggregation	O
assays	O
were	O
performed	O
to	O
investigate	O
interactions	O
between	O
oral	O
Bifidobacterium	B-bacteria
adolescentis	I-bacteria
and	O
other	O
oral	O
bacterial	O
species	O
.	O

Bifidobacterium	B-bacteria
adolescentis	I-bacteria
OLB6410	I-bacteria
isolated	O
from	O
the	O
saliva	O
of	O
healthy	O
humans	O
did	O
not	O
coaggregate	O
with	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
JCM8350	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
OLS3293	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
JCM5708	I-bacteria
,	O
Veillonella	B-bacteria
parvula	I-bacteria
ATCC17745	I-bacteria
or	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
OB7124	I-bacteria
,	O
but	O
it	O
did	O
coaggregate	O
with	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
JCM8532	I-bacteria
.	O

Subsequent	O
examination	O
of	O
biofilm	O
formation	O
on	O
saliva	O
-	O
coated	O
hydroxyapatite	O
discs	O
using	O
FISH	O
revealed	O
that	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
OLB6410	I-bacteria
could	O
not	O
directly	O
adhere	O
to	O
the	O
coated	O
discs	O
.	O

It	O
did	O
,	O
however	O
,	O
adhere	O
to	O
biofilms	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
,	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
although	O
it	O
did	O
not	O
coaggregate	O
with	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
nor	O
with	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
.	O

These	O
results	O
suggest	O
that	O
the	O
adhesion	O
of	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
to	O
tooth	O
surfaces	O
is	O
mediated	O
by	O
other	O
oral	O
bacteria	O
.	O

Heat	O
-	O
or	O
proteinase	O
K	O
-	O
treated	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
could	O
not	O
coaggregate	O
with	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
.	O

Similarly	O
,	O
the	O
coaggregation	O
and	O
coadhesion	O
of	O
proteinase	O
K	O
-	O
treated	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
were	O
strongly	O
inhibited	O
.	O

It	O
is	O
therefore	O
probable	O
that	O
proteinaceous	O
factors	O
on	O
the	O
cellular	O
surface	O
of	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
are	O
involved	O
in	O
their	O
interaction	O
.	O

The	O
data	O
presented	O
in	O
this	O
study	O
add	O
to	O
our	O
understanding	O
of	O
bifidobacterial	B-bacteria
colonization	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Oral	O
biofilms	O
are	O
associated	O
with	O
the	O
most	O
common	O
infections	O
of	O
the	O
oral	O
cavity	O
.	O

Bacteria	O
embedded	O
in	O
the	O
biofilms	O
are	O
less	O
sensitive	O
to	O
antibacterial	O
agents	O
than	O
planktonic	O
bacteria	O
are	O
.	O

Recently	O
,	O
an	O
antibacterial	O
synergic	O
effect	O
of	O
noncoherent	O
blue	O
light	O
and	O
hydrogen	O
peroxide	O
(	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
on	O
planktonic	O
Streptococcus	B-bacteria
mutans	I-bacteria
was	O
demonstrated	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
the	O
effect	O
of	O
a	O
combination	O
of	O
light	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
on	O
the	O
vitality	O
and	O
gene	O
expression	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
embedded	O
in	O
biofilm	O
.	O

Biofilms	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
exposed	O
to	O
visible	O
light	O
(	O
wavelengths	O
,	O
400	O
to	O
500	O
nm	O
)	O
for	O
30	O
or	O
60	O
s	O
(	O
equivalent	O
to	O
34	O
or	O
68	O
J	O
/	O
cm	O
(	O
2	O
)	O
)	O
in	O
the	O
presence	O
of	O
3	O
to	O
300	O
mM	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
.	O

The	O
antibacterial	O
effect	O
was	O
assessed	O
by	O
microbial	O
counts	O
of	O
each	O
treated	O
sample	O
compared	O
with	O
that	O
of	O
the	O
control	O
.	O

The	O
effect	O
of	O
light	O
combined	O
with	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
on	O
the	O
different	O
layers	O
of	O
the	O
biofilm	O
was	O
evaluated	O
by	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Gene	O
expression	O
was	O
determined	O
by	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
PCR	O
.	O

Our	O
results	O
show	O
that	O
noncoherent	O
light	O
,	O
in	O
combination	O
with	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
,	O
has	O
a	O
synergistic	O
antibacterial	O
effect	O
through	O
all	O
of	O
the	O
layers	O
of	O
the	O
biofilm	O
.	O

Furthermore	O
,	O
this	O
treatment	O
was	O
more	O
effective	O
against	O
bacteria	O
in	O
biofilm	O
than	O
against	O
planktonic	O
bacteria	O
.	O

The	O
combined	O
light	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
treatment	O
up	O
-	O
regulated	O
the	O
expression	O
of	O
several	O
genes	O
such	O
as	O
gtfB	O
,	O
brp	O
,	O
smu630	O
,	O
and	O
comDE	O
but	O
did	O
not	O
affect	O
relA	O
and	O
ftf	O
.	O

The	O
ability	O
of	O
noncoherent	O
visible	O
light	O
in	O
combination	O
with	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
to	O
affect	O
bacteria	O
in	O
deep	O
layers	O
of	O
the	O
biofilm	O
suggests	O
that	O
this	O
treatment	O
may	O
be	O
applied	O
in	O
biofilm	O
-	O
related	O
diseases	O
as	O
a	O
minimally	O
invasive	O
antibacterial	O
procedure	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
causes	O
peptic	O
ulcer	O
disease	O
and	O
gastric	O
cancer	O
,	O
and	O
the	O
oral	O
cavity	O
is	O
likely	O
to	O
serve	O
as	O
a	O
reservoir	O
for	O
this	O
pathogen	O
.	O

We	O
investigated	O
the	O
binding	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
to	O
the	O
mucins	O
covering	O
the	O
mucosal	O
surfaces	O
in	O
the	O
niches	O
along	O
the	O
oral	O
to	O
gastric	O
infection	O
route	O
and	O
during	O
gastric	O
disease	O
and	O
modeled	O
the	O
outcome	O
of	O
these	O
interactions	O
.	O

A	O
panel	O
of	O
seven	O
H	B-bacteria
.	I-bacteria
pylori		I-bacteria
strains	I-bacteria
with	O
defined	O
binding	O
properties	O
was	O
used	O
to	O
identify	O
binding	O
to	O
human	O
mucins	O
from	O
saliva	O
,	O
gastric	O
juice	O
,	O
cardia	O
,	O
corpus	O
,	O
and	O
antrum	O
of	O
healthy	O
stomachs	O
and	O
of	O
stomachs	O
affected	O
by	O
gastritis	O
at	O
pH	O
7	O
.	O
4	O
and	O
3	O
.	O
0	O
using	O
a	O
microtiter	O
-	O
based	O
method	O
.	O

H	O
.	O
pylori	O
binding	O
to	O
mucins	O
differed	O
substantially	O
with	O
the	O
anatomic	O
site	O
,	O
mucin	O
type	O
,	O
pH	O
,	O
gastritis	O
status	O
,	O
and	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
strain	I-bacteria
all	O
having	O
effect	O
on	O
binding	O
.	O

Mucins	O
from	O
saliva	O
and	O
gastric	O
juice	O
displayed	O
the	O
most	O
diverse	O
binding	O
patterns	O
,	O
involving	O
four	O
modes	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
adhesion	O
and	O
the	O
MUC5B	O
,	O
MUC7	O
,	O
and	O
MUC5AC	O
mucins	O
as	O
well	O
as	O
the	O
salivary	O
agglutinin	O
.	O

Binding	O
occurred	O
via	O
the	O
blood	O
-	O
group	O
antigen	O
-	O
binding	O
adhesin	O
(	O
BabA	O
)	O
,	O
the	O
sialic	O
acid	O
-	O
binding	O
adhesin	O
(	O
SabA	O
)	O
,	O
a	O
charge	O
/	O
low	O
pH	O
-	O
dependent	O
mechanism	O
,	O
and	O
a	O
novel	O
saliva	O
-	O
binding	O
adhesin	O
.	O

In	O
the	O
healthy	O
gastric	O
mucus	O
layer	O
only	O
BabA	O
and	O
acid	O
/	O
charge	O
affect	O
binding	O
to	O
the	O
mucins	O
,	O
whereas	O
in	O
gastritis	O
,	O
the	O
BabA	O
/	O
Le	O
(	O
b	O
)	O
-	O
dependent	O
binding	O
to	O
MUC5AC	O
remained	O
,	O
and	O
SabA	O
and	O
low	O
pH	O
binding	O
increased	O
.	O

The	O
four	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
adhesion	O
modes	O
binding	O
to	O
mucins	O
are	O
likely	O
to	O
play	O
different	O
roles	O
during	O
colonization	O
of	O
the	O
oral	O
to	O
gastric	O
niches	O
and	O
during	O
long	O
-	O
term	O
infection	O
.	O

Compare	O
the	O
microbial	O
profiles	O
on	O
the	O
tongue	O
dorsum	O
in	O
patients	O
with	O
halitosis	O
and	O
control	O
subjects	O
in	O
a	O
UK	O
population	O
using	O
culture	O
-	O
independent	O
techniques	O
.	O

Halitosis	O
patients	O
were	O
screened	O
according	O
to	O
our	O
recently	O
developed	O
recruitment	O
protocol	O
.	O

Scrapings	O
from	O
the	O
tongue	O
dorsum	O
were	O
obtained	O
for	O
12	O
control	O
subjects	O
and	O
20	O
halitosis	O
patients	O
.	O

Bacteria	O
were	O
identified	O
by	O
PCR	O
amplification	O
,	O
cloning	O
and	O
sequencing	O
of	O
16S	O
rRNA	O
genes	O
.	O

The	O
predominant	O
species	O
found	O
in	O
the	O
control	O
samples	O
were	O
Lysobacter	O
-	O
type	O
species	O
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Veillonella	B-bacteria
dispar	I-bacteria
,	O
unidentified	O
oral	O
bacterium	O
,	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
,	O
Atopobium	B-bacteria
parvulum	I-bacteria
and	O
Veillonella	B-bacteria
atypica	I-bacteria
.	O

In	O
the	O
halitosis	O
samples	O
,	O
Lysobacter	O
-	O
type	O
species	O
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
unidentified	O
oral	O
bacterium	O
,	O
Prevotella	B-bacteria
veroralis	I-bacteria
and	O
Prevotella	B-bacteria
pallens	I-bacteria
were	O
the	O
most	O
commonly	O
found	O
species	O
.	O

For	O
the	O
control	O
samples	O
,	O
13	O
-	O
16	O
(	O
4	O
.	O
7	O
-	O
5	O
.	O
8	O
%	O
)	O
of	O
276	O
clones	O
represented	O
uncultured	O
species	O
,	O
whereas	O
in	O
the	O
halitosis	O
samples	O
,	O
this	O
proportion	O
increased	O
to	O
6	O
.	O
5	O
-	O
9	O
.	O
6	O
%	O
(	O
36	O
-	O
53	O
of	O
553	O
clones	O
)	O
.	O

In	O
the	O
control	O
samples	O
,	O
22	O
(	O
8	O
.	O
0	O
%	O
)	O
of	O
276	O
clones	O
represented	O
potentially	O
novel	O
phylotypes	O
,	O
and	O
in	O
the	O
halitosis	O
samples	O
,	O
this	O
figure	O
was	O
39	O
(	O
7	O
.	O
1	O
%	O
)	O
of	O
553	O
clones	O
.	O

The	O
microflora	O
associated	O
with	O
the	O
tongue	O
dorsum	O
is	O
complex	O
in	O
both	O
the	O
control	O
and	O
halitosis	O
groups	O
,	O
but	O
several	O
key	O
species	O
predominate	O
in	O
both	O
groups	O
.	O

The	O
oral	O
cavity	O
presents	O
numerous	O
surfaces	O
for	O
microbial	O
colonization	O
.	O

These	O
surfaces	O
produce	O
biofilms	O
of	O
differing	O
complexities	O
unique	O
to	O
each	O
individual	O
.	O

Several	O
studies	O
have	O
looked	O
at	O
biofilms	O
in	O
dentate	O
patients	O
.	O

There	O
has	O
been	O
limited	O
research	O
regarding	O
biofilms	O
on	O
dentures	O
or	O
soft	O
tissues	O
of	O
edentulous	O
patients	O
.	O

The	O
purpose	O
of	O
the	O
present	O
investigation	O
was	O
to	O
provide	O
meaningful	O
data	O
describing	O
microbial	O
ecological	O
relationships	O
in	O
the	O
oral	O
cavity	O
of	O
edentulous	O
patients	O
and	O
to	O
evaluate	O
the	O
microbiota	O
on	O
hard	O
and	O
soft	O
tissue	O
surfaces	O
and	O
saliva	O
in	O
edentulous	O
patients	O
wearing	O
complete	O
dentures	O
.	O

MATERIALS	O
AND	O
Sixty	O
-	O
one	O
edentulous	O
subjects	O
with	O
complete	O
maxillary	O
and	O
mandibular	O
dentures	O
were	O
recruited	O
.	O

`	O
`	O
Supragingival	O
'	O
'	O
biofilm	O
samples	O
were	O
taken	O
from	O
28	O
denture	O
teeth	O
for	O
each	O
subject	O
.	O

Biofilm	O
samples	O
were	O
also	O
taken	O
from	O
the	O
dorsal	O
,	O
lateral	O
,	O
and	O
ventral	O
surfaces	O
of	O
the	O
tongue	O
,	O
floor	O
of	O
mouth	O
,	O
buccal	O
mucosa	O
,	O
hard	O
palate	O
,	O
vestibule	O
/	O
lip	O
,	O
`	O
`	O
attached	O
gingiva	O
,	O
'	O
'	O
and	O
saliva	O
.	O

Samples	O
were	O
individually	O
analyzed	O
for	O
their	O
content	O
of	O
41	O
bacterial	O
species	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Levels	O
and	O
proportions	O
of	O
each	O
species	O
were	O
determined	O
for	O
every	O
sample	O
location	O
.	O

Periodontal	O
pathogens	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
were	O
clearly	O
present	O
in	O
the	O
samples	O
from	O
the	O
edentulous	O
subjects	O
.	O

Microbial	O
profiles	O
in	O
samples	O
from	O
the	O
soft	O
tissue	O
surfaces	O
differed	O
among	O
site	O
locations	O
.	O

Samples	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
exhibited	O
the	O
highest	O
bacterial	O
counts	O
followed	O
by	O
the	O
`	O
`	O
attached	O
gingiva	O
'	O
'	O
and	O
the	O
lateral	O
surfaces	O
of	O
the	O
tongue	O
,	O
while	O
the	O
lowest	O
mean	O
counts	O
were	O
found	O
in	O
samples	O
from	O
the	O
buccal	O
mucosa	O
and	O
labial	O
vestibules	O
.	O

Using	O
cluster	O
analysis	O
of	O
the	O
proportions	O
of	O
the	O
test	O
species	O
,	O
three	O
clusters	O
were	O
formed	O
.	O

The	O
first	O
cluster	O
comprised	O
saliva	O
,	O
supragingival	O
plaque	O
,	O
and	O
the	O
lateral	O
and	O
dorsal	O
surfaces	O
of	O
the	O
tongue	O
.	O

The	O
second	O
cluster	O
comprised	O
the	O
other	O
six	O
soft	O
tissue	O
surfaces	O
.	O

Species	O
on	O
the	O
denture	O
palate	O
formed	O
a	O
third	O
cluster	O
.	O

One	O
of	O
the	O
major	O
findings	O
in	O
this	O
study	O
was	O
the	O
detection	O
of	O
periodontal	O
pathogens	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
in	O
the	O
edentulous	O
subjects	O
,	O
as	O
these	O
species	O
were	O
thought	O
to	O
disappear	O
after	O
removal	O
of	O
all	O
natural	O
teeth	O
.	O

This	O
finding	O
has	O
implications	O
regarding	O
future	O
dental	O
treatment	O
and	O
the	O
general	O
health	O
of	O
individuals	O
.	O

Distinct	O
patterns	O
of	O
microbial	O
colonization	O
were	O
seen	O
on	O
the	O
different	O
soft	O
tissue	O
surfaces	O
.	O

Thus	O
,	O
this	O
investigation	O
provided	O
the	O
first	O
step	O
in	O
defining	O
the	O
organisms	O
that	O
are	O
associated	O
with	O
edentulous	O
patients	O
on	O
both	O
soft	O
(	O
mucosa	O
)	O
and	O
hard	O
surfaces	O
(	O
denture	O
)	O
.	O

The	O
study	O
also	O
provided	O
meaningful	O
data	O
that	O
described	O
microbial	O
ecological	O
relationships	O
in	O
the	O
oral	O
cavity	O
of	O
edentulous	O
subjects	O
.	O

The	O
authors	O
believe	O
that	O
this	O
study	O
is	O
the	O
first	O
comprehensive	O
assessment	O
of	O
the	O
microbiota	O
in	O
the	O
complete	O
denture	O
-	O
wearing	O
subject	O
.	O

To	O
examine	O
phylogenetic	O
identity	O
and	O
metabolic	O
activity	O
of	O
individual	O
cells	O
in	O
complex	O
microbial	O
communities	O
,	O
we	O
developed	O
a	O
method	O
which	O
combines	O
rRNA	O
-	O
based	O
in	O
situ	O
hybridization	O
with	O
stable	O
isotope	O
imaging	O
based	O
on	O
nanometer	O
-	O
scale	O
secondary	O
-	O
ion	O
mass	O
spectrometry	O
(	O
NanoSIMS	O
)	O
.	O

Fluorine	O
or	O
bromine	O
atoms	O
were	O
introduced	O
into	O
cells	O
via	O
16S	O
rRNA	O
-	O
targeted	O
probes	O
,	O
which	O
enabled	O
phylogenetic	O
identification	O
of	O
individual	O
cells	O
by	O
NanoSIMS	O
imaging	O
.	O

To	O
overcome	O
the	O
natural	O
fluorine	O
and	O
bromine	O
backgrounds	O
,	O
we	O
modified	O
the	O
current	O
catalyzed	O
reporter	O
deposition	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
technique	O
by	O
using	O
halogen	O
-	O
containing	O
fluorescently	O
labeled	O
tyramides	O
as	O
substrates	O
for	O
the	O
enzymatic	O
tyramide	O
deposition	O
.	O

Thereby	O
,	O
we	O
obtained	O
an	O
enhanced	O
element	O
labeling	O
of	O
microbial	O
cells	O
by	O
FISH	O
(	O
EL	O
-	O
FISH	O
)	O
.	O

The	O
relative	O
cellular	O
abundance	O
of	O
fluorine	O
or	O
bromine	O
after	O
EL	O
-	O
FISH	O
exceeded	O
natural	O
background	O
concentrations	O
by	O
up	O
to	O
180	O
-	O
fold	O
and	O
allowed	O
us	O
to	O
distinguish	O
target	O
from	O
non	O
-	O
target	O
cells	O
in	O
NanoSIMS	O
fluorine	O
or	O
bromine	O
images	O
.	O

The	O
method	O
was	O
optimized	O
on	O
single	O
cells	O
of	O
axenic	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
Vibrio	B-bacteria
cholerae	I-bacteria
cultures	O
.	O

EL	O
-	O
FISH	O
/	O
NanoSIMS	O
was	O
then	O
applied	O
to	O
study	O
interrelationships	O
in	O
a	O
dual	O
-	O
species	O
consortium	O
consisting	O
of	O
a	O
filamentous	B-bacteria
cyanobacterium	I-bacteria
and	O
a	O
heterotrophic	B-bacteria
alphaproteobacterium	I-bacteria
.	O

We	O
also	O
evaluated	O
the	O
method	O
on	O
complex	O
microbial	O
aggregates	O
obtained	O
from	O
human	O
oral	O
biofilms	O
.	O

In	O
both	O
samples	O
,	O
we	O
found	O
evidence	O
for	O
metabolic	O
interactions	O
by	O
visualizing	O
the	O
fate	O
of	O
substrates	O
labeled	O
with	O
(	O
13	O
)	O
C	O
-	O
carbon	O
and	O
(	O
15	O
)	O
N	O
-	O
nitrogen	O
,	O
while	O
individual	O
cells	O
were	O
identified	O
simultaneously	O
by	O
halogen	O
labeling	O
via	O
EL	O
-	O
FISH	O
.	O

Our	O
novel	O
approach	O
will	O
facilitate	O
further	O
studies	O
of	O
the	O
ecophysiology	O
of	O
known	O
and	O
uncultured	O
microorganisms	O
in	O
complex	O
environments	O
and	O
communities	O
.	O

Studies	O
have	O
suggested	O
that	O
oral	O
bone	O
loss	O
is	O
independently	O
influenced	O
by	O
local	O
and	O
systemic	O
factors	O
,	O
including	O
osteoporosis	O
.	O

This	O
cross	O
-	O
sectional	O
study	O
of	O
1256	O
post	O
-	O
menopausal	O
women	O
,	O
recruited	O
from	O
the	O
Buffalo	O
center	O
of	O
the	O
Women	O
'	O
s	O
Health	O
Initiative	O
Observational	O
Study	O
,	O
evaluated	O
the	O
influence	O
of	O
oral	O
infection	O
and	O
age	O
on	O
the	O
associations	O
between	O
osteoporosis	O
and	O
oral	O
bone	O
loss	O
.	O

Systemic	O
bone	O
density	O
was	O
measured	O
by	O
dual	O
-	O
energy	O
x	O
-	O
ray	O
absorptiometry	O
.	O

Alveolar	O
crestal	O
height	O
was	O
measured	O
from	O
standardized	O
dental	O
radiographs	O
.	O

Oral	O
infection	O
was	O
assessed	O
from	O
subgingival	O
plaque	O
samples	O
.	O

Total	O
forearm	O
density	O
[	O
beta	O
(	O
SE	O
)	O
=	O
-	O
0	O
.	O
931	O
(	O
0	O
.	O
447	O
)	O
,	O
p	O
=	O
0	O
.	O
038	O
]	O
and	O
presence	O
of	O
Tannerella	B-bacteria
forsythensis	I-bacteria
[	O
beta	O
(	O
SE	O
)	O
=	O
0	O
.	O
125	O
(	O
0	O
.	O
051	O
)	O
,	O
p	O
=	O
0	O
.	O
015	O
]	O
were	O
independently	O
associated	O
with	O
mean	O
alveolar	O
height	O
among	O
women	O
aged	O
<	O
70	O
years	O
after	O
confounder	O
adjustment	O
.	O

Women	O
aged	O
70	O
+	O
years	O
had	O
worse	O
oral	O
bone	O
loss	O
,	O
in	O
general	O
,	O
but	O
neither	O
bone	O
density	O
nor	O
oral	O
infection	O
was	O
significantly	O
associated	O
with	O
mean	O
alveolar	O
height	O
in	O
this	O
age	O
group	O
.	O

Systemic	O
bone	O
density	O
and	O
oral	O
infection	O
independently	O
influenced	O
oral	O
bone	O
loss	O
in	O
post	O
-	O
menopausal	O
women	O
aged	O
<	O
70	O
years	O
.	O

Systemic	O
infection	O
with	O
HIV	O
occurs	O
infrequently	O
through	O
the	O
oral	O
route	O
.	O

The	O
frequency	O
of	O
occurrence	O
may	O
be	O
increased	O
by	O
concomitant	O
bacterial	O
infection	O
of	O
the	O
oral	O
tissues	O
,	O
since	O
co	O
-	O
infection	O
and	O
inflammation	O
of	O
some	O
cell	O
types	O
increases	O
HIV	O
-	O
1	O
replication	O
.	O

A	O
putative	O
periodontal	O
pathogen	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
selectively	O
up	O
-	O
regulates	O
expression	O
of	O
the	O
HIV	O
-	O
1	O
coreceptor	O
CCR5	O
on	O
oral	O
keratinocytes	O
.	O

We	O
,	O
therefore	O
,	O
hypothesized	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
modulates	O
the	O
outcome	O
of	O
HIV	O
infection	O
in	O
oral	O
epithelial	O
cells	O
.	O

Oral	O
and	O
tonsil	O
epithelial	O
cells	O
were	O
pre	O
-	O
incubated	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
inoculated	O
with	O
either	O
an	O
X4	O
-	O
or	O
R5	O
-	O
type	O
HIV	O
-	O
1	O
.	O

Between	O
6	O
and	O
48	O
hours	O
post	O
-	O
inoculation	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
selectively	O
increased	O
the	O
infectivity	O
of	O
R5	O
-	O
tropic	O
HIV	O
-	O
1	O
from	O
oral	O
and	O
tonsil	O
keratinocytes	O
;	O
infectivity	O
of	O
X4	O
-	O
tropic	O
HIV	O
-	O
1	O
remained	O
unchanged	O
.	O

Oral	O
keratinocytes	O
appeared	O
to	O
harbor	O
infectious	O
HIV	O
-	O
1	O
,	O
with	O
no	O
evidence	O
of	O
productive	O
infection	O
.	O

HIV	O
-	O
1	O
was	O
harbored	O
at	O
highest	O
levels	O
during	O
the	O
first	O
6	O
hours	O
after	O
HIV	O
exposure	O
and	O
decreased	O
to	O
barely	O
detectable	O
levels	O
at	O
48	O
hours	O
.	O

HIV	O
did	O
not	O
appear	O
to	O
co	O
-	O
localize	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
which	O
increased	O
selective	O
R5	O
-	O
tropic	O
HIV	O
-	O
1	O
trans	O
infection	O
from	O
keratinocytes	O
to	O
permissive	O
cells	O
.	O

When	O
CCR5	O
was	O
selectively	O
blocked	O
,	O
HIV	O
-	O
1	O
trans	O
infection	O
was	O
reduced	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
up	O
-	O
regulation	O
of	O
CCR5	O
increases	O
trans	O
infection	O
of	O
harbored	O
R5	O
-	O
tropic	O
HIV	O
-	O
1	O
from	O
oral	O
keratinocytes	O
to	O
permissive	O
cells	O
.	O

Oral	O
infections	O
such	O
as	O
periodontitis	O
may	O
,	O
therefore	O
,	O
increase	O
risk	O
for	O
oral	O
infection	O
and	O
dissemination	O
of	O
R5	O
-	O
tropic	O
HIV	O
-	O
1	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
the	O
prevalence	O
and	O
levels	O
of	O
salivary	O
microorganisms	O
in	O
HIV	O
-	O
positive	O
children	O
,	O
and	O
their	O
correlation	O
to	O
HIV	O
status	O
,	O
oral	O
lesions	O
,	O
and	O
salivary	O
IgA	O
levels	O
.	O

Forty	O
-	O
two	O
HIV	O
-	O
positive	O
and	O
36	O
control	O
children	O
were	O
clinically	O
examined	O
,	O
had	O
their	O
saliva	O
collected	O
and	O
processed	O
for	O
the	O
microbiological	O
analysis	O
of	O
38	O
bacterial	O
taxa	O
by	O
the	O
checkerboard	O
method	O
,	O
and	O
salivary	O
IgA	O
quantification	O
by	O
ELISA	O
.	O

The	O
majority	O
of	O
the	O
species	O
tested	O
were	O
more	O
prevalent	O
in	O
control	O
children	O
than	O
in	O
the	O
HIV	O
group	O
.	O

Mean	O
concentration	O
of	O
total	O
salivary	O
IgA	O
was	O
similar	O
in	O
both	O
groups	O
.	O

High	O
levels	O
of	O
Veillonella	B-bacteria
parvula	I-bacteria
were	O
found	O
in	O
children	O
with	O
cheilitis	O
and	O
herpes	O
.	O

Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Eikenella	B-bacteria
Corrodens	I-bacteria
,	O
and	O
Propionibacterium	B-bacteria
acnes	I-bacteria
were	O
prevalent	O
in	O
children	O
with	O
gingivitis	O
,	O
while	O
Fusobacterium	B-bacteria
periodonticum	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
were	O
significantly	O
more	O
frequent	O
in	O
children	O
with	O
no	O
oral	O
lesions	O
.	O

Significant	O
negative	O
correlations	O
between	O
salivary	O
IgA	O
levels	O
and	O
Eubacterium	B-bacteria
nodatum	I-bacteria
and	O
oral	O
streptococci	B-bacteria
were	O
observed	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

HIV	O
-	O
seropositive	O
children	O
presented	O
significantly	O
lower	O
prevalence	O
and	O
levels	O
of	O
several	O
bacterial	O
species	O
in	O
saliva	O
;	O
HIV	O
-	O
positive	O
children	O
are	O
able	O
to	O
mount	O
a	O
mucosal	O
immune	O
response	O
;	O
HIV	O
-	O
seropositive	O
children	O
under	O
highly	O
active	O
antiretroviral	O
therapy	O
presented	O
low	O
prevalence	O
of	O
oral	O
lesions	O
.	O

Viral	O
and	O
bacterial	O
associations	O
appear	O
to	O
be	O
implicated	O
in	O
the	O
development	O
of	O
periodontal	O
infections	O
.	O

Little	O
information	O
is	O
available	O
describing	O
the	O
periodontopathic	O
agents	O
in	O
root	O
canals	O
with	O
necrotic	O
pulp	O
.	O

In	O
this	O
study	O
,	O
the	O
occurrence	O
and	O
the	O
combinations	O
among	O
herpes	O
simplex	O
virus	O
type	O
1	O
(	O
HSV	O
-	O
1	O
)	O
and	O
Dialister	B-bacteria
pneumosintes	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
in	O
patients	O
with	O
chronic	O
periodontitis	O
and	O
necrotic	O
pulp	O
were	O
evaluated	O
.	O

Clinical	O
samples	O
from	O
healthy	O
subjects	O
and	O
patients	O
with	O
periodontal	O
or	O
pulp	O
infections	O
were	O
analyzed	O
using	O
a	O
nested	O
polymeras	O
chain	O
reaction	O
PCR	O
to	O
detect	O
HSV	O
and	O
PCR	O
to	O
detect	O
the	O
3	O
periodontal	O
bacteria	O
.	O

The	O
presence	O
of	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
was	O
observed	O
in	O
healthy	O
,	O
chronic	O
periodontitis	O
,	O
and	O
necrotic	O
pulp	O
patients	O
.	O

HSV	O
was	O
observed	O
in	O
periodontitis	O
and	O
necrotic	O
pulp	O
patients	O
,	O
and	O
no	O
healthy	O
subject	O
harbored	O
D	O
.	O
pneumosintes	O
or	O
HSV	O
.	O

The	O
occurrence	O
of	O
Tannerella	B-bacteria
forsythia	I-bacteria
was	O
not	O
statistically	O
significant	O
in	O
patients	O
with	O
necrotic	O
pulp	O
(	O
P	O
=	O
0	O
.	O
704	O
)	O
.	O

Periodontal	O
bacteria	O
were	O
observed	O
varying	O
from	O
10	O
.	O
3	O
%	O
to	O
20	O
.	O
7	O
%	O
in	O
chronic	O
periodontitis	O
and	O
necrotic	O
pulp	O
patients	O
.	O

The	O
presence	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
-	O
HSV	O
association	O
was	O
predominant	O
in	O
patients	O
showing	O
necrotic	O
pulp	O
(	O
24	O
.	O
1	O
%	O
)	O
;	O
however	O
,	O
HSV	O
alone	O
was	O
observed	O
in	O
one	O
patient	O
with	O
periodontitis	O
and	O
in	O
another	O
patient	O
with	O
necrotic	O
pulp	O
.	O

The	O
presence	O
of	O
double	O
association	O
among	O
bacteria	O
or	O
bacteria	O
-	O
HSV	O
could	O
indicate	O
a	O
role	O
in	O
both	O
periodontitis	O
and	O
necrotic	O
pulp	O
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
-	O
Treponema	B-bacteria
denticola	I-bacteria
-	O
HSV	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
-	O
D	B-bacteria
.	I-bacteria
pneumosintes	I-bacteria
-	O
Treponema	B-bacteria
denticola	I-bacteria
-	O
HSV	O
associations	O
might	O
be	O
important	O
in	O
periodontitis	O
.	O

To	O
evaluate	O
the	O
influence	O
of	O
doxycycline	O
therapy	O
on	O
the	O
composition	O
and	O
antibiotic	O
susceptibility	O
of	O
intestinal	O
bifidobacteria	B-bacteria
.	O

Faecal	O
samples	O
were	O
collected	O
from	O
nine	O
subjects	O
receiving	O
doxycycline	O
therapy	O
and	O
ten	O
control	O
subjects	O
,	O
and	O
analysed	O
for	O
bifidobacteria	B-bacteria
by	O
culturing	O
and	O
PCR	O
-	O
DGGE	O
(	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
)	O
.	O

A	O
marked	O
decrease	O
in	O
the	O
diversity	O
(	O
average	O
number	O
of	O
amplicons	O
detected	O
by	O
PCR	O
-	O
DGGE	O
0	O
.	O
8	O
in	O
the	O
antibiotic	O
vs	O
4	O
.	O
3	O
in	O
the	O
control	O
group	O
)	O
of	O
Bifidobacterium	B-bacteria
populations	O
was	O
observed	O
during	O
doxycycline	O
therapy	O
.	O

The	O
proportion	O
of	O
a	O
tetracycline	O
-	O
resistant	O
bifidobacterial	O
population	O
was	O
higher	O
in	O
the	O
antibiotic	O
group	O
than	O
in	O
the	O
control	O
group	O
(	O
83	O
%	O
vs	O
26	O
%	O
)	O
.	O

Based	O
on	O
the	O
tet	O
gene	O
PCR	O
,	O
resistance	O
could	O
be	O
associated	O
with	O
the	O
presence	O
of	O
tet	O
(	O
W	O
)	O
.	O

In	O
two	O
subjects	O
,	O
strains	O
representing	O
highly	O
similar	O
genetic	O
fingerprints	O
but	O
different	O
tetracycline	O
susceptibilities	O
were	O
detected	O
.	O

A	O
mutation	O
causing	O
lack	O
of	O
functionality	O
in	O
the	O
tet	O
(	O
W	O
)	O
was	O
observed	O
in	O
one	O
of	O
the	O
susceptible	O
strains	O
.	O

Doxycycline	O
therapy	O
had	O
a	O
drastic	O
effect	O
on	O
the	O
diversity	O
and	O
tetracycline	O
susceptibility	O
of	O
intestinal	O
Bifidobacterium	B-bacteria
populations	O
.	O

The	O
use	O
of	O
broad	O
-	O
spectrum	O
antibiotics	O
increased	O
the	O
pool	O
of	O
tetracycline	O
-	O
resistant	O
commensal	O
bacteria	O
in	O
the	O
intestine	O
.	O

The	O
detection	O
of	O
resistance	O
genes	O
alone	O
is	O
not	O
sufficient	O
for	O
the	O
evaluation	O
of	O
bacterial	O
antibiotic	O
resistance	O
.	O

Model	O
systems	O
with	O
oral	O
bacteria	O
from	O
dental	O
plaque	O
have	O
demonstrated	O
that	O
the	O
utilization	O
of	O
complex	O
glycoproteins	O
as	O
a	O
food	O
source	O
can	O
not	O
be	O
undertaken	O
by	O
single	O
species	O
but	O
requires	O
concerted	O
degradation	O
by	O
a	O
multi	O
-	O
species	O
consortium	O
,	O
with	O
each	O
member	O
contributing	O
one	O
or	O
a	O
few	O
hydrolytic	O
enzymes	O
.	O

Unlike	O
previous	O
studies	O
,	O
the	O
aim	O
of	O
the	O
present	O
investigation	O
was	O
to	O
explore	O
the	O
ability	O
of	O
fresh	O
dental	O
plaque	O
to	O
degrade	O
salivary	O
mucin	O
,	O
MUC5B	O
,	O
isolated	O
by	O
methods	O
designed	O
to	O
retain	O
intact	O
the	O
natural	O
polymeric	O
structure	O
and	O
physiological	O
conformation	O
,	O
in	O
an	O
attempt	O
to	O
mimic	O
the	O
naturally	O
occurring	O
interaction	O
between	O
the	O
oral	O
microbiota	O
and	O
salivary	O
mucins	O
.	O

Human	O
salivary	O
MUC5B	O
was	O
isolated	O
from	O
whole	O
saliva	O
by	O
density	O
-	O
gradient	O
centrifugation	O
and	O
incubated	O
with	O
freshly	O
isolated	O
supragingival	O
dental	O
plaque	O
with	O
samples	O
subjected	O
to	O
fluorescent	O
staining	O
for	O
viability	O
and	O
metabolic	O
activity	O
.	O

In	O
addition	O
,	O
the	O
degradation	O
of	O
MUC5B	O
oligosaccharide	O
side	O
chains	O
was	O
studied	O
using	O
a	O
lectin	O
assay	O
,	O
recognizing	O
three	O
different	O
carbohydrate	O
epitopes	O
commonly	O
found	O
on	O
mucin	O
oligosaccharide	O
side	O
chains	O
.	O

The	O
addition	O
of	O
purified	O
salivary	O
MUC5B	O
elicited	O
a	O
strong	O
metabolic	O
response	O
from	O
the	O
biofilm	O
cells	O
,	O
whereas	O
individual	O
strains	O
of	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
isolated	O
from	O
the	O
same	O
plaque	O
were	O
not	O
able	O
to	O
utilize	O
the	O
MUC5B	O
.	O

The	O
degradation	O
of	O
terminal	O
saccharide	O
moieties	O
on	O
the	O
MUC5B	O
was	O
demonstrated	O
by	O
a	O
marked	O
decrease	O
in	O
both	O
sialic	O
acid	O
and	O
fucose	O
reactivity	O
.	O

These	O
results	O
have	O
shown	O
that	O
dental	O
plaque	O
is	O
capable	O
of	O
utilizing	O
human	O
salivary	O
MUC5B	O
as	O
a	O
nutrient	O
source	O
,	O
a	O
process	O
possibly	O
requiring	O
the	O
synergistic	O
degradation	O
of	O
the	O
molecule	O
by	O
a	O
consortium	O
of	O
oral	O
bacteria	O
in	O
the	O
plaque	O
community	O
.	O

Lactobacillus	B-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
,	O
a	O
human	O
oral	O
isolate	O
with	O
antagonistic	O
activity	O
against	O
growth	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Micrococcus	B-bacteria
flavus	I-bacteria
,	O
and	O
Salmonella	B-bacteria
enteritidis	I-bacteria
,	O
probably	O
produces	O
more	O
than	O
one	O
proteinaceous	O
antimicrobial	O
substance	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
the	O
purification	O
of	O
a	O
bacteriocin	O
,	O
named	O
LS1	O
,	O
produced	O
by	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
.	O

A	O
simple	O
and	O
fast	O
procedure	O
for	O
bacteriocin	O
purification	O
was	O
developed	O
,	O
consisting	O
of	O
reverse	O
-	O
phase	O
chromatography	O
of	O
the	O
ammonium	O
sulfate	O
precipitate	O
of	O
cell	O
-	O
free	O
culture	O
supernatant	O
by	O
fast	O
protein	O
liquid	O
chromatography	O
and	O
high	O
-	O
performance	O
liquid	O
chromatography	O
,	O
followed	O
by	O
tricine	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
,	O
with	O
the	O
subsequent	O
extraction	O
of	O
bacteriocin	O
from	O
the	O
gel	O
.	O

The	O
supernatant	O
of	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
culture	O
retained	O
its	O
antimicrobial	O
activity	O
after	O
boiling	O
in	O
a	O
water	O
bath	O
for	O
15	O
min	O
.	O

Its	O
antimicrobial	O
activity	O
was	O
also	O
maintained	O
even	O
after	O
treatment	O
for	O
20	O
min	O
at	O
121	O
degrees	O
C	O
in	O
an	O
autoclave	O
.	O

Bacteriocin	O
LS1	O
was	O
purified	O
to	O
homogeneity	O
.	O

The	O
molecular	O
mass	O
of	O
bacteriocin	O
LS1	O
was	O
estimated	O
to	O
be	O
approximately	O
10	O
kDa	O
,	O
based	O
on	O
tricine	O
SDS	O
-	O
PAGE	O
.	O

During	O
purification	O
,	O
another	O
compound	O
with	O
antimicrobial	O
activity	O
,	O
produced	O
by	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
BGHO1	I-bacteria
,	O
was	O
detected	O
.	O

The	O
molecular	O
mass	O
of	O
this	O
compound	O
was	O
estimated	O
to	O
be	O
approximately	O
5	O
kDa	O
,	O
based	O
on	O
tricine	O
SDS	O
-	O
PAGE	O
.	O

Our	O
results	O
imply	O
that	O
LS1	O
is	O
most	O
probably	O
a	O
new	O
bacteriocin	O
,	O
different	O
from	O
previously	O
described	O
bacteriocins	O
produced	O
by	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strains	I-bacteria
.	O

The	O
purification	O
of	O
bacteriocin	O
LS1	O
enabled	O
the	O
further	O
characterization	O
of	O
LS1	O
on	O
both	O
the	O
molecular	O
and	O
genetic	O
levels	O
.	O

Bacteraemia	O
,	O
defined	O
as	O
the	O
presence	O
of	O
viable	O
bacteria	O
in	O
the	O
circulating	O
blood	O
can	O
result	O
in	O
bloodstream	O
infection	O
,	O
which	O
is	O
one	O
of	O
the	O
most	O
frequent	O
and	O
challenging	O
hospital	O
-	O
acquired	O
infections	O
.	O

Bacteraemia	O
occurs	O
in	O
healthy	O
populations	O
with	O
manipulation	O
of	O
the	O
oral	O
mucosa	O
,	O
including	O
toothbrushing	O
.	O

Oral	O
care	O
is	O
commonly	O
administered	O
to	O
mechanically	O
ventilated	O
patients	O
,	O
it	O
is	O
important	O
to	O
determine	O
whether	O
this	O
practice	O
contributes	O
to	O
the	O
incidence	O
of	O
bacteraemia	O
.	O

This	O
paper	O
reviews	O
the	O
literature	O
on	O
the	O
link	O
between	O
the	O
manipulation	O
of	O
the	O
oral	O
cavity	O
and	O
the	O
development	O
of	O
bacteraemia	O
in	O
mechanically	O
ventilated	O
adults	O
.	O

Searches	O
were	O
conducted	O
using	O
Medline	O
,	O
and	O
the	O
Cochrane	O
Library	O
databases	O
.	O

Article	O
inclusion	O
criteria	O
were	O
(	O
1	O
)	O
a	O
focus	O
on	O
mechanical	O
ventilation	O
and	O
critical	O
illness	O
,	O
(	O
2	O
)	O
human	O
subjects	O
,	O
(	O
3	O
)	O
adult	O
subjects	O
,	O
and	O
(	O
4	O
)	O
publication	O
in	O
English	O
(	O
or	O
available	O
English	O
translation	O
)	O
.	O

Nine	O
articles	O
met	O
inclusion	O
criteria	O
and	O
were	O
critiqued	O
.	O

All	O
relied	O
upon	O
clinical	O
data	O
as	O
outcome	O
measures	O
;	O
many	O
were	O
retrospective	O
.	O

The	O
three	O
organisms	O
most	O
often	O
associated	O
with	O
nosocomial	O
bloodstream	O
infections	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
coagulase	B-bacteria
negative	I-bacteria
staphylococci	I-bacteria
,	O
and	O
Enterococcus	B-bacteria
species	I-bacteria
.	O

Establishing	O
the	O
origin	O
of	O
bacteraemia	O
was	O
problematic	O
in	O
most	O
studies	O
.	O

Additional	O
research	O
is	O
needed	O
to	O
understand	O
the	O
relationship	O
of	O
oral	O
care	O
practices	O
to	O
bacteraemia	O
in	O
mechanically	O
ventilated	O
adults	O
.	O

Evidence	O
is	O
accumulating	O
that	O
oral	O
bacteria	O
are	O
associated	O
with	O
myocardial	O
infarctions	O
(	O
MI	O
)	O
.	O

We	O
were	O
interested	O
in	O
studying	O
the	O
differences	O
in	O
the	O
association	O
between	O
single	O
bacteria	O
or	O
bacteria	O
in	O
combination	O
and	O
the	O
relation	O
to	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
.	O

We	O
examined	O
the	O
levels	O
of	O
antibodies	O
against	O
four	O
major	O
periodontal	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
PG	B-bacteria
)	O
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
AA	B-bacteria
)	O
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
TF	B-bacteria
)	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
TD	B-bacteria
)	O
and	O
CRP	O
in	O
548	O
men	O
with	O
a	O
self	O
-	O
reported	O
history	O
of	O
MI	O
to	O
625	O
controls	O
who	O
took	O
part	O
in	O
the	O
Oslo	O
II	O
study	O
in	O
2000	O
.	O

The	O
mean	O
levels	O
of	O
bacterial	O
antibodies	O
were	O
higher	O
for	O
the	O
cases	O
than	O
the	O
controls	O
,	O
but	O
not	O
significant	O
as	O
standard	O
deviations	O
were	O
large	O
.	O

The	O
level	O
of	O
CRP	O
was	O
higher	O
in	O
the	O
cases	O
than	O
the	O
controls	O
(	O
p	O
=	O
0	O
.	O
010	O
)	O
.	O

Logistic	O
regression	O
analyses	O
comparing	O
the	O
upper	O
quartile	O
value	O
with	O
the	O
lower	O
value	O
of	O
one	O
of	O
either	O
four	O
antibodies	O
(	O
anti	O
-	O
AA	O
,	O
anti	O
-	O
TF	O
,	O
anti	O
-	O
TD	O
and	O
anti	O
-	O
PG	O
)	O
were	O
significantly	O
associated	O
(	O
p	O
=	O
0	O
.	O
032	O
)	O
with	O
MI	O
.	O

Equivalent	O
analyses	O
of	O
either	O
three	O
bacteria	O
showed	O
significant	O
associations	O
for	O
anti	O
-	O
AA	O
,	O
anti	O
-	O
TD	O
and	O
anti	O
-	O
PG	O
(	O
p	O
=	O
0	O
.	O
036	O
)	O
and	O
anti	O
-	O
AA	O
,	O
anti	O
-	O
PG	O
and	O
anti	O
-	O
TF	O
(	O
p	O
=	O
0	O
.	O
040	O
)	O
.	O

CRP	O
showed	O
an	O
increased	O
relative	O
risk	O
with	O
increasing	O
quartile	O
value	O
;	O
trend	O
,	O
p	O
=	O
0	O
.	O
016	O
,	O
but	O
not	O
in	O
multivariate	O
analysis	O
including	O
the	O
oral	O
antigens	O
.	O

No	O
single	O
bacterium	O
but	O
rather	O
combinations	O
were	O
related	O
to	O
increasing	O
relative	O
risk	O
for	O
MI	O
independent	O
of	O
known	O
cardiovascular	O
risk	O
factors	O
.	O

To	O
define	O
the	O
relationship	O
between	O
salivary	O
SIgA	O
antibodies	O
and	O
commensal	O
oral	O
bacteria	O
,	O
we	O
examined	O
the	O
reactivity	O
of	O
SIgA	O
antibodies	O
from	O
the	O
saliva	O
of	O
four	O
infants	O
with	O
their	O
own	O
colonizing	O
Streptococcus	B-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
bv	I-bacteria
1	I-bacteria
)	O
clones	O
(	O
ribotypes	O
)	O
.	O

Immunoblot	O
analysis	O
was	O
used	O
to	O
examine	O
reactivity	O
of	O
these	O
antibodies	O
with	O
persistent	O
ribotypes	O
isolated	O
from	O
the	O
mouths	O
of	O
the	O
infants	O
over	O
the	O
first	O
year	O
postpartum	O
.	O

Results	O
showed	O
that	O
the	O
pattern	O
of	O
SIgA	O
antibody	O
reactivity	O
with	O
the	O
majority	O
of	O
clones	O
increased	O
in	O
complexity	O
after	O
colonization	O
but	O
that	O
most	O
additional	O
bands	O
were	O
common	O
to	O
other	O
clones	O
,	O
indicating	O
that	O
they	O
represented	O
shared	O
antigens	O
.	O

However	O
,	O
unique	O
bands	O
were	O
identified	O
in	O
75	O
%	O
of	O
the	O
selected	O
persistent	O
clones	O
.	O

We	O
hypothesized	O
that	O
if	O
strain	O
-	O
specific	O
SIgA	O
antibody	O
was	O
induced	O
in	O
response	O
to	O
colonization	O
of	O
a	O
particular	O
clone	O
and	O
contributed	O
to	O
its	O
elimination	O
from	O
the	O
mouth	O
,	O
then	O
the	O
appearance	O
of	O
unique	O
bands	O
would	O
immediately	O
precede	O
the	O
disappearance	O
of	O
the	O
strain	O
.	O

Seventy	O
-	O
three	O
percent	O
of	O
all	O
unique	O
bands	O
identified	O
in	O
the	O
study	O
fulfilled	O
this	O
criterion	O
.	O

Because	O
the	O
mouth	O
is	O
an	O
open	O
,	O
dynamic	O
environment	O
and	O
multiple	O
factors	O
are	O
believed	O
to	O
play	O
a	O
role	O
in	O
the	O
immune	O
response	O
at	O
mucosal	O
surfaces	O
,	O
it	O
may	O
not	O
be	O
possible	O
to	O
conclusively	O
define	O
the	O
relationship	O
between	O
SIgA	O
antibody	O
and	O
commensal	O
bacteria	O
.	O

However	O
,	O
our	O
data	O
provide	O
evidence	O
that	O
SIgA	O
antibody	O
,	O
reactive	O
with	O
unique	O
antigens	O
of	O
their	O
own	O
colonizing	O
strains	O
,	O
is	O
produced	O
in	O
infants	O
and	O
may	O
point	O
to	O
a	O
role	O
of	O
this	O
antibody	O
in	O
regulating	O
colonization	O
by	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
bv	I-bacteria
1	I-bacteria
.	O

The	O
effects	O
of	O
oral	O
commensal	O
streptococci	B-bacteria
(	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
salivarius	I-bacteria
)	O
on	O
biofilm	O
formation	O
by	O
cariogenic	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
)	O
were	O
investigated	O
.	O

Cell	O
suspensions	O
were	O
cultured	O
on	O
96	O
-	O
well	O
microtiter	O
plates	O
coated	O
with	O
or	O
without	O
salivary	O
components	O
(	O
SC	O
)	O
,	O
and	O
in	O
flow	O
cell	O
systems	O
coated	O
with	O
SC	O
in	O
tryptic	O
soy	O
broth	O
including	O
0	O
.	O
25	O
%	O
sucrose	O
without	O
dextrose	O
(	O
TSB	O
)	O
.	O

The	O
resultant	O
biofilm	O
formations	O
were	O
stained	O
using	O
safranin	O
or	O
a	O
LIVE	O
/	O
DEAD	O
BacLight	O
Viability	O
Kit	O
,	O
and	O
examined	O
with	O
absorbance	O
at	O
492	O
nm	O
or	O
using	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Mutans	B-bacteria
streptococci	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
biofilms	O
were	O
formed	O
significantly	O
on	O
the	O
polystyrene	O
surfaces	O
in	O
TSB	O
.	O

Further	O
,	O
in	O
combination	O
cultures	O
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
formed	O
a	O
sufficient	O
biofilm	O
when	O
cultured	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

However	O
,	O
when	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
was	O
cultured	O
with	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
biofilm	O
formation	O
was	O
slightly	O
inhibited	O
.	O

S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
also	O
inhibited	O
biofilm	O
formation	O
in	O
the	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
but	O
not	O
when	O
cultured	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
collapsed	O
the	O
biofilm	O
morphology	O
and	O
inhibited	O
volume	O
development	O
in	O
some	O
conditions	O
when	O
cultured	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
.	O

Biofilm	O
formation	O
by	O
mutans	B-bacteria
streptococci	I-bacteria
was	O
challenged	O
and	O
collapsed	O
on	O
the	O
whole	O
by	O
culturing	O
with	O
each	O
of	O
the	O
other	O
oral	O
streptococci	B-bacteria
.	O

These	O
results	O
indicate	O
that	O
co	O
-	O
culturing	O
of	O
multiple	O
species	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
other	O
oral	O
streptococci	B-bacteria
has	O
physical	O
effects	O
related	O
to	O
previous	O
attachment	O
and	O
colonization	O
on	O
the	O
surface	O
,	O
as	O
well	O
as	O
biological	O
effects	O
to	O
regulate	O
biofilm	O
formation	O
.	O

We	O
identified	O
oral	O
bacterial	O
species	O
in	O
blood	O
cultures	O
following	O
single	O
-	O
tooth	O
extraction	O
and	O
tooth	O
brushing	O
.	O

Sequence	O
analysis	O
of	O
16S	O
rRNA	O
genes	O
identified	O
98	O
different	O
bacterial	O
species	O
recovered	O
from	O
151	O
bacteremic	O
subjects	O
.	O

Of	O
interest	O
,	O
48	O
of	O
the	O
isolates	O
represented	O
19	O
novel	O
species	O
of	O
Prevotella	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
Capnocytophaga	B-bacteria
,	O
Selenomonas	B-bacteria
,	O
and	O
Veillonella	B-bacteria
.	O

This	O
study	O
investigated	O
whether	O
an	O
improvement	O
in	O
periodontal	O
health	O
resulted	O
in	O
changes	O
in	O
the	O
prevalence	O
of	O
periodontopathogenic	O
bacteria	O
in	O
saliva	O
and	O
tongue	O
coatings	O
and	O
a	O
reduction	O
in	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
:	O
H	O
(	O
2	O
)	O
S	O
and	O
CH	O
(	O
3	O
)	O
SH	O
)	O
linked	O
to	O
oral	O
malodour	O
.	O

The	O
subjects	O
were	O
35	O
patients	O
who	O
visited	O
the	O
breath	O
odour	O
clinic	O
of	O
Kyushu	O
Dental	O
College	O
,	O
Japan	O
.	O

Their	O
mean	O
age	O
was	O
51	O
.	O
2	O
+	O
/	O
-	O
18	O
.	O
3	O
years	O
(	O
mean	O
+	O
/	O
-	O
sd	O
)	O
.	O

A	O
clinical	O
examination	O
performed	O
at	O
baseline	O
and	O
2	O
months	O
after	O
periodontal	O
treatment	O
assessed	O
VSCs	O
in	O
mouth	O
air	O
using	O
gas	O
chromatography	O
,	O
periodontal	O
probing	O
depth	O
and	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
in	O
all	O
subjects	O
;	O
saliva	O
and	O
tongue	O
coatings	O
were	O
also	O
collected	O
.	O

Genomic	O
DNA	O
was	O
isolated	O
from	O
the	O
samples	O
,	O
and	O
the	O
proportions	O
of	O
five	O
periodontopathogenic	O
bacteria	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Prevotella	B-bacteria
nigrescens	I-bacteria
)	O
were	O
investigated	O
using	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

The	O
subjects	O
were	O
classified	O
into	O
four	O
groups	O
based	O
on	O
the	O
presence	O
of	O
a	O
periodontal	O
pocket	O
of	O
more	O
than	O
4	O
mm	O
(	O
PD	O
)	O
and	O
VSCs	O
above	O
the	O
organoleptic	O
threshold	O
level	O
(	O
VSCT	O
)	O
as	O
follows	O
:	O
-	O
PD	O
/	O
-	O
VSCT	O
group	O
,	O
subjects	O
without	O
PD	O
or	O
VSCT	O
;	O
-	O
PD	O
/	O
+	O
VSCT	O
group	O
,	O
those	O
without	O
PD	O
but	O
with	O
VSCT	O
;	O
+	O
PD	O
/	O
-	O
VSCT	O
group	O
,	O
those	O
with	O
PD	O
but	O
without	O
VSCT	O
;	O
and	O
+	O
PD	O
/	O
+	O
VSCT	O
group	O
,	O
those	O
with	O
PD	O
and	O
VSCT	O
.	O

Although	O
the	O
mean	O
PD	O
values	O
in	O
the	O
+	O
PD	O
/	O
-	O
VSCT	O
and	O
+	O
PD	O
/	O
+	O
VSCT	O
groups	O
,	O
BOP	O
in	O
the	O
+	O
PD	O
/	O
+	O
VSCT	O
group	O
,	O
and	O
H	O
(	O
2	O
)	O
S	O
and	O
CH	O
(	O
3	O
)	O
SH	O
concentrations	O
in	O
the	O
-	O
PD	O
/	O
+	O
VSCT	O
and	O
+	O
PD	O
/	O
+	O
VSCT	O
groups	O
were	O
greater	O
than	O
in	O
the	O
other	O
groups	O
at	O
baseline	O
,	O
we	O
found	O
no	O
significant	O
difference	O
among	O
the	O
four	O
groups	O
after	O
periodontal	O
treatment	O
.	O

The	O
proportion	O
of	O
periodontopathogenic	O
bacteria	O
in	O
saliva	O
was	O
higher	O
in	O
the	O
+	O
PD	O
/	O
-	O
VSCT	O
and	O
+	O
PD	O
/	O
+	O
VSCT	O
groups	O
than	O
in	O
the	O
-	O
PD	O
/	O
-	O
VSCT	O
and	O
-	O
PD	O
/	O
+	O
VSCT	O
groups	O
at	O
baseline	O
and	O
after	O
treatment	O
,	O
but	O
the	O
proportions	O
of	O
bacteria	O
in	O
saliva	O
after	O
treatment	O
were	O
reduced	O
compared	O
to	O
the	O
baseline	O
.	O

Furthermore	O
,	O
the	O
differences	O
in	O
the	O
proportions	O
of	O
the	O
five	O
target	O
bacteria	O
in	O
the	O
tongue	O
coating	O
were	O
not	O
as	O
apparent	O
as	O
those	O
in	O
saliva	O
at	O
baseline	O
or	O
after	O
treatment	O
.	O

The	O
prevalence	O
of	O
periodontopathogenic	O
bacteria	O
in	O
saliva	O
may	O
reflect	O
periodontal	O
health	O
status	O
and	O
influence	O
VSC	O
levels	O
in	O
mouth	O
air	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
while	O
performing	O
the	O
(	O
14	O
)	O
C	O
-	O
urea	O
breath	O
test	O
(	O
(	O
14	O
)	O
C	O
-	O
UBT	O
)	O
for	O
the	O
detection	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
)	O
,	O
there	O
is	O
possibility	O
of	O
false	O
-	O
positive	O
results	O
due	O
to	O
the	O
other	O
urease	O
producing	O
bacteria	O
present	O
in	O
oropharynx	O
,	O
if	O
breath	O
samples	O
are	O
obtained	O
within	O
30	O
min	O
after	O
administration	O
of	O
non	O
-	O
capsulated	O
(	O
14	O
)	O
C	O
-	O
urea	O
.	O

Therefore	O
,	O
we	O
have	O
exclusively	O
evaluated	O
the	O
kinetics	O
of	O
(	O
14	O
)	O
carbon	O
dioxide	O
(	O
(	O
14	O
)	O
CO	O
(	O
2	O
)	O
)	O
excretion	O
by	O
oral	O
commensal	O
flora	O
to	O
theoretically	O
propose	O
optimum	O
breath	O
collection	O
timings	O
for	O
(	O
14	O
)	O
C	O
-	O
UBT	O
.	O

Multiple	O
breath	O
samples	O
up	O
to	O
15	O
min	O
were	O
collected	O
in	O
0	O
.	O
25	O
mmol	O
benzethonium	O
hydroxide	O
from	O
25	O
healthy	O
volunteers	O
after	O
they	O
withheld	O
37	O
kBq	O
(	O
1	O
muCi	O
)	O
of	O
(	O
14	O
)	O
C	O
-	O
urea	O
in	O
their	O
mouths	O
for	O
15	O
s	O
and	O
then	O
expectorated	O
the	O
tracer	O
.	O

The	O
test	O
was	O
repeated	O
on	O
the	O
same	O
subjects	O
without	O
and	O
with	O
mouth	O
cleansing	O
protocols	O
.	O

Breath	O
(	O
14	O
)	O
CO	O
(	O
2	O
)	O
content	O
was	O
measured	O
by	O
the	O
Liquid	O
Scintillation	O
Counter	O
(	O
1409	O
;	O
Wallac	O
,	O
Turku	O
,	O
Finland	O
)	O
and	O
results	O
were	O
expressed	O
as	O
(	O
14	O
)	O
CO	O
(	O
2	O
)	O
excretion	O
per	O
mmol	O
breath	O
CO	O
(	O
2	O
)	O
(	O
%	O
administered	O
dose	O
)	O
.	O

Peak	O
breath	O
radioactivity	O
at	O
1	O
min	O
in	O
the	O
former	O
protocol	O
was	O
3	O
.	O
53	O
times	O
higher	O
than	O
the	O
latter	O
which	O
declined	O
subsequently	O
with	O
a	O
half	O
time	O
of	O
1	O
min	O
and	O
2	O
.	O
5	O
min	O
,	O
and	O
reached	O
baseline	O
levels	O
by	O
15	O
and	O
10	O
min	O
,	O
respectively	O
.	O

The	O
peak	O
radioactivity	O
(	O
100	O
%	O
)	O
at	O
1	O
min	O
declined	O
by	O
94	O
%	O
and	O
97	O
.	O
8	O
%	O
in	O
the	O
former	O
and	O
later	O
protocols	O
,	O
respectively	O
,	O
at	O
15	O
min	O
.	O

Although	O
magnitude	O
of	O
the	O
peak	O
varied	O
in	O
different	O
subjects	O
,	O
the	O
shape	O
of	O
curve	O
remained	O
almost	O
similar	O
in	O
all	O
cases	O
.	O

Without	O
mouth	O
cleansing	O
,	O
oral	O
micro	O
flora	O
excreted	O
more	O
(	O
14	O
)	O
CO	O
(	O
2	O
)	O
up	O
to	O
15	O
min	O
after	O
administration	O
of	O
non	O
-	O
capsulated	O
(	O
14	O
)	O
C	O
-	O
urea	O
.	O

Therefore	O
,	O
it	O
is	O
proposed	O
that	O
two	O
breath	O
samples	O
may	O
be	O
obtained	O
either	O
at	O
15	O
and	O
20	O
min	O
without	O
or	O
at	O
10	O
and	O
15	O
min	O
with	O
mouth	O
cleansing	O
protocols	O
for	O
reliable	O
analysis	O
of	O
(	O
14	O
)	O
C	O
-	O
UBT	O
data	O
for	O
H	O
.	O
pylori	O
detection	O
.	O

The	O
induction	O
of	O
tissue	O
-	O
destructive	O
molecules	O
from	O
neutrophils	O
by	O
periodontopathic	O
bacteria	O
has	O
been	O
suggested	O
as	O
one	O
of	O
the	O
mechanisms	O
of	O
periodontal	O
destruction	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
the	O
ability	O
to	O
stimulate	O
neutrophils	O
is	O
an	O
authentic	O
characteristic	O
of	O
periodontopathic	O
bacteria	O
.	O

We	O
evaluated	O
,	O
along	O
with	O
phagocytosis	O
,	O
the	O
production	O
of	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
,	O
matrix	O
metalloproteinase	O
-	O
8	O
(	O
MMP	O
-	O
8	O
)	O
,	O
and	O
interleukin	O
-	O
1beta	O
by	O
neutrophils	O
in	O
response	O
to	O
non	O
-	O
periodontopathic	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
periodontopathic	O
bacteria	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
in	O
the	O
absence	O
or	O
presence	O
of	O
antibodies	O
.	O

Phagocytosis	O
,	O
the	O
death	O
of	O
neutrophils	O
,	O
and	O
intracellular	O
ROS	O
production	O
were	O
measured	O
by	O
flow	O
cytometry	O
and	O
the	O
concentrations	O
of	O
MMP	O
-	O
8	O
and	O
interleukin	O
-	O
1beta	O
secreted	O
into	O
medium	O
were	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
induced	O
greater	O
production	O
of	O
ROS	O
,	O
MMP	O
-	O
8	O
,	O
and	O
interleukin	O
-	O
1beta	O
than	O
did	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

The	O
levels	O
of	O
tissue	O
-	O
destructive	O
molecules	O
produced	O
by	O
neutrophils	O
had	O
a	O
positive	O
correlation	O
with	O
phagocytosis	O
.	O

Opsonization	O
of	O
bacteria	O
with	O
antibodies	O
significantly	O
increased	O
phagocytosis	O
and	O
ROS	O
production	O
and	O
release	O
,	O
thus	O
increasing	O
both	O
bacterial	O
clearance	O
and	O
potential	O
tissue	O
damage	O
.	O

The	O
ability	O
of	O
oral	O
bacteria	O
to	O
induce	O
tissue	O
-	O
destructive	O
molecules	O
from	O
neutrophils	O
is	O
not	O
an	O
inherent	O
characteristic	O
of	O
periodontopathic	O
bacteria	O
,	O
which	O
would	O
provide	O
a	O
new	O
insight	O
into	O
the	O
role	O
of	O
neutrophils	O
in	O
periodontal	O
destruction	O
.	O

To	O
investigate	O
foam	O
generation	O
during	O
brushing	O
,	O
and	O
the	O
oral	O
debris	O
and	O
bacteria	O
removal	O
efficacy	O
of	O
an	O
experimental	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
compared	O
to	O
a	O
commercially	O
-	O
available	O
dentifrice	O
after	O
brushing	O
.	O

Thirty	O
-	O
four	O
subjects	O
participated	O
in	O
this	O
blinded	O
,	O
crossover	O
study	O
.	O

After	O
a	O
wash	O
-	O
out	O
period	O
prior	O
to	O
each	O
session	O
of	O
product	O
use	O
,	O
subjects	O
reported	O
to	O
the	O
site	O
having	O
abstained	O
from	O
oral	O
hygiene	O
,	O
eating	O
and	O
drinking	O
from	O
22	O
:	O
00	O
h	O
on	O
the	O
evening	O
prior	O
to	O
treatment	O
visits	O
.	O

The	O
subjects	O
brushed	O
with	O
a	O
weighed	O
dose	O
of	O
assigned	O
paste	O
and	O
were	O
asked	O
to	O
expectorate	O
their	O
toothpaste	O
slurry	O
into	O
a	O
collection	O
vessel	O
at	O
30	O
and	O
60	O
seconds	O
during	O
supervised	O
brushing	O
.	O

The	O
expectorated	O
foam	O
was	O
measured	O
immediately	O
,	O
after	O
which	O
subjects	O
rinsed	O
with	O
10	O
ml	O
of	O
sterile	O
water	O
and	O
expectorated	O
into	O
the	O
same	O
vessel	O
.	O

Samples	O
were	O
placed	O
on	O
ice	O
and	O
immediately	O
transported	O
to	O
the	O
laboratory	O
for	O
analysis	O
.	O

Bacteria	O
(	O
total	O
anaerobes	O
and	O
VSC	O
-	O
producing	O
bacteria	O
)	O
were	O
enumerated	O
using	O
appropriate	O
selective	O
media	O
.	O

To	O
calculate	O
the	O
amount	O
of	O
debris	O
,	O
a	O
measured	O
portion	O
of	O
the	O
sample	O
was	O
deposited	O
onto	O
a	O
pre	O
-	O
weighed	O
dish	O
and	O
weighed	O
.	O

Dishes	O
were	O
dried	O
thoroughly	O
and	O
weighed	O
again	O
after	O
cooling	O
.	O

Use	O
of	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
resulted	O
in	O
105	O
%	O
greater	O
foam	O
volume	O
compared	O
with	O
use	O
of	O
the	O
control	O
dentifrice	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

Further	O
,	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
removed	O
15	O
.	O
77	O
%	O
more	O
debris	O
than	O
the	O
control	O
dentifrice	O
(	O
p	O
-	O
value	O
=	O
0	O
.	O
0342	O
)	O
.	O

There	O
was	O
greater	O
removal	O
of	O
total	O
anaerobes	O
and	O
VSC	O
-	O
producing	O
bacteria	O
by	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
versus	O
the	O
control	O
dentifrice	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
0001	O
)	O
.	O

Single	O
use	O
of	O
a	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
generated	O
a	O
greater	O
volume	O
of	O
foam	O
and	O
removed	O
a	O
greater	O
amount	O
of	O
oral	O
debris	O
and	O
bacteria	O
during	O
brushing	O
than	O
a	O
standard	O
dentifrice	O
.	O

To	O
investigate	O
the	O
topographic	O
distribution	O
of	O
bacterial	O
types	O
and	O
loads	O
associated	O
with	O
mid	O
-	O
morning	O
oral	O
malodour	O
on	O
the	O
tongue	O
surface	O
.	O

Fifty	O
subjects	O
with	O
good	O
oral	O
health	O
and	O
at	O
least	O
20	O
natural	O
uncrowned	O
teeth	O
were	O
included	O
.	O

Samples	O
were	O
taken	O
with	O
sterile	O
brushes	O
from	O
the	O
dorsal	O
anterior	O
(	O
DA	O
)	O
,	O
dorsal	O
middle	O
(	O
DM	O
)	O
,	O
dorsal	O
posterior	O
(	O
DP	O
)	O
,	O
dorsal	O
posterior	O
to	O
the	O
circumvallate	O
papillae	O
(	O
DPCP	O
)	O
,	O
lateral	O
posterior	O
(	O
LP	O
)	O
and	O
ventral	O
posterior	O
(	O
VP	O
)	O
tongue	O
surfaces	O
.	O

Samples	O
were	O
cultured	O
on	O
appropriate	O
media	O
for	O
anaerobic	O
bacteria	O
,	O
aerobic	O
bacteria	O
,	O
Gram	O
-	O
negative	O
anaerobic	O
bacteria	O
,	O
volatile	O
sulphur	O
compound	O
(	O
VSC	O
)	O
-	O
producing	O
bacteria	O
and	O
Streptococcus	B-bacteria
saliuarius	I-bacteria
.	O

Malodour	O
was	O
assessed	O
by	O
trained	O
judges	O
on	O
an	O
intensity	O
basis	O
.	O

The	O
counts	O
of	O
all	O
bacterial	O
groups	O
were	O
consistently	O
highest	O
at	O
the	O
DPCP	O
surface	O
.	O

Mean	O
VSC	O
-	O
producing	O
bacterial	O
counts	O
(	O
colony	O
forming	O
units	O
/	O
brush	O
x10	O
(	O
5	O
)	O
)	O
were	O
1	O
.	O
45	O
,	O
5	O
.	O
67	O
,	O
32	O
.	O
52	O
,	O
88	O
.	O
94	O
,	O
6	O
.	O
46	O
and	O
0	O
.	O
33	O
at	O
DA	O
,	O
DM	O
,	O
DP	O
,	O
DPCP	O
,	O
LP	O
and	O
VP	O
surfaces	O
,	O
respectively	O
.	O

Anaerobic	O
,	O
Gram	O
-	O
negative	O
and	O
VSC	O
counts	O
at	O
DPCP	O
surfaces	O
increased	O
with	O
malodour	O
intensity	O
,	O
whereas	O
aerobic	O
and	O
S	B-bacteria
.	I-bacteria
saliuarius	I-bacteria
counts	O
decreased	O
;	O
however	O
these	O
differences	O
were	O
not	O
statistically	O
significant	O
.	O

It	O
is	O
concluded	O
that	O
the	O
DPCP	O
area	O
consistently	O
carries	O
the	O
highest	O
load	O
of	O
bacteria	O
capable	O
of	O
contributing	O
to	O
oral	O
malodour	O
.	O

The	O
study	O
demonstrates	O
that	O
tongue	O
surfaces	O
not	O
accessible	O
to	O
routine	O
oral	O
hygiene	O
procedures	O
can	O
significantly	O
contribute	O
to	O
oral	O
malodour	O
.	O

We	O
isolated	O
oral	O
bacteria	O
that	O
coexisted	O
with	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
in	O
a	O
hamster	O
periodontitis	O
model	O
.	O

As	O
predominant	O
bacteria	O
in	O
the	O
periodontitis	O
site	O
,	O
Collinsella	O
-	O
reltaed	O
strains	O
,	O
Eubacterium	O
-	O
reltaed	O
strains	O
,	O
Streptococcus	O
suis	O
-	O
related	O
strains	O
,	O
and	O
Veillonella	O
parvula	O
-	O
reltaed	O
strains	O
were	O
detected	O
.	O

In	O
addition	O
,	O
Actinomyces	B-bacteria
,	O
Bacteroides	B-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
also	O
isolated	O
predominantly	O
.	O

The	O
results	O
suggest	O
that	O
the	O
bacterial	O
composition	O
of	O
the	O
periodontitis	O
site	O
in	O
hamsters	O
is	O
complex	O
,	O
as	O
in	O
human	O
periodontitis	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
compound	O
light	O
yellow	O
Sophora	O
root	O
collutory	O
on	O
oral	O
erosive	O
lichen	O
planus	O
and	O
analyze	O
the	O
salivary	O
microbial	O
contents	O
and	O
proportion	O
.	O

30	O
patients	O
with	O
oral	O
erosive	O
lichen	O
planus	O
were	O
chosen	O
and	O
treated	O
with	O
compound	O
light	O
yellow	O
Sophora	O
root	O
collutory	O
.	O

Pain	O
index	O
and	O
clinical	O
symptoms	O
were	O
observed	O
,	O
the	O
changes	O
of	O
quantity	O
and	O
proportion	O
of	O
salivary	O
bacteria	O
were	O
investigated	O
before	O
and	O
after	O
taking	O
drugs	O
.	O

SAS6	O
.	O
12	O
software	O
package	O
was	O
used	O
for	O
statistical	O
analysis	O
.	O

The	O
extravasate	O
and	O
congest	O
of	O
the	O
erosive	O
mucous	O
membrane	O
were	O
relieved	O
.	O

The	O
pain	O
caused	O
by	O
erosion	O
were	O
significantly	O
relieved	O
after	O
taking	O
the	O
drugs	O
.	O

The	O
quantity	O
of	O
oral	O
Staphylococcus	B-bacteria
was	O
significantly	O
decreased	O
after	O
taking	O
the	O
drugs	O
.	O

Oral	O
Staphylococcus	B-bacteria
can	O
be	O
inhibited	O
by	O
light	O
yellow	O
Sophora	O
root	O
collutory	O
.	O

The	O
use	O
of	O
compound	O
light	O
yellow	O
Sophora	O
root	O
collutory	O
is	O
one	O
of	O
the	O
safe	O
and	O
effective	O
local	O
therapies	O
on	O
oral	O
lichen	O
planus	O
.	O

In	O
recent	O
years	O
,	O
patients	O
have	O
benefited	O
from	O
the	O
development	O
of	O
better	O
and	O
more	O
esthetic	O
materials	O
,	O
including	O
all	O
-	O
ceramics	O
dental	O
restorative	O
materials	O
.	O

Dental	O
plaque	O
formation	O
on	O
teeth	O
and	O
restorative	O
materials	O
plays	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
oral	O
diseases	O
.	O

This	O
study	O
investigates	O
initial	O
adhesion	O
of	O
stationary	O
phase	O
streptococcal	B-bacteria
species	I-bacteria
to	O
different	O
all	O
-	O
ceramics	O
dental	O
restorative	O
materials	O
.	O

The	O
saliva	O
-	O
coated	O
materials	O
were	O
incubated	O
with	O
the	O
bacteria	O
for	O
1	O
h	O
in	O
an	O
in	O
vitro	O
flow	O
chamber	O
which	O
mimics	O
environmental	O
conditions	O
in	O
the	O
oral	O
cavity	O
.	O

Number	O
and	O
vitality	O
of	O
adhering	O
bacteria	O
were	O
determined	O
microscopically	O
after	O
staining	O
.	O

Surface	O
roughness	O
and	O
the	O
composition	O
of	O
the	O
materials	O
had	O
no	O
distinctive	O
influence	O
on	O
bacterial	O
adhesion	O
.	O

However	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
adhered	O
about	O
tenfold	O
less	O
numerous	O
to	O
all	O
materials	O
than	O
the	O
other	O
streptococcal	B-bacteria
species	I-bacteria
.	O

Further	O
,	O
there	O
was	O
a	O
correlation	O
between	O
bacterial	O
vitality	O
and	O
materials	O
'	O
glass	O
content	O
.	O

The	O
results	O
showed	O
that	O
early	O
plaque	O
formation	O
was	O
influenced	O
predominantly	O
by	O
the	O
presence	O
of	O
the	O
salivary	O
pellicle	O
rather	O
than	O
by	O
material	O
dependent	O
parameters	O
whereas	O
the	O
composition	O
of	O
the	O
all	O
-	O
ceramics	O
appeared	O
to	O
have	O
influenced	O
the	O
percentage	O
of	O
viable	O
cells	O
during	O
the	O
adhesion	O
process	O
.	O

This	O
presented	O
in	O
vitro	O
technique	O
may	O
provide	O
a	O
useful	O
model	O
to	O
study	O
the	O
influence	O
of	O
different	O
parameters	O
on	O
adherence	O
of	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
initially	O
colonizes	O
the	O
oral	O
cavity	O
by	O
interacting	O
with	O
organisms	O
in	O
supragingival	O
plaque	O
,	O
such	O
as	O
the	O
oralis	O
group	O
of	O
oral	O
streptococci	B-bacteria
.	O

This	O
interaction	O
involves	O
the	O
association	O
of	O
the	O
streptococcal	O
antigen	O
I	O
/	O
II	O
with	O
the	O
minor	O
fimbrial	O
antigen	O
(	O
Mfa1	O
)	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Our	O
previous	O
studies	O
showed	O
that	O
a	O
peptide	O
(	O
BAR	O
)	O
derived	O
from	O
antigen	O
I	O
/	O
II	O
inhibits	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adherence	O
and	O
subsequent	O
biofilm	O
formation	O
on	O
streptococcal	O
substrates	O
.	O

In	O
addition	O
,	O
screening	O
a	O
combinatorial	O
peptide	O
library	O
identified	O
select	O
amino	O
acid	O
substitutions	O
in	O
the	O
NITVK	O
active	O
region	O
of	O
BAR	O
that	O
increased	O
the	O
adherence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
to	O
streptococci	B-bacteria
.	O

Here	O
we	O
report	O
that	O
incorporating	O
these	O
residues	O
in	O
a	O
synthetic	O
peptide	O
results	O
in	O
more	O
-	O
potent	O
inhibition	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adherence	O
and	O
biofilm	O
formation	O
(	O
I	O
(	O
50	O
)	O
[	O
50	O
%	O
inhibition	O
]	O
at	O
0	O
.	O
52	O
microM	O
versus	O
I	O
(	O
50	O
)	O
at	O
1	O
.	O
25	O
microM	O
for	O
BAR	O
)	O
.	O

In	O
addition	O
,	O
a	O
second	O
structural	O
motif	O
in	O
BAR	O
,	O
comprised	O
of	O
the	O
amino	O
acids	O
KKVQDLLKK	O
,	O
was	O
shown	O
to	O
contribute	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adherence	O
to	O
streptococci	B-bacteria
.	O

Consistent	O
with	O
this	O
,	O
the	O
KKVQDLLKK	O
and	O
NITVK	O
motifs	O
are	O
conserved	O
only	O
in	O
antigen	O
I	O
/	O
II	O
proteins	O
expressed	O
by	O
the	O
oralis	O
group	O
of	O
streptococci	B-bacteria
,	O
which	O
interact	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Interestingly	O
,	O
the	O
primary	O
and	O
secondary	O
structures	O
and	O
the	O
functional	O
characteristics	O
of	O
the	O
amphipathic	O
VQDLL	O
core	O
alpha	O
-	O
helix	O
resemble	O
the	O
consensus	O
nuclear	O
receptor	O
(	O
NR	O
)	O
box	O
protein	O
-	O
protein	O
interacting	O
domain	O
sequence	O
(	O
LXXLL	O
)	O
of	O
eukaryotes	O
.	O

BAR	O
peptides	O
containing	O
amino	O
acid	O
substitutions	O
with	O
the	O
potential	O
to	O
disrupt	O
the	O
secondary	O
structure	O
of	O
VQDLL	O
were	O
less	O
-	O
effective	O
inhibitors	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adherence	O
and	O
biofilm	O
formation	O
,	O
suggesting	O
that	O
the	O
alpha	O
-	O
helical	O
character	O
of	O
VQDLL	O
is	O
important	O
.	O

Furthermore	O
,	O
replacing	O
the	O
lysines	O
that	O
flank	O
VQDLL	O
with	O
acidic	O
amino	O
acids	O
also	O
reduced	O
inhibitory	O
activity	O
,	O
suggesting	O
that	O
the	O
association	O
of	O
VQDLL	O
with	O
Mfa1	O
may	O
be	O
stabilized	O
by	O
a	O
charge	O
clamp	O
.	O

These	O
results	O
indicate	O
that	O
the	O
Mfa1	O
-	O
interacting	O
interface	O
of	O
streptococcal	B-bacteria
antigen	O
I	O
/	O
II	O
encompasses	O
both	O
the	O
KKVQDLLKK	O
and	O
NITVK	O
motif	O
and	O
suggest	O
that	O
the	O
adherence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
to	O
streptococci	B-bacteria
is	O
driven	O
by	O
a	O
protein	O
-	O
protein	O
interaction	O
domain	O
that	O
resembles	O
the	O
eukaryotic	O
NR	O
box	O
.	O

Thus	O
,	O
both	O
motifs	O
must	O
be	O
taken	O
into	O
account	O
in	O
designing	O
potential	O
peptidomimetics	O
that	O
target	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adherence	O
and	O
biofilm	O
formation	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
two	O
different	O
methods	O
of	O
identifying	O
oral	O
bacteri	O
from	O
blood	O
samples	O
after	O
dental	O
extractions	O
.	O

Blood	O
cultures	O
were	O
taken	O
before	O
,	O
during	O
,	O
and	O
after	O
a	O
single	O
tooth	O
extraction	O
in	O
30	O
subjects	O
and	O
cultured	O
using	O
aerobic	O
and	O
anaerobic	O
Bactec	O
media	O
.	O

Positive	O
cultures	O
from	O
22	O
subjects	O
were	O
subcultured	O
on	O
selective	O
and	O
nonselective	O
media	O
,	O
resulting	O
in	O
58	O
isolates	O
.	O

Bacterial	O
identification	O
was	O
performed	O
by	O
biochemical	O
analysis	O
and	O
sequence	O
analysis	O
of	O
16S	O
rRNA	O
gene	O
.	O

Of	O
the	O
58	O
isolates	O
,	O
only	O
10	O
(	O
17	O
%	O
)	O
were	O
the	O
same	O
species	O
by	O
both	O
methods	O
.	O

Thirty	O
-	O
two	O
(	O
55	O
%	O
)	O
belonged	O
to	O
the	O
same	O
genus	O
but	O
different	O
species	O
,	O
and	O
16	O
(	O
28	O
%	O
)	O
showed	O
no	O
correlation	O
at	O
all	O
.	O

There	O
were	O
31	O
and	O
40	O
diverse	O
species	O
by	O
the	O
biochemical	O
and	O
the	O
sequencing	O
methods	O
,	O
respectively	O
.	O

Streptococci	B-bacteria
were	O
the	O
dominant	O
species	O
.	O

DNA	O
sequencing	O
results	O
in	O
more	O
accurate	O
identification	O
and	O
a	O
more	O
diverse	O
population	O
of	O
bacteria	O
from	O
bacteremia	O
following	O
dental	O
extractions	O
.	O

Silent	O
aspiration	O
of	O
oropharyngeal	O
pathogenic	O
organisms	O
is	O
a	O
significant	O
risk	O
factor	O
causing	O
pneumonia	O
in	O
the	O
elderly	O
.	O

We	O
hypothesized	O
that	O
regular	O
oral	O
hygiene	O
care	O
will	O
affect	O
the	O
presence	O
of	O
oropharyngeal	O
bacteria	O
.	O

Professional	O
cleaning	O
of	O
the	O
oral	O
cavity	O
and	O
/	O
or	O
the	O
gargling	O
of	O
a	O
disinfectant	O
liquid	O
solution	O
was	O
performed	O
over	O
a	O
five	O
-	O
month	O
period	O
in	O
three	O
facilities	O
for	O
the	O
dependent	O
elderly	O
.	O

Total	O
oropharyngeal	O
bacteria	O
,	O
streptococci	B-bacteria
,	O
staphylococci	B-bacteria
,	O
Candida	O
,	O
Pseudomonas	B-bacteria
,	O
and	O
black	O
-	O
pigmented	O
Bacteroides	B-bacteria
species	I-bacteria
were	O
monitored	O
.	O

The	O
levels	O
of	O
these	O
oropharyngeal	O
bacteria	O
decreased	O
or	O
disappeared	O
after	O
weekly	O
professional	O
oral	O
health	O
care	O
,	O
i	O
.	O
e	O
.	O
,	O
cleaning	O
of	O
teeth	O
,	O
dentures	O
,	O
tongue	O
,	O
and	O
oral	O
mucous	O
membrane	O
by	O
dental	O
hygienists	O
.	O

After	O
lunch	O
,	O
gargling	O
with	O
povidone	O
iodine	O
was	O
shown	O
to	O
be	O
less	O
effective	O
than	O
professional	O
oral	O
care	O
.	O

These	O
findings	O
indicate	O
that	O
weekly	O
professional	O
mechanical	O
cleaning	O
of	O
the	O
oral	O
cavity	O
,	O
rather	O
than	O
a	O
daily	O
chemical	O
disinfection	O
of	O
the	O
mouth	O
,	O
can	O
be	O
an	O
important	O
strategy	O
to	O
prevent	O
aspiration	O
pneumonia	O
in	O
the	O
dependent	O
elderly	O
.	O

Oral	O
viridans	B-bacteria
streptococci	I-bacteria
are	O
a	O
reservoir	O
of	O
resistance	O
genes	O
for	O
pathogens	O
.	O

Through	O
prolonged	O
exposure	O
,	O
long	O
-	O
acting	O
macrolides	O
(	O
e	O
.	O
g	O
.	O
,	O
azithromycin	O
)	O
may	O
induce	O
the	O
resistance	O
of	O
the	O
commensals	O
to	O
macrolides	O
more	O
frequently	O
than	O
macrolides	O
with	O
a	O
shorter	O
half	O
-	O
life	O
(	O
e	O
.	O
g	O
.	O
,	O
clarithromycin	O
)	O
.	O

In	O
a	O
prospective	O
,	O
randomized	O
,	O
evaluator	O
-	O
blinded	O
trial	O
in	O
healthy	O
volunteers	O
receiving	O
standard	O
courses	O
of	O
either	O
azithromycin	O
(	O
n	O
=	O
20	O
)	O
or	O
clarithromycin	O
(	O
n	O
=	O
20	O
)	O
,	O
we	O
compared	O
the	O
susceptibility	O
of	O
oral	O
viridans	B-bacteria
streptococci	I-bacteria
to	O
macrolides	O
over	O
a	O
period	O
of	O
12	O
weeks	O
.	O

There	O
was	O
a	O
significant	O
temporal	O
increase	O
in	O
the	O
numbers	O
of	O
resistant	O
isolates	O
in	O
both	O
groups	O
(	O
p	O
<	O
0	O
.	O
0005	O
at	O
week	O
1	O
)	O
.	O

The	O
proportion	O
of	O
macrolide	O
-	O
resistant	O
isolates	O
over	O
time	O
was	O
significantly	O
higher	O
following	O
azithromycin	O
treatment	O
(	O
p	O
=	O
0	O
.	O
0005	O
)	O
,	O
but	O
returned	O
to	O
baseline	O
values	O
until	O
week	O
12	O
in	O
both	O
groups	O
.	O

Temporal	O
differential	O
effects	O
of	O
azithromycin	O
and	O
clarithromycin	O
on	O
the	O
induction	O
of	O
resistance	O
were	O
observed	O
and	O
need	O
to	O
be	O
investigated	O
regarding	O
their	O
effect	O
on	O
co	O
-	O
colonizing	O
pathogens	O
.	O

A	O
relationship	O
between	O
the	O
distribution	O
of	O
periodontal	O
bacteria	O
species	O
and	O
malodor	O
in	O
children	O
has	O
not	O
been	O
sufficiently	O
investigated	O
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
determine	O
the	O
presence	O
of	O
3	O
periodontopathic	O
bacteria	O
(	O
Prevotella	B-bacteria
spp	I-bacteria
.	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
)	O
in	O
the	O
supragingival	O
plaques	O
of	O
3	O
to	O
16	O
-	O
year	O
-	O
old	O
children	O
with	O
different	O
oral	O
health	O
conditions	O
and	O
oral	O
malodor	O
.	O

The	O
number	O
of	O
decayed	O
and	O
filled	O
primary	O
teeth	O
(	O
df	O
)	O
and	O
Decayed	O
,	O
Missing	O
and	O
Filled	O
permanent	O
teeth	O
(	O
DMF	O
)	O
,	O
Papillary	O
Marginal	O
and	O
Attached	O
gingivitis	O
(	O
PMA	O
)	O
index	O
,	O
Oral	O
Hygiene	O
Index	O
(	O
OHI	O
)	O
,	O
and	O
oral	O
malodor	O
of	O
each	O
subject	O
were	O
determined	O
prior	O
to	O
the	O
collection	O
of	O
supragingival	O
plaques	O
.	O

Three	O
periodontopathic	O
bacteria	O
(	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
)	O
in	O
supragingival	O
plaques	O
were	O
detected	O
by	O
using	O
an	O
immunoslot	O
blot	O
assay	O
with	O
monoclonal	O
antibodies	O
specific	O
for	O
each	O
microorganism	O
.	O

The	O
frequencies	O
of	O
periodontopathic	O
bacteria	O
in	O
children	O
with	O
and	O
without	O
caries	O
were	O
not	O
significantly	O
different	O
from	O
each	O
other	O
.	O

Positivity	O
for	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
but	O
not	O
for	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
or	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
was	O
correlated	O
with	O
oral	O
malodor	O
.	O

Oral	O
malodor	O
was	O
also	O
correlated	O
with	O
the	O
debris	O
index	O
,	O
a	O
component	O
of	O
OHI	O
.	O

The	O
group	O
with	O
the	O
higher	O
OHI	O
showed	O
a	O
higher	O
prevalence	O
of	O
periodontopathic	O
bacteria	O
.	O

For	O
the	O
3	O
periodontopathic	O
bacteria	O
in	O
the	O
subjects	O
tested	O
,	O
plaques	O
positive	O
for	O
any	O
of	O
them	O
were	O
not	O
age	O
related	O
.	O

However	O
the	O
frequencies	O
of	O
all	O
3	O
periodontopathic	O
bacteria	O
were	O
the	O
highest	O
in	O
the	O
3	O
-	O
6	O
-	O
year	O
olds	O
.	O

The	O
supragingival	O
plaques	O
in	O
children	O
can	O
harbor	O
3	O
species	O
of	O
periodontopathic	O
bacteria	O
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
.	O

The	O
aim	O
of	O
this	O
in	O
vitro	O
study	O
was	O
to	O
evaluate	O
the	O
effects	O
of	O
nicotine	O
,	O
cotinine	O
,	O
and	O
caffeine	O
on	O
the	O
viability	O
of	O
some	O
oral	O
bacterial	O
species	O
.	O

It	O
also	O
evaluated	O
the	O
ability	O
of	O
these	O
bacteria	O
to	O
metabolize	O
those	O
substances	O
.	O

Single	O
-	O
species	O
biofilms	O
of	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
or	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
dual	O
-	O
species	O
biofilms	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
-	O
-	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
-	O
-	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
grown	O
on	O
hydroxyapatite	O
discs	O
.	O

Seven	O
species	O
were	O
studied	O
as	O
planktonic	O
cells	O
,	O
including	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
and	O
the	O
species	O
mentioned	O
above	O
.	O

The	O
viability	O
of	O
planktonic	O
cells	O
and	O
biofilms	O
was	O
analyzed	O
by	O
susceptibility	O
tests	O
and	O
time	O
-	O
kill	O
assays	O
,	O
respectively	O
,	O
against	O
different	O
concentrations	O
of	O
nicotine	O
,	O
cotinine	O
,	O
and	O
caffeine	O
.	O

High	O
-	O
performance	O
liquid	O
chromatography	O
was	O
performed	O
to	O
quantify	O
nicotine	O
,	O
cotinine	O
,	O
and	O
caffeine	O
concentrations	O
in	O
the	O
culture	O
media	O
after	O
the	O
assays	O
.	O

Susceptibility	O
tests	O
and	O
viability	O
assays	O
showed	O
that	O
nicotine	O
,	O
cotinine	O
,	O
and	O
caffeine	O
can	O
not	O
reduce	O
or	O
stimulate	O
bacterial	O
growth	O
.	O

High	O
-	O
performance	O
liquid	O
chromatography	O
results	O
showed	O
that	O
nicotine	O
,	O
cotinine	O
,	O
and	O
caffeine	O
concentrations	O
were	O
not	O
altered	O
after	O
bacteria	O
exposure	O
.	O

These	O
findings	O
indicate	O
that	O
nicotine	O
,	O
cotinine	O
,	O
and	O
caffeine	O
,	O
in	O
the	O
concentrations	O
used	O
,	O
can	O
not	O
affect	O
significantly	O
the	O
growth	O
of	O
these	O
oral	O
bacterial	O
strains	O
.	O

Moreover	O
,	O
these	O
species	O
do	O
not	O
seem	O
to	O
metabolize	O
these	O
substances	O
.	O

To	O
evaluate	O
the	O
efficacy	O
of	O
common	O
antiseptic	O
mouth	O
rinses	O
and	O
octenidine	O
dihydrochloride	O
(	O
OCT	O
)	O
.	O

The	O
antibacterial	O
activities	O
of	O
antiseptics	O
against	O
total	O
and	O
cariogenic	O
bacteria	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
species	I-bacteria
)	O
in	O
saliva	O
were	O
studied	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

After	O
unstimulated	O
saliva	O
was	O
collected	O
,	O
one	O
of	O
the	O
mouth	O
rinse	O
solutions	O
was	O
applied	O
for	O
30seconds	O
.	O

Saliva	O
samples	O
were	O
collected	O
15	O
,	O
30	O
,	O
60	O
,	O
and	O
120min	O
later	O
and	O
evaluated	O
for	O
their	O
bacterial	O
count	O
.	O

OCT	O
had	O
a	O
significantly	O
greater	O
inhibitory	O
effect	O
on	O
the	O
studied	O
bacteria	O
than	O
0	O
.	O
2	O
%	O
chlorhexidine	O
gluconate	O
(	O
CHX	O
)	O
and	O
7	O
.	O
5	O
%	O
polyvinylpyrrolidone	O
-	O
iodine	O
complex	O
(	O
PVP	O
-	O
I	O
)	O
from	O
15min	O
to	O
120min	O
following	O
the	O
application	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
antiseptic	O
efficacy	O
of	O
0	O
.	O
2	O
%	O
CHX	O
on	O
total	O
bacteria	O
and	O
Lactobacillus	B-bacteria
species	I-bacteria
was	O
very	O
similar	O
to	O
the	O
efficacy	O
observed	O
with	O
7	O
.	O
5	O
%	O
PVP	O
-	O
I	O
mouth	O
solution	O
from	O
15min	O
up	O
to	O
120min	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
was	O
completely	O
inhibited	O
by	O
0	O
.	O
15mg	O
/	O
ml	O
PVP	O
-	O
I	O
,	O
0	O
.	O
5mg	O
/	O
ml	O
CHX	O
,	O
and	O
0	O
.	O
1mg	O
/	O
ml	O
OCT	O
concentrations	O
,	O
while	O
Streptococcus	B-bacteria
salivarius	I-bacteria
was	O
inhibited	O
by	O
0	O
.	O
15mg	O
/	O
ml	O
PVP	O
-	O
I	O
,	O
2mg	O
/	O
ml	O
CHX	O
,	O
and	O
0	O
.	O
8mg	O
/	O
ml	O
OCT	O
concentrations	O
.	O

Lactococcus	B-bacteria
lactis	I-bacteria
subspecies	I-bacteria
lactis	I-bacteria
was	O
inhibited	O
with	O
0	O
.	O
00313mg	O
/	O
ml	O
OCT	O
,	O
30mg	O
/	O
ml	O
PVP	O
-	O
I	O
,	O
and	O
0	O
.	O
0063mg	O
/	O
ml	O
CHX	O
concentrations	O
.	O

OCT	O
compared	O
favorably	O
with	O
CHX	O
and	O
PVP	O
-	O
I	O
in	O
its	O
antibacterial	O
effects	O
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Leptotrichia	B-bacteria
species	I-bacteria
typically	O
colonize	O
the	O
oral	O
cavity	O
and	O
genitourinary	O
tract	O
.	O

These	O
anaerobic	O
bacteria	O
belong	O
to	O
the	O
normal	O
flora	O
of	O
humans	O
and	O
are	O
seldom	O
found	O
in	O
clinically	O
significant	O
specimens	O
.	O

However	O
,	O
on	O
rare	O
occasions	O
,	O
Leptotrichia	B-bacteria
has	O
been	O
isolated	O
from	O
blood	O
cultures	O
of	O
patients	O
with	O
lesions	O
in	O
the	O
oral	O
mucosa	O
,	O
in	O
particular	O
from	O
patients	O
with	O
neutropenia	O
.	O

These	O
organisms	O
should	O
be	O
considered	O
potential	O
pathogens	O
in	O
neutropenic	O
patients	O
,	O
especially	O
when	O
breaks	O
in	O
the	O
mucosal	O
barriers	O
are	O
present	O
through	O
which	O
they	O
frequently	O
spread	O
to	O
the	O
bloodstream	O
.	O

Leptotrichia	B-bacteria
has	O
also	O
been	O
recovered	O
from	O
immunocompetent	O
persons	O
,	O
e	O
.	O
g	O
.	O
patients	O
with	O
endocarditis	O
.	O

Although	O
their	O
role	O
in	O
infections	O
remains	O
elusive	O
and	O
not	O
much	O
is	O
known	O
,	O
they	O
have	O
been	O
suggested	O
as	O
emerging	O
pathogens	O
.	O

The	O
present	O
review	O
deals	O
with	O
taxonomy	O
,	O
diagnosis	O
,	O
clinical	O
importance	O
,	O
pathogenesis	O
,	O
host	O
defence	O
,	O
infection	O
control	O
,	O
and	O
spectrum	O
of	O
Leptotrichia	B-bacteria
infections	O
,	O
and	O
ends	O
with	O
a	O
few	O
typical	O
case	O
reports	O
.	O

Currently	O
,	O
six	O
species	O
have	O
been	O
validly	O
published	O
,	O
but	O
a	O
number	O
of	O
yet	O
uncultivable	O
species	O
exist	O
.	O

Molecular	O
methods	O
recovering	O
uncultivable	O
species	O
should	O
be	O
used	O
to	O
get	O
a	O
real	O
idea	O
of	O
their	O
role	O
as	O
pathogens	O
.	O

Coaggregation	O
is	O
believed	O
to	O
facilitate	O
the	O
integration	O
of	O
new	O
bacterial	O
species	O
into	O
polymicrobial	O
communities	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
coaggregation	O
between	O
and	O
among	O
human	O
oral	O
and	O
enteric	O
bacteria	O
.	O

Stationary	O
phase	O
cultures	O
of	O
10	O
oral	O
and	O
10	O
enteric	O
species	O
,	O
chosen	O
on	O
the	O
basis	O
of	O
numerical	O
and	O
ecological	O
significance	O
in	O
their	O
respective	O
environments	O
together	O
with	O
their	O
ease	O
of	O
cultivation	O
,	O
were	O
tested	O
using	O
a	O
quantitative	O
spectrophotometric	O
coaggregation	O
assay	O
in	O
all	O
possible	O
pairwise	O
combinations	O
to	O
provide	O
quantitative	O
coaggregation	O
scores	O
.	O

While	O
40	O
%	O
of	O
possible	O
partnerships	O
coaggregated	O
strongly	O
for	O
oral	O
strains	O
,	O
strong	O
interactions	O
between	O
oral	O
and	O
gut	O
strains	O
were	O
considerably	O
less	O
common	O
(	O
4	O
%	O
incidence	O
)	O
.	O

Coaggregation	O
scores	O
were	O
also	O
weak	O
between	O
members	O
of	O
the	O
intestinal	O
microbiota	O
(	O
7	O
%	O
incidence	O
)	O
,	O
apart	O
from	O
Bacteroides	B-bacteria
fragilis	I-bacteria
with	O
Clostridium	B-bacteria
perfringens	I-bacteria
,	O
and	O
Bifidobacterium	B-bacteria
adolescentis	I-bacteria
withenteric	O
C	I-bacteria
.	I-bacteria
perfringens	I-bacteria
.	O

Oral	O
and	O
intestinal	O
bacteria	O
did	O
not	O
strongly	O
interact	O
,	O
apart	O
from	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
with	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
with	O
C	B-bacteria
.	I-bacteria
perfringens	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
with	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
.	O

Heating	O
and	O
sugar	O
-	O
addition	O
experiments	O
indicated	O
that	O
similar	O
to	O
oral	O
microorganisms	O
,	O
interactions	O
within	O
intestinal	O
bacteria	O
and	O
between	O
intestinal	O
and	O
oral	O
strains	O
were	O
mediated	O
by	O
lectin	O
-	O
carbohydrate	O
interactions	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
examine	O
oral	O
mucosal	O
lesions	O
,	O
microbial	O
changes	O
,	O
and	O
taste	O
disturbances	O
induced	O
by	O
adjuvant	O
chemotherapy	O
(	O
CT	O
)	O
in	O
breast	O
cancer	O
patients	O
during	O
and	O
1	O
year	O
after	O
treatment	O
.	O

Forty	O
-	O
five	O
consecutive	O
breast	O
cancer	O
patients	O
,	O
eligible	O
for	O
adjuvant	O
CT	O
with	O
cyclophosphamide	O
,	O
epirubicin	O
or	O
methotrexate	O
,	O
and	O
5	O
-	O
fluorouracil	O
were	O
followed	O
before	O
,	O
during	O
,	O
6	O
months	O
and	O
1	O
year	O
after	O
CT	O
and	O
were	O
compared	O
to	O
a	O
control	O
group	O
of	O
31	O
breast	O
cancer	O
patients	O
not	O
receiving	O
adjuvant	O
CT	O
.	O
During	O
CT	O
,	O
oral	O
mucosal	O
lesions	O
developed	O
including	O
erythema	O
(	O
n	O
=	O
10	O
,	O
22	O
%	O
)	O
and	O
ulceration	O
(	O
n	O
=	O
7	O
,	O
16	O
%	O
)	O
.	O

Five	O
patients	O
(	O
11	O
%	O
)	O
were	O
diagnosed	O
with	O
oral	O
candidosis	O
.	O

Scores	O
of	O
dental	O
bacterial	O
plaque	O
and	O
gingival	O
inflammation	O
increased	O
during	O
CT	O
and	O
the	O
oral	O
microbial	O
composition	O
changed	O
towards	O
a	O
more	O
acidophilic	O
flora	O
.	O

Taste	O
disturbances	O
were	O
experienced	O
by	O
84	O
%	O
(	O
n	O
=	O
38	O
)	O
of	O
the	O
patients	O
in	O
the	O
CT	O
group	O
.	O

In	O
breast	O
cancer	O
patients	O
,	O
moderate	O
-	O
intensive	O
adjuvant	O
CT	O
caused	O
oral	O
mucosal	O
lesions	O
,	O
oral	O
candidosis	O
,	O
taste	O
disturbances	O
and	O
a	O
more	O
acidophilic	O
oral	O
microflora	O
.	O

These	O
adverse	O
effects	O
were	O
temporary	O
and	O
the	O
majority	O
of	O
the	O
patients	O
were	O
mildly	O
affected	O
.	O

A	O
powder	O
preparation	O
of	O
the	O
oral	O
probiotic	O
Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
has	O
been	O
given	O
to	O
19	O
young	O
otitis	O
media	O
-	O
prone	O
children	O
following	O
a	O
3	O
-	O
day	O
course	O
of	O
amoxicillin	O
administered	O
as	O
a	O
preliminary	O
to	O
ventilation	O
tube	O
placement	O
.	O

In	O
two	O
subjects	O
,	O
the	O
use	O
of	O
strain	O
K12	B-bacteria
appeared	O
to	O
effect	O
the	O
expansion	O
of	O
an	O
indigenous	O
population	O
of	O
inhibitory	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
.	O

In	O
other	O
children	O
,	O
strain	O
K12	B-bacteria
colonisation	O
extended	O
beyond	O
the	O
oral	O
cavity	O
to	O
also	O
include	O
the	O
nasopharynx	O
or	O
adenoid	O
tissue	O
.	O

The	O
relatively	O
low	O
proportion	O
(	O
33	O
%	O
)	O
of	O
subjects	O
that	O
colonised	O
was	O
attributed	O
to	O
failure	O
of	O
the	O
amoxicillin	O
pre	O
-	O
treatment	O
to	O
sufficiently	O
reduce	O
the	O
indigenous	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
populations	O
prior	O
to	O
dosing	O
with	O
strain	O
K12	B-bacteria
powder	O
.	O

Porphyromonas	B-bacteria
species	I-bacteria
are	O
frequently	O
isolated	O
from	O
the	O
oral	O
cavity	O
and	O
are	O
associated	O
with	O
periodontal	O
disease	O
in	O
both	O
animals	O
and	O
humans	O
.	O

Black	O
,	O
pigmented	O
Porphyromonas	B-bacteria
spp	I-bacteria
.	I-bacteria
isolated	O
from	O
the	O
gingival	O
margins	O
of	O
selected	O
wild	O
and	O
captive	O
Australian	O
marsupials	O
with	O
varying	O
degrees	O
of	O
periodontal	O
disease	O
(	O
brushtail	O
possums	O
,	O
koalas	O
and	O
macropods	O
)	O
were	O
compared	O
phylogenetically	O
to	O
Porphyromonas	B-bacteria
strains	I-bacteria
from	O
non	O
-	O
marsupials	O
(	O
bear	O
,	O
wolf	O
,	O
coyote	O
,	O
cats	O
and	O
dogs	O
)	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
strains	I-bacteria
from	O
humans	O
using	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
.	O

The	O
results	O
of	O
the	O
phylogenetic	O
analysis	O
identified	O
three	O
distinct	O
groups	O
of	O
strains	O
.	O

A	O
monophyletic	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
group	O
(	O
Group	O
1	O
)	O
contained	O
only	O
strains	O
isolated	O
from	O
humans	O
and	O
a	O
Porphyromonas	B-bacteria
gulae	I-bacteria
group	O
(	O
Group	O
2	O
)	O
was	O
divided	O
into	O
three	O
distinct	O
subclades	O
,	O
each	O
containing	O
both	O
marsupial	O
and	O
non	O
-	O
marsupial	O
strains	O
.	O

Group	O
3	O
,	O
which	O
contained	O
only	O
marsupial	O
strains	O
,	O
including	O
all	O
six	O
strains	O
isolated	O
from	O
captive	O
koalas	O
,	O
was	O
genetically	O
distinct	O
from	O
P	B-bacteria
.	I-bacteria
gulae	I-bacteria
and	O
may	O
constitute	O
a	O
new	O
Porphyromonas	B-bacteria
species	I-bacteria
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
urease	O
-	O
positive	O
non	O
-	O
Helicobacter	B-bacteria
pylori	I-bacteria
bacteria	O
on	O
the	O
results	O
of	O
a	O
urea	O
breath	O
test	O
(	O
UBT	O
)	O
to	O
evaluate	O
the	O
diagnostic	O
utility	O
of	O
a	O
UBT	O
using	O
film	O
-	O
coated	O
[	O
(	O
13	O
)	O
C	O
]	O
urea	O
tablets	O
.	O

The	O
UBT	O
was	O
performed	O
in	O
102	O
patients	O
treated	O
with	O
a	O
proton	O
pump	O
inhibitor	O
and	O
antibiotics	O
for	O
the	O
eradication	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Urease	O
-	O
producing	O
bacteria	O
other	O
than	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
were	O
isolated	O
and	O
identified	O
from	O
the	O
oral	O
cavity	O
and	O
stomach	O
.	O

In	O
4	O
/	O
102	O
patients	O
,	O
the	O
UBT	O
gave	O
false	O
-	O
positive	O
results	O
.	O

These	O
false	O
-	O
positive	O
results	O
were	O
found	O
to	O
be	O
caused	O
by	O
the	O
presence	O
of	O
urease	O
-	O
positive	O
bacteria	O
in	O
the	O
oral	O
cavity	O
and	O
stomach	O
.	O

Five	O
bacterial	O
species	O
with	O
urease	O
activity	O
(	O
Proteus	B-bacteria
mirabilis	I-bacteria
,	O
Citrobacter	B-bacteria
freundii	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
Enterobacter	B-bacteria
cloacae	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
)	O
were	O
subsequently	O
isolated	O
from	O
the	O
oral	O
cavity	O
and	O
/	O
or	O
stomach	O
.	O

As	O
there	O
was	O
no	O
correlation	O
between	O
the	O
in	O
vitro	O
urease	O
activity	O
of	O
urease	O
-	O
positive	O
non	O
-	O
H	O
.	O
pylori	O
bacteria	O
and	O
the	O
UBT	O
value	O
,	O
and	O
all	O
of	O
the	O
patients	O
with	O
a	O
false	O
-	O
positive	O
UBT	O
result	O
were	O
suffering	O
from	O
atrophic	O
gastritis	O
,	O
it	O
is	O
possible	O
that	O
the	O
false	O
-	O
positive	O
results	O
in	O
the	O
UBT	O
were	O
a	O
result	O
of	O
colonization	O
of	O
urease	O
-	O
positive	O
bacteria	O
and	O
gastric	O
hypochlorhydric	O
conditions	O
.	O

Thus	O
,	O
for	O
the	O
diagnosis	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
using	O
a	O
UBT	O
,	O
the	O
influence	O
of	O
stomach	O
bacteria	O
must	O
be	O
considered	O
when	O
interpreting	O
the	O
results	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
confirm	O
further	O
the	O
efficacy	O
and	O
safety	O
of	O
levofloxacin	O
in	O
patients	O
with	O
chronic	O
bacterial	O
prostatitis	O
(	O
CBP	O
)	O
in	O
Europe	O
.	O

Men	O
with	O
a	O
history	O
of	O
CBP	O
were	O
enrolled	O
in	O
a	O
prospective	O
,	O
multinational	O
(	O
eight	O
countries	O
)	O
,	O
open	O
-	O
label	O
study	O
to	O
receive	O
levofloxacin	O
500	O
mg	O
once	O
daily	O
per	O
os	O
(	O
p	O
.	O
o	O
.	O
)	O

for	O
28	O
days	O
.	O

Patients	O
were	O
followed	O
for	O
6	O
months	O
.	O

A	O
total	O
of	O
117	O
patients	O
were	O
treated	O
.	O

Gram	O
-	O
negative	O
bacteria	O
were	O
identified	O
in	O
57	O
/	O
106	O
patients	O
(	O
mainly	O
Escherichia	B-bacteria
coli	I-bacteria
(	O
n	O
=	O
37	O
)	O
)	O
and	O
Gram	O
-	O
positive	O
bacteria	O
in	O
60	O
/	O
106	O
patients	O
(	O
mainly	O
Enterococcus	B-bacteria
faecalis	I-bacteria
(	O
n	O
=	O
18	O
)	O
and	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
(	O
n	O
=	O
14	O
)	O
)	O
.	O

Among	O
the	O
intention	O
-	O
to	O
-	O
treat	O
population	O
(	O
n	O
=	O
116	O
)	O
,	O
the	O
clinical	O
success	O
rate	O
(	O
cured	O
and	O
improved	O
patients	O
)	O
was	O
92	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
84	O
.	O
8	O
-	O
96	O
.	O
5	O
%	O
)	O
,	O
77	O
.	O
4	O
%	O
(	O
95	O
%	O
CI	O
68	O
.	O
2	O
-	O
84	O
.	O
9	O
%	O
)	O
,	O
66	O
.	O
0	O
%	O
(	O
95	O
%	O
CI	O
56	O
.	O
2	O
-	O
75	O
.	O
0	O
%	O
)	O
and	O
61	O
.	O
9	O
%	O
(	O
95	O
%	O
CI	O
51	O
.	O
9	O
-	O
71	O
.	O
2	O
%	O
)	O
at	O
5	O
-	O
12	O
days	O
,	O
1	O
month	O
,	O
3	O
months	O
and	O
6	O
months	O
post	O
treatment	O
.	O

The	O
microbiological	O
eradication	O
rate	O
according	O
to	O
evaluation	O
scheme	O
II	O
was	O
82	O
/	O
98	O
(	O
83	O
.	O
7	O
%	O
,	O
95	O
%	O
CI	O
74	O
.	O
8	O
-	O
90	O
.	O
4	O
%	O
)	O
at	O
1	O
month	O
and	O
the	O
continued	O
eradication	O
rate	O
was	O
52	O
/	O
57	O
(	O
91	O
.	O
2	O
%	O
,	O
95	O
%	O
CI	O
80	O
.	O
7	O
-	O
97	O
.	O
1	O
%	O
)	O
at	O
6	O
months	O
post	O
treatment	O
.	O

Comparison	O
of	O
four	O
classification	O
schemes	O
showed	O
similar	O
results	O
.	O

Thus	O
,	O
the	O
present	O
investigation	O
is	O
suitably	O
comparable	O
in	O
methods	O
and	O
results	O
to	O
previous	O
studies	O
.	O

Levofloxacin	O
was	O
well	O
tolerated	O
.	O

Four	O
patients	O
(	O
3	O
.	O
4	O
%	O
)	O
discontinued	O
therapy	O
due	O
to	O
adverse	O
events	O
and	O
15	O
patients	O
(	O
12	O
.	O
8	O
%	O
)	O
experienced	O
at	O
least	O
one	O
adverse	O
event	O
.	O

Levofloxacin	O
500	O
mg	O
p	O
.	O
o	O
.	O
once	O
daily	O
for	O
28	O
days	O
is	O
clinically	O
and	O
microbiologically	O
effective	O
in	O
the	O
treatment	O
of	O
CBP	O
caused	O
by	O
susceptible	O
pathogens	O
and	O
is	O
well	O
tolerated	O
.	O

Hydroxychavicol	O
isolated	O
from	O
the	O
chloroform	O
extraction	O
of	O
aqueous	O
extract	O
of	O
Piper	O
betle	O
leaves	O
showed	O
inhibitory	O
activity	O
against	O
oral	O
cavity	O
pathogens	O
.	O

It	O
exhibited	O
an	O
inhibitory	O
effect	O
on	O
all	O
of	O
the	O
oral	O
cavity	O
pathogens	O
tested	O
(	O
MICs	O
of	O
62	O
.	O
5	O
to	O
500	O
microg	O
/	O
ml	O
)	O
with	O
a	O
minimal	O
bactericidal	O
concentration	O
that	O
was	O
twofold	O
greater	O
than	O
the	O
inhibitory	O
concentration	O
.	O

Hydroxychavicol	O
exhibited	O
concentration	O
-	O
dependent	O
killing	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
up	O
to	O
4x	O
MIC	O
and	O
also	O
prevented	O
the	O
formation	O
of	O
water	O
-	O
insoluble	O
glucan	O
.	O

Interestingly	O
,	O
hydroxychavicol	O
exhibited	O
an	O
extended	O
postantibiotic	O
effect	O
of	O
6	O
to	O
7	O
h	O
and	O
prevented	O
the	O
emergence	O
of	O
mutants	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
and	O
Actinomyces	B-bacteria
viscosus	I-bacteria
ATCC	I-bacteria
15987	I-bacteria
at	O
2x	O
MIC	O
.	O

Furthermore	O
,	O
it	O
also	O
inhibited	O
the	O
growth	O
of	O
biofilms	O
generated	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
and	O
reduced	O
the	O
preformed	O
biofilms	O
by	O
these	O
bacteria	O
.	O

Increased	O
uptake	O
of	O
propidium	O
iodide	O
by	O
hydroxychavicol	O
-	O
treated	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
indicated	O
that	O
hydroxychavicol	O
probably	O
works	O
through	O
the	O
disruption	O
of	O
the	O
permeability	O
barrier	O
of	O
microbial	O
membrane	O
structures	O
.	O

Hydroxychavicol	O
also	O
exhibited	O
potent	O
antioxidant	O
and	O
anti	O
-	O
inflammatory	O
activities	O
.	O

This	O
was	O
evident	O
from	O
its	O
concentration	O
-	O
dependent	O
inhibition	O
of	O
lipid	O
peroxidation	O
and	O
significant	O
suppression	O
of	O
tumor	O
necrosis	O
factor	O
alpha	O
expression	O
in	O
human	O
neutrophils	O
.	O

Its	O
efficacy	O
against	O
adherent	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
water	O
-	O
insoluble	O
glucan	O
in	O
the	O
presence	O
of	O
sucrose	O
suggests	O
that	O
hydroxychavicol	O
would	O
be	O
a	O
useful	O
compound	O
for	O
the	O
development	O
of	O
antibacterial	O
agents	O
against	O
oral	O
pathogens	O
and	O
that	O
it	O
has	O
great	O
potential	O
for	O
use	O
in	O
mouthwash	O
for	O
preventing	O
and	O
treating	O
oral	O
infections	O
.	O

The	O
use	O
of	O
probiotic	O
bacteria	O
is	O
increasing	O
worldwide	O
and	O
at	O
least	O
some	O
of	O
them	O
can	O
transiently	O
colonize	O
the	O
oral	O
cavity	O
.	O

Several	O
studies	O
have	O
shown	O
that	O
probiotic	O
bacteria	O
,	O
which	O
are	O
often	O
thought	O
of	O
in	O
relation	O
only	O
to	O
intestinal	O
health	O
,	O
can	O
also	O
affect	O
the	O
oral	O
ecology	O
,	O
but	O
the	O
mechanisms	O
for	O
this	O
are	O
largely	O
unknown	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
in	O
vitro	O
if	O
the	O
probiotic	O
bacteria	O
used	O
in	O
commercial	O
products	O
affect	O
the	O
protein	O
composition	O
of	O
the	O
salivary	O
pellicle	O
and	O
the	O
adherence	O
of	O
other	O
oral	O
bacteria	O
.	O

salivary	O
pellicle	O
on	O
hydroxyapatite	O
and	O
the	O
adhesion	O
of	O
two	O
oral	O
streptococci	B-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
were	O
used	O
as	O
a	O
model	O
.	O

Probiotic	O
bacteria	O
that	O
bound	O
to	O
saliva	O
-	O
coated	O
hydroxyapatite	O
reduced	O
the	O
adhesion	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
but	O
the	O
inhibitory	O
effect	O
on	O
the	O
adherence	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
was	O
weaker	O
.	O

salivary	O
pellicle	O
protein	O
composition	O
was	O
modified	O
by	O
all	O
the	O
strains	O
tested	O
.	O

The	O
modifications	O
in	O
the	O
pellicle	O
affected	O
the	O
adherence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
but	O
not	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

Two	O
of	O
the	O
proteins	O
missing	O
from	O
the	O
pellicles	O
made	O
of	O
saliva	O
-	O
treated	O
with	O
the	O
probiotic	O
bacteria	O
were	O
identified	O
as	O
salivary	O
agglutinin	O
gp340	O
and	O
salivary	O
peroxidase	O
.	O

All	O
bacterial	O
strains	O
bound	O
salivary	O
agglutinin	O
gp340	O
.	O

The	O
ability	O
of	O
the	O
probiotic	O
bacteria	O
to	O
degrade	O
peroxidase	O
was	O
demonstrated	O
with	O
purified	O
bovine	O
lactoperoxidase	O
and	O
two	O
of	O
the	O
probiotic	O
strains	O
.	O

This	O
in	O
vitro	O
study	O
showed	O
that	O
probiotic	O
strains	O
used	O
in	O
commercial	O
products	O
may	O
affect	O
the	O
oral	O
ecology	O
by	O
specifically	O
preventing	O
the	O
adherence	O
of	O
other	O
bacteria	O
and	O
by	O
modifying	O
the	O
protein	O
composition	O
of	O
the	O
salivary	O
pellicle	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
characterize	O
a	O
novel	O
conjugative	O
transposon	O
Tn6009	O
composed	O
of	O
a	O
Tn916	O
linked	O
to	O
a	O
Staphylococcus	B-bacteria
aureus	I-bacteria
mer	O
operon	O
in	O
representative	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
isolated	O
in	O
Nigeria	O
and	O
Portugal	O
.	O

Eighty	O
-	O
three	O
Gram	O
-	O
positive	O
and	O
34	O
Gram	O
-	O
negative	O
bacteria	O
were	O
screened	O
for	O
the	O
presence	O
of	O
the	O
Tn6009	O
using	O
DNA	O
-	O
DNA	O
hybridization	O
,	O
PCR	O
,	O
hybridization	O
of	O
PCR	O
products	O
,	O
sequencing	O
and	O
mating	O
experiments	O
by	O
established	O
procedures	O
.	O

Forty	O
-	O
three	O
oral	O
and	O
23	O
urine	O
Gram	O
-	O
negative	O
and	O
Gram	O
-	O
positive	O
isolates	O
carried	O
the	O
Tn6009	O
.	O

Sequencing	O
was	O
performed	O
to	O
verify	O
the	O
direct	O
linkage	O
between	O
the	O
mer	O
resistance	O
genes	O
and	O
the	O
tet	O
(	O
M	O
)	O
gene	O
.	O

A	O
Nigerian	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
isolated	O
from	O
a	O
urinary	O
tract	O
infection	O
patient	O
,	O
and	O
one	O
commensal	O
isolate	O
from	O
each	O
of	O
the	O
other	O
Tn6009	O
-	O
positive	O
genera	O
,	O
Serratia	B-bacteria
liquefaciens	I-bacteria
,	O
Pseudomonas	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Enterococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
isolated	O
from	O
the	O
oral	O
and	O
urine	O
samples	O
of	O
healthy	O
Portuguese	O
children	O
,	O
were	O
able	O
to	O
act	O
as	O
donors	O
and	O
conjugally	O
transfer	O
the	O
Tn6009	O
to	O
the	O
Enterococcus	B-bacteria
faecalis	I-bacteria
JH2	I-bacteria
-	I-bacteria
2	I-bacteria
recipient	O
,	O
resulting	O
in	O
tetracycline	O
-	O
and	O
mercury	O
-	O
resistant	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
transconjugants	O
.	O

This	O
study	O
reports	O
a	O
novel	O
non	O
-	O
composite	O
conjugative	O
transposon	O
Tn6009	O
containing	O
a	O
Tn916	O
element	O
linked	O
to	O
an	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
mer	O
operon	O
carrying	O
genes	O
coding	O
for	O
inorganic	O
mercury	O
resistance	O
(	O
merA	O
)	O
,	O
an	O
organic	O
mercury	O
resistance	O
(	O
merB	O
)	O
,	O
a	O
regulatory	O
protein	O
(	O
merR	O
)	O
and	O
a	O
mercury	O
transporter	O
(	O
merT	O
)	O
.	O

This	O
transposon	O
was	O
identified	O
in	O
66	O
isolates	O
from	O
two	O
Gram	O
-	O
positive	O
and	O
three	O
Gram	O
-	O
negative	O
genera	O
and	O
is	O
the	O
first	O
transposon	O
in	O
the	O
Tn916	O
family	O
to	O
carry	O
the	O
Gram	O
-	O
positive	O
mer	O
genes	O
directly	O
linked	O
to	O
the	O
tet	O
(	O
M	O
)	O
gene	O
.	O

Bacterial	O
vaginosis	O
frequently	O
persists	O
after	O
treatment	O
.	O

The	O
role	O
of	O
newly	O
defined	O
bacterial	O
vaginosis	O
-	O
associated	O
bacteria	O
(	O
BVAB	O
)	O
,	O
which	O
have	O
a	O
specificity	O
for	O
this	O
condition	O
of	O
97	O
%	O
or	O
greater	O
,	O
has	O
not	O
been	O
assessed	O
.	O

To	O
define	O
risks	O
for	O
bacterial	O
vaginosis	O
persistence	O
,	O
including	O
pretreatment	O
detection	O
of	O
specific	O
vaginal	O
bacteria	O
,	O
among	O
women	O
reporting	O
sex	O
with	O
women	O
.	O

Observational	O
cohort	O
study	O
.	O

University	O
-	O
based	O
research	O
clinic	O
.	O

335	O
women	O
age	O
16	O
to	O
29	O
years	O
reporting	O
sex	O
with	O
at	O
least	O
1	O
woman	O
in	O
the	O
past	O
year	O
.	O

Participants	O
were	O
recruited	O
through	O
advertisements	O
and	O
provider	O
referral	O
.	O

Bacterial	O
vaginosis	O
was	O
treated	O
with	O
intravaginal	O
metronidazole	O
gel	O
(	O
0	O
.	O
75	O
%	O
)	O
,	O
37	O
.	O
5	O
mg	O
nightly	O
for	O
5	O
nights	O
.	O

Species	O
-	O
specific	O
16S	O
recombinant	O
DNA	O
polymerase	O
chain	O
reaction	O
assays	O
targeting	O
17	O
bacterial	O
species	O
were	O
applied	O
to	O
vaginal	O
fluid	O
obtained	O
at	O
baseline	O
.	O

Test	O
of	O
cure	O
by	O
clinical	O
criteria	O
and	O
Gram	O
stain	O
analysis	O
and	O
repeated	O
polymerase	O
chain	O
reaction	O
assays	O
of	O
vaginal	O
fluid	O
were	O
performed	O
1	O
month	O
after	O
treatment	O
,	O
and	O
interim	O
behaviors	O
were	O
assessed	O
by	O
using	O
computer	O
-	O
assisted	O
self	O
-	O
interview	O
.	O

Of	O
335	O
women	O
,	O
24	O
%	O
of	O
whom	O
also	O
reported	O
sex	O
with	O
men	O
within	O
3	O
months	O
before	O
enrollment	O
,	O
131	O
(	O
39	O
%	O
)	O
had	O
bacterial	O
vaginosis	O
.	O

In	O
the	O
120	O
(	O
92	O
%	O
)	O
women	O
who	O
returned	O
for	O
follow	O
-	O
up	O
,	O
the	O
incidence	O
of	O
persistent	O
bacterial	O
vaginosis	O
was	O
26	O
%	O
and	O
was	O
statistically	O
significantly	O
higher	O
in	O
women	O
with	O
baseline	O
detection	O
of	O
3	O
Clostridiales	B-bacteria
bacteria	I-bacteria
,	O
designated	O
as	O
BVAB1	O
(	O
risk	O
ratio	O
,	O
2	O
.	O
0	O
[	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
to	O
4	O
.	O
0	O
]	O
)	O
,	O
BVAB2	O
(	O
risk	O
ratio	O
,	O
8	O
.	O
7	O
[	O
CI	O
,	O
2	O
.	O
5	O
to	O
infinity	O
]	O
)	O
,	O
or	O
BVAB3	O
(	O
risk	O
ratio	O
,	O
3	O
.	O
1	O
[	O
CI	O
,	O
1	O
.	O
7	O
to	O
5	O
.	O
8	O
]	O
)	O
;	O
Peptoniphilus	B-bacteria
lacrimalis	I-bacteria
(	O
risk	O
ratio	O
,	O
3	O
.	O
5	O
[	O
CI	O
,	O
1	O
.	O
6	O
to	O
15	O
.	O
5	O
]	O
)	O
;	O
and	O
Megasphaera	B-bacteria
phylotype	I-bacteria
2	I-bacteria
(	O
risk	O
ratio	O
,	O
3	O
.	O
4	O
[	O
CI	O
,	O
1	O
.	O
4	O
to	O
5	O
.	O
5	O
]	O
)	O
.	O

Persistence	O
was	O
lower	O
with	O
treatment	O
adherence	O
(	O
risk	O
ratio	O
,	O
0	O
.	O
4	O
[	O
0	O
.	O
2	O
to	O
0	O
.	O
9	O
]	O
)	O
.	O

Detection	O
of	O
these	O
bacteria	O
at	O
the	O
test	O
-	O
of	O
-	O
cure	O
visit	O
was	O
associated	O
with	O
persistence	O
,	O
whereas	O
posttreatment	O
sexual	O
activity	O
was	O
not	O
.	O

LIMITATIONS	O
:	O
Findings	O
may	O
not	O
be	O
generalizable	O
to	O
women	O
who	O
have	O
sex	O
only	O
with	O
men	O
,	O
or	O
to	O
women	O
whose	O
bacterial	O
vaginosis	O
is	O
treated	O
with	O
oral	O
antibiotics	O
.	O

The	O
study	O
may	O
be	O
too	O
small	O
and	O
may	O
involve	O
a	O
population	O
that	O
is	O
too	O
highly	O
selected	O
to	O
draw	O
definitive	O
conclusions	O
about	O
associations	O
of	O
persistent	O
infection	O
with	O
posttreatment	O
sexual	O
behaviors	O
.	O

Persistent	O
bacterial	O
vaginosis	O
is	O
associated	O
with	O
several	O
bacteria	O
in	O
the	O
Clostridiales	B-bacteria
order	O
,	O
Megasphaera	B-bacteria
phylotype	I-bacteria
2	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
lacrimalis	I-bacteria
,	O
suggesting	O
that	O
vaginal	O
microbiology	O
at	O
diagnosis	O
may	O
determine	O
risk	O
for	O
antibiotic	O
failure	O
.	O

The	O
ability	O
of	O
oral	O
bacteria	O
to	O
enter	O
a	O
non	O
-	O
growing	O
state	O
is	O
believed	O
to	O
be	O
an	O
important	O
mechanism	O
for	O
survival	O
in	O
the	O
starved	O
micro	O
-	O
environments	O
of	O
the	O
oral	O
cavity	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
reactivation	O
of	O
nutrient	O
-	O
deprived	O
cells	O
of	O
two	O
oral	O
bacteria	O
in	O
biofilms	O
,	O
Streptococcus	B-bacteria
anginosus	I-bacteria
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
.	O

Non	O
-	O
growing	O
cells	O
were	O
generated	O
by	O
incubation	O
in	O
10	O
mM	O
potassium	O
phosphate	O
buffer	O
for	O
24	O
h	O
and	O
the	O
results	O
were	O
compared	O
to	O
those	O
of	O
planktonic	O
cultures	O
.	O

When	O
both	O
types	O
of	O
cells	O
were	O
shifted	O
from	O
a	O
rich	O
,	O
peptone	O
-	O
yeast	O
extract	O
-	O
glucose	O
(	O
PYG	O
)	O
medium	O
to	O
buffer	O
for	O
24	O
h	O
,	O
dehydrogenase	O
and	O
esterase	O
activity	O
measured	O
by	O
the	O
fluorescent	O
dyes	O
5	O
-	O
cyano	O
-	O
2	O
,	O
3	O
-	O
ditolyl	O
-	O
tetrazolium	O
chloride	O
(	O
CTC	O
)	O
and	O
fluorescein	O
diacetate	O
(	O
FDA	O
)	O
,	O
respectively	O
,	O
was	O
absent	O
in	O
both	O
species	O
.	O

However	O
,	O
the	O
membranes	O
of	O
the	O
vast	O
majority	O
of	O
nutrient	O
-	O
deprived	O
cells	O
remained	O
intact	O
as	O
assessed	O
by	O
LIVE	O
/	O
DEAD	O
staining	O
.	O

Metabolic	O
reactivation	O
of	O
the	O
nutrient	O
-	O
deprived	O
biofilm	O
cells	O
was	O
not	O
observed	O
for	O
at	O
least	O
48	O
h	O
following	O
addition	O
of	O
fresh	O
PYG	O
medium	O
,	O
whereas	O
the	O
non	O
-	O
growing	O
planktonic	O
cultures	O
of	O
the	O
same	O
two	O
strains	O
were	O
in	O
rapid	O
growth	O
in	O
less	O
than	O
2	O
h	O
.	O
At	O
72	O
h	O
,	O
the	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
biofilm	O
cells	O
had	O
recovered	O
78	O
%	O
of	O
the	O
dehydrogenase	O
activity	O
and	O
61	O
%	O
of	O
the	O
esterase	O
activity	O
and	O
the	O
biomass	O
mm	O
(	O
-	O
2	O
)	O
had	O
increased	O
by	O
30	O
-	O
35	O
%	O
.	O

With	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
at	O
72	O
h	O
,	O
the	O
biofilms	O
had	O
recovered	O
56	O
%	O
and	O
75	O
%	O
of	O
dehydrogenase	O
and	O
esterase	O
activity	O
,	O
respectively	O
.	O

Reactivation	O
of	O
both	O
species	O
in	O
biofilms	O
was	O
enhanced	O
by	O
removal	O
of	O
glucose	O
from	O
PYG	O
,	O
and	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
cells	O
were	O
particularly	O
responsive	O
to	O
yeast	O
extract	O
(	O
YE	O
)	O
medium	O
.	O

The	O
data	O
suggest	O
that	O
the	O
low	O
reactivity	O
of	O
non	O
-	O
growing	O
biofilm	O
cells	O
to	O
the	O
introduction	O
of	O
fresh	O
nutrients	O
may	O
be	O
a	O
survival	O
strategy	O
employed	O
by	O
micro	O
-	O
organisms	O
in	O
the	O
oral	O
cavity	O
.	O

Many	O
neuropeptides	O
are	O
similar	O
in	O
size	O
,	O
amino	O
acid	O
composition	O
and	O
charge	O
to	O
antimicrobial	O
peptides	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
whether	O
the	O
neuropeptides	O
substance	O
P	O
(	O
SP	O
)	O
,	O
neurokinin	O
A	O
(	O
NKA	O
)	O
,	O
calcitonin	O
gene	O
-	O
related	O
peptide	O
(	O
CGRP	O
)	O
,	O
neuropeptide	O
Y	O
(	O
NPY	O
)	O
and	O
vasoactive	O
intestinal	O
polypeptide	O
(	O
VIP	O
)	O
,	O
displayed	O
antimicrobial	O
activity	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Candida	O
albicans	O
.	O

SP	O
,	O
NPY	O
,	O
VIP	O
and	O
CGRP	O
displayed	O
variable	O
degrees	O
of	O
antimicrobial	O
activity	O
against	O
all	O
the	O
pathogens	O
tested	O
with	O
the	O
exception	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
.	O

These	O
antimicrobial	O
activities	O
add	O
a	O
further	O
dimension	O
to	O
the	O
immunomodulatory	O
roles	O
for	O
neuropeptides	O
in	O
the	O
inflammatory	O
and	O
immune	O
responses	O
.	O

Glucosyltransferases	O
(	O
GTF	O
)	O
play	O
an	O
important	O
role	O
in	O
the	O
adherence	O
of	O
bacteria	O
to	O
acquired	O
pellicle	O
.	O

Cocoa	O
bean	O
husk	O
extract	O
(	O
CBHE	O
)	O
has	O
been	O
shown	O
to	O
possess	O
anti	O
-	O
glucosyltransferase	O
and	O
antibacterial	O
activity	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
effect	O
of	O
CBHE	O
on	O
plaque	O
accumulation	O
and	O
mutans	B-bacteria
streptococcus	I-bacteria
count	O
when	O
used	O
as	O
a	O
mouth	O
rinse	O
by	O
children	O
.	O

Scaling	O
of	O
the	O
teeth	O
of	O
the	O
selected	O
children	O
was	O
done	O
and	O
the	O
children	O
were	O
instructed	O
to	O
refrain	O
from	O
their	O
routine	O
oral	O
hygiene	O
practices	O
till	O
the	O
morning	O
of	O
the	O
fourth	O
day	O
;	O
they	O
were	O
instead	O
given	O
a	O
placebo	O
mouth	O
rinse	O
for	O
use	O
during	O
this	O
period	O
.	O

On	O
the	O
fourth	O
day	O
,	O
saliva	O
was	O
collected	O
from	O
each	O
subject	O
for	O
microbiological	O
analysis	O
and	O
plaque	O
was	O
disclosed	O
and	O
scored	O
using	O
the	O
modified	O
Quigley	O
and	O
Hein	O
plaque	O
index	O
;	O
later	O
,	O
the	O
teeth	O
were	O
cleaned	O
.	O

After	O
1	O
week	O
,	O
scaling	O
of	O
the	O
subjects	O
was	O
done	O
and	O
they	O
were	O
given	O
CBHE	O
mouth	O
rinse	O
to	O
rinse	O
their	O
mouth	O
,	O
following	O
the	O
above	O
protocol	O
.	O

The	O
data	O
was	O
statistically	O
analyzed	O
using	O
Wilcoxon	O
'	O
s	O
signed	O
rank	O
test	O
.	O

There	O
was	O
a	O
20	O
.	O
9	O
%	O
decrease	O
in	O
mutans	B-bacteria
streptococci	I-bacteria
counts	O
and	O
a	O
49	O
.	O
6	O
%	O
decrease	O
in	O
plaque	O
scores	O
in	O
the	O
CBHE	O
group	O
as	O
compared	O
to	O
the	O
placebo	O
group	O
,	O
which	O
was	O
highly	O
significant	O
(	O
P	O
value	O
Conclusion	O
:	O
CBHE	O
is	O
highly	O
effective	O
in	O
reducing	O
mutans	B-bacteria
streptococci	I-bacteria
counts	O
and	O
plaque	O
deposition	O
when	O
used	O
as	O
a	O
mouth	O
rinse	O
by	O
children	O
.	O

People	O
living	O
without	O
piped	O
water	O
and	O
sewer	O
can	O
be	O
at	O
increased	O
risk	O
for	O
diseases	O
transmitted	O
via	O
the	O
fecal	O
-	O
oral	O
route	O
.	O

One	O
rural	O
Alaskan	O
community	O
that	O
relies	O
on	O
hauling	O
water	O
into	O
homes	O
and	O
sewage	O
from	O
homes	O
was	O
studied	O
to	O
determine	O
the	O
pathways	O
of	O
fecal	O
contamination	O
of	O
drinking	O
water	O
and	O
the	O
human	O
environment	O
so	O
that	O
barriers	O
can	O
be	O
established	O
to	O
protect	O
health	O
.	O

Samples	O
were	O
tested	O
for	O
the	O
fecal	O
indicator	O
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
and	O
the	O
less	O
specific	O
indicator	O
group	O
,	O
total	O
coliforms	B-bacteria
.	O

Shoes	O
transported	O
fecal	O
contamination	O
from	O
outside	O
to	O
floor	O
material	O
inside	O
buildings	O
.	O

Contamination	O
in	O
puddles	O
on	O
the	O
road	O
,	O
in	O
conjunction	O
with	O
contamination	O
found	O
on	O
all	O
-	O
terrain	O
vehicle	O
(	O
ATV	O
)	O
tires	O
,	O
supports	O
vehicle	O
traffic	O
as	O
a	O
mechanism	O
for	O
transporting	O
contamination	O
from	O
the	O
dumpsite	O
or	O
other	O
source	O
areas	O
to	O
the	O
rest	O
of	O
the	O
community	O
.	O

The	O
abundance	O
of	O
fecal	O
bacteria	O
transported	O
around	O
the	O
community	O
on	O
shoes	O
and	O
ATV	O
tires	O
suggests	O
that	O
centralized	O
measures	O
for	O
waste	O
disposal	O
as	O
well	O
as	O
shoe	O
removal	O
in	O
buildings	O
could	O
improve	O
sanitation	O
and	O
health	O
in	O
the	O
community	O
.	O

Bacterial	O
glycosyltransferases	O
have	O
drawn	O
growing	O
attention	O
as	O
economical	O
enzymes	O
for	O
oligosaccharide	O
synthesis	O
,	O
with	O
their	O
easy	O
expression	O
and	O
relatively	O
broad	O
substrate	O
specificity	O
.	O

Here	O
,	O
we	O
characterized	O
a	O
glycosyltransferase	O
homolog	O
(	O
Fnu	O
_	O
GT	O
)	O
from	O
a	O
human	O
oral	O
pathogen	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Bioinformatic	O
analysis	O
showed	O
that	O
Fnu	O
_	O
GT	O
belongs	O
to	O
the	O
glycosyltransferases	O
family	O
II	O
.	O

The	O
recombinant	O
Fnu	O
_	O
GT	O
(	O
rFnu	O
_	O
GT	O
)	O
expressed	O
in	O
Escherichia	B-bacteria
coli	I-bacteria
displayed	O
the	O
highest	O
glycosylation	O
activity	O
when	O
UDP	O
-	O
galactose	O
(	O
Gal	O
)	O
was	O
used	O
as	O
a	O
donor	O
nucleotide	O
-	O
sugar	O
with	O
heptose	O
or	O
Nacetylglucosamine	O
(	O
GlcNAc	O
)	O
as	O
an	O
acceptor	O
sugar	O
.	O

Interestingly	O
,	O
rFnu	O
_	O
GT	O
transferred	O
the	O
galactose	O
moiety	O
of	O
UDP	O
-	O
Gal	O
to	O
a	O
nonreducing	O
terminal	O
GlcNAc	O
attached	O
to	O
the	O
trimannosyl	O
core	O
glycan	O
,	O
indicating	O
its	O
potential	O
as	O
an	O
enzyme	O
for	O
humantype	O
N	O
-	O
glycan	O
synthesis	O
.	O

The	O
aim	O
of	O
the	O
study	O
is	O
was	O
to	O
evaluate	O
anaerobic	O
periodontal	O
microbes	O
in	O
120	O
postpartum	O
mothers	O
.	O

Group	O
I	O
consisted	O
of	O
mothers	O
with	O
a	O
birth	O
weight	O
of	O
less	O
than	O
2	O
,	O
500g	O
and	O
gestational	O
age	O
<	O
37	O
weeks	O
.	O

Group	O
II	O
included	O
mothers	O
with	O
normal	O
birth	O
weight	O
infants	O
.	O

All	O
women	O
in	O
both	O
of	O
groups	O
were	O
subjected	O
to	O
a	O
full	O
-	O
mouth	O
periodontal	O
examination	O
to	O
determine	O
a	O
periodontal	O
status	O
.	O

The	O
microbial	O
investigation	O
for	O
anaerobic	O
bacteria	O
of	O
deepest	O
periodontal	O
pockets	O
was	O
performed	O
in	O
35	O
cases	O
of	O
periodontits	O
.	O

A	O
significantly	O
higher	O
incidence	O
of	O
preterm	O
low	O
birth	O
weight	O
cases	O
in	O
patiens	O
with	O
periodontitis	O
was	O
documented	O
.	O

In	O
addition	O
higher	O
variety	O
of	O
anaerobic	O
bacteria	O
of	O
periodontal	O
pockets	O
in	O
mothers	O
with	O
preterm	O
low	O
birth	O
weight	O
infants	O
comparison	O
to	O
control	O
group	O
was	O
observed	O
.	O

Genes	O
encoding	O
virulence	O
determinants	O
are	O
transferred	O
between	O
species	O
in	O
many	O
different	O
environments	O
.	O

In	O
this	O
review	O
we	O
describe	O
gene	O
transfer	O
events	O
to	O
and	O
from	O
different	O
species	O
of	O
bacteria	O
,	O
from	O
bacteria	O
to	O
plants	O
,	O
and	O
from	O
plants	O
to	O
bacteria	O
.	O

Examples	O
of	O
the	O
setting	O
for	O
these	O
transfer	O
events	O
include	O
:	O
the	O
GI	O
tract	O
,	O
the	O
rumen	O
,	O
the	O
oral	O
cavity	O
,	O
and	O
in	O
food	O
matrixes	O
.	O

As	O
a	O
case	O
study	O
,	O
the	O
flux	O
of	O
virulence	O
factors	O
from	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
O157	I-bacteria
:	I-bacteria
H7	I-bacteria
is	O
described	O
as	O
an	O
example	O
of	O
gene	O
flow	O
in	O
the	O
environment	O
.	O

Implants	O
showing	O
signs	O
of	O
peri	O
-	O
implantitis	O
harbor	O
a	O
microbiota	O
similar	O
to	O
that	O
of	O
periodontitis	O
-	O
affected	O
teeth	O
.	O

This	O
case	O
report	O
describes	O
the	O
subgingival	O
microbiota	O
of	O
a	O
45	O
-	O
year	O
-	O
old	O
female	O
with	O
advanced	O
periodontitis	O
before	O
and	O
after	O
complete	O
edentulation	O
and	O
reconstruction	O
with	O
dental	O
implants	O
.	O

A	O
3	O
-	O
month	O
healing	O
period	O
post	O
extraction	O
passed	O
before	O
implants	O
were	O
placed	O
using	O
a	O
two	O
-	O
stage	O
submerged	O
implant	O
protocol	O
.	O

At	O
4	O
-	O
to	O
6	O
-	O
month	O
recall	O
visits	O
after	O
definitive	O
prosthetic	O
reconstruction	O
,	O
some	O
implant	O
sites	O
showed	O
bleeding	O
on	O
probing	O
and	O
localized	O
mucositis	O
.	O

Microbiological	O
culture	O
of	O
three	O
inflamed	O
peri	O
-	O
implant	O
sites	O
showed	O
an	O
almost	O
identical	O
spectrum	O
of	O
pathogens	O
,	O
including	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
other	O
major	O
pathogenic	O
bacteria	O
characteristic	O
of	O
aggressive	O
periodontitis	O
.	O

As	O
natural	O
teeth	O
were	O
absent	O
for	O
8	O
months	O
,	O
this	O
case	O
report	O
suggests	O
that	O
periodontal	O
pathogens	O
can	O
be	O
retained	O
for	O
a	O
prolonged	O
period	O
of	O
time	O
in	O
nondental	O
sites	O
,	O
from	O
where	O
they	O
can	O
later	O
colonize	O
and	O
compromise	O
the	O
health	O
of	O
dental	O
implants	O
.	O

The	O
therapeutic	O
implications	O
of	O
this	O
finding	O
are	O
discussed	O
.	O

Leprosy	O
is	O
a	O
chronic	O
infection	O
caused	O
by	O
Mycobacterium	B-bacteria
leprae	I-bacteria
,	O
a	O
bacillus	O
that	O
presents	O
a	O
peculiar	O
tropism	O
for	O
the	O
skin	O
and	O
peripheral	O
nerves	O
.	O

The	O
clinical	O
spectrum	O
of	O
leprosy	O
ranges	O
from	O
the	O
tuberculoid	O
form	O
(	O
TT	O
)	O
to	O
the	O
disseminative	O
and	O
progressive	O
lepromatous	O
form	O
(	O
LL	O
)	O
.	O

Oral	O
lesions	O
are	O
rare	O
but	O
,	O
when	O
present	O
,	O
occur	O
in	O
the	O
lepromatous	O
form	O
.	O

This	O
article	O
describes	O
the	O
clinical	O
and	O
microscopic	O
findings	O
of	O
three	O
cases	O
of	O
LL	O
with	O
oral	O
manifestations	O
.	O

All	O
patients	O
had	O
the	O
lepromatous	O
form	O
and	O
their	O
leprosy	O
-	O
specific	O
oral	O
lesions	O
occurred	O
in	O
the	O
palate	O
.	O

The	O
diagnosis	O
was	O
based	O
on	O
clinical	O
,	O
serological	O
and	O
histopathological	O
findings	O
,	O
and	O
multidrug	O
therapy	O
for	O
multibacillary	O
leprosy	O
was	O
started	O
and	O
continued	O
for	O
24	O
months	O
.	O

All	O
patients	O
completed	O
treatment	O
,	O
but	O
developed	O
reaction	O
episodes	O
which	O
were	O
treated	O
with	O
prednisone	O
and	O
/	O
or	O
thalidomide	O
.	O

The	O
authors	O
emphasize	O
the	O
importance	O
of	O
oral	O
mucosa	O
evaluation	O
by	O
a	O
dental	O
health	O
professional	O
during	O
patient	O
care	O
since	O
oral	O
lesions	O
may	O
act	O
as	O
a	O
source	O
of	O
infection	O
.	O

Two	O
kaurane	O
diterpenes	O
,	O
ent	O
-	O
kaur	O
-	O
16	O
(	O
17	O
)	O
-	O
en	O
-	O
19	O
-	O
oic	O
acid	O
(	O
KA	O
)	O
and	O
15	O
-	O
beta	O
-	O
isovaleryloxy	O
-	O
ent	O
-	O
kaur	O
-	O
16	O
(	O
17	O
)	O
-	O
en	O
-	O
19	O
-	O
oic	O
acid	O
(	O
KA	O
-	O
Ival	O
)	O
,	O
isolated	O
from	O
Aspilia	O
foliacea	O
,	O
and	O
the	O
methyl	O
ester	O
derivative	O
of	O
KA	O
(	O
KA	O
-	O
Me	O
)	O
were	O
evaluated	O
against	O
oral	O
pathogens	O
.	O

KA	O
was	O
the	O
most	O
active	O
compound	O
,	O
with	O
MIC	O
values	O
of	O
10	O
microg	O
mL	O
(	O
-	O
1	O
)	O
against	O
the	O
following	O
microorganisms	O
:	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
.	O

However	O
,	O
KA	O
did	O
not	O
show	O
significant	O
activity	O
against	O
Streptococcus	B-bacteria
salivarius	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
with	O
MIC	O
values	O
equal	O
to	O
100	O
and	O
200	O
microg	O
mL	O
(	O
-	O
1	O
)	O
,	O
respectively	O
.	O

Our	O
results	O
show	O
that	O
KA	O
has	O
potential	O
to	O
be	O
used	O
as	O
a	O
prototype	O
for	O
the	O
discovery	O
of	O
new	O
effective	O
anti	O
-	O
infection	O
agents	O
against	O
microorganisms	O
responsible	O
for	O
caries	O
and	O
periodontal	O
diseases	O
.	O

Moreover	O
,	O
these	O
results	O
allow	O
to	O
conclude	O
that	O
minor	O
structural	O
differences	O
among	O
these	O
diterpenes	O
significantly	O
influence	O
their	O
antimicrobial	O
activity	O
,	O
bringing	O
new	O
perspectives	O
to	O
studies	O
on	O
the	O
structure	O
-	O
activity	O
relationship	O
of	O
this	O
type	O
of	O
metabolites	O
with	O
respect	O
to	O
caries	O
and	O
periodontal	O
diseases	O
.	O

Ethanol	O
extracts	O
of	O
eight	O
plant	O
species	O
used	O
traditionally	O
in	O
South	O
Africa	O
for	O
the	O
treatment	O
of	O
oral	O
diseases	O
were	O
investigated	O
for	O
in	O
vitro	O
antimicrobial	O
activity	O
against	O
oral	O
pathogens	O
namely	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Candida	O
albicans	O
,	O
Porphyromonus	B-bacteria
gingivalis	I-bacteria
,	O
Privotella	B-bacteria
intermedia	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
using	O
the	O
disk	O
diffusion	O
method	O
.	O

Minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
and	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
of	O
ethanol	O
extracts	O
were	O
determined	O
against	O
these	O
microorganisms	O
using	O
micro	O
dilution	O
.	O

The	O
cytotoxicity	O
and	O
therapeutic	O
index	O
(	O
TI	O
)	O
of	O
selected	O
active	O
extracts	O
were	O
also	O
determined	O
.	O

Out	O
of	O
eight	O
plants	O
,	O
six	O
(	O
Annona	O
senegalensis	O
,	O
Englerophytum	O
magalismontanum	O
,	O
Dicerocarym	O
senecioides	O
,	O
Euclea	O
divinorum	O
,	O
Euclea	O
natalensis	O
,	O
Solanum	O
panduriforme	O
and	O
Parinari	O
curatellifolia	O
)	O
exhibited	O
MIC	O
values	O
ranging	O
from	O
25	O
.	O
0	O
mg	O
/	O
ml	O
to	O
0	O
.	O
8	O
mg	O
/	O
ml	O
.	O

Gram	O
negative	O
bacteria	O
were	O
found	O
to	O
be	O
more	O
resistant	O
to	O
the	O
plant	O
extracts	O
than	O
Gram	O
positive	O
bacteria	O
,	O
except	O
for	O
Euclea	O
natalensis	O
which	O
inhibited	O
all	O
three	O
Gram	O
negative	O
bacteria	O
tested	O
in	O
this	O
study	O
.	O

All	O
plant	O
extracts	O
showed	O
moderate	O
cytotoxicity	O
on	O
the	O
Vero	O
cell	O
line	O
.	O

The	O
fifty	O
percent	O
inhibitory	O
concentration	O
(	O
IC	O
(	O
50	O
)	O
)	O
of	O
all	O
plants	O
tested	O
range	O
from	O
92	O
.	O
3	O
to	O
285	O
.	O
1	O
microg	O
/	O
ml	O
.	O

Mucosal	O
surfaces	O
are	O
the	O
primary	O
oral	O
reservoirs	O
of	O
Candida	O
species	O
,	O
but	O
these	O
species	O
can	O
also	O
be	O
found	O
in	O
subgingival	O
biofilm	O
.	O

The	O
present	O
study	O
investigated	O
the	O
genetic	O
diversity	O
and	O
production	O
of	O
exoenzymes	O
of	O
C	O
.	O
albicans	O
and	O
C	O
.	O
dubliniensis	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
systemically	O
healthy	O
patients	O
with	O
periodontitis	O
.	O

Fifty	O
-	O
three	O
patients	O
were	O
analysed	O
.	O

Samples	O
were	O
collected	O
from	O
three	O
oral	O
cavity	O
sites	O
(	O
periodontal	O
pocket	O
,	O
gingival	O
sulci	O
and	O
oral	O
mucosa	O
)	O
,	O
plated	O
and	O
,	O
after	O
isolation	O
,	O
suspect	O
strains	O
of	O
C	O
.	O
albicans	O
and	O
C	O
.	O
dubliniensis	O
were	O
identified	O
by	O
PCR	O
.	O

The	O
genetic	O
diversity	O
of	O
the	O
isolates	O
was	O
evaluated	O
by	O
RAPD	O
and	O
the	O
activities	O
of	O
the	O
secreted	O
aspartyl	O
proteinases	O
and	O
phospholipases	O
were	O
evaluated	O
by	O
the	O
agar	O
plate	O
method	O
.	O

Twenty	O
-	O
one	O
patients	O
showed	O
positive	O
results	O
for	O
Candida	O
spp	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
genders	O
,	O
or	O
between	O
sites	O
.	O

C	O
.	O
albicans	O
was	O
the	O
most	O
frequently	O
found	O
specie	O
,	O
while	O
C	O
.	O
dubliniensis	O
was	O
isolated	O
from	O
the	O
periodontal	O
pocket	O
of	O
only	O
one	O
patient	O
.	O

Sixteen	O
genotypes	O
were	O
detected	O
among	O
the	O
C	O
.	O
albicans	O
isolates	O
,	O
and	O
one	O
among	O
the	O
C	O
.	O
dubliniensis	O
isolates	O
.	O

The	O
similarity	O
coefficient	O
(	O
S	O
(	O
SM	O
)	O
)	O
values	O
among	O
the	O
C	O
.	O
albicans	O
genotypes	O
ranged	O
from	O
0	O
.	O
684	O
to	O
1	O
.	O
0	O
with	O
an	O
average	O
of	O
0	O
.	O
905	O
+	O
/	O
-	O
0	O
.	O
074	O
.	O

All	O
isolates	O
produced	O
high	O
levels	O
of	O
Saps	O
and	O
most	O
of	O
them	O
produced	O
high	O
levels	O
of	O
phospholipases	O
.	O

No	O
relationship	O
was	O
found	O
between	O
the	O
genotypes	O
and	O
the	O
pattern	O
of	O
enzymatic	O
production	O
.	O

There	O
was	O
no	O
association	O
between	O
specific	O
genotypes	O
and	O
their	O
site	O
of	O
isolation	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
suggest	O
that	O
genetically	O
homogeneous	O
strains	O
of	O
C	O
.	O
albicans	O
are	O
present	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
periodontitis	O
and	O
that	O
these	O
strains	O
are	O
capable	O
of	O
producing	O
high	O
levels	O
of	O
exoenzyme	O
.	O

The	O
chewing	O
stick	O
(	O
miswak	O
)	O
is	O
used	O
for	O
oral	O
hygiene	O
in	O
many	O
parts	O
of	O
the	O
world	O
.	O

In	O
addition	O
to	O
the	O
mechanical	O
removal	O
of	O
plaque	O
,	O
an	O
antibacterial	O
effect	O
has	O
been	O
postulated	O
;	O
however	O
,	O
tests	O
of	O
miswak	O
extract	O
from	O
Salvadora	O
persica	O
(	O
Arak	O
)	O
disclosed	O
only	O
low	O
to	O
moderate	O
antibacterial	O
effects	O
.	O

This	O
may	O
be	O
attributable	O
to	O
the	O
extraction	O
process	O
.	O

Our	O
aim	O
was	O
to	O
test	O
in	O
vitro	O
the	O
antibacterial	O
effect	O
of	O
miswak	O
pieces	O
,	O
without	O
extraction	O
,	O
on	O
bacteria	O
implicated	O
in	O
the	O
etiology	O
of	O
periodontitis	O
and	O
caries	O
.	O

Miswak	O
pieces	O
were	O
standardized	O
by	O
size	O
and	O
weight	O
(	O
0	O
.	O
07	O
and	O
0	O
.	O
14	O
g	O
)	O
and	O
tested	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
,	O
as	O
a	O
reference	O
,	O
Haemophilus	B-bacteria
influenzae	I-bacteria
.	O

The	O
miswak	O
pieces	O
were	O
tested	O
in	O
two	O
ways	O
:	O
embedded	O
in	O
the	O
agar	O
plate	O
or	O
suspended	O
above	O
the	O
agar	O
plate	O
.	O

The	O
inhibitory	O
effect	O
was	O
most	O
pronounced	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
H	B-bacteria
.	I-bacteria
influenzae	I-bacteria
,	O
less	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
least	O
on	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

Suspended	O
miswak	O
had	O
comparable	O
or	O
stronger	O
effects	O
than	O
miswak	O
embedded	O
in	O
agar	O
.	O

The	O
0	O
.	O
14	O
-	O
g	O
suspended	O
miswak	O
exhibited	O
significantly	O
greater	O
inhibition	O
on	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
H	B-bacteria
.	I-bacteria
influenzae	I-bacteria
than	O
the	O
0	O
.	O
14	O
-	O
g	O
miswak	O
embedded	O
in	O
agar	O
(	O
P	O
<	O
0	O
.	O
01	O
and	O
P	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
.	O

Miswak	O
embedded	O
in	O
agar	O
or	O
suspended	O
above	O
the	O
agar	O
plate	O
had	O
strong	O
antibacterial	O
effects	O
against	O
all	O
bacteria	O
tested	O
.	O

The	O
antibacterial	O
effect	O
of	O
suspended	O
miswak	O
pieces	O
suggests	O
the	O
presence	O
of	O
volatile	O
active	O
antibacterial	O
compounds	O
.	O

Three	O
strains	O
of	O
anaerobic	O
,	O
variably	O
pigmenting	O
,	O
Gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
human	O
oral	O
mucosal	O
tissue	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
and	O
DNA	O
-	O
DNA	O
hybridization	O
revealed	O
that	O
the	O
strains	O
constituted	O
a	O
novel	O
group	O
within	O
the	O
genus	O
Prevotella	B-bacteria
,	O
being	O
most	O
closely	O
related	O
to	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
and	O
Prevotella	B-bacteria
veroralis	I-bacteria
.	O

A	O
novel	O
species	O
,	O
Prevotella	B-bacteria
histicola	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
to	O
accommodate	O
these	O
strains	O
.	O

Prevotella	B-bacteria
histicola	I-bacteria
is	O
saccharolytic	O
and	O
produces	O
acetic	O
acid	O
and	O
succinic	O
acid	O
as	O
major	O
end	O
products	O
of	O
fermentation	O
and	O
trace	O
to	O
minor	O
amounts	O
of	O
isovaleric	O
acid	O
and	O
lactic	O
acid	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
the	O
type	O
strain	O
is	O
43	O
mol	O
%	O
.	O

The	O
type	O
strain	O
of	O
Prevotella	B-bacteria
histicola	I-bacteria
is	O
T05	B-bacteria
-	I-bacteria
04T	I-bacteria
(	O
=	O
DSM	B-bacteria
19854T	I-bacteria
=	O
CCUG	B-bacteria
55407T	I-bacteria
)	O
.	O

There	O
is	O
now	O
strong	O
evidence	O
that	O
probiotic	O
bacteria	O
can	O
regulate	O
inflammatory	O
immune	O
responses	O
.	O

Here	O
,	O
we	O
analyzed	O
whether	O
oral	O
supplementation	O
with	O
the	O
probiotic	O
bacterial	O
strain	O
Lactobacillus	B-bacteria
johnsonii	I-bacteria
(	O
La1	B-bacteria
)	O
could	O
interfere	O
with	O
skin	O
immune	O
status	O
following	O
UV	O
exposure	O
.	O

A	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
controlled	O
clinical	O
trial	O
was	O
conducted	O
with	O
54	O
healthy	O
volunteers	O
receiving	O
either	O
La1	B-bacteria
or	O
placebo	O
,	O
during	O
six	O
weeks	O
prior	O
to	O
solar	O
-	O
simulated	O
UV	O
irradiation	O
.	O

Blister	O
roofs	O
and	O
skin	O
biopsies	O
were	O
recovered	O
1	O
,	O
4	O
and	O
10	O
days	O
after	O
UV	O
exposure	O
from	O
un	O
-	O
irradiated	O
and	O
irradiated	O
skin	O
and	O
used	O
for	O
immunohistochemical	O
analysis	O
and	O
mixed	O
epidermal	O
cell	O
lymphocyte	O
reaction	O
(	O
MECLR	O
)	O
,	O
respectively	O
.	O

La1	B-bacteria
supplementation	O
did	O
not	O
prevent	O
the	O
UV	O
-	O
induced	O
phenotypic	O
maturation	O
of	O
Langerhans	O
cells	O
(	O
LCs	O
)	O
or	O
the	O
decrease	O
in	O
MECLR	O
in	O
irradiated	O
skin	O
samples	O
,	O
one	O
day	O
post	O
-	O
irradiation	O
.	O

On	O
day	O
4	O
,	O
MECLR	O
was	O
still	O
decreased	O
in	O
the	O
placebo	O
group	O
,	O
with	O
a	O
parallel	O
reduction	O
in	O
the	O
CD1a	O
LC	O
marker	O
in	O
irradiated	O
epidermis	O
.	O

In	O
contrast	O
,	O
the	O
allostimulatory	O
capacity	O
of	O
epidermal	O
cells	O
was	O
totally	O
recovered	O
in	O
the	O
La1	B-bacteria
group	O
correlating	O
with	O
the	O
normalization	O
of	O
CD1a	O
expression	O
within	O
the	O
epidermis	O
.	O

For	O
the	O
first	O
time	O
,	O
the	O
results	O
provide	O
evidence	O
that	O
ingested	O
probiotic	O
bacteria	O
accelerate	O
the	O
recovery	O
of	O
skin	O
immune	O
homeostasis	O
after	O
UV	O
-	O
induced	O
immunosuppression	O
.	O

The	O
oral	O
cavity	O
has	O
been	O
suspected	O
as	O
an	O
extra	O
-	O
gastroduodenal	O
reservoir	O
for	O
Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
and	O
transmission	O
,	O
but	O
conflicting	O
evidence	O
exists	O
regarding	O
the	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
mouth	O
,	O
independently	O
of	O
stomach	O
colonization	O
.	O

Ninety	O
-	O
four	O
gastric	O
biopsy	O
patients	O
were	O
analysed	O
for	O
the	O
concurrent	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
mouth	O
and	O
stomach	O
.	O

Samples	O
were	O
collected	O
from	O
different	O
areas	O
within	O
the	O
mouth	O
and	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
DNA	O
was	O
amplified	O
by	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
verified	O
by	O
sequencing	O
.	O

Helicobacter	O
pylori	O
-	O
specific	O
serology	O
was	O
performed	O
,	O
and	O
stomach	O
colonization	O
was	O
determined	O
by	O
culture	O
.	O

In	O
addition	O
,	O
relevant	O
dental	O
and	O
periodontal	O
parameters	O
,	O
as	O
well	O
as	O
general	O
health	O
parameters	O
,	O
were	O
recorded	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
was	O
found	O
in	O
the	O
stomach	O
of	O
29	O
patients	O
and	O
in	O
the	O
oral	O
cavity	O
of	O
16	O
patients	O
.	O

In	O
only	O
six	O
patients	O
was	O
the	O
bacterium	O
detected	O
simultaneously	O
in	O
the	O
stomach	O
and	O
mouth	O
.	O

Notably	O
,	O
the	O
10	O
patients	O
in	O
whom	O
the	O
bacterium	O
was	O
found	O
solely	O
in	O
the	O
mouth	O
did	O
not	O
have	O
serum	O
antibodies	O
to	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

The	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
mouth	O
was	O
found	O
to	O
be	O
correlated	O
neither	O
to	O
any	O
general	O
or	O
oral	O
health	O
parameters	O
,	O
nor	O
to	O
any	O
particular	O
site	O
of	O
collection	O
.	O

This	O
study	O
shows	O
that	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
can	O
occur	O
in	O
the	O
oral	O
cavity	O
independently	O
of	O
stomach	O
colonization	O
.	O

The	O
aim	O
of	O
this	O
randomized	O
double	O
-	O
blinded	O
preliminary	O
study	O
was	O
to	O
evaluate	O
the	O
clinical	O
and	O
microbiological	O
long	O
-	O
term	O
effects	O
of	O
an	O
essential	O
-	O
oil	O
-	O
containing	O
mouth	O
rinse	O
as	O
the	O
active	O
agent	O
utilized	O
in	O
the	O
`	O
`	O
one	O
-	O
stage	O
full	O
-	O
mouth	O
disinfection	O
protocol	O
.	O
'	O
'	O

Probing	O
pocket	O
depth	O
and	O
plaque	O
and	O
gingival	O
indices	O
were	O
evaluated	O
by	O
the	O
same	O
calibrated	O
examiner	O
in	O
all	O
teeth	O
of	O
20	O
moderate	O
chronic	O
periodontitis	O
subjects	O
.	O

Presence	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythensis	I-bacteria
were	O
determined	O
by	O
polymerase	O
chain	O
reaction	O
in	O
nonstimulated	O
saliva	O
,	O
tongue	O
dorsum	O
,	O
and	O
pooled	O
subgingival	O
samples	O
.	O

The	O
subjects	O
were	O
randomized	O
into	O
two	O
groups	O
:	O
full	O
-	O
mouth	O
disinfection	O
plus	O
essential	O
oils	O
(	O
Listerine	O
)	O
or	O
full	O
-	O
mouth	O
disinfection	O
plus	O
placebo	O
.	O

Clinical	O
and	O
microbial	O
parameters	O
were	O
evaluated	O
at	O
baseline	O
(	O
T0	O
)	O
,	O
45	O
(	O
T1	O
)	O
and	O
180	O
(	O
T2	O
)	O
days	O
after	O
therapy	O
and	O
analyzed	O
using	O
analysis	O
of	O
variance	O
,	O
Student	O
t	O
,	O
and	O
Wilcoxon	O
tests	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

No	O
significant	O
differences	O
were	O
observed	O
between	O
groups	O
regarding	O
clinical	O
measurements	O
at	O
baseline	O
.	O

However	O
,	O
in	O
the	O
later	O
examinations	O
,	O
T1	O
and	O
T2	O
,	O
the	O
test	O
group	O
always	O
presented	O
higher	O
reductions	O
of	O
pocket	O
depth	O
,	O
plaque	O
index	O
,	O
and	O
gingival	O
index	O
compared	O
to	O
the	O
control	O
group	O
.	O

The	O
essential	O
-	O
oils	O
group	O
revealed	O
significant	O
reduction	O
on	O
occurrence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
saliva	O
comparing	O
baseline	O
and	O
45	O
days	O
;	O
this	O
difference	O
still	O
remain	O
at	O
180	O
days	O
.	O

The	O
essential	O
-	O
oil	O
-	O
containing	O
mouth	O
rinse	O
demonstrated	O
beneficial	O
effects	O
on	O
clinical	O
parameters	O
.	O

Microbiological	O
findings	O
were	O
less	O
consistent	O
.	O

The	O
results	O
of	O
this	O
preliminary	O
study	O
suggest	O
further	O
investigations	O
.	O

The	O
antimicrobial	O
and	O
biofilm	O
formation	O
preventive	O
properties	O
of	O
Mentha	O
piperita	O
and	O
Rosmarinus	O
officinalis	O
essential	O
oils	O
and	O
chlorhexidine	O
were	O
assessed	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
.	O

26	O
and	O
20	O
compounds	O
were	O
identified	O
by	O
GC	O
and	O
GC	O
-	O
MS	B-bacteria
analysis	O
in	O
hydrodistilled	O
oils	O
from	O
M	O
.	O
piperita	O
and	O
R	O
.	O
officinalis	O
,	O
respectively	O
.	O

The	O
minimal	O
bactericidal	O
concentrations	O
(	O
MBC	O
)	O
of	O
the	O
M	O
.	O
piperita	O
and	O
R	O
.	O
officinalis	O
oils	O
and	O
chlorhexidine	O
were	O
(	O
6000	O
,	O
2000	O
,	O
8000	O
ppm	O
)	O
and	O
(	O
1000	O
,	O
4000	O
,	O
1000	O
ppm	O
)	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
,	O
respectively	O
.	O

The	O
decimal	O
reduction	O
time	O
(	O
D	O
)	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
exposed	O
to	O
the	O
oils	O
at	O
their	O
MBC	O
levels	O
was	O
2	O
.	O
8	O
min	O
while	O
chlorhexidine	O
showed	O
a	O
longer	O
time	O
.	O

The	O
D	O
values	O
of	O
S	B-bacteria
.	I-bacteria
pyogenes	I-bacteria
on	O
exposure	O
to	O
the	O
MBC	O
levels	O
of	O
M	O
.	O
piperita	O
and	O
R	O
.	O
officinalis	O
oils	O
and	O
of	O
chlorhexidine	O
were	O
2	O
.	O
14	O
,	O
4	O
.	O
28	O
and	O
2	O
.	O
8	O
min	O
,	O
indicating	O
a	O
higher	O
efficacy	O
of	O
M	O
.	O
piperita	O
oil	O
.	O

Biofilm	O
formation	O
was	O
performed	O
by	O
growing	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
culture	O
with	O
and	O
without	O
essential	O
oils	O
in	O
LB	B-bacteria
medium	O
in	O
polystyrene	O
tubes	O
.	O

In	O
vitro	O
biofilm	O
inhibitory	O
properties	O
were	O
in	O
the	O
order	O
M	O
.	O
piperita	O
>	O
R	O
.	O
officinalis	O
>	O
chlorhexidine	O
.	O

In	O
vivo	O
experiments	O
on	O
the	O
antibiofilm	O
properties	O
revealed	O
that	O
all	O
concentrations	O
of	O
the	O
oils	O
were	O
significantly	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
more	O
effective	O
than	O
chlorhexidine	O
.	O

In	O
conclusion	O
,	O
essential	O
oils	O
may	O
be	O
considered	O
as	O
safe	O
agents	O
in	O
the	O
development	O
of	O
novel	O
antibiofilm	O
agents	O
.	O

to	O
compare	O
the	O
concentration	O
and	O
serotype	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
in	O
saliva	O
of	O
Down	O
syndrome	O
(	O
DS	O
)	O
,	O
mental	O
retarded	O
(	O
MR	O
)	O
and	O
healthy	O
control	O
(	O
C	O
)	O
individuals	O
of	O
the	O
Region	O
Metropolitana	O
Sur	O
of	O
Santiago	O
of	O
Chile	O
.	O

Hundred	O
and	O
seventy	O
nine	O
male	O
and	O
females	O
children	O
and	O
adolescents	O
,	O
aged	O
between	O
5	O
to	O
19	O
years	O
,	O
59	O
DS	O
,	O
60	O
MR	O
and	O
60	O
C	O
were	O
studied	O
.	O

Saliva	O
samples	O
were	O
cultured	O
in	O
TYCSB	O
agar	O
for	O
quantification	O
,	O
biochemical	O
and	O
serological	O
tests	O
.	O

ANOVA	O
and	O
Chi	O
-	O
square	O
for	O
homogeneity	O
tests	O
were	O
applied	O
.	O

C	O
,	O
DS	O
and	O
MR	O
presented	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
serotypes	O
c	O
,	O
e	O
,	O
f	O
)	O
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
(	O
d	O
,	O
g	O
,	O
h	O
)	O
,	O
but	O
only	O
among	O
DS	O
and	O
MR	O
non	O
-	O
typifiable	O
(	O
No	O
-	O
tip	O
)	O
Streptococcus	B-bacteria
mutans	I-bacteria
were	O
found	O
.	O

MR	O
and	O
DS	O
showed	O
higher	O
bacteria	O
concentration	O
scores	O
than	O
C	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
.	O

Serotypes	O
showed	O
a	O
significant	O
heterogeneity	O
of	O
concentration	O
scores	O
:	O
d	O
,	O
g	O
,	O
h	O
showed	O
the	O
highest	O
and	O
No	O
-	O
tip	O
the	O
lowest	O
one	O
(	O
P	O
=	O
0	O
.	O
037	O
)	O
.	O

No	O
-	O
tip	O
bacteria	O
were	O
absent	O
in	O
C	O
and	O
present	O
in	O
MR	O
and	O
DS	O
;	O
this	O
result	O
indicates	O
different	O
immune	O
and	O
ecological	O
conditions	O
among	O
these	O
human	O
groups	O
.	O

The	O
score	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
in	O
saliva	O
was	O
higher	O
in	O
DS	O
and	O
MR	O
than	O
in	O
C	O
.	O

Probiotics	O
are	O
frequently	O
used	O
for	O
multiple	O
objectives	O
and	O
the	O
majority	O
of	O
applications	O
are	O
performed	O
both	O
in	O
human	O
beings	O
and	O
in	O
different	O
animals	O
.	O

The	O
specificity	O
of	O
species	O
showed	O
by	O
the	O
members	O
of	O
the	O
indigenous	O
microbiotia	O
led	O
us	O
to	O
isolate	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
from	O
their	O
natural	O
bovine	O
ecosystems	O
and	O
to	O
select	O
those	O
with	O
probiotic	O
potentiality	O
.	O

The	O
beneficial	O
probiotic	O
LAB	B-bacteria
were	O
isolated	O
from	O
the	O
vaginal	O
tract	O
and	O
mammary	O
gland	O
of	O
adult	O
heifers	O
,	O
faeces	O
and	O
oral	O
cavity	O
of	O
newborn	O
calves	O
.	O

Bacterial	O
strains	O
and	O
their	O
numbers	O
varied	O
in	O
each	O
tract	O
under	O
study	O
.	O

Their	O
surface	O
properties	O
,	O
evaluated	O
using	O
the	O
MATH	O
test	O
,	O
revealed	O
that	O
the	O
higher	O
number	O
of	O
low	O
hydrophobic	O
strains	O
were	O
isolated	O
from	O
vaginal	O
tract	O
,	O
mammary	O
gland	O
or	O
faeces	O
.	O

The	O
capability	O
of	O
autoaggregation	O
also	O
differed	O
with	O
higher	O
degree	O
in	O
those	O
isolated	O
from	O
vagina	O
,	O
whereas	O
those	O
that	O
originated	O
in	O
the	O
mammary	O
gland	O
or	O
faeces	O
showed	O
low	O
autoaggregation	O
characteristics	O
.	O

The	O
production	O
of	O
antagonistic	O
substances	O
showed	O
that	O
the	O
production	O
of	O
hydrogen	O
peroxide	O
was	O
higher	O
in	O
the	O
strains	O
isolated	O
from	O
the	O
vaginal	O
tract	O
,	O
while	O
those	O
able	O
to	O
produce	O
organic	O
acid	O
were	O
isolated	O
from	O
all	O
the	O
environments	O
.	O

A	O
few	O
strains	O
were	O
able	O
to	O
produce	O
bacteriocins	O
and	O
were	O
isolated	O
only	O
from	O
the	O
mammary	O
gland	O
and	O
faeces	O
,	O
but	O
not	O
from	O
the	O
vaginal	O
tract	O
.	O

Further	O
studies	O
are	O
being	O
performed	O
to	O
complete	O
the	O
functional	O
characterization	O
of	O
the	O
strains	O
in	O
order	O
to	O
evaluate	O
their	O
survival	O
in	O
the	O
environmental	O
conditions	O
of	O
each	O
tract	O
.	O

Finally	O
,	O
the	O
selected	O
strains	O
could	O
be	O
combined	O
for	O
the	O
design	O
of	O
probiotic	O
products	O
to	O
be	O
used	O
both	O
in	O
adult	O
cows	O
and	O
in	O
neonates	O
,	O
based	O
on	O
the	O
host	O
-	O
specificity	O
,	O
due	O
to	O
their	O
autochthonous	O
origin	O
and	O
their	O
potential	O
use	O
in	O
the	O
tract	O
where	O
they	O
were	O
isolated	O
.	O

Human	O
beta	O
-	O
defensin	O
-	O
3	O
(	O
HBD3	O
)	O
,	O
an	O
endogenous	O
antimicrobial	O
peptide	O
,	O
has	O
strong	O
broad	O
-	O
spectrum	O
antimicrobial	O
activity	O
.	O

This	O
study	O
aimed	O
to	O
obtain	O
recombinant	O
HBD3	O
(	O
rHBD3	O
)	O
and	O
to	O
test	O
the	O
hypothesis	O
that	O
the	O
antimicrobial	O
characteristics	O
of	O
HBD3	O
may	O
offer	O
an	O
advantage	O
over	O
conventional	O
medicine	O
in	O
reducing	O
intracanal	O
bacteria	O
.	O

Genetic	O
engineering	O
was	O
used	O
to	O
obtain	O
active	O
rHBD3	O
and	O
analysis	O
revealed	O
that	O
it	O
exhibited	O
a	O
broad	O
spectrum	O
of	O
antibacterial	O
activity	O
at	O
low	O
micromolar	O
concentrations	O
against	O
not	O
only	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Escherichia	B-bacteria
coli	I-bacteria
but	O
also	O
against	O
some	O
critical	O
pathogenic	O
microbes	O
in	O
infected	O
root	O
canals	O
,	O
including	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
Peptostreptococcus	B-bacteria
anaerobius	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Candida	O
albicans	O
.	O

In	O
an	O
in	O
vitro	O
antibacterial	O
experiment	O
,	O
rHBD3	O
significantly	O
eliminated	O
pathogenic	O
bacteria	O
in	O
root	O
canals	O
.	O

The	O
ratio	O
of	O
bacterial	O
death	O
was	O
up	O
to	O
98	O
%	O
.	O

We	O
conclude	O
that	O
HBD3	O
has	O
the	O
potential	O
to	O
eliminate	O
bacteria	O
effectively	O
and	O
rapidly	O
in	O
the	O
local	O
microenvironment	O
of	O
the	O
root	O
canal	O
system	O
and	O
that	O
it	O
may	O
contribute	O
to	O
successful	O
endodontic	O
treatment	O
.	O

To	O
facilitate	O
the	O
identification	O
of	O
anaerobes	O
cultivated	O
from	O
periodontal	O
disease	O
,	O
whole	O
cell	O
bacterial	O
identification	O
by	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
-	O
MS	O
)	O
was	O
evaluated	O
.	O

A	O
total	O
of	O
84	O
strains	O
(	O
nine	O
reference	O
strains	O
and	O
75	O
recent	O
clinical	O
isolates	O
from	O
33	O
patients	O
with	O
aggressive	O
periodontitis	O
)	O
previously	O
identified	O
with	O
phenotypic	O
methods	O
were	O
used	O
.	O

All	O
the	O
references	O
and	O
10	O
clinical	O
isolates	O
belonging	O
to	O
the	O
same	O
species	O
as	O
the	O
reference	O
strains	O
were	O
genotypically	O
identified	O
by	O
sequence	O
analysis	O
of	O
the	O
16S	O
ribosomal	O
RNA	O
gene	O
.	O

All	O
the	O
strains	O
were	O
then	O
analyzed	O
using	O
MALDI	O
-	O
TOF	O
-	O
MS	O
.	O

The	O
reference	O
strains	O
of	O
anaerobic	O
bacteria	O
used	O
showed	O
characteristic	O
MALDI	O
-	O
TOF	O
-	O
MS	O
spectra	O
with	O
peaks	O
between	O
m	O
/	O
z	O
2000	O
and	O
up	O
to	O
about	O
m	O
/	O
z	O
13	O
,	O
000	O
.	O

On	O
visual	O
inspection	O
,	O
the	O
similarity	O
of	O
spectra	O
produced	O
by	O
strains	O
of	O
a	O
single	O
genus	O
could	O
be	O
recognized	O
.	O

Obvious	O
differences	O
between	O
spectra	O
produced	O
by	O
strains	O
of	O
different	O
species	O
were	O
also	O
easily	O
noticed	O
.	O

The	O
reproducibility	O
of	O
the	O
method	O
was	O
proved	O
by	O
the	O
similarity	O
of	O
spectra	O
belonging	O
to	O
the	O
same	O
species	O
.	O

The	O
spectra	O
of	O
the	O
Prevotella	B-bacteria
intermedia	I-bacteria
strains	I-bacteria
identified	O
with	O
MALDI	O
clustered	O
together	O
and	O
clustered	O
separately	O
from	O
the	O
spectra	O
of	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
proving	O
that	O
MALDI	O
-	O
TOF	O
-	O
MS	O
is	O
an	O
accurate	O
method	O
that	O
is	O
capable	O
of	O
separating	O
these	O
two	O
species	O
.	O

The	O
quality	O
of	O
clustering	O
was	O
characterized	O
by	O
calculating	O
an	O
inconsistency	O
coefficient	O
(	O
Our	O
results	O
suggest	O
that	O
MALDI	O
-	O
TOF	O
-	O
MS	O
might	O
become	O
a	O
useful	O
method	O
for	O
the	O
identification	O
of	O
anaerobic	O
bacteria	O
,	O
especially	O
for	O
those	O
that	O
can	O
not	O
be	O
readily	O
identified	O
by	O
biochemical	O
analysis	O
.	O

It	O
may	O
become	O
an	O
attractive	O
system	O
even	O
for	O
the	O
routine	O
identification	O
of	O
clinical	O
isolates	O
.	O

A	O
poorly	O
described	O
bacterium	O
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
has	O
been	O
implicated	O
as	O
an	O
etiological	O
agent	O
of	O
periodontal	O
disease	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
use	O
a	O
comparative	O
genomics	O
approach	O
to	O
identify	O
genes	O
that	O
contribute	O
to	O
the	O
lifestyle	O
of	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
as	O
an	O
oral	O
pathogen	O
.	O

Suppressive	O
subtractive	O
hybridization	O
was	O
used	O
to	O
identify	O
genes	O
encoded	O
by	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
ATCC	I-bacteria
33238	I-bacteria
,	O
but	O
not	O
present	O
in	O
the	O
genome	O
of	O
a	O
related	O
Campylobacter	B-bacteria
species	I-bacteria
,	O
Campylobacter	B-bacteria
jejuni	I-bacteria
ATCC	I-bacteria
11168	I-bacteria
.	O

Suppressive	O
subtractive	O
hybridization	O
identified	O
154	O
unique	O
DNA	O
sequences	O
from	O
the	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
genome	O
.	O

Ninety	O
-	O
two	O
of	O
the	O
154	O
clones	O
were	O
classified	O
as	O
C	O
.	O
rectus	O
-	O
specific	O
,	O
as	O
they	O
did	O
not	O
show	O
significant	O
sequence	O
homology	O
to	O
genes	O
identified	O
in	O
any	O
strain	O
of	O
C	B-bacteria
.	I-bacteria
jejuni	I-bacteria
(	O
blast	O
E	O
-	O
value	O
>	O
1E	O
-	O
3	O
)	O
.	O

blast	O
analysis	O
predicted	O
that	O
the	O
92	O
C	O
.	O
rectus	O
-	O
specific	O
gene	O
fragments	O
play	O
a	O
role	O
in	O
a	O
variety	O
of	O
biological	O
processes	O
including	O
signal	O
transduction	O
mechanisms	O
(	O
histidine	O
kinase	O
,	O
response	O
regulators	O
,	O
diguanylate	O
cyclases	O
,	O
chemotaxis	O
receptor	O
)	O
and	O
potentially	O
virulence	O
(	O
S	O
-	O
layer	O
RTX	O
and	O
cysteine	O
desulfhydrase	O
)	O
.	O

Further	O
analysis	O
of	O
the	O
C	O
.	O
rectus	O
-	O
specific	O
clones	O
showed	O
that	O
10	O
genes	O
had	O
Campylobacter	B-bacteria
homologues	O
that	O
were	O
only	O
found	O
in	O
species	O
that	O
commonly	O
reside	O
within	O
the	O
oral	O
cavity	O
of	O
humans	O
and	O
10	O
other	O
fragments	O
shared	O
homology	O
only	O
with	O
non	O
-	O
campylobacter	O
organisms	O
.	O

These	O
data	O
provide	O
the	O
first	O
substantial	O
insights	O
into	O
the	O
genomic	O
content	O
of	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
,	O
a	O
significant	O
oral	O
pathogen	O
.	O

The	O
genes	O
identified	O
in	O
this	O
study	O
are	O
a	O
valuable	O
resource	O
for	O
initiating	O
new	O
research	O
on	O
the	O
virulence	O
of	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
during	O
periodontitis	O
.	O

Ginger	O
(	O
Zingiber	O
officinale	O
Roscoe	O
)	O
has	O
been	O
used	O
widely	O
as	O
a	O
food	O
spice	O
and	O
an	O
herbal	O
medicine	O
.	O

In	O
particular	O
,	O
its	O
gingerol	O
-	O
related	O
components	O
have	O
been	O
reported	O
to	O
possess	O
antimicrobial	O
and	O
antifungal	O
properties	O
,	O
as	O
well	O
as	O
several	O
pharmaceutical	O
properties	O
.	O

However	O
,	O
the	O
effective	O
ginger	O
constituents	O
that	O
inhibit	O
the	O
growth	O
of	O
oral	O
bacteria	O
associated	O
with	O
periodontitis	O
in	O
the	O
human	O
oral	O
cavity	O
have	O
not	O
been	O
elucidated	O
.	O

This	O
study	O
revealed	O
that	O
the	O
ethanol	O
and	O
n	O
-	O
hexane	O
extracts	O
of	O
ginger	O
exhibited	O
antibacterial	O
activities	O
against	O
three	O
anaerobic	O
Gram	O
-	O
negative	O
bacteria	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
53978	I-bacteria
,	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
ATCC	I-bacteria
35406	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
ATCC	I-bacteria
25611	I-bacteria
,	O
causing	O
periodontal	O
diseases	O
.	O

Thereafter	O
,	O
five	O
ginger	O
constituents	O
were	O
isolated	O
by	O
a	O
preparative	O
high	O
-	O
performance	O
liquid	O
chromatographic	O
method	O
from	O
the	O
active	O
silica	O
-	O
gel	O
column	O
chromatography	O
fractions	O
,	O
elucidated	O
their	O
structures	O
by	O
nuclear	O
magnetic	O
resonance	O
spectroscopy	O
and	O
electrospray	O
ionization	O
mass	O
spectrometry	O
and	O
their	O
antibacterial	O
activity	O
evaluated	O
.	O

In	O
conclusion	O
,	O
two	O
highly	O
alkylated	O
gingerols	O
,	O
[	O
10	O
]	O
-	O
gingerol	O
and	O
[	O
12	O
]	O
-	O
gingerol	O
effectively	O
inhibited	O
the	O
growth	O
of	O
these	O
oral	O
pathogens	O
at	O
a	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
range	O
of	O
6	O
-	O
30	O
microg	O
/	O
mL	O
.	O

These	O
ginger	O
compounds	O
also	O
killed	O
the	O
oral	O
pathogens	O
at	O
a	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
range	O
of	O
4	O
-	O
20	O
microg	O
/	O
mL	O
,	O
but	O
not	O
the	O
other	O
ginger	O
compounds	O
5	O
-	O
acetoxy	O
-	O
[	O
6	O
]	O
-	O
gingerol	O
,	O
3	O
,	O
5	O
-	O
diacetoxy	O
-	O
[	O
6	O
]	O
-	O
gingerdiol	O
and	O
galanolactone	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
efficacy	O
of	O
semi	O
fermented	O
and	O
non	O
fermented	O
Camellia	O
sinensis	O
extracts	O
(	O
Black	O
and	O
Green	O
tea	O
)	O
and	O
comparison	O
between	O
them	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
9811	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
ATCC	I-bacteria
10556	I-bacteria
that	O
are	O
responsible	O
for	O
dental	O
caries	O
and	O
bacteremias	O
following	O
dental	O
manipulations	O
.	O

Minimum	O
inhibitory	O
concentrations	O
of	O
both	O
tea	O
extracts	O
were	O
assessed	O
by	O
Well	O
diffusion	O
and	O
Broth	O
dilution	O
methods	O
and	O
examination	O
of	O
cell	O
adherence	O
(	O
Biofilm	O
inhibitory	O
concentrations	O
)	O
was	O
observed	O
on	O
glass	O
slides	O
under	O
phase	O
contrast	O
microscope	O
and	O
colony	O
counts	O
from	O
glass	O
beads	O
.	O

Concentration	O
of	O
1	O
mg	O
mL	O
(	O
-	O
1	O
)	O
of	O
semi	O
fermented	O
tea	O
extract	O
was	O
completely	O
biofilm	O
inhibitor	O
but	O
biofilm	O
formation	O
by	O
these	O
bacteria	O
was	O
seen	O
7	O
days	O
after	O
treatment	O
with	O
1	O
mg	O
mL	O
(	O
-	O
1	O
)	O
of	O
non	O
fermented	O
Camellia	O
sinensis	O
on	O
glass	O
beads	O
and	O
BIC	O
for	O
oral	O
streptococci	B-bacteria
treated	O
with	O
this	O
extract	O
was	O
1	O
.	O
5	O
,	O
2	O
.	O
5	O
mg	O
mL	O
(	O
-	O
1	O
)	O
of	O
semi	O
fermented	O
and	O
3	O
mg	O
mL	O
(	O
-	O
1	O
)	O
of	O
non	O
fermented	O
extracts	O
had	O
bactericidal	O
effect	O
on	O
these	O
bacteria	O
.	O

Semi	O
fermented	O
and	O
non	O
fermented	O
Camellia	O
sinensis	O
extracts	O
were	O
able	O
to	O
prevent	O
growth	O
of	O
oral	O
streptococci	B-bacteria
.	O

Therefore	O
dental	O
caries	O
significantly	O
reduce	O
and	O
the	O
efficiency	O
of	O
semi	O
fermented	O
tea	O
was	O
higher	O
due	O
to	O
rich	O
content	O
of	O
volatile	O
components	O
rather	O
than	O
non	O
fermented	O
extracts	O
.	O

We	O
present	O
a	O
novel	O
concept	O
on	O
carcinogenesis	O
mediated	O
by	O
oral	O
microbiota	O
.	O

Oral	O
micro	O
-	O
organisms	O
are	O
capable	O
of	O
metabolizing	O
alcohol	O
to	O
acetaldehyde	O
.	O

This	O
finding	O
casts	O
light	O
on	O
the	O
observed	O
association	O
between	O
poor	O
oral	O
hygiene	O
and	O
oral	O
cancer	O
.	O

Ethanol	O
,	O
as	O
such	O
,	O
is	O
not	O
carcinogenic	O
,	O
but	O
its	O
first	O
metabolite	O
acetaldehyde	O
is	O
indisputably	O
carcinogenic	O
.	O

Several	O
gastro	O
-	O
intestinal	O
microbial	O
species	O
possess	O
the	O
enzyme	O
alcohol	O
dehydrogenase	O
(	O
ADH	O
)	O
,	O
which	O
is	O
also	O
the	O
enzyme	O
responsible	O
for	O
alcohol	O
metabolism	O
in	O
the	O
liver	O
.	O

In	O
oral	O
microbiota	O
,	O
we	O
observed	O
that	O
species	O
such	O
as	O
the	O
ubiquitous	O
viridans	B-bacteria
streptococci	I-bacteria
and	O
Candida	O
also	O
possess	O
ADH	O
.	O

Ethanol	O
can	O
be	O
detected	O
in	O
the	O
mouth	O
hours	O
after	O
the	O
consumption	O
of	O
alcoholic	O
beverages	O
.	O

Patients	O
with	O
poor	O
oral	O
health	O
status	O
have	O
shown	O
higher	O
salivary	O
acetaldehyde	O
concentrations	O
than	O
those	O
with	O
better	O
oral	O
health	O
.	O

It	O
is	O
thus	O
understandable	O
that	O
ADH	O
-	O
containing	O
micro	O
-	O
organisms	O
in	O
the	O
mouth	O
present	O
a	O
risk	O
for	O
carcinogenic	O
acetaldehyde	O
production	O
,	O
with	O
subsequent	O
potential	O
for	O
the	O
development	O
of	O
oral	O
cancer	O
,	O
particularly	O
among	O
heavy	O
drinkers	O
.	O

In	O
this	O
article	O
,	O
we	O
briefly	O
review	O
this	O
area	O
of	O
investigation	O
and	O
conclude	O
by	O
highlighting	O
some	O
future	O
possibilities	O
for	O
the	O
control	O
of	O
carcinogenesis	O
.	O

Generally	O
,	O
mechanical	O
plaque	O
control	O
without	O
chemical	O
support	O
is	O
insufficient	O
to	O
prevent	O
oral	O
diseases	O
,	O
and	O
an	O
ongoing	O
quest	O
exists	O
for	O
new	O
antimicrobials	O
for	O
use	O
in	O
oral	O
healthcare	O
.	O

Chitosans	O
are	O
polycationic	O
,	O
naturally	O
occurring	O
antimicrobials	O
that	O
are	O
rapidly	O
finding	O
their	O
way	O
into	O
oral	O
healthcare	O
.	O

In	O
this	O
study	O
we	O
determined	O
the	O
effects	O
of	O
pellicle	O
treatment	O
with	O
chitosan	O
on	O
bacterial	O
adhesion	O
and	O
growth	O
.	O

Chitosan	O
caused	O
a	O
reduction	O
in	O
bacterial	O
adhesion	O
and	O
was	O
responsible	O
for	O
bacterial	O
death	O
upon	O
contact	O
compared	O
with	O
a	O
buffer	O
control	O
.	O

Exposure	O
of	O
adhering	O
bacteria	O
to	O
a	O
chitosan	O
solution	O
or	O
a	O
buffer	O
control	O
did	O
not	O
cause	O
detachment	O
,	O
but	O
the	O
chitosan	O
solution	O
left	O
a	O
small	O
proportion	O
of	O
the	O
adhering	O
bacteria	O
alive	O
.	O

Growth	O
after	O
exposure	O
to	O
chitosan	O
was	O
similar	O
to	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC700610	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
HM1	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
HG1025	I-bacteria
)	O
or	O
less	O
than	O
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
NS	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
HM1	I-bacteria
)	O
that	O
of	O
the	O
control	O
,	O
while	O
biofilm	O
viability	O
after	O
chitosan	O
treatment	O
was	O
lower	O
than	O
that	O
of	O
the	O
control	O
,	O
except	O
for	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
HM1	I-bacteria
.	O

Therefore	O
,	O
chitosan	O
is	O
a	O
promising	O
antimicrobial	O
for	O
use	O
in	O
oral	O
healthcare	O
.	O

A	O
multitude	O
of	O
molecular	O
methods	O
are	O
currently	O
used	O
for	O
identification	O
and	O
characterization	O
of	O
oral	O
biofilms	O
or	O
for	O
community	O
profiling	O
.	O

However	O
,	O
multiplex	O
PCR	O
techniques	O
that	O
are	O
able	O
to	O
routinely	O
identify	O
several	O
species	O
in	O
a	O
single	O
assay	O
are	O
not	O
available	O
.	O

Multiplex	O
Ligation	O
-	O
dependent	O
Probe	O
Amplification	O
(	O
MLPA	O
)	O
identifies	O
up	O
to	O
45	O
unique	O
fragments	O
in	O
a	O
single	O
tube	O
PCR	O
.	O

Here	O
we	O
report	O
a	O
novel	O
use	O
of	O
MLPA	O
in	O
the	O
relative	O
quantification	O
of	O
targeted	O
microorganisms	O
in	O
a	O
community	O
of	O
oral	O
microbiota	O
.	O

We	O
designed	O
9	O
species	O
specific	O
probes	O
for	O
:	O
Actinomyces	B-bacteria
gerencseriae	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
,	O
Candida	O
albicans	O
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Veillonella	B-bacteria
parvula	I-bacteria
;	O
and	O
genus	O
specific	O
probes	O
for	O
selected	O
oral	O
Streptococci	B-bacteria
and	O
Lactobacilli	B-bacteria
based	O
on	O
their	O
16S	O
rDNA	O
sequences	O
.	O

MLPA	O
analysis	O
of	O
DNA	O
pooled	O
from	O
the	O
strains	O
showed	O
the	O
expected	O
specific	O
MLPA	O
products	O
.	O

Relative	O
quantification	O
of	O
a	O
serial	O
dilution	O
of	O
equimolar	O
DNA	O
showed	O
that	O
as	O
little	O
as	O
10	O
pg	O
templates	O
can	O
be	O
detected	O
with	O
clearly	O
discernible	O
signals	O
.	O

Moreover	O
,	O
a	O
2	O
to	O
7	O
%	O
divergence	O
in	O
relative	O
signal	O
ratio	O
of	O
amplified	O
probes	O
observed	O
from	O
normalized	O
peak	O
area	O
values	O
suggests	O
MLPA	O
can	O
be	O
a	O
cheaper	O
alternative	O
to	O
using	O
qPCR	O
for	O
quantification	O
.	O

We	O
observed	O
2	O
to	O
6	O
fold	O
fluctuations	O
in	O
signal	O
intensities	O
of	O
MLPA	O
products	O
in	O
DNAs	O
isolated	O
from	O
multispecies	O
biofilms	O
grown	O
in	O
various	O
media	O
for	O
various	O
culture	O
times	O
.	O

Furthermore	O
,	O
MLPA	O
analyses	O
of	O
DNA	O
isolated	O
from	O
saliva	O
obtained	O
from	O
different	O
donors	O
gave	O
a	O
varying	O
number	O
and	O
intensity	O
of	O
signals	O
.	O

This	O
clearly	O
shows	O
the	O
usefulness	O
of	O
MLPA	O
in	O
a	O
quantitative	O
description	O
of	O
microbial	O
shifts	O
.	O

In	O
the	O
last	O
decade	O
,	O
as	O
a	O
result	O
of	O
the	O
widespread	O
use	O
of	O
PCR	O
and	O
DNA	O
sequencing	O
,	O
16S	O
rDNA	O
sequencing	O
has	O
played	O
a	O
pivotal	O
role	O
in	O
the	O
accurate	O
identification	O
of	O
bacterial	O
isolates	O
and	O
the	O
discovery	O
of	O
novel	O
bacteria	O
in	O
clinical	O
microbiology	O
laboratories	O
.	O

For	O
bacterial	O
identification	O
,	O
16S	O
rDNA	O
sequencing	O
is	O
particularly	O
important	O
in	O
the	O
case	O
of	O
bacteria	O
with	O
unusual	O
phenotypic	O
profiles	O
,	O
rare	O
bacteria	O
,	O
slow	O
-	O
growing	O
bacteria	O
,	O
uncultivable	O
bacteria	O
and	O
culture	O
-	O
negative	O
infections	O
.	O

Not	O
only	O
has	O
it	O
provided	O
insights	O
into	O
aetiologies	O
of	O
infectious	O
disease	O
,	O
but	O
it	O
also	O
helps	O
clinicians	O
in	O
choosing	O
antibiotics	O
and	O
in	O
determining	O
the	O
duration	O
of	O
treatment	O
and	O
infection	O
control	O
procedures	O
.	O

With	O
the	O
use	O
of	O
16S	O
rDNA	O
sequencing	O
,	O
215	O
novel	O
bacterial	O
species	O
,	O
29	O
of	O
which	O
belong	O
to	O
novel	O
genera	O
,	O
have	O
been	O
discovered	O
from	O
human	O
specimens	O
in	O
the	O
past	O
7	O
years	O
of	O
the	O
21st	O
century	O
(	O
2001	O
-	O
2007	O
)	O
.	O

One	O
hundred	O
of	O
the	O
215	O
novel	O
species	O
,	O
15	O
belonging	O
to	O
novel	O
genera	O
,	O
have	O
been	O
found	O
in	O
four	O
or	O
more	O
subjects	O
.	O

The	O
largest	O
number	O
of	O
novel	O
species	O
discovered	O
were	O
of	O
the	O
genera	O
Mycobacterium	B-bacteria
(	O
n	O
=	O
12	O
)	O
and	O
Nocardia	B-bacteria
(	O
n	O
=	O
6	O
)	O
.	O

The	O
oral	O
cavity	O
/	O
dental	O
-	O
related	O
specimens	O
(	O
n	O
=	O
19	O
)	O
and	O
the	O
gastrointestinal	O
tract	O
(	O
n	O
=	O
26	O
)	O
were	O
the	O
most	O
important	O
sites	O
for	O
discovery	O
and	O
/	O
or	O
reservoirs	O
of	O
novel	O
species	O
.	O

Among	O
the	O
100	O
novel	O
species	O
,	O
Streptococcus	B-bacteria
sinensis	I-bacteria
,	O
Laribacter	B-bacteria
hongkongensis	I-bacteria
,	O
Clostridium	B-bacteria
hathewayi	I-bacteria
and	O
Borrelia	B-bacteria
spielmanii	I-bacteria
have	O
been	O
most	O
thoroughly	O
characterized	O
,	O
with	O
the	O
reservoirs	O
and	O
routes	O
of	O
transmission	O
documented	O
,	O
and	O
S	O
.	O
sinensis	O
,	O
L	O
.	O
hongkongensis	O
and	O
C	O
.	O
hathewayi	O
have	O
been	O
found	O
globally	O
.	O

One	O
of	O
the	O
greatest	O
hurdles	O
in	O
putting	O
16S	O
rDNA	O
sequencing	O
into	O
routine	O
use	O
in	O
clinical	O
microbiology	O
laboratories	O
is	O
automation	O
of	O
the	O
technology	O
.	O

The	O
only	O
step	O
that	O
can	O
be	O
automated	O
at	O
the	O
moment	O
is	O
input	O
of	O
the	O
16S	O
rDNA	O
sequence	O
of	O
the	O
bacterial	O
isolate	O
for	O
identification	O
into	O
one	O
of	O
the	O
software	O
packages	O
that	O
will	O
generate	O
the	O
result	O
of	O
the	O
identity	O
of	O
the	O
isolate	O
on	O
the	O
basis	O
of	O
its	O
sequence	O
database	O
.	O

However	O
,	O
studies	O
on	O
the	O
accuracy	O
of	O
the	O
software	O
packages	O
have	O
given	O
highly	O
varied	O
results	O
,	O
and	O
interpretation	O
of	O
results	O
remains	O
difficult	O
for	O
most	O
technicians	O
,	O
and	O
even	O
for	O
clinical	O
microbiologists	O
.	O

To	O
fully	O
utilize	O
16S	O
rDNA	O
sequencing	O
in	O
clinical	O
microbiology	O
,	O
better	O
guidelines	O
are	O
needed	O
for	O
interpretation	O
of	O
the	O
identification	O
results	O
,	O
and	O
additional	O
/	O
supplementary	O
methods	O
are	O
necessary	O
for	O
bacterial	O
species	O
that	O
can	O
not	O
be	O
identified	O
confidently	O
by	O
16S	O
rDNA	O
sequencing	O
alone	O
.	O

To	O
obtain	O
deeper	O
insights	O
into	O
the	O
etiology	O
of	O
oral	O
disease	O
,	O
an	O
understanding	O
of	O
the	O
composition	O
of	O
the	O
surrounding	O
bacterial	O
environments	O
that	O
lead	O
to	O
health	O
or	O
disease	O
is	O
required	O
,	O
which	O
is	O
attracting	O
increasing	O
attention	O
.	O

In	O
this	O
study	O
,	O
the	O
bacterial	O
compositions	O
in	O
the	O
saliva	O
of	O
200	O
subjects	O
aged	O
15	O
-	O
40	O
years	O
were	O
depicted	O
as	O
peak	O
patterns	O
by	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
T	O
-	O
RFLP	O
)	O
analysis	O
of	O
16S	O
rRNA	O
genes	O
.	O

The	O
subjects	O
were	O
classified	O
into	O
three	O
clusters	O
by	O
partitioning	O
around	O
medoids	O
clustering	O
based	O
on	O
their	O
T	O
-	O
RFLP	O
profiles	O
,	O
and	O
the	O
clinical	O
oral	O
health	O
parameters	O
of	O
the	O
clusters	O
were	O
compared	O
.	O

The	O
clustering	O
of	O
the	O
T	O
-	O
RFLP	O
profiles	O
in	O
this	O
study	O
was	O
mainly	O
based	O
on	O
differences	O
in	O
the	O
abundance	O
distribution	O
of	O
the	O
dominant	O
terminal	O
restriction	O
fragments	O
(	O
TRFs	O
)	O
detected	O
in	O
most	O
of	O
the	O
subjects	O
.	O

Predicted	O
from	O
the	O
sizes	O
of	O
the	O
TRFs	O
,	O
the	O
characteristically	O
more	O
predominant	O
members	O
of	O
each	O
were	O
Prevotella	B-bacteria
and	O
Veillonella	B-bacteria
species	I-bacteria
in	O
cluster	O
I	O
;	O
Streptococcus	B-bacteria
species	I-bacteria
in	O
cluster	O
II	O
and	O
Neisseria	B-bacteria
,	O
Haemophilus	B-bacteria
or	O
Aggregatibacter	B-bacteria
species	I-bacteria
and	O
Porphyromonas	B-bacteria
species	I-bacteria
in	O
cluster	O
III	O
.	O

The	O
parameters	O
associated	O
with	O
periodontal	O
disease	O
were	O
significantly	O
different	O
among	O
the	O
clusters	O
.	O

Clusters	O
I	O
and	O
II	O
had	O
a	O
higher	O
percentage	O
of	O
sites	O
of	O
periodontal	O
pockets	O
greater	O
than	O
4	O
mm	O
than	O
cluster	O
III	O
,	O
and	O
cluster	O
I	O
contained	O
sites	O
exhibiting	O
bleeding	O
on	O
probing	O
more	O
often	O
than	O
cluster	O
II	O
or	O
III	O
;	O
no	O
significant	O
differences	O
were	O
observed	O
in	O
other	O
parameters	O
.	O

These	O
results	O
suggest	O
that	O
the	O
abundance	O
distribution	O
of	O
commensal	O
bacteria	O
in	O
saliva	O
is	O
correlated	O
with	O
periodontal	O
health	O
,	O
and	O
might	O
be	O
involved	O
in	O
the	O
susceptibility	O
of	O
an	O
individual	O
to	O
periodontal	O
disease	O
.	O

The	O
microbiota	O
of	O
the	O
human	O
oral	O
mucosa	O
consists	O
of	O
a	O
myriad	O
of	O
bacterial	O
species	O
that	O
normally	O
exist	O
in	O
commensal	O
harmony	O
with	O
the	O
host	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
an	O
aetiological	O
agent	O
in	O
severe	O
forms	O
of	O
periodontitis	O
(	O
a	O
chronic	O
inflammatory	O
disease	O
)	O
,	O
is	O
a	O
prominent	O
component	O
of	O
the	O
oral	O
microbiome	O
and	O
a	O
successful	O
colonizer	O
of	O
the	O
oral	O
epithelium	O
.	O

This	O
Gram	O
-	O
negative	O
anaerobe	O
can	O
also	O
exist	O
within	O
the	O
host	O
epithelium	O
without	O
the	O
existence	O
of	O
overt	O
disease	O
.	O

Gingival	O
epithelial	O
cells	O
,	O
the	O
outer	O
lining	O
of	O
the	O
gingival	O
mucosa	O
,	O
which	O
function	O
as	O
an	O
important	O
part	O
of	O
the	O
innate	O
immune	O
system	O
,	O
are	O
among	O
the	O
first	O
host	O
cells	O
colonized	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

This	O
review	O
describes	O
recent	O
studies	O
implicating	O
the	O
co	O
-	O
existence	O
and	O
intracellular	O
adaptation	O
of	O
the	O
organism	O
in	O
these	O
target	O
host	O
cells	O
.	O

Specifically	O
,	O
recent	O
findings	O
on	O
the	O
putative	O
mechanisms	O
of	O
persistence	O
,	O
intercellular	O
dissemination	O
and	O
opportunism	O
are	O
highlighted	O
.	O

These	O
new	O
findings	O
may	O
also	O
represent	O
an	O
original	O
and	O
valuable	O
model	O
for	O
mechanistic	O
characterization	O
of	O
other	O
successful	O
host	O
-	O
adapted	O
,	O
self	O
-	O
limiting	O
,	O
persistent	O
intracellular	O
bacteria	O
in	O
human	O
epithelial	O
tissues	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
colonization	O
of	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
in	O
the	O
tongue	O
and	O
cheek	O
of	O
newborns	O
and	O
elderly	O
individuals	O
with	O
no	O
teeth	O
.	O

Seventy	O
-	O
four	O
edentulous	O
subjects	O
were	O
included	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
.	O

Microbiologic	O
samples	O
were	O
taken	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
and	O
cheek	O
mucosa	O
of	O
all	O
individuals	O
and	O
analyzed	O
using	O
a	O
bacterial	O
DNA	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
.	O

C	B-bacteria
.	I-bacteria
rectus	I-bacteria
was	O
the	O
most	O
prevalent	O
species	O
in	O
both	O
groups	O
(	O
20	O
.	O
9	O
%	O
in	O
the	O
cheek	O
of	O
newborns	O
,	O
and	O
77	O
.	O
4	O
%	O
in	O
the	O
tongue	O
of	O
elderly	O
subjects	O
)	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
were	O
not	O
detected	O
in	O
any	O
of	O
the	O
43	O
newborns	O
;	O
however	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
recovered	O
from	O
the	O
tongue	O
and	O
cheek	O
(	O
3	O
.	O
2	O
%	O
)	O
of	O
elderly	O
individuals	O
,	O
whereas	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
was	O
detected	O
in	O
the	O
tongue	O
(	O
9	O
.	O
6	O
%	O
)	O
and	O
cheek	O
(	O
3	O
.	O
2	O
%	O
)	O
of	O
elderly	O
individuals	O
.	O

T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
was	O
detected	O
in	O
newborns	O
as	O
well	O
as	O
elderly	O
individuals	O
,	O
although	O
the	O
highest	O
prevalence	O
was	O
observed	O
in	O
the	O
tongue	O
of	O
newborns	O
(	O
6	O
.	O
9	O
%	O
)	O
and	O
elderly	O
(	O
9	O
.	O
6	O
%	O
)	O
individuals	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
was	O
not	O
found	O
in	O
the	O
tongue	O
of	O
newborns	O
,	O
but	O
we	O
observed	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
in	O
the	O
cheek	O
(	O
2	O
.	O
3	O
%	O
)	O
of	O
newborns	O
and	O
in	O
the	O
tongue	O
(	O
12	O
.	O
9	O
%	O
)	O
and	O
cheek	O
(	O
6	O
.	O
4	O
%	O
)	O
of	O
elderly	O
patients	O
.	O

Although	O
we	O
did	O
not	O
detect	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
in	O
newborns	O
,	O
periodontal	O
pathogens	O
could	O
be	O
detected	O
from	O
the	O
oral	O
mucous	O
membranes	O
of	O
edentulous	O
individuals	O
.	O

Our	O
results	O
suggest	O
that	O
major	O
attention	O
should	O
be	O
paid	O
to	O
edentulous	O
individuals	O
as	O
an	O
important	O
measure	O
in	O
the	O
prevention	O
of	O
the	O
initial	O
colonization	O
of	O
natural	O
teeth	O
and	O
dental	O
implants	O
by	O
periodontal	O
pathogens	O
.	O

Changes	O
in	O
the	O
levels	O
of	O
female	O
sex	O
hormones	O
during	O
the	O
menstrual	O
cycle	O
may	O
cause	O
cyclic	O
differences	O
in	O
subgingival	O
bacterial	O
colonization	O
patterns	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
hormonal	O
changes	O
in	O
the	O
menstrual	O
cycle	O
cause	O
changes	O
in	O
the	O
oral	O
microbiota	O
.	O

Bacterial	O
plaque	O
samples	O
were	O
collected	O
in	O
20	O
systemically	O
and	O
periodontally	O
healthy	O
women	O
using	O
no	O
hormonal	O
contraceptives	O
(	O
test	O
group	O
)	O
over	O
a	O
period	O
of	O
6	O
weeks	O
.	O

Twenty	O
age	O
-	O
matched	O
systemically	O
and	O
periodontally	O
healthy	O
men	O
were	O
assigned	O
to	O
the	O
control	O
group	O
.	O

Samples	O
were	O
processed	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
assay	O
,	O
and	O
74	O
species	O
were	O
analyzed	O
.	O

No	O
cyclic	O
pattern	O
of	O
bacterial	O
colonization	O
was	O
identified	O
for	O
any	O
of	O
the	O
74	O
species	O
studied	O
in	O
women	O
not	O
using	O
hormonal	O
contraceptives	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
(	O
Y4	B-bacteria
)	O
was	O
common	O
at	O
the	O
beginning	O
of	O
menstruation	O
(	O
mean	O
:	O
32	O
%	O
)	O
and	O
increased	O
during	O
the	O
following	O
2	O
weeks	O
(	O
36	O
%	O
)	O
in	O
women	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

No	O
cyclic	O
differences	O
in	O
bacterial	O
presence	O
were	O
found	O
among	O
the	O
men	O
(	O
P	O
values	O
varied	O
between	O
0	O
.	O
14	O
and	O
0	O
.	O
98	O
)	O
.	O

Men	O
presented	O
with	O
significantly	O
higher	O
bacterial	O
counts	O
for	O
40	O
of	O
74	O
species	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
including	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
but	O
not	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
P	O
=	O
0	O
.	O
15	O
)	O
or	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
(	O
P	O
=	O
0	O
.	O
42	O
)	O
.	O

During	O
a	O
menstruation	O
period	O
,	O
cyclic	O
variation	O
in	O
the	O
subgingival	O
microbiota	O
of	O
periodontally	O
healthy	O
women	O
of	O
child	O
-	O
bearing	O
age	O
who	O
were	O
not	O
using	O
oral	O
hormonal	O
contraceptives	O
could	O
not	O
be	O
confirmed	O
.	O

Male	O
control	O
subjects	O
presented	O
with	O
higher	O
levels	O
of	O
many	O
species	O
but	O
also	O
without	O
a	O
cyclic	O
pattern	O
.	O

The	O
presence	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
.	O

in	O
the	O
oral	O
cavity	O
remains	O
controversial	O
and	O
the	O
most	O
appropriate	O
method	O
for	O
detection	O
of	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
has	O
yet	O
to	O
be	O
established	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
four	O
different	O
primer	O
sets	O
on	O
the	O
detection	O
of	O
H	B-bacteria
.	I-bacteria
pylor	I-bacteria
in	O
gastric	O
biopsies	O
and	O
oral	O
samples	O
using	O
real	O
-	O
time	O
PCR	O
.	O

Gastric	O
biopsy	O
and	O
oral	O
samples	O
were	O
collected	O
from	O
eight	O
patients	O
with	O
gastric	O
symptoms	O
.	O

DNA	O
from	O
clinical	O
samples	O
was	O
extracted	O
and	O
analyzed	O
for	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
real	O
-	O
time	O
PCR	O
(	O
LightCycler	O
2	O
.	O
0	O
)	O
using	O
four	O
pairs	O
of	O
primers	O
which	O
targeted	O
16S	O
rRNA	O
(	O
16S	O
rRNA	O
#	O
295	O
;	O
16S	O
rRNA	O
#	O
120	O
)	O
or	O
glmM	O
(	O
glmM	O
#	O
294	O
;	O
glmM	O
#	O
722	O
)	O
DNA	O
genes	O
.	O

Three	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
strains	I-bacteria
and	O
three	O
clinical	O
isolates	O
served	O
as	O
reference	O
.	O

The	O
specificities	O
of	O
the	O
four	O
primer	O
pairs	O
were	O
examined	O
for	O
seven	O
oral	O
microorganisms	O
and	O
two	O
Helicobacter	B-bacteria
non	I-bacteria
-	I-bacteria
pylori	I-bacteria
species	I-bacteria
.	O

Primer	O
pair	O
16S	O
rRNA	O
#	O
120	O
showed	O
an	O
acceptable	O
specificity	O
and	O
a	O
high	O
sensitivity	O
.	O

Primer	O
pairs	O
glmM	O
#	O
294	O
and	O
glmM	O
#	O
722	O
demonstrated	O
a	O
high	O
specificity	O
but	O
a	O
low	O
sensitivity	O
and	O
primer	O
pair	O
16S	O
rRNA	O
#	O
295	O
demonstrated	O
a	O
poor	O
specificity	O
but	O
acceptable	O
sensitivity	O
.	O

Four	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
positive	O
gastric	O
biopsies	O
were	O
demonstrated	O
by	O
culture	O
,	O
histology	O
and	O
real	O
-	O
time	O
PCR	O
with	O
primer	O
pairs	O
16S	O
rRNA	O
#	O
295	O
or	O
16S	O
rRNA	O
#	O
120	O
.	O

No	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
detected	O
in	O
oral	O
samples	O
,	O
either	O
by	O
culture	O
or	O
by	O
real	O
-	O
time	O
PCR	O
.	O

Of	O
the	O
four	O
different	O
primer	O
pairs	O
examined	O
,	O
16S	O
rRNA	O
#	O
120	O
was	O
the	O
most	O
appropriate	O
to	O
detect	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
clinical	O
samples	O
using	O
real	O
-	O
time	O
PCR	O
.	O

Conventional	O
culture	O
methods	O
and	O
Multiplex	O
PCR	O
,	O
both	O
of	O
which	O
we	O
have	O
been	O
used	O
for	O
a	O
long	O
time	O
in	O
our	O
clinical	O
microbiology	O
laboratory	O
,	O
were	O
compared	O
for	O
their	O
ability	O
to	O
detect	O
a	O
selected	O
panel	O
of	O
periodontopathic	O
bacteria	O
:	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
.	O

Tests	O
were	O
performed	O
in	O
a	O
single	O
subgingival	O
sample	O
taken	O
from	O
a	O
periodontal	O
diseased	O
site	O
with	O
a	O
probing	O
depth	O
equal	O
to	O
or	O
greater	O
than	O
6mm	O
.	O

The	O
results	O
were	O
compared	O
site	O
-	O
by	O
-	O
site	O
,	O
taking	O
into	O
account	O
the	O
quality	O
and	O
the	O
presence	O
or	O
absence	O
of	O
pathogens	O
.	O

529	O
samples	O
of	O
subgingival	O
plaque	O
were	O
analysed	O
and	O
the	O
prevalence	O
of	O
the	O
six	O
species	O
monitored	O
varied	O
in	O
relation	O
to	O
the	O
species	O
itself	O
and	O
the	O
method	O
of	O
detection	O
.	O

The	O
most	O
represented	O
species	O
is	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
with	O
a	O
percentage	O
of	O
positive	O
variability	O
between	O
44	O
.	O
9	O
%	O
PCR	O
and	O
46	O
.	O
5	O
%	O
culture	O
test	O
.	O

Generally	O
,	O
the	O
lowest	O
prevalence	O
was	O
determined	O
by	O
culture	O
test	O
,	O
with	O
the	O
exception	O
of	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
which	O
,	O
unlike	O
other	O
bacteria	O
,	O
have	O
been	O
seen	O
in	O
higher	O
percentages	O
in	O
culture	O
with	O
respect	O
to	O
PCR	O
.	O

For	O
both	O
methods	O
,	O
there	O
was	O
a	O
good	O
degree	O
of	O
accuracy	O
in	O
the	O
determination	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

It	O
becomes	O
weak	O
for	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
.	O

Both	O
culture	O
and	O
PCR	O
techniques	O
introduced	O
many	O
methodological	O
problems	O
when	O
applied	O
in	O
oral	O
microbiology	O
,	O
but	O
the	O
ideal	O
technique	O
for	O
accurate	O
detection	O
of	O
pathogens	O
in	O
subgingival	O
plaque	O
samples	O
has	O
yet	O
to	O
be	O
developed	O
.	O

This	O
crossover	O
design	O
clinical	O
study	O
compared	O
the	O
anti	O
-	O
microbial	O
effects	O
of	O
a	O
new	O
1	O
%	O
zinc	O
citrate	O
dentifrice	O
with	O
a	O
control	O
formulation	O
.	O

Thirty	O
adults	O
completed	O
a	O
washout	O
phase	O
and	O
baseline	O
samples	O
of	O
dental	O
plaque	O
,	O
buccal	O
mucosa	O
,	O
tongue	O
,	O
saliva	O
,	O
and	O
plaque	O
collected	O
to	O
enumerate	O
anaerobes	O
and	O
streptococci	B-bacteria
.	O

Subjects	O
were	O
randomly	O
assigned	O
a	O
test	O
dentifrice	O
to	O
use	O
for	O
the	O
next	O
13	O
days	O
.	O

Oral	O
samples	O
similar	O
to	O
the	O
baseline	O
were	O
collected	O
on	O
day	O
14	O
prior	O
to	O
oral	O
hygiene	O
for	O
microbial	O
analysis	O
.	O

The	O
subject	O
then	O
placed	O
a	O
custom	O
intra	O
-	O
oral	O
stent	O
with	O
hydroxyapatite	O
(	O
HA	O
)	O
squares	O
and	O
brushed	O
their	O
teeth	O
with	O
their	O
assigned	O
dentifrice	O
.	O

Oral	O
samples	O
and	O
HA	O
squares	O
were	O
collected	O
5	O
h	O
later	O
for	O
microbial	O
analyses	O
.	O

This	O
completed	O
the	O
study	O
with	O
one	O
test	O
dentifrice	O
.	O

The	O
entire	O
study	O
was	O
repeated	O
with	O
the	O
alternate	O
dentifrice	O
after	O
a	O
second	O
washout	O
phase	O
.	O

Whereas	O
baseline	O
samples	O
demonstrated	O
no	O
significant	O
differences	O
in	O
microbial	O
parameters	O
between	O
the	O
two	O
treatment	O
groups	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
,	O
subjects	O
provided	O
the	O
zinc	O
citrate	O
dentifrice	O
demonstrated	O
24	O
-	O
52	O
%	O
reductions	O
in	O
anaerobic	O
bacteria	O
and	O
streptococci	B-bacteria
on	O
day	O
14	O
versus	O
the	O
control	O
paste	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
the	O
5	O
-	O
h	O
post	O
-	O
brushing	O
samples	O
,	O
subjects	O
provided	O
the	O
zinc	O
citrate	O
toothpaste	O
demonstrated	O
27	O
-	O
49	O
%	O
reductions	O
for	O
anaerobic	O
bacteria	O
and	O
streptococci	B-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Additionally	O
,	O
in	O
situ	O
microbial	O
biofilm	O
formation	O
on	O
HA	O
disks	O
was	O
significantly	O
inhibited	O
amongst	O
the	O
zinc	O
citrate	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Significant	O
reductions	O
in	O
anaerobic	O
bacteria	O
and	O
streptococci	B-bacteria
were	O
observed	O
amongst	O
all	O
intra	O
-	O
oral	O
locations	O
along	O
with	O
in	O
situ	O
biofilm	O
formation	O
after	O
use	O
of	O
the	O
zinc	O
citrate	O
dentifrice	O
.	O

Apical	O
periodontitis	O
is	O
an	O
infectious	O
disease	O
caused	O
by	O
microorganisms	O
colonizing	O
the	O
root	O
canal	O
system	O
.	O

For	O
an	O
optimal	O
outcome	O
of	O
the	O
endodontic	O
treatment	O
to	O
be	O
achieved	O
,	O
bacterial	O
populations	O
within	O
the	O
root	O
canal	O
should	O
be	O
ideally	O
eliminated	O
or	O
at	O
least	O
significantly	O
reduced	O
to	O
levels	O
that	O
are	O
compatible	O
with	O
periradicular	O
tissue	O
healing	O
.	O

If	O
bacteria	O
persist	O
after	O
chemomechanical	O
preparation	O
supplemented	O
or	O
not	O
with	O
an	O
intracanal	O
medication	O
,	O
there	O
is	O
an	O
increased	O
risk	O
of	O
adverse	O
outcome	O
of	O
the	O
endodontic	O
treatment	O
.	O

Therefore	O
,	O
bacterial	O
presence	O
in	O
the	O
root	O
canal	O
at	O
the	O
time	O
of	O
filling	O
has	O
been	O
shown	O
to	O
be	O
a	O
risk	O
factor	O
for	O
posttreatment	O
apical	O
periodontitis	O
.	O

About	O
100	O
species	O
/	O
phylotypes	O
have	O
already	O
been	O
detected	O
in	O
postinstrumentation	O
and	O
/	O
or	O
postmedication	O
samples	O
,	O
and	O
gram	O
-	O
positive	O
bacteria	O
are	O
the	O
most	O
dominant	O
.	O

However	O
,	O
it	O
remains	O
to	O
be	O
determined	O
by	O
longitudinal	O
studies	O
if	O
any	O
species	O
/	O
phylotypes	O
persisting	O
after	O
treatment	O
procedures	O
can	O
influence	O
outcome	O
.	O

This	O
review	O
article	O
discusses	O
diverse	O
aspects	O
of	O
bacterial	O
persistence	O
after	O
treatment	O
,	O
including	O
the	O
microbiology	O
,	O
bacterial	O
strategies	O
to	O
persist	O
,	O
the	O
requisites	O
for	O
persisting	O
bacteria	O
to	O
affect	O
the	O
outcome	O
,	O
and	O
future	O
directions	O
of	O
research	O
in	O
this	O
field	O
.	O

The	O
microbial	O
community	O
present	O
in	O
the	O
human	O
mouth	O
is	O
engaged	O
in	O
a	O
complex	O
network	O
of	O
diverse	O
metabolic	O
activities	O
.	O

In	O
addition	O
to	O
serving	O
as	O
energy	O
and	O
building	O
-	O
block	O
sources	O
,	O
metabolites	O
are	O
key	O
players	O
in	O
interspecies	O
and	O
host	O
-	O
pathogen	O
interactions	O
.	O

Metabolites	O
are	O
also	O
implicated	O
in	O
triggering	O
the	O
local	O
inflammatory	O
response	O
,	O
which	O
can	O
affect	O
systemic	O
conditions	O
such	O
as	O
atherosclerosis	O
,	O
obesity	O
,	O
and	O
diabetes	O
.	O

While	O
the	O
genome	O
of	O
several	O
oral	O
pathogens	O
has	O
been	O
sequenced	O
,	O
quantitative	O
understanding	O
of	O
the	O
metabolic	O
functions	O
of	O
any	O
oral	O
pathogen	O
at	O
the	O
system	O
level	O
has	O
not	O
been	O
explored	O
yet	O
.	O

Here	O
we	O
pursue	O
the	O
computational	O
construction	O
and	O
analysis	O
of	O
the	O
genome	O
-	O
scale	O
metabolic	O
network	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
a	O
gram	O
-	O
negative	O
anaerobe	O
that	O
is	O
endemic	O
in	O
the	O
human	O
population	O
and	O
largely	O
responsible	O
for	O
adult	O
periodontitis	O
.	O

Integrating	O
information	O
from	O
the	O
genome	O
,	O
online	O
databases	O
,	O
and	O
literature	O
screening	O
,	O
we	O
built	O
a	O
stoichiometric	O
model	O
that	O
encompasses	O
679	O
metabolic	O
reactions	O
.	O

By	O
using	O
flux	O
balance	O
approaches	O
and	O
automated	O
network	O
visualization	O
,	O
we	O
analyze	O
the	O
growth	O
capacity	O
under	O
amino	O
-	O
acid	O
-	O
rich	O
medium	O
and	O
provide	O
evidence	O
that	O
amino	O
acid	O
preference	O
and	O
cytotoxic	O
by	O
-	O
product	O
secretion	O
rates	O
are	O
suitably	O
reproduced	O
by	O
the	O
model	O
.	O

To	O
provide	O
further	O
insight	O
into	O
the	O
basic	O
metabolic	O
functions	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
suggest	O
potential	O
drug	O
targets	O
,	O
we	O
study	O
systematically	O
how	O
the	O
network	O
responds	O
to	O
any	O
reaction	O
knockout	O
.	O

We	O
focus	O
specifically	O
on	O
the	O
lipopolysaccharide	O
biosynthesis	O
pathway	O
and	O
identify	O
eight	O
putative	O
targets	O
,	O
one	O
of	O
which	O
has	O
been	O
recently	O
verified	O
experimentally	O
.	O

The	O
current	O
model	O
,	O
which	O
is	O
amenable	O
to	O
further	O
experimental	O
testing	O
and	O
refinements	O
,	O
could	O
prove	O
useful	O
in	O
evaluating	O
the	O
oral	O
microbiome	O
dynamics	O
and	O
in	O
the	O
development	O
of	O
novel	O
biomedical	O
applications	O
.	O

Oral	O
epithelial	O
cells	O
may	O
be	O
invaded	O
by	O
a	O
polymicrobial	O
intracellular	O
flora	O
,	O
including	O
pathogens	O
together	O
with	O
commensals	O
.	O

Various	O
oral	O
pathogens	O
can	O
induce	O
the	O
production	O
of	O
interleukin	O
-	O
8	O
,	O
a	O
potent	O
neutrophil	O
chemotractant	O
,	O
in	O
oral	O
epithelial	O
cells	O
.	O

Evidence	O
from	O
the	O
gut	O
suggests	O
that	O
commensal	O
species	O
may	O
modulate	O
inflammatory	O
responses	O
to	O
pathogens	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
interleukin	O
-	O
8	O
responses	O
of	O
oral	O
epithelial	O
cells	O
to	O
an	O
oral	O
pro	O
-	O
inflammatory	O
species	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
in	O
combination	O
with	O
an	O
oral	O
commensal	O
,	O
Streptococcus	B-bacteria
cristatus	I-bacteria
.	O

KB	O
,	O
TERT	O
-	O
2	O
,	O
TR146	O
and	O
SCC15	O
cells	O
were	O
cocultured	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
,	O
either	O
alone	O
or	O
in	O
combination	O
,	O
at	O
37	O
degrees	O
C	O
in	O
5	O
%	O
CO2	O
under	O
various	O
conditions	O
.	O

The	O
mRNA	O
expression	O
of	O
interleukin	O
-	O
8	O
was	O
analyzed	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
and	O
protein	O
secretion	O
was	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
alone	O
evoked	O
a	O
potent	O
interleukin	O
-	O
8	O
response	O
,	O
whereas	O
S	O
.	O
cristatus	O
alone	O
did	O
not	O
induce	O
significant	O
interleukin	O
-	O
8	O
expression	O
in	O
oral	O
epithelial	O
cells	O
.	O

When	O
present	O
together	O
,	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
attenuated	O
the	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
-	O
induced	O
interleukin	O
-	O
8	O
production	O
in	O
the	O
four	O
oral	O
epithelial	O
cell	O
lines	O
to	O
varying	O
degrees	O
.	O

The	O
inhibitory	O
effect	O
of	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
was	O
independent	O
of	O
its	O
viability	O
and	O
its	O
co	O
-	O
aggregation	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
was	O
not	O
related	O
to	O
soluble	O
bacterial	O
products	O
and	O
appeared	O
to	O
require	O
bacterial	O
contact	O
with	O
epithelial	O
cells	O
.	O

Similar	O
effects	O
were	O
seen	O
with	O
several	O
other	O
species	O
of	O
oral	O
streptococci	B-bacteria
.	O

Our	O
data	O
suggest	O
that	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
may	O
exert	O
immunomodulatory	O
effects	O
on	O
the	O
interleukin	O
-	O
8	O
response	O
of	O
oral	O
epithelial	O
cells	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
challenge	O
.	O

To	O
study	O
the	O
distribution	O
and	O
drug	O
resistance	O
of	O
the	O
isolated	O
bacteria	O
from	O
children	O
with	O
acute	O
respiratory	O
infection	O
(	O
ARI	O
)	O
in	O
Dalian	O
.	O

Between	O
January	O
2006	O
and	O
February	O
2007	O
,	O
930	O
children	O
with	O
ARI	O
were	O
enrolled	O
,	O
including	O
364	O
with	O
acute	O
upper	O
respiratory	O
infection	O
(	O
AURI	O
)	O
,	O
and	O
566	O
with	O
acute	O
lower	O
respiratory	O
infection	O
(	O
ALRI	O
)	O
.	O

The	O
AURI	O
children	O
,	O
who	O
did	O
not	O
receive	O
antimicrobial	O
agent	O
treatment	O
or	O
received	O
oral	O
antimicrobial	O
agents	O
1	O
-	O
2	O
times	O
,	O
had	O
bacterial	O
cultures	O
of	O
pharyngeal	O
swab	O
.	O

The	O
ALRI	O
children	O
,	O
who	O
received	O
intravenous	O
antibacterial	O
agents	O
more	O
than	O
3	O
days	O
,	O
had	O
bacterial	O
cultures	O
of	O
sputum	O
and	O
bronchoalveolar	O
lavage	O
fluid	O
(	O
BALF	O
)	O
.	O

Isolated	O
bacteria	O
were	O
identified	O
by	O
the	O
ATB	O
system	O
(	O
Bio	O
-	O
Merieux	O
,	O
France	O
)	O
.	O

Antimicrobial	O
susceptibility	O
testing	O
was	O
carried	O
out	O
by	O
means	O
of	O
Kirby	O
-	O
bauer	O
.	O

A	O
total	O
of	O
404	O
isolates	O
(	O
43	O
.	O
4	O
%	O
)	O
were	O
identified	O
.	O

Haemophilus	B-bacteria
influenzae	I-bacteria
,	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
accounted	O
for	O
22	O
.	O
5	O
%	O
,	O
12	O
.	O
1	O
%	O
and	O
7	O
.	O
4	O
%	O
respectively	O
.	O

In	O
the	O
isolates	O
from	O
AURI	O
,	O
Haemophilus	B-bacteria
influenzae	I-bacteria
,	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
accounted	O
for	O
43	O
.	O
9	O
%	O
,	O
22	O
.	O
0	O
%	O
and	O
9	O
.	O
1	O
%	O
respectively	O
;	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Klebsiella	B-bacteria
pneumonia	I-bacteria
and	O
Nonfermenters	B-bacteria
accounted	O
for	O
4	O
.	O
5	O
%	O
,	O
8	O
.	O
3	O
%	O
and	O
3	O
.	O
0	O
%	O
respectively	O
.	O

In	O
the	O
isolates	O
from	O
ALRI	O
,	O
Haemophilus	B-bacteria
influenzae	I-bacteria
,	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
accounted	O
for	O
12	O
.	O
1	O
%	O
,	O
7	O
.	O
4	O
%	O
and	O
6	O
.	O
6	O
%	O
respectively	O
;	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
and	O
Nonfermenters	B-bacteria
accounted	O
for	O
16	O
.	O
9	O
%	O
,	O
13	O
.	O
2	O
%	O
and	O
21	O
.	O
8	O
%	O
respectively	O
.	O

The	O
resistant	O
rates	O
of	O
Haemophilus	B-bacteria
to	O
ampicillin	O
and	O
TMP	O
-	O
SMZ	O
were	O
29	O
.	O
3	O
%	O
and	O
32	O
.	O
9	O
%	O
respectively	O
,	O
and	O
to	O
amoxicillin	O
-	O
clavulanic	O
acid	O
,	O
cefalotin	O
,	O
cefaclor	O
,	O
cefuroxime	O
and	O
cefotaxime	O
were	O
12	O
.	O
1	O
%	O
,	O
10	O
.	O
0	O
%	O
,	O
10	O
.	O
0	O
%	O
,	O
11	O
.	O
4	O
%	O
and	O
5	O
.	O
7	O
%	O
,	O
respectively	O
.	O

The	O
resistant	O
rate	O
of	O
Haemophilus	B-bacteria
to	O
ampicillin	O
,	O
amoxicillin	O
-	O
clavulanic	O
acid	O
,	O
cefaclor	O
,	O
tetracycine	O
and	O
TMP	O
-	O
SMZ	O
in	O
the	O
ALRI	O
group	O
were	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
AURI	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
or	O
0	O
.	O
01	O
)	O
.	O

In	O
Dalian	O
,	O
Haemophilus	B-bacteria
was	O
the	O
main	O
isolate	O
of	O
children	O
with	O
ARI	O
.	O

The	O
distribution	O
of	O
bacteria	O
was	O
different	O
between	O
ALRI	O
and	O
AURI	O
.	O

In	O
ALRI	O
,	O
Gram	O
-	O
negative	O
bacilli	O
were	O
in	O
a	O
higher	O
proportion	O
,	O
and	O
the	O
resistant	O
rates	O
of	O
Haemophilus	B-bacteria
influenzae	I-bacteria
and	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
to	O
ampicillin	O
,	O
amoxicillin	O
-	O
clavulanic	O
acid	O
and	O
cefaclor	O
were	O
higher	O
.	O

Parotid	O
secretory	O
protein	O
(	O
PSP	O
)	O
(	O
SPLUNC2	O
)	O
,	O
a	O
potential	O
host	O
-	O
defense	O
protein	O
related	O
to	O
bactericidal	O
/	O
permeability	O
-	O
increasing	O
protein	O
(	O
BPI	O
)	O
,	O
was	O
used	O
as	O
a	O
template	O
to	O
design	O
antibacterial	O
peptides	O
.	O

Based	O
on	O
the	O
structure	O
of	O
BPI	O
,	O
new	O
PSP	O
peptides	O
were	O
designed	O
and	O
tested	O
for	O
antibacterial	O
activity	O
.	O

The	O
peptides	O
did	O
not	O
exhibit	O
significant	O
bactericidal	O
activity	O
or	O
inhibit	O
growth	O
but	O
the	O
peptide	O
GL	O
-	O
13	O
induced	O
bacterial	O
matting	O
,	O
suggesting	O
passive	O
agglutination	O
of	O
bacteria	O
.	O

GL	O
-	O
13	O
was	O
shown	O
to	O
agglutinate	O
the	O
Gram	O
negative	O
bacteria	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Aggregatibacter	B-bacteria
(	I-bacteria
Actinobacillus	I-bacteria
)	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
Gram	O
positive	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
uncoated	O
sheep	O
erythrocytes	O
.	O

Bacterial	O
agglutination	O
was	O
time	O
and	O
dose	O
-	O
dependent	O
and	O
involved	O
hydrophobic	O
interactions	O
.	O

Variant	O
forms	O
of	O
GL	O
-	O
13	O
revealed	O
that	O
agglutination	O
also	O
depended	O
on	O
the	O
number	O
of	O
amine	O
groups	O
on	O
the	O
peptide	O
.	O

GL	O
-	O
13	O
inhibited	O
the	O
adhesion	O
of	O
bacteria	O
to	O
plastic	O
surfaces	O
and	O
the	O
peptide	O
prevented	O
the	O
spread	O
of	O
P	B-bacteria
.	I-bacteria
aeruginos	I-bacteria
infection	O
in	O
a	O
lettuce	O
leaf	O
model	O
,	O
suggesting	O
that	O
GL	O
-	O
13	O
is	O
active	O
in	O
vivo	O
.	O

Moreover	O
,	O
GL	O
-	O
13	O
-	O
induced	O
agglutination	O
enhanced	O
the	O
phagocytosis	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
by	O
RAW	O
264	O
.	O
7	O
macrophage	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
GL	O
-	O
13	O
represents	O
a	O
class	O
of	O
antimicrobial	O
peptides	O
,	O
which	O
do	O
not	O
directly	O
kill	O
bacteria	O
but	O
instead	O
reduce	O
bacterial	O
adhesion	O
and	O
promote	O
agglutination	O
,	O
leading	O
to	O
increased	O
clearance	O
by	O
host	O
phagocytic	O
cells	O
.	O

Such	O
peptides	O
may	O
cause	O
less	O
bacterial	O
resistance	O
than	O
traditional	O
antibiotic	O
peptides	O
.	O

tet	O
(	O
32	O
)	O
Was	O
identified	O
in	O
three	O
bacterial	O
isolates	O
and	O
in	O
metagenomic	O
DNA	O
from	O
the	O
human	O
oral	O
cavity	O
.	O

The	O
regions	O
immediately	O
flanking	O
the	O
gene	O
were	O
found	O
to	O
have	O
similarities	O
to	O
the	O
mobile	O
elements	O
TnB1230	O
from	O
Butyrivibrio	B-bacteria
fibrisolvens	I-bacteria
,	O
ATE	O
-	O
3	O
from	O
Arcanobacterium	B-bacteria
pyogenes	I-bacteria
,	O
and	O
CTn5	O
from	O
Clostridium	B-bacteria
difficile	I-bacteria
.	O

Dental	O
caries	O
is	O
among	O
the	O
more	O
prevalent	O
chronic	O
human	O
infections	O
for	O
which	O
an	O
effective	O
human	O
vaccine	O
has	O
not	O
yet	O
been	O
achieved	O
.	O

Enolase	O
from	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
has	O
been	O
identified	O
as	O
an	O
immunomodulatory	O
protein	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
recombinant	O
enolase	O
(	O
rEnolase	O
)	O
as	O
a	O
target	O
antigen	O
and	O
assessed	O
its	O
therapeutic	O
effect	O
in	O
a	O
rat	O
model	O
of	O
Dental	O
caries	O
.	O

Wistar	O
rats	O
that	O
were	O
fed	O
a	O
cariogenic	O
solid	O
diet	O
on	O
day	O
18	O
after	O
birth	O
were	O
orally	O
infected	O
with	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
on	O
day	O
19	O
after	O
birth	O
and	O
for	O
5	O
consecutive	O
days	O
thereafter	O
.	O

Five	O
days	O
after	O
infection	O
and	O
,	O
again	O
,	O
3	O
weeks	O
later	O
,	O
rEnolase	O
plus	O
alum	O
adjuvant	O
was	O
delivered	O
into	O
the	O
oral	O
cavity	O
of	O
the	O
rats	O
.	O

A	O
sham	O
-	O
immunized	O
group	O
of	O
rats	O
was	O
contemporarily	O
treated	O
with	O
adjuvant	O
alone	O
.	O

In	O
the	O
rEnolase	O
-	O
immunized	O
rats	O
,	O
increased	O
levels	O
of	O
salivary	O
IgA	O
and	O
IgG	O
antibodies	O
specific	O
for	O
this	O
recombinant	O
protein	O
were	O
detected	O
.	O

A	O
significant	O
decrease	O
in	O
sulcal	O
,	O
proximal	O
enamel	O
,	O
and	O
Dental	O
caries	O
scores	O
was	O
observed	O
in	O
these	O
animals	O
,	O
compared	O
with	O
sham	O
-	O
immunized	O
control	O
animals	O
.	O

No	O
detectable	O
histopathologic	O
alterations	O
were	O
observed	O
in	O
all	O
immunized	O
animals	O
.	O

Furthermore	O
,	O
the	O
antibodies	O
produced	O
against	O
bacterial	O
enolase	O
did	O
not	O
react	O
with	O
human	O
enolase	O
.	O

Overall	O
,	O
these	O
results	O
indicate	O
that	O
rEnolase	O
could	O
be	O
a	O
promising	O
and	O
safe	O
candidate	O
for	O
testing	O
in	O
trials	O
of	O
vaccines	O
against	O
Dental	O
caries	O
in	O
humans	O
.	O

The	O
genome	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
harbours	O
13	O
two	O
-	O
component	O
signal	O
transduction	O
systems	O
(	O
TCSTSs	O
)	O
.	O

Of	O
these	O
,	O
a	O
peptide	O
-	O
mediated	O
quorum	O
-	O
sensing	O
system	O
,	O
ComCDE	O
,	O
and	O
the	O
HK	O
/	O
RR11	O
two	O
-	O
component	O
system	O
are	O
well	O
known	O
to	O
regulate	O
several	O
virulence	O
-	O
associated	O
traits	O
in	O
in	O
vitro	O
experiments	O
,	O
including	O
genetic	O
competence	O
,	O
bacteriocin	O
production	O
,	O
biofilm	O
formation	O
and	O
stress	O
responses	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
hypothesis	O
that	O
inactivation	O
of	O
ComCDE	O
,	O
HK	O
/	O
RR11	O
or	O
both	O
systems	O
would	O
attenuate	O
the	O
virulence	O
and	O
cariogenicity	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
results	O
showed	O
that	O
simultaneous	O
inactivation	O
of	O
both	O
signal	O
transduction	O
systems	O
additively	O
attenuated	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
virulence	O
and	O
cariogenicity	O
,	O
since	O
inactivation	O
of	O
either	O
of	O
these	O
systems	O
alone	O
did	O
not	O
result	O
in	O
the	O
same	O
degree	O
of	O
effect	O
.	O

The	O
double	O
deletion	O
mutant	O
SMcde	O
-	O
hk11	O
was	O
defective	O
in	O
genetic	O
competence	O
,	O
had	O
a	O
reduced	O
acid	O
production	O
,	O
was	O
unable	O
to	O
grow	O
at	O
pH	O
5	O
.	O
0	O
and	O
formed	O
an	O
abnormal	O
biofilm	O
with	O
reduced	O
biomass	O
.	O

Animal	O
studies	O
showed	O
that	O
this	O
mutant	O
had	O
reduced	O
capabilities	O
for	O
oral	O
colonization	O
,	O
succession	O
and	O
initiation	O
of	O
dental	O
caries	O
.	O

A	O
competitive	O
index	O
(	O
CI	O
)	O
analysis	O
using	O
a	O
mixed	O
-	O
infection	O
animal	O
model	O
revealed	O
that	O
all	O
the	O
mutants	O
,	O
particularly	O
SMcde	O
-	O
hk11	O
,	O
had	O
reduced	O
fitness	O
in	O
their	O
ecological	O
niches	O
and	O
were	O
unable	O
to	O
compete	O
with	O
the	O
wild	O
-	O
type	O
strain	O
for	O
persistence	O
in	O
dental	O
biofilms	O
.	O

The	O
evidence	O
from	O
this	O
study	O
suggests	O
that	O
the	O
ComCDE	O
and	O
HK	O
/	O
RR11	O
signal	O
transduction	O
systems	O
can	O
be	O
considered	O
to	O
be	O
novel	O
targets	O
for	O
the	O
development	O
of	O
strategies	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
infections	O
.	O

Little	O
is	O
known	O
regarding	O
the	O
factors	O
that	O
affect	O
the	O
microbial	O
composition	O
of	O
supragingival	O
biofilms	O
.	O

This	O
study	O
was	O
designed	O
to	O
test	O
the	O
hypothesis	O
that	O
tooth	O
location	O
affects	O
the	O
microbial	O
composition	O
of	O
supragingival	O
plaque	O
beyond	O
the	O
effect	O
due	O
to	O
plaque	O
mass	O
as	O
reflected	O
by	O
total	O
DNA	O
probe	O
count	O
.	O

Supragingival	O
plaque	O
samples	O
were	O
taken	O
from	O
the	O
mesiobuccal	O
aspect	O
of	O
each	O
tooth	O
in	O
187	O
subjects	O
(	O
n	O
=	O
4745	O
samples	O
)	O
.	O

All	O
samples	O
were	O
individually	O
analyzed	O
for	O
their	O
content	O
of	O
40	O
bacterial	O
species	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Significance	O
of	O
differences	O
in	O
mean	O
species	O
counts	O
and	O
proportions	O
were	O
determined	O
among	O
tooth	O
surfaces	O
and	O
six	O
tooth	O
type	O
categories	O
:	O
molars	O
,	O
bicuspids	O
,	O
incisors	O
/	O
canines	O
in	O
the	O
mandible	O
and	O
maxilla	O
separately	O
using	O
the	O
Kruskal	O
-	O
Wallis	O
test	O
.	O

Stepwise	O
multiple	O
linear	O
regression	O
was	O
employed	O
to	O
examine	O
the	O
relationship	O
between	O
species	O
proportions	O
and	O
total	O
DNA	O
probe	O
count	O
,	O
tooth	O
location	O
,	O
periodontal	O
and	O
smoking	O
status	O
,	O
age	O
and	O
sex	O
.	O

All	O
species	O
differed	O
significantly	O
among	O
tooth	O
types	O
and	O
among	O
the	O
six	O
tooth	O
categories	O
.	O

Higher	O
plaque	O
levels	O
were	O
seen	O
on	O
molars	O
and	O
lower	O
incisors	O
.	O

Some	O
differences	O
observed	O
between	O
tooth	O
types	O
could	O
be	O
partly	O
explained	O
by	O
the	O
level	O
of	O
plaque	O
.	O

Teeth	O
with	O
high	O
plaque	O
mass	O
exhibited	O
high	O
levels	O
of	O
Capnocytophaga	B-bacteria
gingivalis	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
2	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
and	O
Campylobacter	B-bacteria
showae	I-bacteria
.	O

However	O
,	O
certain	O
species	O
,	O
such	O
as	O
Veillonella	B-bacteria
parvula	I-bacteria
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
differed	O
significantly	O
at	O
different	O
tooth	O
locations	O
despite	O
similarities	O
in	O
plaque	O
mass	O
.	O

Twenty	O
of	O
the	O
test	O
species	O
exhibited	O
a	O
significant	O
association	O
with	O
tooth	O
location	O
after	O
adjusting	O
for	O
total	O
DNA	O
probe	O
count	O
and	O
subject	O
level	O
factors	O
.	O

While	O
plaque	O
mass	O
was	O
associated	O
with	O
differences	O
in	O
proportions	O
of	O
many	O
species	O
in	O
supragingival	O
biofilms	O
,	O
tooth	O
location	O
also	O
was	O
strongly	O
associated	O
with	O
species	O
proportions	O
in	O
both	O
univariate	O
and	O
multivariate	O
analyses	O
.	O

Treating	O
a	O
carious	O
tooth	O
in	O
children	O
with	O
high	O
caries	O
experience	O
by	O
providing	O
a	O
restoration	O
does	O
not	O
cure	O
the	O
disease	O
.	O

If	O
the	O
unfavorable	O
oral	O
environment	O
that	O
caused	O
the	O
cavity	O
persists	O
so	O
will	O
the	O
disease	O
and	O
more	O
restorations	O
will	O
be	O
required	O
in	O
future	O
.	O

Treating	O
the	O
oral	O
infection	O
by	O
reducing	O
the	O
number	O
of	O
cariogenic	O
microorganisms	O
and	O
establishing	O
a	O
favorable	O
oral	O
environment	O
to	O
promote	O
predominantly	O
remineralization	O
of	O
tooth	O
structure	O
over	O
time	O
will	O
stop	O
the	O
caries	O
process	O
.	O

The	O
present	O
study	O
was	O
conducted	O
:	O
(	O
1	O
)	O
To	O
evaluate	O
the	O
efficacy	O
of	O
povidone	O
-	O
iodine	O
and	O
chlorhexidine	O
mouth	O
rinses	O
on	O
plaque	O
Streptococcus	B-bacteria
mutans	I-bacteria
when	O
used	O
as	O
an	O
adjunct	O
to	O
restoration	O
.	O

(	O
2	O
)	O
To	O
compare	O
the	O
anti	O
-	O
microbial	O
effect	O
of	O
1	O
%	O
povidone	O
-	O
iodine	O
and	O
0	O
.	O
2	O
%	O
chlorhexidine	O
mouth	O
rinses	O
on	O
plaque	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
count	O
.	O

STUDY	O
Forty	O
-	O
five	O
study	O
participants	O
in	O
the	O
age	O
group	O
of	O
6	O
-	O
12	O
years	O
with	O
dmft	O
(	O
decay	O
component	O
)	O
of	O
three	O
or	O
four	O
were	O
selected	O
from	O
one	O
government	O
school	O
in	O
Bangalore	O
city	O
.	O

They	O
were	O
divided	O
into	O
three	O
groups	O
after	O
the	O
restorative	O
treatment	O
.	O

Group	O
-	O
A	O
,	O
Group	O
-	O
B	O
,	O
and	O
Group	O
-	O
C	O
received	O
1	O
%	O
povidone	O
-	O
iodine	O
mouth	O
rinse	O
,	O
0	O
.	O
2	O
%	O
chlorhexidine	O
mouth	O
rinse	O
and	O
placebo	O
mouth	O
rinse	O
,	O
respectively	O
,	O
twice	O
daily	O
for	O
14	O
days	O
.	O

The	O
plaque	O
sample	O
was	O
collected	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
count	O
was	O
estimated	O
at	O
six	O
phases	O
:	O
(	O
1	O
)	O
Baseline	O
,	O
(	O
2	O
)	O
3	O
weeks	O
after	O
restoration	O
,	O
(	O
3	O
)	O
First	O
day	O
after	O
mouth	O
rinse	O
therapy	O
,	O
(	O
4	O
)	O
15	O
days	O
after	O
mouth	O
rinse	O
therapy	O
,	O
(	O
5	O
)	O
1	O
month	O
and	O
(	O
6	O
)	O
3	O
months	O
after	O
mouth	O
rinse	O
therapy	O
After	O
the	O
restoration	O
the	O
percentage	O
change	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
count	O
was	O
28	O
.	O
4	O
%	O
.	O

Immediately	O
after	O
mouth	O
rinse	O
therapy	O
there	O
was	O
significant	O
reduction	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
count	O
in	O
all	O
the	O
three	O
groups	O
.	O

After	O
which	O
the	O
count	O
started	O
to	O
increase	O
gradually	O
and	O
after	O
3	O
months	O
the	O
bacterial	O
counts	O
in	O
the	O
povidone	O
-	O
iodine	O
group	O
and	O
placebo	O
group	O
were	O
almost	O
near	O
the	O
postrestorative	O
count	O
.	O

Mouth	O
rinses	O
can	O
be	O
used	O
as	O
adjunct	O
to	O
restoration	O
for	O
short	O
duration	O
as	O
temporary	O
measure	O
in	O
reduction	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
count	O
and	O
restorations	O
provide	O
longer	O
effect	O
.	O

In	O
case	O
a	O
mouth	O
rinse	O
has	O
to	O
be	O
used	O
,	O
chlorhexidine	O
can	O
be	O
recommended	O
as	O
it	O
has	O
shown	O
to	O
have	O
better	O
effect	O
than	O
Povidone	O
-	O
iodine	O
and	O
placebo	O
.	O

Periodontitis	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
cardiovascular	O
diseases	O
(	O
CVD	O
)	O
,	O
but	O
the	O
underlying	O
mechanisms	O
are	O
poorly	O
understood	O
.	O

Recently	O
,	O
we	O
showed	O
that	O
platelets	O
from	O
periodontitis	O
patients	O
are	O
more	O
activated	O
than	O
those	O
from	O
controls	O
.	O

Given	O
the	O
regularly	O
occurring	O
bacteremic	O
episodes	O
in	O
periodontitis	O
patients	O
,	O
we	O
hypothesized	O
that	O
platelets	O
and	O
/	O
or	O
leukocytes	O
from	O
periodontitis	O
patients	O
are	O
more	O
sensitive	O
to	O
stimulation	O
by	O
oral	O
bacteria	O
,	O
in	O
particular	O
the	O
known	O
periodontal	O
pathogens	O
,	O
than	O
platelets	O
from	O
control	O
subjects	O
.	O

Three	O
-	O
color	O
flow	O
cytometry	O
analysis	O
was	O
performed	O
to	O
quantify	O
activation	O
of	O
platelets	O
(	O
P	O
-	O
selectin	O
,	O
PAC	O
-	O
1	O
,	O
CD63	O
)	O
and	O
leukocytes	O
(	O
CD11b	O
)	O
in	O
whole	O
blood	O
from	O
patients	O
with	O
periodontitis	O
(	O
n	O
=	O
19	O
)	O
and	O
controls	O
(	O
n	O
=	O
18	O
)	O
,	O
with	O
and	O
without	O
stimulation	O
by	O
oral	O
bacteria	O
.	O

Phagocytosis	O
was	O
assessed	O
by	O
using	O
green	O
-	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
-	O
expressing	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
Aa	B-bacteria
)	O
.	O

Neutrophils	O
and	O
monocytes	O
were	O
activated	O
by	O
all	O
species	O
of	O
oral	O
bacteria	O
tested	O
,	O
but	O
no	O
differences	O
were	O
observed	O
between	O
patients	O
and	O
controls	O
.	O

In	O
response	O
to	O
several	O
species	O
of	O
oral	O
bacteria	O
,	O
platelets	O
from	O
periodontitis	O
patients	O
showed	O
,	O
compared	O
with	O
controls	O
,	O
increased	O
exposure	O
of	O
P	O
-	O
selectin	O
(	O
P	O
=	O
0	O
.	O
027	O
)	O
and	O
increased	O
formation	O
of	O
platelet	O
-	O
monocyte	O
complexes	O
(	O
P	O
=	O
0	O
.	O
040	O
)	O
.	O

Platelet	O
-	O
leukocyte	O
complexes	O
bound	O
and	O
/	O
or	O
phagocytosed	O
more	O
GFP	O
-	O
Aa	O
than	O
platelet	O
-	O
free	O
leukocytes	O
(	O
for	O
neutrophils	O
and	O
monocytes	O
,	O
in	O
both	O
patients	O
and	O
controls	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

In	O
periodontitis	O
,	O
increased	O
platelet	O
response	O
to	O
oral	O
bacteria	O
is	O
paralleled	O
by	O
increased	O
formation	O
of	O
platelet	O
-	O
leukocyte	O
complexes	O
with	O
elevated	O
capacity	O
for	O
bacterial	O
clearance	O
.	O

We	O
speculate	O
that	O
activated	O
platelets	O
and	O
leukocytes	O
might	O
contribute	O
to	O
increased	O
atherothrombotic	O
activity	O
.	O

Ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
is	O
usually	O
caused	O
by	O
aspiration	O
of	O
pathogenic	O
bacteria	O
from	O
the	O
oropharynx	O
.	O

Oral	O
decontamination	O
with	O
antiseptics	O
,	O
such	O
as	O
chlorhexidine	O
(	O
CHX	O
)	O
or	O
antibiotics	O
,	O
has	O
been	O
used	O
as	O
prophylaxis	O
against	O
this	O
complication	O
.	O

We	O
hypothesised	O
that	O
the	O
probiotic	O
bacteria	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
299	I-bacteria
(	O
Lp299	B-bacteria
)	O
would	O
be	O
as	O
efficient	O
as	O
CHX	O
in	O
reducing	O
the	O
pathogenic	O
bacterial	O
load	O
in	O
the	O
oropharynx	O
of	O
tracheally	O
intubated	O
,	O
mechanically	O
ventilated	O
,	O
critically	O
ill	O
patients	O
.	O

Fifty	O
critically	O
ill	O
patients	O
on	O
mechanical	O
ventilation	O
were	O
randomised	O
to	O
either	O
oral	O
mechanical	O
cleansing	O
followed	O
by	O
washing	O
with	O
0	O
.	O
1	O
%	O
CHX	O
solution	O
or	O
to	O
the	O
same	O
cleansing	O
procedure	O
followed	O
by	O
oral	O
application	O
of	O
an	O
emulsion	O
of	O
Lp299	B-bacteria
.	O

Samples	O
for	O
microbiological	O
analyses	O
were	O
taken	O
from	O
the	O
oropharynx	O
and	O
trachea	O
at	O
inclusion	O
and	O
at	O
defined	O
intervals	O
thereafter	O
.	O

Potentially	O
pathogenic	O
bacteria	O
that	O
were	O
not	O
present	O
at	O
inclusion	O
were	O
identified	O
in	O
oropharyngeal	O
samples	O
from	O
eight	O
of	O
the	O
patients	O
treated	O
with	O
Lp299	O
and	O
13	O
of	O
those	O
treated	O
with	O
CHX	O
(	O
p	O
=	O
0	O
.	O
13	O
)	O
.	O

Analysis	O
of	O
tracheal	O
samples	O
yielded	O
similar	O
results	O
.	O

Lp299	B-bacteria
was	O
recovered	O
from	O
the	O
oropharynx	O
of	O
all	O
patients	O
in	O
the	O
Lp299	B-bacteria
group	O
.	O

In	O
this	O
pilot	O
study	O
,	O
we	O
found	O
no	O
difference	O
between	O
the	O
effect	O
of	O
Lp299	B-bacteria
and	O
CHX	O
used	O
in	O
oral	O
care	O
procedures	O
,	O
when	O
we	O
examined	O
the	O
effects	O
of	O
those	O
agents	O
on	O
colonisation	O
of	O
potentially	O
pathogenic	O
bacteria	O
in	O
the	O
oropharynx	O
of	O
intubated	O
,	O
mechanically	O
ventilated	O
patients	O
.	O

Processing	O
of	O
bronchoscopes	O
after	O
a	O
physical	O
examination	O
has	O
to	O
eliminate	O
all	O
micro	O
-	O
organisms	O
that	O
could	O
have	O
contaminated	O
the	O
endoscope	O
and	O
that	O
may	O
harm	O
the	O
following	O
patient	O
.	O

The	O
aim	O
of	O
this	O
analysis	O
is	O
to	O
define	O
those	O
micro	O
-	O
organisms	O
that	O
may	O
contaminate	O
the	O
bronchoscope	O
during	O
the	O
examination	O
and	O
that	O
may	O
cause	O
disease	O
in	O
other	O
patients	O
.	O

Research	O
of	O
literature	O
and	O
analysis	O
of	O
laboratory	O
data	O
.	O

During	O
the	O
passage	O
of	O
the	O
respiratory	O
tract	O
the	O
bronchoscope	O
will	O
be	O
contaminated	O
by	O
the	O
physiological	O
flora	O
of	O
oral	O
cavity	O
,	O
nasopharynx	O
,	O
trachea	O
,	O
bronchi	O
,	O
and	O
pulmonary	O
tissues	O
.	O

Whilst	O
the	O
oral	O
cavity	O
,	O
the	O
nasopharynx	O
and	O
the	O
pharynx	O
are	O
the	O
habitat	O
for	O
a	O
great	O
variety	O
of	O
bacteria	O
the	O
lower	O
respiratory	O
tract	O
is	O
virtually	O
free	O
of	O
micro	O
-	O
organisms	O
.	O

However	O
,	O
in	O
ventilated	O
patients	O
trachea	O
and	O
bronchi	O
can	O
become	O
colonized	O
as	O
the	O
result	O
of	O
bypassing	O
the	O
cleansing	O
effect	O
of	O
the	O
ciliated	O
epithelium	O
.	O

In	O
addition	O
all	O
agents	O
that	O
can	O
cause	O
bronchitis	O
or	O
pneumonia	O
in	O
immunocompromised	O
or	O
otherwise	O
healthy	O
individuals	O
are	O
potential	O
contaminants	O
of	O
bronchoscopes	O
.	O

These	O
microorganisms	O
include	O
bacteria	O
,	O
mycobacteria	B-bacteria
,	O
yeasts	O
and	O
moulds	O
,	O
enveloped	O
and	O
non	O
-	O
enveloped	O
viruses	O
and	O
rarely	O
parasites	O
.	O

The	O
bronchoscopic	O
procedure	O
can	O
result	O
in	O
epithelial	O
injury	O
with	O
subsequent	O
bleeding	O
.	O

Therefore	O
,	O
all	O
blood	O
-	O
borne	O
pathogens	O
,	O
e	O
.	O
g	O
.	O
HIV	O
or	O
HBV	O
are	O
also	O
potential	O
contaminants	O
of	O
the	O
bronchoscope	O
.	O

There	O
are	O
several	O
reports	O
of	O
transmission	O
of	O
micro	O
-	O
organisms	O
due	O
to	O
incomplete	O
or	O
faulty	O
cleaning	O
and	O
disinfection	O
procedures	O
of	O
bronchoscopes	O
.	O

These	O
incidents	O
include	O
nearly	O
all	O
classes	O
of	O
micro	O
-	O
organisms	O
but	O
not	O
parasites	O
or	O
viruses	O
.	O

However	O
,	O
the	O
incubation	O
period	O
of	O
viruses	O
can	O
be	O
long	O
and	O
the	O
association	O
between	O
bronchoscopy	O
and	O
infection	O
may	O
be	O
obscure	O
.	O

Endospore	O
forming	O
micro	O
-	O
organisms	O
and	O
parasites	O
are	O
not	O
part	O
of	O
the	O
normal	O
flora	O
of	O
the	O
respiratory	O
tract	O
and	O
may	O
rarely	O
cause	O
disease	O
,	O
usually	O
only	O
in	O
severely	O
immunocompromised	O
patients	O
,	O
but	O
transmission	O
of	O
such	O
organisms	O
by	O
bronchoscopy	O
has	O
never	O
been	O
reported	O
.	O

The	O
antimicrobial	O
activity	O
of	O
the	O
disinfection	O
process	O
,	O
including	O
chemical	O
disinfectants	O
for	O
endoscopes	O
has	O
to	O
include	O
bacteria	O
,	O
fungi	O
and	O
viruses	O
.	O

Sporicidal	O
activity	O
may	O
be	O
only	O
warranted	O
in	O
specific	O
patient	O
populations	O
,	O
i	O
.	O
e	O
.	O
after	O
bronchoscopy	O
of	O
suspected	O
anthrax	O
patients	O
or	O
before	O
examination	O
of	O
severely	O
immunocompromised	O
patients	O
.	O

To	O
investigate	O
the	O
probiotic	O
characteristics	O
of	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
(	I-bacteria
L	I-bacteria
.	I-bacteria
plantarum	I-bacteria
)	I-bacteria
HO	I-bacteria
-	I-bacteria
69	I-bacteria
in	O
oral	O
cavity	O
.	O

The	O
adhesion	O
ratios	O
to	O
teeth	O
and	O
dentine	O
surface	O
were	O
determined	O
by	O
in	O
vitro	O
models	O
.	O

Hydrophobicity	O
and	O
surface	O
charges	O
were	O
measured	O
by	O
MATH	O
method	O
.	O

Inhibitory	O
activity	O
was	O
measured	O
by	O
agar	O
well	O
diffusion	O
method	O
.	O

The	O
adhesion	O
ratios	O
to	O
hard	O
tissue	O
were	O
quite	O
low	O
.	O

The	O
hydrophobicity	O
and	O
surface	O
charges	O
were	O
high	O
,	O
and	O
it	O
exhibited	O
inhibitory	O
activity	O
against	O
some	O
pathogens	O
.	O

The	O
probability	O
is	O
low	O
for	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
HO	I-bacteria
-	I-bacteria
69	I-bacteria
to	O
initiate	O
or	O
accelerate	O
dental	O
caries	O
.	O

It	O
shows	O
broad	O
-	O
spectrum	O
inhibitory	O
activity	O
and	O
is	O
potential	O
probiotics	O
applied	O
in	O
oral	O
cavity	O
.	O

In	O
this	O
paper	O
we	O
have	O
developed	O
a	O
model	O
of	O
antimicrobial	O
effect	O
of	O
gramicidin	O
S	O
.	O
This	O
model	O
has	O
allowed	O
us	O
to	O
predict	O
the	O
dependence	O
of	O
antimicrobial	O
effect	O
of	O
the	O
drug	O
applied	O
as	O
oral	O
melting	O
tablets	O
on	O
dosage	O
,	O
time	O
of	O
resorption	O
and	O
minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
the	O
drug	O
characterizing	O
its	O
ability	O
to	O
kill	O
different	O
bacteria	O
.	O

The	O
model	O
has	O
been	O
employed	O
to	O
optimize	O
dosing	O
regime	O
of	O
gramicidin	O
S	O
containing	O
drug	O
Grammidin	O
.	O

Efficacy	O
of	O
the	O
drug	O
has	O
been	O
studied	O
for	O
the	O
diverse	O
gram	O
-	O
positive	O
and	O
gram	O
-	O
negative	O
bacteria	O
with	O
different	O
MIC	O
.	O

The	O
number	O
of	O
bacteria	O
located	O
in	O
the	O
oral	O
cavity	O
and	O
killed	O
by	O
one	O
-	O
pass	O
administration	O
of	O
the	O
drug	O
(	O
resolution	O
of	O
one	O
tablet	O
)	O
has	O
been	O
calculated	O
under	O
condition	O
of	O
various	O
dosing	O
regimes	O
.	O

Based	O
on	O
the	O
simulation	O
results	O
it	O
has	O
been	O
found	O
that	O
(	O
1	O
)	O
twofold	O
prolongation	O
of	O
prescribed	O
resorption	O
time	O
(	O
from	O
30	O
to	O
60min	O
)	O
of	O
the	O
tablet	O
comprising	O
standard	O
dosage	O
of	O
3mg	O
of	O
gramicidin	O
S	O
results	O
in	O
1	O
.	O
5	O
-	O
fold	O
increase	O
in	O
efficacy	O
,	O
(	O
2	O
)	O
1	O
.	O
5	O
-	O
fold	O
decrease	O
in	O
gramicidin	O
S	O
dosage	O
(	O
from	O
3	O
to	O
2mg	O
per	O
administration	O
)	O
under	O
condition	O
of	O
holding	O
prescribed	O
resorption	O
time	O
(	O
30min	O
)	O
does	O
not	O
lead	O
to	O
any	O
considerable	O
decrease	O
in	O
the	O
efficacy	O
of	O
the	O
drug	O
.	O

Lactobacillus	B-bacteria
paracasei	I-bacteria
KW3110	I-bacteria
is	O
a	O
strain	O
which	O
has	O
been	O
reported	O
to	O
possess	O
a	O
strong	O
antiallergic	O
activity	O
.	O

Since	O
many	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
have	O
shown	O
to	O
be	O
useful	O
as	O
the	O
probiotics	O
,	O
the	O
possibility	O
of	O
this	O
strain	O
for	O
use	O
as	O
a	O
probiotic	O
was	O
studied	O
.	O

An	O
in	O
vitro	O
test	O
showed	O
that	O
this	O
strain	O
is	O
strong	O
enough	O
to	O
survive	O
in	O
the	O
gastric	O
juice	O
.	O

In	O
addition	O
,	O
this	O
strain	O
showed	O
exceptionally	O
strong	O
adherence	O
to	O
human	O
intestinal	O
epithelial	O
cells	O
,	O
Caco	O
-	O
2	O
and	O
HT29	O
compared	O
to	O
normal	O
L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
strains	I-bacteria
.	O

Human	O
oral	O
administration	O
testing	O
of	O
L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
KW3110	I-bacteria
showed	O
that	O
this	O
strain	O
survived	O
in	O
the	O
human	O
gut	O
and	O
increased	O
the	O
number	O
of	O
bifidobacteria	B-bacteria
and	O
lactobacilli	B-bacteria
in	O
the	O
fecal	O
samples	O
of	O
the	O
subjects	O
.	O

In	O
addition	O
,	O
KW	B-bacteria
3110	I-bacteria
was	O
detected	O
in	O
50	O
%	O
of	O
the	O
subjects	O
up	O
to	O
1	O
week	O
after	O
the	O
end	O
of	O
the	O
administration	O
test	O
.	O

These	O
results	O
showed	O
that	O
L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
KW3110	I-bacteria
has	O
a	O
strong	O
ability	O
to	O
survive	O
in	O
and	O
colonize	O
the	O
human	O
gut	O
and	O
improve	O
the	O
human	O
intestinal	O
microflora	O
.	O

Pseudomonas	B-bacteria
aeruginosa	I-bacteria
is	O
an	O
important	O
opportunistic	O
bacterial	O
pathogen	O
,	O
causing	O
infections	O
of	O
the	O
respiratory	O
and	O
other	O
organ	O
systems	O
in	O
susceptible	O
hosts	O
.	O

P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
infection	O
is	O
initiated	O
by	O
adhesion	O
to	O
and	O
invasion	O
of	O
mucosal	O
epithelial	O
cells	O
.	O

The	O
failure	O
of	O
host	O
defenses	O
to	O
eliminate	O
P	O
.	O
aeruginosa	O
from	O
mucosal	O
surfaces	O
results	O
in	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
proliferation	O
,	O
sometimes	O
followed	O
by	O
overt	O
infection	O
and	O
tissue	O
destruction	O
.	O

There	O
is	O
growing	O
evidence	O
that	O
associates	O
poor	O
oral	O
health	O
and	O
respiratory	O
infection	O
.	O

An	O
in	O
vitro	O
model	O
system	O
for	O
bacterial	O
invasion	O
of	O
respiratory	O
epithelial	O
cells	O
was	O
used	O
to	O
investigate	O
the	O
influence	O
of	O
oral	O
bacteria	O
on	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
epithelial	O
cell	O
invasion	O
.	O

Oral	O
pathogens	O
including	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Aggregatibacter	B-bacteria
(	I-bacteria
Actinobacillus	I-bacteria
)	I-bacteria
actinomycetemcomitans	I-bacteria
increased	O
invasion	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
into	O
HEp	O
-	O
2	O
cells	O
from	O
one	O
-	O
to	O
threefold	O
.	O

In	O
contrast	O
,	O
non	O
-	O
pathogenic	O
oral	O
bacteria	O
such	O
as	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
showed	O
no	O
significant	O
influence	O
on	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
invasion	O
.	O

P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
together	O
with	O
oral	O
bacteria	O
stimulated	O
greater	O
cytokine	O
production	O
from	O
HEp	O
-	O
2	O
cells	O
than	O
did	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
alone	O
.	O

P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
in	O
combination	O
with	O
periodontal	O
pathogens	O
also	O
increased	O
apoptosis	O
of	O
HEp	O
-	O
2	O
cells	O
and	O
induced	O
elevated	O
caspase	O
-	O
3	O
activity	O
.	O

These	O
results	O
suggest	O
that	O
oral	O
bacteria	O
,	O
especially	O
periodontal	O
pathogens	O
,	O
may	O
foster	O
P	B-bacteria
.	I-bacteria
aeruginos	I-bacteria
invasion	O
into	O
respiratory	O
epithelial	O
cells	O
to	O
enhance	O
host	O
cell	O
cytokine	O
release	O
and	O
apoptosis	O
.	O

Many	O
of	O
the	O
protective	O
immune	O
responses	O
of	O
old	O
people	O
are	O
impaired	O
and	O
this	O
leads	O
to	O
an	O
increased	O
risk	O
of	O
oral	O
bacterial	O
infections	O
.	O

Little	O
is	O
known	O
about	O
the	O
interaction	O
between	O
the	O
systemic	O
immune	O
response	O
on	O
one	O
hand	O
and	O
oral	O
infections	O
and	O
oral	O
diseases	O
on	O
the	O
other	O
.	O

Here	O
,	O
we	O
conducted	O
an	O
epidemiological	O
study	O
of	O
the	O
independent	O
elderly	O
to	O
determine	O
the	O
relationships	O
between	O
activated	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
and	O
oral	O
bacterial	O
infections	O
:	O
oral	O
diseases	O
such	O
as	O
dental	O
caries	O
and	O
periodontal	O
disease	O
.	O

One	O
hundred	O
independent	O
elderly	O
people	O
aged	O
77	O
years	O
old	O
(	O
53	O
males	O
,	O
47	O
females	O
)	O
were	O
examined	O
.	O

Blood	O
samples	O
were	O
drawn	O
,	O
and	O
activated	O
NK	O
cells	O
were	O
evaluated	O
using	O
CD16	O
,	O
CD56	O
,	O
and	O
CD69	O
monoclonal	O
antibodies	O
with	O
flow	O
cytometry	O
.	O

Bacterial	O
counts	O
for	O
oral	O
streptococci	B-bacteria
,	O
lactobacillus	B-bacteria
,	O
and	O
opportunistic	O
pathogens	O
were	O
performed	O
using	O
culture	O
techniques	O
.	O

Oral	O
disease	O
examinations	O
were	O
performed	O
by	O
dentists	O
.	O

A	O
larger	O
percentage	O
of	O
CD69	O
(	O
+	O
)	O
NK	O
cells	O
(	O
CD16	O
(	O
+	O
)	O
CD56	O
(	O
+	O
)	O
)	O
showed	O
significant	O
correlations	O
to	O
the	O
isolation	O
numbers	O
of	O
total	O
streptococci	B-bacteria
(	O
r	O
=	O
0	O
.	O
409	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
the	O
species	O
numbers	O
of	O
opportunistic	O
pathogens	O
(	O
r	O
=	O
-	O
0	O
.	O
318	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
the	O
numbers	O
of	O
decayed	O
teeth	O
(	O
r	O
=	O
-	O
0	O
.	O
223	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
the	O
amount	O
of	O
bridge	O
work	O
(	O
r	O
=	O
0	O
.	O
219	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

A	O
higher	O
proportion	O
of	O
CD69	O
(	O
+	O
)	O
NK	O
cells	O
is	O
associated	O
with	O
the	O
incidence	O
of	O
dental	O
caries	O
and	O
the	O
number	O
of	O
opportunistic	O
pathogens	O
and	O
total	O
streptococci	B-bacteria
in	O
the	O
oral	O
cavity	O
of	O
the	O
elderly	O
.	O

This	O
suggests	O
that	O
the	O
proportionate	O
number	O
of	O
CD69	O
(	O
+	O
)	O
NK	O
cells	O
may	O
be	O
a	O
useful	O
indicator	O
for	O
oral	O
infection	O
in	O
elderly	O
subjects	O
.	O

Lactobacilli	B-bacteria
were	O
isolated	O
from	O
oral	O
cavity	O
of	O
healthy	O
children	O
and	O
identified	O
by	O
using	O
standard	O
bacteriological	O
methods	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
show	O
the	O
prevalent	O
of	O
Lactobacilli	B-bacteria
in	O
the	O
oral	O
cavity	O
and	O
to	O
emphasis	O
on	O
the	O
antagonistic	O
activity	O
of	O
oral	O
Lactobacilli	B-bacteria
on	O
oral	O
pathogens	O
.	O

Our	O
results	O
revealed	O
that	O
a	O
variety	O
of	O
lactobacillus	B-bacteria
species	I-bacteria
were	O
inhabited	O
the	O
healthy	O
oral	O
cavity	O
of	O
children	O
and	O
quantitative	O
assay	O
using	O
Lactobacillus	B-bacteria
filtered	O
supernatant	O
is	O
more	O
reliable	O
than	O
Lactobacillus	B-bacteria
non	O
filtered	O
supernatant	O
for	O
screening	O
of	O
in	O
vitro	O
antagonistic	O
activity	O
.	O

Recent	O
studies	O
suggest	O
an	O
association	O
between	O
sciatica	O
and	O
Propionibacterium	B-bacteria
acnes	I-bacteria
.	O

`	O
`	O
Modic	O
type	O
I	O
changes	O
'	O
'	O
in	O
the	O
vertebrae	O
are	O
closely	O
associated	O
with	O
sciatica	O
and	O
lower	O
back	O
pain	O
,	O
and	O
recent	O
studies	O
have	O
questioned	O
the	O
ability	O
of	O
conventional	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
to	O
differentiate	O
between	O
degenerative	O
Modic	O
type	O
I	O
changes	O
and	O
vertebral	O
abnormalities	O
caused	O
by	O
infection	O
.	O

To	O
test	O
whether	O
bacteria	O
could	O
be	O
cultured	O
from	O
biopsies	O
of	O
Modic	O
type	O
I	O
changes	O
.	O

Twenty	O
-	O
four	O
consecutive	O
patients	O
with	O
Modic	O
type	O
I	O
changes	O
in	O
lumbar	O
vertebrae	O
had	O
a	O
biopsy	O
taken	O
from	O
the	O
affected	O
vertebra	O
by	O
a	O
strict	O
aseptic	O
procedure	O
.	O

The	O
biopsy	O
was	O
split	O
into	O
two	O
specimens	O
,	O
which	O
were	O
inoculated	O
into	O
thioglycolate	O
agar	O
tubes	O
in	O
the	O
surgical	O
theatre	O
and	O
transported	O
to	O
the	O
microbiology	O
laboratory	O
.	O

In	O
the	O
laboratory	O
,	O
one	O
specimen	O
was	O
streaked	O
onto	O
plates	O
and	O
analyzed	O
for	O
anaerobic	O
and	O
aerobic	O
culture	O
.	O

The	O
other	O
tube	O
was	O
left	O
unopened	O
and	O
incubated	O
directly	O
.	O

Plates	O
and	O
tubes	O
were	O
incubated	O
for	O
2	O
weeks	O
and	O
observed	O
for	O
visible	O
growth	O
.	O

None	O
of	O
the	O
biopsies	O
yielded	O
growth	O
of	O
anaerobic	O
bacteria	O
.	O

In	O
one	O
patient	O
,	O
both	O
biopsies	O
yielded	O
growth	O
of	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
,	O
and	O
in	O
another	O
patient	O
coagulase	O
-	O
negative	O
staphylococci	B-bacteria
were	O
isolated	O
from	O
one	O
biopsy	O
.	O

Both	O
patients	O
received	O
oral	O
antibiotics	O
without	O
convincing	O
effect	O
on	O
symptoms	O
.	O

Our	O
results	O
showed	O
no	O
evidence	O
of	O
bacteria	O
in	O
vertebrae	O
with	O
Modic	O
type	O
I	O
changes	O
.	O

The	O
isolation	O
of	O
staphylococci	B-bacteria
from	O
two	O
patients	O
probably	O
represented	O
contamination	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
strict	O
supragingival	O
plaque	O
control	O
on	O
the	O
subgingival	O
microbiota	O
in	O
smokers	O
and	O
never	O
-	O
smokers	O
.	O

Research	O
into	O
the	O
impact	O
of	O
supragingival	O
plaque	O
control	O
on	O
the	O
number	O
of	O
subgingival	O
bacteria	O
has	O
resulted	O
in	O
contradictory	O
findings	O
.	O

Real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
has	O
been	O
suggested	O
as	O
a	O
valid	O
alternative	O
to	O
current	O
microbiologic	O
methods	O
based	O
on	O
bacteria	O
cultures	O
.	O

Forty	O
-	O
five	O
subjects	O
with	O
chronic	O
periodontitis	O
were	O
selected	O
.	O

Twenty	O
-	O
four	O
of	O
them	O
had	O
never	O
smoked	O
,	O
and	O
21	O
were	O
active	O
smokers	O
.	O

Four	O
sites	O
per	O
patient	O
were	O
selected	O
for	O
sampling	O
.	O

Supragingival	O
debridement	O
was	O
performed	O
at	O
baseline	O
,	O
and	O
the	O
subjects	O
received	O
weekly	O
instructions	O
on	O
oral	O
hygiene	O
for	O
180	O
days	O
.	O

A	O
clinical	O
examination	O
and	O
subgingival	O
plaque	O
sampling	O
were	O
carried	O
out	O
at	O
baseline	O
and	O
at	O
30	O
,	O
90	O
,	O
and	O
180	O
days	O
.	O

A	O
real	O
-	O
time	O
PCR	O
assay	O
was	O
used	O
to	O
detect	O
and	O
quantify	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
(	O
previously	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
or	O
Micromonas	B-bacteria
micros	I-bacteria
)	O
,	O
Dialister	B-bacteria
pneumosintes	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
and	O
the	O
total	O
bacteria	O
load	O
(	O
eubacteria	O
)	O
in	O
the	O
subgingival	O
samples	O
.	O

Statistical	O
analysis	O
was	O
performed	O
using	O
linear	O
models	O
adjusted	O
for	O
the	O
clustering	O
of	O
observations	O
within	O
individuals	O
.	O

Smokers	O
and	O
never	O
-	O
smokers	O
exhibited	O
a	O
similar	O
and	O
significant	O
reduction	O
in	O
total	O
bacteria	O
counts	O
over	O
time	O
.	O

Irrespective	O
of	O
smoking	O
status	O
,	O
deep	O
sites	O
consistently	O
harbored	O
greater	O
quantities	O
of	O
total	O
bacteria	O
throughout	O
the	O
study	O
.	O

Higher	O
numbers	O
of	O
the	O
bacteria	O
investigated	O
were	O
associated	O
with	O
bleeding	O
on	O
probing	O
.	O

Supragingival	O
plaque	O
control	O
markedly	O
reduced	O
subgingival	O
microbiota	O
counts	O
in	O
smokers	O
and	O
never	O
-	O
smokers	O
.	O

The	O
bacterial	O
colonization	O
of	O
the	O
oral	O
mucosa	O
was	O
evaluated	O
in	O
patients	O
with	O
asymptomatic	O
oral	O
lichen	O
planus	O
(	O
OLP	O
)	O
and	O
compared	O
to	O
the	O
microbiologic	O
status	O
in	O
mucosally	O
healthy	O
subjects	O
.	O

Bacteria	O
from	O
patients	O
with	O
clinically	O
and	O
histopathologically	O
diagnosed	O
OLP	O
from	O
the	O
Stomatology	O
Service	O
,	O
Department	O
of	O
Oral	O
Surgery	O
and	O
Stomatology	O
,	O
School	O
of	O
Dental	O
Medicine	O
,	O
University	O
of	O
Bern	O
,	O
were	O
collected	O
with	O
a	O
non	O
-	O
invasive	O
swab	O
system	O
.	O

Samples	O
were	O
taken	O
from	O
OLP	O
lesions	O
on	O
the	O
gingiva	O
and	O
from	O
non	O
-	O
affected	O
sites	O
on	O
the	O
contralateral	O
side	O
of	O
the	O
mouth	O
.	O

The	O
control	O
population	O
did	O
not	O
have	O
OLP	O
and	O
was	O
recruited	O
from	O
the	O
student	O
clinic	O
.	O

All	O
samples	O
were	O
processed	O
with	O
the	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
method	O
using	O
well	O
-	O
defined	O
bacterial	O
species	O
for	O
the	O
analysis	O
.	O

Significantly	O
higher	O
bacterial	O
counts	O
of	O
Bacteroides	B-bacteria
ureolyticus	I-bacteria
(	O
P	O
=	O
0	O
.	O
001	O
)	O
,	O
Dialister	B-bacteria
species	I-bacteria
(	O
sp	O
.	O
)	O

(	O
P	O
=	O
0	O
.	O
006	O
)	O
,	O
Staphylococcus	B-bacteria
haemolyticus	I-bacteria
(	O
P	O
=	O
0	O
.	O
007	O
)	O
,	O
and	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
(	O
P	O
=	O
0	O
.	O
006	O
)	O
were	O
found	O
in	O
samples	O
taken	O
from	O
OLP	O
lesions	O
compared	O
to	O
sites	O
with	O
no	O
clinical	O
evidence	O
of	O
OLP	O
.	O

Significantly	O
higher	O
bacterial	O
counts	O
were	O
found	O
for	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Lactobacillus	B-bacteria
crispatus	I-bacteria
,	O
Mobiluncus	B-bacteria
curtisii	I-bacteria
,	O
Neisseria	B-bacteria
mucosa	I-bacteria
,	O
Prevotella	B-bacteria
bivia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
agalactiae	I-bacteria
at	O
sites	O
with	O
lesions	O
in	O
subjects	O
with	O
OLP	O
compared	O
to	O
sites	O
in	O
control	O
subjects	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Microbiologic	O
differences	O
were	O
found	O
between	O
sites	O
with	O
OLP	O
and	O
sites	O
in	O
subjects	O
without	O
a	O
diagnosis	O
of	O
OLP	O
.	O

Specifically	O
,	O
higher	O
counts	O
of	O
staphylococci	B-bacteria
and	O
S	B-bacteria
.	I-bacteria
agalactiae	I-bacteria
were	O
found	O
in	O
OLP	O
lesions	O
.	O

Bacteriological	O
air	O
sampling	O
was	O
conducted	O
at	O
25	O
dental	O
units	O
during	O
restorative	O
treatment	O
sessions	O
before	O
and	O
after	O
disinfection	O
of	O
dental	O
unit	O
waterlines	O
(	O
DUWL	O
)	O
with	O
hydrogen	O
peroxide	O
.	O

Air	O
samples	O
for	O
determining	O
the	O
concentration	O
and	O
species	O
composition	O
of	O
aerobic	O
and	O
facultatively	O
anaerobic	O
bacteria	O
were	O
collected	O
with	O
the	O
portable	O
Reuter	O
Centrifugal	O
Sampler	O
(	O
RCS	O
Plus	O
)	O
in	O
the	O
dental	O
operation	O
area	O
close	O
to	O
patient	O
'	O
s	O
mouth	O
.	O

Large	O
concentrations	O
of	O
airborne	O
bacteria	O
in	O
the	O
range	O
of	O
0	O
.	O
35	O
-	O
40	O
.	O
08	O
x	O
10	O
(	O
3	O
)	O
cfu	O
/	O
m	O
(	O
3	O
)	O
(	O
median	O
=	O
1	O
.	O
63	O
x	O
10	O
(	O
3	O
)	O
cfu	O
/	O
m	O
(	O
3	O
)	O
)	O
were	O
recorded	O
before	O
DUWL	O
disinfection	O
.	O

After	O
disinfection	O
,	O
the	O
concentrations	O
were	O
significantly	O
lower	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
ranging	O
from	O
0	O
.	O
51	O
-	O
3	O
.	O
82	O
x	O
10	O
(	O
3	O
)	O
cfu	O
/	O
m	O
(	O
3	O
)	O
(	O
median	O
=	O
0	O
.	O
9	O
x	O
10	O
(	O
3	O
)	O
cfu	O
/	O
m	O
(	O
3	O
)	O
)	O
.	O

Streptococci	B-bacteria
were	O
most	O
numerous	O
among	O
airborne	O
bacteria	O
before	O
DUWL	O
disinfection	O
,	O
forming	O
79	O
.	O
23	O
%	O
of	O
total	O
isolates	O
.	O

The	O
remaining	O
isolates	O
were	O
staphylococci	B-bacteria
/	O
micrococci	B-bacteria
(	O
15	O
.	O
7	O
%	O
)	O
,	O
corynebacteria	B-bacteria
(	O
2	O
.	O
3	O
%	O
)	O
,	O
endospore	O
-	O
forming	O
bacilli	O
(	O
1	O
.	O
45	O
%	O
)	O
,	O
Gram	O
-	O
negative	O
bacteria	O
(	O
1	O
.	O
31	O
%	O
)	O
,	O
and	O
actinomycetes	B-bacteria
(	O
0	O
.	O
01	O
%	O
)	O
.	O

After	O
DUWL	O
disinfection	O
,	O
a	O
significant	O
decrease	O
in	O
the	O
numbers	O
of	O
streptococci	B-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
Gram	O
-	O
negative	O
bacteria	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
was	O
noted	O
,	O
while	O
the	O
numbers	O
of	O
other	O
types	O
of	O
bacteria	O
were	O
unaffected	O
.	O

Altogether	O
,	O
50	O
species	O
or	O
genera	O
of	O
bacteria	O
were	O
identified	O
in	O
the	O
examined	O
air	O
samples	O
before	O
and	O
after	O
DUWL	O
disinfection	O
.	O

Of	O
these	O
,	O
36	O
species	O
or	O
genera	O
are	O
considered	O
potentially	O
pathogenic	O
,	O
as	O
a	O
potential	O
cause	O
of	O
infection	O
,	O
allergic	O
disease	O
or	O
intoxication	O
.	O

In	O
conclusion	O
,	O
the	O
high	O
pollution	O
of	O
dental	O
operation	O
area	O
with	O
bacteria	O
indicates	O
a	O
need	O
for	O
use	O
of	O
preventive	O
measures	O
protecting	O
dental	O
staff	O
and	O
patients	O
,	O
such	O
as	O
DUWL	O
disinfection	O
that	O
proved	O
efficient	O
in	O
decrease	O
of	O
exposure	O
in	O
the	O
present	O
study	O
.	O

Periodontitis	O
is	O
an	O
inflammatory	O
disease	O
of	O
the	O
supporting	O
tissues	O
of	O
teeth	O
and	O
is	O
a	O
major	O
cause	O
of	O
tooth	O
loss	O
in	O
adults	O
.	O

The	O
onset	O
and	O
progression	O
of	O
periodontal	O
disease	O
is	O
attributed	O
to	O
the	O
presence	O
of	O
elevated	O
levels	O
of	O
a	O
consortium	O
of	O
pathogenic	O
bacteria	O
.	O

Gram	O
negative	O
bacteria	O
,	O
mainly	O
strict	O
anaerobes	O
,	O
play	O
the	O
major	O
role	O
.	O

The	O
present	O
study	O
aimed	O
to	O
assess	O
the	O
presence	O
of	O
the	O
main	O
types	O
of	O
microorganisms	O
involved	O
in	O
the	O
aetiopathogenesis	O
of	O
periodontal	O
disease	O
:	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tanerella	B-bacteria
forsythia	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
in	O
different	O
samples	O
collected	O
from	O
the	O
oral	O
cavity	O
of	O
90	O
patients	O
diagnosed	O
with	O
Periodontitis	O
.	O

Bacterial	O
DNA	O
detection	O
was	O
performed	O
in	O
diverse	O
biological	O
materials	O
,	O
namely	O
in	O
dental	O
plaque	O
,	O
gingival	O
tissue	O
and	O
saliva	O
,	O
by	O
means	O
of	O
multiplex	O
PCR	O
,	O
a	O
technique	O
that	O
allows	O
simultaneous	O
identification	O
of	O
two	O
different	O
bacterial	O
genomes	O
.	O

In	O
the	O
dental	O
plaque	O
of	O
the	O
Periodontitis	O
patients	O
,	O
Treponema	B-bacteria
denticola	I-bacteria
dominated	O
.	O

In	O
the	O
gingival	O
tissue	O
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
were	O
the	O
microbiota	O
most	O
frequently	O
detected	O
,	O
whilst	O
in	O
saliva	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Eikenella	B-bacteria
corrodens	I-bacteria
were	O
found	O
with	O
the	O
highest	O
percentage	O
.	O

The	O
identification	O
of	O
microorganisms	O
by	O
multiplex	O
PCR	O
is	O
specific	O
and	O
sensitive	O
.	O

Rapid	O
and	O
precise	O
assessment	O
of	O
different	O
types	O
of	O
periodontopathogens	O
is	O
extremely	O
important	O
for	O
early	O
detection	O
of	O
the	O
infection	O
and	O
consequently	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
periodontal	O
disease	O
.	O

In	O
everyday	O
clinical	O
practice	O
,	O
for	O
routine	O
bacterial	O
evaluation	O
in	O
patients	O
with	O
periodontal	O
disease	O
,	O
the	O
dental	O
plaque	O
is	O
the	O
most	O
suitable	O
biological	O
material	O
,	O
because	O
it	O
is	O
the	O
richest	O
in	O
periodontal	O
bacteria	O
.	O

Dental	O
caries	O
in	O
babies	O
and	O
toddlers	O
is	O
called	O
Early	O
Childhood	O
Caries	O
(	O
ECC	O
)	O
.	O

It	O
is	O
an	O
infectious	O
and	O
transmissible	O
die	O
-	O
to	O
-	O
bacterial	O
disease	O
.	O

Detailed	O
knowledge	O
regarding	O
the	O
acquisition	O
and	O
transmission	O
of	O
infectious	O
agents	O
facilitates	O
a	O
more	O
comprehensive	O
approach	O
toward	O
prevention	O
.	O

Mutans	B-bacteria
streptococci	I-bacteria
are	O
important	O
organisms	O
in	O
the	O
initiation	O
and	O
progression	O
of	O
dental	O
caries	O
.	O

Recent	O
evidence	O
demonstrates	O
that	O
these	O
bacteria	O
are	O
found	O
in	O
the	O
mouths	O
of	O
pre	O
-	O
dentate	O
infants	O
and	O
are	O
acquired	O
via	O
vertical	O
and	O
/	O
or	O
horizontal	O
transmission	O
from	O
human	O
reservoirs	O
.	O

This	O
information	O
should	O
facilitate	O
the	O
focusing	O
of	O
clinical	O
interventions	O
that	O
prevent	O
or	O
delay	O
infant	O
infection	O
,	O
thereby	O
reducing	O
the	O
prevalence	O
of	O
dental	O
caries	O
(	O
ECC	O
)	O
in	O
babies	O
and	O
toddlers	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
observe	O
the	O
coexistence	O
of	O
periodontal	O
bacteria	O
DNA	O
(	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
in	O
coronary	O
atheromatous	O
plaques	O
and	O
subgingival	O
plaques	O
in	O
patients	O
scheduled	O
for	O
coronary	O
artery	O
bypass	O
graft	O
.	O

Coronary	O
atheromatous	O
plaque	O
and	O
subgingival	O
plaque	O
samples	O
were	O
obtained	O
from	O
51	O
patients	O
and	O
examined	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
technique	O
with	O
specific	O
primers	O
for	O
periodontal	O
bacteria	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
33	O
%	O
)	O
,	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
(	O
31	O
%	O
)	O
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
(	O
18	O
%	O
)	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
12	O
%	O
)	O
were	O
detected	O
while	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
was	O
negative	O
and	O
not	O
found	O
in	O
coronary	O
atheromatous	O
plaques	O
;	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
(	O
84	O
%	O
)	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
78	O
%	O
)	O
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
(	O
59	O
%	O
)	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
39	O
%	O
)	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
22	O
%	O
)	O
were	O
detected	O
in	O
subgingival	O
plaque	O
samples	O
.	O

Coexistence	O
of	O
periodontal	O
bacteria	O
DNA	O
in	O
coronary	O
atheromatous	O
and	O
subgingival	O
plaque	O
samples	O
was	O
evidenced	O
in	O
32	O
patients	O
.	O

The	O
coexistence	O
of	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
coronary	O
atheromatous	O
plaques	O
and	O
the	O
subgingival	O
plaque	O
samples	O
in	O
CAD	O
patients	O
could	O
suggest	O
a	O
potential	O
role	O
for	O
periodontal	O
pathogenic	O
bacteria	O
in	O
atherosclerosis	O
disease	O
process	O
.	O

Maternal	O
periodontitis	O
has	O
emerged	O
as	O
a	O
putative	O
risk	O
factor	O
for	O
preterm	O
births	O
in	O
humans	O
.	O

The	O
periodontitis	O
-	O
associated	O
dental	O
biofilm	O
is	O
thought	O
to	O
serve	O
as	O
an	O
important	O
source	O
of	O
oral	O
bacteria	O
and	O
related	O
virulence	O
factors	O
that	O
hematogenously	O
disseminate	O
and	O
affect	O
the	O
fetoplacental	O
unit	O
;	O
however	O
the	O
underlying	O
biological	O
mechanisms	O
are	O
yet	O
to	O
be	O
fully	O
elucidated	O
.	O

This	O
study	O
hypothesized	O
that	O
an	O
oral	O
infection	O
with	O
the	O
human	O
periodontal	O
pathogens	O
Campylobacter	B-bacteria
rectus	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
is	O
able	O
to	O
induce	O
fetal	O
growth	O
restriction	O
,	O
placental	O
inflammation	O
and	O
enhance	O
Toll	O
-	O
like	O
receptors	O
type	O
4	O
(	O
TLR4	O
)	O
expression	O
in	O
a	O
murine	O
pregnancy	O
model	O
.	O

Female	O
Balb	O
/	O
C	O
mice	O
(	O
n	O
=	O
40	O
)	O
were	O
orally	O
infected	O
with	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
and	O
/	O
or	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
over	O
a	O
16	O
-	O
week	O
period	O
and	O
mated	O
once	O
/	O
week	O
.	O

Pregnant	O
mice	O
were	O
sacrificed	O
at	O
embryonic	O
day	O
(	O
E	O
)	O
16	O
.	O
5	O
and	O
placentas	O
were	O
collected	O
and	O
analyzed	O
for	O
TLR4	O
mRNA	O
levels	O
and	O
qualitative	O
protein	O
expression	O
by	O
real	O
-	O
time	O
PCR	O
and	O
immunofluorescence	O
.	O

TLR4	O
mRNA	O
expression	O
was	O
found	O
to	O
be	O
increased	O
in	O
the	O
C	O
.	O
rectus	O
-	O
infected	O
group	O
(	O
1	O
.	O
98	O
+	O
/	O
-	O
0	O
.	O
886	O
-	O
fold	O
difference	O
,	O
P	O
<	O
0	O
.	O
01	O
,	O
ANOVA	O
)	O
compared	O
to	O
controls	O
.	O

Microscopic	O
analysis	O
of	O
murine	O
placentas	O
showed	O
enhanced	O
immunofluorescence	O
of	O
TLR4	O
in	O
trophoblasts	O
,	O
mainly	O
in	O
the	O
placental	O
labyrinth	O
layer	O
.	O

Also	O
,	O
combined	O
oral	O
infection	O
with	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
significantly	O
reduced	O
the	O
overall	O
fecundity	O
compared	O
to	O
controls	O
(	O
16	O
.	O
7	O
%	O
vs	O
.	O
75	O
%	O
,	O
infected	O
vs	O
.	O
non	O
-	O
infected	O
mice	O
respectively	O
,	O
P	O
=	O
0	O
.	O
03	O
,	O
Kaplan	O
-	O
Meier	O
)	O
.	O

The	O
results	O
supported	O
an	O
enhanced	O
placental	O
TLR4	O
expression	O
after	O
oral	O
infection	O
with	O
periodontal	O
pathogens	O
.	O

The	O
TLR4	O
pathway	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
preterm	O
births	O
;	O
therefore	O
the	O
abnormal	O
regulation	O
of	O
placental	O
TLR4	O
may	O
give	O
new	O
insights	O
into	O
how	O
maternal	O
periodontitis	O
and	O
periodontal	O
pathogens	O
might	O
be	O
linked	O
to	O
placental	O
inflammation	O
and	O
preterm	O
birth	O
pathogenesis	O
.	O

This	O
study	O
examined	O
the	O
ability	O
of	O
methyl	O
gallate	O
(	O
MG	O
)	O
and	O
gallic	O
acid	O
(	O
GA	O
)	O
,	O
the	O
main	O
compounds	O
of	O
gallo	O
-	O
tannins	O
in	O
Galla	O
Rhois	O
,	O
to	O
inhibit	O
the	O
proliferation	O
of	O
oral	O
bacterial	O
and	O
the	O
in	O
vitro	O
formation	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
biofilms	O
.	O

The	O
antimicrobial	O
activities	O
of	O
these	O
compounds	O
were	O
evaluated	O
in	O
vitro	O
using	O
the	O
broth	O
microdilution	O
method	O
and	O
a	O
beaker	O
-	O
wire	O
test	O
.	O

Both	O
MG	O
and	O
GA	O
had	O
inhibitory	O
effects	O
on	O
the	O
growth	O
of	O
cariogenic	O
(	O
MIC	O
<	O
8	O
mg	O
/	O
ml	O
)	O
and	O
periodontopathic	O
bacteria	O
(	O
MIC	O
=	O
1	O
mg	O
/	O
ml	O
)	O
.	O

Moreover	O
,	O
these	O
compounds	O
significantly	O
inhibited	O
the	O
in	O
vitro	O
formation	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
(	O
MG	O
,	O
1	O
mg	O
/	O
ml	O
;	O
GA	O
,	O
4	O
mg	O
/	O
ml	O
;	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

MG	O
was	O
more	O
effective	O
in	O
inhibiting	O
bacterial	O
growth	O
and	O
the	O
formation	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
than	O
GA	O
.	O

In	O
conclusion	O
,	O
MG	O
and	O
GA	O
can	O
inhibit	O
the	O
growth	O
of	O
oral	O
pathogens	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
formation	O
,	O
and	O
may	O
be	O
used	O
to	O
prevent	O
the	O
formation	O
of	O
oral	O
biofilms	O
.	O

We	O
evaluated	O
the	O
ability	O
of	O
a	O
dual	O
-	O
species	O
community	O
of	O
oral	O
bacteria	O
to	O
produce	O
the	O
universal	O
signalling	O
molecule	O
,	O
autoinducer	O
-	O
2	O
(	O
AI	O
-	O
2	O
)	O
,	O
in	O
saliva	O
-	O
fed	O
biofilms	O
.	O

Streptococcus	B-bacteria
oralis	I-bacteria
34	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
34	I-bacteria
luxS	I-bacteria
mutant	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
were	O
grown	O
as	O
single	O
-	O
and	O
dual	O
-	O
species	O
biofilms	O
within	O
sorbarods	O
fed	O
with	O
25	O
%	O
human	O
saliva	O
.	O

AI	O
-	O
2	O
concentration	O
in	O
biofilm	O
effluents	O
was	O
determined	O
by	O
the	O
Vibrio	B-bacteria
harveyi	I-bacteria
BB170	I-bacteria
bioluminescence	O
assay	O
.	O

After	O
homogenizing	O
the	O
sorbarods	O
to	O
release	O
biofilm	O
cells	O
,	O
cell	O
numbers	O
were	O
determined	O
by	O
fluorometric	O
analysis	O
of	O
fluorescent	O
antibody	O
-	O
labelled	O
cells	O
.	O

After	O
48	O
h	O
,	O
dual	O
-	O
species	O
biofilm	O
communities	O
of	O
interdigitated	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
34	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
contained	O
3	O
.	O
2	O
x	O
10	O
(	O
9	O
)	O
cells	O
:	O
fivefold	O
more	O
than	O
single	O
-	O
species	O
biofilms	O
.	O

However	O
,	O
these	O
48	O
-	O
h	O
dual	O
-	O
species	O
biofilms	O
exhibited	O
the	O
lowest	O
concentration	O
ratio	O
of	O
AI	O
-	O
2	O
to	O
cell	O
density	O
.	O

Oral	O
bacteria	O
produce	O
AI	O
-	O
2	O
in	O
saliva	O
-	O
fed	O
biofilms	O
.	O

The	O
decrease	O
of	O
more	O
than	O
10	O
-	O
fold	O
in	O
concentration	O
ratio	O
seen	O
between	O
1	O
and	O
48	O
h	O
in	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
34	I-bacteria
-	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
biofilms	O
suggests	O
that	O
peak	O
production	O
of	O
AI	O
-	O
2	O
occurs	O
early	O
and	O
is	O
followed	O
by	O
a	O
very	O
low	O
steady	O
-	O
state	O
level	O
.	O

High	O
oral	O
bacterial	O
biofilm	O
densities	O
may	O
be	O
achieved	O
by	O
inter	O
-	O
species	O
AI	O
-	O
2	O
signalling	O
.	O

We	O
propose	O
that	O
low	O
concentrations	O
of	O
AI	O
-	O
2	O
contribute	O
to	O
the	O
establishment	O
of	O
oral	O
commensal	O
biofilm	O
communities	O
.	O

Oral	O
bacteria	O
,	O
including	O
cariogenic	O
and	O
periodontal	O
pathogens	O
,	O
are	O
thought	O
to	O
be	O
etiological	O
factors	O
in	O
the	O
development	O
of	O
cardiovascular	O
diseases	O
.	O

To	O
define	O
this	O
relationship	O
,	O
we	O
analyzed	O
the	O
distribution	O
of	O
oral	O
bacterial	O
species	O
in	O
cardiovascular	O
specimens	O
.	O

Following	O
acceptance	O
into	O
the	O
study	O
,	O
203	O
consecutive	O
patients	O
were	O
analyzed	O
,	O
from	O
whom	O
82	O
aortic	O
valve	O
specimens	O
,	O
35	O
mitral	O
valve	O
specimens	O
,	O
and	O
86	O
aortic	O
aneurysmal	O
wall	O
specimens	O
,	O
of	O
which	O
16	O
contained	O
aneurysmal	O
thrombus	O
tissues	O
,	O
were	O
obtained	O
.	O

In	O
addition	O
,	O
a	O
total	O
of	O
58	O
dental	O
plaque	O
specimens	O
were	O
collected	O
from	O
the	O
same	O
group	O
of	O
patients	O
who	O
underwent	O
heart	O
valve	O
replacement	O
or	O
removal	O
of	O
aortic	O
aneurysms	O
.	O

Bacterial	O
DNA	O
was	O
extracted	O
from	O
both	O
cardiovascular	O
tissues	O
and	O
dental	O
plaque	O
in	O
those	O
cases	O
and	O
then	O
species	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
assays	O
were	O
used	O
to	O
analyze	O
the	O
occurrences	O
of	O
six	O
oral	O
streptococcal	B-bacteria
and	O
six	O
periodontal	O
bacterial	O
species	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
was	O
the	O
most	O
frequently	O
detected	O
species	O
in	O
the	O
cardiovascular	O
specimens	O
,	O
followed	O
by	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

As	O
for	O
dental	O
plaque	O
specimens	O
from	O
patients	O
who	O
underwent	O
cardiovascular	O
operations	O
,	O
most	O
of	O
the	O
tested	O
periodontitis	O
-	O
related	O
species	O
as	O
well	O
as	O
oral	O
streptococci	B-bacteria
were	O
detected	O
at	O
high	O
frequencies	O
.	O

Furthermore	O
,	O
the	O
positive	O
rate	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
cardiovascular	O
specimens	O
from	O
patients	O
whose	O
dental	O
plaque	O
specimens	O
were	O
also	O
positive	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
78	O
%	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
any	O
other	O
tested	O
species	O
when	O
the	O
same	O
analysis	O
was	O
performed	O
.	O

Our	O
results	O
suggest	O
that	O
specific	O
oral	O
bacterial	O
species	O
,	O
such	O
as	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
are	O
related	O
to	O
bacteremia	O
and	O
may	O
be	O
etiologic	O
factors	O
for	O
the	O
development	O
of	O
cardiovascular	O
diseases	O
.	O

Quantative	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
in	O
combination	O
with	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
may	O
help	O
to	O
increase	O
our	O
knowledge	O
about	O
biofilm	O
formation	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
develop	O
and	O
evaluate	O
a	O
stereological	O
method	O
for	O
quantification	O
of	O
bacteria	O
in	O
intact	O
biofilm	O
.	O

The	O
method	O
was	O
applied	O
in	O
a	O
quantitative	O
study	O
of	O
the	O
proportion	O
of	O
streptococci	B-bacteria
relative	O
to	O
other	O
bacteria	O
in	O
initial	O
in	O
-	O
situ	O
-	O
grown	O
dental	O
biofilms	O
as	O
a	O
function	O
of	O
time	O
.	O

Biofilms	O
were	O
collected	O
on	O
standardized	O
glass	O
slabs	O
mounted	O
in	O
intra	O
-	O
oral	O
appliances	O
and	O
worn	O
by	O
10	O
individuals	O
for	O
6	O
,	O
12	O
,	O
24	O
,	O
and	O
48	O
h	O
.	O
Biofilms	O
were	O
analysed	O
using	O
CLSM	O
.	O

Quantification	O
of	O
bacteria	O
labelled	O
with	O
16S	O
ribosomal	O
RNA	O
oligonucleotide	O
probes	O
was	O
performed	O
with	O
stereological	O
tools	O
:	O
the	O
unbiased	O
counting	O
frame	O
and	O
the	O
two	O
-	O
dimensional	O
fractionator	O
.	O

Results	O
showed	O
a	O
notable	O
increase	O
in	O
the	O
total	O
number	O
of	O
bacteria	O
and	O
streptococci	B-bacteria
over	O
time	O
,	O
with	O
a	O
considerable	O
inter	O
-	O
individual	O
variation	O
at	O
each	O
time	O
-	O
point	O
.	O

After	O
48	O
h	O
there	O
was	O
a	O
12	O
.	O
5	O
-	O
fold	O
difference	O
between	O
individuals	O
in	O
the	O
total	O
number	O
of	O
bacteria	O
and	O
a	O
12	O
.	O
6	O
-	O
fold	O
difference	O
in	O
the	O
number	O
of	O
streptococci	B-bacteria
.	O

The	O
number	O
of	O
streptococci	B-bacteria
exceeded	O
that	O
of	O
other	O
bacteria	O
and	O
over	O
the	O
examination	O
period	O
there	O
was	O
a	O
relatively	O
constant	O
relationship	O
between	O
the	O
number	O
of	O
streptococci	B-bacteria
and	O
other	O
bacteria	O
(	O
streptococci	B-bacteria
vs	O
.	O
non	B-bacteria
-	I-bacteria
streptococci	I-bacteria
:	O
median	O
15	O
.	O
2	O
;	O
minimum	O
1	O
.	O
0	O
;	O
maximum	O
89	O
.	O
3	O
)	O
.	O

The	O
study	O
demonstrates	O
that	O
the	O
combined	O
use	O
of	O
FISH	O
and	O
stereology	O
is	O
a	O
relevant	O
and	O
reliable	O
tool	O
for	O
obtaining	O
unbiased	O
information	O
about	O
the	O
numerical	O
contributions	O
of	O
specific	O
bacterial	O
populations	O
during	O
early	O
biofilm	O
formation	O
.	O

Although	O
commensal	O
bacteria	O
are	O
known	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
proper	O
maturation	O
of	O
the	O
immune	O
system	O
of	O
their	O
mammalian	O
hosts	O
,	O
the	O
molecular	O
mechanisms	O
underlying	O
this	O
immunomodulation	O
are	O
poorly	O
characterized	O
.	O

The	O
present	O
review	O
summarizes	O
recent	O
findings	O
in	O
the	O
field	O
and	O
describes	O
new	O
knowledge	O
on	O
the	O
interplay	O
of	O
the	O
innate	O
and	O
adaptive	O
arms	O
of	O
the	O
immune	O
response	O
induced	O
by	O
symbiotic	O
bacterial	O
carbohydrate	O
antigens	O
.	O

Commensal	O
bacteria	O
in	O
the	O
intestine	O
not	O
only	O
interact	O
directly	O
with	O
dendritic	O
cells	O
but	O
also	O
engage	O
in	O
cross	O
-	O
talk	O
with	O
epithelial	O
cells	O
.	O

These	O
interactions	O
lead	O
to	O
the	O
induction	O
of	O
tolerogenic	O
antigen	O
-	O
presenting	O
cells	O
in	O
the	O
lamina	O
propria	O
and	O
ultimately	O
to	O
the	O
regulation	O
of	O
functional	O
maturation	O
of	O
effector	O
T	O
cells	O
.	O

Upon	O
recognition	O
of	O
capsular	O
polysaccharide	O
antigens	O
of	O
commensal	O
bacteria	O
by	O
dendritic	O
cells	O
(	O
through	O
toll	O
-	O
like	O
receptor	O
2	O
)	O
,	O
innate	O
immune	O
responses	O
facilitate	O
and	O
act	O
in	O
conjunction	O
with	O
adaptive	O
responses	O
to	O
promote	O
optimal	O
Th1	O
polarization	O
.	O

In	O
contrast	O
,	O
adaptive	O
immunoglobulin	O
A	O
responses	O
to	O
symbiotic	O
bacteria	O
regulate	O
the	O
magnitude	O
of	O
oxidative	O
innate	O
immune	O
responses	O
in	O
the	O
mucosa	O
as	O
well	O
as	O
bacterial	O
epitope	O
expression	O
in	O
the	O
lumen	O
.	O

Accumulating	O
evidence	O
is	O
elucidating	O
surface	O
carbohydrate	O
structures	O
of	O
symbiotic	O
bacteria	O
that	O
drive	O
the	O
modulation	O
of	O
the	O
intestinal	O
immune	O
system	O
,	O
resulting	O
in	O
mature	O
,	O
balanced	O
immune	O
responses	O
and	O
oral	O
tolerance	O
.	O

Seven	O
pimarane	O
type	O
-	O
diterpenes	O
re	O
-	O
isolated	O
from	O
Viguiera	O
arenaria	O
Baker	O
and	O
two	O
semi	O
-	O
synthetic	O
pimarane	O
derivatives	O
were	O
evaluated	O
in	O
vitro	O
against	O
the	O
following	O
main	O
microorganisms	O
responsible	O
for	O
dental	O
caries	O
:	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
.	O

The	O
compounds	O
ent	O
-	O
pimara	O
-	O
8	O
(	O
14	O
)	O
,	O
15	O
-	O
dien	O
-	O
19	O
-	O
oic	O
acid	O
(	O
PA	O
)	O
;	O
ent	O
-	O
8	O
(	O
14	O
)	O
,	O
15	O
-	O
pimaradien	O
-	O
3beta	O
-	O
ol	O
;	O
ent	O
-	O
15	O
-	O
pimarene	O
-	O
8beta	O
,	O
19	O
-	O
diol	O
;	O
ent	O
-	O
8	O
(	O
14	O
)	O
,	O
15	O
-	O
pimaradien	O
-	O
3beta	O
-	O
acetoxy	O
and	O
the	O
sodium	O
salt	O
derivative	O
of	O
PA	O
were	O
the	O
most	O
active	O
compounds	O
,	O
displaying	O
MIC	O
values	O
ranging	O
from	O
2	O
to	O
8	O
microg	O
mL	O
(	O
-	O
1	O
)	O
.	O

Thus	O
,	O
this	O
class	O
of	O
compounds	O
seems	O
promising	O
as	O
a	O
class	O
of	O
new	O
effective	O
anticariogenic	O
agents	O
.	O

Furthermore	O
,	O
our	O
results	O
also	O
allow	O
us	O
to	O
conclude	O
that	O
minor	O
structural	O
differences	O
among	O
these	O
diterpenes	O
significantly	O
influence	O
their	O
antimicrobial	O
activity	O
,	O
bringing	O
new	O
perspectives	O
to	O
the	O
discovery	O
of	O
new	O
natural	O
compounds	O
that	O
could	O
be	O
employed	O
in	O
the	O
development	O
of	O
oral	O
care	O
products	O
.	O

To	O
evaluate	O
the	O
number	O
of	O
bacteria	O
extruded	O
apically	O
from	O
extracted	O
teeth	O
ex	O
vivo	O
after	O
canal	O
instrumentation	O
using	O
a	O
manual	O
technique	O
and	O
three	O
engine	O
-	O
driven	O
techniques	O
utilizing	O
nickel	O
-	O
titanium	O
instruments	O
(	O
K3	O
,	O
RaCe	O
,	O
and	O
FlexMaster	O
)	O
.	O

Seventy	O
extracted	O
human	O
mandibular	O
premolar	O
teeth	O
with	O
similar	O
dimensions	O
were	O
used	O
.	O

Access	O
cavities	O
were	O
prepared	O
and	O
root	O
canals	O
were	O
then	O
contaminated	O
with	O
a	O
suspension	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
then	O
dried	O
.	O

The	O
contaminated	O
roots	O
were	O
divided	O
into	O
four	O
experimental	O
groups	O
of	O
15	O
teeth	O
each	O
and	O
one	O
control	O
group	O
of	O
10	O
teeth	O
.	O

G1	O
.	O

RaCe	O
group	O
:	O
the	O
root	O
canals	O
were	O
instrumented	O
using	O
RaCe	O
instruments	O
.	O

G2	O
.	O

K3	O
group	O
:	O
the	O
root	O
canals	O
were	O
instrumented	O
using	O
K3	O
instruments	O
.	O

G3	O
.	O

FlexMaster	O
group	O
:	O
the	O
root	O
canals	O
were	O
instrumented	O
using	O
FlexMaster	O
instruments	O
.	O

G4	O
.	O

Manual	O
technique	O
group	O
:	O
the	O
root	O
canals	O
were	O
instrumented	O
using	O
K	O
-	O
type	O
stainless	O
steel	O
instruments	O
.	O

G5	O
.	O

no	O
instrumentation	O
was	O
attempted	O
.	O

Bacteria	O
extruded	O
from	O
the	O
apical	O
foramen	O
during	O
instrumentation	O
were	O
collected	O
into	O
vials	O
.	O

The	O
resultant	O
microbiological	O
samples	O
were	O
removed	O
from	O
the	O
vials	O
and	O
then	O
incubated	O
in	O
culture	O
media	O
for	O
24	O
h	O
.	O
The	O
number	O
of	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
was	O
determined	O
for	O
each	O
sample	O
.	O

The	O
data	O
obtained	O
were	O
analysed	O
using	O
the	O
Kruskal	O
-	O
Wallis	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
and	O
Mann	O
-	O
Whitney	O
U	O
-	O
tests	O
,	O
with	O
alpha	O
=	O
0	O
.	O
05	O
as	O
the	O
level	O
for	O
statistical	O
significance	O
.	O

There	O
was	O
a	O
significant	O
difference	O
between	O
experimental	O
-	O
control	O
and	O
engine	O
-	O
driven	O
-	O
manual	O
technique	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
manual	O
technique	O
was	O
associated	O
with	O
the	O
greatest	O
extrusion	O
of	O
microorganism	O
.	O

All	O
instrumentation	O
techniques	O
extruded	O
intracanal	O
bacteria	O
apically	O
.	O

No	O
significant	O
difference	O
was	O
found	O
in	O
the	O
number	O
of	O
CFU	O
among	O
the	O
engine	O
-	O
driven	O
techniques	O
;	O
manual	O
techniques	O
extruded	O
significantly	O
more	O
microorganisms	O
.	O

The	O
current	O
study	O
was	O
conducted	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
a	O
Chinese	O
population	O
.	O

Nested	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
used	O
to	O
investigate	O
whether	O
individuals	O
with	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
show	O
more	O
possibility	O
of	O
gastric	O
infection	O
and	O
to	O
examine	O
the	O
relationship	O
between	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
and	O
the	O
presence	O
of	O
the	O
bacteria	O
in	O
the	O
oral	O
cavity	O
.	O

A	O
total	O
of	O
443	O
dyspeptic	O
patients	O
participated	O
in	O
the	O
study	O
.	O

Gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
detected	O
by	O
the	O
rapid	O
urease	O
test	O
and	O
histology	O
with	O
Giemsa	O
staining	O
,	O
PCR	O
,	O
or	O
smear	O
examination	O
,	O
whereas	O
the	O
presence	O
of	O
the	O
bacteria	O
in	O
the	O
oral	O
cavity	O
was	O
observed	O
by	O
nested	O
PCR	O
from	O
dental	O
plaque	O
.	O

Relevant	O
periodontal	O
and	O
dental	O
parameters	O
were	O
recorded	O
in	O
the	O
process	O
of	O
oral	O
examination	O
.	O

Of	O
the	O
443	O
study	O
patients	O
,	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
in	O
the	O
dental	O
plaque	O
of	O
263	O
(	O
59	O
.	O
4	O
%	O
)	O
and	O
the	O
stomach	O
of	O
273	O
(	O
61	O
.	O
6	O
%	O
)	O
.	O

Additionally	O
,	O
in	O
all	O
four	O
age	O
groups	O
,	O
the	O
prevalence	O
of	O
gastric	O
infection	O
was	O
significantly	O
higher	O
among	O
the	O
patients	O
with	O
positive	O
tests	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
dental	O
plaque	O
than	O
in	O
the	O
patients	O
with	O
no	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
dental	O
plaque	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
oral	O
cavity	O
may	O
be	O
a	O
potential	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
and	O
the	O
prevalence	O
of	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
approximated	O
that	O
of	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
studied	O
population	O
.	O

Furthermore	O
,	O
a	O
close	O
relationship	O
may	O
exist	O
between	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
and	O
bacteria	O
in	O
the	O
stomach	O
or	O
gastric	O
infection	O
,	O
and	O
dyspeptic	O
patients	O
with	O
gastric	O
infection	O
are	O
more	O
likely	O
to	O
harbor	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
oral	O
cavity	O
.	O

Saliva	O
may	O
become	O
a	O
potential	O
source	O
of	O
contamination	O
through	O
vertical	O
and	O
horizontal	O
transmissions	O
as	O
well	O
as	O
cross	O
-	O
infections	O
.	O

This	O
study	O
aims	O
to	O
use	O
saliva	O
as	O
a	O
screening	O
tool	O
to	O
detect	O
putative	O
periodontal	O
pathogens	O
in	O
a	O
young	O
population	O
with	O
fairly	O
good	O
oral	O
hygiene	O
.	O

Stimulated	O
saliva	O
samples	O
were	O
obtained	O
from	O
134	O
dental	O
students	O
(	O
20	O
.	O
5	O
+	O
/	O
-	O
1	O
years	O
,	O
range	O
18	O
-	O
22	O
years	O
)	O
.	O

Among	O
those	O
,	O
77	O
subjects	O
also	O
completed	O
a	O
periodontal	O
examination	O
including	O
attachment	O
loss	O
,	O
modified	O
dental	O
,	O
gingival	O
and	O
plaque	O
indices	O
(	O
AL	O
,	O
mDI	O
,	O
GI	O
and	O
PI	O
)	O
.	O

The	O
test	O
bacteria	O
were	O
identified	O
using	O
a	O
16S	O
rRNA	O
-	O
based	O
PCR	O
detection	O
method	O
.	O

One	O
or	O
more	O
of	O
the	O
test	O
bacteria	O
was	O
found	O
in	O
67	O
%	O
of	O
the	O
subjects	O
.	O

Prevotella	B-bacteria
nigrescens	I-bacteria
was	O
detected	O
as	O
single	O
bacterium	O
in	O
16	O
%	O
of	O
the	O
subjects	O
followed	O
by	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
4	O
%	O
)	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
2	O
%	O
)	O
,	O
Aggregatibacter	B-bacteria
(	I-bacteria
formerly	I-bacteria
Actinobacillus	I-bacteria
)	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
1	O
%	O
)	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
1	O
%	O
)	O
.	O

Two	O
or	O
more	O
pathogens	O
were	O
detected	O
in	O
42	O
%	O
of	O
the	O
subjects	O
.	O

Clinical	O
examination	O
revealed	O
health	O
with	O
no	O
attachment	O
loss	O
(	O
AL	O
)	O
in	O
84	O
%	O
of	O
the	O
students	O
.	O

In	O
no	O
AL	O
group	O
,	O
38	O
%	O
of	O
the	O
students	O
were	O
pathogen	O
free	O
while	O
this	O
was	O
25	O
%	O
for	O
students	O
in	O
localized	O
AL	O
group	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

There	O
was	O
a	O
statistically	O
significant	O
association	O
between	O
the	O
detection	O
of	O
salivary	O
periodontal	O
pathogen	O
in	O
general	O
and	O
higher	O
PI	O
(	O
p	O
=	O
0	O
.	O
018	O
)	O
and	O
GI	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
.	O

Within	O
the	O
limits	O
of	O
this	O
study	O
,	O
it	O
is	O
possible	O
to	O
detect	O
all	O
six	O
periodontal	O
pathogens	O
in	O
the	O
saliva	O
of	O
dental	O
students	O
.	O

Although	O
a	O
correlation	O
can	O
be	O
observed	O
between	O
the	O
presence	O
of	O
salivary	O
periodontal	O
pathogen	O
and	O
clinical	O
signs	O
of	O
inflammation	O
such	O
as	O
plaque	O
accumulation	O
and	O
gingival	O
bleeding	O
,	O
detection	O
of	O
specific	O
bacteria	O
in	O
saliva	O
is	O
not	O
related	O
to	O
the	O
presence	O
of	O
localized	O
AL	O
based	O
on	O
the	O
presented	O
study	O
population	O
.	O

To	O
determine	O
characteristics	O
of	O
microbial	O
associations	O
and	O
degree	O
of	O
oral	O
cavity	O
colonization	O
by	O
different	O
biotopes	O
in	O
healthy	O
adolescents	O
and	O
patients	O
with	O
chronic	O
gastroduodenitis	O
.	O

Saliva	O
,	O
dental	O
deposit	O
,	O
content	O
of	O
tooth	O
-	O
gingival	O
cavity	O
and	O
material	O
from	O
buccal	O
and	O
lingual	O
mucous	O
surfaces	O
of	O
24	O
healthy	O
adolescents	O
and	O
29	O
patients	O
of	O
the	O
same	O
age	O
with	O
gastroduodenitis	O
were	O
used	O
for	O
bacteriological	O
analysis	O
.	O

Inoculation	O
were	O
made	O
on	O
the	O
following	O
growth	O
media	O
:	O
yolk	O
-	O
salt	O
agar	O
,	O
Endo	O
,	O
Saburo	O
,	O
MRS	O
as	O
well	O
as	O
on	O
Columbia	O
and	O
Saedler	O
blood	O
agars	O
.	O

It	O
was	O
shown	O
that	O
rate	O
of	O
isolation	O
of	O
peptostreptococci	B-bacteria
from	O
oral	O
cavity	O
of	O
patients	O
was	O
90	O
%	O
lower	O
compared	O
with	O
controls	O
;	O
rate	O
of	O
isolation	O
of	O
lactobacilli	B-bacteria
,	O
Veillonella	B-bacteria
,	O
and	O
stomatococci	B-bacteria
was	O
30	O
%	O
lower	O
,	O
whereas	O
hemolytic	O
Porphyromonas	B-bacteria
,	O
staphylococci	B-bacteria
and	O
streptococci	B-bacteria
were	O
isolated	O
20	O
%	O
more	O
frequently	O
.	O

Concentration	O
of	O
peptostreptococci	B-bacteria
and	O
streptococci	B-bacteria
was	O
7	O
.	O
0	O
lg	O
CFU	O
/	O
ml	O
,	O
whereas	O
concentration	O
of	O
Porphyromonas	B-bacteria
,	O
Veillonella	B-bacteria
,	O
peptococci	B-bacteria
and	O
staphylococci	B-bacteria
was	O
6	O
.	O
0	O
lg	O
CFU	O
/	O
ml	O
,	O
Neisseria	B-bacteria
-	O
-	O
5	O
.	O
0	O
lg	O
CFU	O
/	O
ml	O
,	O
stomatococci	B-bacteria
,	O
bacilli	O
and	O
Candida	O
fungi	O
-	O
-	O
4	O
.	O
5	O
lg	O
CFU	O
/	O
ml	O
.	O

Decrease	O
of	O
concentration	O
of	O
lactobacilli	B-bacteria
to	O
4	O
.	O
0	O
lg	O
CFU	O
/	O
ml	O
was	O
noted	O
.	O

Compared	O
with	O
healthy	O
group	O
of	O
children	O
,	O
widened	O
spectrum	O
of	O
microorganisms	O
in	O
all	O
studied	O
biotopes	O
of	O
oral	O
cavity	O
was	O
observed	O
in	O
patients	O
with	O
chronic	O
gastroduodenitis	O
;	O
species	O
belonging	O
to	O
pathogenic	O
microflora	O
were	O
detected	O
in	O
patients	O
more	O
frequently	O
and	O
in	O
more	O
quantities	O
.	O

Microbial	O
spectrum	O
and	O
non	O
-	O
specific	O
as	O
well	O
as	O
specific	O
IgA1	O
protease	O
activity	O
of	O
isolated	O
microorganisms	O
were	O
investigated	O
in	O
gingival	O
liquid	O
of	O
patients	O
with	O
periodontitis	O
.	O

Microorganisms	O
from	O
the	O
gingival	O
liqud	O
of	O
these	O
patients	O
belonged	O
to	O
conditional	O
-	O
pathogenic	O
obligate	O
and	O
facultatively	O
anaerobic	O
bacteria	O
.	O

24	O
strains	O
of	O
microorganisms	O
have	O
been	O
identified	O
.	O

Nonspecific	O
proteolytic	O
activity	O
was	O
found	O
in	O
the	O
following	O
microorganisms	O
:	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Aerococcus	B-bacteria
viridans	I-bacteria
,	O
Bifidobacterium	B-bacteria
longum	I-bacteria
,	O
Neisseria	B-bacteria
subflave	I-bacteria
,	O
Streptococcus	B-bacteria
parvulus	I-bacteria
,	O
Eubacterium	B-bacteria
alactolyticum	I-bacteria
,	O
Lactobaccilus	B-bacteria
catenoforme	I-bacteria
,	O
Bacillus	B-bacteria
spp	I-bacteria
.	O

Specific	O
IgA1	O
-	O
protease	O
activity	O
and	O
lack	O
of	O
proteolytic	O
activity	O
towards	O
IgG	O
was	O
found	O
in	O
Streptococcus	B-bacteria
acidominimus	I-bacteria
,	O
Streptococcus	B-bacteria
hansenii	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Leptotrychia	B-bacteria
buccalis	I-bacteria
,	O
Staphylococcus	B-bacteria
haemolyticus	I-bacteria
and	O
Neisseria	B-bacteria
sicca	I-bacteria
.	O

No	O
proteolytic	O
activity	O
was	O
found	O
in	O
cultivation	O
medium	O
of	O
Eubacterium	B-bacteria
alactolyticum	I-bacteria
(	O
1	O
strain	O
)	O
,	O
Prevotella	B-bacteria
buccalis	I-bacteria
,	O
Aerococcus	B-bacteria
viridans	I-bacteria
and	O
Streptococcus	B-bacteria
sanguis	I-bacteria
.	O

Nucleic	O
acid	O
amplification	O
tests	O
are	O
sensitive	O
and	O
specific	O
for	O
identifying	O
Mycobacterium	B-bacteria
tuberculosis	I-bacteria
in	O
sputum	O
smear	O
-	O
positive	O
populations	O
,	O
but	O
they	O
are	O
less	O
sensitive	O
in	O
sputum	O
smear	O
-	O
negative	O
populations	O
.	O

Few	O
studies	O
have	O
assessed	O
their	O
performance	O
among	O
patients	O
infected	O
with	O
HIV	O
,	O
and	O
no	O
studies	O
have	O
assessed	O
their	O
performance	O
with	O
oral	O
wash	O
specimens	O
,	O
which	O
may	O
be	O
easier	O
to	O
obtain	O
than	O
sputum	O
samples	O
.	O

We	O
performed	O
a	O
prospective	O
study	O
involving	O
127	O
adults	O
from	O
2	O
populations	O
who	O
were	O
undergoing	O
evaluation	O
for	O
respiratory	O
complaints	O
at	O
Mulago	O
Hospital	O
in	O
Kampala	O
,	O
Uganda	O
.	O

We	O
obtained	O
and	O
tested	O
sputum	O
samples	O
for	O
Mycobacterium	B-bacteria
tuberculosis	I-bacteria
,	O
and	O
we	O
simultaneously	O
obtained	O
oral	O
wash	O
specimens	O
to	O
test	O
for	O
M	B-bacteria
.	I-bacteria
tuberculosis	I-bacteria
DNA	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
amplification	O
of	O
a	O
novel	O
locus	O
,	O
the	O
secA1	O
gene	O
.	O

A	O
positive	O
mycobacterial	O
culture	O
of	O
sputum	O
was	O
used	O
to	O
define	O
cases	O
of	O
tuberculosis	O
;	O
we	O
calculated	O
the	O
sensitivity	O
and	O
specificity	O
of	O
the	O
PCR	O
assay	O
with	O
sputum	O
or	O
oral	O
wash	O
specimens	O
in	O
reference	O
to	O
the	O
standard	O
of	O
sputum	O
culture	O
results	O
.	O

Tuberculosis	O
(	O
75	O
[	O
59	O
%	O
]	O
of	O
127	O
patients	O
)	O
and	O
HIV	O
infection	O
(	O
58	O
[	O
46	O
%	O
]	O
of	O
126	O
patients	O
)	O
were	O
both	O
common	O
in	O
the	O
study	O
population	O
.	O

PCR	O
of	O
sputum	O
samples	O
was	O
highly	O
sensitive	O
(	O
sensitivity	O
,	O
99	O
%	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
93	O
%	O
-	O
100	O
%	O
)	O
and	O
specific	O
(	O
specificity	O
,	O
88	O
%	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
77	O
%	O
-	O
96	O
%	O
)	O
for	O
detection	O
of	O
pulmonary	O
tuberculosis	O
and	O
performed	O
well	O
among	O
HIV	O
-	O
infected	O
patients	O
and	O
among	O
patients	O
with	O
negative	O
sputum	O
smear	O
results	O
.	O

PCR	O
of	O
oral	O
wash	O
specimens	O
was	O
less	O
sensitive	O
(	O
sensitivity	O
,	O
73	O
%	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
62	O
%	O
-	O
83	O
%	O
)	O
but	O
also	O
detected	O
a	O
substantial	O
proportion	O
of	O
tuberculosis	O
cases	O
.	O

PCR	O
targeting	O
the	O
secA1	O
gene	O
was	O
highly	O
sensitive	O
and	O
specific	O
for	O
identifying	O
M	B-bacteria
.	I-bacteria
tuberculosis	I-bacteria
in	O
sputum	O
samples	O
,	O
independent	O
of	O
smear	O
or	O
HIV	O
infection	O
status	O
.	O

Oral	O
washes	O
showed	O
promise	O
as	O
an	O
easily	O
obtained	O
respiratory	O
specimen	O
for	O
tuberculosis	O
diagnosis	O
.	O

PCR	O
of	O
sputum	O
for	O
detection	O
of	O
the	O
secA1	O
gene	O
could	O
be	O
a	O
rapid	O
,	O
effective	O
diagnostic	O
tool	O
for	O
tuberculosis	O
referral	O
centers	O
.	O

Knowledge	O
of	O
the	O
colonization	O
patterns	O
and	O
composition	O
of	O
the	O
oral	O
microbiota	O
can	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
disease	O
initiation	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
distribution	O
of	O
selected	O
cariogenic	O
bacteria	O
in	O
samples	O
from	O
five	O
different	O
oral	O
habitats	O
in	O
young	O
Greek	O
children	O
.	O

Ninety	O
-	O
three	O
children	O
3	O
-	O
12	O
years	O
old	O
(	O
mean	O
+	O
SD	O
7	O
.	O
9	O
+	O
/	O
-	O
2	O
.	O
5	O
)	O
(	O
60	O
.	O
2	O
%	O
male	O
,	O
39	O
.	O
8	O
%	O
female	O
)	O
participated	O
and	O
split	O
into	O
three	O
different	O
age	O
groups	O
:	O
primary	O
(	O
3	O
-	O
6	O
years	O
)	O
,	O
early	O
mixed	O
(	O
6	O
-	O
9	O
years	O
)	O
,	O
and	O
mixed	O
dentition	O
(	O
9	O
-	O
12	O
years	O
)	O
.	O

Samples	O
for	O
bacterial	O
enumeration	O
were	O
taken	O
from	O
saliva	O
,	O
supragingival	O
and	O
subgingival	O
plaque	O
,	O
tongue	O
dorsum	O
,	O
and	O
soft	O
tissues	O
from	O
each	O
child	O
,	O
and	O
were	O
further	O
analysed	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Mean	O
counts	O
and	O
proportions	O
of	O
all	O
the	O
test	O
bacteria	O
differed	O
significantly	O
among	O
sample	O
locations	O
.	O

Cariogenic	O
bacteria	O
were	O
present	O
in	O
almost	O
all	O
healthy	O
children	O
.	O

Mean	O
proportions	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
isolated	O
from	O
soft	O
tissue	O
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
from	O
soft	O
tissue	O
,	O
subgingival	O
and	O
saliva	O
samples	O
increased	O
significantly	O
with	O
age	O
,	O
whereas	O
the	O
opposite	O
was	O
seen	O
for	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
.	O

Cariogenic	O
bacteria	O
were	O
present	O
in	O
almost	O
all	O
young	O
children	O
.	O

Soft	O
tissues	O
,	O
saliva	O
,	O
and	O
tongue	O
were	O
more	O
often	O
colonized	O
by	O
cariogenic	O
streptococcal	B-bacteria
species	I-bacteria
than	O
teeth	O
.	O

These	O
surfaces	O
may	O
serve	O
as	O
reservoirs	O
for	O
oral	O
pathogens	O
,	O
requiring	O
attention	O
during	O
preventive	O
interventions	O
.	O

As	O
modern	O
humans	O
(	O
Homo	O
sapiens	O
)	O
migrated	O
out	O
of	O
Africa	O
to	O
different	O
parts	O
of	O
the	O
world	O
,	O
their	O
obligate	O
indigenous	O
bacterial	O
biota	O
accompanied	O
them	O
.	O

As	O
both	O
evolved	O
,	O
the	O
accumulations	O
of	O
mutations	O
in	O
their	O
DNA	O
can	O
reveal	O
their	O
phylogenies	O
.	O

Here	O
,	O
we	O
describe	O
the	O
evolutionary	O
history	O
of	O
an	O
indigenous	O
bacteria	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
from	O
the	O
oral	O
cavity	O
.	O

Using	O
several	O
genetic	O
markers	O
,	O
four	O
distinct	O
clusters	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
genetic	O
traits	O
coincide	O
with	O
individuals	O
of	O
distinct	O
geographic	O
or	O
racial	O
groups	O
comprised	O
of	O
two	O
African	O
clades	O
and	O
an	O
Asian	O
and	O
a	O
Caucasian	O
clade	O
.	O

The	O
evolutionary	O
lineage	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
is	O
in	O
agreement	O
with	O
anthropological	O
artifacts	O
marking	O
the	O
trail	O
of	O
human	O
migrations	O
.	O

To	O
evaluate	O
the	O
presence	O
of	O
Arcobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
different	O
biological	O
samples	O
from	O
domestic	O
cats	O
in	O
Southern	O
Italy	O
by	O
using	O
a	O
species	O
-	O
specific	O
PCR	O
assay	O
and	O
thus	O
to	O
elucidate	O
their	O
potential	O
significance	O
as	O
sources	O
of	O
human	O
infection	O
.	O

We	O
investigated	O
the	O
prevalence	O
of	O
Arcobacter	B-bacteria
DNA	O
in	O
oral	O
swabs	O
,	O
in	O
peripheral	O
blood	O
samples	O
and	O
fine	O
needle	O
lymph	O
node	O
aspirate	O
specimens	O
from	O
85	O
cats	O
of	O
which	O
17	O
were	O
clinically	O
healthy	O
and	O
68	O
had	O
clinical	O
signs	O
of	O
oral	O
disease	O
or	O
lymphadenomegaly	O
.	O

Overall	O
,	O
molecular	O
analysis	O
has	O
shown	O
that	O
Arcobacter	O
-	O
specific	O
DNA	O
was	O
found	O
in	O
78	O
.	O
8	O
%	O
(	O
67	O
of	O
85	O
)	O
of	O
all	O
the	O
cats	O
.	O

In	O
the	O
67	O
Arcobacter	O
-	O
positive	O
cats	O
,	O
66	O
(	O
77	O
.	O
6	O
%	O
)	O
and	O
29	O
(	O
34	O
.	O
1	O
%	O
)	O
were	O
found	O
positive	O
for	O
Arcobacter	B-bacteria
butzleri	I-bacteria
and	O
Arcobacter	B-bacteria
cryaerophilus	I-bacteria
,	O
respectively	O
.	O

None	O
of	O
the	O
examined	O
samples	O
gave	O
a	O
PCR	O
product	O
for	O
Arcobacter	B-bacteria
skirrowii	I-bacteria
.	O

This	O
study	O
demonstrates	O
that	O
pet	O
cats	O
commonly	O
carry	O
Arcobacter	B-bacteria
in	O
the	O
oral	O
cavity	O
.	O

According	O
to	O
the	O
clinical	O
data	O
,	O
the	O
Arcobacter	B-bacteria
detection	O
results	O
showed	O
no	O
significant	O
difference	O
between	O
cats	O
with	O
oral	O
pathology	O
and	O
those	O
suffering	O
from	O
other	O
different	O
pathologies	O
.	O

Pet	O
cats	O
harbour	O
Arcobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
may	O
play	O
a	O
role	O
in	O
their	O
dissemination	O
in	O
the	O
domestic	O
habitat	O
.	O

The	O
high	O
prevalence	O
in	O
a	O
limited	O
number	O
of	O
cat	O
samples	O
in	O
this	O
study	O
may	O
be	O
of	O
significance	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
the	O
one	O
-	O
stage	O
full	O
-	O
mouth	O
disinfection	O
(	O
FMD	O
)	O
provides	O
greater	O
clinical	O
and	O
microbiological	O
improvement	O
compared	O
with	O
full	O
-	O
mouth	O
scaling	O
and	O
root	O
planing	O
(	O
FM	O
-	O
SRP	O
)	O
within	O
24	O
h	O
and	O
quadrant	O
scaling	O
and	O
root	O
planing	O
(	O
Q	O
-	O
SRP	O
)	O
in	O
patients	O
with	O
generalized	O
chronic	O
periodontitis	O
.	O

Twenty	O
-	O
eight	O
patients	O
were	O
randomized	O
into	O
three	O
groups	O
.	O

25	O
patients	O
completed	O
the	O
study	O
and	O
were	O
the	O
basis	O
for	O
analysis	O
.	O

The	O
Q	O
-	O
SRP	O
group	O
was	O
scaled	O
quadrant	O
-	O
wise	O
at	O
1	O
-	O
week	O
intervals	O
.	O

The	O
other	O
groups	O
received	O
a	O
one	O
-	O
stage	O
full	O
-	O
mouth	O
scaling	O
with	O
(	O
FMD	O
)	O
and	O
without	O
(	O
FM	O
-	O
SRP	O
)	O
chlorhexidine	O
.	O

At	O
baseline	O
,	O
after	O
1	O
,	O
2	O
,	O
4	O
and	O
8	O
months	O
clinical	O
parameters	O
were	O
recorded	O
and	O
microbiological	O
analysis	O
was	O
performed	O
.	O

All	O
three	O
treatment	O
modalities	O
resulted	O
in	O
significant	O
clinical	O
improvement	O
at	O
any	O
time	O
.	O

There	O
were	O
only	O
group	O
differences	O
after	O
1	O
and	O
2	O
months	O
:	O
in	O
the	O
FM	O
-	O
SRP	O
group	O
was	O
a	O
significantly	O
higher	O
reduction	O
of	O
probing	O
depth	O
and	O
bleeding	O
on	O
probing	O
compared	O
with	O
the	O
other	O
two	O
groups	O
.	O

The	O
bacteria	O
could	O
be	O
reduced	O
in	O
every	O
group	O
although	O
this	O
reduction	O
was	O
only	O
significant	O
for	O
Prevotella	B-bacteria
intermedia	I-bacteria
in	O
the	O
FMD	O
group	O
8	O
months	O
after	O
treatment	O
.	O

All	O
three	O
treatment	O
modalities	O
lead	O
to	O
an	O
improvement	O
of	O
the	O
clinical	O
and	O
microbiological	O
parameters	O
,	O
however	O
,	O
without	O
significant	O
group	O
differences	O
after	O
8	O
months	O
.	O

Alkali	O
generation	O
by	O
oral	O
bacteria	O
plays	O
a	O
key	O
role	O
in	O
plaque	O
pH	O
homeostasis	O
and	O
may	O
be	O
a	O
major	O
impediment	O
to	O
the	O
development	O
of	O
dental	O
caries	O
.	O

To	O
determine	O
if	O
the	O
capacity	O
of	O
oral	O
samples	O
to	O
produce	O
ammonia	O
from	O
arginine	O
or	O
urea	O
was	O
related	O
to	O
caries	O
experience	O
,	O
the	O
arginine	O
deiminase	O
system	O
(	O
ADS	O
)	O
and	O
urease	O
activity	O
in	O
saliva	O
and	O
dental	O
plaque	O
samples	O
were	O
measured	O
in	O
45	O
adult	O
subjects	O
.	O

The	O
subjects	O
were	O
divided	O
into	O
three	O
groups	O
according	O
to	O
caries	O
status	O
;	O
13	O
caries	O
-	O
free	O
(	O
CF	O
)	O
individuals	O
(	O
decayed	O
,	O
missing	O
,	O
and	O
filled	O
teeth	O
=	O
0	O
)	O
;	O
21	O
caries	O
-	O
active	O
(	O
CA	O
)	O
individuals	O
(	O
decayed	O
teeth	O
>	O
or	O
=	O
4	O
)	O
;	O
and	O
11	O
caries	O
-	O
experienced	O
(	O
CE	O
)	O
individuals	O
(	O
decayed	O
teeth	O
=	O
0	O
;	O
missing	O
and	O
filled	O
teeth	O
>	O
0	O
)	O
.	O

Real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
was	O
used	O
to	O
quantify	O
the	O
proportion	O
of	O
certain	O
acid	O
-	O
or	O
alkali	O
-	O
producing	O
organisms	O
in	O
the	O
samples	O
.	O

The	O
amount	O
of	O
ammonia	O
generated	O
from	O
the	O
test	O
substrates	O
by	O
plaque	O
samples	O
was	O
generally	O
higher	O
than	O
that	O
produced	O
by	O
salivary	O
samples	O
in	O
all	O
groups	O
.	O

Significantly	O
higher	O
levels	O
of	O
salivary	O
ADS	O
activity	O
and	O
plaque	O
urease	O
activity	O
were	O
observed	O
in	O
CF	O
subjects	O
compared	O
to	O
CA	O
subjects	O
(	O
P	O
=	O
0	O
.	O
0004	O
and	O
P	O
=	O
0	O
.	O
014	O
,	O
respectively	O
)	O
.	O

The	O
proportions	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
from	O
saliva	O
and	O
dental	O
plaque	O
of	O
CA	O
subjects	O
were	O
significantly	O
higher	O
than	O
those	O
from	O
the	O
CF	O
group	O
(	O
P	O
=	O
0	O
.	O
0153	O
and	O
P	O
=	O
0	O
.	O
0009	O
,	O
respectively	O
)	O
.	O

In	O
the	O
CA	O
group	O
,	O
there	O
was	O
an	O
inverse	O
relationship	O
between	O
urease	O
activity	O
and	O
the	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

This	O
study	O
supports	O
the	O
theory	O
that	O
increased	O
caries	O
risk	O
is	O
associated	O
with	O
reduced	O
alkali	O
-	O
generating	O
capacity	O
of	O
the	O
bacteria	O
colonizing	O
the	O
oral	O
cavity	O
;	O
providing	O
compelling	O
evidence	O
to	O
further	O
our	O
understanding	O
of	O
oral	O
alkali	O
-	O
generation	O
in	O
health	O
and	O
disease	O
.	O

The	O
oral	O
cavity	O
harbors	O
a	O
diverse	O
and	O
complex	O
microbial	O
community	O
.	O

Bacteria	O
accumulate	O
on	O
both	O
the	O
hard	O
and	O
soft	O
oral	O
tissues	O
in	O
sessile	O
biofilms	O
and	O
engage	O
the	O
host	O
in	O
an	O
intricate	O
cellular	O
dialog	O
,	O
which	O
normally	O
constrains	O
the	O
bacteria	O
to	O
a	O
state	O
of	O
commensal	O
harmony	O
.	O

Dendritic	O
cells	O
(	O
DCs	O
)	O
are	O
likely	O
to	O
balance	O
tolerance	O
and	O
active	O
immunity	O
to	O
commensal	O
microorganisms	O
as	O
part	O
of	O
chronic	O
inflammatory	O
responses	O
.	O

While	O
the	O
role	O
played	O
by	O
DCs	O
in	O
maintaining	O
intestinal	O
homeostasis	O
has	O
been	O
investigated	O
extensively	O
,	O
relatively	O
little	O
is	O
known	O
about	O
DC	O
responses	O
to	O
oral	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
pulsed	O
human	O
monocyte	O
-	O
derived	O
immature	O
DCs	O
(	O
iDCs	O
)	O
with	O
cell	O
wall	O
extracts	O
from	O
pathogenic	O
and	O
commensal	O
gram	O
-	O
positive	O
or	O
gram	O
-	O
negative	O
oral	O
bacteria	O
.	O

Although	O
all	O
bacterial	O
extracts	O
tested	O
induced	O
iDCs	O
to	O
mature	O
and	O
produce	O
cytokines	O
/	O
chemokines	O
including	O
interleukin	O
-	O
12p40	O
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
and	O
monocyte	O
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
)	O
,	O
the	O
most	O
important	O
factor	O
for	O
programming	O
DCs	O
by	O
oral	O
bacteria	O
was	O
whether	O
they	O
were	O
gram	O
-	O
positive	O
or	O
gram	O
-	O
negative	O
,	O
not	O
whether	O
they	O
were	O
commensal	O
or	O
pathogenic	O
.	O

In	O
general	O
,	O
gram	O
-	O
negative	O
oral	O
bacteria	O
,	O
except	O
for	O
periodontopathic	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
stimulated	O
DC	O
maturation	O
and	O
cytokine	O
production	O
at	O
lower	O
concentrations	O
than	O
gram	O
-	O
positive	O
oral	O
bacteria	O
.	O

The	O
threshold	O
of	O
bacteria	O
needed	O
to	O
stimulate	O
chemokine	O
production	O
was	O
100	O
-	O
fold	O
to	O
1000	O
-	O
fold	O
lower	O
than	O
that	O
needed	O
to	O
induce	O
cytokines	O
.	O

In	O
addition	O
,	O
very	O
low	O
doses	O
of	O
oral	O
commensal	O
bacteria	O
triggered	O
monocytes	O
to	O
migrate	O
toward	O
DC	O
-	O
derived	O
MCP	O
-	O
1	O
.	O

Oral	O
commensal	O
and	O
pathogenic	O
bacteria	O
do	O
not	O
differ	O
qualitatively	O
in	O
how	O
they	O
program	O
DCs	O
.	O

DC	O
-	O
derived	O
MCP	O
-	O
1	O
induced	O
in	O
response	O
to	O
oral	O
commensal	O
bacteria	O
may	O
play	O
a	O
role	O
,	O
at	O
least	O
in	O
part	O
,	O
in	O
the	O
maintenance	O
of	O
oral	O
tissue	O
integrity	O
by	O
attracting	O
monocytes	O
.	O

Ceragenin	O
CSA	O
-	O
13	O
is	O
a	O
bile	O
-	O
acid	O
-	O
based	O
mimic	O
of	O
endogenous	O
antimicrobial	O
peptides	O
and	O
shares	O
a	O
mechanism	O
of	O
action	O
with	O
many	O
of	O
these	O
antimicrobial	O
agents	O
.	O

Because	O
CSA	O
-	O
13	O
is	O
not	O
peptide	O
based	O
,	O
it	O
is	O
not	O
a	O
substrate	O
for	O
the	O
proteases	O
that	O
are	O
found	O
in	O
the	O
oral	O
cavity	O
,	O
which	O
are	O
capable	O
of	O
degrading	O
antimicrobial	O
peptides	O
.	O

Furthermore	O
,	O
the	O
simplicity	O
of	O
the	O
ceragenins	O
makes	O
them	O
easier	O
to	O
prepare	O
and	O
purify	O
than	O
antimicrobial	O
peptides	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
antimicrobial	O
activities	O
of	O
CSA	O
-	O
13	O
against	O
oral	O
pathogens	O
and	O
found	O
that	O
this	O
compound	O
was	O
bactericidal	O
against	O
all	O
of	O
the	O
strains	O
tested	O
.	O

The	O
strains	O
used	O
were	O
isolates	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Porphyromonas	B-bacteria
species	I-bacteria
.	O

Minimum	O
inhibitory	O
concentrations	O
(	O
MIC	O
)	O
were	O
determined	O
using	O
agar	O
dilution	O
methods	O
.	O

In	O
susceptibility	O
testing	O
,	O
viable	O
counts	O
were	O
determined	O
after	O
incubation	O
with	O
CSA	O
-	O
13	O
.	O

CSA	O
-	O
13	O
was	O
potent	O
against	O
all	O
23	O
strains	O
tested	O
with	O
MICs	O
of	O
1	O
-	O
8	O
microg	O
/	O
ml	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
1	O
-	O
16	O
microg	O
/	O
ml	O
for	O
24	O
strains	O
of	O
the	O
genus	O
Porphyromonas	B-bacteria
.	O

The	O
MIC	O
(	O
50	O
)	O
was	O
2	O
and	O
the	O
MIC	O
(	O
90	O
)	O
was	O
8	O
mug	O
/	O
ml	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

MIC	O
ranges	O
for	O
protease	O
-	O
positive	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
cangingivalis	I-bacteria
were	O
2	O
-	O
16	O
microg	O
/	O
ml	O
,	O
and	O
1	O
-	O
2	O
microg	O
/	O
ml	O
for	O
protease	O
-	O
negative	O
P	B-bacteria
.	I-bacteria
circumdentaria	I-bacteria
.	O

CSA	O
-	O
13	O
interacted	O
with	O
lipopolysaccharide	O
-	O
sensitized	O
erythrocytes	O
at	O
a	O
concentration	O
of	O
5	O
.	O
0	O
-	O
20	O
.	O
0	O
microg	O
/	O
ml	O
.	O

CSA	O
-	O
13	O
displays	O
broad	O
-	O
spectrum	O
activity	O
against	O
cariogenic	O
and	O
periodontopathic	O
bacteria	O
.	O

CSA	O
-	O
13	O
was	O
effective	O
against	O
protease	O
-	O
positive	O
Porphyromonas	B-bacteria
.	O

It	O
was	O
shown	O
to	O
bind	O
to	O
erythrocytes	O
coated	O
with	O
lipopolysaccharide	O
and	O
lipoteichoic	O
acid	O
from	O
diverse	O
bacterial	O
strains	O
.	O

These	O
results	O
suggest	O
that	O
CSA	O
-	O
13	O
may	O
be	O
useful	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
oral	O
microbial	O
diseases	O
.	O

Actinomyces	B-bacteria
naeslundii	I-bacteria
is	O
an	O
important	O
early	O
colonizer	O
in	O
the	O
oral	O
biofilm	O
and	O
consists	O
of	O
three	O
genospecies	O
(	O
1	O
,	O
2	O
and	O
WVA	O
963	O
)	O
which	O
can	O
not	O
be	O
readily	O
differentiated	O
using	O
conventional	O
phenotypic	O
testing	O
or	O
on	O
the	O
basis	O
of	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

We	O
have	O
investigated	O
a	O
representative	O
collection	O
of	O
type	O
and	O
reference	O
strains	O
and	O
clinical	O
and	O
oral	O
isolates	O
(	O
n	O
=	O
115	O
)	O
and	O
determined	O
the	O
partial	O
gene	O
sequences	O
of	O
six	O
housekeeping	O
genes	O
(	O
atpA	O
,	O
rpoB	O
,	O
pgi	O
,	O
metG	O
,	O
gltA	O
and	O
gyrA	O
)	O
.	O

These	O
sequences	O
identified	O
the	O
three	O
genospecies	O
and	O
differentiated	O
them	O
from	O
Actinomyces	B-bacteria
viscosus	I-bacteria
isolated	O
from	O
rodents	O
.	O

The	O
partial	O
sequences	O
of	O
atpA	O
and	O
metG	O
gave	O
best	O
separation	O
of	O
the	O
three	O
genospecies	O
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
and	I-bacteria
2	I-bacteria
formed	O
two	O
distinct	O
clusters	O
,	O
well	O
separated	O
from	O
both	O
genospecies	O
WVA	B-bacteria
963	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
.	O

Analysis	O
of	O
the	O
same	O
genes	O
in	O
other	O
oral	O
Actinomyces	B-bacteria
species	I-bacteria
(	O
Actinomyces	B-bacteria
gerencseriae	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
israelii	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
meyeri	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
georgiae	I-bacteria
)	O
indicated	O
that	O
,	O
when	O
sequence	O
data	O
were	O
obtained	O
,	O
these	O
species	O
each	O
exhibited	O
<	O
90	O
%	O
similarity	O
with	O
the	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	O
.	O

Based	O
on	O
these	O
data	O
,	O
we	O
propose	O
the	O
name	O
Actinomyces	B-bacteria
oris	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
(	O
type	O
strain	O
ATCC	B-bacteria
27044	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
34288	I-bacteria
(	O
T	O
)	O
)	O
for	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
2	I-bacteria
and	O
Actinomyces	B-bacteria
johnsonii	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
(	O
type	O
strain	O
ATCC	B-bacteria
49338	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
34287	I-bacteria
(	O
T	O
)	O
)	O
for	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
WVA	I-bacteria
963	I-bacteria
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
genospecies	I-bacteria
1	I-bacteria
should	O
remain	O
as	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
sensu	O
stricto	O
,	O
with	O
the	O
type	O
strain	O
ATCC	B-bacteria
12104	I-bacteria
(	O
T	O
)	O
=	O
NCTC	B-bacteria
10301	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
2238	I-bacteria
(	O
T	O
)	O
.	O

The	O
gut	O
associated	O
lymphoid	O
tissue	O
(	O
GALT	O
)	O
is	O
anatomical	O
and	O
functionally	O
divided	O
in	O
inductive	O
and	O
effectors	O
sites	O
.	O

In	O
previous	O
works	O
we	O
demonstrated	O
that	O
non	O
-	O
pathogenic	O
bacteria	O
with	O
probiotic	O
characteristics	O
can	O
improve	O
the	O
gut	O
mucosal	O
immune	O
system	O
,	O
with	O
an	O
increase	O
in	O
the	O
number	O
of	O
IgA	O
and	O
cytokines	O
producing	O
cells	O
in	O
the	O
effector	O
site	O
of	O
the	O
intestine	O
.	O

In	O
the	O
present	O
work	O
we	O
studied	O
the	O
effect	O
of	O
non	O
-	O
pathogenic	O
Gram	O
(	O
+	O
)	O
,	O
Gram	O
(	O
-	O
)	O
bacteria	O
and	O
a	O
Gram	O
(	O
+	O
)	O
probiotic	O
strain	O
on	O
the	O
inductor	O
site	O
(	O
PP	O
)	O
after	O
the	O
oral	O
administration	O
to	O
BALB	O
/	O
c	O
mice	O
.	O

We	O
also	O
studied	O
some	O
signals	O
induced	O
by	O
the	O
assayed	O
strain	O
in	O
the	O
effectors	O
site	O
,	O
such	O
as	O
the	O
enzyme	O
calcineurin	O
and	O
TLR	O
-	O
9	O
as	O
a	O
way	O
to	O
understand	O
the	O
mechanisms	O
induced	O
in	O
such	O
bacterial	O
stimulation	O
.	O

The	O
implicance	O
of	O
the	O
lipoteichoic	O
acid	O
(	O
LTA	O
)	O
in	O
the	O
immunostimulation	O
was	O
analyzed	O
.	O

All	O
strains	O
increased	O
the	O
number	O
of	O
IFN	O
-	O
gamma	O
and	O
TNF	O
-	O
alpha	O
(	O
+	O
)	O
cells	O
,	O
but	O
not	O
of	O
IL	O
-	O
10	O
(	O
+	O
)	O
cells	O
in	O
the	O
total	O
population	O
of	O
PP	O
.	O

The	O
release	O
of	O
IFN	O
-	O
gamma	O
and	O
TNF	O
-	O
alpha	O
was	O
only	O
induced	O
by	O
LPS	O
stimulation	O
.	O

All	O
assayed	O
strains	O
increased	O
the	O
number	O
of	O
calcineurin	O
(	O
+	O
)	O
cells	O
,	O
while	O
only	O
Gram	O
(	O
+	O
)	O
strains	O
increased	O
the	O
number	O
of	O
TLR	O
-	O
9	O
(	O
+	O
)	O
cells	O
.	O

The	O
immunostimulatory	O
properties	O
of	O
the	O
purified	O
LTA	O
from	O
Gram	O
(	O
+	O
)	O
strains	O
was	O
evaluated	O
on	O
a	O
monocyte	O
-	O
macrophage	O
U937	O
cell	O
line	O
.	O

These	O
cells	O
showed	O
capacity	O
to	O
release	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
10	O
in	O
response	O
to	O
all	O
LTA	O
assayed	O
in	O
a	O
dose	O
-	O
dependent	O
way	O
.	O

Gram	O
(	O
+	O
)	O
strains	O
induced	O
signals	O
through	O
the	O
calcineurin	O
enzyme	O
able	O
to	O
activate	O
the	O
transcriptional	O
factor	O
NFAT	O
and	O
through	O
TLR	O
-	O
9	O
.	O

The	O
LTA	O
molecule	O
from	O
Gram	O
(	O
+	O
)	O
strains	O
would	O
not	O
be	O
the	O
only	O
structure	O
involved	O
in	O
the	O
immunostimulatory	O
properties	O
observed	O
,	O
specially	O
for	O
the	O
probiotic	O
strain	O
.	O

Periodontitis	O
is	O
the	O
major	O
cause	O
of	O
tooth	O
loss	O
in	O
adults	O
and	O
is	O
linked	O
to	O
systemic	O
illnesses	O
,	O
such	O
as	O
cardiovascular	O
disease	O
and	O
stroke	O
.	O

The	O
development	O
of	O
rapid	O
point	O
-	O
of	O
-	O
care	O
(	O
POC	O
)	O
chairside	O
diagnostics	O
has	O
the	O
potential	O
for	O
the	O
early	O
detection	O
of	O
periodontal	O
infection	O
and	O
progression	O
to	O
identify	O
incipient	O
disease	O
and	O
reduce	O
health	O
care	O
costs	O
.	O

However	O
,	O
validation	O
of	O
effective	O
diagnostics	O
requires	O
the	O
identification	O
and	O
verification	O
of	O
biomarkers	O
correlated	O
with	O
disease	O
progression	O
.	O

This	O
clinical	O
study	O
sought	O
to	O
determine	O
the	O
ability	O
of	O
putative	O
host	O
-	O
and	O
microbially	O
derived	O
biomarkers	O
to	O
identify	O
periodontal	O
disease	O
status	O
from	O
whole	O
saliva	O
and	O
plaque	O
biofilm	O
.	O

One	O
hundred	O
human	O
subjects	O
were	O
equally	O
recruited	O
into	O
a	O
healthy	O
/	O
gingivitis	O
group	O
or	O
a	O
periodontitis	O
population	O
.	O

Whole	O
saliva	O
was	O
collected	O
from	O
all	O
subjects	O
and	O
analyzed	O
using	O
antibody	O
arrays	O
to	O
measure	O
the	O
levels	O
of	O
multiple	O
proinflammatory	O
cytokines	O
and	O
bone	O
resorptive	O
/	O
turnover	O
markers	O
.	O

Salivary	O
biomarker	O
data	O
were	O
correlated	O
to	O
comprehensive	O
clinical	O
,	O
radiographic	O
,	O
and	O
microbial	O
plaque	O
biofilm	O
levels	O
measured	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
for	O
the	O
generation	O
of	O
models	O
for	O
periodontal	O
disease	O
identification	O
.	O

Significantly	O
elevated	O
levels	O
of	O
matrix	O
metalloproteinase	O
(	O
MMP	O
)	O
-	O
8	O
and	O
-	O
9	O
were	O
found	O
in	O
subjects	O
with	O
advanced	O
periodontitis	O
with	O
Random	O
Forest	O
importance	O
scores	O
of	O
7	O
.	O
1	O
and	O
5	O
.	O
1	O
,	O
respectively	O
.	O

The	O
generation	O
of	O
receiver	O
operating	O
characteristic	O
curves	O
demonstrated	O
that	O
permutations	O
of	O
salivary	O
biomarkers	O
and	O
pathogen	O
biofilm	O
values	O
augmented	O
the	O
prediction	O
of	O
disease	O
category	O
.	O

Multiple	O
combinations	O
of	O
salivary	O
biomarkers	O
(	O
especially	O
MMP	O
-	O
8	O
and	O
-	O
9	O
and	O
osteoprotegerin	O
)	O
combined	O
with	O
red	O
-	O
complex	O
anaerobic	O
periodontal	O
pathogens	O
(	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
or	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
provided	O
highly	O
accurate	O
predictions	O
of	O
periodontal	O
disease	O
category	O
.	O

Elevated	O
salivary	O
MMP	O
-	O
8	O
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
biofilm	O
levels	O
displayed	O
robust	O
combinatorial	O
characteristics	O
in	O
predicting	O
periodontal	O
disease	O
severity	O
(	O
area	O
under	O
the	O
curve	O
=	O
0	O
.	O
88	O
;	O
odds	O
ratio	O
=	O
24	O
.	O
6	O
;	O
95	O
%	O
confidence	O
interval	O
:	O
5	O
.	O
2	O
to	O
116	O
.	O
5	O
)	O
.	O

Using	O
qPCR	O
and	O
sensitive	O
immunoassays	O
,	O
we	O
identified	O
host	O
-	O
and	O
bacterially	O
derived	O
biomarkers	O
correlated	O
with	O
periodontal	O
disease	O
.	O

This	O
approach	O
offers	O
significant	O
potential	O
for	O
the	O
discovery	O
of	O
biomarker	O
signatures	O
useful	O
in	O
the	O
development	O
of	O
rapid	O
POC	O
chairside	O
diagnostics	O
for	O
oral	O
and	O
systemic	O
diseases	O
.	O

Studies	O
are	O
ongoing	O
to	O
apply	O
this	O
approach	O
to	O
the	O
longitudinal	O
predictions	O
of	O
disease	O
activity	O
.	O

Measurement	O
of	O
salivary	O
IgA	O
antibody	O
(	O
PAc	O
-	O
peptide	O
antibody	O
,	O
PPA	O
)	O
to	O
amino	O
acid	O
residues	O
361	O
-	O
386	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
PAc	O
,	O
which	O
possess	O
a	O
multiple	O
binding	O
motif	O
to	O
various	O
HLA	O
-	O
DR	O
molecules	O
and	O
a	O
B	O
-	O
cell	O
epitope	O
that	O
recognises	O
the	O
inhibiting	O
antibody	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
is	O
an	O
indicator	O
for	O
the	O
population	O
numbers	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
in	O
human	O
saliva	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
clarify	O
the	O
role	O
of	O
PPA	O
in	O
infection	O
control	O
of	O
MS	B-bacteria
after	O
professional	O
oral	O
hygiene	O
care	O
.	O

Thirty	O
-	O
nine	O
dependently	O
living	O
institutionalised	O
elderly	O
subjects	O
(	O
75	O
.	O
9	O
+	O
/	O
-	O
7	O
.	O
5	O
years	O
;	O
10	O
males	O
,	O
29	O
females	O
)	O
participated	O
in	O
the	O
study	O
.	O

The	O
measurements	O
of	O
PPA	O
,	O
MS	B-bacteria
,	O
total	O
streptococci	B-bacteria
(	O
TS	B-bacteria
)	O
and	O
lactobacilli	B-bacteria
(	O
LB	B-bacteria
)	O
were	O
performed	O
by	O
ELISA	O
and	O
culture	O
techniques	O
from	O
saliva	O
,	O
plaque	O
and	O
tongue	O
samples	O
from	O
the	O
elderly	O
.	O

After	O
treatment	O
using	O
professional	O
oral	O
care	O
,	O
the	O
numbers	O
of	O
MS	B-bacteria
decreased	O
significantly	O
at	O
6	O
months	O
in	O
saliva	O
and	O
tongue	O
samples	O
from	O
the	O
group	O
not	O
having	O
PPA	O
in	O
comparison	O
with	O
the	O
primary	O
data	O
;	O
whereas	O
in	O
the	O
PPA	O
-	O
detected	O
group	O
,	O
a	O
significant	O
decrease	O
in	O
MS	B-bacteria
number	O
was	O
shown	O
immediately	O
following	O
professional	O
care	O
at	O
1	O
-	O
12	O
months	O
in	O
all	O
samples	O
.	O

There	O
was	O
little	O
difference	O
in	O
the	O
numbers	O
of	O
LB	B-bacteria
at	O
any	O
of	O
the	O
time	O
points	O
.	O

The	O
numbers	O
of	O
TS	O
decreased	O
rapidly	O
in	O
PPA	O
-	O
not	O
detected	O
group	O
in	O
comparison	O
with	O
the	O
PPA	O
-	O
detected	O
group	O
.	O

PPA	O
may	O
be	O
more	O
effective	O
for	O
controlling	O
MS	B-bacteria
number	O
in	O
the	O
oral	O
cavity	O
after	O
professional	O
treatment	O
.	O

The	O
measurement	O
of	O
PPA	O
may	O
be	O
used	O
for	O
preventive	O
instruction	O
to	O
dental	O
caries	O
at	O
the	O
chair	O
side	O
in	O
the	O
clinical	O
setting	O
.	O

The	O
study	O
was	O
conducted	O
to	O
evaluate	O
a	O
new	O
cefixime	O
-	O
clavulanic	O
acid	O
combination	O
for	O
in	O
vitro	O
susceptibility	O
towards	O
gram	O
-	O
negative	O
bacteria	O
.	O

A	O
total	O
of	O
220	O
isolates	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
Pseudomonas	B-bacteria
aeroginosa	I-bacteria
,	O
Acinetobacter	B-bacteria
spp	I-bacteria
,	O
Salmonella	B-bacteria
enterica	I-bacteria
serovar	I-bacteria
Typhi	I-bacteria
and	O
Salmonella	B-bacteria
enterica	I-bacteria
serovar	I-bacteria
Typhimurium	I-bacteria
were	O
included	O
in	O
the	O
study	O
.	O

The	O
isolates	O
were	O
tested	O
for	O
susceptibility	O
towards	O
the	O
new	O
combination	O
antimicrobial	O
molecule	O
cefixime	O
with	O
clavulanic	O
acid	O
by	O
disk	O
diffusion	O
and	O
Epsilometer	O
strip	O
(	O
E	O
-	O
strip	O
)	O
Minimum	O
Inhibitary	O
Concentration	O
(	O
MIC	O
)	O
method	O
.	O

Of	O
the	O
101	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
isolates	I-bacteria
,	O
62	O
.	O
4	O
%	O
were	O
found	O
to	O
be	O
extended	O
spectrum	O
beta	O
-	O
lactamase	O
(	O
ESBL	O
)	O
producers	O
.	O

Almost	O
half	O
of	O
these	O
were	O
from	O
the	O
community	O
and	O
55	O
.	O
6	O
%	O
were	O
hospital	O
isolates	O
.	O

Of	O
the	O
ESBL	O
isolates	O
,	O
19	O
%	O
were	O
AmpC	O
(	O
cephalosporinases	O
that	O
are	O
poorly	O
inhibited	O
by	O
beta	O
lactamase	O
inhibitor	O
)	O
producers	O
while	O
the	O
remaining	O
81	O
%	O
were	O
non	O
AmpC	O
ESBL	O
producers	O
.	O

The	O
AmpC	O
producers	O
were	O
resistant	O
to	O
both	O
cefixime	O
and	O
the	O
combination	O
,	O
while	O
the	O
non	O
-	O
AmpC	O
producers	O
were	O
sensitive	O
to	O
the	O
combination	O
.	O

The	O
addition	O
of	O
clavulanate	O
to	O
cefixime	O
did	O
not	O
improve	O
the	O
sensitivities	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
and	O
Acinetobacter	B-bacteria
isolates	I-bacteria
.	O

There	O
were	O
no	O
ESBL	O
isolates	O
among	O
the	O
S	B-bacteria
.	I-bacteria
Typhi	I-bacteria
isolates	I-bacteria
,	O
all	O
of	O
which	O
were	O
sensitive	O
to	O
cefixime	O
.	O

Of	O
the	O
S	B-bacteria
.	I-bacteria
Typhimurium	I-bacteria
,	O
88	O
.	O
9	O
%	O
were	O
ESBL	O
producers	O
and	O
all	O
of	O
these	O
were	O
resistant	O
to	O
cefixime	O
but	O
sensitive	O
to	O
the	O
combination	O
.	O

The	O
combination	O
of	O
cefixime	O
with	O
clavulanic	O
acid	O
offers	O
the	O
advantage	O
of	O
oral	O
administration	O
and	O
appears	O
to	O
be	O
a	O
viable	O
option	O
for	O
the	O
treatment	O
of	O
uncomplicated	O
community	O
acquired	O
infections	O
caused	O
by	O
non	O
-	O
AmpC	O
ESBL	O
producing	O
gram	O
-	O
negative	O
bacteria	O
.	O

Adrenomedullin	O
(	O
ADM	O
)	O
promotes	O
epithelial	O
cell	O
proliferation	O
and	O
antimicrobial	O
activity	O
in	O
the	O
gastrointestinal	O
tract	O
.	O

Since	O
ADM	O
is	O
also	O
present	O
in	O
saliva	O
,	O
it	O
was	O
the	O
objective	O
of	O
our	O
study	O
to	O
investigate	O
the	O
role	O
of	O
salivary	O
ADM	O
in	O
the	O
maintenance	O
of	O
oral	O
health	O
.	O

We	O
found	O
mRNA	O
for	O
ADM	O
and	O
the	O
specific	O
receptors	O
CRLR	O
-	O
RAMP2	O
and	O
CRLR	O
-	O
RAMP3	O
expressed	O
by	O
the	O
salivary	O
glands	O
and	O
by	O
oral	O
keratinocytes	O
.	O

The	O
hormone	O
was	O
detected	O
in	O
the	O
glandular	O
tissues	O
by	O
western	O
blot	O
,	O
being	O
slightly	O
bigger	O
than	O
the	O
synthetic	O
peptide	O
,	O
indicating	O
a	O
posttranslational	O
modification	O
.	O

ADM	O
was	O
localized	O
using	O
immunohistochemistry	O
and	O
immunofluorescence	O
.	O

Staining	O
specific	O
for	O
ADM	O
was	O
observed	O
near	O
the	O
cell	O
nuclei	O
of	O
the	O
salivary	O
ducts	O
and	O
acini	O
.	O

There	O
was	O
no	O
correlation	O
between	O
ADM	O
from	O
matched	O
saliva	O
and	O
serum	O
of	O
healthy	O
volunteers	O
.	O

The	O
physiological	O
role	O
of	O
salivary	O
ADM	O
in	O
the	O
oral	O
cavity	O
was	O
investigated	O
by	O
incubating	O
buccal	O
keratinocytes	O
with	O
ADM	O
and	O
measurement	O
of	O
the	O
cell	O
proliferation	O
using	O
bromodeoxyuridine	O
(	O
BrDU	O
)	O
assays	O
.	O

There	O
was	O
a	O
significant	O
,	O
dose	O
dependent	O
increase	O
(	O
up	O
to	O
5	O
-	O
fold	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
of	O
the	O
BrDU	O
incorporation	O
after	O
stimulation	O
with	O
ADM	O
(	O
1	O
.	O
5	O
to	O
50	O
ng	O
/	O
mL	O
)	O
.	O

The	O
antibacterial	O
properties	O
of	O
salivary	O
ADM	O
was	O
studied	O
by	O
incubation	O
of	O
Gram	O
+	O
and	O
Gram	O
-	O
bacteria	O
and	O
yeast	O
,	O
isolated	O
from	O
human	O
oral	O
flora	O
,	O
with	O
ADM	O
(	O
0	O
.	O
01	O
-	O
1000	O
ng	O
/	O
mL	O
)	O
for	O
24	O
h	O
.	O
Bacterial	O
growth	O
was	O
inhibited	O
dose	O
dependently	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
whereas	O
the	O
yeast	O
was	O
not	O
affected	O
.	O

This	O
finding	O
was	O
consistent	O
when	O
using	O
radial	O
growth	O
inhibition	O
test	O
on	O
agarose	O
plates	O
as	O
well	O
as	O
photometric	O
measurement	O
in	O
microtiter	O
plates	O
.	O

Our	O
findings	O
suggest	O
an	O
important	O
role	O
of	O
salivary	O
ADM	O
in	O
the	O
maintenance	O
of	O
oral	O
health	O
,	O
being	O
involved	O
as	O
well	O
as	O
in	O
oral	O
cell	O
proliferation	O
and	O
anti	O
-	O
bacterial	O
defense	O
.	O

Four	O
strains	O
of	O
anaerobic	O
Gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
the	O
human	O
mouth	O
were	O
characterized	O
using	O
a	O
variety	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
.	O

The	O
strains	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
and	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
revealed	O
them	O
to	O
be	O
distinct	O
from	O
but	O
related	O
to	O
a	O
loose	O
cluster	O
of	O
Prevotella	B-bacteria
species	I-bacteria
including	O
Prevotella	B-bacteria
buccalis	I-bacteria
,	O
Prevotella	B-bacteria
nanceiensis	I-bacteria
and	O
Prevotella	B-bacteria
marshii	I-bacteria
.	O

A	O
novel	O
species	O
,	O
Prevotella	B-bacteria
micans	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
to	O
accommodate	O
these	O
strains	O
.	O

Prevotella	B-bacteria
micans	I-bacteria
is	O
saccharolytic	O
and	O
produces	O
acetic	O
,	O
isovaleric	O
and	O
succinic	O
acids	O
and	O
minor	O
amounts	O
of	O
isobutyric	O
acid	O
as	O
end	O
products	O
of	O
fermentation	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
the	O
type	O
strain	O
is	O
46	O
mol	O
%	O
.	O

The	O
type	O
strain	O
of	O
Prevotella	B-bacteria
micans	I-bacteria
is	O
E7	B-bacteria
.	I-bacteria
56	I-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
21469	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
56105	I-bacteria
(	O
T	O
)	O
)	O
.	O

Results	O
of	O
study	O
of	O
microecological	O
disorders	O
in	O
oral	O
cavity	O
of	O
patients	O
with	O
non	O
-	O
specific	O
ulcerative	O
colitis	O
(	O
NSUC	O
)	O
and	O
Crohn	O
'	O
s	O
disease	O
(	O
CD	O
)	O
and	O
control	O
subjects	O
(	O
patients	O
with	O
hypertension	O
)	O
.	O

Condition	O
of	O
mucosa	O
was	O
assessed	O
on	O
the	O
basis	O
of	O
morphological	O
data	O
and	O
electrophoretic	O
mobility	O
of	O
cell	O
nuclei	O
,	O
whereas	O
structure	O
of	O
microbiocenosis	O
and	O
metabolic	O
activity	O
of	O
microflora	O
-	O
-	O
on	O
the	O
basis	O
of	O
saliva	O
bacterial	O
culture	O
and	O
contents	O
and	O
profile	O
of	O
volatile	O
fat	O
acids	O
in	O
it	O
.	O

Detection	O
rate	O
of	O
negative	O
charge	O
of	O
the	O
cell	O
nuclei	O
(	O
decrease	O
of	O
functional	O
activity	O
of	O
epithelium	O
)	O
was	O
significantly	O
higher	O
in	O
patients	O
with	O
NSUC	O
and	O
CD	O
(	O
66	O
.	O
6	O
%	O
)	O
compared	O
with	O
controls	O
(	O
10	O
%	O
)	O
.	O

This	O
fact	O
was	O
directly	O
related	O
with	O
hypercolonization	O
of	O
oral	O
cavity	O
by	O
Gram	O
-	O
negative	O
microflora	O
.	O

Lesions	O
of	O
mucosa	O
which	O
are	O
characteristic	O
of	O
NSUC	O
and	O
CD	O
and	O
determined	O
by	O
pathologic	O
immune	O
mechanisms	O
correlated	O
with	O
quantity	O
of	O
pathogenic	O
microflora	O
(	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Candida	O
)	O
.	O

Marked	O
differences	O
of	O
chromatograms	O
'	O
patterns	O
were	O
observed	O
in	O
patients	O
with	O
NSUC	O
and	O
CD	O
indicating	O
the	O
suppression	O
of	O
anaerobic	O
microflora	O
in	O
patients	O
with	O
CD	O
and	O
hypercolonization	O
of	O
oral	O
cavity	O
by	O
anaerobic	O
microflora	O
in	O
majority	O
of	O
patients	O
with	O
NSUC	O
.	O

Members	O
of	O
the	O
phylum	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
have	O
frequently	O
been	O
detected	O
in	O
the	O
human	O
oral	O
cavity	O
at	O
sites	O
of	O
dental	O
disease	O
,	O
but	O
they	O
have	O
rarely	O
been	O
detected	O
in	O
studies	O
of	O
oral	O
health	O
.	O

Only	O
two	O
oral	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
taxa	O
are	O
cultivable	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
investigate	O
the	O
diversity	O
of	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
in	O
the	O
oral	O
cavity	O
,	O
to	O
establish	O
whether	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
taxa	O
are	O
more	O
strongly	O
associated	O
with	O
periodontitis	O
than	O
with	O
oral	O
health	O
,	O
and	O
to	O
visualize	O
unculturable	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
in	O
situ	O
.	O

Sixty	O
samples	O
(	O
saliva	O
,	O
dental	O
plaque	O
,	O
and	O
mucosal	O
swabs	O
)	O
were	O
collected	O
from	O
five	O
subjects	O
with	O
periodontitis	O
and	O
five	O
periodontally	O
healthy	O
controls	O
.	O

Using	O
phylum	O
-	O
specific	O
16S	O
rRNA	O
gene	O
primers	O
,	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
were	O
identified	O
by	O
PCR	O
,	O
cloning	O
,	O
and	O
sequencing	O
of	O
48	O
clones	O
per	O
PCR	O
-	O
positive	O
sample	O
.	O

Subgingival	O
plaque	O
samples	O
were	O
labeled	O
with	O
probes	O
targeting	O
rRNA	O
of	O
unculturable	O
oral	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
using	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

Analysis	O
of	O
1	O
,	O
664	O
clones	O
revealed	O
12	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
at	O
the	O
99	O
%	O
sequence	O
identity	O
level	O
,	O
5	O
of	O
which	O
were	O
novel	O
.	O

`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
OTU	O
4	O
.	O
2	O
was	O
found	O
in	O
significantly	O
more	O
subjects	O
with	O
periodontitis	O
than	O
controls	O
(	O
P	O
=	O
0	O
.	O
048	O
)	O
and	O
was	O
more	O
abundant	O
in	O
subgingival	O
plaque	O
at	O
diseased	O
sites	O
than	O
at	O
healthy	O
sites	O
in	O
subjects	O
with	O
periodontitis	O
(	O
P	O
=	O
0	O
.	O
019	O
)	O
or	O
controls	O
(	O
P	O
=	O
0	O
.	O
019	O
)	O
.	O

FISH	O
analysis	O
revealed	O
that	O
unculturable	O
oral	O
`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
cells	O
were	O
large	O
curved	O
bacilli	O
.	O

The	O
human	O
oral	O
cavity	O
harbors	O
a	O
diverse	O
population	O
of	O
`	O
`	O
Synergistetes	B-bacteria
.	O
'	O
'	O

`	O
`	O
Synergistetes	B-bacteria
'	O
'	O
OTU	O
4	O
.	O
2	O
is	O
associated	O
with	O
periodontitis	O
and	O
may	O
have	O
a	O
pathogenic	O
role	O
.	O

Parvimonas	B-bacteria
micra	I-bacteria
are	O
gram	O
positive	O
anaerobic	O
cocci	O
isolated	O
from	O
the	O
oral	O
cavity	O
and	O
frequently	O
related	O
to	O
polymicrobial	O
infections	O
in	O
humans	O
.	O

Despite	O
reports	O
about	O
phenotypic	O
differences	O
,	O
the	O
genotypic	O
variation	O
of	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
and	O
its	O
role	O
in	O
virulence	O
are	O
still	O
not	O
elucidated	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
genotypic	O
diversity	O
of	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
isolates	I-bacteria
obtained	O
from	O
the	O
subgingival	O
biofilm	O
of	O
subjects	O
with	O
different	O
periodontal	O
conditions	O
and	O
to	O
correlate	O
these	O
findings	O
with	O
phenotypic	O
traits	O
.	O

Three	O
reference	O
strains	O
and	O
35	O
isolates	O
of	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
were	O
genotyped	O
by	O
16S	O
rRNA	O
PCR	O
-	O
RFLP	O
and	O
phenotypic	O
traits	O
such	O
as	O
collagenase	O
production	O
,	O
elastolytic	O
and	O
hemolytic	O
activities	O
were	O
evaluated	O
.	O

16S	O
rRNA	O
PCR	O
-	O
RFLP	O
showed	O
that	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
could	O
be	O
grouped	O
into	O
two	O
main	O
clusters	O
:	O
C1	O
and	O
C2	O
;	O
cluster	O
C1	O
harbored	O
three	O
genotypes	O
(	O
HG1259	O
-	O
like	O
,	O
HG1467	O
-	O
like	O
and	O
ICBMO583	O
-	O
like	O
)	O
while	O
cluster	O
C2	O
harbored	O
two	O
genotypes	O
(	O
ATCC33270	O
-	O
like	O
and	O
ICBMO36	O
)	O
.	O

A	O
wide	O
variability	O
in	O
collagenolytic	O
activity	O
intensities	O
was	O
observed	O
among	O
all	O
isolates	O
,	O
while	O
elastolytic	O
activity	O
was	O
detected	O
in	O
only	O
two	O
isolates	O
.	O

There	O
was	O
an	O
association	O
between	O
hemolytic	O
activity	O
in	O
rabbit	O
erythrocytes	O
and	O
cluster	O
C2	O
.	O

There	O
was	O
an	O
association	O
between	O
hemolytic	O
activity	O
in	O
rabbit	O
erythrocytes	O
and	O
cluster	O
C1	O
.	O

Although	O
these	O
data	O
suggest	O
a	O
possible	O
association	O
between	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
genetic	O
diversity	O
and	O
their	O
pathogenic	O
potential	O
,	O
further	O
investigations	O
are	O
needed	O
to	O
confirm	O
this	O
hypothesis	O
.	O

We	O
examined	O
the	O
associations	O
between	O
preterm	O
birth	O
and	O
low	O
birth	O
weight	O
and	O
maternal	O
caries	O
history	O
,	O
maternal	O
periodontal	O
status	O
,	O
and	O
salivary	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
Lactobacilli	B-bacteria
.	O

This	O
study	O
was	O
a	O
matched	O
case	O
-	O
control	O
study	O
in	O
women	O
during	O
their	O
pregnancy	O
or	O
up	O
to	O
8	O
weeks	O
after	O
delivery	O
.	O

SUBJECTS	O
AND	O
Thirty	O
-	O
four	O
women	O
delivering	O
before	O
37	O
weeks	O
gestation	O
were	O
recruited	O
along	O
with	O
73	O
term	O
controls	O
matched	O
for	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

Demographic	O
and	O
obstetric	O
information	O
was	O
collected	O
from	O
questionnaires	O
and	O
medical	O
records	O
and	O
oral	O
examinations	O
along	O
with	O
commercial	O
salivary	O
tests	O
were	O
completed	O
within	O
the	O
study	O
groups	O
.	O

The	O
main	O
outcome	O
variables	O
were	O
the	O
preterm	O
birth	O
and	O
low	O
birth	O
weight	O
status	O
.	O

The	O
independent	O
variables	O
measured	O
were	O
the	O
salivary	O
levels	O
of	O
Lactobacilli	B-bacteria
and	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
the	O
caries	O
and	O
periodontal	O
status	O
of	O
the	O
subjects	O
.	O

The	O
odds	O
ratio	O
comparing	O
low	O
levels	O
of	O
bacteria	O
in	O
preterm	O
mothers	O
and	O
controls	O
was	O
statistically	O
significant	O
for	O
Lactobacilli	B-bacteria
(	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
3	O
.	O
45	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
1	O
.	O
27	O
to	O
10	O
.	O
00	O
)	O
and	O
almost	O
significant	O
for	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
OR	O
=	O
2	O
.	O
63	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
95	O
to	O
8	O
.	O
33	O
)	O
.	O

Clinical	O
caries	O
and	O
periodontal	O
disease	O
measures	O
did	O
not	O
differ	O
significantly	O
between	O
groups	O
.	O

Within	O
the	O
limitation	O
of	O
our	O
study	O
,	O
low	O
levels	O
of	O
Lactobacilli	B-bacteria
in	O
saliva	O
were	O
found	O
to	O
be	O
associated	O
with	O
preterm	O
birth	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
describe	O
the	O
bacterial	O
diversity	O
in	O
the	O
oral	O
cavity	O
of	O
the	O
elderly	O
without	O
root	O
caries	O
using	O
bacterial	O
microarrays	O
,	O
and	O
to	O
determine	O
the	O
site	O
-	O
and	O
subject	O
-	O
specificity	O
of	O
bacterial	O
colonization	O
.	O

Samples	O
were	O
collected	O
from	O
the	O
tongue	O
dorsum	O
,	O
mucosa	O
of	O
the	O
buccal	O
fold	O
,	O
hard	O
palate	O
,	O
supragingival	O
plaque	O
from	O
sound	O
root	O
surfaces	O
,	O
and	O
subgingival	O
plaque	O
from	O
the	O
same	O
roots	O
.	O

A	O
new	O
16	O
S	O
rRNA	O
gene	O
-	O
based	O
microarray	O
method	O
was	O
used	O
for	O
the	O
simultaneous	O
detection	O
of	O
approximately	O
300	O
bacterial	O
species	O
.	O

Overall	O
,	O
175	O
species	O
and	O
clusters	O
were	O
detected	O
,	O
representing	O
eight	O
phyla	O
.	O

Species	O
belonging	O
to	O
the	O
genera	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
and	O
Fusobacterium	B-bacteria
were	O
common	O
in	O
all	O
sites	O
.	O

The	O
number	O
of	O
species	O
per	O
subject	O
varied	O
from	O
51	O
to	O
81	O
.	O

Statistical	O
analyses	O
revealed	O
about	O
40	O
species	O
or	O
clusters	O
with	O
significant	O
associations	O
with	O
at	O
least	O
one	O
of	O
the	O
sites	O
.	O

The	O
bacterial	O
diversity	O
was	O
highest	O
in	O
the	O
cheek	O
and	O
palate	O
regions	O
.	O

Species	O
typically	O
associated	O
with	O
caries	O
and	O
periodontitis	O
were	O
detected	O
rarely	O
or	O
not	O
at	O
all	O
.	O

The	O
oral	O
bacterial	O
flora	O
of	O
the	O
elderly	O
appears	O
to	O
be	O
diverse	O
,	O
and	O
,	O
to	O
a	O
large	O
extent	O
,	O
site	O
-	O
rather	O
than	O
subject	O
-	O
specific	O
.	O

Surface	O
adhesion	O
plays	O
an	O
essential	O
part	O
in	O
the	O
survival	O
of	O
the	O
commensal	O
organism	O
Streptococcus	B-bacteria
gordonii	I-bacteria
in	O
the	O
oral	O
cavity	O
as	O
well	O
as	O
during	O
opportunistic	O
infections	O
such	O
as	O
endocarditis	O
.	O

At	O
least	O
two	O
types	O
of	O
cell	O
surface	O
protein	O
involved	O
in	O
adhesion	O
are	O
found	O
on	O
the	O
surface	O
of	O
Gram	O
-	O
positive	O
bacteria	O
:	O
those	O
anchored	O
via	O
an	O
LPXTG	O
motif	O
by	O
the	O
enzyme	O
sortase	O
A	O
(	O
SrtA	O
)	O
and	O
those	O
associated	O
with	O
the	O
cell	O
surface	O
by	O
,	O
as	O
yet	O
,	O
unknown	O
mechanisms	O
.	O

In	O
srtA	O
(	O
-	O
)	O
mutants	O
,	O
LPXTG	O
-	O
containing	O
proteins	O
have	O
been	O
shown	O
to	O
be	O
released	O
rather	O
than	O
cross	O
-	O
linked	O
to	O
the	O
cell	O
wall	O
.	O

We	O
have	O
therefore	O
used	O
2D	O
gel	O
electrophoresis	O
of	O
released	O
proteins	O
from	O
an	O
srtA	O
(	O
-	O
)	O
mutant	O
as	O
well	O
as	O
the	O
wild	O
-	O
type	O
strain	O
,	O
followed	O
by	O
peptide	O
identification	O
by	O
MS	B-bacteria
,	O
to	O
identify	O
a	O
set	O
of	O
novel	O
proteins	O
predicted	O
to	O
be	O
present	O
on	O
the	O
surface	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
DL1	I-bacteria
.	O

This	O
includes	O
two	O
large	O
LPXTG	O
-	O
linked	O
proteins	O
(	O
SGO	O
_	O
0707	O
and	O
SGO	O
_	O
1487	O
)	O
,	O
which	O
both	O
contain	O
tandemly	O
repeated	O
sequences	O
similar	O
to	O
those	O
present	O
in	O
known	O
fibrillar	O
adhesins	O
.	O

A	O
5	O
'	O
-	O
nucleotidase	O
and	O
a	O
protein	O
with	O
a	O
putative	O
collagen	O
-	O
binding	O
domain	O
,	O
both	O
containing	O
LPXTG	O
motifs	O
,	O
were	O
also	O
identified	O
.	O

Anchorless	O
proteins	O
with	O
known	O
chaperone	O
,	O
stress	O
response	O
and	O
elongation	O
factor	O
functions	O
,	O
apparently	O
responsible	O
for	O
bacterial	O
binding	O
to	O
keratinocytes	O
and	O
saliva	O
-	O
coated	O
surfaces	O
in	O
the	O
absence	O
of	O
the	O
LPXTG	O
-	O
linked	O
adhesins	O
,	O
were	O
also	O
associated	O
with	O
the	O
cell	O
surface	O
.	O

These	O
data	O
reveal	O
a	O
range	O
of	O
proteins	O
to	O
be	O
present	O
on	O
the	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
DL1	I-bacteria
cell	O
surface	O
,	O
the	O
expression	O
of	O
which	O
plays	O
an	O
important	O
role	O
in	O
adhesion	O
to	O
epithelia	O
and	O
which	O
represent	O
likely	O
candidates	O
for	O
novel	O
virulence	O
factors	O
in	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
microbiologically	O
analyze	O
oral	O
mucosal	O
samples	O
collected	O
during	O
2	O
years	O
from	O
patients	O
with	O
oral	O
mucosal	O
complaints	O
.	O

Mucosal	O
scraping	O
samples	O
were	O
taken	O
from	O
297	O
patients	O
and	O
semiquantified	O
by	O
culture	O
for	O
detection	O
of	O
opportunistic	O
microorganisms	O
e	O
.	O
g	O
.	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
enterococci	B-bacteria
,	O
aerobic	O
Gram	O
-	O
negative	O
bacilli	O
(	O
AGNB	O
)	O
and	O
yeasts	O
.	O

Antibiotic	O
susceptibility	O
test	O
was	O
performed	O
.	O

Altogether	O
297	O
patients	O
were	O
sampled	O
(	O
mean	O
age	O
56	O
.	O
8	O
+	O
/	O
-	O
20	O
.	O
7	O
)	O
.	O

Among	O
the	O
110	O
patients	O
with	O
known	O
medical	O
condition	O
,	O
48	O
were	O
systemically	O
immunocompromised	O
,	O
35	O
had	O
systemic	O
diseases	O
,	O
and	O
27	O
had	O
only	O
local	O
oral	O
complaints	O
.	O

Opportunists	O
in	O
moderate	O
growth	O
or	O
more	O
were	O
present	O
commonly	O
in	O
all	O
three	O
groups	O
and	O
most	O
frequent	O
in	O
the	O
immunocompromised	O
patients	O
(	O
66	O
.	O
7	O
%	O
)	O
.	O

Candida	O
species	O
were	O
the	O
most	O
frequent	O
opportunist	O
(	O
68	O
.	O
8	O
%	O
)	O
,	O
however	O
,	O
their	O
level	O
was	O
low	O
and	O
combinations	O
with	O
bacterial	O
opportunists	O
were	O
common	O
(	O
39	O
.	O
6	O
%	O
)	O
.	O

All	O
bacterial	O
opportunists	O
tested	O
were	O
antibiotic	O
multiresistant	O
.	O

Follow	O
-	O
up	O
samples	O
were	O
collected	O
in	O
23	O
cases	O
out	O
of	O
which	O
seven	O
showed	O
still	O
presence	O
of	O
opportunists	O
in	O
heavy	O
growth	O
despite	O
repeated	O
treatment	O
with	O
ciprofloxacin	O
.	O

This	O
study	O
showed	O
a	O
frequent	O
presence	O
of	O
bacterial	O
and	O
fungal	O
opportunists	O
in	O
patients	O
with	O
oral	O
mucosal	O
complaints	O
,	O
which	O
were	O
most	O
common	O
in	O
immunocompromised	O
individuals	O
,	O
however	O
,	O
also	O
frequent	O
in	O
patients	O
with	O
local	O
oral	O
complaints	O
only	O
.	O

Systematic	O
evaluation	O
of	O
different	O
treatment	O
strategies	O
is	O
needed	O
.	O

Polyphenols	O
are	O
antibacterial	O
and	O
anti	O
-	O
oxidative	O
natural	O
agents	O
.	O

The	O
present	O
in	O
situ	O
study	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
different	O
polyphenolic	O
beverages	O
on	O
initial	O
bacterial	O
adherence	O
to	O
enamel	O
in	O
the	O
oral	O
cavity	O
.	O

Initial	O
biofilm	O
formation	O
was	O
performed	O
on	O
bovine	O
enamel	O
specimens	O
mounted	O
buccally	O
on	O
individual	O
upper	O
jaw	O
splints	O
and	O
carried	O
by	O
six	O
subjects	O
.	O

After	O
1	O
min	O
of	O
pellicle	O
formation	O
,	O
oral	O
rinses	O
with	O
black	O
tea	O
,	O
green	O
tea	O
,	O
grape	O
juice	O
,	O
Cistus	O
tea	O
or	O
red	O
wine	O
were	O
performed	O
for	O
10	O
min	O
.	O

Afterwards	O
the	O
slabs	O
were	O
carried	O
for	O
another	O
19	O
or	O
109	O
min	O
,	O
respectively	O
.	O

Samples	O
exposed	O
to	O
the	O
oral	O
fluids	O
for	O
30	O
and	O
120	O
min	O
served	O
as	O
controls	O
.	O

Following	O
intraoral	O
exposure	O
,	O
the	O
slabs	O
were	O
rinsed	O
with	O
saline	O
solution	O
.	O

The	O
amount	O
of	O
adherent	O
bacteria	O
was	O
determined	O
with	O
DAPI	O
-	O
staining	O
(	O
4	O
'	O
,	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	O
)	O
and	O
with	O
fluorescence	O
-	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
of	O
eubacteria	O
and	O
streptococci	B-bacteria
.	O

Rinses	O
with	O
all	O
beverages	O
reduced	O
the	O
amount	O
of	O
detectable	O
bacteria	O
.	O

Lowest	O
number	O
of	O
adherent	O
bacteria	O
was	O
found	O
following	O
rinses	O
with	O
red	O
wine	O
,	O
Cistus	O
tea	O
and	O
black	O
tea	O
as	O
measured	O
with	O
DAPI	O
(	O
up	O
to	O
66	O
%	O
reduction	O
of	O
adherent	O
bacteria	O
vs	O
.	O
controls	O
)	O
.	O

Also	O
FISH	O
revealed	O
significant	O
impact	O
of	O
most	O
tested	O
beverages	O
.	O

Rinses	O
with	O
certain	O
polyphenolic	O
beverages	O
as	O
well	O
as	O
consumption	O
of	O
these	O
foodstuffs	O
may	O
contribute	O
to	O
prevention	O
of	O
biofilm	O
induced	O
diseases	O
in	O
the	O
oral	O
cavity	O
.	O

To	O
establish	O
the	O
effects	O
of	O
three	O
factors	O
:	O
previous	O
caries	O
experience	O
;	O
colonization	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
;	O
and	O
final	O
pH	O
on	O
autologous	O
lactobacilli	O
-	O
mediated	O
inhibition	O
against	O
a	O
panel	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
young	O
subjects	O
with	O
different	O
caries	O
experiences	O
.	O

The	O
inhibition	O
capacity	O
was	O
determined	O
by	O
the	O
use	O
of	O
the	O
agar	O
overlay	O
method	O
and	O
the	O
final	O
pH	O
in	O
culture	O
medium	O
was	O
measured	O
after	O
20	O
h	O
.	O
Using	O
a	O
logistic	O
regression	O
model	O
,	O
the	O
risk	O
of	O
having	O
an	O
incomplete	O
lactobacilli	O
-	O
mediated	O
inhibition	O
was	O
calculated	O
.	O

All	O
three	O
factors	O
significantly	O
influenced	O
the	O
interference	O
outcome	O
in	O
the	O
order	O
;	O
final	O
pH	O
of	O
the	O
Lactobacillus	B-bacteria
strains	I-bacteria
,	O
oral	O
colonization	O
of	O
autologous	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
caries	O
experience	O
.	O

A	O
high	O
risk	O
occurred	O
at	O
a	O
lower	O
pH	O
and	O
at	O
a	O
wider	O
pH	O
range	O
for	O
individuals	O
with	O
previous	O
caries	O
experience	O
and	O
autologous	O
colonization	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
compared	O
with	O
caries	O
-	O
free	O
subjects	O
who	O
were	O
not	O
colonized	O
.	O

At	O
a	O
final	O
pH	O
of	O
4	O
.	O
0	O
,	O
this	O
risk	O
was	O
approximately	O
eight	O
times	O
higher	O
than	O
that	O
of	O
the	O
latter	O
group	O
.	O

Two	O
mutans	B-bacteria
Streptococcus	I-bacteria
strains	I-bacteria
in	O
the	O
test	O
panel	O
demonstrated	O
high	O
individual	O
predictive	O
values	O
of	O
inhibition	O
mediated	O
by	O
oral	O
lactobacilli	B-bacteria
.	O

Generation	O
of	O
a	O
low	O
pH	O
either	O
directly	O
via	O
organic	O
acid	O
production	O
and	O
/	O
or	O
production	O
of	O
bacteriocins	O
or	O
metabolites	O
at	O
a	O
low	O
pH	O
may	O
promote	O
mutans	B-bacteria
Streptococcus	I-bacteria
growth	O
inhibition	O
,	O
in	O
vitro	O
.	O

Furthermore	O
,	O
a	O
shift	O
of	O
pH	O
range	O
for	O
the	O
risk	O
of	O
incomplete	O
inhibition	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
suggests	O
a	O
less	O
effective	O
inhibition	O
at	O
a	O
wider	O
pH	O
range	O
for	O
naturally	O
occurring	O
lactobacilli	B-bacteria
from	O
individuals	O
with	O
earlier	O
caries	O
experience	O
containing	O
own	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Four	O
strains	O
of	O
anaerobic	O
,	O
Gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
distinct	O
from	O
any	O
species	O
with	O
validly	O
published	O
names	O
.	O

16S	O
rRNA	O
and	O
23S	O
rRNA	O
gene	O
sequence	O
analyses	O
and	O
DNA	O
-	O
DNA	O
reassociation	O
data	O
revealed	O
that	O
the	O
strains	O
constituted	O
a	O
novel	O
group	O
within	O
the	O
phylum	O
'	O
Synergistetes	B-bacteria
'	O
and	O
were	O
most	O
closely	O
related	O
to	O
Jonquetella	B-bacteria
anthropi	I-bacteria
.	O

Two	O
libraries	O
of	O
randomly	O
cloned	O
DNA	O
were	O
prepared	O
from	O
strain	O
W5455	B-bacteria
(	O
T	O
)	O
and	O
were	O
sequenced	O
to	O
provide	O
a	O
genome	O
survey	O
as	O
a	O
resource	O
for	O
metagenomic	O
studies	O
.	O

A	O
new	O
genus	O
and	O
novel	O
species	O
,	O
Pyramidobacter	B-bacteria
piscolens	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
to	O
accommodate	O
these	O
strains	O
.	O

The	O
genus	O
Pyramidobacter	B-bacteria
comprises	O
strains	O
that	O
are	O
anaerobic	O
,	O
non	O
-	O
motile	O
,	O
asaccharolytic	O
bacilli	O
that	O
produce	O
acetic	O
and	O
isovaleric	O
acids	O
and	O
minor	O
to	O
trace	O
amounts	O
of	O
propionic	O
,	O
isobutyric	O
,	O
succinic	O
and	O
phenylacetic	O
acids	O
as	O
end	O
products	O
of	O
metabolism	O
.	O

P	B-bacteria
.	I-bacteria
piscolens	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
produced	O
hydrogen	O
sulphide	O
but	O
was	O
otherwise	O
largely	O
biochemically	O
unreactive	O
.	O

Growth	O
was	O
stimulated	O
by	O
the	O
addition	O
of	O
glycine	O
to	O
broth	O
media	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
the	O
type	O
strain	O
was	O
59	O
mol	O
%	O
.	O

The	O
type	O
strain	O
of	O
Pyramidobacter	B-bacteria
piscolens	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
is	O
W5455	B-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
21147	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
55836	I-bacteria
(	O
T	O
)	O
)	O
.	O

The	O
combined	O
use	O
of	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
and	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
offers	O
new	O
opportunities	O
for	O
analysis	O
of	O
the	O
spatial	O
relationships	O
and	O
temporal	O
changes	O
of	O
specific	O
members	O
of	O
the	O
microbiota	O
of	O
intact	O
dental	O
biofilms	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
analyse	O
the	O
patterns	O
of	O
colonization	O
and	O
population	O
dynamics	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
compared	O
to	O
streptococci	B-bacteria
and	O
other	O
bacteria	O
during	O
the	O
initial	O
48	O
h	O
of	O
biofilm	O
formation	O
in	O
the	O
oral	O
cavity	O
.	O

Biofilms	O
developed	O
on	O
standardized	O
glass	O
slabs	O
mounted	O
in	O
intra	O
-	O
oral	O
appliances	O
worn	O
by	O
ten	O
individuals	O
for	O
6	O
,	O
12	O
,	O
24	O
and	O
48	O
h	O
.	O
The	O
biofilms	O
were	O
subsequently	O
labelled	O
with	O
probes	O
against	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
(	O
ACT476	B-bacteria
)	O
,	O
streptococci	B-bacteria
(	O
STR405	B-bacteria
)	O
or	O
all	O
bacteria	O
(	O
EUB338	O
)	O
,	O
and	O
were	O
analysed	O
by	O
CLSM	O
.	O

Labelled	O
bacteria	O
were	O
quantified	O
by	O
stereological	O
tools	O
.	O

The	O
results	O
showed	O
a	O
notable	O
increase	O
in	O
the	O
number	O
of	O
streptococci	B-bacteria
and	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
over	O
time	O
,	O
with	O
a	O
tendency	O
towards	O
a	O
slower	O
growth	O
rate	O
for	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
compared	O
with	O
streptococci	B-bacteria
.	O

A	O
.	O
naeslundii	O
was	O
located	O
mainly	O
in	O
the	O
inner	O
part	O
of	O
the	O
multilayered	O
biofilm	O
,	O
indicating	O
that	O
it	O
is	O
one	O
of	O
the	O
species	O
that	O
attaches	O
directly	O
to	O
the	O
acquired	O
pellicle	O
.	O

The	O
participation	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
in	O
the	O
initial	O
stages	O
of	O
dental	O
biofilm	O
formation	O
may	O
have	O
important	O
ecological	O
consequences	O
.	O

TGF	O
-	O
beta1	O
exerts	O
diverse	O
functions	O
in	O
tooth	O
development	O
and	O
tissue	O
repair	O
,	O
but	O
its	O
role	O
in	O
microbial	O
defenses	O
of	O
the	O
tooth	O
is	O
not	O
well	O
-	O
understood	O
.	O

Odontoblasts	O
extending	O
their	O
cellular	O
processes	O
into	O
the	O
dentin	O
are	O
the	O
first	O
cells	O
to	O
recognize	O
signals	O
from	O
TGF	O
-	O
beta1	O
and	O
bacteria	O
in	O
carious	O
dentin	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
the	O
role	O
of	O
TGF	O
-	O
beta1	O
in	O
modulating	O
odontoblast	O
responses	O
to	O
oral	O
bacteria	O
.	O

We	O
show	O
that	O
these	O
responses	O
depend	O
upon	O
the	O
expression	O
levels	O
of	O
microbial	O
recognition	O
receptors	O
TLR2	O
and	O
TLR4	O
on	O
the	O
cell	O
surface	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
activated	O
both	O
TLRs	O
,	O
but	O
TLR4	O
played	O
a	O
greater	O
role	O
.	O

Lack	O
of	O
cell	O
-	O
surface	O
TLR2	O
was	O
associated	O
with	O
poor	O
response	O
to	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
.	O

TGF	O
-	O
beta1	O
inhibited	O
TLR2	O
and	O
TLR4	O
expression	O
and	O
attenuated	O
odontoblast	O
responses	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
balance	O
between	O
TLR	O
-	O
mediated	O
inflammation	O
and	O
TGF	O
-	O
beta1	O
anti	O
-	O
inflammatory	O
activity	O
plays	O
an	O
important	O
role	O
in	O
pulpal	O
inflammation	O
.	O

This	O
study	O
was	O
performed	O
to	O
detect	O
the	O
opportunistic	O
bacteria	O
and	O
fungi	O
from	O
the	O
oral	O
cavities	O
of	O
orthodontic	O
patients	O
and	O
examine	O
the	O
ability	O
of	O
the	O
organisms	O
to	O
adhere	O
to	O
saliva	O
-	O
coated	O
metallic	O
brackets	O
.	O

Opportunistic	O
bacteria	O
and	O
fungi	O
were	O
isolated	O
from	O
58	O
patients	O
(	O
orthodontic	O
group	O
:	O
42	O
;	O
non	O
-	O
orthodontic	O
group	O
:	O
16	O
)	O
using	O
culture	O
methods	O
and	O
were	O
identified	O
based	O
on	O
their	O
biochemical	O
and	O
enzymatic	O
profiles	O
.	O

Seven	O
opportunistic	O
and	O
four	O
streptococcal	B-bacteria
strains	I-bacteria
were	O
tested	O
for	O
their	O
ability	O
to	O
adhere	O
to	O
saliva	O
-	O
coated	O
metallic	O
brackets	O
.	O

More	O
opportunistic	O
bacteria	O
and	O
fungi	O
were	O
detected	O
in	O
the	O
orthodontic	O
group	O
than	O
in	O
the	O
non	O
-	O
orthodontic	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Opportunistic	O
bacteria	O
adhered	O
to	O
saliva	O
-	O
coated	O
metallic	O
brackets	O
to	O
the	O
same	O
degree	O
as	O
oral	O
streptococci	B-bacteria
.	O

The	O
isolation	O
frequencies	O
of	O
opportunistic	O
bacteria	O
and	O
fungi	O
increase	O
during	O
orthodontic	O
treatment	O
,	O
suggesting	O
the	O
importance	O
of	O
paying	O
special	O
attention	O
to	O
oral	O
hygiene	O
in	O
orthodontic	O
patients	O
to	O
prevent	O
periodontal	O
disease	O
and	O
the	O
aggravation	O
of	O
systemic	O
disease	O
in	O
immunocompromised	O
conditions	O
.	O

Knowledge	O
of	O
the	O
early	O
oral	O
colonization	O
patterns	O
could	O
provide	O
a	O
better	O
understanding	O
of	O
oral	O
biofilm	O
development	O
and	O
disease	O
initiation	O
that	O
in	O
turn	O
could	O
be	O
the	O
basis	O
for	O
early	O
preventive	O
programmes	O
.	O

Microbial	O
samples	O
were	O
collected	O
from	O
five	O
different	O
oral	O
habitats	O
from	O
a	O
total	O
of	O
93	O
children	O
(	O
age	O
3	O
-	O
12	O
years	O
)	O
,	O
attending	O
the	O
Dental	O
School	O
of	O
the	O
University	O
of	O
Athens	O
,	O
who	O
were	O
split	O
into	O
three	O
age	O
groups	O
.	O

A	O
total	O
of	O
38	O
microbial	O
species	O
were	O
sought	O
out	O
by	O
the	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
.	O

All	O
of	O
the	O
test	O
species	O
,	O
except	O
Parvimonas	B-bacteria
micra	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
differed	O
significantly	O
among	O
sample	O
locations	O
providing	O
quite	O
distinct	O
microbial	O
profiles	O
for	O
the	O
different	O
oral	O
surfaces	O
.	O

Supragingival	O
and	O
subgingival	O
plaque	O
had	O
similar	O
profiles	O
and	O
exhibited	O
higher	O
proportions	O
of	O
Actinomyces	B-bacteria
species	I-bacteria
and	O
Green	O
complex	O
while	O
soft	O
tissue	O
samples	O
were	O
dominated	O
by	O
streptococci	B-bacteria
of	O
the	O
Yellow	O
complex	O
.	O

The	O
profiles	O
of	O
the	O
tongue	O
dorsum	O
and	O
saliva	O
were	O
also	O
similar	O
.	O

Many	O
of	O
the	O
species	O
were	O
in	O
similar	O
proportions	O
in	O
all	O
three	O
age	O
groups	O
for	O
a	O
given	O
location	O
.	O

Periodontal	O
pathogens	O
showed	O
increases	O
in	O
proportions	O
with	O
increasing	O
age	O
.	O

Specifically	O
,	O
the	O
Red	O
complex	O
species	O
(	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
showed	O
a	O
significant	O
increase	O
in	O
proportion	O
with	O
age	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
all	O
sample	O
locations	O
.	O

The	O
results	O
showed	O
a	O
pattern	O
of	O
colonization	O
in	O
children	O
similar	O
to	O
that	O
previously	O
found	O
in	O
adults	O
.	O

Differences	O
in	O
the	O
profile	O
between	O
age	O
groups	O
suggest	O
a	O
gradual	O
maturation	O
of	O
the	O
oral	O
microbiota	O
,	O
with	O
it	O
being	O
made	O
up	O
of	O
an	O
increasing	O
number	O
of	O
Orange	O
and	O
Red	O
complex	O
species	O
.	O

We	O
investigated	O
receptor	O
activator	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
ligand	O
(	O
RANKL	O
)	O
expression	O
by	O
B	O
lymphocytes	O
during	O
early	O
and	O
late	O
aspects	O
of	O
the	O
immune	O
response	O
to	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
a	O
gram	O
-	O
negative	O
,	O
anaerobic	O
bacterium	O
associated	O
with	O
aggressive	O
periodontal	O
disease	O
.	O

Expression	O
of	O
messenger	O
RNA	O
transcripts	O
(	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
Toll	O
-	O
like	O
receptors	O
4	O
and	O
9	O
,	O
interleukins	O
4	O
and	O
10	O
,	O
and	O
RANKL	O
)	O
involved	O
in	O
early	O
(	O
1	O
-	O
day	O
)	O
and	O
late	O
(	O
10	O
-	O
day	O
)	O
responses	O
in	O
cultured	O
rat	O
splenocytes	O
was	O
examined	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

The	O
immune	O
cell	O
distribution	O
(	O
T	O
,	O
B	O
,	O
and	O
natural	O
killer	O
cells	O
and	O
macrophages	O
)	O
in	O
cultured	O
rat	O
splenocytes	O
and	O
RANKL	O
expression	O
in	O
B	O
cells	O
were	O
determined	O
by	O
flow	O
cytometric	O
analyses	O
.	O

B	O
-	O
cell	O
capacity	O
for	O
induction	O
of	O
osteoclast	O
differentiation	O
was	O
evaluated	O
by	O
coculture	O
with	O
RAW	O
264	O
.	O
7	O
cells	O
followed	O
by	O
a	O
tartrate	O
-	O
resistant	O
acid	O
phosphatase	O
(	O
TRAP	O
)	O
activity	O
assay	O
.	O

The	O
expression	O
levels	O
of	O
interleukins	O
4	O
and	O
10	O
in	O
cultured	O
cells	O
were	O
not	O
changed	O
in	O
the	O
presence	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
until	O
cultured	O
for	O
3	O
days	O
,	O
and	O
peaked	O
after	O
7	O
days	O
.	O

After	O
culture	O
for	O
10	O
days	O
,	O
the	O
percentages	O
of	O
B	O
and	O
T	O
cells	O
,	O
the	O
overall	O
RANKL	O
messenger	O
RNA	O
transcripts	O
,	O
and	O
the	O
percentage	O
of	O
RANKL	O
-	O
expressing	O
immunoglobulin	O
G	O
-	O
positive	O
cells	O
were	O
significantly	O
increased	O
in	O
the	O
presence	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

These	O
increases	O
were	O
considerably	O
greater	O
in	O
cells	O
isolated	O
from	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
-	O
immunized	O
animals	O
than	O
from	O
non	O
-	O
immunized	O
animals	O
.	O

RAW	O
264	O
.	O
7	O
cells	O
demonstrated	O
significantly	O
increased	O
TRAP	O
activity	O
when	O
cocultured	O
with	O
B	O
cells	O
from	O
A	O
.	O
actinomycetemcomitans	O
-	O
immunized	O
animals	O
.	O

The	O
addition	O
of	O
human	O
osteoprotegerin	O
-	O
Fc	O
to	O
the	O
culture	O
significantly	O
diminished	O
such	O
increases	O
.	O

This	O
study	O
suggests	O
that	O
B	O
-	O
lymphocyte	O
involvement	O
in	O
the	O
immune	O
response	O
to	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
through	O
upregulation	O
of	O
RANKL	O
expression	O
potentially	O
contribute	O
to	O
bone	O
resorption	O
in	O
periodontal	O
disease	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
is	O
very	O
prevalent	O
in	O
Brazil	O
,	O
infecting	O
almost	O
65	O
%	O
of	O
the	O
population	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
presence	O
of	O
this	O
bacterium	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
functional	O
dyspepsia	O
(	O
epigastric	O
pain	O
syndrome	O
)	O
,	O
establish	O
the	O
main	O
sites	O
of	O
infection	O
in	O
the	O
mouth	O
,	O
and	O
assess	O
the	O
frequency	O
of	O
cagA	O
and	O
vacA	O
genotypes	O
of	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

All	O
43	O
outpatients	O
with	O
epigastric	O
pain	O
syndrome	O
,	O
who	O
entered	O
the	O
study	O
,	O
were	O
submitted	O
to	O
upper	O
gastrointestinal	O
endoscopy	O
to	O
rule	O
out	O
organic	O
diseases	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
in	O
the	O
stomach	O
was	O
confirmed	O
by	O
a	O
rapid	O
urease	O
test	O
and	O
urea	O
breath	O
tests	O
.	O

Samples	O
of	O
saliva	O
,	O
the	O
tongue	O
dorsum	O
and	O
supragingival	O
dental	O
plaque	O
were	O
collected	O
from	O
the	O
oral	O
cavity	O
of	O
each	O
subject	O
and	O
subgingival	O
dental	O
plaque	O
samples	O
were	O
collected	O
from	O
the	O
patients	O
with	O
periodontitis	O
;	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
verified	O
by	O
polymerase	O
chain	O
reaction	O
using	O
primers	O
that	O
amplify	O
the	O
DNA	O
sequence	O
of	O
a	O
species	O
-	O
specific	O
antigen	O
present	O
in	O
all	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
strains	I-bacteria
;	O
primers	O
that	O
amplify	O
a	O
region	O
of	O
urease	O
gene	O
,	O
and	O
primers	O
for	O
cagA	O
and	O
vacA	O
(	O
m1	O
,	O
m2	O
,	O
s1a	O
,	O
s1b	O
,	O
s2	O
)	O
genotyping	O
.	O

Thirty	O
patients	O
harbored	O
H	O
.	O
pylori	O
in	O
the	O
stomach	O
,	O
but	O
it	O
was	O
not	O
possible	O
to	O
detect	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
any	O
oral	O
samples	O
using	O
P1	O
/	O
P2	O
and	O
Urease	O
A	O
/	O
B	O
.	O

The	O
genotype	O
cagA	O
was	O
also	O
negative	O
in	O
all	O
samples	O
and	O
vacA	O
genotype	O
could	O
not	O
be	O
characterized	O
(	O
s	O
-	O
m	O
-	O
)	O
.	O

The	O
oral	O
cavity	O
may	O
not	O
be	O
a	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
patients	O
with	O
epigastric	O
pain	O
syndrome	O
,	O
the	O
bacterium	O
being	O
detected	O
exclusively	O
in	O
the	O
stomach	O
.	O

Streptococcus	B-bacteria
oralis	I-bacteria
is	O
a	O
member	O
of	O
the	O
normal	O
human	O
oral	O
microbiota	O
,	O
capable	O
of	O
opportunistic	O
pathogenicity	O
;	O
like	O
related	O
oral	O
streptococci	B-bacteria
,	O
it	O
exhibits	O
appreciable	O
phenotypic	O
and	O
genetic	O
variation	O
.	O

A	O
multilocus	O
sequence	O
typing	O
(	O
MLST	O
)	O
scheme	O
for	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
was	O
developed	O
and	O
the	O
resultant	O
data	O
analysed	O
to	O
examine	O
the	O
population	O
structure	O
of	O
the	O
species	O
.	O

Analysis	O
of	O
113	O
isolates	O
,	O
confirmed	O
as	O
belonging	O
to	O
the	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
/	I-bacteria
mitis	I-bacteria
group	O
by	O
16S	O
rRNA	O
gene	O
sequencing	O
,	O
characterized	O
the	O
population	O
as	O
highly	O
diverse	O
and	O
undergoing	O
inter	O
-	O
and	O
intra	O
-	O
species	O
recombination	O
with	O
a	O
probable	O
clonal	O
complex	O
structure	O
.	O

ClonalFrame	O
analysis	O
of	O
these	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
isolates	I-bacteria
along	O
with	O
examples	O
of	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
pseudopneumoniae	I-bacteria
grouped	O
the	O
named	O
species	O
into	O
distinct	O
,	O
coherent	O
populations	O
and	O
did	O
not	O
support	O
the	O
clustering	O
of	O
S	B-bacteria
.	I-bacteria
pseudopneumoniae	I-bacteria
with	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
as	O
reported	O
previously	O
using	O
distance	O
-	O
based	O
methods	O
.	O

Analysis	O
of	O
the	O
individual	O
loci	O
suggested	O
that	O
this	O
discrepancy	O
was	O
due	O
to	O
the	O
possible	O
hybrid	O
nature	O
of	O
S	B-bacteria
.	I-bacteria
pseudopneumoniae	I-bacteria
.	O

This	O
randomized	O
clinical	O
trial	O
evaluated	O
the	O
effects	O
of	O
an	O
essential	O
oils	O
-	O
containing	O
mouthrinse	O
for	O
full	O
-	O
mouth	O
disinfection	O
.	O

Fifty	O
patients	O
were	O
assigned	O
to	O
receive	O
full	O
-	O
mouth	O
disinfection	O
with	O
either	O
essential	O
oils	O
or	O
placebo	O
.	O

At	O
baseline	O
,	O
2	O
and	O
6	O
months	O
of	O
treatment	O
the	O
primary	O
outcomes	O
probing	O
depth	O
(	O
PD	O
)	O
,	O
plaque	O
index	O
(	O
PlI	O
)	O
and	O
modified	O
gingival	O
index	O
(	O
MGI	O
)	O
were	O
monitored	O
.	O

Additional	O
monitoring	O
included	O
bacterial	O
presence	O
(	O
by	O
polymerase	O
chain	O
reaction	O
)	O
in	O
subgingival	O
,	O
saliva	O
and	O
tongue	O
samples	O
;	O
flows	O
,	O
pH	O
,	O
total	O
protein	O
and	O
alkaline	O
phosphatase	O
salivary	O
levels	O
.	O

The	O
following	O
statistics	O
were	O
used	O
:	O
ANOVA	O
,	O
Student	O
'	O
s	O
t	O
-	O
test	O
,	O
chi	O
(	O
2	O
)	O
and	O
Kruskal	O
-	O
Wallis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Mean	O
PD	O
>	O
or	O
=	O
3	O
.	O
5	O
mm	O
was	O
reduced	O
over	O
time	O
in	O
both	O
the	O
placebo	O
and	O
the	O
test	O
groups	O
,	O
but	O
there	O
was	O
no	O
difference	O
in	O
PD	O
reduction	O
between	O
groups	O
at	O
2	O
and	O
6	O
months	O
.	O

At	O
2	O
and	O
6	O
months	O
,	O
PlI	O
and	O
MGI	O
showed	O
greater	O
reductions	O
in	O
the	O
test	O
group	O
than	O
in	O
the	O
placebo	O
group	O
.	O

Porphyromona	B-bacteria
gingivalis	I-bacteria
was	O
not	O
reduced	O
in	O
any	O
site	O
.	O

At	O
6	O
months	O
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
increased	O
in	O
both	O
groups	O
,	O
while	O
Tannerella	B-bacteria
forsythensis	I-bacteria
decreased	O
subgingivally	O
in	O
the	O
test	O
group	O
.	O

S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
increased	O
,	O
except	O
subgingivally	O
,	O
in	O
the	O
placebo	O
group	O
.	O

Salivary	O
pH	O
and	O
flows	O
were	O
not	O
altered	O
.	O

Total	O
protein	O
reduced	O
only	O
in	O
the	O
test	O
group	O
.	O

Alkaline	O
phosphatase	O
did	O
not	O
change	O
in	O
either	O
group	O
.	O

Essential	O
oils	O
for	O
full	O
-	O
mouth	O
disinfection	O
showed	O
clinical	O
benefits	O
,	O
namely	O
reducing	O
plaque	O
and	O
gingival	O
inflammation	O
without	O
altering	O
basic	O
salivary	O
parameters	O
.	O

To	O
purify	O
and	O
partially	O
characterize	O
a	O
bacteriocin	O
produced	O
by	O
a	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
strain	I-bacteria
.	O
Following	O
protein	O
precipitation	O
the	O
effect	O
of	O
different	O
treatments	O
on	O
a	O
bacteriocin	O
produced	O
by	O
a	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strain	I-bacteria
named	O
P12	B-bacteria
.	I-bacteria
2	I-bacteria
isolated	O
from	O
a	O
patient	O
with	O
periodontitis	O
was	O
evaluated	O
.	O

The	O
antagonistic	O
activity	O
of	O
the	O
intracellular	O
fraction	O
obtained	O
at	O
80	O
%	O
ammonium	O
sulphate	O
was	O
preserved	O
at	O
pH	O
values	O
from	O
6	O
.	O
0	O
to	O
9	O
.	O
0	O
and	O
showed	O
to	O
be	O
sensitive	O
to	O
high	O
temperatures	O
and	O
to	O
treatment	O
with	O
proteases	O
.	O

The	O
fraction	O
was	O
submitted	O
to	O
sequential	O
steps	O
of	O
gel	O
filtration	O
,	O
ion	O
exchange	O
,	O
and	O
reverse	O
phase	O
chromatography	O
,	O
and	O
SDS	O
-	O
PAGE	O
.	O

Data	O
obtained	O
by	O
mass	O
spectrometry	O
revealed	O
that	O
the	O
molecular	O
mass	O
of	O
the	O
protein	O
was	O
27	O
,	O
296	O
Da	O
.	O

For	O
the	O
first	O
time	O
a	O
bacteriocin	O
produced	O
by	O
a	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strain	I-bacteria
was	O
purified	O
and	O
characterized	O
.	O

This	O
is	O
the	O
first	O
description	O
on	O
characterization	O
of	O
a	O
bacteriocin	O
produced	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

It	O
is	O
possible	O
that	O
the	O
bacteriocin	O
plays	O
a	O
role	O
in	O
the	O
regulation	O
of	O
population	O
levels	O
of	O
periodontopathic	O
organisms	O
.	O

Bacteria	O
settled	O
in	O
the	O
apical	O
root	O
canal	O
are	O
in	O
a	O
privileged	O
position	O
to	O
inflict	O
damage	O
to	O
the	O
periradicular	O
tissues	O
.	O

Therefore	O
,	O
the	O
species	O
identified	O
in	O
this	O
region	O
can	O
be	O
of	O
special	O
relevance	O
for	O
the	O
pathogenesis	O
of	O
apical	O
periodontitis	O
.	O

This	O
study	O
investigated	O
the	O
occurrence	O
and	O
levels	O
of	O
several	O
bacterial	O
taxa	O
in	O
the	O
apical	O
root	O
canal	O
of	O
teeth	O
with	O
apical	O
periodontitis	O
.	O

DNA	O
extracts	O
from	O
samples	O
taken	O
from	O
the	O
apical	O
part	O
of	O
the	O
root	O
canal	O
of	O
extracted	O
teeth	O
evincing	O
chronic	O
apical	O
periodontitis	O
lesions	O
served	O
as	O
templates	O
for	O
analysis	O
of	O
the	O
presence	O
and	O
levels	O
of	O
28	O
bacterial	O
species	O
/	O
phylotypes	O
using	O
a	O
16S	O
ribosomal	O
RNA	O
gene	O
-	O
based	O
reverse	O
-	O
capture	O
checkerboard	O
hybridization	O
assay	O
.	O

Bacterial	O
DNA	O
was	O
detected	O
in	O
19	O
out	O
of	O
20	O
samples	O
.	O

Detected	O
taxa	O
included	O
Pseudoramibacter	B-bacteria
alactolyticus	I-bacteria
(	O
32	O
%	O
)	O
,	O
Bacteroidetes	B-bacteria
clone	I-bacteria
X083	I-bacteria
(	O
26	O
%	O
)	O
,	O
Streptococcus	B-bacteria
species	I-bacteria
(	O
21	O
%	O
)	O
,	O
Olsenella	B-bacteria
uli	I-bacteria
(	O
10	O
.	O
5	O
%	O
)	O
,	O
Synergistes	B-bacteria
clone	I-bacteria
BA121	I-bacteria
(	O
10	O
.	O
5	O
%	O
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
10	O
.	O
5	O
%	O
)	O
,	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
(	O
10	O
.	O
5	O
%	O
)	O
,	O
Dialister	B-bacteria
clone	I-bacteria
BS016	I-bacteria
(	O
5	O
%	O
)	O
,	O
Filifactor	B-bacteria
alocis	I-bacteria
(	O
5	O
%	O
)	O
,	O
Parvimonas	B-bacteria
micra	I-bacteria
(	O
5	O
%	O
)	O
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
5	O
%	O
)	O
.	O

Of	O
these	O
,	O
only	O
Bacteroidetes	B-bacteria
clone	I-bacteria
X083	I-bacteria
and	O
Synergistes	B-bacteria
clone	I-bacteria
BA121	I-bacteria
were	O
found	O
at	O
levels	O
above	O
10	O
(	O
5	O
)	O
.	O

Occurrence	O
of	O
these	O
bacterial	O
taxa	O
in	O
the	O
apical	O
part	O
of	O
infected	O
root	O
canals	O
indicates	O
their	O
potential	O
pathogenetic	O
role	O
in	O
the	O
etiology	O
of	O
apical	O
periodontitis	O
.	O

The	O
oral	O
microbial	O
flora	O
comprises	O
one	O
of	O
the	O
most	O
diverse	O
human	O
-	O
associated	O
biofilms	O
.	O

Its	O
development	O
is	O
heavily	O
influenced	O
by	O
oral	O
streptococci	B-bacteria
,	O
which	O
are	O
considered	O
the	O
main	O
group	O
of	O
early	O
colonizers	O
.	O

Their	O
initial	O
attachment	O
determines	O
the	O
composition	O
of	O
later	O
colonizers	O
in	O
the	O
oral	O
biofilm	O
and	O
impacts	O
the	O
health	O
or	O
disease	O
status	O
of	O
the	O
host	O
.	O

Thus	O
,	O
the	O
role	O
of	O
streptococci	B-bacteria
in	O
the	O
development	O
of	O
oral	O
diseases	O
is	O
best	O
described	O
in	O
the	O
context	O
of	O
bacterial	O
ecology	O
,	O
which	O
itself	O
is	O
further	O
influenced	O
by	O
interactions	O
with	O
host	O
epithelial	O
cells	O
,	O
the	O
immune	O
system	O
,	O
and	O
salivary	O
components	O
.	O

The	O
tractability	O
of	O
the	O
oral	O
biofilm	O
makes	O
it	O
an	O
excellent	O
model	O
system	O
for	O
studies	O
of	O
complex	O
,	O
biofilm	O
-	O
associated	O
polymicrobial	O
diseases	O
.	O

Using	O
this	O
system	O
,	O
numerous	O
cooperative	O
and	O
antagonistic	O
bacterial	O
interactions	O
have	O
been	O
demonstrated	O
to	O
occur	O
within	O
the	O
community	O
and	O
with	O
the	O
host	O
.	O

In	O
this	O
review	O
,	O
several	O
recent	O
identified	O
interactions	O
are	O
presented	O
.	O

The	O
oral	O
microbial	O
consortium	O
is	O
the	O
most	O
characterized	O
polymicrobial	O
microbial	O
community	O
associated	O
with	O
the	O
human	O
host	O
.	O

Extensive	O
sampling	O
of	O
both	O
microbial	O
and	O
tissue	O
samples	O
has	O
demonstrated	O
that	O
there	O
is	O
a	O
strong	O
association	O
between	O
the	O
type	O
of	O
microbial	O
community	O
found	O
in	O
the	O
gingival	O
crevice	O
and	O
the	O
status	O
of	O
innate	O
host	O
mediator	O
expression	O
.	O

The	O
strong	O
clinical	O
association	O
between	O
the	O
microbial	O
community	O
and	O
the	O
innate	O
host	O
response	O
in	O
both	O
clinically	O
healthy	O
and	O
diseased	O
tissue	O
suggests	O
that	O
the	O
oral	O
consortium	O
has	O
a	O
direct	O
effect	O
on	O
periodontal	O
tissue	O
expression	O
of	O
innate	O
defense	O
mediators	O
.	O

A	O
preliminary	O
study	O
in	O
germ	O
-	O
free	O
mice	O
has	O
demonstrated	O
that	O
the	O
oral	O
commensal	O
consortium	O
has	O
direct	O
effect	O
on	O
IL	O
-	O
1beta	O
expression	O
,	O
indicating	O
that	O
this	O
microbial	O
community	O
may	O
contribute	O
to	O
the	O
strong	O
protective	O
status	O
of	O
healthy	O
gingival	O
tissue	O
.	O

Likewise	O
,	O
the	O
lipopolysaccharide	O
composition	O
and	O
invasion	O
characteristics	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
an	O
oral	O
bacterium	O
strongly	O
associated	O
with	O
periodontitis	O
,	O
suggest	O
that	O
it	O
may	O
be	O
a	O
keystone	O
member	O
of	O
the	O
oral	O
microbial	O
community	O
and	O
facilitate	O
a	O
destructive	O
change	O
in	O
the	O
protective	O
gingival	O
innate	O
host	O
status	O
.	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
whether	O
the	O
oral	O
administration	O
of	O
lactobacilli	B-bacteria
could	O
change	O
the	O
bacterial	O
population	O
in	O
supra	O
/	O
subgingival	O
plaque	O
.	O

Sixty	O
-	O
six	O
healthy	O
volunteers	O
without	O
severe	O
periodontitis	O
were	O
randomized	O
into	O
two	O
groups	O
to	O
receive	O
lactobacilli	B-bacteria
or	O
placebo	O
for	O
8	O
weeks	O
(	O
8W	O
)	O
:	O
the	O
test	O
group	O
(	O
n	O
=	O
34	O
)	O
received	O
2	O
.	O
01	O
x	O
10	O
(	O
9	O
)	O
CFU	O
/	O
day	O
of	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
WB21	I-bacteria
and	O
xylitol	O
in	O
tablets	O
;	O
the	O
control	O
group	O
(	O
n	O
=	O
32	O
)	O
received	O
placebo	O
with	O
xylitol	O
.	O

Supra	O
/	O
subgingival	O
plaque	O
samples	O
were	O
collected	O
at	O
the	O
baseline	O
and	O
after	O
4	O
weeks	O
(	O
4W	O
)	O
and	O
8W	O
.	O

The	O
bacterial	O
amounts	O
in	O
plaque	O
samples	O
were	O
analysed	O
by	O
quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
.	O

The	O
numerical	O
sum	O
of	O
five	O
selected	O
periodontopathic	O
bacteria	O
in	O
the	O
test	O
group	O
was	O
decreased	O
significantly	O
in	O
subgingival	O
plaque	O
at	O
4W	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
3	O
.	O
13	O
,	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
=	O
1	O
.	O
28	O
-	O
7	O
.	O
65	O
,	O
p	O
=	O
0	O
.	O
012	O
]	O
.	O

Multivariate	O
analysis	O
showed	O
that	O
significantly	O
higher	O
odds	O
were	O
obtained	O
for	O
the	O
reduction	O
of	O
Tannerella	B-bacteria
forsythia	I-bacteria
in	O
subgingival	O
plaque	O
of	O
the	O
test	O
group	O
at	O
both	O
4W	O
(	O
OR	O
=	O
6	O
.	O
69	O
,	O
95	O
%	O
CI	O
=	O
2	O
.	O
51	O
-	O
17	O
.	O
9	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
8W	O
(	O
OR	O
=	O
3	O
.	O
67	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
45	O
-	O
9	O
.	O
26	O
,	O
p	O
=	O
0	O
.	O
006	O
)	O
.	O

Oral	O
administration	O
of	O
probiotic	O
lactobacilli	B-bacteria
reduced	O
the	O
numerical	O
sum	O
of	O
five	O
selected	O
periodontopathic	O
bacteria	O
and	O
could	O
contribute	O
to	O
the	O
beneficial	O
effects	O
on	O
periodontal	O
conditions	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
is	O
a	O
periodontal	O
pathogen	O
that	O
resides	O
in	O
a	O
complex	O
multispecies	O
microbial	O
biofilm	O
community	O
known	O
as	O
dental	O
plaque	O
.	O

Confocal	O
laser	O
scanning	O
microscopy	O
showed	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
assemble	O
into	O
communities	O
in	O
vitro	O
with	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
common	O
constituents	O
of	O
dental	O
plaque	O
.	O

Whole	O
cell	O
quantitative	O
proteomics	O
,	O
along	O
with	O
mutant	O
construction	O
and	O
analysis	O
,	O
were	O
conducted	O
to	O
investigate	O
how	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adapts	O
to	O
this	O
three	O
species	O
community	O
.	O

1156	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
proteins	O
were	O
detected	O
qualitatively	O
during	O
comparison	O
of	O
the	O
three	O
species	O
model	O
community	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
incubated	O
alone	O
under	O
the	O
same	O
conditions	O
.	O

Integration	O
of	O
spectral	O
counting	O
and	O
summed	O
signal	O
intensity	O
analyses	O
of	O
the	O
dataset	O
showed	O
that	O
403	O
proteins	O
were	O
down	O
-	O
regulated	O
and	O
89	O
proteins	O
up	O
-	O
regulated	O
.	O

The	O
proteomics	O
results	O
were	O
inspected	O
manually	O
and	O
an	O
ontology	O
analysis	O
conducted	O
using	O
DAVID	O
.	O

Significant	O
decreases	O
were	O
seen	O
in	O
proteins	O
involved	O
in	O
cell	O
shape	O
and	O
the	O
formation	O
of	O
the	O
cell	O
envelope	O
,	O
as	O
well	O
as	O
thiamine	O
,	O
cobalamin	O
,	O
and	O
pyrimidine	O
synthesis	O
and	O
DNA	O
repair	O
.	O

An	O
overall	O
increase	O
was	O
seen	O
in	O
proteins	O
involved	O
in	O
protein	O
synthesis	O
.	O

HmuR	O
,	O
a	O
TonB	O
dependent	O
outer	O
membrane	O
receptor	O
,	O
was	O
up	O
-	O
regulated	O
in	O
the	O
community	O
and	O
an	O
hmuR	O
deficient	O
mutant	O
was	O
deficient	O
in	O
three	O
species	O
community	O
formation	O
,	O
but	O
was	O
unimpaired	O
in	O
its	O
ability	O
to	O
form	O
mono	O
-	O
or	O
dual	O
-	O
species	O
biofilms	O
.	O

Collectively	O
,	O
these	O
results	O
indicate	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
assemble	O
into	O
a	O
heterotypic	O
community	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
and	O
that	O
a	O
community	O
lifestyle	O
provides	O
physiologic	O
support	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Proteins	O
such	O
as	O
HmuR	O
,	O
that	O
are	O
up	O
-	O
regulated	O
,	O
can	O
be	O
necessary	O
for	O
community	O
structure	O
.	O

To	O
investigate	O
the	O
correlation	O
between	O
the	O
changes	O
in	O
oral	O
microflora	O
and	O
recurrent	O
oral	O
ulcers	O
(	O
ROU	O
)	O
.	O

Salivary	O
sample	O
were	O
collected	O
from	O
ROU	O
patients	O
with	O
oral	O
ulcers	O
(	O
group	O
T	O
)	O
and	O
those	O
with	O
ulcer	O
healing	O
(	O
group	O
C	O
)	O
as	O
well	O
as	O
from	O
ROU	O
-	O
free	O
individuals	O
(	O
group	O
N	O
)	O
.	O

The	O
quantity	O
of	O
3	O
common	O
bacteria	O
(	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
and	O
Neisseria	B-bacteria
sp	I-bacteria
.	I-bacteria
)	O

in	O
the	O
salivary	O
samples	O
was	O
detected	O
and	O
compared	O
between	O
the	O
3	O
groups	O
.	O

The	O
quantities	O
of	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
(	O
7	O
.	O
30	O
-	O
/	O
+	O
0	O
.	O
89	O
copies	O
/	O
ml	O
)	O
and	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
(	O
8	O
.	O
29	O
-	O
/	O
+	O
0	O
.	O
77	O
copies	O
/	O
ml	O
)	O
in	O
group	O
T	O
were	O
significantly	O
lower	O
than	O
those	O
in	O
group	O
N	O
(	O
8	O
.	O
15	O
-	O
/	O
+	O
0	O
.	O
55	O
and	O
8	O
.	O
93	O
-	O
/	O
+	O
0	O
.	O
76	O
copies	O
/	O
ml	O
,	O
respectively	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
but	O
similar	O
with	O
those	O
in	O
group	O
C	O
.	O
The	O
quantity	O
of	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
(	O
7	O
.	O
51	O
-	O
/	O
+	O
0	O
.	O
81	O
copies	O
/	O
ml	O
)	O
in	O
group	O
C	O
was	O
significantly	O
lower	O
than	O
that	O
in	O
group	O
N	O
(	O
8	O
.	O
15	O
-	O
/	O
+	O
0	O
.	O
55	O
copies	O
/	O
ml	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
but	O
the	O
quantity	O
of	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
was	O
similar	O
between	O
the	O
two	O
groups	O
.	O

No	O
significant	O
difference	O
were	O
found	O
in	O
the	O
quantity	O
of	O
Neisseria	B-bacteria
sp	I-bacteria
.	I-bacteria
between	O
the	O
3	O
groups	O
.	O

The	O
quantity	O
of	O
oral	O
microflora	O
differs	O
significantly	O
between	O
patients	O
with	O
recurrent	O
oral	O
ulcers	O
and	O
normal	O
individuals	O
,	O
suggesting	O
a	O
possible	O
correlation	O
between	O
oral	O
microfora	O
and	O
recurrent	O
oral	O
ulcers	O
.	O

Separation	O
of	O
bacterial	O
DNA	O
from	O
human	O
DNA	O
in	O
clinical	O
samples	O
may	O
have	O
an	O
important	O
impact	O
on	O
downstream	O
applications	O
,	O
involving	O
microbial	O
diagnostic	O
systems	O
.	O

We	O
evaluated	O
two	O
commercially	O
available	O
reagents	O
(	O
MolYsis	O
)	O
,	O
Molzym	O
GmbH	O
&	O
Co	O
.	O
KG	O
,	O
Bremen	O
and	O
Pureprove	O
,	O
SIRS	O
-	O
Lab	O
GmbH	O
,	O
Jena	O
,	O
both	O
Germany	O
)	O
for	O
their	O
potential	O
to	O
isolate	O
and	O
purify	O
bacterial	O
DNA	O
from	O
human	O
DNA	O
.	O

We	O
chose	O
oral	O
samples	O
,	O
which	O
usually	O
contain	O
very	O
high	O
amounts	O
of	O
both	O
human	O
and	O
bacterial	O
cells	O
.	O

Three	O
different	O
DNA	O
preparations	O
each	O
were	O
made	O
from	O
eight	O
caries	O
and	O
eight	O
periodontal	O
specimens	O
using	O
the	O
two	O
reagents	O
above	O
and	O
a	O
conventional	O
DNA	O
extraction	O
strategy	O
as	O
reference	O
.	O

Based	O
on	O
target	O
-	O
specific	O
real	O
-	O
time	O
-	O
quantitative	O
PCR	O
assays	O
we	O
compared	O
the	O
reduction	O
of	O
human	O
DNA	O
versus	O
loss	O
of	O
bacterial	O
DNA	O
.	O

Human	O
DNA	O
was	O
monitored	O
by	O
targeting	O
the	O
beta	O
-	O
2	O
-	O
microglobulin	O
gene	O
,	O
while	O
bacteria	O
were	O
monitored	O
by	O
targeting	O
16S	O
rDNA	O
(	O
total	O
bacteria	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
or	O
the	O
glycosyltransferase	O
gene	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
)	O
.	O

We	O
found	O
that	O
in	O
most	O
cases	O
at	O
least	O
90	O
%	O
of	O
human	O
DNA	O
could	O
successfully	O
be	O
removed	O
,	O
with	O
complete	O
removal	O
in	O
eight	O
of	O
16	O
cases	O
using	O
MolYsis	O
,	O
and	O
two	O
(	O
of	O
16	O
)	O
cases	O
using	O
Pureprove	O
.	O

Conversely	O
,	O
detection	O
of	O
bacterial	O
DNA	O
was	O
possible	O
in	O
all	O
cases	O
with	O
a	O
recovery	O
rate	O
generally	O
ranging	O
from	O
35	O
%	O
to	O
50	O
%	O
.	O

In	O
conclusion	O
,	O
both	O
strategies	O
have	O
the	O
potential	O
to	O
reduce	O
background	O
interference	O
from	O
the	O
host	O
DNA	O
which	O
may	O
be	O
of	O
remarkable	O
value	O
for	O
nucleic	O
-	O
acid	O
based	O
microbial	O
diagnostic	O
systems	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
abilities	O
of	O
probiotic	O
bacteria	O
derived	O
from	O
consumer	O
products	O
to	O
coaggregate	O
with	O
caries	O
-	O
associated	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Six	O
lactobacillus	B-bacteria
strains	I-bacteria
(	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
(	O
CCUG	B-bacteria
5917	I-bacteria
)	O
,	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
299v	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
GG	I-bacteria
and	O
LB21	B-bacteria
,	O
L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
F19	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
PTA5289	I-bacteria
)	O
were	O
cultivated	O
under	O
anaerobic	O
conditions	O
at	O
37	O
degrees	O
C	O
in	O
Man	O
Rogosa	O
Sharpe	O
(	O
MSB	O
)	O
broth	O
for	O
24	O
h	O
.	O
Four	O
strains	O
of	O
human	O
streptococci	B-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
Ingbritt	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
ATCC	B-bacteria
25175	I-bacteria
)	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
GS	I-bacteria
-	I-bacteria
5	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
(	O
ATCC	B-bacteria
33478	I-bacteria
)	O
were	O
similarly	O
grown	O
in	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
broth	O
.	O

A	O
gastrointestinal	O
pathogen	O
(	O
Escherichia	B-bacteria
coli	I-bacteria
)	O
was	O
aerobically	O
cultivated	O
on	O
BHI	O
broth	O
as	O
a	O
positive	O
control	O
.	O

After	O
incubation	O
,	O
the	O
bacteria	O
were	O
aerobically	O
harvested	O
,	O
washed	O
,	O
and	O
suspended	O
in	O
10	O
mmol	O
/	O
l	O
phosphate	O
-	O
buffered	O
saline	O
(	O
pH	O
7	O
.	O
2	O
)	O
.	O

The	O
probiotic	O
strains	O
were	O
characterized	O
with	O
the	O
API	O
50	O
CH	O
system	O
to	O
confirm	O
their	O
identity	O
.	O

Coaggregation	O
was	O
determined	O
by	O
spectrophotometry	O
in	O
mixtures	O
and	O
bacterial	O
suspensions	O
alone	O
after	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
24	O
h	O
and	O
expressed	O
as	O
the	O
aggregation	O
ratio	O
(	O
%	O
)	O
.	O

All	O
probiotic	O
strains	O
showed	O
coaggregation	O
abilities	O
with	O
the	O
oral	O
pathogens	O
and	O
the	O
results	O
were	O
strain	O
specific	O
and	O
dependent	O
on	O
time	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
GS	I-bacteria
-	I-bacteria
5	I-bacteria
exhibited	O
a	O
significantly	O
higher	O
ability	O
to	O
coaggregate	O
with	O
all	O
the	O
probiotic	O
strains	O
than	O
the	O
other	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

The	O
differences	O
among	O
the	O
probiotic	O
strains	O
were	O
modest	O
with	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
being	O
the	O
most	O
prone	O
and	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
LB21	I-bacteria
the	O
least	O
prone	O
to	O
coaggregate	O
with	O
the	O
oral	O
streptococci	B-bacteria
.	O

The	O
results	O
demonstrated	O
different	O
abilities	O
of	O
lactobacilli	O
-	O
derived	O
probiotic	O
bacteria	O
to	O
coaggregate	O
with	O
selected	O
oral	O
streptococci	B-bacteria
.	O

Aggregation	O
assays	O
may	O
be	O
a	O
useful	O
complement	O
for	O
screening	O
of	O
probiotic	O
candidates	O
with	O
possible	O
anti	O
-	O
caries	O
properties	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
ATCC	I-bacteria
55730	I-bacteria
can	O
be	O
detected	O
in	O
the	O
oral	O
cavity	O
after	O
discontinuation	O
of	O
administration	O
of	O
a	O
product	O
prepared	O
with	O
this	O
bacterium	O
.	O

The	O
study	O
consisted	O
of	O
three	O
2	O
-	O
week	O
periods	O
:	O
clearance	O
period	O
,	O
intervention	O
period	O
,	O
and	O
post	O
-	O
treatment	O
period	O
.	O

Twenty	O
-	O
five	O
volunteers	O
consumed	O
a	O
chewable	O
tablet	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
ATCC	I-bacteria
55730	I-bacteria
(	O
10	O
(	O
8	O
)	O
cfu	O
/	O
tablet	O
)	O
during	O
a	O
14	O
-	O
day	O
trial	O
period	O
.	O

Saliva	O
samples	O
were	O
collected	O
and	O
cultured	O
onto	O
MRS	O
agar	O
after	O
a	O
clearance	O
period	O
of	O
2	O
weeks	O
and	O
then	O
daily	O
after	O
a	O
2	O
-	O
week	O
intervention	O
period	O
for	O
as	O
long	O
as	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
was	O
found	O
.	O

Lactobacillus	B-bacteria
reuteri	I-bacteria
colonies	O
were	O
analysed	O
in	O
saliva	O
samples	O
.	O

The	O
analysis	O
was	O
performed	O
using	O
selective	O
media	O
for	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
followed	O
by	O
confirmation	O
using	O
the	O
specific	O
detection	O
of	O
reuterin	O
produced	O
by	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
.	O

The	O
number	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
carriers	O
decreased	O
gradually	O
,	O
and	O
after	O
1	O
week	O
only	O
8	O
%	O
of	O
the	O
subjects	O
harboured	O
the	O
bacterium	O
.	O

After	O
5	O
weeks	O
,	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
subjects	O
.	O

Consuming	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
for	O
2	O
weeks	O
does	O
not	O
seem	O
to	O
be	O
sufficient	O
for	O
permanent	O
colonization	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

To	O
conduct	O
a	O
pilot	O
human	O
clinical	O
trial	O
to	O
assess	O
the	O
safety	O
and	O
to	O
test	O
the	O
ability	O
of	O
a	O
probiotic	O
mouthwash	O
,	O
ProBiora	O
(	O
3	O
)	O
,	O
to	O
affect	O
the	O
levels	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
certain	O
known	O
periodontal	O
pathogens	O
in	O
the	O
mouth	O
when	O
administered	O
twice	O
daily	O
over	O
a	O
period	O
of	O
4	O
weeks	O
.	O
The	O
mouthwash	O
contained	O
three	O
specific	O
strains	O
of	O
naturally	O
occurring	O
oral	O
bacteria	O
and	O
was	O
tested	O
at	O
two	O
dose	O
levels	O
:	O
10	O
(	O
6	O
)	O
and	O
10	O
(	O
8	O
)	O
colony	O
forming	O
units	O
each	O
of	O
Strep	B-bacteria
.	I-bacteria
oralis	I-bacteria
strain	I-bacteria
KJ3sm	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
uberis	I-bacteria
strain	I-bacteria
KJ2sm	I-bacteria
,	O
and	O
the	O
spontaneous	O
lactic	O
acid	O
-	O
deficient	O
variant	O
of	O
Strep	B-bacteria
.	I-bacteria
rattus	I-bacteria
,	O
strain	O
JH145	B-bacteria
.	O

Substantial	O
decreases	O
in	O
the	O
levels	O
of	O
the	O
marker	O
bacteria	O
were	O
observed	O
.	O

No	O
safety	O
issues	O
were	O
noted	O
with	O
the	O
twice	O
daily	O
application	O
of	O
this	O
mouthwash	O
.	O

Despite	O
the	O
small	O
number	O
of	O
subjects	O
and	O
the	O
use	O
of	O
young	O
,	O
orally	O
healthy	O
adults	O
,	O
along	O
with	O
the	O
inherent	O
variability	O
in	O
the	O
microbiological	O
measurements	O
,	O
the	O
probiotic	O
mouthwash	O
was	O
able	O
to	O
substantially	O
affect	O
the	O
levels	O
of	O
dental	O
pathogens	O
in	O
saliva	O
and	O
periodontal	O
pathogens	O
in	O
subgingival	O
plaque	O
.	O

The	O
results	O
of	O
this	O
pilot	O
human	O
study	O
suggest	O
that	O
the	O
probiotic	O
mouthwash	O
product	O
may	O
be	O
safe	O
for	O
daily	O
use	O
as	O
an	O
aid	O
in	O
maintaining	O
both	O
dental	O
and	O
periodontal	O
health	O
.	O

Microbial	O
association	O
distinctive	O
features	O
and	O
colonization	O
degree	O
of	O
different	O
oral	O
cavity	O
biotope	O
were	O
established	O
in	O
healthy	O
teenagers	O
and	O
patients	O
with	O
chronic	O
gastritis	O
and	O
gastroduodenitis	O
.	O

There	O
were	O
studied	O
mucous	O
membrane	O
surfaces	O
of	O
cheek	O
,	O
tongue	O
,	O
content	O
of	O
gingival	O
crevice	O
,	O
oral	O
fluid	O
and	O
dental	O
plaque	O
of	O
24	O
healthy	O
persons	O
of	O
the	O
age	O
12	O
-	O
17	O
years	O
and	O
29	O
patients	O
of	O
the	O
same	O
age	O
with	O
gastritis	O
and	O
gastroduodenitis	O
.	O

On	O
the	O
mucous	O
membranes	O
of	O
the	O
ill	O
teenagers	O
there	O
were	O
found	O
Porphiromonas	O
type	O
bacteria	O
,	O
20	O
%	O
more	O
Staphylococcus	B-bacteria
,	O
90	O
%	O
less	O
Peptostreptococcus	B-bacteria
,	O
30	O
%	O
less	O
Lactobacillus	B-bacteria
,	O
20	O
%	O
less	O
Veillonella	B-bacteria
and	O
Stomatococcus	B-bacteria
.	O

In	O
saliva	O
anaerobic	O
Peptostreptococcus	B-bacteria
and	O
facultative	O
anaerobic	O
Streptococcus	B-bacteria
(	O
7	O
lg	O
COE	O
/	O
ml	O
)	O
;	O
Porphiromonas	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Peptococcus	B-bacteria
and	O
Staphylococcus	B-bacteria
(	O
6	O
lg	O
COE	O
/	O
ml	O
)	O
;	O
Neisseria	B-bacteria
(	O
5	O
lg	O
COE	O
/	O
ml	O
)	O
;	O
Stomatococcus	B-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
Bacillus	B-bacteria
(	O
4	O
.	O
6	O
lg	O
COE	O
/	O
ml	O
)	O
;	O
Lactobacillus	B-bacteria
and	O
Candida	O
(	O
4	O
lg	O
COE	O
/	O
ml	O
)	O
predominated	O
.	O

In	O
patients	O
with	O
chronic	O
pathology	O
in	O
all	O
tested	O
biotopes	O
there	O
was	O
found	O
the	O
increase	O
of	O
the	O
whole	O
microbiota	O
spectra	O
(	O
representatives	O
of	O
opportunistic	O
pathogenic	O
microfiora	O
were	O
detected	O
more	O
often	O
)	O
as	O
well	O
as	O
the	O
bacteria	O
number	O
if	O
compared	O
with	O
healthy	O
teenagers	O
.	O

Our	O
study	O
demonstrates	O
that	O
staurosporine	O
(	O
STS	O
)	O
,	O
a	O
protein	O
kinase	O
inhibitor	O
from	O
Streptomyces	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
induces	O
apoptosis	O
in	O
human	O
papillomavirus	O
positive	O
oral	O
carcinoma	O
cells	O
(	O
KB	O
)	O
in	O
a	O
dose	O
dependent	O
manner	O
.	O

Growth	O
inhibition	O
studies	O
revealed	O
an	O
IC	O
(	O
50	O
)	O
value	O
of	O
approximately	O
100	O
nM	O
.	O

STS	O
induced	O
marked	O
nuclear	O
fragmentation	O
and	O
inter	O
-	O
nucleosomal	O
cleavage	O
compared	O
to	O
untreated	O
cells	O
.	O

It	O
also	O
caused	O
dose	O
dependent	O
disruption	O
of	O
mitochondrial	O
membrane	O
potential	O
and	O
activation	O
of	O
caspase	O
-	O
3	O
,	O
indicating	O
involvement	O
of	O
mitochondria	O
-	O
mediated	O
cell	O
death	O
signaling	O
in	O
KB	O
cell	O
apoptosis	O
.	O

We	O
found	O
time	O
-	O
dependent	O
arrest	O
of	O
the	O
KB	O
cells	O
at	O
G2	O
/	O
M	O
phase	O
of	O
cell	O
cycle	O
.	O

Using	O
fluorescence	O
microscopy	O
,	O
we	O
have	O
further	O
shown	O
that	O
STS	O
treatment	O
disrupts	O
microtubules	O
and	O
reorganizes	O
F	O
-	O
actin	O
after	O
6h	O
exposure	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
STS	O
induces	O
mitochondria	O
-	O
mediated	O
KB	O
cell	O
apoptosis	O
at	O
G2	O
/	O
M	O
phase	O
by	O
altering	O
cell	O
cytoskeletal	O
network	O
.	O

Bacterial	O
vaginosis	O
(	O
BV	O
)	O
is	O
a	O
common	O
condition	O
that	O
is	O
associated	O
with	O
preterm	O
birth	O
and	O
acquisition	O
of	O
complex	O
communities	O
of	O
vaginal	O
bacteria	O
that	O
include	O
several	O
fastidious	O
species	O
.	O

Treatment	O
of	O
BV	O
in	O
pregnancy	O
has	O
mixed	O
effects	O
on	O
the	O
risk	O
of	O
preterm	O
delivery	O
,	O
which	O
some	O
hypothesize	O
is	O
due	O
to	O
variable	O
antibiotic	O
efficacy	O
for	O
the	O
fastidious	O
bacteria	O
.	O

Both	O
oral	O
and	O
intravaginal	O
metronidazole	O
can	O
be	O
used	O
to	O
treat	O
bacterial	O
vaginosis	O
in	O
pregnancy	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
impact	O
of	O
different	O
routes	O
of	O
antibiotic	O
administration	O
on	O
concentrations	O
of	O
fastidious	O
vaginal	O
bacteria	O
.	O

This	O
was	O
a	O
sub	O
-	O
study	O
of	O
a	O
larger	O
randomized	O
trial	O
of	O
oral	O
versus	O
vaginal	O
metronidazole	O
for	O
treatment	O
of	O
BV	O
in	O
pregnancy	O
.	O

Fifty	O
-	O
three	O
women	O
were	O
evaluated	O
,	O
including	O
30	O
women	O
who	O
received	O
oral	O
metronidazole	O
and	O
23	O
who	O
received	O
intravaginal	O
metronidazole	O
.	O

Bacterial	O
taxon	O
-	O
specific	O
quantitative	O
PCR	O
assays	O
were	O
used	O
to	O
measure	O
concentrations	O
of	O
bacterial	O
vaginosis	O
associated	O
bacterium	O
(	O
BVAB	O
)	O
1	O
,	O
2	O
,	O
and	O
3	O
,	O
Gardnerella	B-bacteria
vaginalis	I-bacteria
,	O
Atopobium	B-bacteria
species	I-bacteria
,	O
Leptotrichia	B-bacteria
/	I-bacteria
Sneathia	I-bacteria
species	I-bacteria
,	O
Megasphaera	B-bacteria
species	I-bacteria
,	O
and	O
Lactobacillus	B-bacteria
crispatus	I-bacteria
before	O
and	O
after	O
antibiotic	O
treatment	O
.	O

Concentrations	O
of	O
Leptotrichia	B-bacteria
and	O
Sneathia	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
the	O
fastidious	O
Clostridia	O
-	O
like	O
bacterium	O
designated	O
BVAB1	O
decreased	O
significantly	O
with	O
oral	O
(	O
p	O
=	O
.	O
002	O
,	O
p	O
=	O
.	O
02	O
)	O
but	O
not	O
vaginal	O
therapy	O
(	O
p	O
=	O
.	O
141	O
,	O
p	O
=	O
.	O
126	O
)	O
.	O

The	O
fastidious	O
bacterium	O
BVAB3	O
did	O
not	O
significantly	O
decrease	O
with	O
either	O
treatment	O
.	O

Concentrations	O
of	O
Atopobium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
reportedly	O
resistant	O
to	O
metronidazole	O
in	O
vitro	O
,	O
dropped	O
significantly	O
with	O
oral	O
(	O
p	O
=	O
.	O
002	O
)	O
and	O
vaginal	O
(	O
p	O
=	O
.	O
001	O
)	O
treatment	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
magnitude	O
of	O
change	O
in	O
bacterial	O
concentrations	O
between	O
oral	O
and	O
vaginal	O
treatment	O
arms	O
for	O
any	O
of	O
the	O
bacterial	O
species	O
.	O

Lactobacillus	B-bacteria
crispatus	I-bacteria
concentrations	O
did	O
not	O
change	O
.	O

Both	O
oral	O
and	O
vaginal	O
metronidazole	O
therapy	O
in	O
pregnant	O
women	O
result	O
in	O
a	O
significant	O
decrease	O
in	O
concentrations	O
of	O
most	O
BV	O
-	O
associated	O
anaerobic	O
bacteria	O
,	O
with	O
the	O
exception	O
that	O
Leptotrichia	B-bacteria
,	O
Sneathia	B-bacteria
and	O
BVAB1	B-bacteria
do	O
not	O
significantly	O
decrease	O
with	O
vaginal	O
metronidazole	O
therapy	O
.	O

These	O
data	O
suggest	O
that	O
the	O
route	O
of	O
antibiotic	O
administration	O
has	O
a	O
minor	O
impact	O
on	O
bacterial	O
eradication	O
in	O
pregnant	O
women	O
with	O
BV	O
.	O

This	O
trial	O
is	O
registered	O
with	O
ClinicalTrials	O
.	O
gov	O
,	O
number	O
NCT00153517	O
.	O

The	O
bacterial	O
colonization	O
of	O
teeth	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
StrepM	B-bacteria
)	O
represents	O
a	O
major	O
risk	O
factor	O
for	O
the	O
development	O
of	O
dental	O
caries	O
.	O

At	O
present	O
,	O
no	O
clinical	O
studies	O
have	O
explored	O
the	O
effect	O
of	O
a	O
combined	O
mechanical	O
-	O
chemical	O
antisepsis	O
protocol	O
in	O
a	O
periodontally	O
-	O
healthy	O
population	O
and	O
the	O
pattern	O
of	O
recolonization	O
of	O
StrepM	B-bacteria
in	O
subjects	O
whose	O
StrepM	B-bacteria
infection	O
was	O
successfully	O
eradicated	O
.	O

The	O
present	O
study	O
was	O
designed	O
in	O
order	O
to	O
1	O
)	O
determine	O
the	O
salivary	O
and	O
plaque	O
changes	O
in	O
StrepM	B-bacteria
content	O
after	O
a	O
combined	O
mechanical	O
/	O
chemical	O
antisepsis	O
protocol	O
;	O
and	O
2	O
)	O
evaluate	O
the	O
pattern	O
of	O
recolonization	O
when	O
StrepM	B-bacteria
was	O
successfully	O
eradicated	O
from	O
saliva	O
and	O
plaque	O
.	O

Thirty	O
-	O
five	O
periodontally	O
-	O
healthy	O
and	O
caries	O
-	O
susceptible	O
subjects	O
successfully	O
entered	O
and	O
concluded	O
the	O
study	O
.	O

At	O
baseline	O
,	O
non	O
-	O
surgical	O
periodontal	O
therapy	O
was	O
performed	O
according	O
to	O
the	O
principles	O
of	O
full	O
mouth	O
disinfection	O
.	O

Adjunctive	O
home	O
-	O
based	O
rinsing	O
with	O
a	O
0	O
.	O
2	O
%	O
chlorhexidine	O
mouthrinse	O
was	O
requested	O
for	O
the	O
following	O
week	O
.	O

StrepM	B-bacteria
concentration	O
was	O
assessed	O
in	O
saliva	O
and	O
plaque	O
at	O
the	O
initial	O
contact	O
appointment	O
,	O
at	O
baseline	O
,	O
and	O
1	O
-	O
week	O
,	O
1	O
-	O
month	O
,	O
3	O
-	O
month	O
and	O
6	O
-	O
month	O
follow	O
-	O
up	O
.	O

A	O
significant	O
effect	O
of	O
'	O
'	O
time	O
'	O
'	O
on	O
StrepM	B-bacteria
concentration	O
in	O
saliva	O
and	O
plaque	O
was	O
observed	O
(	O
P	O
<	O
0	O
.	O
000	O
)	O
.	O

In	O
subjects	O
with	O
successful	O
eradication	O
of	O
StrepM	B-bacteria
at	O
1	O
week	O
(	O
N	O
=	O
17	O
plaque	O
samples	O
)	O
,	O
StrepM	B-bacteria
infection	O
recurrence	O
occurred	O
within	O
3	O
-	O
6	O
months	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
demonstrated	O
that	O
1	O
)	O
the	O
application	O
of	O
the	O
investigated	O
mechanical	O
/	O
chemical	O
antisepsis	O
protocol	O
can	O
effectively	O
reduce	O
StrepM	B-bacteria
colonies	O
in	O
saliva	O
and	O
plaque	O
of	O
periodontally	O
healthy	O
subjects	O
;	O
and	O
2	O
)	O
in	O
plaque	O
samples	O
,	O
StrepM	B-bacteria
infection	O
recurrence	O
tends	O
to	O
occur	O
within	O
3	O
-	O
6	O
months	O
.	O

To	O
determine	O
the	O
absolute	O
and	O
relative	O
antibacterial	O
activity	O
of	O
octenidine	O
dihydrochloride	O
(	O
OCT	O
)	O
against	O
total	O
and	O
cariogenic	O
bacteria	O
in	O
saliva	O
samples	O
of	O
patients	O
with	O
fixed	O
orthodontic	O
appliances	O
during	O
5	O
days	O
of	O
usage	O
.	O

The	O
study	O
group	O
consisted	O
of	O
5	O
male	O
and	O
13	O
female	O
subjects	O
who	O
were	O
selected	O
from	O
patients	O
in	O
the	O
Clinic	O
of	O
Orthodontics	O
.	O

Each	O
patient	O
was	O
given	O
physiologic	O
saline	O
(	O
PS	O
)	O
,	O
chlorhexidine	O
gluconate	O
(	O
CHX	O
)	O
,	O
polyvinylpyrrolidone	O
-	O
iodine	O
complex	O
(	O
PVP	O
-	O
I	O
)	O
,	O
and	O
OCT	O
every	O
morning	O
for	O
5	O
days	O
,	O
each	O
separated	O
by	O
a	O
2	O
-	O
week	O
interval	O
.	O

Total	O
and	O
cariogenic	O
bacteria	O
in	O
saliva	O
samples	O
of	O
orthodontically	O
treated	O
patients	O
with	O
fixed	O
appliances	O
were	O
collected	O
during	O
5	O
days	O
of	O
usage	O
.	O

Unstimulated	O
saliva	O
was	O
collected	O
as	O
a	O
baseline	O
sample	O
.	O

Saliva	O
samples	O
were	O
collected	O
at	O
15	O
minutes	O
,	O
and	O
on	O
the	O
second	O
,	O
third	O
,	O
and	O
fifth	O
day	O
after	O
rinsing	O
the	O
mouth	O
with	O
any	O
of	O
the	O
solutions	O
for	O
30	O
seconds	O
,	O
and	O
bacterial	O
counts	O
were	O
detected	O
.	O

OCT	O
showed	O
an	O
ultimate	O
reduction	O
of	O
total	O
viable	O
oral	O
bacteria	O
,	O
Lactobacillus	B-bacteria
species	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
in	O
vivo	O
.	O

OCT	O
also	O
had	O
a	O
significantly	O
greater	O
inhibitory	O
effect	O
than	O
0	O
.	O
2	O
%	O
CHX	O
and	O
7	O
.	O
5	O
%	O
PVP	O
-	O
I	O
,	O
from	O
the	O
beginning	O
of	O
the	O
study	O
until	O
the	O
fifth	O
day	O
after	O
the	O
orthodontic	O
appliances	O
were	O
bonded	O
(	O
P	O
<	O
.	O
1	O
)	O
.	O

OCT	O
compared	O
favorably	O
with	O
respect	O
to	O
CHX	O
and	O
PVP	O
-	O
I	O
complex	O
in	O
orthodontically	O
treated	O
patients	O
with	O
fixed	O
appliances	O
(	O
P	O
<	O
/	O
=	O
.	O
1	O
)	O
.	O

Infective	O
endocarditis	O
(	O
IE	O
)	O
is	O
a	O
rare	O
but	O
life	O
-	O
threatening	O
infection	O
.	O

Bacteremia	O
with	O
organisms	O
known	O
to	O
cause	O
IE	O
occurs	O
commonly	O
in	O
association	O
with	O
invasive	O
dental	O
origin	O
.	O

Despite	O
daily	O
oral	O
activities	O
as	O
well	O
as	O
professional	O
dental	O
treatments	O
inducing	O
bacteremia	O
and	O
the	O
dental	O
bacteremia	O
as	O
a	O
risk	O
factor	O
of	O
IE	O
,	O
the	O
details	O
of	O
dental	O
bacteria	O
in	O
the	O
pathogenesis	O
of	O
IE	O
are	O
far	O
from	O
elucidation	O
to	O
date	O
.	O

How	O
do	O
a	O
few	O
microorganisms	O
survive	O
host	O
defenses	O
or	O
escape	O
from	O
antibiotic	O
attacking	O
to	O
seed	O
target	O
organs	O
and	O
cause	O
distant	O
infections	O
?	O

Why	O
are	O
Gram	O
-	O
positive	O
bacteria	O
more	O
frequently	O
detected	O
than	O
Gram	O
-	O
negative	O
bacteria	O
in	O
IE	O
?	O

Cell	O
wall	O
-	O
deficient	O
bacteria	O
(	O
CWDB	O
)	O
were	O
traditionally	O
defined	O
as	O
bacteria	O
with	O
altered	O
morphology	O
and	O
consistent	O
with	O
damaged	O
or	O
absent	O
cell	O
wall	O
structures	O
identified	O
by	O
EM	O
.	O

A	O
number	O
of	O
case	O
reports	O
and	O
laboratory	O
studies	O
suggest	O
that	O
CWDB	O
may	O
be	O
found	O
in	O
the	O
peripheral	O
blood	O
of	O
patients	O
with	O
IE	O
,	O
and	O
may	O
also	O
be	O
demonstrated	O
in	O
vegetations	O
on	O
the	O
valves	O
of	O
patients	O
with	O
IE	O
.	O

CWDB	O
,	O
in	O
vitro	O
,	O
are	O
resistant	O
to	O
antibiotics	O
that	O
act	O
on	O
cell	O
wall	O
biosynthesis	O
.	O

Recent	O
studies	O
indicate	O
that	O
the	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
strains	O
,	O
the	O
major	O
cariogenic	O
bacterium	O
,	O
isolated	O
from	O
the	O
infected	O
valve	O
were	O
deficient	O
in	O
some	O
wall	O
-	O
associated	O
proteins	O
which	O
are	O
main	O
cariogenic	O
virulence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
the	O
deficient	O
stains	O
exhibited	O
less	O
susceptible	O
to	O
antibiotics	O
that	O
act	O
on	O
cell	O
wall	O
biosynthesis	O
.	O

Further	O
,	O
the	O
cloned	O
deficient	O
mutans	O
were	O
less	O
susceptible	O
to	O
phagocytosis	O
by	O
human	O
polymorphonuclear	O
leukocytes	O
but	O
to	O
possess	O
higher	O
platelet	O
aggregation	O
properties	O
than	O
their	O
parent	O
strains	O
.	O

As	O
outlined	O
above	O
,	O
we	O
hypothesize	O
that	O
defect	O
of	O
cell	O
wall	O
construction	O
may	O
shield	O
oral	O
bacteria	O
'	O
s	O
survival	O
in	O
bloodstream	O
and	O
cause	O
IE	O
.	O

The	O
oral	O
cavity	O
has	O
been	O
considered	O
a	O
potential	O
reservoir	O
for	O
Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
pylori	I-bacteria
)	O
,	O
from	O
where	O
the	O
organism	O
causes	O
recurrent	O
gastric	O
infections	O
.	O

With	O
this	O
case	O
-	O
control	O
study	O
we	O
tried	O
to	O
evaluate	O
the	O
role	O
of	O
H	B-bacteria
pylori	I-bacteria
in	O
the	O
etiology	O
of	O
mucosal	O
inflammation	O
,	O
a	O
condition	O
that	O
compounds	O
the	O
morbid	O
state	O
associated	O
with	O
oral	O
submucous	O
fibrosis	O
(	O
OSF	O
)	O
.	O

Subjects	O
(	O
n	O
=	O
150	O
)	O
were	O
selected	O
following	O
institutional	O
regulations	O
on	O
sample	O
collection	O
and	O
grouped	O
into	O
test	O
cases	O
and	O
positive	O
and	O
negative	O
controls	O
based	O
on	O
the	O
presence	O
of	O
mucosal	O
fibrosis	O
and	O
inflammation	O
.	O

The	O
negative	O
controls	O
had	O
none	O
of	O
the	O
clinical	O
signs	O
.	O

All	O
patients	O
underwent	O
an	O
oral	O
examination	O
as	O
well	O
as	O
tests	O
to	O
assess	O
oral	O
hygiene	O
/	O
periodontal	O
disease	O
status	O
;	O
a	O
rapid	O
urease	O
test	O
(	O
RUT	O
)	O
of	O
plaque	O
samples	O
was	O
also	O
done	O
to	O
estimate	O
the	O
H	B-bacteria
pylori	I-bacteria
bacterial	O
load	O
.	O

We	O
used	O
univariate	O
and	O
mutivariate	O
logistic	O
regression	O
for	O
statistical	O
analysis	O
of	O
the	O
data	O
and	O
calculated	O
the	O
odds	O
ratios	O
to	O
assess	O
the	O
risk	O
posed	O
by	O
the	O
different	O
variables	O
.	O

The	O
RUT	O
results	O
differed	O
significantly	O
between	O
the	O
groups	O
,	O
reflecting	O
the	O
variations	O
in	O
the	O
bacterial	O
loads	O
in	O
each	O
category	O
.	O

The	O
test	O
was	O
positive	O
in	O
52	O
%	O
in	O
the	O
positive	O
controls	O
(	O
where	O
nonspecific	O
inflammation	O
of	O
oral	O
mucosa	O
was	O
seen	O
unassociated	O
with	O
fibrosis	O
)	O
,	O
in	O
46	O
%	O
of	O
the	O
test	O
cases	O
,	O
and	O
in	O
18	O
%	O
of	O
the	O
negative	O
controls	O
(	O
healthy	O
volunteers	O
)	O
(	O
chi2	O
=	O
13	O
.	O
887	O
;	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

A	O
positive	O
correlation	O
was	O
seen	O
between	O
the	O
oral	O
hygiene	O
/	O
periodontal	O
disease	O
indices	O
and	O
RUT	O
reactivity	O
in	O
all	O
the	O
three	O
groups	O
.	O

The	O
contribution	O
of	O
the	O
H	B-bacteria
pylori	I-bacteria
in	O
dental	O
plaque	O
to	O
mucosal	O
inflammation	O
and	O
periodontal	O
disease	O
was	O
significant	O
.	O

Logistic	O
regression	O
analysis	O
showed	O
gastrointestinal	O
disease	O
and	O
poor	O
oral	O
hygiene	O
as	O
being	O
the	O
greatest	O
risk	O
factors	O
for	O
bacterial	O
colonization	O
,	O
irrespective	O
of	O
the	O
subject	O
groups	O
.	O

A	O
positive	O
correlation	O
exists	O
between	O
RUT	O
reactivity	O
and	O
the	O
frequency	O
of	O
mucosal	O
inflammation	O
.	O

The	O
purpose	O
of	O
this	O
review	O
is	O
to	O
evaluate	O
the	O
association	O
between	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
and	O
periodontopathic	O
bacteria	O
.	O

Clinical	O
studies	O
of	O
RA	O
and	O
periodontal	O
disease	O
have	O
provided	O
evidence	O
for	O
a	O
significant	O
association	O
between	O
the	O
two	O
disorders	O
.	O

Patients	O
with	O
long	O
-	O
standing	O
active	O
RA	O
have	O
a	O
substantially	O
increased	O
frequency	O
of	O
periodontal	O
disease	O
compared	O
with	O
that	O
among	O
healthy	O
subjects	O
.	O

High	O
levels	O
of	O
oral	O
anaerobic	O
bacterial	O
antibodies	O
have	O
been	O
found	O
in	O
the	O
serum	O
and	O
synovial	O
fluid	O
of	O
RA	O
patients	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
have	O
been	O
identified	O
in	O
RA	O
synovial	O
fluid	O
.	O

Ornidazole	O
,	O
levofloxacin	O
,	O
and	O
clarithromycin	O
are	O
used	O
in	O
the	O
treatment	O
of	O
infections	O
caused	O
by	O
anaerobic	O
bacteria	O
.	O

These	O
antibiotics	O
have	O
been	O
shown	O
to	O
be	O
effective	O
against	O
RA	O
.	O

The	O
evidence	O
in	O
this	O
review	O
indicates	O
that	O
oral	O
bacteria	O
directly	O
associate	O
with	O
etiopathogenesis	O
of	O
RA	O
.	O

The	O
degradation	O
of	O
complex	O
substrates	O
,	O
like	O
salivary	O
mucins	O
,	O
requires	O
an	O
arsenal	O
of	O
glycosidases	O
and	O
proteases	O
to	O
sequentially	O
degrade	O
the	O
oligosaccharides	O
and	O
polypeptide	O
backbone	O
.	O

The	O
mucin	O
MUC5B	O
is	O
a	O
complex	O
oligomeric	O
glycoprotein	O
,	O
heterogeneous	O
in	O
molecular	O
mass	O
(	O
14	O
-	O
40	O
x	O
10	O
(	O
6	O
)	O
Da	O
)	O
,	O
with	O
a	O
diverse	O
repertoire	O
of	O
oligosaccharides	O
,	O
differing	O
in	O
composition	O
and	O
charge	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
proteolytic	O
degradation	O
of	O
the	O
mucin	O
polypeptide	O
backbone	O
could	O
be	O
identified	O
and	O
if	O
cooperation	O
of	O
dental	O
biofilm	O
bacteria	O
was	O
required	O
.	O

Cooperative	O
bacteria	O
-	O
mediated	O
proteolysis	O
of	O
MUC5B	O
was	O
determined	O
by	O
comparing	O
individual	O
species	O
and	O
mixed	O
consortia	O
of	O
strains	O
isolated	O
from	O
supragingival	O
plaque	O
,	O
and	O
freshly	O
harvested	O
supragingival	O
plaque	O
.	O

Proteolytic	O
activity	O
was	O
analysed	O
using	O
fluorescent	O
labelled	O
substrate	O
and	O
by	O
visualizing	O
mucin	O
degradation	O
by	O
SDS	O
-	O
PAGE	O
.	O

Dental	O
plaque	O
degraded	O
the	O
polypeptide	O
backbone	O
of	O
the	O
salivary	O
MUC5B	O
mucin	O
.	O

The	O
mucin	O
was	O
also	O
degraded	O
by	O
a	O
specific	O
consortium	O
of	O
isolated	O
species	O
from	O
supragingival	O
plaque	O
,	O
although	O
individual	O
species	O
and	O
other	O
consortia	O
did	O
not	O
.	O

Certain	O
bacteria	O
in	O
supragingival	O
dental	O
plaque	O
therefore	O
cooperate	O
as	O
a	O
consortium	O
to	O
proteolyse	O
human	O
salivary	O
MUC5B	O
and	O
hydrolyse	O
glycosides	O
.	O

Recent	O
progress	O
in	O
identification	O
of	O
oral	O
microorganisms	O
has	O
shown	O
that	O
the	O
oropharynx	O
can	O
be	O
a	O
site	O
of	O
origin	O
for	O
dissemination	O
of	O
pathogenic	O
organisms	O
to	O
distant	O
body	O
sites	O
,	O
such	O
as	O
the	O
lungs	O
.	O

To	O
compare	O
the	O
oropharyngeal	O
microbiological	O
profile	O
,	O
duration	O
of	O
mechanical	O
ventilation	O
,	O
and	O
length	O
of	O
stay	O
in	O
the	O
intensive	O
care	O
unit	O
of	O
children	O
receiving	O
mechanical	O
ventilation	O
who	O
had	O
pharmacological	O
or	O
nonpharmacological	O
oral	O
care	O
.	O

A	O
randomized	O
and	O
controlled	O
study	O
was	O
performed	O
in	O
a	O
pediatric	O
intensive	O
unit	O
in	O
Sao	O
Paulo	O
,	O
Brazil	O
.	O

A	O
total	O
of	O
56	O
children	O
were	O
randomly	O
assigned	O
to	O
an	O
experimental	O
group	O
(	O
n	O
=	O
27	O
,	O
48	O
%	O
)	O
that	O
received	O
oral	O
care	O
with	O
use	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
digluconate	O
or	O
a	O
control	O
group	O
(	O
n	O
=	O
29	O
,	O
52	O
%	O
)	O
that	O
received	O
oral	O
care	O
without	O
an	O
antiseptic	O
.	O

Oropharyngeal	O
secretions	O
were	O
collected	O
and	O
cultured	O
on	O
days	O
0	O
,	O
2	O
,	O
and	O
4	O
,	O
and	O
at	O
discharge	O
.	O

The	O
2	O
groups	O
had	O
similar	O
demographic	O
characteristics	O
,	O
preexisting	O
underlying	O
diseases	O
,	O
and	O
pharmacological	O
,	O
nutritional	O
,	O
and	O
ventilatory	O
support	O
.	O

Gram	O
-	O
negative	O
bacteria	O
were	O
the	O
predominant	O
pathogens	O
:	O
Acinetobacter	B-bacteria
baumannii	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
and	O
Enter	O
-	O
obacter	O
species	O
.	O

The	O
2	O
groups	O
did	O
not	O
differ	O
significantly	O
in	O
the	O
colonization	O
of	O
normal	O
(	O
P	O
=	O
.	O
72	O
)	O
or	O
pathogenic	O
(	O
P	O
=	O
.	O
62	O
)	O
flora	O
,	O
in	O
the	O
duration	O
of	O
mechanical	O
ventilation	O
(	O
P	O
=	O
.	O
67	O
)	O
,	O
or	O
in	O
length	O
of	O
stay	O
in	O
the	O
intensive	O
care	O
(	O
P	O
=	O
.	O
22	O
)	O
.	O

Use	O
of	O
chlorhexidine	O
combined	O
with	O
nonpharmacological	O
oral	O
care	O
did	O
not	O
decrease	O
the	O
colonization	O
profile	O
,	O
duration	O
of	O
mechanical	O
ventilation	O
,	O
or	O
length	O
of	O
stay	O
in	O
critically	O
ill	O
children	O
receiving	O
mechanical	O
ventilation	O
.	O

Although	O
oral	O
health	O
affects	O
systemic	O
health	O
,	O
studies	O
of	O
oral	O
health	O
during	O
intubation	O
among	O
critically	O
ill	O
neuroscience	O
patients	O
are	O
lacking	O
.	O

Furthermore	O
,	O
the	O
effect	O
of	O
oral	O
care	O
on	O
intracranial	O
pressure	O
among	O
critically	O
ill	O
patients	O
in	O
a	O
neuroscience	O
intensive	O
care	O
unit	O
is	O
unknown	O
.	O

To	O
describe	O
changes	O
in	O
oral	O
health	O
and	O
development	O
of	O
ventilator	O
-	O
associated	O
pneumonia	O
during	O
intubation	O
among	O
patients	O
in	O
a	O
neuroscience	O
intensive	O
care	O
unit	O
and	O
to	O
assess	O
the	O
influence	O
of	O
oral	O
care	O
on	O
intracranial	O
pressure	O
.	O

Data	O
on	O
45	O
consecutive	O
intubated	O
patients	O
admitted	O
to	O
a	O
neuroscience	O
intensive	O
care	O
unit	O
during	O
1	O
year	O
were	O
collected	O
by	O
using	O
oral	O
cultures	O
and	O
the	O
Oral	O
Assessment	O
Guide	O
throughout	O
intubation	O
and	O
48	O
hours	O
after	O
extubation	O
.	O

Occurrence	O
of	O
ventilator	O
-	O
associated	O
pneumonia	O
and	O
intracranial	O
pressures	O
associated	O
with	O
oral	O
care	O
were	O
recorded	O
.	O

Oral	O
health	O
,	O
assessed	O
by	O
the	O
Oral	O
Assessment	O
Guide	O
,	O
deteriorated	O
significantly	O
during	O
intubation	O
and	O
improved	O
to	O
almost	O
baseline	O
levels	O
48	O
hours	O
after	O
extubation	O
.	O

During	O
intubation	O
,	O
occurrence	O
of	O
oral	O
gram	O
-	O
negative	O
bacteria	O
and	O
yeast	O
increased	O
.	O

The	O
incidence	O
of	O
ventilator	O
-	O
associated	O
pneumonia	O
was	O
24	O
%	O
among	O
patients	O
enrolled	O
for	O
4	O
to	O
10	O
days	O
.	O

During	O
or	O
after	O
879	O
instances	O
of	O
oral	O
care	O
,	O
overall	O
intracranial	O
pressure	O
did	O
not	O
increase	O
.	O

Among	O
30	O
instances	O
in	O
which	O
intracranial	O
pressure	O
was	O
greater	O
than	O
20	O
mm	O
Hg	O
before	O
oral	O
care	O
,	O
pressure	O
decreased	O
during	O
and	O
30	O
minutes	O
after	O
the	O
procedure	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

Intubation	O
may	O
contribute	O
to	O
worsening	O
of	O
oral	O
health	O
among	O
patients	O
in	O
neuroscience	O
intensive	O
care	O
units	O
.	O

Execution	O
of	O
oral	O
care	O
does	O
not	O
seem	O
to	O
affect	O
intracranial	O
pressure	O
adversely	O
.	O

Oral	O
care	O
should	O
be	O
explored	O
further	O
to	O
promote	O
good	O
oral	O
and	O
systemic	O
health	O
in	O
patients	O
in	O
neuroscience	O
intensive	O
care	O
units	O
and	O
to	O
determine	O
its	O
effect	O
on	O
ventilator	O
-	O
associated	O
pneumonia	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
a	O
commensal	O
opportunistic	O
oral	O
bacterium	O
,	O
is	O
capable	O
of	O
invading	O
gingival	O
epithelial	O
cells	O
,	O
but	O
the	O
entrance	O
into	O
human	O
primary	O
oral	O
fibroblast	O
cells	O
has	O
not	O
been	O
documented	O
.	O

This	O
study	O
evaluated	O
the	O
ability	O
of	O
three	O
strains	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
.	I-bacteria
polymorphum	I-bacteria
,	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
.	I-bacteria
vincentii	I-bacteria
)	O
to	O
enter	O
gingival	O
fibroblasts	O
(	O
GFs	O
)	O
and	O
periodontal	O
ligament	O
fibroblasts	O
(	O
PLFs	O
)	O
.	O

GFs	O
and	O
PLFs	O
were	O
cocultured	O
for	O
various	O
periods	O
of	O
time	O
with	O
different	O
strains	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Scanning	O
and	O
transmission	O
electron	O
microscopy	O
,	O
together	O
with	O
confocal	O
laser	O
scanning	O
microscopy	O
,	O
were	O
used	O
to	O
visualize	O
the	O
entrance	O
and	O
presence	O
of	O
bacteria	O
in	O
host	O
cells	O
.	O

Flow	O
cytometry	O
was	O
performed	O
to	O
compare	O
the	O
load	O
of	O
internalized	O
bacteria	O
in	O
GFs	O
and	O
PLFs	O
exposed	O
for	O
3	O
and	O
5	O
hours	O
to	O
live	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
labeled	O
with	O
fluorescein	O
isothiocyanate	O
.	O

All	O
three	O
strains	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
were	O
found	O
entering	O
and	O
located	O
in	O
the	O
cytoplasm	O
of	O
GFs	O
and	O
PLFs	O
after	O
1	O
hour	O
of	O
exposure	O
.	O

Flow	O
cytometry	O
tests	O
revealed	O
a	O
significant	O
increase	O
in	O
the	O
fluorescent	O
signal	O
,	O
compared	O
to	O
baseline	O
,	O
derived	O
from	O
bacteria	O
internalized	O
in	O
fibroblasts	O
exposed	O
for	O
3	O
hours	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
;	O
a	O
further	O
increase	O
was	O
found	O
at	O
5	O
hours	O
.	O

The	O
greatest	O
bacterial	O
mass	O
in	O
exposed	O
fibroblasts	O
of	O
both	O
types	O
was	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
.	I-bacteria
polymorphum	I-bacteria
;	O
the	O
smallest	O
was	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
.	I-bacteria
vincentii	I-bacteria
.	O

Although	O
not	O
statistically	O
significant	O
,	O
PLFs	O
had	O
a	O
higher	O
bacterial	O
load	O
than	O
corresponding	O
GFs	O
.	O

F	I-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
capable	O
of	O
entering	O
GFs	O
and	O
PLFs	O
in	O
a	O
manner	O
that	O
is	O
dependent	O
on	O
the	O
cell	O
type	O
and	O
the	O
bacterial	O
strain	O
.	O

In	O
vitro	O
plaque	O
removal	O
studies	O
require	O
biofilm	O
models	O
that	O
resemble	O
in	O
vivo	O
dental	O
plaque	O
.	O

Here	O
,	O
we	O
compare	O
contact	O
and	O
non	O
-	O
contact	O
removal	O
of	O
single	O
and	O
dual	O
-	O
species	O
biofilms	O
as	O
well	O
as	O
of	O
biofilms	O
grown	O
from	O
human	O
whole	O
saliva	O
in	O
vitro	O
using	O
different	O
biofilm	O
models	O
.	O

Bacteria	O
were	O
adhered	O
to	O
a	O
salivary	O
pellicle	O
for	O
2	O
h	O
or	O
grown	O
after	O
adhesion	O
for	O
16	O
h	O
,	O
after	O
which	O
,	O
their	O
removal	O
was	O
evaluated	O
.	O

In	O
a	O
contact	O
mode	O
,	O
no	O
differences	O
were	O
observed	O
between	O
the	O
manual	O
,	O
rotating	O
,	O
or	O
sonic	O
brushing	O
;	O
and	O
removal	O
was	O
on	O
average	O
39	O
%	O
,	O
84	O
%	O
,	O
and	O
95	O
%	O
for	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
respectively	O
,	O
and	O
90	O
%	O
and	O
54	O
%	O
for	O
the	O
dual	O
-	O
and	O
multi	O
-	O
species	O
biofilms	O
,	O
respectively	O
.	O

However	O
,	O
in	O
a	O
non	O
-	O
contact	O
mode	O
,	O
rotating	O
and	O
sonic	O
brushes	O
still	O
removed	O
considerable	O
numbers	O
of	O
bacteria	O
(	O
24	O
-	O
40	O
%	O
)	O
,	O
while	O
the	O
manual	O
brush	O
as	O
a	O
control	O
(	O
5	O
-	O
11	O
%	O
)	O
did	O
not	O
.	O

Single	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
and	O
dual	O
-	O
species	O
(	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
)	O
biofilms	O
were	O
more	O
difficult	O
to	O
remove	O
after	O
16	O
h	O
growth	O
than	O
after	O
2	O
h	O
adhesion	O
(	O
on	O
average	O
,	O
62	O
%	O
and	O
93	O
%	O
for	O
16	O
-	O
and	O
2	O
-	O
h	O
-	O
old	O
biofilms	O
,	O
respectively	O
)	O
,	O
while	O
in	O
contrast	O
,	O
biofilms	O
grown	O
from	O
whole	O
saliva	O
were	O
easier	O
to	O
remove	O
(	O
97	O
%	O
after	O
16	O
h	O
and	O
54	O
%	O
after	O
2	O
h	O
of	O
growth	O
)	O
.	O

Considering	O
the	O
strong	O
adhesion	O
of	O
dual	O
-	O
species	O
biofilms	O
and	O
their	O
easier	O
more	O
reproducible	O
growth	O
compared	O
with	O
biofilms	O
grown	O
from	O
whole	O
saliva	O
,	O
dual	O
-	O
species	O
biofilms	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
are	O
suggested	O
to	O
be	O
preferred	O
for	O
use	O
in	O
mechanical	O
plaque	O
removal	O
studies	O
in	O
vitro	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
whether	O
Enterococcus	B-bacteria
faecalis	I-bacteria
isolates	I-bacteria
from	O
endodontic	O
patients	O
(	O
from	O
saliva	O
and	O
from	O
a	O
root	O
canal	O
)	O
are	O
able	O
to	O
prevail	O
against	O
salivary	O
bacteria	O
when	O
grown	O
in	O
coculture	O
in	O
a	O
biofilm	O
reactor	O
.	O

Saliva	O
that	O
was	O
tested	O
to	O
be	O
free	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
used	O
as	O
the	O
inoculum	O
.	O

The	O
fate	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
examined	O
by	O
using	O
culture	O
techniques	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

The	O
root	O
canal	O
isolate	O
accounted	O
for	O
37	O
.	O
4	O
%	O
of	O
the	O
biofilm	O
and	O
31	O
.	O
9	O
%	O
of	O
the	O
planktonic	O
phase	O
when	O
examined	O
by	O
the	O
culture	O
technique	O
,	O
whereas	O
the	O
proportions	O
examined	O
by	O
FISH	O
showed	O
15	O
.	O
3	O
%	O
in	O
the	O
biofilm	O
and	O
11	O
.	O
7	O
%	O
in	O
the	O
planktonic	O
phase	O
.	O

The	O
saliva	O
isolate	O
(	O
as	O
examined	O
by	O
the	O
culture	O
technique	O
)	O
accounted	O
for	O
32	O
.	O
4	O
%	O
in	O
the	O
biofilm	O
and	O
27	O
.	O
1	O
%	O
in	O
the	O
planktonic	O
phase	O
,	O
respectively	O
,	O
compared	O
with	O
14	O
.	O
1	O
%	O
in	O
the	O
biofilm	O
and	O
9	O
.	O
5	O
%	O
in	O
the	O
planktonic	O
phase	O
when	O
examined	O
by	O
FISH	O
analysis	O
.	O

These	O
results	O
led	O
to	O
the	O
suggestion	O
that	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
could	O
persist	O
in	O
the	O
biofilm	O
of	O
the	O
human	O
oral	O
cavity	O
.	O

Because	O
of	O
the	O
ubiquitous	O
presence	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
root	O
canal	O
infections	O
may	O
arise	O
from	O
different	O
sources	O
.	O

Members	O
of	O
the	O
genus	O
Veillonella	B-bacteria
can	O
not	O
be	O
reliably	O
distinguished	O
by	O
their	O
biochemical	O
characteristics	O
and	O
phenotypic	O
features	O
.	O

Moreover	O
,	O
DNA	O
-	O
DNA	O
hybridization	O
and	O
sequence	O
analyses	O
of	O
the	O
16S	O
ribosomal	O
RNA	O
gene	O
including	O
random	O
fragment	O
length	O
polymorphism	O
analysis	O
,	O
are	O
complex	O
and	O
time	O
-	O
consuming	O
procedures	O
that	O
are	O
not	O
well	O
-	O
suited	O
to	O
identifying	O
oral	O
species	O
of	O
Veillonella	B-bacteria
:	O
Veillonella	B-bacteria
atypica	I-bacteria
,	O
Veillonella	B-bacteria
denticariosi	I-bacteria
,	O
Veillonella	B-bacteria
dispar	I-bacteria
,	O
Veillonella	B-bacteria
parvula	I-bacteria
,	O
and	O
Veillonella	B-bacteria
rogosae	I-bacteria
.	O

In	O
this	O
study	O
,	O
five	O
forward	O
primers	O
and	O
a	O
reverse	O
primer	O
were	O
designed	O
for	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
according	O
to	O
the	O
partial	O
sequences	O
of	O
the	O
rpoB	O
genes	O
of	O
these	O
oral	O
Veillonella	B-bacteria
species	I-bacteria
.	O

The	O
forward	O
primers	O
were	O
species	O
-	O
specific	O
for	O
these	O
five	O
Veillonella	B-bacteria
species	I-bacteria
,	O
and	O
could	O
produce	O
specific	O
amplicons	O
when	O
used	O
together	O
with	O
reverse	O
primer	O
and	O
individual	O
DNA	O
templates	O
of	O
these	O
species	O
in	O
PCR	O
.	O

These	O
primer	O
pairs	O
were	O
also	O
found	O
to	O
discriminate	O
between	O
the	O
respective	O
species	O
,	O
and	O
the	O
Veillonella	B-bacteria
strains	I-bacteria
isolated	O
from	O
human	O
oral	O
cavities	O
were	O
successfully	O
assigned	O
to	O
one	O
of	O
the	O
five	O
oral	O
species	O
of	O
the	O
genus	O
Veillonella	B-bacteria
based	O
on	O
their	O
specific	O
products	O
by	O
PCR	O
.	O

A	O
simple	O
two	O
-	O
step	O
PCR	O
procedure	O
using	O
the	O
five	O
sets	O
of	O
primer	O
pairs	O
developed	O
in	O
the	O
present	O
study	O
is	O
a	O
rapid	O
and	O
reliable	O
method	O
for	O
the	O
identification	O
of	O
the	O
recognized	O
oral	O
Veillonella	B-bacteria
species	I-bacteria
.	O

In	O
this	O
study	O
,	O
the	O
bacteriostatic	O
effect	O
of	O
Piper	O
betle	O
and	O
Psidium	O
guajava	O
extracts	O
on	O
selected	O
early	O
dental	O
plaque	O
bacteria	O
was	O
investigated	O
based	O
on	O
changes	O
in	O
the	O
doubling	O
time	O
(	O
g	O
)	O
and	O
specific	O
growth	O
rates	O
(	O
micro	O
)	O
.	O

Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Actinomyces	B-bacteria
sp	I-bacteria
.	I-bacteria
were	O
cultured	O
in	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
in	O
the	O
presence	O
and	O
absence	O
of	O
the	O
extracts	O
.	O

The	O
growth	O
of	O
bacteria	O
was	O
monitored	O
periodically	O
every	O
15	O
min	O
over	O
a	O
period	O
of	O
9	O
h	O
to	O
allow	O
for	O
a	O
complete	O
growth	O
cycle	O
.	O

Growth	O
profiles	O
of	O
the	O
bacteria	O
in	O
the	O
presence	O
of	O
the	O
extracts	O
were	O
compared	O
to	O
those	O
in	O
the	O
absence	O
and	O
deviation	O
in	O
the	O
g	O
and	O
micro	O
were	O
determined	O
and	O
analyzed	O
.	O

It	O
was	O
found	O
that	O
the	O
g	O
and	O
mu	O
were	O
affected	O
by	O
both	O
extracts	O
.	O

At	O
4	O
mg	O
mL	O
(	O
-	O
1	O
)	O
of	O
P	O
.	O
betle	O
the	O
g	O
-	O
values	O
for	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
were	O
increased	O
by	O
12	O
.	O
0	O
-	O
and	O
10	O
.	O
4	O
-	O
fold	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

At	O
similar	O
concentration	O
P	O
.	O
guajava	O
increased	O
the	O
g	O
-	O
value	O
by	O
1	O
.	O
8	O
-	O
and	O
2	O
.	O
6	O
-	O
fold	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
effect	O
on	O
Actinomyces	B-bacteria
sp	I-bacteria
.	I-bacteria
was	O
observed	O
at	O
a	O
much	O
lower	O
magnitude	O
.	O

It	O
appears	O
that	O
P	O
.	O
betle	O
and	O
P	O
.	O
guajava	O
extracts	O
have	O
bacteriostatic	O
effect	O
on	O
the	O
plaque	O
bacteria	O
by	O
creating	O
a	O
stressed	O
environment	O
that	O
had	O
suppressed	O
the	O
growth	O
and	O
propagation	O
of	O
the	O
cells	O
.	O

Within	O
the	O
context	O
of	O
the	O
dental	O
plaque	O
,	O
this	O
would	O
ensure	O
the	O
attainment	O
of	O
thin	O
and	O
healthy	O
plaque	O
.	O

Thus	O
,	O
decoctions	O
of	O
these	O
plants	O
would	O
be	O
suitable	O
if	O
used	O
in	O
the	O
control	O
of	O
dental	O
plaque	O
.	O

The	O
world	O
-	O
wide	O
explosion	O
of	O
overweight	O
people	O
has	O
been	O
called	O
an	O
epidemic	O
.	O

The	O
inflammatory	O
nature	O
of	O
obesity	O
is	O
widely	O
recognized	O
.	O

Could	O
it	O
really	O
be	O
an	O
epidemic	O
involving	O
an	O
infectious	O
agent	O
?	O

In	O
this	O
climate	O
of	O
concern	O
over	O
the	O
increasing	O
prevalence	O
of	O
overweight	O
conditions	O
in	O
our	O
society	O
,	O
we	O
focus	O
on	O
the	O
possible	O
role	O
of	O
oral	O
bacteria	O
as	O
a	O
potential	O
direct	O
contributor	O
to	O
obesity	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
measured	O
salivary	O
bacterial	O
populations	O
of	O
overweight	O
women	O
.	O

Saliva	O
was	O
collected	O
from	O
313	O
women	O
with	O
a	O
body	O
mass	O
index	O
between	O
27	O
and	O
32	O
,	O
and	O
bacterial	O
populations	O
were	O
measured	O
by	O
DNA	O
probe	O
analysis	O
.	O

Levels	O
in	O
this	O
group	O
were	O
compared	O
with	O
data	O
from	O
a	O
population	O
of	O
232	O
healthy	O
individuals	O
from	O
periodontal	O
disease	O
studies	O
.	O

The	O
median	O
percentage	O
difference	O
of	O
7	O
of	O
the	O
40	O
bacterial	O
species	O
measured	O
was	O
greater	O
than	O
2	O
%	O
in	O
the	O
saliva	O
of	O
overweight	O
women	O
.	O

Classification	O
tree	O
analysis	O
of	O
salivary	O
microbiological	O
composition	O
revealed	O
that	O
98	O
.	O
4	O
%	O
of	O
the	O
overweight	O
women	O
could	O
be	O
identified	O
by	O
the	O
presence	O
of	O
a	O
single	O
bacterial	O
species	O
(	O
Selenomonas	B-bacteria
noxia	I-bacteria
)	O
at	O
levels	O
greater	O
than	O
1	O
.	O
05	O
%	O
of	O
the	O
total	O
salivary	O
bacteria	O
.	O

Analysis	O
of	O
these	O
data	O
suggests	O
that	O
the	O
composition	O
of	O
salivary	O
bacteria	O
changes	O
in	O
overweight	O
women	O
.	O

It	O
seems	O
likely	O
that	O
these	O
bacterial	O
species	O
could	O
serve	O
as	O
biological	O
indicators	O
of	O
a	O
developing	O
overweight	O
condition	O
.	O

Of	O
even	O
greater	O
interest	O
,	O
and	O
the	O
subject	O
of	O
future	O
research	O
,	O
is	O
the	O
possibility	O
that	O
oral	O
bacteria	O
may	O
participate	O
in	O
the	O
pathology	O
that	O
leads	O
to	O
obesity	O
.	O

Beach	O
sand	O
contains	O
fecal	O
indicator	O
bacteria	O
,	O
often	O
in	O
densities	O
greatly	O
exceeding	O
the	O
adjacent	O
swimming	O
waters	O
.	O

We	O
examined	O
the	O
transferability	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
F	O
+	O
coliphage	O
(	O
MS2	O
)	O
from	O
beach	O
sand	O
to	O
hands	O
in	O
order	O
to	O
estimate	O
the	O
potential	O
subsequent	O
health	O
risk	O
.	O

Sand	O
with	O
high	O
initial	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
concentrations	O
was	O
collected	O
from	O
a	O
Chicago	O
beach	O
.	O

Individuals	O
manipulated	O
the	O
sand	O
for	O
60	O
seconds	O
,	O
and	O
rinse	O
water	O
was	O
analysed	O
for	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
coliphage	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
densities	O
transferred	O
were	O
correlated	O
with	O
density	O
in	O
sand	O
rather	O
than	O
surface	O
area	O
of	O
an	O
individual	O
'	O
s	O
hand	O
,	O
and	O
the	O
amount	O
of	O
coliphage	O
transferred	O
from	O
seeded	O
sand	O
was	O
different	O
among	O
individuals	O
.	O

In	O
sequential	O
rinsing	O
,	O
percentage	O
reduction	O
was	O
92	O
%	O
for	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
and	O
98	O
%	O
for	O
coliphage	O
.	O

Using	O
dose	O
-	O
response	O
estimates	O
developed	O
for	O
swimming	O
water	O
,	O
it	O
was	O
determined	O
that	O
the	O
number	O
of	O
individuals	O
per	O
thousand	O
that	O
would	O
develop	O
gastrointestinal	O
symptoms	O
would	O
be	O
11	O
if	O
all	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
on	O
the	O
fingertip	O
were	O
ingested	O
or	O
33	O
if	O
all	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
on	O
the	O
hand	O
were	O
ingested	O
.	O

These	O
results	O
suggest	O
that	O
beach	O
sand	O
may	O
be	O
an	O
important	O
medium	O
for	O
microbial	O
exposure	O
;	O
bacteria	O
transfer	O
is	O
related	O
to	O
initial	O
concentration	O
in	O
the	O
sand	O
;	O
and	O
rinsing	O
may	O
be	O
effective	O
in	O
limiting	O
oral	O
exposure	O
to	O
sand	O
-	O
borne	O
microbes	O
of	O
human	O
concern	O
.	O

Photodynamic	O
therapy	O
has	O
been	O
advocated	O
as	O
an	O
alternative	O
to	O
antimicrobial	O
agents	O
to	O
suppress	O
subgingival	O
species	O
and	O
to	O
treat	O
periodontitis	O
.	O

Bacteria	O
located	O
within	O
dense	O
biofilms	O
,	O
such	O
as	O
those	O
encountered	O
in	O
dental	O
plaque	O
,	O
have	O
been	O
found	O
to	O
be	O
relatively	O
resistant	O
to	O
antimicrobial	O
therapy	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
ability	O
of	O
photodynamic	O
therapy	O
to	O
reduce	O
the	O
number	O
of	O
bacteria	O
in	O
biofilms	O
by	O
comparing	O
the	O
photodynamic	O
effects	O
of	O
methylene	O
blue	O
on	O
human	O
dental	O
plaque	O
microorganisms	O
in	O
the	O
planktonic	O
phase	O
and	O
in	O
biofilms	O
.	O

Dental	O
plaque	O
samples	O
were	O
obtained	O
from	O
10	O
subjects	O
with	O
chronic	O
periodontitis	O
.	O

Suspensions	O
of	O
plaque	O
microorganisms	O
from	O
five	O
subjects	O
were	O
sensitized	O
with	O
methylene	O
blue	O
(	O
25	O
microg	O
/	O
mL	O
)	O
for	O
5	O
min	O
then	O
exposed	O
to	O
red	O
light	O
.	O

Multispecies	O
microbial	O
biofilms	O
developed	O
from	O
the	O
same	O
plaque	O
samples	O
were	O
also	O
exposed	O
to	O
methylene	O
blue	O
(	O
25	O
microg	O
/	O
mL	O
)	O
and	O
the	O
same	O
light	O
conditions	O
as	O
their	O
planktonic	O
counterparts	O
.	O

In	O
a	O
second	O
set	O
of	O
experiments	O
,	O
biofilms	O
were	O
developed	O
with	O
plaque	O
bacteria	O
from	O
five	O
subjects	O
,	O
sensitized	O
with	O
25	O
or	O
50	O
microg	O
/	O
mL	O
of	O
methylene	O
blue	O
and	O
then	O
exposed	O
to	O
red	O
light	O
.	O

After	O
photodynamic	O
therapy	O
,	O
survival	O
fractions	O
were	O
calculated	O
by	O
counting	O
the	O
number	O
of	O
colony	O
-	O
forming	O
units	O
.	O

Photodynamic	O
therapy	O
killed	O
approximately	O
63	O
%	O
of	O
bacteria	O
present	O
in	O
suspension	O
.	O

By	O
contrast	O
,	O
in	O
biofilms	O
,	O
photodynamic	O
therapy	O
had	O
much	O
less	O
of	O
an	O
effect	O
on	O
the	O
viability	O
of	O
bacteria	O
(	O
32	O
%	O
maximal	O
killing	O
)	O
.	O

Oral	O
bacteria	O
in	O
biofilms	O
are	O
affected	O
less	O
by	O
photodynamic	O
therapy	O
than	O
bacteria	O
in	O
the	O
planktonic	O
phase	O
.	O

The	O
antibacterial	O
effect	O
of	O
photodynamic	O
therapy	O
is	O
reduced	O
in	O
biofilm	O
bacteria	O
but	O
not	O
to	O
the	O
same	O
degree	O
as	O
has	O
been	O
reported	O
for	O
treatment	O
with	O
antibiotics	O
under	O
similar	O
conditions	O
.	O

Three	O
strains	O
of	O
anaerobic	O
,	O
pleomorphic	O
,	O
Gram	O
-	O
positive	O
-	O
staining	O
bacilli	O
,	O
which	O
were	O
isolated	O
from	O
human	O
carious	O
dentine	O
,	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
.	O

The	O
strains	O
were	O
saccharolytic	O
and	O
produced	O
acetic	O
and	O
propionic	O
acids	O
in	O
large	O
amounts	O
,	O
and	O
succinic	O
acid	O
in	O
moderate	O
amounts	O
,	O
as	O
the	O
end	O
products	O
of	O
fermentation	O
.	O

16S	O
rRNA	O
gene	O
and	O
RpoB	O
protein	O
sequence	O
analyses	O
revealed	O
that	O
the	O
strains	O
constituted	O
a	O
novel	O
group	O
within	O
the	O
genus	O
Propionibacterium	B-bacteria
,	O
most	O
closely	O
related	O
to	O
Propionibacterium	B-bacteria
australiense	I-bacteria
but	O
sharing	O
only	O
8	O
%	O
DNA	O
-	O
DNA	O
relatedness	O
with	O
the	O
type	O
strain	O
of	O
that	O
species	O
.	O

Therefore	O
,	O
a	O
novel	O
species	O
,	O
Propionibacterium	B-bacteria
acidifaciens	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
to	O
accommodate	O
these	O
strains	O
.	O

The	O
DNA	O
G	O
+	O
C	O
content	O
of	O
the	O
type	O
strain	O
is	O
70	O
mol	O
%	O
.	O

The	O
type	O
strain	O
is	O
C3M	B-bacteria
_	I-bacteria
31	I-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
21887	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
57100	I-bacteria
(	O
T	O
)	O
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
monitor	O
changes	O
in	O
oral	O
health	O
and	O
oral	O
biofilm	O
composition	O
in	O
vivo	O
during	O
an	O
experiment	O
simulating	O
prehistoric	O
lifestyle	O
and	O
diet	O
and	O
poor	O
oral	O
hygiene	O
.	O

Thirteen	O
subjects	O
lived	O
for	O
a	O
period	O
of	O
8	O
weeks	O
under	O
Neolithic	O
conditions	O
.	O

The	O
following	O
clinical	O
parameters	O
were	O
recorded	O
before	O
and	O
after	O
the	O
project	O
:	O
gingival	O
and	O
plaque	O
index	O
(	O
Loe	O
and	O
Silness	O
,	O
Acta	O
Odontol	O
Scand	O
21	O
:	O
533	O
,	O
1963	O
;	O
Silness	O
and	O
Loe	O
,	O
Acta	O
Odontol	O
Scand	O
22	O
:	O
121	O
-	O
135	O
,	O
1964	O
)	O
,	O
probing	O
pocket	O
depth	O
,	O
and	O
bleeding	O
upon	O
probing	O
.	O

In	O
addition	O
,	O
supragingival	O
plaque	O
samples	O
were	O
collected	O
both	O
before	O
and	O
after	O
the	O
project	O
and	O
were	O
analysed	O
quantitatively	O
using	O
multiplex	O
fluorescence	O
in	O
situ	O
hybridization	O
and	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

The	O
following	O
plaque	O
bacteria	O
were	O
evaluated	O
:	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
.	O

The	O
plaque	O
index	O
increased	O
significantly	O
from	O
1	O
.	O
12	O
up	O
to	O
1	O
.	O
55	O
over	O
the	O
8	O
-	O
week	O
period	O
(	O
gingival	O
index	O
before	O
,	O
0	O
.	O
46	O
;	O
after	O
,	O
0	O
.	O
93	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

A	O
strong	O
correlation	O
of	O
both	O
indices	O
was	O
recorded	O
before	O
(	O
r	O
=	O
0	O
.	O
77	O
)	O
and	O
after	O
(	O
r	O
=	O
0	O
.	O
83	O
)	O
participation	O
in	O
the	O
study	O
.	O

Each	O
of	O
the	O
children	O
in	O
the	O
study	O
showed	O
a	O
progression	O
of	O
carious	O
lesions	O
and	O
/	O
or	O
new	O
areas	O
of	O
demineralisation	O
.	O

The	O
probing	O
pocket	O
depth	O
and	O
bleeding	O
upon	O
probing	O
were	O
not	O
affected	O
.	O

All	O
subjects	O
yielded	O
an	O
intra	O
-	O
individual	O
shift	O
in	O
biofilm	O
composition	O
.	O

The	O
proportion	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
decreased	O
across	O
all	O
subjects	O
.	O

The	O
proportion	O
of	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
increased	O
among	O
the	O
children	O
.	O

Poor	O
oral	O
hygiene	O
and	O
change	O
of	O
diet	O
lead	O
to	O
an	O
increase	O
in	O
oral	O
plaque	O
and	O
gingival	O
inflammation	O
.	O

The	O
inter	O
-	O
individual	O
comparison	O
indicated	O
a	O
shift	O
in	O
bacterial	O
composition	O
.	O

Bacillus	B-bacteria
subtilis	I-bacteria
is	O
an	O
effective	O
probiotic	O
product	O
for	O
prevention	O
of	O
enteric	O
infections	O
both	O
in	O
humans	O
and	O
animals	O
.	O

We	O
hypothesized	O
that	O
a	O
mouth	O
rinse	O
containing	O
Bacillus	B-bacteria
subtilis	I-bacteria
should	O
adhere	O
to	O
and	O
colonize	O
part	O
of	O
the	O
oral	O
bacteria	O
on	O
periodontal	O
tissue	O
.	O

The	O
rinsing	O
ability	O
of	O
Extraction	O
300E	O
(	O
containing	O
Bacillus	B-bacteria
subtilis	I-bacteria
:	O
E	O
-	O
300	O
)	O
was	O
compared	O
with	O
that	O
of	O
a	O
mouth	O
wash	O
liquid	O
,	O
Neosteline	O
Green	O
(	O
benzethonium	O
chloride	O
;	O
NG	O
)	O
that	O
is	O
commonly	O
used	O
in	O
Japan	O
.	O

Compared	O
with	O
NG	O
rinsing	O
,	O
E	O
-	O
300	O
rinsing	O
resulted	O
in	O
a	O
marked	O
change	O
in	O
the	O
BANA	O
-	O
score	O
.	O

The	O
mean	O
BANA	O
values	O
(	O
score	O
+	O
/	O
-	O
SD	O
)	O
over	O
the	O
course	O
of	O
the	O
study	O
from	O
0	O
to	O
30	O
days	O
were	O
1	O
.	O
52	O
+	O
/	O
-	O
0	O
.	O
51	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
1	O
)	O
and	O
0	O
.	O
30	O
+	O
/	O
-	O
0	O
.	O
47	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
01	O
)	O
for	O
E	O
-	O
300	O
,	O
and	O
1	O
.	O
56	O
+	O
/	O
-	O
0	O
.	O
51	O
and	O
0	O
.	O
93	O
+	O
/	O
-	O
0	O
.	O
68	O
for	O
NG	O
,	O
respectively	O
.	O

Gingival	O
Index	O
also	O
had	O
improvement	O
,	O
while	O
probing	O
pocket	O
depth	O
and	O
bleeding	O
on	O
probing	O
showed	O
small	O
improvements	O
.	O

Mouth	O
rinsing	O
with	O
E	O
-	O
300	O
significantly	O
reduced	O
periodontal	O
pathogens	O
compared	O
with	O
NG	O
.	O

These	O
results	O
suggest	O
that	O
Bacillus	B-bacteria
subtilis	I-bacteria
is	O
an	O
appropriate	O
mouth	O
rinse	O
for	O
patients	O
with	O
periodontitis	O
.	O

Two	O
anaerobic	O
,	O
pigmented	O
,	O
non	O
-	O
spore	O
-	O
forming	O
,	O
Gram	O
-	O
stain	O
-	O
negative	O
,	O
rod	O
-	O
shaped	O
strains	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
,	O
OMA31	O
(	O
T	O
)	O
and	O
OMA130	O
,	O
were	O
characterized	O
by	O
determining	O
their	O
phenotypic	O
and	O
biochemical	O
features	O
,	O
cellular	O
fatty	O
acid	O
profiles	O
and	O
phylogenetic	O
positions	O
based	O
on	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
showed	O
that	O
the	O
new	O
isolates	O
belonged	O
to	O
a	O
single	O
species	O
of	O
the	O
genus	O
Prevotella	B-bacteria
.	O

The	O
two	O
isolates	O
showed	O
100	O
%	O
16S	O
rRNA	O
gene	O
sequence	O
similarity	O
with	O
each	O
other	O
and	O
were	O
most	O
closely	O
related	O
to	O
Prevotella	B-bacteria
intermedia	I-bacteria
ATCC	I-bacteria
25611	I-bacteria
(	O
T	O
)	O
with	O
96	O
.	O
4	O
%	O
16S	O
rRNA	O
gene	O
sequence	O
similarity	O
;	O
the	O
next	O
most	O
closely	O
related	O
strains	O
to	O
the	O
isolates	O
were	O
Prevotella	B-bacteria
pallens	I-bacteria
AHN	I-bacteria
10371	I-bacteria
(	O
T	O
)	O
(	O
96	O
.	O
1	O
%	O
)	O
and	O
Prevotella	B-bacteria
falsenii	I-bacteria
JCM	I-bacteria
15124	I-bacteria
(	O
T	O
)	O
(	O
95	O
.	O
3	O
%	O
)	O
.	O

Phenotypic	O
and	O
biochemical	O
characteristics	O
of	O
the	O
isolates	O
were	O
the	O
same	O
as	O
those	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
JCM	I-bacteria
12248	I-bacteria
(	O
T	O
)	O
,	O
P	B-bacteria
.	I-bacteria
falsenii	I-bacteria
JCM	I-bacteria
15124	I-bacteria
(	O
T	O
)	O
and	O
Prevotella	B-bacteria
nigrescens	I-bacteria
JCM	I-bacteria
12250	I-bacteria
(	O
T	O
)	O
.	O

The	O
isolates	O
could	O
be	O
differentiated	O
from	O
P	B-bacteria
.	I-bacteria
pallens	I-bacteria
JCM	I-bacteria
11140	I-bacteria
(	O
T	O
)	O
by	O
mannose	O
fermentation	O
and	O
alpha	O
-	O
fucosidase	O
activity	O
.	O

Conventional	O
biochemical	O
tests	O
were	O
unable	O
to	O
differentiate	O
the	O
new	O
isolates	O
from	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
falsenii	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
.	O

However	O
,	O
hsp60	O
gene	O
sequence	O
analysis	O
suggested	O
that	O
strain	O
OMA31	B-bacteria
(	O
T	O
)	O
was	O
not	O
a	O
representative	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
pallens	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
falsenii	I-bacteria
or	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
.	O

Based	O
on	O
these	O
data	O
,	O
a	O
novel	O
species	O
of	O
the	O
genus	O
Prevotella	B-bacteria
,	O
Prevotella	B-bacteria
aurantiaca	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
,	O
with	O
OMA31	B-bacteria
(	O
T	O
)	O
(	O
=	O
JCM	B-bacteria
15754	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
57723	I-bacteria
(	O
T	O
)	O
)	O
as	O
the	O
type	O
strain	O
.	O

Lichen	O
planus	O
(	O
LP	O
)	O
is	O
a	O
mucocutaneous	O
disease	O
of	O
unknown	O
aetiology	O
,	O
which	O
may	O
involve	O
the	O
gastrointestinal	O
(	O
GI	O
)	O
mucosa	O
.	O

The	O
association	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
with	O
LP	O
has	O
been	O
a	O
subject	O
of	O
debate	O
.	O

To	O
investigate	O
upper	O
GI	O
findings	O
and	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
GI	O
mucosa	O
and	O
oral	O
LP	O
(	O
OLP	O
)	O
.	O

Oral	O
biopsies	O
from	O
20	O
patients	O
with	O
erosive	O
OLP	O
and	O
20	O
with	O
non	O
-	O
erosive	O
OLP	O
were	O
investigated	O
for	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
histopathological	O
examination	O
and	O
PCR	O
.	O

Upper	O
GI	O
endoscopy	O
and	O
GI	O
mucosal	O
biopsies	O
were	O
examined	O
for	O
LP	O
lesions	O
and	O
/	O
or	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

The	O
endoscopic	O
findings	O
of	O
both	O
groups	O
were	O
oesophagitis	O
,	O
antral	O
gastritis	O
and	O
duodenitis	O
.	O

No	O
LP	O
or	O
LP	O
-	O
like	O
changes	O
were	O
found	O
in	O
the	O
upper	O
GI	O
mucosa	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
by	O
histopathological	O
examination	O
in	O
the	O
gastric	O
mucosa	O
of	O
18	O
patients	O
(	O
45	O
%	O
)	O
,	O
with	O
equal	O
distribution	O
in	O
both	O
the	O
control	O
and	O
study	O
groups	O
.	O

Positive	O
PCR	O
results	O
were	O
obtained	O
from	O
biopsy	O
specimens	O
of	O
oral	O
lesions	O
in	O
all	O
patients	O
with	O
erosive	O
OLP	O
and	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
(	O
9	O
patients	O
)	O
,	O
but	O
in	O
none	O
of	O
the	O
patients	O
with	O
non	O
-	O
erosive	O
OLP	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
.	O

We	O
did	O
not	O
find	O
any	O
difference	O
in	O
symptoms	O
,	O
endoscopic	O
findings	O
and	O
histopathological	O
results	O
between	O
patients	O
with	O
erosive	O
and	O
non	O
-	O
erosive	O
OLP	O
.	O

However	O
,	O
the	O
concomitant	O
presence	O
of	O
erosive	O
OLP	O
,	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
nucleic	O
acid	O
in	O
erosive	O
OLP	O
and	O
the	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
organisms	O
in	O
gastric	O
mucosa	O
implies	O
a	O
possible	O
pathogenic	O
connection	O
between	O
this	O
bacterium	O
and	O
erosive	O
OLP	O
.	O

A	O
predominant	O
kgp	O
biovar	O
colonized	O
subgingival	O
sites	O
and	O
buccal	O
and	O
tongue	O
mucosa	O
in	O
45	O
of	O
56	O
adults	O
in	O
an	O
isolated	O
community	O
.	O

The	O
presence	O
of	O
biovars	O
381	O
,	O
W83	O
,	O
and	O
W83v	O
,	O
but	O
not	O
HG66	O
,	O
correlated	O
with	O
the	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
load	O
at	O
diseased	O
sites	O
.	O

Biovars	O
W83	O
and	O
W83v	O
poorly	O
colonized	O
tongue	O
and	O
buccal	O
mucosa	O
.	O

to	O
determine	O
the	O
simultaneous	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
both	O
the	O
oral	O
cavity	O
and	O
gastric	O
mucosal	O
in	O
patients	O
suffering	O
digestive	O
pathologies	O
and	O
to	O
establish	O
the	O
possible	O
association	O
between	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
and	O
the	O
gingivoperiodontal	O
pathology	O
.	O

Patients	O
with	O
gastric	O
symptoms	O
(	O
case	O
group	O
)	O
and	O
asymptomatic	O
patients	O
(	O
control	O
group	O
)	O
seen	O
at	O
the	O
Gastroenterology	O
Department	O
of	O
Dr	O
.	O
Julio	O
C	O
.	O
Perrando	O
Hospital	O
(	O
Resistencia	O
,	O
Argentina	O
)	O
were	O
selected	O
.	O

Dental	O
plaque	O
and	O
saliva	O
samples	O
from	O
both	O
groups	O
were	O
obtained	O
.	O

In	O
the	O
case	O
group	O
,	O
gastric	O
biopsy	O
samples	O
were	O
also	O
taken	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
detected	O
in	O
gastric	O
biopsies	O
by	O
histological	O
stains	O
,	O
and	O
Polymerase	O
Chain	O
Reaction	O
(	O
PCR	O
)	O
was	O
carried	O
out	O
on	O
the	O
oral	O
samples	O
.	O

Among	O
the	O
98	O
patients	O
(	O
43	O
cases	O
and	O
55	O
controls	O
)	O
,	O
196	O
oral	O
samples	O
(	O
saliva	O
98	O
,	O
dental	O
plaque	O
98	O
)	O
and	O
43	O
gastric	O
biopsias	O
were	O
obtained	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
detected	O
in	O
oral	O
samples	O
in	O
18	O
/	O
98	O
patients	O
,	O
in	O
gastric	O
biopsies	O
in	O
38	O
/	O
43	O
patients	O
,	O
and	O
in	O
both	O
samples	O
in	O
15	O
/	O
43	O
patients	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
patients	O
suffering	O
digestive	O
pathologies	O
is	O
more	O
frequent	O
in	O
those	O
patients	O
harbouring	O
a	O
gingivoperiodontal	O
disease	O
,	O
and	O
this	O
fact	O
could	O
represent	O
an	O
obstacle	O
for	O
the	O
eradication	O
of	O
the	O
bacterium	O
.	O

At	O
the	O
same	O
time	O
,	O
it	O
could	O
constitute	O
a	O
risk	O
factor	O
for	O
gastrointestinal	O
reinfection	O
after	O
treatment	O
.	O

Toxoplasma	O
gondii	O
is	O
a	O
universally	O
distributed	O
pathogen	O
that	O
infects	O
over	O
one	O
billion	O
people	O
worldwide	O
.	O

Host	O
resistance	O
to	O
this	O
protozoan	O
parasite	O
depends	O
on	O
a	O
Th1	O
immune	O
response	O
with	O
potent	O
production	O
of	O
the	O
cytokines	O
interleukin	O
-	O
12	O
and	O
interferon	O
gamma	O
.	O

Although	O
Toll	O
-	O
like	O
receptor	O
11	O
(	O
TLR11	O
)	O
plays	O
a	O
major	O
role	O
in	O
controlling	O
Th1	O
immunity	O
to	O
this	O
pathogen	O
in	O
mice	O
,	O
this	O
innate	O
immune	O
receptor	O
is	O
nonfunctional	O
in	O
humans	O
,	O
and	O
the	O
mechanisms	O
of	O
TLR11	O
-	O
independent	O
sensing	O
of	O
T	O
.	O
gondii	O
remain	O
elusive	O
.	O

Here	O
,	O
we	O
show	O
that	O
oral	O
infection	O
by	O
T	B-bacteria
.	I-bacteria
gondii	I-bacteria
triggers	O
a	O
TLR11	O
-	O
independent	O
but	O
MyD88	O
-	O
dependent	O
Th1	O
response	O
that	O
is	O
impaired	O
in	O
TLR2xTLR4	O
double	O
knockout	O
and	O
TLR9	O
single	O
knockout	O
mice	O
.	O

These	O
mucosal	O
innate	O
and	O
adaptive	O
immune	O
responses	O
to	O
T	B-bacteria
.	I-bacteria
gondii	I-bacteria
rely	O
on	O
the	O
indirect	O
stimulation	O
of	O
dendritic	O
cells	O
by	O
normal	O
gut	O
microflora	O
.	O

Thus	O
,	O
our	O
results	O
reveal	O
that	O
gut	O
commensal	O
bacteria	O
can	O
serve	O
as	O
molecular	O
adjuvants	O
during	O
parasitic	O
infection	O
,	O
providing	O
indirect	O
immunostimulation	O
that	O
protects	O
against	O
T	B-bacteria
.	I-bacteria
gondii	I-bacteria
in	O
the	O
absence	O
of	O
TLR11	O
.	O

Streptococcus	B-bacteria
is	O
a	O
dominant	O
genus	O
in	O
the	O
human	O
oral	O
cavity	O
,	O
making	O
up	O
about	O
20	O
%	O
of	O
the	O
more	O
than	O
800	O
species	O
of	O
bacteria	O
that	O
have	O
been	O
identified	O
,	O
and	O
about	O
80	O
%	O
of	O
the	O
early	O
biofilm	O
colonizers	O
.	O

Oral	O
streptococci	B-bacteria
include	O
both	O
health	O
-	O
compatible	O
(	O
e	O
.	O
g	O
.	O
Streptococcus	B-bacteria
gordonii	I-bacteria
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
)	O
and	O
pathogenic	O
strains	O
(	O
e	O
.	O
g	O
.	O
the	O
cariogenic	O
Streptococcus	B-bacteria
mutans	I-bacteria
)	O
.	O

Because	O
the	O
streptococci	B-bacteria
have	O
similar	O
metabolic	O
requirements	O
,	O
they	O
have	O
developed	O
defence	O
strategies	O
that	O
lead	O
to	O
antagonism	O
(	O
also	O
known	O
as	O
bacterial	O
interference	O
)	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
expresses	O
bacteriocins	O
that	O
are	O
cytotoxic	O
toward	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
whereas	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
differentially	O
produce	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
(	O
under	O
aerobic	O
growth	O
conditions	O
)	O
,	O
which	O
is	O
relatively	O
toxic	O
toward	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Superimposed	O
on	O
the	O
inter	O
-	O
bacterial	O
combat	O
are	O
the	O
effects	O
of	O
the	O
host	O
defensive	O
mechanisms	O
.	O

We	O
report	O
here	O
on	O
the	O
multifarious	O
effects	O
of	O
bovine	O
lactoperoxidase	O
(	O
bLPO	O
)	O
on	O
the	O
antagonism	O
between	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
versus	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Some	O
of	O
the	O
effects	O
are	O
apparently	O
counterproductive	O
with	O
respect	O
to	O
maintaining	O
a	O
health	O
-	O
compatible	O
population	O
of	O
streptococci	B-bacteria
.	O

For	O
example	O
,	O
the	O
bLPO	O
system	O
(	O
comprised	O
of	O
bLPO	O
+	O
SCN	O
(	O
-	O
)	O
+	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
destroys	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
,	O
thereby	O
abolishing	O
the	O
ability	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
to	O
inhibit	O
the	O
growth	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Furthermore	O
,	O
bLPO	O
protein	O
(	O
with	O
or	O
without	O
its	O
substrate	O
)	O
inhibits	O
bacterial	O
growth	O
in	O
a	O
biofilm	O
assay	O
,	O
but	O
sucrose	O
negates	O
the	O
inhibitory	O
effects	O
of	O
the	O
bLPO	O
protein	O
,	O
thereby	O
facilitating	O
adherence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
lieu	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

Our	O
findings	O
may	O
be	O
relevant	O
to	O
environmental	O
pressures	O
that	O
select	O
early	O
supragingival	O
colonizers	O
.	O

Human	O
cells	O
express	O
membrane	O
-	O
bound	O
complement	O
regulatory	O
proteins	O
to	O
prevent	O
complement	O
-	O
mediated	O
autologous	O
tissue	O
damage	O
.	O

In	O
this	O
study	O
,	O
we	O
hypothesized	O
that	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
the	O
major	O
etiological	O
agent	O
of	O
chronic	O
periodontitis	O
,	O
causes	O
the	O
shedding	O
or	O
proteolysis	O
of	O
the	O
complement	O
regulatory	O
protein	O
CD46	O
expressed	O
by	O
oral	O
epithelial	O
cells	O
.	O

Oral	O
epithelial	O
cells	O
were	O
treated	O
with	O
a	O
culture	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
before	O
measurement	O
of	O
membrane	O
-	O
bound	O
and	O
shedt	O
CD46	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
.	O

The	O
effect	O
of	O
soluble	O
recombinant	O
CD46	O
on	O
secretion	O
of	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
by	O
epithelial	O
cells	O
was	O
evaluated	O
by	O
ELISA	O
.	O

The	O
susceptibility	O
of	O
soluble	O
recombinant	O
CD46	O
to	O
proteolytic	O
degradation	O
by	O
cells	O
and	O
purified	O
Lys	O
-	O
gingipain	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
investigated	O
by	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
/	O
western	O
immunoblotting	O
analysis	O
.	O

Oral	O
epithelial	O
cells	O
treated	O
with	O
a	O
culture	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
showed	O
a	O
lower	O
reactivity	O
with	O
antibodies	O
directed	O
to	O
CD46	O
.	O

ELISA	O
revealed	O
that	O
such	O
a	O
treatment	O
resulted	O
in	O
increased	O
amounts	O
of	O
CD46	O
in	O
the	O
conditioned	O
media	O
suggesting	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
caused	O
the	O
shedding	O
of	O
membrane	O
-	O
anchored	O
CD46	O
.	O

Stimulation	O
of	O
epithelial	O
cells	O
with	O
soluble	O
recombinant	O
CD46	O
induced	O
IL	O
-	O
8	O
secretion	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Whole	O
cells	O
and	O
purified	O
Lys	O
-	O
gingipain	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
degraded	O
recombinant	O
CD46	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

This	O
study	O
showed	O
the	O
ability	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
to	O
induce	O
the	O
shedding	O
/	O
proteolysis	O
of	O
CD46	O
from	O
the	O
surface	O
of	O
oral	O
epithelial	O
cells	O
.	O

This	O
may	O
render	O
host	O
cells	O
susceptible	O
to	O
the	O
complement	O
system	O
and	O
contribute	O
to	O
tissue	O
damage	O
and	O
the	O
inflammatory	O
process	O
in	O
periodontitis	O
.	O

The	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
can	O
integrate	O
into	O
T	O
cells	O
,	O
macrophages	O
and	O
dendritic	O
cells	O
resulting	O
in	O
a	O
latent	O
infection	O
.	O

Reports	O
have	O
also	O
demonstrated	O
that	O
various	O
microbial	O
and	O
host	O
cell	O
factors	O
can	O
trigger	O
HIV	O
reactivation	O
leading	O
to	O
HIV	O
recrudescence	O
,	O
potentially	O
undermining	O
highly	O
active	O
antiretroviral	O
therapies	O
.	O

This	O
study	O
evaluated	O
the	O
capacity	O
of	O
oral	O
bacteria	O
associated	O
with	O
chronic	O
periodontal	O
infections	O
to	O
stimulate	O
HIV	O
promoter	O
activation	O
in	O
various	O
cell	O
models	O
of	O
HIV	O
latency	O
.	O

T	O
cells	O
(	O
1G5	O
)	O
challenged	O
with	O
oral	O
bacteria	O
demonstrated	O
a	O
dose	O
-	O
response	O
of	O
HIV	O
promoter	O
activation	O
with	O
a	O
subset	O
of	O
the	O
bacteria	O
,	O
as	O
well	O
as	O
kinetics	O
that	O
were	O
generally	O
similar	O
irrespective	O
of	O
the	O
stimuli	O
.	O

Direct	O
bacterial	O
challenge	O
of	O
the	O
T	O
cells	O
resulted	O
in	O
increased	O
activation	O
of	O
approximately	O
1	O
.	O
5	O
-	O
to	O
7	O
-	O
fold	O
over	O
controls	O
.	O

Challenge	O
of	O
macrophages	O
(	O
BF24	O
)	O
indicated	O
different	O
kinetics	O
for	O
individual	O
bacteria	O
and	O
resulted	O
in	O
consistent	O
increases	O
in	O
promoter	O
activation	O
of	O
five	O
fold	O
to	O
six	O
fold	O
over	O
basal	O
levels	O
for	O
all	O
bacteria	O
except	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

Dendritic	O
cells	O
showed	O
increases	O
in	O
HIV	O
reactivation	O
of	O
7	O
-	O
to	O
34	O
-	O
fold	O
specific	O
for	O
individual	O
species	O
of	O
bacteria	O
.	O

These	O
results	O
suggested	O
that	O
oral	O
bacteria	O
have	O
the	O
capability	O
to	O
reactivate	O
HIV	O
from	O
latently	O
infected	O
cells	O
,	O
showing	O
a	O
relationship	O
of	O
mature	O
dendritic	O
cells	O
>	O
immature	O
dendritic	O
cells	O
>	O
macrophages	O
>	O
or	O
=	O
T	O
cells	O
.	O

Expression	O
of	O
various	O
pattern	O
recognition	O
receptors	O
on	O
these	O
various	O
cell	O
types	O
may	O
provide	O
insight	O
into	O
the	O
primary	O
receptors	O
/	O
signaling	O
pathways	O
used	O
for	O
reactivation	O
by	O
the	O
bacteria	O
.	O

Lactoferrin	O
(	O
Lf	O
)	O
,	O
an	O
iron	O
-	O
binding	O
salivary	O
glycoprotein	O
,	O
plays	O
an	O
important	O
role	O
in	O
human	O
innate	O
defense	O
against	O
local	O
mucosal	O
infection	O
.	O

We	O
hypothesized	O
that	O
Lf	O
interferes	O
with	O
initial	O
oral	O
bacterial	O
attachment	O
to	O
surfaces	O
by	O
iron	O
sequestration	O
,	O
so	O
inhibiting	O
subsequent	O
biofilm	O
formation	O
.	O

The	O
objective	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
Lf	O
on	O
the	O
early	O
stages	O
of	O
single	O
-	O
species	O
and	O
multi	O
-	O
species	O
oral	O
biofilm	O
development	O
.	O

Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
were	O
used	O
in	O
this	O
study	O
.	O

Glass	O
disks	O
of	O
a	O
two	O
-	O
track	O
flow	O
cell	O
coated	O
with	O
flowing	O
artificial	O
saliva	O
(	O
0	O
.	O
3	O
ml	O
/	O
min	O
)	O
with	O
and	O
without	O
Lf	O
(	O
100	O
microg	O
/	O
ml	O
)	O
were	O
used	O
for	O
studying	O
bacterial	O
attachment	O
(	O
3	O
h	O
,	O
37	O
degrees	O
C	O
)	O
.	O

Attachment	O
was	O
also	O
examined	O
by	O
incubating	O
single	O
or	O
multiple	O
species	O
of	O
test	O
bacteria	O
(	O
10	O
(	O
7	O
)	O
colony	O
-	O
forming	O
units	O
/	O
ml	O
)	O
with	O
Lf	O
-	O
coated	O
(	O
20	O
-	O
100	O
microg	O
/	O
ml	O
)	O
and	O
uncoated	O
glass	O
slides	O
.	O

The	O
effects	O
of	O
beta	O
-	O
lactoglobulin	O
,	O
2	O
,	O
2	O
'	O
-	O
dipyridyl	O
(	O
25	O
-	O
100	O
microg	O
/	O
ml	O
)	O
,	O
an	O
iron	O
chelator	O
,	O
and	O
FeCl3	O
on	O
attachment	O
were	O
also	O
examined	O
.	O

Lf	O
inhibited	O
the	O
initial	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
(	O
50	O
.	O
3	O
%	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
but	O
not	O
that	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

However	O
,	O
the	O
attachment	O
of	O
a	O
dual	O
-	O
species	O
biofilm	O
containing	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
(	O
i	O
.	O
e	O
.	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
/	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
/	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
was	O
significantly	O
reduced	O
(	O
48	O
.	O
7	O
%	O
or	O
62	O
.	O
1	O
%	O
,	O
respectively	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
presence	O
of	O
Lf	O
.	O

beta	O
-	O
Lactoglobulin	O
did	O
not	O
affect	O
the	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

In	O
the	O
presence	O
of	O
100	O
microm	O
2	O
,	O
2	O
'	O
-	O
dipyridyl	O
,	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
was	O
reduced	O
by	O
53	O
.	O
87	O
%	O
.	O

No	O
reduction	O
in	O
attachment	O
was	O
noted	O
in	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
pretreated	O
with	O
Lf	O
(	O
100	O
microg	O
/	O
ml	O
)	O
and	O
FeCl3	O
(	O
20	O
-	O
200	O
microm	O
)	O
.	O

Lf	O
suppresses	O
initial	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
coaggregates	O
by	O
iron	O
sequestration	O
.	O

This	O
may	O
lead	O
to	O
subsequent	O
inhibition	O
of	O
oral	O
biofilm	O
development	O
.	O

Increasing	O
evidence	O
suggests	O
a	O
role	O
for	O
methanogenic	O
archaea	O
(	O
methanogens	O
)	O
in	O
human	O
health	O
and	O
disease	O
via	O
syntrophic	O
interactions	O
with	O
bacteria	O
.	O

Here	O
we	O
assessed	O
the	O
prevalence	O
and	O
distribution	O
of	O
methanogens	O
and	O
possible	O
associations	O
with	O
bacteria	O
in	O
oral	O
biofilms	O
.	O

Forty	O
-	O
four	O
periodontal	O
and	O
32	O
endodontic	O
samples	O
from	O
necrotic	O
teeth	O
with	O
radiographic	O
evidence	O
of	O
apical	O
periodontitis	O
were	O
analysed	O
.	O

Terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
based	O
on	O
the	O
mcrA	O
gene	O
,	O
specific	O
to	O
methanogens	O
,	O
was	O
applied	O
.	O

The	O
prevalence	O
and	O
amounts	O
of	O
methanogens	O
in	O
endodontic	O
samples	O
were	O
compared	O
with	O
those	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Treponema	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Synergistes	B-bacteria
spp	I-bacteria
.	I-bacteria
based	O
on	O
real	O
-	O
time	O
quantitative	O
polymerase	O
chain	O
reactions	O
.	O

Besides	O
dominance	O
of	O
the	O
mcrA	O
gene	O
corresponding	O
to	O
Methanobrevibacter	B-bacteria
oralis	I-bacteria
,	O
one	O
mcrA	O
gene	O
type	O
,	O
for	O
which	O
no	O
cultivated	O
member	O
has	O
been	O
reported	O
previously	O
,	O
was	O
identified	O
in	O
five	O
periodontal	O
samples	O
and	O
one	O
endodontic	O
sample	O
.	O

Rates	O
of	O
non	O
-	O
synonymous	O
vs	O
.	O
synonymous	O
nucleotide	O
substitutions	O
suggest	O
that	O
this	O
mcrA	O
gene	O
type	O
codes	O
for	O
a	O
functionally	O
active	O
methyl	O
-	O
coenzyme	O
M	O
reductase	O
.	O

Methanobrevibacter	B-bacteria
smithii	I-bacteria
,	O
the	O
prominent	O
methanogent	O
in	O
the	O
human	O
gut	O
system	O
,	O
was	O
not	O
detected	O
.	O

Mean	O
proportions	O
of	O
methanogenst	O
were	O
comparable	O
to	O
Synergistes	B-bacteria
spp	I-bacteria
.	I-bacteria
ranging	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
0	O
%	O
of	O
the	O
total	O
microbial	O
community	O
.	O

Treponema	B-bacteria
spp	I-bacteria
.	I-bacteria
dominated	O
with	O
a	O
mean	O
proportion	O
of	O
10	O
%	O
,	O
while	O
the	O
mean	O
proportions	O
of	O
the	O
other	O
endodontic	O
pathogens	O
were	O
below	O
0	O
.	O
1	O
%	O
.	O

A	O
positive	O
association	O
between	O
methanogens	O
and	O
Synergistes	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
found	O
.	O

Our	O
data	O
provide	O
evidence	O
of	O
a	O
novel	O
,	O
as	O
yet	O
uncultured	O
methanogenict	O
phylotypet	O
in	O
association	O
with	O
oral	O
infections	O
,	O
and	O
indicate	O
possible	O
interactions	O
between	O
methanogenst	O
and	O
Synergistes	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
the	O
nature	O
of	O
which	O
deserves	O
further	O
investigation	O
.	O

This	O
study	O
compared	O
the	O
subgingival	O
microbiota	O
of	O
subjects	O
with	O
refractory	O
periodontitis	O
(	O
RP	O
)	O
to	O
those	O
in	O
subjects	O
with	O
treatable	O
periodontitis	O
(	O
GRs	O
=	O
good	O
responders	O
)	O
or	O
periodontal	O
health	O
(	O
PH	O
)	O
using	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
.	O

At	O
baseline	O
,	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
from	O
47	O
subjects	O
with	O
periodontitis	O
and	O
20	O
individuals	O
with	O
PH	O
and	O
analyzed	O
for	O
the	O
presence	O
of	O
300	O
species	O
by	O
HOMIM	O
.	O

The	O
subjects	O
with	O
periodontitis	O
were	O
classified	O
as	O
having	O
RP	O
(	O
n	O
=	O
17	O
)	O
based	O
on	O
mean	O
attachment	O
loss	O
(	O
AL	O
)	O
and	O
/	O
or	O
more	O
than	O
three	O
sites	O
with	O
AL	O
>	O
or	O
=	O
2	O
.	O
5	O
mm	O
after	O
scaling	O
and	O
root	O
planing	O
,	O
surgery	O
,	O
and	O
systemically	O
administered	O
amoxicillin	O
and	O
metronidazole	O
or	O
as	O
GRs	O
(	O
n	O
=	O
30	O
)	O
based	O
on	O
mean	O
attachment	O
gain	O
and	O
no	O
sites	O
with	O
AL	O
>	O
or	O
=	O
2	O
.	O
5	O
mm	O
after	O
treatment	O
.	O

Significant	O
differences	O
in	O
taxa	O
among	O
the	O
groups	O
were	O
sought	O
using	O
the	O
Kruskal	O
-	O
Wallis	O
and	O
chi	O
(	O
2	O
)	O
tests	O
.	O

More	O
species	O
were	O
detected	O
in	O
patients	O
with	O
disease	O
(	O
GR	O
or	O
RP	O
)	O
than	O
in	O
those	O
without	O
disease	O
(	O
PH	O
)	O
.	O

Subjects	O
with	O
RP	O
were	O
distinguished	O
from	O
GRs	O
or	O
those	O
with	O
PH	O
by	O
a	O
significantly	O
higher	O
frequency	O
of	O
putative	O
periodontal	O
pathogens	O
,	O
such	O
as	O
Parvimonas	B-bacteria
micra	I-bacteria
(	O
previously	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
or	O
Micromonas	B-bacteria
micros	I-bacteria
)	O
,	O
Campylobacter	B-bacteria
gracilis	I-bacteria
,	O
Eubacterium	B-bacteria
nodatum	I-bacteria
,	O
Selenomonas	B-bacteria
noxia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Treponema	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
as	O
well	O
as	O
unusual	O
species	O
(	O
Pseudoramibacter	B-bacteria
alactolyticus	I-bacteria
,	O
TM7	B-bacteria
spp	I-bacteria
.	I-bacteria
oral	I-bacteria
taxon	I-bacteria
[	I-bacteria
OT	I-bacteria
]	I-bacteria
346	I-bacteria
/	I-bacteria
356	I-bacteria
,	O
Bacteroidetes	B-bacteria
sp	I-bacteria
.	I-bacteria
OT	I-bacteria
272	I-bacteria
/	I-bacteria
274	I-bacteria
,	O
Solobacterium	B-bacteria
moorei	I-bacteria
,	O
Desulfobulbus	B-bacteria
sp	I-bacteria
.	I-bacteria
OT	I-bacteria
041	I-bacteria
,	O
Brevundimonas	B-bacteria
diminuta	I-bacteria
,	O
Sphaerocytophaga	B-bacteria
sp	I-bacteria
.	O

OT	B-bacteria
337	I-bacteria
,	O
Shuttleworthia	B-bacteria
satelles	I-bacteria
,	O
Filifactor	B-bacteria
alocis	I-bacteria
,	O
Dialister	B-bacteria
invisus	I-bacteria
/	I-bacteria
pneumosintes	I-bacteria
,	O
Granulicatella	B-bacteria
adiacens	I-bacteria
,	O
Mogibacterium	B-bacteria
timidum	I-bacteria
,	O
Veillonella	B-bacteria
atypica	I-bacteria
,	O
Mycoplasma	B-bacteria
salivarium	I-bacteria
,	O
Synergistes	B-bacteria
sp	I-bacteria
.	I-bacteria
cluster	I-bacteria
II	I-bacteria
,	O
and	O
Acidaminococcaceae	B-bacteria
[	I-bacteria
G	I-bacteria
-	I-bacteria
1	I-bacteria
]	I-bacteria
sp	I-bacteria
.	I-bacteria
OT	I-bacteria
132	I-bacteria
/	I-bacteria
150	I-bacteria
/	I-bacteria
155	I-bacteria
/	I-bacteria
148	I-bacteria
/	I-bacteria
135	I-bacteria
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Species	O
that	O
were	O
more	O
prevalent	O
in	O
subjects	O
with	O
PH	O
than	O
in	O
patients	O
with	O
periodontitis	O
included	O
Actinomyces	B-bacteria
sp	I-bacteria
.	I-bacteria
OT	I-bacteria
170	I-bacteria
,	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
cluster	I-bacteria
I	I-bacteria
,	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
,	O
Cardiobacterium	B-bacteria
hominis	I-bacteria
,	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
,	O
Lautropia	B-bacteria
mirabilis	I-bacteria
,	O
Propionibacterium	B-bacteria
propionicum	I-bacteria
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
/	I-bacteria
mucilaginosa	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

As	O
determined	O
by	O
HOMIM	O
,	O
patients	O
with	O
RP	O
presented	O
a	O
distinct	O
microbial	O
profile	O
compared	O
to	O
patients	O
in	O
the	O
GR	O
and	O
PH	O
groups	O
.	O

We	O
have	O
analyzed	O
the	O
total	O
metagenomic	O
DNA	O
from	O
both	O
human	O
oral	O
and	O
fecal	O
samples	O
derived	O
from	O
healthy	O
volunteers	O
from	O
six	O
European	O
countries	O
to	O
determine	O
the	O
molecular	O
basis	O
for	O
tetracycline	O
and	O
erythromycin	O
resistance	O
.	O

We	O
have	O
determined	O
that	O
tet	O
(	O
M	O
)	O
and	O
tet	O
(	O
W	O
)	O
are	O
the	O
most	O
prevalent	O
tetracycline	O
resistance	O
genes	O
assayed	O
for	O
in	O
the	O
oral	O
and	O
fecal	O
metagenomes	O
,	O
respectively	O
.	O

Additionally	O
,	O
tet	O
(	O
Q	O
)	O
,	O
tet	O
(	O
O	O
)	O
,	O
and	O
tet	O
(	O
O	O
/	O
32	O
/	O
O	O
)	O
have	O
been	O
shown	O
to	O
be	O
common	O
.	O

We	O
have	O
also	O
shown	O
that	O
erm	O
(	O
B	O
)	O
,	O
erm	O
(	O
V	O
)	O
,	O
and	O
erm	O
(	O
E	O
)	O
are	O
common	O
erythromycin	O
resistance	O
genes	O
present	O
in	O
these	O
environments	O
.	O

Further	O
,	O
we	O
have	O
demonstrated	O
the	O
ubiquitous	O
presence	O
of	O
the	O
Tn916	O
integrase	O
in	O
the	O
oral	O
metagenomes	O
and	O
the	O
Tn4451	O
and	O
Tn1549	O
integrase	O
genes	O
within	O
the	O
fecal	O
metagenomes	O
.	O

To	O
characterize	O
the	O
clinical	O
manifestations	O
of	O
Actinomyces	O
-	O
associated	O
lesions	O
of	O
the	O
oral	O
mucosa	O
and	O
jawbones	O
,	O
and	O
to	O
correlate	O
the	O
clinical	O
course	O
and	O
treatment	O
requirements	O
with	O
the	O
findings	O
of	O
histomorphometric	O
analysis	O
.	O

The	O
study	O
was	O
a	O
10	O
-	O
year	O
retrospective	O
analysis	O
of	O
archived	O
cases	O
with	O
microscopic	O
identification	O
of	O
Actinomyces	B-bacteria
infection	O
.	O

Actinomyces	B-bacteria
colonies	O
were	O
identified	O
,	O
using	O
hematoxylin	O
-	O
eosin	O
,	O
Gram	O
,	O
and	O
periodic	O
acid	O
-	O
Schiff	O
stains	O
,	O
exhibiting	O
filamentous	O
morphology	O
with	O
color	O
variation	O
between	O
center	O
and	O
periphery	O
.	O

Only	O
colonies	O
with	O
adjacent	O
tissue	O
reaction	O
(	O
inflammation	O
,	O
fibrosis	O
)	O
were	O
analyzed	O
.	O

Actinomyces	B-bacteria
density	O
(	O
AD	O
)	O
was	O
calculated	O
by	O
dividing	O
total	O
number	O
of	O
colonies	O
by	O
tissue	O
surface	O
,	O
Actinomyces	B-bacteria
relative	O
surface	O
(	O
ARS	O
)	O
was	O
calculated	O
by	O
dividing	O
total	O
bacterial	O
surface	O
by	O
tissue	O
surface	O
.	O

The	O
study	O
included	O
106	O
cases	O
(	O
48	O
male	O
,	O
58	O
female	O
;	O
aged	O
13	O
-	O
84	O
years	O
,	O
mean	O
50	O
.	O
5	O
years	O
)	O
.	O

Cases	O
presented	O
a	O
wide	O
clinical	O
spectrum	O
,	O
involving	O
jawbone	O
and	O
/	O
or	O
oral	O
soft	O
tissues	O
.	O

Cases	O
included	O
osteomyelitis	O
associated	O
with	O
bisphosphonates	O
,	O
osteoradionecrosis	O
,	O
osteomyelitis	O
unrelated	O
to	O
radiation	O
or	O
bisphosphonates	O
,	O
periapical	O
lesions	O
,	O
odontogenic	O
cysts	O
,	O
periimplantitis	O
,	O
and	O
lesion	O
mimicking	O
periodontal	O
disease	O
.	O

The	O
AD	O
correlated	O
with	O
median	O
length	O
of	O
antibiotic	O
treatment	O
(	O
R	O
=	O
0	O
.	O
284	O
;	O
P	O
=	O
.	O
028	O
)	O
.	O

Because	O
we	O
were	O
able	O
to	O
identify	O
106	O
such	O
cases	O
,	O
the	O
results	O
indicate	O
that	O
Actinomyces	O
-	O
associated	O
lesions	O
may	O
not	O
be	O
as	O
rare	O
as	O
would	O
be	O
expected	O
from	O
the	O
relatively	O
low	O
number	O
of	O
cases	O
in	O
the	O
literature	O
.	O

Actinomyces	O
-	O
associated	O
lesions	O
presented	O
in	O
a	O
wide	O
spectrum	O
of	O
clinical	O
settings	O
and	O
a	O
variety	O
of	O
contributing	O
factors	O
.	O

Quantitative	O
analysis	O
of	O
the	O
number	O
of	O
bacterial	O
colonies	O
(	O
representing	O
bacterial	O
load	O
)	O
could	O
help	O
in	O
evaluating	O
the	O
aggressive	O
potential	O
of	O
the	O
lesion	O
and	O
help	O
in	O
treatment	O
planning	O
.	O

Dental	O
plaque	O
biofilms	O
are	O
colonized	O
by	O
respiratory	O
pathogens	O
in	O
mechanically	O
-	O
ventilated	O
intensive	O
care	O
unit	O
patients	O
.	O

Thus	O
,	O
improvements	O
in	O
oral	O
hygiene	O
in	O
these	O
patients	O
may	O
prevent	O
ventilator	O
-	O
associated	O
pneumonia	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
minimum	O
frequency	O
(	O
once	O
or	O
twice	O
a	O
day	O
)	O
for	O
0	O
.	O
12	O
%	O
chlorhexidine	O
gluconate	O
application	O
necessary	O
to	O
reduce	O
oral	O
colonization	O
by	O
pathogens	O
in	O
175	O
intubated	O
patients	O
in	O
a	O
trauma	O
intensive	O
care	O
unit	O
.	O

A	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
clinical	O
trial	O
tested	O
oral	O
topical	O
0	O
.	O
12	O
%	O
chlorhexidine	O
gluconate	O
or	O
placebo	O
(	O
vehicle	O
alone	O
)	O
,	O
applied	O
once	O
or	O
twice	O
a	O
day	O
by	O
staff	O
nurses	O
.	O

Quantitation	O
of	O
colonization	O
of	O
the	O
oral	O
cavity	O
by	O
respiratory	O
pathogens	O
(	O
teeth	O
/	O
denture	O
/	O
buccal	O
mucosa	O
)	O
was	O
measured	O
.	O

Subjects	O
were	O
recruited	O
from	O
1	O
March	O
,	O
2004	O
until	O
30	O
November	O
,	O
2007	O
.	O

While	O
175	O
subjects	O
were	O
randomized	O
,	O
microbiologic	O
baseline	O
data	O
was	O
available	O
for	O
146	O
subjects	O
,	O
with	O
115	O
subjects	O
having	O
full	O
outcome	O
assessment	O
after	O
at	O
least	O
48	O
hours	O
.	O

Chlorhexidine	O
reduced	O
the	O
number	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
but	O
not	O
the	O
total	O
number	O
of	O
enterics	B-bacteria
,	O
Pseudomonas	B-bacteria
or	O
Acinetobacter	B-bacteria
in	O
the	O
dental	O
plaque	O
of	O
test	O
subjects	O
.	O

A	O
non	O
-	O
significant	O
reduction	O
in	O
pneumonia	O
rate	O
was	O
noted	O
in	O
groups	O
treated	O
with	O
chlorhexidine	O
compared	O
with	O
the	O
placebo	O
group	O
(	O
OR	O
=	O
0	O
.	O
54	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
23	O
to	O
1	O
.	O
25	O
,	O
P	O
=	O
0	O
.	O
15	O
)	O
.	O

No	O
evidence	O
for	O
resistance	O
to	O
chlorhexidine	O
was	O
noted	O
,	O
and	O
no	O
adverse	O
events	O
were	O
observed	O
.	O

No	O
differences	O
were	O
noted	O
in	O
microbiologic	O
or	O
clinical	O
outcomes	O
between	O
treatment	O
arms	O
.	O

While	O
decontamination	O
of	O
the	O
oral	O
cavity	O
with	O
chlorhexidine	O
did	O
not	O
reduce	O
the	O
total	O
number	O
of	O
potential	O
respiratory	O
pathogens	O
,	O
it	O
did	O
reduce	O
the	O
number	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
dental	O
plaque	O
of	O
trauma	O
intensive	O
care	O
patients	O
.	O

The	O
human	O
gastrointestinal	O
tract	O
is	O
home	O
to	O
hundreds	O
of	O
species	O
of	O
bacteria	O
and	O
the	O
balance	O
between	O
beneficial	O
and	O
pathogenic	O
bacteria	O
plays	O
a	O
critical	O
role	O
in	O
human	O
health	O
and	O
disease	O
.	O

The	O
human	O
infant	O
,	O
however	O
,	O
is	O
born	O
with	O
a	O
sterile	O
gut	O
and	O
the	O
complex	O
gastrointestinal	O
host	O
/	O
bacterial	O
ecosystem	O
is	O
only	O
established	O
after	O
birth	O
by	O
rapid	O
bacterial	O
colonization	O
.	O

Composition	O
of	O
newborn	O
gut	O
flora	O
depends	O
on	O
several	O
factors	O
including	O
type	O
of	O
birth	O
(	O
Ceasarian	O
or	O
natural	O
)	O
,	O
manner	O
of	O
early	O
feeding	O
(	O
breast	O
milk	O
or	O
formula	O
)	O
,	O
and	O
exposure	O
to	O
local	O
,	O
physical	O
environment	O
.	O

Imbalance	O
in	O
normal	O
,	O
healthy	O
gut	O
flora	O
contributes	O
to	O
several	O
adult	O
human	O
diseases	O
including	O
inflammatory	O
bowel	O
(	O
ulcerative	O
colitis	O
and	O
Crohn	O
'	O
s	O
disease	O
)	O
and	O
Clostridium	B-bacteria
difficile	I-bacteria
associated	O
disease	O
,	O
and	O
early	O
childhood	O
diseases	O
such	O
as	O
necrotizing	O
enterocolitis	O
.	O

As	O
a	O
first	O
step	O
towards	O
characterization	O
of	O
the	O
role	O
of	O
gut	O
bacteria	O
in	O
human	O
health	O
and	O
disease	O
,	O
we	O
conducted	O
an	O
850	O
MHz	O
(	O
1	O
)	O
H	O
nuclear	O
magnetic	O
resonance	O
spectroscopy	O
study	O
to	O
monitor	O
changes	O
in	O
metabolic	O
profiles	O
of	O
urine	O
and	O
fecal	O
extracts	O
of	O
15	O
mice	O
following	O
gut	O
sterilization	O
by	O
the	O
broad	O
-	O
spectrum	O
antibiotic	O
enrofloxacin	O
(	O
also	O
known	O
as	O
Baytril	O
)	O
.	O

Ten	O
metabolites	O
changed	O
in	O
urine	O
following	O
enrofloxacin	O
treatment	O
including	O
decreased	O
acetate	O
due	O
to	O
loss	O
of	O
microbial	O
catabolism	O
of	O
sugars	O
and	O
polysaccharides	O
,	O
decreased	O
trimethylamine	O
-	O
N	O
-	O
oxide	O
due	O
to	O
loss	O
of	O
microbial	O
catabolism	O
of	O
choline	O
,	O
and	O
increased	O
creatine	O
and	O
creatinine	O
due	O
to	O
loss	O
of	O
microbial	O
enzyme	O
degradation	O
.	O

Eight	O
metabolites	O
changed	O
in	O
fecal	O
extracts	O
of	O
mice	O
treated	O
with	O
enrofloxacin	O
including	O
depletion	O
of	O
amino	O
acids	O
produced	O
by	O
microbial	O
proteases	O
,	O
reduction	O
in	O
metabolites	O
generated	O
by	O
lactate	O
-	O
utilizing	O
bacteria	O
,	O
and	O
increased	O
urea	O
caused	O
by	O
loss	O
of	O
microbial	O
ureases	O
.	O

Mouth	O
dryness	O
is	O
one	O
of	O
the	O
major	O
problems	O
that	O
can	O
lead	O
to	O
several	O
oral	O
diseases	O
such	O
as	O
dental	O
caries	O
,	O
periodontitis	O
and	O
oral	O
infection	O
.	O

Mouth	O
dryness	O
has	O
also	O
been	O
associated	O
with	O
type	O
2	O
diabetes	O
mellitus	O
(	O
DM	O
)	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
xerostomia	O
(	O
feeling	O
of	O
mouth	O
dryness	O
)	O
,	O
hyposalivation	O
(	O
the	O
reduction	O
of	O
saliva	O
)	O
,	O
and	O
oral	O
microbiota	O
in	O
Thai	O
patients	O
with	O
type	O
2	O
DM	O
.	O

One	O
hundred	O
and	O
fifty	O
-	O
four	O
ambulatory	O
patients	O
with	O
type	O
2	O
DM	O
and	O
50	O
non	O
-	O
diabetic	O
control	O
subjects	O
were	O
interviewed	O
for	O
symptoms	O
of	O
xerostomia	O
.	O

The	O
medical	O
records	O
of	O
these	O
subjects	O
were	O
reviewed	O
for	O
pertinent	O
medical	O
history	O
and	O
laboratory	O
investigations	O
regarding	O
their	O
diabetic	O
control	O
.	O

Oral	O
examination	O
and	O
measurement	O
of	O
hyposalivation	O
using	O
a	O
modified	O
Schirmer	O
test	O
(	O
MST	O
)	O
were	O
performed	O
The	O
presence	O
of	O
oral	O
microbial	O
flora	O
was	O
investigated	O
using	O
a	O
modified	O
dip	O
-	O
slide	O
test	O
.	O

The	O
prevalence	O
of	O
xerostomia	O
was	O
62	O
%	O
in	O
patients	O
with	O
type	O
2	O
DM	O
compared	O
with	O
36	O
%	O
in	O
the	O
nondiabetic	O
control	O
group	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O

The	O
prevalence	O
of	O
hyposalivation	O
(	O
defined	O
as	O
MST	O
values	O
<	O
or	O
=	O
25	O
mm	O
at	O
3	O
min	O
)	O
was	O
46	O
%	O
in	O
the	O
patient	O
group	O
,	O
whereas	O
only	O
28	O
%	O
of	O
the	O
control	O
group	O
had	O
hyposalivation	O
(	O
p	O
=	O
0	O
.	O
03	O
)	O
.	O

Patients	O
with	O
hyposalivation	O
had	O
significantly	O
higher	O
numbers	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Candida	O
spp	O
.	O
in	O
the	O
saliva	O
compared	O
with	O
those	O
without	O
hyposalivation	O
.	O

These	O
results	O
suggested	O
that	O
xerostomia	O
and	O
hyposalivation	O
were	O
prevalent	O
in	O
patients	O
with	O
type	O
2	O
DM	O
and	O
were	O
associated	O
with	O
higher	O
numbers	O
of	O
oral	O
pathogens	O
in	O
the	O
saliva	O
.	O

Betel	O
chewing	O
has	O
been	O
shown	O
to	O
predispose	O
to	O
periodontal	O
disease	O
and	O
oral	O
cancer	O
.	O

Studies	O
show	O
that	O
people	O
with	O
gum	O
disease	O
are	O
more	O
likely	O
to	O
test	O
positive	O
for	O
Helicobacter	B-bacteria
pylori	I-bacteria
(	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
)	O
.	O

It	O
is	O
not	O
known	O
if	O
the	O
lesions	O
produced	O
by	O
betel	O
quid	O
and	O
the	O
resulting	O
,	O
chemical	O
changes	O
predispose	O
to	O
colonization	O
by	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Further	O
the	O
role	O
of	O
this	O
organism	O
in	O
oral	O
cancer	O
is	O
not	O
known	O
.	O

Our	O
objective	O
was	O
to	O
determine	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
lesions	O
of	O
thirty	O
oral	O
cancer	O
patients	O
and	O
to	O
determine	O
the	O
presence	O
of	O
IgG	O
antibodies	O
to	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cancer	O
patients	O
who	O
are	O
betel	O
chewers	O
and	O
non	O
betel	O
chewers	O
,	O
healthy	O
betel	O
chewers	O
and	O
healthy	O
non	O
-	O
betel	O
chewers	O
and	O
to	O
compare	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
these	O
four	O
groups	O
.	O

This	O
case	O
control	O
study	O
was	O
conducted	O
at	O
the	O
Cancer	O
Institute	O
Maharagama	O
and	O
the	O
Department	O
of	O
Microbiology	O
,	O
Faculty	O
of	O
Medical	O
Sciences	O
,	O
University	O
of	O
Sri	O
Jayewardenepura	O
.	O

One	O
hundred	O
and	O
seventy	O
three	O
subjects	O
,	O
of	O
whom	O
fifty	O
three	O
were	O
patients	O
presenting	O
with	O
oral	O
cancer	O
to	O
the	O
Cancer	O
Institute	O
Maharagama	O
,	O
sixty	O
healthy	O
betel	O
chewers	O
and	O
sixty	O
healthy	O
non	O
-	O
betel	O
chewers	O
from	O
the	O
Religious	O
and	O
Welfare	O
Service	O
Centre	O
Maharagama	O
were	O
tested	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
serology	O
.	O

Thirty	O
oral	O
biopsies	O
from	O
oral	O
cancer	O
patients	O
were	O
cultured	O
under	O
microaerophilic	O
condition	O
to	O
isolate	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

The	O
statistic	O
used	O
was	O
Chi	O
-	O
square	O
test	O
.	O

Of	O
the	O
fifty	O
-	O
three	O
oral	O
cancer	O
patients	O
,	O
forty	O
-	O
four	O
were	O
betel	O
chewers	O
.	O

Among	O
the	O
53	O
oral	O
cancer	O
patients	O
examined	O
,	O
ten	O
of	O
forty	O
-	O
four	O
(	O
10	O
/	O
44	O
=	O
22	O
.	O
7	O
%	O
)	O
patients	O
who	O
are	O
betel	O
chewers	O
and	O
four	O
of	O
nine	O
(	O
4	O
/	O
9	O
=	O
44	O
.	O
4	O
%	O
)	O
patients	O
who	O
are	O
non	O
-	O
betel	O
chewers	O
were	O
detected	O
positive	O
for	O
IgG	O
antibody	O
against	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

In	O
the	O
healthy	O
group	O
(	O
betel	O
chewers	O
and	O
non	O
betel	O
chewers	O
)	O
ten	O
(	O
16	O
.	O
7	O
%	O
)	O
of	O
the	O
healthy	O
betel	O
chewers	O
tested	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
serology	O
.	O

None	O
of	O
the	O
healthy	O
non	O
-	O
betel	O
chewers	O
tested	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
Fourteen	O
[	O
26	O
.	O
4	O
%	O
]	O
of	O
oral	O
cancer	O
patients	O
tested	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
serology	O
,	O
of	O
which	O
two	O
were	O
also	O
culture	O
positive	O
(	O
Only	O
thirty	O
samples	O
were	O
cultured	O
)	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria	O
pylori	I-bacteria
in	O
betel	O
chewers	O
(	O
with	O
or	O
without	O
cancer	O
)	O
compared	O
to	O
non	O
-	O
betel	O
chewers	O
was	O
statistically	O
significant	O
.	O

(	O
Chi	O
-	O
square	O
test	O
p	O
<	O
0	O
.	O
05	O
)	O
The	O
use	O
of	O
tobacco	O
and	O
areca	O
nut	O
in	O
betel	O
chewers	O
was	O
significant	O
with	O
the	O
presence	O
of	O
H	O
.	O
pylori	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

There	O
is	O
a	O
significant	O
higher	O
proportion	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
betel	O
chewers	O
compared	O
to	O
non	O
-	O
betel	O
chewers	O
but	O
not	O
between	O
oral	O
cancer	O
patients	O
compared	O
to	O
patients	O
without	O
oral	O
cancer	O
.	O

Hence	O
Betel	O
chewing	O
may	O
predispose	O
to	O
colonisation	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
digestive	O
tract	O
through	O
swallowing	O
the	O
quid	O
or	O
during	O
betel	O
chewing	O
.	O

We	O
present	O
a	O
case	O
series	O
of	O
5	O
patients	O
admitted	O
over	O
5	O
months	O
to	O
Queen	O
Elizabeth	O
Central	O
Hospital	O
who	O
had	O
sustained	O
injuries	O
from	O
a	O
crocodile	O
bite	O
.	O

Three	O
patients	O
required	O
amputation	O
of	O
a	O
limb	O
.	O

The	O
severe	O
soft	O
tissue	O
injury	O
associated	O
with	O
a	O
crocodile	O
bite	O
and	O
the	O
unusual	O
normal	O
oral	O
flora	O
of	O
the	O
crocodile	O
create	O
challenges	O
in	O
treatment	O
.	O

Progressive	O
tissue	O
destruction	O
and	O
haemolysis	O
are	O
complications	O
of	O
such	O
infected	O
wounds	O
.	O

An	O
antibiotic	O
regime	O
is	O
recommended	O
that	O
covers	O
gram	O
negative	O
rods	O
,	O
anaerobes	O
and	O
may	O
include	O
doxycycline	O
,	O
as	O
well	O
as	O
the	O
need	O
to	O
have	O
a	O
low	O
threshold	O
for	O
early	O
amputation	O
.	O

In	O
our	O
study	O
of	O
nursing	O
home	O
residents	O
with	O
clinically	O
suspected	O
urinary	O
tract	O
infection	O
who	O
did	O
not	O
require	O
the	O
use	O
of	O
an	O
indwelling	O
catheter	O
,	O
we	O
identified	O
bacteria	O
isolated	O
from	O
urine	O
samples	O
,	O
the	O
resistance	O
patterns	O
of	O
these	O
isolated	O
bacteria	O
,	O
and	O
the	O
antibiotic	O
therapy	O
prescribed	O
to	O
the	O
residents	O
.	O

Escherichia	B-bacteria
coli	I-bacteria
,	O
the	O
predominant	O
organism	O
isolated	O
,	O
frequently	O
was	O
resistant	O
to	O
commonly	O
prescribed	O
oral	O
antibiotics	O
.	O

Trimethoprim	O
-	O
sulfamethoxazole	O
remains	O
the	O
best	O
empiric	O
antimicrobial	O
therapy	O
for	O
a	O
urinary	O
tract	O
infection	O
,	O
but	O
nitrofurantoin	O
should	O
be	O
considered	O
if	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
is	O
identified	O
.	O

To	O
date	O
,	O
metagenomic	O
studies	O
have	O
relied	O
on	O
the	O
utilization	O
and	O
analysis	O
of	O
reads	O
obtained	O
using	O
454	O
pyrosequencing	O
to	O
replace	O
conventional	O
Sanger	O
sequencing	O
.	O

After	O
extensively	O
scanning	O
the	O
16S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
gene	O
,	O
we	O
identified	O
the	O
V5	O
hypervariable	O
region	O
as	O
a	O
short	O
region	O
providing	O
reliable	O
identification	O
of	O
bacterial	O
sequences	O
available	O
in	O
public	O
databases	O
such	O
as	O
the	O
Human	O
Oral	O
Microbiome	O
Database	O
.	O

We	O
amplified	O
samples	O
from	O
the	O
oral	O
cavity	O
of	O
three	O
healthy	O
individuals	O
using	O
primers	O
covering	O
an	O
approximately	O
82	O
-	O
base	O
segment	O
of	O
the	O
V5	O
loop	O
,	O
and	O
sequenced	O
using	O
the	O
Illumina	O
technology	O
in	O
a	O
single	O
orientation	O
.	O

We	O
identified	O
135	O
genera	O
or	O
higher	O
taxonomic	O
ranks	O
from	O
the	O
resulting	O
1	O
,	O
373	O
,	O
824	O
sequences	O
.	O

While	O
the	O
abundances	O
of	O
the	O
most	O
common	O
phyla	O
(	O
Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Actinobacteria	B-bacteria
,	O
Fusobacteria	B-bacteria
and	O
TM7	B-bacteria
)	O
are	O
largely	O
comparable	O
to	O
previous	O
studies	O
,	O
Bacteroidetes	B-bacteria
were	O
less	O
present	O
.	O

Potential	O
sources	O
for	O
this	O
difference	O
include	O
classification	O
bias	O
in	O
this	O
region	O
of	O
the	O
16S	O
rRNA	O
gene	O
,	O
human	O
sample	O
variation	O
,	O
sample	O
preparation	O
and	O
primer	O
bias	O
.	O

Using	O
an	O
Illumina	O
sequencing	O
approach	O
,	O
we	O
achieved	O
a	O
much	O
greater	O
depth	O
of	O
coverage	O
than	O
previous	O
oral	O
microbiota	O
studies	O
,	O
allowing	O
us	O
to	O
identify	O
several	O
taxa	O
not	O
yet	O
discovered	O
in	O
these	O
types	O
of	O
samples	O
,	O
and	O
to	O
assess	O
that	O
at	O
least	O
30	O
,	O
000	O
additional	O
reads	O
would	O
be	O
required	O
to	O
identify	O
only	O
one	O
additional	O
phylotype	O
.	O

The	O
evolution	O
of	O
high	O
-	O
throughput	O
sequencing	O
technologies1	O
,	O
and	O
their	O
subsequent	O
improvements	O
in	O
read	O
length	O
enable	O
the	O
utilization	O
of	O
different	O
platforms	O
for	O
studying	O
communities	O
of	O
complex	O
flora	O
.	O

Access	O
to	O
large	O
amounts	O
of	O
data	O
is	O
already	O
leading	O
to	O
a	O
better	O
representation	O
of	O
sample	O
diversity	O
at	O
a	O
reasonable	O
cost	O
.	O

Infection	O
of	O
Galleria	O
mellonella	O
by	O
feeding	O
a	O
mixture	O
of	O
Bacillus	B-bacteria
thuringiensis	I-bacteria
spores	O
or	O
vegetative	O
bacteria	O
in	O
association	O
with	O
the	O
toxin	O
Cry1C	O
results	O
in	O
high	O
levels	O
of	O
larval	O
mortality	O
.	O

Under	O
these	O
conditions	O
the	O
toxin	O
or	O
bacteria	O
have	O
minimal	O
effects	O
on	O
the	O
larva	O
when	O
inoculated	O
separately	O
.	O

In	O
order	O
to	O
evaluate	O
whether	O
G	O
.	O
mellonella	O
can	O
function	O
as	O
an	O
oral	O
infection	O
model	O
for	O
human	O
and	O
entomo	O
-	O
bacterial	O
pathogens	O
,	O
we	O
tested	O
strains	O
of	O
Bacillus	B-bacteria
cereus	I-bacteria
,	O
Bacillus	B-bacteria
anthracis	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Listeria	B-bacteria
monocytogenes	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
a	O
Drosophila	B-bacteria
targeting	I-bacteria
Pseudomonas	I-bacteria
entomophila	I-bacteria
strain	I-bacteria
.	O

Six	O
B	B-bacteria
.	I-bacteria
cereus	I-bacteria
strains	I-bacteria
(	O
5	O
diarrheal	O
,	O
1	O
environmental	O
isolate	O
)	O
were	O
first	O
screened	O
in	O
2nd	O
instar	O
G	B-bacteria
.	I-bacteria
mellonella	I-bacteria
larvae	O
by	O
free	O
ingestion	O
and	O
four	O
of	O
them	O
were	O
analyzed	O
by	O
force	O
-	O
feeding	O
5th	O
instar	O
larvae	O
.	O

The	O
virulence	O
of	O
these	O
B	B-bacteria
.	I-bacteria
cereus	I-bacteria
strains	I-bacteria
did	O
not	O
differ	O
from	O
the	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
virulent	O
reference	O
strain	O
407Cry	O
(	O
-	O
)	O
with	O
the	O
exception	O
of	O
strain	O
D19	O
(	O
NVH391	O
/	O
98	O
)	O
that	O
showed	O
a	O
lower	O
virulence	O
.	O

Following	O
force	O
-	O
feeding	O
,	O
5th	O
instar	O
G	B-bacteria
.	I-bacteria
mellonella	I-bacteria
larvae	O
survived	O
infection	O
with	O
B	B-bacteria
.	I-bacteria
anthracis	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
strains	I-bacteria
in	O
contrast	O
to	O
the	O
P	B-bacteria
.	I-bacteria
entomophila	I-bacteria
strain	I-bacteria
which	O
led	O
to	O
high	O
mortality	O
even	O
without	O
Cry1C	O
toxin	O
co	O
-	O
ingestion	O
.	O

Thus	O
,	O
specific	O
virulence	O
factors	O
adapted	O
to	O
the	O
insect	O
intestine	O
might	O
exist	O
in	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
/	O
B	I-bacteria
.	I-bacteria
cereus	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
entomophila	I-bacteria
.	O

This	O
suggests	O
a	O
co	O
-	O
evolution	O
between	O
host	O
and	O
pathogens	O
and	O
supports	O
the	O
close	O
links	O
between	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
cereus	I-bacteria
and	O
more	O
distant	O
links	O
to	O
their	O
relative	O
B	B-bacteria
.	I-bacteria
anthracis	I-bacteria
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
a	O
type	O
of	O
Gram	O
-	O
negative	O
periodontopathogen	O
,	O
causes	O
periodontal	O
disease	O
by	O
activating	O
intracellular	O
signaling	O
pathways	O
that	O
produce	O
excessive	O
inflammatory	O
responses	O
such	O
as	O
matrix	O
metalloproteinases	O
(	O
MMPs	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
that	O
panduratin	O
A	O
,	O
a	O
chalcone	O
compound	O
isolated	O
from	O
Kaempferia	O
pandurata	O
ROXB	O
.	O
,	O
caused	O
the	O
decreased	O
levels	O
of	O
MMP	O
-	O
9	O
secretion	O
,	O
protein	O
,	O
and	O
gene	O
expression	O
in	O
human	O
oral	O
epidermoid	O
KB	O
cells	O
exposed	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
supernatant	O
.	O

In	O
this	O
study	O
,	O
we	O
clarified	O
if	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
signaling	O
mediated	O
MMP	O
-	O
9	O
expression	O
by	O
examining	O
the	O
effect	O
of	O
specific	O
MAPK	O
inhibitors	O
,	O
i	O
.	O
e	O
.	O

U0126	O
,	O
SB203580	O
,	O
and	O
SP600125	O
,	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
supernatant	O
-	O
stimulated	O
MMP	O
-	O
9	O
expression	O
in	O
KB	O
cells	O
.	O

We	O
next	O
elucidated	O
the	O
molecular	O
mechanism	O
by	O
which	O
panduratin	O
A	O
attenuated	O
signaling	O
pathways	O
involved	O
in	O
MMP	O
-	O
9	O
expression	O
by	O
performing	O
gelatin	O
zymography	O
,	O
Western	O
blotting	O
,	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
and	O
promoter	O
assays	O
.	O

Exposure	O
of	O
KB	O
cells	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
supernatant	O
up	O
-	O
regulated	O
the	O
expression	O
of	O
MMP	O
-	O
9	O
protein	O
and	O
gene	O
,	O
and	O
activation	O
of	O
activator	O
protein	O
-	O
1	O
(	O
AP	O
-	O
1	O
)	O
element	O
,	O
MAPK	O
phosphorylation	O
(	O
extracellular	O
signal	O
-	O
related	O
kinase	O
1	O
/	O
2	O
(	O
ERK1	O
/	O
2	O
)	O
,	O
p38	O
,	O
and	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
)	O
,	O
and	O
transcription	O
factors	O
(	O
Elk1	O
,	O
c	O
-	O
Jun	O
,	O
and	O
c	O
-	O
Fos	O
)	O
.	O

A	O
JNK	O
inhibitor	O
(	O
SP600125	O
)	O
significantly	O
attenuated	O
MMP	O
-	O
9	O
gene	O
expression	O
and	O
AP	O
-	O
1	O
activity	O
in	O
KB	O
cells	O
in	O
response	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
supernatant	O
.	O

Similar	O
to	O
SP600125	O
,	O
panduratin	O
A	O
was	O
found	O
to	O
strongly	O
suppress	O
the	O
level	O
of	O
phosphorylated	O
JNK	O
and	O
block	O
AP	O
-	O
1	O
activity	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
supernatant	O
-	O
stimulated	O
KB	O
cells	O
.	O

In	O
summary	O
,	O
JNK	O
and	O
AP	O
-	O
1	O
are	O
the	O
major	O
signaling	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
supernatant	O
-	O
stimulated	O
MMP	O
-	O
9	O
expression	O
in	O
KB	O
cells	O
,	O
and	O
panduratin	O
A	O
markedly	O
down	O
-	O
regulates	O
MMP	O
-	O
9	O
expression	O
through	O
inhibition	O
of	O
these	O
signaling	O
.	O

Periodontitis	O
is	O
a	O
polymicrobial	O
infection	O
caused	O
by	O
selected	O
gram	O
-	O
negative	O
bacteria	O
including	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

Host	O
cell	O
invasion	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
has	O
been	O
proposed	O
as	O
a	O
possible	O
mechanism	O
of	O
pathogenesis	O
in	O
periodontitis	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
assess	O
the	O
influence	O
of	O
periodontopathogens	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
of	O
gingival	O
epithelial	O
cells	O
in	O
polymicrobial	O
infection	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
tested	O
for	O
its	O
ability	O
to	O
invade	O
a	O
human	O
gingival	O
epithelial	O
cell	O
line	O
Ca9	O
-	O
22	O
in	O
co	O
-	O
infection	O
with	O
periodontopathogens	O
,	O
using	O
an	O
antibiotic	O
protection	O
assay	O
.	O

Among	O
the	O
pathogens	O
tested	O
,	O
only	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
demonstrated	O
the	O
ability	O
to	O
significantly	O
promote	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

This	O
increased	O
invasion	O
was	O
confirmed	O
by	O
confocal	O
scanning	O
laser	O
microscopy	O
utilizing	O
a	O
dual	O
labeling	O
technique	O
.	O

In	O
contrast	O
,	O
co	O
-	O
infection	O
with	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
or	O
Tannerella	B-bacteria
forsythia	I-bacteria
attenuated	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
.	O

The	O
fusobacterial	O
enhancement	O
of	O
host	O
cell	O
invasion	O
was	O
not	O
observed	O
in	O
co	O
-	O
incubation	O
with	O
other	O
periodontopathogens	O
tested	O
.	O

These	O
results	O
suggested	O
that	O
complex	O
synergistic	O
or	O
antagonistic	O
physiologic	O
mechanisms	O
are	O
intimately	O
involved	O
in	O
host	O
cell	O
invasion	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
polymicrobial	O
infection	O
.	O

To	O
investigate	O
the	O
patterns	O
of	O
microbial	O
infection	O
on	O
the	O
apical	O
external	O
root	O
surfaces	O
of	O
treated	O
and	O
untreated	O
teeth	O
associated	O
with	O
chronic	O
apical	O
periodontitis	O
and	O
to	O
study	O
bacteria	O
in	O
the	O
biofilm	O
in	O
order	O
to	O
find	O
out	O
the	O
species	O
,	O
constitution	O
and	O
origination	O
of	O
bacteria	O
in	O
periapical	O
biofilm	O
.	O

Ten	O
teeth	O
with	O
chronic	O
apical	O
periodontitis	O
from	O
patients	O
of	O
the	O
Department	O
of	O
Stomatology	O
of	O
People	O
'	O
s	O
Hospital	O
,	O
Peking	O
University	O
:	O
5	O
untreated	O
teeth	O
with	O
a	O
radiographically	O
visible	O
chronic	O
periradicular	O
lesions	O
and	O
5	O
teeth	O
with	O
extensive	O
carious	O
lesions	O
,	O
radiolucent	O
lesions	O
of	O
varying	O
sizes	O
and	O
attached	O
periradicular	O
tissues	O
were	O
selected	O
for	O
study	O
.	O

Using	O
aseptic	O
techniques	O
and	O
sterile	O
instruments	O
,	O
bacterial	O
samples	O
of	O
the	O
root	O
canals	O
were	O
taken	O
,	O
inoculated	O
and	O
separated	O
according	O
to	O
usual	O
practice	O
.	O

After	O
extraction	O
,	O
ten	O
teeth	O
were	O
fixed	O
and	O
the	O
apical	O
5	O
mm	O
portion	O
of	O
one	O
root	O
was	O
sectioned	O
.	O

Root	O
tips	O
were	O
dehydrated	O
,	O
sputter	O
coated	O
with	O
gold	O
,	O
and	O
then	O
examined	O
for	O
the	O
occurrence	O
of	O
bacteria	O
on	O
the	O
apical	O
root	O
surfaces	O
using	O
scanning	O
electron	O
microscope	O
.	O

Five	O
healthy	O
teeth	O
with	O
vital	O
pulp	O
were	O
used	O
as	O
controls	O
.	O

Microbial	O
study	O
showed	O
that	O
ten	O
specimens	O
yielded	O
bacterial	O
growth	O
.	O

The	O
most	O
prevalent	O
bacteria	O
were	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nueleatum	I-bacteria
.	O

In	O
the	O
5	O
untreated	O
teeth	O
,	O
bacterial	O
cells	O
were	O
usually	O
observed	O
close	O
to	O
the	O
apical	O
foramen	O
in	O
only	O
1	O
specimen	O
.	O

Morphologically	O
,	O
these	O
bacteria	O
consisted	O
of	O
cocci	O
.	O

In	O
the	O
5	O
treated	O
teeth	O
,	O
a	O
dense	O
bacterial	O
aggregation	O
composed	O
mainly	O
of	O
cocci	O
and	O
rods	O
was	O
observed	O
surrounding	O
the	O
apical	O
foramen	O
of	O
all	O
specimens	O
.	O

Besides	O
rods	O
,	O
other	O
bacterial	O
morphological	O
types	O
were	O
recognized	O
,	O
including	O
coaggregations	O
of	O
cocci	O
and	O
filaments	O
,	O
characterizing	O
a	O
fully	O
developed	O
`	O
`	O
corn	O
-	O
cob	O
'	O
'	O
.	O

No	O
microorganisms	O
were	O
found	O
in	O
the	O
healthy	O
controls	O
.	O

Bacterial	O
biofilm	O
was	O
always	O
present	O
in	O
teeth	O
with	O
post	O
-	O
treatment	O
endodontic	O
disease	O
.	O

The	O
presence	O
of	O
apical	O
bacterial	O
biofilm	O
is	O
clinically	O
important	O
,	O
and	O
it	O
may	O
cause	O
failure	O
of	O
endodontic	O
treatment	O
as	O
a	O
consequence	O
of	O
persistent	O
infection	O
.	O

To	O
evaluate	O
the	O
safety	O
of	O
two	O
probiotic	O
bacterial	O
strains	O
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
strain	I-bacteria
Shirota	I-bacteria
(	O
LcS	B-bacteria
)	O
and	O
Bifidobacterium	B-bacteria
breve	I-bacteria
strain	I-bacteria
Yakult	I-bacteria
(	O
BbY	B-bacteria
)	O
,	O
these	O
probiotics	O
were	O
orally	O
administered	O
to	O
Lewis	O
rats	O
with	O
experimental	O
autoimmune	O
encephalomyelitis	O
(	O
EAE	O
)	O
,	O
the	O
experimental	O
model	O
of	O
human	O
multiple	O
sclerosis	O
.	O

We	O
examined	O
three	O
experimental	O
designs	O
by	O
combining	O
different	O
antigen	O
types	O
and	O
probiotic	O
administration	O
periods	O
:	O
(	O
1	O
)	O
EAE	O
was	O
induced	O
with	O
a	O
homogenate	O
of	O
guinea	O
pig	O
spinal	O
cord	O
as	O
the	O
sensitizing	O
antigen	O
,	O
and	O
LcS	B-bacteria
was	O
orally	O
administered	O
from	O
one	O
week	O
before	O
this	O
sensitization	O
until	O
the	O
end	O
of	O
the	O
experiment	O
;	O
(	O
2	O
)	O
EAE	O
was	O
induced	O
using	O
guinea	O
pig	O
originated	O
myelin	O
basic	O
protein	O
(	O
MBP	O
)	O
as	O
the	O
sensitizing	O
antigen	O
,	O
and	O
LcS	B-bacteria
was	O
orally	O
administered	O
from	O
one	O
week	O
before	O
this	O
sensitization	O
to	O
the	O
end	O
of	O
the	O
experiment	O
;	O
(	O
3	O
)	O
EAE	O
was	O
induced	O
using	O
guinea	O
pig	O
MBP	O
as	O
the	O
sensitizing	O
antigen	O
,	O
and	O
the	O
probiotic	O
strains	O
(	O
LcS	B-bacteria
and	O
BbY	B-bacteria
)	O
were	O
administered	O
starting	O
in	O
infancy	O
(	O
two	O
weeks	O
old	O
)	O
and	O
continued	O
until	O
the	O
end	O
of	O
the	O
experiment	O
.	O

In	O
experiment	O
1	O
,	O
oral	O
administration	O
of	O
LcS	B-bacteria
tended	O
to	O
suppress	O
the	O
development	O
of	O
neurological	O
symptoms	O
.	O

Differences	O
in	O
neurological	O
symptoms	O
between	O
the	O
control	O
group	O
and	O
the	O
administration	O
groups	O
did	O
not	O
reach	O
statistical	O
significance	O
in	O
experiments	O
2	O
and	O
3	O
.	O

These	O
results	O
support	O
the	O
notion	O
that	O
neither	O
LcS	B-bacteria
nor	O
BbY	B-bacteria
exacerbates	O
autoimmune	O
disease	O
.	O

In	O
Mexico	O
,	O
more	O
than	O
80	O
%	O
of	O
the	O
population	O
is	O
infected	O
with	O
Helicobacter	B-bacteria
pylori	I-bacteria
.	O

The	O
frequency	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
detection	O
in	O
the	O
oral	O
cavity	O
is	O
unknown	O
,	O
as	O
its	O
relationship	O
with	O
gastroesophageal	O
pathology	O
.	O

To	O
detect	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
in	O
Mexican	O
population	O
by	O
PCR	O
and	O
to	O
determine	O
its	O
association	O
with	O
gastroesophageal	O
disease	O
.	O

Patients	O
were	O
divided	O
into	O
two	O
groups	O
with	O
different	O
clinic	O
conditions	O
from	O
whom	O
gastric	O
biopsy	O
,	O
dental	O
plaque	O
,	O
and	O
saliva	O
samples	O
were	O
taken	O
and	O
analyzed	O
.	O

The	O
first	O
group	O
comprised	O
of	O
hospitalized	O
patients	O
,	O
the	O
majority	O
of	O
whom	O
were	O
diagnosed	O
with	O
gastroesophageal	O
disease	O
,	O
while	O
the	O
second	O
group	O
was	O
selected	O
from	O
a	O
dental	O
clinic	O
(	O
ambulatory	O
population	O
)	O
the	O
majority	O
of	O
whom	O
appeared	O
to	O
be	O
healthy	O
subjects	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
detected	O
in	O
gastric	O
biopsy	O
,	O
dental	O
plaque	O
and	O
saliva	O
samples	O
by	O
PCR	O
using	O
a	O
set	O
of	O
specific	O
primers	O
for	O
the	O
signal	O
sequence	O
of	O
the	O
vacuolating	O
cytotoxin	O
gene	O
;	O
detection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
general	O
was	O
higher	O
in	O
gastric	O
biopsy	O
and	O
dental	O
plaque	O
samples	O
than	O
in	O
saliva	O
samples	O
.	O

Detection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
is	O
significantly	O
(	O
P	O
=	O
0	O
.	O
0001	O
)	O
associated	O
with	O
patients	O
presenting	O
gastroesophageal	O
disease	O
,	O
while	O
healthy	O
subjects	O
and	O
those	O
with	O
other	O
non	O
-	O
gastric	O
disease	O
do	O
not	O
present	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
their	O
oral	O
cavity	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
detection	O
in	O
the	O
oral	O
cavity	O
is	O
associated	O
to	O
gastroesophageal	O
disease	O
.	O

In	O
addition	O
,	O
it	O
is	O
suggested	O
that	O
all	O
patients	O
presenting	O
gastric	O
symptoms	O
and	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
detection	O
in	O
the	O
oral	O
cavity	O
would	O
begin	O
bacterial	O
treatment	O
immediately	O
.	O

Mouse	O
prolactin	O
-	O
inducible	O
protein	O
(	O
mPIP	O
)	O
is	O
secreted	O
in	O
mouse	O
saliva	O
and	O
has	O
been	O
found	O
to	O
bind	O
oral	O
bacteria	O
,	O
showing	O
the	O
highest	O
affinity	O
for	O
streptococci	B-bacteria
.	O

Comparisons	O
between	O
the	O
oral	O
flora	O
of	O
mPIP	O
knockout	O
mice	O
and	O
their	O
wild	O
-	O
type	O
controls	O
showed	O
differences	O
in	O
the	O
genera	O
colonizing	O
the	O
two	O
groups	O
of	O
mice	O
.	O

These	O
findings	O
suggested	O
a	O
role	O
for	O
mPIP	O
in	O
the	O
colonization	O
of	O
the	O
mouse	O
oral	O
cavity	O
,	O
possibly	O
modulating	O
the	O
oral	O
flora	O
.	O

In	O
this	O
in	O
vitro	O
study	O
,	O
we	O
focused	O
on	O
the	O
contribution	O
of	O
this	O
protein	O
to	O
aggregation	O
of	O
oral	O
bacteria	O
,	O
a	O
process	O
thought	O
to	O
promote	O
the	O
clearance	O
of	O
bacteria	O
from	O
the	O
oral	O
cavity	O
,	O
and	O
one	O
that	O
could	O
influence	O
the	O
composition	O
of	O
the	O
oral	O
bacterial	O
community	O
.	O

The	O
aggregation	O
of	O
selected	O
human	O
and	O
mouse	O
oral	O
streptococci	B-bacteria
was	O
measured	O
spectrophotometrically	O
.	O

The	O
aggregation	O
of	O
oral	O
bacteria	O
by	O
saliva	O
from	O
mPIP	O
knockout	O
mice	O
,	O
which	O
lack	O
mPIP	O
,	O
was	O
compared	O
with	O
that	O
of	O
saliva	O
from	O
wild	O
-	O
type	O
mice	O
.	O

Both	O
wild	O
-	O
type	O
saliva	O
and	O
mPIP	O
knockout	O
mouse	O
saliva	O
induced	O
aggregation	O
of	O
human	O
strain	O
Streptococcus	B-bacteria
gordonii	I-bacteria
SK120	I-bacteria
and	O
mouse	O
streptococci	B-bacteria
strains	I-bacteria
M105	I-bacteria
/	I-bacteria
6	I-bacteria
and	O
M106	B-bacteria
/	I-bacteria
2	I-bacteria
.	O

Bacterial	O
aggregation	O
induced	O
by	O
the	O
saliva	O
of	O
wild	O
-	O
type	O
mice	O
was	O
significantly	O
higher	O
than	O
the	O
aggregation	O
induced	O
by	O
saliva	O
from	O
mPIP	O
knockout	O
mice	O
for	O
all	O
the	O
bacterial	O
strains	O
.	O

In	O
this	O
study	O
it	O
was	O
confirmed	O
that	O
mPIP	O
plays	O
a	O
role	O
in	O
the	O
aggregation	O
of	O
oral	O
bacteria	O
.	O

The	O
salivary	O
components	O
promoting	O
aggregation	O
of	O
oral	O
bacteria	O
are	O
considered	O
to	O
be	O
part	O
of	O
the	O
oral	O
defense	O
mechanisms	O
so	O
these	O
findings	O
provide	O
insight	O
into	O
a	O
possible	O
function	O
of	O
mPIP	O
in	O
host	O
defense	O
by	O
promoting	O
aggregation	O
of	O
oral	O
bacteria	O
.	O

Weak	O
oral	O
bacteria	O
,	O
such	O
as	O
periodontal	O
bacteria	O
,	O
have	O
been	O
found	O
in	O
various	O
vascular	O
lesions	O
,	O
including	O
atheroma	O
,	O
the	O
thrombus	O
of	O
the	O
occluded	O
artery	O
of	O
Buerger	O
'	O
s	O
disease	O
,	O
the	O
abdominal	O
aortic	O
aneurismal	O
wall	O
and	O
varicose	O
veins	O
.	O

Serum	O
titer	O
levels	O
of	O
each	O
bacterium	O
are	O
now	O
available	O
and	O
have	O
shown	O
a	O
significant	O
relationship	O
between	O
severity	O
and	O
individual	O
differences	O
.	O

The	O
Medline	O
and	O
Tokyo	O
Medical	O
and	O
Dental	O
University	O
databases	O
were	O
searched	O
to	O
identify	O
the	O
literature	O
currently	O
available	O
on	O
oral	O
bacteria	O
and	O
vascular	O
diseases	O
.	O

It	O
is	O
estimated	O
that	O
lymph	O
vessel	O
openings	O
trap	O
bacteria	O
en	O
route	O
from	O
the	O
mouth	O
to	O
the	O
bloodstream	O
and	O
then	O
carry	O
them	O
to	O
the	O
vein	O
of	O
the	O
venous	O
angle	O
near	O
the	O
supraclavicular	O
area	O
.	O

In	O
the	O
case	O
of	O
periodontal	O
bacteria	O
,	O
a	O
typical	O
bacterium	O
,	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
strongly	O
activates	O
platelets	O
and	O
makes	O
them	O
mass	O
,	O
including	O
the	O
bacteria	O
without	O
phagocytosis	O
.	O

Simultaneously	O
,	O
cytokines	O
and	O
serotonin	O
are	O
discharged	O
.	O

Platelet	O
engulfment	O
was	O
clearly	O
demonstrated	O
by	O
electron	O
microscopy	O
analysis	O
.	O

An	O
animal	O
study	O
using	O
rats	O
showed	O
the	O
formation	O
of	O
a	O
small	O
arterial	O
thrombus	O
after	O
continuous	O
intravenous	O
infusion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
for	O
2	O
-	O
4	O
wk	O
.	O

Weak	O
oral	O
bacteria	O
,	O
such	O
as	O
periodontal	O
bacteria	O
,	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
development	O
of	O
various	O
vascular	O
diseases	O
,	O
such	O
as	O
Buerger	O
'	O
s	O
disease	O
,	O
atherosclerosis	O
and	O
varicose	O
veins	O
,	O
through	O
bacteremia	O
.	O

Dental	O
caries	O
disproportionately	O
affects	O
disadvantaged	O
subjects	O
.	O

This	O
study	O
hypothesized	O
that	O
there	O
were	O
greater	O
caries	O
extent	O
and	O
higher	O
levels	O
of	O
caries	O
-	O
associated	O
and	O
anaerobic	O
subgingival	O
bacterial	O
species	O
in	O
oral	O
samples	O
of	O
Hispanic	O
and	O
immigrant	O
children	O
compared	O
with	O
non	O
-	O
Hispanic	O
and	O
US	O
born	O
children	O
.	O

Children	O
from	O
a	O
school	O
-	O
based	O
dental	O
clinic	O
serving	O
a	O
community	O
with	O
a	O
large	O
Hispanic	O
component	O
were	O
examined	O
,	O
and	O
the	O
extent	O
of	O
caries	O
was	O
recorded	O
.	O

Microbial	O
samples	O
were	O
taken	O
from	O
teeth	O
and	O
the	O
tongues	O
of	O
children	O
.	O

Samples	O
were	O
analyzed	O
using	O
DNA	O
probes	O
to	O
18	O
oral	O
bacterial	O
species	O
.	O

Seventy	O
five	O
children	O
were	O
examined	O
.	O

Extent	O
of	O
caries	O
increased	O
with	O
child	O
age	O
in	O
immigrant	O
,	O
but	O
not	O
in	O
US	O
born	O
or	O
Hispanic	O
children	O
.	O

There	O
were	O
no	O
differences	O
in	O
the	O
microbiota	O
based	O
on	O
ethnicity	O
or	O
whether	O
the	O
child	O
was	O
born	O
in	O
US	O
or	O
not	O
.	O

There	O
was	O
a	O
higher	O
species	O
detection	O
frequency	O
from	O
teeth	O
than	O
tongue	O
samples	O
.	O

Levels	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
other	O
Streptococcus	B-bacteria
spp	I-bacteria
increased	O
with	O
caries	O
extent	O
.	O

Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Selenomonas	B-bacteria
spp	I-bacteria
were	O
detected	O
at	O
low	O
levels	O
in	O
these	O
children	O
.	O

We	O
conclude	O
that	O
,	O
while	O
there	O
was	O
a	O
high	O
rate	O
of	O
dental	O
caries	O
in	O
disadvantaged	O
school	O
children	O
,	O
there	O
were	O
no	O
differences	O
in	O
the	O
caries	O
-	O
associated	O
microbiota	O
,	O
including	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
based	O
on	O
ethnicity	O
or	O
immigration	O
status	O
.	O

Furthermore	O
,	O
while	O
anaerobic	O
subgingival	O
,	O
periodontal	O
pathogens	O
were	O
also	O
detected	O
in	O
children	O
,	O
there	O
was	O
no	O
difference	O
in	O
species	O
detection	O
based	O
on	O
ethnicity	O
or	O
immigration	O
status	O
.	O

Increased	O
levels	O
of	O
streptococci	B-bacteria
,	O
including	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
however	O
,	O
were	O
detected	O
with	O
high	O
caries	O
levels	O
.	O

This	O
suggested	O
that	O
while	O
it	O
is	O
beneficial	O
to	O
target	O
preventive	O
and	O
treatment	O
programs	O
to	O
disadvantaged	O
populations	O
,	O
there	O
is	O
likely	O
no	O
additional	O
benefit	O
to	O
focus	O
on	O
subgroups	O
within	O
a	O
population	O
already	O
at	O
high	O
risk	O
for	O
dental	O
disease	O
.	O

Human	O
odontoblasts	O
trigger	O
immune	O
response	O
s	O
to	O
oral	O
bacteria	O
that	O
invade	O
dental	O
tissues	O
during	O
the	O
caries	O
process	O
.	O

To	O
date	O
,	O
their	O
ability	O
to	O
regulate	O
the	O
expression	O
of	O
the	O
nucleotide	O
-	O
binding	O
domain	O
leucine	O
-	O
rich	O
repeat	O
containing	O
receptor	O
NOD2	O
when	O
challenged	O
by	O
Gram	O
-	O
positive	O
bacteria	O
is	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
NOD2	O
expression	O
in	O
healthy	O
and	O
inflamed	O
human	O
dental	O
pulps	O
challenged	O
by	O
bacteria	O
,	O
and	O
in	O
cultured	O
odontoblast	O
-	O
like	O
cells	O
stimulated	O
with	O
lipoteichoic	O
acid	O
(	O
LTA	O
)	O
,	O
a	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
2	O
agonist	O
which	O
is	O
specific	O
for	O
Gram	O
-	O
positive	O
bacteria	O
.	O

We	O
found	O
that	O
NOD2	O
gene	O
expression	O
was	O
significantly	O
up	O
-	O
regulated	O
in	O
pulps	O
with	O
acute	O
inflammation	O
compared	O
to	O
healthy	O
ones	O
.	O

In	O
vitro	O
,	O
LTA	O
augmented	O
NOD2	O
gene	O
expression	O
and	O
protein	O
level	O
in	O
odontoblast	O
-	O
like	O
cells	O
.	O

The	O
increase	O
was	O
more	O
pronounced	O
in	O
odontoblast	O
-	O
like	O
cells	O
compared	O
to	O
dental	O
pulp	O
fibroblasts	O
.	O

Blocking	O
experiments	O
in	O
odontoblast	O
-	O
like	O
cells	O
with	O
anti	O
-	O
TLR2	O
antibody	O
strongly	O
reduced	O
the	O
NOD2	O
gene	O
expression	O
increase	O
,	O
whereas	O
stimulation	O
with	O
the	O
synthetic	O
TLR2	O
ligand	O
Pam	O
(	O
2	O
)	O
CSK	O
(	O
4	O
)	O
confirmed	O
NOD2	O
gene	O
up	O
-	O
regulation	O
following	O
TLR2	O
engagement	O
.	O

These	O
data	O
suggest	O
that	O
NOD2	O
up	O
-	O
regulation	O
is	O
part	O
of	O
the	O
odontoblast	O
immune	O
response	O
to	O
Gram	O
-	O
positive	O
bacteria	O
and	O
might	O
be	O
important	O
in	O
protecting	O
human	O
dental	O
pulp	O
from	O
the	O
deleterious	O
effects	O
of	O
cariogenic	O
pathogens	O
.	O

Nitrogen	O
-	O
containing	O
bisphosphonates	O
such	O
as	O
zoledronic	O
acid	O
(	O
ZOL	O
)	O
and	O
pamidronate	O
have	O
been	O
widely	O
and	O
successfully	O
used	O
for	O
the	O
treatment	O
of	O
cancer	O
patients	O
with	O
bone	O
metastases	O
and	O
/	O
or	O
hypercalcemia	O
.	O

Accumulating	O
recent	O
reports	O
have	O
shown	O
that	O
cancer	O
patients	O
who	O
have	O
received	O
these	O
bisphosphonates	O
occasionally	O
manifest	O
bisphosphonate	O
-	O
related	O
osteonecrosis	O
of	O
the	O
jaw	O
(	O
BRONJ	O
)	O
following	O
dental	O
treatments	O
,	O
including	O
tooth	O
extraction	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
pathogenesis	O
of	O
BRONJ	O
to	O
date	O
.	O

Here	O
,	O
to	O
understand	O
the	O
underlying	O
pathogenesis	O
of	O
BRONJ	O
,	O
we	O
examined	O
the	O
effects	O
of	O
ZOL	O
on	O
wound	O
healing	O
of	O
the	O
tooth	O
extraction	O
socket	O
using	O
a	O
mouse	O
tooth	O
extraction	O
model	O
.	O

Histomorphometrical	O
analysis	O
revealed	O
that	O
the	O
amount	O
of	O
new	O
bone	O
and	O
the	O
numbers	O
of	O
blood	O
vessels	O
in	O
the	O
socket	O
were	O
significantly	O
decreased	O
in	O
ZOL	O
-	O
treated	O
mice	O
compared	O
to	O
control	O
mice	O
.	O

Consistent	O
with	O
these	O
results	O
,	O
ZOL	O
significantly	O
inhibited	O
angiogenesis	O
induced	O
by	O
vascular	O
endothelial	O
growth	O
factor	O
in	O
vivo	O
and	O
the	O
proliferation	O
of	O
endothelial	O
cells	O
in	O
culture	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

In	O
contrast	O
,	O
etidronate	O
,	O
a	O
non	O
-	O
nitrogen	O
-	O
containing	O
bisphosphonate	O
,	O
showed	O
no	O
effects	O
on	O
osteogenesis	O
and	O
angiogenesis	O
in	O
the	O
socket	O
.	O

ZOL	O
also	O
suppressed	O
the	O
migration	O
of	O
oral	O
epithelial	O
cells	O
,	O
which	O
is	O
a	O
crucial	O
step	O
for	O
tooth	O
socket	O
closure	O
.	O

In	O
addition	O
,	O
ZOL	O
promoted	O
the	O
adherence	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
to	O
hydroxyapatite	O
and	O
the	O
proliferation	O
of	O
oral	O
bacteria	O
obtained	O
from	O
healthy	O
individuals	O
,	O
suggesting	O
that	O
ZOL	O
may	O
increase	O
the	O
bacterial	O
infection	O
.	O

In	O
conclusion	O
,	O
our	O
data	O
suggest	O
that	O
ZOL	O
delays	O
wound	O
healing	O
of	O
the	O
tooth	O
extraction	O
socket	O
by	O
inhibiting	O
osteogenesis	O
and	O
angiogenesis	O
.	O

Our	O
data	O
also	O
suggest	O
that	O
ZOL	O
alters	O
oral	O
bacterial	O
behaviors	O
.	O

These	O
actions	O
of	O
ZOL	O
may	O
be	O
relevant	O
to	O
the	O
pathogenesis	O
of	O
BRONJ	O
.	O

To	O
evaluate	O
the	O
antimicrobial	O
activity	O
of	O
10	O
%	O
and	O
37	O
%	O
carbamide	O
peroxide	O
during	O
dental	O
bleaching	O
in	O
three	O
different	O
modes	O
.	O

This	O
five	O
-	O
week	O
double	O
-	O
blind	O
randomized	O
controlled	O
trial	O
included	O
32	O
volunteers	O
assigned	O
to	O
four	O
groups	O
(	O
n	O
=	O
8	O
)	O
.	O

Each	O
group	O
received	O
bleaching	O
agents	O
or	O
placebo	O
as	O
an	O
in	O
-	O
office	O
and	O
at	O
-	O
home	O
treatment	O
.	O

The	O
dental	O
bleaching	O
techniques	O
were	O
:	O
In	O
-	O
office	O
bleaching	O
(	O
37	O
%	O
carbamide	O
peroxide	O
:	O
CP37	O
)	O
;	O
at	O
-	O
home	O
bleaching	O
(	O
10	O
%	O
carbamide	O
peroxide	O
:	O
CP10	O
)	O
and	O
the	O
association	O
of	O
both	O
(	O
CP37	O
and	O
CP10	O
)	O
.	O

Saliva	O
samples	O
were	O
collected	O
right	O
before	O
(	O
baseline	O
)	O
,	O
right	O
after	O
,	O
12	O
hours	O
after	O
,	O
and	O
seven	O
days	O
after	O
the	O
treatment	O
.	O

Counts	O
of	O
total	O
microorganisms	O
,	O
Streptococci	B-bacteria
,	O
and	O
Mutans	B-bacteria
streptococci	I-bacteria
were	O
carried	O
out	O
.	O

Friedman	O
test	O
(	O
alpha	O
=	O
0	O
.	O
05	O
)	O
was	O
used	O
to	O
compare	O
the	O
microorganism	O
counts	O
.	O

The	O
number	O
of	O
the	O
all	O
oral	O
microorganisms	O
remained	O
stable	O
during	O
all	O
experiment	O
.	O

No	O
bleaching	O
agent	O
(	O
CP37	O
,	O
CP10	O
or	O
the	O
combination	O
of	O
both	O
)	O
was	O
able	O
to	O
reduce	O
the	O
oral	O
microorganisms	O
tested	O
.	O

Hydrogen	O
sulfide	O
is	O
one	O
of	O
the	O
predominant	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
produced	O
by	O
oral	O
bacteria	O
.	O

This	O
study	O
developed	O
and	O
evaluated	O
a	O
system	O
for	O
detecting	O
hydrogen	O
sulfide	O
production	O
by	O
oral	O
bacteria	O
.	O

L	O
-	O
methionine	O
-	O
alpha	O
-	O
deamino	O
-	O
gamma	O
-	O
mercaptomethane	O
-	O
lyase	O
(	O
METase	O
)	O
and	O
beta	O
carbon	O
-	O
sulfur	O
(	O
beta	O
C	O
-	O
S	O
)	O
lyase	O
were	O
used	O
to	O
degrade	O
homocysteine	O
and	O
cysteine	O
,	O
respectively	O
,	O
to	O
produce	O
hydrogen	O
sulfide	O
.	O

Enzymatic	O
reactions	O
resulting	O
in	O
hydrogen	O
sulfide	O
production	O
were	O
assayed	O
by	O
reaction	O
with	O
bismuth	O
trichloride	O
,	O
which	O
forms	O
a	O
black	O
precipitate	O
when	O
mixed	O
with	O
hydrogen	O
sulfide	O
.	O

The	O
enzymatic	O
activities	O
of	O
various	O
oral	O
bacteria	O
that	O
result	O
in	O
hydrogen	O
sulfide	O
production	O
and	O
the	O
capacity	O
of	O
bacteria	O
from	O
periodontal	O
sites	O
to	O
form	O
hydrogen	O
sulfide	O
in	O
reaction	O
mixtures	O
containing	O
L	O
-	O
cysteine	O
or	O
DL	O
-	O
homocysteine	O
were	O
assayed	O
.	O

With	O
L	O
-	O
cysteine	O
as	O
the	O
substrate	O
,	O
Streptococcus	B-bacteria
anginosus	I-bacteria
FW73	I-bacteria
produced	O
the	O
most	O
hydrogen	O
sulfide	O
,	O
whereas	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
American	I-bacteria
Type	I-bacteria
Culture	I-bacteria
Collection	I-bacteria
(	I-bacteria
ATCC	I-bacteria
)	I-bacteria
33277	I-bacteria
and	I-bacteria
W83	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
10953	I-bacteria
produced	O
approximately	O
35	O
%	O
of	O
the	O
amount	O
produced	O
by	O
the	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
.	O

Finally	O
,	O
the	O
hydrogen	O
sulfide	O
found	O
in	O
subgingival	O
plaque	O
was	O
analyzed	O
.	O

Using	O
bismuth	O
trichloride	O
,	O
the	O
hydrogen	O
sulfide	O
produced	O
by	O
oral	O
bacteria	O
was	O
visually	O
detectable	O
as	O
a	O
black	O
precipitate	O
.	O

Hydrogen	O
sulfide	O
production	O
by	O
oral	O
bacteria	O
was	O
easily	O
analyzed	O
using	O
bismuth	O
trichloride	O
.	O

However	O
,	O
further	O
innovation	O
is	O
required	O
for	O
practical	O
use	O
.	O

To	O
investigate	O
if	O
oral	O
health	O
parameters	O
were	O
impaired	O
in	O
patients	O
with	O
myocardial	O
infarction	O
(	O
MI	O
)	O
and	O
if	O
there	O
was	O
an	O
association	O
with	O
serum	O
antibody	O
levels	O
against	O
the	O
periodontal	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
Aa	B-bacteria
)	O
.	O

A	O
case	O
-	O
control	O
study	O
consisting	O
of	O
100	O
patients	O
with	O
MI	O
and	O
100	O
age	O
-	O
and	O
sex	O
-	O
matched	O
controls	O
from	O
the	O
same	O
geographic	O
area	O
was	O
investigated	O
regarding	O
oral	O
health	O
.	O

The	O
MI	O
group	O
had	O
significantly	O
more	O
periodontal	O
bone	O
loss	O
(	O
PBL	O
)	O
,	O
number	O
of	O
deepened	O
pockets	O
(	O
NDP	O
)	O
,	O
and	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
,	O
and	O
lower	O
number	O
of	O
teeth	O
(	O
NT	O
)	O
than	O
the	O
controls	O
.	O

After	O
adjustment	O
for	O
known	O
cardiovascular	O
risk	O
factors	O
NT	O
,	O
BOP	O
,	O
and	O
NDP	O
still	O
remained	O
significantly	O
related	O
to	O
MI	O
(	O
p	O
=	O
0	O
.	O
014	O
,	O
p	O
=	O
0	O
.	O
02	O
,	O
and	O
p	O
=	O
0	O
.	O
0069	O
,	O
respectively	O
)	O
.	O

IgG	O
antibody	O
levels	O
against	O
Pg	B-bacteria
were	O
higher	O
in	O
subjects	O
with	O
MI	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
,	O
as	O
well	O
as	O
in	O
those	O
with	O
>	O
4	O
deepened	O
pockets	O
(	O
p	O
=	O
0	O
.	O
05	O
)	O
,	O
BOP	O
>	O
20	O
%	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
PBL	O
(	O
p	O
=	O
0	O
.	O
0003	O
)	O
.	O

However	O
,	O
indicating	O
a	O
causal	O
pathway	O
,	O
the	O
relationship	O
between	O
MI	O
and	O
Pg	O
IgG	O
disappeared	O
when	O
the	O
oral	O
parameters	O
were	O
included	O
in	O
the	O
logistic	O
regression	O
model	O
(	O
p	O
=	O
0	O
.	O
69	O
)	O
.	O

No	O
correlation	O
was	O
seen	O
between	O
MI	O
and	O
Aa	O
in	O
the	O
present	O
study	O
.	O

Patients	O
with	O
MI	O
had	O
an	O
impaired	O
oral	O
health	O
compared	O
to	O
controls	O
.	O

Furthermore	O
,	O
IgG	O
levels	O
against	O
Pg	O
were	O
related	O
to	O
both	O
MI	O
and	O
oral	O
health	O
,	O
suggesting	O
this	O
pathogen	O
as	O
a	O
possible	O
link	O
between	O
oral	O
health	O
and	O
CVD	O
.	O

A	O
modified	O
titanium	O
surface	O
,	O
anodized	O
after	O
being	O
discharged	O
in	O
electrolytes	O
,	O
provides	O
antibacterial	O
activity	O
against	O
oral	O
bacteria	O
as	O
well	O
as	O
osteoconductivity	O
.	O

However	O
,	O
the	O
mechanism	O
of	O
this	O
antibacterial	O
effect	O
against	O
oral	O
bacteria	O
is	O
still	O
unclear	O
.	O

This	O
study	O
aims	O
to	O
investigate	O
whether	O
it	O
is	O
the	O
chloride	O
or	O
the	O
hydrophilicity	O
properties	O
of	O
the	O
anodized	O
titanium	O
,	O
which	O
is	O
effective	O
against	O
the	O
oral	O
bacteria	O
.	O

Titanium	O
plates	O
are	O
anodized	O
in	O
various	O
electrolytes	O
with	O
or	O
without	O
chloride	O
and	O
are	O
characterized	O
.	O

Then	O
the	O
survival	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
on	O
each	O
specimen	O
is	O
evaluated	O
.	O

The	O
results	O
demonstrate	O
that	O
the	O
peroxidation	O
effects	O
of	O
HClO	O
generated	O
from	O
the	O
TiCl	O
(	O
3	O
)	O
formed	O
on	O
the	O
titanium	O
surface	O
anodized	O
in	O
various	O
chloride	O
solutions	O
efficiently	O
killed	O
adherent	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
on	O
the	O
surface	O
whereas	O
the	O
presence	O
of	O
hydrophilicity	O
alone	O
do	O
not	O
demonstrate	O
antibacterial	O
activity	O
.	O

This	O
method	O
of	O
anodizing	O
titanium	O
surface	O
in	O
a	O
chloride	O
solution	O
may	O
provide	O
a	O
novel	O
strategy	O
for	O
use	O
in	O
orthopedic	O
or	O
dental	O
implant	O
systems	O
.	O

To	O
monitor	O
the	O
intra	O
-	O
oral	O
microbiological	O
changes	O
after	O
full	O
-	O
mouth	O
extraction	O
using	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
.	O

Nine	O
patients	O
with	O
severe	O
,	O
aggressive	O
periodontitis	O
,	O
for	O
whom	O
a	O
full	O
-	O
mouth	O
tooth	O
extraction	O
was	O
the	O
only	O
remaining	O
treatment	O
option	O
were	O
recruited	O
.	O

Before	O
and	O
6	O
months	O
after	O
extraction	O
,	O
microbial	O
samples	O
were	O
obtained	O
(	O
tongue	O
,	O
saliva	O
and	O
subgingival	O
plaque	O
)	O
and	O
analysed	O
by	O
qPCR	O
.	O

The	O
elimination	O
of	O
subgingival	O
niches	O
,	O
by	O
extraction	O
of	O
all	O
natural	O
teeth	O
,	O
resulted	O
in	O
a	O
3	O
-	O
log	O
reduction	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
more	O
modest	O
reductions	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
.	O

However	O
,	O
the	O
detection	O
frequencies	O
of	O
these	O
periodontopathogens	O
in	O
saliva	O
and	O
on	O
the	O
tongue	O
remained	O
unchanged	O
after	O
full	O
-	O
mouth	O
tooth	O
extraction	O
.	O

In	O
contrast	O
to	O
what	O
has	O
been	O
believed	O
so	O
far	O
,	O
full	O
-	O
mouth	O
tooth	O
extraction	O
does	O
not	O
result	O
in	O
eradication	O
of	O
all	O
periodontopathogens	O
but	O
only	O
in	O
a	O
significant	O
reduction	O
.	O

The	O
clinical	O
consequences	O
of	O
this	O
observation	O
remain	O
speculative	O
.	O

Hydrogen	O
sulfide	O
(	O
H	O
(	O
2	O
)	O
S	O
)	O
,	O
a	O
volatile	O
sulfur	O
compound	O
,	O
is	O
implicated	O
as	O
a	O
cause	O
of	O
inflammation	O
,	O
especially	O
when	O
it	O
is	O
produced	O
by	O
bacteria	O
colonizing	O
gastrointestinal	O
organs	O
.	O

However	O
,	O
it	O
is	O
unclear	O
if	O
H	O
(	O
2	O
)	O
S	O
produced	O
by	O
periodontal	O
pathogens	O
affects	O
the	O
inflammatory	O
responses	O
mediated	O
by	O
oral	O
/	O
gingival	O
epithelial	O
cells	O
.	O

Therefore	O
,	O
the	O
aims	O
of	O
this	O
study	O
were	O
(	O
1	O
)	O
to	O
compare	O
the	O
in	O
vitro	O
production	O
of	O
H	O
(	O
2	O
)	O
S	O
among	O
14	O
strains	O
of	O
oral	O
bacteria	O
and	O
(	O
2	O
)	O
to	O
evaluate	O
the	O
effects	O
of	O
H	O
(	O
2	O
)	O
S	O
on	O
inflammatory	O
response	O
induced	O
in	O
host	O
oral	O
/	O
gingival	O
epithelial	O
cells	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
produced	O
the	O
most	O
H	O
(	O
2	O
)	O
S	O
in	O
culture	O
,	O
which	O
,	O
in	O
turn	O
,	O
resulted	O
in	O
the	O
promotion	O
of	O
proinflammatory	O
cytokine	O
IL	O
-	O
8	O
from	O
both	O
gingival	O
and	O
oral	O
epithelial	O
cells	O
.	O

The	O
up	O
-	O
regulation	O
of	O
IL	O
-	O
8	O
expression	O
was	O
reproduced	O
by	O
the	O
exogenously	O
applied	O
H	O
(	O
2	O
)	O
S	O
.	O
Furthermore	O
,	O
the	O
mutant	O
strains	O
of	O
Pg	B-bacteria
that	O
do	O
not	O
produce	O
major	O
soluble	O
virulent	O
factors	O
,	O
i	O
.	O
e	O
.	O
gingipains	O
,	O
still	O
showed	O
the	O
production	O
of	O
H	O
(	O
2	O
)	O
S	O
,	O
as	O
well	O
as	O
the	O
promotion	O
of	O
epithelial	O
IL	O
-	O
8	O
production	O
,	O
which	O
was	O
abrogated	O
by	O
H	O
(	O
2	O
)	O
S	O
scavenging	O
reagents	O
.	O

These	O
results	O
demonstrated	O
that	O
Pg	B-bacteria
produces	O
a	O
concentration	O
of	O
H	O
(	O
2	O
)	O
S	O
capable	O
of	O
up	O
-	O
regulating	O
IL	O
-	O
8	O
expression	O
induced	O
in	O
gingival	O
and	O
oral	O
epithelial	O
cells	O
,	O
revealing	O
a	O
possible	O
mechanism	O
that	O
may	O
promote	O
the	O
inflammation	O
in	O
periodontal	O
disease	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
correlate	O
the	O
presence	O
of	O
Enterobacteriaceae	B-bacteria
,	O
Pseudomonadaceae	B-bacteria
,	O
Moraxellaceae	B-bacteria
and	O
Xanthomonadaceae	B-bacteria
on	O
the	O
posterior	O
dorsum	O
of	O
the	O
human	O
tongue	O
with	O
the	O
presence	O
of	O
tongue	O
coating	O
,	O
gender	O
,	O
age	O
,	O
smoking	O
habit	O
and	O
denture	O
use	O
.	O

Bacteria	O
were	O
isolated	O
from	O
the	O
posterior	O
tongue	O
dorsum	O
of	O
100	O
individuals	O
in	O
MacConkey	O
agar	O
medium	O
and	O
were	O
identified	O
by	O
the	O
API	O
20E	O
system	O
(	O
Biolab	O
-	O
Merieux	O
)	O
.	O

43	O
%	O
of	O
the	O
individuals	O
,	O
presented	O
the	O
target	O
microorganisms	O
on	O
the	O
tongue	O
dorsum	O
,	O
with	O
greater	O
prevalence	O
among	O
individuals	O
between	O
40	O
and	O
50	O
years	O
of	O
age	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
non	O
-	O
smokers	O
(	O
p	O
=	O
0	O
.	O
0485	O
)	O
.	O

A	O
higher	O
prevalence	O
of	O
Enterobacteriaceae	B-bacteria
and	O
Pseudomonadaceae	B-bacteria
was	O
observed	O
on	O
the	O
tongue	O
dorsum	O
of	O
the	O
individuals	O
evaluated	O
.	O

There	O
was	O
no	O
correlation	O
between	O
these	O
species	O
and	O
the	O
presence	O
and	O
thickness	O
of	O
tongue	O
coating	O
,	O
gender	O
and	O
presence	O
of	O
dentures	O
.	O

The	O
incidence	O
of	O
potential	O
periodontal	O
pathogens	O
(	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
formerly	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Capnocytophaga	B-bacteria
ochracea	I-bacteria
)	O
was	O
monitored	O
in	O
patients	O
with	O
chronic	O
periodontitis	O
and	O
in	O
healthy	O
control	O
subjects	O
.	O

Two	O
types	O
of	O
studies	O
were	O
carried	O
out	O
in	O
which	O
the	O
composition	O
of	O
the	O
bacterial	O
communities	O
in	O
different	O
niches	O
of	O
the	O
same	O
oral	O
cavity	O
ecosystem	O
was	O
investigated	O
.	O

Fluctuation	O
or	O
at	O
least	O
pronounced	O
quantitative	O
changes	O
in	O
the	O
incidence	O
of	O
individual	O
species	O
in	O
time	O
were	O
documented	O
in	O
the	O
long	O
-	O
term	O
study	O
as	O
well	O
as	O
after	O
the	O
local	O
administration	O
of	O
antibacterial	O
drug	O
Chlo	O
-	O
Site	O
or	O
Metronidazole	O
.	O

Even	O
within	O
two	O
weeks	O
,	O
a	O
turnover	O
of	O
the	O
monitored	O
bacteria	O
in	O
separate	O
niches	O
of	O
the	O
oral	O
biotope	O
can	O
be	O
detected	O
.	O

A	O
relatively	O
high	O
incidence	O
of	O
the	O
tested	O
periopathogens	O
in	O
the	O
clinically	O
healthy	O
teeth	O
of	O
patients	O
implies	O
that	O
even	O
the	O
`	O
`	O
healthy	O
'	O
'	O
niches	O
in	O
the	O
periodontal	O
biotope	O
function	O
as	O
a	O
dynamic	O
reservoir	O
of	O
periopathogenic	O
microorganisms	O
.	O

This	O
should	O
be	O
kept	O
in	O
mind	O
when	O
a	O
local	O
application	O
of	O
antibacterial	O
compounds	O
is	O
used	O
in	O
the	O
therapy	O
of	O
periodontal	O
disease	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
oral	O
colonisation	O
by	O
bacterial	O
respiratory	O
pathogens	O
in	O
hospitalised	O
patients	O
.	O

Thirty	O
patients	O
undergoing	O
myocardium	O
revascularisation	O
surgery	O
were	O
evaluated	O
.	O

At	O
baseline	O
(	O
pre	O
-	O
operative	O
phase	O
)	O
,	O
full	O
-	O
mouth	O
clinical	O
periodontal	O
assessment	O
was	O
performed	O
.	O

Saliva	O
and	O
biofilm	O
samples	O
were	O
obtained	O
from	O
subjects	O
at	O
baseline	O
and	O
at	O
the	O
post	O
-	O
operative	O
phase	O
,	O
after	O
orotracheal	O
extubation	O
.	O

DNA	O
was	O
extracted	O
from	O
samples	O
and	O
species	O
of	O
Acinetobacter	B-bacteria
,	O
Pseudomonas	B-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Dialister	B-bacteria
pneumosintes	I-bacteria
were	O
detected	O
by	O
PCR	O
or	O
culture	O
(	O
for	O
staphylococci	B-bacteria
isolates	I-bacteria
)	O
.	O

Most	O
of	O
the	O
subjects	O
were	O
males	O
,	O
with	O
history	O
of	O
hypertension	O
and	O
smoking	O
.	O

Thirteen	O
were	O
edentulous	O
(	O
ED	O
)	O
and	O
17	O
were	O
dentate	O
(	O
DE	O
)	O
,	O
with	O
moderate	O
chronic	O
periodontitis	O
.	O

The	O
most	O
prevalent	O
bacteria	O
in	O
saliva	O
were	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
85	O
.	O
7	O
%	O
)	O
,	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
83	O
.	O
8	O
%	O
)	O
,	O
and	O
Acinetobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
53	O
.	O
3	O
%	O
)	O
.	O

There	O
was	O
a	O
trend	O
for	O
D	O
.	O
pneumosintes	O
to	O
be	O
more	O
frequently	O
detected	O
in	O
DE	O
(	O
43	O
.	O
7	O
%	O
)	O
than	O
ED	O
(	O
11	O
.	O
5	O
%	O
)	O
patients	O
.	O

In	O
plaque	O
samples	O
,	O
DE	O
with	O
>	O
14	O
teeth	O
showed	O
a	O
higher	O
prevalence	O
of	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
100	O
%	O
)	O
than	O
individuals	O
with	O
<	O
or	O
=	O
14	O
teeth	O
(	O
69	O
.	O
1	O
%	O
;	O
p	O
=	O
0	O
.	O
048	O
)	O
.	O

Conversely	O
,	O
P	O
.	O
aeruginosa	O
was	O
more	O
prevalent	O
in	O
subjects	O
with	O
fewer	O
teeth	O
(	O
35	O
.	O
5	O
%	O
)	O
than	O
with	O
>	O
14	O
teeth	O
(	O
5	O
.	O
7	O
%	O
;	O
p	O
=	O
0	O
.	O
037	O
)	O
.	O

All	O
staphylococci	B-bacteria
isolates	I-bacteria
were	O
coagulase	O
-	O
negative	O
,	O
and	O
about	O
11	O
%	O
were	O
positive	O
for	O
the	O
mecA	O
gene	O
.	O

These	O
mecA	O
-	O
positive	O
isolates	O
showed	O
a	O
tendency	O
to	O
increase	O
in	O
all	O
samples	O
,	O
whereas	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
reduced	O
after	O
surgery	O
.	O

A	O
strong	O
correlation	O
between	O
the	O
presence	O
of	O
Acinetobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
observed	O
(	O
rho	O
=	O
0	O
.	O
886	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
oral	O
cavity	O
of	O
hospitalised	O
patients	O
harbours	O
high	O
frequencies	O
of	O
bacterial	O
respiratory	O
pathogens	O
,	O
supporting	O
its	O
potential	O
role	O
as	O
a	O
reservoir	O
for	O
these	O
species	O
.	O

Two	O
strains	O
of	O
anaerobic	O
,	O
Gram	O
-	O
stain	O
-	O
negative	O
bacilli	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
(	O
D033B	O
-	O
12	O
-	O
2	O
(	O
T	O
)	O
and	O
D080A	O
-	O
01	O
)	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
be	O
distinct	O
from	O
any	O
previously	O
described	O
species	O
.	O

16S	O
rRNA	O
gene	O
sequence	O
analysis	O
revealed	O
that	O
the	O
strains	O
were	O
related	O
most	O
closely	O
to	O
the	O
type	O
strain	O
of	O
Prevotella	B-bacteria
marshii	I-bacteria
(	O
93	O
.	O
5	O
%	O
sequence	O
identity	O
)	O
.	O

The	O
novel	O
strains	O
were	O
saccharolytic	O
and	O
produced	O
acetic	O
acid	O
and	O
succinic	O
acid	O
as	O
end	O
products	O
of	O
fermentation	O
.	O

The	O
principal	O
cellular	O
long	O
-	O
chain	O
fatty	O
acids	O
were	O
C	O
(	O
1	O
)	O
(	O
6	O
)	O
:	O
(	O
0	O
)	O
)	O
,	O
iso	O
-	O
C	O
(	O
1	O
)	O
(	O
4	O
)	O
:	O
(	O
0	O
)	O
,	O
C	O
(	O
1	O
)	O
(	O
4	O
)	O
:	O
(	O
0	O
)	O
,	O
anteiso	O
-	O
C	O
(	O
1	O
)	O
(	O
5	O
)	O
:	O
(	O
0	O
)	O
,	O
iso	O
-	O
C	O
(	O
1	O
)	O
(	O
6	O
)	O
:	O
(	O
0	O
)	O
and	O
C	O
(	O
1	O
)	O
(	O
6	O
)	O
:	O
(	O
0	O
)	O
)	O
3	O
-	O
OH	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
strain	O
D033B	B-bacteria
-	I-bacteria
12	I-bacteria
-	I-bacteria
2	I-bacteria
(	O
T	O
)	O
was	O
44	O
mol	O
%	O
.	O

Strains	O
D033B	B-bacteria
-	I-bacteria
12	I-bacteria
-	I-bacteria
2	I-bacteria
(	O
T	O
)	O
and	O
D080A	B-bacteria
-	I-bacteria
01	I-bacteria
are	O
considered	O
to	O
represent	O
a	O
single	O
novel	O
species	O
of	O
the	O
genus	O
Prevotella	B-bacteria
,	O
for	O
which	O
the	O
name	O
Prevotella	B-bacteria
saccharolytica	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
is	O
proposed	O
.	O

The	O
type	O
strain	O
is	O
D033B	B-bacteria
-	O
12	O
-	O
2	O
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
22473	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
57944	I-bacteria
(	O
T	O
)	O
)	O
.	O

We	O
reported	O
previously	O
that	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
one	O
of	O
the	O
periodontal	O
pathogens	O
,	O
suppresses	O
the	O
expression	O
of	O
human	O
beta	O
-	O
defensins	O
(	O
HBDs	O
)	O
in	O
human	O
gingival	O
epithelial	O
cells	O
.	O

To	O
identify	O
the	O
mechanisms	O
involved	O
in	O
this	O
suppression	O
,	O
immortalized	O
and	O
normal	O
human	O
gingival	O
epithelial	O
cells	O
were	O
infected	O
with	O
live	O
or	O
heat	O
-	O
killed	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
for	O
24	O
h	O
,	O
and	O
then	O
the	O
expression	O
of	O
HBDs	O
was	O
examined	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

Live	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
suppressed	O
the	O
expression	O
of	O
HBD	O
-	O
3	O
substantially	O
and	O
also	O
suppressed	O
the	O
expression	O
of	O
HBD	O
-	O
1	O
and	O
HBD	O
-	O
2	O
.	O

However	O
,	O
heat	O
-	O
killed	O
bacteria	O
did	O
not	O
produce	O
a	O
suppressive	O
effect	O
but	O
instead	O
slightly	O
upregulated	O
the	O
levels	O
of	O
HBD	O
-	O
2	O
and	O
HBD	O
-	O
3	O
.	O

In	O
contrast	O
to	O
live	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
which	O
reduced	O
the	O
activation	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
NF	O
-	O
kappaB	O
within	O
an	O
hour	O
of	O
infection	O
,	O
heat	O
-	O
killed	O
bacteria	O
did	O
not	O
show	O
any	O
inhibitory	O
effect	O
on	O
the	O
MAPK	O
and	O
NF	O
-	O
kappaB	O
signaling	O
pathways	O
.	O

Knockdown	O
of	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
via	O
RNA	O
interference	O
abolished	O
the	O
suppressive	O
effect	O
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
on	O
the	O
expression	O
of	O
HBD	O
-	O
3	O
.	O

Heat	O
-	O
killed	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
but	O
not	O
live	O
bacteria	O
could	O
activate	O
TLR2	O
in	O
CHO	O
/	O
CD14	O
/	O
TLR2	O
reporter	O
cells	O
,	O
suggesting	O
that	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
contains	O
a	O
heat	O
-	O
labile	O
inhibitor	O
(	O
s	O
)	O
of	O
TLR2	O
in	O
addition	O
to	O
ligands	O
recognized	O
by	O
TLR2	O
.	O

Indeed	O
,	O
live	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
able	O
to	O
inhibit	O
TLR2	O
activation	O
by	O
Pam	O
(	O
3	O
)	O
CSK	O
.	O

In	O
conclusion	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
suppressed	O
the	O
expression	O
of	O
HBD	O
-	O
3	O
by	O
inhibiting	O
the	O
TLR2	O
axis	O
in	O
gingival	O
epithelial	O
cells	O
.	O

These	O
results	O
may	O
provide	O
new	O
insight	O
into	O
the	O
pathogenesis	O
of	O
periodontitis	O
caused	O
by	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

Most	O
studies	O
examining	O
the	O
commensal	O
human	O
oral	O
microbiome	O
are	O
focused	O
on	O
disease	O
or	O
are	O
limited	O
in	O
methodology	O
.	O

In	O
order	O
to	O
diagnose	O
and	O
treat	O
diseases	O
at	O
an	O
early	O
and	O
reversible	O
stage	O
an	O
in	O
-	O
depth	O
definition	O
of	O
health	O
is	O
indispensible	O
.	O

The	O
aim	O
of	O
this	O
study	O
therefore	O
was	O
to	O
define	O
the	O
healthy	O
oral	O
microbiome	O
using	O
recent	O
advances	O
in	O
sequencing	O
technology	O
(	O
454	O
pyrosequencing	O
)	O
.	O

We	O
sampled	O
and	O
sequenced	O
microbiomes	O
from	O
several	O
intraoral	O
niches	O
(	O
dental	O
surfaces	O
,	O
cheek	O
,	O
hard	O
palate	O
,	O
tongue	O
and	O
saliva	O
)	O
in	O
three	O
healthy	O
individuals	O
.	O

Within	O
an	O
individual	O
oral	O
cavity	O
,	O
we	O
found	O
over	O
3600	O
unique	O
sequences	O
,	O
over	O
500	O
different	O
OTUs	O
or	O
`	O
`	O
species	O
-	O
level	O
'	O
'	O
phylotypes	O
(	O
sequences	O
that	O
clustered	O
at	O
3	O
%	O
genetic	O
difference	O
)	O
and	O
88	O
-	O
104	O
higher	O
taxa	O
(	O
genus	O
or	O
more	O
inclusive	O
taxon	O
)	O
.	O

The	O
predominant	O
taxa	O
belonged	O
to	O
Firmicutes	B-bacteria
(	O
genus	B-bacteria
Streptococcus	I-bacteria
,	O
family	B-bacteria
Veillonellaceae	I-bacteria
,	O
genus	B-bacteria
Granulicatella	I-bacteria
)	O
,	O
Proteobacteria	B-bacteria
(	O
genus	B-bacteria
Neisseria	I-bacteria
,	O
Haemophilus	B-bacteria
)	O
,	O
Actinobacteria	B-bacteria
(	O
genus	B-bacteria
Corynebacterium	I-bacteria
,	O
Rothia	B-bacteria
,	O
Actinomyces	B-bacteria
)	O
,	O
Bacteroidetes	B-bacteria
(	O
genus	B-bacteria
Prevotella	I-bacteria
,	O
Capnocytophaga	B-bacteria
,	O
Porphyromonas	B-bacteria
)	O
and	O
Fusobacteria	B-bacteria
(	O
genus	B-bacteria
Fusobacterium	I-bacteria
)	O
.	O
Each	O
individual	O
sample	O
harboured	O
on	O
average	O
266	O
`	O
`	O
species	O
-	O
level	O
'	O
'	O
phylotypes	O
(	O
SD	O
67	O
;	O
range	O
123	O
-	O
326	O
)	O
with	O
cheek	O
samples	O
being	O
the	O
least	O
diverse	O
and	O
the	O
dental	O
samples	O
from	O
approximal	O
surfaces	O
showing	O
the	O
highest	O
diversity	O
.	O

Principal	O
component	O
analysis	O
discriminated	O
the	O
profiles	O
of	O
the	O
samples	O
originating	O
from	O
shedding	O
surfaces	O
(	O
mucosa	O
of	O
tongue	O
,	O
cheek	O
and	O
palate	O
)	O
from	O
the	O
samples	O
that	O
were	O
obtained	O
from	O
solid	O
surfaces	O
(	O
teeth	O
)	O
.	O
There	O
was	O
a	O
large	O
overlap	O
in	O
the	O
higher	O
taxa	O
,	O
`	O
`	O
species	O
-	O
level	O
'	O
'	O
phylotypes	O
and	O
unique	O
sequences	O
among	O
the	O
three	O
microbiomes	O
:	O
84	O
%	O
of	O
the	O
higher	O
taxa	O
,	O
75	O
%	O
of	O
the	O
OTUs	O
and	O
65	O
%	O
of	O
the	O
unique	O
sequences	O
were	O
present	O
in	O
at	O
least	O
two	O
of	O
the	O
three	O
microbiomes	O
.	O

The	O
three	O
individuals	O
shared	O
1660	O
of	O
6315	O
unique	O
sequences	O
.	O

These	O
1660	O
sequences	O
(	O
the	O
`	O
`	O
core	O
microbiome	O
'	O
'	O
)	O
contributed	O
66	O
%	O
of	O
the	O
reads	O
.	O

The	O
overlapping	O
OTUs	O
contributed	O
to	O
94	O
%	O
of	O
the	O
reads	O
,	O
while	O
nearly	O
all	O
reads	O
(	O
99	O
.	O
8	O
%	O
)	O
belonged	O
to	O
the	O
shared	O
higher	O
taxa	O
.	O

We	O
obtained	O
the	O
first	O
insight	O
into	O
the	O
diversity	O
and	O
uniqueness	O
of	O
individual	O
oral	O
microbiomes	O
at	O
a	O
resolution	O
of	O
next	O
-	O
generation	O
sequencing	O
.	O

We	O
showed	O
that	O
a	O
major	O
proportion	O
of	O
bacterial	O
sequences	O
of	O
unrelated	O
healthy	O
individuals	O
is	O
identical	O
,	O
supporting	O
the	O
concept	O
of	O
a	O
core	O
microbiome	O
at	O
health	O
.	O

This	O
study	O
identified	O
the	O
bacterial	O
taxa	O
enduring	O
endodontic	O
treatment	O
procedures	O
by	O
using	O
a	O
combined	O
16S	O
ribosomal	O
RNA	O
-	O
based	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
reverse	O
-	O
capture	O
checkerboard	O
hybridization	O
approach	O
.	O

Samples	O
were	O
taken	O
from	O
infected	O
canals	O
of	O
15	O
teeth	O
with	O
apical	O
periodontitis	O
before	O
treatment	O
(	O
S1	O
)	O
,	O
after	O
chemomechanical	O
preparation	O
with	O
NaOCl	O
as	O
the	O
irrigant	O
(	O
S2	O
)	O
,	O
and	O
after	O
interappointment	O
medication	O
with	O
a	O
calcium	O
hydroxide	O
paste	O
(	O
S3	O
)	O
.	O

Bacterial	O
presence	O
was	O
first	O
screened	O
by	O
a	O
DNA	O
-	O
based	O
single	O
PCR	O
assay	O
.	O

RNA	O
extracts	O
were	O
subjected	O
to	O
RT	O
-	O
PCR	O
,	O
and	O
the	O
resulting	O
products	O
were	O
surveyed	O
for	O
the	O
presence	O
of	O
28	O
targeted	O
taxa	O
by	O
using	O
the	O
checkerboard	O
method	O
.	O

Bacteria	O
were	O
found	O
in	O
all	O
S1	O
samples	O
.	O

Detectable	O
levels	O
of	O
bacterial	O
ribosomal	O
RNA	O
,	O
used	O
as	O
an	O
indicator	O
of	O
viability	O
,	O
were	O
observed	O
in	O
60	O
%	O
of	O
the	O
cases	O
after	O
chemomechanical	O
preparation	O
and	O
53	O
%	O
after	O
intracanal	O
medication	O
.	O

The	O
most	O
prevalent	O
taxa	O
in	O
S1	O
were	O
Olsenella	B-bacteria
uli	I-bacteria
(	O
67	O
%	O
)	O
,	O
Pyramidobacter	B-bacteria
piscolens	I-bacteria
(	O
60	O
%	O
)	O
,	O
Streptococcus	B-bacteria
species	I-bacteria
(	O
53	O
%	O
)	O
,	O
and	O
Bacteroidetes	B-bacteria
clone	I-bacteria
X083	I-bacteria
(	O
53	O
%	O
)	O
.	O

Streptococcus	B-bacteria
species	I-bacteria
(	O
47	O
%	O
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
40	O
%	O
)	O
,	O
and	O
O	O
.	O
uli	O
(	O
33	O
%	O
)	O
prevailed	O
in	O
S2	O
,	O
whereas	O
Streptococcus	B-bacteria
species	I-bacteria
(	O
47	O
%	O
)	O
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
(	O
27	O
%	O
)	O
,	O
and	O
O	O
.	O
uli	O
(	O
27	O
%	O
)	O
were	O
the	O
most	O
frequent	O
taxa	O
in	O
S3	O
.	O

The	O
present	O
study	O
with	O
a	O
combined	O
molecular	O
approach	O
revealed	O
that	O
bacterial	O
diversity	O
was	O
overall	O
markedly	O
reduced	O
by	O
treatment	O
procedures	O
.	O

Although	O
bacterial	O
taxa	O
more	O
frequently	O
identified	O
in	O
post	O
-	O
treatment	O
samples	O
emerge	O
as	O
potential	O
risk	O
factors	O
for	O
persistent	O
disease	O
,	O
this	O
remains	O
to	O
be	O
determined	O
by	O
longitudinal	O
studies	O
.	O

Streptococcus	B-bacteria
sanguinis	I-bacteria
is	O
a	O
predominant	O
bacterium	O
in	O
the	O
human	O
oral	O
cavity	O
and	O
occasionally	O
causes	O
infective	O
endocarditis	O
.	O

We	O
identified	O
a	O
unique	O
cell	O
surface	O
polymeric	O
structure	O
named	O
pili	O
in	O
this	O
species	O
and	O
investigated	O
its	O
functions	O
in	O
regard	O
to	O
its	O
potential	O
virulence	O
.	O

Pili	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
strain	I-bacteria
SK36	I-bacteria
were	O
shown	O
to	O
be	O
composed	O
of	O
three	O
distinctive	O
pilus	O
proteins	O
(	O
PilA	O
,	O
PilB	O
,	O
and	O
PilC	O
)	O
,	O
and	O
a	O
pili	O
-	O
deficient	O
mutant	O
demonstrated	O
reduced	O
bacterial	O
adherence	O
to	O
HeLa	O
and	O
human	O
oral	O
epithelial	O
cells	O
.	O

PilC	O
showed	O
a	O
binding	O
ability	O
to	O
fibronectin	O
,	O
suggesting	O
that	O
pili	O
are	O
involved	O
in	O
colonization	O
by	O
this	O
species	O
.	O

In	O
addition	O
,	O
ATCC10556	O
,	O
a	O
standard	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
strain	I-bacteria
,	O
was	O
unable	O
to	O
produce	O
pili	O
due	O
to	O
defective	O
pilus	O
genes	O
,	O
which	O
indicates	O
a	O
diversity	O
of	O
pilus	O
expression	O
among	O
various	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
strains	I-bacteria
.	O

Shear	O
-	O
enhanced	O
adhesion	O
,	O
although	O
not	O
observed	O
for	O
fimbria	O
-	O
mediated	O
adhesion	O
of	O
oral	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
was	O
noted	O
for	O
Hsa	O
-	O
mediated	O
adhesion	O
of	O
Streptococcus	B-bacteria
gordonii	I-bacteria
to	O
sialic	O
acid	O
-	O
containing	O
receptors	O
,	O
an	O
interaction	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
infective	O
endocarditis	O
.	O

Bifidobacteria	B-bacteria
,	O
one	O
of	O
the	O
relatively	O
dominant	O
components	O
of	O
the	O
human	O
intestinal	O
microbiota	O
,	O
are	O
considered	O
one	O
of	O
the	O
key	O
groups	O
of	O
beneficial	O
intestinal	O
bacteria	O
(	O
probiotic	O
bacteria	O
)	O
.	O

However	O
,	O
in	O
addition	O
to	O
health	O
-	O
promoting	O
taxa	O
,	O
the	O
genus	O
Bifidobacterium	B-bacteria
also	O
includes	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
,	O
an	O
opportunistic	O
cariogenic	O
pathogen	O
.	O

The	O
genetic	O
basis	O
for	O
the	O
ability	O
of	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
to	O
survive	O
in	O
the	O
oral	O
cavity	O
and	O
contribute	O
to	O
caries	O
development	O
is	O
not	O
understood	O
.	O

The	O
genome	O
of	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
Bd1	I-bacteria
,	O
a	O
strain	O
isolated	O
from	O
dental	O
caries	O
,	O
was	O
sequenced	O
to	O
completion	O
to	O
uncover	O
a	O
single	O
circular	O
2	O
,	O
636	O
,	O
368	O
base	O
pair	O
chromosome	O
with	O
2	O
,	O
143	O
predicted	O
open	O
reading	O
frames	O
.	O

Annotation	O
of	O
the	O
genome	O
sequence	O
revealed	O
multiple	O
ways	O
in	O
which	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
has	O
adapted	O
to	O
the	O
oral	O
environment	O
through	O
specialized	O
nutrient	O
acquisition	O
,	O
defences	O
against	O
antimicrobials	O
,	O
and	O
gene	O
products	O
that	O
increase	O
fitness	O
and	O
competitiveness	O
within	O
the	O
oral	O
niche	O
.	O

B	B-bacteria
.	I-bacteria
dentium	I-bacteria
Bd1	I-bacteria
was	O
shown	O
to	O
metabolize	O
a	O
wide	O
variety	O
of	O
carbohydrates	O
,	O
consistent	O
with	O
genome	O
-	O
based	O
predictions	O
,	O
while	O
colonization	O
and	O
persistence	O
factors	O
implicated	O
in	O
tissue	O
adhesion	O
,	O
acid	O
tolerance	O
,	O
and	O
the	O
metabolism	O
of	O
human	O
saliva	O
-	O
derived	O
compounds	O
were	O
also	O
identified	O
.	O

Global	O
transcriptome	O
analysis	O
demonstrated	O
that	O
many	O
of	O
the	O
genes	O
encoding	O
these	O
predicted	O
traits	O
are	O
highly	O
expressed	O
under	O
relevant	O
physiological	O
conditions	O
.	O

This	O
is	O
the	O
first	O
report	O
to	O
identify	O
,	O
through	O
various	O
genomic	O
approaches	O
,	O
specific	O
genetic	O
adaptations	O
of	O
a	O
Bifidobacterium	B-bacteria
taxon	I-bacteria
,	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
Bd1	I-bacteria
,	O
to	O
a	O
lifestyle	O
as	O
a	O
cariogenic	O
microorganism	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
silico	O
analysis	O
and	O
comparative	O
genomic	O
hybridization	O
experiments	O
clearly	O
reveal	O
a	O
high	O
level	O
of	O
genome	O
conservation	O
among	O
various	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
strains	I-bacteria
.	O

The	O
data	O
indicate	O
that	O
the	O
genome	O
of	O
this	O
opportunistic	O
cariogen	O
has	O
evolved	O
through	O
a	O
very	O
limited	O
number	O
of	O
horizontal	O
gene	O
acquisition	O
events	O
,	O
highlighting	O
the	O
narrow	O
boundaries	O
that	O
separate	O
commensals	O
from	O
opportunistic	O
pathogens	O
.	O

Seasonal	O
changes	O
in	O
day	O
length	O
(	O
i	O
.	O
e	O
.	O
,	O
photoperiod	O
)	O
provide	O
animals	O
with	O
a	O
reliable	O
environmental	O
cue	O
to	O
determine	O
time	O
of	O
year	O
,	O
and	O
many	O
physiological	O
changes	O
occur	O
in	O
laboratory	O
animals	O
simply	O
by	O
extending	O
or	O
shortening	O
day	O
length	O
.	O

Male	O
Siberian	O
hamsters	O
(	O
Phodopus	O
sungorus	O
)	O
housed	O
in	O
long	O
summer	O
-	O
like	O
day	O
lengths	O
have	O
significantly	O
elevated	O
body	O
and	O
fat	O
masses	O
compared	O
to	O
short	O
-	O
day	O
hamsters	O
.	O

Because	O
others	O
have	O
demonstrated	O
that	O
the	O
intestinal	O
microbiota	O
of	O
humans	O
and	O
rodents	O
promotes	O
host	O
adiposity	O
,	O
we	O
hypothesized	O
that	O
photoperiod	O
-	O
induced	O
changes	O
in	O
body	O
and	O
fat	O
masses	O
could	O
be	O
associated	O
with	O
changes	O
in	O
the	O
microbial	O
composition	O
in	O
the	O
intestines	O
.	O

We	O
used	O
bacterial	O
tag	O
-	O
encoded	O
FLX	O
amplicon	O
pyrosequencing	O
(	O
bTEFAP	O
)	O
to	O
assess	O
microbial	O
diversity	O
in	O
the	O
cecal	O
contents	O
of	O
hamsters	O
;	O
long	O
days	O
significantly	O
increased	O
the	O
relative	O
abundance	O
of	O
bacteria	O
in	O
the	O
phylum	O
Proteobacteria	B-bacteria
.	O

This	O
effect	O
was	O
primarily	O
due	O
to	O
a	O
significant	O
increase	O
in	O
the	O
abundance	O
of	O
the	O
genus	O
Citrobacter	B-bacteria
,	O
with	O
both	O
the	O
abundance	O
of	O
Proteobacteria	B-bacteria
and	O
Citrobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
significantly	O
correlated	O
with	O
body	O
mass	O
and	O
with	O
inguinal	O
fat	O
mass	O
.	O

In	O
general	O
,	O
the	O
abundance	O
of	O
the	O
Firmicutes	B-bacteria
phylum	I-bacteria
was	O
inversely	O
associated	O
with	O
body	O
mass	O
.	O

These	O
data	O
indicate	O
that	O
the	O
intestinal	O
microbiota	O
are	O
responsive	O
to	O
changes	O
in	O
photoperiod	O
and	O
suggest	O
that	O
these	O
changes	O
may	O
in	O
part	O
influence	O
photoperiodic	O
changes	O
in	O
body	O
and	O
fat	O
masses	O
.	O

Epidemiologic	O
studies	O
of	O
periodontal	O
infection	O
as	O
a	O
risk	O
factor	O
for	O
cardiovascular	O
disease	O
often	O
use	O
clinical	O
periodontal	O
measures	O
as	O
a	O
surrogate	O
for	O
the	O
underlying	O
bacterial	O
exposure	O
of	O
interest	O
.	O

There	O
are	O
currently	O
no	O
methodological	O
studies	O
evaluating	O
which	O
clinical	O
periodontal	O
measures	O
best	O
reflect	O
the	O
levels	O
of	O
subgingival	O
bacterial	O
colonization	O
in	O
population	O
-	O
based	O
settings	O
.	O

We	O
investigated	O
the	O
characteristics	O
of	O
clinical	O
periodontal	O
definitions	O
that	O
were	O
most	O
representative	O
of	O
exposure	O
to	O
bacterial	O
species	O
that	O
are	O
believed	O
to	O
be	O
either	O
markers	O
,	O
or	O
themselves	O
etiologic	O
,	O
of	O
periodontal	O
disease	O
.	O

706	O
men	O
and	O
women	O
aged	O
>	O
or	O
=	O
55	O
years	O
,	O
residing	O
in	O
northern	O
Manhattan	O
were	O
enrolled	O
.	O

Using	O
DNA	O
-	O
DNA	O
checkerboard	O
hybridization	O
in	O
subgingival	O
biofilms	O
,	O
standardized	O
values	O
for	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
were	O
averaged	O
within	O
mouth	O
and	O
summed	O
to	O
define	O
`	O
`	O
bacterial	O
burden	O
'	O
'	O
.	O

Correlations	O
of	O
bacterial	O
burden	O
with	O
clinical	O
periodontal	O
constructs	O
defined	O
by	O
the	O
severity	O
and	O
extent	O
of	O
attachment	O
loss	O
(	O
AL	O
)	O
,	O
pocket	O
depth	O
(	O
PD	O
)	O
and	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
were	O
assessed	O
.	O

Clinical	O
periodontal	O
constructs	O
demonstrating	O
the	O
highest	O
correlations	O
with	O
bacterial	O
burden	O
were	O
:	O
i	O
)	O
percent	O
of	O
sites	O
with	O
BOP	O
(	O
r	O
=	O
0	O
.	O
62	O
)	O
;	O
ii	O
)	O
percent	O
of	O
sites	O
with	O
PD	O
>	O
or	O
=	O
3	O
mm	O
(	O
r	O
=	O
0	O
.	O
61	O
)	O
;	O
and	O
iii	O
)	O
number	O
of	O
sites	O
with	O
BOP	O
(	O
r	O
=	O
0	O
.	O
59	O
)	O
.	O

Increasing	O
PD	O
or	O
AL	O
severity	O
thresholds	O
consistently	O
attenuated	O
correlations	O
,	O
i	O
.	O
e	O
.	O
,	O
the	O
correlation	O
of	O
bacterial	O
burden	O
with	O
the	O
percent	O
of	O
sites	O
with	O
PD	O
>	O
or	O
=	O
8	O
mm	O
was	O
only	O
r	O
=	O
0	O
.	O
16	O
.	O

Clinical	O
exposure	O
definitions	O
of	O
periodontal	O
disease	O
should	O
incorporate	O
relatively	O
shallow	O
pockets	O
to	O
best	O
reflect	O
whole	O
mouth	O
exposure	O
to	O
bacterial	O
burden	O
.	O

It	O
has	O
been	O
suggested	O
that	O
use	O
of	O
systemic	O
antibiotics	O
should	O
be	O
limited	O
to	O
patients	O
with	O
specific	O
microbiologic	O
profiles	O
.	O

The	O
main	O
purpose	O
of	O
the	O
present	O
analysis	O
was	O
to	O
study	O
whether	O
microbiologic	O
testing	O
before	O
therapy	O
was	O
of	O
value	O
in	O
predicting	O
which	O
patients	O
would	O
specifically	O
benefit	O
from	O
adjunctive	O
amoxicillin	O
and	O
metronidazole	O
,	O
given	O
in	O
the	O
context	O
of	O
full	O
-	O
mouth	O
scaling	O
and	O
root	O
planing	O
(	O
SRP	O
)	O
within	O
48	O
hours	O
.	O

This	O
was	O
a	O
6	O
-	O
month	O
,	O
single	O
-	O
center	O
,	O
double	O
-	O
masked	O
,	O
placebo	O
-	O
controlled	O
,	O
randomized	O
longitudinal	O
study	O
.	O

Fifty	O
-	O
one	O
patients	O
received	O
full	O
-	O
mouth	O
periodontal	O
debridement	O
,	O
performed	O
within	O
48	O
hours	O
;	O
then	O
,	O
25	O
subjects	O
received	O
metronidazole	O
,	O
500	O
mg	O
,	O
and	O
amoxicillin	O
,	O
375	O
mg	O
,	O
three	O
times	O
a	O
day	O
for	O
7	O
days	O
,	O
and	O
26	O
received	O
a	O
placebo	O
(	O
control	O
group	O
)	O
.	O

Pooled	O
microbiologic	O
samples	O
were	O
taken	O
from	O
the	O
deepest	O
pocket	O
at	O
baseline	O
in	O
each	O
quadrant	O
before	O
and	O
6	O
months	O
after	O
treatment	O
.	O

Six	O
periodontal	O
pathogens	O
were	O
quantified	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
.	O

Forty	O
-	O
seven	O
patients	O
were	O
followed	O
for	O
6	O
months	O
.	O

After	O
treatment	O
,	O
test	O
subjects	O
had	O
a	O
substantially	O
lower	O
mean	O
number	O
of	O
persisting	O
sites	O
with	O
probing	O
depth	O
>	O
4	O
mm	O
and	O
bleeding	O
on	O
probing	O
than	O
did	O
control	O
subjects	O
(	O
0	O
.	O
4	O
versus	O
3	O
.	O
0	O
;	O
P	O
=	O
0	O
.	O
005	O
;	O
month	O
6	O
)	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
could	O
not	O
be	O
detected	O
in	O
the	O
antibiotic	O
group	O
after	O
treatment	O
.	O

However	O
,	O
in	O
the	O
placebo	O
group	O
,	O
three	O
of	O
six	O
subjects	O
positive	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
continued	O
to	O
be	O
positive	O
.	O

Lower	O
frequencies	O
were	O
also	O
noted	O
in	O
the	O
test	O
group	O
for	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
P	O
=	O
0	O
.	O
013	O
)	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
(	O
P	O
=	O
0	O
.	O
007	O
)	O
.	O

However	O
,	O
even	O
subjects	O
testing	O
negative	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
at	O
baseline	O
had	O
a	O
significantly	O
better	O
primary	O
clinical	O
outcome	O
if	O
they	O
received	O
the	O
active	O
drugs	O
.	O

The	O
presence	O
of	O
six	O
putative	O
periodontal	O
pathogens	O
(	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
spp	I-bacteria
.	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
)	O
quantified	O
prior	O
to	O
therapy	O
was	O
not	O
correlated	O
with	O
the	O
outcome	O
of	O
full	O
-	O
mouth	O
SRP	O
with	O
or	O
without	O
amoxicillin	O
and	O
metronidazole	O
.	O

Excellent	O
clinical	O
results	O
in	O
the	O
antibiotics	O
group	O
were	O
obtained	O
regardless	O
of	O
the	O
presence	O
or	O
absence	O
of	O
six	O
classic	O
periodontal	O
periopathogens	O
prior	O
to	O
treatment	O
.	O

The	O
intestinal	O
ecosystem	O
is	O
formed	O
by	O
a	O
complex	O
,	O
yet	O
highly	O
characteristic	O
microbial	O
community	O
.	O

The	O
parameters	O
defining	O
whether	O
this	O
community	O
permits	O
invasion	O
of	O
a	O
new	O
bacterial	O
species	O
are	O
unclear	O
.	O

In	O
particular	O
,	O
inhibition	O
of	O
enteropathogen	O
infection	O
by	O
the	O
gut	O
microbiota	O
(	O
=	O
colonization	O
resistance	O
)	O
is	O
poorly	O
understood	O
.	O

To	O
analyze	O
the	O
mechanisms	O
of	O
microbiota	O
-	O
mediated	O
protection	O
from	O
Salmonella	B-bacteria
enterica	I-bacteria
induced	O
enterocolitis	O
,	O
we	O
used	O
a	O
mouse	O
infection	O
model	O
and	O
large	O
scale	O
high	O
-	O
throughput	O
pyrosequencing	O
.	O

In	O
contrast	O
to	O
conventional	O
mice	O
(	O
CON	O
)	O
,	O
mice	O
with	O
a	O
gut	O
microbiota	O
of	O
low	O
complexity	O
(	O
LCM	O
)	O
were	O
highly	O
susceptible	O
to	O
S	O
.	O
enterica	O
induced	O
colonization	O
and	O
enterocolitis	O
.	O

Colonization	O
resistance	O
was	O
partially	O
restored	O
in	O
LCM	O
-	O
animals	O
by	O
co	O
-	O
housing	O
with	O
conventional	O
mice	O
for	O
21	O
days	O
(	O
LCM	O
(	O
con21	O
)	O
)	O
.	O

16S	O
rRNA	O
sequence	O
analysis	O
comparing	O
LCM	O
,	O
LCM	O
(	O
con21	O
)	O
and	O
CON	O
gut	O
microbiota	O
revealed	O
that	O
gut	O
microbiota	O
complexity	O
increased	O
upon	O
conventionalization	O
and	O
correlated	O
with	O
increased	O
resistance	O
to	O
S	O
.	O
enterica	O
infection	O
.	O

Comparative	O
microbiota	O
analysis	O
of	O
mice	O
with	O
varying	O
degrees	O
of	O
colonization	O
resistance	O
allowed	O
us	O
to	O
identify	O
intestinal	O
ecosystem	O
characteristics	O
associated	O
with	O
susceptibility	O
to	O
S	B-bacteria
.	I-bacteria
enterica	I-bacteria
infection	O
.	O

Moreover	O
,	O
this	O
system	O
enabled	O
us	O
to	O
gain	O
further	O
insights	O
into	O
the	O
general	O
principles	O
of	O
gut	O
ecosystem	O
invasion	O
by	O
non	O
-	O
pathogenic	O
,	O
commensal	O
bacteria	O
.	O

Mice	O
harboring	O
high	O
commensal	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
densities	O
were	O
more	O
susceptible	O
to	O
S	B-bacteria
.	I-bacteria
enterica	I-bacteria
induced	O
gut	O
inflammation	O
.	O

Similarly	O
,	O
mice	O
with	O
high	O
titers	O
of	O
Lactobacilli	B-bacteria
were	O
more	O
efficiently	O
colonized	O
by	O
a	O
commensal	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
(	O
RR	B-bacteria
)	O
strain	O
after	O
oral	O
inoculation	O
.	O

Upon	O
examination	O
of	O
16S	O
rRNA	O
sequence	O
data	O
from	O
9	O
CON	O
mice	O
we	O
found	O
that	O
closely	O
related	O
phylotypes	O
generally	O
display	O
significantly	O
correlated	O
abundances	O
(	O
co	O
-	O
occurrence	O
)	O
,	O
more	O
so	O
than	O
distantly	O
related	O
phylotypes	O
.	O

Thus	O
,	O
in	O
essence	O
,	O
the	O
presence	O
of	O
closely	O
related	O
species	O
can	O
increase	O
the	O
chance	O
of	O
invasion	O
of	O
newly	O
incoming	O
species	O
into	O
the	O
gut	O
ecosystem	O
.	O

We	O
provide	O
evidence	O
that	O
this	O
principle	O
might	O
be	O
of	O
general	O
validity	O
for	O
invasion	O
of	O
bacteria	O
in	O
preformed	O
gut	O
ecosystems	O
.	O

This	O
might	O
be	O
of	O
relevance	O
for	O
human	O
enteropathogen	O
infections	O
as	O
well	O
as	O
therapeutic	O
use	O
of	O
probiotic	O
commensal	O
bacteria	O
.	O

To	O
explore	O
a	O
selected	O
-	O
media	O
of	O
Bifidobacterium	B-bacteria
from	O
oral	O
cavity	O
,	O
to	O
detect	O
the	O
distribution	O
of	O
Bifidobacterium	B-bacteria
in	O
different	O
sites	O
of	O
children	O
and	O
primarily	O
investigate	O
the	O
relationship	O
between	O
oral	O
Bifidobacterium	B-bacteria
and	O
early	O
childhood	O
caries	O
.	O

70	O
children	O
aged	O
from	O
3	O
to	O
5	O
-	O
year	O
-	O
old	O
were	O
selected	O
,	O
30	O
children	O
were	O
caries	O
-	O
free	O
and	O
40	O
were	O
severe	O
early	O
childhood	O
caries	O
(	O
S	O
-	O
ECC	O
)	O
.	O

Saliva	O
was	O
collected	O
and	O
plaque	O
samples	O
from	O
the	O
30	O
healthy	O
subjects	O
were	O
pooled	O
.	O

For	O
S	O
-	O
ECC	O
group	O
,	O
plaques	O
were	O
collected	O
separately	O
from	O
four	O
different	O
sites	O
as	O
follows	O
:	O
Saliva	O
,	O
surfaces	O
of	O
intact	O
enamel	O
,	O
surfaces	O
of	O
white	O
spot	O
-	O
lesions	O
,	O
and	O
deep	O
dentin	O
-	O
lesions	O
.	O

Samples	O
would	O
be	O
grown	O
in	O
the	O
selected	O
-	O
media	O
,	O
and	O
the	O
whole	O
DNA	O
of	O
bacteria	O
was	O
extracted	O
.	O

Polymerase	O
chain	O
reaction	O
was	O
performed	O
with	O
specific	O
primers	O
and	O
the	O
results	O
were	O
analyzed	O
by	O
the	O
electrophoresis	O
.	O

Bifidobacterium	B-bacteria
were	O
detected	O
0	O
in	O
the	O
caries	O
-	O
free	O
children	O
,	O
while	O
47	O
.	O
5	O
%	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

There	O
was	O
significant	O
difference	O
between	O
two	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
there	O
was	O
no	O
difference	O
between	O
different	O
sites	O
of	O
teeth	O
in	O
S	O
-	O
ECC	O
group	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

27	O
.	O
5	O
%	O
Bifidobacterium	B-bacteria
were	O
detected	O
in	O
saliva	O
,	O
27	O
.	O
5	O
%	O
on	O
surfaces	O
of	O
intact	O
enamel	O
,	O
20	O
.	O
0	O
%	O
on	O
surfaces	O
of	O
white	O
spot	O
-	O
lesions	O
and	O
22	O
.	O
5	O
%	O
in	O
deep	O
dentin	O
-	O
lesions	O
.	O

10	O
%	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
were	O
detected	O
in	O
saliva	O
,	O
7	O
.	O
5	O
%	O
on	O
surfaces	O
of	O
intact	O
enamel	O
,	O
7	O
.	O
5	O
%	O
on	O
surfaces	O
of	O
white	O
spot	O
-	O
lesions	O
and	O
10	O
.	O
0	O
%	O
in	O
deep	O
dentin	O
-	O
lesions	O
.	O

One	O
type	O
of	O
modified	O
selected	O
media	O
of	O
Bifidobacterium	B-bacteria
in	O
oral	O
cavity	O
was	O
explored	O
.	O

Bifidobacterium	B-bacteria
may	O
be	O
related	O
to	O
the	O
occurrence	O
of	O
the	O
S	O
-	O
ECC	O
and	O
has	O
nothing	O
to	O
do	O
with	O
different	O
sites	O
of	O
teeth	O
in	O
children	O
.	O

Members	O
of	O
the	O
phylum	O
Synergistetes	B-bacteria
have	O
been	O
demonstrated	O
in	O
several	O
environmental	O
ecosystems	O
and	O
mammalian	O
microflorae	O
by	O
culture	O
-	O
independent	O
methods	O
.	O

In	O
the	O
past	O
few	O
years	O
,	O
the	O
clinical	O
relevance	O
of	O
some	O
uncultivated	O
phylotypes	O
has	O
been	O
demonstrated	O
in	O
endodontic	O
infections	O
,	O
and	O
uncultured	O
Synergistetes	B-bacteria
have	O
been	O
demonstrated	O
in	O
human	O
mouth	O
,	O
gut	O
and	O
skin	O
microbiota	O
.	O

However	O
,	O
Synergistetes	B-bacteria
are	O
rarely	O
cultured	O
from	O
human	O
samples	O
,	O
and	O
only	O
17	O
isolates	O
are	O
currently	O
reported	O
.	O

Twelve	O
members	O
of	O
Synergistetes	B-bacteria
isolated	O
in	O
the	O
course	O
of	O
various	O
infectious	O
processes	O
,	O
including	O
3	O
Jonquetella	B-bacteria
anthropi	I-bacteria
,	O
2	O
Cloacibacillus	B-bacteria
evryensis	I-bacteria
,	O
2	O
Pyramidobacter	B-bacteria
piscolens	I-bacteria
and	O
5	O
unidentified	O
strains	O
,	O
as	O
well	O
as	O
56	O
clones	O
obtained	O
by	O
specific	O
PCR	O
from	O
the	O
normal	O
vaginal	O
microflora	O
,	O
were	O
studied	O
.	O

16S	O
rRNA	O
gene	O
-	O
based	O
phylogeny	O
showed	O
that	O
the	O
clones	O
were	O
grouped	O
into	O
3	O
clusters	O
,	O
corresponding	O
to	O
the	O
genus	O
Jonquetella	B-bacteria
,	O
P	B-bacteria
.	I-bacteria
piscolens	I-bacteria
and	O
one	O
novel	O
Synergistetes	B-bacteria
taxon	O
.	O

The	O
presence	O
and	O
diversity	O
of	O
Synergistetes	B-bacteria
were	O
reported	O
for	O
the	O
first	O
time	O
in	O
the	O
vaginal	O
microflora	O
.	O

Synergistetes	B-bacteria
were	O
found	O
in	O
healthy	O
patients	O
,	O
suggesting	O
that	O
they	O
could	O
play	O
a	O
functional	O
role	O
in	O
human	O
microflorae	O
,	O
but	O
may	O
also	O
act	O
as	O
opportunistic	O
pathogens	O
.	O

Studying	O
the	O
phylogenetic	O
relationships	O
between	O
environmental	O
and	O
mammalian	O
strains	O
and	O
clones	O
revealed	O
clearly	O
delineated	O
independent	O
lineages	O
according	O
to	O
the	O
origin	O
of	O
the	O
sequences	O
.	O

Campylobacter	B-bacteria
species	I-bacteria
(	O
C	B-bacteria
.	I-bacteria
jejuni	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
fetus	I-bacteria
)	O
are	O
enteric	O
abortifacient	O
bacteria	O
in	O
humans	O
and	O
ungulates	O
.	O

Campylobacter	B-bacteria
rectus	I-bacteria
is	O
a	O
periodontal	O
pathogen	O
associated	O
with	O
human	O
fetal	O
exposure	O
and	O
adverse	O
pregnancy	O
outcomes	O
including	O
preterm	O
delivery	O
.	O

Experiments	O
in	O
pregnant	O
mice	O
have	O
demonstrated	O
that	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
can	O
translocate	O
from	O
a	O
distant	O
site	O
of	O
infection	O
to	O
the	O
placenta	O
to	O
induce	O
fetal	O
growth	O
restriction	O
and	O
impair	O
placental	O
development	O
.	O

However	O
,	O
placental	O
tissues	O
from	O
human	O
,	O
small	O
-	O
for	O
-	O
gestational	O
age	O
deliveries	O
have	O
not	O
been	O
reported	O
to	O
harbor	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
despite	O
evidence	O
of	O
maternal	O
infection	O
and	O
fetal	O
exposure	O
by	O
fetal	O
IgM	O
response	O
.	O

This	O
investigation	O
examined	O
the	O
temporal	O
relationship	O
between	O
the	O
placental	O
translocation	O
of	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
and	O
the	O
effects	O
on	O
fetal	O
growth	O
in	O
mice	O
.	O

BALB	O
/	O
c	O
mice	O
were	O
infected	O
at	O
gestational	O
day	O
E7	O
.	O
5	O
to	O
examine	O
placental	O
translocation	O
of	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
by	O
immunohistology	O
.	O

C	B-bacteria
.	I-bacteria
rectus	I-bacteria
significantly	O
decreased	O
fetoplacental	O
weight	O
at	O
E14	O
.	O
5	O
and	O
at	O
E16	O
.	O
5	O
.	O

C	B-bacteria
.	I-bacteria
rectus	I-bacteria
was	O
detected	O
in	O
63	O
%	O
of	O
placentas	O
at	O
E14	O
.	O
5	O
,	O
but	O
not	O
at	O
E16	O
.	O
5	O
.	O

In	O
in	O
vitro	O
trophoblast	O
invasion	O
assays	O
,	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
was	O
able	O
to	O
effectively	O
invade	O
human	O
trophoblasts	O
(	O
BeWo	O
)	O
but	O
not	O
murine	O
trophoblasts	O
(	O
SM9	O
-	O
1	O
)	O
,	O
and	O
showed	O
a	O
trend	O
for	O
more	O
invasiveness	O
than	O
C	B-bacteria
.	I-bacteria
jejuni	I-bacteria
.	O

C	B-bacteria
.	I-bacteria
rectus	I-bacteria
challenge	O
significantly	O
upregulated	O
both	O
mRNA	O
and	O
protein	O
levels	O
of	O
IL	O
-	O
6	O
and	O
TNFalpha	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
in	O
human	O
trophoblasts	O
,	O
but	O
did	O
not	O
increase	O
cytokine	O
expression	O
in	O
murine	O
cells	O
,	O
suggesting	O
a	O
correlation	O
between	O
invasion	O
and	O
cytokine	O
activation	O
.	O

In	O
conclusion	O
,	O
the	O
trophoblast	O
-	O
invasive	O
trait	O
of	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
that	O
appears	O
limited	O
to	O
human	O
trophoblasts	O
may	O
play	O
a	O
role	O
in	O
facilitating	O
bacterial	O
translocation	O
and	O
placental	O
inflammation	O
during	O
early	O
gestation	O
.	O

Intrauterine	O
infection	O
is	O
a	O
recognized	O
cause	O
of	O
adverse	O
pregnancy	O
outcome	O
,	O
but	O
the	O
source	O
of	O
infection	O
is	O
often	O
undetermined	O
.	O

We	O
report	O
a	O
case	O
of	O
stillbirth	O
caused	O
by	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
that	O
originated	O
in	O
the	O
mother	O
'	O
s	O
mouth	O
.	O

A	O
woman	O
with	O
pregnancy	O
-	O
associated	O
gingivitis	O
experienced	O
an	O
upper	O
respiratory	O
tract	O
infection	O
at	O
term	O
,	O
followed	O
by	O
stillbirth	O
a	O
few	O
days	O
later	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
isolated	O
from	O
the	O
placenta	O
and	O
the	O
fetus	O
.	O

Examination	O
of	O
different	O
microbial	O
floras	O
from	O
the	O
mother	O
identified	O
the	O
same	O
clone	O
in	O
her	O
subgingival	O
plaque	O
but	O
not	O
in	O
the	O
supragingival	O
plaque	O
,	O
vagina	O
,	O
or	O
rectum	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
may	O
have	O
translocated	O
from	O
the	O
mother	O
'	O
s	O
mouth	O
to	O
the	O
uterus	O
when	O
the	O
immune	O
system	O
was	O
weakened	O
during	O
the	O
respiratory	O
infection	O
.	O

This	O
case	O
sheds	O
light	O
on	O
patient	O
management	O
for	O
those	O
with	O
pregnancy	O
-	O
associated	O
gingivitis	O
.	O

Carious	O
tissue	O
fluoresces	O
with	O
a	O
wavelength	O
different	O
from	O
sound	O
tissue	O
when	O
stimulated	O
by	O
light	O
with	O
a	O
wavelength	O
of	O
655	O
nm	O
.	O

This	O
difference	O
is	O
thought	O
to	O
have	O
a	O
bacterial	O
origin	O
rather	O
than	O
indicating	O
demineralization	O
.	O

This	O
study	O
aimed	O
to	O
measure	O
fluorescence	O
emitted	O
by	O
normal	O
cultivable	O
caries	O
-	O
associated	O
bacterial	O
flora	O
and	O
typical	O
porphyrin	O
-	O
producing	O
bacteria	O
with	O
DIAGNOdent	O
,	O
and	O
to	O
verify	O
earlier	O
findings	O
that	O
demineralization	O
of	O
the	O
dental	O
hard	O
tissue	O
does	O
not	O
affect	O
DIAGNOdent	O
readings	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
five	O
occlusal	O
caries	O
lesions	O
in	O
three	O
subjects	O
.	O

From	O
these	O
,	O
mixed	O
anaerobic	O
flora	O
,	O
Lactobacilli	B-bacteria
and	O
mutans	B-bacteria
Streptococci	I-bacteria
were	O
cultured	O
in	O
up	O
to	O
three	O
different	O
kinds	O
of	O
culture	O
medium	O
.	O

Colonies	O
of	O
Lactobacilli	B-bacteria
and	O
mutans	B-bacteria
Streptococci	I-bacteria
were	O
also	O
measured	O
after	O
transferring	O
them	O
to	O
glass	O
slides	O
.	O

Laboratory	O
teaching	O
strains	O
of	O
Prevotella	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
were	O
cultured	O
anaerobically	O
and	O
fluorescence	O
measured	O
directly	O
after	O
an	O
appropriate	O
incubation	O
period	O
.	O

Sound	O
enamel	O
surfaces	O
of	O
15	O
extracted	O
premolars	O
were	O
demineralized	O
and	O
changes	O
in	O
fluorescence	O
measured	O
.	O

DIAGNOdent	O
readings	O
>	O
20	O
were	O
only	O
obtained	O
from	O
young	O
colonies	O
of	O
Prevotella	B-bacteria
and	O
from	O
colonies	O
of	O
mutans	B-bacteria
Streptococci	I-bacteria
cultured	O
on	O
mitis	O
-	O
salivarius	O
-	O
bacitracin	O
agar	O
.	O

Higher	O
measurements	O
were	O
obtained	O
as	O
the	O
bacterial	O
colonies	O
aged	O
.	O

Lower	O
measurements	O
were	O
obtained	O
after	O
transferring	O
colonies	O
to	O
glass	O
slides	O
.	O

Demineralization	O
of	O
enamel	O
did	O
not	O
affect	O
the	O
DIAGNOdent	O
measurements	O
.	O

The	O
change	O
in	O
fluorescence	O
measured	O
with	O
DIAGNOdent	O
has	O
a	O
bacterial	O
origin	O
rather	O
than	O
occurring	O
as	O
a	O
result	O
of	O
demineralization	O
.	O

The	O
measurements	O
are	O
presumably	O
dependent	O
on	O
bacterial	O
metabolites	O
rather	O
than	O
bacteria	O
themselves	O
,	O
and	O
probably	O
record	O
synergistic	O
effects	O
during	O
the	O
carious	O
process	O
rather	O
than	O
the	O
quantity	O
or	O
species	O
of	O
bacteria	O
involved	O
.	O

Eleven	O
clinical	O
strains	O
isolated	O
from	O
infected	O
wound	O
specimens	O
were	O
subjected	O
to	O
polyphasic	O
taxonomic	O
analysis	O
.	O

Sequence	O
analysis	O
of	O
the	O
16S	O
rRNA	O
gene	O
showed	O
that	O
all	O
11	O
strains	O
were	O
phylogenetically	O
related	O
to	O
Slackia	B-bacteria
exigua	I-bacteria
.	O

Additionally	O
,	O
conventional	O
and	O
biochemical	O
tests	O
of	O
6	O
of	O
the	O
11	O
strains	O
were	O
performed	O
as	O
supplementary	O
methods	O
to	O
obtain	O
phenotypic	O
identification	O
by	O
comparison	O
with	O
the	O
phenotypes	O
of	O
the	O
relevant	O
type	O
strains	O
.	O

S	B-bacteria
.	I-bacteria
exigua	I-bacteria
has	O
been	O
considered	O
an	O
oral	O
bacterial	O
species	O
in	O
the	O
family	O
Coriobacteriaceae	B-bacteria
.	O

This	O
organism	O
is	O
fastidious	O
and	O
grows	O
poorly	O
,	O
so	O
it	O
may	O
easily	O
be	O
overlooked	O
.	O

The	O
16S	O
rRNA	O
gene	O
sequences	O
and	O
the	O
biochemical	O
characteristics	O
of	O
four	O
of	O
the	O
S	B-bacteria
.	I-bacteria
exigua	I-bacteria
strains	O
isolated	O
for	O
this	O
study	O
from	O
various	O
infections	O
indicative	O
of	O
an	O
intestinal	O
source	O
were	O
almost	O
identical	O
to	O
those	O
of	O
the	O
validated	O
S	B-bacteria
.	I-bacteria
exigua	I-bacteria
type	O
strain	O
from	O
an	O
oral	O
source	O
and	O
two	O
of	O
the	O
S	B-bacteria
.	I-bacteria
exigua	I-bacteria
strains	O
from	O
oral	O
sources	O
evaluated	O
in	O
this	O
study	O
.	O

Thus	O
,	O
we	O
show	O
for	O
the	O
first	O
time	O
that	O
S	B-bacteria
.	I-bacteria
exigua	I-bacteria
species	O
can	O
be	O
isolated	O
from	O
extraoral	O
infections	O
as	O
well	O
as	O
from	O
oral	O
infections	O
.	O

The	O
profiles	O
of	O
susceptibility	O
to	O
selected	O
antimicrobials	O
of	O
this	O
species	O
were	O
also	O
investigated	O
for	O
the	O
first	O
time	O
.	O

Studies	O
with	O
cetylpyridinium	O
chloride	O
(	O
CPC	O
)	O
mouth	O
rinses	O
that	O
range	O
from	O
1	O
use	O
to	O
6	O
months	O
of	O
use	O
have	O
documented	O
the	O
clinical	O
efficacy	O
of	O
these	O
formulations	O
on	O
supragingival	O
plaque	O
and	O
gingivitis	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
a	O
commercially	O
available	O
mouth	O
rinse	O
containing	O
0	O
.	O
05	O
%	O
CPC	O
versus	O
a	O
fluoride	O
mouth	O
rinse	O
on	O
the	O
anaerobic	O
bacteria	O
found	O
in	O
dental	O
plaque	O
.	O

Antimicrobial	O
effects	O
on	O
the	O
organisms	O
of	O
the	O
supragingival	O
plaque	O
,	O
a	O
natural	O
biofilm	O
,	O
were	O
determined	O
after	O
1	O
use	O
and	O
after	O
14	O
days	O
of	O
use	O
of	O
each	O
mouth	O
rinse	O
.	O

After	O
enrollment	O
,	O
adult	O
subjects	O
from	O
China	O
completed	O
a	O
1	O
-	O
week	O
washout	O
period	O
and	O
provided	O
baseline	O
samples	O
of	O
supragingival	O
plaque	O
for	O
analysis	O
of	O
anaerobic	O
bacteria	O
.	O

Subjects	O
were	O
randomly	O
assigned	O
to	O
receive	O
a	O
commercially	O
available	O
mouth	O
rinse	O
formulated	O
with	O
0	O
.	O
05	O
%	O
CPC	O
or	O
a	O
fluoride	O
mouth	O
rinse	O
.	O

Subjects	O
were	O
assigned	O
to	O
each	O
group	O
according	O
to	O
a	O
computer	O
-	O
generated	O
randomization	O
sequence	O
.	O

They	O
were	O
instructed	O
to	O
rinse	O
with	O
20	O
mL	O
of	O
either	O
the	O
CPC	O
or	O
the	O
fluoride	O
mouth	O
rinse	O
for	O
30	O
seconds	O
.	O

Microbiologic	O
analyses	O
of	O
dental	O
plaque	O
samples	O
were	O
conducted	O
12	O
hours	O
after	O
the	O
first	O
use	O
of	O
assigned	O
mouth	O
rinse	O
.	O

Subjects	O
were	O
instructed	O
to	O
continue	O
twice	O
-	O
daily	O
rinsing	O
with	O
their	O
assigned	O
mouth	O
rinse	O
for	O
the	O
next	O
14	O
days	O
in	O
addition	O
to	O
brushing	O
their	O
teeth	O
with	O
a	O
commercial	O
fluoride	O
toothpaste	O
.	O

Dental	O
plaque	O
samples	O
for	O
microbiologic	O
analyses	O
were	O
collected	O
on	O
day	O
15	O
;	O
this	O
was	O
done	O
12	O
hours	O
after	O
the	O
final	O
use	O
of	O
the	O
assigned	O
mouth	O
rinses	O
.	O

A	O
dentist	O
conducted	O
oral	O
examinations	O
before	O
each	O
sample	O
collection	O
to	O
evaluate	O
hard	O
and	O
soft	O
tissue	O
health	O
over	O
the	O
course	O
of	O
the	O
study	O
.	O

The	O
study	O
included	O
117	O
adults	O
(	O
62	O
females	O
,	O
mean	O
age	O
,	O
28	O
.	O
70	O
years	O
;	O
55	O
males	O
,	O
mean	O
age	O
,	O
30	O
.	O
41	O
years	O
)	O
.	O

Subjects	O
rinsing	O
with	O
the	O
CPC	O
mouthwash	O
(	O
n	O
=	O
58	O
;	O
mean	O
age	O
,	O
29	O
.	O
41	O
years	O
)	O
reported	O
significant	O
reductions	O
in	O
anaerobic	O
bacteria	O
versus	O
those	O
issued	O
the	O
fluoride	O
rinse	O
(	O
n	O
=	O
59	O
;	O
mean	O
age	O
,	O
29	O
.	O
61	O
years	O
)	O
12	O
hours	O
after	O
1	O
use	O
and	O
12	O
hours	O
after	O
14	O
days	O
of	O
use	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
mean	O
percent	O
reduction	O
in	O
anaerobic	O
bacteria	O
between	O
the	O
CPC	O
mouth	O
rinse	O
and	O
the	O
fluoride	O
mouth	O
rinse	O
was	O
29	O
.	O
98	O
%	O
after	O
1	O
use	O
and	O
57	O
.	O
90	O
%	O
after	O
14	O
days	O
of	O
use	O
.	O

All	O
enrolled	O
subjects	O
completed	O
the	O
study	O
without	O
any	O
adverse	O
events	O
.	O

Use	O
of	O
the	O
CPC	O
mouth	O
rinse	O
was	O
associated	O
with	O
significant	O
reductions	O
in	O
the	O
anaerobic	O
bacteria	O
of	O
supragingival	O
plaque	O
compared	O
with	O
fluoride	O
mouth	O
rinse	O
use	O
in	O
these	O
adult	O
subjects	O
.	O

Bacterial	O
metabolites	O
demineralize	O
dental	O
hard	O
tissues	O
,	O
and	O
soluble	O
factors	O
lead	O
to	O
tertiary	O
dentinogenesis	O
in	O
the	O
area	O
of	O
the	O
dentin	O
-	O
pulp	O
complex	O
.	O

However	O
,	O
it	O
is	O
unclear	O
whether	O
the	O
oral	O
bacteria	O
are	O
directly	O
involved	O
in	O
the	O
differentiation	O
of	O
dental	O
pulp	O
cells	O
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
oral	O
bacterial	O
extracts	O
on	O
cellular	O
differentiation	O
in	O
human	O
dental	O
pulp	O
-	O
derived	O
cells	O
(	O
hDPC	O
)	O
.	O

The	O
hDPC	O
were	O
obtained	O
from	O
third	O
molar	O
teeth	O
,	O
and	O
the	O
cells	O
were	O
subcultured	O
.	O

The	O
sonicated	O
extracts	O
were	O
obtained	O
from	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
gram	O
-	O
negative	O
)	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
gram	O
-	O
positive	O
)	O
.	O

The	O
effect	O
of	O
bacterial	O
extracts	O
on	O
cellular	O
growth	O
and	O
differentiation	O
in	O
hDPC	O
were	O
tested	O
.	O

Alkaline	O
phosphatase	O
activity	O
and	O
bone	O
sialoprotein	O
(	O
BSP	O
)	O
gene	O
expression	O
were	O
increased	O
in	O
hDPC	O
exposed	O
to	O
low	O
concentrations	O
of	O
both	O
sonicated	O
extracts	O
,	O
whereas	O
the	O
activity	O
was	O
decreased	O
upon	O
exposure	O
to	O
high	O
concentrations	O
of	O
sonicated	O
extracts	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

This	O
is	O
the	O
first	O
evidence	O
that	O
oral	O
bacteria	O
have	O
a	O
positive	O
effect	O
on	O
cellular	O
differentiation	O
in	O
hPDC	O
.	O

Interactions	O
between	O
periodontal	O
bacteria	O
and	O
human	O
oral	O
epithelial	O
cells	O
can	O
lead	O
to	O
the	O
activation	O
and	O
expression	O
of	O
a	O
variety	O
of	O
inflammatory	O
mediators	O
in	O
epithelial	O
cells	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
a	O
filamentous	O
human	O
pathogen	O
that	O
is	O
strongly	O
associated	O
with	O
periodontal	O
diseases	O
.	O

This	O
study	O
examined	O
the	O
effects	O
of	O
methyl	O
gallate	O
(	O
MG	O
)	O
and	O
gallic	O
acid	O
(	O
GA	O
)	O
on	O
the	O
production	O
of	O
inflammatory	O
mediators	O
,	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
and	O
IL	O
-	O
8	O
,	O
by	O
oral	O
epithelial	O
cells	O
stimulated	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

In	O
a	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
and	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
live	O
F	O
.	O
nucleatum	O
induced	O
high	O
levels	O
of	O
gene	O
expression	O
and	O
protein	O
release	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
.	O

The	O
effects	O
of	O
MG	O
and	O
GA	O
were	O
examined	O
by	O
treating	O
KB	O
oral	O
epithelial	O
cells	O
with	O
MG	O
and	O
GA	O
and	O
stimulating	O
them	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

MG	O
and	O
GA	O
inhibited	O
significantly	O
the	O
increases	O
in	O
the	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
gene	O
and	O
protein	O
levels	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

These	O
Compounds	O
also	O
inhibited	O
the	O
growth	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

No	O
visible	O
effects	O
of	O
MG	O
and	O
GA	O
on	O
the	O
adhesion	O
and	O
invasion	O
of	O
KB	O
cells	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
were	O
observed	O
.	O

In	O
conclusion	O
,	O
both	O
MG	O
and	O
GA	O
inhibit	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
production	O
from	O
F	O
.	O
nucleatum	O
-	O
activated	O
KB	O
cells	O
.	O

Previous	O
research	O
has	O
shown	O
the	O
oxidizing	O
properties	O
and	O
microbiological	O
efficacies	O
of	O
chlorine	O
dioxide	O
(	O
ClO2	O
)	O
.	O

Its	O
clinical	O
efficacies	O
on	O
oral	O
malodor	O
have	O
been	O
evaluated	O
and	O
reported	O
only	O
in	O
short	O
duration	O
trials	O
,	O
moreover	O
,	O
no	O
clinical	O
studies	O
have	O
investigated	O
its	O
microbiological	O
efficacies	O
on	O
periodontal	O
and	O
malodorous	O
bacteria	O
.	O

Thus	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
inhibitory	O
effects	O
of	O
a	O
mouthwash	O
containing	O
ClO2	O
used	O
for	O
7	O
days	O
on	O
morning	O
oral	O
malodor	O
and	O
on	O
salivary	O
periodontal	O
and	O
malodorous	O
bacteria	O
.	O

A	O
randomized	O
,	O
double	O
blind	O
,	O
crossover	O
,	O
placebo	O
-	O
controlled	O
trial	O
was	O
conducted	O
among	O
15	O
healthy	O
male	O
volunteers	O
,	O
who	O
were	O
divided	O
into	O
2	O
groups	O
.	O

Subjects	O
were	O
instructed	O
to	O
rinse	O
with	O
the	O
experimental	O
mouthwash	O
containing	O
ClO2	O
or	O
the	O
placebo	O
mouthwash	O
,	O
without	O
ClO2	O
,	O
twice	O
per	O
day	O
for	O
7	O
days	O
.	O

After	O
a	O
one	O
week	O
washout	O
period	O
,	O
each	O
group	O
then	O
used	O
the	O
opposite	O
mouthwash	O
for	O
7	O
days	O
.	O

At	O
baseline	O
and	O
after	O
7	O
days	O
,	O
oral	O
malodor	O
was	O
evaluated	O
with	O
Organoleptic	O
measurement	O
(	O
OM	O
)	O
,	O
and	O
analyzed	O
the	O
concentrations	O
of	O
hydrogen	O
sulfide	O
(	O
H2S	O
)	O
,	O
methyl	O
mercaptan	O
(	O
CH3SH	O
)	O
and	O
dimethyl	O
sulfide	O
(	O
(	O
CH3	O
)	O
2S	O
)	O
,	O
the	O
main	O
VSCs	O
of	O
human	O
oral	O
malodor	O
,	O
were	O
assessed	O
by	O
gas	O
chromatography	O
(	O
GC	O
)	O
.	O

Clinical	O
outcome	O
variables	O
included	O
plaque	O
and	O
gingival	O
indices	O
,	O
and	O
tongue	O
coating	O
index	O
.	O

The	O
samples	O
of	O
saliva	O
were	O
microbiologically	O
investigated	O
.	O

Quantitative	O
and	O
qualitative	O
analyses	O
were	O
performed	O
using	O
the	O
polymerase	O
chain	O
reaction	O
-	O
Invader	O
method	O
.	O

RESULTS	O
AND	O
The	O
baseline	O
oral	O
condition	O
in	O
healthy	O
subjects	O
in	O
the	O
2	O
groups	O
did	O
not	O
differ	O
significantly	O
.	O

After	O
rinsing	O
with	O
the	O
mouthwash	O
containing	O
ClO2	O
for	O
7	O
days	O
,	O
morning	O
bad	O
breath	O
decreased	O
as	O
measured	O
by	O
the	O
OM	O
and	O
reduced	O
the	O
concentrations	O
of	O
H2S	O
,	O
CH3SH	O
and	O
(	O
CH3	O
)	O
2S	O
measured	O
by	O
GC	O
,	O
were	O
found	O
.	O

Moreover	O
ClO2	O
mouthwash	O
used	O
over	O
a	O
7	O
-	O
day	O
period	O
appeared	O
effective	O
in	O
reducing	O
plaque	O
,	O
tongue	O
coating	O
accumulation	O
and	O
the	O
counts	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
in	O
saliva	O
.	O

Future	O
research	O
is	O
needed	O
to	O
examine	O
long	O
-	O
term	O
effects	O
,	O
as	O
well	O
as	O
effects	O
on	O
periodontal	O
diseases	O
and	O
plaque	O
accumulation	O
in	O
a	O
well	O
-	O
defined	O
sample	O
of	O
halitosis	O
patients	O
and	O
broader	O
population	O
samples	O
.	O

ClinicalTrials	O
.	O
gov	O
NCT00748943	O
.	O

Fixed	O
orthodontic	O
appliances	O
can	O
alter	O
the	O
subgingival	O
microbiota	O
.	O

Our	O
aim	O
was	O
to	O
compare	O
the	O
subgingival	O
microbiota	O
and	O
clinical	O
parameters	O
in	O
adolescent	O
subjects	O
at	O
sites	O
of	O
teeth	O
treated	O
with	O
orthodontic	O
bands	O
with	O
margins	O
at	O
(	O
OBM	O
)	O
or	O
below	O
the	O
gingival	O
margin	O
(	O
OBSM	O
)	O
,	O
or	O
with	O
brackets	O
(	O
OBR	O
)	O
.	O

Microbial	O
samples	O
were	O
collected	O
from	O
33	O
subjects	O
(	O
ages	O
,	O
12	O
-	O
18	O
years	O
)	O
in	O
treatment	O
more	O
than	O
6	O
months	O
.	O

The	O
microbiota	O
was	O
assessed	O
by	O
the	O
DNA	O
-	O
DNA	O
checkerboard	O
hybridization	O
method	O
.	O

Bacterial	O
samples	O
were	O
taken	O
from	O
83	O
OBR	O
,	O
103	O
OBSM	O
,	O
and	O
54	O
OBM	O
sites	O
.	O

Probing	O
pocket	O
depths	O
differed	O
by	O
orthodontic	O
type	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
with	O
mean	O
values	O
of	O
2	O
.	O
9	O
mm	O
(	O
SD	O
,	O
0	O
.	O
6	O
)	O
at	O
OBSM	O
sites	O
,	O
2	O
.	O
5	O
mm	O
(	O
SD	O
,	O
0	O
.	O
6	O
)	O
at	O
OBM	O
sites	O
,	O
and	O
2	O
.	O
3	O
mm	O
(	O
SD	O
,	O
0	O
.	O
5	O
)	O
at	O
OBR	O
sites	O
.	O

Only	O
Actinomyces	B-bacteria
israelii	I-bacteria
(	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
(	O
P	O
<	O
0	O
.	O
001	O
)	O
had	O
higher	O
levels	O
at	O
OBR	O
sites	O
,	O
whereas	O
Neisseria	B-bacteria
mucosa	I-bacteria
had	O
higher	O
levels	O
at	O
sites	O
treated	O
with	O
OBSM	O
or	O
OBM	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
was	O
found	O
in	O
25	O
%	O
of	O
sites	O
independent	O
of	O
the	O
appliance	O
.	O

Different	O
types	O
of	O
orthodontic	O
appliances	O
cause	O
minor	O
differences	O
in	O
the	O
subgingival	O
microbiota	O
(	O
A	B-bacteria
israelii	I-bacteria
and	O
A	B-bacteria
naeslundii	I-bacteria
)	O
and	O
higher	O
levels	O
at	O
sites	O
treated	O
with	O
orthodontic	O
brackets	O
.	O

More	O
sites	O
with	O
bleeding	O
on	O
probing	O
and	O
deeper	O
pockets	O
were	O
found	O
around	O
orthodontic	O
bands	O
.	O

Lactoferrin	O
(	O
LF	O
)	O
is	O
a	O
component	O
of	O
saliva	O
and	O
is	O
suspected	O
to	O
be	O
a	O
defense	O
factor	O
against	O
oral	O
pathogens	O
including	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Candida	O
albicans	O
.	O

Periodontitis	O
is	O
a	O
very	O
common	O
oral	O
disease	O
caused	O
by	O
periodontopathic	O
bacteria	O
.	O

Antimicrobial	O
activities	O
and	O
other	O
biological	O
effects	O
of	O
LF	O
against	O
representative	O
periodontopathic	O
bacteria	O
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
have	O
been	O
widely	O
studied	O
.	O

Association	O
of	O
polymorphisms	O
in	O
LF	O
with	O
incidence	O
of	O
aggressive	O
periodontitis	O
and	O
the	O
role	O
of	O
LF	O
in	O
the	O
gingival	O
crevicular	O
fluid	O
as	O
a	O
marker	O
of	O
periodontitis	O
severity	O
have	O
also	O
been	O
reported	O
.	O

Periodontopathic	O
bacteria	O
reside	O
as	O
a	O
biofilm	O
in	O
supragingival	O
and	O
subgingival	O
plaque	O
.	O

Our	O
recent	O
study	O
indicated	O
that	O
LF	O
exhibits	O
antibacterial	O
activity	O
against	O
planktonic	O
forms	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
at	O
higher	O
concentrations	O
,	O
and	O
furthermore	O
,	O
LF	O
effectively	O
inhibits	O
biofilm	O
formation	O
and	O
reduces	O
the	O
established	O
biofilm	O
of	O
these	O
bacteria	O
at	O
physiological	O
concentrations	O
.	O

A	O
small	O
-	O
scale	O
clinical	O
study	O
indicated	O
that	O
oral	O
administration	O
of	O
bovine	O
LF	O
reduces	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
in	O
the	O
subgingival	O
plaque	O
of	O
chronic	O
periodontitis	O
patients	O
.	O

LF	O
seems	O
to	O
be	O
a	O
biofilm	O
inhibitor	O
of	O
periodontopathic	O
bacteria	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

To	O
determine	O
the	O
influence	O
of	O
oral	O
status	O
on	O
halitosis	O
,	O
the	O
relationship	O
between	O
halitosis	O
and	O
periodontopathic	O
bacteria	O
present	O
in	O
plaque	O
on	O
the	O
tongue	O
and	O
the	O
subgingival	O
sulcus	O
was	O
examined	O
in	O
62	O
periodontally	O
healthy	O
adults	O
.	O

Halitosis	O
indicators	O
used	O
were	O
the	O
organoleptic	O
score	O
;	O
gas	O
chromatography	O
results	O
[	O
total	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
=	O
H	O
(	O
2	O
)	O
S	O
+	O
CH	O
(	O
3	O
)	O
SH	O
+	O
(	O
CH	O
(	O
3	O
)	O
)	O
(	O
2	O
)	O
S	O
]	O
;	O
Halimeter	O
values	O
;	O
and	O
the	O
results	O
of	O
three	O
clinical	O
tests	O
,	O
plaque	O
control	O
record	O
(	O
PlCR	O
)	O
,	O
plaque	O
index	O
(	O
PlI	O
)	O
,	O
and	O
tongue	O
coat	O
status	O
.	O

Significant	O
correlations	O
with	O
organoleptic	O
scores	O
was	O
observed	O
for	O
PlCR	O
,	O
PlI	O
,	O
tongue	O
coat	O
status	O
,	O
VSC	O
amounts	O
,	O
and	O
Halimeter	O
values	O
,	O
indicating	O
that	O
halitosis	O
in	O
periodontally	O
healthy	O
subjects	O
tended	O
to	O
originate	O
from	O
tongue	O
plaque	O
deposits	O
.	O

Polymerase	O
chain	O
reaction	O
analysis	O
was	O
used	O
to	O
detect	O
six	O
periodontopathic	O
bacteria	O
(	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
from	O
the	O
tongue	O
and	O
subgingival	O
plaque	O
.	O

Significant	O
effects	O
on	O
the	O
organoleptic	O
scores	O
,	O
tongue	O
coat	O
status	O
,	O
total	O
VSC	O
,	O
H	O
(	O
2	O
)	O
S	O
and	O
CH	O
(	O
3	O
)	O
SH	O
amounts	O
,	O
and	O
Halimeter	O
values	O
were	O
observed	O
only	O
for	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
only	O
in	O
the	O
tongue	O
plaque	O
,	O
not	O
in	O
the	O
subgingival	O
plaque	O
.	O

Thus	O
,	O
therapies	O
developed	O
to	O
inhibit	O
the	O
growth	O
of	O
these	O
bacteria	O
may	O
lead	O
to	O
future	O
treatments	O
of	O
halitosis	O
.	O

Distinguishing	O
expirated	O
bloodstains	O
(	O
blood	O
forced	O
by	O
airflow	O
out	O
of	O
the	O
nose	O
,	O
mouth	O
or	O
a	O
chest	O
wound	O
)	O
from	O
impact	O
spatter	O
(	O
blood	O
from	O
gunshots	O
,	O
explosives	O
,	O
blunt	O
force	O
trauma	O
and	O
/	O
or	O
machinery	O
accidents	O
)	O
is	O
an	O
important	O
challenge	O
in	O
forensic	O
science	O
.	O

Streptococcal	B-bacteria
bacteria	I-bacteria
are	O
only	O
found	O
in	O
the	O
human	O
mouth	O
and	O
saliva	O
.	O

This	O
study	O
developed	O
a	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
method	O
that	O
detects	O
DNA	O
from	O
these	O
bacteria	O
as	O
a	O
sensitive	O
tool	O
to	O
detect	O
the	O
presence	O
of	O
saliva	O
.	O

The	O
PCR	O
method	O
was	O
very	O
specific	O
to	O
human	O
oral	O
streptococci	B-bacteria
,	O
with	O
no	O
PCR	O
product	O
being	O
made	O
from	O
human	O
DNA	O
or	O
DNA	O
from	O
other	O
microbes	O
that	O
were	O
tested	O
.	O

It	O
was	O
also	O
very	O
sensitive	O
,	O
detecting	O
as	O
little	O
as	O
60	O
fg	O
of	O
target	O
DNA	O
.	O

The	O
PCR	O
amplification	O
gave	O
product	O
with	O
99	O
out	O
of	O
100	O
saliva	O
samples	O
tested	O
.	O

PCR	O
was	O
not	O
inhibited	O
by	O
the	O
presence	O
of	O
blood	O
and	O
could	O
detect	O
target	O
DNA	O
in	O
expirated	O
bloodstains	O
in	O
a	O
range	O
of	O
materials	O
and	O
for	O
up	O
to	O
92	O
days	O
after	O
deposit	O
on	O
cardboard	O
or	O
cotton	O
fabric	O
.	O

In	O
a	O
blind	O
trial	O
,	O
the	O
PCR	O
method	O
was	O
able	O
to	O
distinguish	O
three	O
mock	O
forensic	O
samples	O
that	O
contained	O
expirated	O
blood	O
from	O
four	O
that	O
did	O
not	O
.	O

Our	O
data	O
show	O
that	O
bacteria	O
present	O
in	O
the	O
oral	O
cavity	O
can	O
be	O
detected	O
in	O
bloodstains	O
that	O
contain	O
saliva	O
and	O
therefore	O
can	O
potentially	O
be	O
used	O
as	O
a	O
marker	O
in	O
forensic	O
work	O
to	O
distinguish	O
mouth	O
-	O
expirated	O
bloodstains	O
from	O
other	O
types	O
of	O
bloodstains	O
.	O

In	O
this	O
study	O
,	O
specific	O
sequences	O
within	O
three	O
genes	O
(	O
3D	O
,	O
VP4	O
and	O
2B	O
)	O
of	O
the	O
foot	O
-	O
and	O
-	O
mouth	O
disease	O
virus	O
(	O
FMDV	O
)	O
genome	O
were	O
determined	O
to	O
be	O
effective	O
RNAi	O
targets	O
.	O

These	O
sequences	O
are	O
highly	O
conserved	O
among	O
different	O
serotype	O
viruses	O
based	O
on	O
sequence	O
analysis	O
.	O

Small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
-	O
expressing	O
plasmids	O
(	O
p3D	O
-	O
NT19	O
,	O
p3D	O
-	O
NT56	O
,	O
pVP4	O
-	O
NT19	O
,	O
pVP4	O
-	O
NT65	O
and	O
p2B	O
-	O
NT25	O
)	O
were	O
constructed	O
to	O
express	O
siRNA	O
targeting	O
3D	O
,	O
VP4	O
and	O
2B	O
,	O
respectively	O
.	O

The	O
antiviral	O
potential	O
of	O
these	O
siRNA	O
for	O
various	O
FMDV	O
isolates	O
was	O
investigated	O
in	O
baby	O
hamster	O
kidney	O
(	O
BHK	O
-	O
21	O
)	O
cells	O
and	O
suckling	O
mice	O
.	O

The	O
results	O
show	O
that	O
these	O
siRNA	O
inhibited	O
virus	O
yield	O
10	O
-	O
to	O
300	O
-	O
fold	O
for	O
different	O
FMDV	O
isolates	O
of	O
serotype	O
O	O
and	O
serotype	O
Asia	O
I	O
at	O
48	O
h	O
post	O
infection	O
in	O
BHK	O
-	O
21	O
cells	O
compared	O
to	O
control	O
cells	O
.	O

In	O
suckling	O
mice	O
,	O
p3D	O
-	O
NT56	O
and	O
p2B	O
-	O
NT25	O
delayed	O
the	O
death	O
of	O
mice	O
.	O

Twenty	O
percent	O
to	O
40	O
%	O
of	O
the	O
animals	O
that	O
received	O
a	O
single	O
siRNA	O
dose	O
survived	O
5	O
days	O
post	O
infection	O
with	O
serotype	O
O	O
or	O
serotype	O
Asia	O
I	O
.	O

We	O
used	O
an	O
attenuated	O
Salmonella	B-bacteria
choleraesuis	I-bacteria
(	O
C500	O
)	O
vaccine	O
strain	O
,	O
to	O
carry	O
the	O
plasmid	O
that	O
expresses	O
siRNA	O
directed	O
against	O
the	O
polymerase	O
gene	O
3D	O
(	O
p3D	O
-	O
NT56	O
)	O
of	O
FMDV	O
.	O

We	O
used	O
guinea	O
pigs	O
to	O
evaluate	O
the	O
inhibitory	O
effects	O
of	O
recombinant	O
S	O
.	O
cho	O
(	O
p3D	O
-	O
NT56	O
/	O
S	O
.	O
cho	O
)	O
on	O
FMDV	O
infection	O
.	O

The	O
results	O
show	O
that	O
80	O
%	O
of	O
guinea	O
pigs	O
inoculated	O
with	O
10	O
(	O
9	O
)	O
CFU	O
of	O
p3D	O
-	O
NT56	O
/	O
S	O
.	O

cho	O
and	O
challenged	O
36	O
h	O
later	O
with	O
50	O
ID	O
(	O
50	O
)	O
of	O
homologous	O
FMDV	O
were	O
protected	O
.	O

We	O
also	O
measured	O
the	O
antiviral	O
activity	O
of	O
p3D	O
-	O
NT56	O
/	O
S	O
.	O
cho	O
in	O
swine	O
.	O

The	O
results	O
indicate	O
that	O
100	O
%	O
of	O
the	O
animals	O
treated	O
with	O
5	O
x	O
10	O
(	O
9	O
)	O
CFU	O
of	O
p3D	O
-	O
NT56	O
/	O
S	O
.	O
cho	O
were	O
protected	O
in	O
9	O
days	O
.	O

Although	O
many	O
clinical	O
trials	O
on	O
human	O
papillomavirus	O
(	O
HPV	O
)	O
therapeutic	O
vaccines	O
have	O
been	O
performed	O
,	O
clinical	O
responses	O
have	O
not	O
been	O
consistent	O
.	O

We	O
have	O
addressed	O
mucosal	O
cytotoxic	O
cellular	O
immune	O
responses	O
to	O
HPV16	O
E7	O
after	O
oral	O
immunization	O
of	O
mice	O
with	O
recombinant	O
Lactobacillus	B-bacteria
casei	I-bacteria
expressing	O
HPV16	O
E7	O
(	O
LacE7	O
)	O
.	O

C57BL	O
/	O
6	O
mice	O
were	O
orally	O
exposed	O
to	O
0	O
.	O
1	O
-	O
100mg	O
/	O
head	O
of	O
attenuated	O
LacE7	O
or	O
vehicle	O
(	O
Lac	O
)	O
vaccines	O
at	O
weeks	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
8	O
.	O

Responses	O
to	O
subcutaneous	O
or	O
intramuscular	O
injection	O
of	O
an	O
HPV16	O
E7	O
fusion	O
protein	O
using	O
the	O
same	O
timing	O
protocol	O
were	O
used	O
for	O
comparison	O
.	O

Oral	O
immunization	O
with	O
LacE7	O
elicited	O
E7	O
-	O
specific	O
IFN	O
gamma	O
-	O
producing	O
cells	O
(	O
T	O
cells	O
with	O
E7	O
-	O
type	O
1	O
immune	O
responses	O
)	O
among	O
integrin	O
alpha	O
4	O
beta	O
7	O
(	O
+	O
)	O
mucosal	O
lymphocytes	O
collected	O
from	O
gut	O
mucosa	O
.	O

An	O
induction	O
of	O
E7	O
-	O
specific	O
granzyme	O
B	O
-	O
producing	O
cells	O
(	O
E7	O
-	O
CTL	O
)	O
exhibiting	O
killer	O
responses	O
toward	O
HPV16	O
E7	O
-	O
positive	O
cells	O
was	O
also	O
observed	O
.	O

The	O
induction	O
of	O
T	O
cells	O
with	O
specific	O
mucosal	O
E7	O
-	O
type	O
1	O
immune	O
responses	O
was	O
greater	O
after	O
oral	O
immunization	O
with	O
LacE7	O
when	O
compared	O
to	O
subcutaneous	O
or	O
intramuscular	O
antigen	O
delivery	O
.	O

Oral	O
immunization	O
with	O
Lactobacillus	B-bacteria
-	O
based	O
vaccines	O
was	O
also	O
able	O
to	O
induce	O
mucosal	O
cytotoxic	O
cellular	O
immune	O
responses	O
.	O

This	O
novel	O
approach	O
at	O
a	O
therapeutic	O
HPV	O
vaccine	O
may	O
achieve	O
more	O
effective	O
clinical	O
responses	O
through	O
its	O
induction	O
of	O
mucosal	O
E7	O
-	O
specific	O
CTL	O
.	O

Probiotics	O
or	O
health	O
-	O
beneficial	O
bacteria	O
have	O
only	O
recently	O
been	O
introduced	O
in	O
dentistry	O
and	O
oral	O
medicine	O
after	O
years	O
of	O
successful	O
use	O
in	O
mainly	O
gastro	O
-	O
intestinal	O
disorders	O
.	O

The	O
concept	O
of	O
bacteriotherapy	O
and	O
use	O
of	O
health	O
-	O
beneficial	O
micro	O
-	O
organisms	O
to	O
heal	O
diseases	O
or	O
support	O
immune	O
function	O
was	O
first	O
introduced	O
in	O
the	O
beginning	O
of	O
the	O
20th	O
century	O
.	O

Later	O
the	O
concept	O
lead	O
to	O
the	O
development	O
of	O
modem	O
dairy	O
industry	O
and	O
even	O
today	O
most	O
probiotic	O
strains	O
are	O
lactobacilli	B-bacteria
or	O
bifidobacteria	B-bacteria
used	O
in	O
milk	O
fermentation	O
.	O

The	O
mechanisms	O
of	O
probiotic	O
action	O
are	O
mainly	O
unknown	O
but	O
the	O
inter	O
-	O
microbial	O
species	O
interactions	O
are	O
supposed	O
to	O
play	O
a	O
key	O
role	O
in	O
this	O
together	O
with	O
their	O
immuno	O
-	O
stimulatory	O
effects	O
.	O

The	O
introduction	O
of	O
probiotic	O
bacteria	O
in	O
the	O
mouth	O
calls	O
for	O
ascertainment	O
of	O
their	O
particular	O
safety	O
.	O

Since	O
acid	O
production	O
from	O
sugar	O
is	O
detrimental	O
to	O
teeth	O
,	O
care	O
must	O
be	O
taken	O
not	O
to	O
select	O
strains	O
with	O
high	O
fermentation	O
capacity	O
.	O

The	O
first	O
randomized	O
controlled	O
trials	O
have	O
nevertheless	O
shown	O
that	O
probiotics	O
may	O
control	O
dental	O
caries	O
in	O
children	O
due	O
to	O
their	O
inhibitory	O
action	O
against	O
cariogenic	O
streptococci	B-bacteria
.	O

Less	O
evidence	O
exists	O
on	O
their	O
role	O
in	O
periodontal	O
disease	O
or	O
oral	O
yeast	O
infections	O
.	O

Furthermore	O
the	O
best	O
vehicles	O
for	O
oral	O
probiotic	O
applications	O
need	O
to	O
be	O
assessed	O
.	O

So	O
far	O
mainly	O
dairy	O
products	O
have	O
been	O
investigated	O
but	O
other	O
means	O
such	O
as	O
probiotics	O
in	O
chewing	O
gums	O
or	O
lozenges	O
have	O
also	O
been	O
studied	O
.	O

From	O
the	O
clinical	O
practitioner	O
'	O
s	O
point	O
of	O
view	O
direct	O
recommendations	O
for	O
the	O
use	O
of	O
probiotics	O
can	O
not	O
yet	O
be	O
given	O
.	O

However	O
,	O
scientific	O
evidence	O
so	O
far	O
indicates	O
that	O
probiotic	O
therapy	O
may	O
be	O
a	O
reality	O
also	O
in	O
dentistry	O
and	O
oral	O
medicine	O
in	O
the	O
future	O
.	O

The	O
periodontal	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
are	O
strongly	O
associated	O
with	O
periodontal	O
disease	O
and	O
are	O
highly	O
prevalent	O
in	O
humans	O
with	O
periodontitis	O
.	O

Porphyromonas	B-bacteria
and	O
Tannerella	B-bacteria
spp	I-bacteria
.	I-bacteria
have	O
also	O
been	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
cats	O
.	O

The	O
oral	O
microflora	O
in	O
animals	O
was	O
compared	O
with	O
those	O
in	O
humans	O
in	O
earlier	O
studies	O
,	O
but	O
no	O
studies	O
are	O
available	O
on	O
the	O
comparison	O
of	O
the	O
oral	O
microflora	O
from	O
pets	O
and	O
their	O
respective	O
owners	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
presence	O
of	O
these	O
bacteria	O
in	O
the	O
oral	O
microflora	O
of	O
cats	O
and	O
their	O
owners	O
,	O
since	O
animal	O
to	O
human	O
transmission	O
,	O
or	O
vice	O
versa	O
,	O
of	O
oral	O
pathogens	O
could	O
have	O
public	O
health	O
implications	O
.	O

This	O
study	O
investigated	O
the	O
prevalence	O
of	O
Porphyromonas	B-bacteria
gulae	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
in	O
the	O
oral	O
microflora	O
of	O
cats	O
and	O
their	O
owners	O
,	O
using	O
culture	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

All	O
Porphyromonas	B-bacteria
isolates	I-bacteria
from	O
cats	O
(	O
n	O
=	O
64	O
)	O
were	O
catalase	O
positive	O
,	O
whereas	O
the	O
Porphyromonas	B-bacteria
isolates	I-bacteria
from	O
owners	O
(	O
n	O
=	O
7	O
)	O
were	O
catalase	O
negative	O
,	O
suggesting	O
that	O
the	O
isolates	O
from	O
cats	O
were	O
P	B-bacteria
.	I-bacteria
gulae	I-bacteria
whereas	O
those	O
from	O
the	O
owners	O
were	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
was	O
recovered	O
from	O
both	O
cats	O
(	O
n	O
=	O
63	O
)	O
and	O
owners	O
(	O
n	O
=	O
31	O
)	O
;	O
the	O
proportion	O
of	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
relative	O
to	O
the	O
total	O
CFU	O
was	O
higher	O
in	O
cats	O
with	O
periodontitis	O
than	O
in	O
cats	O
without	O
periodontal	O
disease	O
.	O

Genotyping	O
of	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
isolates	I-bacteria
(	O
n	O
=	O
54	O
)	O
in	O
six	O
cat	O
/	O
owner	O
couples	O
showed	O
that	O
in	O
one	O
cat	O
/	O
owner	O
couple	O
the	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
isolates	I-bacteria
(	O
n	O
=	O
6	O
)	O
were	O
identical	O
.	O

These	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
isolates	I-bacteria
were	O
all	O
catalase	O
positive	O
,	O
which	O
led	O
us	O
to	O
hypothesize	O
that	O
transmission	O
from	O
cats	O
to	O
owners	O
had	O
occurred	O
and	O
that	O
cats	O
may	O
be	O
a	O
reservoir	O
of	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
.	O

Periodontitis	O
and	O
caries	O
are	O
infectious	O
diseases	O
of	O
the	O
oral	O
cavity	O
in	O
which	O
oral	O
biofilms	O
play	O
a	O
causative	O
role	O
.	O

Moreover	O
,	O
oral	O
biofilms	O
are	O
widely	O
studied	O
as	O
model	O
systems	O
for	O
bacterial	O
adhesion	O
,	O
biofilm	O
development	O
,	O
and	O
biofilm	O
resistance	O
to	O
antibiotics	O
,	O
due	O
to	O
their	O
widespread	O
presence	O
and	O
accessibility	O
.	O

Despite	O
descriptions	O
of	O
initial	O
plaque	O
formation	O
on	O
the	O
tooth	O
surface	O
,	O
studies	O
on	O
mature	O
plaque	O
and	O
plaque	O
structure	O
below	O
the	O
gum	O
are	O
limited	O
to	O
landmark	O
studies	O
from	O
the	O
1970s	O
,	O
without	O
appreciating	O
the	O
breadth	O
of	O
microbial	O
diversity	O
in	O
the	O
plaque	O
.	O

We	O
used	O
fluorescent	O
in	O
situ	O
hybridization	O
to	O
localize	O
in	O
vivo	O
the	O
most	O
abundant	O
species	O
from	O
different	O
phyla	O
and	O
species	O
associated	O
with	O
periodontitis	O
on	O
seven	O
embedded	O
teeth	O
obtained	O
from	O
four	O
different	O
subjects	O
.	O

The	O
data	O
showed	O
convincingly	O
the	O
dominance	O
of	O
Actinomyces	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Spirochaetes	B-bacteria
,	O
and	O
Synergistetes	B-bacteria
in	O
subgingival	O
plaque	O
.	O

The	O
latter	O
proved	O
to	O
be	O
new	O
with	O
a	O
possibly	O
important	O
role	O
in	O
host	O
-	O
pathogen	O
interaction	O
due	O
to	O
its	O
localization	O
in	O
close	O
proximity	O
to	O
immune	O
cells	O
.	O

The	O
present	O
study	O
identified	O
for	O
the	O
first	O
time	O
in	O
vivo	O
that	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
are	O
the	O
central	O
cells	O
of	O
bacterial	O
aggregates	O
in	O
subgingival	O
plaque	O
,	O
and	O
that	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
and	O
the	O
yeast	O
Candida	O
albicans	O
form	O
corncob	O
structures	O
in	O
supragingival	O
plaque	O
.	O

Finally	O
,	O
periodontal	O
pathogens	O
colonize	O
already	O
formed	O
biofilms	O
and	O
form	O
microcolonies	O
therein	O
.	O

These	O
in	O
vivo	O
observations	O
on	O
oral	O
biofilms	O
provide	O
a	O
clear	O
vision	O
on	O
biofilm	O
architecture	O
and	O
the	O
spatial	O
distribution	O
of	O
predominant	O
species	O
.	O

Irritable	O
bowel	O
syndrome	O
(	O
IBS	O
)	O
reflects	O
several	O
pathogenetic	O
entities	O
including	O
a	O
subgroup	O
with	O
low	O
-	O
grade	O
colonic	O
inflammation	O
.	O

We	O
propose	O
that	O
pathogenic	O
bacteria	O
act	O
as	O
triggers	O
and	O
that	O
disturbances	O
of	O
commensal	O
bacteria	O
maintain	O
low	O
-	O
grade	O
inflammation	O
,	O
that	O
in	O
turn	O
leads	O
to	O
dysfunction	O
in	O
the	O
gut	O
or	O
brain	O
.	O

Studies	O
were	O
performed	O
in	O
mice	O
under	O
specific	O
pathogen	O
-	O
free	O
conditions	O
.	O

Visceral	O
pain	O
was	O
assessed	O
by	O
the	O
visceromotor	O
response	O
and	O
motility	O
was	O
assessed	O
by	O
in	O
vivo	O
fluoroscopy	O
and	O
in	O
vitro	O
by	O
muscle	O
contractility	O
.	O

Brain	O
chemistry	O
was	O
assessed	O
by	O
in	O
situ	O
hybridization	O
and	O
behavior	O
by	O
standard	O
tests	O
.	O

The	O
microbiota	O
was	O
monitored	O
using	O
16s	O
-	O
based	O
RT	O
-	O
PCR	O
and	O
DGGE	O
.	O

Mice	O
transiently	O
infected	O
with	O
the	O
nematode	O
Trichinella	O
spiralis	O
exhibited	O
changes	O
in	O
motility	O
and	O
in	O
visceral	O
perception	O
that	O
persisted	O
for	O
up	O
to	O
6	O
weeks	O
post	O
-	O
infection	O
.	O

This	O
was	O
accompanied	O
by	O
alterations	O
in	O
the	O
microbiota	O
and	O
an	O
upregulation	O
of	O
cyclooxygenase	O
-	O
2	O
which	O
could	O
be	O
reversed	O
by	O
treatment	O
with	O
anti	O
-	O
inflammatory	O
agents	O
or	O
selected	O
probiotics	O
.	O

To	O
investigate	O
the	O
contribution	O
of	O
the	O
microbiota	O
,	O
we	O
treated	O
mice	O
with	O
oral	O
antibiotics	O
and	O
monitored	O
visceral	O
perception	O
and	O
behavior	O
.	O

Antibiotic	O
therapy	O
produced	O
substantial	O
changes	O
in	O
the	O
microbiota	O
,	O
a	O
small	O
increment	O
in	O
inflammatory	O
activity	O
and	O
an	O
increase	O
in	O
substance	O
P	O
or	O
pain	O
perception	O
.	O

Oral	O
,	O
but	O
not	O
systemic	O
antibiotic	O
treatment	O
,	O
produced	O
changes	O
in	O
brain	O
chemistry	O
and	O
an	O
increase	O
in	O
anxiety	O
-	O
like	O
behavior	O
.	O

These	O
studies	O
provide	O
proof	O
of	O
concept	O
that	O
pathogenic	O
microbes	O
can	O
induce	O
persistent	O
gut	O
dysfunction	O
and	O
that	O
changes	O
in	O
microbial	O
composition	O
of	O
the	O
gut	O
can	O
maintain	O
gut	O
dysfunction	O
as	O
well	O
as	O
induce	O
behavioral	O
changes	O
reminiscent	O
of	O
the	O
psychiatric	O
comorbidity	O
that	O
occurs	O
in	O
up	O
to	O
60	O
%	O
of	O
irritable	O
bowel	O
syndrome	O
patients	O
.	O

Protease	O
-	O
activated	O
receptors	O
(	O
PARs	O
)	O
,	O
nucleotide	O
-	O
binding	O
oligomerization	O
domain	O
(	O
NOD	O
)	O
receptors	O
and	O
Toll	O
-	O
like	O
receptors	O
(	O
TLRs	O
)	O
play	O
a	O
role	O
in	O
innate	O
immunity	O
,	O
but	O
little	O
is	O
known	O
about	O
interaction	O
between	O
these	O
receptors	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
how	O
silencing	O
one	O
receptor	O
affects	O
the	O
expression	O
of	O
other	O
receptors	O
and	O
downstream	O
innate	O
immune	O
markers	O
in	O
response	O
to	O
bacteria	O
.	O

Human	O
gingival	O
epithelial	O
cells	O
(	O
GECs	O
)	O
were	O
transfected	O
with	O
siRNA	O
specific	O
for	O
PAR1	O
or	O
PAR2	O
,	O
then	O
stimulated	O
with	O
periopathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
bridging	O
organism	O
between	O
pathogens	O
and	O
non	O
-	O
pathogens	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
or	O
non	O
-	O
pathogen	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

PAR1	O
or	O
PAR2	O
knock	O
-	O
down	O
resulted	O
in	O
up	O
-	O
regulated	O
NOD1	O
and	O
NOD2	O
expression	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
stimulation	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
as	O
well	O
as	O
enhanced	O
TLR2	O
and	O
TLR4	O
expression	O
when	O
cells	O
were	O
stimulated	O
by	O
bacteria	O
that	O
utilize	O
TLR2	O
or	O
TLR4	O
,	O
respectively	O
.	O

Involvement	O
of	O
PARs	O
for	O
induction	O
of	O
CC	O
chemokine	O
ligand	O
20	O
(	O
CCL20	O
)	O
,	O
a	O
cytokine	O
with	O
antimicrobial	O
properties	O
,	O
was	O
observed	O
following	O
stimulation	O
of	O
the	O
three	O
bacterial	O
species	O
.	O

Furthermore	O
,	O
results	O
from	O
multiple	O
cytokine	O
ELISA	O
array	O
showed	O
receptors	O
utilized	O
in	O
the	O
induction	O
of	O
various	O
innate	O
immune	O
markers	O
are	O
tailored	O
to	O
individual	O
bacterium	O
tested	O
.	O

Our	O
data	O
suggest	O
complex	O
interplay	O
of	O
several	O
receptors	O
is	O
required	O
for	O
appropriate	O
innate	O
immune	O
responses	O
to	O
the	O
different	O
types	O
of	O
bacteria	O
present	O
within	O
the	O
oral	O
cavity	O
and	O
that	O
receptor	O
expression	O
itself	O
is	O
altered	O
depending	O
on	O
which	O
organism	O
the	O
cell	O
encounters	O
.	O

To	O
compare	O
the	O
effects	O
of	O
a	O
new	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
to	O
two	O
standard	O
fluoride	O
control	O
dentifrices	O
on	O
foam	O
generation	O
,	O
levels	O
of	O
total	O
viable	O
anaerobes	O
and	O
total	O
viable	O
volatile	O
sulfur	O
compound	O
(	O
VSC	O
)	O
-	O
producing	O
bacteria	O
in	O
expectorate	O
after	O
brushing	O
.	O

36	O
subjects	O
participated	O
in	O
this	O
investigator	O
-	O
blind	O
,	O
randomized	O
,	O
crossover	O
study	O
.	O

After	O
a	O
1	O
-	O
week	O
wash	O
-	O
out	O
period	O
prior	O
to	O
each	O
product	O
use	O
,	O
participants	O
reported	O
to	O
the	O
test	O
site	O
having	O
refrained	O
from	O
oral	O
hygiene	O
,	O
eating	O
and	O
drinking	O
on	O
the	O
morning	O
prior	O
to	O
the	O
visit	O
.	O

Subjects	O
brushed	O
with	O
a	O
full	O
ribbon	O
of	O
assigned	O
dentifrice	O
(	O
Aquafresh	O
Iso	O
-	O
active	O
,	O
Aquafresh	O
Extreme	O
Clean	O
or	O
Aquafresh	O
Fresh	O
&	O
Minty	O
)	O
,	O
then	O
expectorated	O
the	O
slurry	O
into	O
a	O
collection	O
vessel	O
after	O
30	O
and	O
60	O
seconds	O
of	O
supervised	O
brushing	O
.	O

Total	O
foam	O
volume	O
was	O
immediately	O
measured	O
.	O

Subjects	O
then	O
rinsed	O
with	O
sterile	O
water	O
for	O
10	O
seconds	O
and	O
expectorated	O
into	O
the	O
same	O
vessel	O
,	O
which	O
was	O
processed	O
for	O
microbiological	O
analysis	O
.	O

Total	O
viable	O
anaerobes	O
and	O
total	O
viable	O
VSC	O
-	O
producing	O
bacteria	O
were	O
enumerated	O
using	O
appropriate	O
selective	O
media	O
.	O

No	O
statistically	O
significant	O
difference	O
was	O
indicated	O
between	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
and	O
either	O
of	O
the	O
control	O
dentifrices	O
with	O
respect	O
to	O
the	O
level	O
of	O
total	O
viable	O
anaerobes	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
level	O
of	O
total	O
viable	O
VSC	O
-	O
producing	O
bacteria	O
was	O
statistically	O
significantly	O
lower	O
for	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
(	O
Aquafresh	O
Iso	O
-	O
active	O
)	O
than	O
for	O
one	O
of	O
the	O
control	O
dentifrices	O
(	O
Aquafresh	O
Fresh	O
&	O
Minty	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
numerically	O
lower	O
for	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
than	O
for	O
the	O
other	O
control	O
dentifrice	O
(	O
Aquafresh	O
Extreme	O
Clean	O
)	O
(	O
P	O
=	O
0	O
.	O
0526	O
)	O
.	O

Use	O
of	O
the	O
gel	O
-	O
to	O
-	O
foam	O
dentifrice	O
resulted	O
in	O
statistically	O
significantly	O
greater	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
foam	O
generation	O
than	O
the	O
two	O
control	O
dentifrices	O
.	O

Oral	O
malodor	O
develops	O
mostly	O
from	O
the	O
metabolic	O
activities	O
of	O
indigenous	O
bacterial	O
populations	O
within	O
the	O
oral	O
cavity	O
,	O
but	O
whether	O
healthy	O
or	O
oral	O
malodor	O
-	O
related	O
patterns	O
of	O
the	O
global	O
bacterial	O
composition	O
exist	O
remains	O
unclear	O
.	O

In	O
this	O
study	O
,	O
the	O
bacterial	O
compositions	O
in	O
the	O
saliva	O
of	O
240	O
subjects	O
complaining	O
of	O
oral	O
malodor	O
were	O
divided	O
into	O
groups	O
based	O
on	O
terminal	O
-	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
T	O
-	O
RFLP	O
)	O
profiles	O
using	O
hierarchical	O
cluster	O
analysis	O
,	O
and	O
the	O
patterns	O
of	O
the	O
microbial	O
community	O
composition	O
of	O
those	O
exhibiting	O
higher	O
and	O
lower	O
malodor	O
were	O
explored	O
.	O

Four	O
types	O
of	O
bacterial	O
community	O
compositions	O
were	O
detected	O
(	O
clusters	O
I	O
,	O
II	O
,	O
III	O
,	O
and	O
IV	O
)	O
.	O

Two	O
parameters	O
for	O
measuring	O
oral	O
malodor	O
intensity	O
(	O
the	O
concentration	O
of	O
volatile	O
sulfur	O
compounds	O
in	O
mouth	O
air	O
and	O
the	O
organoleptic	O
score	O
)	O
were	O
noticeably	O
lower	O
in	O
cluster	O
I	O
than	O
in	O
the	O
other	O
clusters	O
.	O

Using	O
multivariate	O
analysis	O
,	O
the	O
differences	O
in	O
the	O
levels	O
of	O
oral	O
malodor	O
were	O
significant	O
after	O
adjustment	O
for	O
potential	O
confounding	O
factors	O
such	O
as	O
total	O
bacterial	O
count	O
,	O
mean	O
periodontal	O
pocket	O
depth	O
,	O
and	O
tongue	O
coating	O
score	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Among	O
the	O
four	O
clusters	O
with	O
different	O
proportions	O
of	O
indigenous	O
members	O
,	O
the	O
T	O
-	O
RFLP	O
profiles	O
of	O
cluster	O
I	O
were	O
implicated	O
as	O
the	O
bacterial	O
populations	O
with	O
higher	O
proportions	O
of	O
Streptococcus	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Rothia	B-bacteria
,	O
and	O
Treponema	B-bacteria
species	I-bacteria
than	O
those	O
of	O
the	O
other	O
clusters	O
.	O

These	O
results	O
clearly	O
correlate	O
the	O
global	O
composition	O
of	O
indigenous	O
bacterial	O
populations	O
with	O
the	O
severity	O
of	O
oral	O
malodor	O
.	O

The	O
oral	O
cavity	O
may	O
represent	O
a	O
site	O
of	O
colonization	O
by	O
antibiotic	O
-	O
resistant	O
bacteria	O
,	O
such	O
as	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
staphylococci	I-bacteria
(	O
MRS	B-bacteria
)	O
.	O

To	O
define	O
the	O
prevalence	O
of	O
staphylococci	B-bacteria
and	O
MRS	B-bacteria
in	O
the	O
oral	O
cavity	O
,	O
an	O
observational	O
study	O
was	O
carried	O
out	O
in	O
the	O
city	O
of	O
Bari	O
(	O
Italy	O
)	O
.	O

Sixty	O
subjects	O
were	O
asked	O
to	O
provide	O
oral	O
samples	O
and	O
a	O
questionnaire	O
about	O
risk	O
factors	O
of	O
colonization	O
by	O
MRS	B-bacteria
.	O
An	O
enrichment	O
medium	O
specific	O
for	O
staphylococci	B-bacteria
was	O
used	O
for	O
the	O
isolation	O
.	O

Swabs	O
and	O
corresponding	O
questionnaires	O
were	O
available	O
from	O
36	O
out	O
of	O
60	O
patients	O
.	O

Staphylococci	B-bacteria
were	O
isolated	O
from	O
seven	O
out	O
of	O
36	O
samples	O
(	O
prevalence	O
19	O
.	O
4	O
%	O
)	O
.	O

Among	O
the	O
seven	O
staphylococcal	B-bacteria
isolates	I-bacteria
,	O
three	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
and	O
one	O
strain	O
,	O
belonging	O
to	O
S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
species	I-bacteria
,	O
was	O
found	O
to	O
be	O
MR	O
(	O
1	O
.	O
7	O
%	O
)	O
.	O

No	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
S	I-bacteria
.	I-bacteria
aureus	I-bacteria
were	O
isolated	O
.	O

Five	O
out	O
of	O
seven	O
staphylococcal	B-bacteria
isolates	I-bacteria
exhibited	O
resistance	O
to	O
more	O
than	O
two	O
classes	O
of	O
non	O
-	O
beta	O
-	O
lactams	O
antimicrobials	O
.	O

None	O
of	O
the	O
risk	O
factors	O
analysed	O
correlated	O
with	O
the	O
status	O
of	O
MRS	B-bacteria
carriers	O
,	O
except	O
the	O
presence	O
of	O
oral	O
disease	O
.	O

The	O
results	O
underline	O
the	O
potential	O
role	O
of	O
the	O
oral	O
cavity	O
as	O
a	O
reservoir	O
of	O
staphylococci	B-bacteria
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
is	O
an	O
important	O
pathogen	O
that	O
forms	O
biofilm	O
.	O

In	O
this	O
study	O
,	O
22	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
have	O
been	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
Tunisian	O
children	O
and	O
investigated	O
for	O
slime	O
production	O
using	O
Congo	O
red	O
agar	O
method	O
(	O
CRA	O
)	O
and	O
semi	O
quantitative	O
adherence	O
assay	O
.	O

The	O
hydrophobicity	O
of	O
strains	O
was	O
evaluated	O
by	O
the	O
microbial	O
adhesion	O
to	O
solvent	O
(	O
MATS	O
)	O
test	O
.	O

The	O
adherence	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
to	O
Hep2	O
cells	O
was	O
examined	O
by	O
light	O
microscopy	O
.	O

The	O
genes	O
implicated	O
in	O
adhesion	O
(	O
icaA	O
,	O
icaD	O
,	O
fnbA	O
,	O
cna	O
,	O
clfA	O
)	O
were	O
detected	O
.	O

Polymerase	O
chain	O
reaction	O
was	O
used	O
.	O

The	O
affinity	O
to	O
hexadecane	O
was	O
low	O
proving	O
a	O
hydrophilic	O
character	O
of	O
all	O
the	O
studied	O
strains	O
.	O

Qualitative	O
biofilm	O
production	O
revealed	O
that	O
50	O
%	O
of	O
strains	O
were	O
slime	O
producers	O
.	O

The	O
result	O
of	O
OD	O
(	O
570	O
)	O
showed	O
that	O
four	O
strains	O
isolated	O
from	O
the	O
caries	O
-	O
active	O
children	O
were	O
highly	O
biofilm	O
positive	O
.	O

In	O
addition	O
,	O
50	O
%	O
of	O
strains	O
were	O
icaA	O
and	O
icaD	O
positive	O
.	O

The	O
fnbA	O
gene	O
was	O
present	O
in	O
59	O
.	O
1	O
%	O
of	O
isolated	O
strains	O
.	O

Furthermore	O
,	O
54	O
.	O
5	O
%	O
of	O
strains	O
harboured	O
the	O
cna	O
gene	O
,	O
9	O
.	O
1	O
%	O
were	O
clfA	O
positive	O
and	O
50	O
%	O
were	O
hla	O
positive	O
.	O

Quantitative	O
adherence	O
varied	O
considerably	O
among	O
the	O
tested	O
strains	O
.	O

All	O
strains	O
showed	O
adherence	O
to	O
Hep2	O
cells	O
.	O

However	O
,	O
the	O
level	O
of	O
adhesion	O
varied	O
between	O
strains	O
as	O
follows	O
.	O

Seven	O
strains	O
were	O
defined	O
as	O
moderately	O
adherent	O
,	O
nine	O
as	O
strongly	O
adherent	O
and	O
six	O
as	O
weakly	O
adherent	O
.	O

The	O
percentage	O
of	O
infected	O
cells	O
ranged	O
from	O
15	O
+	O
/	O
-	O
0	O
.	O
0376	O
(	O
B374	O
)	O
to	O
96	O
+	O
/	O
-	O
0	O
.	O
019	O
(	O
B295	O
)	O
and	O
the	O
total	O
number	O
of	O
bacteria	O
per	O
100	O
cells	O
ranged	O
from	O
15	O
+	O
/	O
-	O
5	O
.	O
1	O
(	O
B374	O
)	O
to	O
1824	O
+	O
/	O
-	O
30	O
.	O
1	O
(	O
B295	O
)	O
.	O

This	O
pilot	O
study	O
determined	O
the	O
profile	O
of	O
the	O
oral	O
bacterial	O
flora	O
in	O
an	O
outpatient	O
cancer	O
population	O
before	O
and	O
after	O
chemotherapy	O
using	O
molecular	O
techniques	O
.	O

We	O
recruited	O
9	O
newly	O
diagnosed	O
breast	O
cancer	O
patients	O
scheduled	O
for	O
induction	O
chemotherapy	O
.	O

All	O
were	O
seen	O
immediately	O
before	O
chemotherapy	O
,	O
and	O
7	O
to	O
14	O
days	O
later	O
.	O

At	O
both	O
visits	O
,	O
we	O
performed	O
oral	O
evaluations	O
and	O
obtained	O
mucositis	O
grading	O
(	O
with	O
the	O
World	O
Health	O
Organization	O
[	O
WHO	O
]	O
scale	O
)	O
,	O
absolute	O
neutrophil	O
counts	O
(	O
ANC	O
)	O
,	O
and	O
bacterial	O
samples	O
from	O
the	O
buccal	O
mucosa	O
.	O

Bacterial	O
DNA	O
was	O
isolated	O
,	O
and	O
16S	O
ribosomal	O
RNA	O
gene	O
clonal	O
libraries	O
were	O
constructed	O
.	O

Sequences	O
of	O
genes	O
in	O
the	O
library	O
were	O
used	O
to	O
determine	O
species	O
identity	O
by	O
comparison	O
to	O
known	O
sequences	O
.	O

After	O
chemotherapy	O
,	O
WHO	O
scores	O
of	O
0	O
and	O
1	O
were	O
in	O
3	O
and	O
6	O
patients	O
,	O
respectively	O
,	O
and	O
mean	O
ANC	O
(	O
+	O
/	O
-	O
SD	O
)	O
dropped	O
from	O
3326	O
+	O
/	O
-	O
463	O
to	O
1091	O
+	O
/	O
-	O
1082	O
cells	O
/	O
mm	O
(	O
3	O
)	O
.	O

From	O
pre	O
-	O
and	O
post	O
-	O
chemotherapy	O
samples	O
,	O
41	O
species	O
were	O
detected	O
,	O
with	O
a	O
predominance	O
of	O
Gemella	B-bacteria
haemolysans	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
.	O

More	O
than	O
85	O
%	O
of	O
species	O
have	O
not	O
been	O
previously	O
identified	O
in	O
chemotherapy	O
patients	O
.	O

Seven	O
species	O
appeared	O
exclusively	O
before	O
chemotherapy	O
and	O
25	O
after	O
chemotherapy	O
.	O

After	O
chemotherapy	O
,	O
the	O
number	O
of	O
species	O
per	O
patient	O
increased	O
by	O
a	O
mean	O
of	O
2	O
.	O
6	O
(	O
SD	O
=	O
4	O
.	O
7	O
,	O
P	O
=	O
.	O
052	O
)	O
.	O

We	O
identified	O
species	O
not	O
previously	O
identified	O
in	O
chemotherapy	O
patients	O
.	O

Our	O
results	O
suggest	O
a	O
shift	O
to	O
a	O
more	O
complex	O
oral	O
bacterial	O
profile	O
in	O
patients	O
undergoing	O
cancer	O
chemotherapy	O
.	O

Bacterial	O
and	O
host	O
cell	O
products	O
during	O
coinfections	O
of	O
Human	O
Immunodeficiency	O
Virus	O
type	O
1	O
-	O
positive	O
(	O
HIV	O
-	O
1	O
(	O
+	O
)	O
)	O
patients	O
regulate	O
HIV	O
-	O
1	O
recrudescence	O
in	O
latently	O
infected	O
cells	O
(	O
e	O
.	O
g	O
.	O

T	O
cells	O
,	O
monocytes	O
/	O
macrophages	O
)	O
,	O
impacting	O
highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
)	O
failure	O
and	O
progression	O
of	O
acquired	O
immunodeficiency	O
syndrome	O
.	O

A	O
high	O
frequency	O
of	O
oral	O
opportunistic	O
infections	O
(	O
e	O
.	O
g	O
.	O
periodontitis	O
)	O
in	O
HIV	O
-	O
1	O
(	O
+	O
)	O
patients	O
has	O
been	O
demonstrated	O
;	O
however	O
,	O
their	O
potential	O
to	O
impact	O
HIV	O
-	O
1	O
exacerbation	O
is	O
unclear	O
.	O

We	O
sought	O
to	O
determine	O
the	O
ability	O
of	O
supernatants	O
derived	O
from	O
oral	O
epithelial	O
cells	O
(	O
OKF4	O
)	O
and	O
human	O
gingival	O
fibroblasts	O
(	O
Gin	O
-	O
4	O
)	O
challenged	O
with	O
periodontal	O
pathogens	O
,	O
to	O
modulate	O
the	O
HIV	O
-	O
1	O
promoter	O
activation	O
in	O
monocytes	O
/	O
macrophages	O
.	O

BF24	O
monocytes	O
/	O
macrophages	O
transfected	O
with	O
the	O
HIV	O
-	O
1	O
promoter	O
driving	O
the	O
expression	O
of	O
chloramphenicol	O
acetyltransferase	O
(	O
CAT	O
)	O
were	O
stimulated	O
with	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
or	O
Treponema	B-bacteria
denticola	I-bacteria
in	O
the	O
presence	O
of	O
supernatants	O
from	O
OKF4	O
or	O
Gin4	O
cells	O
either	O
unstimulated	O
or	O
previously	O
pulsed	O
with	O
bacteria	O
.	O

CAT	O
levels	O
were	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
and	O
cytokine	O
production	O
was	O
evaluated	O
by	O
Luminex	O
beadlyte	O
assays	O
.	O

OKF4	O
and	O
Gin4	O
supernatants	O
enhanced	O
HIV	O
-	O
1	O
promoter	O
activation	O
particularly	O
related	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
challenge	O
.	O

An	O
additive	O
effect	O
was	O
observed	O
in	O
HIV	O
-	O
1	O
promoter	O
activation	O
when	O
monocytes	O
/	O
macrophages	O
were	O
simultaneously	O
stimulated	O
with	O
gingival	O
cell	O
supernatants	O
and	O
bacterial	O
extracts	O
.	O

OKF4	O
cells	O
produced	O
higher	O
levels	O
of	O
granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
)	O
and	O
interleukins	O
-	O
6	O
and	O
-	O
8	O
in	O
response	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Preincubation	O
of	O
OKF4	O
supernatants	O
with	O
anti	O
-	O
GM	O
-	O
CSF	O
reduced	O
the	O
additive	O
effect	O
in	O
periodontopathogen	O
-	O
induced	O
HIV	O
-	O
1	O
promoter	O
activation	O
.	O

These	O
results	O
suggest	O
that	O
soluble	O
mediators	O
produced	O
by	O
gingival	O
resident	O
cells	O
in	O
response	O
to	O
periodontopathogens	O
could	O
contribute	O
to	O
HIV	O
-	O
1	O
promoter	O
activation	O
in	O
monocytes	O
/	O
macrophages	O
,	O
albeit	O
this	O
effect	O
is	O
most	O
notable	O
following	O
direct	O
stimulation	O
of	O
the	O
cells	O
with	O
oral	O
gram	O
-	O
negative	O
bacteria	O
.	O

The	O
presence	O
of	O
periodontal	O
pathogens	O
in	O
the	O
oral	O
cavity	O
may	O
impact	O
implant	O
survival	O
.	O

Therefore	O
,	O
this	O
study	O
aimed	O
to	O
determine	O
the	O
prevalence	O
of	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
and	O
Parvimonas	B-bacteria
micra	I-bacteria
in	O
a	O
specific	O
elderly	O
population	O
with	O
a	O
history	O
of	O
periodontitis	O
who	O
have	O
never	O
worn	O
dentures	O
.	O

Thirty	O
dentate	O
subjects	O
(	O
mean	O
age	O
61	O
.	O
7	O
+	O
/	O
-	O
7	O
.	O
05	O
years	O
)	O
and	O
30	O
edentulous	O
subjects	O
(	O
mean	O
age	O
65	O
.	O
8	O
+	O
/	O
-	O
8	O
.	O
05	O
years	O
)	O
were	O
included	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
.	O

Microbiological	O
samples	O
of	O
cheek	O
mucosa	O
and	O
the	O
dorsum	O
of	O
the	O
tongue	O
were	O
taken	O
from	O
all	O
subjects	O
.	O

In	O
addition	O
,	O
sulcus	O
samples	O
were	O
taken	O
from	O
the	O
dentate	O
group	O
.	O

All	O
samples	O
were	O
analysed	O
using	O
a	O
bacterial	O
DNA	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
.	O

All	O
the	O
pathogens	O
studied	O
were	O
detected	O
in	O
dentate	O
and	O
edentulous	O
subjects	O
.	O

When	O
cheek	O
and	O
tongue	O
samples	O
were	O
combined	O
,	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
presented	O
with	O
a	O
similar	O
prevalence	O
in	O
both	O
groups	O
,	O
whereas	O
the	O
other	O
species	O
were	O
more	O
prevalent	O
specifically	O
in	O
the	O
dentate	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
dentate	O
subjects	O
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
present	O
in	O
higher	O
frequencies	O
in	O
the	O
cheek	O
mucosa	O
(	O
26	O
.	O
67	O
%	O
and	O
66	O
.	O
67	O
%	O
,	O
respectively	O
)	O
,	O
whereas	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
were	O
more	O
prevalent	O
in	O
the	O
tongue	O
samples	O
(	O
26	O
.	O
67	O
%	O
and	O
56	O
.	O
67	O
%	O
,	O
respectively	O
)	O
.	O

Periodontal	O
pathogens	O
may	O
persist	O
in	O
the	O
oral	O
cavity	O
of	O
edentulous	O
subjects	O
who	O
have	O
had	O
periodontal	O
disease	O
,	O
even	O
1	O
year	O
after	O
the	O
extraction	O
of	O
all	O
teeth	O
and	O
in	O
the	O
absence	O
of	O
other	O
hard	O
surfaces	O
in	O
the	O
mouth	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
clinically	O
and	O
microbiologically	O
evaluate	O
the	O
effect	O
of	O
photodynamic	O
therapy	O
(	O
PDT	O
)	O
as	O
a	O
full	O
-	O
mouth	O
procedure	O
in	O
Fusobacterium	O
nucleatum	O
-	O
infected	O
patients	O
with	O
periodontitis	O
.	O

In	O
the	O
present	O
study	O
,	O
PDT	O
is	O
administered	O
adjuvantly	O
after	O
scaling	O
and	O
root	O
planing	O
(	O
SRP	O
)	O
to	O
patients	O
with	O
localized	O
chronic	O
periodontitis	O
(	O
LCP	O
)	O
.	O

Twenty	O
-	O
four	O
patients	O
,	O
in	O
whom	O
only	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
detected	O
by	O
baseline	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
after	O
SRP	O
,	O
were	O
randomly	O
assigned	O
to	O
PDT	O
and	O
control	O
groups	O
.	O

PDT	O
was	O
carried	O
out	O
once	O
as	O
a	O
full	O
-	O
mouth	O
disinfection	O
in	O
the	O
test	O
group	O
.	O

The	O
control	O
group	O
was	O
treated	O
with	O
the	O
photosensitizer	O
solution	O
,	O
but	O
without	O
laser	O
irradiation	O
.	O

In	O
all	O
subjects	O
,	O
the	O
clinical	O
parameters	O
plaque	O
index	O
,	O
reddening	O
,	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
,	O
probing	O
depth	O
(	O
PD	O
)	O
,	O
gingival	O
recession	O
,	O
and	O
clinical	O
attachment	O
level	O
(	O
CAL	O
)	O
were	O
determined	O
at	O
the	O
baseline	O
examination	O
and	O
at	O
1	O
,	O
4	O
,	O
and	O
12	O
weeks	O
after	O
PDT	O
.	O

Quantitative	O
analysis	O
of	O
the	O
F	O
.	O
nucleatum	O
DNA	O
concentration	O
was	O
performed	O
by	O
competitive	O
PCR	O
.	O

All	O
clinical	O
indices	O
were	O
calculated	O
for	O
each	O
test	O
and	O
control	O
subject	O
as	O
were	O
the	O
median	O
and	O
interquartile	O
range	O
of	O
each	O
group	O
.	O

In	O
patients	O
with	O
LCP	O
who	O
received	O
PDT	O
treatment	O
,	O
significant	O
reductions	O
in	O
reddening	O
,	O
BOP	O
,	O
and	O
mean	O
PD	O
and	O
CAL	O
were	O
observed	O
during	O
the	O
observation	O
period	O
and	O
with	O
respect	O
to	O
controls	O
.	O

Four	O
and	O
12	O
weeks	O
after	O
PDT	O
,	O
the	O
mean	O
PD	O
and	O
CAL	O
showed	O
significant	O
differences	O
from	O
baseline	O
values	O
and	O
from	O
those	O
of	O
the	O
control	O
group	O
.	O

In	O
the	O
PDT	O
group	O
,	O
12	O
weeks	O
after	O
treatment	O
,	O
the	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
DNA	O
concentration	O
was	O
found	O
to	O
be	O
significantly	O
reduced	O
compared	O
to	O
the	O
baseline	O
level	O
.	O

The	O
results	O
of	O
this	O
study	O
show	O
that	O
the	O
adjuvant	O
application	O
of	O
the	O
described	O
PDT	O
method	O
is	O
appropriate	O
to	O
reduce	O
periodontal	O
inflammatory	O
symptoms	O
and	O
to	O
successfully	O
treat	O
infection	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

The	O
present	O
study	O
evaluates	O
the	O
survival	O
capability	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
strains	I-bacteria
in	O
an	O
aerobic	O
environment	O
and	O
compares	O
the	O
invasive	O
capability	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
in	O
biofilm	O
and	O
planktonic	O
forms	O
in	O
an	O
organotypic	O
cell	O
culture	O
(	O
OCC	O
)	O
model	O
.	O

Biofilms	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
American	I-bacteria
Type	I-bacteria
Culture	I-bacteria
Collection	I-bacteria
(	I-bacteria
ATCC	I-bacteria
)	I-bacteria
25586	I-bacteria
or	O
Anaerobe	B-bacteria
Helsinki	I-bacteria
Negative	I-bacteria
(	I-bacteria
AHN	I-bacteria
)	I-bacteria
9508	I-bacteria
were	O
produced	O
by	O
culturing	O
on	O
semipermeable	O
membranes	O
on	O
brucella	O
agar	O
plates	O
.	O

The	O
oxygen	O
tolerance	O
of	O
the	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strains	I-bacteria
was	O
examined	O
by	O
incubating	O
3	O
-	O
day	O
-	O
old	O
anaerobically	O
grown	O
biofilms	O
in	O
an	O
aerobic	O
environment	O
(	O
CO	O
(	O
2	O
)	O
[	O
5	O
%	O
in	O
air	O
]	O
incubator	O
)	O
for	O
an	O
additional	O
48	O
hours	O
.	O

The	O
OCC	O
model	O
was	O
constructed	O
by	O
seeding	O
keratinocytes	O
on	O
a	O
fibroblast	O
-	O
containing	O
collagen	O
gel	O
.	O

In	O
invasion	O
assays	O
,	O
a	O
3	O
-	O
day	O
-	O
old	O
anaerobically	O
grown	O
biofilm	O
(	O
and	O
planktonic	O
bacteria	O
in	O
solution	O
as	O
the	O
control	O
)	O
was	O
placed	O
upside	O
down	O
on	O
the	O
top	O
of	O
OCC	O
and	O
incubated	O
under	O
5	O
%	O
CO	O
(	O
2	O
)	O
for	O
24	O
hours	O
.	O

Invasion	O
of	O
the	O
bacteria	O
and	O
morphologic	O
changes	O
in	O
OCC	O
were	O
assessed	O
using	O
hematoxylin	O
and	O
eosin	O
,	O
Ki	O
-	O
67	O
,	O
and	O
periodic	O
acid	O
-	O
Schiff	O
stainings	O
.	O

In	O
biofilms	O
,	O
both	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strains	I-bacteria
continuously	O
increased	O
their	O
cell	O
numbers	O
in	O
an	O
aerobic	O
environment	O
for	O
48	O
hours	O
.	O

After	O
incubating	O
the	O
bacterial	O
biofilm	O
in	O
contact	O
with	O
the	O
OCC	O
model	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
AHN	I-bacteria
9508	I-bacteria
was	O
able	O
to	O
pass	O
through	O
the	O
epithelial	O
/	O
basement	O
membrane	O
barrier	O
and	O
invade	O
the	O
collagen	O
matrix	O
.	O

The	O
invasiveness	O
of	O
biofilm	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
was	O
limited	O
to	O
the	O
epithelium	O
.	O

Cytotoxic	O
effects	O
and	O
invasiveness	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
on	O
the	O
OCC	O
were	O
much	O
stronger	O
when	O
the	O
bacteria	O
were	O
in	O
biofilms	O
than	O
in	O
the	O
planktonic	O
form	O
.	O

Biofilm	O
formation	O
regulates	O
the	O
survival	O
and	O
invasiveness	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
in	O
an	O
aerobic	O
environment	O
.	O

During	O
oral	O
procedures	O
,	O
microorganisms	O
from	O
the	O
oral	O
cavity	O
may	O
contaminate	O
nearby	O
surfaces	O
.	O

The	O
authors	O
evaluated	O
the	O
efficacy	O
of	O
a	O
commercial	O
preprocedural	O
mouthrinse	O
containing	O
0	O
.	O
05	O
percent	O
cetylpyridinium	O
chloride	O
(	O
CPC	O
)	O
in	O
reducing	O
the	O
levels	O
and	O
composition	O
of	O
viable	O
bacteria	O
in	O
oral	O
spatter	O
.	O

The	O
authors	O
randomly	O
assigned	O
60	O
participants	O
receiving	O
oral	O
prophylaxis	O
with	O
an	O
ultrasonic	O
scaler	O
to	O
one	O
of	O
four	O
groups	O
:	O
a	O
preprocedural	O
rinse	O
solution	O
containing	O
0	O
.	O
05	O
percent	O
CPC	O
,	O
0	O
.	O
12	O
percent	O
chlorhexidine	O
(	O
CHX	O
)	O
or	O
water	O
,	O
or	O
no	O
rinsing	O
.	O

Airborne	O
microorganisms	O
were	O
collected	O
on	O
blood	O
agar	O
plates	O
.	O

The	O
composition	O
of	O
the	O
spatter	O
was	O
analyzed	O
for	O
39	O
oral	O
bacterial	O
species	O
by	O
means	O
of	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

CPC	O
and	O
CHX	O
were	O
equally	O
effective	O
in	O
lowering	O
the	O
levels	O
of	O
spatter	O
bacteria	O
and	O
performed	O
better	O
than	O
water	O
and	O
no	O
rinsing	O
(	O
P	O
<	O
.	O
05	O
,	O
Kruskal	O
-	O
Wallis	O
test	O
)	O
.	O

The	O
composition	O
of	O
the	O
spatter	O
from	O
the	O
control	O
groups	O
showed	O
higher	O
proportions	O
(	O
P	O
<	O
.	O
05	O
,	O
Kruskal	O
-	O
Wallis	O
test	O
)	O
of	O
Fusobacterium	B-bacteria
species	I-bacteria
and	O
lower	O
proportions	O
of	O
Capnocytophaga	B-bacteria
species	I-bacteria
when	O
compared	O
with	O
the	O
spatter	O
from	O
the	O
CPC	O
and	O
CHX	O
groups	O
.	O

A	O
commercial	O
mouthrinse	O
containing	O
0	O
.	O
05	O
percent	O
CPC	O
when	O
used	O
as	O
a	O
preprocedural	O
mouthrinse	O
was	O
equally	O
effective	O
as	O
CHX	O
in	O
reducing	O
the	O
levels	O
of	O
spatter	O
bacteria	O
generated	O
during	O
ultrasonic	O
scaling	O
.	O

Owing	O
to	O
its	O
strong	O
antibacterial	O
effect	O
and	O
the	O
fact	O
that	O
it	O
has	O
fewer	O
side	O
effects	O
than	O
CHX	O
,	O
a	O
solution	O
containing	O
0	O
.	O
05	O
percent	O
CPC	O
may	O
be	O
a	O
good	O
alternative	O
to	O
that	O
containing	O
0	O
.	O
12	O
CHX	O
as	O
a	O
preprocedural	O
mouthrinse	O
used	O
to	O
help	O
decrease	O
the	O
level	O
of	O
contamination	O
in	O
spatter	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
evaluate	O
the	O
effect	O
of	O
full	O
mouth	O
rehabilitation	O
on	O
the	O
amount	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
children	O
with	O
Early	O
Childhood	O
Caries	O
.	O

Thirty	O
-	O
nine	O
children	O
between	O
2	O
and	O
5	O
years	O
old	O
treated	O
under	O
general	O
anaesthesia	O
participated	O
in	O
this	O
study	O
.	O

Prior	O
to	O
treatment	O
two	O
baselines	O
samples	O
were	O
collected	O
,	O
one	O
of	O
dental	O
plaque	O
and	O
one	O
of	O
saliva	O
.	O

In	O
addition	O
,	O
samples	O
were	O
obtained	O
one	O
week	O
post	O
operatively	O
,	O
and	O
then	O
three	O
months	O
later	O
.	O

In	O
each	O
sampling	O
,	O
the	O
amount	O
and	O
the	O
concentration	O
(	O
cfu	O
/	O
ml	O
)	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
evaluated	O
.	O

The	O
findings	O
demonstrate	O
that	O
the	O
operative	O
procedures	O
under	O
general	O
anaesthesia	O
,	O
significantly	O
decrease	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
the	O
concentration	O
(	O
cfu	O
/	O
ml	O
)	O
and	O
the	O
amount	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
for	O
at	O
least	O
three	O
months	O
.	O

After	O
three	O
months	O
,	O
saliva	O
concentrations	O
and	O
plaque	O
colony	O
numbers	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
increased	O
significantly	O
in	O
relation	O
to	O
one	O
week	O
post	O
-	O
operatively	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

However	O
,	O
none	O
of	O
the	O
saliva	O
or	O
plaque	O
samples	O
collected	O
three	O
months	O
following	O
treatment	O
reached	O
the	O
pretreatment	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
any	O
of	O
our	O
subjects	O
.	O

The	O
data	O
indicates	O
that	O
full	O
mouth	O
rehabilitation	O
under	O
general	O
anaesthesia	O
produces	O
a	O
statistically	O
significant	O
decrease	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
levels	O
for	O
at	O
least	O
three	O
months	O
.	O

The	O
indigenous	O
bacteria	O
create	O
natural	O
cohabitation	O
niches	O
together	O
with	O
mucosal	O
Abs	O
in	O
the	O
gastrointestinal	O
(	O
GI	O
)	O
tract	O
.	O

Here	O
we	O
report	O
that	O
opportunistic	O
bacteria	O
,	O
largely	O
Alcaligenes	B-bacteria
species	I-bacteria
,	O
specifically	O
inhabit	O
host	O
Peyer	O
'	O
s	O
patches	O
(	O
PPs	O
)	O
and	O
isolated	O
lymphoid	O
follicles	O
,	O
with	O
the	O
associated	O
preferential	O
induction	O
of	O
antigen	O
-	O
specific	O
mucosal	O
IgA	O
Abs	O
in	O
the	O
GI	O
tract	O
.	O

Alcaligenes	B-bacteria
were	O
identified	O
as	O
the	O
dominant	O
bacteria	O
on	O
the	O
interior	O
of	O
PPs	O
from	O
naive	O
,	O
specific	O
-	O
pathogen	O
-	O
free	O
but	O
not	O
from	O
germ	O
-	O
free	O
mice	O
.	O

Oral	O
transfer	O
of	O
intratissue	O
uncultured	O
Alcaligenes	B-bacteria
into	O
germ	O
-	O
free	O
mice	O
resulted	O
in	O
the	O
presence	O
of	O
Alcaligenes	B-bacteria
inside	O
the	O
PPs	O
of	O
recipients	O
.	O

This	O
result	O
was	O
further	O
supported	O
by	O
the	O
induction	O
of	O
antigen	O
-	O
specific	O
Ab	O
-	O
producing	O
cells	O
in	O
the	O
mucosal	O
(	O
e	O
.	O
g	O
.	O
,	O
PPs	O
)	O
but	O
not	O
systemic	O
compartment	O
(	O
e	O
.	O
g	O
.	O
,	O
spleen	O
)	O
.	O

The	O
preferential	O
presence	O
of	O
Alcaligenes	B-bacteria
inside	O
PPs	O
and	O
the	O
associated	O
induction	O
of	O
intestinal	O
secretory	O
IgA	O
Abs	O
were	O
also	O
observed	O
in	O
both	O
monkeys	O
and	O
humans	O
.	O

Localized	O
mucosal	O
Ab	O
-	O
mediated	O
symbiotic	O
immune	O
responses	O
were	O
supported	O
by	O
Alcaligenes	O
-	O
stimulated	O
CD11c	O
(	O
+	O
)	O
dendritic	O
cells	O
(	O
DCs	O
)	O
producing	O
the	O
Ab	O
-	O
enhancing	O
cytokines	O
TGF	O
-	O
beta	O
,	O
B	O
-	O
cell	O
-	O
activating	O
factor	O
belonging	O
to	O
the	O
TNF	O
family	O
,	O
and	O
IL	O
-	O
6	O
in	O
PPs	O
.	O

These	O
CD11c	O
(	O
+	O
)	O
DCs	O
did	O
not	O
migrate	O
beyond	O
the	O
draining	O
mesenteric	O
lymph	O
nodes	O
.	O

In	O
the	O
absence	O
of	O
antigen	O
-	O
specific	O
mucosal	O
Abs	O
,	O
the	O
presence	O
of	O
Alcaligenes	B-bacteria
in	O
PPs	O
was	O
greatly	O
diminished	O
.	O

Thus	O
,	O
indigenous	O
opportunistic	O
bacteria	O
uniquely	O
inhabit	O
PPs	O
,	O
leading	O
to	O
PP	O
-	O
DCs	O
-	O
initiated	O
,	O
local	O
antigen	O
-	O
specific	O
Ab	O
production	O
;	O
this	O
may	O
involve	O
the	O
creation	O
of	O
an	O
optimal	O
symbiotic	O
environment	O
on	O
the	O
interior	O
of	O
the	O
PPs	O
.	O

Increasing	O
awareness	O
of	O
hazards	O
associated	O
with	O
the	O
use	O
of	O
antibiotic	O
and	O
chemical	O
agents	O
has	O
accelerated	O
investigations	O
into	O
plants	O
and	O
their	O
extracts	O
as	O
new	O
sources	O
of	O
antimicrobial	O
agents	O
.	O

Therefore	O
,	O
this	O
study	O
aimed	O
at	O
determining	O
the	O
effects	O
of	O
oil	O
and	O
95	O
%	O
ethanol	O
extracts	O
of	O
Boesenbergia	O
pandurata	O
rhizomes	O
and	O
Piper	O
sarmentosum	O
leaf	O
against	O
four	O
oral	O
pathogens	O
which	O
were	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Candida	O
albicans	O
.	O

Employing	O
the	O
disc	O
diffusion	O
and	O
broth	O
microdilution	O
methods	O
,	O
the	O
results	O
showed	O
that	O
B	O
.	O
pandurata	O
oil	O
(	O
BPO	O
)	O
was	O
the	O
most	O
effective	O
extract	O
against	O
C	O
.	O
albicans	O
.	O

Time	O
-	O
kill	O
assay	O
with	O
the	O
BPO	O
demonstrated	O
killing	O
of	O
C	O
.	O
albicans	O
at	O
concentrations	O
equal	O
to	O
2	O
and	O
2	O
.	O
5	O
times	O
the	O
MIC	O
.	O

The	O
times	O
required	O
to	O
reach	O
the	O
fungicidal	O
endpoint	O
at	O
2	O
and	O
2	O
.	O
5	O
times	O
the	O
MIC	O
were	O
60	O
and	O
44	O
min	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
our	O
results	O
also	O
demonstrated	O
that	O
the	O
BPO	O
possesses	O
potent	O
anti	O
-	O
Candida	O
biofilm	O
activity	O
in	O
vitro	O
.	O

Therefore	O
,	O
the	O
BPO	O
could	O
be	O
considered	O
as	O
a	O
natural	O
antifungal	O
agent	O
against	O
Candida	O
infections	O
and	O
has	O
significant	O
potential	O
for	O
further	O
investigation	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
evaluate	O
the	O
influence	O
of	O
oral	O
contraceptive	O
(	O
OC	O
)	O
use	O
on	O
the	O
subgingival	O
occurrence	O
of	O
specific	O
periodontopathogens	O
and	O
the	O
host	O
'	O
s	O
periodontal	O
status	O
.	O

Ninety	O
-	O
two	O
females	O
aged	O
19	O
to	O
40	O
years	O
were	O
included	O
in	O
the	O
study	O
.	O

They	O
were	O
divided	O
into	O
two	O
groups	O
,	O
OC	O
users	O
and	O
non	O
-	O
users	O
,	O
and	O
subgrouped	O
according	O
to	O
the	O
most	O
severe	O
periodontal	O
condition	O
and	O
duration	O
of	O
OC	O
usage	O
.	O

A	O
pooled	O
subgingival	O
sample	O
from	O
each	O
subject	O
was	O
cultured	O
to	O
investigate	O
the	O
presence	O
of	O
Candida	O
species	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
.	O

OC	O
users	O
,	O
particularly	O
smokers	O
,	O
show	O
a	O
statistically	O
significant	O
increase	O
in	O
the	O
prevalence	O
of	O
severe	O
periodontitis	O
.	O

OC	O
users	O
had	O
deeper	O
probing	O
depths	O
(	O
>	O
or	O
=	O
5	O
mm	O
)	O
than	O
non	O
-	O
users	O
.	O

Moreover	O
,	O
OC	O
users	O
had	O
higher	O
gingival	O
index	O
scores	O
and	O
clinical	O
attachment	O
loss	O
,	O
>	O
or	O
=	O
2	O
and	O
>	O
or	O
=	O
5	O
mm	O
,	O
respectively	O
,	O
than	O
non	O
-	O
users	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Patients	O
taking	O
OCs	O
had	O
significantly	O
higher	O
numbers	O
of	O
cultures	O
positive	O
for	O
Candida	O
.	O

Seven	O
Candida	O
species	O
were	O
isolated	O
.	O

Subgingival	O
Candida	O
was	O
associated	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
in	O
82	O
.	O
9	O
%	O
and	O
85	O
.	O
4	O
%	O
,	O
respectively	O
,	O
in	O
patients	O
taking	O
OCs	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
was	O
isolated	O
in	O
patients	O
with	O
moderate	O
and	O
severe	O
periodontitis	O
and	O
was	O
associated	O
with	O
subgingival	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
and	O
Candida	O
.	O

OC	O
use	O
may	O
increase	O
the	O
risk	O
of	O
severe	O
periodontitis	O
and	O
seems	O
to	O
cause	O
a	O
selection	O
of	O
certain	O
Candida	O
species	O
in	O
periodontal	O
pockets	O
.	O

OC	O
users	O
showed	O
a	O
higher	O
prevalence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
compared	O
to	O
non	O
-	O
users	O
.	O

C	O
.	O
albicans	O
,	O
C	O
.	O
parapsilosis	O
,	O
C	O
.	O
krusei	O
,	O
C	O
.	O
tropicalis	O
,	O
and	O
C	O
.	O
glabrata	O
were	O
the	O
species	O
with	O
the	O
ability	O
to	O
survive	O
in	O
the	O
conditions	O
created	O
by	O
the	O
sex	O
hormones	O
after	O
3	O
years	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
adhesion	O
and	O
invasion	O
of	O
periodontopathogenic	O
bacteria	O
in	O
varied	O
mixed	O
infections	O
and	O
the	O
release	O
of	O
interleukins	O
from	O
an	O
epithelial	O
cell	O
line	O
(	O
KB	O
cells	O
)	O
.	O

KB	O
cells	O
were	O
co	O
-	O
cultured	O
with	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
and	O
M5	B-bacteria
-	I-bacteria
1	I-bacteria
-	I-bacteria
2	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
ATCC	I-bacteria
43037	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
ATCC	I-bacteria
35405	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
in	O
single	O
and	O
mixed	O
infections	O
.	O

The	O
numbers	O
of	O
adherent	O
and	O
internalized	O
bacteria	O
were	O
determined	O
up	O
to	O
18	O
h	O
after	O
bacterial	O
exposure	O
.	O

Additionally	O
,	O
the	O
mRNA	O
expression	O
and	O
concentrations	O
of	O
released	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
and	O
IL	O
-	O
8	O
were	O
measured	O
.	O

All	O
periodontopathogenic	O
bacteria	O
adhered	O
and	O
internalized	O
in	O
different	O
numbers	O
to	O
KB	O
cells	O
,	O
but	O
individually	O
without	O
any	O
evidence	O
of	O
co	O
-	O
aggregation	O
also	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

High	O
levels	O
of	O
epithelial	O
mRNA	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
were	O
detectable	O
after	O
all	O
bacterial	O
challenges	O
.	O

After	O
the	O
mixed	O
infection	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
the	O
highest	O
levels	O
of	O
released	O
interleukins	O
were	O
found	O
.	O

No	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
were	O
detectable	O
after	O
the	O
mixed	O
infection	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
M5	I-bacteria
-	I-bacteria
1	I-bacteria
-	I-bacteria
2	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
and	O
the	O
fourfold	O
infection	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
ATCC	I-bacteria
33277	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
ATCC	I-bacteria
35405	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
ATCC	I-bacteria
43037	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
.	O

Anaerobic	O
periodontopathogenic	O
bacteria	O
promote	O
the	O
release	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
by	O
epithelial	O
cells	O
.	O

Despite	O
a	O
continuous	O
epithelial	O
expression	O
of	O
IL	O
-	O
8	O
mRNA	O
by	O
all	O
bacterial	O
infections	O
these	O
effects	O
are	O
temporary	O
because	O
of	O
the	O
time	O
-	O
dependent	O
degradation	O
of	O
cytokines	O
by	O
bacterial	O
proteases	O
.	O

Mixed	O
infections	O
have	O
a	O
stronger	O
virulence	O
potential	O
than	O
single	O
bacteria	O
.	O

Further	O
research	O
is	O
necessary	O
to	O
evaluate	O
the	O
role	O
of	O
mixed	O
infections	O
and	O
biofilms	O
in	O
the	O
pathogenesis	O
of	O
periodontitis	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
is	O
a	O
major	O
pathogen	O
of	O
dental	O
caries	O
and	O
occasionally	O
isolated	O
from	O
the	O
blood	O
of	O
patients	O
with	O
infective	O
endocarditis	O
,	O
though	O
the	O
association	O
of	O
its	O
cell	O
-	O
surface	O
glucosyltransferases	O
(	O
GTFB	O
,	O
GTFC	O
,	O
and	O
GTFD	O
)	O
with	O
pathogenicity	O
for	O
infective	O
endocarditis	O
remains	O
to	O
be	O
elucidated	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
contribution	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
GTFs	O
to	O
platelet	O
aggregation	O
and	O
analysed	O
GTF	O
expression	O
profiles	O
in	O
a	O
large	O
number	O
of	O
clinical	O
oral	O
isolates	O
.	O

The	O
platelet	O
aggregation	O
properties	O
of	O
GTF	O
-	O
defective	O
isogenic	O
mutant	O
strains	O
constructed	O
from	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
reference	O
strain	O
MT8148	B-bacteria
were	O
evaluated	O
using	O
whole	O
blood	O
and	O
platelet	O
-	O
rich	O
plasma	O
(	O
PRP	O
)	O
taken	O
from	O
mice	O
,	O
as	O
well	O
as	O
human	O
PRP	O
.	O

In	O
addition	O
,	O
GTF	O
expression	O
profiles	O
for	O
396	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
oral	O
cavities	O
of	O
396	O
subjects	O
were	O
analysed	O
by	O
western	O
blotting	O
using	O
antisera	O
specific	O
for	O
each	O
GTF	O
.	O

The	O
platelet	O
aggregation	O
activities	O
of	O
the	O
GTF	O
-	O
defective	O
isogenic	O
mutants	O
were	O
significantly	O
lower	O
than	O
that	O
of	O
MT8148	B-bacteria
when	O
added	O
to	O
a	O
large	O
number	O
of	O
cells	O
.	O

Western	O
blotting	O
revealed	O
no	O
strains	O
without	O
GTF	O
expression	O
,	O
though	O
six	O
strains	O
had	O
alterations	O
of	O
GTFB	O
and	O
GTFC	O
as	O
compared	O
to	O
MT8148	B-bacteria
.	O

PCR	O
analyses	O
indicated	O
that	O
the	O
gtfB	O
-	O
gtfC	O
region	O
length	O
was	O
approximately	O
4	O
.	O
5	O
kb	O
shorter	O
in	O
those	O
strains	O
as	O
compared	O
to	O
MT8148	B-bacteria
.	O

These	O
were	O
designated	O
as	O
`	O
`	O
GTFBC	O
-	O
fusion	O
'	O
'	O
strains	O
and	O
they	O
demonstrated	O
lower	O
levels	O
of	O
platelet	O
aggregation	O
.	O

Our	O
findings	O
indicate	O
that	O
GTFs	O
are	O
associated	O
with	O
platelet	O
aggregation	O
.	O

Although	O
the	O
clinical	O
detection	O
frequency	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
with	O
altered	O
expressions	O
is	O
extremely	O
low	O
,	O
GTFBC	O
-	O
fusion	O
strains	O
have	O
activities	O
similar	O
to	O
GTF	O
-	O
defective	O
mutant	O
strains	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
is	O
an	O
important	O
factor	O
in	O
the	O
pathogenesis	O
of	O
numerous	O
diseases	O
including	O
gastro	O
-	O
intestinal	O
,	O
metabolic	O
and	O
vascular	O
disorders	O
.	O

Therefore	O
,	O
identification	O
of	O
individuals	O
at	O
risk	O
of	O
this	O
infection	O
remains	O
of	O
critical	O
importance	O
.	O

Dentists	O
and	O
dental	O
professionals	O
may	O
be	O
at	O
increased	O
risk	O
due	O
to	O
the	O
contact	O
with	O
oral	O
cavity	O
of	O
patients	O
with	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
where	O
it	O
may	O
serve	O
as	O
reservoir	O
for	O
gastric	O
infections	O
and	O
participate	O
in	O
the	O
pathogenesis	O
oral	O
mucosal	O
lesions	O
and	O
ulceration	O
.	O

However	O
,	O
evidence	O
regarding	O
the	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infections	O
and	O
colonization	O
in	O
dentists	O
is	O
conflicting	O
,	O
but	O
has	O
been	O
based	O
mainly	O
on	O
serological	O
studies	O
,	O
which	O
carry	O
significant	O
limitations	O
.	O

Therefore	O
,	O
we	O
attempted	O
to	O
characterize	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
practising	O
dentists	O
in	O
relation	O
to	O
the	O
duration	O
of	O
their	O
work	O
as	O
dental	O
professionals	O
.	O

Moreover	O
,	O
apart	O
from	O
seropositivity	O
,	O
which	O
was	O
used	O
by	O
majority	O
of	O
previous	O
studies	O
,	O
we	O
have	O
performed	O
urea	O
-	O
breath	O
test	O
(	O
UBT	O
)	O
,	O
which	O
has	O
been	O
shown	O
to	O
represent	O
active	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
stomach	O
as	O
well	O
as	O
the	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
culture	O
from	O
the	O
oral	O
cavity	O
.	O

We	O
found	O
that	O
while	O
the	O
occurrence	O
of	O
either	O
gastric	O
or	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dentists	O
is	O
not	O
greater	O
than	O
in	O
general	O
population	O
,	O
it	O
seems	O
that	O
in	O
male	O
dentists	O
there	O
is	O
a	O
greater	O
risk	O
of	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
.	O

Moreover	O
,	O
we	O
found	O
a	O
relationship	O
between	O
the	O
length	O
of	O
dentist	O
occupation	O
with	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
gingival	O
sulcus	O
.	O

In	O
conclusion	O
,	O
while	O
overall	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dentists	O
did	O
not	O
differ	O
from	O
that	O
reported	O
for	O
stomach	O
or	O
oral	O
cavity	O
in	O
general	O
population	O
,	O
there	O
was	O
an	O
increased	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
male	O
dentists	O
and	O
the	O
presence	O
of	O
this	O
germ	O
in	O
the	O
oral	O
cavity	O
appears	O
to	O
be	O
related	O
to	O
the	O
length	O
of	O
professional	O
exposure	O
.	O

Oral	O
immunotherapy	O
with	O
inactivated	O
non	B-bacteria
-	I-bacteria
typeable	I-bacteria
Haemophilus	I-bacteria
influenzae	I-bacteria
(	O
NTHi	B-bacteria
)	O
prevents	O
exacerbations	O
of	O
chronic	O
obstructive	O
pulmonary	O
disease	O
,	O
but	O
the	O
mechanism	O
is	O
unclear	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
mechanism	O
of	O
protection	O
.	O

This	O
was	O
a	O
placebo	O
versus	O
active	O
prospective	O
study	O
over	O
3	O
months	O
in	O
64	O
smokers	O
.	O

The	O
active	O
treatment	O
was	O
three	O
courses	O
of	O
oral	O
NTHi	B-bacteria
given	O
at	O
monthly	O
intervals	O
,	O
followed	O
by	O
measurement	O
of	O
bacteriological	O
and	O
immunological	O
parameters	O
.	O

The	O
results	O
can	O
be	O
summarized	O
:	O
(	O
i	O
)	O
NTHi	O
-	O
specific	O
T	O
cells	O
increased	O
in	O
the	O
placebo	O
treatment	O
group	O
over	O
time	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
;	O
(	O
ii	O
)	O
the	O
T	O
`	O
cell	O
response	O
in	O
the	O
oral	O
NTHi	B-bacteria
group	O
started	O
earlier	O
than	O
that	O
in	O
the	O
placebo	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
;	O
and	O
(	O
iii	O
)	O
serum	O
NTHi	O
-	O
specific	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
had	O
significantly	O
greater	O
variation	O
in	O
the	O
placebo	O
group	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

The	O
increase	O
in	O
antibody	O
in	O
placebos	O
over	O
time	O
correlated	O
with	O
exposure	O
to	O
live	O
H	B-bacteria
.	I-bacteria
influenzae	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
determined	O
from	O
culture	O
of	O
gargles	O
;	O
(	O
iv	O
)	O
reduction	O
in	O
saliva	O
lysozyme	O
over	O
time	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
was	O
detected	O
only	O
in	O
the	O
oral	O
NTHi	B-bacteria
treatment	O
group	O
.	O

These	O
data	O
are	O
consistent	O
with	O
T	O
cell	O
priming	O
of	O
gut	O
lymphoid	O
tissue	O
by	O
aspiration	O
of	O
bronchus	O
content	O
into	O
the	O
gut	O
,	O
with	O
oral	O
immunotherapy	O
augmenting	O
this	O
process	O
leading	O
to	O
enhanced	O
bronchus	O
protection	O
.	O

The	O
evidence	O
for	O
protection	O
was	O
a	O
stable	O
IgG	O
antibody	O
level	O
through	O
the	O
study	O
in	O
the	O
oral	O
NTHi	B-bacteria
treatment	O
group	O
,	O
contrasting	O
with	O
an	O
increase	O
in	O
antibody	O
correlating	O
with	O
exposure	O
of	O
the	O
airways	O
to	O
H	B-bacteria
.	I-bacteria
influenzae	I-bacteria
in	O
the	O
placebo	O
group	O
.	O

Saliva	O
lysozyme	O
was	O
a	O
useful	O
biomarker	O
of	O
mucosal	O
inflammation	O
,	O
falling	O
after	O
oral	O
NTHi	B-bacteria
consistent	O
with	O
a	O
reduction	O
in	O
the	O
level	O
of	O
intralumenal	O
inflammation	O
.	O

This	O
study	O
examined	O
caries	O
level	O
,	O
amount	O
of	O
calculus	O
,	O
and	O
oral	O
microbial	O
environment	O
in	O
gastrostomy	O
tube	O
(	O
GT	O
)	O
-	O
fed	O
children	O
compared	O
with	O
healthy	O
children	O
and	O
children	O
with	O
disabilities	O
orally	O
fed	O
(	O
PO	O
)	O
.	O

STUDY	O
The	O
study	O
group	O
consisted	O
of	O
12	O
GT	O
-	O
fed	O
children	O
and	O
the	O
two	O
control	O
groups	O
consisted	O
of	O
16	O
children	O
with	O
disabilities	O
orally	O
fed	O
and	O
17	O
healthy	O
children	O
.	O

DMF	O
-	O
T	O
/	O
dmf	O
-	O
t	O
index	O
,	O
calculus	O
index	O
,	O
Mutans	B-bacteria
Streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
,	O
Lactobacilli	B-bacteria
(	O
LB	B-bacteria
)	O
levels	O
and	O
salivary	O
buffer	O
capacity	O
were	O
examined	O
.	O

DMF	O
-	O
T	O
/	O
dmf	O
-	O
t	O
index	O
was	O
significantly	O
lower	O
in	O
the	O
tube	O
-	O
fed	O
group	O
.	O

Calculus	O
index	O
was	O
highest	O
in	O
the	O
tube	O
-	O
fed	O
group	O
.	O

MS	B-bacteria
and	O
LB	B-bacteria
levels	O
were	O
the	O
lowest	O
in	O
the	O
tube	O
-	O
fed	O
children	O
.	O

Correlation	O
was	O
found	O
between	O
MS	B-bacteria
and	O
DMF	O
-	O
T	O
/	O
dmf	O
-	O
t	O
.	O
Tube	O
-	O
fed	O
children	O
demonstrated	O
significantly	O
higher	O
calculus	O
levels	O
and	O
less	O
caries	O
,	O
MS	B-bacteria
,	O
and	O
LB	B-bacteria
levels	O
then	O
healthy	O
children	O
or	O
children	O
with	O
disabilities	O
eating	O
PO	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
smoking	O
cessation	O
alters	O
the	O
subgingival	O
microbial	O
profile	O
;	O
however	O
,	O
the	O
response	O
of	O
individual	O
bacteria	O
within	O
this	O
ecosystem	O
has	O
not	O
been	O
well	O
studied	O
.	O

The	O
aim	O
of	O
this	O
investigation	O
,	O
therefore	O
,	O
was	O
to	O
longitudinally	O
examine	O
the	O
effect	O
of	O
smoking	O
cessation	O
on	O
the	O
prevalence	O
and	O
levels	O
of	O
selected	O
subgingival	O
bacteria	O
using	O
molecular	O
approaches	O
for	O
bacterial	O
identification	O
and	O
enumeration	O
.	O

Subgingival	O
plaque	O
was	O
collected	O
from	O
22	O
smokers	O
at	O
the	O
baseline	O
and	O
12	O
months	O
following	O
periodontal	O
nonsurgical	O
management	O
and	O
smoking	O
cessation	O
counseling	O
.	O

The	O
prevalence	O
and	O
abundance	O
of	O
selected	O
organisms	O
were	O
examined	O
using	O
nested	O
PCR	O
and	O
multiplexed	O
bead	O
-	O
based	O
flow	O
cytometry	O
.	O

Eleven	O
subjects	O
successfully	O
quit	O
smoking	O
over	O
12	O
months	O
(	O
quitters	O
)	O
,	O
while	O
11	O
continued	O
to	O
smoke	O
throughout	O
(	O
smokers	O
)	O
.	O

Smoking	O
cessation	O
led	O
to	O
a	O
decrease	O
in	O
the	O
prevalence	O
of	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
and	O
Dialister	B-bacteria
pneumosintes	I-bacteria
at	O
12	O
months	O
and	O
in	O
the	O
levels	O
of	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Filifactor	B-bacteria
alocis	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

Smoking	O
cessation	O
also	O
led	O
to	O
an	O
increase	O
in	O
the	O
levels	O
of	O
Veillonella	B-bacteria
parvula	I-bacteria
.	O

Following	O
nonsurgical	O
periodontal	O
therapy	O
and	O
smoking	O
cessation	O
,	O
the	O
subgingival	O
microbiome	O
is	O
recolonized	O
by	O
a	O
greater	O
number	O
of	O
health	O
-	O
associated	O
species	O
and	O
there	O
are	O
a	O
significantly	O
lower	O
prevalence	O
and	O
abundance	O
of	O
putative	O
periodontal	O
pathogens	O
.	O

The	O
results	O
indicate	O
a	O
critical	O
role	O
for	O
smoking	O
cessation	O
counseling	O
in	O
periodontal	O
therapy	O
for	O
smokers	O
in	O
order	O
to	O
effectively	O
alter	O
the	O
subgingival	O
microbiome	O
.	O

To	O
study	O
a	O
possible	O
influence	O
of	O
betel	O
chewing	O
on	O
the	O
composition	O
of	O
the	O
oral	O
microflora	O
in	O
plaque	O
and	O
saliva	O
and	O
on	O
oral	O
health	O
parameters	O
as	O
well	O
as	O
a	O
possible	O
betel	O
effect	O
on	O
oral	O
bacteria	O
in	O
vitro	O
.	O

Thirty	O
-	O
two	O
adults	O
(	O
16	O
betel	O
chewers	O
and	O
16	O
non	O
-	O
betel	O
-	O
chewing	O
controls	O
)	O
of	O
the	O
Karen	O
Hill	O
tribe	O
in	O
Thailand	O
were	O
investigated	O
.	O

Saliva	O
samples	O
and	O
2	O
pooled	O
supragingival	O
plaque	O
samples	O
were	O
taken	O
from	O
each	O
individual	O
for	O
microbial	O
analysis	O
with	O
culture	O
and	O
4	O
subgingival	O
samples	O
for	O
analysis	O
with	O
the	O
DNA	O
-	O
DNA	O
hybridization	O
method	O
against	O
12	O
periodontitis	O
associated	O
bacterial	O
species	O
.	O

Caries	O
(	O
DMFS	O
)	O
,	O
plaque	O
(	O
PlI	O
%	O
)	O
and	O
bleeding	O
on	O
probing	O
(	O
%	O
BoP	O
)	O
was	O
registered	O
as	O
well	O
as	O
number	O
of	O
sites	O
with	O
>	O
5mm	O
probing	O
pocket	O
depth	O
(	O
PPD	O
)	O
.	O

Water	O
extract	O
of	O
the	O
betel	O
(	O
areca	O
chatechu	O
)	O
nut	O
was	O
tested	O
for	O
its	O
antimicrobial	O
effect	O
in	O
vitro	O
against	O
10	O
oral	O
bacterial	O
species	O
with	O
the	O
agar	O
diffusion	O
method	O
.	O

An	O
antimicrobial	O
effect	O
of	O
betel	O
nut	O
water	O
extract	O
was	O
found	O
on	O
the	O
oral	O
microorganisms	O
in	O
vitro	O
.	O

The	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
in	O
saliva	O
were	O
low	O
or	O
absent	O
in	O
both	O
chewers	O
and	O
controls	O
.	O

The	O
prevalence	O
of	O
the	O
periodontitis	O
associated	O
bacteria	O
was	O
>	O
90	O
%	O
.	O

Betel	O
chewers	O
had	O
significantly	O
lower	O
levels	O
of	O
some	O
bacteria	O
in	O
subgingival	O
plaque	O
(	O
Prevotella	B-bacteria
intermedia	I-bacteria
p	O
<	O
0	O
.	O
001	O
)	O
than	O
non	O
-	O
chewers	O
.	O

This	O
study	O
population	O
was	O
low	O
in	O
missing	O
teeth	O
(	O
mean	O
0	O
.	O
7	O
and	O
0	O
.	O
3	O
)	O
,	O
caries	O
decay	O
(	O
DS	O
2	O
.	O
1	O
vs	O
1	O
.	O
6	O
)	O
,	O
and	O
number	O
of	O
deep	O
pockets	O
(	O
mean	O
1	O
.	O
9	O
vs	O
1	O
.	O
3	O
)	O
.	O

Great	O
variation	O
in	O
oral	O
hygiene	O
(	O
PlI	O
and	O
BoP	O
)	O
between	O
the	O
subjects	O
was	O
seen	O
.	O

An	O
antimicrobial	O
effect	O
of	O
the	O
betel	O
nut	O
was	O
found	O
in	O
vitro	O
and	O
with	O
a	O
possible	O
effect	O
also	O
in	O
vivo	O
;	O
however	O
it	O
did	O
not	O
seem	O
to	O
influence	O
clinical	O
parameters	O
such	O
as	O
plaque	O
index	O
,	O
caries	O
prevalence	O
(	O
DMFS	O
)	O
,	O
bleeding	O
on	O
probing	O
and	O
number	O
of	O
deep	O
pockets	O
.	O

The	O
number	O
of	O
incidents	O
involving	O
sharks	O
and	O
humans	O
at	O
beaches	O
in	O
Recife	O
,	O
on	O
the	O
north	O
-	O
eastern	O
Brazilian	O
coast	O
,	O
is	O
among	O
the	O
highest	O
worldwide	O
.	O

In	O
addition	O
,	O
wound	O
infections	O
in	O
survivors	O
are	O
common	O
;	O
but	O
the	O
nature	O
and	O
risk	O
of	O
the	O
aetiological	O
agents	O
is	O
unknown	O
.	O

In	O
the	O
present	O
study	O
,	O
81	O
potential	O
bacterial	O
pathogens	O
were	O
identified	O
in	O
the	O
oral	O
cavity	O
of	O
sharks	O
involved	O
in	O
attacks	O
in	O
Recife	O
,	O
and	O
were	O
subjected	O
to	O
antibiotic	O
susceptibility	O
tests	O
using	O
the	O
standardized	O
disc	O
-	O
diffusion	O
method	O
.	O

The	O
majority	O
were	O
enterobacteria	B-bacteria
such	O
as	O
Enterobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Citrobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Proteus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Providencia	B-bacteria
alcalifaciens	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Moellerella	B-bacteria
wisconcensis	I-bacteria
and	O
Leclercia	B-bacteria
adecarboxylata	I-bacteria
.	O

Other	O
Gram	O
-	O
negative	O
bacteria	O
included	O
Vibrio	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Burkholderia	B-bacteria
cepaciaQ	I-bacteria
,	O
Acinetobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	O

In	O
addition	O
,	O
coagulase	O
-	O
positive	O
and	O
coagulase	O
-	O
negative	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Enterococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Micrococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
identified	O
,	O
besides	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
from	O
the	O
viridans	O
group	O
.	O

Resistance	O
was	O
especially	O
found	O
in	O
the	O
Proteus	B-bacteria
mirabilis	I-bacteria
and	O
Citrobacter	B-bacteria
freundii	I-bacteria
,	O
and	O
ranged	O
from	O
4	O
to	O
6	O
antibiotics	O
out	O
of	O
the	O
13	O
tested	O
.	O

Gentamicin	O
and	O
vancomycin	O
were	O
the	O
most	O
effective	O
against	O
Gram	O
-	O
positive	O
cocci	O
strains	O
,	O
whereas	O
levofloxacin	O
was	O
fully	O
inhibitory	O
against	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
.	O

These	O
data	O
are	O
discussed	O
in	O
light	O
of	O
a	O
retrospective	O
evaluation	O
of	O
the	O
medical	O
records	O
of	O
three	O
shark	O
victims	O
treated	O
at	O
Restauracao	O
Hospital	O
in	O
Recife	O
.	O

An	O
important	O
risk	O
factor	O
for	O
nosocomial	O
infection	O
in	O
an	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
is	O
prior	O
colonization	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
determine	O
the	O
spectrum	O
of	O
bacterial	O
colonization	O
and	O
predisposing	O
risk	O
factors	O
in	O
patients	O
being	O
admitted	O
to	O
an	O
ICU	O
in	O
India	O
,	O
with	O
special	O
emphasis	O
on	O
extended	O
-	O
spectrum	O
beta	O
-	O
lactamase	O
(	O
ESBL	O
)	O
-	O
and	O
metallo	O
-	O
beta	O
-	O
lactamase	O
(	O
MBL	O
)	O
-	O
producing	O
Gram	O
-	O
negative	O
bacteria	O
.	O

Nasal	O
,	O
oral	O
and	O
rectal	O
swab	O
samples	O
were	O
collected	O
and	O
processed	O
for	O
isolation	O
of	O
ESBL	O
-	O
producing	O
Gram	O
-	O
negative	O
bacteria	O
and	O
MBL	O
-	O
producing	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Acinetobacter	B-bacteria
species	I-bacteria
.	O

Bacterial	O
colonization	O
(	O
of	O
one	O
or	O
more	O
sites	O
)	O
on	O
admission	O
was	O
detected	O
in	O
51	O
out	O
of	O
96	O
patients	O
included	O
in	O
the	O
study	O
.	O

Non	O
-	O
fermenters	O
,	O
i	O
.	O
e	O
.	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
and	O
Acinetobacter	B-bacteria
baumannii	I-bacteria
,	O
were	O
the	O
most	O
common	O
colonizers	O
,	O
present	O
in	O
37	O
patients	O
,	O
with	O
simultaneous	O
colonization	O
in	O
12	O
patients	O
.	O

A	O
total	O
of	O
16	O
patients	O
were	O
colonized	O
with	O
MBL	O
-	O
producing	O
members	O
of	O
the	O
family	O
Enterobacteriaceae	B-bacteria
,	O
out	O
of	O
which	O
11	O
isolates	O
(	O
from	O
5	O
patients	O
)	O
were	O
also	O
carrying	O
ESBL	O
-	O
encoding	O
genes	O
.	O

As	O
for	O
MBLs	O
,	O
most	O
of	O
our	O
patients	O
have	O
shown	O
colonization	O
with	O
ESBL	O
-	O
producing	O
bacteria	O
.	O

On	O
admission	O
,	O
47	O
of	O
51	O
patients	O
(	O
92	O
%	O
)	O
have	O
been	O
colonized	O
by	O
ESBL	O
-	O
producing	O
members	O
of	O
the	O
family	O
Enterobacteriaceae	B-bacteria
,	O
at	O
one	O
or	O
more	O
of	O
the	O
three	O
anatomical	O
sites	O
.	O

The	O
most	O
common	O
MBL	O
subtype	O
was	O
bla	O
(	O
IMP	O
)	O
(	O
51	O
.	O
56	O
%	O
)	O
,	O
whereas	O
bla	O
(	O
CTX	O
)	O
was	O
the	O
most	O
common	O
gene	O
(	O
84	O
.	O
9	O
%	O
)	O
identified	O
among	O
ESBL	O
producers	O
.	O

Risk	O
factors	O
for	O
colonization	O
on	O
admission	O
to	O
the	O
ICU	O
were	O
hospitalization	O
for	O
more	O
than	O
48	O
h	O
,	O
use	O
of	O
>	O
or	O
=	O
3	O
groups	O
of	O
antibiotics	O
,	O
co	O
-	O
morbidities	O
and	O
mechanical	O
ventilation	O
for	O
more	O
than	O
48	O
h	O
prior	O
to	O
ICU	O
admission	O
.	O

There	O
is	O
an	O
increasing	O
incidence	O
of	O
MBLs	O
and	O
ESBLs	O
in	O
the	O
Indian	O
population	O
.	O

The	O
identified	O
risk	O
factors	O
can	O
be	O
used	O
as	O
a	O
guide	O
for	O
empiric	O
antibiotic	O
therapy	O
targeted	O
to	O
these	O
resistant	O
bacteria	O
.	O

Xylitol	O
-	O
sweetened	O
chewing	O
gum	O
has	O
cariostatic	O
properties	O
,	O
but	O
is	O
not	O
suitable	O
for	O
all	O
patients	O
.	O

This	O
study	O
evaluated	O
the	O
effect	O
of	O
xylitol	O
rinse	O
on	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
levels	O
in	O
the	O
mouth	O
.	O

One	O
hundred	O
and	O
five	O
subjects	O
with	O
high	O
salivary	O
MS	B-bacteria
levels	O
were	O
randomly	O
assigned	O
to	O
one	O
of	O
three	O
groups	O
.	O

Subjects	O
in	O
the	O
positive	O
control	O
group	O
(	O
N	O
=	O
35	O
)	O
chewed	O
two	O
xylitol	O
gum	O
pellets	O
for	O
at	O
least	O
5	O
minutes	O
three	O
times	O
daily	O
(	O
xylitol	O
dose	O
:	O
4	O
.	O
3g	O
/	O
day	O
)	O
.	O

The	O
experimental	O
group	O
(	O
N	O
=	O
36	O
)	O
rinsed	O
with	O
20	O
mL	O
of	O
an	O
aqueous	O
solution	O
of	O
xylitol	O
twice	O
daily	O
for	O
60	O
seconds	O
(	O
dose	O
:	O
4	O
.	O
4	O
g	O
/	O
day	O
)	O
.	O

The	O
negative	O
control	O
group	O
(	O
N	O
=	O
34	O
)	O
used	O
neither	O
product	O
.	O

No	O
attempt	O
was	O
made	O
to	O
change	O
the	O
subjects	O
'	O
diet	O
.	O

Mean	O
MS	B-bacteria
levels	O
at	O
baseline	O
were	O
5	O
.	O
6	O
(	O
0	O
.	O
1	O
)	O
in	O
positive	O
control	O
,	O
5	O
.	O
4	O
(	O
0	O
.	O
1	O
)	O
in	O
experimental	O
,	O
and	O
5	O
.	O
5	O
(	O
0	O
.	O
1	O
)	O
in	O
negative	O
control	O
groups	O
.	O

After	O
3	O
months	O
,	O
MS	B-bacteria
levels	O
were	O
4	O
.	O
4	O
(	O
0	O
.	O
2	O
)	O
,	O
4	O
.	O
4	O
(	O
0	O
.	O
2	O
)	O
,	O
and	O
4	O
.	O
9	O
(	O
0	O
.	O
2	O
)	O
,	O
respectively	O
.	O

Differences	O
between	O
groups	O
were	O
not	O
significant	O
by	O
ANOVA	O
(	O
p	O
=	O
.	O
2	O
)	O
;	O
however	O
,	O
MS	B-bacteria
levels	O
tended	O
to	O
be	O
lower	O
in	O
the	O
experimental	O
and	O
positive	O
control	O
groups	O
.	O

Xylitol	O
rinse	O
and	O
chewing	O
gum	O
caused	O
a	O
similar	O
but	O
statistically	O
insignificant	O
reduction	O
in	O
MS	B-bacteria
levels	O
in	O
the	O
mouth	O
.	O

The	O
research	O
described	O
here	O
was	O
aimed	O
at	O
the	O
selection	O
of	O
oral	O
bacteria	O
that	O
displayed	O
properties	O
compatible	O
with	O
their	O
potential	O
use	O
as	O
probiotics	O
for	O
the	O
pharyngeal	O
mucosa	O
.	O

We	O
included	O
in	O
the	O
study	O
56	O
bacteria	O
newly	O
isolated	O
from	O
the	O
pharynges	O
of	O
healthy	O
donors	O
,	O
which	O
were	O
identified	O
at	O
the	O
intraspecies	O
level	O
and	O
characterized	O
in	O
vitro	O
for	O
their	O
probiotic	O
potential	O
.	O

The	O
experiments	O
led	O
us	O
to	O
select	O
two	O
potential	O
probiotic	O
bacterial	O
strains	O
(	O
Streptococcus	B-bacteria
salivarius	I-bacteria
RS1	I-bacteria
and	O
ST3	B-bacteria
)	O
and	O
to	O
compare	O
them	O
with	O
the	O
prototype	O
oral	O
probiotic	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strain	I-bacteria
K12	I-bacteria
.	O

All	O
three	O
strains	O
efficiently	O
bound	O
to	O
FaDu	O
human	O
epithelial	O
pharyngeal	O
cells	O
and	O
thereby	O
antagonized	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
adhesion	O
and	O
growth	O
.	O

All	O
were	O
sensitive	O
to	O
a	O
variety	O
of	O
antibiotics	O
routinely	O
used	O
for	O
the	O
control	O
of	O
upper	O
respiratory	O
tract	O
infections	O
.	O

Immunological	O
in	O
vitro	O
testing	O
on	O
a	O
FaDu	O
layer	O
revealed	O
different	O
responses	O
to	O
RS1	B-bacteria
,	O
ST3	B-bacteria
,	O
and	O
K12	B-bacteria
.	O

RS1	B-bacteria
and	O
ST3	B-bacteria
modulated	O
NF	O
-	O
kappaB	O
activation	O
and	O
biased	O
proinflammatory	O
cytokines	O
at	O
baseline	O
and	O
after	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
induction	O
.	O

In	O
conclusion	O
,	O
we	O
suggest	O
that	O
the	O
selected	O
commensal	O
streptococci	B-bacteria
represent	O
potential	O
pharyngeal	O
probiotic	O
candidates	O
.	O

They	O
could	O
display	O
a	O
good	O
degree	O
of	O
adaptation	O
to	O
the	O
host	O
and	O
possess	O
potential	O
immunomodulatory	O
and	O
anti	O
-	O
inflammatory	O
properties	O
.	O

Our	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
potent	O
protective	O
effects	O
of	O
oral	O
administration	O
of	O
probiotic	O
Lactobacillus	B-bacteria
strains	I-bacteria
against	O
influenza	O
virus	O
(	O
Flu	O
)	O
infection	O
in	O
a	O
mouse	O
model	O
.	O

Lyophilized	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
GG	I-bacteria
(	O
LGG	B-bacteria
)	O
and	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
TMC0356	I-bacteria
(	O
TMC0356	B-bacteria
)	O
were	O
orally	O
administered	O
to	O
BALB	O
/	O
c	O
mice	O
for	O
19	O
days	O
.	O

The	O
test	O
mice	O
were	O
intranasally	O
infected	O
with	O
Flu	O
A	O
/	O
PR	O
/	O
8	O
/	O
34	O
(	O
H1N1	O
)	O
on	O
day	O
14	O
,	O
and	O
any	O
changes	O
in	O
clinical	O
symptoms	O
were	O
monitored	O
.	O

After	O
6	O
days	O
of	O
infection	O
,	O
the	O
mice	O
were	O
killed	O
and	O
pulmonary	O
virus	O
titres	O
were	O
determined	O
.	O

The	O
clinical	O
symptom	O
scores	O
of	O
mice	O
administered	O
oral	O
LGG	B-bacteria
and	O
TMC0356	B-bacteria
were	O
significantly	O
ameliorated	O
,	O
compared	O
to	O
those	O
of	O
the	O
control	O
mice	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
pulmonary	O
virus	O
titres	O
of	O
the	O
mice	O
fed	O
LGG	B-bacteria
and	O
TMC0356	B-bacteria
were	O
also	O
significantly	O
decreased	O
compared	O
to	O
those	O
of	O
control	O
mice	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

These	O
results	O
indicate	O
that	O
oral	O
administration	O
of	O
lactobacilli	B-bacteria
,	O
such	O
as	O
LGG	B-bacteria
and	O
TMC0356	B-bacteria
,	O
might	O
protect	O
a	O
host	O
animal	O
against	O
Flu	O
infection	O
.	O

These	O
results	O
demonstrate	O
that	O
oral	O
administration	O
of	O
selected	O
lactobacilli	B-bacteria
might	O
protect	O
host	O
animals	O
from	O
Flu	O
infection	O
by	O
interactions	O
with	O
gut	O
immunity	O
.	O

Clinical	O
studies	O
with	O
dentifrices	O
formulated	O
with	O
antimicrobial	O
ingredients	O
typically	O
examine	O
the	O
effects	O
of	O
their	O
use	O
on	O
clinical	O
parameters	O
of	O
dental	O
plaque	O
and	O
gingivitis	O
.	O

The	O
effects	O
of	O
routine	O
use	O
of	O
these	O
formulations	O
on	O
the	O
microorganisms	O
found	O
in	O
the	O
distinct	O
regions	O
of	O
the	O
human	O
mouth	O
remain	O
unexplored	O
.	O

The	O
present	O
cross	O
-	O
over	O
design	O
clinical	O
study	O
compared	O
the	O
effects	O
of	O
brushing	O
with	O
a	O
recently	O
formulated	O
dentifrice	O
with	O
1	O
%	O
zinc	O
citrate	O
to	O
a	O
control	O
dentifrice	O
on	O
oral	O
bacteria	O
found	O
in	O
oral	O
niches	O
.	O

A	O
total	O
of	O
35	O
adults	O
completed	O
a	O
1	O
-	O
week	O
wash	O
-	O
out	O
phase	O
prior	O
to	O
providing	O
baseline	O
samples	O
of	O
dental	O
plaque	O
on	O
the	O
teeth	O
,	O
gums	O
,	O
saliva	O
and	O
scrapings	O
from	O
cheeks	O
and	O
tongue	O
to	O
quantify	O
anaerobic	O
bacteria	O
.	O

Subjects	O
brushed	O
twice	O
daily	O
with	O
a	O
randomly	O
assigned	O
test	O
dentifrice	O
for	O
the	O
next	O
13	O
days	O
.	O

On	O
the	O
14th	O
day	O
,	O
they	O
arrived	O
at	O
the	O
dental	O
clinic	O
prior	O
to	O
oral	O
hygiene	O
and	O
provided	O
samples	O
similar	O
to	O
baseline	O
samples	O
for	O
microbiological	O
examinations	O
.	O

Subjects	O
brushed	O
with	O
the	O
test	O
formulation	O
they	O
used	O
in	O
the	O
previous	O
13	O
days	O
,	O
prior	O
to	O
providing	O
additional	O
samples	O
at	O
5	O
-	O
h	O
post	O
-	O
brushing	O
for	O
microbial	O
assessments	O
.	O

An	O
additional	O
wash	O
-	O
out	O
phase	O
was	O
assigned	O
to	O
subjects	O
prior	O
to	O
completing	O
the	O
study	O
with	O
the	O
alternate	O
test	O
dentifrice	O
.	O

Analyses	O
of	O
log10	O
-	O
transformed	O
microbial	O
counts	O
indicated	O
no	O
statistical	O
differences	O
in	O
the	O
baseline	O
samples	O
from	O
each	O
oral	O
site	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
,	O
while	O
brushing	O
with	O
the	O
zinc	O
citrate	O
dentifrice	O
resulted	O
in	O
a	O
significant	O
reduction	O
in	O
bacteria	O
in	O
each	O
post	O
-	O
brushing	O
oral	O
site	O
versus	O
the	O
control	O
paste	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Brushing	O
with	O
the	O
zinc	O
citrate	O
dentifrice	O
resulted	O
in	O
38	O
.	O
56	O
%	O
,	O
23	O
.	O
57	O
%	O
,	O
26	O
.	O
24	O
%	O
and	O
29	O
.	O
1	O
%	O
decreases	O
in	O
anaerobic	O
bacteria	O
from	O
dental	O
plaque	O
,	O
tongue	O
,	O
cheek	O
and	O
saliva	O
,	O
respectively	O
,	O
in	O
the	O
overnight	O
samples	O
collected	O
on	O
the	O
14th	O
day	O
versus	O
the	O
control	O
.	O

Similarly	O
,	O
the	O
5	O
-	O
h	O
post	O
-	O
brushing	O
samples	O
indicated	O
24	O
.	O
8	O
%	O
,	O
34	O
.	O
25	O
%	O
,	O
37	O
.	O
98	O
%	O
and	O
38	O
.	O
31	O
%	O
reductions	O
in	O
anaerobic	O
organisms	O
when	O
compared	O
with	O
control	O
.	O

Toothbrushing	O
with	O
the	O
zinc	O
citrate	O
formulation	O
resulted	O
in	O
significant	O
reductions	O
in	O
oral	O
bacteria	O
from	O
all	O
of	O
the	O
intraoral	O
locations	O
.	O

To	O
determine	O
the	O
antibacterial	O
activity	O
of	O
six	O
kinds	O
of	O
natural	O
herbs	O
in	O
Yunnan	O
on	O
normal	O
oral	O
predominant	O
bacteria	O
in	O
vitro	O
.	O

Agar	O
dilution	O
method	O
,	O
the	O
antimicrobial	O
susceptibility	O
testing	O
of	O
anaerobes	O
which	O
was	O
recommended	O
by	O
National	O
Committee	O
for	O
Clinical	O
Laboratory	O
Standard	O
(	O
NCCLs	O
)	O
,	O
was	O
used	O
to	O
determine	O
the	O
antimicrobial	O
susceptibility	O
of	O
herbs	O
to	O
21	O
kinds	O
of	O
oral	O
model	O
strains	O
and	O
clinical	O
isolates	O
.	O

The	O
results	O
were	O
expressed	O
by	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
.	O

All	O
six	O
kinds	O
of	O
herbs	O
were	O
effective	O
to	O
the	O
oral	O
predominant	O
bacteria	O
.	O

For	O
the	O
ten	O
kinds	O
of	O
cariogenic	O
bacteria	O
,	O
the	O
MIC	O
of	O
caesalpinia	O
sappan	O
lignum	O
was	O
between	O
5	O
-	O
10	O
mg	O
x	O
mL	O
(	O
-	O
1	O
)	O
,	O
and	O
the	O
MIC	O
of	O
other	O
herbs	O
was	O
above	O
20	O
mg	O
x	O
mL	O
(	O
-	O
1	O
)	O
.	O

For	O
the	O
eleven	O
kinds	O
of	O
predominant	O
bacteria	O
which	O
normally	O
involved	O
in	O
pulp	O
periapical	O
disease	O
and	O
periodontitis	O
,	O
the	O
MIC	O
of	O
caesalpinia	O
sappan	O
lignum	O
was	O
below	O
0	O
.	O
062	O
5	O
mg	O
x	O
mL	O
(	O
-	O
1	O
)	O
,	O
and	O
the	O
MIC	O
of	O
the	O
terminalia	O
chebula	O
retz	O
was	O
between	O
10	O
-	O
20	O
mg	O
x	O
mL	O
(	O
-	O
1	O
)	O
,	O
and	O
the	O
others	O
were	O
above	O
20	O
mg	O
x	O
mL	O
(	O
-	O
1	O
)	O
.	O

The	O
six	O
kinds	O
of	O
herbs	O
in	O
Yunnan	O
could	O
be	O
used	O
in	O
treatment	O
or	O
prevention	O
of	O
oral	O
bacterial	O
diseases	O
.	O

This	O
study	O
was	O
conducted	O
to	O
determine	O
if	O
microbial	O
infection	O
was	O
a	O
significant	O
factor	O
in	O
patients	O
with	O
undiagnosed	O
craniofacial	O
pain	O
.	O

Of	O
the	O
150	O
patients	O
from	O
whom	O
intra	O
-	O
bony	O
cultures	O
were	O
obtained	O
,	O
23	O
different	O
groups	O
of	O
isolates	O
were	O
obtained	O
.	O

There	O
were	O
49	O
(	O
32	O
.	O
67	O
%	O
)	O
patients	O
whose	O
cultures	O
exhibited	O
growth	O
of	O
microbes	O
other	O
than	O
routine	O
oral	O
flora	O
,	O
mixed	O
skin	O
flora	O
or	O
routine	O
respiratory	O
flora	O
.	O

The	O
most	O
common	O
was	O
of	O
the	O
Streptococcus	B-bacteria
species	I-bacteria
(	O
11	O
or	O
22	O
.	O
91	O
%	O
)	O
of	O
the	O
49	O
.	O

Sixty	O
-	O
seven	O
(	O
67	O
)	O
(	O
44	O
.	O
67	O
%	O
)	O
of	O
the	O
total	O
cultures	O
demonstrated	O
the	O
growth	O
of	O
mixed	O
skin	O
flora	O
,	O
nineteen	O
(	O
12	O
.	O
67	O
%	O
)	O
demonstrated	O
the	O
growth	O
of	O
routine	O
respiratory	O
flora	O
and	O
sixteen	O
(	O
10	O
.	O
67	O
%	O
)	O
demonstrated	O
the	O
growth	O
of	O
routine	O
oral	O
flora	O
.	O

No	O
bacterial	O
isolates	O
were	O
found	O
in	O
16	O
(	O
10	O
.	O
67	O
%	O
)	O
cultures	O
.	O

The	O
most	O
common	O
histological	O
diagnoses	O
of	O
those	O
who	O
exhibited	O
pathogenic	O
microbial	O
growth	O
were	O
,	O
in	O
order	O
:	O
1	O
.	O
focal	O
osteoporotic	O
marrow	O
defect	O
;	O
2	O
.	O
ischemic	O
osteonecrosis	O
;	O
and	O
3	O
.	O
chronic	O
nonsuppurative	O
osteomyelitis	O
.	O

To	O
elucidate	O
the	O
effects	O
of	O
mucosal	O
care	O
on	O
colonization	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
infection	O
of	O
Candida	O
species	O
,	O
we	O
randomized	O
50	O
functionally	O
dependent	O
nursing	O
home	O
residents	O
,	O
mean	O
age	O
76	O
.	O
1	O
(	O
+	O
/	O
-	O
7	O
.	O
8	O
years	O
)	O
,	O
76	O
%	O
females	O
,	O
to	O
receive	O
oral	O
professional	O
care	O
with	O
or	O
without	O
mucosal	O
care	O
.	O

During	O
12	O
months	O
of	O
follow	O
-	O
up	O
,	O
significant	O
reduction	O
in	O
the	O
numbers	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
saliva	O
and	O
dental	O
plaque	O
samples	O
were	O
observed	O
in	O
both	O
treatment	O
groups	O
.	O

However	O
,	O
there	O
was	O
no	O
reduction	O
in	O
the	O
numbers	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
tongue	O
samples	O
in	O
the	O
non	O
-	O
mucosal	O
group	O
(	O
p	O
=	O
0	O
.	O
150	O
)	O
.	O

In	O
the	O
comparison	O
between	O
the	O
treatment	O
with	O
and	O
without	O
mucosal	O
care	O
,	O
the	O
treatment	O
with	O
mucosal	O
care	O
showed	O
a	O
significant	O
inhibition	O
effects	O
on	O
numbers	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
on	O
the	O
tongue	O
surface	O
at	O
6	O
months	O
after	O
the	O
treatment	O
as	O
compared	O
with	O
the	O
treatment	O
without	O
mucosal	O
care	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
.	O

Mucosal	O
care	O
was	O
not	O
associated	O
with	O
any	O
significant	O
reduction	O
in	O
the	O
rate	O
of	O
opportunistic	O
infection	O
with	O
Candida	O
species	O
in	O
any	O
of	O
the	O
three	O
sites	O
.	O

However	O
,	O
more	O
subjects	O
without	O
mucosal	O
care	O
had	O
Candida	O
infection	O
in	O
dental	O
plaque	O
during	O
the	O
follow	O
-	O
up	O
(	O
p	O
=	O
0	O
.	O
046	O
)	O
.	O

Professional	O
dental	O
care	O
with	O
(	O
versus	O
without	O
)	O
mucosal	O
care	O
had	O
no	O
effect	O
on	O
mutans	B-bacteria
streptococci	I-bacteria
colonization	O
in	O
saliva	O
or	O
plaque	O
.	O

Lack	O
of	O
mucosal	O
care	O
seemed	O
to	O
be	O
associated	O
with	O
higher	O
rates	O
opportunistic	O
infections	O
with	O
Candida	O
species	O
.	O

Two	O
strains	O
of	O
anaerobic	O
,	O
Gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
belong	O
to	O
two	O
separate	O
taxa	O
.	O

Phylogenetic	O
analysis	O
of	O
full	O
-	O
length	O
16S	O
rRNA	O
gene	O
sequences	O
showed	O
that	O
the	O
strains	O
were	O
both	O
related	O
to	O
,	O
but	O
distinct	O
from	O
,	O
the	O
type	O
strain	O
of	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
.	O

Two	O
novel	O
species	O
,	O
Prevotella	B-bacteria
fusca	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
and	O
Prevotella	B-bacteria
scopos	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
are	O
proposed	O
to	O
accommodate	O
these	O
strains	O
.	O

Both	O
strains	O
were	O
saccharolytic	O
and	O
produced	O
acetic	O
and	O
succinic	O
acids	O
,	O
with	O
lesser	O
amounts	O
of	O
lactic	O
and	O
isovaleric	O
acids	O
,	O
as	O
end	O
products	O
of	O
fermentation	O
,	O
and	O
both	O
were	O
sensitive	O
to	O
20	O
%	O
bile	O
.	O

The	O
principal	O
cellular	O
long	O
-	O
chain	O
fatty	O
acids	O
of	O
both	O
strains	O
were	O
ai	O
-	O
C	O
(	O
15	O
:	O
0	O
)	O
,	O
3	O
-	O
OH	O
i	O
-	O
C	O
(	O
17	O
:	O
0	O
)	O
,	O
3	O
-	O
OH	O
C	O
(	O
16	O
:	O
0	O
)	O
,	O
i	O
-	O
C	O
(	O
15	O
:	O
0	O
)	O
and	O
C	O
(	O
16	O
:	O
0	O
)	O
.	O

The	O
DNA	O
G	O
+	O
C	O
contents	O
of	O
the	O
type	O
strains	O
of	O
Prevotella	B-bacteria
fusca	I-bacteria
(	O
W1435	B-bacteria
(	O
T	O
)	O
=	O
DSM	B-bacteria
22504	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
57946	I-bacteria
(	O
T	O
)	O
)	O
and	O
Prevotella	B-bacteria
scopos	I-bacteria
(	O
W2052	B-bacteria
(	O
T	O
)	O
=	O
DSM	B-bacteria
22613	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
57945	I-bacteria
(	O
T	O
)	O
)	O
were	O
43	O
and	O
41	O
mol	O
%	O
,	O
respectively	O
.	O

The	O
two	O
species	O
could	O
be	O
differentiated	O
by	O
gelatin	O
hydrolysis	O
,	O
cellobiose	O
and	O
ribose	O
fermentation	O
,	O
and	O
production	O
of	O
beta	O
-	O
glucosidase	O
.	O

It	O
has	O
been	O
reported	O
that	O
DNA	O
of	O
oral	O
bacterial	O
species	O
,	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
was	O
detected	O
frequently	O
in	O
specimens	O
of	O
arteriosclerotic	O
vessels	O
.	O

However	O
,	O
the	O
source	O
of	O
DNA	O
,	O
whether	O
from	O
live	O
intact	O
bacteria	O
or	O
a	O
part	O
of	O
the	O
bacteria	O
,	O
has	O
not	O
been	O
identified	O
yet	O
.	O

Moreover	O
,	O
there	O
was	O
no	O
precise	O
evidence	O
concerning	O
involvement	O
of	O
oral	O
bacteria	O
in	O
the	O
progression	O
of	O
arteriosclerosis	O
.	O

We	O
tried	O
to	O
clarify	O
the	O
involvement	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
the	O
mechanisms	O
of	O
development	O
of	O
aortic	O
intimal	O
hyperplasia	O
.	O

Intravenous	O
administration	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
dramatically	O
induced	O
intimal	O
hyperplasia	O
in	O
the	O
mouse	O
model	O
with	O
photochemical	O
impairment	O
of	O
the	O
femoral	O
artery	O
.	O

However	O
there	O
were	O
no	O
changes	O
identified	O
in	O
the	O
mice	O
without	O
aortic	O
impairment	O
,	O
even	O
with	O
the	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
infection	O
.	O

Concomitantly	O
,	O
S100	O
calcium	O
-	O
binding	O
protein	O
A9	O
(	O
S100A9	O
)	O
and	O
the	O
embryonic	O
isoform	O
of	O
myosin	O
heavy	O
chain	O
(	O
SMemb	O
)	O
,	O
a	O
proliferative	O
phenotypic	O
marker	O
of	O
smooth	O
muscle	O
cells	O
,	O
were	O
significantly	O
overexpressed	O
on	O
the	O
surfaces	O
of	O
smooth	O
muscle	O
cells	O
present	O
in	O
the	O
injured	O
blood	O
vessels	O
.	O

Similarly	O
,	O
increased	O
expressions	O
of	O
S100A9	O
and	O
SMemb	O
proteins	O
were	O
observed	O
in	O
aneurismal	O
specimens	O
obtained	O
from	O
P	O
.	O
gingivalis	O
-	O
infected	O
patients	O
.	O

We	O
found	O
that	O
bacteremia	O
induced	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
leads	O
to	O
intimal	O
hyperplasia	O
associated	O
with	O
overexpressions	O
of	O
S100A9	O
and	O
SMemb	O
.	O

Our	O
results	O
strongly	O
suggest	O
that	O
oral	O
-	O
hematogenous	O
spreading	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
is	O
a	O
causative	O
event	O
in	O
the	O
development	O
of	O
aortic	O
hyperplasia	O
in	O
periodontitis	O
patients	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
is	O
generally	O
known	O
as	O
a	O
pathogen	O
of	O
dental	O
caries	O
,	O
and	O
it	O
is	O
also	O
considered	O
to	O
cause	O
bacteremia	O
and	O
infective	O
endocarditis	O
(	O
IE	O
)	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
previously	O
classified	O
into	O
3	O
serotypes	O
,	O
c	O
,	O
e	O
,	O
and	O
f	O
,	O
due	O
to	O
the	O
different	O
chemical	O
compositions	O
of	O
the	O
serotype	O
-	O
specific	O
polysaccharides	O
,	O
which	O
are	O
composed	O
of	O
a	O
rhamnose	O
backbone	O
and	O
glucose	O
side	O
chains	O
.	O

We	O
recently	O
designated	O
non	O
-	O
c	O
/	O
e	O
/	O
f	O
serotype	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
as	O
novel	O
serotype	O
k	O
,	O
which	O
is	O
characterized	O
by	O
a	O
drastic	O
reduction	O
in	O
the	O
amount	O
of	O
the	O
glucose	O
side	O
chain	O
.	O

A	O
common	O
biological	O
feature	O
of	O
novel	O
serotype	O
-	O
k	O
strains	O
is	O
a	O
lower	O
level	O
of	O
cariogenicity	O
due	O
to	O
alterations	O
of	O
several	O
major	O
cell	O
surface	O
protein	O
antigens	O
.	O

As	O
for	O
virulence	O
in	O
blood	O
,	O
these	O
strains	O
survive	O
in	O
blood	O
for	O
a	O
longer	O
duration	O
due	O
to	O
lower	O
antigenicity	O
,	O
while	O
the	O
detection	O
rate	O
of	O
all	O
strains	O
carrying	O
the	O
gene	O
encoding	O
collagen	O
-	O
binding	O
adhesin	O
has	O
been	O
shown	O
to	O
be	O
high	O
.	O

Furthermore	O
,	O
molecular	O
biological	O
analyses	O
of	O
infected	O
heart	O
valve	O
specimens	O
obtained	O
from	O
IE	O
patients	O
revealed	O
a	O
high	O
detection	O
rate	O
of	O
serotype	O
-	O
k	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
serotype	O
-	O
k	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
show	O
low	O
cariogenicity	O
but	O
high	O
virulence	O
in	O
blood	O
as	O
compared	O
to	O
the	O
other	O
serotypes	O
,	O
due	O
to	O
alterations	O
of	O
several	O
cell	O
surface	O
structures	O
.	O

Accumulating	O
evidence	O
suggests	O
the	O
involvement	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
,	O
a	O
periodontal	O
pathogen	O
,	O
in	O
cardiovascular	O
diseases	O
.	O

Clinical	O
specimens	O
of	O
aneurysmal	O
tissue	O
and	O
dental	O
plaque	O
collected	O
from	O
patients	O
infected	O
with	O
or	O
without	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
analyzed	O
.	O

The	O
number	O
of	O
aneurysms	O
in	O
the	O
distal	O
aorta	O
in	O
the	O
P	O
.	O
gingivalis	O
-	O
infected	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
non	O
-	O
infected	O
group	O
.	O

Cellular	O
accumulation	O
of	O
adipocytes	O
in	O
aneurysms	O
was	O
less	O
frequently	O
identified	O
in	O
the	O
infected	O
group	O
.	O

The	O
expression	O
of	O
embryonic	O
myosin	O
heavy	O
chain	O
isoform	O
,	O
a	O
phenotypic	O
marker	O
for	O
proliferative	O
smooth	O
muscle	O
cells	O
,	O
was	O
higher	O
in	O
the	O
P	O
.	O
gingivalis	O
-	O
infected	O
group	O
than	O
the	O
non	O
-	O
infected	O
group	O
.	O

Clinical	O
and	O
histopathological	O
features	O
of	O
aortic	O
aneurysms	O
associated	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
infection	O
are	O
different	O
from	O
those	O
present	O
in	O
non	O
-	O
infected	O
patients	O
.	O

The	O
major	O
characteristic	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
infection	O
associated	O
with	O
aneurysms	O
is	O
smooth	O
muscle	O
cell	O
proliferation	O
in	O
the	O
distal	O
aorta	O
.	O

Bifidobacteria	B-bacteria
are	O
aciduric	O
bacteria	O
that	O
might	O
play	O
a	O
role	O
in	O
the	O
caries	O
process	O
.	O

To	O
test	O
the	O
hypothesis	O
that	O
Bifidobacteria	B-bacteria
behave	O
as	O
caries	O
-	O
associated	O
organisms	O
,	O
as	O
predicted	O
by	O
the	O
ecological	O
plaque	O
hypothesis	O
,	O
we	O
determined	O
salivary	O
levels	O
of	O
Bifidobacteria	B-bacteria
and	O
caries	O
-	O
associated	O
organisms	O
for	O
156	O
older	O
adults	O
.	O

Salivary	O
levels	O
of	O
Bifidobacteria	B-bacteria
,	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
lactobacilli	B-bacteria
,	O
and	O
yeasts	O
were	O
correlated	O
with	O
each	O
other	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
negatively	O
correlated	O
with	O
salivary	O
flow	O
rate	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
positively	O
correlated	O
with	O
plaque	O
index	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Salivary	O
Bifidobacteria	B-bacteria
levels	O
were	O
positively	O
associated	O
with	O
the	O
number	O
of	O
filled	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
decayed	O
(	O
p	O
=	O
0	O
.	O
036	O
)	O
tooth	O
surfaces	O
and	O
negatively	O
associated	O
with	O
number	O
of	O
teeth	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
salivary	O
flow	O
rate	O
(	O
p	O
=	O
0	O
.	O
049	O
)	O
.	O

In	O
regression	O
analyses	O
,	O
caries	O
experience	O
was	O
significantly	O
associated	O
with	O
only	O
salivary	O
Bifidobacteria	B-bacteria
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
yeast	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
and	O
the	O
individual	O
'	O
s	O
age	O
(	O
p	O
=	O
0	O
.	O
021	O
)	O
.	O

Bifidobacteria	B-bacteria
should	O
be	O
regarded	O
as	O
caries	O
-	O
associated	O
organisms	O
whose	O
role	O
in	O
the	O
caries	O
process	O
and	O
as	O
markers	O
of	O
caries	O
risk	O
requires	O
further	O
investigation	O
.	O

A	O
straight	O
,	O
non	O
-	O
sporulating	O
,	O
Gram	O
-	O
variable	O
bacillus	O
(	O
HKU24	O
(	O
T	O
)	O
)	O
was	O
recovered	O
from	O
the	O
blood	O
culture	O
of	O
a	O
patient	O
with	O
metastatic	O
breast	O
carcinoma	O
.	O

After	O
repeated	O
subculturing	O
in	O
BACTEC	O
Plus	O
Anaerobic	O
/	O
F	O
blood	O
culture	O
broth	O
,	O
HKU24	O
(	O
T	O
)	O
grew	O
on	O
brucella	O
agar	O
as	O
non	O
-	O
hemolytic	O
,	O
pinpoint	O
colonies	O
after	O
96	O
h	O
of	O
incubation	O
at	O
37	O
degrees	O
C	O
in	O
an	O
anaerobic	O
environment	O
and	O
aerobic	O
environment	O
with	O
5	O
%	O
CO2	O
.	O

Growth	O
was	O
enhanced	O
with	O
a	O
streak	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

HKU24	O
(	O
T	O
)	O
was	O
non	O
-	O
motile	O
and	O
catalase	O
-	O
negative	O
,	O
but	O
positive	O
for	O
alkaline	O
phosphatase	O
,	O
beta	O
-	O
glucosidase	O
,	O
and	O
alpha	O
-	O
glucosidase	O
.	O

It	O
hydrolyzed	O
phenylphosphonate	O
and	O
reduced	O
resazurin	O
.	O

16S	O
rRNA	O
,	O
groEL	O
,	O
gyrB	O
,	O
recA	O
,	O
and	O
rpoB	O
sequencing	O
showed	O
that	O
HKU24	O
(	O
T	O
)	O
occupies	O
a	O
distinct	O
phylogenetic	O
position	O
among	O
the	O
Leptotrichia	B-bacteria
species	I-bacteria
,	O
being	O
most	O
closely	O
related	O
to	O
Leptotrichia	B-bacteria
trevisanii	I-bacteria
.	O

Using	O
HKU24	O
(	O
T	O
)	O
groEL	O
,	O
gyrB	O
,	O
recA	O
,	O
and	O
rpoB	O
gene	O
-	O
specific	O
primers	O
,	O
fragments	O
of	O
these	O
genes	O
were	O
amplified	O
from	O
one	O
of	O
20	O
oral	O
specimens	O
.	O

Based	O
on	O
phenotypic	O
and	O
genotypic	O
characteristics	O
,	O
we	O
propose	O
a	O
new	O
species	O
,	O
Leptotrichia	B-bacteria
hongkongensis	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
to	O
describe	O
this	O
bacterium	O
.	O

Endotracheal	O
(	O
ET	O
)	O
tubes	O
accumulate	O
a	O
biofilm	O
during	O
use	O
,	O
which	O
can	O
harbor	O
potentially	O
pathogenic	O
microorganisms	O
.	O

The	O
enrichment	O
of	O
pathogenic	O
strains	O
in	O
the	O
biofilm	O
may	O
lead	O
to	O
ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
with	O
an	O
increased	O
morbidity	O
rate	O
in	O
intensive	O
care	O
units	O
.	O

We	O
used	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
and	O
gene	O
surveys	O
targeting	O
16S	O
rRNA	O
genes	O
to	O
quantify	O
and	O
identify	O
the	O
bacterial	O
community	O
to	O
detect	O
fastidious	O
/	O
nonculturable	O
organisms	O
present	O
among	O
extubated	O
ET	O
tubes	O
.	O

We	O
collected	O
eight	O
ET	O
tubes	O
with	O
intubation	O
periods	O
between	O
12	O
h	O
and	O
23	O
d	O
from	O
different	O
patients	O
in	O
a	O
surgical	O
and	O
a	O
medical	O
intensive	O
care	O
unit	O
.	O

Our	O
qPCR	O
data	O
showed	O
that	O
ET	O
tubes	O
were	O
colonized	O
within	O
24	O
h	O
.	O
However	O
,	O
the	O
variation	O
between	O
patients	O
was	O
too	O
high	O
to	O
find	O
a	O
positive	O
correlation	O
between	O
the	O
bacterial	O
load	O
and	O
intubation	O
period	O
.	O

We	O
obtained	O
1263	O
near	O
full	O
-	O
length	O
16S	O
rRNA	O
gene	O
sequences	O
from	O
the	O
diverse	O
bacterial	O
communities	O
.	O

Over	O
70	O
%	O
of	O
these	O
sequences	O
were	O
associated	O
with	O
genera	O
of	O
typical	O
oral	O
flora	O
,	O
while	O
only	O
6	O
%	O
were	O
associated	O
with	O
gastrointestinal	O
flora	O
.	O

The	O
most	O
common	O
genus	O
identified	O
was	O
Streptococcus	B-bacteria
(	O
348	O
/	O
1263	O
)	O
,	O
followed	O
by	O
Prevotella	B-bacteria
(	O
179	O
/	O
1263	O
)	O
,	O
and	O
Neisseria	B-bacteria
(	O
143	O
/	O
1263	O
)	O
with	O
the	O
highest	O
relative	O
concentrations	O
for	O
ET	O
tubes	O
with	O
short	O
intubation	O
periods	O
,	O
indicating	O
oral	O
inoculation	O
of	O
the	O
ET	O
tubes	O
.	O

Our	O
study	O
also	O
shows	O
that	O
even	O
though	O
potentially	O
pathogenic	O
bacteria	O
existed	O
in	O
ET	O
tube	O
biofilms	O
within	O
24	O
h	O
of	O
intubation	O
,	O
a	O
longer	O
intubation	O
period	O
increases	O
the	O
opportunity	O
for	O
these	O
organisms	O
to	O
proliferate	O
.	O

In	O
the	O
ET	O
tube	O
that	O
was	O
in	O
place	O
for	O
23	O
d	O
,	O
95	O
%	O
of	O
the	O
sequences	O
belonged	O
to	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
which	O
is	O
a	O
bacterial	O
pathogen	O
that	O
is	O
known	O
to	O
out	O
compete	O
commensal	O
bacteria	O
in	O
biofilms	O
,	O
especially	O
during	O
periods	O
of	O
antibiotic	O
treatment	O
.	O

Harboring	O
such	O
pathogens	O
in	O
ET	O
biofilms	O
may	O
increase	O
the	O
chance	O
of	O
VAP	O
,	O
and	O
should	O
be	O
aggressively	O
monitored	O
and	O
prevented	O
.	O

To	O
determine	O
the	O
pattern	O
of	O
oral	O
bacterial	O
flora	O
and	O
their	O
sensitivity	O
to	O
antibiotics	O
in	O
freshly	O
captured	O
native	O
snakes	O
in	O
Hong	O
Kong	O
SAR	O
,	O
People	O
'	O
s	O
Republic	O
of	O
China	O
.	O

Healthy	O
native	O
snakes	O
were	O
captured	O
and	O
kept	O
in	O
a	O
designated	O
centre	O
.	O

Snake	O
species	O
were	O
identified	O
by	O
experienced	O
herpetologists	O
.	O

Mouth	O
swabs	O
were	O
taken	O
by	O
the	O
veterinarian	O
using	O
strict	O
aseptic	O
techniques	O
.	O

The	O
snakes	O
were	O
released	O
back	O
to	O
the	O
wild	O
immediately	O
after	O
the	O
above	O
procedure	O
.	O

Swabs	O
were	O
sent	O
for	O
microbiological	O
studies	O
of	O
bacterial	O
culture	O
and	O
antibiotic	O
sensitivity	O
.	O

47	O
venomous	O
snakes	O
of	O
the	O
families	O
Colubridae	O
,	O
Elapidae	O
and	O
Viperidae	O
and	O
53	O
non	O
-	O
medically	O
important	O
snakes	O
were	O
captured	O
.	O

406	O
bacterial	O
isolates	O
of	O
72	O
different	O
species	O
were	O
cultured	O
:	O
these	O
included	O
gram	O
negative	O
and	O
positive	O
bacterial	O
species	O
and	O
also	O
anaerobic	O
bacterial	O
species	O
.	O

With	O
the	O
exception	O
of	O
the	O
white	O
-	O
lipped	O
pit	O
viper	O
(	O
Cryptelytrops	O
albolabris	O
)	O
,	O
venomous	O
snakes	O
harboured	O
more	O
pathogenic	O
bacteria	O
and	O
total	O
bacteria	O
species	O
compared	O
to	O
the	O
non	O
-	O
medically	O
important	O
species	O
.	O

Of	O
the	O
venomous	O
snakes	O
,	O
the	O
Chinese	O
cobra	O
(	O
Naja	O
atra	O
)	O
harboured	O
the	O
largest	O
number	O
of	O
bacterial	O
species	O
.	O

In	O
the	O
present	O
study	O
,	O
all	O
gram	O
negative	O
bacteria	O
associated	O
with	O
wound	O
infection	O
were	O
sensitive	O
to	O
levofloxacin	O
,	O
netilmicin	O
and	O
piperacillin	O
/	O
tazobactam	O
.	O

Many	O
gram	O
negative	O
bacteria	O
in	O
the	O
study	O
were	O
not	O
sensitive	O
to	O
cefuroxime	O
axetil	O
.	O

Amoxicillin	O
/	O
clavulanic	O
acid	O
was	O
an	O
appropriate	O
choice	O
to	O
cover	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
anaerobes	O
.	O

In	O
the	O
presence	O
of	O
wound	O
infection	O
from	O
snakebite	O
injury	O
in	O
Hong	O
Kong	O
,	O
first	O
line	O
empirical	O
antibiotics	O
include	O
amoxicillin	O
/	O
clavulanic	O
acid	O
plus	O
levofloxacin	O
.	O

Prophylactic	O
antibiotics	O
may	O
be	O
considered	O
in	O
selected	O
cases	O
of	O
Chinese	O
cobra	O
(	O
N	O
.	O
atra	O
)	O
bite	O
,	O
otherwise	O
prophylactic	O
antibiotics	O
are	O
not	O
recommended	O
in	O
snakebite	O
unless	O
tissue	O
necrosis	O
is	O
present	O
.	O

A	O
70	O
-	O
year	O
-	O
old	O
woman	O
who	O
had	O
for	O
five	O
years	O
been	O
treated	O
with	O
tumour	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-	O
a	O
-	O
inhibitors	O
for	O
rheumatoid	O
arthritis	O
was	O
admitted	O
because	O
of	O
treatment	O
-	O
refractory	O
oral	O
ulcerations	O
and	O
persisting	O
considerable	O
soft	O
-	O
tissue	O
swelling	O
over	O
the	O
left	O
maxilla	O
.	O

Multiple	O
mucosal	O
biopsies	O
from	O
the	O
left	O
maxillary	O
sinus	O
revealed	O
necrotizing	O
granulomatous	O
inflammation	O
suspicious	O
of	O
mycobacterial	O
infection	O
.	O

This	O
was	O
subsequently	O
confirmed	O
in	O
concurrent	O
microbiological	O
cultures	O
and	O
ultimately	O
identified	O
as	O
Mycobacterium	B-bacteria
bovis	I-bacteria
.	O

This	O
species	O
of	O
the	O
mycobacterium	B-bacteria
tuberculosis	I-bacteria
complex	O
has	O
in	O
recent	O
times	O
rarely	O
been	O
seen	O
in	O
clinical	O
practice	O
in	O
Germany	O
.	O

On	O
further	O
questioning	O
the	O
patient	O
reported	O
that	O
she	O
had	O
been	O
treated	O
for	O
`	O
`	O
lung	O
disease	O
'	O
'	O
as	O
a	O
schoolgirl	O
.	O

The	O
patient	O
was	O
isolated	O
and	O
quadruple	O
therapy	O
with	O
isoniazide	O
(	O
INH	O
)	O
,	O
rifampin	O
(	O
RMP	O
)	O
,	O
ethambutol	O
(	O
EMB	O
)	O
and	O
pyrazinamide	O
(	O
PZA	O
)	O
was	O
initiated	O
.	O

Rapid	O
improvement	O
of	O
her	O
condition	O
occurred	O
within	O
two	O
weeks	O
.	O

When	O
microbiological	O
sub	O
-	O
typing	O
using	O
16s	O
-	O
RNA	O
sequencing	O
had	O
confirmed	O
M	B-bacteria
.	I-bacteria
bovis	I-bacteria
,	O
PZA	O
was	O
replaced	O
by	O
moxifloxacin	O
.	O

When	O
investigating	O
the	O
cause	O
of	O
treatment	O
-	O
refractory	O
infections	O
and	O
ulcerations	O
,	O
particularly	O
among	O
immunosuppressed	O
patients	O
,	O
consideration	O
should	O
always	O
be	O
given	O
to	O
mycobacterial	O
infections	O
.	O

Detailed	O
and	O
targeted	O
history	O
-	O
taking	O
is	O
vital	O
.	O

Use	O
of	O
oral	O
antiseptics	O
decreases	O
the	O
bacterial	O
load	O
in	O
the	O
oral	O
cavity	O
.	O

To	O
compare	O
the	O
antimicrobial	O
activity	O
of	O
3	O
novel	O
oral	O
antiseptics	O
with	O
that	O
of	O
chlorhexidine	O
,	O
which	O
is	O
considered	O
the	O
`	O
`	O
gold	O
standard	O
'	O
'	O
of	O
oral	O
hygiene	O
.	O

Comparative	O
in	O
vitro	O
study	O
.	O

Four	O
common	O
oral	O
microorganisms	O
(	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Candida	O
albicans	O
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
)	O
were	O
tested	O
under	O
standard	O
conditions	O
and	O
at	O
different	O
concentrations	O
,	O
by	O
use	O
of	O
a	O
broth	O
dilution	O
assay	O
and	O
an	O
agar	O
diffusion	O
assay	O
and	O
by	O
calculating	O
the	O
log10	O
reduction	O
factor	O
(	O
RF	O
)	O
.	O

The	O
antimicrobial	O
activity	O
of	O
each	O
antiseptic	O
was	O
assessed	O
by	O
counting	O
the	O
difference	O
in	O
bacterial	O
densities	O
(	O
ie	O
,	O
the	O
log10	O
number	O
of	O
colony	O
-	O
forming	O
units	O
of	O
bacteria	O
)	O
before	O
and	O
after	O
the	O
disinfection	O
process	O
.	O

The	O
oral	O
antiseptics	O
containing	O
octenidine	O
(	O
with	O
an	O
RF	O
in	O
the	O
range	O
of	O
7	O
.	O
1	O
-	O
8	O
.	O
24	O
CFU	O
/	O
mL	O
)	O
and	O
polyhexamethylene	O
biguanide	O
(	O
with	O
an	O
RF	O
in	O
the	O
range	O
of	O
7	O
.	O
1	O
-	O
8	O
.	O
24	O
CFU	O
/	O
mL	O
)	O
demonstrated	O
antimicrobial	O
activity	O
comparable	O
to	O
that	O
of	O
chlorhexidine	O
(	O
with	O
an	O
RF	O
in	O
the	O
range	O
of	O
1	O
.	O
03	O
-	O
8	O
.	O
24	O
CFU	O
/	O
mL	O
)	O
,	O
whereas	O
the	O
mouth	O
rinse	O
containing	O
Citroxx	O
(	O
Citroxx	O
Biosciences	O
;	O
with	O
an	O
RF	O
in	O
the	O
range	O
of	O
0	O
.	O
22	O
-	O
1	O
.	O
36	O
CFU	O
/	O
mL	O
)	O
showed	O
significantly	O
weaker	O
antimicrobial	O
efficacy	O
.	O

Overall	O
,	O
octenidine	O
and	O
polyhexamethylene	O
biguanide	O
were	O
more	O
active	O
at	O
lower	O
concentrations	O
.	O
conclusion	O
.	O

Oral	O
antiseptics	O
containing	O
the	O
antimicrobial	O
agent	O
octenidine	O
or	O
polyhexamethylene	O
biguanide	O
may	O
be	O
considered	O
as	O
potent	O
alternatives	O
to	O
chlorhexidine	O
-	O
based	O
preparations	O
.	O

This	O
investigation	O
assessed	O
regional	O
differences	O
in	O
dental	O
plaque	O
and	O
gingivitis	O
within	O
the	O
human	O
dentition	O
in	O
conjunction	O
with	O
microbiological	O
analyses	O
of	O
dental	O
plaque	O
.	O

Forty	O
-	O
one	O
adults	O
(	O
23	O
males	O
and	O
18	O
females	O
;	O
age	O
range	O
19	O
-	O
44	O
years	O
)	O
were	O
enrolled	O
,	O
and	O
a	O
calibrated	O
dental	O
examiner	O
completed	O
whole	O
mouth	O
examinations	O
for	O
dental	O
plaque	O
(	O
PI	O
)	O
and	O
gingivitis	O
(	O
GI	O
)	O
using	O
the	O
Turesky	O
modification	O
of	O
the	O
Quigley	O
-	O
Hein	O
Index	O
(	O
TMQH	O
)	O
and	O
the	O
L6e	O
-	O
Silness	O
(	O
LS	O
)	O
Index	O
,	O
respectively	O
.	O

Dental	O
plaque	O
samples	O
were	O
collected	O
from	O
the	O
anterior	O
surfaces	O
and	O
posterior	O
teeth	O
to	O
determine	O
viable	O
anaerobic	O
bacteria	O
.	O

During	O
this	O
visit	O
,	O
subjects	O
underwent	O
a	O
whole	O
mouth	O
dental	O
prophylaxis	O
and	O
were	O
provided	O
a	O
marketed	O
fluoride	O
dentifrice	O
for	O
twice	O
-	O
daily	O
oral	O
hygiene	O
.	O

Subjects	O
were	O
recalled	O
on	O
day	O
15	O
and	O
day	O
30	O
for	O
whole	O
mouth	O
assessments	O
of	O
PI	O
and	O
GI	O
,	O
followed	O
by	O
the	O
collection	O
of	O
dental	O
plaque	O
from	O
the	O
anterior	O
and	O
posterior	O
teeth	O
for	O
microbiological	O
analyses	O
during	O
these	O
visits	O
.	O

Low	O
plaque	O
and	O
gingival	O
scores	O
were	O
common	O
on	O
anterior	O
surfaces	O
,	O
in	O
contrast	O
to	O
greater	O
frequencies	O
of	O
higher	O
PI	O
and	O
GI	O
scores	O
on	O
the	O
posterior	O
regions	O
or	O
the	O
entire	O
dentition	O
.	O

Correspondingly	O
,	O
mean	O
scores	O
for	O
PI	O
and	O
GI	O
were	O
significantly	O
lower	O
among	O
the	O
anterior	O
surfaces	O
in	O
comparison	O
to	O
all	O
other	O
regions	O
of	O
the	O
mouth	O
(	O
posterior	O
,	O
Ramfjord	O
surfaces	O
,	O
or	O
the	O
entire	O
dentition	O
)	O
over	O
each	O
phase	O
of	O
the	O
study	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

While	O
prophylaxis	O
resulted	O
in	O
lower	O
clinical	O
scores	O
from	O
baseline	O
to	O
the	O
day	O
-	O
15	O
recall	O
visit	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
anterior	O
surfaces	O
demonstrated	O
lower	O
scores	O
than	O
posterior	O
regions	O
during	O
this	O
recall	O
visit	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Although	O
dental	O
plaque	O
scores	O
increased	O
from	O
the	O
day	O
-	O
15	O
to	O
the	O
day	O
-	O
30	O
evaluations	O
,	O
gingival	O
scores	O
maintained	O
broad	O
reductions	O
,	O
with	O
anterior	O
scores	O
consistently	O
lower	O
than	O
the	O
corresponding	O
posterior	O
regions	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Microbiological	O
analyses	O
indicated	O
significantly	O
lower	O
numbers	O
of	O
viable	O
bacteria	O
from	O
the	O
anterior	O
surfaces	O
in	O
comparison	O
to	O
posterior	O
regions	O
at	O
both	O
recall	O
visits	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Anterior	O
surfaces	O
routinely	O
demonstrated	O
lower	O
levels	O
of	O
dental	O
plaque	O
scores	O
than	O
the	O
other	O
regions	O
of	O
the	O
dentition	O
.	O

Higher	O
gingival	O
inflammation	O
levels	O
were	O
also	O
correlated	O
with	O
increased	O
plaque	O
deposits	O
associated	O
with	O
posterior	O
teeth	O
.	O

Microbiological	O
analyses	O
confirm	O
clinical	O
observations	O
with	O
significantly	O
higher	O
numbers	O
of	O
viable	O
bacteria	O
in	O
the	O
dental	O
plaque	O
collected	O
from	O
the	O
posterior	O
regions	O
.	O

The	O
human	O
dentition	O
demonstrates	O
significant	O
regional	O
differences	O
in	O
the	O
prevalence	O
of	O
dental	O
plaque	O
,	O
gingivitis	O
,	O
and	O
corresponding	O
anaerobic	O
bacteria	O
,	O
with	O
posterior	O
surfaces	O
consistently	O
reporting	O
higher	O
scores	O
than	O
the	O
anterior	O
regions	O
.	O

These	O
consistent	O
differences	O
should	O
be	O
taken	O
into	O
account	O
in	O
performing	O
plaque	O
and	O
gingivitis	O
studies	O
when	O
assessing	O
the	O
efficacy	O
of	O
oral	O
health	O
products	O
for	O
controlling	O
dental	O
health	O
.	O

periodontitis	O
is	O
a	O
bacterially	O
induced	O
chronic	O
inflammatory	O
disease	O
.	O

Toll	O
-	O
like	O
receptors	O
(	O
TLRs	O
)	O
,	O
which	O
could	O
recognize	O
microbial	O
pathogens	O
,	O
are	O
important	O
components	O
in	O
the	O
innate	O
and	O
adaptive	O
immune	O
systems	O
.	O

Both	O
qualitatively	O
and	O
quantitatively	O
distinct	O
immune	O
responses	O
might	O
result	O
from	O
different	O
bacteria	O
stimulation	O
and	O
the	O
triggering	O
of	O
different	O
TLRs	O
.	O

This	O
study	O
explores	O
the	O
interaction	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
with	O
TLR2	O
and	O
TLR4	O
.	O

We	O
studied	O
the	O
gene	O
expression	O
changes	O
of	O
TLR2	O
and	O
TLR4	O
and	O
cytokine	O
production	O
(	O
interleukin	O
-	O
1beta	O
,	O
-	O
6	O
,	O
-	O
8	O
,	O
-	O
10	O
,	O
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
)	O
in	O
human	O
periodontal	O
ligament	O
cells	O
(	O
HPDLCs	O
)	O
stimulated	O
with	O
heat	O
-	O
killed	O
bacteria	O
or	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
lipopolysaccharide	O
(	O
LPS	O
)	O
in	O
the	O
presence	O
or	O
absence	O
of	O
monoclonal	O
antibodies	O
to	O
TLR2	O
or	O
TLR4	O
(	O
anti	O
-	O
TLR2	O
/	O
4	O
mAb	O
)	O
.	O

Both	O
test	O
bacteria	O
and	O
10	O
microg	O
/	O
ml	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
treatment	O
increased	O
the	O
gene	O
expression	O
of	O
TLR2	O
and	O
TLR4	O
and	O
cytokine	O
production	O
in	O
HPDLCs	O
.	O

In	O
addition	O
,	O
these	O
upregulations	O
could	O
be	O
blocked	O
by	O
anti	O
-	O
TLR2	O
/	O
4	O
mAb	O
.	O

However	O
,	O
the	O
expression	O
of	O
TLR4	O
mRNA	O
in	O
HPDLCs	O
stimulated	O
with	O
1	O
microg	O
/	O
ml	O
P	O
.	O
gingivalis	O
LPS	O
was	O
not	O
increased	O
.	O

No	O
differences	O
were	O
found	O
in	O
the	O
cytokine	O
production	O
caused	O
by	O
1	O
microg	O
/	O
ml	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
treatment	O
in	O
the	O
presence	O
or	O
absence	O
of	O
anti	O
-	O
TLR4	O
mAb	O
.	O

These	O
patterns	O
of	O
gene	O
expression	O
and	O
cytokine	O
production	O
indicate	O
that	O
Gram	O
-	O
negative	O
periodontal	O
bacteria	O
or	O
their	O
LPS	O
might	O
play	O
a	O
role	O
in	O
triggering	O
TLR2	O
and	O
/	O
or	O
TLR4	O
,	O
and	O
be	O
of	O
importance	O
for	O
the	O
immune	O
responses	O
in	O
periodontitis	O
.	O

Coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
(	O
CoNS	B-bacteria
)	O
are	O
frequently	O
isolated	O
from	O
blood	O
cultures	O
of	O
hematopoietic	O
cell	O
transplantation	O
(	O
HCT	O
)	O
patients	O
.	O

Generally	O
,	O
the	O
use	O
of	O
central	O
venous	O
catheters	O
is	O
recognized	O
as	O
a	O
significant	O
risk	O
factor	O
for	O
CoNS	B-bacteria
infection	O
,	O
while	O
the	O
impact	O
of	O
CoNS	B-bacteria
infection	O
from	O
oral	O
ulcerative	O
mucositis	O
,	O
which	O
occurs	O
frequently	O
in	O
HCT	O
,	O
may	O
be	O
underestimated	O
.	O

Here	O
,	O
we	O
examined	O
the	O
bacteria	O
on	O
the	O
buccal	O
mucosa	O
after	O
HCT	O
.	O

Sixty	O
-	O
one	O
patients	O
were	O
examined	O
for	O
bacteria	O
on	O
the	O
buccal	O
mucosa	O
routinely	O
once	O
a	O
week	O
from	O
1	O
week	O
before	O
to	O
3	O
weeks	O
after	O
allogeneic	O
HCT	O
.	O

Subjects	O
were	O
divided	O
into	O
groups	O
with	O
short	O
and	O
long	O
periods	O
of	O
antibiotic	O
use	O
,	O
and	O
differences	O
in	O
bacterial	O
substitution	O
were	O
evaluated	O
.	O

The	O
relationships	O
between	O
type	O
of	O
HCT	O
(	O
conventional	O
HCT	O
or	O
RIST	O
)	O
and	O
bacterial	O
substitution	O
were	O
also	O
evaluated	O
.	O

The	O
changes	O
in	O
detection	O
frequencies	O
of	O
CoNS	B-bacteria
and	O
alpha	B-bacteria
-	I-bacteria
streptococci	I-bacteria
from	O
before	O
to	O
3	O
weeks	O
after	O
HCT	O
were	O
significant	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
chi	O
(	O
2	O
)	O
test	O
)	O
:	O
14	O
.	O
5	O
-	O
53	O
.	O
3	O
%	O
and	O
92	O
.	O
7	O
-	O
53	O
.	O
1	O
%	O
,	O
respectively	O
.	O

Significant	O
bacterial	O
substitution	O
of	O
CoNS	B-bacteria
for	O
streptococci	B-bacteria
was	O
observed	O
in	O
the	O
long	O
-	O
term	O
antibiotic	O
use	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
chi	O
(	O
2	O
)	O
test	O
)	O
,	O
but	O
also	O
occurred	O
in	O
cases	O
with	O
short	O
-	O
term	O
or	O
no	O
antibiotic	O
use	O
.	O

No	O
relationships	O
between	O
type	O
of	O
HCT	O
(	O
conventional	O
HCT	O
or	O
RIST	O
)	O
were	O
observed	O
.	O

Bacterial	O
substitution	O
of	O
CoNS	B-bacteria
for	O
streptococci	B-bacteria
occurred	O
frequently	O
on	O
the	O
buccal	O
mucosa	O
after	O
HCT	O
.	O

In	O
addition	O
to	O
antibiotic	O
use	O
,	O
environmental	O
factors	O
may	O
be	O
involved	O
in	O
bacterial	O
substitution	O
.	O

It	O
is	O
important	O
to	O
consider	O
the	O
presence	O
of	O
oral	O
mucositis	O
in	O
CoNS	B-bacteria
infection	O
after	O
HCT	O
.	O

Approximately	O
10	O
-	O
20	O
%	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
strains	I-bacteria
have	O
been	O
reported	O
to	O
possess	O
collagen	O
-	O
binding	O
properties	O
,	O
whereas	O
other	O
species	O
in	O
the	O
oral	O
cavity	O
with	O
those	O
properties	O
remain	O
to	O
be	O
elucidated	O
.	O

Aim	O
.	O

To	O
identify	O
strains	O
with	O
collagen	O
-	O
binding	O
properties	O
and	O
analyse	O
their	O
characteristics	O
in	O
comparison	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

A	O
total	O
of	O
110	O
expectorated	O
saliva	O
specimens	O
were	O
collected	O
from	O
55	O
pairs	O
of	O
mothers	O
and	O
their	O
children	O
.	O

Bacterial	O
strains	O
with	O
collagen	O
-	O
binding	O
properties	O
were	O
isolated	O
and	O
the	O
species	O
specified	O
.	O

In	O
addition	O
,	O
strains	O
with	O
collagen	O
-	O
binding	O
properties	O
isolated	O
from	O
mother	O
-	O
child	O
pairs	O
were	O
analysed	O
using	O
molecular	O
biological	O
approaches	O
.	O

The	O
detection	O
frequency	O
of	O
strains	O
with	O
collagen	O
-	O
binding	O
properties	O
was	O
shown	O
to	O
be	O
40	O
.	O
9	O
%	O
,	O
among	O
which	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
was	O
the	O
most	O
frequently	O
detected	O
,	O
followed	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
collagen	O
-	O
binding	O
activity	O
of	O
the	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
group	O
was	O
the	O
highest	O
,	O
followed	O
by	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
.	O

In	O
addition	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strains	I-bacteria
from	O
3	O
and	O
1	O
mother	O
-	O
child	O
pairs	O
,	O
respectively	O
,	O
were	O
shown	O
to	O
be	O
the	O
same	O
clones	O
.	O

Our	O
results	O
indicate	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
are	O
major	O
species	O
with	O
collagen	O
-	O
binding	O
properties	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
that	O
strains	O
with	O
such	O
properties	O
may	O
be	O
related	O
to	O
mother	O
-	O
child	O
transmission	O
.	O

The	O
microbiota	O
of	O
the	O
denture	O
plaque	O
biofilm	O
colonizing	O
the	O
fitting	O
surface	O
of	O
dentures	O
in	O
edentulous	O
subjects	O
with	O
healthy	O
palates	O
(	O
n	O
=	O
20	O
)	O
and	O
in	O
edentulous	O
subjects	O
with	O
denture	O
stomatitis	O
(	O
n	O
=	O
20	O
)	O
was	O
studied	O
.	O

The	O
numbers	O
of	O
bacteria	O
colonizing	O
the	O
dentures	O
of	O
healthy	O
subjects	O
was	O
significantly	O
less	O
than	O
the	O
numbers	O
colonizing	O
the	O
dentures	O
of	O
stomatitis	O
subjects	O
.	O

The	O
proportions	O
and	O
frequency	O
of	O
isolation	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
lactobacilli	B-bacteria
,	O
bifidobacteria	B-bacteria
and	O
yeasts	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
greater	O
in	O
the	O
subjects	O
with	O
denture	O
stomatitis	O
.	O

The	O
proportions	O
of	O
these	O
organisms	O
in	O
the	O
denture	O
plaque	O
biofilm	O
of	O
the	O
subjects	O
with	O
denture	O
stomatitis	O
were	O
similar	O
to	O
those	O
found	O
in	O
carious	O
lesions	O
,	O
indicating	O
that	O
the	O
site	O
is	O
a	O
low	O
pH	O
environment	O
.	O

The	O
predominant	O
bifidobacterial	B-bacteria
species	I-bacteria
in	O
the	O
mouths	O
of	O
dentate	O
subjects	O
is	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
but	O
in	O
the	O
edentulous	O
subjects	O
wearing	O
dentures	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
was	O
isolated	O
from	O
only	O
one	O
of	O
the	O
20	O
subjects	O
with	O
denture	O
stomatitis	O
and	O
from	O
none	O
of	O
the	O
20	O
subjects	O
with	O
healthy	O
palates	O
.	O

Instead	O
,	O
Bifidobacterium	B-bacteria
breve	I-bacteria
,	O
Bifidobacterium	B-bacteria
scardovii	I-bacteria
and	O
Bifidobacterium	B-bacteria
longum	I-bacteria
subsp	I-bacteria
.	I-bacteria
longum	I-bacteria
were	O
isolated	O
.	O

Only	O
a	O
single	O
non	O
-	O
oral	O
bifidobacterial	B-bacteria
species	I-bacteria
was	O
isolated	O
from	O
each	O
individual	O
and	O
repetitive	O
extragenic	O
palindromic	O
-	O
and	O
BOX	O
-	O
polymerase	O
chain	O
reaction	O
typing	O
methods	O
indicated	O
that	O
the	O
same	O
genotypes	O
were	O
shared	O
between	O
subjects	O
.	O

Using	O
deferred	O
antagonism	O
spot	O
plate	O
assays	O
,	O
interspecies	O
inhibition	O
was	O
demonstrated	O
between	O
oral	O
isolates	O
of	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
,	O
B	B-bacteria
.	I-bacteria
breve	I-bacteria
,	O
B	B-bacteria
.	I-bacteria
scardovii	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
longum	I-bacteria
subsp	I-bacteria
.	I-bacteria
longum	I-bacteria
.	O

Here	O
we	O
have	O
shown	O
that	O
bifidobacteria	B-bacteria
and	O
caries	O
-	O
associated	O
microbiota	O
are	O
present	O
in	O
denture	O
plaque	O
at	O
levels	O
similar	O
to	O
those	O
of	O
carious	O
lesions	O
and	O
B	O
.	O
dentium	O
can	O
not	O
be	O
maintained	O
in	O
an	O
edentulous	O
mouth	O
.	O

This	O
study	O
is	O
to	O
assess	O
the	O
antibacterial	O
activity	O
of	O
omega	O
-	O
6	O
,	O
-	O
7	O
,	O
-	O
9	O
(	O
n	O
-	O
6	O
,	O
n	O
-	O
7	O
,	O
n	O
-	O
9	O
)	O
fatty	O
acids	O
against	O
various	O
oral	O
microorganisms	O
.	O

The	O
n	O
-	O
6	O
,	O
n	O
-	O
7	O
,	O
n	O
-	O
9	O
fatty	O
acids	O
,	O
such	O
as	O
gamma	O
-	O
linoleic	O
acid	O
(	O
GLA	O
)	O
,	O
linoleic	O
acid	O
(	O
LA	O
)	O
,	O
arachidonic	O
acid	O
(	O
ARA	O
)	O
,	O
palmitoleic	O
acid	O
(	O
PA	O
)	O
,	O
and	O
oleic	O
acid	O
(	O
OA	O
)	O
,	O
their	O
fatty	O
acid	O
ethyl	O
esters	O
,	O
GLA	O
-	O
EE	O
,	O
LA	O
-	O
EE	O
,	O
ARA	O
-	O
EE	O
,	O
PA	O
-	O
EE	O
,	O
OA	O
-	O
EE	O
,	O
and	O
their	O
fatty	O
acid	O
methyl	O
esters	O
,	O
GLA	O
-	O
ME	O
,	O
LA	O
-	O
ME	O
,	O
ARA	O
-	O
ME	O
,	O
PA	O
-	O
ME	O
,	O
OA	O
-	O
ME	O
,	O
were	O
investigated	O
for	O
antimicrobial	O
activity	O
against	O
oral	O
pathogens	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Candida	O
albicans	O
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

Various	O
concentrations	O
of	O
the	O
fatty	O
acids	O
,	O
their	O
methyl	O
and	O
ethyl	O
esters	O
were	O
tested	O
against	O
various	O
oral	O
pathogens	O
in	O
96	O
-	O
well	O
plates	O
and	O
blood	O
-	O
agar	O
plate	O
.	O

The	O
plates	O
were	O
incubated	O
anaerobically	O
or	O
aerobically	O
at	O
37	O
degrees	O
C	O
for	O
48h	O
,	O
and	O
the	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
were	O
determined	O
.	O

The	O
data	O
demonstrated	O
that	O
select	O
n	O
-	O
6	O
,	O
n	O
-	O
7	O
,	O
n	O
-	O
9	O
fatty	O
acids	O
and	O
their	O
esters	O
exhibited	O
strong	O
antimicrobial	O
activity	O
against	O
these	O
oral	O
microorganisms	O
,	O
demonstrating	O
some	O
specificity	O
for	O
individual	O
microbial	O
species	O
.	O

The	O
potential	O
use	O
or	O
the	O
combinations	O
of	O
the	O
n	O
-	O
6	O
,	O
n	O
-	O
7	O
,	O
n	O
-	O
9	O
fatty	O
acids	O
and	O
/	O
or	O
their	O
esters	O
,	O
provided	O
in	O
a	O
local	O
delivery	O
vehicle	O
to	O
infected	O
sites	O
in	O
the	O
oral	O
cavity	O
,	O
could	O
be	O
considered	O
as	O
an	O
additional	O
therapeutic	O
approach	O
to	O
improving	O
oral	O
health	O
.	O

Non	O
-	O
clinical	O
studies	O
,	O
focusing	O
on	O
the	O
pharmacodynamics	O
(	O
PD	O
)	O
,	O
pharmacokinetics	O
(	O
PK	O
)	O
and	O
safety	O
pharmacology	O
of	O
genetically	O
modified	O
Lactococcus	B-bacteria
lactis	I-bacteria
(	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
)	O
bacteria	O
,	O
engineered	O
to	O
secrete	O
human	O
Trefoil	O
Factor	O
1	O
(	O
hTFF1	O
)	O
,	O
were	O
performed	O
to	O
provide	O
proof	O
-	O
of	O
-	O
concept	O
for	O
the	O
treatment	O
of	O
oral	O
mucositis	O
(	O
OM	O
)	O
patients	O
.	O

L	B-bacteria
.	I-bacteria
lactis	I-bacteria
strain	I-bacteria
sAGX0085	I-bacteria
was	O
constructed	O
by	O
stably	O
inserting	O
an	O
htff1	O
expression	O
cassette	O
into	O
the	O
bacterial	O
genome	O
,	O
and	O
clinically	O
formulated	O
as	O
a	O
mouth	O
rinse	O
(	O
coded	O
AG013	O
)	O
.	O

PD	O
studies	O
,	O
using	O
different	O
oral	O
dosing	O
regimens	O
,	O
were	O
performed	O
in	O
a	O
clinically	O
relevant	O
hamster	O
model	O
for	O
radiation	O
-	O
induced	O
OM	O
.	O

The	O
PK	O
profile	O
was	O
assessed	O
in	O
healthy	O
hamsters	O
and	O
in	O
hamsters	O
with	O
radiation	O
-	O
induced	O
OM	O
.	O

In	O
addition	O
,	O
in	O
vitro	O
and	O
in	O
vivo	O
safety	O
pharmacology	O
studies	O
were	O
conducted	O
,	O
in	O
pooled	O
,	O
complement	O
-	O
preserved	O
human	O
serum	O
,	O
and	O
in	O
neutropenic	O
hamsters	O
and	O
rats	O
respectively	O
.	O

Topical	O
administration	O
of	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
sAGX0085	I-bacteria
/	I-bacteria
AG013	I-bacteria
to	O
the	O
oral	O
mucosa	O
significantly	O
reduced	O
the	O
severity	O
and	O
course	O
of	O
radiation	O
-	O
induced	O
OM	O
.	O

PK	O
studies	O
demonstrated	O
that	O
both	O
living	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
bacteria	I-bacteria
,	O
as	O
well	O
as	O
the	O
hTFF1	O
secreted	O
,	O
could	O
be	O
recovered	O
from	O
the	O
administration	O
site	O
for	O
maximum	O
24h	O
post	O
-	O
dosing	O
,	O
without	O
systemic	O
exposure	O
.	O

The	O
in	O
vitro	O
and	O
in	O
vivo	O
safety	O
pharmacology	O
studies	O
confirmed	O
that	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
sAGX0085	I-bacteria
could	O
not	O
survive	O
in	O
systemic	O
circulation	O
,	O
not	O
even	O
under	O
neutropenic	O
conditions	O
.	O

The	O
results	O
from	O
the	O
PD	O
,	O
PK	O
and	O
safety	O
pharmacology	O
studies	O
reported	O
here	O
indicate	O
that	O
in	O
situ	O
secretion	O
of	O
hTFF1	O
by	O
topically	O
administered	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
bacteria	O
provides	O
a	O
safe	O
and	O
efficacious	O
therapeutic	O
tool	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
OM	O
.	O

The	O
human	O
oropharynx	O
is	O
a	O
reservoir	O
for	O
many	O
potential	O
pathogens	O
,	O
including	O
streptococcal	B-bacteria
species	I-bacteria
that	O
cause	O
endocarditis	O
.	O

Although	O
oropharyngeal	O
microbes	O
have	O
been	O
well	O
described	O
,	O
viral	O
communities	O
are	O
essentially	O
uncharacterized	O
.	O

We	O
conducted	O
a	O
metagenomic	O
study	O
to	O
determine	O
the	O
composition	O
of	O
oropharyngeal	O
DNA	O
viral	O
communities	O
(	O
both	O
phage	O
and	O
eukaryotic	O
viruses	O
)	O
in	O
healthy	O
individuals	O
and	O
to	O
evaluate	O
oropharyngeal	O
swabs	O
as	O
a	O
rapid	O
method	O
for	O
viral	O
detection	O
.	O

Viral	O
DNA	O
was	O
extracted	O
from	O
19	O
pooled	O
oropharyngeal	O
swabs	O
and	O
sequenced	O
.	O

Viral	O
communities	O
consisted	O
almost	O
exclusively	O
of	O
phage	O
,	O
and	O
complete	O
genomes	O
of	O
several	O
phage	O
were	O
recovered	O
,	O
including	O
Escherichia	B-bacteria
coli	I-bacteria
phage	O
T3	O
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
phage	O
PA6	O
,	O
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
phage	O
SM1	O
.	O

Phage	O
relative	O
abundances	O
changed	O
dramatically	O
depending	O
on	O
whether	O
samples	O
were	O
chloroform	O
treated	O
or	O
filtered	O
to	O
remove	O
microbial	O
contamination	O
.	O

pblA	O
and	O
pblB	O
genes	O
of	O
phage	O
SM1	O
were	O
detected	O
in	O
the	O
metagenomes	O
.	O

pblA	O
and	O
pblB	O
mediate	O
the	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
to	O
platelets	O
and	O
play	O
a	O
significant	O
role	O
in	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
virulence	O
in	O
the	O
endocardium	O
,	O
but	O
have	O
never	O
previously	O
been	O
detected	O
in	O
the	O
oral	O
cavity	O
.	O

These	O
genes	O
were	O
also	O
identified	O
in	O
salivary	O
metagenomes	O
from	O
three	O
individuals	O
at	O
three	O
time	O
points	O
and	O
in	O
individual	O
saliva	O
samples	O
by	O
PCR	O
.	O

Additionally	O
,	O
we	O
demonstrate	O
that	O
phage	O
SM1	O
can	O
be	O
induced	O
by	O
commonly	O
ingested	O
substances	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
oral	O
cavity	O
is	O
a	O
reservoir	O
for	O
pblA	O
and	O
pblB	O
genes	O
and	O
for	O
phage	O
SM1	O
itself	O
.	O

Further	O
studies	O
will	O
determine	O
the	O
association	O
between	O
pblA	O
and	O
pblB	O
genes	O
in	O
the	O
oral	O
cavity	O
and	O
the	O
risk	O
of	O
endocarditis	O
.	O

The	O
oral	O
cavity	O
is	O
inhabited	O
by	O
over	O
500	O
different	O
bacterial	O
species	O
that	O
normally	O
exist	O
in	O
ecological	O
balance	O
both	O
with	O
each	O
other	O
and	O
with	O
the	O
host	O
.	O

When	O
this	O
equilibrium	O
is	O
disturbed	O
,	O
an	O
overgrowth	O
of	O
individual	O
organisms	O
can	O
occur	O
,	O
which	O
,	O
in	O
turn	O
,	O
can	O
lead	O
to	O
the	O
onset	O
of	O
pathological	O
processes	O
,	O
notably	O
dental	O
caries	O
and	O
periodontitis	O
.	O

Generally	O
,	O
bacteraemias	O
occur	O
more	O
frequently	O
in	O
individuals	O
with	O
periodontal	O
disease	O
,	O
and	O
these	O
bacteraemias	O
have	O
been	O
implicated	O
in	O
the	O
development	O
of	O
a	O
range	O
of	O
systemic	O
diseases	O
,	O
including	O
atherothrombotic	O
disorders	O
.	O

The	O
mechanism	O
underlying	O
this	O
relationship	O
remains	O
to	O
be	O
precisely	O
defined	O
,	O
although	O
studies	O
have	O
shown	O
a	O
link	O
between	O
bacteria	O
of	O
oral	O
origin	O
and	O
platelet	O
activation	O
.	O

Several	O
orally	O
derived	O
species	O
of	O
bacteria	O
interact	O
with	O
platelets	O
,	O
including	O
those	O
of	O
the	O
Streptococcus	B-bacteria
(	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
,	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
)	O
and	O
Staphylococcus	B-bacteria
(	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
,	O
Staphylococcus	B-bacteria
capitis	I-bacteria
)	O
genera	O
,	O
as	O
well	O
as	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

In	O
addition	O
,	O
some	O
members	O
of	O
both	O
the	O
Streptococcus	B-bacteria
and	O
the	O
Staphylococcus	B-bacteria
genera	I-bacteria
,	O
as	O
well	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
can	O
activate	O
platelets	O
in	O
vitro	O
.	O

The	O
current	O
review	O
describes	O
the	O
heterogeneous	O
mechanisms	O
of	O
platelet	O
activation	O
employed	O
by	O
individual	O
bacterial	O
species	O
.	O

The	O
pathological	O
and	O
clinical	O
implications	O
of	O
platelet	O
activation	O
by	O
orally	O
derived	O
bacteria	O
are	O
discussed	O
.	O

Dentistry	O
has	O
undergone	O
a	O
shift	O
in	O
caries	O
management	O
toward	O
prevention	O
and	O
improved	O
oral	O
hygiene	O
and	O
diagnosis	O
.	O

Caries	O
prevention	O
now	O
represents	O
one	O
of	O
the	O
most	O
important	O
aspects	O
of	O
modern	O
dental	O
practice	O
.	O

The	O
purpose	O
of	O
this	O
cross	O
-	O
sectional	O
study	O
was	O
to	O
demonstrate	O
the	O
use	O
of	O
adenosine	O
triphosphate	O
-	O
(	O
ATP	O
-	O
)	O
driven	O
bioluminescence	O
as	O
an	O
innovative	O
tool	O
for	O
the	O
rapid	O
chairside	O
enumeration	O
of	O
oral	O
bacteria	O
(	O
including	O
plague	O
streptococci	B-bacteria
)	O
and	O
assessment	O
of	O
oral	O
hygiene	O
and	O
caries	O
risk	O
.	O

Thirty	O
-	O
three	O
pediatric	O
patients	O
(	O
7	O
-	O
to	O
12	O
-	O
year	O
-	O
old	O
males	O
and	O
females	O
)	O
were	O
examined	O
,	O
and	O
plague	O
specimens	O
,	O
in	O
addition	O
to	O
stimulated	O
saliva	O
,	O
were	O
collected	O
from	O
representative	O
teeth	O
within	O
each	O
quadrant	O
.	O

Oral	O
specimens	O
(	O
n	O
=	O
150	O
specimens	O
)	O
were	O
assessed	O
by	O
plating	O
on	O
enriched	O
and	O
selective	O
agars	O
,	O
to	O
enumerate	O
total	O
bacteria	O
and	O
streptococci	B-bacteria
,	O
and	O
subjected	O
to	O
adenosine	O
triphosphate	O
-	O
(	O
ATP	O
-	O
)	O
driven	O
bioluminescence	O
determinations	O
using	O
a	O
luciferase	O
-	O
based	O
assay	O
system	O
.	O

Statistical	O
correlations	O
,	O
linking	O
ATP	O
values	O
to	O
numbers	O
of	O
total	O
bacteria	O
,	O
oral	O
streptococci	B-bacteria
and	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
yielded	O
highly	O
significant	O
r	O
values	O
of	O
0	O
.	O
854	O
,	O
0	O
.	O
840	O
,	O
and	O
0	O
.	O
796	O
,	O
respectively	O
Our	O
clinical	O
data	O
is	O
consistent	O
with	O
the	O
hypothesis	O
that	O
ATP	O
measurements	O
have	O
a	O
strong	O
statistical	O
association	O
with	O
bacterial	O
number	O
in	O
plague	O
and	O
saliva	O
specimens	O
,	O
including	O
numbers	O
for	O
oral	O
streptococci	B-bacteria
,	O
and	O
may	O
be	O
used	O
as	O
a	O
potential	O
assessment	O
tool	O
for	O
oral	O
hygiene	O
and	O
caries	O
risk	O
in	O
children	O
.	O

To	O
assess	O
the	O
distribution	O
of	O
elevated	O
antibody	O
titres	O
to	O
multiple	O
periodontal	O
bacteria	O
,	O
including	O
established	O
/	O
putative	O
pathogens	O
and	O
health	O
-	O
related	O
species	O
,	O
by	O
selected	O
demographic	O
,	O
behavioural	O
,	O
and	O
oral	O
-	O
and	O
general	O
health	O
-	O
related	O
characteristics	O
.	O

Data	O
from	O
8153	O
>	O
or	O
=	O
40	O
-	O
year	O
-	O
old	O
participants	O
from	O
the	O
third	O
National	O
Health	O
and	O
Nutrition	O
Examination	O
Survey	O
were	O
used	O
,	O
including	O
1588	O
edentulous	O
individuals	O
.	O

We	O
used	O
checkerboard	O
immunoblotting	O
to	O
assess	O
serum	O
IgG	O
levels	O
to	O
19	O
periodontal	O
species	O
.	O

Thresholds	O
for	O
elevated	O
antibody	O
responses	O
were	O
defined	O
for	O
each	O
species	O
using	O
the	O
90th	O
percentile	O
titre	O
in	O
periodontal	O
healthy	O
participants	O
,	O
using	O
two	O
alternative	O
definitions	O
of	O
periodontitis	O
.	O

Edentulous	O
individuals	O
showed	O
lower	O
antibody	O
responses	O
than	O
dentate	O
participants	O
,	O
notably	O
for	O
titres	O
to	O
`	O
`	O
red	O
complex	O
'	O
'	O
species	O
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

Elevated	O
titres	O
to	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
were	O
twice	O
as	O
prevalent	O
in	O
participants	O
with	O
periodontitis	O
than	O
in	O
periodontal	O
healthy	O
individuals	O
.	O

Non	O
-	O
Hispanic	O
blacks	O
and	O
Mexican	O
-	O
Americans	O
were	O
more	O
likely	O
to	O
display	O
elevated	O
titres	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
compared	O
with	O
non	O
-	O
Hispanic	O
whites	O
(	O
22	O
.	O
9	O
%	O
versus	O
19	O
.	O
4	O
%	O
versus	O
9	O
.	O
5	O
%	O
)	O
.	O

Current	O
smokers	O
were	O
significantly	O
less	O
likely	O
to	O
exhibit	O
high	O
titres	O
to	O
multiple	O
bacteria	O
than	O
never	O
smokers	O
.	O

Demographic	O
,	O
behavioural	O
,	O
and	O
oral	O
-	O
and	O
general	O
health	O
-	O
related	O
characteristics	O
were	O
strong	O
determinants	O
of	O
systemic	O
antibody	O
responses	O
to	O
periodontal	O
bacteria	O
in	O
a	O
nationally	O
representative	O
sample	O
of	O
US	O
adults	O
.	O

Upon	O
delivery	O
,	O
the	O
neonate	O
is	O
exposed	O
for	O
the	O
first	O
time	O
to	O
a	O
wide	O
array	O
of	O
microbes	O
from	O
a	O
variety	O
of	O
sources	O
,	O
including	O
maternal	O
bacteria	O
.	O

Although	O
prior	O
studies	O
have	O
suggested	O
that	O
delivery	O
mode	O
shapes	O
the	O
microbiota	O
'	O
s	O
establishment	O
and	O
,	O
subsequently	O
,	O
its	O
role	O
in	O
child	O
health	O
,	O
most	O
researchers	O
have	O
focused	O
on	O
specific	O
bacterial	O
taxa	O
or	O
on	O
a	O
single	O
body	O
habitat	O
,	O
the	O
gut	O
.	O

Thus	O
,	O
the	O
initiation	O
stage	O
of	O
human	O
microbiome	O
development	O
remains	O
obscure	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
obtain	O
a	O
community	O
-	O
wide	O
perspective	O
on	O
the	O
influence	O
of	O
delivery	O
mode	O
and	O
body	O
habitat	O
on	O
the	O
neonate	O
'	O
s	O
first	O
microbiota	O
.	O

We	O
used	O
multiplexed	O
16S	O
rRNA	O
gene	O
pyrosequencing	O
to	O
characterize	O
bacterial	O
communities	O
from	O
mothers	O
and	O
their	O
newborn	O
babies	O
,	O
four	O
born	O
vaginally	O
and	O
six	O
born	O
via	O
Cesarean	O
section	O
.	O

Mothers	O
'	O
skin	O
,	O
oral	O
mucosa	O
,	O
and	O
vagina	O
were	O
sampled	O
1	O
h	O
before	O
delivery	O
,	O
and	O
neonates	O
'	O
skin	O
,	O
oral	O
mucosa	O
,	O
and	O
nasopharyngeal	O
aspirate	O
were	O
sampled	O
<	O
5	O
min	O
,	O
and	O
meconium	O
<	O
24	O
h	O
,	O
after	O
delivery	O
.	O

We	O
found	O
that	O
in	O
direct	O
contrast	O
to	O
the	O
highly	O
differentiated	O
communities	O
of	O
their	O
mothers	O
,	O
neonates	O
harbored	O
bacterial	O
communities	O
that	O
were	O
undifferentiated	O
across	O
multiple	O
body	O
habitats	O
,	O
regardless	O
of	O
delivery	O
mode	O
.	O

Our	O
results	O
also	O
show	O
that	O
vaginally	O
delivered	O
infants	O
acquired	O
bacterial	O
communities	O
resembling	O
their	O
own	O
mother	O
'	O
s	O
vaginal	O
microbiota	O
,	O
dominated	O
by	O
Lactobacillus	B-bacteria
,	O
Prevotella	B-bacteria
,	O
or	O
Sneathia	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
C	O
-	O
section	O
infants	O
harbored	O
bacterial	O
communities	O
similar	O
to	O
those	O
found	O
on	O
the	O
skin	O
surface	O
,	O
dominated	O
by	O
Staphylococcus	B-bacteria
,	O
Corynebacterium	B-bacteria
,	O
and	O
Propionibacterium	B-bacteria
spp	I-bacteria
.	O

These	O
findings	O
establish	O
an	O
important	O
baseline	O
for	O
studies	O
tracking	O
the	O
human	O
microbiome	O
'	O
s	O
successional	O
development	O
in	O
different	O
body	O
habitats	O
following	O
different	O
delivery	O
modes	O
,	O
and	O
their	O
associated	O
effects	O
on	O
infant	O
health	O
.	O

In	O
the	O
human	O
mouth	O
,	O
fungi	O
and	O
several	O
hundred	O
species	O
of	O
bacteria	O
coexist	O
.	O

Here	O
we	O
report	O
a	O
case	O
of	O
interkingdom	O
signaling	O
in	O
the	O
oral	O
cavity	O
:	O
A	O
compound	O
excreted	O
by	O
the	O
caries	O
bacterium	O
Streptococcus	B-bacteria
mutans	I-bacteria
inhibits	O
the	O
morphological	O
transition	O
from	O
yeast	O
to	O
hyphae	O
,	O
an	O
important	O
virulence	O
trait	O
,	O
in	O
the	O
opportunistic	O
fungus	O
Candida	O
albicans	O
.	O

The	O
compound	O
excreted	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
originally	O
studied	O
because	O
it	O
inhibited	O
signaling	O
by	O
the	O
universal	O
bacterial	O
signal	O
autoinducer	O
-	O
2	O
(	O
AI	O
-	O
2	O
)	O
,	O
determined	O
by	O
the	O
luminescence	O
of	O
a	O
Vibrio	B-bacteria
harveyi	I-bacteria
sensor	O
strain	O
.	O

The	O
inhibitor	O
was	O
purified	O
from	O
cell	O
-	O
free	O
culture	O
supernatants	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
guided	O
by	O
its	O
activity	O
.	O

Its	O
chemical	O
structure	O
was	O
elucidated	O
by	O
using	O
NMR	O
spectroscopy	O
and	O
GC	O
-	O
MS	B-bacteria
and	O
proved	O
to	O
be	O
trans	O
-	O
2	O
-	O
decenoic	O
acid	O
.	O

We	O
show	O
that	O
trans	O
-	O
2	O
-	O
decenoic	O
acid	O
does	O
not	O
inhibit	O
AI	O
-	O
2	O
-	O
specific	O
signaling	O
,	O
but	O
rather	O
the	O
luciferase	O
reaction	O
used	O
for	O
its	O
detection	O
.	O

A	O
potential	O
biological	O
role	O
of	O
trans	O
-	O
2	O
-	O
decenoic	O
acid	O
was	O
then	O
discovered	O
.	O

It	O
is	O
able	O
to	O
suppress	O
the	O
transition	O
from	O
yeast	O
to	O
hyphal	O
morphology	O
in	O
the	O
opportunistic	O
human	O
pathogen	O
Candida	O
albicans	O
at	O
concentrations	O
that	O
do	O
not	O
affect	O
growth	O
.	O

The	O
expression	O
of	O
HWP1	O
,	O
a	O
hyphal	O
-	O
specific	O
signature	O
gene	O
of	O
C	O
.	O
albicans	O
,	O
is	O
abolished	O
by	O
trans	O
-	O
2	O
-	O
decenoic	O
acid	O
.	O

trans	O
-	O
2	O
-	O
Decenoic	O
acid	O
is	O
structurally	O
similar	O
to	O
the	O
diffusible	O
signal	O
factor	O
(	O
DSF	O
)	O
family	O
of	O
interkingdom	O
-	O
signaling	O
molecules	O
and	O
is	O
the	O
first	O
member	O
of	O
this	O
family	O
from	O
a	O
Gram	O
-	O
positive	O
organism	O
(	O
Streptococcus	B-bacteria
DSF	I-bacteria
,	O
SDSF	B-bacteria
)	O
.	O

SDSF	B-bacteria
activity	O
was	O
also	O
found	O
in	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
but	O
not	O
in	O
other	O
oral	O
bacteria	O
.	O

SDSF	B-bacteria
could	O
be	O
relevant	O
in	O
shaping	O
multispecies	O
Candida	O
bacteria	O
biofilms	O
in	O
the	O
human	O
body	O
.	O

Several	O
methods	O
for	O
determining	O
the	O
diversity	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
were	O
evaluated	O
with	O
the	O
purpose	O
of	O
developing	O
a	O
realistic	O
approach	O
for	O
further	O
studies	O
.	O

The	O
patient	O
population	O
was	O
comprised	O
of	O
young	O
children	O
with	O
an	O
oral	O
disease	O
called	O
severe	O
early	O
childhood	O
caries	O
.	O

The	O
ultimate	O
goal	O
of	O
these	O
studies	O
was	O
to	O
ascertain	O
the	O
role	O
of	O
lactobacilli	B-bacteria
in	O
the	O
caries	O
process	O
.	O

To	O
accomplish	O
that	O
goal	O
,	O
we	O
evaluated	O
several	O
methods	O
and	O
approaches	O
for	O
determining	O
diversity	O
including	O
AP	O
-	O
PCR	O
,	O
chromosomal	O
DNA	O
fingerprinting	O
,	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
,	O
and	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

Central	O
to	O
these	O
methods	O
was	O
the	O
gathering	O
and	O
screening	O
of	O
isolates	O
from	O
cultivation	O
medium	O
.	O

Using	O
various	O
estimates	O
of	O
diversity	O
,	O
we	O
addressed	O
the	O
question	O
as	O
to	O
how	O
many	O
isolates	O
represent	O
the	O
overall	O
diversity	O
and	O
how	O
cultivation	O
compares	O
to	O
non	O
-	O
cultivation	O
techniques	O
.	O

Finally	O
,	O
we	O
proposed	O
a	O
working	O
approach	O
for	O
achieving	O
the	O
goals	O
outlined	O
framed	O
by	O
both	O
practical	O
constraints	O
in	O
terms	O
of	O
time	O
,	O
effort	O
and	O
efficacy	O
while	O
yielding	O
a	O
reliable	O
outcome	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
is	O
a	O
facultative	O
member	O
of	O
the	O
oral	O
plaque	O
and	O
is	O
associated	O
with	O
dental	O
caries	O
.	O

It	O
is	O
able	O
to	O
survive	O
long	O
periods	O
of	O
sugar	O
starvation	O
.	O

We	O
show	O
here	O
that	O
inactivation	O
of	O
pdhD	O
,	O
putatively	O
encoding	O
a	O
subunit	O
of	O
the	O
pyruvate	O
dehydrogenase	O
complex	O
,	O
impairs	O
survival	O
of	O
both	O
batch	O
cultures	O
and	O
biofilms	O
.	O

We	O
show	O
that	O
pdhD	O
and	O
the	O
downstream	O
genes	O
pdhA	O
,	O
pdhB	O
,	O
and	O
pdhC	O
form	O
an	O
operon	O
that	O
is	O
predominantly	O
transcribed	O
in	O
stationary	O
phase	O
.	O

Analysis	O
with	O
fluorescent	O
reporters	O
revealed	O
a	O
bimodal	O
expression	O
pattern	O
for	O
the	O
pdh	O
promoter	O
,	O
with	O
less	O
than	O
1	O
%	O
of	O
stationary	O
-	O
phase	O
populations	O
expressing	O
pdh	O
.	O

When	O
it	O
was	O
first	O
detected	O
,	O
after	O
1	O
day	O
of	O
sugar	O
starvation	O
in	O
batch	O
culture	O
,	O
expression	O
was	O
mostly	O
in	O
individual	O
bacteria	O
.	O

At	O
later	O
times	O
,	O
expressing	O
bacteria	O
were	O
often	O
in	O
chains	O
.	O

The	O
lengths	O
of	O
the	O
chains	O
increased	O
with	O
time	O
.	O

We	O
infer	O
that	O
the	O
pdh	O
-	O
expressing	O
subpopulation	O
is	O
able	O
grow	O
and	O
divide	O
and	O
to	O
persist	O
for	O
extended	O
times	O
in	O
stationary	O
phase	O
.	O

Laser	O
light	O
can	O
be	O
used	O
during	O
endodontic	O
procedures	O
to	O
sterilize	O
the	O
root	O
canal	O
by	O
destroying	O
bacteria	O
.	O

Previous	O
in	O
-	O
vitro	O
studies	O
that	O
investigated	O
the	O
mechanism	O
of	O
the	O
destruction	O
of	O
bacteria	O
inhabiting	O
the	O
root	O
canal	O
by	O
1	O
,	O
064	O
-	O
nm	O
Nd	O
:	O
YAG	O
and	O
808	O
-	O
nm	O
diode	O
laser	O
light	O
used	O
substrates	O
that	O
absorb	O
light	O
in	O
the	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
spectrum	O
.	O

These	O
substrates	O
heat	O
the	O
bacterial	O
microenvironment	O
,	O
which	O
possibly	O
contributes	O
to	O
cell	O
death	O
.	O

To	O
determine	O
the	O
direct	O
effect	O
of	O
laser	O
light	O
on	O
the	O
bacterial	O
sample	O
in	O
the	O
absence	O
of	O
detrimental	O
heating	O
,	O
a	O
sapphire	O
substrate	O
,	O
which	O
is	O
virtually	O
transparent	O
in	O
NIR	O
spectrum	O
,	O
was	O
inoculated	O
with	O
bacterial	O
samples	O
and	O
subjected	O
to	O
laser	O
irradiation	O
at	O
1	O
,	O
064	O
nm	O
(	O
1	O
.	O
5	O
W	O
,	O
15	O
Hz	O
)	O
and	O
at	O
808	O
nm	O
(	O
1	O
.	O
5	O
W	O
,	O
20	O
Hz	O
)	O
.	O

Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
bacteria	I-bacteria
were	O
used	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
largely	O
unaffected	O
by	O
laser	O
light	O
.	O

The	O
viability	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
a	O
pigmented	O
bacterium	O
,	O
was	O
directly	O
affected	O
by	O
both	O
NIR	O
wavelengths	O
(	O
a	O
57	O
%	O
decrease	O
of	O
viability	O
at	O
1	O
,	O
064	O
nm	O
and	O
a	O
31	O
%	O
decrease	O
at	O
808	O
nm	O
)	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
primary	O
mediator	O
of	O
cell	O
death	O
appears	O
to	O
be	O
the	O
interaction	O
between	O
NIR	O
laser	O
light	O
and	O
the	O
bacterial	O
microenvironment	O
,	O
most	O
likely	O
in	O
the	O
form	O
of	O
heating	O
.	O

Our	O
research	O
suggests	O
that	O
when	O
optimizing	O
the	O
efficacy	O
of	O
laser	O
-	O
assisted	O
endodontic	O
sterilization	O
of	O
the	O
root	O
canal	O
,	O
the	O
optical	O
characteristics	O
of	O
the	O
bacterial	O
microenvironment	O
play	O
a	O
key	O
role	O
,	O
as	O
nonpigmented	O
bacteria	O
appear	O
to	O
be	O
virtually	O
transparent	O
at	O
808	O
nm	O
and	O
1	O
,	O
064	O
nm	O
.	O

Histoplasmosis	O
is	O
a	O
deep	O
mycosis	O
caused	O
by	O
Histoplasma	O
capsulatum	O
,	O
which	O
is	O
endemic	O
in	O
many	O
areas	O
of	O
the	O
world	O
but	O
is	O
relatively	O
rare	O
in	O
China	O
.	O

Although	O
the	O
majority	O
of	O
cases	O
present	O
as	O
a	O
mild	O
to	O
moderate	O
flu	O
-	O
like	O
disease	O
requiring	O
only	O
supportive	O
therapy	O
,	O
approximately	O
1	O
%	O
of	O
patients	O
experience	O
more	O
serious	O
pulmonary	O
and	O
extrapulmonary	O
disease	O
,	O
which	O
can	O
be	O
life	O
-	O
threatening	O
if	O
diagnosis	O
is	O
delayed	O
or	O
the	O
treatment	O
is	O
not	O
initiated	O
rapidly	O
.	O

Definitive	O
diagnosis	O
is	O
usually	O
made	O
by	O
a	O
combination	O
of	O
culture	O
,	O
detection	O
of	O
the	O
organism	O
in	O
tissues	O
,	O
measurement	O
of	O
antibodies	O
,	O
and	O
detection	O
of	O
antigen	O
.	O

We	O
present	O
the	O
case	O
of	O
a	O
51	O
-	O
year	O
-	O
old	O
patient	O
who	O
presented	O
with	O
histoplasmosis	O
only	O
,	O
with	O
several	O
ulcerated	O
lesions	O
in	O
the	O
oral	O
cavity	O
and	O
without	O
HIV	O
infection	O
,	O
who	O
did	O
not	O
show	O
any	O
detectable	O
signs	O
and	O
symptoms	O
of	O
systemic	O
disease	O
or	O
extra	O
-	O
oral	O
manifestations	O
.	O

Histopathological	O
analysis	O
indicated	O
a	O
chronic	O
inflammatory	O
process	O
with	O
granulomas	O
with	O
yeast	O
-	O
like	O
organisms	O
.	O

Isolation	O
of	O
H	O
.	O
capsulatum	O
and	O
molecular	O
identification	O
provided	O
the	O
definitive	O
diagnosis	O
.	O

Treatment	O
with	O
oral	O
itraconazole	O
led	O
to	O
remission	O
of	O
the	O
oral	O
lesions	O
.	O

This	O
is	O
the	O
first	O
Chinese	O
case	O
report	O
of	O
localized	O
histoplasmosis	O
with	O
lesions	O
restricted	O
to	O
the	O
mouth	O
in	O
an	O
HIV	O
-	O
negative	O
patient	O
.	O

Oral	O
microbiota	O
plays	O
a	O
vital	O
role	O
in	O
maintaining	O
the	O
homeostasis	O
of	O
oral	O
cavity	O
.	O

Dental	O
caries	O
are	O
among	O
the	O
most	O
common	O
oral	O
diseases	O
in	O
children	O
and	O
pathogenic	O
bacteria	O
contribute	O
to	O
the	O
development	O
of	O
the	O
disease	O
.	O

However	O
,	O
the	O
overall	O
structure	O
of	O
bacterial	O
communities	O
in	O
the	O
oral	O
cavity	O
from	O
children	O
with	O
dental	O
caries	O
has	O
not	O
been	O
explored	O
deeply	O
heretofore	O
.	O

We	O
used	O
high	O
-	O
throughput	O
barcoded	O
pyrosequencing	O
and	O
PCR	O
-	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
to	O
examine	O
bacterial	O
diversity	O
of	O
oral	O
microbiota	O
in	O
saliva	O
and	O
supragingival	O
plaques	O
from	O
60	O
children	O
aged	O
3	O
to	O
6	O
years	O
old	O
with	O
and	O
without	O
dental	O
caries	O
from	O
China	O
.	O

The	O
multiplex	O
barcoded	O
pyrosequencing	O
was	O
performed	O
in	O
a	O
single	O
run	O
,	O
with	O
multiple	O
samples	O
tagged	O
uniquely	O
by	O
multiplex	O
identifiers	O
.	O

As	O
PCR	O
-	O
DGGE	O
analysis	O
is	O
a	O
conventional	O
molecular	O
ecological	O
approach	O
,	O
this	O
analysis	O
was	O
also	O
performed	O
on	O
the	O
same	O
samples	O
and	O
the	O
results	O
of	O
both	O
approaches	O
were	O
compared	O
.	O

A	O
total	O
of	O
186	O
,	O
787	O
high	O
-	O
quality	O
sequences	O
were	O
obtained	O
for	O
evaluating	O
bacterial	O
diversity	O
and	O
41	O
,	O
905	O
unique	O
sequences	O
represented	O
all	O
phylotypes	O
.	O

We	O
found	O
that	O
the	O
oral	O
microbiota	O
in	O
children	O
was	O
far	O
more	O
diverse	O
than	O
previous	O
studies	O
reported	O
,	O
and	O
more	O
than	O
200	O
genera	O
belonging	O
to	O
ten	O
phyla	O
were	O
found	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
phylotypes	O
in	O
saliva	O
and	O
supragingival	O
plaques	O
were	O
significantly	O
different	O
and	O
could	O
be	O
divided	O
into	O
two	O
distinct	O
clusters	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
bacterial	O
diversity	O
in	O
oral	O
microbiome	O
analyzed	O
by	O
PCR	O
-	O
DGGE	O
and	O
barcoded	O
pyrosequencing	O
was	O
employed	O
to	O
cross	O
validate	O
the	O
data	O
sets	O
.	O

The	O
genera	O
of	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
and	O
Thiomonas	B-bacteria
in	O
plaques	O
were	O
significantly	O
associated	O
with	O
dental	O
caries	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
results	O
showed	O
that	O
there	O
was	O
no	O
one	O
specific	O
pathogen	O
but	O
rather	O
pathogenic	O
populations	O
in	O
plaque	O
that	O
significantly	O
correlated	O
with	O
dental	O
caries	O
.	O

The	O
enormous	O
diversity	O
of	O
oral	O
microbiota	O
allowed	O
for	O
a	O
better	O
understanding	O
of	O
oral	O
microecosystem	O
,	O
and	O
these	O
pathogenic	O
populations	O
in	O
plaque	O
provide	O
new	O
insights	O
into	O
the	O
etiology	O
of	O
dental	O
caries	O
and	O
suggest	O
new	O
targets	O
for	O
interventions	O
of	O
the	O
disease	O
.	O

This	O
study	O
was	O
designed	O
to	O
explore	O
the	O
biological	O
characteristics	O
of	O
a	O
new	O
oral	O
streptococcus	B-bacteria
species	I-bacteria
Streptococcus	B-bacteria
oligofermentans	I-bacteria
.	O

Plaque	O
samples	O
were	O
collected	O
from	O
caries	O
-	O
free	O
and	O
caries	O
-	O
active	O
subjects	O
.	O

S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
was	O
selectively	O
grown	O
on	O
Mitis	O
salivarius	O
agar	O
plates	O
and	O
identified	O
by	O
using	O
2	O
-	O
step	O
PCR	O
and	O
was	O
isolated	O
from	O
38	O
%	O
of	O
18	O
subjects	O
.	O

Isolates	O
were	O
found	O
mostly	O
on	O
healthy	O
tooth	O
surfaces	O
.	O

S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
had	O
weaker	O
abilities	O
in	O
acid	O
production	O
and	O
demineralizing	O
hydroxyapatite	O
.	O

When	O
Streptococcus	B-bacteria
mutans	I-bacteria
was	O
coincubated	O
with	O
S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
,	O
total	O
number	O
,	O
acid	O
production	O
and	O
calcium	O
release	O
were	O
significantly	O
inhibited	O
.	O

In	O
conclusion	O
,	O
inhibition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
could	O
be	O
a	O
beneficial	O
biological	O
characteristic	O
of	O
S	B-bacteria
.	I-bacteria
oligofermentans	I-bacteria
in	O
oral	O
microecology	O
.	O

Epithelial	O
cells	O
and	O
dendritic	O
cells	O
(	O
DCs	O
)	O
both	O
initiate	O
and	O
contribute	O
to	O
innate	O
immune	O
responses	O
to	O
bacteria	O
.	O

However	O
,	O
much	O
less	O
is	O
known	O
about	O
the	O
coordinated	O
regulation	O
of	O
innate	O
immune	O
responses	O
between	O
GECs	O
and	O
immune	O
cells	O
,	O
particularly	O
DCs	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
present	O
study	O
was	O
conducted	O
to	O
investigate	O
whether	O
their	O
responses	O
are	O
coordinated	O
and	O
are	O
bacteria	O
-	O
specific	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
beta	O
-	O
defensin	O
antimicrobial	O
peptides	O
hBD1	O
,	O
hBD2	O
and	O
hBD3	O
were	O
expressed	O
by	O
immature	O
DCs	O
as	O
well	O
as	O
gingival	O
epithelial	O
cells	O
(	O
GECs	O
)	O
.	O

HBD1	O
,	O
hBD2	O
and	O
hBD3	O
are	O
upregulated	O
in	O
DCs	O
while	O
hBD2	O
and	O
hBD3	O
are	O
upregulated	O
in	O
GECs	O
in	O
response	O
to	O
bacterial	O
stimulation	O
.	O

Responses	O
of	O
both	O
cell	O
types	O
were	O
bacteria	O
-	O
specific	O
,	O
as	O
demonstrated	O
by	O
distinctive	O
profiles	O
of	O
hBDs	O
mRNA	O
expression	O
and	O
secreted	O
cytokines	O
and	O
chemokines	O
in	O
response	O
to	O
cell	O
wall	O
preparations	O
of	O
various	O
bacteria	O
of	O
different	O
pathogenicity	O
:	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
regulation	O
of	O
expression	O
of	O
hBD2	O
,	O
IL	O
-	O
8	O
,	O
CXCL2	O
/	O
GRObeta	O
and	O
CCL	O
-	O
20	O
/	O
MIP3alpha	O
by	O
GECs	O
was	O
greatly	O
enhanced	O
by	O
conditioned	O
medium	O
from	O
bacterially	O
activated	O
DCs	O
.	O

This	O
enhancement	O
was	O
primarily	O
mediated	O
via	O
IL	O
-	O
1beta	O
,	O
since	O
induction	O
was	O
largely	O
attenuated	O
by	O
IL	O
-	O
1	O
receptor	O
antagonist	O
.	O

In	O
addition	O
,	O
the	O
defensins	O
influence	O
DCs	O
by	O
eliciting	O
differential	O
cytokine	O
and	O
chemokine	O
secretion	O
.	O

HBD2	O
significantly	O
induced	O
IL	O
-	O
6	O
,	O
while	O
hBD3	O
induced	O
MCP	O
-	O
1	O
to	O
approximately	O
the	O
same	O
extent	O
as	O
LPS	O
,	O
suggesting	O
a	O
unique	O
role	O
in	O
immune	O
responses	O
.	O

The	O
results	O
suggest	O
that	O
cytokines	O
,	O
chemokines	O
and	O
beta	O
-	O
defensins	O
are	O
involved	O
in	O
interaction	O
of	O
these	O
two	O
cell	O
types	O
,	O
and	O
the	O
responses	O
are	O
bacteria	O
-	O
specific	O
.	O

Differential	O
and	O
coordinated	O
regulation	O
between	O
GECs	O
and	O
DCs	O
may	O
be	O
important	O
in	O
regulation	O
of	O
innate	O
immune	O
homeostasis	O
and	O
response	O
to	O
pathogens	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
human	O
mouth	O
is	O
host	O
to	O
a	O
diverse	O
collection	O
of	O
microorganisms	O
including	O
bacteria	O
,	O
viruses	O
,	O
fungi	O
and	O
protozoa	O
.	O

Recent	O
advances	O
using	O
molecular	O
methods	O
for	O
the	O
analysis	O
of	O
complex	O
bacterial	O
communities	O
have	O
demonstrated	O
the	O
richness	O
of	O
the	O
oral	O
bacterial	O
biota	O
and	O
the	O
presence	O
of	O
numerous	O
previously	O
undescribed	O
lineages	O
.	O

Dental	O
plaque	O
forms	O
in	O
a	O
structured	O
way	O
with	O
pioneer	O
species	O
able	O
to	O
colonise	O
pellicle	O
-	O
coated	O
enamel	O
followed	O
by	O
secondary	O
plaque	O
formers	O
such	O
as	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
that	O
have	O
the	O
capability	O
of	O
coaggregating	O
with	O
a	O
range	O
of	O
other	O
genera	O
and	O
species	O
.	O

The	O
mature	O
plaque	O
biofilm	O
has	O
many	O
features	O
of	O
multicellular	O
organisms	O
with	O
the	O
constituent	O
organisms	O
cooperating	O
to	O
make	O
nutrients	O
available	O
and	O
resist	O
environmental	O
stresses	O
,	O
and	O
communicating	O
to	O
regulate	O
their	O
overall	O
numbers	O
.	O

Control	O
of	O
the	O
oral	O
microbiota	O
to	O
prevent	O
disease	O
has	O
conventionally	O
been	O
by	O
mechanical	O
means	O
augmented	O
with	O
toothpastes	O
and	O
mouthrinses	O
,	O
but	O
improved	O
knowledge	O
of	O
oral	O
microbial	O
ecology	O
is	O
allowing	O
the	O
development	O
of	O
pre	O
and	O
pro	O
-	O
biotic	O
approaches	O
.	O

Other	O
possibilities	O
include	O
interference	O
with	O
the	O
plaque	O
formation	O
process	O
and	O
the	O
perturbation	O
of	O
bacterial	O
communication	O
networks	O
.	O

We	O
aimed	O
to	O
determine	O
oral	O
microflora	O
of	O
patients	O
on	O
long	O
-	O
term	O
hemodialysis	O
and	O
kidney	O
transplant	O
recipients	O
,	O
and	O
to	O
compare	O
them	O
with	O
individuals	O
without	O
kidney	O
disease	O
.	O

We	O
studied	O
on	O
3	O
groups	O
including	O
patients	O
on	O
at	O
least	O
6	O
months	O
of	O
hemodialysis	O
,	O
kidney	O
transplant	O
recipients	O
for	O
more	O
than	O
2	O
years	O
,	O
and	O
controls	O
with	O
a	O
normal	O
kidney	O
function	O
.	O

Staining	O
and	O
culture	O
were	O
applied	O
for	O
samples	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
and	O
the	O
oral	O
floor	O
in	O
order	O
to	O
detect	O
aerobic	O
and	O
anaerobic	O
bacteria	O
and	O
Candida	O
.	O

The	O
participants	O
were	O
49	O
patients	O
on	O
hemodialysis	O
,	O
50	O
kidney	O
transplant	O
recipients	O
,	O
and	O
50	O
volunteers	O
in	O
the	O
control	O
group	O
.	O

The	O
abundance	O
of	O
Candida	O
was	O
significantly	O
higher	O
in	O
the	O
hemodialysis	O
and	O
transplant	O
groups	O
compared	O
with	O
the	O
control	O
group	O
.	O

The	O
mean	O
of	O
various	O
microorganisms	O
was	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
the	O
hemodialysis	O
group	O
than	O
the	O
control	O
group	O
(	O
P	O
=	O
.	O
03	O
)	O
;	O
however	O
,	O
the	O
frequency	O
of	O
these	O
microorganisms	O
in	O
the	O
transplant	O
group	O
was	O
lower	O
than	O
that	O
in	O
the	O
hemodialysis	O
group	O
.	O

Adjusting	O
for	O
confounding	O
factors	O
,	O
the	O
odds	O
of	O
having	O
Candida	O
in	O
the	O
hemodialysis	O
and	O
transplant	O
groups	O
were	O
3	O
.	O
54	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
21	O
to	O
10	O
.	O
41	O
)	O
and	O
3	O
.	O
49	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
27	O
to	O
9	O
.	O
18	O
)	O
times	O
higher	O
compared	O
to	O
the	O
control	O
group	O
,	O
respectively	O
.	O

Hemodialysis	O
and	O
kidney	O
transplantation	O
could	O
affect	O
oral	O
microflora	O
.	O

Candida	O
was	O
significantly	O
more	O
frequent	O
in	O
these	O
patients	O
compared	O
to	O
healthy	O
adults	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacilli	B-bacteria
,	O
Porphyromonas	B-bacteria
,	O
and	O
Candida	O
is	O
seen	O
slightly	O
less	O
frequently	O
after	O
kidney	O
transplantation	O
,	O
which	O
might	O
be	O
in	O
favor	O
of	O
promising	O
effects	O
of	O
kidney	O
transplantation	O
on	O
oral	O
microflora	O
.	O

Within	O
the	O
same	O
human	O
gastrointestinal	O
tract	O
,	O
substantial	O
differences	O
in	O
the	O
bacterial	O
species	O
that	O
inhabit	O
oral	O
cavity	O
and	O
intestinal	O
tract	O
have	O
been	O
noted	O
.	O

Previous	O
research	O
primarily	O
attributed	O
the	O
differences	O
to	O
the	O
influences	O
of	O
host	O
environments	O
and	O
nutritional	O
availabilities	O
(	O
`	O
`	O
host	O
habitat	O
'	O
'	O
effect	O
)	O
.	O

Our	O
recent	O
study	O
indicated	O
that	O
,	O
other	O
than	O
the	O
host	O
habitat	O
effect	O
,	O
an	O
existing	O
microbial	O
community	O
could	O
impose	O
a	O
selective	O
pressure	O
on	O
incoming	O
foreign	O
bacterial	O
species	O
independent	O
of	O
host	O
-	O
mediated	O
selection	O
(	O
`	O
`	O
community	O
selection	O
'	O
'	O
effect	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
employed	O
in	O
vitro	O
microbial	O
floras	O
representing	O
microorganisms	O
that	O
inhabit	O
the	O
oral	O
cavities	O
and	O
intestinal	O
tract	O
of	O
mice	O
in	O
combination	O
with	O
Escherichia	B-bacteria
coli	I-bacteria
as	O
a	O
model	O
intestinal	O
bacterium	O
and	O
demonstrated	O
that	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
displays	O
a	O
striking	O
community	O
preference	O
.	O

It	O
thrived	O
when	O
introduced	O
into	O
the	O
intestinal	O
microbial	O
community	O
and	O
survived	O
poorly	O
in	O
the	O
microbial	O
flora	O
of	O
foreign	O
origin	O
(	O
oral	O
community	O
)	O
.	O

A	O
more	O
detailed	O
examination	O
of	O
this	O
phenomenon	O
showed	O
that	O
the	O
oral	O
community	O
produced	O
oxygen	O
-	O
free	O
radicals	O
in	O
the	O
presence	O
of	O
wild	O
-	O
type	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
while	O
mutants	O
deficient	O
in	O
lipopolysaccharides	O
(	O
LPS	O
)	O
did	O
not	O
trigger	O
significant	O
production	O
of	O
these	O
cell	O
-	O
damaging	O
agents	O
.	O

Furthermore	O
,	O
mutants	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
defective	O
in	O
the	O
oxidative	O
stress	O
response	O
experienced	O
a	O
more	O
drastic	O
reduction	O
in	O
viability	O
when	O
cocultivated	O
with	O
the	O
oral	O
flora	O
,	O
while	O
the	O
exogenous	O
addition	O
of	O
the	O
antioxidant	O
vitamin	O
C	O
was	O
able	O
to	O
rescue	O
it	O
.	O

We	O
concluded	O
that	O
the	O
oral	O
-	O
derived	O
microbial	O
community	O
senses	O
the	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
LPS	O
and	O
kills	O
the	O
bacterium	O
with	O
oxygen	O
-	O
free	O
radicals	O
.	O

This	O
study	O
reveals	O
a	O
new	O
mechanism	O
of	O
community	O
invasion	O
resistance	O
employed	O
by	O
established	O
microflora	O
to	O
defend	O
their	O
domains	O
.	O

Dental	O
plaque	O
is	O
the	O
biofilm	O
found	O
naturally	O
on	O
teeth	O
.	O

Dental	O
plaque	O
is	O
also	O
implicated	O
in	O
dental	O
caries	O
,	O
which	O
is	O
associated	O
with	O
shifts	O
in	O
the	O
microbial	O
balance	O
of	O
the	O
biofilm	O
resulting	O
in	O
increased	O
proportions	O
of	O
acid	O
producing	O
and	O
acid	O
tolerating	O
bacteria	O
,	O
especially	O
(	O
but	O
not	O
exclusively	O
)	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
.	O

The	O
regular	O
intake	O
of	O
fermentable	O
dietary	O
sugars	O
,	O
or	O
impaired	O
saliva	O
flow	O
,	O
produces	O
persistent	O
conditions	O
of	O
low	O
pH	O
within	O
the	O
biofilm	O
,	O
which	O
selects	O
for	O
these	O
cariogenic	O
bacteria	O
.	O

Clinicians	O
should	O
prevent	O
this	O
disruption	O
to	O
the	O
natural	O
microbial	O
balance	O
of	O
the	O
biofilm	O
(	O
relevant	O
approaches	O
are	O
described	O
)	O
rather	O
than	O
merely	O
treating	O
its	O
consequences	O
by	O
restoring	O
cavities	O
.	O

This	O
study	O
investigated	O
the	O
antibacterial	O
effect	O
of	O
a	O
resin	O
composite	O
matrix	O
with	O
or	O
without	O
incorporated	O
triclosan	O
(	O
0	O
.	O
3	O
wt	O
%	O
)	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Actinomyces	B-bacteria
viscosus	I-bacteria
and	O
Lactobacillus	B-bacteria
casei	I-bacteria
.	O

In	O
the	O
quantitative	O
assay	O
,	O
bacterial	O
suspensions	O
were	O
filled	O
into	O
20	O
-	O
mul	O
cavities	O
within	O
temporary	O
restorative	O
resins	O
.	O

After	O
0	O
,	O
4	O
,	O
8	O
,	O
12	O
,	O
24	O
and	O
48	O
h	O
of	O
incubation	O
,	O
the	O
suspensions	O
were	O
removed	O
from	O
the	O
restoratives	O
and	O
the	O
numbers	O
of	O
viable	O
bacteria	O
were	O
determined	O
.	O

Bacterial	O
suspensions	O
incubated	O
without	O
restoratives	O
served	O
as	O
the	O
controls	O
.	O

Ten	O
replicates	O
were	O
carried	O
out	O
for	O
each	O
experiment	O
.	O

The	O
resin	O
composite	O
containing	O
triclosan	O
demonstrated	O
variable	O
degrees	O
of	O
antibacterial	O
activity	O
against	O
the	O
microorganisms	O
,	O
revealing	O
a	O
significant	O
inhibitory	O
effect	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
within	O
12	O
h	O
compared	O
to	O
the	O
control	O
.	O

The	O
viable	O
counts	O
of	O
A	B-bacteria
.	I-bacteria
viscosus	I-bacteria
significantly	O
decreased	O
after	O
24	O
h	O
.	O

A	O
significant	O
reduction	O
of	O
L	B-bacteria
.	I-bacteria
casei	I-bacteria
was	O
observed	O
after	O
48	O
h	O
.	O
The	O
unloaded	O
resin	O
composite	O
did	O
not	O
reveal	O
a	O
marked	O
antibacterial	O
effect	O
.	O

The	O
resin	O
composite	O
loaded	O
with	O
triclosan	O
might	O
be	O
beneficial	O
in	O
preventing	O
cavity	O
contamination	O
and	O
minimizing	O
the	O
risk	O
of	O
pulpal	O
irritation	O
in	O
the	O
short	O
-	O
term	O
.	O

The	O
oral	O
cavity	O
can	O
act	O
as	O
a	O
reservoir	O
of	O
certain	O
pathogens	O
that	O
can	O
cause	O
systemic	O
infections	O
.	O

The	O
periodontal	O
pocket	O
is	O
an	O
ecological	O
niche	O
appropriate	O
for	O
hosting	O
microorganisms	O
that	O
could	O
act	O
as	O
opportunistic	O
pathogens	O
.	O

The	O
ability	O
of	O
Staphylococcus	B-bacteria
spp	I-bacteria
and	O
Candida	O
spp	O
to	O
form	O
a	O
biofilm	O
and	O
live	O
within	O
certain	O
niches	O
allows	O
them	O
to	O
develop	O
mechanisms	O
that	O
increase	O
persistence	O
,	O
such	O
as	O
the	O
evasion	O
of	O
host	O
defenses	O
and	O
antibiotic	O
efficacy	O
.	O

These	O
microorganisms	O
can	O
easily	O
be	O
or	O
become	O
resistant	O
to	O
antibiotics	O
and	O
lead	O
to	O
superinfection	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
assess	O
the	O
presence	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Staphylococcus	B-bacteria
spp	I-bacteria
in	O
biofilm	O
in	O
subgingival	O
plaque	O
and	O
oral	O
cavity	O
of	O
individuals	O
with	O
gingival	O
-	O
periodontal	O
disease	O
,	O
to	O
identify	O
isolates	O
and	O
the	O
relationship	O
with	O
Candida	O
spp	O
.	O

The	O
study	O
included	O
eighty	O
-	O
two	O
patients	O
,	O
aged	O
18	O
-	O
70	O
years	O
with	O
periodontal	O
disease	O
and	O
at	O
least	O
two	O
sites	O
with	O
probing	O
depth	O
>	O
or	O
=	O
3	O
mm	O
.	O

Participants	O
'	O
data	O
were	O
evaluated	O
individually	O
.	O

Subgingival	O
biofilm	O
samples	O
were	O
obtained	O
using	O
Gracey	O
curettes	O
7	O
/	O
8	O
,	O
after	O
supragingival	O
biofilm	O
removal	O
,	O
and	O
a	O
sample	O
from	O
the	O
oral	O
cavity	O
(	O
buccal	O
mucosa	O
,	O
tongue	O
and	O
cheek	O
mucosa	O
)	O
by	O
sterile	O
swab	O
.	O

Of	O
all	O
the	O
patients	O
studied	O
,	O
42	O
.	O
7	O
%	O
exhibited	O
Staphylococcus	B-bacteria
spp	I-bacteria
in	O
the	O
periodontal	O
pocket	O
and	O
69	O
.	O
5	O
%	O
in	O
the	O
oral	O
cavity	O
while	O
25	O
.	O
6	O
%	O
exhibited	O
Candida	O
spp	O
in	O
the	O
periodontal	O
pocket	O
and	O
42	O
.	O
7	O
%	O
in	O
the	O
oral	O
cavity	O
.	O

However	O
,	O
13	O
.	O
4	O
%	O
had	O
both	O
microorganisms	O
in	O
the	O
periodontal	O
pocket	O
and	O
36	O
.	O
6	O
%	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
prevalence	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
13	O
.	O
4	O
%	O
in	O
the	O
periodontal	O
pocket	O
and	O
15	O
.	O
8	O
%	O
in	O
the	O
oral	O
cavity	O
.	O

Candida	O
albicans	O
was	O
the	O
most	O
prevalent	O
yeast	O
in	O
the	O
periodontal	O
pocket	O
(	O
76	O
.	O
2	O
%	O
)	O
and	O
in	O
the	O
oral	O
cavity	O
(	O
63	O
.	O
0	O
%	O
)	O
.	O

The	O
human	O
oral	O
cavity	O
contains	O
a	O
number	O
of	O
different	O
habitats	O
,	O
including	O
the	O
teeth	O
,	O
gingival	O
sulcus	O
,	O
tongue	O
,	O
cheeks	O
,	O
hard	O
and	O
soft	O
palates	O
,	O
and	O
tonsils	O
,	O
which	O
are	O
colonized	O
by	O
bacteria	O
.	O

The	O
oral	O
microbiome	O
is	O
comprised	O
of	O
over	O
600	O
prevalent	O
taxa	O
at	O
the	O
species	O
level	O
,	O
with	O
distinct	O
subsets	O
predominating	O
at	O
different	O
habitats	O
.	O

The	O
oral	O
microbiome	O
has	O
been	O
extensively	O
characterized	O
by	O
cultivation	O
and	O
culture	O
-	O
independent	O
molecular	O
methods	O
such	O
as	O
16S	O
rRNA	O
cloning	O
.	O

Unfortunately	O
,	O
the	O
vast	O
majority	O
of	O
unnamed	O
oral	O
taxa	O
are	O
referenced	O
by	O
clone	O
numbers	O
or	O
16S	O
rRNA	O
GenBank	O
accession	O
numbers	O
,	O
often	O
without	O
taxonomic	O
anchors	O
.	O

The	O
first	O
aim	O
of	O
this	O
research	O
was	O
to	O
collect	O
16S	O
rRNA	O
gene	O
sequences	O
into	O
a	O
curated	O
phylogeny	O
-	O
based	O
database	O
,	O
the	O
Human	O
Oral	O
Microbiome	O
Database	O
(	O
HOMD	O
)	O
,	O
and	O
make	O
it	O
web	O
accessible	O
(	O
www	O
.	O
homd	O
.	O
org	O
)	O
.	O

The	O
HOMD	O
includes	O
619	O
taxa	O
in	O
13	O
phyla	O
,	O
as	O
follows	O
:	O
Actinobacteria	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
Chlamydiae	B-bacteria
,	O
Chloroflexi	B-bacteria
,	O
Euryarchaeota	B-bacteria
,	O
Firmicutes	B-bacteria
,	O
Fusobacteria	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Spirochaetes	B-bacteria
,	O
SR1	B-bacteria
,	O
Synergistetes	B-bacteria
,	O
Tenericutes	B-bacteria
,	O
and	O
TM7	B-bacteria
.	O

The	O
second	O
aim	O
was	O
to	O
analyze	O
36	O
,	O
043	O
16S	O
rRNA	O
gene	O
clones	O
isolated	O
from	O
studies	O
of	O
the	O
oral	O
microbiota	O
to	O
determine	O
the	O
relative	O
abundance	O
of	O
taxa	O
and	O
identify	O
novel	O
candidate	O
taxa	O
.	O

The	O
analysis	O
identified	O
1	O
,	O
179	O
taxa	O
,	O
of	O
which	O
24	O
%	O
were	O
named	O
,	O
8	O
%	O
were	O
cultivated	O
but	O
unnamed	O
,	O
and	O
68	O
%	O
were	O
uncultivated	O
phylotypes	O
.	O

Upon	O
validation	O
,	O
434	O
novel	O
,	O
nonsingleton	O
taxa	O
will	O
be	O
added	O
to	O
the	O
HOMD	O
.	O

The	O
number	O
of	O
taxa	O
needed	O
to	O
account	O
for	O
90	O
%	O
,	O
95	O
%	O
,	O
or	O
99	O
%	O
of	O
the	O
clones	O
examined	O
is	O
259	O
,	O
413	O
,	O
and	O
875	O
,	O
respectively	O
.	O

The	O
HOMD	O
is	O
the	O
first	O
curated	O
description	O
of	O
a	O
human	O
-	O
associated	O
microbiome	O
and	O
provides	O
tools	O
for	O
use	O
in	O
understanding	O
the	O
role	O
of	O
the	O
microbiome	O
in	O
health	O
and	O
disease	O
.	O

To	O
characterize	O
the	O
normal	O
bacterial	O
flora	O
and	O
evaluate	O
the	O
presence	O
of	O
periodontopathogenic	O
bacteria	O
around	O
dental	O
implants	O
and	O
to	O
correlate	O
them	O
with	O
the	O
periodontal	O
flora	O
or	O
,	O
in	O
completely	O
edentulous	O
patients	O
,	O
the	O
alveolar	O
gingival	O
flora	O
.	O

Clinical	O
and	O
radiographic	O
parameters	O
were	O
recorded	O
to	O
exclude	O
peri	O
-	O
implantitis	O
in	O
34	O
partially	O
edentulous	O
and	O
19	O
completely	O
edentulous	O
patients	O
.	O

Partially	O
edentulous	O
patients	O
were	O
subdivided	O
into	O
two	O
subgroups	O
based	O
on	O
the	O
depth	O
of	O
the	O
periodontal	O
pocket	O
:	O
<	O
/	O
=	O
4	O
mm	O
(	O
n	O
=	O
19	O
)	O
and	O
>	O
4	O
mm	O
(	O
n	O
=	O
15	O
)	O
.	O

Microbial	O
samples	O
were	O
collected	O
from	O
peri	O
-	O
implant	O
sulci	O
,	O
the	O
deepest	O
periodontal	O
sulci	O
,	O
and	O
,	O
for	O
completely	O
edentulous	O
patients	O
,	O
from	O
the	O
alveolar	O
gingiva	O
.	O

Predominant	O
aerobic	O
bacteria	O
were	O
determined	O
by	O
microbiologic	O
culturing	O
,	O
and	O
multiplex	O
polymerase	O
chain	O
reaction	O
was	O
used	O
to	O
detect	O
five	O
periodontopathogenic	O
bacteria	O
:	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

In	O
all	O
the	O
examined	O
patients	O
,	O
oral	O
streptococci	B-bacteria
were	O
the	O
most	O
frequent	O
aerobic	O
peri	O
-	O
implant	O
bacteria	O
.	O

The	O
frequency	O
of	O
four	O
periodontopathogenic	O
bacteria	O
in	O
tooth	O
sulci	O
(	O
A	B-bacteria
actino	I-bacteria
?	I-bacteria
mycetemcomitans	I-bacteria
,	O
P	B-bacteria
gingivalis	I-bacteria
,	O
T	B-bacteria
forsythensis	I-bacteria
,	O
T	B-bacteria
denticola	I-bacteria
)	O
was	O
significantly	O
higher	O
around	O
natural	O
teeth	O
with	O
deeper	O
periodontal	O
pockets	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
frequency	O
of	O
the	O
same	O
bacteria	O
in	O
peri	O
-	O
implant	O
sulci	O
in	O
the	O
two	O
partially	O
edentulous	O
subgroups	O
.	O

In	O
contrast	O
,	O
there	O
were	O
no	O
such	O
bacteria	O
in	O
the	O
peri	O
-	O
implant	O
sulci	O
or	O
the	O
alveolar	O
gingiva	O
of	O
completely	O
edentulous	O
patients	O
.	O

In	O
healthy	O
peri	O
-	O
implant	O
sulci	O
,	O
oral	O
streptococci	B-bacteria
constitute	O
the	O
predominant	O
bacterial	O
flora	O
.	O

In	O
partially	O
edentulous	O
patients	O
four	O
periodontopathogenic	O
bacteria	O
were	O
detected	O
around	O
implants	O
,	O
and	O
none	O
of	O
these	O
bacteria	O
were	O
found	O
around	O
implants	O
in	O
completely	O
edentulous	O
patients	O
.	O

The	O
antibacterial	O
properties	O
of	O
self	O
-	O
etching	O
adhesive	O
systems	O
constitute	O
an	O
important	O
issue	O
in	O
operative	O
dentistry	O
,	O
since	O
viable	O
bacteria	O
can	O
still	O
be	O
present	O
after	O
cavity	O
preparation	O
.	O

The	O
current	O
study	O
evaluated	O
the	O
antibacterial	O
activity	O
of	O
five	O
one	O
-	O
step	O
self	O
-	O
etching	O
adhesives	O
(	O
SEAs	O
)	O
and	O
four	O
self	O
-	O
etching	O
primers	O
(	O
SEPs	O
)	O
against	O
oral	O
streptococci	B-bacteria
.	O

Clearfil	O
S3	O
(	O
S3	O
)	O
,	O
One	O
-	O
Up	O
Bond	O
F	O
Plus	O
(	O
OU	O
)	O
,	O
Futurabond	O
NR	O
(	O
FB	O
)	O
,	O
GBond	O
(	O
GB	O
)	O
,	O
Xeno	O
IV	O
(	O
X4	O
)	O
,	O
Clearfil	O
SE	O
Bond	O
(	O
SE	O
)	O
,	O
Clearfil	O
Protect	O
Bond	O
(	O
PB	O
)	O
,	O
Adper	O
SE	O
Plus	O
(	O
AS	O
)	O
and	O
AdheSE	O
(	O
AD	O
)	O
were	O
tested	O
for	O
antibacterial	O
activity	O
against	O
five	O
streptococci	B-bacteria
species	I-bacteria
:	O
S	B-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
sanguinis	I-bacteria
,	O
S	B-bacteria
cricetus	I-bacteria
,	O
S	B-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
sobrinus	I-bacteria
.	O

Chlorhexidine	O
(	O
0	O
.	O
12	O
%	O
)	O
and	O
phosphoric	O
acid	O
(	O
37	O
%	O
)	O
gel	O
were	O
used	O
as	O
control	O
.	O

The	O
agar	O
diffusion	O
test	O
method	O
was	O
used	O
.	O

Plates	O
containing	O
BHI	O
agar	O
and	O
300	O
uL	O
of	O
bacterial	O
cell	O
suspension	O
(	O
0	O
.	O
5	O
MacFarland	O
)	O
were	O
prepared	O
.	O

Holes	O
6	O
mm	O
in	O
diameter	O
were	O
made	O
and	O
partially	O
filled	O
with	O
bacteriological	O
agar	O
.	O

Then	O
,	O
10	O
uL	O
of	O
each	O
SEA	O
or	O
SEP	O
was	O
dropped	O
and	O
the	O
plates	O
were	O
incubated	O
under	O
microaerophilic	O
atmosphere	O
at	O
37	O
degrees	O
C	O
for	O
48	O
hours	O
and	O
the	O
diameter	O
of	O
each	O
halo	O
was	O
registered	O
.	O

The	O
results	O
were	O
analyzed	O
by	O
two	O
-	O
way	O
ANOVA	O
and	O
Tukey	O
test	O
.	O

PB	O
exhibited	O
the	O
most	O
effective	O
antibacterial	O
activity	O
against	O
oral	O
streptococci	B-bacteria
.	O

The	O
performances	O
of	O
SE	O
and	O
FB	O
were	O
similar	O
or	O
better	O
than	O
chlorhexidine	O
for	O
all	O
bacteria	O
.	O

S3	O
,	O
X4	O
,	O
AS	O
,	O
AD	O
,	O
OU	O
and	O
GB	O
showed	O
significantly	O
lower	O
inhibition	O
values	O
.	O

Among	O
the	O
species	O
tested	O
,	O
S	B-bacteria
oralis	I-bacteria
was	O
the	O
most	O
sensitive	O
to	O
all	O
self	O
-	O
etching	O
adhesive	O
systems	O
;	O
on	O
the	O
other	O
hand	O
,	O
S	B-bacteria
cricetus	I-bacteria
,	O
S	B-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
sobrinus	I-bacteria
were	O
more	O
resistant	O
.	O

Among	O
the	O
self	O
-	O
etching	O
adhesive	O
systems	O
evaluated	O
,	O
Clearfil	O
Protect	O
Bond	O
exhibited	O
the	O
most	O
effective	O
antibacterial	O
activity	O
against	O
oral	O
streptococci	B-bacteria
.	O

Colonization	O
of	O
periodontopathic	O
bacteria	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
systemic	O
diseases	O
.	O

However	O
,	O
few	O
studies	O
have	O
investigated	O
the	O
relationships	O
between	O
oral	O
status	O
factors	O
and	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HR	O
-	O
QOL	O
)	O
and	O
the	O
prevalence	O
of	O
such	O
bacteria	O
in	O
elderly	O
individuals	O
.	O

This	O
study	O
investigated	O
the	O
prevalence	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
in	O
165	O
community	O
-	O
dwelling	O
functionally	O
independent	O
85	O
-	O
year	O
-	O
old	O
Japanese	O
individuals	O
(	O
93	O
dentate	O
,	O
72	O
edentulous	O
)	O
and	O
the	O
relationship	O
to	O
oral	O
status	O
,	O
including	O
oral	O
malodour	O
and	O
HR	O
-	O
QOL	O
.	O

All	O
four	O
of	O
the	O
studied	O
periodontopathic	O
bacteria	O
were	O
found	O
more	O
frequently	O
in	O
tongue	O
coating	O
samples	O
from	O
dentate	O
than	O
edentulous	O
subjects	O
,	O
and	O
the	O
prevalence	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
was	O
significantly	O
related	O
to	O
the	O
number	O
of	O
teeth	O
with	O
a	O
periodontal	O
pocket	O
depth	O
>	O
/	O
=	O
4	O
mm	O
.	O

These	O
results	O
suggest	O
the	O
existence	O
of	O
a	O
stable	O
circulation	O
of	O
periodontopathic	O
bacteria	O
between	O
the	O
gingival	O
sulcus	O
and	O
tongue	O
coating	O
over	O
time	O
with	O
teeth	O
.	O

In	O
addition	O
,	O
the	O
presence	O
of	O
teeth	O
with	O
a	O
deep	O
pocket	O
and	O
colonization	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
were	O
positively	O
related	O
to	O
the	O
level	O
of	O
CH	O
(	O
3	O
)	O
SH	O
,	O
whilst	O
the	O
number	O
of	O
present	O
teeth	O
contributed	O
positively	O
to	O
HR	O
-	O
QOL	O
,	O
especially	O
with	O
regard	O
to	O
mental	O
health	O
.	O

In	O
conclusion	O
,	O
as	O
the	O
dentate	O
state	O
can	O
retain	O
colonization	O
of	O
periodontopathic	O
pathogens	O
in	O
the	O
oral	O
cavity	O
,	O
both	O
periodontal	O
treatment	O
and	O
tongue	O
care	O
are	O
important	O
for	O
maintaining	O
a	O
healthy	O
oral	O
status	O
in	O
the	O
elderly	O
,	O
and	O
possibly	O
result	O
in	O
avoidance	O
of	O
risk	O
for	O
tooth	O
loss	O
and	O
decline	O
in	O
HR	O
-	O
QOL	O
,	O
as	O
well	O
as	O
protecting	O
from	O
systemic	O
diseases	O
.	O

Beneficial	O
findings	O
concerning	O
probiotics	O
are	O
increasing	O
day	O
by	O
day	O
.	O

However	O
,	O
one	O
of	O
the	O
most	O
important	O
parameter	O
which	O
affects	O
the	O
probiotic	O
activity	O
of	O
a	O
microorganism	O
is	O
its	O
survival	O
during	O
the	O
gastroduodenal	O
transit	O
.	O

Some	O
microencapsulation	O
techniques	O
could	O
be	O
applied	O
to	O
bacterial	O
cells	O
to	O
improve	O
this	O
parameter	O
.	O

A	O
comparison	O
between	O
the	O
intestinal	O
colonization	O
by	O
microencapsulated	O
bacteria	O
and	O
the	O
same	O
not	O
microencapsulated	O
strains	O
has	O
been	O
conducted	O
in	O
a	O
double	O
blind	O
,	O
randomized	O
,	O
cross	O
-	O
over	O
study	O
.	O

The	O
study	O
(	O
April	O
to	O
July	O
2005	O
)	O
involved	O
44	O
healthy	O
volunteers	O
.	O

In	O
particular	O
,	O
participants	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
A	O
(	O
21	O
participants	O
)	O
received	O
a	O
mix	O
of	O
probiotic	O
strains	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
LP01	I-bacteria
(	O
LMG	B-bacteria
P	I-bacteria
-	I-bacteria
21021	I-bacteria
)	O
and	O
Bifidobacterium	B-bacteria
breve	I-bacteria
BR03	I-bacteria
(	O
DSM	B-bacteria
16604	I-bacteria
)	O
in	O
an	O
uncoated	O
form	O
,	O
group	O
B	O
(	O
23	O
participants	O
)	O
was	O
given	O
the	O
same	O
strains	O
microencapsulated	O
with	O
a	O
gastroresistant	O
material	O
.	O

The	O
not	O
microencapsulated	O
strains	O
were	O
administered	O
at	O
5	O
x	O
10	O
(	O
9	O
)	O
colony	O
forming	O
units	O
/	O
strain	O
/	O
d	O
for	O
21	O
days	O
,	O
whereas	O
the	O
microencapsulated	O
bacteria	O
were	O
given	O
at	O
1	O
x	O
10	O
(	O
9	O
)	O
colony	O
forming	O
units	O
/	O
strain	O
/	O
d	O
for	O
21	O
days	O
.	O

At	O
the	O
end	O
of	O
the	O
first	O
period	O
of	O
treatment	O
with	O
probiotics	O
a	O
3	O
weeks	O
washout	O
phase	O
has	O
been	O
included	O
in	O
the	O
study	O
protocol	O
.	O

At	O
the	O
end	O
of	O
the	O
washout	O
period	O
the	O
groups	O
were	O
crossed	O
:	O
in	O
detail	O
,	O
group	O
A	O
had	O
the	O
microencapsulated	O
and	O
group	O
B	O
the	O
uncoated	O
bacteria	O
.	O

The	O
administered	O
amounts	O
of	O
each	O
strain	O
were	O
the	O
same	O
as	O
the	O
first	O
treatment	O
.	O

The	O
quantitative	O
evaluation	O
of	O
intestinal	O
colonization	O
by	O
strains	O
microencapsulated	O
or	O
not	O
microencapsulated	O
was	O
made	O
by	O
fecal	O
samples	O
examination	O
at	O
the	O
beginning	O
of	O
the	O
clinical	O
trial	O
,	O
after	O
10	O
and	O
21	O
days	O
of	O
each	O
treatment	O
period	O
.	O

In	O
particular	O
,	O
fecal	O
heterofermentative	B-bacteria
Lactobacilli	I-bacteria
and	O
Bifidobacteria	B-bacteria
have	O
been	O
counted	O
.	O

A	O
statistically	O
significant	O
increase	O
in	O
the	O
fecal	O
amounts	O
of	O
Lactobacilli	B-bacteria
and	O
Bifidobacteria	B-bacteria
was	O
recorded	O
in	O
both	O
groups	O
at	O
the	O
end	O
of	O
each	O
treatment	O
compared	O
with	O
d0	O
or	O
d42	O
(	O
P	O
<	O
0	O
.	O
0001	O
and	O
P	O
<	O
0	O
.	O
0001	O
at	O
d21	O
,	O
P	O
<	O
0	O
.	O
0001	O
and	O
P	O
<	O
0	O
.	O
0001	O
at	O
d63	O
for	O
Lactobacilli	B-bacteria
and	O
Bifidobacteria	B-bacteria
,	O
respectively	O
)	O
,	O
confirming	O
the	O
ability	O
of	O
the	O
2	O
strains	O
to	O
colonize	O
the	O
human	O
gut	O
,	O
either	O
in	O
a	O
gastroprotected	O
form	O
or	O
not	O
.	O

Participants	O
treated	O
with	O
the	O
microencapsulated	O
bacteria	O
reported	O
a	O
kinetics	O
of	O
intestinal	O
colonization	O
quite	O
similar	O
to	O
participants	O
who	O
received	O
not	O
coated	O
strains	O
.	O

Probiotics	O
are	O
able	O
to	O
exert	O
many	O
different	O
beneficial	O
effects	O
on	O
the	O
human	O
host	O
.	O

These	O
effects	O
are	O
mediated	O
by	O
the	O
number	O
of	O
viable	O
cells	O
which	O
reach	O
the	O
gut	O
.	O

The	O
microencapsulation	O
technique	O
used	O
in	O
this	O
study	O
is	O
a	O
valid	O
strategy	O
to	O
significantly	O
improve	O
gastroresistance	O
of	O
strains	O
,	O
thus	O
enhancing	O
their	O
probiotic	O
activity	O
and	O
allowing	O
the	O
use	O
of	O
a	O
5	O
times	O
lower	O
amount	O
.	O

The	O
oral	O
and	O
dental	O
complications	O
arising	O
in	O
cancer	O
patients	O
can	O
be	O
attributable	O
to	O
the	O
malignant	O
disease	O
itself	O
and	O
to	O
the	O
various	O
modalities	O
of	O
cancer	O
therapy	O
.	O

Up	O
to	O
37	O
.	O
2	O
%	O
of	O
all	O
patients	O
receiving	O
cancer	O
chemotherapy	O
develop	O
acute	O
oral	O
complications	O
and	O
up	O
to	O
31	O
.	O
1	O
%	O
of	O
all	O
patients	O
receiving	O
cancer	O
radiotherapy	O
develop	O
acute	O
oral	O
manifestations	O
.	O

Oral	O
complications	O
may	O
result	O
in	O
significant	O
morbidity	O
,	O
impaired	O
nutrition	O
,	O
treatment	O
delays	O
,	O
and	O
dose	O
reductions	O
which	O
are	O
affecting	O
the	O
prognosis	O
of	O
the	O
primary	O
disease	O
.	O

We	O
investigated	O
312	O
cases	O
of	O
blood	O
dyscrasia	O
which	O
296	O
cases	O
had	O
oral	O
manifestations	O
(	O
86	O
.	O
2	O
%	O
)	O
.	O

They	O
had	O
a	O
mean	O
age	O
of	O
40	O
,	O
6	O
years	O
(	O
range	O
from	O
7	O
to	O
86	O
years	O
)	O
.	O

The	O
male	O
to	O
female	O
ratio	O
was	O
1	O
.	O
0	O
:	O
0	O
.	O
75	O
(	O
178	O
/	O
134	O
)	O
.	O

Data	O
were	O
statistically	O
analyzed	O
by	O
t	O
test	O
,	O
chi	O
-	O
square	O
,	O
Wilcoxon	O
,	O
Kruskal	O
-	O
Wallis	O
and	O
two	O
-	O
tailed	O
exact	O
Fischer	O
,	O
using	O
the	O
SPSS	O
program	O
,	O
at	O
a	O
significance	O
level	O
of	O
5	O
%	O
.	O

Oral	O
complications	O
are	O
frequently	O
encountered	O
in	O
patients	O
receiving	O
anticancer	O
therapy	O
and	O
these	O
complications	O
may	O
result	O
in	O
significant	O
morbidity	O
,	O
treatment	O
delays	O
,	O
dose	O
reductions	O
,	O
and	O
nutritional	O
deficiencies	O
.	O

The	O
acute	O
effects	O
of	O
anticancer	O
chemotherapy	O
upon	O
the	O
oral	O
cavity	O
include	O
mucositis	O
,	O
infection	O
,	O
hemorrhage	O
,	O
xerostomia	O
and	O
nutritional	O
deficiencies	O
.	O

Patients	O
which	O
undergo	O
radiotherapy	O
,	O
specific	O
in	O
head	O
and	O
neck	O
carcinomas	O
,	O
display	O
a	O
30	O
-	O
60	O
%	O
incidence	O
of	O
the	O
oral	O
manifestations	O
.	O

The	O
antineoplastic	O
therapy	O
will	O
interfere	O
with	O
the	O
turnover	O
of	O
the	O
epithelial	O
cells	O
,	O
followed	O
by	O
mucosal	O
injury	O
,	O
later	O
by	O
infections	O
,	O
due	O
to	O
indirect	O
invasion	O
of	O
Gram	O
-	O
negative	O
bacteria	O
and	O
fungal	O
species	O
,	O
as	O
most	O
of	O
the	O
anti	O
-	O
cancer	O
drugs	O
cause	O
immunological	O
changes	O
.	O

The	O
mucosal	O
surface	O
that	O
is	O
the	O
oral	O
cavity	O
may	O
provide	O
insight	O
into	O
the	O
immune	O
function	O
of	O
the	O
patient	O
.	O

Differential	O
diagnosis	O
is	O
important	O
as	O
many	O
disorders	O
may	O
manifest	O
themselves	O
similarly	O
in	O
the	O
buccal	O
area	O
.	O

Aggregatibacter	B-bacteria
(	I-bacteria
formerly	I-bacteria
Actinobacillus	I-bacteria
)	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
to	O
a	O
lesser	O
extent	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
are	O
Gram	O
-	O
negative	O
species	O
that	O
are	O
associated	O
with	O
destructive	O
periodontitis	O
.	O

Studies	O
from	O
different	O
parts	O
of	O
the	O
world	O
have	O
shown	O
variable	O
detection	O
rates	O
of	O
periodontal	O
organisms	O
.	O

Hardly	O
any	O
data	O
exist	O
on	O
their	O
carriage	O
in	O
children	O
living	O
in	O
the	O
Middle	O
East	O
.	O

This	O
study	O
was	O
designed	O
to	O
determine	O
the	O
detection	O
of	O
these	O
species	O
in	O
the	O
oral	O
cavity	O
of	O
240	O
generally	O
healthy	O
Kuwaiti	O
children	O
,	O
divided	O
into	O
five	O
age	O
groups	O
:	O
<	O
6	O
years	O
(	O
n	O
=	O
40	O
)	O
,	O
6	O
-	O
9	O
years	O
(	O
n	O
=	O
60	O
)	O
,	O
10	O
-	O
12	O
years	O
(	O
n	O
=	O
40	O
)	O
,	O
13	O
-	O
15	O
years	O
(	O
n	O
=	O
40	O
)	O
and	O
16	O
-	O
18	O
years	O
(	O
n	O
=	O
60	O
)	O
.	O

Saliva	O
was	O
used	O
as	O
the	O
microbiological	O
specimen	O
,	O
and	O
the	O
samples	O
were	O
analyzed	O
by	O
molecular	O
methods	O
using	O
multiplex	O
PCR	O
.	O

A	O
total	O
of	O
185	O
(	O
77	O
.	O
1	O
%	O
)	O
of	O
the	O
240	O
children	O
were	O
colonized	O
by	O
at	O
least	O
one	O
of	O
the	O
target	O
periodontal	O
bacteria	O
.	O

In	O
all	O
age	O
groups	O
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
was	O
the	O
most	O
prominent	O
and	O
detected	O
in	O
saliva	O
of	O
15	O
%	O
,	O
32	O
%	O
,	O
63	O
%	O
,	O
50	O
%	O
,	O
and	O
47	O
%	O
of	O
the	O
children	O
at	O
the	O
five	O
age	O
groups	O
,	O
respectively	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
detected	O
only	O
occasionally	O
.	O

Only	O
few	O
pathogens	O
were	O
found	O
before	O
the	O
permanent	O
dentition	O
,	O
i	O
.	O
e	O
.	O
at	O
the	O
age	O
of	O
<	O
6	O
years	O
.	O

The	O
highest	O
carriage	O
rates	O
were	O
from	O
the	O
groups	O
between	O
6	O
and	O
15	O
years	O
of	O
age	O
.	O

The	O
salivary	O
carriage	O
of	O
the	O
pathogens	O
was	O
essentially	O
similar	O
in	O
the	O
age	O
groups	O
of	O
10	O
-	O
12	O
years	O
and	O
13	O
-	O
15	O
years	O
.	O

In	O
conclusion	O
,	O
except	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
the	O
examined	O
periodontal	O
pathogens	O
are	O
relatively	O
common	O
findings	O
in	O
Kuwaiti	O
children	O
and	O
colonize	O
the	O
oral	O
cavity	O
from	O
childhood	O
onwards	O
.	O

Colonization	O
and	O
infection	O
of	O
the	O
human	O
host	O
by	O
opportunistic	O
pathogen	O
Candida	O
albicans	O
derive	O
from	O
an	O
ability	O
of	O
this	O
fungus	O
to	O
colonize	O
mucosal	O
tissues	O
and	O
prosthetic	O
devices	O
within	O
the	O
polymicrobial	O
communities	O
present	O
.	O

To	O
determine	O
the	O
functions	O
of	O
C	O
.	O
albicans	O
cell	O
wall	O
proteins	O
in	O
interactions	O
with	O
host	O
or	O
bacterial	O
molecules	O
,	O
Saccharomyces	O
cerevisiae	O
was	O
utilized	O
as	O
a	O
surrogate	O
host	O
to	O
express	O
C	O
.	O
albicans	O
cell	O
wall	O
proteins	O
Als3p	O
,	O
Eap1p	O
,	O
Hwp1p	O
,	O
and	O
Rbt1p	O
.	O

Salivary	O
pellicle	O
and	O
fibrinogen	O
were	O
identified	O
as	O
novel	O
substrata	O
for	O
Als3p	O
and	O
Hwp1p	O
,	O
while	O
only	O
Als3p	O
mediated	O
adherence	O
of	O
S	O
.	O
cerevisiae	O
to	O
basement	O
membrane	O
collagen	O
type	O
IV	O
.	O

Parental	O
S	B-bacteria
.	I-bacteria
cerevisiae	I-bacteria
cells	O
failed	O
to	O
form	O
biofilms	O
on	O
Salivary	O
pellicle	O
,	O
polystyrene	O
,	O
or	O
silicone	O
,	O
but	O
cells	O
expressing	O
Als3p	O
or	O
Hwp1p	O
exhibited	O
significant	O
attachment	O
to	O
each	O
surface	O
.	O

Virulence	O
factor	O
Rbt1p	O
also	O
conferred	O
lower	O
-	O
level	O
binding	O
to	O
Salivary	O
pellicle	O
and	O
polystyrene	O
.	O

S	O
.	O
cerevisiae	O
cells	O
expressing	O
Eap1p	O
formed	O
robust	O
biofilms	O
upon	O
polystyrene	O
surfaces	O
but	O
not	O
Salivary	O
pellicle	O
.	O

Proteins	O
Als3p	O
and	O
Eap1p	O
,	O
and	O
to	O
a	O
lesser	O
degree	O
Hwp1p	O
,	O
conferred	O
upon	O
S	B-bacteria
.	I-bacteria
cerevisiae	I-bacteria
the	O
ability	O
to	O
bind	O
cells	O
of	O
the	O
oral	O
primary	O
colonizing	O
bacterium	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

These	O
interactions	O
,	O
which	O
occurred	O
independently	O
of	O
amyloid	O
aggregate	O
formation	O
,	O
provide	O
the	O
first	O
examples	O
of	O
specific	O
C	O
.	O
albicans	O
surface	O
proteins	O
serving	O
as	O
receptors	O
for	O
bacterial	O
adhesins	O
.	O

Streptococcus	B-bacteria
gordonii	I-bacteria
did	O
not	O
bind	O
parental	O
S	O
.	O
cerevisiae	O
or	O
cells	O
expressing	O
Rbt1p	O
.	O

Taken	O
collectively	O
,	O
these	O
data	O
suggest	O
that	O
a	O
network	O
of	O
cell	O
wall	O
proteins	O
comprising	O
Als3p	O
,	O
Hwp1p	O
,	O
and	O
Eap1p	O
,	O
with	O
complementary	O
adhesive	O
functions	O
,	O
promotes	O
interactions	O
of	O
C	O
.	O
albicans	O
with	O
host	O
and	O
bacterial	O
molecules	O
,	O
thus	O
leading	O
to	O
effective	O
colonization	O
within	O
polymicrobial	O
communities	O
.	O

The	O
aims	O
of	O
this	O
research	O
were	O
to	O
determine	O
the	O
prevalence	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
and	O
its	O
vacA	O
genotypes	O
in	O
oral	O
cavity	O
in	O
persons	O
without	O
dyspepsia	O
and	O
to	O
establish	O
the	O
association	O
between	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
and	O
oral	O
hygiene	O
.	O

The	O
seroprevalence	O
of	O
anti	O
-	O
H	O
.	O
pylori	O
antibodies	O
and	O
its	O
associated	O
factors	O
were	O
analyzed	O
too	O
.	O

For	O
the	O
study	O
,	O
200	O
adults	O
without	O
dyspepsia	O
symptoms	O
were	O
selected	O
.	O

Dental	O
plaque	O
and	O
saliva	O
samples	O
from	O
each	O
subject	O
were	O
obtained	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
detection	O
in	O
oral	O
samples	O
was	O
carried	O
out	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
for	O
vacA	O
genotyping	O
a	O
semi	O
-	O
nested	O
and	O
nested	O
PCR	O
was	O
used	O
.	O

The	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
used	O
to	O
detect	O
anti	O
-	O
H	O
.	O
pylori	O
IgG	O
and	O
IgM	O
.	O

The	O
data	O
were	O
analyzed	O
with	O
Chi	O
square	O
and	O
Fisher	O
exact	O
test	O
and	O
the	O
statistical	O
significance	O
was	O
set	O
to	O
0	O
.	O
05	O
.	O

Of	O
200	O
subjects	O
tested	O
,	O
124	O
(	O
62	O
%	O
)	O
were	O
seropositive	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
detected	O
in	O
the	O
oral	O
cavity	O
of	O
34	O
subjects	O
(	O
17	O
%	O
)	O
and	O
vacA	O
allelotypes	O
were	O
typified	O
in	O
12	O
of	O
those	O
samples	O
.	O

The	O
s1	O
allele	O
was	O
detected	O
in	O
8	O
(	O
66	O
.	O
7	O
%	O
)	O
samples	O
and	O
in	O
one	O
of	O
them	O
m1	O
y	O
m2	O
alleles	O
were	O
found	O
.	O

In	O
four	O
subjects	O
vacA	O
m1	O
subtypes	O
were	O
found	O
and	O
in	O
two	O
of	O
those	O
both	O
m1	O
and	O
m2	O
alleles	O
were	O
detected	O
.	O

The	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
was	O
higher	O
(	O
18	O
.	O
5	O
%	O
)	O
among	O
seropositive	O
subjects	O
compared	O
with	O
seronegative	O
persons	O
.	O

No	O
association	O
was	O
found	O
between	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
and	O
oral	O
hygiene	O
habits	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
is	O
more	O
frequent	O
in	O
seropositive	O
subjects	O
without	O
dyspepsia	O
symptoms	O
and	O
could	O
represent	O
the	O
source	O
of	O
gastric	O
infection	O
and	O
bacterial	O
transmission	O
.	O

The	O
data	O
suggest	O
that	O
more	O
than	O
one	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
strain	I-bacteria
may	O
exist	O
in	O
the	O
mouth	O
of	O
asymptomatic	O
persons	O
.	O

Colonization	O
of	O
surfaces	O
in	O
the	O
human	O
body	O
by	O
microorganisms	O
is	O
an	O
early	O
,	O
essential	O
,	O
step	O
in	O
the	O
initiation	O
of	O
infectious	O
disease	O
.	O

We	O
have	O
developed	O
in	O
vitro	O
assays	O
to	O
investigate	O
interactions	O
between	O
yeast	O
or	O
bacterial	O
cells	O
and	O
human	O
tissues	O
,	O
fluids	O
,	O
or	O
prostheses	O
.	O

Such	O
assays	O
can	O
be	O
used	O
to	O
identify	O
the	O
adhesins	O
,	O
ligands	O
,	O
and	O
receptors	O
involved	O
in	O
these	O
interactions	O
,	O
for	O
example	O
by	O
determining	O
which	O
components	O
of	O
the	O
microbe	O
or	O
human	O
tissue	O
/	O
fluid	O
interfere	O
with	O
adherence	O
in	O
the	O
assay	O
.	O

The	O
assays	O
can	O
also	O
be	O
applied	O
to	O
finding	O
ways	O
of	O
preventing	O
adhesion	O
,	O
and	O
subsequent	O
disease	O
,	O
by	O
investigating	O
the	O
effects	O
of	O
different	O
conditions	O
and	O
added	O
compounds	O
on	O
adherence	O
in	O
the	O
in	O
vitro	O
assays	O
.	O

We	O
describe	O
six	O
assays	O
for	O
measuring	O
adhesion	O
of	O
the	O
oral	O
yeast	O
Candida	O
albicans	O
,	O
a	O
common	O
commensal	O
and	O
opportunistic	O
pathogen	O
,	O
or	O
the	O
bacterium	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
,	O
which	O
is	O
not	O
normally	O
pathogenic	O
but	O
is	O
known	O
to	O
form	O
biofilms	O
on	O
medical	O
prostheses	O
.	O

The	O
assays	O
described	O
represent	O
two	O
approaches	O
to	O
investigating	O
adhesion	O
;	O
retention	O
at	O
a	O
fixed	O
time	O
point	O
following	O
liquid	O
washes	O
;	O
and	O
retention	O
against	O
a	O
continuous	O
flow	O
of	O
medium	O
.	O

Most	O
bacteria	O
in	O
nature	O
exist	O
in	O
multispecies	O
communities	O
known	O
as	O
biofilms	O
.	O

In	O
the	O
natural	O
habitat	O
where	O
resources	O
(	O
nutrient	O
,	O
space	O
,	O
etc	O
.	O
)	O

are	O
usually	O
limited	O
,	O
individual	O
species	O
must	O
compete	O
or	O
collaborate	O
with	O
other	O
neighboring	O
species	O
in	O
order	O
to	O
perpetuate	O
in	O
the	O
multispecies	O
community	O
.	O

The	O
human	O
oral	O
cavity	O
is	O
colonized	O
by	O
>	O
700	O
microbial	O
species	O
known	O
as	O
the	O
indigenous	O
microflora	O
.	O

This	O
indigenous	O
flora	O
normally	O
maintains	O
an	O
ecological	O
balance	O
through	O
antagonistic	O
as	O
well	O
as	O
mutualistic	O
interspecies	O
interactions	O
.	O

However	O
,	O
environmental	O
perturbation	O
may	O
disrupt	O
this	O
balance	O
,	O
leading	O
to	O
overgrowth	O
of	O
pathogenic	O
species	O
,	O
which	O
could	O
in	O
turn	O
initiate	O
diseases	O
such	O
as	O
dental	O
caries	O
(	O
tooth	O
decay	O
)	O
and	O
periodontitis	O
(	O
gum	O
disease	O
)	O
.	O

Understanding	O
the	O
mechanisms	O
of	O
diversity	O
maintenance	O
may	O
help	O
development	O
of	O
novel	O
approaches	O
to	O
manage	O
these	O
`	O
`	O
polymicrobial	O
diseases	O
.	O
'	O
'	O

In	O
this	O
chapter	O
,	O
we	O
will	O
focus	O
on	O
a	O
well	O
-	O
characterized	O
form	O
of	O
biochemical	O
warfare	O
:	O
bacteriocins	O
produced	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
a	O
primary	O
dental	O
caries	O
pathogen	O
,	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
produced	O
by	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
an	O
oral	O
commensal	O
.	O

We	O
will	O
describe	O
detailed	O
methodologies	O
on	O
the	O
competition	O
assay	O
,	O
isolation	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
bacteriocins	O
.	O

The	O
microbiological	O
effects	O
of	O
biocidal	O
products	O
used	O
for	O
the	O
enhancement	O
of	O
oral	O
hygiene	O
relate	O
to	O
the	O
active	O
compound	O
(	O
s	O
)	O
as	O
well	O
as	O
other	O
formulation	O
components	O
.	O

Here	O
,	O
we	O
test	O
the	O
specificities	O
of	O
selected	O
actives	O
in	O
the	O
absence	O
of	O
multiple	O
excipients	O
.	O

Salivary	O
ecosystems	O
were	O
maintained	O
in	O
tissue	O
culture	O
plate	O
-	O
based	O
hydroxyapatite	O
disc	O
models	O
(	O
HDMs	O
)	O
and	O
modified	O
drip	O
-	O
flow	O
biofilm	O
reactors	O
(	O
MDFRs	O
)	O
.	O

Test	O
compounds	O
stannous	O
fluoride	O
(	O
SF	O
)	O
,	O
SDS	O
,	O
triclosan	O
(	O
TCS	O
)	O
,	O
zinc	O
lactate	O
(	O
ZL	O
)	O
and	O
ZL	O
with	O
SF	O
in	O
combination	O
(	O
ZLSF	O
)	O
were	O
delivered	O
to	O
the	O
HDMs	O
once	O
and	O
four	O
times	O
daily	O
for	O
6	O
days	O
to	O
MDFRs	O
.	O

Plaques	O
were	O
characterized	O
by	O
differential	O
viable	O
counting	O
and	O
PCR	O
-	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
.	O

TCS	O
and	O
SDS	O
were	O
the	O
most	O
effective	O
compounds	O
against	O
HDM	O
plaques	O
,	O
significantly	O
reducing	O
total	O
viable	O
counts	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
whilst	O
SF	O
,	O
ZL	O
and	O
ZLSF	O
were	O
comparatively	O
ineffective	O
.	O

TCS	O
exhibited	O
specificity	O
for	O
streptococci	B-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
Gram	O
-	O
negative	O
anaerobes	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
following	O
a	O
single	O
dosing	O
and	O
also	O
on	O
repeated	O
dosing	O
in	O
MDFRs	O
.	O

In	O
contrast	O
to	O
single	O
exposures	O
,	O
multiple	O
dosing	O
with	O
ZLSF	O
also	O
significantly	O
reduced	O
all	O
bacterial	O
groups	O
,	O
whilst	O
SF	O
and	O
ZL	O
caused	O
significant	O
but	O
transient	O
reductions	O
.	O

According	O
to	O
PCR	O
-	O
DGGE	O
analyses	O
,	O
significant	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
reductions	O
in	O
eubacterial	O
diversity	O
occurred	O
following	O
6	O
day	O
dosing	O
with	O
both	O
TCS	O
and	O
ZLSF	O
.	O

Concordance	O
of	O
MDFR	O
eubacterial	O
profiles	O
with	O
salivary	O
inocula	O
ranged	O
between	O
58	O
and	O
97	O
%	O
.	O

TCS	O
and	O
ZL	O
(	O
SF	O
)	O
exhibited	O
similar	O
specificities	O
to	O
those	O
reported	O
for	O
formulations	O
.	O

TCS	O
was	O
the	O
most	O
potent	O
antibacterial	O
,	O
after	O
single	O
and	O
multiple	O
dosage	O
regimens	O
.	O

Enterotoxigenic	B-bacteria
Escherichia	I-bacteria
coli	I-bacteria
(	O
ETEC	B-bacteria
)	O
is	O
an	O
important	O
cause	O
of	O
diarrheal	O
disease	O
and	O
deaths	O
among	O
children	O
in	O
developing	O
countries	O
and	O
the	O
major	O
cause	O
of	O
traveller	O
'	O
s	O
diarrhea	O
.	O

Since	O
surface	O
protein	O
colonization	O
factors	O
(	O
CFs	O
)	O
of	O
ETEC	B-bacteria
are	O
important	O
for	O
pathogenicity	O
and	O
immune	O
protection	O
is	O
mainly	O
mediated	O
by	O
locally	O
produced	O
IgA	O
antibodies	O
in	O
the	O
gut	O
,	O
much	O
effort	O
has	O
focused	O
on	O
the	O
development	O
of	O
an	O
oral	O
CF	O
-	O
based	O
vaccine	O
.	O

We	O
have	O
recently	O
described	O
the	O
development	O
of	O
recombinant	O
strains	O
over	O
-	O
expressing	O
CFA	O
/	O
I	O
;	O
the	O
most	O
prevalent	O
CF	O
among	O
human	O
clinical	O
ETEC	B-bacteria
isolates	I-bacteria
.	O

Here	O
,	O
non	O
-	O
toxigenic	O
recombinant	O
E	B-bacteria
.		I-bacteria
coli	I-bacteria
strains	I-bacteria
over	O
-	O
expressing	O
Coli	O
surface	O
antigen	O
2	O
(	O
CS2	O
)	O
,	O
CS4	O
,	O
CS5	O
,	O
and	O
CS6	O
,	O
either	O
alone	O
,	O
or	O
each	O
in	O
combination	O
with	O
CFA	O
/	O
I	O
were	O
constructed	O
by	O
cloning	O
the	O
genes	O
required	O
for	O
expression	O
and	O
assembly	O
of	O
each	O
CF	O
into	O
expression	O
vectors	O
harboring	O
a	O
strong	O
promoter	O
.	O

Immunological	O
assays	O
showed	O
that	O
recombinant	O
strains	O
expressing	O
single	O
CFs	O
produced	O
those	O
in	O
significantly	O
larger	O
amounts	O
than	O
did	O
corresponding	O
naturally	O
high	O
producing	O
reference	O
strains	O
.	O

Recombinant	O
strains	O
co	O
-	O
expressing	O
CFA	O
/	O
I	O
together	O
with	O
another	O
CF	O
also	O
expressed	O
significantly	O
larger	O
amounts	O
of	O
both	O
CFs	O
compared	O
with	O
the	O
corresponding	O
references	O
strains	O
.	O

Further	O
,	O
when	O
tested	O
in	O
mice	O
,	O
oral	O
immunization	O
with	O
formalin	O
-	O
killed	O
recombinant	O
bacteria	O
co	O
-	O
expressing	O
one	O
such	O
double	O
-	O
expression	O
CF	O
pair	O
,	O
CFA	O
/	O
I	O
+	O
CS2	O
,	O
induced	O
specific	O
serum	O
IgG	O
+	O
IgM	O
and	O
fecal	O
IgA	O
antibody	O
responses	O
against	O
both	O
CFs	O
exceeding	O
the	O
responses	O
induced	O
by	O
immunizations	O
with	O
natural	O
reference	O
strains	O
expressing	O
CFA	O
/	O
I	O
and	O
CS2	O
,	O
respectively	O
.	O

We	O
conclude	O
that	O
the	O
described	O
type	O
of	O
recombinant	O
bacteria	O
over	O
-	O
expressing	O
major	O
CFs	O
of	O
ETEC	B-bacteria
,	O
alone	O
or	O
in	O
combination	O
,	O
may	O
be	O
useful	O
as	O
candidate	O
strains	O
for	O
use	O
in	O
an	O
oral	O
whole	O
-	O
cell	O
CF	O
-	O
ETEC	O
vaccine	O
.	O

To	O
investigate	O
the	O
polymicrobial	O
infection	O
of	O
periodontal	O
disease	O
,	O
which	O
elicits	O
inflammatory	O
mediators	O
/	O
cytokines	O
/	O
chemokines	O
in	O
the	O
local	O
gingival	O
tissues	O
,	O
and	O
a	O
polybacterial	O
challenge	O
of	O
antigen	O
-	O
presenting	O
cells	O
,	O
e	O
.	O
g	O
.	O
macrophages	O
and	O
dendritic	O
cells	O
(	O
DCs	O
)	O
,	O
at	O
the	O
mucosal	O
surface	O
.	O

The	O
cytokine	O
/	O
chemokine	O
profiles	O
of	O
human	O
macrophages	O
and	O
DCs	O
in	O
response	O
to	O
polybacterial	O
challenges	O
were	O
investigated	O
.	O

Oral	O
Gram	O
-	O
negative	O
bacteria	O
elicited	O
significantly	O
greater	O
IL	O
-	O
8	O
levels	O
from	O
macrophages	O
,	O
compared	O
to	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Gram	O
-	O
positive	O
bacteria	O
did	O
not	O
show	O
synergism	O
in	O
inducing	O
this	O
chemokine	O
from	O
macrophages	O
.	O

In	O
contrast	O
,	O
pairs	O
of	O
oral	O
Gram	O
-	O
negative	O
bacteria	O
elicited	O
synergistic	O
production	O
of	O
IL	O
-	O
8	O
by	O
macrophages	O
.	O

Similar	O
results	O
were	O
not	O
observed	O
with	O
TNFalpha	O
,	O
which	O
only	O
appeared	O
additive	O
with	O
the	O
polybacterial	O
challenge	O
.	O

Selected	O
Gram	O
-	O
negative	O
bacterial	O
pairs	O
synergized	O
in	O
IL	O
-	O
6	O
production	O
by	O
immature	O
DCs	O
.	O

In	O
mature	O
DCs	O
(	O
mDCs	O
)	O
,	O
a	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
/	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Porphyromonas	B-bacteria
intermedia	I-bacteria
/	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
polybacterial	O
challenge	O
resulted	O
in	O
significant	O
synergism	O
for	O
IL	O
-	O
6	O
and	O
TNFalpha	O
levels	O
.	O

However	O
,	O
only	O
the	O
Pi	B-bacteria
/	O
Fn	B-bacteria
combination	O
synergized	O
for	O
IL	O
-	O
12	O
production	O
and	O
there	O
appeared	O
to	O
be	O
no	O
polybacterial	O
effect	O
on	O
IL	O
-	O
10	O
production	O
by	O
the	O
mDCs	O
.	O

These	O
results	O
indicate	O
that	O
a	O
polybacterial	O
challenge	O
of	O
cells	O
linking	O
innate	O
and	O
adaptive	O
immune	O
responses	O
results	O
in	O
varied	O
response	O
profiles	O
that	O
are	O
dependent	O
upon	O
the	O
characteristics	O
of	O
the	O
microorganisms	O
that	O
are	O
components	O
of	O
the	O
polybacterial	O
complex	O
.	O

The	O
nose	O
and	O
throat	O
are	O
important	O
sites	O
of	O
pathogen	O
colonization	O
,	O
yet	O
the	O
microbiota	O
of	O
both	O
is	O
relatively	O
unexplored	O
by	O
culture	O
-	O
independent	O
approaches	O
.	O

We	O
examined	O
the	O
bacterial	O
microbiota	O
of	O
the	O
nostril	O
and	O
posterior	O
wall	O
of	O
the	O
oropharynx	O
from	O
seven	O
healthy	O
adults	O
using	O
two	O
culture	O
-	O
independent	O
methods	O
,	O
a	O
16S	O
rRNA	O
gene	O
microarray	O
(	O
PhyloChip	O
)	O
and	O
16S	O
rRNA	O
gene	O
clone	O
libraries	O
.	O

While	O
the	O
bacterial	O
microbiota	O
of	O
the	O
oropharynx	O
was	O
richer	O
than	O
that	O
of	O
the	O
nostril	O
,	O
the	O
oropharyngeal	O
microbiota	O
varied	O
less	O
among	O
participants	O
than	O
did	O
nostril	O
microbiota	O
.	O

A	O
few	O
phyla	O
accounted	O
for	O
the	O
majority	O
of	O
the	O
bacteria	O
detected	O
at	O
each	O
site	O
:	O
Firmicutes	B-bacteria
and	O
Actinobacteria	B-bacteria
in	O
the	O
nostril	O
and	O
Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
and	O
Bacteroidetes	B-bacteria
in	O
the	O
oropharynx	O
.	O

Compared	O
to	O
culture	O
-	O
independent	O
surveys	O
of	O
microbiota	O
from	O
other	O
body	O
sites	O
,	O
the	O
microbiota	O
of	O
the	O
nostril	O
and	O
oropharynx	O
show	O
distinct	O
phylum	O
-	O
level	O
distribution	O
patterns	O
,	O
supporting	O
niche	O
-	O
specific	O
colonization	O
at	O
discrete	O
anatomical	O
sites	O
.	O

In	O
the	O
nostril	O
,	O
the	O
distribution	O
of	O
Actinobacteria	B-bacteria
and	O
Firmicutes	B-bacteria
was	O
reminiscent	O
of	O
that	O
of	O
skin	O
,	O
though	O
Proteobacteria	B-bacteria
were	O
much	O
less	O
prevalent	O
.	O

The	O
distribution	O
of	O
Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
and	O
Bacteroidetes	B-bacteria
in	O
the	O
oropharynx	O
was	O
most	O
similar	O
to	O
that	O
in	O
saliva	O
,	O
with	O
more	O
Proteobacteria	B-bacteria
than	O
in	O
the	O
distal	O
esophagus	O
or	O
mouth	O
.	O

While	O
Firmicutes	B-bacteria
were	O
prevalent	O
at	O
both	O
sites	O
,	O
distinct	O
families	O
within	O
this	O
phylum	O
dominated	O
numerically	O
in	O
each	O
.	O

At	O
both	O
sites	O
there	O
was	O
an	O
inverse	O
correlation	O
between	O
the	O
prevalences	O
of	O
Firmicutes	B-bacteria
and	O
another	O
phylum	O
:	O
in	O
the	O
oropharynx	O
,	O
Firmicutes	B-bacteria
and	O
Proteobacteria	B-bacteria
,	O
and	O
in	O
the	O
nostril	O
,	O
Firmicutes	B-bacteria
and	O
Actinobacteria	B-bacteria
.	O

In	O
the	O
nostril	O
,	O
this	O
inverse	O
correlation	O
existed	O
between	O
the	O
Firmicutes	B-bacteria
family	I-bacteria
Staphylococcaceae	B-bacteria
and	O
Actinobacteria	B-bacteria
families	I-bacteria
,	O
suggesting	O
potential	O
antagonism	O
between	O
these	O
groups	O
.	O

Oral	O
Bifidobacteriaceae	B-bacteria
,	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
and	O
Bifidobacterium	B-bacteria
longum	I-bacteria
,	O
are	O
known	O
to	O
be	O
isolated	O
together	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
from	O
caries	O
lesions	O
,	O
suggesting	O
that	O
these	O
Bifidobacteriaceae	B-bacteria
are	O
caries	O
associated	O
and	O
acid	O
resistant	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
effects	O
of	O
acidification	O
on	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
longum	I-bacteria
,	O
and	O
to	O
compare	O
them	O
with	O
those	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
.	O

Effects	O
of	O
acidification	O
,	O
growth	O
ability	O
in	O
a	O
complex	O
medium	O
at	O
a	O
pH	O
of	O
4	O
.	O
0	O
-	O
8	O
.	O
0	O
,	O
cell	O
viability	O
in	O
2	O
-	O
morpholinoethanesulfonic	O
acid	O
monohydrate	O
(	O
MES	O
)	O
-	O
KOH	O
buffer	O
at	O
pH	O
4	O
.	O
0	O
,	O
as	O
well	O
as	O
stability	O
of	O
intracellular	O
pH	O
(	O
pH	O
(	O
in	O
)	O
)	O
at	O
an	O
extracellular	O
pH	O
of	O
3	O
.	O
5	O
-	O
8	O
.	O
0	O
estimated	O
using	O
a	O
fluorescent	O
dye	O
,	O
5	O
(	O
6	O
)	O
-	O
carboxyfluorescein	O
diacetate	O
N	O
-	O
succinimidyl	O
ester	O
in	O
MES	O
-	O
KOH	O
,	O
3	O
-	O
(	O
N	O
-	O
morpholino	O
)	O
propanesulfonic	O
acid	O
-	O
KOH	O
or	O
N	O
,	O
N	O
-	O
bis	O
(	O
2	O
-	O
hydroxyethyl	O
)	O
glycine	O
-	O
KOH	O
buffer	O
,	O
were	O
investigated	O
.	O

B	B-bacteria
.	I-bacteria
longum	I-bacteria
grew	O
as	O
well	O
as	O
Streptococcus	B-bacteria
strains	I-bacteria
over	O
a	O
wide	O
pH	O
range	O
,	O
whereas	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
grew	O
best	O
in	O
the	O
narrow	O
pH	O
range	O
around	O
neutral	O
.	O

The	O
cell	O
viability	O
of	O
B	B-bacteria
.	I-bacteria
dentium	I-bacteria
decreased	O
significantly	O
after	O
2	O
h	O
of	O
acidification	O
at	O
a	O
pH	O
of	O
4	O
.	O
0	O
,	O
but	O
this	O
was	O
significantly	O
less	O
than	O
that	O
of	O
the	O
Streptococcus	B-bacteria
and	O
Lactobacillus	B-bacteria
species	I-bacteria
,	O
whereas	O
B	B-bacteria
.	I-bacteria
longum	I-bacteria
maintained	O
almost	O
100	O
%	O
viability	O
.	O

The	O
pH	O
(	O
in	O
)	O
was	O
close	O
to	O
the	O
extracellular	O
pH	O
at	O
pH	O
of	O
5	O
.	O
5	O
-	O
7	O
.	O
5	O
in	O
the	O
Bifidobacterium	B-bacteria
and	O
Streptococcus	B-bacteria
strains	I-bacteria
,	O
while	O
at	O
a	O
pH	O
of	O
<	O
5	O
.	O
0	O
,	O
the	O
pH	O
(	O
in	O
)	O
was	O
higher	O
than	O
the	O
extracellular	O
pH	O
in	O
all	O
the	O
strains	O
,	O
but	O
the	O
pH	O
(	O
in	O
)	O
maintenance	O
ability	O
of	O
Bifidobacterium	B-bacteria
strains	I-bacteria
was	O
higher	O
than	O
that	O
of	O
the	O
Streptococcus	B-bacteria
strains	I-bacteria
.	O

The	O
high	O
survival	O
rate	O
and	O
pH	O
(	O
in	O
)	O
maintenance	O
ability	O
of	O
bifidobacteria	B-bacteria
comparable	O
to	O
that	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
acidic	O
environment	O
may	O
account	O
for	O
why	O
bifidobacteria	B-bacteria
exist	O
as	O
stable	O
species	O
in	O
acidic	O
caries	O
lesions	O
together	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

We	O
investigated	O
the	O
effect	O
of	O
the	O
bacterial	O
flora	O
of	O
the	O
nose	O
and	O
throat	O
on	O
the	O
outcome	O
of	O
the	O
initial	O
repairs	O
of	O
the	O
cleft	O
palate	O
in	O
the	O
presence	O
of	O
prophylactic	O
antibiotics	O
.	O

A	O
retrospective	O
review	O
of	O
90	O
procedures	O
in	O
66	O
patients	O
who	O
had	O
cleft	O
palate	O
repair	O
between	O
April	O
2005	O
and	O
June	O
2007	O
was	O
conducted	O
at	O
Booth	O
Hall	O
Children	O
'	O
s	O
Hospital	O
,	O
Manchester	O
,	O
U	O
.	O
K	O
.	O

Both	O
isolated	O
cleft	O
palate	O
and	O
cleft	O
lip	O
and	O
palate	O
patients	O
were	O
included	O
.	O

Exclusion	O
criteria	O
included	O
syndromic	O
cases	O
,	O
other	O
medical	O
disorders	O
,	O
and	O
revisions	O
of	O
previous	O
cleft	O
palate	O
repairs	O
.	O

Nose	O
and	O
throat	O
swabs	O
were	O
taken	O
on	O
admission	O
.	O

Benzyl	O
penicillin	O
and	O
flucloxacillin	O
were	O
given	O
perioperatively	O
.	O

The	O
occurrence	O
of	O
oronasal	O
fistulas	O
was	O
correlated	O
with	O
the	O
bacteria	O
grown	O
on	O
culture	O
.	O

The	O
oronasal	O
fistula	O
rate	O
was	O
15	O
.	O
9	O
%	O
.	O

The	O
highest	O
fistula	O
rate	O
in	O
procedures	O
with	O
positive	O
swabs	O
was	O
seen	O
with	O
Moraxella	B-bacteria
catarrhalis	I-bacteria
.	O

M	B-bacteria
.	I-bacteria
catarrhalis	I-bacteria
has	O
not	O
been	O
previously	O
recognized	O
as	O
a	O
pathogen	O
in	O
cleft	O
palate	O
repairs	O
.	O

This	O
study	O
demonstrates	O
a	O
higher	O
fistula	O
rate	O
in	O
procedures	O
positive	O
for	O
M	B-bacteria
.	I-bacteria
catarrhalis	I-bacteria
.	O

Other	O
factors	O
that	O
may	O
have	O
contributed	O
to	O
the	O
fistula	O
formation	O
include	O
the	O
severity	O
of	O
the	O
initial	O
cleft	O
and	O
technical	O
factors	O
.	O

Further	O
study	O
is	O
required	O
before	O
a	O
definitive	O
link	O
can	O
be	O
established	O
.	O

In	O
this	O
study	O
the	O
presence	O
of	O
periodontopathic	O
pathogens	O
in	O
atheromatous	O
plaques	O
removed	O
from	O
coronary	O
arteries	O
of	O
patients	O
with	O
chronic	O
periodontitis	O
and	O
periodontally	O
healthy	O
subjects	O
by	O
PCR	O
was	O
detected	O
.	O

Our	O
results	O
indicate	O
a	O
significant	O
association	O
between	O
the	O
presence	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
atheromas	O
,	O
and	O
the	O
periodontal	O
bacteria	O
in	O
oral	O
biofilm	O
may	O
find	O
a	O
way	O
to	O
reach	O
arteries	O
.	O

Prevotella	B-bacteria
species	I-bacteria
are	O
members	O
of	O
the	O
bacterial	O
oral	O
flora	O
and	O
are	O
opportunistic	O
pathogens	O
in	O
polymicrobial	O
infections	O
of	O
soft	O
tissues	O
.	O

Antibiotic	O
resistance	O
to	O
tetracyclines	O
is	O
common	O
in	O
these	O
bacteria	O
,	O
and	O
the	O
gene	O
encoding	O
this	O
resistance	O
has	O
been	O
previously	O
identified	O
as	O
tetQ	O
.	O

The	O
tetQ	O
gene	O
is	O
also	O
found	O
on	O
conjugative	O
transposons	O
in	O
the	O
intestinal	O
Bacteroides	B-bacteria
species	I-bacteria
;	O
whether	O
these	O
related	O
bacteria	O
have	O
transmitted	O
tetQ	O
to	O
Prevotella	B-bacteria
is	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
describe	O
our	O
genetic	O
analysis	O
of	O
mobile	O
tetQ	O
elements	O
in	O
oral	O
Prevotella	B-bacteria
species	I-bacteria
.	O

Our	O
results	O
indicate	O
that	O
the	O
mobile	O
elements	O
encoding	O
tetQ	O
in	O
oral	O
species	O
are	O
distinct	O
from	O
those	O
found	O
in	O
the	O
Bacteroides	B-bacteria
.	O

The	O
intestinal	O
bacteria	O
may	O
act	O
as	O
a	O
reservoir	O
for	O
the	O
tetQ	O
gene	O
,	O
but	O
Prevotella	B-bacteria
has	O
incorporated	O
this	O
gene	O
into	O
an	O
IS21	O
-	O
family	O
transposon	O
.	O

This	O
transposon	O
is	O
present	O
in	O
Prevotella	B-bacteria
species	I-bacteria
from	O
more	O
than	O
one	O
geographical	O
location	O
,	O
implying	O
that	O
the	O
mechanism	O
of	O
tetQ	O
spread	O
between	O
oral	O
Prevotella	B-bacteria
species	I-bacteria
is	O
highly	O
conserved	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
identify	O
cultivable	O
microorganisms	O
from	O
primary	O
teeth	O
with	O
necrotic	O
pulps	O
.	O

This	O
experimental	O
study	O
included	O
21	O
patients	O
of	O
both	O
sexes	O
between	O
4	O
and	O
7	O
years	O
of	O
age	O
with	O
necrotic	O
pulps	O
in	O
primary	O
teeth	O
.	O

Twenty	O
-	O
one	O
maxillary	O
and	O
mandibular	O
molars	O
containing	O
at	O
least	O
1	O
necrotic	O
canal	O
,	O
an	O
abscess	O
or	O
sinus	O
tract	O
,	O
one	O
or	O
more	O
radiolucent	O
areas	O
in	O
the	O
furcation	O
or	O
periapical	O
region	O
,	O
teeth	O
having	O
at	O
least	O
two	O
thirds	O
of	O
root	O
length	O
,	O
and	O
carious	O
lesions	O
directly	O
exposed	O
to	O
the	O
oral	O
environment	O
were	O
included	O
.	O

After	O
antisepsis	O
of	O
the	O
oral	O
cavity	O
,	O
anesthesia	O
of	O
the	O
affected	O
tooth	O
,	O
and	O
isolation	O
and	O
disinfection	O
of	O
the	O
operative	O
field	O
,	O
3	O
sterile	O
absorbent	O
paper	O
points	O
were	O
sequentially	O
placed	O
for	O
30	O
seconds	O
for	O
the	O
collection	O
of	O
samples	O
.	O

The	O
samples	O
were	O
immediately	O
processed	O
in	O
an	O
anaerobic	O
chamber	O
,	O
and	O
all	O
isolated	O
microorganisms	O
were	O
identified	O
.	O

Anaerobic	O
species	O
(	O
anaerobic	O
facultative	O
and	O
moderate	O
anaerobes	O
)	O
were	O
isolated	O
in	O
all	O
root	O
canals	O
;	O
68	O
.	O
4	O
%	O
of	O
root	O
canal	O
samples	O
studied	O
showed	O
a	O
polymicrobial	O
nature	O
.	O

Most	O
of	O
the	O
isolate	O
consisted	O
of	O
Bifidobacterium	B-bacteria
Spp2	I-bacteria
and	O
Streptococcus	B-bacteria
intermedius	I-bacteria
.	O

Other	O
less	O
frequently	O
encountered	O
species	O
were	O
Actinomyces	B-bacteria
israelii	I-bacteria
,	O
Bifidobacterium	B-bacteria
spp	I-bacteria
1	I-bacteria
,	O
Clostridium	B-bacteria
spp	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

Results	O
indicate	O
the	O
existence	O
of	O
combinations	O
of	O
bacterial	O
species	O
in	O
root	O
canal	O
infections	O
of	O
the	O
primary	O
dentition	O
with	O
necrotic	O
pulps	O
,	O
anaerobic	O
bacteria	O
predominating	O
.	O

Protease	O
inhibitor	O
cocktails	O
are	O
routinely	O
added	O
to	O
clinical	O
samples	O
used	O
for	O
proteomic	O
studies	O
to	O
inactivate	O
proteases	O
.	O

As	O
these	O
same	O
samples	O
are	O
often	O
used	O
for	O
microbial	O
studies	O
,	O
we	O
determined	O
whether	O
the	O
addition	O
of	O
protease	O
inhibitors	O
could	O
affect	O
the	O
quantitative	O
or	O
qualitative	O
assessment	O
of	O
microbial	O
profiles	O
.	O

Twenty	O
-	O
two	O
saliva	O
samples	O
were	O
collected	O
and	O
processed	O
immediately	O
with	O
or	O
without	O
the	O
addition	O
of	O
a	O
protease	O
inhibitor	O
cocktail	O
.	O


Conventional	O
cultivation	O
methods	O
were	O
used	O
to	O
evaluate	O
total	O
bacterial	O
growth	O
.	O

Total	O
genomic	O
DNA	O
was	O
isolated	O
and	O
a	O
specific	O
16S	O
rRNA	O
gene	O
-	O
targeted	O
region	O
was	O
PCR	O
-	O
amplified	O
and	O
separated	O
by	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
.	O

A	O
combination	O
of	O
1D	O
sodium	O
dodecyl	O
sulfate	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
methods	O
was	O
used	O
to	O
determine	O
the	O
effect	O
of	O
the	O
protease	O
inhibitors	O
on	O
the	O
integrity	O
of	O
salivary	O
proteins	O
and	O
peptides	O
.	O

Interestingly	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
in	O
either	O
the	O
bacterial	O
growth	O
and	O
composition	O
or	O
the	O
integrity	O
of	O
salivary	O
proteins	O
between	O
the	O
two	O
groups	O
.	O

Correlation	O
coefficients	O
between	O
the	O
paired	O
samples	O
for	O
total	O
cultivable	O
microbiota	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
847	O
)	O
,	O
total	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
898	O
)	O
,	O
total	O
oral	O
lactobacilli	B-bacteria
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
933	O
)	O
,	O
and	O
total	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
870	O
)	O
also	O
exceeded	O
expected	O
values	O
.	O

The	O
results	O
suggest	O
that	O
the	O
addition	O
of	O
a	O
protease	O
inhibitor	O
cocktail	O
in	O
saliva	O
samples	O
does	O
not	O
impact	O
the	O
growth	O
of	O
oral	O
microbiota	O
or	O
compromise	O
the	O
ability	O
to	O
characterize	O
its	O
composition	O
.	O

Using	O
food	O
and	O
commensal	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
as	O
vehicles	O
for	O
DNA	O
delivery	O
into	O
epithelial	O
cells	O
is	O
a	O
new	O
strategy	O
for	O
vaccine	O
delivery	O
or	O
gene	O
therapy	O
.	O

However	O
,	O
present	O
methods	O
for	O
DNA	O
delivery	O
with	O
LAB	B-bacteria
have	O
suffered	O
low	O
efficiency	O
.	O

Our	O
goal	O
was	O
to	O
develop	O
a	O
new	O
system	O
to	O
deliver	O
DNA	O
into	O
epithelial	O
cells	O
with	O
high	O
efficiency	O
using	O
food	O
and	O
commensal	O
LAB	B-bacteria
.	O

An	O
Escherichia	B-bacteria
coli	I-bacteria
-	O
LAB	B-bacteria
shuttle	O
plasmid	O
,	O
pLKV1	O
,	O
for	O
DNA	O
delivery	O
into	O
eukaryotic	O
cells	O
was	O
constructed	O
.	O

Two	O
reporter	O
plasmids	O
with	O
green	O
and	O
red	O
fluorescent	O
protein	O
genes	O
were	O
also	O
constructed	O
to	O
monitor	O
the	O
uptake	O
of	O
protein	O
and	O
DNA	O
,	O
respectively	O
.	O

Bacteria	O
delivering	O
these	O
reporter	O
plasmids	O
into	O
Caco	O
-	O
2	O
cells	O
were	O
monitored	O
by	O
fluorescence	O
microscopy	O
.	O

Several	O
methods	O
that	O
weaken	O
the	O
bacterial	O
cell	O
wall	O
prior	O
to	O
co	O
-	O
culture	O
with	O
Caco	O
-	O
2	O
cells	O
were	O
evaluated	O
for	O
their	O
role	O
in	O
the	O
improvement	O
of	O
gene	O
transfer	O
efficiency	O
.	O

Treating	O
Streptococcus	B-bacteria
gordonii	I-bacteria
with	O
penicillin	O
and	O
lysozyme	O
greatly	O
increased	O
its	O
rate	O
of	O
gene	O
delivery	O
to	O
mammalian	O
cells	O
compared	O
to	O
untreated	O
control	O
bacteria	O
,	O
while	O
glycine	O
pretreatment	O
promoted	O
the	O
highest	O
gene	O
transfer	O
rate	O
for	O
Lactococcus	B-bacteria
lactis	I-bacteria
.	O

Uptake	O
of	O
green	O
fluorescent	O
bacteria	O
by	O
Caco	O
-	O
2	O
cells	O
showed	O
that	O
the	O
cell	O
wall	O
-	O
weakening	O
treatment	O
promoted	O
the	O
internalization	O
of	O
the	O
noninvasive	O
bacteria	O
into	O
Caco	O
-	O
2	O
cells	O
.	O

In	O
conclusion	O
,	O
we	O
have	O
developed	O
a	O
noninvasive	O
system	O
using	O
LAB	B-bacteria
as	O
a	O
vehicle	O
for	O
vaccine	O
delivery	O
or	O
gene	O
therapy	O
,	O
and	O
tested	O
this	O
system	O
in	O
vitro	O
with	O
Caco	O
-	O
2	O
cells	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
is	O
associated	O
with	O
peptic	O
ulcer	O
and	O
gastric	O
carcinoma	O
.	O

The	O
oral	O
cavity	O
may	O
be	O
a	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
;	O
however	O
,	O
the	O
results	O
of	O
studies	O
on	O
this	O
subject	O
are	O
controversial	O
.	O

We	O
employed	O
single	O
-	O
step	O
and	O
nested	O
polymerase	O
chain	O
reactions	O
(	O
PCR	O
)	O
to	O
detect	O
the	O
presence	O
of	O
the	O
vacA	O
,	O
ureA	O
and	O
16S	O
rDNA	O
genes	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
,	O
saliva	O
and	O
dental	O
plaque	O
of	O
30	O
subjects	O
.	O

The	O
results	O
were	O
confirmed	O
by	O
sequencing	O
.	O

Nested	O
16S	O
rDNA	O
and	O
ureA	O
amplification	O
was	O
achieved	O
in	O
80	O
%	O
of	O
gastric	O
,	O
30	O
%	O
of	O
saliva	O
and	O
20	O
%	O
of	O
dental	O
plaque	O
specimens	O
.	O

Sequencing	O
of	O
10	O
,	O
seven	O
and	O
four	O
16S	O
rDNA	O
products	O
from	O
stomach	O
,	O
saliva	O
and	O
dental	O
plaque	O
,	O
respectively	O
,	O
showed	O
>	O
99	O
%	O
identity	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Sequencing	O
of	O
the	O
other	O
four	O
oral	O
cavity	O
PCR	O
products	O
showed	O
similarity	O
with	O
Campylobacter	B-bacteria
and	O
Wolinella	B-bacteria
species	I-bacteria
.	O

Additionally	O
,	O
the	O
vacA	O
genotype	O
identified	O
in	O
the	O
samples	O
of	O
different	O
sites	O
was	O
the	O
same	O
within	O
a	O
given	O
subject	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
may	O
be	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
gastric	O
infection	O
,	O
thus	O
it	O
could	O
be	O
a	O
source	O
of	O
transmission	O
.	O

However	O
,	O
results	O
obtained	O
with	O
detection	O
methods	O
based	O
only	O
on	O
PCR	O
should	O
be	O
interpreted	O
with	O
caution	O
because	O
other	O
microorganisms	O
that	O
are	O
phylogenetically	O
very	O
close	O
to	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
are	O
also	O
present	O
in	O
the	O
mouth	O
.	O

Periodontitis	O
is	O
a	O
chronic	O
inflammatory	O
disease	O
that	O
results	O
in	O
the	O
destruction	O
of	O
the	O
supporting	O
tissues	O
of	O
the	O
teeth	O
.	O

Gingival	O
epithelial	O
cells	O
are	O
an	O
important	O
mechanical	O
barrier	O
and	O
participate	O
in	O
the	O
host	O
inflammatory	O
response	O
to	O
periodontopathogens	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
is	O
to	O
investigate	O
the	O
capacity	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
to	O
bind	O
to	O
the	O
complement	O
regulatory	O
protein	O
CD46	O
expressed	O
by	O
oral	O
epithelial	O
cells	O
and	O
to	O
determine	O
the	O
impact	O
of	O
the	O
binding	O
on	O
the	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
matrix	O
metalloproteinase	O
(	O
MMP	O
)	O
-	O
9	O
by	O
oral	O
epithelial	O
cells	O
.	O

Binding	O
of	O
recombinant	O
human	O
CD46	O
to	O
the	O
surface	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
demonstrated	O
by	O
immunologic	O
assays	O
.	O

After	O
stimulation	O
of	O
oral	O
epithelial	O
cells	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
gene	O
expression	O
was	O
determined	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
analysis	O
while	O
protein	O
secretion	O
was	O
monitored	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
.	O

Heat	O
and	O
protease	O
treatments	O
of	O
bacterial	O
cells	O
reduced	O
CD46	O
binding	O
.	O

F	O
.	O
nucleatum	O
-	O
bound	O
CD46	O
mediated	O
the	O
cleavage	O
of	O
C3b	O
in	O
the	O
presence	O
of	O
factor	O
I	O
.	O

Stimulating	O
oral	O
epithelial	O
cells	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
at	O
a	O
multiplicity	O
of	O
infection	O
of	O
50	O
resulted	O
in	O
a	O
significant	O
upregulation	O
of	O
the	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
MMP	O
-	O
9	O
by	O
oral	O
epithelial	O
cells	O
.	O

However	O
,	O
pretreating	O
the	O
epithelial	O
cells	O
with	O
an	O
anti	O
-	O
CD46	O
polyclonal	O
antibody	O
attenuated	O
the	O
production	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
MMP	O
-	O
9	O
in	O
response	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Such	O
an	O
inhibitory	O
effect	O
was	O
not	O
observed	O
with	O
non	O
-	O
specific	O
antibodies	O
.	O

The	O
present	O
study	O
demonstrates	O
that	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
can	O
bind	O
the	O
complement	O
regulatory	O
protein	O
CD46	O
.	O

The	O
interaction	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
with	O
epithelial	O
cell	O
surface	O
CD46	O
may	O
contribute	O
to	O
increasing	O
the	O
levels	O
of	O
proinflammatory	O
mediators	O
and	O
MMPs	O
in	O
periodontal	O
sites	O
and	O
consequently	O
modulate	O
tissue	O
destruction	O
.	O

The	O
oral	O
microbiota	O
plays	O
an	O
important	O
role	O
in	O
buccal	O
health	O
and	O
in	O
diseases	O
such	O
as	O
periodontitis	O
and	O
meningitis	O
.	O

The	O
study	O
of	O
the	O
human	O
oral	O
bacteria	O
has	O
so	O
far	O
focused	O
on	O
subjects	O
from	O
Western	O
societies	O
,	O
while	O
little	O
is	O
known	O
about	O
subjects	O
from	O
isolated	O
communities	O
.	O

This	O
work	O
determined	O
the	O
composition	O
of	O
the	O
oral	O
mucosa	O
microbiota	O
from	O
six	O
Amazon	O
Amerindians	O
,	O
and	O
tested	O
a	O
sample	O
preservation	O
alternative	O
to	O
freezing	O
.	O

Paired	O
oral	O
swabs	O
were	O
taken	O
from	O
six	O
adults	O
of	O
Guahibo	O
ethnicity	O
living	O
in	O
the	O
community	O
of	O
Platanillal	O
,	O
Amazonas	O
State	O
,	O
Venezuela	O
.	O

Replicate	O
swabs	O
were	O
preserved	O
in	O
liquid	O
nitrogen	O
and	O
in	O
Aware	O
Messenger	O
fluid	O
(	O
Calypte	O
)	O
.	O

Buccal	O
DNA	O
was	O
extracted	O
,	O
and	O
the	O
V2	O
region	O
of	O
the	O
16S	O
rRNA	O
gene	O
was	O
amplified	O
and	O
pyrosequenced	O
.	O

A	O
total	O
of	O
17	O
214	O
oral	O
bacterial	O
sequences	O
were	O
obtained	O
from	O
the	O
six	O
subjects	O
;	O
these	O
were	O
binned	O
into	O
1034	O
OTUs	O
from	O
10	O
phyla	O
,	O
30	O
families	O
and	O
51	O
genera	O
.	O

The	O
oral	O
mucosa	O
was	O
highly	O
dominated	O
by	O
four	O
phyla	O
:	O
Firmicutes	B-bacteria
(	O
mostly	O
the	O
genera	O
Streptococcus	B-bacteria
and	O
Veillonella	B-bacteria
)	O
,	O
Proteobacteria	B-bacteria
(	O
mostly	O
Neisseria	B-bacteria
)	O
,	O
Bacterioidetes	B-bacteria
(	O
Prevotella	B-bacteria
)	O
and	O
Actinobacteria	B-bacteria
(	O
Micrococcineae	B-bacteria
)	O
.	O

Although	O
the	O
microbiota	O
were	O
similar	O
at	O
the	O
phylum	O
level	O
,	O
the	O
Amerindians	O
shared	O
only	O
62	O
%	O
of	O
the	O
families	O
and	O
23	O
%	O
of	O
the	O
genera	O
with	O
non	O
-	O
Amerindians	O
from	O
previous	O
studies	O
,	O
and	O
had	O
a	O
lower	O
richness	O
of	O
genera	O
(	O
51	O
vs	O
177	O
reported	O
in	O
non	O
-	O
Amerindians	O
)	O
.	O

The	O
Amerindians	O
carried	O
unidentified	O
members	O
of	O
the	O
phyla	O
Bacteroidetes	B-bacteria
,	O
Firmicutes	B-bacteria
and	O
Proteobacteria	B-bacteria
and	O
their	O
microbiota	O
included	O
soil	O
bacteria	O
Gp1	O
(	O
Acidobacteriaceae	B-bacteria
)	O
and	O
Xylanibacter	B-bacteria
(	O
Prevotellaceae	B-bacteria
)	O
,	O
and	O
the	O
rare	O
genus	O
Phocoenobacter	B-bacteria
(	O
Pasteurellaceae	B-bacteria
)	O
.	O

Preserving	O
buccal	O
swabs	O
in	O
the	O
Aware	O
Messenger	O
oral	O
fluid	O
collection	O
device	O
substantially	O
altered	O
the	O
bacterial	O
composition	O
in	O
comparison	O
to	O
freezing	O
,	O
and	O
therefore	O
this	O
method	O
can	O
not	O
be	O
used	O
to	O
preserve	O
samples	O
for	O
the	O
study	O
of	O
microbial	O
communities	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
assess	O
the	O
antibacterial	O
activity	O
of	O
sodium	O
citrate	O
against	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
and	O
several	O
oral	O
bacteria	O
.	O

The	O
antibacterial	O
activity	O
was	O
determined	O
by	O
broth	O
microdilution	O
method	O
.	O

The	O
results	O
showed	O
that	O
although	O
Enterocuccus	B-bacteria
faecium	I-bacteria
OB7084	I-bacteria
and	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
OB7088	I-bacteria
had	O
high	O
tolerance	O
to	O
sodium	O
citrate	O
,	O
several	O
oral	O
bacteria	O
including	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
JCM8532	I-bacteria
(	O
T	O
)	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
JCM5705	I-bacteria
(	O
T	O
)	O
and	O
Strep	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
NBRC102642	I-bacteria
(	O
T	O
)	O
were	O
susceptible	O
.	O

Furthermore	O
,	O
the	O
bactericidal	O
activity	O
of	O
sodium	O
citrate	O
against	O
Strep	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
NBRC102642	I-bacteria
(	O
T	O
)	O
was	O
not	O
influenced	O
by	O
pH	O
in	O
the	O
range	O
of	O
5	O
.	O
0	O
-	O
8	O
.	O
0	O
,	O
whereas	O
that	O
of	O
sodium	O
lactate	O
was	O
weakened	O
at	O
neutral	O
or	O
weak	O
alkaline	O
pH	O
.	O

When	O
Strep	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
NBRC102642	I-bacteria
(	O
T	O
)	O
was	O
treated	O
with	O
sodium	O
citrate	O
for	O
2	O
h	O
,	O
many	O
burst	O
cells	O
were	O
observed	O
.	O

However	O
,	O
addition	O
of	O
MgCl	O
(	O
2	O
)	O
or	O
CaCl	O
(	O
2	O
)	O
to	O
an	O
assay	O
medium	O
weakened	O
the	O
antimicrobial	O
activity	O
although	O
ZnCl	O
(	O
2	O
)	O
or	O
MnCl	O
(	O
2	O
)	O
did	O
not	O
influence	O
.	O

Independent	O
of	O
pH	O
,	O
sodium	O
citrate	O
inhibited	O
the	O
growth	O
of	O
oral	O
bacteria	O
,	O
which	O
suggests	O
that	O
the	O
mechanism	O
is	O
different	O
from	O
that	O
of	O
sodium	O
lactate	O
.	O

The	O
results	O
presented	O
in	O
this	O
study	O
would	O
be	O
available	O
for	O
understanding	O
the	O
antimicrobial	O
property	O
of	O
sodium	O
citrate	O
.	O

Acid	O
etching	O
procedures	O
may	O
disrupt	O
residual	O
bacteria	O
and	O
contribute	O
to	O
the	O
success	O
of	O
incomplete	O
caries	O
removal	O
followed	O
by	O
adhesive	O
restoration	O
.	O

This	O
study	O
evaluated	O
the	O
in	O
vivo	O
effect	O
of	O
acid	O
etching	O
on	O
cariogenic	O
bacterial	O
activity	O
within	O
affected	O
dentin	O
after	O
minimally	O
invasive	O
treatment	O
of	O
caries	O
lesions	O
.	O

Twenty	O
-	O
eight	O
carious	O
permanent	O
teeth	O
received	O
standardized	O
selective	O
caries	O
removal	O
and	O
random	O
acid	O
etch	O
treatment	O
(	O
E	O
)	O
or	O
not	O
(	O
NE	O
)	O
prior	O
to	O
adhesive	O
restoration	O
.	O

Baseline	O
and	O
3	O
-	O
month	O
dentin	O
biopsies	O
were	O
collected	O
.	O

The	O
number	O
of	O
bacteria	O
and	O
activity	O
of	O
total	O
bacterial	O
cells	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
were	O
determined	O
by	O
quantitative	O
PCR	O
and	O
RT	O
-	O
PCR	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
observed	O
in	O
total	O
bacterial	O
number	O
and	O
activity	O
between	O
E	O
and	O
NE	O
treatments	O
(	O
p	O
>	O
0	O
.	O
3008	O
)	O
.	O

For	O
NE	O
,	O
however	O
,	O
the	O
residual	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
bacterial	O
cells	O
were	O
reduced	O
(	O
p	O
=	O
0	O
.	O
0027	O
)	O
,	O
while	O
the	O
activity	O
per	O
cell	O
was	O
significantly	O
increased	O
(	O
p	O
=	O
0	O
.	O
0010	O
)	O
after	O
reentry	O
at	O
3	O
months	O
after	O
restoration	O
.	O

This	O
effect	O
was	O
not	O
observed	O
in	O
group	O
E	O
.	O

Although	O
no	O
significant	O
differences	O
were	O
found	O
between	O
groups	O
,	O
this	O
study	O
suggests	O
that	O
acid	O
etching	O
of	O
affected	O
dentin	O
prior	O
to	O
adhesive	O
restoration	O
may	O
directly	O
or	O
indirectly	O
have	O
an	O
inhibitive	O
effect	O
on	O
the	O
activity	O
of	O
residual	O
cariogenic	O
bacteria	O
.	O

Further	O
research	O
is	O
required	O
to	O
investigate	O
this	O
potential	O
effect	O
.	O

Severe	O
early	O
childhood	O
caries	O
is	O
a	O
microbial	O
infection	O
that	O
severely	O
compromises	O
the	O
dentition	O
of	O
young	O
children	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
microbiota	O
of	O
severe	O
early	O
childhood	O
caries	O
.	O

Dental	O
plaque	O
samples	O
from	O
2	O
-	O
to	O
6	O
-	O
year	O
-	O
old	O
children	O
were	O
analyzed	O
using	O
16S	O
rRNA	O
gene	O
cloning	O
and	O
sequencing	O
,	O
and	O
by	O
specific	O
PCR	O
amplification	O
for	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Bifidobacteriaceae	B-bacteria
species	I-bacteria
.	O

Children	O
with	O
severe	O
caries	O
(	O
n	O
=	O
39	O
)	O
had	O
more	O
dental	O
plaque	O
and	O
gingival	O
inflammation	O
than	O
caries	O
-	O
free	O
children	O
(	O
n	O
=	O
41	O
)	O
.	O

Analysis	O
of	O
phylotypes	O
from	O
operational	O
taxonomic	O
unit	O
analysis	O
of	O
16S	O
rRNA	O
clonal	O
metalibraries	O
from	O
severe	O
caries	O
and	O
caries	O
-	O
free	O
children	O
indicated	O
that	O
while	O
libraries	O
differed	O
significantly	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
there	O
was	O
increased	O
diversity	O
than	O
detected	O
in	O
this	O
clonal	O
analysis	O
.	O

Using	O
the	O
Human	O
Oral	O
Microbiome	O
Database	O
,	O
139	O
different	O
taxa	O
were	O
identified	O
.	O

Within	O
the	O
limits	O
of	O
this	O
study	O
,	O
caries	O
-	O
associated	O
taxa	O
included	O
Granulicatella	B-bacteria
elegans	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
780	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
species	O
associated	O
with	O
caries	O
-	O
free	O
children	O
included	O
Capnocytophaga	B-bacteria
gingivalis	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
Abiotrophia	B-bacteria
defectiva	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
Lachnospiraceae	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
100	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
Streptococcus	B-bacteria
cristatus	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

By	O
specific	O
PCR	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
p	O
<	O
0	O
.	O
005	O
)	O
and	O
Bifidobacteriaceae	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
were	O
significantly	O
associated	O
with	O
severe	O
caries	O
.	O

Clonal	O
analysis	O
of	O
80	O
children	O
identified	O
a	O
diverse	O
microbiota	O
that	O
differed	O
between	O
severe	O
caries	O
and	O
caries	O
-	O
free	O
children	O
,	O
but	O
the	O
association	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
with	O
caries	O
was	O
from	O
specific	O
PCR	O
analysis	O
,	O
not	O
from	O
clonal	O
analysis	O
,	O
of	O
samples	O
.	O

To	O
investigate	O
whether	O
short	O
-	O
term	O
daily	O
consumption	O
of	O
yoghurt	O
leads	O
to	O
colonization	O
by	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
in	O
a	O
group	O
of	O
human	O
subjects	O
who	O
were	O
initially	O
totally	O
devoid	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
in	O
their	O
oral	O
cavities	O
.	O

Twenty	O
-	O
three	O
volunteers	O
consumed	O
yogurt	O
containing	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
during	O
a	O
14	O
-	O
day	O
trial	O
stage	O
.	O

Oral	O
and	O
fecal	O
samples	O
were	O
collected	O
at	O
the	O
clearance	O
stage	O
and	O
at	O
the	O
post	O
-	O
yoghurt	O
intake	O
stage	O
until	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
found	O
.	O

Standard	O
polymerase	O
chain	O
reaction	O
methods	O
using	O
specific	O
primers	O
were	O
adopted	O
for	O
the	O
detection	O
and	O
identification	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

The	O
isolation	O
frequency	O
decreased	O
rapidly	O
72	O
h	O
after	O
stopping	O
intake	O
of	O
yoghurt	O
.	O

After	O
1	O
week	O
,	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
absent	O
in	O
all	O
oral	O
samples	O
.	O

Non	O
-	O
significant	O
differences	O
were	O
found	O
between	O
the	O
survival	O
rates	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
in	O
samples	O
of	O
saliva	O
,	O
plaque	O
,	O
tongue	O
surface	O
,	O
and	O
buccal	O
mucosa	O
.	O

L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
also	O
found	O
to	O
remain	O
in	O
the	O
gastrointestinal	O
tract	O
for	O
longer	O
than	O
in	O
the	O
oral	O
cavity	O
.	O

Allochthonous	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
is	O
not	O
likely	O
to	O
permanently	O
colonize	O
the	O
oral	O
cavity	O
and	O
intestine	O
.	O

Quorum	O
sensing	O
is	O
defined	O
as	O
the	O
ability	O
of	O
microorganisms	O
to	O
sense	O
their	O
population	O
density	O
via	O
the	O
release	O
of	O
signaling	O
molecules	O
composed	O
of	O
acyl	O
-	O
homoserine	O
lactone	O
(	O
AHL	O
)	O
,	O
which	O
is	O
a	O
type	O
of	O
autoinducer	O
(	O
AI	O
)	O
.	O

Previous	O
structure	O
-	O
activity	O
relationship	O
(	O
SAR	O
)	O
studies	O
demonstrated	O
that	O
the	O
3	O
-	O
oxo	O
group	O
,	O
homoserine	O
lactone	O
of	O
L	O
-	O
form	O
,	O
and	O
long	O
acyl	O
side	O
chain	O
have	O
crucial	O
roles	O
in	O
apoptosis	O
induction	O
.	O

Various	O
types	O
of	O
synthetic	O
AI	O
analogs	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
were	O
prepared	O
,	O
and	O
SAR	O
study	O
was	O
conducted	O
to	O
determine	O
their	O
effects	O
against	O
human	O
oral	O
squamous	O
carcinoma	O
cells	O
derived	O
from	O
gingival	O
carcinoma	O
Ca9	O
-	O
22	O
cells	O
and	O
tongue	O
cancer	O
SAS	O
cells	O
.	O

Not	O
only	O
the	O
antiproliferative	O
potential	O
but	O
also	O
the	O
radiation	O
-	O
sensitizing	O
effects	O
against	O
these	O
cells	O
were	O
examined	O
.	O

It	O
was	O
found	O
that	O
antiproliferative	O
activity	O
partly	O
depended	O
on	O
HSL	O
structure	O
and	O
acyl	O
side	O
chain	O
length	O
.	O

Moreover	O
,	O
a	O
few	O
compounds	O
,	O
compound	O
5	O
and	O
87	O
,	O
showed	O
antiproliferative	O
effects	O
against	O
both	O
Ca9	O
-	O
22	O
and	O
SAS	O
cells	O
,	O
and	O
also	O
induced	O
radiation	O
-	O
sensitizing	O
effects	O
against	O
Ca9	O
-	O
22	O
cells	O
.	O

Compound	O
5	O
alone	O
induced	O
apoptotic	O
cell	O
death	O
accompanied	O
by	O
sub	O
-	O
G1	O
phase	O
accumulation	O
in	O
cell	O
cycle	O
and	O
caspase	O
-	O
3	O
activation	O
,	O
and	O
radiation	O
-	O
sensitizing	O
effects	O
of	O
compound	O
5	O
could	O
be	O
attributed	O
to	O
enhanced	O
apoptosis	O
induction	O
.	O

In	O
contrast	O
,	O
there	O
were	O
no	O
remarkable	O
alterations	O
in	O
cell	O
cycle	O
distribution	O
in	O
Ca9	O
-	O
22	O
treated	O
with	O
compound	O
87	O
alone	O
or	O
in	O
combination	O
.	O

However	O
,	O
both	O
compounds	O
lack	O
3	O
-	O
oxo	O
and	O
their	O
acyl	O
side	O
chain	O
lengths	O
are	O
not	O
necessarily	O
long	O
.	O

This	O
SAR	O
study	O
demonstrated	O
that	O
HSL	O
analogs	O
,	O
which	O
lacked	O
the	O
recommended	O
characteristics	O
for	O
apoptosis	O
induction	O
clearly	O
showed	O
antiproliferative	O
and	O
radiation	O
-	O
sensitizing	O
activity	O
in	O
Ca9	O
-	O
22	O
cells	O
.	O

This	O
study	O
examined	O
in	O
vivo	O
and	O
in	O
vitro	O
colonization	O
by	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
an	O
organism	O
highly	O
associated	O
with	O
aggressive	O
periodontitis	O
.	O

Thirteen	O
volunteers	O
(	O
5	O
were	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
positive	O
for	O
buccal	O
epithelial	O
cells	O
[	O
BECs	O
]	O
and	O
teeth	O
,	O
5	O
were	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
positive	O
for	O
teeth	O
only	O
,	O
and	O
3	O
were	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
-	O
negative	O
controls	O
)	O
had	O
two	O
mandibular	O
stents	O
fabricated	O
.	O

Each	O
stent	O
contained	O
3	O
removable	O
hydroxyapatite	O
(	O
HA	O
)	O
tooth	O
surrogates	O
.	O

One	O
HA	O
square	O
was	O
removed	O
from	O
a	O
stent	O
at	O
5	O
time	O
points	O
over	O
7	O
h	O
to	O
assess	O
the	O
transfer	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
from	O
teeth	O
or	O
BECs	O
to	O
HA	O
.	O

Streptococcus	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
total	O
anaerobic	O
counts	O
were	O
evaluated	O
on	O
each	O
square	O
over	O
time	O
.	O

In	O
vitro	O
experiments	O
evaluated	O
binding	O
,	O
desorption	O
,	O
transfer	O
,	O
and	O
reattachment	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
wild	O
-	O
type	O
and	O
mutant	O
strains	O
to	O
BECs	O
and	O
saliva	O
-	O
coated	O
HA	O
(	O
SHA	O
)	O
.	O

Streptococcus	B-bacteria
and	O
Actinomyces	B-bacteria
formed	O
80	O
%	O
of	O
the	O
cultivable	O
flora	O
on	O
HA	O
in	O
all	O
subjects	O
.	O

Transfer	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
to	O
HA	O
was	O
not	O
seen	O
in	O
subjects	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
on	O
teeth	O
only	O
.	O

All	O
5	O
subjects	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
on	O
BECs	O
showed	O
transfer	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
to	O
HA	O
.	O

In	O
vitro	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
desorbed	O
from	O
BECs	O
and	O
transferred	O
to	O
SHA	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
binding	O
to	O
SHA	O
was	O
irreversible	O
and	O
did	O
not	O
transfer	O
to	O
BECs	O
.	O

The	O
adhesin	O
Aae	O
showed	O
specificity	O
for	O
BECs	O
.	O

Fimbrial	O
mutants	O
showed	O
the	O
greatest	O
reduction	O
in	O
binding	O
to	O
SHA	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
migrated	O
from	O
BECs	O
to	O
HA	O
in	O
vivo	O
and	O
to	O
SHA	O
in	O
vitro	O
;	O
however	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
movement	O
from	O
teeth	O
and	O
SHA	O
to	O
BECs	O
did	O
not	O
occur	O
.	O

In	O
vivo	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
colonized	O
HA	O
within	O
6	O
h	O
and	O
thus	O
can	O
be	O
considered	O
an	O
early	O
colonizer	O
.	O

BECs	O
are	O
a	O
likely	O
reservoir	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
tooth	O
colonization	O
.	O

Dental	O
caries	O
is	O
initiated	O
by	O
demineralization	O
of	O
the	O
tooth	O
surface	O
through	O
acid	O
production	O
by	O
sugar	O
metabolism	O
of	O
supragingival	O
plaque	O
microflora	O
.	O

To	O
elucidate	O
the	O
sugar	O
metabolic	O
system	O
,	O
we	O
used	O
CE	O
-	O
MS	O
to	O
perform	O
metabolomics	O
of	O
the	O
central	O
carbon	O
metabolism	O
,	O
the	O
EMP	O
pathway	O
,	O
the	O
pentose	O
-	O
phosphate	O
pathway	O
,	O
and	O
the	O
TCA	O
cycle	O
in	O
supra	O
-	O
gingival	O
plaque	O
and	O
representative	O
oral	O
bacteria	O
,	O
Streptococcus	B-bacteria
and	O
Actinomyces	B-bacteria
.	O

Supragingival	O
plaque	O
contained	O
all	O
the	O
targeted	O
metabolites	O
in	O
the	O
central	O
carbon	O
metabolism	O
,	O
except	O
erythrose	O
4	O
-	O
phosphate	O
in	O
the	O
pentose	O
-	O
phosphate	O
pathway	O
.	O

After	O
glucose	O
rinse	O
,	O
glucose	O
6	O
-	O
phosphate	O
,	O
fructose	O
6	O
-	O
phosphate	O
,	O
fructose	O
1	O
,	O
6	O
-	O
bisphosphate	O
,	O
dihydroxyacetone	O
phosphate	O
,	O
and	O
pyruvate	O
in	O
the	O
EMP	O
pathway	O
and	O
6	O
-	O
phosphogluconate	O
,	O
ribulose	O
5	O
-	O
phosphate	O
,	O
and	O
sedoheptulose	O
7	O
-	O
phosphate	O
in	O
the	O
pentose	O
-	O
phosphate	O
pathway	O
,	O
and	O
acetyl	O
CoA	O
were	O
increased	O
.	O

Meanwhile	O
,	O
3	O
-	O
phosphoglycerate	O
and	O
phosphoenolpyruvate	O
in	O
the	O
EMP	O
pathway	O
and	O
succinate	O
,	O
fumarate	O
,	O
and	O
malate	O
in	O
the	O
TCA	O
cycle	O
were	O
decreased	O
.	O

These	O
pathways	O
and	O
changes	O
in	O
metabolites	O
observed	O
in	O
supragingival	O
plaque	O
were	O
similar	O
to	O
the	O
integration	O
of	O
metabolite	O
profiles	O
in	O
Streptococcus	B-bacteria
and	O
Actinomyces	B-bacteria
.	O

Supra	O
-	O
and	O
subgingival	O
biofilm	O
formation	O
is	O
considered	O
to	O
be	O
mainly	O
responsible	O
for	O
early	O
implant	O
failure	O
caused	O
by	O
inflammations	O
of	O
periimplant	O
tissues	O
.	O

Nevertheless	O
,	O
little	O
is	O
known	O
about	O
the	O
complex	O
microbial	O
diversity	O
and	O
interindividual	O
similarities	O
around	O
dental	O
implants	O
.	O

An	O
atraumatic	O
assessment	O
was	O
made	O
of	O
the	O
diversity	O
of	O
microbial	O
communities	O
around	O
titanium	O
implants	O
by	O
single	O
strand	O
conformation	O
polymorphism	O
(	O
SSCP	O
)	O
analysis	O
of	O
the	O
16S	O
rRNA	O
gene	O
amplicons	O
as	O
well	O
as	O
subsequent	O
sequence	O
analysis	O
.	O

Samples	O
of	O
adherent	O
supra	O
-	O
and	O
subgingival	O
periimplant	O
biofilms	O
were	O
collected	O
from	O
ten	O
patients	O
.	O

Additionally	O
,	O
samples	O
of	O
sulcusfluid	O
were	O
taken	O
at	O
titanium	O
implant	O
abutments	O
and	O
remaining	O
teeth	O
.	O

The	O
bacteria	O
in	O
the	O
samples	O
were	O
characterized	O
by	O
SSCP	O
and	O
sequence	O
analysis	O
.	O

A	O
high	O
diversity	O
of	O
bacteria	O
varying	O
between	O
patients	O
and	O
within	O
one	O
patient	O
at	O
different	O
locations	O
was	O
found	O
.	O

Bacteria	O
characteristic	O
for	O
sulcusfluid	O
and	O
supra	O
-	O
and	O
subgingival	O
biofilm	O
communities	O
were	O
identified	O
.	O

Sulcusfluid	O
of	O
the	O
abutments	O
showed	O
higher	O
abundance	O
of	O
Streptococcus	B-bacteria
species	I-bacteria
than	O
from	O
residual	O
teeth	O
.	O

Prevotella	B-bacteria
and	O
Rothia	B-bacteria
species	I-bacteria
frequently	O
reported	O
from	O
the	O
oral	O
cavity	O
were	O
not	O
detected	O
at	O
the	O
abutments	O
suggesting	O
a	O
role	O
as	O
late	O
colonizers	O
.	O

Different	O
niches	O
in	O
the	O
human	O
mouth	O
are	O
characterized	O
by	O
specific	O
groups	O
of	O
bacteria	O
.	O

Implant	O
abutments	O
are	O
a	O
very	O
valuable	O
approach	O
to	O
study	O
dental	O
biofilm	O
development	O
in	O
vivo	O
.	O

Interferon	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
is	O
one	O
of	O
the	O
key	O
regulatory	O
cytokines	O
that	O
has	O
a	O
significant	O
effect	O
on	O
immune	O
responses	O
.	O

It	O
may	O
be	O
important	O
in	O
the	O
chronic	O
inflammatory	O
diseases	O
such	O
as	O
periodontitis	O
in	O
which	O
increased	O
IFN	O
-	O
gamma	O
levels	O
were	O
found	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
+	O
874A	O
/	O
T	O
polymorphism	O
in	O
the	O
IFN	O
-	O
gamma	O
gene	O
and	O
its	O
associations	O
with	O
the	O
presence	O
of	O
periodontopathic	O
bacteria	O
and	O
susceptibility	O
to	O
generalized	O
chronic	O
periodontitis	O
(	O
CP	O
)	O
.	O

A	O
total	O
of	O
498	O
unrelated	O
Czech	O
white	O
subjects	O
were	O
included	O
in	O
the	O
present	O
study	O
.	O

Genomic	O
DNA	O
was	O
obtained	O
from	O
the	O
peripheral	O
blood	O
of	O
244	O
patients	O
with	O
CP	O
and	O
254	O
healthy	O
subjects	O
.	O

The	O
IFN	O
-	O
gamma	O
+	O
874A	O
/	O
T	O
polymorphism	O
was	O
determined	O
by	O
amplification	O
refractory	O
mutation	O
system	O
-	O
polymerase	O
chain	O
reaction	O
(	O
ARMS	O
-	O
PCR	O
)	O
.	O

Subgingival	O
bacterial	O
colonization	O
(	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
in	O
subgingival	O
pockets	O
)	O
was	O
investigated	O
by	O
the	O
DNA	O
-	O
microarray	O
based	O
periodontal	O
pathogen	O
detection	O
kit	O
in	O
a	O
subgroup	O
of	O
subjects	O
(	O
N	O
=	O
110	O
)	O
.	O

Our	O
results	O
showed	O
no	O
differences	O
in	O
the	O
allele	O
and	O
genotype	O
frequencies	O
of	O
the	O
IFN	O
-	O
gamma	O
+	O
874A	O
/	O
T	O
polymorphism	O
between	O
patients	O
with	O
CP	O
and	O
controls	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Although	O
we	O
found	O
significant	O
differences	O
in	O
the	O
occurrence	O
of	O
periodontal	O
bacteria	O
between	O
patients	O
with	O
CP	O
and	O
healthy	O
controls	O
(	O
from	O
P	O
<	O
0	O
.	O
00001	O
to	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
no	O
significant	O
association	O
between	O
IFN	O
-	O
gamma	O
+	O
874A	O
/	O
T	O
polymorphism	O
and	O
periodontal	O
pathogens	O
was	O
observed	O
in	O
any	O
group	O
.	O

In	O
conclusion	O
,	O
these	O
findings	O
indicate	O
that	O
putative	O
functional	O
variant	O
in	O
the	O
IFN	O
-	O
gamma	O
is	O
not	O
associated	O
with	O
susceptibility	O
to	O
chronic	O
periodontitis	O
or	O
microbial	O
composition	O
in	O
the	O
Czech	O
population	O
.	O

Propolis	O
is	O
a	O
multifunctional	O
substance	O
used	O
by	O
bees	O
to	O
maintain	O
the	O
safety	O
of	O
their	O
hives	O
.	O

It	O
is	O
worldwide	O
used	O
for	O
its	O
potential	O
therapeutic	O
effects	O
.	O

In	O
this	O
study	O
,	O
Tunisian	O
propolis	O
ethanol	O
extract	O
(	O
EEP	O
)	O
was	O
tested	O
for	O
their	O
anti	O
-	O
cariogenic	O
,	O
anti	O
-	O
biofilms	O
and	O
antiproliferative	O
effects	O
of	O
many	O
cell	O
lines	O
.	O

The	O
Tunisian	O
EEP	O
was	O
evaluated	O
in	O
vitro	O
against	O
33	O
oral	O
pathogens	O
including	O
streptococci	B-bacteria
and	O
enterococci	B-bacteria
using	O
broth	O
microdilution	O
method	O
.	O

The	O
anti	O
-	O
biofilms	O
activity	O
of	O
EEP	O
was	O
assessed	O
via	O
Crystal	O
Violet	O
staining	O
and	O
MTT	O
assays	O
.	O

The	O
Tunisian	O
EEP	O
antiproliferative	O
effect	O
was	O
evaluated	O
on	O
normal	O
(	O
MRC	O
-	O
5	O
)	O
and	O
cancer	O
cell	O
lines	O
(	O
HT	O
-	O
29	O
,	O
A549	O
,	O
Hep	O
-	O
2	O
,	O
raw	O
264	O
.	O
7	O
,	O
Vero	O
)	O
by	O
the	O
ability	O
of	O
the	O
cells	O
to	O
metabolically	O
reduce	O
MTT	O
to	O
a	O
formazan	O
dye	O
.	O

Our	O
results	O
revealed	O
that	O
Tunisian	O
EEP	O
possessed	O
excellent	O
protective	O
effects	O
against	O
cariogenic	O
and	O
biofilms	O
activity	O
of	O
oral	O
streptococci	B-bacteria
.	O

Furthermore	O
,	O
EEP	O
showed	O
a	O
strong	O
antiproliferative	O
potencies	O
against	O
all	O
studied	O
cancer	O
cell	O
lines	O
as	O
judged	O
by	O
IC50	O
and	O
its	O
value	O
ranges	O
from	O
15	O
.	O
7	O
+	O
/	O
-	O
3	O
.	O
4	O
to	O
200	O
+	O
/	O
-	O
22	O
.	O
2	O
mug	O
mL	O
(	O
-	O
)	O
(	O
1	O
)	O
.	O

These	O
results	O
suggest	O
that	O
EEP	O
is	O
able	O
to	O
inhibit	O
cancer	O
cell	O
proliferation	O
,	O
cariogenic	O
bacteria	O
and	O
oral	O
biofilms	O
formation	O
.	O

It	O
could	O
have	O
a	O
promising	O
role	O
in	O
the	O
future	O
medicine	O
and	O
nutrition	O
when	O
used	O
as	O
antibiotic	O
or	O
food	O
additive	O
.	O

Periodontal	O
disease	O
has	O
been	O
associated	O
with	O
atherosclerosis	O
,	O
suggesting	O
that	O
bacteria	O
from	O
the	O
oral	O
cavity	O
may	O
contribute	O
to	O
the	O
development	O
of	O
atherosclerosis	O
and	O
cardiovascular	O
disease	O
.	O

Furthermore	O
,	O
the	O
gut	O
microbiota	O
may	O
affect	O
obesity	O
,	O
which	O
is	O
associated	O
with	O
atherosclerosis	O
.	O

Using	O
qPCR	O
,	O
we	O
show	O
that	O
bacterial	O
DNA	O
was	O
present	O
in	O
the	O
atherosclerotic	O
plaque	O
and	O
that	O
the	O
amount	O
of	O
DNA	O
correlated	O
with	O
the	O
amount	O
of	O
leukocytes	O
in	O
the	O
atherosclerotic	O
plaque	O
.	O

To	O
investigate	O
the	O
microbial	O
composition	O
of	O
atherosclerotic	O
plaques	O
and	O
test	O
the	O
hypothesis	O
that	O
the	O
oral	O
or	O
gut	O
microbiota	O
may	O
contribute	O
to	O
atherosclerosis	O
in	O
humans	O
,	O
we	O
used	O
454	O
pyrosequencing	O
of	O
16S	O
rRNA	O
genes	O
to	O
survey	O
the	O
bacterial	O
diversity	O
of	O
atherosclerotic	O
plaque	O
,	O
oral	O
,	O
and	O
gut	O
samples	O
of	O
15	O
patients	O
with	O
atherosclerosis	O
,	O
and	O
oral	O
and	O
gut	O
samples	O
of	O
healthy	O
controls	O
.	O

We	O
identified	O
Chryseomonas	B-bacteria
in	O
all	O
atherosclerotic	O
plaque	O
samples	O
,	O
and	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
in	O
the	O
majority	O
.	O

Interestingly	O
,	O
the	O
combined	O
abundances	O
of	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
in	O
atherosclerotic	O
plaques	O
correlated	O
with	O
their	O
abundance	O
in	O
the	O
oral	O
cavity	O
.	O

Moreover	O
,	O
several	O
additional	O
bacterial	O
phylotypes	O
were	O
common	O
to	O
the	O
atherosclerotic	O
plaque	O
and	O
oral	O
or	O
gut	O
samples	O
within	O
the	O
same	O
individual	O
.	O

Interestingly	O
,	O
several	O
bacterial	O
taxa	O
in	O
the	O
oral	O
cavity	O
and	O
the	O
gut	O
correlated	O
with	O
plasma	O
cholesterol	O
levels	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
suggest	O
that	O
bacteria	O
from	O
the	O
oral	O
cavity	O
,	O
and	O
perhaps	O
even	O
the	O
gut	O
,	O
may	O
correlate	O
with	O
disease	O
markers	O
of	O
atherosclerosis	O
.	O

Mother	O
'	O
s	O
milk	O
is	O
a	O
source	O
of	O
bacteria	O
that	O
influences	O
the	O
development	O
of	O
the	O
infant	O
commensal	O
gut	O
microbiota	O
.	O

To	O
date	O
,	O
the	O
species	O
diversity	O
and	O
relative	O
abundance	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
in	O
the	O
milk	O
of	O
non	O
-	O
human	O
primates	O
have	O
not	O
been	O
described	O
.	O

Milk	O
samples	O
were	O
aseptically	O
obtained	O
from	O
54	O
female	O
rhesus	O
monkeys	O
(	O
Macaca	O
mulatta	O
)	O
at	O
peak	O
lactation	O
.	O

Following	O
GM17	B-bacteria
and	O
MRS	B-bacteria
agar	O
plating	O
,	O
single	O
bacterial	O
colonies	O
were	O
isolated	O
based	O
on	O
difference	O
in	O
morphotypes	O
,	O
then	O
grouped	O
based	O
on	O
whole	O
-	O
cell	O
protein	O
profiles	O
on	O
SDS	O
-	O
PAGE	O
.	O

Bacterial	O
DNA	O
was	O
isolated	O
and	O
the	O
sequence	O
the	O
16S	O
rRNA	O
gene	O
was	O
analyzed	O
.	O

A	O
total	O
of	O
106	O
strains	O
of	O
19	O
distinct	O
bacterial	O
species	O
,	O
belonging	O
to	O
five	O
genera	O
,	O
Bacillus	B-bacteria
,	O
Enterococcus	B-bacteria
,	O
Lactobacillus	B-bacteria
,	O
Pediococcus	B-bacteria
,	O
and	O
Streptococcus	B-bacteria
,	O
were	O
identified	O
.	O

Maternal	O
gut	O
and	O
oral	O
commensal	O
bacteria	O
may	O
be	O
translocated	O
to	O
the	O
mammary	O
gland	O
during	O
lactation	O
and	O
present	O
in	O
milk	O
.	O

This	O
pathway	O
can	O
be	O
an	O
important	O
source	O
of	O
commensal	O
bacteria	O
to	O
the	O
infant	O
gut	O
and	O
oral	O
cavity	O
.	O

To	O
study	O
the	O
plasma	O
treatment	O
effects	O
on	O
deactivation	O
effectiveness	O
of	O
oral	O
bacteria	O
.	O

A	O
low	O
temperature	O
atmospheric	O
argon	O
plasma	O
brush	O
were	O
used	O
to	O
study	O
the	O
oral	O
bacterial	O
deactivation	O
effects	O
in	O
terms	O
of	O
plasma	O
conditions	O
,	O
plasma	O
exposure	O
time	O
,	O
and	O
bacterial	O
supporting	O
media	O
.	O

Oral	O
bacteria	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
with	O
an	O
initial	O
bacterial	O
population	O
density	O
between	O
1	O
.	O
0x10	O
(	O
8	O
)	O
and	O
5	O
.	O
0x10	O
(	O
8	O
)	O
cfu	O
/	O
ml	O
were	O
seeded	O
on	O
various	O
media	O
and	O
their	O
survivability	O
with	O
plasma	O
exposure	O
was	O
examined	O
.	O

Scanning	O
electron	O
microscopy	O
was	O
used	O
to	O
examine	O
the	O
morphological	O
changes	O
of	O
the	O
plasma	O
treated	O
bacteria	O
.	O

Optical	O
absorption	O
was	O
used	O
to	O
determine	O
the	O
leakage	O
of	O
intracellular	O
proteins	O
and	O
DNAs	O
of	O
the	O
plasma	O
treated	O
bacteria	O
.	O

The	O
experimental	O
data	O
indicated	O
that	O
the	O
argon	O
atmospheric	O
plasma	O
brush	O
was	O
very	O
effective	O
in	O
deactivating	O
oral	O
bacteria	O
.	O

The	O
plasma	O
exposure	O
time	O
for	O
a	O
99	O
.	O
9999	O
%	O
cell	O
reduction	O
was	O
less	O
than	O
15s	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
within	O
5	O
min	O
for	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

It	O
was	O
found	O
that	O
the	O
plasma	O
deactivation	O
efficiency	O
was	O
also	O
dependent	O
on	O
the	O
bacterial	O
supporting	O
media	O
.	O

With	O
plasma	O
exposure	O
,	O
significant	O
damages	O
to	O
bacterial	O
cell	O
structures	O
were	O
observed	O
with	O
both	O
bacterium	O
species	O
.	O

Leakage	O
of	O
intracellular	O
proteins	O
and	O
DNAs	O
after	O
plasma	O
exposure	O
was	O
observed	O
through	O
monitoring	O
the	O
absorbance	O
peaks	O
at	O
wavelengths	O
of	O
280	O
nm	O
and	O
260	O
nm	O
,	O
respectively	O
.	O

The	O
experimental	O
results	O
from	O
this	O
study	O
indicated	O
that	O
low	O
temperature	O
atmospheric	O
plasma	O
treatment	O
was	O
very	O
effective	O
in	O
deactivation	O
of	O
oral	O
bacteria	O
and	O
could	O
be	O
a	O
promising	O
technique	O
in	O
various	O
dental	O
clinical	O
applications	O
such	O
as	O
bacterial	O
disinfection	O
and	O
caries	O
early	O
prevention	O
.	O

Enterococci	B-bacteria
,	O
particularly	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
are	O
still	O
a	O
primary	O
concern	O
in	O
endodontic	O
infections	O
.	O

To	O
date	O
,	O
enterococci	B-bacteria
have	O
been	O
considered	O
to	O
be	O
only	O
transiently	O
present	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
whether	O
different	O
enterococci	B-bacteria
from	O
food	O
are	O
able	O
to	O
reside	O
in	O
oral	O
biofilm	O
.	O

Six	O
healthy	O
volunteers	O
wore	O
dental	O
splints	O
loaded	O
with	O
enamel	O
slabs	O
.	O

After	O
3	O
days	O
,	O
the	O
volunteers	O
consumed	O
cheese	O
containing	O
enterococci	B-bacteria
.	O

The	O
fate	O
of	O
the	O
enterococci	B-bacteria
was	O
analyzed	O
by	O
culture	O
technique	O
and	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

All	O
isolates	O
were	O
characterized	O
genotypically	O
by	O
macrorestriction	O
analysis	O
(	O
SmaI	O
)	O
and	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
also	O
analyzed	O
by	O
using	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
avium	I-bacteria
,	O
and	O
E	B-bacteria
.	I-bacteria
durans	I-bacteria
were	O
detected	O
in	O
the	O
initial	O
biofilm	O
after	O
2	O
hours	O
,	O
as	O
well	O
as	O
in	O
the	O
5	O
-	O
day	O
-	O
old	O
oral	O
biofilm	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
,	O
and	O
E	B-bacteria
.	I-bacteria
avium	I-bacteria
isolated	O
from	O
the	O
initial	O
biofilm	O
and	O
from	O
the	O
5	O
-	O
day	O
-	O
old	O
biofilm	O
,	O
as	O
well	O
as	O
those	O
isolated	O
from	O
cheese	O
,	O
showed	O
genetic	O
homogeneity	O
.	O

E	B-bacteria
.	I-bacteria
faecium	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
avium	I-bacteria
had	O
integrated	O
into	O
a	O
pre	O
-	O
existing	O
3	O
-	O
day	O
-	O
old	O
biofilm	O
.	O

No	O
genetic	O
similarity	O
between	O
E	B-bacteria
.	I-bacteria
durans	I-bacteria
strains	I-bacteria
isolated	O
from	O
cheese	O
and	O
those	O
from	O
the	O
initial	O
and	O
5	O
-	O
day	O
-	O
old	O
oral	O
biofilm	O
was	O
detected	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
also	O
detected	O
in	O
the	O
oral	O
biofilm	O
by	O
using	O
FISH	O
.	O

Food	O
-	O
borne	O
enterococci	B-bacteria
,	O
particularly	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
might	O
not	O
only	O
be	O
transient	O
but	O
could	O
also	O
survive	O
in	O
the	O
oral	O
biofilm	O
and	O
become	O
a	O
source	O
for	O
endodontic	O
infections	O
.	O

Moreover	O
,	O
genotypic	O
analysis	O
is	O
required	O
to	O
study	O
the	O
source	O
of	O
oral	O
enterococci	B-bacteria
.	O

Dental	O
caries	O
and	O
periodontitis	O
are	O
common	O
oral	O
bacterial	O
infectious	O
diseases	O
.	O

Their	O
prevention	O
and	O
treatment	O
requires	O
control	O
of	O
the	O
causative	O
pathogens	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
that	O
exist	O
within	O
dental	O
plaque	O
.	O

As	O
one	O
of	O
the	O
attractive	O
future	O
substitutes	O
for	O
conventional	O
antibiotics	O
,	O
antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
,	O
both	O
natural	O
and	O
synthetic	O
,	O
have	O
been	O
widely	O
tested	O
and	O
used	O
for	O
controlling	O
bacterial	O
infections	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
antimicrobial	O
activity	O
of	O
KSL	O
(	O
KKVVFKVKFK	O
-	O
NH	O
(	O
2	O
)	O
)	O
,	O
a	O
novel	O
AMP	O
,	O
against	O
several	O
major	O
cariogenic	O
and	O
periodontopathogenic	O
bacteria	O
as	O
well	O
as	O
Candida	O
albicans	O
in	O
vitro	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
causative	O
agent	O
of	O
dental	O
caries	O
,	O
was	O
chosen	O
for	O
in	O
-	O
depth	O
testing	O
.	O

Bacterial	O
susceptibility	O
and	O
time	O
-	O
kill	O
assays	O
were	O
performed	O
to	O
investigate	O
the	O
sensitivity	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
KSL	O
.	O

The	O
effect	O
of	O
KSL	O
on	O
biofilm	O
formation	O
and	O
on	O
pre	O
-	O
formed	O
biofilm	O
was	O
also	O
examined	O
.	O

For	O
biofilm	O
studies	O
,	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
was	O
used	O
to	O
observe	O
and	O
analyse	O
bacterial	O
biofilm	O
.	O

The	O
results	O
showed	O
that	O
KSL	O
had	O
antimicrobial	O
activity	O
against	O
a	O
variety	O
of	O
oral	O
bacteria	O
and	O
fungi	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
were	O
the	O
most	O
susceptible	O
strains	O
to	O
KSL	O
peptide	O
[	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
0	O
.	O
0625	O
mg	O
/	O
mL	O
]	O
compared	O
with	O
other	O
species	O
tested	O
(	O
MICs	O
of	O
0	O
.	O
125	O
-	O
1mg	O
/	O
mL	O
)	O
.	O

KSL	O
also	O
inhibited	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
formation	O
,	O
with	O
a	O
minimum	O
biofilm	O
inhibition	O
concentration	O
of	O
0	O
.	O
0625	O
-	O
0	O
.	O
125	O
mg	O
/	O
mL	O
,	O
and	O
reduced	O
1	O
-	O
day	O
-	O
old	O
developed	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
,	O
with	O
a	O
minimum	O
biofilm	O
reduction	O
concentration	O
of	O
0	O
.	O
25	O
-	O
0	O
.	O
5mg	O
/	O
mL	O
.	O

CLSM	O
images	O
showed	O
that	O
KSL	O
significantly	O
reduced	O
the	O
viability	O
of	O
biofilm	O
cells	O
.	O

This	O
study	O
suggests	O
that	O
KSL	O
may	O
have	O
a	O
potential	O
clinical	O
application	O
in	O
treating	O
dental	O
caries	O
by	O
killing	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
within	O
dental	O
plaque	O
.	O

Caries	O
and	O
periodontitis	O
are	O
important	O
human	O
diseases	O
associated	O
with	O
formation	O
of	O
multi	O
-	O
species	O
biofilms	O
.	O

The	O
involved	O
bacteria	O
are	O
intensively	O
studied	O
to	O
understand	O
the	O
molecular	O
basis	O
of	O
the	O
interactions	O
in	O
such	O
biofilms	O
.	O

This	O
study	O
established	O
a	O
basic	O
in	O
vitro	O
single	O
and	O
mixed	O
-	O
species	O
culture	O
model	O
for	O
oral	O
bacteria	O
combining	O
three	O
complimentary	O
methods	O
.	O

The	O
setup	O
allows	O
a	O
rapid	O
screening	O
for	O
effects	O
in	O
the	O
mutual	O
species	O
interaction	O
.	O

Furthermore	O
,	O
it	O
is	O
easy	O
to	O
handle	O
,	O
inexpensive	O
,	O
and	O
reproducible	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
typical	O
inhabitants	O
of	O
the	O
healthy	O
oral	O
cavity	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
as	O
main	O
carriogenic	O
species	O
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
as	O
periodontitis	O
-	O
associated	O
bacteria	O
,	O
were	O
investigated	O
for	O
their	O
biofilm	O
forming	O
ability	O
.	O

Different	O
liquid	O
growth	O
media	O
were	O
evaluated	O
.	O

Safranin	O
-	O
staining	O
allowed	O
monitoring	O
of	O
biofilm	O
formation	O
under	O
the	O
chosen	O
conditions	O
.	O

Viable	O
counts	O
and	O
microscopy	O
permitted	O
investigation	O
of	O
biofilm	O
behavior	O
in	O
mixed	O
-	O
species	O
and	O
transwell	O
setups	O
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
failed	O
to	O
form	O
biofilm	O
structures	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
established	O
abundant	O
biofilm	O
masses	O
in	O
CDM	O
/	O
sucrose	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
formed	O
patchy	O
monolayers	O
.	O

For	O
in	O
depth	O
analysis	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
were	O
chosen	O
,	O
because	O
i	O
)	O
they	O
are	O
representatives	O
of	O
the	O
physiological	O
-	O
,	O
cariogenic	O
and	O
periodontitis	O
-	O
associated	O
bacterial	O
flora	O
,	O
respectively	O
and	O
ii	O
)	O
their	O
difference	O
in	O
their	O
biofilm	O
forming	O
ability	O
.	O

Microscopic	O
analysis	O
confirmed	O
the	O
results	O
of	O
safranin	O
staining	O
.	O

Investigation	O
of	O
two	O
species	O
combinations	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
with	O
either	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
revealed	O
bacterial	O
interactions	O
influencing	O
biofilm	O
mass	O
,	O
biofilm	O
structure	O
and	O
cell	O
viability	O
.	O

This	O
setup	O
shows	O
safranin	O
staining	O
,	O
microscopic	O
analysis	O
and	O
viable	O
counts	O
together	O
are	O
crucial	O
for	O
basic	O
examination	O
and	O
evaluation	O
of	O
biofilms	O
.	O

Our	O
experiment	O
generated	O
meaningful	O
results	O
,	O
exemplified	O
by	O
the	O
noted	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
influence	O
,	O
and	O
allows	O
a	O
fast	O
decision	O
about	O
the	O
most	O
important	O
bacterial	O
interactions	O
which	O
should	O
be	O
investigated	O
in	O
depth	O
.	O

Whereas	O
periodontal	O
disease	O
is	O
ultimately	O
of	O
bacterial	O
etiology	O
,	O
from	O
multispecies	O
biofilms	O
of	O
gram	O
-	O
negative	O
anaerobic	O
microorganisms	O
,	O
much	O
of	O
the	O
deleterious	O
effects	O
are	O
caused	O
by	O
the	O
resultant	O
epithelial	O
inflammatory	O
response	O
.	O

Hence	O
,	O
development	O
of	O
a	O
treatment	O
that	O
combines	O
anti	O
-	O
biofilm	O
antibiotic	O
activity	O
with	O
anti	O
-	O
inflammatory	O
activity	O
would	O
be	O
of	O
great	O
utility	O
.	O

Antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
such	O
as	O
defensins	O
are	O
naturally	O
occurring	O
peptides	O
that	O
exhibit	O
broad	O
-	O
spectrum	O
activity	O
as	O
well	O
as	O
a	O
variety	O
of	O
immunomodulatory	O
activities	O
.	O

Furthermore	O
,	O
bacteria	O
do	O
not	O
readily	O
develop	O
resistance	O
to	O
these	O
agents	O
.	O

However	O
,	O
clinical	O
studies	O
have	O
suggested	O
that	O
they	O
do	O
not	O
represent	O
optimal	O
candidates	O
for	O
exogenous	O
therapeutic	O
agents	O
.	O

Small	O
-	O
molecule	O
mimetics	O
of	O
these	O
AMPs	O
exhibit	O
similar	O
activities	O
to	O
the	O
parent	O
peptides	O
,	O
in	O
addition	O
to	O
having	O
low	O
toxicity	O
,	O
high	O
stability	O
and	O
low	O
cost	O
.	O

To	O
determine	O
whether	O
AMP	O
mimetics	O
have	O
the	O
potential	O
for	O
treatment	O
of	O
periodontal	O
disease	O
,	O
we	O
examined	O
the	O
activity	O
of	O
one	O
mimetic	O
,	O
mPE	O
,	O
against	O
biofilm	O
cultures	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

Metabolic	O
assays	O
as	O
well	O
as	O
culture	O
and	O
biomass	O
measurement	O
assays	O
demonstrated	O
that	O
mPE	O
exhibits	O
potent	O
activity	O
against	O
biofilm	O
cultures	O
of	O
both	O
species	O
.	O

Furthermore	O
,	O
as	O
little	O
as	O
2	O
mug	O
ml	O
(	O
-	O
1	O
)	O
mPE	O
was	O
sufficient	O
to	O
inhibit	O
interleukin	O
-	O
1beta	O
-	O
induced	O
secretion	O
of	O
interleukin	O
-	O
8	O
in	O
both	O
gingival	O
epithelial	O
cells	O
and	O
THP	O
-	O
1	O
cells	O
.	O

This	O
anti	O
-	O
inflammatory	O
activity	O
is	O
associated	O
with	O
a	O
reduction	O
in	O
activation	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
,	O
suggesting	O
that	O
mPE	O
can	O
act	O
both	O
as	O
an	O
anti	O
-	O
biofilm	O
agent	O
in	O
an	O
anaerobic	O
environment	O
and	O
as	O
an	O
anti	O
-	O
inflammatory	O
agent	O
in	O
infected	O
tissues	O
.	O

Oral	O
lesions	O
of	O
tuberculosis	O
though	O
uncommon	O
,	O
are	O
seen	O
both	O
in	O
the	O
primary	O
as	O
well	O
as	O
the	O
secondary	O
stages	O
of	O
the	O
disease	O
.	O

In	O
secondary	O
tuberculosis	O
,	O
the	O
oral	O
manifestations	O
are	O
accompanied	O
by	O
lesions	O
in	O
the	O
lung	O
,	O
lymph	O
nodes	O
,	O
or	O
any	O
other	O
organ	O
system	O
of	O
the	O
body	O
.	O

This	O
can	O
be	O
detected	O
by	O
the	O
usual	O
clinical	O
history	O
and	O
systemic	O
examination	O
.	O

Primary	O
oral	O
tuberculosis	O
may	O
thus	O
present	O
as	O
a	O
diagnostic	O
challenge	O
to	O
the	O
clinician	O
.	O

Amongst	O
the	O
oral	O
lesions	O
also	O
,	O
tongue	O
is	O
the	O
usual	O
site	O
for	O
tubercular	O
infection	O
,	O
with	O
the	O
upper	O
lip	O
and	O
soft	O
palate	O
being	O
the	O
least	O
affected	O
.	O

The	O
authors	O
report	O
two	O
rare	O
cases	O
of	O
children	O
with	O
isolated	O
primary	O
tuberculosis	O
of	O
the	O
lip	O
and	O
uvula	O
.	O

Interestingly	O
,	O
the	O
first	O
case	O
presenting	O
just	O
as	O
a	O
diffuse	O
swelling	O
of	O
the	O
upper	O
lip	O
,	O
and	O
the	O
second	O
as	O
pain	O
in	O
throat	O
with	O
congestion	O
and	O
granulations	O
on	O
the	O
uvula	O
.	O

We	O
suggest	O
a	O
distinct	O
Indian	O
social	O
habit	O
which	O
predisposes	O
to	O
primary	O
lip	O
and	O
uvular	O
tuberculosis	O
,	O
sites	O
not	O
common	O
in	O
the	O
rest	O
of	O
the	O
world	O
.	O

The	O
habit	O
of	O
doing	O
`	O
`	O
datoon	O
'	O
'	O
i	O
.	O
e	O
.	O
brushing	O
of	O
the	O
teeth	O
with	O
neem	O
twigs	O
in	O
rural	O
India	O
,	O
which	O
at	O
times	O
causes	O
trauma	O
on	O
the	O
palate	O
and	O
thus	O
predisposing	O
to	O
seedling	O
of	O
the	O
wound	O
with	O
mycobacterium	B-bacteria
tuberculosis	I-bacteria
.	O

Oral	O
streptococci	B-bacteria
are	O
a	O
heterogeneous	O
group	O
of	O
human	O
commensals	O
,	O
with	O
a	O
potential	O
to	O
cause	O
serious	O
infections	O
.	O

Activation	O
of	O
plasminogen	O
has	O
been	O
shown	O
to	O
increase	O
the	O
virulence	O
of	O
typical	O
human	O
pathogenic	O
streptococci	B-bacteria
such	O
as	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
.	O

One	O
important	O
factor	O
for	O
plasminogen	O
activation	O
is	O
the	O
streptococcal	B-bacteria
alpha	O
-	O
enolase	O
.	O

Here	O
we	O
report	O
that	O
plasminogen	O
activation	O
is	O
also	O
common	O
in	O
oral	O
streptococci	B-bacteria
species	I-bacteria
involved	O
in	O
clinical	O
infection	O
and	O
that	O
it	O
depends	O
on	O
the	O
action	O
of	O
human	O
plasminogen	O
activators	O
.	O

The	O
ability	O
to	O
activate	O
plasminogen	O
did	O
not	O
require	O
full	O
conservation	O
of	O
the	O
internal	O
plasminogen	O
binding	O
sequence	O
motif	O
FYDKERKVY	O
of	O
alpha	O
-	O
enolase	O
that	O
was	O
previously	O
described	O
as	O
crucial	O
for	O
increased	O
plasminogen	O
binding	O
,	O
activation	O
and	O
virulence	O
.	O

Instead	O
,	O
experiments	O
with	O
recombinant	O
alpha	O
-	O
enolase	O
variants	O
indicate	O
that	O
the	O
naturally	O
occurring	O
variations	O
do	O
not	O
impair	O
plasminogen	O
binding	O
.	O

In	O
spite	O
of	O
these	O
variations	O
in	O
the	O
internal	O
plasminogen	O
binding	O
motif	O
oral	O
streptococci	B-bacteria
showed	O
similar	O
activation	O
of	O
plasminogen	O
.	O

We	O
conclude	O
that	O
the	O
pathomechanism	O
of	O
plasminogen	O
activation	O
is	O
conserved	O
in	O
oral	O
streptococci	B-bacteria
that	O
cause	O
infections	O
in	O
human	O
.	O

This	O
may	O
contribute	O
to	O
their	O
opportunistic	O
pathogenic	O
character	O
that	O
is	O
unfurled	O
in	O
certain	O
niches	O
.	O

The	O
antibacterial	O
activity	O
and	O
cytotoxicity	O
of	O
two	O
novel	O
cross	O
-	O
linking	O
antibacterial	O
monomers	O
,	O
2	O
-	O
methacryloxylethyl	O
dodecyl	O
methyl	O
ammonium	O
bromide	O
(	O
MAE	O
-	O
DB	O
)	O
and	O
2	O
-	O
methacryloxylethyl	O
hexadecyl	O
methyl	O
ammonium	O
bromide	O
(	O
MAE	O
-	O
HB	O
)	O
were	O
tested	O
in	O
this	O
study	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
and	O
the	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
of	O
unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
against	O
eight	O
strains	O
of	O
oral	O
bacteria	O
were	O
tested	O
using	O
a	O
broth	O
dilution	O
test	O
.	O

Time	O
-	O
kill	O
determinations	O
were	O
performed	O
to	O
examine	O
the	O
kinetics	O
of	O
unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
UA159	I-bacteria
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
ATCC6715	I-bacteria
.	O

Bacterial	O
morphology	O
was	O
observed	O
using	O
a	O
field	O
emission	O
scanning	O
electron	O
microscope	O
(	O
Fe	O
-	O
SEM	O
)	O
.	O

The	O
cytotoxicity	O
of	O
unpolymerized	O
two	O
new	O
monomers	O
and	O
Bis	O
-	O
GMA	O
on	O
the	O
human	O
gingival	O
fibroblast	O
cell	O
line	O
H2620	O
was	O
assessed	O
using	O
a	O
methyl	O
thiazolyl	O
tetrazolium	O
assay	O
.	O

Unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
showed	O
strong	O
bactericidal	O
activity	O
against	O
oral	O
bacteria	O
.	O

The	O
MBC	O
value	O
of	O
MAE	O
-	O
DB	O
ranged	O
from	O
12	O
.	O
2	O
to	O
24	O
.	O
4mug	O
/	O
ml	O
and	O
the	O
MBC	O
value	O
of	O
MAE	O
-	O
HB	O
ranged	O
from	O
6	O
.	O
2	O
to	O
48	O
.	O
8mug	O
/	O
ml	O
.	O

Time	O
-	O
kill	O
determinations	O
indicated	O
that	O
unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
had	O
rapid	O
killing	O
effects	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
UA159	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
ATCC6715	I-bacteria
at	O
the	O
concentration	O
of	O
4x	O
MBC	O
.	O

The	O
Fe	O
-	O
SEM	O
observation	O
showed	O
that	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
could	O
disturb	O
the	O
integrity	O
of	O
bacteria	O
and	O
cause	O
lysis	O
of	O
bacterial	O
cells	O
.	O

The	O
median	O
lethal	O
concentration	O
values	O
on	O
human	O
gingival	O
fibroblast	O
for	O
both	O
monomers	O
were	O
between	O
10	O
and	O
20mug	O
/	O
ml	O
,	O
and	O
greater	O
than	O
that	O
of	O
Bis	O
-	O
GMA	O
.	O

Unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
monomers	O
had	O
strong	O
bactericidal	O
activity	O
against	O
eight	O
strains	O
of	O
oral	O
bacteria	O
.	O

Their	O
cytotoxicities	O
were	O
less	O
than	O
that	O
of	O
Bis	O
-	O
GMA	O
.	O

The	O
gingival	O
epithelium	O
plays	O
an	O
important	O
role	O
in	O
the	O
protection	O
of	O
oral	O
tissues	O
from	O
microbial	O
challenge	O
.	O

Oral	O
keratinocytes	O
form	O
various	O
cellular	O
contacts	O
,	O
including	O
tight	O
junctions	O
,	O
and	O
thus	O
are	O
able	O
to	O
create	O
an	O
epithelial	O
barrier	O
.	O

A	O
measurable	O
indicator	O
of	O
barrier	O
function	O
in	O
vitro	O
is	O
the	O
transepithelial	O
electrical	O
resistance	O
(	O
TER	O
)	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
is	O
recognized	O
as	O
a	O
major	O
aetiologic	O
agent	O
of	O
periodontal	O
disease	O
and	O
exhibits	O
a	O
variety	O
of	O
virulence	O
factors	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
,	O
in	O
vitro	O
,	O
of	O
infection	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
gingival	O
barriers	O
composed	O
of	O
primary	O
and	O
immortalized	O
human	O
keratinocytes	O
.	O

Primary	O
and	O
immortalized	O
human	O
gingival	O
keratinocytes	O
were	O
infected	O
with	O
different	O
strains	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

The	O
impact	O
of	O
the	O
bacterial	O
challenge	O
on	O
the	O
barrier	O
was	O
analysed	O
by	O
measuring	O
the	O
TER	O
.	O

The	O
destructive	O
effects	O
of	O
gingipains	O
were	O
blocked	O
by	O
specific	O
enzyme	O
inhibitors	O
.	O

After	O
an	O
initial	O
increase	O
of	O
about	O
20	O
-	O
30	O
%	O
in	O
infected	O
wells	O
,	O
the	O
TER	O
decreased	O
to	O
zero	O
.	O

Gingipain	O
inhibitors	O
delayed	O
the	O
destruction	O
of	O
the	O
barrier	O
by	O
12	O
+	O
/	O
-	O
4	O
h	O
.	O
In	O
all	O
cases	O
,	O
the	O
loss	O
of	O
TER	O
was	O
accelerated	O
if	O
the	O
system	O
was	O
infected	O
from	O
the	O
basolateral	O
side	O
.	O

A	O
distinct	O
effect	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
the	O
epithelial	O
barrier	O
function	O
of	O
three	O
-	O
dimensional	O
cultured	O
epithelial	O
cell	O
models	O
was	O
demonstrated	O
,	O
which	O
can	O
partly	O
be	O
attributed	O
to	O
the	O
activity	O
of	O
gingipains	O
.	O

Pneumonia	O
is	O
reported	O
to	O
be	O
associated	O
with	O
high	O
morbidity	O
in	O
elderly	O
and	O
compromised	O
individuals	O
,	O
with	O
poor	O
oral	O
health	O
demonstrated	O
to	O
be	O
a	O
significant	O
risk	O
factor	O
for	O
pneumonia	O
.	O

Several	O
opportunistic	O
pathogens	O
,	O
such	O
as	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
have	O
been	O
detected	O
in	O
patients	O
with	O
pneumonia	O
.	O

We	O
investigated	O
the	O
prevalence	O
of	O
opportunistic	O
pathogens	O
in	O
the	O
oral	O
cavity	O
of	O
healthy	O
independent	O
living	O
Japanese	O
elderly	O
subjects	O
and	O
analysed	O
factors	O
related	O
to	O
harbouring	O
those	O
pathogens	O
.	O

We	O
studied	O
265	O
subjects	O
,	O
each	O
of	O
whom	O
received	O
a	O
dental	O
examination	O
,	O
during	O
which	O
specimens	O
were	O
collected	O
with	O
a	O
tongue	O
swab	O
and	O
examined	O
for	O
the	O
presence	O
of	O
10	O
oral	O
opportunistic	O
pathogens	O
using	O
single	O
or	O
multiple	O
selective	O
media	O
.	O

Furthermore	O
,	O
the	O
presence	O
of	O
occult	O
blood	O
in	O
saliva	O
was	O
examined	O
using	O
test	O
paper	O
strips	O
.	O

Oral	O
opportunistic	O
pathogens	O
were	O
detected	O
in	O
13	O
.	O
6	O
%	O
of	O
the	O
subjects	O
.	O

Those	O
positive	O
for	O
occult	O
blood	O
in	O
saliva	O
had	O
a	O
significantly	O
higher	O
rate	O
of	O
harbouring	O
the	O
pathogens	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
addition	O
,	O
age	O
was	O
a	O
significant	O
factor	O
for	O
the	O
presence	O
of	O
pathogenic	O
microbes	O
in	O
the	O
oral	O
cavity	O
(	O
p	O
=	O
0	O
.	O
033	O
)	O
.	O

Positive	O
findings	O
of	O
occult	O
blood	O
in	O
saliva	O
and	O
older	O
age	O
are	O
suggested	O
to	O
be	O
significant	O
factors	O
for	O
harbouring	O
opportunistic	O
pathogens	O
in	O
the	O
oral	O
cavity	O
.	O

Data	O
concerning	O
treatment	O
outcomes	O
in	O
patients	O
with	O
generalized	O
aggressive	O
periodontitis	O
(	O
GAgP	O
)	O
are	O
limited	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
6	O
-	O
month	O
clinical	O
and	O
microbiologic	O
outcomes	O
of	O
the	O
one	O
-	O
stage	O
full	O
-	O
mouth	O
disinfection	O
(	O
OSFMD	O
)	O
in	O
the	O
management	O
of	O
patients	O
with	O
GAgP	O
.	O

Twenty	O
-	O
seven	O
patients	O
with	O
advanced	O
GAgP	O
were	O
included	O
in	O
this	O
prospective	O
follow	O
-	O
up	O
intervention	O
study	O
.	O

Clinical	O
and	O
microbiologic	O
parameters	O
were	O
collected	O
at	O
baseline	O
and	O
3	O
and	O
6	O
months	O
after	O
the	O
OSFMD	O
.	O

Patient	O
-	O
,	O
tooth	O
-	O
,	O
and	O
site	O
-	O
level	O
analyses	O
were	O
carried	O
out	O
.	O

Subgingival	O
samples	O
from	O
moderate	O
(	O
4	O
to	O
5	O
mm	O
)	O
and	O
deep	O
(	O
>	O
/	O
=	O
6	O
mm	O
)	O
pocket	O
sites	O
were	O
analyzed	O
using	O
a	O
polymerase	O
chain	O
reaction	O
for	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

The	O
OSFMD	O
resulted	O
in	O
significant	O
improvements	O
in	O
all	O
parameters	O
.	O

After	O
6	O
months	O
,	O
the	O
whole	O
-	O
mouth	O
probing	O
depth	O
(	O
PD	O
)	O
decreased	O
from	O
4	O
.	O
2	O
+	O
/	O
-	O
1	O
.	O
1	O
mm	O
to	O
2	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
6	O
mm	O
,	O
and	O
the	O
clinical	O
attachment	O
level	O
was	O
reduced	O
from	O
4	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
2	O
mm	O
to	O
3	O
.	O
4	O
+	O
/	O
-	O
1	O
.	O
1	O
mm	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

When	O
data	O
were	O
analyzed	O
based	O
on	O
the	O
frequency	O
distribution	O
of	O
PD	O
,	O
the	O
number	O
of	O
sites	O
with	O
PD	O
>	O
/	O
=	O
5	O
mm	O
decreased	O
by	O
61	O
%	O
from	O
baseline	O
values	O
,	O
and	O
mean	O
PD	O
reductions	O
of	O
1	O
.	O
5	O
and	O
2	O
.	O
5	O
mm	O
were	O
noted	O
in	O
moderate	O
and	O
deep	O
pockets	O
,	O
respectively	O
.	O

At	O
6	O
months	O
,	O
percentages	O
of	O
moderate	O
and	O
deep	O
sites	O
free	O
of	O
pathogens	O
were	O
40	O
%	O
and	O
27	O
%	O
,	O
respectively	O
.	O

The	O
OSFMD	O
may	O
be	O
a	O
viable	O
approach	O
to	O
deal	O
with	O
severe	O
GAgP	O
.	O

After	O
incubation	O
of	O
saliva	O
from	O
58	O
semi	O
-	O
bedridden	O
elderly	O
persons	O
,	O
the	O
cultures	O
were	O
identified	O
based	O
on	O
the	O
16S	O
rRNA	O
gene	O
base	O
sequence	O
to	O
compare	O
the	O
identification	O
by	O
the	O
conventional	O
culture	O
method	O
.	O

As	O
a	O
result	O
,	O
the	O
16S	O
rRNA	O
gene	O
base	O
sequence	O
of	O
198	O
strains	O
identified	O
by	O
the	O
culture	O
method	O
showed	O
98	O
.	O
5	O
%	O
or	O
more	O
homology	O
in	O
some	O
of	O
the	O
Human	O
Oral	O
Microbiome	O
database	O
,	O
and	O
the	O
identification	O
of	O
bacterial	O
species	O
and	O
genus	O
was	O
possible	O
.	O

When	O
an	O
organism	O
identified	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
was	O
compared	O
with	O
that	O
by	O
the	O
culture	O
method	O
,	O
the	O
concordance	O
rates	O
were	O
54	O
.	O
5	O
%	O
at	O
the	O
genus	O
level	O
and	O
35	O
.	O
9	O
%	O
at	O
the	O
species	O
level	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
strains	I-bacteria
most	O
frequently	O
isolated	O
from	O
saliva	O
that	O
were	O
identified	O
by	O
the	O
culture	O
method	O
were	O
identified	O
as	O
the	O
same	O
species	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
(	O
32	O
/	O
35	O
)	O
,	O
and	O
all	O
the	O
11	O
Streptococcus	B-bacteria
salivarius	I-bacteria
strains	I-bacteria
identified	O
by	O
the	O
culture	O
method	O
were	O
identified	O
as	O
the	O
same	O
species	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
.	O

All	O
the	O
strains	O
identified	O
as	O
Streptococcus	B-bacteria
anginosus	I-bacteria
group	O
by	O
the	O
culture	O
method	O
and	O
8	O
of	O
the	O
9	O
strains	O
identified	O
as	O
Prevotella	B-bacteria
species	I-bacteria
by	O
the	O
culture	O
method	O
were	O
identified	O
as	O
the	O
same	O
group	O
and	O
genus	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
.	O

When	O
an	O
oral	O
microbial	O
flora	O
test	O
with	O
saliva	O
samples	O
from	O
elderly	O
persons	O
is	O
performed	O
,	O
the	O
16S	O
rRNA	O
gene	O
sequence	O
identification	O
enables	O
us	O
to	O
identify	O
major	O
indigenous	O
bacteria	O
and	O
pathogenic	O
bacteria	O
and	O
is	O
considered	O
useful	O
as	O
a	O
means	O
of	O
supplementing	O
the	O
conventional	O
culture	O
method	O
.	O

The	O
focus	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
potential	O
use	O
of	O
the	O
predatoryO	O
bacteriaO	O
Bdellovibrio	O
bacteriovorus	O
and	O
Micavibrio	O
aeruginosavorus	O
to	O
control	O
the	O
pathogens	O
associated	O
with	O
human	O
infection	O
.	O

By	O
coculturing	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
109J	I-bacteria
and	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
ARL	I-bacteria
-	I-bacteria
13	I-bacteria
with	O
selected	O
pathogens	O
,	O
we	O
have	O
demonstrated	O
that	O
predatory	O
bacteria	O
are	O
able	O
to	O
attack	O
bacteria	O
from	O
the	O
genus	O
Acinetobacter	B-bacteria
,	O
Aeromonas	B-bacteria
,	O
Bordetella	B-bacteria
,	O
Burkholderia	B-bacteria
,	O
Citrobacter	B-bacteria
,	O
Enterobacter	B-bacteria
,	O
Escherichia	B-bacteria
,	O
Klebsiella	B-bacteria
,	O
Listonella	B-bacteria
,	O
Morganella	B-bacteria
,	O
Proteus	B-bacteria
,	O
Pseudomonas	B-bacteria
,	O
Salmonella	B-bacteria
,	O
Serratia	B-bacteria
,	O
Shigella	B-bacteria
,	O
Vibrio	B-bacteria
and	O
Yersinia	B-bacteria
.	O

Predation	O
was	O
measured	O
in	O
single	O
and	O
multispecies	O
microbial	O
cultures	O
as	O
well	O
as	O
on	O
monolayer	O
and	O
multilayer	O
preformed	O
biofilms	O
.	O

Additional	O
experiments	O
aimed	O
at	O
assessing	O
the	O
optimal	O
predation	O
characteristics	O
of	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
demonstrated	O
that	O
the	O
predator	O
is	O
able	O
to	O
prey	O
at	O
temperatures	O
of	O
25	O
-	O
37	O
degrees	O
C	O
but	O
is	O
unable	O
to	O
prey	O
under	O
oxygen	O
-	O
limiting	O
conditions	O
.	O

In	O
addition	O
,	O
an	O
increase	O
in	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
ARL	I-bacteria
-	I-bacteria
13	I-bacteria
prey	O
range	O
was	O
also	O
observed	O
.	O

Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
and	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
have	O
an	O
ability	O
to	O
prey	O
and	O
reduce	O
many	O
of	O
the	O
multidrug	O
-	O
resistant	O
pathogens	O
associated	O
with	O
human	O
infection	O
.	O

Infectious	O
complications	O
caused	O
by	O
micro	O
-	O
organisms	O
that	O
have	O
become	O
resistant	O
to	O
drug	O
therapy	O
are	O
an	O
increasing	O
problem	O
in	O
medicine	O
,	O
with	O
more	O
infections	O
becoming	O
difficult	O
to	O
treat	O
using	O
traditional	O
antimicrobial	O
agents	O
.	O

The	O
work	O
presented	O
here	O
highlights	O
the	O
potential	O
use	O
of	O
predatory	O
bacteria	O
as	O
a	O
biological	O
-	O
based	O
agent	O
for	O
eradicating	O
multidrug	O
-	O
resistant	O
bacteria	O
,	O
with	O
the	O
hope	O
of	O
paving	O
the	O
way	O
for	O
future	O
studies	O
in	O
animal	O
models	O
.	O

During	O
the	O
past	O
few	O
years	O
there	O
has	O
been	O
a	O
global	O
spread	O
of	O
resistant	O
gram	O
-	O
negative	O
bacteria	O
that	O
are	O
insensitive	O
to	O
cephalosporins	O
and	O
carbapenems	O
.	O

Extended	O
spectrum	O
beta	O
-	O
lactamase	O
(	O
ESBL	O
)	O
-	O
producing	O
bacteria	O
are	O
capable	O
of	O
inactivating	O
the	O
newest	O
generation	O
of	O
cephalosporins	O
.	O

It	O
is	O
notable	O
that	O
ESBL	O
-	O
producing	O
bacteria	O
are	O
found	O
predominantly	O
outside	O
the	O
hospital	O
situation	O
in	O
the	O
environment	O
,	O
in	O
food	O
and	O
in	O
meat	O
products	O
,	O
which	O
leads	O
to	O
the	O
presumption	O
that	O
the	O
food	O
chain	O
is	O
contributing	O
to	O
the	O
rapid	O
spread	O
of	O
these	O
bacteria	O
.	O

Several	O
types	O
of	O
carbapenemase	O
-	O
producing	O
bacteria	O
have	O
been	O
distinguished	O
,	O
of	O
which	O
the	O
'	O
New	O
Delhi	O
metallo	O
beta	O
-	O
lactamase	O
1	O
(	O
NDM	O
-	O
1	O
)	O
'	O
type	O
seems	O
to	O
be	O
prevalent	O
in	O
Asia	O
outside	O
the	O
hospital	O
situation	O
in	O
the	O
community	O
,	O
and	O
is	O
now	O
being	O
transmitted	O
to	O
other	O
continents	O
as	O
a	O
result	O
of	O
migration	O
and	O
tourism	O
.	O

With	O
the	O
rise	O
of	O
ESBL	O
-	O
and	O
carbapenemase	O
-	O
producing	O
gram	O
-	O
negative	O
bacteria	O
(	O
which	O
are	O
also	O
often	O
resistant	O
to	O
most	O
other	O
antibiotics	O
)	O
comes	O
the	O
very	O
real	O
concern	O
that	O
treatment	O
of	O
infections	O
such	O
as	O
urinary	O
tract	O
infections	O
that	O
are	O
currently	O
simple	O
to	O
treat	O
with	O
common	O
oral	O
antibiotics	O
will	O
be	O
problematic	O
in	O
the	O
future	O
.	O

The	O
widespread	O
use	O
of	O
antibiotics	O
in	O
animal	O
husbandry	O
is	O
an	O
important	O
factor	O
in	O
the	O
problem	O
of	O
antibiotic	O
resistance	O
.	O

Since	O
economic	O
motives	O
are	O
of	O
importance	O
,	O
a	O
coordinated	O
approach	O
from	O
many	O
parties	O
concerned	O
will	O
be	O
necessary	O
,	O
not	O
just	O
from	O
the	O
medical	O
sector	O
but	O
also	O
from	O
the	O
veterinary	O
and	O
agricultural	O
world	O
,	O
and	O
from	O
food	O
producers	O
and	O
pharmaceutical	O
companies	O
to	O
combat	O
the	O
spread	O
of	O
multiresistant	O
gram	O
-	O
negative	O
bacteria	O
effectively	O
.	O

The	O
placement	O
of	O
cadavers	O
in	O
shallow	O
,	O
clandestine	O
graves	O
may	O
alter	O
the	O
microbial	O
and	O
geochemical	O
composition	O
of	O
the	O
underlying	O
and	O
adjacent	O
soils	O
.	O

Using	O
amplicon	O
length	O
heterogeneity	O
-	O
PCR	O
(	O
LH	O
-	O
PCR	O
)	O
the	O
microbial	O
community	O
changes	O
in	O
these	O
soils	O
can	O
be	O
assessed	O
.	O

In	O
this	O
investigation	O
,	O
nine	O
different	O
grave	O
sites	O
were	O
examined	O
over	O
a	O
period	O
of	O
16weeks	O
.	O

The	O
results	O
indicated	O
that	O
measurable	O
changes	O
occurred	O
in	O
the	O
soil	O
bacterial	O
community	O
during	O
the	O
decomposition	O
process	O
.	O

In	O
this	O
study	O
,	O
amplicons	O
corresponding	O
to	O
anaerobic	O
bacteria	O
,	O
not	O
indigenous	O
to	O
the	O
soil	O
,	O
were	O
shown	O
to	O
produce	O
differences	O
between	O
grave	O
sites	O
and	O
control	O
soils	O
.	O

Among	O
the	O
bacteria	O
linked	O
to	O
these	O
amplicons	O
are	O
those	O
that	O
are	O
most	O
often	O
part	O
of	O
the	O
commensal	O
flora	O
of	O
the	O
intestines	O
,	O
mouth	O
and	O
skin	O
.	O

In	O
addition	O
,	O
over	O
the	O
16week	O
sampling	O
interval	O
,	O
the	O
level	O
of	O
indicator	O
organisms	O
(	O
i	O
.	O
e	O
.	O
,	O
nitrogen	O
fixing	O
bacteria	O
)	O
dropped	O
as	O
the	O
body	O
decomposed	O
and	O
after	O
four	O
weeks	O
of	O
environmental	O
exposure	O
they	O
began	O
to	O
increase	O
again	O
;	O
thus	O
differences	O
in	O
the	O
abundance	O
of	O
nitrogen	O
fixing	O
bacteria	O
were	O
also	O
found	O
to	O
contribute	O
to	O
the	O
variation	O
between	O
controls	O
and	O
grave	O
soils	O
.	O

These	O
results	O
were	O
verified	O
using	O
primers	O
that	O
specifically	O
targeted	O
the	O
nifH	O
gene	O
coding	O
for	O
nitrogenase	O
reductase	O
.	O

LH	O
-	O
PCR	O
provides	O
a	O
fast	O
,	O
robust	O
and	O
reproducible	O
method	O
to	O
measure	O
microbial	O
changes	O
in	O
soil	O
and	O
could	O
be	O
used	O
to	O
determine	O
potential	O
cadaveric	O
contact	O
in	O
a	O
given	O
area	O
.	O

The	O
results	O
obtained	O
with	O
this	O
method	O
could	O
ultimately	O
provide	O
leads	O
to	O
investigators	O
in	O
criminal	O
or	O
missing	O
person	O
scenarios	O
and	O
allow	O
for	O
further	O
analysis	O
using	O
human	O
specific	O
DNA	O
assays	O
to	O
establish	O
the	O
identity	O
of	O
the	O
buried	O
body	O
.	O

Internalin	O
A	O
(	O
InlA	O
)	O
is	O
a	O
critical	O
virulence	O
factor	O
which	O
mediates	O
the	O
initiation	O
of	O
Listeria	B-bacteria
monocytogenes	I-bacteria
infection	O
by	O
the	O
oral	O
route	O
in	O
permissive	O
hosts	O
.	O

The	O
interaction	O
of	O
InlA	O
with	O
the	O
host	O
cell	O
ligand	O
E	O
-	O
cadherin	O
efficiently	O
stimulates	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
entry	O
into	O
human	O
enterocytes	O
,	O
but	O
has	O
only	O
a	O
limited	O
interaction	O
with	O
murine	O
cells	O
.	O

We	O
have	O
created	O
a	O
surface	O
display	O
library	O
of	O
randomly	O
mutated	O
InlA	O
in	O
a	O
non	O
-	O
invasive	O
heterologous	O
host	O
Lactococcus	B-bacteria
lactis	I-bacteria
in	O
order	O
to	O
create	O
and	O
screen	O
novel	O
variants	O
of	O
this	O
invasion	O
factor	O
.	O

After	O
sequential	O
passage	O
through	O
a	O
murine	O
cell	O
line	O
(	O
CT	O
-	O
26	O
)	O
,	O
multiple	O
clones	O
with	O
enhanced	O
invasion	O
characteristics	O
were	O
identified	O
.	O

Competitive	O
index	O
experiments	O
were	O
conducted	O
in	O
mice	O
using	O
selected	O
mutations	O
introduced	O
into	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
EGD	O
-	O
e	O
background	O
.	O

A	O
novel	O
single	O
amino	O
acid	O
change	O
was	O
identified	O
which	O
enhanced	O
virulence	O
by	O
the	O
oral	O
route	O
in	O
the	O
murine	O
model	O
and	O
will	O
form	O
the	O
basis	O
of	O
further	O
engineering	O
approaches	O
.	O

As	O
a	O
control	O
a	O
previously	O
described	O
EGD	O
-	O
InlA	O
(	O
m	O
)	O
murinized	O
strain	O
was	O
also	O
re	O
-	O
created	O
as	O
part	O
of	O
this	O
study	O
with	O
minor	O
modifications	O
and	O
designated	O
EGD	O
-	O
e	O
InlA	O
(	O
m	O
)	O
*	O
.	O

The	O
strain	O
was	O
created	O
using	O
a	O
procedure	O
that	O
minimizes	O
the	O
likelihood	O
of	O
secondary	O
mutations	O
and	O
incorporates	O
Listeria	B-bacteria
-	O
optimized	O
codons	O
encoding	O
the	O
altered	O
amino	O
acids	O
.	O

L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
EGD	O
-	O
e	O
InlA	O
(	O
m	O
)	O
*	O
yielded	O
consistently	O
higher	O
level	O
murine	O
infections	O
by	O
the	O
oral	O
route	O
when	O
compared	O
to	O
EGD	O
-	O
e	O
,	O
but	O
did	O
not	O
display	O
the	O
two	O
-	O
fold	O
increased	O
invasion	O
into	O
a	O
human	O
cell	O
line	O
that	O
was	O
previously	O
described	O
for	O
the	O
EGD	O
-	O
InlA	O
(	O
m	O
)	O
strain	O
.	O

We	O
have	O
used	O
both	O
site	O
-	O
directed	O
mutagenesis	O
and	O
directed	O
evolution	O
to	O
create	O
variants	O
of	O
InlA	O
which	O
may	O
inform	O
future	O
structure	O
-	O
function	O
analyses	O
of	O
this	O
protein	O
.	O

During	O
the	O
course	O
of	O
the	O
study	O
we	O
engineered	O
a	O
murinized	O
strain	O
of	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
EGD	O
-	O
e	O
which	O
shows	O
reproducibly	O
higher	O
infectivity	O
in	O
the	O
intragastric	O
murine	O
infection	O
model	O
than	O
the	O
wild	O
type	O
,	O
but	O
does	O
not	O
display	O
enhanced	O
entry	O
into	O
human	O
cells	O
as	O
previously	O
observed	O
.	O

This	O
murinized	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
strain	I-bacteria
will	O
provide	O
a	O
useful	O
tool	O
for	O
the	O
analysis	O
of	O
the	O
gastrointestinal	O
phase	O
of	O
listeriosis	O
.	O

Is	O
low	O
-	O
concentration	O
chlorhexidine	O
effective	O
against	O
reducing	O
the	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
in	O
saliva	O
?	O

To	O
compare	O
the	O
efficacy	O
of	O
different	O
concentrations	O
of	O
chlorhexidine	O
mouth	O
rinses	O
,	O
i	O
.	O
e	O
.	O

0	O
.	O
02	O
%	O
,	O
0	O
.	O
06	O
%	O
and	O
0	O
.	O
12	O
%	O
,	O
in	O
reducing	O
the	O
mutants	B-bacteria
streptococci	I-bacteria
count	O
in	O
saliva	O
.	O

Forty	O
subjects	O
in	O
the	O
age	O
group	O
of	O
12	O
-	O
14	O
years	O
were	O
selected	O
from	O
the	O
schools	O
of	O
Chennai	O
and	O
were	O
equally	O
divided	O
into	O
four	O
groups	O
.	O

The	O
first	O
three	O
were	O
study	O
groups	O
and	O
the	O
fourth	O
group	O
was	O
the	O
control	O
group	O
.	O

The	O
subjects	O
were	O
instructed	O
to	O
rinse	O
with	O
a	O
measured	O
amount	O
of	O
mouth	O
rinse	O
for	O
1	O
min	O
,	O
twice	O
-	O
daily	O
,	O
for	O
1	O
week	O
.	O

Salivary	O
samples	O
were	O
collected	O
at	O
baseline	O
and	O
1	O
week	O
after	O
mouth	O
rinsing	O
with	O
various	O
concentrations	O
and	O
were	O
cultured	O
on	O
MSB	O
agar	O
.	O

The	O
number	O
of	O
MS	B-bacteria
colonies	O
was	O
counted	O
on	O
agar	O
medium	O
under	O
anaerobic	O
conditions	O
.	O

The	O
results	O
of	O
the	O
study	O
confirmed	O
that	O
children	O
using	O
chlorhexidine	O
of	O
concentration	O
0	O
.	O
12	O
%	O
showed	O
the	O
maximum	O
reduction	O
in	O
MS	B-bacteria
when	O
compared	O
with	O
subjects	O
using	O
0	O
.	O
02	O
%	O
and	O
0	O
.	O
06	O
%	O
concentrations	O
.	O

But	O
,	O
children	O
using	O
chlorhexidine	O
of	O
concentration	O
0	O
.	O
06	O
%	O
also	O
showed	O
significant	O
reduction	O
in	O
MS	B-bacteria
when	O
compared	O
with	O
the	O
control	O
group	O
.	O

From	O
the	O
above	O
study	O
,	O
we	O
conclude	O
that	O
chlorhexidine	O
used	O
in	O
different	O
concentrations	O
(	O
0	O
.	O
02	O
%	O
,	O
0	O
.	O
06	O
%	O
,	O
0	O
.	O
12	O
%	O
)	O
efficiently	O
reduced	O
the	O
mutans	O
count	O
.	O

Probiotic	O
technology	O
represents	O
a	O
breakthrough	O
approach	O
to	O
maintaining	O
oral	O
health	O
by	O
utilizing	O
natural	O
beneficial	O
bacteria	O
commonly	O
found	O
in	O
healthy	O
mouths	O
to	O
provide	O
a	O
natural	O
defense	O
against	O
those	O
bacteria	O
thought	O
to	O
be	O
harmful	O
to	O
teeth	O
and	O
gums	O
.	O

However	O
,	O
data	O
are	O
still	O
sparse	O
on	O
the	O
probiotic	O
action	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
review	O
article	O
on	O
probiotics	O
in	O
children	O
published	O
by	O
Twetman	O
and	O
Stecksen	O
-	O
Blicks	O
in	O
2008	O
showed	O
only	O
one	O
study	O
of	O
dental	O
interest	O
on	O
probiotics	O
in	O
children	O
.	O

The	O
present	O
study	O
evaluated	O
clinically	O
the	O
efficacy	O
of	O
a	O
probiotic	O
and	O
chlorhexidine	O
mouth	O
rinses	O
on	O
plaque	O
and	O
gingival	O
accumulation	O
in	O
children	O
.	O

The	O
trial	O
design	O
is	O
a	O
double	O
-	O
blind	O
parallel	O
group	O
,	O
14	O
days	O
comparative	O
study	O
between	O
a	O
probiotic	O
mouth	O
rinse	O
and	O
a	O
chlorhexidine	O
mouth	O
rinse	O
,	O
which	O
included	O
45	O
healthy	O
children	O
in	O
the	O
age	O
group	O
of	O
6	O
-	O
8	O
years	O
.	O

The	O
Probiotic	O
and	O
Chlorhexidine	O
groups	O
had	O
less	O
plaque	O
accumulations	O
compared	O
with	O
the	O
Control	O
group	O
at	O
the	O
end	O
of	O
14	O
years	O
(	O
P	O
<	O
0	O
.	O
001	O
and	O
P	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
.	O

But	O
,	O
unlike	O
the	O
plaque	O
score	O
,	O
there	O
was	O
a	O
significant	O
difference	O
in	O
the	O
Gingival	O
Index	O
between	O
the	O
Probiotic	O
and	O
the	O
Chlorhexidine	O
groups	O
(	O
P	O
=	O
0	O
.	O
009	O
)	O
,	O
Probiotic	O
group	O
being	O
better	O
than	O
the	O
Chlorhexidine	O
group	O
(	O
mean	O
=	O
0	O
.	O
2300	O
and	O
0	O
.	O
6805	O
,	O
respectively	O
)	O
.	O

The	O
Probiotic	O
mouth	O
rinse	O
was	O
found	O
effective	O
in	O
reducing	O
plaque	O
accumulation	O
and	O
gingival	O
inflammation	O
.	O

Therefore	O
,	O
probiotic	O
mouth	O
rinse	O
obviously	O
has	O
a	O
potential	O
therapeutic	O
value	O
and	O
further	O
long	O
-	O
term	O
study	O
is	O
recommended	O
to	O
determine	O
its	O
efficacy	O
.	O

To	O
compare	O
the	O
use	O
of	O
the	O
Halimeter	O
and	O
the	O
Oral	O
Chroma	O
to	O
assess	O
the	O
ability	O
of	O
common	O
oral	O
anaerobic	O
bacteria	O
isolated	O
from	O
the	O
Kuwaiti	O
population	O
to	O
produce	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
.	O

Broth	O
cultures	O
of	O
common	O
anaerobes	O
isolated	O
from	O
supragingival	O
plaque	O
were	O
centrifuged	O
and	O
pellets	O
resuspended	O
in	O
phosphate	O
buffer	O
(	O
pH	O
7	O
.	O
7	O
)	O
with	O
an	O
optical	O
density	O
OD	O
(	O
550	O
)	O
of	O
0	O
.	O
3	O
.	O

100	O
mul	O
of	O
this	O
suspension	O
and	O
870	O
mul	O
of	O
buffer	O
were	O
added	O
in	O
2	O
sterile	O
15	O
-	O
ml	O
head	O
space	O
vials	O
.	O

Reaction	O
was	O
initiated	O
by	O
addition	O
of	O
30	O
mul	O
of	O
33	O
mML	O
-	O
methionine	O
and	O
L	O
-	O
cysteine	O
,	O
respectively	O
,	O
in	O
each	O
vial	O
and	O
incubation	O
at	O
37	O
degrees	O
C	O
for	O
90	O
min	O
.	O

500	O
mul	O
of	O
3	O
M	O
phosphoric	O
acid	O
was	O
added	O
to	O
tubes	O
and	O
was	O
kept	O
aside	O
for	O
10	O
min	O
.	O

Production	O
of	O
VSCs	O
was	O
measured	O
using	O
the	O
Halimeter	O
and	O
the	O
Oral	O
Chroma	O
.	O

The	O
major	O
VSC	O
producers	O
identified	O
by	O
both	O
Halimeter	O
and	O
Oral	O
Chroma	O
with	O
L	O
-	O
cystenine	O
as	O
substrate	O
were	O
Campylobacter	B-bacteria
ureolyticus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Gemella	B-bacteria
morbillorum	I-bacteria
.	O

The	O
concentrations	O
of	O
hydrogen	O
sulfide	O
recorded	O
by	O
both	O
Halimeter	O
and	O
Oral	O
Chroma	O
were	O
essentially	O
identical	O
.	O

With	O
L	O
-	O
methionine	O
as	O
substrate	O
,	O
both	O
Halimeter	O
and	O
Oral	O
Chroma	O
identified	O
different	O
complements	O
of	O
anaerobes	O
with	O
C	B-bacteria
.	I-bacteria
ureolyticus	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
as	O
major	O
VSC	O
producers	O
.	O

The	O
concentrations	O
of	O
methyl	O
mercaptan	O
recorded	O
by	O
the	O
Halimeter	O
were	O
lower	O
compared	O
to	O
those	O
assessed	O
by	O
the	O
Oral	O
Chroma	O
.	O

The	O
results	O
suggest	O
that	O
the	O
Oral	O
Chroma	O
may	O
produce	O
a	O
more	O
comprehensive	O
assessment	O
of	O
VSC	O
production	O
by	O
oral	O
microflora	O
than	O
the	O
Halimeter	O
.	O

The	O
aim	O
of	O
the	O
present	O
pilot	O
study	O
was	O
to	O
investigate	O
the	O
microbial	O
profile	O
in	O
saliva	O
and	O
supragingival	O
plaque	O
samples	O
collected	O
from	O
caries	O
-	O
active	O
adolescents	O
before	O
and	O
after	O
a	O
daily	O
short	O
-	O
term	O
intake	O
of	O
milk	O
supplemented	O
with	O
the	O
probiotic	O
bacteria	O
.	O

The	O
present	O
study	O
group	O
consisted	O
of	O
18	O
caries	O
-	O
active	O
adolescents	O
of	O
both	O
sexes	O
who	O
volunteered	O
for	O
participation	O
giving	O
an	O
informed	O
consent	O
.	O

The	O
study	O
has	O
a	O
randomised	O
placebo	O
-	O
controlled	O
double	O
-	O
blind	O
pilot	O
design	O
with	O
two	O
parallel	O
arms	O
.	O

After	O
a	O
2	O
-	O
week	O
run	O
-	O
in	O
period	O
,	O
the	O
subjects	O
were	O
instructed	O
to	O
drink	O
2	O
.	O
5	O
dl	O
of	O
milk	O
supplemented	O
with	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
LB21	I-bacteria
(	O
107	O
CFU	O
/	O
ml	O
)	O
(	O
test	O
)	O
or	O
standard	O
control	O
milk	O
(	O
placebo	O
)	O
once	O
daily	O
for	O
a	O
period	O
of	O
2	O
weeks	O
(	O
intervention	O
period	O
)	O
.	O

Samples	O
of	O
stimulated	O
whole	O
saliva	O
and	O
supragingival	O
plaque	O
were	O
collected	O
at	O
baseline	O
(	O
after	O
run	O
-	O
in	O
)	O
and	O
immediately	O
after	O
the	O
end	O
of	O
the	O
intervention	O
period	O
(	O
follow	O
-	O
up	O
)	O
.	O

The	O
salivary	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
were	O
estimated	O
by	O
conventional	O
culturing	O
on	O
selective	O
agar	O
plates	O
.	O

The	O
presence	O
and	O
level	O
of	O
19	O
oral	O
species	O
associated	O
with	O
the	O
caries	O
process	O
were	O
determined	O
using	O
the	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridisation	O
technique	O
.	O

Differences	O
between	O
the	O
groups	O
were	O
assessed	O
using	O
the	O
non	O
-	O
parametric	O
Wilcoxon	O
-	O
Mann	O
-	O
Whitney	O
and	O
chi	O
-	O
square	O
tests	O
.	O

The	O
mean	O
caries	O
experience	O
was	O
high	O
with	O
an	O
average	O
of	O
7	O
.	O
0	O
+	O
/	O
-	O
3	O
.	O
8	O
proximal	O
enamel	O
lesions	O
.	O

The	O
most	O
prevalent	O
dominating	O
species	O
in	O
the	O
plaque	O
samples	O
were	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Veillonella	B-bacteria
parvula	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

The	O
saliva	O
samples	O
displayed	O
a	O
more	O
mixed	O
profile	O
,	O
with	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
and	O
Lactobacillus	B-bacteria
curvata	I-bacteria
being	O
frequently	O
identified	O
species	O
.	O

All	O
of	O
the	O
subjects	O
harboured	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
their	O
saliva	O
,	O
with	O
61	O
%	O
of	O
them	O
colonised	O
with	O
salivary	O
lactobacilli	B-bacteria
.	O

No	O
statistically	O
significant	O
differences	O
in	O
the	O
microbial	O
profiles	O
or	O
the	O
estimated	O
counts	O
between	O
the	O
baseline	O
and	O
follow	O
-	O
up	O
samples	O
,	O
or	O
between	O
the	O
two	O
study	O
groups	O
,	O
were	O
observed	O
.	O

The	O
present	O
study	O
showed	O
that	O
a	O
short	O
-	O
term	O
daily	O
intake	O
of	O
milk	O
supplemented	O
with	O
the	O
probiotic	O
bacterium	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
LB21	I-bacteria
did	O
not	O
significantly	O
affect	O
the	O
microbial	O
profiles	O
or	O
the	O
levels	O
of	O
caries	O
-	O
associated	O
bacteria	O
in	O
saliva	O
and	O
supragingival	O
plaque	O
samples	O
collected	O
from	O
caries	O
-	O
active	O
adolescents	O
.	O

The	O
antibacterial	O
activity	O
of	O
Coffea	O
canephora	O
extract	O
was	O
evaluated	O
in	O
vitro	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
.	O

The	O
viability	O
of	O
planktonic	O
cells	O
was	O
analysed	O
by	O
susceptibility	O
tests	O
(	O
MIC	O
and	O
MBC	O
)	O
and	O
time	O
-	O
kill	O
assays	O
.	O

The	O
effect	O
of	O
the	O
extract	O
on	O
dental	O
demineralisation	O
was	O
also	O
investigated	O
.	O

Primary	O
1st	O
molar	O
fragments	O
(	O
n	O
=	O
24	O
)	O
were	O
inoculated	O
with	O
a	O
saliva	O
pool	O
and	O
sustained	O
in	O
a	O
multiple	O
plaque	O
growth	O
system	O
for	O
10	O
days	O
to	O
form	O
biofilm	O
.	O

The	O
biofilm	O
was	O
treated	O
with	O
light	O
roasted	O
C	O
.	O
canephora	O
extract	O
at	O
20	O
%	O
,	O
Milli	O
-	O
Q	O
water	O
(	O
negative	O
control	O
)	O
and	O
chlorhexidine	O
(	O
positive	O
control	O
)	O
once	O
a	O
day	O
,	O
during	O
a	O
week	O
.	O

Blank	O
controls	O
comprised	O
fragments	O
without	O
treatment	O
.	O

biofilm	O
pH	O
was	O
monitored	O
in	O
the	O
last	O
day	O
of	O
treatment	O
.	O

Changes	O
in	O
tooth	O
mineralisation	O
were	O
assessed	O
by	O
cross	O
-	O
sectional	O
microhardness	O
(	O
CSMH	O
)	O
test	O
.	O

MIC	O
and	O
MBC	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
7	O
+	O
/	O
-	O
2	O
mg	O
/	O
mL	O
and	O
160	O
+	O
/	O
-	O
0	O
mg	O
/	O
mL	O
,	O
respectively	O
,	O
showing	O
no	O
activity	O
for	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
.	O

The	O
extract	O
produced	O
a	O
4	O
-	O
log	O
reduction	O
in	O
the	O
number	O
of	O
colonies	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
after	O
3	O
-	O
h	O
treatment	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
with	O
undiluted	O
extract	O
(	O
20	O
%	O
)	O
and	O
MBC	O
concentration	O
(	O
16	O
%	O
)	O
.	O

There	O
was	O
no	O
difference	O
among	O
negative	O
/	O
blank	O
controls	O
and	O
coffee	O
plaque	O
pH	O
.	O

Differences	O
between	O
CSMH	O
values	O
of	O
dental	O
fragments	O
subjected	O
to	O
the	O
coffee	O
extract	O
and	O
to	O
chlorhexidine	O
were	O
not	O
significant	O
.	O

At	O
depths	O
up	O
to	O
30	O
mum	O
from	O
the	O
enamel	O
surface	O
,	O
coffee	O
extract	O
and	O
chlorhexidine	O
promoted	O
higher	O
CSMH	O
values	O
when	O
compared	O
to	O
blank	O
/	O
negative	O
controls	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Our	O
data	O
suggest	O
that	O
light	O
roasted	O
C	O
.	O
canephora	O
extract	O
is	O
beneficial	O
as	O
an	O
anticariogenic	O
substance	O
.	O

To	O
evaluate	O
the	O
antimicrobial	O
efficacies	O
of	O
two	O
toothpaste	O
formulations	O
containing	O
natural	O
antimicrobials	O
(	O
herbal	O
extracts	O
and	O
chitosan	O
)	O
against	O
oral	O
biofilms	O
of	O
different	O
composition	O
and	O
maturational	O
status	O
.	O

Bacteria	O
from	O
a	O
buffer	O
suspension	O
or	O
fresh	O
saliva	O
were	O
adhered	O
for	O
2h	O
to	O
a	O
salivary	O
conditioning	O
film	O
and	O
subsequently	O
grown	O
for	O
16h	O
.	O

Dual	O
-	O
species	O
biofilms	O
were	O
prepared	O
from	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
-	I-bacteria
J1	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
J22	I-bacteria
,	O
whilst	O
multi	O
-	O
species	O
biofilms	O
were	O
grown	O
from	O
freshly	O
collected	O
human	O
saliva	O
.	O

Biofilms	O
were	O
exposed	O
to	O
25wt	O
%	O
toothpaste	O
supernatants	O
.	O

A	O
chlorhexidine	O
-	O
containing	O
mouthrinse	O
and	O
a	O
buffer	O
were	O
used	O
as	O
positive	O
-	O
and	O
negative	O
-	O
controls	O
,	O
respectively	O
.	O

Antibacterial	O
efficacy	O
was	O
concluded	O
from	O
acute	O
killing	O
,	O
bacterial	O
removal	O
,	O
prevention	O
of	O
bacterial	O
re	O
-	O
deposition	O
and	O
continued	O
killing	O
during	O
re	O
-	O
deposition	O
.	O

The	O
herbal	O
-	O
and	O
chitosan	O
-	O
based	O
supernatants	O
showed	O
immediate	O
killing	O
of	O
oral	O
biofilm	O
bacteria	O
,	O
comparable	O
with	O
chlorhexidine	O
.	O

Moreover	O
,	O
exposure	O
of	O
a	O
biofilm	O
to	O
these	O
supernatants	O
or	O
chlorhexidine	O
,	O
yielded	O
ongoing	O
killing	O
of	O
biofilm	O
bacteria	O
after	O
exposure	O
during	O
re	O
-	O
deposition	O
of	O
bacteria	O
to	O
a	O
matured	O
16h	O
biofilm	O
,	O
but	O
not	O
to	O
a	O
much	O
thinner	O
initial	O
biofilm	O
formed	O
by	O
2h	O
adhesion	O
only	O
.	O

This	O
suggests	O
that	O
thicker	O
,	O
more	O
matured	O
biofilms	O
can	O
absorb	O
and	O
release	O
oral	O
antimicrobials	O
.	O

Supernatants	O
based	O
on	O
herbal	O
-	O
and	O
chitosan	O
-	O
based	O
toothpastes	O
have	O
comparable	O
immediate	O
and	O
ongoing	O
antibacterial	O
efficacies	O
as	O
chlorhexidine	O
.	O

Natural	O
antimicrobials	O
and	O
chlorhexidine	O
absorb	O
in	O
oral	O
biofilms	O
which	O
contributes	O
to	O
their	O
substantive	O
action	O
.	O

The	O
composition	O
of	O
oral	O
microbiota	O
in	O
comatose	O
patients	O
remains	O
uncertain	O
.	O

Some	O
pulmonary	O
pathogens	O
may	O
be	O
found	O
in	O
dental	O
biofilms	O
or	O
as	O
part	O
of	O
the	O
saliva	O
microbiota	O
.	O

It	O
is	O
supposed	O
that	O
some	O
pneumopathogenic	O
microorganisms	O
may	O
overgrow	O
in	O
the	O
mouths	O
of	O
comatose	O
patients	O
and	O
spread	O
to	O
their	O
lungs	O
.	O

The	O
oral	O
colonization	O
dynamics	O
of	O
staphylococci	B-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
yeasts	O
in	O
nine	O
comatose	O
patients	O
(	O
group	O
1	O
)	O
,	O
and	O
in	O
12	O
conscious	O
patients	O
that	O
brushed	O
their	O
teeth	O
at	O
least	O
twice	O
a	O
day	O
(	O
group	O
2	O
)	O
was	O
evaluated	O
.	O

Both	O
groups	O
were	O
followed	O
up	O
for	O
7	O
days	O
after	O
hospitalization	O
.	O

Daily	O
samples	O
of	O
saliva	O
were	O
obtained	O
,	O
dispersed	O
and	O
plated	O
on	O
selective	O
culture	O
media	O
and	O
colony	O
forming	O
units	O
of	O
each	O
microbial	O
group	O
were	O
obtained	O
.	O

For	O
patients	O
in	O
group	O
1	O
,	O
the	O
counts	O
of	O
total	O
viable	O
bacteria	O
,	O
staphylococci	B-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
yeasts	O
progressively	O
increased	O
in	O
a	O
time	O
-	O
dependant	O
manner	O
.	O

For	O
the	O
conscious	O
patients	O
of	O
group	O
2	O
,	O
there	O
was	O
no	O
increase	O
.	O

It	O
would	O
appear	O
that	O
concomitant	O
consciousness	O
and	O
brushing	O
teeth	O
are	O
determinants	O
in	O
controlling	O
the	O
selected	O
pneumopathogen	O
counts	O
in	O
resting	O
saliva	O
.	O

The	O
increase	O
in	O
microbial	O
counts	O
in	O
comatose	O
patients	O
is	O
understandable	O
because	O
these	O
microorganisms	O
could	O
spread	O
to	O
the	O
lungs	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
is	O
associated	O
with	O
numerous	O
gastroduodenal	O
diseases	O
.	O

The	O
oral	O
cavity	O
could	O
be	O
a	O
potential	O
extragastric	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
and	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
might	O
cause	O
gastric	O
reinfection	O
after	O
the	O
eradication	O
therapy	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
of	O
patients	O
with	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
and	O
to	O
examine	O
the	O
effectiveness	O
of	O
the	O
eradication	O
therapy	O
against	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
stomach	O
and	O
in	O
the	O
oral	O
cavity	O
.	O

Fifty	O
-	O
six	O
patients	O
with	O
chronic	O
periodontitis	O
and	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
were	O
enrolled	O
in	O
the	O
study	O
.	O

Gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
determined	O
using	O
(	O
13	O
)	O
C	O
-	O
urea	O
breath	O
test	O
before	O
and	O
3	O
months	O
after	O
eradication	O
therapy	O
.	O

The	O
presence	O
of	O
the	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
assessed	O
using	O
polymerase	O
chain	O
reaction	O
before	O
and	O
3	O
months	O
after	O
eradication	O
therapy	O
.	O

The	O
1	O
-	O
week	O
eradication	O
therapy	O
consisted	O
of	O
amoxycilin	O
1	O
g	O
,	O
clarithromycin	O
500	O
mg	O
,	O
and	O
proton	O
pump	O
inhibitor	O
20	O
mg	O
twice	O
a	O
day	O
.	O

Of	O
56	O
subjects	O
with	O
gastric	O
infection	O
,	O
23	O
(	O
41	O
.	O
1	O
%	O
)	O
harbored	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

Eradication	O
rate	O
in	O
stomach	O
was	O
78	O
.	O
3	O
%	O
,	O
whereas	O
in	O
the	O
oral	O
cavity	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
detected	O
from	O
any	O
sample	O
after	O
the	O
eradication	O
therapy	O
.	O

Almost	O
half	O
of	O
the	O
patients	O
with	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
harbored	O
the	O
bacterium	O
in	O
the	O
oral	O
cavity	O
.	O

After	O
the	O
eradication	O
therapy	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
detected	O
in	O
the	O
oral	O
cavity	O
,	O
what	O
suggests	O
high	O
effectiveness	O
of	O
the	O
therapy	O
protocol	O
in	O
the	O
oral	O
cavity	O
,	O
or	O
it	O
is	O
possible	O
that	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
is	O
of	O
a	O
transient	O
character	O
.	O

Leprosy	O
is	O
an	O
important	O
health	O
problem	O
in	O
Brazil	O
despite	O
extensive	O
use	O
of	O
multidrug	O
therapy	O
.	O

The	O
nasal	O
mucosa	O
is	O
the	O
preferential	O
site	O
of	O
entry	O
and	O
exit	O
of	O
Mycobacterium	B-bacteria
leprae	I-bacteria
,	O
and	O
although	O
lesions	O
have	O
been	O
found	O
in	O
the	O
oral	O
mucosa	O
,	O
its	O
potential	O
involvement	O
in	O
the	O
transmission	O
of	O
leprosy	O
bacilli	O
has	O
never	O
been	O
investigated	O
.	O

We	O
investigated	O
the	O
presence	O
of	O
the	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
DNA	O
in	O
buccal	O
swabs	O
of	O
leprosy	O
patients	O
(	O
334	O
)	O
and	O
household	O
contacts	O
(	O
1288	O
)	O
through	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
and	O
correlated	O
this	O
with	O
clinical	O
and	O
laboratorial	O
evaluations	O
.	O

The	O
overall	O
positivity	O
for	O
patients	O
and	O
contacts	O
was	O
18	O
.	O
26	O
%	O
and	O
6	O
.	O
83	O
%	O
,	O
respectively	O
.	O

Subclinical	O
infection	O
among	O
contacts	O
was	O
considered	O
when	O
PCR	O
and	O
anti	O
-	O
PGL	O
-	O
1	O
ELISA	O
presented	O
positive	O
results	O
.	O

This	O
study	O
provides	O
evidence	O
that	O
the	O
oral	O
mucosa	O
may	O
be	O
a	O
secondary	O
site	O
of	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
transmission	O
and	O
infection	O
,	O
and	O
contacts	O
with	O
bacillary	O
DNA	O
may	O
be	O
actively	O
involved	O
in	O
transmission	O
.	O

We	O
have	O
also	O
shown	O
that	O
bacilli	O
DNA	O
is	O
more	O
frequently	O
found	O
in	O
the	O
oral	O
mucosa	O
of	O
PB	O
patients	O
.	O

Our	O
findings	O
have	O
great	O
epidemiological	O
relevance	O
and	O
indicate	O
an	O
additional	O
strategy	O
for	O
leprosy	O
control	O
programmes	O
and	O
dental	O
clinics	O
.	O

In	O
the	O
oral	O
cavity	O
,	O
chronic	O
inflammation	O
has	O
been	O
observed	O
at	O
various	O
stages	O
of	O
oral	O
squamous	O
cell	O
carcinomas	O
(	O
OSCC	O
)	O
.	O

Such	O
inflammation	O
could	O
result	O
from	O
persistent	O
mucosal	O
or	O
epithelial	O
cell	O
colonization	O
by	O
microorganisms	O
.	O

There	O
is	O
increasing	O
evidence	O
of	O
the	O
involvement	O
of	O
oral	O
bacteria	O
in	O
inflammation	O
,	O
warranting	O
further	O
studies	O
on	O
the	O
association	O
of	O
bacteria	O
with	O
the	O
progression	O
of	O
OSCC	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
diversity	O
and	O
relative	O
abundance	O
of	O
bacteria	O
in	O
the	O
saliva	O
of	O
subjects	O
with	O
OSCC	O
.	O

Using	O
454	O
parallel	O
DNA	O
sequencing	O
,	O
approximately	O
58	O
,	O
000	O
PCR	O
amplicons	O
that	O
span	O
the	O
V4	O
-	O
V5	O
hypervariable	O
region	O
of	O
rRNAs	O
from	O
five	O
subjects	O
were	O
sequenced	O
.	O

Members	O
of	O
eight	O
phyla	O
(	O
divisions	O
)	O
of	O
bacteria	O
were	O
detected	O
.	O

The	O
majority	O
of	O
classified	O
sequences	O
belonged	O
to	O
the	O
phyla	O
Firmicutes	B-bacteria
(	O
45	O
%	O
)	O
and	O
Bacteroidetes	B-bacteria
(	O
25	O
%	O
)	O
.	O

Further	O
,	O
52	O
different	O
genera	O
containing	O
approximately	O
860	O
(	O
16	O
.	O
51	O
%	O
)	O
known	O
species	O
were	O
identified	O
and	O
1077	O
(	O
67	O
%	O
)	O
sequences	O
belonging	O
to	O
various	O
uncultured	O
bacteria	O
or	O
unclassified	O
groups	O
.	O

The	O
species	O
diversity	O
estimates	O
obtained	O
with	O
abundance	O
-	O
based	O
coverage	O
estimators	O
and	O
Chao1	O
were	O
greater	O
than	O
published	O
analyses	O
of	O
other	O
microbial	O
profiles	O
from	O
the	O
oral	O
cavity	O
.	O

Fifteen	O
unique	O
phylotypes	O
were	O
present	O
in	O
all	O
three	O
OSCC	O
subjects	O
.	O

Periodontal	O
disease	O
is	O
associated	O
with	O
specific	O
periodontal	O
pathogens	O
and	O
may	O
persist	O
as	O
gingivitis	O
or	O
progress	O
to	O
more	O
severe	O
disease	O
.	O

The	O
bacteria	O
involved	O
in	O
disease	O
initiation	O
and	O
progression	O
have	O
not	O
been	O
identified	O
.	O

We	O
used	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
to	O
compare	O
the	O
levels	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
total	O
bacteria	O
detected	O
by	O
different	O
sampling	O
methods	O
.	O

On	O
the	O
basis	O
of	O
the	O
results	O
of	O
clinical	O
examinations	O
,	O
57	O
patients	O
were	O
divided	O
into	O
3	O
groups	O
:	O
healthy	O
group	O
(	O
group	O
A	O
)	O
,	O
gingivitis	O
group	O
(	O
group	O
B	O
)	O
,	O
and	O
periodontitis	O
group	O
(	O
group	O
C	O
)	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
saliva	O
,	O
mouthwash	O
,	O
and	O
by	O
paper	O
-	O
point	O
sampling	O
of	O
gingival	O
crevicular	O
fluid	O
(	O
GCF	O
)	O
,	O
and	O
the	O
samples	O
were	O
analyzed	O
with	O
quantitative	O
PCR	O
targeting	O
16S	O
rRNA	O
.	O

The	O
numbers	O
of	O
total	O
bacteria	O
in	O
samples	O
of	O
GCF	O
,	O
saliva	O
,	O
and	O
mouthwash	O
were	O
10	O
(	O
5	O
)	O
to	O
10	O
(	O
6	O
)	O
,	O
10	O
(	O
8	O
)	O
,	O
and	O
10	O
(	O
7	O
)	O
,	O
respectively	O
,	O
per	O
milliliter	O
.	O

The	O
number	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
GCF	O
samples	O
was	O
lower	O
than	O
10	O
in	O
group	O
A	O
;	O
however	O
,	O
in	O
groups	O
B	O
and	O
C	O
,	O
the	O
values	O
were	O
10	O
(	O
3	O
)	O
and	O
10	O
(	O
4	O
)	O
,	O
respectively	O
,	O
indicating	O
that	O
the	O
number	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
increased	O
with	O
worsening	O
clinical	O
status	O
.	O

Findings	O
were	O
similar	O
in	O
the	O
samples	O
of	O
saliva	O
and	O
mouthwash	O
.	O

The	O
numbers	O
of	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
showed	O
a	O
pattern	O
similar	O
to	O
that	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
all	O
3	O
samples	O
.	O

These	O
results	O
suggest	O
that	O
saliva	O
and	O
mouthwash	O
samples	O
are	O
clinically	O
useful	O
for	O
bacterial	O
testing	O
of	O
periodontal	O
diseases	O
by	O
quantitative	O
PCR	O
.	O

In	O
addition	O
,	O
mouthwash	O
sampling	O
is	O
more	O
feasible	O
and	O
straightforward	O
than	O
saliva	O
sampling	O
.	O

The	O
epithelial	O
cell	O
barrier	O
is	O
the	O
first	O
line	O
of	O
host	O
defense	O
against	O
bacterial	O
aggression	O
in	O
periodontal	O
sites	O
.	O

In	O
view	O
of	O
the	O
fact	O
that	O
oral	O
epithelial	O
cells	O
do	O
not	O
express	O
membrane	O
CD14	O
and	O
that	O
high	O
levels	O
of	O
the	O
soluble	O
form	O
of	O
the	O
CD14	O
receptor	O
have	O
been	O
detected	O
in	O
the	O
gingival	O
crevicular	O
fluid	O
of	O
patients	O
with	O
periodontitis	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
recombinant	O
soluble	O
CD14	O
(	O
rsCD14	O
)	O
,	O
alone	O
and	O
in	O
combination	O
with	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
lipopolysaccharide	O
(	O
LPS	O
)	O
on	O
the	O
inflammatory	O
response	O
of	O
human	O
oral	O
epithelial	O
cells	O
.	O

The	O
oral	O
epithelial	O
cell	O
line	O
GMSM	O
-	O
K	O
was	O
stimulated	O
with	O
rsCD14	O
,	O
alone	O
or	O
in	O
combination	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
LPS	O
,	O
and	O
the	O
levels	O
of	O
the	O
inflammatory	O
mediators	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
5	O
(	O
CCL5	O
)	O
were	O
determined	O
using	O
ELISAs	O
.	O

Activation	O
of	O
the	O
transcription	O
factors	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
and	O
activator	O
protein	O
-	O
1	O
was	O
also	O
monitored	O
using	O
ELISAs	O
.	O

rsCD14	O
significantly	O
induced	O
the	O
secretion	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
CCL5	O
by	O
oral	O
epithelial	O
cells	O
.	O

The	O
combination	O
of	O
rsCD14	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
LPS	O
augmented	O
this	O
effect	O
.	O

Activation	O
of	O
the	O
NF	O
-	O
kappaB	O
pathway	O
was	O
significantly	O
increased	O
in	O
epithelial	O
cells	O
treated	O
with	O
rsCD14	O
compared	O
with	O
a	O
nonstimulated	O
control	O
,	O
whereas	O
there	O
was	O
no	O
effect	O
on	O
the	O
activation	O
of	O
activator	O
protein	O
-	O
1	O
.	O

rsCD14	O
stimulated	O
the	O
inflammation	O
cascade	O
in	O
oral	O
epithelial	O
cells	O
,	O
both	O
alone	O
or	O
when	O
associated	O
with	O
bacterial	O
LPS	O
,	O
through	O
an	O
NF	O
-	O
kappaB	O
-	O
dependent	O
pathway	O
.	O

This	O
suggests	O
that	O
the	O
presence	O
of	O
soluble	O
CD14	O
in	O
periodontitis	O
lesions	O
may	O
contribute	O
to	O
the	O
inflammatory	O
process	O
of	O
periodontal	O
disease	O
.	O

Periodontal	O
diseases	O
are	O
multifactorial	O
infections	O
elicited	O
by	O
a	O
complex	O
of	O
primarily	O
gram	O
-	O
negative	O
bacteria	O
that	O
interact	O
with	O
host	O
tissues	O
and	O
lead	O
to	O
the	O
destruction	O
of	O
the	O
periodontal	O
structures	O
.	O

Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
is	O
a	O
gram	O
-	O
negative	O
bacterium	O
that	O
preys	O
upon	O
other	O
gram	O
-	O
negative	O
bacteria	O
.	O

It	O
was	O
previously	O
shown	O
that	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
has	O
an	O
ability	O
to	O
attack	O
and	O
remove	O
surface	O
-	O
attached	O
bacteria	O
or	O
biofilms	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
host	O
specificity	O
of	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
strain	I-bacteria
109J	I-bacteria
and	O
its	O
ability	O
to	O
prey	O
on	O
oral	O
pathogens	O
associated	O
with	O
periodontitis	O
,	O
including	O
;	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
.	O

We	O
further	O
demonstrated	O
that	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
109J	I-bacteria
has	O
an	O
ability	O
to	O
remove	O
biofilms	O
of	O
Ei	B-bacteria
.	I-bacteria
corrodens	I-bacteria
as	O
well	O
as	O
biofilms	O
composed	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
was	O
able	O
to	O
remove	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
biofilms	O
developed	O
on	O
hydroxyapatite	O
surfaces	O
and	O
in	O
the	O
presence	O
of	O
saliva	O
,	O
as	O
well	O
as	O
to	O
detach	O
metabolically	O
inactive	O
biofilms	O
.	O

Experiments	O
aimed	O
at	O
enhancing	O
the	O
biofilm	O
removal	O
aptitude	O
of	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
with	O
the	O
aid	O
of	O
extracellular	O
-	O
polymeric	O
-	O
substance	O
-	O
degrading	O
enzymes	O
demonstrated	O
that	O
proteinase	O
-	O
K	O
inhibits	O
predation	O
.	O

However	O
,	O
treating	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
biofilms	O
with	O
DspB	O
,	O
a	O
poly	O
-	O
N	O
-	O
acetylglucosamine	O
(	O
PGA	O
)	O
-	O
hydrolysing	O
enzyme	O
,	O
increased	O
biofilm	O
removal	O
.	O

Increased	O
biofilm	O
removal	O
was	O
also	O
recorded	O
when	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
PGA	O
-	O
defective	O
mutants	O
were	O
used	O
as	O
host	O
cells	O
,	O
suggesting	O
that	O
PGA	O
degradation	O
could	O
enhance	O
the	O
removal	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
biofilm	O
by	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
.	O

Recently	O
,	O
the	O
predation	O
of	O
Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
on	O
a	O
periodontal	O
pathogen	O
has	O
been	O
described	O
.	O

The	O
current	O
study	O
explores	O
the	O
potential	O
antimicrobial	O
activity	O
of	O
a	O
range	O
of	O
predatory	O
bacteria	O
against	O
key	O
periodontal	O
pathogens	O
.	O

A	O
number	O
of	O
representatives	O
from	O
the	O
Bdellovibrio	B-bacteria
,	O
Bacteriovorax	B-bacteria
and	O
Peredibacter	B-bacteria
lineages	O
(	O
called	O
'	O
BALOs	O
'	O
)	O
were	O
tested	O
for	O
their	O
activity	O
towards	O
a	O
group	O
of	O
key	O
periodontal	O
pathogens	O
and	O
an	O
optimal	O
multiplicity	O
of	O
infection	O
was	O
established	O
.	O

As	O
the	O
oral	O
cavity	O
contains	O
a	O
wide	O
variety	O
of	O
bacteria	O
that	O
are	O
not	O
preyed	O
upon	O
,	O
it	O
was	O
investigated	O
if	O
they	O
can	O
have	O
an	O
effect	O
on	O
the	O
predation	O
efficiency	O
of	O
BALOs	O
.	O

It	O
was	O
concluded	O
that	O
a	O
number	O
of	O
important	O
variables	O
involved	O
in	O
bacterial	O
predation	O
are	O
found	O
to	O
be	O
compatible	O
with	O
the	O
composition	O
of	O
the	O
oral	O
microbiota	O
.	O

This	O
finding	O
makes	O
the	O
case	O
for	O
continued	O
study	O
of	O
the	O
potential	O
for	O
BALOs	O
to	O
combat	O
periodontal	O
pathogens	O
.	O

Oral	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
are	O
the	O
major	O
commensal	O
bacteria	O
of	O
the	O
supragingival	O
oral	O
biofilm	O
and	O
have	O
been	O
detected	O
in	O
human	O
atheromatous	O
plaque	O
.	O

Atherosclerosis	O
involves	O
an	O
ongoing	O
inflammatory	O
response	O
,	O
reportedly	O
involving	O
chronic	O
infection	O
caused	O
by	O
multiple	O
pathogens	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
invasion	O
of	O
human	O
aortic	O
endothelial	O
cells	O
(	O
HAECs	O
)	O
by	O
oral	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
and	O
the	O
subsequent	O
cytokine	O
production	O
by	O
viable	O
invaded	O
HAECs	O
.	O

The	O
invasion	O
of	O
HAECs	O
by	O
bacteria	O
was	O
examined	O
using	O
antibiotic	O
protection	O
assays	O
and	O
was	O
visualized	O
by	O
confocal	O
scanning	O
laser	O
microscopy	O
.	O

The	O
inhibitory	O
effects	O
of	O
catalase	O
and	O
cytochalasin	O
D	O
on	O
the	O
invasion	O
of	O
HAECs	O
were	O
also	O
examined	O
.	O

The	O
production	O
of	O
cytokines	O
by	O
invaded	O
or	O
infected	O
HAECs	O
was	O
determined	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
,	O
and	O
a	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
method	O
was	O
used	O
to	O
evaluate	O
the	O
expression	O
of	O
cytokine	O
messenger	O
RNA	O
.	O

The	O
oral	O
streptococci	B-bacteria
tested	O
were	O
capable	O
of	O
invading	O
HAECs	O
.	O

The	O
number	O
of	O
invasive	O
bacteria	O
increased	O
with	O
the	O
length	O
of	O
the	O
co	O
-	O
culture	O
period	O
.	O

After	O
a	O
certain	O
co	O
-	O
culture	O
period	O
,	O
some	O
organisms	O
were	O
cytotoxic	O
to	O
the	O
HAECs	O
.	O

Catalase	O
and	O
cytochalasin	O
D	O
inhibited	O
the	O
invasion	O
of	O
HAECs	O
by	O
the	O
organism	O
.	O

HAECs	O
invaded	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
Xc	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
DL1	I-bacteria
(	O
Challis	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
ATCC	I-bacteria
10558	I-bacteria
and	O
Streptococcus	B-bacteria
salivarius	I-bacteria
ATCC	I-bacteria
13419	I-bacteria
produced	O
more	O
cytokine	O
(	O
s	O
)	O
(	O
interleukin	O
-	O
6	O
,	O
interleukin	O
-	O
8	O
,	O
monocyte	O
chemoattractant	O
protein	O
-	O
1	O
)	O
than	O
non	O
-	O
invaded	O
HAECs	O
.	O

The	O
HAECs	O
invaded	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
Xc	I-bacteria
produced	O
the	O
largest	O
amounts	O
of	O
cytokines	O
,	O
and	O
the	O
messenger	O
RNA	O
expression	O
of	O
cytokines	O
by	O
invaded	O
HAECs	O
increased	O
markedly	O
compared	O
with	O
that	O
by	O
non	O
-	O
invaded	O
HAECs	O
.	O

These	O
results	O
suggest	O
that	O
oral	O
streptococci	B-bacteria
may	O
participate	O
in	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
.	O

The	O
human	O
oral	O
microbial	O
biota	O
represents	O
a	O
highly	O
diverse	O
biofilm	O
.	O

Twenty	O
-	O
five	O
species	O
of	O
oral	O
streptococci	B-bacteria
inhabit	O
the	O
human	O
oral	O
cavity	O
and	O
represent	O
about	O
20	O
%	O
of	O
the	O
total	O
oral	O
bacteria	O
.	O

Taxonomy	O
of	O
these	O
bacteria	O
is	O
complex	O
and	O
remains	O
provisional	O
.	O

Oral	O
streptococci	B-bacteria
encompass	O
friends	O
and	O
foes	O
bacteria	O
.	O

Each	O
species	O
has	O
developed	O
specific	O
properties	O
for	O
colonizing	O
the	O
different	O
oral	O
sites	O
subjected	O
to	O
constantly	O
changing	O
conditions	O
,	O
for	O
competing	O
against	O
competitors	O
,	O
and	O
for	O
resisting	O
external	O
agressions	O
(	O
host	O
immune	O
system	O
,	O
physico	O
-	O
chemical	O
shocks	O
,	O
and	O
mechanical	O
frictions	O
)	O
.	O

Imbalance	O
in	O
the	O
indigenous	O
microbial	O
biota	O
generates	O
oral	O
diseases	O
,	O
and	O
under	O
proper	O
conditions	O
,	O
commensal	O
streptococci	B-bacteria
can	O
switch	O
to	O
opportunistic	O
pathogens	O
that	O
initiate	O
disease	O
in	O
and	O
damage	O
to	O
the	O
host	O
.	O

The	O
group	O
of	O
`	O
`	O
mutans	B-bacteria
streptococci	I-bacteria
'	O
'	O
was	O
described	O
as	O
the	O
most	O
important	O
bacteria	O
related	O
to	O
the	O
formation	O
of	O
dental	O
caries	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
although	O
naturally	O
present	O
among	O
the	O
human	O
oral	O
microbiota	O
,	O
is	O
the	O
microbial	O
species	O
most	O
strongly	O
associated	O
with	O
carious	O
lesions	O
.	O

This	O
minireview	O
describes	O
the	O
oral	O
streptococci	B-bacteria
ecology	O
and	O
their	O
biofilm	O
life	O
style	O
by	O
focusing	O
on	O
the	O
mutans	O
group	O
,	O
mainly	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Virulence	O
traits	O
,	O
interactions	O
in	O
the	O
biofilm	O
,	O
and	O
influence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
dental	O
caries	O
etiology	O
are	O
discussed	O
.	O

Some	O
gastrointestinal	O
bacteria	O
synthesize	O
hydrogen	O
(	O
H	O
(	O
2	O
)	O
)	O
by	O
fermentation	O
.	O

Despite	O
the	O
presence	O
of	O
bactericidal	O
factors	O
in	O
human	O
saliva	O
,	O
a	O
large	O
number	O
of	O
bacteria	O
also	O
live	O
in	O
the	O
oral	O
cavity	O
.	O

It	O
has	O
never	O
been	O
shown	O
that	O
oral	O
bacteria	O
also	O
produce	O
H	O
(	O
2	O
)	O
or	O
what	O
role	O
H	O
(	O
2	O
)	O
might	O
play	O
in	O
the	O
oral	O
cavity	O
.	O

It	O
was	O
found	O
that	O
a	O
significant	O
amount	O
of	O
H	O
(	O
2	O
)	O
is	O
synthesized	O
in	O
the	O
oral	O
cavity	O
of	O
healthy	O
human	O
subjects	O
,	O
and	O
that	O
its	O
generation	O
is	O
enhanced	O
by	O
the	O
presence	O
of	O
glucose	O
but	O
inhibited	O
by	O
either	O
teeth	O
brushing	O
or	O
sterilization	O
with	O
povidone	O
iodine	O
.	O

These	O
observations	O
suggest	O
the	O
presence	O
of	O
H	O
(	O
2	O
)	O
-	O
generating	O
bacteria	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
screening	O
of	O
commensal	O
bacteria	O
in	O
the	O
oral	O
cavity	O
revealed	O
that	O
a	O
variety	O
of	O
anaerobic	O
bacteria	O
generate	O
H	O
(	O
2	O
)	O
.	O

Among	O
them	O
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
(	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
)	O
generated	O
significantly	O
large	O
amounts	O
of	O
H	O
(	O
2	O
)	O
in	O
the	O
presence	O
of	O
glucose	O
.	O

Biochemical	O
analysis	O
revealed	O
that	O
various	O
proteins	O
in	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
are	O
carbonylated	O
under	O
standard	O
culture	O
conditions	O
,	O
and	O
that	O
oxidative	O
stress	O
induced	O
by	O
the	O
presence	O
of	O
Fe	O
(	O
+	O
+	O
)	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
increases	O
the	O
number	O
of	O
carbonylated	O
proteins	O
,	O
particularly	O
when	O
their	O
hydrogenase	O
activity	O
is	O
inhibited	O
by	O
KCN	O
.	O

Inhibition	O
of	O
H	O
(	O
2	O
)	O
generation	O
markedly	O
suppresses	O
the	O
growth	O
of	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
.	O

These	O
observations	O
suggest	O
that	O
H	O
(	O
2	O
)	O
generation	O
and	O
/	O
or	O
the	O
reduction	O
of	O
oxidative	O
stress	O
is	O
important	O
for	O
the	O
survival	O
and	O
growth	O
of	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

The	O
oral	O
cavity	O
is	O
a	O
specialized	O
ecosystem	O
composed	O
of	O
dentition	O
and	O
mucosa	O
exposed	O
to	O
the	O
effects	O
of	O
saliva	O
and	O
gingival	O
liquid	O
.	O

Its	O
structure	O
provides	O
advantageous	O
conditions	O
for	O
various	O
microorganisms	O
,	O
both	O
aerobic	O
streptococci	B-bacteria
and	O
anaerobic	O
bacilli	O
.	O

The	O
dynamic	O
balance	O
of	O
the	O
oral	O
cavity	O
ecosystem	O
can	O
be	O
threatened	O
by	O
various	O
factors	O
.	O

Lip	O
and	O
palatal	O
clefts	O
are	O
the	O
most	O
frequent	O
disorders	O
in	O
embryonic	O
facial	O
development	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
whether	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
and	O
oral	O
cavity	O
hygiene	O
in	O
patients	O
with	O
cleft	O
palate	O
treated	O
orthodontically	O
are	O
significantly	O
different	O
compared	O
with	O
patients	O
without	O
these	O
congenital	O
malformations	O
.	O

The	O
study	O
group	O
consisted	O
of	O
200	O
patients	O
aged	O
6	O
-	O
21	O
who	O
were	O
divided	O
into	O
two	O
groups	O
depending	O
on	O
the	O
presence	O
of	O
cleft	O
palate	O
and	O
treatment	O
method	O
.	O

Group	O
C	O
(	O
control	O
)	O
consisted	O
of	O
50	O
orthodontically	O
untreated	O
patients	O
with	O
occlusal	O
dental	O
defects	O
.	O

The	O
performed	O
studies	O
consisted	O
of	O
2	O
parts	O
:	O
the	O
clinical	O
-	O
laboratory	O
part	O
and	O
statistical	O
analysis	O
.	O

Clinical	O
-	O
laboratory	O
part	O
High	O
bacteria	O
levels	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
in	O
saliva	O
of	O
patients	O
were	O
comparably	O
frequent	O
between	O
groups	O
,	O
but	O
there	O
were	O
statistically	O
significant	O
differences	O
in	O
inter	O
-	O
group	O
comparisons	O
.	O

As	O
the	O
orthodontic	O
treatment	O
changes	O
the	O
oral	O
environment	O
,	O
control	O
of	O
proper	O
hygienic	O
behavior	O
is	O
an	O
essential	O
element	O
of	O
health	O
education	O
.	O

Introduction	O
of	O
preventive	O
programs	O
is	O
also	O
very	O
important	O
.	O

The	O
oral	O
cavity	O
contains	O
the	O
greatest	O
biodiversity	O
,	O
over	O
70	O
species	O
being	O
isolated	O
from	O
mouth	O
mucosa	O
,	O
saliva	O
,	O
denture	O
surfaces	O
and	O
/	O
or	O
dental	O
-	O
plaque	O
.	O

The	O
oral	O
streptococci	B-bacteria
,	O
representing	O
over	O
80	O
%	O
of	O
the	O
mouth	O
micro	O
flora	O
,	O
are	O
able	O
to	O
synthesize	O
glucosyl	O
-	O
transferases	O
,	O
enzymes	O
involved	O
in	O
glucans	O
production	O
.	O

Glucans	O
are	O
involved	O
in	O
production	O
of	O
an	O
extracellular	O
slime	O
layer	O
promoting	O
adhesion	O
and	O
formation	O
of	O
a	O
dental	O
plaque	O
biofilm	O
.	O

The	O
43	O
isolates	O
studied	O
obtained	O
from	O
partially	O
and	O
/	O
or	O
totally	O
edentulous	O
,	O
were	O
identified	O
by	O
VITEK	O
system	O
using	O
gram	O
-	O
positive	O
identification	O
cards	O
.	O

Species	O
-	O
specific	O
regions	O
within	O
the	O
genes	O
coding	O
for	O
glucosyl	O
-	O
transferases	O
(	O
gtf	O
genes	O
)	O
were	O
targeted	O
for	O
PCR	O
identification	O
of	O
isolates	O
.	O

Sequencing	O
of	O
16S	O
rRNA	O
was	O
used	O
as	O
gold	O
standard	O
for	O
strain	O
confirmation	O
.	O

system	O
identified	O
a	O
number	O
of	O
11	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
/	I-bacteria
oralis	I-bacteria
,	O
12	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
/	I-bacteria
gordonii	I-bacteria
,	O
12	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
/	I-bacteria
parasanguinis	I-bacteria
,	O
3	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
3	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
plurianimalium	I-bacteria
,	O
1	O
strain	O
as	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
and	O
1	O
strain	O
as	O
S	B-bacteria
.	I-bacteria
alactolyticus	I-bacteria
,	O
respectively	O
.	O

The	O
PCR	O
system	O
targeting	O
gtf	O
genes	O
was	O
able	O
to	O
identify	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
strains	I-bacteria
.	O

Sequence	O
of	O
16S	O
rRNA	O
discriminated	O
among	O
streptococci	B-bacteria
species	I-bacteria
and	O
revealed	O
16	O
strains	O
of	O
Leuconostoc	B-bacteria
mesenteroides	I-bacteria
.	O

Many	O
studies	O
are	O
needed	O
in	O
order	O
to	O
select	O
the	O
most	O
reliable	O
phenotypic	O
and	O
genotypic	O
methods	O
in	O
order	O
to	O
improve	O
the	O
identification	O
algorithm	O
for	O
oral	O
streptococci	B-bacteria
used	O
by	O
clinical	O
laboratories	O
.	O

Their	O
accurate	O
identification	O
is	O
mandatory	O
for	O
better	O
understanding	O
their	O
role	O
in	O
human	O
infections	O
.	O

Streptococcus	B-bacteria
sanguinis	I-bacteria
is	O
a	O
member	O
of	O
oral	O
streptococci	B-bacteria
and	O
one	O
of	O
the	O
most	O
abundant	O
species	O
found	O
in	O
oral	O
biofilm	O
called	O
dental	O
plaque	O
.	O

Colonization	O
of	O
the	O
oral	O
streptococci	B-bacteria
on	O
the	O
tooth	O
surface	O
depends	O
on	O
the	O
adhesion	O
of	O
bacteria	O
to	O
salivary	O
components	O
adsorbed	O
to	O
the	O
tooth	O
surface	O
.	O

Recently	O
,	O
we	O
identified	O
unique	O
cell	O
surface	O
long	O
filamentous	O
structures	O
named	O
pili	O
in	O
this	O
species	O
.	O

Herein	O
,	O
we	O
investigated	O
the	O
role	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
pili	O
in	O
biofilm	O
formation	O
.	O

We	O
found	O
that	O
pili	O
-	O
deficient	O
mutant	O
,	O
in	O
which	O
the	O
genes	O
encoding	O
the	O
three	O
pilus	O
proteins	O
PilA	O
,	O
PilB	O
and	O
PilC	O
have	O
been	O
deleted	O
,	O
showed	O
an	O
impaired	O
bacterial	O
accumulation	O
on	O
saliva	O
-	O
coated	O
surfaces	O
.	O

Confocal	O
microscopic	O
observations	O
suggested	O
that	O
the	O
mutant	O
was	O
incapable	O
of	O
producing	O
typical	O
three	O
-	O
dimensional	O
layer	O
of	O
biofilm	O
.	O

Ligand	O
blot	O
analysis	O
showed	O
that	O
the	O
ancillary	O
pilus	O
proteins	O
PilB	O
and	O
PilC	O
bound	O
to	O
human	O
whole	O
saliva	O
.	O

Additional	O
analysis	O
demonstrated	O
that	O
PilC	O
bound	O
to	O
multiple	O
salivary	O
components	O
,	O
and	O
one	O
of	O
which	O
was	O
found	O
to	O
be	O
salivary	O
alpha	O
-	O
amylase	O
.	O

These	O
results	O
indicate	O
that	O
pilus	O
proteins	O
are	O
members	O
of	O
saliva	O
-	O
binding	O
proteins	O
of	O
oral	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
and	O
suggest	O
the	O
involvement	O
of	O
pili	O
in	O
its	O
colonization	O
on	O
saliva	O
-	O
coated	O
tooth	O
surfaces	O
and	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Capnocytophaga	B-bacteria
canimorsus	I-bacteria
is	O
a	O
potentially	O
pathogenic	O
microorganism	O
when	O
transmitted	O
to	O
humans	O
from	O
the	O
oral	O
cavity	O
of	O
canines	O
.	O

Although	O
there	O
is	O
some	O
knowledge	O
about	O
the	O
frequency	O
of	O
occurrence	O
in	O
canines	O
,	O
it	O
is	O
uncertain	O
whether	O
there	O
is	O
a	O
correlation	O
between	O
its	O
occurrence	O
and	O
lifestyle	O
,	O
health	O
,	O
or	O
breed	O
of	O
dog	O
.	O

Samples	O
of	O
tooth	O
plaque	O
from	O
a	O
total	O
of	O
131	O
canines	O
were	O
collected	O
,	O
cultured	O
on	O
selective	O
media	O
,	O
and	O
tested	O
using	O
physiological	O
and	O
molecular	O
analyses	O
to	O
help	O
discern	O
the	O
presence	O
of	O
C	B-bacteria
.	I-bacteria
canimorsus	I-bacteria
.	O

Phylogenetic	O
analyses	O
determined	O
that	O
49	O
.	O
2	O
%	O
of	O
canines	O
sampled	O
carried	O
a	O
species	O
of	O
Capnocytophaga	B-bacteria
and	O
21	O
.	O
7	O
%	O
of	O
the	O
canines	O
sampled	O
in	O
this	O
study	O
carried	O
C	B-bacteria
.	I-bacteria
canimorsus	I-bacteria
.	O

Statistical	O
analyses	O
found	O
that	O
male	O
dogs	O
and	O
those	O
that	O
are	O
neutered	O
and	O
spayed	O
are	O
more	O
likely	O
to	O
host	O
Capnocytophaga	B-bacteria
species	I-bacteria
.	O

The	O
data	O
also	O
suggested	O
that	O
breed	O
was	O
a	O
statistically	O
significant	O
predictor	O
of	O
C	B-bacteria
.	I-bacteria
canimorsus	I-bacteria
,	O
with	O
the	O
smaller	O
breeds	O
more	O
likely	O
to	O
carry	O
the	O
potential	O
pathogen	O
.	O

In	O
addition	O
,	O
three	O
`	O
`	O
human	O
'	O
'	O
species	O
of	O
Capnocytophaga	B-bacteria
;	O
C	B-bacteria
.	I-bacteria
ochracea	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
haemolytica	I-bacteria
,	O
and	O
one	O
isolate	O
of	O
either	O
C	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
C	B-bacteria
.	I-bacteria
granulosa	I-bacteria
were	O
cultured	O
from	O
five	O
canines	O
.	O

Sixteen	O
canines	O
sampled	O
carried	O
an	O
unidentified	O
Capnocytophaga	B-bacteria
species	I-bacteria
,	O
with	O
the	O
sequences	O
from	O
all	O
isolates	O
forming	O
a	O
well	O
-	O
defined	O
phylogenetic	O
clade	O
with	O
100	O
%	O
bootstrap	O
support	O
that	O
may	O
well	O
represent	O
a	O
new	O
species	O
of	O
Capnocytophaga	B-bacteria
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
the	O
principal	O
etiologic	O
agents	O
of	O
caries	O
decay	O
of	O
teeth	O
,	O
are	O
generally	O
acquired	O
in	O
oral	O
cavity	O
at	O
the	O
moment	O
of	O
tooth	O
eruption	O
.	O

However	O
,	O
as	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
has	O
been	O
detected	O
in	O
oral	O
cavity	O
of	O
predentate	O
children	O
,	O
the	O
eruption	O
of	O
teeth	O
seems	O
not	O
to	O
be	O
a	O
necessary	O
prerequisite	O
,	O
suggesting	O
that	O
this	O
species	O
may	O
be	O
not	O
confined	O
to	O
dental	O
plaque	O
.	O

Here	O
,	O
we	O
evaluate	O
the	O
ability	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
in	O
planktonic	O
and	O
biofilm	O
lifestyle	O
to	O
adhere	O
,	O
invade	O
and	O
survive	O
within	O
human	O
gingival	O
fibroblast	O
(	O
HGF	O
-	O
1	O
)	O
cells	O
.	O

Planktonic	O
and	O
biofilm	O
streptococci	B-bacteria
adhered	O
and	O
invaded	O
host	O
cells	O
to	O
different	O
extents	O
,	O
showing	O
higher	O
efficiencies	O
of	O
biofilm	O
than	O
planktonic	O
counterparts	O
.	O

Moreover	O
,	O
planktonic	O
and	O
biofilm	O
streptococci	B-bacteria
showed	O
the	O
same	O
percentage	O
of	O
survival	O
within	O
host	O
cells	O
.	O

Transmission	O
electron	O
and	O
confocal	O
microscopy	O
observations	O
confirmed	O
intracellular	O
localization	O
of	O
planktonic	O
and	O
biofilm	O
bacteria	O
.	O

The	O
adhesion	O
,	O
invasion	O
and	O
survival	O
abilities	O
within	O
human	O
oral	O
cells	O
may	O
be	O
considered	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
virulence	O
mechanisms	O
to	O
colonize	O
and	O
persist	O
in	O
the	O
oral	O
cavity	O
in	O
the	O
absence	O
of	O
tooth	O
surface	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
design	O
and	O
evaluate	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
probes	O
for	O
the	O
single	O
-	O
cell	O
detection	O
and	O
enumeration	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
in	O
particular	O
organisms	O
belonging	O
to	O
the	O
major	O
phylogenetic	O
groups	O
and	O
species	O
of	O
oral	O
lactobacilli	B-bacteria
and	O
to	O
Abiotrophia	B-bacteria
/	O
Granulicatella	I-bacteria
.	O

As	O
lactobacilli	B-bacteria
are	O
known	O
for	O
notorious	O
resistance	O
to	O
probe	O
penetration	O
,	O
probe	O
-	O
specific	O
assay	O
protocols	O
were	O
experimentally	O
developed	O
to	O
provide	O
maximum	O
cell	O
wall	O
permeability	O
,	O
probe	O
accessibility	O
,	O
hybridization	O
stringency	O
,	O
and	O
fluorescence	O
intensity	O
.	O

The	O
new	O
assays	O
were	O
then	O
applied	O
in	O
a	O
pilot	O
study	O
to	O
three	O
biofilm	O
samples	O
harvested	O
from	O
variably	O
demineralized	O
bovine	O
enamel	O
discs	O
that	O
had	O
been	O
carried	O
in	O
situ	O
for	O
10	O
days	O
by	O
different	O
volunteers	O
.	O

Best	O
probe	O
penetration	O
and	O
fluorescent	O
labeling	O
of	O
reference	O
strains	O
were	O
obtained	O
after	O
combined	O
lysozyme	O
and	O
achromopeptidase	O
treatment	O
followed	O
by	O
exposure	O
to	O
lipase	O
.	O

Hybridization	O
stringency	O
had	O
to	O
be	O
established	O
strictly	O
for	O
each	O
probe	O
.	O

Thereafter	O
all	O
probes	O
showed	O
the	O
expected	O
specificity	O
with	O
reference	O
strains	O
and	O
labeled	O
the	O
anticipated	O
morphotypes	O
in	O
dental	O
plaques	O
.	O

Applied	O
to	O
in	O
situ	O
grown	O
biofilms	O
the	O
set	O
of	O
probes	O
detected	O
only	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
and	O
bacteria	O
of	O
the	O
Lactobacillus	B-bacteria
casei	I-bacteria
group	O
.	O

The	O
most	O
cariogenic	O
biofilm	O
contained	O
two	O
orders	O
of	O
magnitude	O
higher	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
cell	O
numbers	O
than	O
the	O
other	O
biofilms	O
.	O

Abiotrophia	B-bacteria
/	O
Granulicatella	B-bacteria
and	O
streptococci	B-bacteria
from	O
the	O
mitis	O
group	O
were	O
found	O
in	O
all	O
samples	O
at	O
high	O
levels	O
,	O
whereas	O
Streptococcus	B-bacteria
mutans	I-bacteria
was	O
detected	O
in	O
only	O
one	O
sample	O
in	O
very	O
low	O
numbers	O
.	O

Application	O
of	O
these	O
new	O
group	O
-	O
and	O
species	O
-	O
specific	O
FISH	O
probes	O
to	O
oral	O
biofilm	O
-	O
forming	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
will	O
allow	O
a	O
clearer	O
understanding	O
of	O
the	O
supragingival	O
biome	O
,	O
its	O
spatial	O
architecture	O
and	O
of	O
structure	O
-	O
function	O
relationships	O
implicated	O
during	O
plaque	O
homeostasis	O
and	O
caries	O
development	O
.	O

The	O
probes	O
should	O
prove	O
of	O
value	O
far	O
beyond	O
the	O
field	O
of	O
oral	O
microbiology	O
,	O
as	O
many	O
of	O
them	O
detect	O
non	O
-	O
oral	O
species	O
and	O
phylogenetic	O
groups	O
of	O
importance	O
in	O
a	O
variety	O
of	O
medical	O
conditions	O
and	O
the	O
food	O
industry	O
.	O

Gingival	O
epithelia	O
utilize	O
multiple	O
signaling	O
pathways	O
to	O
regulate	O
innate	O
immune	O
responses	O
to	O
various	O
oral	O
bacteria	O
,	O
but	O
little	O
is	O
understood	O
about	O
how	O
these	O
bacteria	O
alter	O
epithelial	O
epigenetic	O
status	O
.	O

In	O
this	O
study	O
we	O
report	O
that	O
DNA	O
methyltransferase	O
(	O
DNMT1	O
)	O
and	O
histone	O
deacetylase	O
expression	O
were	O
decreased	O
in	O
gingival	O
epithelial	O
cells	O
treated	O
with	O
oral	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
nonpathogen	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Pretreatment	O
with	O
trichostatin	O
A	O
and	O
sodium	O
butyrate	O
,	O
which	O
increase	O
acetylation	O
of	O
chromatin	O
histones	O
,	O
significantly	O
enhanced	O
the	O
gene	O
expression	O
of	O
antimicrobial	O
proteins	O
human	O
beta	O
-	O
defensin	O
2	O
(	O
hBD2	O
)	O
and	O
CC	O
chemokine	O
ligand	O
20	O
(	O
CCL20	O
)	O
in	O
response	O
to	O
both	O
bacterial	O
challenges	O
.	O

Pretreatment	O
with	O
DNMT	O
inhibitor	O
5	O
'	O
-	O
azacytidine	O
increased	O
hBD2	O
and	O
CCL20	O
expression	O
in	O
response	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
but	O
not	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Furthermore	O
,	O
we	O
observed	O
a	O
differential	O
pattern	O
of	O
protein	O
levels	O
of	O
H3K4me3	O
,	O
which	O
has	O
been	O
associated	O
with	O
chromatin	O
remodeling	O
and	O
activation	O
of	O
gene	O
transcription	O
,	O
in	O
response	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
vs	O
.	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

This	O
study	O
provides	O
a	O
new	O
insight	O
into	O
the	O
bacteria	O
-	O
specific	O
innate	O
immune	O
responses	O
via	O
epigenetic	O
regulation	O
.	O

Early	O
childhood	O
caries	O
(	O
ECC	O
)	O
is	O
a	O
virulent	O
form	O
of	O
dental	O
caries	O
that	O
can	O
destroy	O
the	O
primary	O
dentition	O
of	O
toddlers	O
and	O
preschool	O
children	O
.	O

It	O
occurs	O
worldwide	O
,	O
afflicting	O
predominantly	O
disadvantaged	O
children	O
.	O

Although	O
Streptococcus	B-bacteria
mutans	I-bacteria
is	O
the	O
most	O
likely	O
causative	O
agent	O
,	O
diet	O
also	O
plays	O
a	O
critical	O
role	O
in	O
the	O
acquisition	O
and	O
clinical	O
expression	O
of	O
this	O
infection	O
.	O

Early	O
acquisition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
via	O
vertical	O
or	O
horizontal	O
transmission	O
is	O
a	O
key	O
event	O
in	O
the	O
natural	O
history	O
of	O
the	O
disease	O
that	O
coupled	O
with	O
caries	O
promoting	O
feeding	O
behaviours	O
results	O
in	O
accumulation	O
of	O
these	O
organisms	O
to	O
levels	O
exceeding	O
30	O
%	O
of	O
the	O
total	O
cultivable	O
plaque	O
flora	O
,	O
which	O
in	O
turn	O
leads	O
to	O
rapid	O
demineralization	O
of	O
the	O
tooth	O
structure	O
.	O

Inflicted	O
children	O
may	O
also	O
have	O
other	O
associated	O
health	O
problems	O
,	O
ranging	O
from	O
local	O
infections	O
to	O
oral	O
pain	O
that	O
manifest	O
as	O
difficulty	O
in	O
eating	O
and	O
sleeping	O
,	O
reduced	O
growth	O
and	O
altered	O
behaviour	O
.	O

Oral	O
rehabilitation	O
usually	O
consists	O
of	O
restoration	O
or	O
surgical	O
removal	O
of	O
carious	O
teeth	O
along	O
with	O
recommendations	O
regarding	O
feeding	O
habits	O
.	O

Although	O
treatment	O
can	O
be	O
instituted	O
in	O
the	O
dental	O
clinic	O
,	O
it	O
becomes	O
costly	O
sometimes	O
when	O
cooperative	O
capacity	O
of	O
babies	O
and	O
preschool	O
children	O
necessitates	O
the	O
use	O
of	O
general	O
anaesthesia	O
.	O

Primary	O
prevention	O
of	O
ECC	O
has	O
largely	O
been	O
restricted	O
to	O
counselling	O
parents	O
regarding	O
proper	O
feeding	O
behaviour	O
,	O
oral	O
hygiene	O
measures	O
and	O
new	O
strategies	O
that	O
address	O
the	O
infectious	O
component	O
through	O
use	O
of	O
topical	O
antimicrobial	O
therapy	O
in	O
order	O
to	O
defeat	O
this	O
common	O
oral	O
affliction	O
.	O

Chronic	O
periodontitis	O
is	O
associated	O
with	O
systemic	O
diseases	O
such	O
as	O
atherosclerosis	O
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
serum	O
IgG	O
antibody	O
titer	O
to	O
periodontal	O
bacteria	O
for	O
prognosis	O
of	O
periodontitis	O
recurrence	O
during	O
supportive	O
periodontal	O
therapy	O
(	O
SPT	O
)	O
phase	O
.	O

The	O
139	O
patients	O
during	O
SPT	O
phase	O
were	O
selected	O
and	O
divided	O
to	O
two	O
groups	O
as	O
follows	O
:	O
`	O
`	O
Stable	O
'	O
'	O
and	O
`	O
`	O
Recurrence	O
'	O
'	O
group	O
at	O
SPT	O
phase	O
for	O
case	O
-	O
control	O
study	O
:	O
`	O
`	O
High	O
IgG	O
titer	O
'	O
'	O
and	O
`	O
`	O
Normal	O
IgG	O
titer	O
'	O
'	O
group	O
before	O
transition	O
to	O
SPT	O
phase	O
for	O
cohort	O
study	O
.	O

We	O
examined	O
whether	O
clinical	O
findings	O
or	O
serum	O
IgG	O
antibody	O
titers	O
to	O
periodontal	O
bacteria	O
are	O
risk	O
factors	O
for	O
the	O
development	O
of	O
periodontitis	O
recurrence	O
.	O

Case	O
-	O
control	O
study	O
showed	O
that	O
there	O
were	O
significant	O
differences	O
between	O
the	O
stable	O
and	O
recurrence	O
groups	O
in	O
age	O
and	O
number	O
of	O
teeth	O
.	O

The	O
serum	O
IgG	O
antibody	O
titer	O
to	O
Eikenella	B-bacteria
corrodens	I-bacteria
FDC1073	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
SU63	I-bacteria
,	O
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
ATCC33238	I-bacteria
was	O
significantly	O
higher	O
in	O
the	O
recurrence	O
group	O
.	O

Next	O
,	O
we	O
found	O
,	O
that	O
the	O
recurrence	O
ratio	O
in	O
the	O
high	O
IgG	O
titer	O
group	O
to	O
Gram	O
-	O
negative	O
obligate	O
anaerobe	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
normal	O
IgG	O
titer	O
group	O
.	O

Taken	O
together	O
,	O
serum	O
IgG	O
antibody	O
titer	O
test	O
is	O
useful	O
in	O
the	O
prognosis	O
of	O
periodontitis	O
recurrence	O
during	O
the	O
SPT	O
phase	O
.	O

There	O
are	O
few	O
in	O
vitro	O
models	O
available	O
in	O
the	O
scientific	O
literature	O
for	O
study	O
of	O
the	O
structure	O
,	O
formation	O
and	O
development	O
of	O
the	O
subgingival	O
biofilm	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
develop	O
and	O
validate	O
an	O
in	O
vitro	O
biofilm	O
model	O
,	O
using	O
representative	O
selected	O
bacteria	O
from	O
the	O
subgingival	O
microbiota	O
.	O

Six	O
standard	O
reference	O
strains	O
were	O
used	O
to	O
develop	O
biofilms	O
over	O
sterile	O
ceramic	O
calcium	O
hydroxyapatite	O
discs	O
coated	O
with	O
saliva	O
within	O
the	O
wells	O
of	O
presterilized	O
polystyrene	O
tissue	O
culture	O
plates	O
.	O

The	O
selected	O
species	O
represent	O
initial	O
(	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
)	O
,	O
early	O
(	O
Veillonella	B-bacteria
parvula	I-bacteria
)	O
,	O
secondary	O
(	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
)	O
and	O
late	O
colonizers	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
.	O

The	O
structure	O
of	O
the	O
biofilm	O
obtained	O
was	O
studied	O
using	O
a	O
vital	O
fluorescence	O
technique	O
in	O
conjunction	O
with	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

The	O
biofilm	O
bacterial	O
kinetics	O
were	O
studied	O
by	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
.	O

After	O
12	O
h	O
,	O
initial	O
and	O
early	O
colonizers	O
were	O
the	O
first	O
microorganisms	O
detected	O
adhering	O
to	O
the	O
calcium	O
hydroxyapatite	O
discs	O
.	O

The	O
intermediate	O
colonizer	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
not	O
detected	O
in	O
the	O
model	O
until	O
24	O
h	O
of	O
incubation	O
.	O

Late	O
colonizers	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
could	O
be	O
measured	O
inside	O
the	O
biofilm	O
after	O
48	O
h	O
.	O

The	O
biofilm	O
reached	O
its	O
steady	O
state	O
between	O
72	O
and	O
96	O
h	O
after	O
inoculation	O
,	O
with	O
bacterial	O
vitality	O
increasing	O
from	O
the	O
hydroxyapatite	O
surface	O
to	O
the	O
central	O
part	O
of	O
the	O
biofilm	O
.	O

An	O
in	O
vitro	O
biofilm	O
model	O
was	O
developed	O
and	O
validated	O
,	O
demonstrating	O
a	O
pattern	O
of	O
bacterial	O
colonization	O
and	O
maturation	O
similar	O
to	O
the	O
in	O
vivo	O
development	O
of	O
the	O
subgingival	O
biofilm	O
.	O

In	O
vitro	O
testing	O
of	O
antimicrobial	O
agents	O
is	O
an	O
important	O
tool	O
in	O
the	O
testing	O
hierarchy	O
,	O
and	O
may	O
provide	O
interesting	O
insights	O
into	O
their	O
potential	O
clinical	O
efficacy	O
.	O

Agents	O
with	O
demonstrable	O
in	O
vitro	O
antimicrobial	O
activity	O
may	O
be	O
effective	O
against	O
the	O
same	O
microorganisms	O
in	O
vivo	O
,	O
whereas	O
agents	O
without	O
demonstrable	O
in	O
vitro	O
antimicrobial	O
activity	O
are	O
unlikely	O
to	O
exhibit	O
in	O
vivo	O
antimicrobial	O
activity	O
.	O

In	O
addition	O
,	O
these	O
methods	O
may	O
also	O
be	O
useful	O
in	O
screening	O
antimicrobial	O
agents	O
in	O
product	O
formulations	O
because	O
such	O
agents	O
with	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
activity	O
may	O
have	O
reduced	O
antimicrobial	O
effects	O
when	O
formulated	O
into	O
a	O
dentifrice	O
.	O

Accordingly	O
,	O
this	O
study	O
examined	O
the	O
in	O
vitro	O
and	O
ex	O
vivo	O
antimicrobial	O
activity	O
of	O
three	O
commercial	O
dentifrices	O
:	O
one	O
formulated	O
with	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
(	O
Crest	O
Cavity	O
Protection	O
Toothpaste	O
-	O
Regular	O
)	O
;	O
one	O
with	O
0	O
.	O
454	O
%	O
stannous	O
fluoride	O
,	O
sodium	O
hexametaphosphate	O
,	O
and	O
zinc	O
lactate	O
(	O
Crest	O
Pro	O
-	O
Health	O
)	O
,	O
and	O
one	O
with	O
0	O
.	O
3	O
%	O
triclosan	O
,	O
2	O
.	O
0	O
%	O
PVM	O
/	O
MA	O
copolymer	O
,	O
and	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
(	O
Colgate	O
Total	O
)	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
each	O
dentifrice	O
was	O
determined	O
for	O
resident	O
oral	O
bacterial	O
species	O
,	O
including	O
bacteria	O
that	O
are	O
associated	O
with	O
dental	O
caries	O
;	O
periodontitis	O
,	O
and	O
oral	O
halitosis	O
.	O

Evaluations	O
were	O
performed	O
on	O
individual	O
laboratory	O
strains	O
,	O
and	O
on	O
oral	O
bacteria	O
from	O
supragingival	O
plaque	O
samples	O
obtained	O
from	O
10	O
adults	O
and	O
from	O
oral	O
rinse	O
samples	O
obtained	O
from	O
18	O
adults	O
.	O

The	O
lowest	O
MICs	O
against	O
the	O
oral	O
strains	O
and	O
human	O
samples	O
,	O
i	O
.	O
e	O
.	O
,	O
greatest	O
antimicrobial	O
activity	O
,	O
were	O
seen	O
for	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
.	O

There	O
was	O
,	O
in	O
general	O
,	O
a	O
four	O
-	O
fold	O
difference	O
in	O
MICs	O
between	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
and	O
the	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
dentifrice	O
.	O

The	O
triclosan	O
/	O
copolymer	O
dentifrice	O
significantly	O
inhibited	O
periodontal	O
pathogens	O
,	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

In	O
ex	O
vivo	O
tests	O
measuring	O
antimicrobial	O
effects	O
,	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
substantially	O
inhibited	O
bacterial	O
growth	O
after	O
30	O
-	O
,	O
60	O
-	O
,	O
and	O
120	O
-	O
second	O
exposures	O
compared	O
to	O
the	O
sodium	O
fluoride	O
or	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
dentifrices	O
.	O

Similarly	O
,	O
in	O
ex	O
vivo	O
tests	O
measuring	O
antimicrobial	O
effects	O
on	O
supragingival	O
plaque	O
biofilms	O
,	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
substantially	O
inhibited	O
bacterial	O
growth	O
compared	O
to	O
the	O
other	O
test	O
dentifrices	O
.	O

Different	O
in	O
vitro	O
and	O
ex	O
vivo	O
analyses	O
show	O
that	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
has	O
significant	O
antimicrobial	O
activity	O
on	O
oral	O
bacteria	O
,	O
including	O
species	O
causing	O
dental	O
caries	O
,	O
periodontitis	O
,	O
and	O
oral	O
halitosis	O
,	O
and	O
it	O
provides	O
superior	O
efficacy	O
compared	O
to	O
the	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
dentifrice	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
have	O
been	O
found	O
in	O
the	O
oral	O
cavity	O
and	O
stomach	O
.	O

This	O
study	O
is	O
to	O
establish	O
whether	O
there	O
might	O
be	O
any	O
associations	O
between	O
isolates	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
and	O
those	O
in	O
the	O
stomach	O
by	O
meta	O
-	O
analysis	O
.	O

Studies	O
reporting	O
raw	O
data	O
on	O
the	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
the	O
oral	O
cavity	O
in	O
gastric	O
H	O
.	O
pylori	O
-	O
positive	O
and	O
H	O
.	O
pylori	O
-	O
negative	O
patients	O
,	O
in	O
patients	O
with	O
gastroesophageal	O
diseases	O
,	O
and	O
in	O
healthy	O
individuals	O
and	O
studies	O
reporting	O
data	O
on	O
the	O
eradication	O
rate	O
in	O
the	O
oral	O
cavity	O
or	O
stomach	O
,	O
published	O
in	O
the	O
English	O
language	O
,	O
were	O
identified	O
through	O
MEDLINE	O
and	O
EMBASE	O
up	O
to	O
May	O
2010	O
.	O

The	O
prevalence	O
of	O
H	O
.	O
pylori	O
infection	O
in	O
the	O
oral	O
cavity	O
in	O
gastric	O
H	O
.	O
pylori	O
-	O
positive	O
patients	O
was	O
significantly	O
higher	O
(	O
45	O
.	O
0	O
%	O
)	O
than	O
that	O
in	O
gastric	O
H	O
.	O
pylori	O
-	O
negative	O
patients	O
(	O
23	O
.	O
9	O
%	O
)	O
.	O

The	O
pooled	O
odds	O
ration	O
(	O
OR	O
)	O
was	O
3	O
.	O
61	O
and	O
the	O
95	O
%	O
CI	O
was	O
1	O
.	O
91	O
-	O
6	O
.	O
82	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

Different	O
diagnostic	O
methods	O
produced	O
different	O
pooled	O
ORs	O
with	O
PCR	O
the	O
highest	O
(	O
OR	O
=	O
5	O
.	O
11	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
08	O
-	O
12	O
.	O
54	O
,	O
P	O
=	O
0	O
.	O
0004	O
)	O
and	O
rapid	O
urease	O
test	O
(	O
RUT	O
)	O
the	O
lowest	O
(	O
OR	O
=	O
2	O
.	O
00	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
80	O
-	O
5	O
.	O
00	O
,	O
P	O
=	O
0	O
.	O
14	O
)	O
.	O

The	O
44	O
.	O
8	O
%	O
(	O
91	O
/	O
203	O
)	O
prevalence	O
of	O
H	O
.	O
pylori	O
infection	O
in	O
the	O
oral	O
cavity	O
in	O
patients	O
with	O
clinical	O
and	O
/	O
or	O
histological	O
gastroesophageal	O
diseases	O
was	O
significantly	O
higher	O
than	O
the	O
13	O
.	O
2	O
%	O
(	O
21	O
/	O
159	O
)	O
in	O
patients	O
with	O
non	O
-	O
ulcerous	O
dyspepsia	O
or	O
healthy	O
controls	O
(	O
OR	O
=	O
5	O
.	O
15	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
97	O
-	O
8	O
.	O
92	O
,	O
P	O
<	O
0	O
.	O
00001	O
)	O
.	O

The	O
eradication	O
efficiency	O
in	O
stomach	O
is	O
85	O
.	O
8	O
%	O
(	O
187	O
/	O
218	O
)	O
,	O
while	O
in	O
oral	O
cavity	O
it	O
is	O
only	O
5	O
.	O
7	O
%	O
(	O
9	O
/	O
158	O
)	O
.	O

The	O
OR	O
is	O
55	O
.	O
59	O
,	O
P	O
<	O
0	O
.	O
00001	O
.	O

There	O
is	O
a	O
close	O
relation	O
between	O
the	O
infection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
and	O
stomach	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
are	O
more	O
difficult	O
to	O
be	O
eradicated	O
than	O
in	O
the	O
stomach	O
.	O

It	O
may	O
be	O
a	O
source	O
of	O
reinfection	O
.	O

Candida	O
albicans	O
is	O
a	O
commensal	O
organism	O
that	O
can	O
be	O
isolated	O
from	O
the	O
majority	O
of	O
healthy	O
individuals	O
.	O

However	O
,	O
in	O
certain	O
susceptible	O
individuals	O
C	O
.	O
albicans	O
can	O
become	O
pathogenic	O
leading	O
to	O
the	O
mucocutaneous	O
infection	O
;	O
oral	O
candidiasis	O
.	O

Murine	O
models	O
and	O
in	O
vitro	O
monolayer	O
cultures	O
have	O
generated	O
some	O
data	O
on	O
the	O
likely	O
virulence	O
and	O
host	O
factors	O
that	O
contribute	O
to	O
oral	O
candidiasis	O
but	O
these	O
models	O
have	O
limitations	O
.	O

Recently	O
,	O
tissue	O
engineered	O
oral	O
mucosal	O
models	O
have	O
been	O
developed	O
to	O
mimic	O
the	O
normal	O
oral	O
mucosa	O
but	O
little	O
information	O
is	O
available	O
on	O
their	O
true	O
representation	O
.	O

In	O
this	O
study	O
,	O
we	O
assessed	O
the	O
histological	O
features	O
of	O
three	O
different	O
tissue	O
engineered	O
oral	O
mucosal	O
models	O
compared	O
to	O
the	O
normal	O
oral	O
mucosa	O
and	O
analysed	O
both	O
cell	O
damage	O
and	O
cytokine	O
release	O
following	O
infection	O
with	O
C	O
.	O
albicans	O
.	O

Models	O
comprised	O
of	O
normal	O
oral	O
keratinocytes	O
and	O
a	O
fibroblast	O
-	O
containing	O
matrix	O
displayed	O
more	O
similar	O
immunohistological	O
and	O
proliferation	O
characteristics	O
to	O
normal	O
mucosa	O
,	O
compared	O
to	O
models	O
composed	O
of	O
an	O
oral	O
carcinoma	O
cell	O
line	O
.	O

Although	O
all	O
models	O
were	O
invaded	O
and	O
damaged	O
by	O
C	O
.	O
albicans	O
in	O
a	O
similar	O
manner	O
,	O
the	O
cytokine	O
response	O
was	O
much	O
more	O
pronounced	O
in	O
models	O
containing	O
normal	O
keratinocytes	O
.	O

These	O
data	O
suggest	O
that	O
models	O
based	O
on	O
normal	O
keratinocytes	O
atop	O
a	O
fibroblast	O
-	O
containing	O
connective	O
tissue	O
will	O
significantly	O
aid	O
in	O
dissecting	O
the	O
molecular	O
pathogenesis	O
of	O
oral	O
candidiasis	O
.	O

Metagenomic	O
techniques	O
are	O
used	O
to	O
analyse	O
bacterial	O
communities	O
allowing	O
both	O
culturable	O
and	O
unculturable	O
species	O
to	O
be	O
represented	O
.	O

However	O
,	O
the	O
screening	O
of	O
oral	O
metagenomic	O
samples	O
can	O
be	O
hindered	O
by	O
high	O
animal	O
host	O
DNA	O
content	O
.	O

This	O
study	O
evaluated	O
methods	O
for	O
the	O
reduction	O
of	O
human	O
DNA	O
concentrations	O
within	O
oral	O
metagenomic	O
samples	O
.	O

Plaque	O
samples	O
were	O
collected	O
from	O
27	O
patients	O
presenting	O
with	O
periodontal	O
disease	O
and	O
treated	O
to	O
remove	O
human	O
DNA	O
using	O
either	O
selective	O
lysis	O
of	O
eukaryotic	O
cells	O
at	O
several	O
buffer	O
concentrations	O
or	O
differential	O
centrifugation	O
after	O
treatment	O
with	O
trypsin	O
and	O
/	O
or	O
detergents	O
.	O

Human	O
and	O
bacterial	O
DNA	O
levels	O
were	O
determined	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
.	O

The	O
human	O
DNA	O
content	O
of	O
plaque	O
extracts	O
was	O
significantly	O
reduced	O
by	O
all	O
treatments	O
compared	O
with	O
an	O
untreated	O
control	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

However	O
,	O
differential	O
centrifugation	O
simultaneously	O
reduced	O
the	O
bacterial	O
DNA	O
content	O
unless	O
samples	O
were	O
pretreated	O
with	O
a	O
detergent	O
.	O

Observations	O
of	O
Gram	O
stained	O
samples	O
that	O
were	O
processed	O
using	O
differential	O
centrifugation	O
without	O
detergent	O
suggest	O
that	O
many	O
bacteria	O
remain	O
adhered	O
to	O
human	O
cells	O
.	O

An	O
approach	O
that	O
uses	O
differential	O
centrifugation	O
in	O
parallel	O
with	O
selective	O
lysis	O
is	O
recommended	O
to	O
fully	O
represent	O
the	O
oral	O
microbiota	O
in	O
metagenomic	O
samples	O
,	O
including	O
those	O
tightly	O
adhered	O
to	O
human	O
cells	O
and	O
more	O
delicate	O
bacteria	O
such	O
as	O
Mycoplasma	B-bacteria
.	O

Smoking	O
is	O
an	O
independent	O
risk	O
factor	O
for	O
the	O
initiation	O
,	O
extent	O
and	O
severity	O
of	O
periodontal	O
disease	O
.	O

This	O
study	O
examined	O
the	O
ability	O
of	O
the	O
host	O
immune	O
system	O
to	O
discriminate	O
commensal	O
oral	O
bacteria	O
from	O
pathogens	O
at	O
mucosal	O
surfaces	O
,	O
i	O
.	O
e	O
.	O

oral	O
cavity	O
.	O

Serum	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
antibody	O
reactive	O
with	O
three	O
pathogenic	O
and	O
five	O
commensal	O
oral	O
bacteria	O
in	O
301	O
current	O
smokers	O
(	O
age	O
range	O
21	O
-	O
66	O
years	O
)	O
were	O
examined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Clinical	O
features	O
of	O
periodontal	O
health	O
were	O
used	O
as	O
measures	O
of	O
periodontitis	O
.	O

Antibody	O
to	O
the	O
pathogens	O
and	O
salivary	O
cotinine	O
levels	O
were	O
related	O
positively	O
to	O
disease	O
severity	O
;	O
however	O
,	O
the	O
antibody	O
levels	O
were	O
best	O
described	O
by	O
the	O
clinical	O
disease	O
unrelated	O
to	O
the	O
amount	O
of	O
smoking	O
.	O

The	O
data	O
showed	O
a	O
greater	O
immune	O
response	O
to	O
pathogens	O
than	O
commensals	O
that	O
was	O
related	O
specifically	O
to	O
disease	O
extent	O
,	O
and	O
most	O
noted	O
in	O
black	O
males	O
.	O

Significant	O
correlations	O
in	O
individual	O
patient	O
responses	O
to	O
the	O
pathogens	O
and	O
commensals	O
were	O
lost	O
with	O
an	O
increasing	O
extent	O
of	O
periodontitis	O
and	O
serum	O
antibody	O
to	O
the	O
pathogens	O
.	O

Antibody	O
to	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
particularly	O
distinct	O
with	O
respect	O
to	O
the	O
discriminatory	O
nature	O
of	O
the	O
immune	O
responses	O
in	O
recognizing	O
the	O
pathogens	O
.	O

Antibody	O
responses	O
to	O
selected	O
pathogenic	O
and	O
commensal	O
oral	O
microorganisms	O
differed	O
among	O
racial	O
groups	O
and	O
genders	O
.	O

The	O
antibody	O
response	O
to	O
the	O
pathogens	O
was	O
related	O
to	O
disease	O
severity	O
.	O

The	O
level	O
of	O
antibody	O
to	O
the	O
pathogens	O
,	O
and	O
in	O
particular	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
was	O
correlated	O
with	O
disease	O
severity	O
in	O
black	O
and	O
male	O
subsets	O
of	O
patients	O
.	O

The	O
amount	O
of	O
smoking	O
did	O
not	O
appear	O
to	O
impact	O
directly	O
serum	O
antibody	O
levels	O
to	O
these	O
oral	O
bacteria	O
.	O

Investigate	O
the	O
presence	O
of	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
in	O
saliva	O
after	O
supplementation	O
with	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
and	O
the	O
probiotic	O
effect	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
on	O
plaque	O
index	O
and	O
supra	O
-	O
and	O
subgingival	O
microbiota	O
.	O

The	O
study	O
included	O
23	O
healthy	O
individuals	O
,	O
randomised	O
into	O
test	O
or	O
control	O
subjects	O
.	O

At	O
baseline	O
and	O
after	O
12	O
weeks	O
saliva	O
samples	O
,	O
plaque	O
index	O
and	O
supra	O
-	O
and	O
subgingival	O
plaque	O
samples	O
were	O
obtained	O
.	O

The	O
test	O
subjects	O
were	O
given	O
the	O
study	O
product	O
(	O
containing	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
,	O
ATCC	B-bacteria
55730	I-bacteria
and	O
ATCC	B-bacteria
PTA	I-bacteria
5289	I-bacteria
)	O
and	O
the	O
control	O
subjects	O
placebo	O
for	O
12	O
weeks	O
.	O

Microbiological	O
analyses	O
were	O
done	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
and	O
selective	O
culturing	O
for	O
lactobacilli	B-bacteria
determination	O
.	O

A	O
significant	O
increase	O
in	O
total	O
Lactobacillus	B-bacteria
counts	O
in	O
saliva	O
occurred	O
in	O
both	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
with	O
a	O
significant	O
increase	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
(	O
p	O
=	O
0	O
.	O
008	O
)	O
in	O
the	O
test	O
group	O
.	O

Termination	O
of	O
intervention	O
resulted	O
in	O
a	O
wash	O
out	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
.	O

The	O
control	O
group	O
demonstrated	O
a	O
statistically	O
significant	O
increase	O
in	O
PII	O
after	O
12	O
weeks	O
(	O
p	O
=	O
0	O
.	O
023	O
)	O
whilst	O
there	O
was	O
no	O
significant	O
change	O
in	O
the	O
test	O
group	O
.	O

A	O
significant	O
increase	O
was	O
found	O
for	O
most	O
bacterial	O
species	O
in	O
both	O
groups	O
in	O
supra	O
-	O
and	O
subgingival	O
plaque	O
with	O
no	O
significant	O
difference	O
for	O
any	O
of	O
the	O
species	O
between	O
the	O
groups	O
.	O

The	O
ratio	O
between	O
`	O
`	O
bad	O
/	O
good	O
'	O
'	O
supragingival	O
bacteria	O
decreased	O
for	O
the	O
test	O
group	O
but	O
this	O
decrease	O
did	O
not	O
reach	O
significance	O
.	O

The	O
corresponding	O
ratio	O
for	O
subgingival	O
bacteria	O
decreased	O
significantly	O
in	O
both	O
groups	O
.	O

Supplementation	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
resulted	O
in	O
presence	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
saliva	O
but	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
was	O
washed	O
out	O
after	O
termination	O
of	O
intervention	O
.	O

No	O
significant	O
effect	O
on	O
supra	O
-	O
or	O
subgingival	O
microbiota	O
was	O
observed	O
.	O

The	O
significant	O
increase	O
in	O
PII	O
in	O
the	O
control	O
group	O
with	O
no	O
significant	O
change	O
in	O
the	O
test	O
group	O
may	O
,	O
however	O
,	O
indicate	O
a	O
probiotic	O
effect	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
this	O
study	O
population	O
.	O

This	O
study	O
evaluated	O
the	O
resistance	O
to	O
antimicrobials	O
of	O
aerobes	O
and	O
facultative	O
anaerobes	O
isolated	O
from	O
patients	O
wearing	O
complete	O
dentures	O
,	O
patients	O
with	O
gingivitis	O
and	O
periodontitis	O
,	O
and	O
periodontally	O
health	O
subjects	O
.	O

Three	O
hundred	O
and	O
four	O
isolates	O
were	O
tested	O
.	O

The	O
minimal	O
inhibitory	O
concentrations	O
of	O
the	O
drugs	O
were	O
evaluated	O
through	O
the	O
agar	O
dilution	O
method	O
using	O
Mueller	O
-	O
Hinton	O
agar	O
.	O

The	O
most	O
active	O
antimicrobial	O
drugs	O
were	O
the	O
carbapenems	O
(	O
meropenem	O
and	O
imipenem	O
)	O
,	O
and	O
resistance	O
to	O
these	O
drugs	O
was	O
restrict	O
to	O
1	O
.	O
6	O
-	O
2	O
.	O
3	O
%	O
of	O
the	O
isolates	O
,	O
as	O
well	O
as	O
ciprofloxacin	O
and	O
rifampin	O
.	O

Microbial	O
resistance	O
to	O
ampicillin	O
,	O
amoxicillin	O
/	O
clavulanic	O
acid	O
,	O
cefoxitin	O
,	O
cephalothin	O
,	O
amikacin	O
,	O
chloramphenicol	O
and	O
nalidixic	O
acid	O
was	O
particularly	O
high	O
.	O

In	O
most	O
cases	O
,	O
the	O
resistance	O
to	O
beta	O
-	O
lactams	O
was	O
mediated	O
by	O
the	O
production	O
of	O
hydrolytic	O
enzymes	O
,	O
especially	O
in	O
gram	O
-	O
negative	O
enteric	O
rods	O
,	O
while	O
enterococci	B-bacteria
did	O
not	O
evidence	O
production	O
of	O
these	O
enzymes	O
.	O

The	O
association	O
amoxicillin	O
/	O
clavulanic	O
acid	O
was	O
not	O
effective	O
in	O
28	O
.	O
3	O
%	O
of	O
the	O
tested	O
isolates	O
.	O

The	O
results	O
of	O
this	O
investigation	O
confirmed	O
that	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
periodontitis	O
and	O
gingivitis	O
,	O
and	O
particularly	O
edentulous	O
patients	O
wearing	O
complete	O
dentures	O
could	O
harbor	O
microorganisms	O
with	O
several	O
antimicrobial	O
resistance	O
markers	O
,	O
and	O
these	O
microorganisms	O
are	O
frequently	O
implicated	O
in	O
multiresistant	O
,	O
systemic	O
,	O
oral	O
or	O
nosocomial	O
infections	O
.	O

Examination	O
of	O
dental	O
deposits	O
from	O
45	O
healthy	O
individuals	O
detected	O
3	O
lactobacillus	B-bacteria
strains	I-bacteria
showing	O
a	O
high	O
antagonism	O
toward	O
test	O
cultures	O
.	O

The	O
api	O
50	O
CH	O
`	O
`	O
bio	O
Merieux	O
'	O
'	O
test	O
systems	O
were	O
employed	O
to	O
identify	O
strains	O
as	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
39	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
24	I-bacteria
and	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
50	I-bacteria
.	O

The	O
results	O
of	O
analyzing	O
the	O
sequences	O
of	O
the	O
16S	O
rRNA	O
genes	O
of	O
the	O
test	O
strains	O
confirmed	O
this	O
identification	O
,	O
except	O
for	O
the	O
latter	O
strain	O
.	O

The	O
taxonomic	O
status	O
of	O
the	O
third	O
strain	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
50	I-bacteria
was	O
determined	O
by	O
the	O
bioinformative	O
analysis	O
of	O
the	O
nucleotide	O
sequence	O
of	O
the	O
16S	O
rRNA	O
genes	O
.	O

A	O
newly	O
acquired	O
rhesus	O
macaque	O
was	O
suffering	O
from	O
rapid	O
destruction	O
of	O
the	O
left	O
cheek	O
caused	O
by	O
necrotizing	O
stomatitis	O
.	O

To	O
restore	O
reconstructive	O
surgery	O
and	O
intensive	O
care	O
with	O
antibiotics	O
,	O
wound	O
protection	O
,	O
wound	O
healing	O
agents	O
,	O
and	O
debridement	O
were	O
applied	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
were	O
isolated	O
from	O
the	O
culture	O
of	O
the	O
lesion	O
,	O
and	O
the	O
antibiotic	O
susceptibility	O
test	O
revealed	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
infection	O
.	O

Vancomycin	O
and	O
ampicillin	O
-	O
sulbactam	O
effectively	O
treated	O
the	O
bacterial	O
infections	O
,	O
and	O
reconstructive	O
surgery	O
was	O
performed	O
once	O
the	O
infection	O
was	O
cleared	O
.	O

Topical	O
application	O
of	O
recombinant	O
human	O
epidermal	O
growth	O
factor	O
(	O
rhEGF	O
)	O
was	O
useful	O
to	O
treat	O
exposed	O
wound	O
of	O
the	O
noma	O
lesion	O
.	O

Simian	O
noma	O
associated	O
with	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
had	O
not	O
previously	O
been	O
reported	O
in	O
non	O
-	O
human	O
primates	O
.	O

Although	O
noma	O
associated	O
with	O
MRSA	B-bacteria
is	O
hard	O
to	O
cure	O
because	O
of	O
its	O
rapid	O
and	O
destructive	O
progress	O
,	O
the	O
aggressive	O
therapy	O
used	O
in	O
this	O
study	O
led	O
to	O
the	O
successful	O
resolution	O
of	O
an	O
acute	O
necrotic	O
stomatitis	O
lesion	O
in	O
a	O
rhesus	O
macaque	O
.	O

This	O
study	O
assessed	O
the	O
antibacterial	O
activity	O
of	O
short	O
-	O
,	O
medium	O
-	O
,	O
and	O
long	O
-	O
chain	O
fatty	O
acids	O
against	O
various	O
oral	O
microorganisms	O
.	O

The	O
short	O
-	O
chain	O
fatty	O
acids	O
[	O
formic	O
acid	O
(	O
C1	O
)	O
,	O
acetic	O
acid	O
(	O
C2	O
)	O
,	O
propionic	O
acid	O
(	O
C3	O
)	O
,	O
butyric	O
acid	O
(	O
C4	O
)	O
,	O
isobutyric	O
acid	O
(	O
C4	O
)	O
,	O
isovaleric	O
acid	O
(	O
C5	O
)	O
,	O
hexanoic	O
acid	O
(	O
C6	O
)	O
]	O
,	O
medium	O
-	O
chain	O
fatty	O
acids	O
[	O
octanoic	O
acid	O
(	O
C8	O
)	O
,	O
capric	O
acid	O
(	O
C10	O
)	O
,	O
lauric	O
acid	O
(	O
12	O
)	O
]	O
,	O
and	O
long	O
-	O
chain	O
fatty	O
acids	O
[	O
myristic	O
acid	O
(	O
C14	O
)	O
,	O
palmitic	O
acid	O
(	O
C16	O
)	O
]	O
,	O
were	O
investigated	O
for	O
antimicrobial	O
activity	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Candida	O
albicans	O
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
data	O
demonstrated	O
that	O
the	O
fatty	O
acids	O
exhibited	O
patterns	O
of	O
inhibition	O
against	O
oral	O
bacteria	O
with	O
some	O
specificity	O
that	O
appeared	O
related	O
more	O
to	O
the	O
bacterial	O
species	O
that	O
the	O
general	O
structural	O
characteristics	O
of	O
the	O
microorganism	O
.	O

As	O
a	O
group	O
the	O
fatty	O
acids	O
were	O
much	O
less	O
effective	O
against	O
C	O
.	O
albicans	O
than	O
the	O
oral	O
bacteria	O
,	O
with	O
effectiveness	O
limited	O
to	O
hexanoic	O
,	O
octanoic	O
,	O
and	O
lauric	O
acids	O
.	O

Formic	O
acid	O
,	O
capric	O
,	O
and	O
lauric	O
acids	O
were	O
broadly	O
inhibitory	O
for	O
the	O
bacteria	O
.	O

Interestingly	O
,	O
fatty	O
acids	O
that	O
are	O
produced	O
at	O
metabolic	O
end	O
-	O
products	O
by	O
a	O
number	O
of	O
these	O
bacteria	O
,	O
were	O
specifically	O
inactive	O
against	O
the	O
producing	O
species	O
,	O
whilst	O
substantially	O
inhibiting	O
the	O
growth	O
of	O
other	O
oral	O
microorganisms	O
.	O

The	O
results	O
indicate	O
that	O
the	O
antimicrobial	O
activity	O
of	O
short	O
-	O
chain	O
fatty	O
acids	O
(	O
SCFAs	O
)	O
,	O
medium	O
-	O
chain	O
fatty	O
acids	O
(	O
MCFAs	O
)	O
,	O
long	O
-	O
chain	O
fatty	O
acids	O
(	O
LCFAs	O
)	O
could	O
influence	O
the	O
microbial	O
ecology	O
in	O
the	O
oral	O
cavity	O
via	O
at	O
least	O
2	O
potential	O
pathways	O
.	O

First	O
,	O
the	O
agents	O
delivered	O
exogenously	O
as	O
therapeutic	O
adjuncts	O
could	O
be	O
packaged	O
to	O
enhance	O
a	O
microbial	O
-	O
regulatory	O
environment	O
in	O
the	O
subgingival	O
sulcus	O
.	O

Second	O
,	O
it	O
would	O
be	O
the	O
intrinsic	O
nature	O
of	O
these	O
fatty	O
acid	O
inhibitors	O
in	O
contributing	O
to	O
the	O
characteristics	O
of	O
the	O
microbial	O
biofilms	O
,	O
their	O
evolution	O
,	O
and	O
emergence	O
of	O
species	O
within	O
the	O
biofilms	O
.	O

Further	O
studies	O
on	O
these	O
functions	O
are	O
required	O
to	O
better	O
understand	O
the	O
nature	O
of	O
these	O
potential	O
microbial	O
interactions	O
in	O
the	O
biofilms	O
.	O

Studies	O
on	O
the	O
adherence	O
properties	O
of	O
oral	O
bacteria	O
have	O
been	O
a	O
major	O
focus	O
in	O
microbiology	O
research	O
for	O
several	O
decades	O
.	O

The	O
ability	O
of	O
bacteria	O
to	O
adhere	O
to	O
the	O
variety	O
of	O
surfaces	O
present	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
to	O
become	O
integrated	O
within	O
the	O
resident	O
microbial	O
communities	O
,	O
confers	O
growth	O
and	O
survival	O
properties	O
.	O

Molecular	O
analyses	O
have	O
revealed	O
several	O
families	O
of	O
Gram	O
-	O
positive	O
bacterial	O
surface	O
proteins	O
,	O
including	O
serine	O
-	O
rich	O
repeat	O
,	O
antigen	O
I	O
/	O
II	O
,	O
and	O
pilus	O
families	O
,	O
that	O
mediate	O
adherence	O
to	O
a	O
variety	O
of	O
salivary	O
and	O
oral	O
bacterial	O
receptors	O
.	O

In	O
Gram	O
-	O
negative	O
bacteria	O
,	O
pili	O
,	O
auto	O
-	O
transporters	O
,	O
and	O
extracellular	O
matrix	O
-	O
binding	O
proteins	O
provide	O
components	O
for	O
host	O
tissue	O
recognition	O
and	O
building	O
of	O
complex	O
microbial	O
communities	O
.	O

Future	O
studies	O
will	O
reveal	O
in	O
greater	O
detail	O
the	O
binding	O
pockets	O
for	O
these	O
adhesin	O
families	O
and	O
their	O
receptors	O
.	O

This	O
information	O
will	O
be	O
crucial	O
for	O
the	O
development	O
of	O
new	O
inhibitors	O
or	O
vaccines	O
that	O
target	O
the	O
functional	O
regions	O
of	O
bacterial	O
proteins	O
that	O
are	O
involved	O
in	O
colonization	O
and	O
pathogenesis	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
investigate	O
how	O
teenage	O
smoking	O
affects	O
the	O
prevalence	O
of	O
periodontal	O
bacteria	O
and	O
periodontal	O
health	O
with	O
the	O
hypothesis	O
that	O
smoking	O
increases	O
the	O
prevalence	O
of	O
the	O
bacteria	O
.	O

Oral	O
health	O
of	O
264	O
adolescents	O
(	O
15	O
-	O
to	O
16	O
-	O
year	O
-	O
olds	O
)	O
was	O
clinically	O
examined	O
,	O
and	O
their	O
smoking	O
history	O
was	O
recorded	O
.	O

The	O
participants	O
also	O
filled	O
in	O
a	O
structured	O
questionnaire	O
recording	O
their	O
general	O
health	O
and	O
health	O
habits	O
.	O

Pooled	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
for	O
polymerase	O
chain	O
reaction	O
analysis	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

The	O
prevalence	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
(	O
21	O
%	O
vs	O
.	O
4	O
%	O
,	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
(	O
23	O
%	O
vs	O
.	O
8	O
%	O
,	O
p	O
<	O
0	O
.	O
05	O
,	O
for	O
both	O
)	O
was	O
higher	O
among	O
female	O
smokers	O
than	O
among	O
non	O
-	O
smokers	O
.	O

T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
more	O
often	O
associated	O
with	O
bleeding	O
on	O
probing	O
(	O
29	O
%	O
vs	O
.	O
12	O
%	O
;	O
25	O
%	O
vs	O
.	O
10	O
%	O
,	O
respectively	O
)	O
and	O
deep	O
pockets	O
(	O
25	O
%	O
vs	O
.	O
15	O
%	O
;	O
23	O
%	O
vs	O
.	O
10	O
%	O
,	O
respectively	O
)	O
with	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

Among	O
the	O
girls	O
,	O
a	O
significant	O
association	O
was	O
found	O
between	O
pack	O
-	O
years	O
and	O
the	O
prevalence	O
of	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
(	O
p	O
<	O
0	O
.	O
007	O
)	O
.	O

In	O
both	O
genders	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
rare	O
in	O
this	O
study	O
.	O

To	O
conclude	O
,	O
periodontal	O
bacteria	O
were	O
associated	O
with	O
higher	O
periodontal	O
index	O
scores	O
among	O
all	O
teenage	O
smokers	O
.	O

Smoking	O
girls	O
harbored	O
more	O
frequently	O
certain	O
periodontal	O
bacteria	O
than	O
non	O
-	O
smokers	O
,	O
but	O
this	O
was	O
not	O
seen	O
in	O
boys	O
.	O

Hence	O
,	O
our	O
study	O
hypothesis	O
was	O
only	O
partly	O
confirmed	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
ability	O
of	O
biofilm	O
formation	O
among	O
mutans	O
and	O
non	O
mutans	O
oral	O
streptococci	B-bacteria
and	O
to	O
determine	O
the	O
effect	O
of	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
DSM	I-bacteria
20079	I-bacteria
as	O
a	O
probiot	O
on	O
the	O
adhesion	O
of	O
selected	O
streptococcal	B-bacteria
strains	I-bacteria
on	O
the	O
surfaces	O
.	O

The	O
sample	O
comprised	O
40	O
isolates	O
of	O
oral	O
streptococci	B-bacteria
from	O
dental	O
plaque	O
and	O
caries	O
of	O
volunteer	O
persons	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
ATCC35668	I-bacteria
(	O
no24	O
)	O
was	O
as	O
an	O
standard	O
strain	O
.	O

The	O
probiotic	O
strain	O
was	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
DSM	I-bacteria
20079	I-bacteria
.	O

The	O
ability	O
of	O
biofilm	O
formation	O
was	O
investigated	O
with	O
colorimetric	O
method	O
and	O
the	O
strongest	O
isolates	O
were	O
selected	O
.	O

Then	O
the	O
effect	O
of	O
probiotic	O
strain	O
on	O
the	O
adhesion	O
of	O
streptococci	B-bacteria
isolates	I-bacteria
was	O
determined	O
in	O
polystyrene	O
microtiter	O
plate	O
simultaneously	O
and	O
30	O
minutes	O
before	O
streptococci	B-bacteria
entrance	O
to	O
the	O
system	O
.	O

The	O
results	O
showed	O
that	O
42	O
%	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
were	O
strongly	O
adherent	O
(	O
SA	O
)	O
and	O
in	O
non	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
only	O
23	O
.	O
5	O
%	O
of	O
isolates	O
were	O
found	O
strongly	O
adherent	O
.	O

The	O
strong	O
biofilm	O
forming	O
bacterium	O
isolated	O
was	O
Streptococcus	B-bacteria
mutans	I-bacteria
strain22	I-bacteria
.	O

In	O
the	O
next	O
step	O
,	O
in	O
the	O
presence	O
of	O
probiotic	O
strain	O
the	O
streptococcal	O
adhesion	O
were	O
reduced	O
,	O
and	O
this	O
reduction	O
was	O
non	O
significantly	O
stronger	O
if	O
the	O
probiotic	O
strain	O
was	O
inoculated	O
to	O
the	O
system	O
before	O
the	O
oral	O
bacteria	O
.	O

The	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
had	O
more	O
effect	O
on	O
adherence	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
than	O
non	B-bacteria
mutans	I-bacteria
streptococci	I-bacteria
with	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Adhesion	O
reduction	O
is	O
likely	O
due	O
to	O
bacterial	O
interactions	O
and	O
colonization	O
of	O
adhesion	O
sites	O
with	O
probiotic	O
strain	O
before	O
the	O
presence	O
of	O
streptococci	B-bacteria
.	O

Adhesion	O
reduction	O
can	O
be	O
an	O
effective	O
way	O
on	O
decreasing	O
cariogenic	O
potential	O
of	O
oral	O
streptococci	B-bacteria
.	O

Novel	O
phosphorylated	O
dihydroceramide	O
(	O
PDHC	O
)	O
lipids	O
produced	O
by	O
the	O
periodontal	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
include	O
phosphoethanolamine	O
(	O
PE	O
DHC	O
)	O
and	O
phosphoglycerol	O
dihydroceramides	O
(	O
PG	O
DHC	O
)	O
lipids	O
.	O

These	O
PDHC	O
lipids	O
mediate	O
cellular	O
effects	O
through	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
including	O
promotion	O
of	O
IL	O
-	O
6	O
secretion	O
from	O
dendritic	O
cells	O
and	O
inhibition	O
of	O
osteoblast	O
differentiation	O
and	O
function	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
PE	O
DHC	O
lipids	O
also	O
enhance	O
(	O
TLR2	O
)	O
-	O
dependent	O
murine	O
experimental	O
autoimmune	O
encephalomyelitis	O
(	O
EAE	O
)	O
,	O
a	O
model	O
for	O
multiple	O
sclerosis	O
.	O

The	O
unique	O
non	O
-	O
mammalian	O
structures	O
of	O
these	O
lipids	O
allows	O
for	O
their	O
specific	O
quantification	O
in	O
bacteria	O
and	O
human	O
tissues	O
using	O
multiple	O
reaction	O
monitoring	O
(	O
MRM	O
)	O
-	O
mass	O
spectrometry	O
(	O
MS	O
)	O
.	O

Synthesis	O
of	O
these	O
lipids	O
by	O
other	O
common	O
human	O
bacteria	O
and	O
the	O
presence	O
of	O
these	O
lipids	O
in	O
human	O
tissues	O
have	O
not	O
yet	O
been	O
determined	O
.	O

We	O
now	O
report	O
that	O
synthesis	O
of	O
these	O
lipids	O
can	O
be	O
attributed	O
to	O
a	O
small	O
number	O
of	O
intestinal	O
and	O
oral	O
organisms	O
within	O
the	O
Bacteroides	B-bacteria
,	O
Parabacteroides	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Tannerella	B-bacteria
and	O
Porphyromonas	B-bacteria
genera	I-bacteria
.	O

Additionally	O
,	O
the	O
PDHCs	O
are	O
not	O
only	O
present	O
in	O
gingival	O
tissues	O
,	O
but	O
are	O
also	O
present	O
in	O
human	O
blood	O
,	O
vasculature	O
tissues	O
and	O
brain	O
.	O

Finally	O
,	O
the	O
distribution	O
of	O
these	O
TLR2	O
-	O
activating	O
lipids	O
in	O
human	O
tissues	O
varies	O
with	O
both	O
the	O
tissue	O
site	O
and	O
disease	O
status	O
of	O
the	O
tissue	O
suggesting	O
a	O
role	O
for	O
PDHCs	O
in	O
human	O
disease	O
.	O

To	O
develop	O
a	O
convenient	O
method	O
for	O
the	O
localization	O
and	O
quantification	O
of	O
live	O
and	O
dead	O
bacteria	O
in	O
human	O
ex	O
vivo	O
mineralized	O
dentinal	O
tubules	O
.	O

The	O
roots	O
from	O
human	O
single	O
-	O
rooted	O
teeth	O
(	O
n	O
=	O
12	O
)	O
were	O
infected	O
with	O
Enterococcus	B-bacteria
faecalis	I-bacteria
V583	I-bacteria
and	O
either	O
treated	O
with	O
calcium	O
hydroxide	O
paste	O
or	O
left	O
untreated	O
;	O
six	O
control	O
roots	O
were	O
uninoculated	O
and	O
untreated	O
.	O

Following	O
further	O
incubation	O
,	O
roots	O
were	O
stained	O
with	O
fluorescent	O
DNA	O
-	O
binding	O
reagents	O
,	O
washed	O
thoroughly	O
,	O
sectioned	O
and	O
examined	O
by	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Computer	O
-	O
assisted	O
determinations	O
of	O
fluorescence	O
(	O
bacterial	O
viability	O
)	O
were	O
compared	O
statistically	O
.	O

Bacteria	O
were	O
distributed	O
in	O
the	O
tubules	O
throughout	O
the	O
length	O
of	O
the	O
roots	O
but	O
tubule	O
penetration	O
distance	O
was	O
slightly	O
reduced	O
in	O
the	O
apical	O
sections	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
bacterial	O
tubule	O
penetration	O
between	O
roots	O
from	O
different	O
teeth	O
and	O
small	O
standard	O
deviations	O
indicated	O
reproducibility	O
appropriate	O
for	O
experimental	O
application	O
.	O

Following	O
treatment	O
with	O
calcium	O
hydroxide	O
paste	O
,	O
live	O
and	O
dead	O
bacteria	O
were	O
readily	O
distinguishable	O
by	O
contrasting	O
green	O
and	O
red	O
fluorescence	O
.	O

Bacterial	O
viability	O
determinations	O
amongst	O
roots	O
treated	O
in	O
the	O
same	O
way	O
were	O
not	O
significantly	O
different	O
,	O
and	O
the	O
small	O
standard	O
deviation	O
is	O
commensurate	O
with	O
experimental	O
application	O
.	O

Fluorescent	O
viability	O
staining	O
is	O
a	O
convenient	O
,	O
accurate	O
and	O
reproducible	O
method	O
for	O
localizing	O
and	O
quantifying	O
live	O
and	O
dead	O
bacteria	O
in	O
human	O
ex	O
vivo	O
mineralized	O
dentinal	O
tubules	O
.	O

Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
are	O
opportunistic	O
microorganisms	O
known	O
for	O
their	O
capacity	O
to	O
develop	O
resistance	O
against	O
antimicrobial	O
agents	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
photodynamic	O
therapy	O
(	O
PDT	O
)	O
on	O
20	O
Staphylococcus	B-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
,	O
including	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
schleiferi	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
capitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
haemolyticus	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
lentus	I-bacteria
.	O

A	O
suspension	O
of	O
each	O
Staphylococcus	B-bacteria
strain	I-bacteria
(	O
10	O
(	O
6	O
)	O
cells	O
/	O
mL	O
)	O
was	O
submitted	O
to	O
PDT	O
using	O
methylene	O
blue	O
and	O
a	O
low	O
power	O
laser	O
.	O

The	O
isolated	O
effects	O
of	O
methylene	O
blue	O
,	O
laser	O
treatment	O
and	O
ciprofloxacin	O
were	O
also	O
evaluated	O
.	O

After	O
the	O
experimental	O
treatments	O
,	O
0	O
.	O
1	O
mL	O
aliquots	O
of	O
the	O
suspensions	O
were	O
seeded	O
onto	O
BHI	O
agar	O
for	O
determination	O
of	O
the	O
number	O
of	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
/	O
mL	O
)	O
.	O

The	O
results	O
were	O
analyzed	O
by	O
analysis	O
of	O
variance	O
and	O
Tukey	O
'	O
s	O
test	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
mean	O
reduction	O
in	O
bacterial	O
counts	O
of	O
the	O
strains	O
submitted	O
to	O
PDT	O
ranged	O
from	O
4	O
.	O
89	O
to	O
6	O
.	O
83	O
CFU	O
(	O
log10	O
)	O
/	O
mL	O
,	O
with	O
the	O
observation	O
of	O
a	O
decreasing	O
susceptibility	O
to	O
treatment	O
of	O
S	B-bacteria
.	I-bacteria
schleiferi	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
haemolyticus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
capitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
lentus	I-bacteria
.	O

The	O
results	O
showed	O
that	O
PDT	O
was	O
effective	O
in	O
reducing	O
the	O
number	O
of	O
viable	O
cells	O
of	O
all	O
clinical	O
Staphylococcus	B-bacteria
isolates	I-bacteria
studied	O
.	O

We	O
investigated	O
in	O
a	O
nationally	O
representative	O
sample	O
,	O
how	O
periodontitis	O
modifies	O
the	O
association	O
between	O
the	O
carriage	O
of	O
periodontal	O
pathogens	O
and	O
serology	O
.	O

The	O
population	O
comprised	O
1586	O
dentate	O
subjects	O
who	O
participated	O
in	O
an	O
interview	O
,	O
clinical	O
and	O
radiological	O
oral	O
health	O
examination	O
,	O
and	O
saliva	O
collection	O
.	O

Serum	O
immunoglobulin	O
A	O
(	O
IgA	O
)	O
-	O
and	O
IgG	O
-	O
class	O
antibody	O
levels	O
against	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
their	O
salivary	O
occurrence	O
were	O
determined	O
in	O
the	O
whole	O
population	O
.	O

The	O
quantity	O
of	O
the	O
pathogens	O
was	O
measured	O
in	O
a	O
subpopulation	O
.	O

In	O
the	O
univariate	O
analyses	O
,	O
the	O
corresponding	O
antibody	O
levels	O
were	O
higher	O
in	O
the	O
pathogen	O
carriers	O
compared	O
with	O
the	O
non	O
-	O
carriers	O
,	O
and	O
clearly	O
higher	O
in	O
the	O
carriers	O
with	O
periodontal	O
pockets	O
compared	O
with	O
the	O
carriers	O
without	O
.	O

In	O
the	O
multi	O
-	O
variate	O
analyses	O
,	O
however	O
,	O
all	O
antibody	O
levels	O
associated	O
strongly	O
with	O
age	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
carriage	O
of	O
the	O
corresponding	O
pathogen	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
only	O
weakly	O
with	O
the	O
presence	O
or	O
number	O
of	O
teeth	O
with	O
periodontal	O
pockets	O
.	O

In	O
the	O
subpopulation	O
,	O
the	O
antibody	O
levels	O
and	O
the	O
numbers	O
of	O
corresponding	O
bacteria	O
in	O
saliva	O
had	O
a	O
positive	O
association	O
,	O
which	O
was	O
not	O
affected	O
by	O
the	O
disease	O
.	O

The	O
carriage	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
is	O
the	O
strongest	O
determinant	O
of	O
the	O
systemic	O
antibody	O
response	O
to	O
these	O
pathogens	O
,	O
and	O
the	O
extent	O
of	O
periodontitis	O
has	O
at	O
most	O
a	O
modest	O
modifying	O
effect	O
.	O

West	O
Virginia	O
has	O
the	O
worst	O
oral	O
health	O
in	O
the	O
United	O
States	O
,	O
but	O
the	O
reasons	O
for	O
this	O
are	O
unclear	O
.	O

This	O
pilot	O
study	O
explored	O
the	O
etiology	O
of	O
this	O
disparity	O
using	O
culture	O
-	O
independent	O
analyses	O
to	O
identify	O
bacterial	O
species	O
associated	O
with	O
oral	O
disease	O
.	O

Bacteria	O
in	O
subgingival	O
plaque	O
samples	O
from	O
twelve	O
participants	O
in	O
two	O
independent	O
West	O
Virginia	O
dental	O
-	O
related	O
studies	O
were	O
characterized	O
using	O
16S	O
rRNA	O
gene	O
sequencing	O
and	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
analysis	O
.	O

Unifrac	O
analysis	O
was	O
used	O
to	O
characterize	O
phylogenetic	O
differences	O
between	O
bacterial	O
communities	O
obtained	O
from	O
plaque	O
of	O
participants	O
with	O
low	O
or	O
high	O
oral	O
disease	O
,	O
which	O
was	O
further	O
evaluated	O
using	O
clustering	O
and	O
Principal	O
Coordinate	O
Analysis	O
.	O

Statistically	O
different	O
bacterial	O
signatures	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
were	O
identified	O
in	O
subgingival	O
plaque	O
of	O
individuals	O
with	O
low	O
or	O
high	O
oral	O
disease	O
in	O
West	O
Virginia	O
based	O
on	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

Low	O
disease	O
contained	O
a	O
high	O
frequency	O
of	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
,	O
with	O
a	O
moderate	O
number	O
of	O
Capnocytophaga	B-bacteria
.	O

High	O
disease	O
exhibited	O
substantially	O
increased	O
bacterial	O
diversity	O
and	O
included	O
a	O
large	O
proportion	O
of	O
Clostridiales	B-bacteria
cluster	I-bacteria
bacteria	I-bacteria
(	O
Selenomonas	B-bacteria
,	O
Eubacterium	B-bacteria
,	O
Dialister	B-bacteria
)	O
.	O

Phylogenetic	O
trees	O
constructed	O
using	O
16S	O
rRNA	O
gene	O
sequencing	O
revealed	O
that	O
Clostridiales	B-bacteria
were	O
repeated	O
colonizers	O
in	O
plaque	O
associated	O
with	O
high	O
oral	O
disease	O
,	O
providing	O
evidence	O
that	O
the	O
oral	O
environment	O
is	O
somehow	O
influencing	O
the	O
bacterial	O
signature	O
linked	O
to	O
disease	O
.	O

Culture	O
-	O
independent	O
analyses	O
identified	O
an	O
atypical	O
bacterial	O
signature	O
associated	O
with	O
high	O
oral	O
disease	O
in	O
West	O
Virginians	O
and	O
provided	O
evidence	O
that	O
the	O
oral	O
environment	O
influenced	O
this	O
signature	O
.	O

Both	O
findings	O
provide	O
insight	O
into	O
the	O
etiology	O
of	O
the	O
oral	O
disparity	O
in	O
West	O
Virginia	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
zirconium	O
oxide	O
and	O
titanium	O
alloys	O
with	O
respect	O
to	O
their	O
tendency	O
to	O
adhesion	O
and	O
colonization	O
of	O
two	O
periodontal	O
pathogens	O
on	O
both	O
hard	O
surfaces	O
and	O
on	O
soft	O
tissues	O
in	O
vivo	O
.	O

The	O
present	O
study	O
was	O
designed	O
as	O
a	O
prospective	O
stratified	O
randomized	O
controlled	O
clinical	O
trial	O
.	O

Patients	O
were	O
scheduled	O
to	O
receive	O
two	O
implants	O
with	O
different	O
types	O
of	O
abutments	O
in	O
the	O
posterior	O
mandible	O
.	O

Three	O
months	O
after	O
implant	O
placement	O
,	O
titanium	O
and	O
zirconium	O
abutments	O
were	O
connected	O
.	O

Five	O
weeks	O
after	O
abutment	O
connections	O
,	O
the	O
abutments	O
were	O
removed	O
,	O
probing	O
depth	O
measurements	O
were	O
recorded	O
,	O
and	O
gingival	O
biopsy	O
samples	O
were	O
obtained	O
.	O

Abutments	O
and	O
biopsy	O
specimens	O
were	O
analyzed	O
by	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
to	O
compare	O
the	O
DNA	O
copy	O
numbers	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
total	O
bacteria	O
.	O

The	O
surface	O
free	O
energy	O
of	O
the	O
abutments	O
was	O
calculated	O
by	O
sesile	O
water	O
drop	O
before	O
replacement	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
found	O
between	O
probing	O
depths	O
or	O
DNA	O
copy	O
numbers	O
of	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
gingivalis	I-bacteria
,	O
and	O
total	O
bacteria	O
both	O
for	O
both	O
titanium	O
alloys	O
and	O
zirconium	O
oxide	O
surfaces	O
and	O
the	O
biops	O
specimens	O
obtained	O
from	O
their	O
buccal	O
gingival	O
.	O

With	O
respect	O
to	O
the	O
surface	O
free	O
energy	O
of	O
zirconium	O
and	O
titanium	O
abutments	O
,	O
zirconium	O
abutments	O
showed	O
lower	O
surface	O
free	O
energy	O
than	O
titanium	O
abutments	O
.	O

The	O
results	O
of	O
this	O
study	O
showed	O
that	O
zirconium	O
oxide	O
surfaces	O
have	O
comparable	O
properties	O
to	O
titanium	O
alloy	O
surfaces	O
in	O
their	O
tendency	O
to	O
adhesion	O
and	O
colonization	O
of	O
two	O
periodontal	O
pathogens	O
on	O
both	O
hard	O
surfaces	O
and	O
in	O
soft	O
tissues	O
.	O

Epidemiological	O
evidence	O
suggests	O
that	O
infections	O
may	O
contribute	O
to	O
atherogenesis	O
.	O

However	O
,	O
with	O
the	O
exception	O
of	O
Chlamydophila	B-bacteria
pneumoniae	I-bacteria
,	O
cultivable	O
bacteria	O
have	O
not	O
been	O
recovered	O
from	O
atherosclerotic	O
lesions	O
.	O

Therefore	O
,	O
we	O
aimed	O
at	O
developing	O
an	O
approach	O
to	O
recover	O
uncultivable	O
bacteria	O
from	O
atherectomy	O
tissues	O
.	O

We	O
cultured	O
homogenates	O
from	O
atherectomy	O
specimens	O
from	O
seven	O
nonseptic	O
patients	O
undergoing	O
surgery	O
for	O
arterial	O
obstruction	O
either	O
alone	O
or	O
together	O
with	O
THP	O
-	O
1	O
monocyte	O
-	O
like	O
cells	O
.	O

We	O
performed	O
16S	O
rDNA	O
analysis	O
,	O
biochemical	O
tests	O
,	O
random	O
amplification	O
of	O
polymorphic	O
DNA	O
PCR	O
analysis	O
,	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
and	O
immunohistofluorescence	O
to	O
identify	O
the	O
cultivated	O
bacteria	O
.	O

Wilcoxon	O
signed	O
-	O
rank	O
tests	O
were	O
used	O
to	O
determine	O
whether	O
THP	O
-	O
1	O
treatment	O
yielded	O
a	O
higher	O
number	O
of	O
isolates	O
than	O
did	O
the	O
untreated	O
controls	O
.	O

We	O
recovered	O
more	O
bacteria	O
from	O
cocultures	O
of	O
atherectomy	O
specimens	O
with	O
THP	O
-	O
1	O
cells	O
than	O
atherectomy	O
specimens	O
cultured	O
alone	O
.	O

On	O
average	O
,	O
tissue	O
homogenates	O
incubated	O
with	O
THP	O
-	O
1	O
cells	O
versus	O
control	O
yielded	O
124	O
vs	O
.	O
22	O
colony	O
-	O
forming	O
units	O
,	O
a	O
median	O
of	O
140	O
vs	O
.	O
7	O
,	O
respectively	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
.	O

We	O
recovered	O
872	O
isolates	O
of	O
limited	O
number	O
of	O
species	O
,	O
including	O
Propionibacterium	B-bacteria
acnes	I-bacteria
,	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
and	O
Streptococcus	B-bacteria
infantis	I-bacteria
and	O
the	O
fastidious	O
anaerobe	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
confirmed	O
its	O
presence	O
in	O
tissue	O
using	O
double	O
immunofluorescence	O
imaging	O
.	O

qPCR	O
demonstrated	O
the	O
presence	O
of	O
>	O
/	O
=	O
3	O
.	O
5	O
x	O
10	O
(	O
3	O
)	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
genomes	O
per	O
gram	O
of	O
atheromatous	O
tissue	O
.	O

These	O
results	O
indicate	O
that	O
viable	O
previously	O
uncultivable	O
bacterial	O
species	O
are	O
present	O
within	O
atheromas	O
.	O

Our	O
results	O
suggest	O
revisiting	O
the	O
hypothesis	O
that	O
infections	O
may	O
have	O
a	O
causative	O
role	O
in	O
atherosclerotic	O
inflammation	O
and	O
have	O
implications	O
for	O
research	O
regarding	O
novel	O
diagnostics	O
and	O
treatments	O
for	O
cardiovascular	O
disease	O
.	O

An	O
understanding	O
of	O
the	O
relation	O
of	O
commensal	O
microbiota	O
to	O
health	O
is	O
essential	O
in	O
preventing	O
disease	O
.	O

Here	O
we	O
studied	O
the	O
oral	O
microbial	O
composition	O
of	O
children	O
(	O
N	O
=	O
74	O
,	O
aged	O
3	O
-	O
18	O
years	O
)	O
in	O
natural	O
transition	O
from	O
their	O
deciduous	O
to	O
a	O
permanent	O
dentition	O
and	O
related	O
the	O
microbial	O
profiles	O
to	O
their	O
oral	O
health	O
status	O
.	O

The	O
microbial	O
composition	O
of	O
saliva	O
was	O
assessed	O
by	O
barcoded	O
pyrosequencing	O
of	O
the	O
V5	O
-	O
V6	O
hypervariable	O
regions	O
of	O
the	O
16	O
S	O
rRNA	O
,	O
as	O
well	O
as	O
by	O
using	O
phylogenetic	O
microarrays	O
.	O

Pyrosequencing	O
reads	O
(	O
126174	O
reads	O
,	O
1045	O
unique	O
sequences	O
)	O
represented	O
8	O
phyla	O
and	O
113	O
higher	O
taxa	O
in	O
saliva	O
samples	O
.	O

Four	O
phyla	O
-	O
-	O
Firmicutes	B-bacteria
,	O
Bacteriodetes	B-bacteria
,	O
Proteobacteria	B-bacteria
and	O
Actinobacteria	B-bacteria
-	O
-	O
predominated	O
in	O
all	O
groups	O
.	O

The	O
deciduous	O
dentition	O
harboured	O
a	O
higher	O
proportion	O
of	O
Proteobacteria	B-bacteria
(	O
Gammaproteobacteria	B-bacteria
,	O
Moraxellaceae	B-bacteria
)	O
than	O
Bacteroidetes	B-bacteria
,	O
while	O
in	O
all	O
other	O
groups	O
Bacteroidetes	B-bacteria
were	O
at	O
least	O
as	O
abundant	O
as	O
Proteobacteria	B-bacteria
.	O

Bacteroidetes	B-bacteria
(	O
mainly	O
genus	B-bacteria
Prevotella	I-bacteria
)	O
,	O
Veillonellaceae	B-bacteria
family	I-bacteria
,	O
Spirochaetes	B-bacteria
and	O
candidate	O
division	O
TM7	B-bacteria
increased	O
with	O
increasing	O
age	O
,	O
reflecting	O
maturation	O
of	O
the	O
microbiome	O
driven	O
by	O
biological	O
changes	O
with	O
age	O
.	O

Microarray	O
analysis	O
enabled	O
further	O
analysis	O
of	O
the	O
individual	O
salivary	O
microbiota	O
.	O

Of	O
350	O
microarray	O
probes	O
,	O
156	O
gave	O
a	O
positive	O
signal	O
with	O
,	O
on	O
average	O
,	O
77	O
(	O
range	O
48	O
-	O
93	O
)	O
probes	O
per	O
individual	O
sample	O
.	O

A	O
caries	O
-	O
free	O
oral	O
status	O
significantly	O
associated	O
with	O
the	O
higher	O
signal	O
of	O
the	O
probes	O
targeting	O
Porphyromonas	B-bacteria
catoniae	I-bacteria
and	O
Neisseria	B-bacteria
flavescens	I-bacteria
.	O

The	O
potential	O
role	O
of	O
P	B-bacteria
.	I-bacteria
catoniae	I-bacteria
and	O
N	B-bacteria
.	I-bacteria
flavescens	I-bacteria
as	O
oral	O
health	O
markers	O
should	O
be	O
assessed	O
in	O
large	O
-	O
scale	O
clinical	O
studies	O
.	O

The	O
combination	O
of	O
both	O
open	O
-	O
ended	O
and	O
targeted	O
molecular	O
approaches	O
provides	O
us	O
with	O
information	O
that	O
will	O
increase	O
our	O
understanding	O
of	O
the	O
interplay	O
between	O
the	O
human	O
host	O
and	O
its	O
microbiome	O
.	O

We	O
show	O
that	O
bacteria	O
with	O
methylotrophic	O
potential	O
are	O
ubiquitous	O
in	O
the	O
human	O
mouth	O
microbiota	O
.	O

Numerous	O
strains	O
of	O
Actinobacteria	B-bacteria
(	O
Brevibacterium	B-bacteria
,	O
Gordonia	B-bacteria
,	O
Leifsonia	B-bacteria
,	O
Microbacterium	B-bacteria
,	O
Micrococcus	B-bacteria
,	O
Rhodococcus	B-bacteria
)	O
and	O
Proteobacteria	B-bacteria
(	O
Achromobacter	B-bacteria
,	O
Klebsiella	B-bacteria
,	O
Methylobacterium	B-bacteria
,	O
Pseudomonas	B-bacteria
,	O
Ralstonia	B-bacteria
)	O
were	O
isolated	O
,	O
and	O
one	O
strain	O
of	O
each	O
of	O
the	O
eleven	O
genera	O
was	O
studied	O
in	O
detail	O
.	O

These	O
strains	O
expressed	O
enzymes	O
associated	O
with	O
methylotrophic	O
metabolism	O
(	O
methanol	O
,	O
methylamine	O
,	O
and	O
formate	O
dehydrogenases	O
)	O
,	O
and	O
the	O
assimilation	O
of	O
one	O
-	O
carbon	O
compounds	O
by	O
the	O
serine	O
pathway	O
(	O
hydroxypyruvate	O
reductase	O
)	O
.	O

Methylotrophic	O
growth	O
of	O
the	O
strains	O
was	O
enhanced	O
by	O
the	O
addition	O
of	O
glass	O
beads	O
to	O
cultures	O
,	O
suggesting	O
that	O
they	O
may	O
naturally	O
occur	O
in	O
biofilms	O
in	O
the	O
mouth	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
Gordonia	B-bacteria
,	O
Leifsonia	B-bacteria
,	O
and	O
Rhodococcus	B-bacteria
being	O
present	O
in	O
the	O
mouth	O
and	O
of	O
the	O
unequivocal	O
demonstration	O
for	O
the	O
first	O
time	O
of	O
the	O
methylotrophic	O
potential	O
of	O
strains	O
of	O
Gordonia	B-bacteria
,	O
Leifsonia	B-bacteria
,	O
and	O
Microbacterium	B-bacteria
.	O

To	O
determine	O
ability	O
of	O
lactobacilli	B-bacteria
strains	I-bacteria
indigenous	O
for	O
oral	O
cavity	O
of	O
healthy	O
persons	O
to	O
adhesion	O
,	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
and	O
formation	O
of	O
biofilms	O
.	O

Twenty	O
-	O
three	O
anatagonistically	O
active	O
isolates	O
of	O
lactobacilli	B-bacteria
,	O
including	O
5	O
strains	O
of	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
,	O
6	O
-	O
-	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
,	O
4	O
-	O
-	O
L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
,	O
and	O
8	O
-	O
-	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
,	O
were	O
studied	O
.	O

Characteristics	O
of	O
lactobacilli	B-bacteria
associated	O
with	O
adhesion	O
,	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
,	O
and	O
formation	O
of	O
biofilms	O
were	O
determined	O
.	O

Bacteria	O
were	O
characterized	O
by	O
high	O
and	O
intermediate	O
level	O
of	O
adhesion	O
,	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
expressed	O
ability	O
to	O
form	O
biofilms	O
and	O
different	O
coaggregation	O
activity	O
relative	O
to	O
test	O
-	O
strains	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Candida	O
albicans	O
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
and	O
Bacillus	B-bacteria
subtilis	I-bacteria
.	O

Studied	O
characteristics	O
of	O
lactobacilli	B-bacteria
could	O
be	O
used	O
for	O
development	O
of	O
new	O
probiotics	O
aimed	O
at	O
stabilization	O
of	O
oral	O
cavity	O
normoflora	O
.	O

The	O
loads	O
and	O
locations	O
of	O
bacterial	O
types	O
associated	O
with	O
oral	O
malodour	O
on	O
the	O
tongue	O
surface	O
and	O
gingival	O
crevice	O
were	O
investigated	O
in	O
man	O
and	O
the	O
dog	O
respectively	O
.	O

In	O
the	O
human	O
study	O
,	O
samples	O
were	O
taken	O
from	O
50	O
subjects	O
with	O
brushes	O
at	O
the	O
dorsal	O
anterior	O
,	O
dorsal	O
middle	O
,	O
dorsal	O
posterior	O
,	O
dorsal	O
posterior	O
to	O
the	O
circumvallate	O
papillae	O
(	O
DPCP	O
)	O
,	O
lateral	O
posterior	O
and	O
ventral	O
posterior	O
(	O
VP	O
)	O
surfaces	O
,	O
and	O
cultured	O
appropriately	O
.	O

Malodour	O
was	O
assessed	O
by	O
trained	O
judges	O
.	O

Mean	O
volatile	O
sulfur	O
compound	O
(	O
VSC	O
)	O
producing	O
bacterial	O
counts	O
(	O
colony	O
forming	O
units	O
/	O
brush	O
x	O
10	O
(	O
5	O
)	O
)	O
were	O
found	O
to	O
be	O
highest	O
(	O
88	O
.	O
94	O
)	O
and	O
lowest	O
(	O
0	O
.	O
33	O
)	O
at	O
the	O
DPCP	O
and	O
VP	O
sites	O
respectively	O
.	O

Anaerobic	O
,	O
gram	O
-	O
negative	O
and	O
VSC	O
counts	O
at	O
DPCP	O
surfaces	O
increased	O
with	O
malodour	O
intensity	O
,	O
whereas	O
aerobic	O
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
counts	O
decreased	O
.	O

The	O
prevalence	O
and	O
populations	O
of	O
the	O
VSC	O
producing	O
Porphyromonas	B-bacteria
and	O
Prevotella	B-bacteria
species	I-bacteria
were	O
determined	O
in	O
the	O
dental	O
plaque	O
from	O
34	O
dogs	O
.	O

Porphyromonas	B-bacteria
gulae	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
were	O
present	O
in	O
68	O
%	O
and	O
44	O
%	O
of	O
dogs	O
,	O
and	O
47	O
%	O
and	O
23	O
%	O
of	O
plaque	O
samples	O
respectively	O
.	O

P	B-bacteria
.	I-bacteria
gulae	I-bacteria
and	O
Prev	B-bacteria
.	I-bacteria
intermedia	I-bacteria
counts	O
increased	O
with	O
plaque	O
quantity	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
gingivitis	O
(	O
P	O
<	O
0	O
.	O
1	O
)	O
.	O

The	O
close	O
association	O
observed	O
between	O
canine	O
periodontal	O
disease	O
and	O
measurements	O
of	O
oral	O
malodour	O
is	O
supported	O
.	O

Pathogens	O
related	O
to	O
systemic	O
infections	O
have	O
been	O
detected	O
in	O
the	O
periodontal	O
microbiota	O
.	O

The	O
relationship	O
amongst	O
these	O
pathogens	O
,	O
periodontal	O
bacteria	O
and	O
periodontal	O
clinical	O
status	O
is	O
poorly	O
understood	O
.	O

This	O
study	O
evaluated	O
the	O
association	O
amongst	O
red	O
complex	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
)	O
and	O
non	O
-	O
oral	O
pathogenic	O
bacteria	O
in	O
subjects	O
with	O
good	O
periodontal	O
health	O
(	O
PH	O
)	O
,	O
gingivitis	O
(	O
G	O
)	O
,	O
chronic	O
(	O
CP	O
)	O
and	O
aggressive	O
(	O
AP	O
)	O
periodontitis	O
.	O

Subgingival	O
biofilm	O
samples	O
were	O
obtained	O
from	O
51	O
PH	O
,	O
42	O
G	O
,	O
219	O
CP	O
and	O
90	O
AP	O
subjects	O
.	O

The	O
presence	O
and	O
levels	O
of	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
,	O
red	O
complex	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
,	O
Acinetobacter	B-bacteria
baumannii	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
were	O
determined	O
by	O
DNA	O
probes	O
and	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
.	O

CP	O
and	O
AP	O
subjects	O
presented	O
significantly	O
higher	O
prevalence	O
and	O
levels	O
of	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
,	O
red	O
complex	O
and	O
A	B-bacteria
.	I-bacteria
baumannii	I-bacteria
than	O
G	O
and	O
PH	O
individuals	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
whereas	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
was	O
detected	O
in	O
lower	O
frequency	O
and	O
counts	O
in	O
AP	O
as	O
compared	O
to	O
the	O
other	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
predictor	O
variables	O
age	O
,	O
prevalence	O
of	O
red	O
complex	O
,	O
and	O
the	O
presence	O
of	O
A	B-bacteria
.	I-bacteria
baumannii	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
were	O
strongly	O
associated	O
with	O
the	O
frequency	O
of	O
sites	O
with	O
PD	O
and	O
CAL	O
>	O
/	O
=	O
5	O
mm	O
.	O

Increasing	O
age	O
(	O
OR	O
1	O
.	O
08	O
)	O
,	O
high	O
frequency	O
of	O
red	O
complex	O
(	O
OR	O
6	O
.	O
10	O
)	O
,	O
and	O
the	O
presence	O
of	O
A	O
.	O
a	O
with	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
OR	O
1	O
.	O
90	O
)	O
were	O
associated	O
with	O
periodontal	O
disease	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Subjects	O
harbouring	O
a	O
high	O
prevalence	O
of	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
baumannii	I-bacteria
,	O
and	O
red	O
complex	O
with	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
were	O
more	O
likely	O
to	O
have	O
AP	O
than	O
CP	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Putative	O
periodontal	O
pathogens	O
and	O
non	O
-	O
oral	O
bacteria	O
alone	O
or	O
in	O
association	O
were	O
strongly	O
associated	O
with	O
periodontitis	O
.	O

Prunus	O
mume	O
is	O
a	O
common	O
fruit	O
in	O
Asia	O
,	O
which	O
has	O
been	O
used	O
in	O
traditional	O
Chinese	O
medicine	O
.	O

In	O
this	O
study	O
,	O
we	O
focused	O
on	O
the	O
antimicrobial	O
properties	O
of	O
Prunus	O
mume	O
extract	O
against	O
oral	O
pathogens	O
related	O
to	O
dental	O
caries	O
and	O
periodontal	O
diseases	O
.	O

A	O
total	O
of	O
15	O
oral	O
pathogens	O
including	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
Candida	O
species	O
were	O
included	O
in	O
the	O
study	O
.	O

Initially	O
,	O
agar	O
diffusion	O
assay	O
was	O
performed	O
to	O
screen	O
the	O
antimicrobial	O
activities	O
of	O
Prunus	O
mume	O
extract	O
.	O

Minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
and	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
were	O
then	O
determined	O
for	O
sensitive	O
species	O
.	O

Effect	O
of	O
Prunus	O
mume	O
extract	O
on	O
human	O
oral	O
keratinocytes	O
(	O
HOK	O
)	O
viability	O
was	O
also	O
tested	O
.	O

In	O
the	O
agar	O
diffusion	O
assay	O
,	O
drug	O
suspension	O
of	O
2	O
g	O
/	O
mL	O
was	O
able	O
to	O
inhibit	O
all	O
the	O
bacterial	O
species	O
tested	O
,	O
but	O
not	O
the	O
fungal	O
species	O
.	O

MIC	O
and	O
MBC	O
range	O
of	O
Prunus	O
mume	O
extract	O
against	O
the	O
oral	O
bacteria	O
was	O
0	O
.	O
15625	O
-	O
0	O
.	O
0003	O
g	O
/	O
mL	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
being	O
the	O
most	O
susceptible	O
species	O
.	O

Prune	O
extract	O
did	O
not	O
cause	O
any	O
detrimental	O
effect	O
on	O
HOK	O
.	O

Prunus	O
mume	O
extract	O
may	O
be	O
a	O
potential	O
candidate	O
for	O
developing	O
an	O
oral	O
antimicrobial	O
agent	O
to	O
control	O
or	O
prevent	O
dental	O
diseases	O
associated	O
with	O
oral	O
pathogenic	O
bacteria	O
.	O

This	O
study	O
assessed	O
the	O
prevalence	O
of	O
colonization	O
by	O
Staphylococcus	B-bacteria
aureus	I-bacteria
in	O
hospital	O
housekeepers	O
,	O
and	O
their	O
knowledge	O
and	O
beliefs	O
regarding	O
this	O
problem	O
.	O

Three	O
saliva	O
samples	O
were	O
collected	O
and	O
a	O
questionnaire	O
regarding	O
knowledge	O
and	O
beliefs	O
was	O
applied	O
.	O

Of	O
the	O
92	O
workers	O
,	O
63	O
(	O
68	O
.	O
5	O
%	O
)	O
participated	O
in	O
the	O
study	O
;	O
20	O
were	O
not	O
and	O
43	O
were	O
colonized	O
;	O
13	O
by	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
and	O
30	O
by	O
methicillin	B-bacteria
sensitive	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
.	O

Persistent	O
carrier	O
status	O
of	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
was	O
detected	O
in	O
15	O
.	O
4	O
%	O
of	O
cases	O
.	O

Low	O
knowledge	O
and	O
perception	O
of	O
occupational	O
risk	O
were	O
observed	O
.	O

The	O
mouth	O
was	O
identified	O
as	O
an	O
important	O
reservoir	O
of	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
.	O

Analyzing	O
knowledge	O
and	O
beliefs	O
,	O
as	O
well	O
as	O
the	O
state	O
of	O
carrier	O
,	O
is	O
an	O
important	O
strategy	O
to	O
be	O
added	O
to	O
educational	O
actions	O
for	O
the	O
prevention	O
of	O
workers	O
'	O
colonization	O
.	O

In	O
this	O
work	O
,	O
we	O
review	O
the	O
state	O
of	O
knowledge	O
of	O
Archaea	O
associated	O
with	O
the	O
human	O
microbiome	O
.	O

These	O
prokaryotes	O
,	O
initially	O
discovered	O
in	O
extreme	O
environments	O
,	O
were	O
named	O
Archaea	O
because	O
these	O
environments	O
were	O
thought	O
to	O
be	O
the	O
most	O
primitive	O
on	O
Earth	O
.	O

Further	O
research	O
revealed	O
that	O
this	O
terminology	O
is	O
misleading	O
because	O
these	O
organisms	O
were	O
later	O
found	O
in	O
various	O
non	O
-	O
extreme	O
environments	O
,	O
including	O
the	O
human	O
host	O
.	O

Further	O
examination	O
of	O
the	O
human	O
microbiome	O
has	O
enabled	O
the	O
isolation	O
of	O
three	O
archaeal	O
species	O
,	O
Methanobrevibacter	B-bacteria
smithii	I-bacteria
,	O
Methanosphaera	B-bacteria
stadtmanae	I-bacteria
and	O
Methanobrevibacter	B-bacteria
oralis	I-bacteria
,	O
which	O
are	O
associated	O
with	O
oral	O
,	O
intestinal	O
and	O
vaginal	O
mucosae	O
in	O
humans	O
.	O

Moreover	O
,	O
molecular	O
studies	O
including	O
metagenomic	O
analyses	O
detected	O
DNA	O
sequences	O
indicative	O
of	O
the	O
presence	O
of	O
additional	O
methanogenic	O
and	O
non	O
-	O
methanogenic	O
Archaea	O
in	O
the	O
human	O
intestinal	O
tract	O
.	O

All	O
three	O
culturable	O
Archaea	O
are	O
strict	O
anaerobes	O
,	O
although	O
their	O
potential	O
role	O
in	O
human	O
diseases	O
remains	O
to	O
be	O
established	O
.	O

Future	O
research	O
aims	O
to	O
detect	O
and	O
culture	O
additional	O
human	O
mucosa	O
-	O
associated	O
Archaea	O
and	O
to	O
look	O
for	O
their	O
presence	O
in	O
additional	O
human	O
tissues	O
,	O
to	O
establish	O
their	O
role	O
in	O
human	O
infections	O
involving	O
complex	O
flora	O
.	O

The	O
aim	O
was	O
to	O
evaluate	O
the	O
presence	O
of	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
Pseudomonadaceae	B-bacteria
in	O
the	O
oral	O
cavities	O
of	O
HIV	O
-	O
positive	O
patients	O
.	O

Forty	O
-	O
five	O
individuals	O
diagnosed	O
as	O
HIV	O
-	O
positive	O
by	O
ELISA	O
and	O
Western	O
-	O
blot	O
,	O
and	O
under	O
anti	O
-	O
retroviral	O
therapy	O
for	O
at	O
least	O
1	O
year	O
,	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
control	O
group	O
constituted	O
45	O
systemically	O
healthy	O
individuals	O
matched	O
to	O
the	O
HIV	O
patients	O
to	O
gender	O
,	O
age	O
and	O
oral	O
conditions	O
.	O

Oral	O
rinses	O
were	O
collected	O
and	O
isolates	O
were	O
identified	O
by	O
API	O
system	O
.	O

Counts	O
of	O
microorganisms	O
from	O
HIV	O
and	O
control	O
groups	O
were	O
compared	O
statistically	O
by	O
a	O
Mann	O
-	O
Whitney	O
test	O
(	O
alpha	O
=	O
5	O
%	O
)	O
.	O

The	O
percentages	O
of	O
individuals	O
positive	O
for	O
staphylococci	B-bacteria
were	O
similar	O
between	O
the	O
groups	O
(	O
p	O
=	O
0	O
.	O
764	O
)	O
,	O
whereas	O
for	O
Gram	O
-	O
negative	O
rods	O
,	O
a	O
higher	O
percentage	O
was	O
observed	O
amongst	O
HIV	O
-	O
positive	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O

There	O
was	O
no	O
difference	O
in	O
Staphylococcus	B-bacteria
counts	O
between	O
HIV	O
and	O
control	O
groups	O
(	O
p	O
=	O
0	O
.	O
1008	O
)	O
.	O

Counts	O
were	O
lower	O
in	O
the	O
oral	O
cavities	O
of	O
patients	O
with	O
low	O
viral	O
load	O
(	O
p	O
=	O
0	O
.	O
021	O
)	O
,	O
and	O
no	O
difference	O
was	O
observed	O
in	O
relation	O
to	O
CD4	O
counts	O
(	O
p	O
=	O
0	O
.	O
929	O
)	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
the	O
most	O
frequently	O
isolated	O
species	O
in	O
HIV	O
group	O
,	O
and	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
was	O
the	O
prevalent	O
species	O
in	O
the	O
control	O
group	O
.	O

Significantly	O
higher	O
numbers	O
of	O
enteric	O
bacteria	O
and	O
pseudomonas	B-bacteria
were	O
detected	O
in	O
the	O
oral	O
cavities	O
of	O
the	O
HIV	O
group	O
than	O
in	O
the	O
control	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
.	O

Enterobacter	B-bacteria
cloacae	I-bacteria
was	O
the	O
most	O
frequently	O
isolated	O
species	O
in	O
both	O
groups	O
.	O

Counts	O
of	O
enteric	O
bacteria	O
and	O
pseudomonas	B-bacteria
were	O
significantly	O
lower	O
in	O
patients	O
with	O
low	O
CD4	O
counts	O
(	O
p	O
=	O
0	O
.	O
011	O
)	O
;	O
however	O
,	O
there	O
was	O
no	O
difference	O
relating	O
to	O
viral	O
load	O
.	O

It	O
may	O
be	O
concluded	O
that	O
HIV	O
group	O
showed	O
greater	O
species	O
diversity	O
and	O
a	O
higher	O
prevalence	O
of	O
Enterobacteriaceae	B-bacteria
/	O
Pseudomonadaceae	B-bacteria
.	O

The	O
AIDS	O
pandemic	O
continues	O
.	O

Little	O
is	O
understood	O
about	O
how	O
HIV	O
gains	O
access	O
to	O
permissive	O
cells	O
across	O
mucosal	O
surfaces	O
,	O
yet	O
such	O
knowledge	O
is	O
crucial	O
to	O
the	O
development	O
of	O
successful	O
topical	O
anti	O
-	O
HIV	O
-	O
1	O
agents	O
and	O
mucosal	O
vaccines	O
.	O

HIV	O
-	O
1	O
rapidly	O
internalizes	O
and	O
integrates	O
into	O
the	O
mucosal	O
keratinocyte	O
genome	O
,	O
and	O
integrated	O
copies	O
of	O
HIV	O
-	O
1	O
persist	O
upon	O
cell	O
passage	O
.	O

The	O
virus	O
does	O
not	O
appear	O
to	O
replicate	O
,	O
and	O
the	O
infection	O
may	O
become	O
latent	O
.	O

Interactions	O
between	O
HIV	O
-	O
1	O
and	O
oral	O
keratinocytes	O
have	O
been	O
modeled	O
in	O
the	O
context	O
of	O
key	O
environmental	O
factors	O
,	O
including	O
putative	O
copathogens	O
and	O
saliva	O
.	O

In	O
keratinocytes	O
,	O
HIV	O
-	O
1	O
internalizes	O
within	O
minutes	O
;	O
in	O
saliva	O
,	O
an	O
infectious	O
fraction	O
escapes	O
inactivation	O
and	O
is	O
harbored	O
and	O
transferable	O
to	O
permissive	O
target	O
cells	O
for	O
up	O
to	O
48	O
hours	O
.	O

When	O
incubated	O
with	O
the	O
common	O
oral	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
CCR5	O
-	O
oral	O
keratinocytes	O
signal	O
through	O
protease	O
-	O
activated	O
receptors	O
and	O
Toll	O
-	O
like	O
receptors	O
to	O
induce	O
expression	O
of	O
CCR5	O
,	O
which	O
increases	O
selective	O
uptake	O
of	O
infectious	O
R5	O
-	O
tropic	O
HIV	O
-	O
1	O
into	O
oral	O
keratinocytes	O
and	O
transfer	O
to	O
permissive	O
cells	O
.	O

Hence	O
,	O
oral	O
keratinocytes	O
-	O
like	O
squamous	O
keratinocytes	O
of	O
other	O
tissues	O
-	O
may	O
be	O
targets	O
for	O
low	O
-	O
level	O
HIV	O
-	O
1	O
internalization	O
and	O
subsequent	O
dissemination	O
by	O
transfer	O
to	O
permissive	O
cells	O
.	O

Oral	O
biofilms	O
such	O
as	O
dental	O
plaque	O
cause	O
dental	O
caries	O
and	O
periodontitis	O
,	O
as	O
well	O
as	O
aspiration	O
pneumonia	O
and	O
infectious	O
endocarditis	O
by	O
translocation	O
.	O

Hence	O
,	O
the	O
suppression	O
of	O
oral	O
biofilm	O
formation	O
is	O
an	O
issue	O
of	O
considerable	O
importance	O
.	O

Mechanical	O
removal	O
,	O
disinfectants	O
,	O
inhibition	O
of	O
polysaccharide	O
formation	O
,	O
and	O
artificial	O
sugar	O
have	O
been	O
used	O
for	O
the	O
reduction	O
of	O
oral	O
biofilm	O
.	O

From	O
the	O
viewpoint	O
of	O
the	O
inhibition	O
of	O
bacterial	O
adherence	O
,	O
we	O
investigated	O
whether	O
aqueous	O
biocompatible	O
2	O
-	O
methacryloyloxyethyl	O
phosphorylcholine	O
(	O
MPC	O
)	O
-	O
polymer	O
can	O
reduce	O
streptococcal	B-bacteria
colonization	O
and	O
biofilm	O
formation	O
.	O

We	O
examined	O
the	O
effects	O
of	O
MPC	O
-	O
polymer	O
on	O
streptococcal	O
adherence	O
to	O
saliva	O
-	O
coated	O
hydroxyapatite	O
and	O
oral	O
epithelial	O
cells	O
,	O
and	O
the	O
adherence	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
to	O
streptococcal	B-bacteria
biofilm	O
.	O

MPC	O
-	O
polymer	O
application	O
markedly	O
inhibited	O
both	O
the	O
adherence	O
and	O
biofilm	O
formation	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
on	O
saliva	O
-	O
coated	O
hydroxyapatite	O
and	O
streptococcal	O
adherence	O
to	O
oral	O
epithelial	O
cells	O
,	O
and	O
reduced	O
the	O
adherence	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
streptococcal	O
biofilms	O
.	O

A	O
small	O
-	O
scale	O
clinical	O
trial	O
revealed	O
that	O
mouthrinsing	O
with	O
MPC	O
-	O
polymer	O
inhibited	O
the	O
increase	O
of	O
oral	O
bacterial	O
numbers	O
,	O
especially	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

These	O
findings	O
suggest	O
that	O
MPC	O
-	O
polymer	O
is	O
a	O
potent	O
inhibitor	O
of	O
bacterial	O
adherence	O
and	O
biofilm	O
development	O
,	O
and	O
may	O
be	O
useful	O
to	O
prevent	O
dental	O
-	O
plaque	O
-	O
related	O
diseases	O
.	O

Dental	O
caries	O
(	O
tooth	O
decay	O
)	O
is	O
caused	O
by	O
a	O
specific	O
group	O
of	O
cariogenic	O
bacteria	O
,	O
like	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
which	O
convert	O
dietary	O
sugars	O
into	O
acids	O
that	O
dissolve	O
the	O
mineral	O
in	O
tooth	O
structure	O
.	O

Killing	O
cariogenic	O
bacteria	O
is	O
an	O
effective	O
way	O
to	O
control	O
or	O
prevent	O
tooth	O
decay	O
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
discovered	O
a	O
novel	O
compound	O
(	O
Glycyrrhizol	O
A	O
)	O
,	O
from	O
the	O
extraction	O
of	O
licorice	O
roots	O
,	O
with	O
strong	O
antimicrobial	O
activity	O
against	O
cariogenic	O
bacteria	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
developed	O
a	O
method	O
to	O
produce	O
these	O
specific	O
herbal	O
extracts	O
in	O
large	O
quantities	O
,	O
and	O
then	O
used	O
these	O
extracts	O
to	O
develop	O
a	O
sugar	O
-	O
free	O
lollipop	O
that	O
effectively	O
kills	O
cariogenic	O
bacteria	O
like	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

Further	O
studies	O
showed	O
that	O
these	O
sugar	O
-	O
free	O
lollipops	O
are	O
safe	O
and	O
their	O
antimicrobial	O
activity	O
is	O
stable	O
.	O

Two	O
pilot	O
human	O
studies	O
indicate	O
that	O
a	O
brief	O
application	O
of	O
these	O
lollipops	O
(	O
twice	O
a	O
day	O
for	O
ten	O
days	O
)	O
led	O
to	O
a	O
marked	O
reduction	O
of	O
cariogenic	O
bacteria	O
in	O
oral	O
cavity	O
among	O
most	O
human	O
subjects	O
tested	O
.	O

This	O
herbal	O
lollipop	O
could	O
be	O
a	O
novel	O
tool	O
to	O
promote	O
oral	O
health	O
through	O
functional	O
foods	O
.	O

The	O
cytolethal	O
distending	O
toxin	O
(	O
Cdt	O
)	O
,	O
expressed	O
by	O
the	O
periodontal	O
pathogen	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
inhibits	O
the	O
proliferation	O
of	O
cultured	O
epithelial	O
cells	O
by	O
arresting	O
the	O
cell	O
cycle	O
.	O

The	O
gingival	O
epithelium	O
is	O
an	O
early	O
line	O
of	O
defense	O
against	O
microbial	O
assault	O
.	O

When	O
damaged	O
,	O
bacteria	O
collectively	O
gain	O
entry	O
into	O
underlying	O
connective	O
biofilm	O
where	O
microbial	O
products	O
can	O
affect	O
infiltrating	O
inflammatory	O
cells	O
,	O
leading	O
to	O
the	O
destruction	O
of	O
the	O
attachment	O
apparatus	O
.	O

Histological	O
evaluation	O
of	O
rat	O
and	O
healthy	O
human	O
gingival	O
biofilm	O
exposed	O
ex	O
vivo	O
to	O
the	O
Cdt	O
for	O
36	O
and	O
18	O
hours	O
,	O
respectively	O
,	O
revealed	O
extensive	O
detachment	O
of	O
the	O
keratinized	O
outer	O
layer	O
and	O
distention	O
of	O
spinous	O
and	O
basal	O
cells	O
in	O
the	O
oral	O
epithelium	O
.	O

Treated	O
human	O
biofilm	O
also	O
exhibited	O
disruption	O
of	O
rete	O
pegs	O
and	O
dissolution	O
of	O
cell	O
junctions	O
.	O

Cells	O
in	O
the	O
connective	O
biofilm	O
appeared	O
unaffected	O
.	O

Primary	O
gingival	O
epithelial	O
cells	O
,	O
but	O
not	O
gingival	O
fibroblasts	O
,	O
isolated	O
from	O
the	O
same	O
healthy	O
human	O
biofilm	O
were	O
cell	O
-	O
cycle	O
-	O
arrested	O
when	O
treated	O
with	O
the	O
toxin	O
.	O

These	O
findings	O
provide	O
new	O
evidence	O
that	O
the	O
Cdt	O
severely	O
damages	O
the	O
oral	O
epithelium	O
,	O
ex	O
vivo	O
,	O
by	O
specifically	O
targeting	O
epithelial	O
cells	O
,	O
in	O
situ	O
.	O

The	O
Cdt	O
shows	O
preferential	O
targeting	O
of	O
the	O
epithelium	O
as	O
opposed	O
to	O
connective	O
biofilm	O
in	O
animal	O
and	O
human	O
gingival	O
explant	O
models	O
.	O

cytolethal	O
distending	O
toxin	O
(	O
Cdt	O
)	O
,	O
connective	O
biofilm	O
(	O
CT	O
)	O
,	O
4	O
'	O
,	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	O
(	O
DAPI	O
)	O
,	O
human	O
gingival	O
epithelial	O
cells	O
(	O
HGEC	O
)	O
,	O
human	O
gingival	O
explants	O
(	O
HGX	O
)	O
,	O
human	O
gingival	O
fibroblasts	O
(	O
HGF	O
)	O
,	O
junctional	O
epithelium	O
(	O
JE	O
)	O
,	O
oral	O
epithelium	O
(	O
OE	O
)	O
,	O
rete	O
pegs	O
(	O
RP	O
)	O
,	O
sulcular	O
epithelium	O
(	O
SE	O
)	O
.	O

Cranberry	O
juice	O
cocktail	O
(	O
CJC	O
)	O
has	O
been	O
shown	O
to	O
inhibit	O
the	O
formation	O
of	O
biofilm	O
by	O
uropathogenic	O
Escherichia	B-bacteria
coli	I-bacteria
.	O

In	O
order	O
to	O
investigate	O
whether	O
the	O
anti	O
-	O
adhesive	O
components	O
could	O
reach	O
the	O
urinary	O
tract	O
after	O
oral	O
consumption	O
of	O
CJC	O
,	O
a	O
volunteer	O
was	O
given	O
16	O
oz	O
of	O
either	O
water	O
or	O
CJC	O
.	O

Urine	O
samples	O
were	O
collected	O
at	O
0	O
,	O
2	O
,	O
4	O
,	O
6	O
,	O
and	O
8	O
hours	O
after	O
consumption	O
of	O
a	O
single	O
dose	O
.	O

The	O
ability	O
of	O
compounds	O
in	O
the	O
urine	O
to	O
influence	O
bacterial	O
adhesion	O
was	O
tested	O
for	O
six	O
clinical	O
uropathogenic	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
strains	I-bacteria
,	O
including	O
four	O
P	O
-	O
fimbriated	O
strains	O
(	O
B37	O
,	O
CFT073	O
,	O
BF1023	O
,	O
and	O
J96	O
)	O
and	O
two	O
strains	O
not	O
expressing	O
P	O
-	O
fimbriae	O
but	O
exhibiting	O
mannose	O
-	O
resistant	O
hemagglutination	O
(	O
B73	O
and	O
B78	O
)	O
.	O

A	O
non	O
-	O
fimbriated	O
strain	O
,	O
HB101	B-bacteria
,	O
was	O
used	O
as	O
a	O
control	O
.	O

Atomic	O
force	O
microscopy	O
(	O
AFM	O
)	O
was	O
used	O
to	O
measure	O
the	O
adhesion	O
force	O
between	O
a	O
silicon	O
nitride	O
probe	O
and	O
bacteria	O
treated	O
with	O
urine	O
samples	O
.	O

Within	O
2	O
hours	O
after	O
CJC	O
consumption	O
,	O
bacteria	O
of	O
the	O
clinical	O
strains	O
treated	O
with	O
the	O
corresponding	O
urine	O
sample	O
demonstrated	O
lower	O
adhesion	O
forces	O
than	O
those	O
treated	O
with	O
urine	O
collected	O
before	O
CJC	O
consumption	O
.	O

The	O
adhesion	O
forces	O
continued	O
decreasing	O
with	O
time	O
after	O
CJC	O
consumption	O
over	O
the	O
8	O
-	O
hour	O
measurement	O
period	O
.	O

The	O
adhesion	O
forces	O
of	O
bacteria	O
after	O
exposure	O
to	O
urine	O
collected	O
following	O
water	O
consumption	O
did	O
not	O
change	O
.	O

HB101	B-bacteria
showed	O
low	O
adhesion	O
forces	O
following	O
both	O
water	O
and	O
CJC	O
consumption	O
,	O
and	O
these	O
did	O
not	O
change	O
over	O
time	O
.	O

The	O
AFM	O
adhesion	O
force	O
measurements	O
were	O
consistent	O
with	O
the	O
results	O
of	O
a	O
hemagglutination	O
assay	O
,	O
confirming	O
that	O
oral	O
consumption	O
of	O
CJC	O
could	O
act	O
against	O
adhesion	O
of	O
uropathogenic	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

To	O
investigate	O
the	O
root	O
canal	O
microbiota	O
of	O
primary	O
teeth	O
with	O
apical	O
periodontitis	O
and	O
the	O
in	O
vivo	O
antimicrobial	O
effects	O
of	O
a	O
calcium	O
hydroxide	O
/	O
chlorhexidine	O
paste	O
used	O
as	O
root	O
canal	O
dressing	O
.	O

Baseline	O
samples	O
were	O
collected	O
from	O
30	O
root	O
canals	O
of	O
primary	O
teeth	O
with	O
apical	O
periodontitis	O
.	O

Then	O
,	O
the	O
root	O
canals	O
were	O
filled	O
with	O
a	O
calcium	O
hydroxide	O
paste	O
containing	O
1	O
%	O
chlorhexidine	O
for	O
14	O
days	O
and	O
the	O
second	O
bacteriologic	O
samples	O
were	O
taken	O
prior	O
to	O
root	O
canal	O
filling	O
.	O

Samples	O
were	O
submitted	O
to	O
microbiologic	O
culture	O
procedure	O
to	O
detect	O
root	O
canal	O
bacteria	O
and	O
processed	O
for	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Baseline	O
microbial	O
culture	O
revealed	O
high	O
prevalence	O
and	O
cfu	O
number	O
of	O
anaerobic	O
,	O
black	O
-	O
pigmented	O
bacteroides	O
,	O
Streptococcus	B-bacteria
,	O
and	O
aerobic	O
microorganisms	O
.	O

Following	O
root	O
canal	O
dressing	O
,	O
the	O
overall	O
number	O
of	O
cfu	O
was	O
dramatically	O
diminished	O
compared	O
to	O
initial	O
contamination	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
although	O
prevalence	O
did	O
not	O
change	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Of	O
35	O
probes	O
used	O
for	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
,	O
31	O
(	O
88	O
.	O
57	O
%	O
)	O
were	O
present	O
at	O
baseline	O
,	O
and	O
following	O
root	O
canal	O
dressing	O
,	O
the	O
number	O
of	O
positive	O
probes	O
reduced	O
to	O
13	O
(	O
37	O
.	O
14	O
%	O
)	O
.	O

Similarly	O
,	O
the	O
number	O
of	O
bacterial	O
cells	O
diminished	O
folowing	O
application	O
of	O
calcium	O
hydroxide	O
/	O
chlorhexidine	O
root	O
canal	O
dressing	O
(	O
P	O
=	O
0	O
.	O
006	O
)	O
.	O

Apical	O
periodontitis	O
is	O
caused	O
by	O
a	O
polymicrobial	O
infection	O
,	O
and	O
a	O
calcium	O
hydroxide	O
/	O
chlorhexidine	O
paste	O
is	O
effective	O
in	O
reducing	O
the	O
number	O
of	O
bacteria	O
inside	O
root	O
canals	O
when	O
applied	O
as	O
a	O
root	O
canal	O
dressing	O
.	O

Information	O
on	O
co	O
-	O
adherence	O
of	O
different	O
oral	O
bacterial	O
species	O
is	O
important	O
for	O
understanding	O
interspecies	O
interactions	O
within	O
oral	O
microbial	O
community	O
.	O

Current	O
knowledge	O
on	O
this	O
topic	O
is	O
heavily	O
based	O
on	O
pariwise	O
coaggregation	O
of	O
known	O
,	O
cultivable	O
species	O
.	O

In	O
this	O
study	O
,	O
we	O
employed	O
a	O
membrane	O
binding	O
assay	O
coupled	O
with	O
polymerase	O
chain	O
reaction	O
-	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
PCR	O
-	O
DGGE	O
)	O
to	O
systematically	O
analyze	O
the	O
co	O
-	O
adherence	O
profiles	O
of	O
oral	O
bacterial	O
species	O
,	O
and	O
achieved	O
a	O
more	O
profound	O
knowledge	O
beyond	O
pairwise	O
coaggregation	O
.	O

Two	O
oral	O
bacterial	O
species	O
were	O
selected	O
to	O
serve	O
as	O
`	O
`	O
bait	O
'	O
'	O
:	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
)	O
whose	O
ability	O
to	O
adhere	O
to	O
a	O
multitude	O
of	O
oral	O
bacterial	O
species	O
has	O
been	O
extensively	O
studied	O
for	O
pairwise	O
interactions	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
whose	O
interacting	O
partners	O
are	O
largely	O
unknown	O
.	O

To	O
enable	O
screening	O
of	O
interacting	O
partner	O
species	O
within	O
bacterial	O
mixtures	O
,	O
cells	O
of	O
the	O
`	O
`	O
bait	O
'	O
'	O
oral	O
bacterium	O
were	O
immobilized	O
on	O
nitrocellulose	O
membranes	O
which	O
were	O
washed	O
and	O
blocked	O
to	O
prevent	O
unspecific	O
binding	O
.	O

The	O
`	O
`	O
prey	O
'	O
'	O
bacterial	O
mixtures	O
(	O
including	O
known	O
species	O
or	O
natural	O
saliva	O
samples	O
)	O
were	O
added	O
,	O
unbound	O
cells	O
were	O
washed	O
off	O
after	O
the	O
incubation	O
period	O
and	O
the	O
remaining	O
cells	O
were	O
eluted	O
using	O
0	O
.	O
2	O
mol	O
x	O
L	O
(	O
-	O
1	O
)	O
glycine	O
.	O

Genomic	O
DNA	O
was	O
extracted	O
,	O
subjected	O
to	O
16S	O
rRNA	O
PCR	O
amplification	O
and	O
separation	O
of	O
the	O
resulting	O
PCR	O
products	O
by	O
DGGE	O
.	O

Selected	O
bands	O
were	O
recovered	O
from	O
the	O
gel	O
,	O
sequenced	O
and	O
identified	O
via	O
Nucleotide	O
searches	O
against	O
different	O
databases	O
.	O

While	O
few	O
bacterial	O
species	O
bound	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
consistent	O
with	O
previous	O
findings	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adhered	O
to	O
a	O
variety	O
of	O
bacterial	O
species	O
including	O
uncultivable	O
and	O
uncharacterized	O
ones	O
.	O

This	O
new	O
approach	O
can	O
more	O
effectively	O
analyze	O
the	O
co	O
-	O
adherence	O
profiles	O
of	O
oral	O
bacteria	O
,	O
and	O
could	O
facilitate	O
the	O
systematic	O
study	O
of	O
interbacterial	O
binding	O
of	O
oral	O
microbial	O
species	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
confirm	O
the	O
association	O
among	O
oral	O
health	O
behaviors	O
,	O
periodontitis	O
,	O
and	O
preeclampsia	O
in	O
Korean	O
women	O
.	O

This	O
study	O
is	O
designed	O
as	O
a	O
case	O
-	O
control	O
study	O
.	O

Sixteen	O
women	O
with	O
preeclampsia	O
and	O
48	O
without	O
preeclampsia	O
post	O
-	O
delivery	O
were	O
included	O
in	O
this	O
study	O
from	O
November	O
2007	O
to	O
January	O
2010	O
.	O

Information	O
was	O
collected	O
on	O
demographics	O
,	O
health	O
behaviors	O
,	O
and	O
obstetric	O
and	O
systemic	O
diseases	O
that	O
may	O
influence	O
the	O
periodontal	O
condition	O
and	O
preeclampsia	O
.	O

Full	O
-	O
mouth	O
periodontal	O
probing	O
was	O
conducted	O
by	O
one	O
trained	O
examiner	O
(	O
KHB	O
)	O
.	O

Localized	O
periodontitis	O
was	O
defined	O
as	O
periodontal	O
clinical	O
attachment	O
loss	O
(	O
AL	O
)	O
>	O
/	O
=	O
3	O
.	O
5	O
mm	O
on	O
two	O
or	O
three	O
sites	O
not	O
on	O
the	O
same	O
tooth	O
.	O

In	O
addition	O
,	O
generalized	O
periodontitis	O
was	O
defined	O
as	O
clinical	O
AL	O
>	O
/	O
=	O
3	O
.	O
5	O
mm	O
on	O
>	O
/	O
=	O
4	O
sites	O
not	O
on	O
the	O
same	O
tooth	O
.	O

Gingival	O
crevicular	O
fluid	O
was	O
collected	O
using	O
a	O
sterilized	O
paper	O
point	O
for	O
quantitative	O
analysis	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
Pi	B-bacteria
)	O
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
.	O

After	O
adjusting	O
for	O
confounders	O
,	O
the	O
adjusted	O
odds	O
ratio	O
(	O
OR	O
)	O
was	O
4	O
.	O
79	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
1	O
.	O
02	O
to	O
29	O
.	O
72	O
)	O
for	O
localized	O
periodontitis	O
and	O
6	O
.	O
60	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
25	O
to	O
41	O
.	O
61	O
)	O
for	O
generalized	O
periodontitis	O
.	O

In	O
addition	O
,	O
the	O
proportion	O
of	O
floss	O
or	O
interdental	O
brush	O
users	O
in	O
women	O
with	O
preeclampsia	O
was	O
lower	O
than	O
that	O
in	O
women	O
without	O
(	O
adjusted	O
OR	O
:	O
0	O
.	O
21	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
02	O
to	O
0	O
.	O
93	O
)	O
.	O

Pi	O
was	O
significantly	O
more	O
prevalent	O
in	O
women	O
with	O
preeclampsia	O
(	O
P	O
=	O
0	O
.	O
028	O
)	O
.	O

These	O
results	O
indicate	O
that	O
preeclampsia	O
could	O
be	O
associated	O
with	O
the	O
maternal	O
periodontal	O
condition	O
and	O
interdental	O
cleaning	O
.	O

Recent	O
studies	O
showed	O
that	O
qPCR	O
could	O
detect	O
bacteria	O
related	O
to	O
periodontitis	O
and	O
peri	O
-	O
implantitis	O
in	O
a	O
low	O
concentration	O
after	O
full	O
-	O
mouth	O
tooth	O
extraction	O
.	O

This	O
study	O
monitored	O
the	O
microbiota	O
from	O
tooth	O
extraction	O
,	O
over	O
9	O
months	O
of	O
full	O
edentulism	O
,	O
up	O
to	O
1	O
year	O
after	O
abutment	O
connection	O
.	O

Ten	O
patients	O
with	O
severe	O
periodontitis	O
were	O
recruited	O
.	O

Six	O
months	O
after	O
tooth	O
extraction	O
,	O
implants	O
were	O
inserted	O
.	O

Three	O
to	O
6	O
months	O
later	O
,	O
they	O
were	O
connected	O
to	O
abutments	O
.	O

Plaque	O
samples	O
were	O
collected	O
from	O
the	O
tongue	O
dorsum	O
,	O
saliva	O
,	O
and	O
subgingival	O
area	O
(	O
teeth	O
/	O
implants	O
)	O
before	O
extraction	O
up	O
to	O
1	O
year	O
after	O
abutment	O
connection	O
,	O
and	O
analysed	O
via	O
culture	O
,	O
qPCR	O
,	O
and	O
checkerboard	O
technology	O
.	O

A	O
reduction	O
in	O
the	O
total	O
amount	O
of	O
aerobic	O
and	O
anaerobic	O
CFU	O
/	O
ml	O
was	O
observed	O
.	O

The	O
concentration	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
qPCR	O
and	O
checkerboard	O
)	O
in	O
the	O
saliva	O
and	O
,	O
to	O
a	O
lower	O
extent	O
,	O
on	O
the	O
tongue	O
dorsum	O
reduced	O
.	O

For	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
changes	O
were	O
negligible	O
and	O
no	O
changes	O
could	O
be	O
detected	O
for	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

The	O
pristine	O
subgingival	O
niches	O
were	O
quickly	O
colonized	O
by	O
key	O
pathogens	O
.	O

Their	O
final	O
concentration	O
remained	O
low	O
,	O
while	O
the	O
detection	O
frequencies	O
remained	O
very	O
high	O
over	O
time	O
.	O

Complete	O
edentulation	O
results	O
in	O
a	O
significant	O
reduction	O
of	O
bacteria	O
related	O
to	O
periodontitis	O
and	O
peri	O
-	O
implantitis	O
,	O
with	O
the	O
exception	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
which	O
might	O
indicate	O
that	O
key	O
pathogens	O
can	O
survive	O
without	O
pockets	O
.	O

To	O
monitor	O
microbial	O
shifts	O
during	O
dental	O
biofilm	O
re	O
-	O
development	O
.	O

Supra	O
-	O
and	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
separately	O
from	O
28	O
teeth	O
in	O
38	O
healthy	O
and	O
17	O
periodontitis	O
subjects	O
at	O
baseline	O
and	O
immediately	O
after	O
tooth	O
cleaning	O
.	O

Samples	O
were	O
taken	O
again	O
from	O
seven	O
teeth	O
in	O
randomly	O
selected	O
quadrants	O
during	O
1	O
,	O
2	O
,	O
4	O
and	O
7	O
days	O
of	O
no	O
oral	O
hygiene	O
.	O

Samples	O
were	O
analysed	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Species	O
counts	O
were	O
averaged	O
within	O
subjects	O
at	O
each	O
time	O
point	O
.	O

Significant	O
differences	O
in	O
the	O
counts	O
between	O
healthy	O
and	O
periodontitis	O
subjects	O
were	O
determined	O
using	O
the	O
Mann	O
-	O
Whitney	O
test	O
.	O

The	O
total	O
supra	O
-	O
and	O
subgingival	O
counts	O
were	O
significantly	O
higher	O
in	O
periodontitis	O
on	O
entry	O
and	O
reached	O
or	O
exceeded	O
the	O
baseline	O
values	O
after	O
day	O
2	O
.	O

Supragingival	O
counts	O
of	O
Veillonella	B-bacteria
parvula	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ss	I-bacteria
vincentii	I-bacteria
and	O
Neisseria	B-bacteria
mucosa	I-bacteria
increased	O
from	O
2	O
to	O
7	O
days	O
.	O

Subgingival	O
counts	O
were	O
greater	O
for	O
Actinomyces	B-bacteria
,	O
green	O
and	O
orange	O
complex	O
species	O
.	O

Significant	O
differences	O
between	O
groups	O
in	O
supragingival	O
counts	O
occurred	O
for	O
17	O
of	O
41	O
species	O
at	O
entry	O
,	O
0	O
at	O
day	O
7	O
;	O
for	O
subgingival	O
plaque	O
,	O
these	O
values	O
were	O
39	O
/	O
41	O
taxa	O
at	O
entry	O
,	O
17	O
/	O
41	O
at	O
day	O
7	O
.	O

Supragingival	O
plaque	O
re	O
-	O
development	O
was	O
similar	O
in	O
periodontitis	O
and	O
health	O
,	O
but	O
subgingival	O
species	O
recolonization	O
was	O
more	O
marked	O
in	O
periodontitis	O
.	O

This	O
study	O
evaluated	O
the	O
occurrence	O
of	O
enteric	O
bacteria	O
and	O
pseudomonads	O
resistant	O
to	O
tetracycline	O
and	O
beta	O
-	O
lactams	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
exhibiting	O
gingivitis	O
(	O
n	O
=	O
89	O
)	O
,	O
periodontitis	O
(	O
n	O
=	O
79	O
)	O
,	O
periodontally	O
healthy	O
(	O
n	O
=	O
50	O
)	O
and	O
wearing	O
complete	O
dentures	O
(	O
n	O
=	O
41	O
)	O
.	O

Microbial	O
identification	O
and	O
presence	O
of	O
resistance	O
markers	O
associated	O
with	O
the	O
production	O
of	O
beta	O
-	O
lactamases	O
and	O
tetracycline	O
resistance	O
were	O
performed	O
by	O
using	O
biochemical	O
tests	O
and	O
PCR	O
.	O

Susceptibility	O
tests	O
were	O
carried	O
out	O
in	O
201	O
isolates	O
of	O
enteric	O
cocci	O
and	O
rods	O
.	O

Resistance	O
to	O
ampicillin	O
,	O
amoxicillin	O
/	O
clavulanic	O
acid	O
,	O
imipenem	O
,	O
meropenem	O
and	O
tetracycline	O
was	O
detected	O
in	O
57	O
.	O
4	O
%	O
,	O
34	O
.	O
6	O
%	O
,	O
2	O
.	O
4	O
%	O
,	O
1	O
.	O
9	O
%	O
and	O
36	O
.	O
5	O
%	O
of	O
the	O
isolates	O
,	O
respectively	O
.	O

beta	O
-	O
lactamase	O
production	O
was	O
observed	O
in	O
41	O
.	O
2	O
%	O
of	O
tested	O
microorganisms	O
,	O
while	O
the	O
most	O
commonly	O
found	O
beta	O
-	O
lactamase	O
genetic	O
determinant	O
was	O
gene	O
blaTEM	O
.	O

Tetracycline	O
resistance	O
was	O
disseminated	O
and	O
a	O
wide	O
scope	O
of	O
tet	O
genes	O
were	O
detected	O
in	O
all	O
studied	O
microbial	O
genus	O
.	O

Disseminated	O
histoplasmosis	O
caused	O
by	O
Histoplasma	O
capsulatum	O
,	O
a	O
zoonotic	O
fungal	O
organism	O
,	O
is	O
an	O
important	O
disease	O
in	O
animals	O
and	O
humans	O
,	O
particularly	O
those	O
with	O
compromised	O
immune	O
systems	O
.	O

Reports	O
of	O
disseminated	O
histoplasmosis	O
in	O
an	O
avian	O
species	O
are	O
not	O
available	O
within	O
the	O
current	O
literature	O
.	O

Candida	O
albicans	O
,	O
another	O
fungal	O
agent	O
with	O
zoonotic	O
importance	O
,	O
is	O
a	O
commensal	O
of	O
the	O
avian	O
digestive	O
tract	O
that	O
is	O
often	O
associated	O
with	O
opportunistic	O
infections	O
particularly	O
in	O
young	O
or	O
immunocompromised	O
birds	O
.	O

This	O
report	O
describes	O
a	O
case	O
of	O
concomitant	O
histoplasmosis	O
and	O
candidiasis	O
in	O
an	O
Eclectus	O
parrot	O
(	O
Eclectus	O
roratus	O
)	O
characterized	O
by	O
severe	O
granulomatous	O
glossitis	O
,	O
blepharitis	O
and	O
osteomyelitis	O
with	O
numerous	O
intrahistiocytic	O
and	O
extracellular	O
yeasts	O
(	O
H	O
.	O
capsulatum	O
)	O
as	O
well	O
as	O
intralesional	O
hyphae	O
,	O
pseudohyphae	O
and	O
conidia	O
(	O
C	O
.	O
albicans	O
)	O
.	O

To	O
our	O
knowledge	O
,	O
co	O
-	O
infection	O
with	O
H	O
.	O
capsulatum	O
and	O
C	O
.	O
albicans	O
has	O
not	O
been	O
reported	O
in	O
an	O
avian	O
species	O
.	O

The	O
highly	O
antagonistic	O
lactobacillus	B-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
human	O
individuals	O
were	O
genetically	O
passported	O
as	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
39	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
50	I-bacteria
,	O
and	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
24	I-bacteria
,	O
by	O
applying	O
the	O
RAPD	O
-	O
PCR	O
technique	O
with	O
two	O
types	O
of	O
primers	O
(	O
M13	O
,	O
MSP	O
)	O
.	O

These	O
lactobacillus	B-bacteria
strains	I-bacteria
showed	O
high	O
degrees	O
of	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
,	O
and	O
adhesion	O
.	O

These	O
characteristics	O
determine	O
the	O
obvious	O
capacity	O
of	O
lactobacilli	B-bacteria
to	O
form	O
biofilms	O
,	O
which	O
may	O
be	O
used	O
to	O
design	O
new	O
probiotic	O
agents	O
.	O

Samples	O
were	O
taken	O
under	O
strictly	O
anaerobic	O
conditions	O
from	O
the	O
root	O
canals	O
of	O
22	O
patients	O
having	O
a	O
tooth	O
in	O
which	O
necrotic	O
pulp	O
was	O
associated	O
with	O
an	O
inflammatory	O
peri	O
-	O
apical	O
lesion	O
an	O
optical	O
periodontitis	O
.	O

In	O
the	O
majority	O
of	O
cases	O
(	O
85	O
%	O
)	O
,	O
these	O
lesions	O
were	O
chronic	O
and	O
the	O
pulp	O
chamber	O
was	O
closed	O
.	O

One	O
hundred	O
and	O
two	O
strains	O
were	O
isolated	O
,	O
71	O
.	O
7	O
%	O
of	O
the	O
bacteria	O
being	O
obligate	O
anaerobes	O
and	O
49	O
.	O
8	O
%	O
being	O
Gram	O
-	O
negative	O
bacilli	O
.	O

Their	O
ability	O
to	O
produce	O
beta	O
-	O
lactamases	O
was	O
tested	O
and	O
8	O
.	O
8	O
%	O
gave	O
a	O
positive	O
reaction	O
in	O
a	O
cefinase	O
test	O
.	O

These	O
cefinase	O
positive	O
strains	O
were	O
nevertheless	O
susceptible	O
to	O
3rd	O
-	O
generation	O
cephalosporins	O
(	O
cefoxitin	O
)	O
and	O
to	O
amoxicillin	O
-	O
clavulanate	O
,	O
with	O
the	O
exception	O
of	O
M	B-bacteria
.	I-bacteria
Morganii	I-bacteria
.	O

Microbial	O
agents	O
in	O
root	O
canal	O
systems	O
can	O
induce	O
periodontal	O
inflammation	O
.	O

The	O
aims	O
of	O
this	O
study	O
are	O
to	O
detect	O
anaerobic	O
microorganisms	O
in	O
endodontic	O
-	O
periodontal	O
lesions	O
,	O
determine	O
the	O
genetic	O
diversity	O
among	O
them	O
,	O
and	O
assess	O
the	O
simultaneous	O
colonization	O
of	O
the	O
pulp	O
and	O
periodontal	O
microenvironments	O
by	O
a	O
single	O
clone	O
.	O

Twenty	O
-	O
seven	O
teeth	O
of	O
patients	O
with	O
endodontic	O
-	O
periodontal	O
lesions	O
were	O
selected	O
.	O

Samples	O
were	O
spread	O
on	O
an	O
agar	O
-	O
blood	O
medium	O
,	O
the	O
detection	O
of	O
each	O
species	O
was	O
performed	O
using	O
a	O
polymerase	O
chain	O
reaction	O
,	O
and	O
the	O
determination	O
of	O
the	O
simultaneous	O
presence	O
of	O
the	O
same	O
species	O
in	O
the	O
microenvironments	O
by	O
one	O
or	O
more	O
clones	O
was	O
determined	O
using	O
arbitrarily	O
primed	O
PCR	O
.	O

Prevotella	B-bacteria
intermedia	I-bacteria
(	O
Pi	B-bacteria
)	O
was	O
the	O
most	O
prevalent	O
species	O
of	O
the	O
colonies	O
in	O
periodontal	O
pockets	O
,	O
whereas	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
and	O
Pi	B-bacteria
were	O
the	O
more	O
prevalent	O
in	O
root	O
canals	O
.	O

Isolates	O
of	O
Pi	B-bacteria
and	O
Pg	B-bacteria
were	O
simultaneously	O
identified	O
in	O
root	O
canals	O
and	O
periodontal	O
pockets	O
.	O

Eighteen	O
percent	O
of	O
teeth	O
exhibited	O
the	O
simultaneous	O
colonization	O
by	O
Pg	B-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
in	O
the	O
pulp	O
and	O
periodontal	O
microenvironments	O
.	O

The	O
presence	O
of	O
these	O
species	O
was	O
noted	O
even	O
in	O
niches	O
from	O
which	O
no	O
colonies	O
were	O
isolated	O
.	O

Seventeen	O
different	O
genotypes	O
were	O
found	O
in	O
periodontal	O
and	O
pulp	O
sites	O
,	O
with	O
the	O
majority	O
of	O
sites	O
colonized	O
by	O
one	O
or	O
two	O
different	O
genotypes	O
.	O

A	O
high	O
degree	O
of	O
genotype	O
similarity	O
was	O
found	O
for	O
samples	O
of	O
Pg	B-bacteria
isolated	O
from	O
only	O
one	O
site	O
as	O
well	O
as	O
for	O
those	O
isolated	O
from	O
both	O
microenvironments	O
.	O

Different	O
clones	O
of	O
Pi	B-bacteria
and	O
Pg	B-bacteria
with	O
a	O
high	O
intraspecific	O
genotype	O
similarity	O
were	O
found	O
to	O
colonize	O
the	O
same	O
anatomic	O
sites	O
in	O
endodontic	O
-	O
periodontal	O
infections	O
.	O

A	O
variety	O
of	O
oral	O
topical	O
agents	O
have	O
been	O
used	O
for	O
prevention	O
and	O
management	O
of	O
radiotherapy	O
-	O
induced	O
adverse	O
effects	O
.	O

The	O
antimicrobial	O
nature	O
of	O
some	O
of	O
the	O
commonly	O
used	O
agents	O
is	O
unknown	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
antimicrobial	O
efficacies	O
of	O
various	O
oral	O
topical	O
agents	O
on	O
common	O
microorganisms	O
associated	O
with	O
radiated	O
head	O
and	O
neck	O
cancer	O
patients	O
.	O

Seven	O
commonly	O
used	O
topical	O
oral	O
agents	O
-	O
0	O
.	O
12	O
%	O
chlorhexidine	O
with	O
alcohol	O
,	O
0	O
.	O
12	O
%	O
chlorhexidine	O
without	O
alcohol	O
,	O
baking	O
soda	O
-	O
salt	O
rinse	O
,	O
0	O
.	O
4	O
%	O
stannous	O
fluoride	O
gel	O
,	O
0	O
.	O
63	O
%	O
stannous	O
fluoride	O
rinse	O
,	O
calcium	O
phosphate	O
mouthrinse	O
,	O
and	O
acemannan	O
hydrogel	O
(	O
aloe	O
vera	O
)	O
rinse	O
-	O
were	O
evaluated	O
in	O
vitro	O
for	O
their	O
antimicrobial	O
efficacies	O
against	O
four	O
common	O
microorganisms	O
.	O

A	O
combination	O
of	O
baking	O
soda	O
-	O
salt	O
rinse	O
and	O
0	O
.	O
4	O
%	O
stannous	O
fluoride	O
gel	O
was	O
evaluated	O
as	O
the	O
eighth	O
agent	O
.	O

The	O
microorganisms	O
used	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
group	B-bacteria
B	I-bacteria
Streptococcus	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

An	O
ELISA	O
reader	O
was	O
used	O
to	O
measure	O
the	O
turbidity	O
of	O
microbial	O
culture	O
wells	O
and	O
optical	O
density	O
(	O
OD	O
)	O
values	O
for	O
each	O
of	O
the	O
960	O
wells	O
recorded	O
.	O

Mean	O
OD	O
values	O
were	O
rank	O
ordered	O
based	O
on	O
their	O
turbidity	O
.	O

One	O
-	O
way	O
ANOVA	O
with	O
Tukey	O
HSD	O
post	O
hoc	O
analysis	O
was	O
used	O
to	O
study	O
differences	O
in	O
OD	O
values	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Mean	O
OD	O
values	O
classified	O
for	O
topical	O
agents	O
from	O
lowest	O
to	O
highest	O
were	O
chlorhexidine	O
with	O
alcohol	O
,	O
chlorhexidine	O
without	O
alcohol	O
,	O
baking	O
soda	O
-	O
salt	O
,	O
calcium	O
phosphate	O
rinse	O
,	O
and	O
the	O
combination	O
of	O
baking	O
soda	O
-	O
salt	O
and	O
stannous	O
fluoride	O
gel	O
.	O

Mean	O
OD	O
values	O
classified	O
for	O
microorganisms	O
from	O
lowest	O
to	O
highest	O
were	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
group	B-bacteria
B	I-bacteria
Streptococcus	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

A	O
significant	O
difference	O
among	O
the	O
antimicrobial	O
efficacies	O
of	O
topical	O
agents	O
was	O
evident	O
for	O
each	O
of	O
four	O
microorganisms	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

There	O
was	O
also	O
a	O
significant	O
difference	O
among	O
the	O
antimicrobial	O
efficacies	O
of	O
the	O
same	O
topical	O
agent	O
on	O
the	O
four	O
microorganisms	O
tested	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Dental	O
implants	O
and	O
peri	O
-	O
implant	O
tissue	O
are	O
susceptible	O
to	O
disease	O
conditions	O
that	O
may	O
lead	O
to	O
implant	O
loss	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
describe	O
teeth	O
and	O
implant	O
surroundings	O
as	O
well	O
as	O
clinical	O
health	O
indices	O
and	O
oral	O
microbiologic	O
parameters	O
.	O

A	O
group	O
of	O
83	O
adults	O
(	O
42	O
men	O
and	O
41	O
women	O
)	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Clinical	O
assessments	O
of	O
dental	O
implants	O
and	O
contralateral	O
natural	O
teeth	O
included	O
dental	O
plaque	O
,	O
gingival	O
inflammation	O
,	O
and	O
bleeding	O
on	O
probing	O
.	O

Microbiologic	O
assessments	O
included	O
bacterial	O
culture	O
,	O
light	O
and	O
phase	O
contrast	O
microscopy	O
,	O
and	O
DNA	O
probe	O
hybridization	O
for	O
a	O
panel	O
of	O
14	O
target	O
microorganisms	O
.	O

Clinical	O
and	O
microbiologic	O
data	O
were	O
compared	O
by	O
paired	O
t	O
test	O
and	O
ANOVA	O
.	O

P	O
<	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

The	O
Plaque	O
Index	O
for	O
the	O
implants	O
was	O
1	O
.	O
85	O
+	O
/	O
-	O
0	O
.	O
47	O
,	O
whereas	O
the	O
score	O
for	O
natural	O
teeth	O
was	O
significantly	O
higher	O
,	O
2	O
.	O
15	O
+	O
/	O
-	O
0	O
.	O
52	O
.	O

Compared	O
to	O
the	O
samples	O
obtained	O
from	O
the	O
dental	O
implants	O
,	O
the	O
samples	O
from	O
natural	O
teeth	O
demonstrated	O
significantly	O
higher	O
total	O
bacterial	O
cell	O
numbers	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Consistent	O
with	O
the	O
clinical	O
measures	O
of	O
dental	O
plaque	O
,	O
significantly	O
higher	O
numbers	O
of	O
oral	O
bacteria	O
,	O
including	O
aerobic	O
and	O
anaerobic	O
bacteria	O
,	O
were	O
found	O
in	O
dental	O
plaque	O
samples	O
from	O
teeth	O
(	O
aerobic	O
5	O
.	O
648	O
+	O
/	O
-	O
0	O
.	O
512	O
,	O
anaerobic	O
6	O
.	O
243	O
+	O
/	O
-	O
0	O
.	O
535	O
,	O
P	O
<	O
.	O
0001	O
)	O
compared	O
to	O
implants	O
(	O
aerobic	O
5	O
.	O
430	O
+	O
/	O
-	O
0	O
.	O
541	O
,	O
anaerobic	O
5	O
.	O
917	O
+	O
/	O
-	O
0	O
.	O
523	O
,	O
P	O
<	O
.	O
0001	O
)	O
.	O

In	O
addition	O
,	O
there	O
were	O
significantly	O
higher	O
numbers	O
of	O
anaerobic	O
(	O
6	O
.	O
243	O
+	O
/	O
-	O
0	O
.	O
535	O
and	O
5	O
.	O
917	O
+	O
/	O
-	O
0	O
.	O
523	O
,	O
P	O
<	O
.	O
0001	O
)	O
than	O
aerobic	O
(	O
5	O
.	O
648	O
+	O
/	O
-	O
0	O
.	O
512	O
and	O
5	O
.	O
430	O
+	O
/	O
-	O
0	O
.	O
541	O
,	O
P	O
<	O
.	O
008	O
)	O
bacteria	O
for	O
samples	O
from	O
teeth	O
and	O
implants	O
,	O
respectively	O
.	O

Clinical	O
and	O
microbiologic	O
analyses	O
provide	O
consistent	O
findings	O
that	O
suggest	O
differences	O
in	O
quantity	O
of	O
plaque	O
and	O
bacterial	O
species	O
between	O
teeth	O
and	O
dental	O
implants	O
.	O

For	O
long	O
-	O
term	O
treatment	O
success	O
,	O
the	O
importance	O
of	O
plaque	O
control	O
and	O
oral	O
hygiene	O
of	O
both	O
periodontal	O
and	O
dental	O
implant	O
therapy	O
is	O
emphasized	O
.	O

Topical	O
tetracyclines	O
,	O
such	O
as	O
minocycline	O
ointment	O
,	O
are	O
frequently	O
used	O
for	O
the	O
treatment	O
of	O
periodontal	O
infection	O
.	O

We	O
investigated	O
the	O
influence	O
of	O
minocycline	O
ointment	O
use	O
on	O
oral	O
bacteria	O
,	O
using	O
supragingival	O
plaque	O
samples	O
from	O
adults	O
who	O
had	O
not	O
taken	O
any	O
antibiotics	O
for	O
6	O
months	O
.	O

Initially	O
we	O
investigated	O
the	O
effect	O
of	O
topical	O
minocycline	O
administration	O
on	O
the	O
emergence	O
of	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
in	O
four	O
healthy	O
adults	O
.	O

The	O
isolation	O
frequency	O
of	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
to	O
total	O
viable	O
bacteria	O
increased	O
substantially	O
on	O
day	O
6	O
after	O
treatment	O
,	O
although	O
it	O
returned	O
to	O
baseline	O
on	O
day	O
25	O
.	O

Subsequently	O
we	O
investigated	O
the	O
isolation	O
frequency	O
of	O
tetracycline	B-bacteria
-	I-bacteria
resistant	I-bacteria
oral	I-bacteria
streptococci	I-bacteria
(	O
TOS	B-bacteria
)	O
as	O
a	O
representative	O
oral	O
bacterium	O
,	O
using	O
samples	O
from	O
41	O
subjects	O
with	O
periodontal	O
diseases	O
.	O

The	O
percentage	O
of	O
TOS	B-bacteria
(	O
of	O
the	O
total	O
oral	O
streptococci	B-bacteria
)	O
increased	O
significantly	O
(	O
from	O
11	O
.	O
9	O
+	O
/	O
-	O
15	O
.	O
6	O
%	O
to	O
34	O
.	O
2	O
+	O
/	O
-	O
24	O
.	O
0	O
%	O
)	O
after	O
minocycline	O
treatment	O
.	O

Various	O
TOS	B-bacteria
species	I-bacteria
were	O
identified	O
;	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
were	O
frequently	O
isolated	O
.	O

PCR	O
and	O
Southern	O
blotting	O
allowed	O
us	O
to	O
identify	O
tetM	O
on	O
the	O
Tn916	O
-	O
like	O
elements	O
as	O
the	O
gene	O
responsible	O
for	O
tetracycline	O
-	O
resistance	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
potential	O
risk	O
of	O
the	O
spread	O
of	O
similar	O
genetic	O
elements	O
through	O
bacteria	O
in	O
the	O
oral	O
cavity	O
should	O
be	O
considered	O
.	O

Autism	O
of	O
the	O
regressive	O
variety	O
is	O
selected	O
as	O
an	O
example	O
of	O
the	O
importance	O
of	O
intestinal	O
bacterial	O
microflora	O
in	O
disease	O
other	O
than	O
classical	O
infection	O
.	O

Our	O
studies	O
have	O
indicated	O
that	O
intestinal	O
bacteria	O
play	O
a	O
role	O
in	O
this	O
disease	O
since	O
it	O
responds	O
to	O
oral	O
vancomycin	O
,	O
a	O
drug	O
that	O
is	O
not	O
absorbed	O
from	O
the	O
GI	O
tract	O
.	O

Pyrosequencing	O
studies	O
document	O
an	O
abnormal	O
gut	O
microflora	O
in	O
regressive	O
autism	O
subjects	O
as	O
compared	O
to	O
controls	O
.	O

Finally	O
,	O
we	O
present	O
preliminary	O
evidence	O
suggesting	O
that	O
Desulfovibrio	B-bacteria
may	O
play	O
a	O
key	O
role	O
in	O
this	O
disease	O
.	O

The	O
hygiene	O
hypothesis	O
contends	O
that	O
fewer	O
opportunities	O
for	O
infections	O
and	O
microbial	O
exposures	O
have	O
resulted	O
in	O
more	O
widespread	O
asthma	O
and	O
atopic	O
disease	O
.	O

Consistent	O
with	O
that	O
hypothesis	O
,	O
decreases	O
in	O
infectious	O
oral	O
diseases	O
over	O
the	O
past	O
half	O
century	O
have	O
coincided	O
with	O
increases	O
in	O
the	O
prevalence	O
of	O
asthma	O
and	O
other	O
allergic	O
diseases	O
.	O

This	O
observation	O
has	O
led	O
some	O
researchers	O
to	O
speculate	O
that	O
exposures	O
to	O
oral	O
bacteria	O
,	O
including	O
pathogens	O
associated	O
with	O
periodontal	O
diseases	O
,	O
such	O
as	O
gingivitis	O
and	O
periodontitis	O
,	O
might	O
play	O
a	O
protective	O
role	O
in	O
the	O
development	O
of	O
asthma	O
and	O
allergy	O
.	O

Colonization	O
of	O
the	O
oral	O
cavity	O
with	O
bacteria	O
,	O
including	O
some	O
species	O
of	O
periodontal	O
pathogens	O
,	O
begins	O
shortly	O
after	O
birth	O
,	O
and	O
the	O
detection	O
of	O
serum	O
antibodies	O
to	O
oral	O
pathogens	O
in	O
early	O
childhood	O
provides	O
evidence	O
of	O
an	O
early	O
immune	O
response	O
to	O
these	O
bacteria	O
.	O

Current	O
knowledge	O
of	O
the	O
immune	O
response	O
to	O
oral	O
bacteria	O
and	O
the	O
immunologic	O
pathogenesis	O
of	O
periodontal	O
diseases	O
suggests	O
biologically	O
plausible	O
mechanisms	O
by	O
which	O
oral	O
pathogens	O
could	O
influence	O
the	O
risk	O
of	O
allergic	O
disease	O
.	O

However	O
,	O
studies	O
investigating	O
the	O
association	O
between	O
oral	O
pathogen	O
exposures	O
and	O
allergic	O
disease	O
are	O
few	O
in	O
number	O
and	O
limited	O
by	O
cross	O
-	O
sectional	O
or	O
case	O
-	O
control	O
design	O
,	O
exclusion	O
of	O
young	O
children	O
,	O
and	O
use	O
of	O
surrogate	O
measures	O
of	O
oral	O
bacterial	O
colonization	O
.	O

Additional	O
studies	O
,	O
particularly	O
well	O
-	O
designed	O
case	O
-	O
control	O
studies	O
among	O
very	O
young	O
children	O
and	O
prospective	O
birth	O
cohort	O
studies	O
,	O
are	O
needed	O
.	O

The	O
oral	O
cavity	O
contains	O
almost	O
half	O
of	O
the	O
commensal	O
bacterial	O
population	O
present	O
in	O
the	O
human	O
body	O
.	O

An	O
increase	O
in	O
the	O
number	O
of	O
these	O
microorganisms	O
may	O
result	O
in	O
systemic	O
diseases	O
such	O
as	O
infective	O
endocarditis	O
and	O
aspiration	O
pneumonia	O
as	O
well	O
as	O
oral	O
infections	O
.	O

It	O
is	O
essential	O
to	O
control	O
the	O
total	O
numbers	O
of	O
these	O
microorganisms	O
in	O
order	O
to	O
suppress	O
disease	O
onset	O
.	O

Thus	O
,	O
we	O
examined	O
the	O
antimicrobial	O
activity	O
of	O
a	O
newly	O
developed	O
gel	O
-	O
entrapped	O
catechin	O
(	O
GEC	O
)	O
preparation	O
against	O
oral	O
microorganisms	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
GEC	O
was	O
determined	O
based	O
on	O
the	O
relationship	O
between	O
a	O
modified	O
agar	O
diffusion	O
method	O
and	O
a	O
broth	O
microdilution	O
method	O
.	O

GEC	O
inhibited	O
the	O
growth	O
of	O
the	O
Actinomyces	B-bacteria
,	O
periodontopathic	O
bacteria	O
and	O
Candida	O
strains	O
tested	O
,	O
but	O
did	O
not	O
inhibit	O
the	O
growth	O
of	O
the	O
oral	O
streptococci	B-bacteria
that	O
are	O
important	O
in	O
the	O
normal	O
oral	O
flora	O
.	O

Commercially	O
available	O
moisture	O
gels	O
containing	O
antimicrobial	O
components	O
showed	O
antimicrobial	O
activity	O
against	O
all	O
of	O
the	O
tested	O
strains	O
.	O

After	O
a	O
series	O
of	O
washes	O
and	O
after	O
a	O
24	O
-	O
h	O
incubation	O
,	O
GEC	O
retained	O
the	O
antimicrobial	O
activity	O
of	O
the	O
catechins	O
.	O

Catalase	O
prevented	O
GEC	O
-	O
induced	O
growth	O
inhibition	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
suggesting	O
that	O
hydrogen	O
peroxide	O
may	O
be	O
involved	O
in	O
the	O
antimicrobial	O
activity	O
of	O
catechins	O
.	O

These	O
results	O
suggest	O
that	O
GEC	O
may	O
be	O
useful	O
for	O
controlling	O
oral	O
microorganism	O
populations	O
and	O
reducing	O
the	O
accumulation	O
of	O
dental	O
plaque	O
,	O
thereby	O
helping	O
to	O
prevent	O
periodontal	O
disease	O
and	O
oral	O
candidiasis	O
.	O

To	O
determine	O
the	O
genetic	O
diversity	O
and	O
possible	O
origin	O
of	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
found	O
in	O
the	O
oral	O
biofilm	O
.	O

Lactobacilli	B-bacteria
were	O
isolated	O
from	O
a	O
biofilm	O
model	O
,	O
formed	O
in	O
situ	O
prior	O
to	O
and	O
during	O
a	O
period	O
of	O
exposure	O
to	O
20	O
%	O
sucrose	O
solution	O
(	O
28	O
days	O
)	O
,	O
using	O
Rogosa	O
Agar	O
.	O

The	O
lactobacillus	B-bacteria
colonies	O
were	O
randomly	O
selected	O
(	O
n	O
=	O
222	O
)	O
and	O
subcultured	O
.	O

The	O
isolates	O
were	O
identified	O
using	O
pheS	O
or	O
rpoA	O
gene	O
sequence	O
analysis	O
.	O

Lactobacilli	B-bacteria
identified	O
as	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
(	O
n	O
=	O
75	O
)	O
were	O
subjected	O
to	O
multilocus	O
sequencing	O
typing	O
(	O
MLST	O
)	O
analysis	O
by	O
determining	O
partial	O
sequences	O
of	O
seven	O
housekeeping	O
genes	O
fusA	O
,	O
ileS	O
,	O
lepA	O
,	O
leuS	O
,	O
pyrG	O
,	O
recA	O
and	O
recG	O
.	O

An	O
increase	O
recovery	O
of	O
lactobacilli	B-bacteria
after	O
sucrose	O
phase	O
compared	O
with	O
nonsucrose	O
period	O
was	O
observed	O
(	O
31	O
prior	O
to	O
and	O
191	O
following	O
a	O
sucrose	O
exposure	O
period	O
)	O
.	O

Seven	O
subjects	O
harboured	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
and	O
these	O
represented	O
14	O
sequence	O
types	O
(	O
ST	O
)	O
.	O

Comparison	O
of	O
the	O
STs	O
showed	O
that	O
unrelated	O
subjects	O
may	O
harbour	O
the	O
same	O
ST	O
and	O
that	O
individuals	O
harbour	O
multiple	O
STs	O
.	O

Three	O
subjects	O
harboured	O
STs	O
previously	O
isolated	O
from	O
dairy	O
products	O
.	O

The	O
present	O
data	O
supports	O
the	O
hypothesis	O
that	O
oral	O
lactobacilli	B-bacteria
may	O
be	O
of	O
exogenous	O
origin	O
.	O

The	O
study	O
allow	O
us	O
to	O
gain	O
insight	O
into	O
the	O
genetic	O
diversity	O
of	O
lactobacilli	B-bacteria
paracasei	I-bacteria
in	O
oral	O
biofilm	O
.	O

The	O
interaction	O
between	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
,	O
a	O
probiotic	O
bacterium	O
,	O
and	O
oral	O
pathogenic	O
bacteria	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

This	O
study	O
examined	O
the	O
effects	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
on	O
the	O
proliferation	O
of	O
periodontopathic	O
bacteria	O
including	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
on	O
the	O
formation	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
biofilms	O
.	O

Human	O
-	O
derived	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
strains	I-bacteria
(	O
KCTC	B-bacteria
3594	I-bacteria
and	O
KCTC	B-bacteria
3678	I-bacteria
)	O
and	O
rat	O
-	O
derived	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
KCTC	I-bacteria
3679	I-bacteria
were	O
used	O
.	O

All	O
strains	O
exhibited	O
significant	O
inhibitory	O
effects	O
on	O
the	O
growth	O
of	O
periodontopathic	O
bacteria	O
and	O
the	O
formation	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

These	O
antibacterial	O
activities	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
were	O
attributed	O
to	O
the	O
production	O
of	O
organic	O
acids	O
,	O
hydrogen	O
peroxide	O
,	O
and	O
a	O
bacteriocin	O
-	O
like	O
compound	O
.	O

Reuterin	O
,	O
an	O
antimicrobial	O
factor	O
,	O
was	O
produced	O
only	O
by	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
KCTC	I-bacteria
3594	I-bacteria
.	O

In	O
addition	O
,	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
inhibited	O
the	O
production	O
of	O
methyl	O
mercaptan	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Overall	O
,	O
these	O
results	O
suggest	O
that	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
may	O
be	O
useful	O
as	O
a	O
probiotic	O
agent	O
for	O
improving	O
oral	O
health	O
.	O

As	O
peri	O
-	O
implantitis	O
is	O
an	O
emerging	O
problem	O
,	O
the	O
development	O
of	O
validated	O
animal	O
models	O
is	O
mandatory	O
.	O

The	O
aim	O
of	O
this	O
pilot	O
study	O
was	O
to	O
provide	O
a	O
first	O
step	O
in	O
describing	O
the	O
normal	O
oral	O
flora	O
of	O
minipigs	O
.	O

In	O
five	O
minipigs	O
,	O
samples	O
of	O
the	O
oral	O
flora	O
were	O
collected	O
with	O
sterile	O
cotton	O
swabs	O
from	O
the	O
buccal	O
gingiva	O
of	O
the	O
lower	O
jaw	O
.	O

Two	O
swabs	O
per	O
animal	O
were	O
collected	O
,	O
followed	O
by	O
bacterial	O
isolation	O
under	O
both	O
aerobe	O
and	O
anaerobe	O
conditions	O
.	O

Microbiological	O
analyses	O
included	O
biochemical	O
tests	O
,	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
and	O
16S	O
rDNA	O
gene	O
sequence	O
analysis	O
.	O

A	O
total	O
of	O
61	O
taxa	O
were	O
detected	O
,	O
14	O
-	O
21	O
different	O
bacterial	O
taxa	O
from	O
each	O
minipig	O
.	O

Among	O
the	O
Gram	O
-	O
positive	O
cocci	O
,	O
mainly	O
staphylococcal	B-bacteria
and	O
streptococcal	B-bacteria
species	I-bacteria
were	O
identified	O
.	O

Different	O
Actinomyces	B-bacteria
species	I-bacteria
were	O
the	O
most	O
abundant	O
taxa	O
in	O
the	O
group	O
of	O
Gram	O
-	O
positive	O
rods	O
.	O

Among	O
the	O
anaerobic	O
bacteria	O
,	O
the	O
Gram	O
-	O
negative	O
genera	O
Fusobacterium	B-bacteria
,	O
Bacteroides	B-bacteria
and	O
Prevotella	B-bacteria
were	O
the	O
most	O
often	O
observed	O
taxa	O
.	O

This	O
is	O
the	O
first	O
study	O
which	O
begins	O
to	O
describe	O
the	O
normal	O
oral	O
flora	O
in	O
minipigs	O
in	O
cultures	O
to	O
allow	O
for	O
the	O
detection	O
of	O
a	O
broad	O
spectrum	O
.	O

Several	O
bacterial	O
species	O
identified	O
are	O
different	O
from	O
human	O
ones	O
.	O

No	O
specific	O
species	O
for	O
peri	O
-	O
implantitis	O
could	O
be	O
detected	O
in	O
that	O
healthy	O
sample	O
.	O

Membrane	O
-	O
anchored	O
complement	O
regulatory	O
proteins	O
(	O
CRPs	O
)	O
,	O
including	O
CD46	O
,	O
CD55	O
,	O
and	O
CD59	O
,	O
protect	O
host	O
cells	O
from	O
complement	O
attack	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
whether	O
periodontopathogen	O
lipopolysaccharide	O
and	O
proinflammatory	O
cytokines	O
modulate	O
CRP	O
gene	O
/	O
protein	O
expression	O
in	O
human	O
oral	O
epithelial	O
cells	O
.	O

The	O
lipopolysaccharide	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
were	O
the	O
most	O
potent	O
for	O
increasing	O
the	O
gene	O
expression	O
of	O
CD55	O
and	O
CD59	O
,	O
and	O
to	O
a	O
lesser	O
extent	O
CD46	O
,	O
after	O
a	O
48	O
-	O
h	O
stimulation	O
.	O

An	O
lipopolysaccharide	O
-	O
induced	O
upregulation	O
of	O
epithelial	O
cell	O
-	O
surface	O
CRP	O
was	O
also	O
demonstrated	O
.	O

The	O
stimulation	O
of	O
epithelial	O
cells	O
with	O
lipopolysaccharide	O
was	O
associated	O
with	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
IL	O
-	O
8	O
secretion	O
.	O

Although	O
these	O
two	O
cytokines	O
had	O
no	O
effect	O
on	O
CD46	O
and	O
CD55	O
gene	O
expression	O
in	O
epithelial	O
cells	O
,	O
IL	O
-	O
1beta	O
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
induced	O
a	O
significant	O
upregulation	O
.	O

The	O
cell	O
-	O
surface	O
expression	O
of	O
CRP	O
was	O
also	O
increased	O
by	O
the	O
stimulation	O
of	O
epithelial	O
cells	O
with	O
cytokines	O
.	O

The	O
CD46	O
,	O
CD55	O
,	O
and	O
CD59	O
gene	O
/	O
protein	O
expression	O
was	O
upregulated	O
by	O
periodontopathogen	O
lipopolysaccharide	O
and	O
proinflammatory	O
cytokines	O
.	O

It	O
can	O
be	O
hypothesized	O
that	O
,	O
when	O
faced	O
with	O
bacterial	O
challenges	O
and	O
inflammatory	O
conditions	O
associated	O
with	O
active	O
periodontal	O
sites	O
,	O
oral	O
epithelial	O
cells	O
may	O
respond	O
by	O
increasing	O
CRP	O
gene	O
/	O
protein	O
expression	O
to	O
avoid	O
cell	O
lysis	O
by	O
the	O
complement	O
system	O
,	O
which	O
is	O
activated	O
during	O
periodontitis	O
.	O

Primary	O
gingival	O
epithelial	O
cells	O
were	O
cultured	O
in	O
multilayers	O
as	O
a	O
model	O
for	O
the	O
study	O
of	O
interactions	O
with	O
oral	O
bacteria	O
associated	O
with	O
health	O
and	O
periodontal	O
disease	O
.	O

Multilayers	O
maintained	O
at	O
an	O
air	O
-	O
liquid	O
interface	O
in	O
low	O
-	O
calcium	O
medium	O
displayed	O
differentiation	O
and	O
cytokeratin	O
properties	O
characteristic	O
of	O
junctional	O
epithelium	O
.	O

Multilayers	O
were	O
infected	O
with	O
fluorescently	O
labeled	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
or	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
bacterial	O
association	O
was	O
determined	O
by	O
confocal	O
microscopy	O
and	O
quantitative	O
image	O
analysis	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
invaded	O
intracellularly	O
and	O
spread	O
from	O
cell	O
to	O
cell	O
;	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
remained	O
extracellular	O
and	O
showed	O
intercellular	O
movement	O
through	O
the	O
multilayer	O
;	O
whereas	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
remained	O
extracellular	O
and	O
predominantly	O
associated	O
with	O
the	O
superficial	O
cell	O
layer	O
.	O

None	O
of	O
the	O
bacterial	O
species	O
disrupted	O
barrier	O
function	O
as	O
measured	O
by	O
transepithelial	O
electrical	O
resistance	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
did	O
not	O
elicit	O
secretion	O
of	O
proinflammatory	O
cytokines	O
.	O

However	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
induced	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
secretion	O
;	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
stimulated	O
production	O
of	O
IL	O
-	O
1beta	O
and	O
TNF	O
-	O
alpha	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
but	O
not	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
increased	O
levels	O
of	O
apoptosis	O
after	O
24	O
h	O
infection	O
.	O

The	O
results	O
indicate	O
that	O
the	O
organisms	O
with	O
pathogenic	O
potential	O
were	O
able	O
to	O
traverse	O
the	O
epithelium	O
,	O
whereas	O
the	O
commensal	O
bacteria	O
did	O
not	O
.	O

In	O
addition	O
,	O
distinct	O
host	O
responses	O
characterized	O
the	O
interaction	O
between	O
the	O
junctional	O
epithelium	O
and	O
oral	O
bacteria	O
.	O

In	O
the	O
oral	O
biofilm	O
,	O
the	O
'	B-bacteria
mitis	I-bacteria
'	I-bacteria
streptococci	I-bacteria
are	O
among	O
the	O
first	O
group	O
of	O
organisms	O
to	O
colonize	O
the	O
tooth	O
surface	O
.	O

Their	O
proliferation	O
is	O
thought	O
to	O
be	O
an	O
important	O
factor	O
required	O
for	O
antagonizing	O
the	O
growth	O
of	O
cariogenic	O
species	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

In	O
this	O
study	O
,	O
we	O
used	O
a	O
three	O
-	O
species	O
mixed	O
culture	O
to	O
demonstrate	O
that	O
another	O
ubiquitous	O
early	O
colonizing	O
species	O
,	O
Veillonella	B-bacteria
parvula	I-bacteria
,	O
can	O
greatly	O
affect	O
the	O
outcome	O
of	O
the	O
competition	O
between	O
a	O
pair	O
of	O
antagonists	O
such	O
as	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

Transcriptome	O
analysis	O
further	O
revealed	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
responds	O
differentially	O
to	O
its	O
friend	O
(	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
)	O
and	O
foe	O
(	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
)	O
.	O

In	O
the	O
mixed	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
all	O
but	O
one	O
of	O
the	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
sugar	O
uptake	O
and	O
metabolic	O
genes	O
were	O
downregulated	O
,	O
while	O
genes	O
for	O
alternative	O
energy	O
source	O
utilization	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
tolerance	O
were	O
upregulated	O
,	O
resulting	O
in	O
a	O
slower	O
but	O
persistent	O
growth	O
.	O

In	O
contrast	O
,	O
when	O
cultured	O
with	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
grew	O
equally	O
well	O
or	O
better	O
than	O
in	O
monoculture	O
and	O
exhibited	O
relatively	O
few	O
changes	O
within	O
its	O
transcriptome	O
.	O

When	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
was	O
introduced	O
into	O
the	O
mixed	O
culture	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
it	O
rescued	O
the	O
growth	O
inhibition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

In	O
this	O
three	O
-	O
species	O
environment	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
increased	O
the	O
expression	O
of	O
genes	O
required	O
for	O
the	O
uptake	O
and	O
metabolism	O
of	O
minor	O
sugars	O
,	O
while	O
genes	O
required	O
for	O
oxidative	O
stress	O
tolerance	O
were	O
downregulated	O
.	O

We	O
conclude	O
that	O
the	O
major	O
factors	O
that	O
affect	O
the	O
competition	O
between	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
are	O
carbohydrate	O
utilization	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
resistance	O
.	O

The	O
presence	O
of	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
in	O
the	O
tri	O
-	O
species	O
culture	O
mitigates	O
these	O
two	O
major	O
factors	O
and	O
allows	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
proliferate	O
,	O
despite	O
the	O
presence	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

Despite	O
the	O
targeted	O
and	O
incidental	O
exposure	O
of	O
the	O
oral	O
cavity	O
to	O
probiotic	O
bacteria	O
,	O
relatively	O
little	O
information	O
is	O
available	O
concerning	O
their	O
bacteriological	O
effects	O
or	O
ecological	O
fate	O
in	O
this	O
environment	O
.	O

We	O
have	O
investigated	O
the	O
effects	O
of	O
an	O
oral	O
probiotic	O
bacterium	O
,	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
on	O
salivary	O
biofilm	O
microcosms	O
.	O

Nascent	O
in	O
vitro	O
plaques	O
in	O
hydroxyapatite	O
disc	O
model	O
and	O
mature	O
continuous	O
culture	O
plaques	O
within	O
constant	O
depth	O
film	O
fermenters	O
(	O
CDFFs	O
)	O
were	O
exposed	O
to	O
probiotic	O
strains	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
.	O

Microbial	O
composition	O
was	O
assessed	O
using	O
differential	O
viable	O
counting	O
and	O
CDFF	O
plaques	O
were	O
additionally	O
characterised	O
using	O
qPCR	O
and	O
PCR	O
-	O
DGGE	O
.	O

Probiotic	O
dosing	O
of	O
nascent	O
plaques	O
was	O
associated	O
with	O
significant	O
increases	O
in	O
lactobacilli	B-bacteria
and	O
Gram	O
-	O
negative	O
anaerobes	O
in	O
both	O
biofilm	O
and	O
planktonic	O
phases	O
,	O
and	O
with	O
elevated	O
counts	O
of	O
streptococci	B-bacteria
in	O
the	O
planktonic	O
phase	O
that	O
were	O
not	O
accompanied	O
by	O
decreases	O
in	O
pH	O
.	O

In	O
mature	O
CDFF	O
plaques	O
,	O
differential	O
culture	O
indicated	O
that	O
whilst	O
significant	O
increases	O
in	O
lactobacillus	B-bacteria
counts	O
occurred	O
during	O
dosing	O
,	O
numbers	O
of	O
other	O
bacterial	O
groups	O
and	O
pH	O
did	O
not	O
significantly	O
change	O
.	O

Monitoring	O
the	O
probiotic	O
strain	O
in	O
CDFFs	O
using	O
selective	O
culture	O
and	O
qPCR	O
indicated	O
that	O
the	O
exogenous	O
bacterium	O
reached	O
and	O
maintained	O
c	O
.	O
5	O
log	O
(	O
10	O
)	O
CFU	O
/	O
mm	O
(	O
2	O
)	O
during	O
dosing	O
and	O
20	O
days	O
after	O
cessation	O
.	O

The	O
apparent	O
lack	O
of	O
marked	O
bacterial	O
inhibition	O
by	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
both	O
model	O
systems	O
was	O
supported	O
by	O
the	O
absence	O
of	O
antagonism	O
in	O
binary	O
antagonism	O
assays	O
.	O

The	O
largest	O
compositional	O
changes	O
occurred	O
in	O
nascent	O
plaques	O
where	O
the	O
addition	O
of	O
lactobacilli	B-bacteria
caused	O
significant	O
increases	O
in	O
streptococci	B-bacteria
and	O
Gram	O
-	O
negative	O
anaerobes	O
,	O
the	O
latter	O
possibly	O
via	O
lactate	O
syntrophy	O
.	O

Exogenous	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
persisted	O
in	O
mature	O
plaque	O
microcosms	O
after	O
dosing	O
ceased	O
.	O

The	O
present	O
study	O
aimed	O
to	O
develop	O
an	O
innovative	O
,	O
strain	O
-	O
specific	O
means	O
of	O
identifying	O
the	O
probiotic	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
TMC0356	I-bacteria
and	O
to	O
determine	O
whether	O
orally	O
administered	O
TMC0356	B-bacteria
could	O
be	O
recovered	O
from	O
the	O
human	O
intestine	O
.	O

High	O
molecular	O
weight	O
genomic	O
DNA	O
was	O
isolated	O
from	O
TMC0356	B-bacteria
and	O
14	O
reference	O
strains	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
,	O
including	O
the	O
type	O
strain	O
.	O

The	O
DNA	O
samples	O
were	O
digested	O
with	O
the	O
selected	O
rare	O
-	O
cutting	O
restriction	O
endonucleases	O
SmaI	O
,	O
SacII	O
and	O
ApaI	O
and	O
the	O
resulting	O
fragments	O
separated	O
by	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
(	O
PFGE	O
)	O
in	O
a	O
size	O
range	O
between	O
20	O
to	O
290	O
kb	O
.	O

TMC0356	B-bacteria
could	O
be	O
distinguished	O
from	O
the	O
other	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
strains	I-bacteria
on	O
the	O
basis	O
of	O
the	O
SmaI	O
and	O
SacII	O
macrorestriction	O
patterns	O
.	O

Furthermore	O
,	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
feces	O
of	O
subjects	O
who	O
had	O
ingested	O
TMC0356	B-bacteria
were	O
identical	O
to	O
TMC0356	B-bacteria
in	O
the	O
SmaI	O
,	O
SacII	O
and	O
ApaI	O
macrorestriction	O
fragments	O
of	O
digested	O
DNA	O
.	O

These	O
results	O
suggest	O
that	O
PFGE	O
of	O
genomic	O
DNA	O
digested	O
with	O
SmaI	O
,	O
SacII	O
,	O
could	O
be	O
a	O
practical	O
means	O
of	O
identification	O
of	O
TMC0356	B-bacteria
.	O

Furthermore	O
,	O
these	O
results	O
indicate	O
that	O
ingested	O
TMC0356	B-bacteria
can	O
survive	O
in	O
,	O
and	O
colonize	O
,	O
the	O
human	O
intestine	O
.	O

The	O
present	O
study	O
focused	O
on	O
the	O
antibacterial	O
and	O
biofilm	O
inhibitory	O
potential	O
of	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
isolated	O
from	O
aerial	O
parts	O
(	O
stem	O
and	O
leaves	O
)	O
of	O
Aralia	O
cachemirica	O
L	O
.	O
(	O
Araliaceae	O
)	O
against	O
oral	O
cavity	O
pathogens	O
.	O

4	O
-	O
epi	O
-	O
Pimaric	O
acid	O
exhibited	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
in	O
the	O
range	O
of	O
4	O
-	O
16	O
mug	O
/	O
ml	O
and	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
two	O
-	O
to	O
four	O
-	O
folds	O
higher	O
than	O
MIC	O
.	O

There	O
was	O
significant	O
inhibition	O
in	O
the	O
biofilm	O
formation	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
on	O
the	O
saliva	O
coated	O
surface	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
confocal	O
microscopy	O
revealed	O
that	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
inhibited	O
the	O
clumping	O
and	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

At	O
8	O
x	O
MIC	O
concentration	O
,	O
it	O
significantly	O
prevented	O
the	O
pH	O
drop	O
and	O
reduced	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Increased	O
propidium	O
iodide	O
staining	O
and	O
leakage	O
of	O
260	O
-	O
and	O
280	O
-	O
nm	O
absorbing	O
material	O
by	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
treated	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
suggested	O
that	O
it	O
probably	O
causes	O
disruption	O
of	O
the	O
cytoplasmic	O
membrane	O
structure	O
.	O

It	O
also	O
exhibited	O
significant	O
suppression	O
of	O
TNF	O
-	O
alpha	O
expression	O
in	O
human	O
neutrophils	O
,	O
suggestive	O
of	O
its	O
anti	O
-	O
inflammatory	O
activity	O
.	O

Furthermore	O
,	O
the	O
compound	O
was	O
found	O
to	O
be	O
significantly	O
safe	O
(	O
IC	O
(	O
50	O
)	O
>	O
100	O
mug	O
/	O
ml	O
)	O
in	O
the	O
MTT	O
assay	O
on	O
AML	O
-	O
12	O
cell	O
lines	O
.	O

In	O
conclusion	O
,	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
showed	O
promising	O
antibacterial	O
,	O
anti	O
-	O
biofilm	O
and	O
anti	O
-	O
inflammatory	O
potency	O
and	O
this	O
compound	O
can	O
be	O
exploited	O
for	O
therapeutic	O
application	O
in	O
oral	O
microbial	O
infections	O
.	O

Research	O
using	O
low	O
frequency	O
atmospheric	O
pressure	O
plasma	O
jets	O
(	O
LF	O
jet	O
)	O
is	O
becoming	O
increasingly	O
more	O
common	O
.	O

We	O
carried	O
out	O
experiments	O
to	O
evaluate	O
the	O
sterilizing	O
effects	O
of	O
this	O
technology	O
on	O
oral	O
pathogenic	O
microorganisms	O
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
C	O
.	O
albicans	O
and	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
)	O
and	O
to	O
determine	O
its	O
potential	O
for	O
clinical	O
application	O
.	O

We	O
performed	O
the	O
direct	O
exposure	O
test	O
on	O
a	O
solid	O
surface	O
,	O
indirect	O
exposure	O
test	O
on	O
a	O
liquid	O
phase	O
,	O
and	O
ROS	O
(	O
reactive	O
oxygen	O
species	O
)	O
inhibitory	O
test	O
.	O

The	O
results	O
showed	O
the	O
LF	O
jet	O
had	O
microbicidal	O
effects	O
on	O
oral	O
pathogens	O
,	O
and	O
that	O
the	O
ROS	O
influenced	O
this	O
sterilization	O
effect	O
.	O

The	O
experiments	O
of	O
this	O
study	O
revealed	O
that	O
LF	O
jet	O
had	O
a	O
sterilizing	O
effect	O
on	O
oral	O
pathogenic	O
microorganisms	O
present	O
in	O
both	O
the	O
solid	O
and	O
liquid	O
phases	O
.	O

The	O
sterilizing	O
mechanism	O
was	O
considered	O
to	O
be	O
related	O
to	O
the	O
effect	O
of	O
superoxide	O
anion	O
radicals	O
.	O

These	O
results	O
indicate	O
that	O
LF	O
jets	O
may	O
represent	O
a	O
novel	O
technology	O
that	O
can	O
be	O
applied	O
to	O
the	O
field	O
of	O
clinical	O
dentistry	O
.	O

Suppression	O
of	O
immune	O
system	O
in	O
treated	O
cancer	O
patients	O
may	O
lead	O
to	O
secondary	O
infections	O
that	O
obviate	O
the	O
need	O
of	O
antibiotics	O
.	O

In	O
the	O
present	O
study	O
,	O
an	O
attempt	O
was	O
made	O
to	O
understand	O
the	O
occurrence	O
of	O
secondary	O
infections	O
in	O
immuno	O
-	O
suppressed	O
patients	O
along	O
with	O
herbal	O
control	O
of	O
these	O
infections	O
with	O
the	O
following	O
objectives	O
to	O
:	O
(	O
a	O
)	O
isolate	O
the	O
microbial	O
species	O
from	O
the	O
treated	O
oral	O
cancer	O
patients	O
along	O
with	O
the	O
estimation	O
of	O
absolute	O
neutrophile	O
counts	O
of	O
patients	O
(	O
b	O
)	O
assess	O
the	O
in	O
vitro	O
antimicrobial	O
activity	O
medicinal	O
plants	O
against	O
the	O
above	O
clinical	O
isolates	O
.	O

Blood	O
and	O
oral	O
swab	O
cultures	O
were	O
taken	O
from	O
40	O
oral	O
cancer	O
patients	O
undergoing	O
treatment	O
in	O
the	O
radiotherapy	O
unit	O
of	O
Regional	O
Cancer	O
Institute	O
,	O
Pt	O
.	O
B	O
.	O
D	O
.	O
S	O
.	O

Health	O
University	O
,	O
Rohtak	O
,	O
Haryana	O
.	O

Clinical	O
isolates	O
were	O
identified	O
by	O
following	O
general	O
microbiological	O
,	O
staining	O
and	O
biochemical	O
methods	O
.	O

The	O
absolute	O
neutrophile	O
counts	O
were	O
done	O
by	O
following	O
the	O
standard	O
methods	O
.	O

The	O
medicinal	O
plants	O
selected	O
for	O
antimicrobial	O
activity	O
analysis	O
were	O
Asphodelus	O
tenuifolius	O
Cav	O
.	O
,	O
Asparagus	O
racemosus	O
Willd	O
.	O
,	O
Balanites	O
aegyptiaca	O
L	O
.	O
,	O
Cestrum	O
diurnum	O
L	O
.	O
,	O
Cordia	O
dichotoma	O
G	O
.	O
Forst	O
,	O
Eclipta	O
alba	O
L	O
.	O
,	O
Murraya	O
koenigii	O
(	O
L	O
.	O
)	O
Spreng	O
.	O

,	O
Pedalium	O
murex	O
L	O
.	O
,	O
Ricinus	O
communis	O
L	O
.	O
and	O
Trigonella	O
foenum	O
graecum	O
L	O
.	O
The	O
antimicrobial	O
efficacy	O
of	O
medicinal	O
plants	O
was	O
evaluated	O
by	O
modified	O
Kirby	O
-	O
Bauer	O
disc	O
diffusion	O
method	O
.	O

MIC	O
and	O
MFC	O
were	O
investigated	O
by	O
serial	O
two	O
fold	O
microbroth	O
dilution	O
method	O
.	O

Prevalent	O
bacterial	O
pathogens	O
isolated	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
(	O
23	O
.	O
2	O
%	O
)	O
,	O
Escherichia	B-bacteria
coli	I-bacteria
(	O
15	O
.	O
62	O
%	O
)	O
,	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
(	O
12	O
.	O
5	O
%	O
)	O
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
(	O
9	O
.	O
37	O
%	O
)	O
,	O
Klebsiella	B-bacteria
pneumonia	I-bacteria
(	O
7	O
.	O
81	O
%	O
)	O
,	O
Proteus	B-bacteria
mirabilis	I-bacteria
(	O
3	O
.	O
6	O
%	O
)	O
,	O
Proteus	B-bacteria
vulgaris	I-bacteria
(	O
4	O
.	O
2	O
%	O
)	O
and	O
the	O
fungal	O
pathogens	O
were	O
Candida	O
albicans	O
(	O
14	O
.	O
6	O
%	O
)	O
,	O
Aspergillus	O
fumigatus	O
(	O
9	O
.	O
37	O
%	O
)	O
.	O

Out	O
of	O
40	O
cases	O
,	O
35	O
(	O
87	O
.	O
5	O
%	O
)	O
were	O
observed	O
as	O
neutropenic	O
.	O

Eight	O
medicinal	O
plants	O
(	O
A	O
.	O
tenuifolius	O
,	O
A	O
.	O
racemosus	O
,	O
B	O
.	O
aegyptiaca	O
,	O
E	O
.	O
alba	O
,	O
M	O
.	O
koenigii	O
,	O
P	O
.	O
murex	O
R	O
.	O
communis	O
and	O
T	O
.	O
foenum	O
graecum	O
)	O
showed	O
significant	O
antimicrobial	O
activity	O
(	O
P	O
<	O
.	O
05	O
)	O
against	O
most	O
of	O
the	O
isolates	O
.	O

The	O
MIC	O
and	O
MFC	O
values	O
were	O
ranged	O
from	O
31	O
to	O
500	O
mug	O
/	O
ml	O
.	O

P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
was	O
observed	O
highest	O
susceptible	O
bacteria	O
(	O
46	O
.	O
6	O
%	O
)	O
on	O
the	O
basis	O
of	O
susceptible	O
index	O
.	O

It	O
can	O
be	O
concluded	O
that	O
treated	O
oral	O
cancer	O
patients	O
were	O
neutropenic	O
and	O
prone	O
to	O
secondary	O
infection	O
of	O
microbes	O
.	O

The	O
medicinal	O
plant	O
can	O
prove	O
as	O
effective	O
antimicrobial	O
agent	O
to	O
check	O
the	O
secondary	O
infections	O
in	O
treated	O
cancer	O
patients	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
quantify	O
nine	O
selected	O
cariogenic	O
bacteria	O
in	O
plaque	O
from	O
sound	O
root	O
surfaces	O
and	O
initial	O
carious	O
root	O
lesions	O
using	O
TaqMan	O
PCR	O
and	O
to	O
analyse	O
a	O
putative	O
dependence	O
on	O
the	O
kind	O
of	O
initial	O
periodontal	O
treatment	O
.	O

Fifty	O
-	O
four	O
subjects	O
with	O
generalized	O
chronic	O
periodontitis	O
were	O
randomly	O
allocated	O
to	O
one	O
of	O
the	O
following	O
initial	O
periodontal	O
therapies	O
:	O
full	O
-	O
mouth	O
disinfection	O
,	O
full	O
-	O
mouth	O
scaling	O
and	O
root	O
planing	O
or	O
scaling	O
and	O
root	O
planing	O
within	O
7	O
days	O
.	O

Plaque	O
samples	O
were	O
taken	O
before	O
and	O
after	O
periodontal	O
treatment	O
and	O
analysed	O
by	O
TaqMan	O
PCR	O
.	O

The	O
quantity	O
of	O
the	O
cariogenic	O
bacteria	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacilllus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
and	O
Neisseria	B-bacteria
mucosa	O
were	O
significantly	O
higher	O
,	O
while	O
the	O
quantity	O
of	O
Veillonella	B-bacteria
parvula	I-bacteria
was	O
significantly	O
lower	O
on	O
initial	O
carious	O
lesions	O
than	O
on	O
the	O
sound	O
surfaces	O
both	O
before	O
and	O
after	O
periodontal	O
therapy	O
.	O

No	O
significant	O
differences	O
could	O
be	O
found	O
in	O
any	O
of	O
the	O
tested	O
bacteria	O
except	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
on	O
initial	O
carious	O
lesions	O
and	O
sound	O
surfaces	O
for	O
both	O
examinations	O
between	O
the	O
groups	O
.	O

All	O
the	O
nine	O
species	O
analysed	O
were	O
found	O
to	O
be	O
present	O
in	O
initial	O
carious	O
root	O
lesions	O
as	O
well	O
as	O
sound	O
root	O
surfaces	O
but	O
in	O
different	O
quantities	O
,	O
independent	O
of	O
the	O
different	O
periodontal	O
therapies	O
.	O

To	O
investigate	O
the	O
effect	O
of	O
PG0839	O
gene	O
form	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
on	O
inflammatory	O
cytokine	O
expression	O
in	O
human	O
oral	O
epidermoid	O
carcinoma	O
KB	O
cell	O
.	O

A	O
mutant	O
in	O
the	O
PG0839	O
gene	O
of	O
Pg	B-bacteria
was	O
created	O
by	O
insertional	O
inactivation	O
.	O

Group	O
1	O
was	O
chanllenged	O
with	O
PgW83	B-bacteria
strain	I-bacteria
,	O
group	O
2	O
with	O
PG0839	O
-	O
defective	O
mutant	O
,	O
and	O
the	O
control	O
group	O
with	O
Dulbecco	O
'	O
s	O
modified	O
Eagle	O
'	O
s	O
medium	O
only	O
.	O

KB	O
cells	O
were	O
co	O
-	O
cultured	O
with	O
presence	O
of	O
bacteria	O
for	O
24	O
h	O
.	O
At	O
the	O
time	O
point	O
of	O
0	O
.	O
5	O
,	O
2	O
,	O
6	O
,	O
12	O
and	O
24	O
h	O
,	O
cells	O
were	O
stored	O
in	O
Trizol	O
.	O

The	O
mRNA	O
expression	O
of	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
and	O
Toll	O
like	O
recepector	O
-	O
4	O
(	O
TLR	O
-	O
4	O
)	O
was	O
examined	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

At	O
2	O
h	O
and	O
6	O
h	O
,	O
IL	O
-	O
1beta	O
mRNA	O
expression	O
was	O
lower	O
in	O
group	O
2	O
than	O
in	O
group	O
1	O
(	O
2	O
h	O
:	O
0	O
.	O
31	O
+	O
/	O
-	O
0	O
.	O
11	O
versus	O
0	O
.	O
95	O
+	O
/	O
-	O
0	O
.	O
48	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
6	O
h	O
:	O
0	O
.	O
57	O
+	O
/	O
-	O
0	O
.	O
20	O
versus	O
1	O
.	O
29	O
+	O
/	O
-	O
0	O
.	O
55	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

At	O
0	O
.	O
5	O
h	O
and	O
6	O
h	O
,	O
TLR	O
-	O
4	O
mRNA	O
expression	O
was	O
lower	O
in	O
group	O
2	O
than	O
in	O
group	O
1	O
(	O
0	O
.	O
5	O
h	O
:	O
0	O
.	O
20	O
+	O
/	O
-	O
0	O
.	O
09	O
versus	O
0	O
.	O
58	O
+	O
/	O
-	O
0	O
.	O
09	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
6	O
h	O
:	O
0	O
.	O
34	O
+	O
/	O
-	O
0	O
.	O
04	O
versus	O
0	O
.	O
71	O
+	O
/	O
-	O
0	O
.	O
18	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

PG0839	O
gene	O
may	O
play	O
an	O
important	O
role	O
in	O
Pg	O
-	O
induced	O
inflammatory	O
effects	O
of	O
KB	O
cell	O
.	O

Tannerella	B-bacteria
forsythia	I-bacteria
,	O
a	O
Gram	O
-	O
negative	O
anaerobe	O
implicated	O
in	O
periodontitis	O
,	O
has	O
been	O
detected	O
within	O
human	O
buccal	O
epithelial	O
cells	O
and	O
shown	O
to	O
invade	O
oral	O
epithelial	O
cells	O
in	O
vitro	O
.	O

We	O
have	O
previously	O
shown	O
that	O
this	O
bacterium	O
triggers	O
host	O
tyrosine	O
kinase	O
-	O
dependent	O
phosphorylation	O
and	O
actin	O
-	O
dependent	O
cytoskeleton	O
reorganization	O
for	O
invasion	O
.	O

On	O
the	O
bacterial	O
side	O
,	O
the	O
leucine	O
-	O
rich	O
repeat	O
cell	O
-	O
surface	O
BspA	O
protein	O
is	O
important	O
for	O
entry	O
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
identify	O
host	O
signalling	O
molecules	O
during	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
entry	O
into	O
human	O
oral	O
and	O
cervical	O
epithelial	O
cells	O
.	O

Specifically	O
,	O
the	O
roles	O
of	O
phosphatidylinositol	O
3	O
-	O
kinase	O
(	O
PI3K	O
)	O
,	O
Rho	O
-	O
family	O
GTPases	O
,	O
cholesterol	O
-	O
rich	O
membrane	O
microdomains	O
and	O
the	O
endocytic	O
protein	O
clathrin	O
were	O
investigated	O
.	O

For	O
this	O
purpose	O
,	O
cell	O
lines	O
were	O
pretreated	O
with	O
chemical	O
inhibitors	O
or	O
small	O
interfering	O
RNAs	O
(	O
siRNAs	O
)	O
that	O
target	O
PI3Ks	O
,	O
Rho	O
GTPases	O
,	O
clathrin	O
and	O
cholesterol	O
(	O
a	O
critical	O
component	O
of	O
'	O
lipid	O
rafts	O
'	O
)	O
,	O
and	O
the	O
resulting	O
effects	O
on	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
uptake	O
were	O
determined	O
.	O

Our	O
studies	O
revealed	O
that	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
entry	O
is	O
dependent	O
on	O
host	O
PI3K	O
signalling	O
,	O
and	O
that	O
purified	O
BspA	O
protein	O
causes	O
activation	O
of	O
this	O
lipid	O
kinase	O
.	O

Bacterial	O
entry	O
also	O
requires	O
the	O
cooperation	O
of	O
host	O
Rac1	O
GTPase	O
.	O

Finally	O
,	O
our	O
findings	O
indicate	O
an	O
important	O
role	O
for	O
clathrin	O
and	O
cholesterol	O
-	O
rich	O
lipid	O
microdomains	O
in	O
the	O
internalization	O
process	O
.	O

Cumulative	O
interceptive	O
supportive	O
therapy	O
(	O
CIST	O
)	O
is	O
currently	O
used	O
as	O
a	O
guideline	O
for	O
treating	O
peri	O
-	O
implant	O
diseases	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
determine	O
the	O
detection	O
rate	O
and	O
measure	O
the	O
number	O
of	O
periodontopathic	O
bacteria	O
in	O
lesions	O
of	O
different	O
CIST	O
levels	O
and	O
thereby	O
characterize	O
peri	O
-	O
implant	O
disease	O
from	O
a	O
bacteriological	O
viewpoint	O
.	O

This	O
study	O
included	O
105	O
patients	O
who	O
had	O
both	O
residual	O
natural	O
teeth	O
and	O
implants	O
with	O
peri	O
-	O
implant	O
disease	O
.	O

A	O
total	O
of	O
105	O
implants	O
were	O
divided	O
into	O
levels	O
A	O
,	O
B	O
,	O
C	O
and	O
D	O
according	O
to	O
the	O
CIST	O
classification	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
peri	O
-	O
implant	O
pockets	O
and	O
four	O
periodontopathic	O
bacteria	O
were	O
measured	O
by	O
PCR	O
and	O
PCR	O
-	O
Invader	O
assay	O
.	O

The	O
number	O
of	O
periodontopathic	O
bacteria	O
increased	O
in	O
line	O
with	O
CIST	O
level	O
,	O
and	O
the	O
detection	O
rate	O
was	O
also	O
associated	O
with	O
CIST	O
level	O
.	O

However	O
,	O
no	O
difference	O
was	O
found	O
in	O
the	O
bacterial	O
detection	O
rate	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
between	O
CIST	O
-	O
B	O
and	O
CIST	O
-	O
C	O
.	O

There	O
was	O
a	O
higher	O
detection	O
rate	O
of	O
all	O
periodontopathic	O
bacteria	O
for	O
CIST	O
-	O
D	O
.	O

The	O
number	O
of	O
periodontopathic	O
bacteria	O
and	O
detection	O
rate	O
increased	O
as	O
peri	O
-	O
implant	O
disease	O
advanced	O
.	O

However	O
,	O
there	O
were	O
no	O
major	O
differences	O
in	O
the	O
detection	O
rate	O
between	O
CIST	O
-	O
B	O
and	O
CIST	O
-	O
C	O
.	O
On	O
the	O
other	O
hand	O
,	O
a	O
higher	O
detection	O
rate	O
of	O
periodontopathic	O
bacteria	O
was	O
seen	O
for	O
CIST	O
-	O
D	O
.	O

The	O
mitis	B-bacteria
group	I-bacteria
streptococci	I-bacteria
(	O
MGS	B-bacteria
)	O
are	O
widespread	O
in	O
the	O
oral	O
cavity	O
and	O
are	O
traditionally	O
associated	O
with	O
oral	O
health	O
.	O

However	O
,	O
these	O
organisms	O
have	O
many	O
attributes	O
that	O
contribute	O
to	O
the	O
development	O
of	O
pathogenic	O
oral	O
communities	O
.	O

MGS	B-bacteria
adhere	O
rapidly	O
to	O
saliva	O
-	O
coated	O
tooth	O
surfaces	O
,	O
thereby	O
providing	O
an	O
attachment	O
substratum	O
for	O
more	O
overtly	O
pathogenic	O
organisms	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
the	O
two	O
species	O
assemble	O
into	O
heterotypic	O
communities	O
.	O

Close	O
physical	O
association	O
facilitates	O
physiologic	O
support	O
,	O
and	O
pathogens	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
display	O
resource	O
partitioning	O
to	O
favour	O
carbon	O
sources	O
generated	O
by	O
streptococcal	B-bacteria
metabolism	O
.	O

MGS	B-bacteria
exchange	O
information	O
with	O
community	O
members	O
through	O
a	O
number	O
of	O
interspecies	O
signalling	O
systems	O
including	O
AI	O
-	O
2	O
and	O
contact	O
dependent	O
mechanisms	O
.	O

Signal	O
transduction	O
systems	O
induced	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
are	O
based	O
on	O
protein	O
dephosphorylation	O
mediated	O
by	O
the	O
tyrosine	O
phosphatase	O
Ltp1	O
,	O
and	O
converge	O
on	O
a	O
LuxR	O
-	O
family	O
transcriptional	O
regulator	O
,	O
CdhR	O
.	O

Phenotypic	O
responses	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
include	O
regulation	O
of	O
hemin	O
uptake	O
systems	O
and	O
gingipain	O
activity	O
,	O
processes	O
that	O
are	O
intimately	O
linked	O
to	O
the	O
virulence	O
of	O
the	O
organism	O
.	O

Furthermore	O
,	O
communities	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
are	O
more	O
pathogenic	O
in	O
animal	O
models	O
than	O
the	O
constituent	O
species	O
alone	O
.	O

We	O
propose	O
that	O
MGS	B-bacteria
should	O
be	O
considered	O
accessory	O
pathogens	O
,	O
organisms	O
whose	O
pathogenic	O
potential	O
only	O
becomes	O
evident	O
in	O
the	O
context	O
of	O
a	O
heterotypic	O
microbial	O
community	O
.	O

Early	O
in	O
life	O
,	O
vaginally	O
delivered	O
infants	O
exhibit	O
a	O
different	O
composition	O
of	O
the	O
gut	O
flora	O
compared	O
with	O
infants	O
delivered	O
by	O
caesarean	O
section	O
(	O
C	O
-	O
section	O
)	O
;	O
however	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
also	O
applies	O
to	O
the	O
oral	O
cavity	O
.	O

AIM	O
.	O

To	O
investigate	O
and	O
compare	O
the	O
oral	O
microbial	O
profile	O
between	O
infants	O
delivered	O
vaginally	O
and	O
by	O
C	O
-	O
section	O
.	O

This	O
is	O
a	O
cross	O
-	O
sectional	O
case	O
-	O
control	O
study	O
.	O

Eighty	O
-	O
four	O
infants	O
delivered	O
either	O
vaginally	O
(	O
n	O
=	O
42	O
)	O
or	O
by	O
C	O
-	O
section	O
(	O
n	O
=	O
42	O
)	O
were	O
randomly	O
selected	O
from	O
the	O
2009	O
birth	O
cohort	O
at	O
the	O
County	O
Hospital	O
in	O
Halmstad	O
,	O
Sweden	O
.	O

Medically	O
compromised	O
and	O
premature	O
children	O
(	O
<	O
32	O
weeks	O
)	O
were	O
excluded	O
.	O

The	O
mean	O
age	O
was	O
8	O
.	O
25	O
months	O
(	O
range	O
6	O
-	O
10	O
months	O
)	O
,	O
and	O
parents	O
were	O
asked	O
to	O
complete	O
a	O
questionnaire	O
on	O
socioeconomic	O
factors	O
,	O
lifestyle	O
,	O
and	O
hygiene	O
habits	O
.	O

Saliva	O
was	O
collected	O
and	O
analysed	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

RESULTS	O
.	O

A	O
higher	O
prevalence	O
of	O
salivary	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Lactobacillus	B-bacteria
curvata	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
and	O
Lactobacuillus	B-bacteria
casei	I-bacteria
was	O
detected	O
in	O
infants	O
delivered	O
vaginally	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
caries	O
-	O
associated	O
bacteria	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
were	O
detected	O
in	O
63	O
%	O
and	O
59	O
%	O
of	O
all	O
children	O
,	O
respectively	O
.	O

A	O
significantly	O
higher	O
prevalence	O
of	O
certain	O
strains	O
of	O
health	O
-	O
related	O
streptococci	B-bacteria
and	O
lactobacilli	B-bacteria
was	O
found	O
in	O
vaginally	O
delivered	O
infants	O
compared	O
with	O
infants	O
delivered	O
by	O
C	O
-	O
section	O
.	O

The	O
possible	O
long	O
-	O
term	O
effects	O
on	O
oral	O
health	O
need	O
to	O
be	O
further	O
investigated	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
inhibitory	O
effect	O
of	O
a	O
commercially	O
available	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
12	O
hours	O
after	O
a	O
single	O
rinse	O
and	O
two	O
weeks	O
of	O
twice	O
daily	O
rinsing	O
,	O
on	O
volatile	O
sulphur	O
compounds	O
(	O
VSC	O
)	O
producing	O
bacteria	O
on	O
the	O
tongue	O
.	O

The	O
study	O
was	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
controlled	O
crossover	O
design	O
.	O

Thirty	O
-	O
six	O
healthy	O
subjects	O
,	O
aged	O
20	O
-	O
48	O
years	O
,	O
volunteered	O
to	O
participate	O
in	O
the	O
study	O
.	O

Subjects	O
were	O
randomly	O
assigned	O
to	O
rinse	O
twice	O
daily	O
with	O
either	O
an	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
(	O
Cool	O
Mint	O
Listerine	O
Antiseptic	O
)	O
or	O
a	O
negative	O
control	O
rinse	O
.	O

Bacteria	O
samples	O
were	O
taken	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
at	O
baseline	O
,	O
after	O
the	O
first	O
rinse	O
and	O
two	O
weeks	O
later	O
.	O

They	O
were	O
plated	O
on	O
OOPS	O
medium	O
to	O
enumerate	O
the	O
VSC	O
-	O
producing	O
bacteria	O
.	O

Intergroup	O
comparisons	O
of	O
log10	O
transformed	O
colony	O
-	O
forming	O
units	O
of	O
the	O
samples	O
were	O
made	O
using	O
analysis	O
of	O
covariance	O
.	O

Each	O
comparison	O
was	O
performed	O
at	O
a	O
5	O
%	O
significance	O
level	O
.	O

The	O
mean	O
VSC	O
-	O
producing	O
bacteria	O
in	O
subjects	O
using	O
the	O
essential	O
oil	O
mouth	O
rinse	O
were	O
significantly	O
lower	O
than	O
those	O
using	O
the	O
control	O
rinse	O
twice	O
daily	O
.	O

In	O
healthy	O
subjects	O
,	O
rinsing	O
with	O
an	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
can	O
have	O
a	O
significant	O
effect	O
on	O
VSC	O
-	O
producing	O
bacteria	O
on	O
the	O
tongue	O
and	O
may	O
be	O
useful	O
for	O
controlling	O
intrinsic	O
oral	O
malodor	O
over	O
prolonged	O
periods	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
effect	O
of	O
lead	O
(	O
Pb	O
)	O
on	O
growth	O
of	O
bacterial	O
species	O
related	O
to	O
dental	O
diseases	O
in	O
vitro	O
.	O

The	O
effects	O
of	O
lead	O
acetate	O
on	O
representative	O
species	O
of	O
the	O
oral	O
flora	O
were	O
examined	O
at	O
0	O
.	O
1	O
-	O
10	O
mmol	O
l	O
(	O
-	O
1	O
)	O
and	O
compared	O
with	O
the	O
effect	O
of	O
silver	O
nitrate	O
and	O
ferrous	O
sulfate	O
.	O

The	O
minimal	O
inhibitory	O
concentration	O
of	O
lead	O
acetate	O
was	O
between	O
0	O
.	O
15	O
and	O
5	O
mmol	O
l	O
(	O
-	O
1	O
)	O
for	O
the	O
bacterial	O
strains	O
tested	O
.	O

The	O
minimal	O
bactericidal	O
concentration	O
of	O
lead	O
acetate	O
for	O
most	O
oral	O
species	O
was	O
detected	O
in	O
the	O
range	O
of	O
5	O
-	O
10	O
mmol	O
l	O
(	O
-	O
1	O
)	O
.	O

Silver	O
nitrate	O
at	O
a	O
concentration	O
of	O
1	O
.	O
25	O
mmol	O
l	O
(	O
-	O
1	O
)	O
was	O
sufficient	O
to	O
exhibit	O
antibacterial	O
activity	O
against	O
almost	O
all	O
bacteria	O
tested	O
.	O

Ferrous	O
sulfate	O
had	O
the	O
lowest	O
effect	O
.	O

The	O
study	O
indicated	O
a	O
general	O
antimicrobial	O
effect	O
of	O
lead	O
on	O
oral	O
bacterial	O
species	O
in	O
the	O
range	O
of	O
0	O
.	O
15	O
-	O
10	O
mmol	O
l	O
(	O
-	O
1	O
)	O
.	O

The	O
toxicity	O
of	O
silver	O
nitrate	O
was	O
the	O
highest	O
,	O
whereas	O
that	O
of	O
ferrous	O
sulfate	O
was	O
the	O
lowest	O
.	O

Gram	O
-	O
positive	O
species	O
had	O
a	O
tendency	O
to	O
be	O
less	O
susceptible	O
for	O
metals	O
than	O
Gram	O
-	O
negatives	O
.	O

The	O
study	O
shows	O
that	O
it	O
is	O
possible	O
that	O
microbiological	O
changes	O
may	O
occur	O
in	O
the	O
dental	O
plaque	O
in	O
children	O
because	O
of	O
toxic	O
exposure	O
of	O
environmental	O
lead	O
.	O

The	O
oral	O
cavity	O
of	O
humans	O
is	O
inhabited	O
by	O
hundreds	O
of	O
bacterial	O
species	O
and	O
some	O
of	O
them	O
have	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
oral	O
diseases	O
,	O
mainly	O
dental	O
caries	O
and	O
periodontitis	O
.	O

We	O
describe	O
for	O
the	O
first	O
time	O
the	O
metagenome	O
of	O
the	O
human	O
oral	O
cavity	O
under	O
health	O
and	O
diseased	O
conditions	O
,	O
with	O
a	O
focus	O
on	O
supragingival	O
dental	O
plaque	O
and	O
cavities	O
.	O

Direct	O
pyrosequencing	O
of	O
eight	O
samples	O
with	O
different	O
oral	O
-	O
health	O
status	O
produced	O
1	O
Gbp	O
of	O
sequence	O
without	O
the	O
biases	O
imposed	O
by	O
PCR	O
or	O
cloning	O
.	O

These	O
data	O
show	O
that	O
cavities	O
are	O
not	O
dominated	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
the	O
species	O
originally	O
identified	O
as	O
the	O
ethiological	O
agent	O
of	O
dental	O
caries	O
)	O
but	O
are	O
in	O
fact	O
a	O
complex	O
community	O
formed	O
by	O
tens	O
of	O
bacterial	O
species	O
,	O
in	O
agreement	O
with	O
the	O
view	O
that	O
caries	O
is	O
a	O
polymicrobial	O
disease	O
.	O

The	O
analysis	O
of	O
the	O
reads	O
indicated	O
that	O
the	O
oral	O
cavity	O
is	O
functionally	O
a	O
different	O
environment	O
from	O
the	O
gut	O
,	O
with	O
many	O
functional	O
categories	O
enriched	O
in	O
one	O
of	O
the	O
two	O
environments	O
and	O
depleted	O
in	O
the	O
other	O
.	O

Individuals	O
who	O
had	O
never	O
suffered	O
from	O
dental	O
caries	O
showed	O
an	O
over	O
-	O
representation	O
of	O
several	O
functional	O
categories	O
,	O
like	O
genes	O
for	O
antimicrobial	O
peptides	O
and	O
quorum	O
sensing	O
.	O

In	O
addition	O
,	O
they	O
did	O
not	O
have	O
mutans	B-bacteria
streptococci	I-bacteria
but	O
displayed	O
high	O
recruitment	O
of	O
other	O
species	O
.	O

Several	O
isolates	O
belonging	O
to	O
these	O
dominant	O
bacteria	O
in	O
healthy	O
individuals	O
were	O
cultured	O
and	O
shown	O
to	O
inhibit	O
the	O
growth	O
of	O
cariogenic	O
bacteria	O
,	O
suggesting	O
the	O
use	O
of	O
these	O
commensal	O
bacterial	O
strains	O
as	O
probiotics	O
to	O
promote	O
oral	O
health	O
and	O
prevent	O
dental	O
caries	O
.	O

The	O
etiology	O
of	O
dental	O
caries	O
remains	O
elusive	O
because	O
of	O
our	O
limited	O
understanding	O
of	O
the	O
complex	O
oral	O
microbiomes	O
.	O

The	O
current	O
methodologies	O
have	O
been	O
limited	O
by	O
insufficient	O
depth	O
and	O
breadth	O
of	O
microbial	O
sampling	O
,	O
paucity	O
of	O
data	O
for	O
diseased	O
hosts	O
particularly	O
at	O
the	O
population	O
level	O
,	O
inconsistency	O
of	O
sampled	O
sites	O
and	O
the	O
inability	O
to	O
distinguish	O
the	O
underlying	O
microbial	O
factors	O
.	O

By	O
cross	O
-	O
validating	O
16S	O
rRNA	O
gene	O
amplicon	O
-	O
based	O
and	O
whole	O
-	O
genome	O
-	O
based	O
deep	O
-	O
sequencing	O
technologies	O
,	O
we	O
report	O
the	O
most	O
in	O
-	O
depth	O
,	O
comprehensive	O
and	O
collaborated	O
view	O
to	O
date	O
of	O
the	O
adult	O
saliva	O
microbiomes	O
in	O
pilot	O
populations	O
of	O
19	O
caries	O
-	O
active	O
and	O
26	O
healthy	O
human	O
hosts	O
.	O

We	O
found	O
that	O
:	O
first	O
,	O
saliva	O
microbiomes	O
in	O
human	O
population	O
were	O
featured	O
by	O
a	O
vast	O
phylogenetic	O
diversity	O
yet	O
a	O
minimal	O
organismal	O
core	O
;	O
second	O
,	O
caries	O
microbiomes	O
were	O
significantly	O
more	O
variable	O
in	O
community	O
structure	O
whereas	O
the	O
healthy	O
ones	O
were	O
relatively	O
conserved	O
;	O
third	O
,	O
abundance	O
changes	O
of	O
certain	O
taxa	O
such	O
as	O
overabundance	O
of	O
Prevotella	B-bacteria
Genus	I-bacteria
distinguished	O
caries	O
microbiota	O
from	O
healthy	O
ones	O
,	O
and	O
furthermore	O
,	O
caries	O
-	O
active	O
and	O
normal	O
individuals	O
carried	O
different	O
arrays	O
of	O
Prevotella	B-bacteria
species	I-bacteria
;	O
and	O
finally	O
,	O
no	O
'	O
caries	O
-	O
specific	O
'	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
were	O
detected	O
,	O
yet	O
147	O
OTUs	O
were	O
'	O
caries	O
associated	O
'	O
,	O
that	O
is	O
,	O
differentially	O
distributed	O
yet	O
present	O
in	O
both	O
healthy	O
and	O
caries	O
-	O
active	O
populations	O
.	O

These	O
findings	O
underscored	O
the	O
necessity	O
of	O
species	O
-	O
and	O
strain	O
-	O
level	O
resolution	O
for	O
caries	O
prognosis	O
,	O
and	O
were	O
consistent	O
with	O
the	O
ecological	O
hypothesis	O
where	O
the	O
shifts	O
in	O
community	O
structure	O
,	O
instead	O
of	O
the	O
presence	O
or	O
absence	O
of	O
particular	O
groups	O
of	O
microbes	O
,	O
underlie	O
the	O
cariogenesis	O
.	O

Aerobic	O
and	O
facultatively	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
(	O
AGNB	O
)	O
are	O
opportunistic	O
pathogens	O
and	O
continue	O
to	O
cause	O
a	O
large	O
number	O
of	O
hospital	O
-	O
acquired	O
infections	O
.	O

AGNB	O
residing	O
in	O
the	O
oral	O
cavity	O
and	O
oropharynx	O
have	O
been	O
linked	O
to	O
nosocomial	O
pneumonia	O
and	O
septicemia	O
.	O

Although	O
AGNB	O
are	O
not	O
considered	O
members	O
of	O
the	O
normal	O
oral	O
and	O
oropharyngeal	O
flora	O
,	O
medically	O
compromised	O
patients	O
have	O
been	O
demonstrated	O
to	O
be	O
susceptible	O
to	O
AGNB	O
colonization	O
.	O

A	O
literature	O
search	O
was	O
conducted	O
to	O
retrieve	O
articles	O
that	O
evaluated	O
the	O
effectiveness	O
of	O
oral	O
hygiene	O
interventions	O
in	O
reducing	O
the	O
oral	O
and	O
oropharyngeal	O
carriage	O
of	O
AGNB	O
in	O
medically	O
compromised	O
patients	O
.	O

Few	O
studies	O
have	O
documented	O
the	O
use	O
of	O
mechanical	O
oral	O
hygiene	O
interventions	O
alone	O
against	O
AGNB	O
.	O

Although	O
a	O
number	O
of	O
studies	O
have	O
employed	O
oral	O
hygiene	O
interventions	O
complemented	O
by	O
antiseptic	O
agents	O
such	O
as	O
chlorhexidine	O
and	O
povidone	O
iodine	O
,	O
there	O
appears	O
to	O
be	O
a	O
discrepancy	O
between	O
their	O
in	O
vitro	O
and	O
in	O
vivo	O
effectiveness	O
.	O

With	O
the	O
recognition	O
of	O
the	O
oral	O
cavity	O
and	O
oropharynx	O
as	O
a	O
reservoir	O
of	O
AGNB	O
and	O
the	O
recent	O
emergence	O
of	O
multidrug	O
and	O
pandrug	O
resistance	O
in	O
hospital	O
settings	O
,	O
there	O
is	O
a	O
pressing	O
need	O
for	O
additional	O
high	O
-	O
quality	O
randomized	O
controlled	O
trials	O
to	O
determine	O
which	O
oral	O
hygiene	O
interventions	O
or	O
combination	O
of	O
interventions	O
are	O
most	O
effective	O
in	O
eliminating	O
or	O
reducing	O
AGNB	O
carriage	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
is	O
naturally	O
a	O
predominant	O
member	O
of	O
the	O
human	O
oropharynx	O
and	O
the	O
commercial	O
probiotic	O
strain	O
K12	B-bacteria
has	O
been	O
consumed	O
for	O
more	O
than	O
a	O
decade	O
.	O

The	O
present	O
study	O
examines	O
the	O
health	O
responses	O
of	O
human	O
volunteers	O
to	O
oral	O
ingestion	O
of	O
high	O
doses	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
.	O

A	O
randomized	O
group	O
of	O
53	O
subjects	O
received	O
a	O
dose	O
of	O
1	O
x	O
10	O
(	O
10	O
)	O
cfu	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
(	O
N	O
=	O
25	O
)	O
or	O
placebo	O
(	O
N	O
=	O
28	O
)	O
for	O
28	O
days	O
,	O
followed	O
by	O
a	O
28	O
-	O
day	O
wash	O
out	O
period	O
.	O

Blood	O
,	O
urine	O
and	O
saliva	O
samples	O
were	O
collected	O
at	O
baseline	O
and	O
following	O
treatment	O
and	O
analyzed	O
,	O
while	O
the	O
oral	O
and	O
gastrointestinal	O
tolerance	O
of	O
the	O
subjects	O
to	O
the	O
dosing	O
regimen	O
was	O
determined	O
by	O
use	O
of	O
questionnaires	O
.	O

Adverse	O
events	O
(	O
AE	O
)	O
s	O
were	O
recorded	O
for	O
both	O
groups	O
.	O

No	O
statistically	O
significant	O
differences	O
between	O
the	O
probiotic	O
and	O
placebo	O
treated	O
groups	O
were	O
detected	O
in	O
either	O
the	O
blood	O
clinical	O
chemistry	O
or	O
hematology	O
results	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
questionnaire	O
responses	O
of	O
the	O
subjects	O
indicated	O
that	O
both	O
treatments	O
were	O
well	O
tolerated	O
.	O

The	O
frequency	O
and	O
intensity	O
of	O
AEs	O
was	O
similar	O
in	O
the	O
two	O
groups	O
.	O

This	O
data	O
demonstrates	O
that	O
the	O
daily	O
ingestion	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
over	O
a	O
28	O
-	O
day	O
period	O
does	O
not	O
adversely	O
affect	O
the	O
human	O
host	O
and	O
supports	O
the	O
safety	O
of	O
its	O
oral	O
delivery	O
in	O
a	O
food	O
-	O
based	O
carrier	O
.	O

The	O
up	O
-	O
regulation	O
of	O
the	O
B7	O
-	O
H1	O
receptors	O
in	O
host	O
cells	O
might	O
influence	O
the	O
chronicity	O
of	O
inflammatory	O
disorders	O
that	O
frequently	O
precede	O
the	O
development	O
of	O
human	O
cancers	O
.	O

B7	O
-	O
H1	O
expression	O
has	O
been	O
detected	O
in	O
the	O
majority	O
of	O
human	O
cancers	O
,	O
leading	O
to	O
anergy	O
and	O
apoptosis	O
of	O
activated	O
T	O
cells	O
,	O
and	O
enabling	O
tumor	O
cells	O
to	O
overcome	O
host	O
response	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
,	O
a	O
putative	O
periodontal	O
pathogen	O
,	O
is	O
an	O
etiologic	O
agent	O
of	O
periodontitis	O
and	O
expresses	O
a	O
variety	O
of	O
virulence	O
factors	O
.	O

In	O
this	O
study	O
,	O
the	O
expression	O
of	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
receptors	O
on	O
squamous	O
cell	O
carcinoma	O
cells	O
SCC	O
-	O
25	O
and	O
BHY	O
and	O
primary	O
human	O
gingival	O
keratinocytes	O
(	O
PHGK	O
)	O
was	O
analyzed	O
after	O
infection	O
with	O
two	O
virulent	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
in	O
vitro	O
.	O

After	O
48h	O
,	O
the	O
cells	O
were	O
stained	O
with	O
antibodies	O
for	O
human	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
and	O
further	O
analyzed	O
by	O
flow	O
cytometry	O
.	O

RNA	O
was	O
extracted	O
and	O
gene	O
expression	O
of	O
B7	O
-	O
H1	O
or	O
B7	O
-	O
DC	O
was	O
quantified	O
by	O
real	O
time	O
PCR	O
.	O

After	O
infection	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
both	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
receptors	O
were	O
up	O
-	O
regulated	O
.	O

The	O
mean	O
fluorescence	O
intensity	O
(	O
MFI	O
)	O
increased	O
from	O
4	O
.	O
5	O
to	O
9	O
.	O
9	O
(	O
B7	O
-	O
H1	O
)	O
and	O
from	O
6	O
.	O
9	O
to	O
15	O
.	O
0	O
(	O
B7	O
-	O
DC	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
respectively	O
)	O
in	O
SCC	O
-	O
25	O
cells	O
.	O

PHGK	O
showed	O
an	O
increase	O
from	O
4	O
.	O
8	O
to	O
12	O
.	O
4	O
(	O
B7	O
-	O
H1	O
)	O
and	O
from	O
5	O
.	O
5	O
to	O
15	O
.	O
6	O
(	O
B7	O
-	O
DC	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
respectively	O
)	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
,	O
a	O
commensal	O
bacterium	O
,	O
caused	O
no	O
up	O
-	O
regulation	O
.	O

After	O
24h	O
,	O
the	O
expression	O
of	O
B7H1	O
and	O
B7	O
-	O
DC	O
mRNA	O
in	O
infected	O
cells	O
,	O
normalized	O
to	O
GAPDH	O
and	O
in	O
relation	O
to	O
non	O
-	O
infected	O
cells	O
,	O
was	O
6	O
.	O
4	O
fold	O
(	O
B7	O
-	O
H1	O
)	O
and	O
8	O
.	O
6	O
fold	O
(	O
B7	O
-	O
DC	O
)	O
higher	O
.	O

In	O
PHGK	O
B7	O
-	O
H1	O
/	O
DC	O
mRNA	O
expression	O
increased	O
8	O
.	O
2	O
fold	O
(	O
B7	O
-	O
H1	O
)	O
and	O
5	O
.	O
9	O
fold	O
(	O
B7DC	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
respectively	O
.	O

The	O
results	O
of	O
the	O
study	O
demonstrate	O
that	O
in	O
contrast	O
to	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
virulent	O
P	I-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
are	O
able	O
to	O
induce	O
the	O
expression	O
of	O
the	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
receptors	O
in	O
squamous	O
carcinoma	O
cells	O
and	O
human	O
gingival	O
keratinocytes	O
,	O
which	O
might	O
facilitate	O
immune	O
evasion	O
by	O
oral	O
cancers	O
.	O

Products	O
have	O
been	O
developed	O
to	O
provide	O
palliation	O
for	O
persons	O
with	O
dry	O
mouth	O
.	O

In	O
addition	O
to	O
mouth	O
-	O
wetting	O
agents	O
,	O
some	O
products	O
incorporate	O
antimicrobial	O
constituents	O
with	O
the	O
goal	O
of	O
improving	O
oral	O
microbial	O
defenses	O
.	O

The	O
aim	O
of	O
this	O
in	O
vitro	O
study	O
was	O
to	O
investigate	O
the	O
potential	O
antimicrobial	O
and	O
antifungal	O
effects	O
of	O
two	O
commercially	O
available	O
saliva	O
substitutes	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
and	O
Candida	O
albicans	O
by	O
using	O
the	O
agar	O
-	O
well	O
diffusion	O
method	O
.	O

Antimicrobial	O
activity	O
as	O
measured	O
by	O
the	O
size	O
of	O
the	O
inhibition	O
zone	O
growth	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
observed	O
only	O
with	O
Biotene	O
Dry	O
Mouth	O
Oral	O
Rinse	O
(	O
R	O
)	O
and	O
BioXtra	O
(	O
R	O
)	O
gel	O
.	O

The	O
zone	O
of	O
inhibition	O
of	O
Biotene	O
Dry	O
Mouth	O
Oral	O
Rinse	O
was	O
larger	O
than	O
that	O
of	O
BioXtra	O
gel	O
(	O
p	O
=	O
0	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

No	O
anticandidal	O
effect	O
was	O
seen	O
with	O
any	O
of	O
the	O
test	O
products	O
.	O

The	O
pH	O
of	O
the	O
preparations	O
,	O
the	O
variations	O
between	O
the	O
amount	O
of	O
active	O
ingredients	O
within	O
the	O
products	O
,	O
and	O
the	O
potential	O
antimicrobial	O
effects	O
of	O
inactive	O
ingredients	O
should	O
be	O
investigated	O
to	O
determine	O
the	O
factors	O
that	O
impacted	O
microbial	O
inhibition	O
.	O

The	O
mechanisms	O
by	O
which	O
intestinal	O
bacteria	O
achieve	O
their	O
associated	O
health	O
benefits	O
can	O
be	O
complex	O
and	O
multifaceted	O
.	O

In	O
this	O
respect	O
,	O
the	O
diverse	O
microbial	O
composition	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
(	O
GIT	O
)	O
provides	O
an	O
almost	O
unlimited	O
potential	O
source	O
of	O
bioactive	O
substances	O
(	O
pharmabiotics	O
)	O
which	O
can	O
directly	O
or	O
indirectly	O
affect	O
human	O
health	O
.	O

Bacteriocins	O
and	O
fatty	O
acids	O
are	O
just	O
two	O
examples	O
of	O
pharmabiotic	O
substances	O
which	O
may	O
contribute	O
to	O
probiotic	O
functionality	O
within	O
the	O
mammalian	O
GIT	O
.	O

Bacteriocin	O
production	O
is	O
believed	O
to	O
confer	O
producing	O
strains	O
with	O
a	O
competitive	O
advantage	O
within	O
complex	O
microbial	O
environments	O
as	O
a	O
consequence	O
of	O
their	O
associated	O
antimicrobial	O
activity	O
.	O

This	O
has	O
the	O
potential	O
to	O
enable	O
the	O
establishment	O
and	O
prevalence	O
of	O
producing	O
strains	O
as	O
well	O
as	O
directly	O
inhibiting	O
pathogens	O
within	O
the	O
GIT	O
.	O

Consequently	O
,	O
these	O
antimicrobial	O
peptides	O
and	O
the	O
associated	O
intestinal	O
producing	O
strains	O
may	O
be	O
exploited	O
to	O
beneficially	O
influence	O
microbial	O
populations	O
.	O

Intestinal	O
bacteria	O
are	O
also	O
known	O
to	O
produce	O
a	O
diverse	O
array	O
of	O
health	O
-	O
promoting	O
fatty	O
acids	O
.	O

Indeed	O
,	O
certain	O
strains	O
of	O
intestinal	O
bifidobacteria	B-bacteria
have	O
been	O
shown	O
to	O
produce	O
conjugated	O
linoleic	O
acid	O
(	O
CLA	O
)	O
,	O
a	O
fatty	O
acid	O
which	O
has	O
been	O
associated	O
with	O
a	O
variety	O
of	O
systemic	O
health	O
-	O
promoting	O
effects	O
.	O

Recently	O
,	O
the	O
ability	O
to	O
modulate	O
the	O
fatty	O
acid	O
composition	O
of	O
the	O
liver	O
and	O
adipose	O
tissue	O
of	O
the	O
host	O
upon	O
oral	O
administration	O
of	O
CLA	O
-	O
producing	O
bifidobacteria	B-bacteria
and	O
lactobacilli	B-bacteria
was	O
demonstrated	O
in	O
a	O
murine	O
model	O
.	O

Importantly	O
,	O
this	O
implies	O
a	O
potential	O
therapeutic	O
role	O
for	O
probiotics	O
in	O
the	O
treatment	O
of	O
certain	O
metabolic	O
and	O
immunoinflammatory	O
disorders	O
.	O

Such	O
examples	O
serve	O
to	O
highlight	O
the	O
potential	O
contribution	O
of	O
pharmabiotic	O
production	O
to	O
probiotic	O
functionality	O
in	O
relation	O
to	O
human	O
health	O
maintenance	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
(	O
HP	B-bacteria
)	O
infection	O
usually	O
occurs	O
in	O
childhood	O
.	O

While	O
there	O
are	O
various	O
studies	O
on	O
the	O
prevalence	O
of	O
HP	B-bacteria
in	O
dental	O
plaque	O
,	O
ours	O
is	O
the	O
first	O
to	O
analyze	O
its	O
prevalence	O
during	O
orthodontic	O
therapy	O
and	O
its	O
interaction	O
with	O
competitive	O
bacteria	O
in	O
adolescents	O
.	O

The	O
prevalence	O
of	O
HP	B-bacteria
was	O
examined	O
before	O
and	O
during	O
the	O
first	O
12	O
weeks	O
of	O
orthodontic	O
therapy	O
with	O
fixed	O
appliances	O
in	O
11	O
patients	O
with	O
a	O
mean	O
age	O
of	O
12	O
.	O
7	O
years	O
.	O

A	O
total	O
of	O
93	O
plaque	O
samples	O
were	O
analyzed	O
using	O
PCR	O
.	O

The	O
data	O
acquired	O
at	O
every	O
consultation	O
were	O
the	O
following	O
:	O
PCR	O
analysis	O
of	O
dental	O
plaque	O
and	O
(	O
13	O
)	O
C	O
urea	O
breath	O
tests	O
for	O
HP	B-bacteria
,	O
quantitative	O
analyses	O
of	O
saliva	O
for	O
Lactobacilli	B-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
interproximal	O
plaque	O
index	O
(	O
API	O
)	O
,	O
and	O
sulcus	O
bleeding	O
index	O
(	O
SBI	O
)	O
.	O

The	O
prevalence	O
of	O
HP	B-bacteria
in	O
plaque	O
was	O
82	O
%	O
before	O
orthodontic	O
therapy	O
,	O
dropping	O
to	O
54	O
%	O
during	O
therapy	O
(	O
t	O
test	O
,	O
p	O
<	O
/	O
=	O
0	O
.	O
05	O
)	O
.	O

In	O
contrast	O
to	O
HP	B-bacteria
'	O
s	O
prevalence	O
,	O
the	O
Lactobacilli	B-bacteria
count	O
rose	O
(	O
p	O
<	O
/	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
number	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
bacteria	I-bacteria
in	O
saliva	O
decreased	O
during	O
orthodontic	O
therapy	O
(	O
p	O
<	O
/	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
prevalence	O
of	O
HP	O
in	O
dental	O
plaque	O
amounted	O
to	O
82	O
%	O
.	O

Orthodontic	O
treatment	O
did	O
not	O
reduce	O
its	O
prevalence	O
.	O

The	O
prevalence	O
of	O
Lactobacilli	B-bacteria
was	O
inversely	O
proportional	O
to	O
that	O
of	O
HP	B-bacteria
.	O

To	O
assess	O
and	O
compare	O
the	O
effect	O
of	O
0	O
.	O
2	O
%	O
Chlorhexidine	O
mouth	O
rinse	O
,	O
Listerine	O
mouth	O
rinse	O
and	O
4	O
%	O
Tulsi	O
extract	O
mouth	O
rinse	O
on	O
salivary	O
Streptococcus	B-bacteria
mutans	I-bacteria
level	O
.	O

The	O
present	O
study	O
is	O
an	O
experimental	O
study	O
of	O
cross	O
over	O
type	O
,	O
employing	O
Latin	O
square	O
design	O
.	O

45	O
school	O
children	O
aged	O
14	O
-	O
15	O
years	O
were	O
divided	O
into	O
three	O
groups	O
/	O
blocks	O
.	O

The	O
baseline	O
unstimulated	O
saliva	O
samples	O
were	O
obtained	O
from	O
each	O
group	O
and	O
assessed	O
for	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
.	O

The	O
study	O
was	O
divided	O
in	O
to	O
three	O
phases	O
,	O
each	O
phase	O
lasted	O
for	O
8	O
days	O
separated	O
by	O
a	O
washout	O
period	O
of	O
15	O
days	O
in	O
between	O
them	O
.	O

Groups	O
A	O
,	O
B	O
and	O
C	O
were	O
treated	O
with	O
0	O
.	O
2	O
%	O
Chlorhexidine	O
,	O
Listerine	O
and	O
4	O
%	O
Tulsi	O
extract	O
mouth	O
rinses	O
respectively	O
in	O
the	O
phase	O
I	O
.	O

The	O
study	O
subjects	O
were	O
instructed	O
to	O
use	O
the	O
assigned	O
mouth	O
rinse	O
twice	O
daily	O
for	O
1	O
min	O
for	O
7	O
days	O
.	O

On	O
day	O
8th	O
the	O
subjects	O
were	O
instructed	O
to	O
use	O
the	O
mouth	O
rinse	O
only	O
once	O
in	O
the	O
morning	O
.	O

The	O
follow	O
up	O
unstimulated	O
saliva	O
samples	O
were	O
collected	O
1h	O
after	O
the	O
use	O
of	O
the	O
assigned	O
mouth	O
rinse	O
and	O
assessed	O
for	O
salivary	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
.	O

After	O
phase	O
I	O
,	O
mouth	O
rinses	O
were	O
crossed	O
over	O
as	O
dictated	O
by	O
the	O
Latin	O
square	O
design	O
in	O
phase	O
II	O
and	O
III	O
.	O

All	O
the	O
three	O
mouth	O
rinses	O
have	O
individually	O
shown	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
salivary	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
.	O

When	O
the	O
three	O
mouth	O
rinses	O
were	O
compared	O
the	O
difference	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

Tulsi	O
has	O
stood	O
the	O
test	O
and	O
is	O
as	O
effective	O
as	O
Chlorhexidine	O
and	O
Listerine	O
in	O
reducing	O
the	O
salivary	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
levels	O
.	O

Oral	O
streptococci	B-bacteria
are	O
major	O
pathogens	O
of	O
infective	O
endocarditis	O
.	O

Prophylactic	O
antibiotics	O
are	O
commonly	O
given	O
to	O
subjects	O
with	O
certain	O
kinds	O
of	O
heart	O
disorders	O
when	O
invasive	O
dental	O
treatments	O
are	O
performed	O
,	O
with	O
amoxicillin	O
(	O
AMPC	O
)	O
being	O
widely	O
used	O
for	O
this	O
purpose	O
.	O

However	O
,	O
there	O
is	O
little	O
information	O
regarding	O
AMPC	O
-	O
resistant	O
oral	O
streptococci	B-bacteria
.	O

Here	O
,	O
a	O
total	O
of	O
344	O
dental	O
plaque	O
specimens	O
collected	O
from	O
253	O
healthy	O
Japanese	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
(	O
aged	O
2	O
-	O
22	O
years	O
)	O
were	O
diluted	O
and	O
streaked	O
onto	O
culture	O
medium	O
containing	O
high	O
-	O
dose	O
AMPC	O
.	O

The	O
MICs	O
for	O
the	O
isolated	O
strains	O
were	O
evaluated	O
using	O
a	O
macrodilution	O
broth	O
method	O
described	O
by	O
the	O
Clinical	O
and	O
Laboratory	O
Standards	O
Institute	O
.	O

Bacterial	O
DNA	O
was	O
extracted	O
from	O
each	O
strain	O
and	O
the	O
entire	O
sequences	O
of	O
the	O
16S	O
rRNA	O
gene	O
were	O
compared	O
with	O
those	O
in	O
GenBank	O
to	O
identify	O
the	O
species	O
.	O

The	O
results	O
showed	O
that	O
strains	O
with	O
AMPC	O
MICs	O
>	O
16	O
microg	O
ml	O
(	O
-	O
1	O
)	O
were	O
isolated	O
from	O
18	O
specimens	O
from	O
14	O
patients	O
.	O

Analyses	O
of	O
the	O
16S	O
rRNA	O
gene	O
sequences	O
of	O
these	O
strains	O
identified	O
them	O
as	O
major	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
,	O
including	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
.	O

These	O
findings	O
indicate	O
that	O
oral	O
streptococci	B-bacteria
with	O
elevated	O
MICs	O
for	O
AMPC	O
exist	O
in	O
certain	O
small	O
populations	O
of	O
healthy	O
children	O
,	O
and	O
highlight	O
the	O
need	O
for	O
further	O
studies	O
to	O
determine	O
risk	O
factors	O
that	O
lead	O
to	O
the	O
appearance	O
of	O
such	O
strains	O
.	O

To	O
determine	O
the	O
inhibitory	O
effect	O
of	O
oral	O
Lactobacillus	B-bacteria
against	O
putative	O
oral	O
pathogens	O
.	O

Total	O
357	O
strains	O
comprising	O
10	O
species	O
of	O
oral	O
Lactobacillus	B-bacteria
,	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
(	O
195	O
)	O
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
(	O
53	O
)	O
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
(	O
20	O
)	O
,	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
(	O
18	O
)	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
(	O
14	O
)	O
,	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
(	O
12	O
)	O
,	O
Lactobacillus	B-bacteria
mucosae	I-bacteria
(	O
12	O
)	O
,	O
Lactobacillus	B-bacteria
oris	I-bacteria
(	O
12	O
)	O
,	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
(	O
11	O
)	O
and	O
Lactobacillus	B-bacteria
vaginalis	I-bacteria
(	O
10	O
)	O
were	O
used	O
as	O
producer	O
strains	O
.	O

Inhibitory	O
effect	O
against	O
a	O
panel	O
of	O
indicators	O
,	O
periodontitis	O
-	O
and	O
caries	O
-	O
related	O
pathogens	O
,	O
was	O
assessed	O
.	O

Most	O
oral	O
Lactobacillus	B-bacteria
was	O
able	O
to	O
inhibit	O
the	O
growth	O
of	O
both	O
periodontitis	O
-	O
and	O
caries	O
-	O
related	O
pathogens	O
.	O

The	O
strongest	O
inhibitory	O
activity	O
was	O
associated	O
with	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
,	O
Lact	B-bacteria
.	I-bacteria
plantarum	I-bacteria
,	O
Lact	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
,	O
Lact	B-bacteria
.	I-bacteria
casei	I-bacteria
and	O
Lact	B-bacteria
.	I-bacteria
salivarius	I-bacteria
.	O

Lactobacillus	B-bacteria
SD1	I-bacteria
-	I-bacteria
SD6	I-bacteria
,	O
representing	O
the	O
six	O
species	O
with	O
the	O
strong	O
inhibitory	O
effect	O
,	O
inhibited	O
growth	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
in	O
the	O
biofilm	O
model	O
.	O

Also	O
,	O
it	O
was	O
demonstrated	O
that	O
growth	O
of	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
inhibited	O
in	O
a	O
mixture	O
with	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
SD1	I-bacteria
.	O

The	O
inhibition	O
was	O
enhanced	O
in	O
acidic	O
condition	O
and	O
5	O
%	O
glucose	O
.	O

The	O
results	O
have	O
shown	O
that	O
oral	O
Lactobacillus	B-bacteria
SD1	I-bacteria
-	I-bacteria
SD6	I-bacteria
showed	O
a	O
strong	O
inhibitory	O
effect	O
against	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
as	O
well	O
as	O
,	O
Gram	O
-	O
negative	O
periodontal	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

The	O
results	O
indicated	O
that	O
Lactobacillus	B-bacteria
may	O
be	O
of	O
benefit	O
as	O
probiotics	O
for	O
the	O
prevention	O
of	O
oral	O
diseases	O
.	O

Complex	O
and	O
highly	O
variable	O
site	O
-	O
dependent	O
bacterial	O
ecosystems	O
exist	O
throughout	O
the	O
length	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
.	O

Until	O
relatively	O
recently	O
,	O
the	O
majority	O
of	O
our	O
information	O
on	O
intestinal	O
microbiotas	O
has	O
come	O
from	O
studies	O
on	O
feces	O
,	O
or	O
from	O
aspirates	O
taken	O
from	O
the	O
upper	O
gut	O
.	O

However	O
,	O
there	O
is	O
evidence	O
showing	O
that	O
mucosal	O
bacteria	O
growing	O
in	O
biofilms	O
on	O
surfaces	O
lining	O
the	O
gut	O
differ	O
from	O
luminal	O
populations	O
,	O
and	O
that	O
due	O
to	O
their	O
proximity	O
to	O
the	O
epithelial	O
surface	O
,	O
these	O
organisms	O
may	O
be	O
important	O
in	O
modulating	O
the	O
host	O
'	O
s	O
immune	O
system	O
and	O
contributing	O
to	O
some	O
chronic	O
inflammatory	O
diseases	O
.	O

Over	O
the	O
past	O
decade	O
,	O
increasing	O
interest	O
in	O
mucosal	O
bacteria	O
,	O
coupled	O
with	O
advances	O
in	O
molecular	O
approaches	O
for	O
assessing	O
microbial	O
diversity	O
,	O
has	O
begun	O
to	O
provide	O
some	O
insight	O
into	O
the	O
complexity	O
of	O
these	O
mucosa	O
-	O
associated	O
communities	O
.	O

In	O
gastrointestinal	O
conditions	O
such	O
as	O
inflammatory	O
bowel	O
diseases	O
(	O
ulcerative	O
colitis	O
,	O
Crohn	O
'	O
s	O
disease	O
)	O
,	O
it	O
has	O
been	O
shown	O
that	O
a	O
dysbiosis	O
exists	O
in	O
microbial	O
community	O
structure	O
,	O
and	O
that	O
there	O
is	O
a	O
reduction	O
in	O
putatively	O
protective	O
mucosal	O
organisms	O
such	O
as	O
bifidobacteria	B-bacteria
.	O

Therefore	O
,	O
manipulation	O
of	O
mucosal	O
communities	O
may	O
be	O
beneficial	O
in	O
restoring	O
normal	O
functionality	O
in	O
the	O
gut	O
,	O
thereby	O
improving	O
the	O
immune	O
status	O
and	O
general	O
health	O
of	O
the	O
host	O
.	O

Biofilm	O
structure	O
and	O
function	O
has	O
been	O
studied	O
intensively	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
as	O
a	O
consequence	O
,	O
mucosal	O
communities	O
in	O
the	O
mouth	O
will	O
not	O
be	O
covered	O
in	O
this	O
chapter	O
.	O

This	O
review	O
addresses	O
our	O
current	O
knowledge	O
of	O
mucosal	O
populations	O
in	O
the	O
gastrointestinal	O
tract	O
,	O
changes	O
that	O
can	O
occur	O
in	O
community	O
structure	O
in	O
disease	O
,	O
and	O
therapeutic	O
modulation	O
of	O
biofilm	O
composition	O
by	O
antibiotics	O
,	O
prebiotics	O
,	O
and	O
probiotics	O
.	O

Enteral	O
tube	O
feeding	O
is	O
widely	O
used	O
to	O
maintain	O
nutrition	O
for	O
elderly	O
adults	O
with	O
eating	O
difficulties	O
,	O
but	O
its	O
long	O
-	O
term	O
use	O
alters	O
the	O
environment	O
of	O
the	O
oral	O
ecosystem	O
.	O

This	O
study	O
characterized	O
the	O
tongue	O
microbiota	O
of	O
tube	O
-	O
fed	O
elderly	O
adults	O
by	O
analyzing	O
the	O
16S	O
rRNA	O
gene	O
.	O

The	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
T	O
-	O
RFLP	O
)	O
profiles	O
of	O
44	O
tube	O
-	O
fed	O
subjects	O
were	O
compared	O
with	O
those	O
of	O
54	O
subjects	O
fed	O
orally	O
(	O
average	O
age	O
,	O
86	O
.	O
4	O
+	O
/	O
-	O
6	O
.	O
9	O
years	O
)	O
.	O

Bar	O
-	O
coded	O
pyrosequencing	O
data	O
were	O
also	O
obtained	O
for	O
a	O
subset	O
of	O
the	O
subjects	O
from	O
each	O
group	O
(	O
15	O
tube	O
-	O
fed	O
subjects	O
and	O
16	O
subjects	O
fed	O
orally	O
)	O
.	O

The	O
T	O
-	O
RFLP	O
profiles	O
demonstrated	O
that	O
the	O
microbiota	O
of	O
the	O
tube	O
-	O
fed	O
subjects	O
was	O
distinct	O
from	O
that	O
of	O
the	O
subjects	O
fed	O
orally	O
(	O
permutational	O
multivariate	O
analysis	O
of	O
variance	O
[	O
perMANOVA	O
]	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
pyrosequencing	O
data	O
revealed	O
that	O
22	O
bacterial	O
genera	O
,	O
including	O
Corynebacterium	B-bacteria
,	O
Peptostreptococcus	B-bacteria
,	O
and	O
Fusobacterium	B-bacteria
,	O
were	O
significantly	O
more	O
predominant	O
in	O
tube	O
-	O
fed	O
subjects	O
,	O
whereas	O
the	O
dominant	O
genera	O
in	O
the	O
subjects	O
fed	O
orally	O
,	O
such	O
as	O
Streptococcus	B-bacteria
and	O
Veillonella	B-bacteria
,	O
were	O
present	O
in	O
much	O
lower	O
proportions	O
.	O

Opportunistic	O
pathogens	O
rarely	O
detected	O
in	O
the	O
normal	O
oral	O
microbiota	O
,	O
such	O
as	O
Corynebacterium	B-bacteria
striatum	I-bacteria
and	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
,	O
were	O
often	O
found	O
in	O
high	O
proportions	O
in	O
tube	O
-	O
fed	O
subjects	O
.	O

The	O
oral	O
indigenous	O
microbiota	O
is	O
disrupted	O
by	O
the	O
use	O
of	O
enteral	O
feeding	O
,	O
allowing	O
health	O
-	O
threatening	O
bacteria	O
to	O
thrive	O
.	O

The	O
human	O
oral	O
microbiome	O
is	O
potentially	O
related	O
to	O
diverse	O
health	O
conditions	O
and	O
high	O
-	O
throughput	O
technology	O
provides	O
the	O
possibility	O
of	O
surveying	O
microbial	O
community	O
structure	O
at	O
high	O
resolution	O
.	O

We	O
compared	O
two	O
oral	O
microbiome	O
survey	O
methods	O
:	O
broad	O
-	O
based	O
microbiome	O
identification	O
by	O
16S	O
rRNA	O
gene	O
sequencing	O
and	O
targeted	O
characterization	O
of	O
microbes	O
by	O
custom	O
DNA	O
microarray	O
.	O

Oral	O
wash	O
samples	O
were	O
collected	O
from	O
20	O
individuals	O
at	O
Memorial	O
Sloan	O
-	O
Kettering	O
Cancer	O
Center	O
.	O

16S	O
rRNA	O
gene	O
survey	O
was	O
performed	O
by	O
454	O
pyrosequencing	O
of	O
the	O
V3	O
-	O
V5	O
region	O
(	O
450	O
bp	O
)	O
.	O

Targeted	O
identification	O
by	O
DNA	O
microarray	O
was	O
carried	O
out	O
with	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
.	O

Correlations	O
and	O
relative	O
abundance	O
were	O
compared	O
at	O
phylum	O
and	O
genus	O
level	O
,	O
between	O
16S	O
rRNA	O
sequence	O
read	O
ratio	O
and	O
HOMIM	O
hybridization	O
intensity	O
.	O

The	O
major	O
phyla	O
,	O
Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
Actinobacteria	B-bacteria
,	O
and	O
Fusobacteria	B-bacteria
were	O
identified	O
with	O
high	O
correlation	O
by	O
the	O
two	O
methods	O
(	O
r	O
=	O
0	O
.	O
70	O
approximately	O
0	O
.	O
86	O
)	O
.	O

16S	O
rRNA	O
gene	O
pyrosequencing	O
identified	O
77	O
genera	O
and	O
HOMIM	O
identified	O
49	O
,	O
with	O
37	O
genera	O
detected	O
by	O
both	O
methods	O
;	O
more	O
than	O
98	O
%	O
of	O
classified	O
bacteria	O
were	O
assigned	O
in	O
these	O
37	O
genera	O
.	O

Concordance	O
by	O
the	O
two	O
assays	O
(	O
presence	O
/	O
absence	O
)	O
and	O
correlations	O
were	O
high	O
for	O
common	O
genera	O
(	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
Prevotella	B-bacteria
,	O
and	O
Haemophilus	B-bacteria
;	O
Correlation	O
=	O
0	O
.	O
70	O
-	O
0	O
.	O
84	O
)	O
.	O

Microbiome	O
community	O
profiles	O
assessed	O
by	O
16S	O
rRNA	O
pyrosequencing	O
and	O
HOMIM	O
were	O
highly	O
correlated	O
at	O
the	O
phylum	O
level	O
and	O
,	O
when	O
comparing	O
the	O
more	O
commonly	O
detected	O
taxa	O
,	O
also	O
at	O
the	O
genus	O
level	O
.	O

Both	O
methods	O
are	O
currently	O
suitable	O
for	O
high	O
-	O
throughput	O
epidemiologic	O
investigations	O
relating	O
identified	O
and	O
more	O
common	O
oral	O
microbial	O
taxa	O
to	O
disease	O
risk	O
;	O
yet	O
,	O
pyrosequencing	O
may	O
provide	O
a	O
broader	O
spectrum	O
of	O
taxa	O
identification	O
,	O
a	O
distinct	O
sequence	O
-	O
read	O
record	O
,	O
and	O
greater	O
detection	O
sensitivity	O
.	O

Extracellular	O
matrix	O
metalloproteinase	O
inducer	O
(	O
EMMPRIN	O
)	O
or	O
CD147	O
is	O
a	O
transmembrane	O
glycoprotein	O
expressed	O
by	O
various	O
cell	O
types	O
,	O
including	O
oral	O
epithelial	O
cells	O
.	O

Recent	O
studies	O
have	O
brought	O
evidence	O
that	O
EMMPRIN	O
plays	O
a	O
role	O
in	O
periodontitis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
a	O
major	O
pathogen	O
in	O
chronic	O
periodontitis	O
,	O
on	O
the	O
shedding	O
of	O
membrane	O
-	O
anchored	O
EMMPRIN	O
and	O
on	O
the	O
expression	O
of	O
the	O
EMMPRIN	O
gene	O
by	O
oral	O
epithelial	O
cells	O
.	O

A	O
potential	O
contribution	O
of	O
shed	O
EMMPRIN	O
to	O
the	O
inflammatory	O
process	O
of	O
periodontitis	O
was	O
analyzed	O
by	O
evaluating	O
the	O
effect	O
of	O
recombinant	O
EMMPRIN	O
on	O
cytokine	O
and	O
matrix	O
metalloproteinase	O
(	O
MMP	O
)	O
secretion	O
by	O
human	O
gingival	O
fibroblasts	O
.	O

ELISA	O
and	O
immunofluorescence	O
analyses	O
revealed	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
mediated	O
the	O
shedding	O
of	O
epithelial	O
cell	O
-	O
surface	O
EMMPRIN	O
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

Cysteine	O
proteinase	O
(	O
gingipain	O
)	O
-	O
deficient	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
mutants	O
were	O
used	O
to	O
demonstrate	O
that	O
both	O
Arg	O
-	O
and	O
Lys	O
-	O
gingipain	O
activities	O
are	O
involved	O
in	O
EMMPRIN	O
shedding	O
.	O

Real	O
-	O
time	O
PCR	O
showed	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
had	O
no	O
significant	O
effect	O
on	O
the	O
expression	O
of	O
the	O
EMMPRIN	O
gene	O
in	O
epithelial	O
cells	O
.	O

Recombinant	O
EMMPRIN	O
induced	O
the	O
secretion	O
of	O
IL	O
-	O
6	O
and	O
MMP	O
-	O
3	O
by	O
gingival	O
fibroblasts	O
,	O
a	O
phenomenon	O
that	O
appears	O
to	O
involve	O
mitogen	O
activated	O
protein	O
kinases	O
.	O

The	O
present	O
study	O
brought	O
to	O
light	O
a	O
new	O
mechanism	O
by	O
which	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
promote	O
the	O
inflammatory	O
response	O
during	O
periodontitis	O
.	O

Indigenous	O
microbes	O
are	O
known	O
to	O
influence	O
human	O
health	O
outcomes	O
and	O
various	O
approaches	O
are	O
now	O
being	O
made	O
to	O
positively	O
modulate	O
these	O
microbe	O
-	O
induced	O
outcomes	O
via	O
the	O
administration	O
of	O
probiotics	O
.	O

The	O
application	O
of	O
probiotics	O
that	O
are	O
specific	O
to	O
the	O
oral	O
cavity	O
is	O
a	O
relatively	O
undeveloped	O
field	O
,	O
and	O
their	O
emergence	O
has	O
largely	O
occurred	O
as	O
a	O
reasoned	O
follow	O
-	O
up	O
to	O
initial	O
studies	O
in	O
which	O
probiotics	O
that	O
had	O
already	O
been	O
developed	O
and	O
obtained	O
regulatory	O
approval	O
for	O
intestinal	O
applications	O
were	O
then	O
also	O
evaluated	O
for	O
their	O
putative	O
influence	O
on	O
oral	O
microbiota	O
functionality	O
.	O

These	O
attempts	O
to	O
extend	O
the	O
application	O
of	O
existing	O
probiotics	O
were	O
probably	O
at	O
least	O
in	O
part	O
motivated	O
by	O
recognition	O
of	O
the	O
substantial	O
safety	O
and	O
regulatory	O
hurdles	O
that	O
must	O
be	O
overcome	O
prior	O
to	O
the	O
introduction	O
of	O
a	O
novel	O
probiotic	O
agent	O
.	O

Nevertheless	O
,	O
from	O
an	O
efficacy	O
perspective	O
it	O
appears	O
more	O
logical	O
to	O
develop	O
microbes	O
of	O
oral	O
origin	O
as	O
the	O
specific	O
providers	O
of	O
probiotic	O
solutions	O
for	O
oral	O
diseases	O
,	O
rather	O
than	O
attempting	O
to	O
adapt	O
intestinally	O
-	O
derived	O
strains	O
for	O
this	O
role	O
.	O

Oral	O
bacteria	O
and	O
their	O
bioactive	O
molecules	O
have	O
evolved	O
to	O
operate	O
optimally	O
in	O
this	O
environment	O
and	O
in	O
some	O
cases	O
are	O
known	O
to	O
persist	O
only	O
in	O
oral	O
sites	O
.	O

Amongst	O
the	O
bacteria	O
of	O
more	O
than	O
700	O
species	O
now	O
identified	O
within	O
the	O
human	O
oral	O
microbiota	O
,	O
it	O
is	O
the	O
streptococci	B-bacteria
that	O
are	O
numerically	O
predominant	O
.	O

Although	O
this	O
review	O
highlights	O
the	O
development	O
of	O
the	O
oral	O
cavity	O
bacterium	O
Streptococcus	B-bacteria
salivarius	I-bacteria
as	O
an	O
oral	O
probiotic	O
,	O
a	O
number	O
of	O
other	O
streptococcal	B-bacteria
species	I-bacteria
have	O
also	O
been	O
shown	O
to	O
have	O
considerable	O
potential	O
as	O
probiotic	O
candidates	O
.	O

Posttympanostomy	O
tube	O
otorrhea	O
(	O
PTTO	O
)	O
results	O
in	O
significant	O
health	O
care	O
cost	O
and	O
decreased	O
satisfaction	O
with	O
care	O
.	O

The	O
authors	O
reviewed	O
PTTO	O
failing	O
initial	O
ototopical	O
and	O
/	O
or	O
oral	O
antibiotic	O
therapy	O
and	O
microbiology	O
/	O
susceptibility	O
data	O
from	O
cultures	O
.	O

Case	O
series	O
with	O
chart	O
review	O
.	O

A	O
community	O
university	O
satellite	O
ambulatory	O
clinic	O
and	O
the	O
outpatient	O
clinic	O
of	O
a	O
children	O
'	O
s	O
hospital	O
.	O

Review	O
of	O
202	O
patients	O
with	O
228	O
discrete	O
episodes	O
of	O
culture	O
-	O
positive	O
otorrhea	O
from	O
January	O
2004	O
to	O
January	O
2009	O
.	O

PTTO	O
occurred	O
an	O
average	O
of	O
13	O
months	O
after	O
tube	O
placement	O
.	O

Median	O
otorrhea	O
duration	O
was	O
21	O
days	O
(	O
mean	O
,	O
42	O
days	O
)	O
.	O

A	O
mean	O
of	O
1	O
.	O
6	O
visits	O
(	O
range	O
,	O
1	O
-	O
6	O
)	O
to	O
the	O
pediatric	O
otolaryngology	O
office	O
was	O
required	O
for	O
PTTO	O
resolution	O
.	O

Ototopical	O
therapy	O
was	O
reported	O
used	O
in	O
198	O
of	O
228	O
(	O
87	O
%	O
)	O
episodes	O
of	O
otorrhea	O
prior	O
to	O
pediatric	O
otolaryngology	O
visit	O
.	O

Nearly	O
50	O
%	O
of	O
patients	O
were	O
prescribed	O
at	O
least	O
1	O
or	O
more	O
courses	O
of	O
systemic	O
antibiotics	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
accounted	O
for	O
52	O
%	O
of	O
the	O
organisms	O
cultured	O
,	O
with	O
57	O
%	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
S	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
.	O

S	B-bacteria
aureus	I-bacteria
resistance	O
to	O
clindamycin	O
was	O
high	O
(	O
49	O
%	O
)	O
and	O
resistance	O
to	O
levofloxacin	O
was	O
low	O
(	O
1	O
.	O
8	O
%	O
)	O
.	O

MRSA	B-bacteria
was	O
68	O
%	O
clindamycin	O
resistant	O
,	O
much	O
higher	O
than	O
both	O
ours	O
and	O
the	O
children	O
'	O
s	O
hospital	O
'	O
s	O
clindamycin	O
resistance	O
rate	O
of	O
MRSA	B-bacteria
cultured	O
from	O
all	O
other	O
body	O
sites	O
.	O

PTTO	O
that	O
presents	O
as	O
having	O
failed	O
ototopical	O
and	O
/	O
or	O
oral	O
antibiotics	O
most	O
commonly	O
consists	O
of	O
S	B-bacteria
aureus	I-bacteria
,	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

MRSA	B-bacteria
is	O
highly	O
prevalent	O
in	O
this	O
population	O
.	O

It	O
is	O
not	O
necessary	O
to	O
culture	O
PTTO	O
that	O
presents	O
to	O
an	O
otolaryngology	O
office	O
,	O
as	O
resistance	O
to	O
levofloxacin	O
was	O
only	O
1	O
.	O
8	O
%	O
.	O

It	O
is	O
unclear	O
why	O
the	O
same	O
fluoroquinolone	O
ototopical	O
therapy	O
that	O
failed	O
initially	O
is	O
often	O
successful	O
in	O
treating	O
PTTO	O
after	O
otolaryngologist	O
visit	O
.	O

Five	O
species	O
of	O
oral	O
Veillonella	B-bacteria
,	O
V	B-bacteria
.	I-bacteria
atypica	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
denticariosi	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
dispar	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
,	O
and	O
V	B-bacteria
.	I-bacteria
rogosae	I-bacteria
,	O
have	O
been	O
suggested	O
to	O
be	O
early	O
colonizers	O
of	O
dental	O
biofilm	O
and	O
causes	O
of	O
opportunistic	O
infections	O
and	O
oral	O
mucosa	O
.	O

However	O
,	O
the	O
pathogenicity	O
and	O
the	O
distribution	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
have	O
not	O
been	O
clarified	O
.	O

Previously	O
,	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
identified	O
by	O
using	O
16S	O
rDNA	O
sequence	O
analysis	O
.	O

In	O
addition	O
,	O
recently	O
,	O
Veillonella	B-bacteria
isolates	I-bacteria
from	O
human	O
tongue	O
biofilm	O
were	O
identified	O
by	O
rpoB	O
gene	O
sequences	O
,	O
but	O
these	O
procedures	O
are	O
time	O
-	O
consuming	O
and	O
complex	O
.	O

To	O
overcome	O
this	O
problem	O
,	O
Igarashi	O
et	O
al	O
.	O
have	O
designed	O
species	O
-	O
specific	O
primer	O
sets	O
for	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
by	O
using	O
a	O
highly	O
variable	O
region	O
in	O
the	O
rpoB	O
gene	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
tongue	O
biofilm	O
of	O
healthy	O
adults	O
in	O
their	O
20s	O
were	O
examined	O
by	O
using	O
these	O
species	O
-	O
specific	O
primer	O
sets	O
.	O

Tongue	O
biofilm	O
of	O
these	O
subjects	O
were	O
found	O
to	O
be	O
divided	O
into	O
two	O
groups	O
based	O
on	O
the	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	O

In	O
one	O
group	O
,	O
V	B-bacteria
.	I-bacteria
rogosae	I-bacteria
was	O
the	O
predominant	O
species	O
;	O
the	O
other	O
group	O
consisted	O
of	O
mainly	O
V	B-bacteria
.	I-bacteria
dispar	I-bacteria
and	O
V	B-bacteria
.	I-bacteria
atypica	I-bacteria
.	O

Multiple	O
factors	O
may	O
influence	O
these	O
differences	O
in	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
tongue	O
biofilm	O
.	O

This	O
is	O
the	O
first	O
report	O
also	O
demonstrating	O
the	O
availability	O
of	O
the	O
species	O
-	O
specific	O
primer	O
sets	O
for	O
PCR	O
to	O
determine	O
the	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
tongue	O
biofilm	O
of	O
healthy	O
adults	O
in	O
their	O
20s	O
.	O

Bacterial	O
contribution	O
to	O
oral	O
disease	O
has	O
been	O
studied	O
in	O
young	O
children	O
,	O
but	O
there	O
is	O
a	O
lack	O
of	O
data	O
addressing	O
the	O
developmental	O
perspective	O
in	O
edentulous	O
infants	O
.	O

Our	O
primary	O
objectives	O
were	O
to	O
use	O
pyrosequencing	O
to	O
phylogenetically	O
characterize	O
the	O
salivary	O
bacterial	O
microbiome	O
of	O
edentulous	O
infants	O
and	O
to	O
make	O
comparisons	O
against	O
their	O
mothers	O
.	O

Saliva	O
samples	O
were	O
collected	O
from	O
5	O
edentulous	O
infants	O
(	O
mean	O
age	O
=	O
4	O
.	O
6	O
+	O
/	O
-	O
1	O
.	O
2	O
mo	O
old	O
)	O
and	O
their	O
mothers	O
or	O
primary	O
care	O
givers	O
(	O
mean	O
age	O
=	O
30	O
.	O
8	O
+	O
/	O
-	O
9	O
.	O
5	O
y	O
old	O
)	O
.	O

Salivary	O
DNA	O
was	O
extracted	O
,	O
used	O
to	O
generate	O
DNA	O
amplicons	O
of	O
the	O
V4	O
-	O
V6	O
hypervariable	O
region	O
of	O
the	O
bacterial	O
16S	O
rDNA	O
gene	O
,	O
and	O
subjected	O
to	O
454	O
-	O
pyrosequencing	O
.	O

On	O
average	O
,	O
over	O
80	O
,	O
000	O
sequences	O
per	O
sample	O
were	O
generated	O
.	O

High	O
bacterial	O
diversity	O
was	O
noted	O
in	O
the	O
saliva	O
of	O
adults	O
[	O
1012	O
operational	O
taxonomical	O
units	O
(	O
OTU	O
)	O
at	O
3	O
%	O
divergence	O
]	O
and	O
infants	O
(	O
578	O
OTU	O
at	O
3	O
%	O
divergence	O
)	O
.	O

Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Actinobacteria	B-bacteria
,	O
and	O
Fusobacteria	B-bacteria
were	O
predominant	O
bacterial	O
phyla	O
present	O
in	O
all	O
samples	O
.	O

A	O
total	O
of	O
397	O
bacterial	O
genera	O
were	O
present	O
in	O
our	O
dataset	O
.	O

Of	O
the	O
28	O
genera	O
different	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
between	O
infants	O
and	O
adults	O
,	O
27	O
had	O
a	O
greater	O
prevalence	O
in	O
adults	O
.	O

The	O
exception	O
was	O
Streptococcus	B-bacteria
,	O
which	O
was	O
the	O
predominant	O
genera	O
in	O
infant	O
saliva	O
(	O
62	O
.	O
2	O
%	O
in	O
infants	O
vs	O
.	O
20	O
.	O
4	O
%	O
in	O
adults	O
;	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Veillonella	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Rothia	B-bacteria
,	O
Haemophilus	B-bacteria
,	O
Gemella	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
and	O
Fusobacterium	B-bacteria
were	O
also	O
predominant	O
genera	O
in	O
infant	O
samples	O
,	O
while	O
Haemophilus	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Oribacterium	B-bacteria
,	O
Rothia	B-bacteria
,	O
Treponema	B-bacteria
,	O
and	O
Actinomyces	B-bacteria
were	O
predominant	O
in	O
adults	O
.	O

Our	O
data	O
demonstrate	O
that	O
although	O
the	O
adult	O
saliva	O
bacterial	O
microbiome	O
had	O
a	O
greater	O
OTU	O
count	O
than	O
infants	O
,	O
a	O
rich	O
bacterial	O
community	O
exists	O
in	O
the	O
infant	O
oral	O
cavity	O
prior	O
to	O
tooth	O
eruption	O
.	O

Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
and	O
Neisseria	B-bacteria
are	O
the	O
predominant	O
bacterial	O
genera	O
present	O
in	O
infants	O
.	O

Further	O
research	O
is	O
required	O
to	O
characterize	O
the	O
development	O
of	O
oral	O
microbiota	O
early	O
in	O
life	O
and	O
identify	O
environmental	O
factors	O
that	O
impact	O
colonization	O
and	O
oral	O
and	O
gastrointestinal	O
disease	O
risk	O
.	O

Recent	O
evidence	O
suggests	O
that	O
smoking	O
affects	O
the	O
composition	O
of	O
the	O
disease	O
-	O
associated	O
subgingival	O
biofilm	O
,	O
yet	O
little	O
is	O
known	O
about	O
its	O
effects	O
during	O
the	O
formation	O
of	O
this	O
biofilm	O
.	O

The	O
present	O
investigation	O
was	O
undertaken	O
to	O
examine	O
the	O
contributions	O
of	O
smoking	O
to	O
the	O
composition	O
and	O
proinflammatory	O
characteristics	O
of	O
the	O
biofilm	O
during	O
de	O
novo	O
plaque	O
formation	O
.	O

Marginal	O
and	O
subgingival	O
plaque	O
and	O
gingival	O
crevicular	O
fluid	O
samples	O
were	O
collected	O
from	O
15	O
current	O
smokers	O
and	O
from	O
15	O
individuals	O
who	O
had	O
never	O
smoked	O
(	O
nonsmokers	O
)	O
following	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
7	O
days	O
of	O
undisturbed	O
plaque	O
formation	O
.	O

16S	O
rRNA	O
gene	O
cloning	O
and	O
sequencing	O
were	O
used	O
for	O
bacterial	O
identification	O
,	O
and	O
multiplex	O
bead	O
-	O
based	O
flow	O
cytometry	O
was	O
used	O
to	O
quantify	O
the	O
levels	O
of	O
27	O
immune	O
mediators	O
.	O

Smokers	O
demonstrated	O
a	O
highly	O
diverse	O
,	O
relatively	O
unstable	O
initial	O
colonization	O
of	O
both	O
marginal	O
and	O
subgingival	O
biofilms	O
,	O
with	O
lower	O
niche	O
saturation	O
than	O
that	O
seen	O
in	O
nonsmokers	O
.	O

Periodontal	O
pathogens	O
belonging	O
to	O
the	O
genera	O
Fusobacterium	B-bacteria
,	O
Cardiobacterium	B-bacteria
,	O
Synergistes	B-bacteria
,	O
and	O
Selenomonas	B-bacteria
,	O
as	O
well	O
as	O
respiratory	O
pathogens	O
belonging	O
to	O
the	O
genera	O
Haemophilus	B-bacteria
and	O
Pseudomonas	B-bacteria
,	O
colonized	O
the	O
early	O
biofilms	O
of	O
smokers	O
and	O
continued	O
to	O
persist	O
over	O
the	O
observation	O
period	O
,	O
suggesting	O
that	O
smoking	O
favors	O
early	O
acquisition	O
and	O
colonization	O
of	O
pathogens	O
in	O
oral	O
biofilms	O
.	O

Smokers	O
also	O
demonstrated	O
an	O
early	O
proinflammatory	O
response	O
to	O
this	O
colonization	O
,	O
which	O
persisted	O
over	O
7	O
days	O
.	O

Further	O
,	O
a	O
positive	O
correlation	O
between	O
proinflammatory	O
cytokine	O
levels	O
and	O
commensal	O
bacteria	O
was	O
observed	O
in	O
smokers	O
but	O
not	O
in	O
nonsmokers	O
.	O

Taken	O
together	O
,	O
the	O
data	O
suggest	O
that	O
smoking	O
influences	O
both	O
the	O
composition	O
of	O
the	O
nascent	O
biofilm	O
and	O
the	O
host	O
response	O
to	O
this	O
colonization	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
major	O
etiological	O
agent	O
of	O
dental	O
caries	O
,	O
has	O
a	O
measurable	O
impact	O
on	O
domestic	O
and	O
global	O
health	O
care	O
costs	O
.	O

Though	O
persistent	O
in	O
the	O
oral	O
cavity	O
despite	O
conventional	O
oral	O
hygiene	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
can	O
be	O
excluded	O
from	O
intact	O
oral	O
biofilms	O
through	O
competitive	O
exclusion	O
by	O
other	O
microorganisms	O
.	O

This	O
suggests	O
that	O
therapies	O
capable	O
of	O
selectively	O
eliminating	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
while	O
limiting	O
the	O
damage	O
to	O
the	O
normal	O
oral	O
flora	O
might	O
be	O
effective	O
long	O
-	O
term	O
interventions	O
to	O
fight	O
cariogenesis	O
.	O

To	O
meet	O
this	O
challenge	O
,	O
we	O
designed	O
C16G2	O
,	O
a	O
novel	O
synthetic	O
specifically	O
targeted	O
antimicrobial	O
peptide	O
with	O
specificity	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

C16G2	O
consists	O
of	O
a	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
-	O
selective	O
'	O
targeting	O
region	O
'	O
comprised	O
of	O
a	O
fragment	O
from	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
competence	O
stimulation	O
peptide	O
(	O
CSP	O
)	O
conjoined	O
to	O
a	O
'	O
killing	O
region	O
'	O
consisting	O
of	O
a	O
broad	O
-	O
spectrum	O
antimicrobial	O
peptide	O
(	O
G2	O
)	O
.	O

In	O
vitro	O
studies	O
have	O
indicated	O
that	O
C16G2	O
has	O
robust	O
efficacy	O
and	O
selectivity	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
not	O
other	O
oral	O
bacteria	O
,	O
and	O
affects	O
targeted	O
bacteria	O
within	O
seconds	O
of	O
contact	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
C16G2	O
for	O
clinical	O
utility	O
in	O
vitro	O
,	O
followed	O
by	O
a	O
pilot	O
efficacy	O
study	O
to	O
examine	O
the	O
impact	O
of	O
a	O
0	O
.	O
04	O
%	O
(	O
w	O
/	O
v	O
)	O
C16G2	O
rinse	O
in	O
an	O
intra	O
-	O
oral	O
remineralization	O
/	O
demineralization	O
model	O
.	O

C16G2	O
rinse	O
usage	O
was	O
associated	O
with	O
reductions	O
in	O
plaque	O
and	O
salivary	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
lactic	O
acid	O
production	O
,	O
and	O
enamel	O
demineralization	O
.	O

The	O
impact	O
on	O
total	O
plaque	O
bacteria	O
was	O
minimal	O
.	O

These	O
results	O
suggest	O
that	O
C16G2	O
is	O
effective	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
vivo	O
and	O
should	O
be	O
evaluated	O
further	O
in	O
the	O
clinic	O
.	O

In	O
view	O
of	O
the	O
morbidity	O
potential	O
of	O
oral	O
complications	O
in	O
patients	O
with	O
leukemia	O
,	O
this	O
study	O
evaluated	O
the	O
clinical	O
and	O
microbiological	O
alterations	O
that	O
occur	O
in	O
the	O
oral	O
mucosa	O
of	O
children	O
with	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
undergoing	O
antineoplastic	O
chemotherapy	O
and	O
prophylactic	O
administration	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
gluconate	O
.	O

The	O
sample	O
consisted	O
of	O
17	O
children	O
aged	O
2	O
to	O
12	O
years	O
that	O
underwent	O
clinical	O
examination	O
of	O
the	O
oral	O
mucosa	O
for	O
the	O
detection	O
of	O
oral	O
lesions	O
.	O

In	O
addition	O
,	O
biological	O
material	O
was	O
collected	O
from	O
labial	O
and	O
buccal	O
mucosa	O
for	O
microbiological	O
analysis	O
.	O

Oral	O
mucositis	O
was	O
observed	O
in	O
only	O
5	O
(	O
29	O
.	O
4	O
%	O
)	O
patients	O
.	O

Microbiological	O
analysis	O
revealed	O
a	O
reduced	O
number	O
of	O
potentially	O
pathogenic	O
microorganisms	O
,	O
such	O
as	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
(	O
47	O
%	O
)	O
,	O
Candida	O
albicans	O
(	O
35	O
.	O
3	O
%	O
)	O
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
(	O
5	O
.	O
9	O
%	O
)	O
,	O
enteropathogenic	B-bacteria
Escherichia	I-bacteria
coli	I-bacteria
(	O
5	O
.	O
9	O
%	O
)	O
,	O
and	O
Stenotrophomonas	B-bacteria
maltophilia	I-bacteria
(	O
5	O
.	O
9	O
%	O
)	O
.	O

Patients	O
with	O
oral	O
mucositis	O
showed	O
a	O
higher	O
frequency	O
of	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
(	O
80	O
%	O
)	O
when	O
compared	O
with	O
patients	O
with	O
normal	O
oral	O
mucosa	O
(	O
33	O
.	O
3	O
%	O
)	O
.	O

In	O
conclusion	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
suggest	O
that	O
the	O
prophylactic	O
use	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
gluconate	O
reduces	O
the	O
frequency	O
of	O
oral	O
mucositis	O
and	O
oral	O
pathogens	O
in	O
children	O
with	O
ALL	O
.	O

In	O
addition	O
,	O
the	O
present	O
findings	O
suggest	O
a	O
possible	O
relationship	O
between	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
and	O
the	O
development	O
of	O
oral	O
mucositis	O
.	O

We	O
compared	O
the	O
clinical	O
efficacy	O
,	O
the	O
bactericidal	O
effects	O
,	O
effect	O
on	O
the	O
oral	O
microbial	O
flora	O
,	O
and	O
adverse	O
reactions	O
between	O
cefditoren	O
pivoxil	O
(	O
CDTR	O
-	O
PI	O
)	O
for	O
5	O
days	O
and	O
amoxicillin	O
(	O
AMPC	O
)	O
for	O
10	O
days	O
in	O
children	O
with	O
acute	O
group	B-bacteria
A	I-bacteria
beta	I-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
(	O
GAS	B-bacteria
)	O
tonsillopharyngitis	O
,	O
and	O
simultaneously	O
examined	O
the	O
emm	O
genotype	O
and	O
drug	O
susceptibility	O
of	O
the	O
isolated	O
GAS	O
.	O

The	O
results	O
showed	O
that	O
the	O
clinical	O
efficacy	O
was	O
100	O
%	O
for	O
CDTR	O
-	O
PI	O
and	O
97	O
.	O
9	O
%	O
for	O
AMPC	O
,	O
with	O
no	O
difference	O
between	O
the	O
two	O
groups	O
,	O
and	O
the	O
bacterial	O
elimination	O
rate	O
was	O
100	O
%	O
in	O
both	O
groups	O
.	O

No	O
serious	O
adverse	O
event	O
was	O
noted	O
in	O
either	O
group	O
.	O

On	O
the	O
other	O
hand	O
,	O
concerning	O
changes	O
in	O
the	O
oral	O
microbial	O
flora	O
between	O
before	O
and	O
after	O
treatment	O
,	O
the	O
amount	O
of	O
bacteria	O
showed	O
no	O
change	O
in	O
the	O
CDTR	O
-	O
PI	O
group	O
(	O
p	O
=	O
0	O
.	O
5761	O
)	O
but	O
clearly	O
decreased	O
in	O
the	O
AMPC	O
group	O
(	O
p	O
=	O
0	O
.	O
0049	O
)	O
.	O

This	O
indicates	O
that	O
CDTR	O
-	O
PI	O
does	O
not	O
disturb	O
the	O
oral	O
microbial	O
flora	O
compared	O
with	O
AMPC	O
.	O

Also	O
,	O
the	O
emm	O
types	O
determined	O
in	O
the	O
112	O
GAS	B-bacteria
strains	I-bacteria
isolated	O
in	O
this	O
study	O
were	O
similar	O
to	O
those	O
that	O
have	O
recently	O
been	O
isolated	O
frequently	O
in	O
Japan	O
.	O

Concerning	O
the	O
drug	O
resistance	O
,	O
none	O
of	O
the	O
isolates	O
showed	O
resistance	O
to	O
beta	O
-	O
lactam	O
antibiotics	O
,	O
but	O
45	O
%	O
of	O
them	O
were	O
resistant	O
to	O
macrolides	O
.	O

The	O
advantages	O
of	O
short	O
-	O
term	O
treatment	O
are	O
considered	O
to	O
include	O
a	O
lower	O
cost	O
,	O
improvement	O
in	O
drug	O
compliance	O
,	O
decrease	O
in	O
the	O
frequency	O
of	O
the	O
occurrence	O
of	O
adverse	O
reactions	O
,	O
decrease	O
in	O
the	O
frequency	O
of	O
the	O
appearance	O
of	O
drug	O
-	O
resistant	O
strains	O
,	O
and	O
alleviation	O
of	O
the	O
psychological	O
burden	O
of	O
patients	O
and	O
their	O
parents	O
.	O

For	O
these	O
reasons	O
,	O
we	O
conclude	O
that	O
CDTR	O
-	O
PI	O
for	O
5	O
days	O
is	O
a	O
useful	O
option	O
for	O
the	O
treatment	O
of	O
acute	O
GAS	B-bacteria
tonsillopharyngitis	O
in	O
children	O
.	O

Oral	O
cancer	O
is	O
the	O
most	O
common	O
cancer	O
diagnosed	O
in	O
Indian	O
men	O
and	O
is	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
have	O
been	O
reported	O
to	O
be	O
present	O
in	O
0	O
-	O
40	O
%	O
of	O
the	O
cases	O
with	O
head	O
neck	O
cancer	O
.	O

A	O
higher	O
percentage	O
has	O
been	O
identified	O
in	O
laryngeal	O
and	O
pharangeal	O
cancer	O
.	O

We	O
here	O
carried	O
out	O
a	O
hospital	O
-	O
based	O
,	O
case	O
-	O
control	O
study	O
of	O
20	O
patients	O
with	O
newly	O
diagnosed	O
oral	O
cancer	O
and	O
20	O
healthy	O
controls	O
without	O
any	O
cancer	O
to	O
evaluate	O
associations	O
between	O
H	B-bacteria
pylori	I-bacteria
infection	O
and	O
oral	O
cancer	O
using	O
culture	O
and	O
16sRNA	O
PCR	O
technique	O
for	O
bacterial	O
identification	O
.	O

H	B-bacteria
pylori	I-bacteria
was	O
isolated	O
from	O
the	O
culture	O
of	O
three	O
cases	O
and	O
one	O
control	O
,	O
while	O
three	O
cases	O
and	O
two	O
control	O
showed	O
PCR	O
positivity	O
for	O
H	B-bacteria
Pylori	I-bacteria
16sRNA	O
.	O

The	O
odds	O
ratio	O
by	O
culture	O
was	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
26	O
.	O
4	O
and	O
1	O
.	O
5	O
,	O
95	O
%	O
CI	O
0	O
.	O
28	O
-	O
8	O
.	O
03	O
by	O
PCR	O
.	O

None	O
of	O
the	O
observed	O
odds	O
ratio	O
was	O
statistically	O
significant	O
.	O

However	O
,	O
the	O
results	O
of	O
this	O
pilot	O
study	O
suggest	O
a	O
possible	O
association	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
with	O
an	O
increased	O
risk	O
of	O
oral	O
cancer	O
.	O

Additional	O
studies	O
in	O
larger	O
populations	O
are	O
necessary	O
to	O
confirm	O
and	O
to	O
quantify	O
this	O
possible	O
association	O
more	O
accurately	O
.	O

Oral	O
lesions	O
are	O
rarely	O
reported	O
in	O
paucibacillary	O
forms	O
of	O
leprosy	O
.	O

We	O
report	O
here	O
a	O
case	O
with	O
an	O
erythematous	O
hyposensitive	O
lesion	O
in	O
the	O
palate	O
and	O
no	O
skin	O
lesions	O
.	O

In	O
addition	O
to	O
routine	O
tests	O
,	O
biopsies	O
of	O
the	O
lesion	O
in	O
the	O
palate	O
and	O
of	O
clinically	O
normal	O
surrounding	O
areas	O
were	O
performed	O
and	O
subjected	O
to	O
real	O
-	O
time	O
PCR	O
for	O
detection	O
of	O
Mycobacterium	B-bacteria
leprae	I-bacteria
DNA	O
.	O

The	O
biopsy	O
of	O
the	O
oral	O
lesion	O
was	O
positive	O
for	O
bacilli	O
DNA	O
,	O
followed	O
by	O
positive	O
serum	O
anti	O
-	O
PGL	O
-	O
1	O
and	O
Mitsuda	O
test	O
,	O
but	O
with	O
negative	O
histopathology	O
.	O

The	O
patient	O
was	O
diagnosed	O
with	O
a	O
borderline	O
tuberculoid	O
form	O
.	O

After	O
multidrug	O
therapy	O
the	O
lesion	O
had	O
significantly	O
regressed	O
and	O
the	O
bacilli	O
DNA	O
detection	O
in	O
the	O
former	O
lesion	O
was	O
negative	O
.	O

The	O
bacilli	O
DNA	O
detection	O
in	O
an	O
oral	O
lesion	O
by	O
real	O
-	O
time	O
PCR	O
not	O
only	O
improved	O
leprosy	O
diagnosis	O
,	O
but	O
also	O
helped	O
in	O
the	O
classification	O
of	O
clinical	O
form	O
,	O
and	O
in	O
the	O
establishment	O
of	O
the	O
appropriate	O
therapeutic	O
regime	O
.	O

It	O
is	O
a	O
well	O
-	O
established	O
fact	O
that	O
colonization	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
occurs	O
early	O
in	O
life	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
correlation	O
between	O
mode	O
of	O
delivery	O
and	O
other	O
associating	O
factors	O
with	O
colonization	O
of	O
oral	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
infants	O
.	O

The	O
newborns	O
were	O
divided	O
into	O
two	O
groups	O
according	O
to	O
the	O
mode	O
of	O
delivery	O
:	O
Infants	O
who	O
were	O
delivered	O
by	O
either	O
caesarean	O
section	O
(	O
Group	O
-	O
C	O
)	O
or	O
vaginally	O
(	O
Group	O
-	O
V	O
)	O
.	O

A	O
total	O
number	O
of	O
60	O
mother	O
-	O
infant	O
pairs	O
were	O
included	O
and	O
followed	O
for	O
1	O
year	O
.	O

The	O
swab	O
samples	O
were	O
collected	O
for	O
the	O
detection	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Analysis	O
of	O
data	O
demonstrated	O
the	O
possible	O
influence	O
of	O
prolonged	O
bottle	O
feeding	O
(	O
P	O
=	O
0	O
.	O
007	O
)	O
,	O
socioeconomic	O
status	O
(	O
P	O
=	O
0	O
.	O
00030	O
)	O
and	O
tasting	O
of	O
food	O
by	O
the	O
mothers	O
(	O
P	O
=	O
0	O
.	O
0065	O
)	O
on	O
the	O
initial	O
acquisition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
infants	O
.	O

The	O
causes	O
for	O
initial	O
acquisition	O
of	O
oral	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
infants	O
were	O
postnatal	O
factors	O
like	O
feeding	O
and	O
oral	O
hygiene	O
practices	O
.	O

Previous	O
reports	O
have	O
associated	O
salivary	O
beta	O
-	O
galactosidase	O
activity	O
with	O
non	O
-	O
periodontopathic	O
oral	O
malodour	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
localization	O
of	O
beta	O
-	O
galactosidase	O
and	O
elucidated	O
the	O
relationship	O
between	O
its	O
enzymatic	O
activity	O
and	O
physiological	O
oral	O
malodour	O
.	O

Fifty	O
-	O
six	O
patients	O
complaining	O
of	O
halitosis	O
were	O
separated	O
into	O
two	O
groups	O
:	O
periodontally	O
healthy	O
and	O
periodontitis	O
.	O

Saliva	O
samples	O
from	O
the	O
subjects	O
were	O
separated	O
by	O
centrifugation	O
,	O
and	O
the	O
level	O
of	O
beta	O
-	O
galactosidase	O
activity	O
was	O
measured	O
in	O
the	O
supernatant	O
,	O
pellet	O
lysate	O
,	O
and	O
whole	O
saliva	O
using	O
the	O
chromogenic	O
substrate	O
o	O
-	O
nitrophenyl	O
-	O
beta	O
-	O
d	O
-	O
galactopyranoside	O
.	O

The	O
correlation	O
of	O
salivary	O
beta	O
-	O
galactosidase	O
activity	O
with	O
breath	O
odour	O
and	O
associated	O
parameters	O
was	O
examined	O
.	O

Similar	O
levels	O
of	O
beta	O
-	O
galactosidase	O
activity	O
were	O
detected	O
in	O
the	O
pellet	O
lysate	O
and	O
whole	O
saliva	O
,	O
but	O
not	O
in	O
the	O
saliva	O
supernatant	O
.	O

Positive	O
correlations	O
were	O
observed	O
between	O
the	O
beta	O
-	O
galactosidase	O
activity	O
in	O
whole	O
saliva	O
and	O
oral	O
malodour	O
levels	O
in	O
the	O
periodontally	O
healthy	O
group	O
,	O
but	O
not	O
in	O
the	O
periodontitis	O
group	O
.	O

In	O
addition	O
,	O
the	O
plaque	O
index	O
and	O
tongue	O
coating	O
score	O
were	O
positively	O
correlated	O
with	O
beta	O
-	O
galactosidase	O
activity	O
in	O
the	O
periodontally	O
healthy	O
group	O
.	O

Overall	O
,	O
stimulated	O
salivary	O
flow	O
and	O
salivary	O
pH	O
were	O
negatively	O
correlated	O
with	O
enzyme	O
activity	O
.	O

The	O
amounts	O
of	O
total	O
bacteria	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
salivarius	I-bacteria
were	O
positively	O
associated	O
with	O
beta	O
-	O
galactosidase	O
activity	O
in	O
the	O
periodontally	O
healthy	O
group	O
.	O

Furthermore	O
,	O
the	O
amounts	O
of	O
total	O
bacteria	O
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
were	O
positively	O
associated	O
with	O
the	O
amount	O
of	O
volatile	O
sulphur	O
compounds	O
.	O

Our	O
results	O
indicate	O
that	O
beta	O
-	O
galactosidase	O
is	O
located	O
on	O
the	O
cell	O
surface	O
of	O
oral	O
bacteria	O
derived	O
from	O
dental	O
plaque	O
and	O
tongue	O
coating	O
,	O
and	O
it	O
plays	O
an	O
important	O
role	O
in	O
producing	O
the	O
malodour	O
underlying	O
physiological	O
oral	O
malodour	O
.	O

Campylobacter	B-bacteria
concisus	I-bacteria
infections	O
of	O
the	O
gastrointestinal	O
tract	O
can	O
be	O
accompanied	O
by	O
diarrhea	O
and	O
inflammation	O
,	O
whereas	O
colonization	O
of	O
the	O
human	O
oral	O
cavity	O
might	O
have	O
a	O
commensal	O
nature	O
.	O

We	O
focus	O
on	O
the	O
pathophysiology	O
of	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
and	O
the	O
effects	O
of	O
different	O
clinical	O
oral	O
and	O
fecal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	O
on	O
human	O
HT	O
-	O
29	O
/	O
B6	O
colon	O
cells	O
.	O

Six	O
oral	O
and	O
eight	O
fecal	O
strains	O
of	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
were	O
isolated	O
.	O

Mucus	O
-	O
producing	O
HT	O
-	O
29	O
/	O
B6	O
epithelial	O
monolayers	O
were	O
infected	O
with	O
the	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	O
.	O

Transepithelial	O
electrical	O
resistance	O
(	O
R	O
(	O
t	O
)	O
)	O
and	O
tracer	O
fluxes	O
of	O
different	O
molecule	O
size	O
were	O
measured	O
in	O
Ussing	O
chambers	O
.	O

Tight	O
junction	O
(	O
TJ	O
)	O
protein	O
expression	O
was	O
determined	O
by	O
Western	O
blotting	O
,	O
and	O
subcellular	O
TJ	O
distribution	O
was	O
analyzed	O
by	O
confocal	O
laser	O
-	O
scanning	O
microscopy	O
.	O

Apoptosis	O
induction	O
was	O
examined	O
by	O
TUNEL	O
-	O
staining	O
and	O
Western	O
blot	O
of	O
caspase	O
-	O
3	O
activation	O
.	O

All	O
strains	O
invaded	O
confluent	O
HT	O
-	O
29	O
/	O
B6	O
cells	O
and	O
impaired	O
epithelial	O
barrier	O
function	O
,	O
characterized	O
by	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
decrease	O
in	O
R	O
(	O
t	O
)	O
either	O
after	O
infection	O
from	O
the	O
apical	O
side	O
but	O
even	O
more	O
from	O
the	O
basolateral	O
compartment	O
.	O

TJ	O
protein	O
expression	O
changes	O
were	O
sparse	O
,	O
only	O
in	O
apoptotic	O
areas	O
of	O
infected	O
monolayers	O
TJ	O
proteins	O
were	O
redistributed	O
.	O

Solely	O
the	O
barrier	O
-	O
forming	O
TJ	O
protein	O
claudin	O
-	O
5	O
showed	O
a	O
reduced	O
expression	O
level	O
to	O
66	O
+	O
/	O
-	O
8	O
%	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
by	O
expression	O
regulation	O
from	O
the	O
gene	O
.	O

Concomitantly	O
,	O
Lactate	O
dehydrogenase	O
release	O
was	O
elevated	O
to	O
3	O
.	O
1	O
+	O
/	O
-	O
0	O
.	O
3	O
%	O
versus	O
0	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
1	O
%	O
in	O
control	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
suggesting	O
cytotoxic	O
effects	O
.	O

Furthermore	O
,	O
oral	O
and	O
fecal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	O
elevated	O
apoptotic	O
events	O
to	O
5	O
-	O
fold	O
.	O

C	B-bacteria
.	I-bacteria
concisus	I-bacteria
-	O
infected	O
monolayers	O
revealed	O
an	O
increased	O
permeability	O
for	O
332	O
Da	O
fluorescein	O
(	O
1	O
.	O
74	O
+	O
/	O
-	O
0	O
.	O
13	O
vs	O
.	O
0	O
.	O
56	O
+	O
/	O
-	O
0	O
.	O
17	O
10	O
(	O
-	O
6	O
)	O
cm	O
/	O
s	O
in	O
control	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
but	O
showed	O
no	O
difference	O
in	O
permeability	O
for	O
4	O
kDa	O
FITC	O
-	O
dextran	O
(	O
FD	O
-	O
4	O
)	O
.	O

The	O
same	O
was	O
true	O
in	O
camptothecin	O
-	O
exposed	O
monolayers	O
,	O
where	O
camptothecin	O
was	O
used	O
for	O
apoptosis	O
induction	O
.	O
In	O
conclusion	O
,	O
epithelial	O
barrier	O
dysfunction	O
by	O
oral	O
and	O
fecal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	O
could	O
mainly	O
be	O
assigned	O
to	O
apoptotic	O
leaks	O
together	O
with	O
moderate	O
TJ	O
changes	O
,	O
demonstrating	O
a	O
leak	O
-	O
flux	O
mechanism	O
that	O
parallels	O
the	O
clinical	O
manifestation	O
of	O
diarrhea	O
.	O

Halitosis	O
has	O
been	O
correlated	O
with	O
the	O
concentration	O
of	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
produced	O
in	O
the	O
oral	O
cavity	O
by	O
metabolic	O
activity	O
of	O
bacteria	O
colonizing	O
the	O
periodontal	O
pockets	O
and	O
the	O
dorsum	O
of	O
the	O
tongue	O
.	O

It	O
has	O
been	O
assumed	O
that	O
there	O
is	O
a	O
relationship	O
between	O
periodontal	O
disease	O
and	O
diabetes	O
mellitus	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
assess	O
the	O
malodor	O
using	O
the	O
organoleptic	O
method	O
and	O
tanita	O
device	O
;	O
to	O
quantify	O
odoriferous	O
microorganisms	O
of	O
subgingival	O
plaque	O
and	O
tongue	O
coating	O
,	O
such	O
as	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
(	O
Tf	B-bacteria
)	O
,	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
Fn	B-bacteria
)	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
nondiabetic	O
and	O
diabetic	O
chronic	O
periodontitis	O
patients	O
.	O

Thirty	O
chronic	O
periodontitis	O
patients	O
(	O
with	O
and	O
without	O
diabetes	O
)	O
with	O
5	O
-	O
7	O
mm	O
pocket	O
depth	O
,	O
radiographic	O
evidence	O
of	O
bone	O
loss	O
,	O
and	O
presence	O
of	O
oral	O
malodor	O
participated	O
in	O
this	O
study	O
.	O

Subjective	O
assessment	O
of	O
mouth	O
air	O
was	O
done	O
organoleptically	O
and	O
by	O
using	O
a	O
portable	O
sulfide	O
monitor	O
.	O

Tongue	O
coating	O
was	O
also	O
assessed	O
.	O

The	O
scores	O
of	O
plaque	O
index	O
,	O
gingival	O
index	O
,	O
gingival	O
bleeding	O
index	O
,	O
VSC	O
levels	O
,	O
and	O
tongue	O
coating	O
between	O
the	O
nondiabetic	O
and	O
diabetic	O
patients	O
were	O
not	O
significant	O
(	O
P	O
>	O
0	O
.	O
5	O
)	O
.	O

In	O
nondiabetic	O
patients	O
,	O
Fn	B-bacteria
was	O
found	O
to	O
be	O
significantly	O
(	O
P	O
<	O
0	O
.	O
5	O
)	O
more	O
in	O
tongue	O
samples	O
,	O
whereas	O
Pg	B-bacteria
and	O
Tf	B-bacteria
have	O
not	O
shown	O
significant	O
values	O
(	O
P	O
>	O
0	O
.	O
5	O
)	O
.	O

In	O
diabetic	O
patients	O
,	O
Fn	B-bacteria
and	O
Tf	B-bacteria
have	O
shown	O
significant	O
(	O
P	O
<	O
0	O
.	O
5	O
)	O
an	O
increase	O
in	O
subgingival	O
and	O
tongue	O
samples	O
,	O
respectively	O
,	O
whereas	O
Pg	B-bacteria
has	O
not	O
shown	O
significant	O
difference	O
between	O
subgingival	O
and	O
tongue	O
samples	O
.	O

The	O
results	O
confirm	O
that	O
there	O
is	O
no	O
difference	O
in	O
clinical	O
parameters	O
between	O
nondiabetic	O
and	O
diabetic	O
periodontitis	O
patients	O
,	O
but	O
the	O
odoriferous	O
microbial	O
profiles	O
in	O
tongue	O
samples	O
of	O
diabetic	O
patients	O
were	O
found	O
to	O
be	O
high	O
.	O

However	O
,	O
there	O
is	O
a	O
weak	O
positive	O
correlation	O
between	O
VSC	O
levels	O
,	O
clinical	O
parameters	O
,	O
and	O
odoriferous	O
microbial	O
profiles	O
.	O

There	O
has	O
been	O
a	O
paradigm	O
shift	O
toward	O
ecological	O
and	O
microbial	O
community	O
-	O
based	O
approach	O
in	O
understanding	O
oral	O
diseases	O
.	O

A	O
marked	O
improvement	O
in	O
gastrointestinal	O
health	O
has	O
been	O
reported	O
after	O
using	O
probiotic	O
bacteria	O
and	O
/	O
or	O
prebiotic	O
supplements	O
,	O
which	O
has	O
prompted	O
much	O
interest	O
in	O
the	O
use	O
of	O
this	O
approach	O
for	O
oral	O
applications	O
.	O

Treatment	O
of	O
periodontal	O
disease	O
in	O
recent	O
years	O
has	O
moved	O
toward	O
an	O
antibiotic	O
/	O
antimicrobial	O
model	O
of	O
disease	O
management	O
.	O

With	O
increase	O
in	O
the	O
incidence	O
of	O
resistance	O
to	O
antibiotics	O
,	O
probiotics	O
may	O
be	O
a	O
promising	O
area	O
of	O
research	O
in	O
periodontal	O
therapy	O
.	O

This	O
paper	O
reviews	O
the	O
evidences	O
for	O
the	O
use	O
of	O
probiotics	O
or	O
prebiotics	O
for	O
the	O
prevention	O
of	O
dental	O
caries	O
or	O
periodontal	O
diseases	O
,	O
and	O
also	O
adresses	O
the	O
risk	O
associated	O
with	O
their	O
prolonged	O
use	O
.	O

Many	O
questions	O
have	O
been	O
raised	O
pertaining	O
to	O
the	O
benefits	O
of	O
probiotic	O
administration	O
,	O
as	O
the	O
role	O
of	O
probiotics	O
in	O
periodontics	O
is	O
still	O
in	O
infancy	O
,	O
and	O
a	O
complete	O
understanding	O
of	O
the	O
broad	O
ecological	O
changes	O
induced	O
in	O
the	O
mouth	O
by	O
probiotics	O
or	O
prebiotics	O
is	O
essential	O
to	O
assess	O
their	O
long	O
-	O
term	O
consequences	O
for	O
oral	O
health	O
and	O
disease	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
three	O
strains	O
of	O
bacteria	O
could	O
impact	O
the	O
mechanical	O
or	O
surface	O
properties	O
of	O
a	O
dental	O
resin	O
material	O
.	O

Resin	O
material	O
specimens	O
were	O
incubated	O
at	O
37	O
degrees	O
C	O
in	O
sterile	O
saline	O
,	O
tryptic	O
soy	O
broth	O
supplemented	O
with	O
sucrose	O
(	O
TSBS	O
)	O
,	O
or	O
TSBS	O
inoculated	O
with	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
or	O
Streptococcus	B-bacteria
sanguis	I-bacteria
.	O

The	O
specimens	O
were	O
subjected	O
to	O
Fourier	O
transform	O
infrared	O
spectroscopy	O
before	O
and	O
after	O
incubation	O
.	O

The	O
flexural	O
strength	O
test	O
was	O
performed	O
once	O
a	O
week	O
for	O
6	O
weeks	O
.	O

Microhardness	O
and	O
scanning	O
electron	O
microscopy	O
(	O
SEM	O
)	O
was	O
performed	O
on	O
specimens	O
at	O
1	O
and	O
6	O
weeks	O
.	O

Differences	O
in	O
the	O
area	O
under	O
the	O
carbonyl	O
peak	O
were	O
statistically	O
significant	O
for	O
the	O
specimens	O
incubated	O
in	O
the	O
media	O
inoculated	O
with	O
either	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

To	O
determine	O
why	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
did	O
not	O
produce	O
changes	O
as	O
the	O
other	O
bacteria	O
did	O
,	O
triethylene	O
glycol	O
dimethacrylate	O
,	O
methacrylic	O
acid	O
,	O
and	O
triethylene	O
glycol	O
were	O
added	O
to	O
bacterial	O
cultures	O
at	O
increasing	O
concentrations	O
.	O

Both	O
methacrylic	O
acid	O
and	O
triethylene	O
glycol	O
reduced	O
the	O
number	O
of	O
colony	O
-	O
forming	O
units	O
of	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
.	O

Specimens	O
incubated	O
in	O
TSBS	O
,	O
saline	O
or	O
in	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
demonstrated	O
a	O
decrease	O
in	O
peak	O
stress	O
in	O
week	O
1	O
of	O
the	O
flexure	O
strength	O
test	O
.	O

SEM	O
demonstrated	O
that	O
surface	O
topology	O
changed	O
for	O
those	O
specimens	O
incubated	O
in	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

The	O
changes	O
in	O
surface	O
topology	O
demonstrated	O
here	O
could	O
contribute	O
to	O
the	O
secondary	O
caries	O
and	O
changes	O
in	O
esthetic	O
properties	O
seen	O
clinically	O
with	O
the	O
use	O
of	O
resin	O
materials	O
in	O
dental	O
restorations	O
.	O

Lactobacillus	B-bacteria
species	I-bacteria
are	O
commensal	O
bacteria	O
that	O
have	O
long	O
been	O
recognized	O
as	O
probiotic	O
microbes	O
and	O
are	O
generally	O
regarded	O
as	O
safe	O
(	O
GRAS	O
)	O
for	O
human	O
consumption	O
.	O

We	O
have	O
investigated	O
the	O
use	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
as	O
a	O
vaccine	O
vector	O
for	O
oral	O
immunization	O
against	O
mucosal	O
pathogens	O
.	O

Recent	O
research	O
has	O
shown	O
that	O
the	O
immune	O
response	O
to	O
different	O
lactobacilli	B-bacteria
can	O
vary	O
widely	O
depending	O
on	O
the	O
species	O
or	O
subspecies	O
of	O
Lactobacillus	B-bacteria
being	O
studied	O
.	O

While	O
some	O
lactobacilli	B-bacteria
seem	O
to	O
induce	O
oral	O
tolerance	O
,	O
others	O
induce	O
an	O
adaptive	O
immune	O
response	O
.	O

This	O
study	O
characterized	O
the	O
systemic	O
and	O
mucosal	O
immune	O
response	O
to	O
wild	O
-	O
type	O
and	O
genetically	O
modified	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
.	O

L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
primarily	O
activates	O
TLR2	O
/	O
6	O
,	O
with	O
additional	O
activation	O
through	O
the	O
TLR2	O
homodimer	O
.	O

To	O
expand	O
the	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
activation	O
profile	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
and	O
the	O
immunogenicity	O
of	O
the	O
vector	O
,	O
a	O
plasmid	O
containing	O
fliC	O
,	O
the	O
gene	O
encoding	O
bacterial	O
flagellin	O
,	O
was	O
introduced	O
which	O
resulted	O
in	O
the	O
strong	O
activation	O
of	O
TLR5	O
.	O

The	O
treatment	O
of	O
human	O
myeloid	O
dendritic	O
cells	O
with	O
recombinant	O
lactobacilli	B-bacteria
expressing	O
flagellin	O
triggered	O
phenotypic	O
maturation	O
and	O
the	O
release	O
of	O
proinflammatory	O
cytokines	O
.	O

In	O
contrast	O
,	O
bacterial	O
treatment	O
also	O
resulted	O
in	O
a	O
statistically	O
significant	O
increase	O
in	O
IL	O
-	O
10	O
production	O
.	O

In	O
vivo	O
studies	O
established	O
that	O
treatment	O
with	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
led	O
to	O
a	O
diversification	O
of	O
B	O
-	O
cell	O
populations	O
in	O
the	O
lamina	O
propria	O
of	O
the	O
murine	O
colon	O
.	O

Furthermore	O
,	O
treatment	O
with	O
genetically	O
modified	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
led	O
to	O
a	O
significant	O
decrease	O
in	O
the	O
percentage	O
of	O
FoxP3	O
(	O
+	O
)	O
colonic	O
lymphocytes	O
.	O

Taken	O
together	O
,	O
these	O
data	O
clarify	O
the	O
interaction	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
with	O
the	O
host	O
immune	O
system	O
and	O
support	O
further	O
investigation	O
of	O
the	O
in	O
vivo	O
immunogenicity	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
expressing	O
both	O
flagellin	O
and	O
candidate	O
vaccine	O
antigens	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
bactericidal	O
effects	O
and	O
bactericidal	O
time	O
of	O
an	O
acidified	O
sodium	O
chlorite	O
compound	O
gel	O
(	O
ASC	O
-	O
Gel	O
)	O
on	O
bacteria	O
isolated	O
from	O
the	O
peri	O
-	O
implant	O
sulci	O
of	O
10	O
patients	O
who	O
received	O
implants	O
3	O
-	O
27	O
years	O
previously	O
,	O
and	O
the	O
depth	O
of	O
each	O
peri	O
-	O
implant	O
sulcus	O
was	O
5	O
mm	O
or	O
less	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
ATCC33277	B-bacteria
)	O
was	O
used	O
as	O
the	O
control	O
bacterium	O
.	O

Five	O
ASC	O
-	O
Gel	O
preparations	O
were	O
created	O
by	O
adding	O
3	O
.	O
3	O
%	O
,	O
5	O
.	O
0	O
%	O
,	O
7	O
.	O
0	O
%	O
,	O
9	O
.	O
0	O
%	O
,	O
and	O
11	O
.	O
0	O
%	O
citric	O
acid	O
(	O
CA	O
)	O
(	O
condition	O
a	O
,	O
b	O
,	O
c	O
,	O
d	O
,	O
and	O
e	O
,	O
respectively	O
)	O
into	O
an	O
oral	O
moisturizing	O
gel	O
containing	O
sodium	O
chlorite	O
.	O

The	O
concentrations	O
of	O
chlorine	O
dioxide	O
(	O
ClO2	O
)	O
generated	O
in	O
ASC	O
-	O
Gel	O
under	O
conditions	O
(	O
a	O
)	O
to	O
(	O
e	O
)	O
were	O
12	O
.	O
1	O
,	O
14	O
.	O
1	O
,	O
17	O
.	O
2	O
,	O
21	O
.	O
2	O
,	O
and	O
39	O
.	O
3	O
ppm	O
,	O
respectively	O
.	O

We	O
examined	O
the	O
bactericidal	O
effects	O
of	O
the	O
5	O
ASC	O
-	O
Gel	O
preparations	O
at	O
volumes	O
of	O
0	O
.	O
5	O
,	O
1	O
.	O
0	O
,	O
and	O
2	O
.	O
0	O
mL	O
,	O
and	O
measured	O
the	O
bactericidal	O
time	O
when	O
2	O
.	O
0	O
mL	O
of	O
ASC	O
-	O
Gel	O
was	O
used	O
under	O
condition	O
(	O
e	O
)	O
.	O

The	O
bactericidal	O
effects	O
of	O
ASC	O
-	O
Gel	O
became	O
significantly	O
greater	O
with	O
increased	O
concentrations	O
of	O
CA	O
and	O
ClO2	O
and	O
with	O
increased	O
usage	O
(	O
0	O
.	O
5	O
-	O
2	O
.	O
0	O
mL	O
)	O
of	O
the	O
gel	O
.	O

All	O
bacteria	O
were	O
killed	O
by	O
using	O
2	O
.	O
0	O
mL	O
of	O
ASC	O
-	O
Gel	O
under	O
condition	O
(	O
e	O
)	O
.	O

ASC	O
-	O
Gel	O
also	O
needed	O
between	O
45	O
and	O
90	O
minutes	O
to	O
kill	O
all	O
microbes	O
under	O
condition	O
(	O
e	O
)	O
.	O

Within	O
the	O
limits	O
of	O
the	O
present	O
investigation	O
,	O
these	O
results	O
suggest	O
that	O
ASC	O
-	O
Gel	O
is	O
useful	O
as	O
a	O
chemical	O
disinfectant	O
against	O
bacteria	O
in	O
the	O
peri	O
-	O
implant	O
sulcus	O
.	O

Further	O
studies	O
are	O
also	O
required	O
to	O
protect	O
teeth	O
,	O
the	O
surface	O
of	O
hydroxyapatite	O
-	O
coated	O
implants	O
,	O
and	O
the	O
surrounding	O
soft	O
tissues	O
from	O
effects	O
of	O
chemical	O
dissolution	O
such	O
as	O
acid	O
erosion	O
due	O
to	O
the	O
low	O
pH	O
of	O
ASC	O
-	O
Gel	O
.	O

To	O
investigate	O
the	O
impact	O
on	O
microbiologic	O
variables	O
of	O
full	O
-	O
mouth	O
scaling	O
(	O
FMS	O
)	O
and	O
conventional	O
scaling	O
and	O
root	O
planing	O
(	O
cSRP	O
)	O
after	O
12	O
months	O
.	O

In	O
a	O
prospective	O
randomized	O
controlled	O
clinical	O
study	O
,	O
37	O
volunteers	O
with	O
moderate	O
chronic	O
periodontitis	O
were	O
treated	O
by	O
FMS	O
or	O
by	O
cSRP	O
in	O
two	O
sessions	O
at	O
4	O
-	O
week	O
intervals	O
.	O

Clinical	O
attachment	O
level	O
,	O
probing	O
depth	O
,	O
and	O
bleeding	O
on	O
probing	O
were	O
recorded	O
at	O
baseline	O
as	O
well	O
as	O
at	O
6	O
and	O
12	O
months	O
.	O

Four	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
from	O
the	O
deepest	O
sites	O
in	O
premolars	O
and	O
molars	O
at	O
baseline	O
and	O
after	O
12	O
months	O
.	O

Pooled	O
sample	O
analysis	O
was	O
performed	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
for	O
the	O
identification	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

At	O
baseline	O
,	O
the	O
bacterial	O
load	O
of	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
was	O
significantly	O
higher	O
in	O
the	O
cSRP	O
group	O
compared	O
to	O
the	O
FMS	O
group	O
(	O
P	O
=	O
.	O
042	O
)	O
.	O

In	O
the	O
cSRP	O
group	O
,	O
this	O
load	O
decreased	O
significantly	O
(	O
P	O
=	O
.	O
011	O
)	O
,	O
leading	O
to	O
similar	O
quantities	O
of	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
in	O
both	O
groups	O
.	O

Further	O
,	O
significant	O
reductions	O
in	O
frequency	O
were	O
found	O
in	O
the	O
FMS	O
group	O
for	O
T	B-bacteria
forsythia	I-bacteria
and	O
P	B-bacteria
gingivalis	I-bacteria
and	O
in	O
the	O
cSRP	O
group	O
for	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
T	B-bacteria
denticola	I-bacteria
.	O

The	O
data	O
suggest	O
that	O
both	O
therapy	O
modalities	O
lead	O
to	O
similar	O
effects	O
on	O
target	O
periodontal	O
pathogen	O
species	O
.	O

FMS	O
compared	O
to	O
cSRP	O
was	O
not	O
favorable	O
in	O
reduction	O
of	O
periodontopathogens	O
.	O

Changes	O
in	O
the	O
microbial	O
flora	O
on	O
the	O
oral	O
mucosa	O
after	O
cancerous	O
alteration	O
may	O
lead	O
to	O
both	O
local	O
and	O
systemic	O
infections	O
.	O

In	O
this	O
study	O
,	O
we	O
assessed	O
the	O
microbial	O
flora	O
associated	O
with	O
the	O
surfaces	O
of	O
oral	O
squamous	O
cell	O
carcinoma	O
.	O

A	O
comparative	O
evaluation	O
of	O
these	O
microbial	O
contents	O
was	O
made	O
with	O
that	O
of	O
the	O
contralateral	O
healthy	O
mucosa	O
and	O
control	O
(	O
healthy	O
)	O
mucosa	O
.	O

We	O
also	O
assessed	O
the	O
microbial	O
flora	O
from	O
the	O
saliva	O
culture	O
in	O
subjects	O
with	O
oral	O
squamous	O
cell	O
carcinoma	O
and	O
healthy	O
controls	O
.	O

The	O
case	O
control	O
study	O
was	O
made	O
up	O
of	O
30	O
subjects	O
with	O
oral	O
squamous	O
cell	O
carcinoma	O
as	O
the	O
study	O
group	O
;	O
30	O
healthy	O
age	O
-	O
,	O
sex	O
-	O
,	O
habit	O
-	O
,	O
and	O
dentition	O
-	O
matched	O
subjects	O
served	O
as	O
the	O
control	O
group	O
.	O

In	O
the	O
study	O
group	O
,	O
microbial	O
samples	O
were	O
collected	O
from	O
the	O
carcinoma	O
site	O
,	O
contralateral	O
healthy	O
mucosa	O
,	O
and	O
saliva	O
,	O
whereas	O
in	O
the	O
control	O
group	O
,	O
samples	O
were	O
collected	O
from	O
the	O
healthy	O
mucosa	O
and	O
saliva	O
.	O

These	O
samples	O
were	O
stored	O
on	O
ice	O
and	O
subsequently	O
transported	O
to	O
the	O
laboratory	O
in	O
2	O
mL	O
of	O
thioglycollate	O
transport	O
media	O
,	O
where	O
the	O
microbial	O
cultures	O
were	O
carried	O
out	O
.	O

Oral	O
squamous	O
cell	O
carcinoma	O
sites	O
harbor	O
significantly	O
more	O
microbial	O
flora	O
(	O
bacteria	O
and	O
yeasts	O
)	O
compared	O
to	O
those	O
of	O
healthy	O
mucosa	O
(	O
control	O
group	O
)	O
.	O

The	O
microbial	O
flora	O
predominantly	O
isolated	O
from	O
the	O
carcinoma	O
site	O
were	O
Streptococcus	B-bacteria
species	I-bacteria
,	O
Staphylococcus	B-bacteria
species	I-bacteria
,	O
Moraxella	B-bacteria
species	I-bacteria
,	O
Enterococcus	B-bacteria
feacalis	I-bacteria
,	O
Aerobic	B-bacteria
spore	I-bacteria
bearers	I-bacteria
,	O
Klebsiella	B-bacteria
species	I-bacteria
,	O
Citrobacter	B-bacteria
species	I-bacteria
,	O
Proteus	B-bacteria
species	I-bacteria
,	O
Pseudomonas	B-bacteria
species	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

The	O
median	O
number	O
of	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
mL	O
at	O
carcinoma	O
sites	O
(	O
3	O
.	O
85	O
x	O
105	O
CFU	O
/	O
mL	O
)	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
healthy	O
mucosa	O
(	O
0	O
.	O
571	O
x	O
105	O
CFU	O
/	O
mL	O
;	O
P	O
=	O
.	O
0000	O
,	O
Wilcoxon	O
nonparametric	O
test	O
)	O
.	O

Similarly	O
,	O
in	O
saliva	O
of	O
carcinoma	O
subjects	O
,	O
the	O
median	O
number	O
of	O
CFU	O
/	O
mL	O
(	O
2	O
.	O
408	O
x	O
105	O
CFU	O
/	O
mL	O
)	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
saliva	O
in	O
control	O
subjects	O
(	O
0	O
.	O
78	O
x	O
105	O
CFU	O
/	O
mL	O
;	O
P	O
=	O
.	O
0000	O
,	O
Wilcoxon	O
nonparametric	O
test	O
)	O
.	O

The	O
present	O
study	O
clearly	O
indicates	O
that	O
the	O
subjects	O
with	O
oral	O
squamous	O
cell	O
carcinoma	O
harbor	O
significantly	O
more	O
microbial	O
flora	O
.	O

Emphasis	O
has	O
to	O
be	O
given	O
to	O
preventing	O
microbial	O
flora	O
in	O
the	O
oral	O
cavity	O
and	O
treating	O
these	O
patients	O
with	O
appropriate	O
antimicrobial	O
agents	O
,	O
thus	O
reducing	O
their	O
morbidity	O
.	O

There	O
are	O
many	O
studies	O
on	O
the	O
effect	O
of	O
preprocedural	O
mouth	O
rinses	O
in	O
adults	O
,	O
but	O
there	O
is	O
a	O
dearth	O
of	O
the	O
literature	O
on	O
the	O
effects	O
of	O
these	O
mouth	O
rinses	O
in	O
children	O
.	O

This	O
study	O
aims	O
to	O
evaluate	O
the	O
efficacy	O
of	O
two	O
commercially	O
available	O
brands	O
,	O
one	O
containing	O
chlorhexidine	O
0	O
.	O
12	O
%	O
(	O
Colgate	O
Periogard	O
)	O
and	O
the	O
other	O
containing	O
cetylpyridinium	O
chloride	O
0	O
.	O
05	O
%	O
(	O
Johnson	O
and	O
Johnson	O
'	O
s	O
Reach	O
)	O
used	O
as	O
preprocedural	O
mouth	O
rinses	O
in	O
children	O
.	O

The	O
study	O
was	O
conducted	O
on	O
18	O
patients	O
in	O
the	O
age	O
group	O
of	O
10	O
-	O
15	O
years	O
.	O

A	O
crossover	O
design	O
was	O
used	O
with	O
the	O
random	O
assignment	O
of	O
the	O
first	O
rinse	O
tested	O
and	O
a	O
wash	O
out	O
period	O
of	O
at	O
least	O
1	O
week	O
before	O
the	O
second	O
rinse	O
was	O
used	O
.	O

The	O
saliva	O
samples	O
were	O
collected	O
prerinse	O
,	O
2	O
min	O
,	O
30	O
min	O
,	O
and	O
60	O
min	O
after	O
rinsing	O
with	O
the	O
solution	O
.	O

The	O
samples	O
were	O
inoculated	O
and	O
cultured	O
for	O
aerobic	O
and	O
anaerobic	O
microorganisms	O
.	O

After	O
48	O
h	O
,	O
the	O
resultant	O
bacterial	O
colonies	O
were	O
counted	O
.	O

Statistical	O
analysis	O
was	O
done	O
using	O
Wilcoxon	O
'	O
s	O
signed	O
rank	O
test	O
,	O
ANOVA	O
,	O
and	O
Newman	O
-	O
Keul	O
'	O
s	O
studentized	O
range	O
test	O
.	O

Periogard	O
had	O
the	O
highest	O
percentage	O
reduction	O
in	O
both	O
aerobic	O
and	O
anaerobic	O
microorganisms	O
followed	O
by	O
Reach	O
and	O
the	O
least	O
effective	O
was	O
normal	O
saline	O
which	O
was	O
used	O
as	O
a	O
control	O
.	O

Periogard	O
is	O
comparatively	O
better	O
as	O
a	O
preprocedural	O
mouth	O
rinse	O
than	O
Reach	O
.	O

Commercially	O
available	O
photodynamic	O
therapy	O
for	O
periodontal	O
diseases	O
utilizes	O
methylene	O
blue	O
as	O
a	O
photosensitizer	O
.	O

Here	O
we	O
propose	O
a	O
novel	O
photosensitizer	O
dye	O
,	O
indocyanine	O
green	O
(	O
ICG	O
)	O
,	O
because	O
it	O
can	O
be	O
readily	O
activated	O
by	O
commercially	O
available	O
dental	O
810	O
nm	O
diode	O
lasers	O
and	O
has	O
an	O
established	O
safety	O
record	O
as	O
an	O
intravascular	O
agent	O
in	O
cardiac	O
imaging	O
and	O
ophthalmologic	O
photodynamic	O
therapy	O
.	O

Therefore	O
,	O
we	O
aim	O
to	O
characterize	O
ICG	O
uptake	O
and	O
killing	O
of	O
key	O
periodontal	O
pathogens	O
to	O
explore	O
its	O
potential	O
as	O
a	O
periodontal	O
photodynamic	O
therapy	O
agent	O
.	O

We	O
tested	O
ICG	O
uptake	O
by	O
spectroscopy	O
in	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
381	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
in	O
addition	O
to	O
Escherichia	B-bacteria
coli	I-bacteria
DH5alpha	I-bacteria
and	O
a	O
human	O
gingival	O
epithelial	O
cell	O
line	O
,	O
HepG	O
,	O
in	O
relation	O
to	O
ICG	O
dose	O
and	O
exposure	O
time	O
.	O

We	O
then	O
measured	O
killing	O
of	O
bacteria	O
by	O
determining	O
viable	O
bacteria	O
counts	O
before	O
and	O
after	O
exposure	O
to	O
ICG	O
and	O
810	O
nm	O
diode	O
laser	O
light	O
(	O
0	O
-	O
0	O
.	O
5	O
W	O
output	O
settings	O
,	O
0	O
-	O
5	O
seconds	O
)	O
.	O

ICG	O
was	O
also	O
applied	O
to	O
extracted	O
,	O
restored	O
teeth	O
,	O
and	O
the	O
teeth	O
inspected	O
visually	O
for	O
staining	O
after	O
rinsing	O
with	O
saline	O
.	O

We	O
found	O
rapid	O
and	O
significant	O
uptake	O
of	O
indocyanine	O
green	O
into	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
381	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
67	I-bacteria
,	O
compared	O
to	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
DH5alpha	I-bacteria
and	O
HepG	O
gingival	O
cell	O
line	O
.	O

This	O
correlated	O
with	O
significant	O
killing	O
of	O
strains	O
381	O
and	O
67	O
compared	O
to	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
with	O
less	O
than	O
10	O
%	O
survival	O
.	O

ICG	O
does	O
not	O
appear	O
to	O
stain	O
tooth	O
surfaces	O
and	O
materials	O
except	O
calculus	O
.	O

ICG	O
combined	O
with	O
an	O
810	O
nm	O
diode	O
laser	O
may	O
be	O
useful	O
as	O
a	O
photodynamic	O
adjunct	O
for	O
reduction	O
of	O
bacterial	O
load	O
in	O
periodontal	O
pockets	O
.	O

Periodontal	O
diseases	O
are	O
known	O
to	O
be	O
major	O
diseases	O
in	O
humans	O
,	O
and	O
are	O
also	O
common	O
in	O
dogs	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
analyze	O
the	O
distribution	O
of	O
periodontitis	O
-	O
related	O
bacterial	O
species	O
using	O
oral	O
swab	O
specimens	O
collected	O
from	O
26	O
pet	O
dogs	O
.	O

The	O
distribution	O
of	O
an	O
animal	O
gingival	O
organism	O
Porphyromonas	B-bacteria
gulae	I-bacteria
,	O
in	O
addition	O
to	O
10	O
human	O
periodontitis	O
-	O
related	O
bacterial	O
species	O
,	O
including	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Capnocytophaga	B-bacteria
ochracea	I-bacteria
,	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
and	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
were	O
evaluated	O
by	O
polymerase	O
chain	O
reaction	O
with	O
species	O
-	O
specific	O
sets	O
of	O
primers	O
.	O

Porphyromonas	B-bacteria
gulae	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
were	O
detected	O
in	O
almost	O
all	O
dogs	O
analyzed	O
,	O
all	O
of	O
which	O
should	O
be	O
regarded	O
as	O
common	O
members	O
of	O
oral	O
flora	O
in	O
dogs	O
.	O

Then	O
,	O
isolation	O
and	O
identification	O
of	O
the	O
Porphyromonas	B-bacteria
species	I-bacteria
in	O
swab	O
specimens	O
were	O
performed	O
.	O

There	O
were	O
35	O
strains	O
isolated	O
from	O
22	O
dogs	O
,	O
and	O
broad	O
-	O
range	O
polymerase	O
chain	O
reaction	O
and	O
sequencing	O
methods	O
revealed	O
that	O
approximately	O
70	O
%	O
of	O
them	O
were	O
Porphyromonas	B-bacteria
gulae	I-bacteria
.	O

In	O
contrast	O
,	O
the	O
frequency	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
extremely	O
low	O
.	O

These	O
findings	O
indicate	O
the	O
presence	O
of	O
specific	O
periodontitis	O
-	O
related	O
pathogens	O
in	O
pet	O
dogs	O
,	O
especially	O
Porphyromonas	B-bacteria
gulae	I-bacteria
.	O

For	O
paediatric	O
dentists	O
,	O
an	O
indicator	O
to	O
assess	O
caries	O
risk	O
of	O
infants	O
is	O
very	O
important	O
.	O

Conventionally	O
,	O
the	O
number	O
and	O
/	O
or	O
proportions	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
have	O
been	O
employed	O
as	O
risk	O
indicator	O
;	O
however	O
,	O
because	O
such	O
figures	O
reflect	O
the	O
existing	O
situation	O
,	O
they	O
are	O
not	O
suitable	O
for	O
assessing	O
caries	O
risk	O
of	O
infants	O
that	O
have	O
not	O
yet	O
been	O
infected	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Thus	O
,	O
we	O
searched	O
for	O
an	O
indicator	O
for	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

To	O
evaluate	O
the	O
changes	O
caused	O
by	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
microbiota	O
of	O
the	O
infant	O
oral	O
cavity	O
,	O
we	O
monitored	O
changes	O
in	O
the	O
oral	O
microbiota	O
of	O
two	O
pre	O
-	O
dentate	O
infants	O
over	O
a	O
3	O
-	O
year	O
period	O
and	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
40	O
nursery	O
school	O
-	O
aged	O
children	O
by	O
cultivation	O
of	O
saliva	O
on	O
nonselective	O
blood	O
agar	O
,	O
Mitis	O
-	O
Salivarius	O
agar	O
,	O
and	O
Mitis	O
-	O
Salivarius	O
agar	O
supplemented	O
with	O
bacitracin	O
combined	O
with	O
identification	O
of	O
selected	O
isolates	O
.	O

Two	O
longitudinal	O
observations	O
suggested	O
that	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
would	O
induce	O
a	O
decrease	O
in	O
alpha	O
-	O
haemolytic	O
bacteria	O
in	O
the	O
microbial	O
population	O
of	O
the	O
oral	O
cavity	O
.	O

This	O
suggestion	O
was	O
compensated	O
with	O
the	O
results	O
of	O
cross	O
-	O
sectional	O
study	O
,	O
and	O
it	O
was	O
revealed	O
that	O
the	O
establishment	O
of	O
10	O
(	O
3	O
)	O
CFU	O
/	O
mL	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
saliva	O
might	O
be	O
predicted	O
by	O
a	O
microbiota	O
comprising	O
less	O
than	O
approximately	O
55	O
%	O
of	O
alpha	O
-	O
haemolytic	O
.	O

Decrease	O
in	O
the	O
proportion	O
of	O
alpha	O
-	O
haemolytic	O
bacteria	O
in	O
saliva	O
of	O
infant	O
was	O
found	O
to	O
be	O
applicable	O
as	O
an	O
indicator	O
to	O
predict	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
to	O
assess	O
dental	O
caries	O
risk	O
as	O
a	O
background	O
for	O
planning	O
of	O
dental	O
care	O
and	O
treatment	O
in	O
the	O
infants	O
before	O
infection	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

We	O
report	O
the	O
age	O
-	O
related	O
prevalence	O
of	O
red	O
complex	O
periodontal	O
pathogens	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
along	O
with	O
four	O
strains	O
of	O
orange	O
complex	O
pathogens	O
.	O

The	O
bacteria	O
present	O
in	O
samples	O
isolated	O
from	O
tongue	O
,	O
cheek	O
,	O
and	O
subgingival	O
sulcus	O
in	O
edentulous	O
newborns	O
and	O
children	O
with	O
mixed	O
dentition	O
were	O
monitored	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
not	O
detected	O
in	O
any	O
site	O
of	O
any	O
subject	O
in	O
the	O
two	O
groups	O
tested	O
.	O

However	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
not	O
only	O
found	O
in	O
the	O
6	O
-	O
13	O
years	O
age	O
group	O
,	O
but	O
also	O
in	O
edentulous	O
newborns	O
at	O
a	O
relatively	O
high	O
prevalence	O
,	O
indicating	O
non	O
-	O
dentition	O
-	O
related	O
colonization	O
by	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
and	O
Parvimonas	B-bacteria
micra	I-bacteria
were	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
most	O
subjects	O
belonging	O
to	O
the	O
6	O
-	O
13	O
years	O
age	O
group	O
compared	O
to	O
newborns	O
.	O

This	O
suggested	O
a	O
pronounced	O
association	O
between	O
these	O
colonizing	O
bacteria	O
and	O
the	O
presence	O
of	O
teeth	O
.	O

There	O
was	O
also	O
a	O
strong	O
relation	O
between	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
for	O
their	O
prevalence	O
in	O
the	O
subgingival	O
sulcus	O
of	O
the	O
6	O
-	O
13	O
years	O
age	O
group	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
but	O
not	O
in	O
the	O
other	O
sites	O
tested	O
,	O
suggesting	O
that	O
the	O
colonization	O
of	O
dentition	O
-	O
related	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
may	O
be	O
associated	O
with	O
the	O
increased	O
prevalence	O
of	O
non	O
-	O
dentition	O
-	O
related	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
in	O
the	O
subgingival	O
sulcus	O
.	O

Overall	O
,	O
these	O
results	O
suggest	O
that	O
dentition	O
is	O
a	O
key	O
determinant	O
of	O
bacterial	O
colonization	O
,	O
especially	O
orange	O
complex	O
bacteria	O
and	O
the	O
red	O
complex	O
bacterium	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
colonisation	O
by	O
periodontopathic	O
bacteria	O
and	O
the	O
sites	O
of	O
colonisation	O
in	O
elderly	O
upper	O
and	O
lower	O
complete	O
denture	O
wearers	O
.	O

We	O
also	O
investigated	O
the	O
relationship	O
between	O
level	O
of	O
oral	O
hygiene	O
and	O
colonisation	O
by	O
periodontopathic	O
bacteria	O
.	O

Forty	O
edentulous	O
and	O
37	O
dentate	O
volunteers	O
participated	O
in	O
this	O
study	O
.	O

Samples	O
were	O
collected	O
from	O
whole	O
saliva	O
,	O
and	O
levels	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
were	O
determined	O
by	O
PCR	O
Invader	O
technology	O
.	O

Detection	O
of	O
these	O
species	O
on	O
oral	O
mucosal	O
and	O
denture	O
surfaces	O
was	O
performed	O
by	O
PCR	O
.	O

Fisher	O
'	O
s	O
exact	O
test	O
was	O
used	O
for	O
the	O
statistical	O
analysis	O
.	O

Cluster	O
analysis	O
was	O
employed	O
to	O
investigate	O
trends	O
in	O
the	O
periodontopathic	O
bacteria	O
flora	O
in	O
each	O
sampling	O
area	O
.	O

Detection	O
rates	O
of	O
periodontopathic	O
bacteria	O
in	O
whole	O
saliva	O
were	O
lower	O
under	O
edentulous	O
conditions	O
than	O
under	O
dentulous	O
conditions	O
,	O
except	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Detection	O
rate	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
the	O
highest	O
in	O
all	O
areas	O
.	O

A	O
positive	O
correlation	O
was	O
observed	O
between	O
DNA	O
quantification	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
number	O
of	O
Candida	O
species	O
in	O
saliva	O
.	O

Cluster	O
analysis	O
of	O
the	O
test	O
species	O
identified	O
two	O
clusters	O
.	O

Tongue	O
-	O
coating	O
status	O
was	O
associated	O
with	O
the	O
detection	O
rate	O
of	O
all	O
periodontopathic	O
bacteria	O
investigated	O
,	O
and	O
denture	O
plaque	O
status	O
was	O
associated	O
with	O
the	O
detection	O
rate	O
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Results	O
indicate	O
the	O
presence	O
of	O
periodontopathic	O
bacteria	O
under	O
edentulous	O
conditions	O
and	O
that	O
the	O
status	O
of	O
oral	O
hygiene	O
of	O
the	O
mucosal	O
or	O
denture	O
surfaces	O
affects	O
colonisation	O
by	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Carbonic	O
anhydrase	O
VI	O
(	O
CA	O
VI	O
)	O
,	O
encoded	O
by	O
type	O
A	O
transcripts	O
of	O
the	O
gene	O
Car6	O
,	O
is	O
a	O
secretory	O
product	O
of	O
salivary	O
glands	O
and	O
is	O
found	O
in	O
the	O
enamel	O
pellicle	O
.	O

Because	O
higher	O
caries	O
prevalence	O
is	O
associated	O
with	O
lower	O
salivary	O
concentrations	O
of	O
CA	O
VI	O
in	O
humans	O
,	O
we	O
tested	O
whether	O
CA	O
VI	O
protects	O
enamel	O
surfaces	O
from	O
caries	O
induced	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
using	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
in	O
which	O
salivary	O
CA	O
VI	O
expression	O
is	O
absent	O
.	O

We	O
detected	O
aberrant	O
Car6	O
type	O
A	O
transcripts	O
in	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
likely	O
targets	O
for	O
nonsense	O
-	O
mediated	O
mRNA	O
decay	O
.	O

Expression	O
of	O
the	O
intracellular	O
stress	O
-	O
induced	O
isoform	O
of	O
CA	O
VI	O
encoded	O
by	O
type	O
B	O
transcripts	O
was	O
restricted	O
to	O
parotid	O
and	O
submandibular	O
glands	O
of	O
wild	O
type	O
mice	O
.	O

The	O
salivary	O
function	O
of	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
was	O
normal	O
as	O
assessed	O
by	O
the	O
histology	O
and	O
protein	O
/	O
glycoprotein	O
profiles	O
of	O
glands	O
,	O
salivary	O
flow	O
rates	O
and	O
protein	O
/	O
glycoprotein	O
compositions	O
of	O
saliva	O
.	O

Surprisingly	O
,	O
total	O
smooth	O
surface	O
caries	O
and	O
sulcal	O
caries	O
in	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
more	O
than	O
6	O
-	O
fold	O
and	O
2	O
-	O
fold	O
lower	O
than	O
in	O
wild	O
type	O
mice	O
after	O
infection	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strain	I-bacteria
UA159	I-bacteria
.	O

Recoveries	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
total	O
microbiota	O
from	O
molars	O
were	O
also	O
lower	O
in	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

To	O
explore	O
possible	O
mechanisms	O
for	O
increased	O
caries	O
susceptibility	O
,	O
we	O
found	O
no	O
differences	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
adherence	O
to	O
salivary	O
pellicles	O
,	O
in	O
vitro	O
.	O

Interestingly	O
,	O
higher	O
levels	O
of	O
Lactobacillus	B-bacteria
murinus	I-bacteria
and	O
an	O
unidentified	O
Streptococcus	B-bacteria
species	I-bacteria
were	O
cultivated	O
from	O
the	O
oral	O
microbiota	O
of	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Collective	O
results	O
suggest	O
salivary	O
CA	O
VI	O
may	O
promote	O
caries	O
by	O
modulating	O
the	O
oral	O
microbiota	O
to	O
favor	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
colonization	O
and	O
/	O
or	O
by	O
the	O
enzymatic	O
production	O
of	O
acid	O
within	O
plaque	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
inhibitory	O
effects	O
of	O
herbal	O
extracts	O
on	O
caries	O
-	O
related	O
bacteria	O
,	O
glucan	O
and	O
biofilm	O
in	O
vitro	O
.	O

Sensitive	O
tests	O
of	O
bacteria	O
were	O
carried	O
out	O
by	O
broth	O
dilution	O
method	O
on	O
a	O
96	O
-	O
microwell	O
plate	O
.	O

Glucan	O
inhibition	O
tests	O
were	O
carried	O
out	O
using	O
the	O
phenol	O
sulphate	O
method	O
.	O

A	O
minimum	O
biofilm	O
inhibitory	O
concentration	O
(	O
MBIC	O
)	O
test	O
was	O
performed	O
in	O
an	O
artificial	O
mouth	O
model	O
.	O

The	O
results	O
of	O
the	O
MBIC	O
of	O
agents	O
were	O
8	O
,	O
16	O
and	O
32	O
mg	O
mL	O
(	O
-	O
1	O
)	O
for	O
eugenol	O
,	O
tannic	O
acid	O
and	O
magnolol	O
,	O
respectively	O
.	O

For	O
the	O
results	O
of	O
glucan	O
inhibition	O
tests	O
,	O
over	O
63	O
%	O
,	O
28	O
%	O
and	O
27	O
%	O
inhibition	O
occurred	O
on	O
insoluble	O
glucan	O
syntheses	O
of	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
for	O
eugenol	O
,	O
magnolol	O
and	O
tannic	O
acid	O
,	O
respectively	O
.	O

Over	O
46	O
%	O
,	O
16	O
%	O
and	O
13	O
%	O
inhibition	O
on	O
soluble	O
glucan	O
syntheses	O
for	O
eugenol	O
,	O
magnolol	O
and	O
tannic	O
acid	O
,	O
respectively	O
,	O
were	O
also	O
observed	O
.	O

In	O
conclusion	O
,	O
the	O
inhibition	O
of	O
eugenol	O
on	O
glucan	O
is	O
essential	O
for	O
the	O
biofilm	O
inhibition	O
effect	O
on	O
caries	O
-	O
related	O
biofilm	O
in	O
an	O
artificial	O
mouth	O
model	O
in	O
vitro	O
.	O

Gluten	O
proteins	O
,	O
prominent	O
constituents	O
of	O
barley	O
,	O
wheat	O
and	O
rye	O
,	O
cause	O
celiac	O
disease	O
in	O
genetically	O
predisposed	O
subjects	O
.	O

Gluten	O
is	O
notoriously	O
difficult	O
to	O
digest	O
by	O
mammalian	O
proteolytic	O
enzymes	O
and	O
the	O
protease	O
-	O
resistant	O
domains	O
contain	O
multiple	O
immunogenic	O
epitopes	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
novel	O
sources	O
of	O
gluten	O
-	O
digesting	O
microbial	O
enzymes	O
from	O
the	O
upper	O
gastro	O
-	O
intestinal	O
tract	O
with	O
the	O
potential	O
to	O
neutralize	O
gluten	O
epitopes	O
.	O

Oral	O
microorganisms	O
with	O
gluten	O
-	O
degrading	O
capacity	O
were	O
obtained	O
by	O
a	O
selective	O
plating	O
strategy	O
using	O
gluten	O
agar	O
.	O

Microbial	O
speciations	O
were	O
carried	O
out	O
by	O
16S	O
rDNA	O
gene	O
sequencing	O
.	O

Enzyme	O
activities	O
were	O
assessed	O
using	O
gliadin	O
-	O
derived	O
enzymatic	O
substrates	O
,	O
gliadins	O
in	O
solution	O
,	O
gliadin	O
zymography	O
,	O
and	O
33	O
-	O
mer	O
alpha	O
-	O
gliadin	O
and	O
26	O
-	O
mer	O
gamma	O
-	O
gliadin	O
immunogenic	O
peptides	O
.	O

Fragments	O
of	O
the	O
gliadin	O
peptides	O
were	O
separated	O
by	O
RP	O
-	O
HPLC	O
and	O
structurally	O
characterized	O
by	O
mass	O
spectrometry	O
.	O

Strains	O
with	O
high	O
activity	O
towards	O
gluten	O
were	O
typed	O
as	O
Rothia	B-bacteria
mucilaginosa	I-bacteria
and	O
Rothia	B-bacteria
aeria	I-bacteria
.	O

Gliadins	O
(	O
250	O
microg	O
/	O
ml	O
)	O
added	O
to	O
Rothia	B-bacteria
cell	O
suspensions	O
(	O
OD	O
(	O
620	O
)	O
1	O
.	O
2	O
)	O
were	O
degraded	O
by	O
50	O
%	O
after	O
approximately	O
30	O
min	O
of	O
incubation	O
.	O

Importantly	O
,	O
the	O
33	O
-	O
mer	O
and	O
26	O
-	O
mer	O
immunogenic	O
peptides	O
were	O
also	O
cleaved	O
,	O
primarily	O
C	O
-	O
terminal	O
to	O
Xaa	O
-	O
Pro	O
-	O
Gln	O
(	O
XPQ	O
)	O
and	O
Xaa	O
-	O
Pro	O
-	O
Tyr	O
(	O
XPY	O
)	O
.	O

The	O
major	O
gliadin	O
-	O
degrading	O
enzymes	O
produced	O
by	O
the	O
Rothia	B-bacteria
strains	I-bacteria
were	O
approximately	O
70	O
-	O
75	O
kDa	O
in	O
size	O
,	O
and	O
the	O
enzyme	O
expressed	O
by	O
Rothia	B-bacteria
aeria	I-bacteria
was	O
active	O
over	O
a	O
wide	O
pH	O
range	O
(	O
pH	O
3	O
-	O
10	O
)	O
.	O

While	O
the	O
human	O
digestive	O
enzyme	O
system	O
lacks	O
the	O
capacity	O
to	O
cleave	O
immunogenic	O
gluten	O
,	O
such	O
activities	O
are	O
naturally	O
present	O
in	O
the	O
oral	O
microbial	O
enzyme	O
repertoire	O
.	O

The	O
identified	O
bacteria	O
may	O
be	O
exploited	O
for	O
physiologic	O
degradation	O
of	O
harmful	O
gluten	O
peptides	O
.	O

Gelclair	O
is	O
an	O
oral	O
lubricating	O
gel	O
used	O
in	O
the	O
management	O
of	O
oral	O
mucositis	O
(	O
OM	O
)	O
.	O

We	O
evaluated	O
its	O
efficacy	O
,	O
tolerance	O
and	O
impact	O
on	O
oral	O
cavity	O
microbial	O
colonization	O
in	O
patients	O
with	O
OM	O
after	O
allogeneic	O
hematopoietic	O
stem	O
cells	O
transplantation	O
.	O

Gelclair	O
was	O
administered	O
in	O
a	O
group	O
of	O
22	O
patients	O
with	O
active	O
OM	O
.	O

A	O
control	O
group	O
of	O
15	O
patients	O
used	O
other	O
rinsing	O
solutions	O
(	O
chlorhexidine	O
,	O
benzydamine	O
,	O
salvia	O
)	O
.	O

Tests	O
with	O
oral	O
cavity	O
swabs	O
for	O
microbiology	O
analysis	O
were	O
performed	O
once	O
a	O
week	O
.	O

The	O
characteristics	O
of	O
OM	O
in	O
both	O
groups	O
were	O
comparable	O
,	O
and	O
rinsing	O
solutions	O
had	O
satisfactory	O
tolerability	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
median	O
improvement	O
of	O
oral	O
intake	O
and	O
OM	O
-	O
related	O
pain	O
relief	O
,	O
which	O
was	O
assessed	O
mostly	O
as	O
`	O
`	O
slight	O
effect	O
'	O
'	O
.	O

In	O
the	O
Gelclair	O
group	O
,	O
the	O
effect	O
duration	O
was	O
longer	O
(	O
median	O
3	O
[	O
0	O
-	O
5	O
]	O
vs	O
.	O
1	O
[	O
0	O
-	O
3	O
]	O
hours	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O

There	O
was	O
significant	O
increase	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Candida	O
sp	O
.	O
colonization	O
of	O
the	O
oral	O
cavity	O
over	O
the	O
course	O
of	O
the	O
hospitalization	O
and	O
significantly	O
reduced	O
incidence	O
of	O
such	O
colonization	O
in	O
patients	O
with	O
OM	O
in	O
the	O
Gelclair	O
group	O
:	O
1	O
/	O
22	O
(	O
5	O
%	O
)	O
vs	O
.	O
6	O
/	O
15	O
(	O
40	O
%	O
)	O
,	O
p	O
=	O
0	O
.	O
01	O
.	O

In	O
vitro	O
tests	O
showed	O
inhibited	O
growth	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Candida	O
sp	O
.	O
colonies	O
within	O
the	O
area	O
of	O
the	O
Gelclair	O
application	O
.	O

Gelclair	O
may	O
be	O
individually	O
helpful	O
in	O
the	O
management	O
of	O
OM	O
and	O
pain	O
in	O
patients	O
after	O
allogeneic	O
stem	O
cells	O
transplantation	O
.	O

Its	O
use	O
did	O
not	O
lead	O
to	O
worsened	O
oral	O
bacterial	O
and	O
yeast	O
colonization	O
and	O
probably	O
even	O
helped	O
to	O
protect	O
mucosa	O
from	O
Enterococcus	B-bacteria
and	O
Candida	O
sp	O
.	O

Further	O
studies	O
based	O
on	O
larger	O
cohorts	O
are	O
needed	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
might	O
offer	O
opportunities	O
as	O
oral	O
probiotics	O
provided	O
candidate	O
strains	O
persist	O
in	O
the	O
mouth	O
.	O

After	O
intake	O
of	O
a	O
mixture	O
of	O
69	O
LAB	B-bacteria
,	O
strains	O
of	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
were	O
especially	O
recovered	O
.	O

Coaggregation	O
with	O
other	O
microbes	O
is	O
likely	O
not	O
a	O
prerequisite	O
for	O
persistence	O
since	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strongly	O
coaggregated	O
with	O
typical	O
oral	O
cavity	O
isolates	O
,	O
whereas	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
failed	O
to	O
display	O
this	O
phenotype	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
evaluate	O
the	O
effect	O
of	O
a	O
self	O
-	O
etching	O
adhesive	O
system	O
containing	O
an	O
antibacterial	O
monomer	O
on	O
periodontal	O
health	O
and	O
subgingival	O
microbiologic	O
composition	O
in	O
orthodontic	O
patients	O
and	O
to	O
compare	O
it	O
with	O
a	O
conventional	O
adhesive	O
system	O
.	O

A	O
split	O
-	O
mouth	O
design	O
was	O
chosen	O
,	O
and	O
15	O
patients	O
were	O
included	O
in	O
the	O
study	O
.	O

Brackets	O
in	O
contralateral	O
quadrants	O
were	O
bonded	O
with	O
either	O
a	O
conventional	O
adhesive	O
system	O
(	O
control	O
)	O
or	O
a	O
self	O
-	O
etching	O
adhesive	O
system	O
that	O
contained	O
an	O
antibacterial	O
monomer	O
.	O

Clinical	O
periodontal	O
parameters	O
including	O
plaque	O
index	O
,	O
gingival	O
index	O
,	O
probing	O
depths	O
,	O
and	O
bleeding	O
on	O
probing	O
were	O
determined	O
.	O

Subgingival	O
plaque	O
samples	O
were	O
collected	O
before	O
bracket	O
placement	O
(	O
T0	O
)	O
and	O
at	O
the	O
6	O
-	O
month	O
follow	O
-	O
up	O
(	O
T1	O
)	O
.	O

The	O
real	O
-	O
time	O
TaqMan	O
polymerase	O
chain	O
reaction	O
assay	O
was	O
used	O
to	O
determine	O
the	O
subgingival	O
counts	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
.	O

For	O
clinical	O
periodontal	O
parameters	O
,	O
analysis	O
of	O
covariance	O
(	O
ANCOVA	O
)	O
and	O
,	O
for	O
bacterial	O
counts	O
,	O
Wilcoxon	O
tests	O
were	O
used	O
for	O
statistical	O
comparisons	O
at	O
the	O
P	O
<	O
0	O
.	O
05	O
level	O
.	O

Clinical	O
periodontal	O
parameters	O
were	O
not	O
changed	O
,	O
and	O
they	O
were	O
not	O
different	O
between	O
the	O
groups	O
from	O
T0	O
to	O
T1	O
.	O

T	B-bacteria
forsythensis	I-bacteria
and	O
F	B-bacteria
nucleatum	I-bacteria
increased	O
during	O
the	O
treatment	O
period	O
in	O
both	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
majority	O
of	O
the	O
bacteria	O
were	O
T	B-bacteria
nucleatum	I-bacteria
at	O
T0	O
and	O
T1	O
in	O
both	O
groups	O
.	O

Changes	O
in	O
bacterial	O
load	O
from	O
T0	O
to	O
T1	O
were	O
not	O
different	O
between	O
groups	O
except	O
for	O
T	B-bacteria
forsythensis	I-bacteria
and	O
F	B-bacteria
nucleatum	I-bacteria
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
use	O
of	O
an	O
antibacterial	O
monomer	O
did	O
not	O
have	O
an	O
additional	O
positive	O
effect	O
on	O
clinical	O
periodontal	O
parameters	O
.	O

When	O
used	O
in	O
bonding	O
orthodontic	O
brackets	O
,	O
the	O
antibacterial	O
monomer	O
failed	O
to	O
reduce	O
periodontopathogenic	O
bacteria	O
when	O
compared	O
with	O
the	O
conventional	O
adhesive	O
system	O
during	O
a	O
6	O
-	O
month	O
treatment	O
period	O
.	O

Preterm	O
birth	O
significantly	O
impacts	O
on	O
neonatal	O
morbidity	O
and	O
mortality	O
and	O
is	O
apparently	O
increasing	O
world	O
-	O
wide	O
.	O

Several	O
studies	O
have	O
attempted	O
to	O
define	O
a	O
causative	O
role	O
for	O
periodontal	O
disease	O
in	O
adverse	O
pregnancy	O
outcomes	O
but	O
few	O
have	O
focused	O
on	O
the	O
microbiology	O
of	O
periodontal	O
disease	O
in	O
relation	O
to	O
these	O
outcomes	O
.	O

The	O
evidence	O
for	O
a	O
positive	O
correlation	O
is	O
strong	O
,	O
supported	O
by	O
microbiological	O
and	O
immunological	O
findings	O
.	O

Conflicting	O
results	O
are	O
often	O
associated	O
with	O
uncontrolled	O
confounding	O
factors	O
.	O

A	O
literature	O
search	O
was	O
conducted	O
in	O
order	O
to	O
establish	O
whether	O
or	O
not	O
a	O
role	O
exists	O
for	O
oral	O
Gram	O
-	O
negative	O
bacteria	O
in	O
adverse	O
pregnancy	O
outcomes	O
.	O

Association	O
and	O
intervention	O
studies	O
are	O
summarized	O
along	O
with	O
pathogenic	O
potential	O
of	O
the	O
Gram	O
-	O
negative	O
bacteria	O
most	O
frequently	O
implicated	O
in	O
periodontal	O
disease	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
one	O
of	O
the	O
most	O
common	O
anaerobic	O
bacteria	O
present	O
in	O
the	O
oral	O
cavity	O
and	O
is	O
often	O
isolated	O
from	O
infections	O
involving	O
other	O
body	O
sites	O
.	O

To	O
characterise	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strains	I-bacteria
from	O
patients	O
attending	O
a	O
teaching	O
hospital	O
in	O
Nigeria	O
in	O
order	O
to	O
provide	O
information	O
on	O
the	O
methods	O
for	O
accurate	O
identification	O
of	O
anaerobes	O
in	O
clinical	O
specimen	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
specie	I-bacteria
from	O
50	O
patients	O
presenting	O
with	O
oro	O
-	O
facial	O
infections	O
were	O
studied	O
by	O
culture	O
on	O
Fusobacterium	B-bacteria
selective	O
agar	O
and	O
fastidious	O
anaerobe	O
agar	O
.	O

The	O
isolates	O
were	O
characterised	O
based	O
on	O
colonial	O
morphology	O
,	O
microscopy	O
,	O
lipase	O
production	O
,	O
susceptibility	O
to	O
kanamycin	O
and	O
colistin	O
and	O
resistance	O
to	O
vancomycin	O
.	O

Biochemical	O
tests	O
were	O
performed	O
using	O
a	O
commercial	O
test	O
kit	O
.	O

The	O
identity	O
of	O
the	O
isolates	O
was	O
confirmed	O
based	O
on	O
molecular	O
characterization	O
performed	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
analysis	O
.	O

Forty	O
-	O
eight	O
(	O
96	O
%	O
)	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
isolates	I-bacteria
were	O
obtained	O
from	O
the	O
50	O
patients	O
by	O
culture	O
and	O
all	O
the	O
isolates	O
were	O
identified	O
by	O
colonial	O
appearance	O
and	O
microscopy	O
based	O
on	O
their	O
unique	O
spindle	O
shape	O
with	O
tapered	O
ends	O
.	O

Only	O
26	O
(	O
54	O
.	O
2	O
%	O
)	O
of	O
the	O
48	O
isolates	O
were	O
identified	O
by	O
commercial	O
API	O
20A	O
test	O
kit	O
while	O
PCR	O
confirmed	O
the	O
identity	O
of	O
all	O
the	O
isolates	O
.	O

Anaerobes	O
are	O
involved	O
in	O
human	O
infections	O
and	O
their	O
study	O
is	O
quite	O
cumbersome	O
due	O
to	O
tedious	O
nature	O
and	O
high	O
cost	O
of	O
the	O
techniques	O
involved	O
.	O

Cultural	O
method	O
is	O
reliable	O
in	O
the	O
isolation	O
and	O
identification	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
species	I-bacteria
.	O

PCR	O
is	O
a	O
rapid	O
and	O
simple	O
method	O
that	O
can	O
complement	O
the	O
phenotypic	O
identification	O
of	O
anaerobes	O
and	O
would	O
assist	O
in	O
their	O
full	O
identification	O
.	O

Oral	O
pathology	O
is	O
a	O
commonly	O
reported	O
extraintestinal	O
manifestation	O
of	O
Crohn	O
'	O
s	O
disease	O
(	O
CD	O
)	O
.	O

The	O
host	O
-	O
microbe	O
interaction	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
in	O
genetically	O
susceptible	O
hosts	O
,	O
yet	O
limited	O
information	O
exists	O
about	O
oral	O
microbes	O
in	O
IBD	O
.	O

We	O
hypothesize	O
that	O
the	O
microbiology	O
of	O
the	O
oral	O
cavity	O
may	O
differ	O
in	O
patients	O
with	O
IBD	O
.	O

Our	O
laboratory	O
has	O
developed	O
a	O
16S	O
rRNA	O
-	O
based	O
technique	O
known	O
as	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
to	O
study	O
the	O
oral	O
microbiome	O
of	O
children	O
and	O
young	O
adults	O
with	O
IBD	O
.	O

Tongue	O
and	O
buccal	O
mucosal	O
brushings	O
from	O
healthy	O
controls	O
,	O
CD	O
,	O
and	O
ulcerative	O
colitis	O
(	O
UC	O
)	O
patients	O
were	O
analyzed	O
using	O
HOMIM	O
.	O

Shannon	O
Diversity	O
Index	O
(	O
SDI	O
)	O
and	O
Principal	O
Component	O
Analysis	O
(	O
PCA	O
)	O
were	O
employed	O
to	O
compare	O
population	O
and	O
phylum	O
-	O
level	O
changes	O
among	O
our	O
study	O
groups	O
.	O

In	O
all	O
,	O
114	O
unique	O
subjects	O
from	O
the	O
Children	O
'	O
s	O
Hospital	O
Boston	O
were	O
enrolled	O
.	O

Tongue	O
samples	O
from	O
patients	O
with	O
CD	O
showed	O
a	O
significant	O
decrease	O
in	O
overall	O
microbial	O
diversity	O
as	O
compared	O
with	O
the	O
same	O
location	O
in	O
healthy	O
controls	O
(	O
P	O
=	O
0	O
.	O
015	O
)	O
with	O
significant	O
changes	O
seen	O
in	O
Fusobacteria	B-bacteria
(	O
P	O
<	O
0	O
.	O
0002	O
)	O
and	O
Firmicutes	B-bacteria
(	O
P	O
=	O
0	O
.	O
022	O
)	O
.	O

Tongue	O
samples	O
from	O
patients	O
with	O
UC	O
did	O
not	O
show	O
a	O
significant	O
change	O
in	O
overall	O
microbial	O
diversity	O
as	O
compared	O
with	O
healthy	O
controls	O
(	O
P	O
=	O
0	O
.	O
418	O
)	O
.	O

As	O
detected	O
by	O
HOMIM	O
,	O
we	O
found	O
a	O
significant	O
decrease	O
in	O
overall	O
diversity	O
in	O
the	O
oral	O
microbiome	O
of	O
pediatric	O
CD	O
.	O

Considering	O
the	O
proposed	O
microbe	O
-	O
host	O
interaction	O
in	O
IBD	O
,	O
the	O
ease	O
of	O
visualization	O
and	O
direct	O
oral	O
mucosal	O
sampling	O
of	O
the	O
oral	O
cavity	O
,	O
further	O
study	O
of	O
the	O
oral	O
microbiome	O
in	O
IBD	O
is	O
of	O
potential	O
diagnostic	O
and	O
prognostic	O
value	O
.	O

To	O
test	O
the	O
hypothesis	O
whether	O
microbiota	O
in	O
oral	O
biofilm	O
is	O
linked	O
with	O
obesity	O
in	O
adolescents	O
we	O
designed	O
this	O
cross	O
-	O
sectional	O
study	O
.	O

Obese	O
adolescents	O
(	O
n	O
=	O
29	O
)	O
with	O
a	O
mean	O
age	O
of	O
14	O
.	O
7	O
years	O
and	O
normal	O
weight	O
subjects	O
(	O
n	O
=	O
58	O
)	O
matched	O
by	O
age	O
and	O
gender	O
were	O
examined	O
with	O
respect	O
to	O
visible	O
plaque	O
index	O
(	O
VPI	O
%	O
)	O
and	O
gingival	O
inflammation	O
(	O
bleeding	O
on	O
probing	O
(	O
BOP	O
%	O
)	O
)	O
.	O

Stimulated	O
saliva	O
was	O
collected	O
.	O

They	O
answered	O
a	O
questionnaire	O
concerning	O
medical	O
history	O
,	O
medication	O
,	O
oral	O
hygiene	O
habits	O
,	O
smoking	O
habits	O
,	O
and	O
sociodemographic	O
background	O
.	O

Microbiological	O
samples	O
taken	O
from	O
the	O
gingival	O
crevice	O
was	O
analyzed	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
.	O

The	O
sum	O
of	O
bacterial	O
cells	O
in	O
subgingival	O
biofilm	O
was	O
significantly	O
associated	O
with	O
obesity	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
link	O
between	O
sum	O
of	O
bacterial	O
cells	O
and	O
obesity	O
was	O
not	O
confounded	O
by	O
any	O
of	O
the	O
studied	O
variables	O
(	O
chronic	O
disease	O
,	O
medication	O
,	O
VPI	O
%	O
,	O
BOP	O
%	O
,	O
flow	O
rate	O
of	O
whole	O
saliva	O
,	O
or	O
meal	O
frequency	O
)	O
.	O

Totally	O
23	O
bacterial	O
species	O
were	O
present	O
in	O
approximately	O
threefold	O
higher	O
amounts	O
,	O
on	O
average	O
,	O
in	O
obese	O
subjects	O
compared	O
with	O
normal	O
weight	O
controls	O
.	O

Of	O
the	O
Proteobacteria	B-bacteria
phylum	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
and	O
Neisseria	B-bacteria
mucosa	I-bacteria
were	O
present	O
in	O
sixfold	O
higher	O
amounts	O
among	O
obese	O
subjects	O
.	O

The	O
association	O
between	O
obesity	O
and	O
sum	O
of	O
bacterial	O
cells	O
in	O
oral	O
subgingival	O
biofilm	O
indicates	O
a	O
possible	O
link	O
between	O
oral	O
microbiota	O
and	O
obesity	O
in	O
adolescents	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
is	O
the	O
key	O
causative	O
agent	O
of	O
caries	O
and	O
infective	O
endocarditis	O
.	O

The	O
first	O
step	O
in	O
biofilm	O
development	O
and	O
the	O
consequent	O
initiation	O
of	O
further	O
disease	O
is	O
bacterial	O
adherence	O
to	O
host	O
cell	O
surfaces	O
.	O

Therefore	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
inhibitory	O
effect	O
of	O
curcumin	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
adherence	O
to	O
extracellular	O
matrices	O
and	O
tooth	O
surfaces	O
.	O

The	O
effect	O
of	O
curcumin	O
on	O
the	O
ability	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
adhere	O
to	O
glass	O
surfaces	O
coated	O
with	O
collagen	O
and	O
fibronectin	O
was	O
tested	O
in	O
order	O
to	O
determine	O
whether	O
the	O
decrease	O
of	O
the	O
bacterial	O
adhesion	O
by	O
curcumin	O
is	O
achieved	O
by	O
hindering	O
the	O
bacteria	O
in	O
adhering	O
to	O
collagen	O
and	O
/	O
or	O
fibronectin	O
.	O

Also	O
,	O
human	O
teeth	O
inoculated	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
treated	O
with	O
curcumin	O
in	O
vitro	O
in	O
order	O
to	O
assess	O
the	O
relevance	O
of	O
the	O
anti	O
-	O
adhesive	O
effect	O
to	O
oral	O
conditions	O
in	O
vivo	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
at	O
which	O
curcumin	O
completely	O
inhibited	O
bacterial	O
growth	O
was	O
128	O
mug	O
/	O
mL	O
.	O

The	O
addition	O
of	O
curcumin	O
below	O
the	O
MIC	O
diminished	O
bacterial	O
adherence	O
onto	O
both	O
collagen	O
-	O
and	O
fibronectin	O
-	O
coated	O
glass	O
surfaces	O
and	O
human	O
tooth	O
surfaces	O
.	O

It	O
appears	O
that	O
the	O
anti	O
-	O
adhesive	O
effect	O
of	O
curcumin	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
is	O
mediated	O
through	O
collagen	O
and	O
fibronectin	O
.	O

These	O
results	O
support	O
the	O
widespread	O
use	O
of	O
curcumin	O
as	O
a	O
food	O
-	O
based	O
antimicrobial	O
agent	O
.	O

Both	O
oral	O
cavity	O
and	O
subgingival	O
pocket	O
are	O
ecological	O
niches	O
conducive	O
to	O
hosting	O
microorganisms	O
that	O
may	O
act	O
as	O
opportunistic	O
pathogens	O
,	O
such	O
as	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
especially	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
.	O

Early	O
detection	O
of	O
MRSA	B-bacteria
is	O
a	O
matter	O
of	O
concern	O
to	O
Public	O
Health	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
determine	O
phenotypic	O
and	O
genotypic	O
detection	O
of	O
methicillin	O
resistance	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
oral	O
mucosa	O
and	O
subgingival	O
pocket	O
in	O
102	O
patients	O
with	O
gingivitis	O
-	O
periodontitis	O
.	O

The	O
prevalence	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
was	O
10	O
.	O
8	O
%	O
(	O
n	O
=	O
11	O
)	O
in	O
subgingival	O
pocket	O
and	O
19	O
.	O
6	O
%	O
(	O
n	O
=	O
20	O
)	O
in	O
oral	O
mucosa	O
.	O

We	O
obtained	O
31	O
isolates	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
of	O
which	O
13	O
were	O
mecA	O
positive	O
and	O
18	O
were	O
mecA	O
negative	O
.	O

Detection	O
of	O
mecA	O
gene	O
by	O
PCR	O
was	O
used	O
as	O
the	O
reference	O
method	O
to	O
compare	O
the	O
results	O
of	O
phenotypic	O
methods	O
to	O
determine	O
methicillin	O
resistance	O
.	O

Early	O
,	O
accurate	O
detection	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
through	O
phenotyping	O
and	O
genotyping	O
methods	O
is	O
crucial	O
for	O
assessing	O
the	O
colonization	O
and	O
preventing	O
the	O
spread	O
of	O
MRSA	B-bacteria
.	O

To	O
determine	O
the	O
relation	O
between	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
supra	O
-	O
gingival	O
dental	O
plaque	O
with	O
oral	O
hygiene	O
habits	O
and	O
oral	O
health	O
status	O
of	O
patients	O
suffering	O
from	O
symptomatic	O
dyspepsia	O
.	O

Descriptive	O
study	O
.	O

The	O
Department	O
of	O
Oral	O
Health	O
Sciences	O
,	O
Shaikh	O
Zayed	O
FPGMI	O
,	O
Lahore	O
,	O
from	O
September	O
2008	O
to	O
August	O
2009	O
.	O

One	O
hundred	O
and	O
fifty	O
dyspeptic	O
subjects	O
with	O
dental	O
plaque	O
were	O
enrolled	O
.	O

After	O
recording	O
brushing	O
frequency	O
,	O
oral	O
health	O
status	O
and	O
plaque	O
load	O
,	O
the	O
supra	O
-	O
gingival	O
dental	O
plaque	O
samples	O
were	O
collected	O
by	O
sterile	O
curettes	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
were	O
detected	O
in	O
dental	O
plaque	O
samples	O
through	O
PCR	O
assay	O
.	O

Presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dental	O
plaque	O
was	O
found	O
to	O
be	O
37	O
.	O
5	O
%	O
in	O
the	O
sample	O
.	O

Most	O
of	O
the	O
subjects	O
brushed	O
once	O
daily	O
,	O
had	O
plaque	O
index	O
score	O
of	O
1	O
and	O
had	O
fair	O
to	O
poor	O
oral	O
hygiene	O
status	O
.	O

Approximately	O
35	O
%	O
of	O
the	O
individuals	O
who	O
brushed	O
once	O
or	O
twice	O
a	O
day	O
harbored	O
the	O
bacterium	O
in	O
their	O
dental	O
plaque	O
.	O

There	O
was	O
no	O
difference	O
between	O
bacterial	O
detection	O
rates	O
among	O
different	O
categories	O
of	O
plaque	O
index	O
and	O
oral	O
health	O
status	O
of	O
the	O
study	O
subjects	O
.	O

Presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dental	O
plaque	O
was	O
found	O
to	O
be	O
associated	O
with	O
neither	O
brushing	O
frequency	O
nor	O
with	O
the	O
plaque	O
load	O
nor	O
with	O
the	O
oral	O
health	O
status	O
of	O
individuals	O
suffering	O
from	O
symptomatic	O
dyspepsia	O
.	O

Lactobacilli	B-bacteria
are	O
present	O
in	O
the	O
intestine	O
and	O
oral	O
cavity	O
of	O
most	O
adults	O
.	O

Secretory	O
IgA	O
in	O
mucosal	O
secretions	O
may	O
provide	O
carbohydrate	O
receptors	O
for	O
bacterial	O
adhesins	O
.	O

Here	O
,	O
oral	O
and	O
faecal	O
samples	O
from	O
33	O
IgA	O
-	O
deficient	O
individuals	O
and	O
34	O
controls	O
were	O
cultured	O
for	O
lactobacilli	B-bacteria
,	O
which	O
were	O
identified	O
using	O
species	O
-	O
specific	O
PCR	O
or	O
partial	O
16S	O
rDNA	O
sequencing	O
and	O
tested	O
for	O
expression	O
of	O
mannose	O
-	O
specific	O
adhesins	O
.	O

Lactobacilli	B-bacteria
were	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
76	O
%	O
of	O
IgA	O
-	O
deficient	O
and	O
85	O
%	O
of	O
control	O
individuals	O
.	O

Lactobacillus	B-bacteria
paracasei	I-bacteria
and	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
dominated	O
in	O
both	O
groups	O
.	O

Lactobacillus	B-bacteria
fermentum	I-bacteria
was	O
less	O
common	O
in	O
IgA	O
-	O
deficient	O
individuals	O
than	O
in	O
controls	O
(	O
p	O
=	O
0	O
.	O
0055	O
)	O
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
was	O
less	O
common	O
in	O
symptomatic	O
than	O
in	O
healthy	O
IgA	O
-	O
deficient	O
individuals	O
(	O
p	O
=	O
0	O
.	O
0051	O
)	O
.	O

Faecal	O
samples	O
yielded	O
lactobacilli	B-bacteria
in	O
most	O
individuals	O
.	O

L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
was	O
most	O
frequent	O
,	O
followed	O
by	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
and	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
.	O

Mannose	O
-	O
specific	O
adhesins	O
were	O
expressed	O
more	O
frequently	O
by	O
oral	O
than	O
by	O
faecal	O
isolates	O
(	O
p	O
=	O
0	O
.	O
032	O
)	O
and	O
oral	O
isolates	O
adhered	O
in	O
higher	O
numbers	O
than	O
faecal	O
isolates	O
(	O
46	O
vs	O
.	O
14	O
bacteria	O
/	O
cell	O
,	O
p	O
=	O
0	O
.	O
0038	O
)	O
.	O

Faecal	O
isolates	O
from	O
IgA	O
-	O
deficient	O
individuals	O
more	O
frequently	O
expressed	O
mannose	O
-	O
specific	O
adhesins	O
than	O
faecal	O
isolates	O
from	O
controls	O
(	O
p	O
=	O
0	O
.	O
039	O
)	O
.	O

Mannose	O
-	O
specific	O
adhesins	O
may	O
be	O
a	O
colonisation	O
factor	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
the	O
presence	O
of	O
secretory	O
IgA	O
may	O
modify	O
adhesin	O
expression	O
.	O

However	O
,	O
secretory	O
IgA	O
seems	O
to	O
have	O
little	O
influence	O
on	O
Lactobacillus	B-bacteria
species	I-bacteria
distribution	O
.	O

To	O
determine	O
the	O
Helicobacter	B-bacteria
spp	I-bacteria
present	O
in	O
the	O
oral	O
cavity	O
of	O
dogs	O
and	O
the	O
relationship	O
of	O
those	O
organisms	O
with	O
gastric	O
Helicobacter	B-bacteria
spp	I-bacteria
to	O
better	O
define	O
the	O
potential	O
for	O
dog	O
-	O
human	O
and	O
dog	O
-	O
dog	O
transmission	O
.	O

:	O
Saliva	O
and	O
dental	O
plaque	O
from	O
28	O
dogs	O
and	O
gastric	O
biopsy	O
specimens	O
from	O
a	O
subset	O
of	O
8	O
dogs	O
.	O

PCR	O
-	O
based	O
screening	O
for	O
Helicobacter	B-bacteria
spp	I-bacteria
was	O
conducted	O
on	O
samples	O
obtained	O
from	O
the	O
oral	O
cavity	O
of	O
28	O
dogs	O
.	O

Comparative	O
analysis	O
was	O
conducted	O
on	O
Helicobacteraceae	B-bacteria
16S	O
rDNA	O
clone	O
libraries	O
from	O
the	O
oral	O
cavity	O
and	O
stomach	O
of	O
a	O
subset	O
of	O
8	O
dogs	O
(	O
5	O
vomiting	O
and	O
3	O
healthy	O
)	O
that	O
had	O
positive	O
PCR	O
results	O
for	O
Helicobacter	B-bacteria
spp	I-bacteria
.	O

Helicobacteraceae	B-bacteria
DNA	O
was	O
identified	O
in	O
the	O
oral	O
cavity	O
of	O
24	O
of	O
28	O
dogs	O
.	O

Analysis	O
of	O
cloned	O
16S	O
rDNA	O
amplicons	O
from	O
8	O
dogs	O
revealed	O
that	O
Wolinella	B-bacteria
spp	I-bacteria
was	O
the	O
most	O
common	O
(	O
8	O
/	O
8	O
dogs	O
)	O
and	O
abundant	O
(	O
52	O
/	O
57	O
[	O
91	O
%	O
]	O
clones	O
)	O
member	O
of	O
the	O
Helicobacteraceae	B-bacteria
family	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

Only	O
2	O
of	O
8	O
dogs	O
harbored	O
Helicobacter	B-bacteria
spp	I-bacteria
in	O
the	O
oral	O
cavity	O
,	O
and	O
1	O
of	O
those	O
was	O
coinfected	O
with	O
Helicobacter	B-bacteria
heilmannii	I-bacteria
and	O
Helicobacter	B-bacteria
felis	I-bacteria
in	O
samples	O
obtained	O
from	O
the	O
stomach	O
and	O
saliva	O
.	O

Evaluation	O
of	O
oral	O
cavity	O
DNA	O
with	O
Wolinella	O
-	O
specific	O
PCR	O
primers	O
yielded	O
positive	O
results	O
for	O
16	O
of	O
20	O
other	O
dogs	O
(	O
24	O
/	O
28	O
samples	O
were	O
positive	O
for	O
Wolinella	B-bacteria
spp	I-bacteria
)	O
.	O

Wolinella	B-bacteria
spp	I-bacteria
rather	O
than	O
Helicobacter	B-bacteria
spp	I-bacteria
were	O
the	O
predominant	O
Helicobacteraceae	B-bacteria
in	O
the	O
oral	O
cavity	O
of	O
dogs	O
.	O

The	O
oral	O
cavity	O
of	O
dogs	O
was	O
apparently	O
not	O
a	O
zoonotically	O
important	O
reservoir	O
of	O
Helicobacter	B-bacteria
spp	I-bacteria
that	O
were	O
non	B-bacteria
-	I-bacteria
Helicobacter	I-bacteria
pylori	I-bacteria
organisms	O
.	O

The	O
mechanism	O
of	O
Cronobacter	B-bacteria
pathogenesis	O
in	O
neonatal	O
meningitis	O
and	O
potential	O
virulence	O
factors	O
(	O
aside	O
from	O
host	O
cell	O
invasion	O
ability	O
)	O
remain	O
largely	O
unknown	O
.	O

To	O
ascertain	O
whether	O
Cronobacter	B-bacteria
can	O
invade	O
and	O
transcytose	O
across	O
intestinal	O
epithelial	O
cells	O
,	O
enter	O
into	O
the	O
blood	O
stream	O
and	O
then	O
transcytose	O
across	O
the	O
blood	O
-	O
brain	O
-	O
barrier	O
,	O
we	O
have	O
utilized	O
human	O
intestinal	O
INT407	O
and	O
Caco	O
-	O
2	O
cells	O
and	O
brain	O
microvascular	O
endothelial	O
cell	O
(	O
HBMEC	O
)	O
monolayers	O
on	O
Transwell	O
filters	O
as	O
experimental	O
model	O
systems	O
.	O

Our	O
data	O
indicate	O
a	O
wide	O
range	O
of	O
heterogeneity	O
with	O
respect	O
to	O
invasion	O
efficiency	O
among	O
twenty	O
-	O
three	O
Cronobacter	B-bacteria
isolates	I-bacteria
screened	O
.	O

For	O
selected	O
isolates	O
,	O
we	O
observed	O
significant	O
levels	O
of	O
transcytosis	O
for	O
Cronobacter	B-bacteria
sakazakii	I-bacteria
across	O
tight	O
monolayers	O
of	O
both	O
Caco	O
-	O
2	O
and	O
HBMEC	O
,	O
mimicking	O
in	O
vivo	O
ability	O
to	O
cross	O
the	O
intestine	O
as	O
well	O
as	O
the	O
blood	O
brain	O
barrier	O
,	O
and	O
at	O
a	O
frequency	O
equivalent	O
to	O
that	O
of	O
a	O
control	O
meningitis	O
-	O
causing	O
Escherichia	B-bacteria
coli	I-bacteria
K1	I-bacteria
strain	I-bacteria
.	O

Finally	O
,	O
EM	O
analysis	O
demonstrated	O
intracellular	O
Cronobacter	B-bacteria
bacteria	I-bacteria
within	O
host	O
vacuoles	O
in	O
HBMEC	O
,	O
as	O
well	O
as	O
transcytosed	O
bacteria	O
at	O
the	O
basolateral	O
surface	O
.	O

These	O
data	O
reveal	O
that	O
certain	O
Cronobacter	B-bacteria
isolates	I-bacteria
can	O
invade	O
and	O
translocate	O
across	O
both	O
cultured	O
human	O
intestinal	O
epithelial	O
cells	O
and	O
HBMEC	O
,	O
thus	O
demonstrating	O
a	O
potential	O
path	O
for	O
neonatal	O
infections	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
following	O
oral	O
ingestion	O
.	O

Clinical	O
benefits	O
of	O
probiotics	O
have	O
been	O
clearly	O
reported	O
in	O
different	O
gastrointestinal	O
disorders	O
,	O
many	O
of	O
them	O
caused	O
by	O
enterobacteria	B-bacteria
.	O

The	O
oral	O
cavity	O
is	O
a	O
port	O
of	O
entry	O
and	O
can	O
be	O
an	O
important	O
reservoir	O
of	O
these	O
microorganisms	O
.	O

This	O
work	O
evaluated	O
whether	O
consumption	O
of	O
probiotics	O
was	O
able	O
to	O
influence	O
the	O
presence	O
of	O
enterobacteria	B-bacteria
in	O
the	O
oral	O
cavity	O
and	O
the	O
specific	O
secretory	O
response	O
against	O
these	O
microorganisms	O
.	O

Saliva	O
samples	O
of	O
healthy	O
individuals	O
were	O
collected	O
and	O
plated	O
in	O
MacConkey	O
agar	O
.	O

Carriers	O
of	O
Gram	O
-	O
negative	O
,	O
rod	O
-	O
shaped	O
microorganisms	O
in	O
the	O
oral	O
cavity	O
were	O
selected	O
and	O
instructed	O
to	O
use	O
the	O
probiotic	O
Yakult	O
LB	B-bacteria
for	O
20	O
days	O
.	O

Saliva	O
was	O
then	O
collected	O
and	O
enterobacteria	B-bacteria
species	I-bacteria
were	O
identified	O
using	O
the	O
API	O
20	O
E	O
system	O
and	O
by	O
ELISA	O
using	O
anti	O
-	O
enterobacteria	O
IgA	O
.	O

The	O
results	O
showed	O
reduction	O
in	O
the	O
prevalence	O
of	O
enterobacteria	B-bacteria
,	O
but	O
no	O
significant	O
changes	O
in	O
enterobacterial	O
counts	O
(	O
log	O
CFU	O
/	O
mL	O
;	O
p	O
=	O
0	O
.	O
3457	O
)	O
.	O

The	O
species	O
most	O
frequently	O
isolated	O
were	O
Enterobacter	B-bacteria
cloacae	I-bacteria
and	O
Klebsiella	B-bacteria
oxytoca	I-bacteria
,	O
both	O
before	O
and	O
after	O
probiotic	O
consumption	O
.	O

No	O
significant	O
changes	O
were	O
observed	O
in	O
anti	O
-	O
enterobacteria	O
IgA	O
levels	O
.	O

In	O
conclusion	O
,	O
probiotic	O
consumption	O
had	O
some	O
influence	O
on	O
enterobacterial	O
presence	O
in	O
the	O
oral	O
cavity	O
,	O
but	O
did	O
not	O
affect	O
enterobacterial	O
counts	O
or	O
the	O
specific	O
immune	O
secretory	O
response	O
against	O
them	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
is	O
a	O
Gram	O
-	O
positive	O
bacterial	O
commensal	O
and	O
pioneer	O
colonizer	O
of	O
the	O
human	O
oral	O
cavity	O
.	O

Many	O
strains	O
produce	O
ribosomally	O
synthesized	O
proteinaceous	O
antibiotics	O
(	O
bacteriocins	O
)	O
,	O
and	O
some	O
strains	O
have	O
been	O
developed	O
for	O
use	O
as	O
oral	O
probiotics	O
.	O

Here	O
,	O
we	O
present	O
the	O
draft	O
genome	O
sequence	O
of	O
the	O
bacteriocin	O
-	O
producing	O
oral	O
probiotic	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strain	I-bacteria
M18	I-bacteria
.	O

We	O
sought	O
to	O
develop	O
Bifidobacterium	B-bacteria
infantis	I-bacteria
(	O
BI	B-bacteria
)	O
as	O
a	O
vehicle	O
for	O
the	O
expression	O
of	O
heterologous	O
antigens	O
.	O

Two	O
proteins	O
of	O
enterotoxigenic	B-bacteria
Escherichia	I-bacteria
coli	I-bacteria
(	O
ETEC	B-bacteria
)	O
were	O
expressed	O
in	O
BI	O
:	O
CfaB	O
,	O
a	O
major	O
fimbrial	O
subunit	O
protein	O
,	O
and	O
LTB	O
,	O
the	O
B	O
subunit	O
of	O
heat	O
-	O
labile	O
enterotoxin	O
.	O

The	O
expression	O
of	O
CfaB	O
and	O
LTB	O
in	O
BI	B-bacteria
was	O
verified	O
by	O
electrophoretic	O
analysis	O
.	O

Sprague	O
-	O
Dawley	O
rats	O
were	O
then	O
subjected	O
to	O
intragastric	O
immunization	O
with	O
BI	O
-	O
CfaB	O
and	O
BI	O
-	O
LTB	O
systems	O
both	O
separately	O
and	O
together	O
.	O

ELISA	O
was	O
used	O
to	O
characterize	O
the	O
serum	O
and	O
mucosal	O
immune	O
responses	O
against	O
ETEC	B-bacteria
antigens	O
.	O

The	O
immunized	O
rats	O
were	O
intraperitoneally	O
challenged	O
with	O
wild	O
-	O
type	O
ETEC	B-bacteria
H10407	I-bacteria
to	O
study	O
the	O
immune	O
response	O
in	O
vivo	O
.	O

The	O
serum	O
titres	O
of	O
IgG	O
and	O
faecal	O
IgA	O
antibodies	O
in	O
the	O
BI	O
-	O
CfaB	O
plus	O
BI	O
-	O
LTB	O
mixed	O
vaccination	O
group	O
were	O
significantly	O
greater	O
than	O
those	O
in	O
the	O
other	O
two	O
groups	O
,	O
which	O
were	O
immunized	O
with	O
a	O
single	O
vaccine	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

However	O
,	O
no	O
significant	O
difference	O
was	O
seen	O
between	O
the	O
two	O
groups	O
that	O
received	O
a	O
single	O
immunization	O
.	O

These	O
results	O
suggest	O
that	O
expressing	O
CfaB	O
and	O
LTB	O
in	O
BI	O
provides	O
a	O
probiotic	O
system	O
with	O
immunogenic	O
properties	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
LTB	O
in	O
BI	O
preserved	O
its	O
mucosal	O
adjuvant	O
effect	O
.	O

So	O
this	O
study	O
confirms	O
that	O
BI	O
can	O
be	O
used	O
as	O
a	O
novel	O
oral	O
vaccine	O
expression	O
system	O
for	O
a	O
heterologous	O
antigen	O
and	O
BI	O
-	O
LTB	O
can	O
provide	O
mucosal	O
adjuvant	O
properties	O
.	O

Native	O
bees	O
of	O
the	O
tribe	O
Meliponini	O
produce	O
a	O
distinct	O
kind	O
of	O
propolis	O
called	O
geopropolis	O
.	O

Although	O
many	O
pharmacological	O
activities	O
of	O
propolis	O
have	O
already	O
been	O
demonstrated	O
,	O
little	O
is	O
known	O
about	O
geopropolis	O
,	O
particularly	O
regarding	O
its	O
antimicrobial	O
activity	O
against	O
oral	O
pathogens	O
.	O

The	O
present	O
study	O
aimed	O
at	O
investigating	O
the	O
antimicrobial	O
activity	O
of	O
M	B-bacteria
.	I-bacteria
fasciculata	I-bacteria
geopropolis	O
against	O
oral	O
pathogens	O
,	O
its	O
effects	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
,	O
and	O
the	O
chemical	O
contents	O
of	O
the	O
extracts	O
.	O

A	O
gel	O
prepared	O
with	O
a	O
geopropolis	O
extract	O
was	O
also	O
analyzed	O
for	O
its	O
activity	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
its	O
immunotoxicological	O
potential	O
.	O

Antimicrobial	O
activities	O
of	O
three	O
hydroalcoholic	O
extracts	O
(	O
HAEs	O
)	O
of	O
geopropolis	O
,	O
and	O
hexane	O
and	O
chloroform	O
fractions	O
of	O
one	O
extract	O
,	O
were	O
evaluated	O
using	O
the	O
agar	O
diffusion	O
method	O
and	O
the	O
broth	O
dilution	O
technique	O
.	O

Ethanol	O
(	O
70	O
%	O
,	O
v	O
/	O
v	O
)	O
and	O
chlorhexidine	O
(	O
0	O
.	O
12	O
%	O
,	O
w	O
/	O
w	O
)	O
were	O
used	O
as	O
negative	O
and	O
positive	O
controls	O
,	O
respectively	O
.	O

Total	O
phenol	O
and	O
flavonoid	O
concentrations	O
were	O
assayed	O
by	O
spectrophotometry	O
.	O

Immunotoxicity	O
was	O
evaluated	O
in	O
mice	O
by	O
topical	O
application	O
in	O
the	O
oral	O
cavity	O
followed	O
by	O
quantification	O
of	O
biochemical	O
and	O
immunological	O
parameters	O
,	O
and	O
macro	O
-	O
microscopic	O
analysis	O
of	O
animal	O
organs	O
.	O

Two	O
extracts	O
,	O
HAE	O
-	O
2	O
and	O
HAE	O
-	O
3	O
,	O
showed	O
inhibition	O
zones	O
ranging	O
from	O
9	O
to	O
13	O
mm	O
in	O
diameter	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
C	O
.	O
albicans	O
,	O
but	O
presented	O
no	O
activity	O
against	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

The	O
MBCs	O
for	O
HAE	O
-	O
2	O
and	O
HAE	O
-	O
3	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
6	O
.	O
25	O
mg	O
/	O
mL	O
and	O
12	O
.	O
5	O
mg	O
/	O
mL	O
,	O
respectively	O
.	O

HAE	O
-	O
2	O
was	O
fractionated	O
,	O
and	O
its	O
chloroform	O
fraction	O
had	O
an	O
MBC	O
of	O
14	O
.	O
57	O
mg	O
/	O
mL	O
.	O

HAE	O
-	O
2	O
also	O
exhibited	O
bactericidal	O
effects	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
after	O
3	O
h	O
of	O
treatment	O
.	O

Significant	O
differences	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
total	O
phenol	O
and	O
flavonoid	O
concentrations	O
were	O
observed	O
among	O
the	O
samples	O
.	O

Signs	O
toxic	O
effects	O
were	O
not	O
observed	O
after	O
application	O
of	O
the	O
geopropolis	O
-	O
based	O
gel	O
,	O
but	O
an	O
increase	O
in	O
the	O
production	O
of	O
IL	O
-	O
4	O
and	O
IL	O
-	O
10	O
,	O
anti	O
-	O
inflammatory	O
cytokines	O
,	O
was	O
detected	O
.	O

In	O
summary	O
,	O
geopropolis	O
produced	O
by	O
M	B-bacteria
.	I-bacteria
fasciculata	I-bacteria
can	O
exert	O
antimicrobial	O
action	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
C	O
.	O
albicans	O
,	O
with	O
significant	O
inhibitory	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

The	O
extract	O
with	O
the	O
highest	O
flavonoid	O
concentration	O
,	O
HAE	O
-	O
2	O
,	O
presented	O
the	O
highest	O
antimicrobial	O
activity	O
.	O

In	O
addition	O
,	O
a	O
geopropolis	O
-	O
based	O
gel	O
is	O
not	O
toxic	O
in	O
an	O
animal	O
model	O
and	O
displays	O
anti	O
-	O
inflammatory	O
effect	O
.	O

As	O
part	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
,	O
the	O
oral	O
cavity	O
represents	O
a	O
complex	O
biological	O
system	O
and	O
harbors	O
diverse	O
bacterial	O
species	O
.	O

Unlike	O
the	O
gut	O
microbiota	O
,	O
which	O
is	O
often	O
considered	O
a	O
health	O
asset	O
,	O
studies	O
of	O
the	O
oral	O
commensal	O
microbiota	O
have	O
been	O
largely	O
limited	O
to	O
their	O
implication	O
in	O
oral	O
conditions	O
such	O
as	O
dental	O
caries	O
and	O
periodontal	O
disease	O
.	O

Less	O
emphasis	O
has	O
been	O
given	O
to	O
their	O
potential	O
beneficial	O
roles	O
,	O
especially	O
the	O
protective	O
effects	O
against	O
oral	O
colonization	O
by	O
foreign	O
or	O
pathogenic	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
salivary	O
microbiota	O
derived	O
from	O
healthy	O
human	O
subjects	O
to	O
investigate	O
protective	O
effects	O
against	O
colonization	O
and	O
integration	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
`	O
E	O
-	O
bacteria	O
,	O
an	O
opportunistic	O
bacterial	O
pathogen	O
,	O
into	O
developing	O
or	O
pre	O
-	O
formed	O
salivary	O
biofilms	O
.	O

When	O
co	O
-	O
cultivated	O
in	O
saliva	O
medium	O
,	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
persisted	O
in	O
the	O
planktonic	O
phase	O
,	O
but	O
failed	O
to	O
integrate	O
into	O
the	O
salivary	O
microbial	O
community	O
during	O
biofilm	O
formation	O
.	O

Furthermore	O
,	O
in	O
saliva	O
medium	O
supplemented	O
with	O
sucrose	O
,	O
the	O
oral	O
microbiota	O
inhibited	O
the	O
growth	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
by	O
producing	O
lactic	O
acid	O
.	O

More	O
interestingly	O
,	O
while	O
pre	O
-	O
formed	O
salivary	O
biofilms	O
were	O
able	O
to	O
prevent	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
colonization	O
,	O
the	O
same	O
biofilms	O
recovered	O
from	O
mild	O
chlorhexidine	O
gluconate	O
treatment	O
displayed	O
a	O
shift	O
in	O
microbial	O
composition	O
and	O
showed	O
a	O
drastic	O
reduction	O
in	O
protection	O
.	O

Our	O
study	O
indicates	O
that	O
normal	O
oral	O
communities	O
with	O
balanced	O
microbial	O
compositions	O
could	O
be	O
important	O
in	O
effectively	O
preventing	O
the	O
integration	O
of	O
foreign	O
or	O
pathogenic	O
bacterial	O
species	O
,	O
such	O
as	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
.	O

Probiotics	O
have	O
been	O
proven	O
effective	O
for	O
preventing	O
caries	O
.	O

In	O
contrast	O
,	O
the	O
effect	O
of	O
probiotics	O
on	O
improving	O
oral	O
diseases	O
such	O
as	O
gingivitis	O
,	O
periodontitis	O
and	O
halitosis	O
has	O
been	O
less	O
explored	O
.	O

To	O
perform	O
a	O
screening	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
according	O
to	O
international	O
guidelines	O
for	O
the	O
evaluation	O
of	O
probiotics	O
,	O
in	O
order	O
to	O
select	O
candidate	O
probiotic	O
strains	O
for	O
preventing	O
oral	O
disorders	O
.	O

The	O
strains	O
were	O
isolated	O
from	O
healthy	O
children	O
and	O
were	O
subjected	O
to	O
a	O
variety	O
of	O
in	O
vitro	O
tests	O
in	O
order	O
to	O
show	O
their	O
functionality	O
.	O

The	O
safety	O
of	O
the	O
strains	O
was	O
assessed	O
by	O
determining	O
antibiotic	O
susceptibility	O
and	O
production	O
of	O
lactic	O
acid	O
.	O

Forty	O
-	O
six	O
of	O
the	O
100	O
new	O
isolates	O
were	O
assigned	O
to	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
genera	O
after	O
a	O
biochemical	O
characterization	O
.	O

Most	O
of	O
the	O
new	O
isolated	O
strains	O
seem	O
to	O
be	O
resistant	O
to	O
oral	O
conditions	O
,	O
have	O
great	O
ability	O
to	O
form	O
aggregates	O
and	O
have	O
high	O
antagonistic	O
activity	O
against	O
oral	O
pathogens	O
.	O

None	O
of	O
the	O
strains	O
produced	O
unpleasant	O
volatile	O
compounds	O
.	O

The	O
strains	O
showed	O
high	O
ability	O
to	O
adhere	O
to	O
oral	O
tissues	O
and	O
they	O
do	O
not	O
present	O
any	O
antibiotic	O
resistance	O
.	O

Moreover	O
,	O
an	O
increased	O
risk	O
of	O
developing	O
caries	O
due	O
to	O
their	O
ability	O
to	O
produce	O
lactic	O
acid	O
was	O
discarded	O
in	O
seven	O
pre	O
-	O
selected	O
probiotic	O
candidates	O
.	O

These	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
show	O
promising	O
properties	O
to	O
be	O
used	O
as	O
potential	O
probiotics	O
for	O
improving	O
oral	O
health	O
.	O

Cytotoxic	O
chemotherapy	O
induces	O
changes	O
in	O
the	O
oral	O
microflora	O
that	O
may	O
cause	O
oral	O
and	O
systemic	O
infections	O
in	O
myelosuppressed	O
cancer	O
patients	O
.	O

These	O
complications	O
prompted	O
us	O
to	O
assess	O
the	O
antimicrobial	O
activity	O
of	O
a	O
topical	O
Iseganan	O
HCl	O
mouthwash	O
vs	O
.	O
placebo	O
on	O
the	O
aerobic	O
and	O
facultatively	O
anaerobic	O
oral	O
flora	O
in	O
these	O
patients	O
.	O

Two	O
hundred	O
and	O
twenty	O
-	O
five	O
chemotherapy	O
patients	O
were	O
recruited	O
into	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
,	O
conducted	O
at	O
multiple	O
centers	O
.	O

The	O
study	O
compared	O
the	O
antimicrobial	O
efficacy	O
of	O
Iseganan	O
HCl	O
vs	O
.	O
placebo	O
(	O
95	O
%	O
of	O
the	O
Iseganan	O
and	O
97	O
%	O
of	O
the	O
control	O
group	O
received	O
myeloablative	O
chemotherapy	O
)	O
.	O

Iseganan	O
HCl	O
9	O
mg	O
/	O
3	O
ml	O
was	O
administered	O
as	O
a	O
swish	O
and	O
swallow	O
solution	O
,	O
six	O
times	O
daily	O
for	O
21	O
-	O
28	O
days	O
.	O

Microbial	O
cultures	O
were	O
made	O
before	O
and	O
after	O
the	O
daily	O
Iseganan	O
mouth	O
rinse	O
on	O
the	O
first	O
and	O
final	O
days	O
of	O
chemotherapy	O
.	O

The	O
reduction	O
in	O
total	O
microbial	O
load	O
after	O
the	O
first	O
day	O
of	O
treatment	O
was	O
statistically	O
significant	O
(	O
1	O
.	O
59	O
vs	O
.	O
0	O
.	O
18	O
log10	O
CFU	O
for	O
the	O
Iseganan	O
HCl	O
and	O
placebo	O
groups	O
,	O
respectively	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

Iseganan	O
HCl	O
rinse	O
had	O
a	O
cumulative	O
effect	O
demonstrated	O
by	O
the	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
on	O
the	O
last	O
day	O
of	O
the	O
study	O
(	O
i	O
.	O
e	O
.	O
completion	O
of	O
Iseganan	O
daily	O
treatment	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
reduction	O
was	O
mainly	O
due	O
to	O
decreased	O
densities	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
non	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
,	O
and	O
yeasts	O
.	O

The	O
minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
Iseganan	O
HCl	O
remained	O
the	O
same	O
throughout	O
the	O
course	O
of	O
treatment	O
.	O

Topical	O
Iseganan	O
HCl	O
significantly	O
reduces	O
the	O
total	O
oral	O
aerobic	O
bacterial	O
,	O
streptococcal	B-bacteria
,	O
and	O
yeast	O
load	O
.	O

Its	O
potential	O
as	O
an	O
oral	O
antimicrobial	O
agent	O
in	O
preventing	O
these	O
types	O
of	O
infections	O
is	O
clear	O
.	O

The	O
co	O
-	O
aggregation	O
of	O
oral	O
bacteria	O
leads	O
to	O
their	O
clearance	O
from	O
the	O
oral	O
cavity	O
.	O

Poor	O
oral	O
hygiene	O
and	O
high	O
saliva	O
viscosity	O
are	O
common	O
amongst	O
the	O
elderly	O
;	O
thus	O
,	O
they	O
frequently	O
suffer	O
from	O
pneumonia	O
caused	O
by	O
the	O
aspiration	O
of	O
oral	O
microorganisms	O
.	O

To	O
examine	O
the	O
direct	O
effect	O
of	O
saliva	O
viscosity	O
on	O
the	O
co	O
-	O
aggregation	O
of	O
oral	O
streptococci	B-bacteria
with	O
actinomyces	B-bacteria
.	O

Fifteen	O
oral	O
streptococcal	B-bacteria
and	O
a	O
single	O
actinomyces	B-bacteria
strain	I-bacteria
were	O
used	O
.	O

Co	O
-	O
aggregation	O
was	O
assessed	O
by	O
a	O
visual	O
assay	O
in	O
phosphate	O
buffer	O
and	O
a	O
spectrophotometric	O
assay	O
in	O
the	O
same	O
buffer	O
containing	O
0	O
-	O
60	O
%	O
glycerol	O
or	O
whole	O
saliva	O
.	O

Nine	O
oral	O
streptococci	B-bacteria
co	O
-	O
aggregated	O
with	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
ATCC12104	I-bacteria
in	O
the	O
visual	O
assay	O
and	O
were	O
subsequently	O
used	O
for	O
the	O
spectrophotometric	O
analysis	O
.	O

All	O
tested	O
strains	O
displayed	O
a	O
decrease	O
in	O
co	O
-	O
aggregation	O
with	O
increasing	O
amounts	O
of	O
glycerol	O
in	O
the	O
buffer	O
.	O

The	O
co	O
-	O
aggregation	O
of	O
Streptococcus	B-bacteria
oralis	I-bacteria
with	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
recovered	O
to	O
baseline	O
level	O
following	O
the	O
removal	O
of	O
glycerol	O
.	O

The	O
per	O
cent	O
co	O
-	O
aggregation	O
of	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
with	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
was	O
significantly	O
correlated	O
with	O
the	O
viscosity	O
in	O
unstimulated	O
and	O
stimulated	O
whole	O
saliva	O
samples	O
(	O
correlation	O
coefficients	O
:	O
-	O
0	O
.	O
52	O
and	O
-	O
0	O
.	O
48	O
,	O
respectively	O
)	O
.	O

This	O
study	O
suggests	O
that	O
saliva	O
viscosity	O
affects	O
the	O
co	O
-	O
aggregation	O
of	O
oral	O
streptococci	B-bacteria
with	O
actinomyces	B-bacteria
and	O
that	O
bacterial	O
co	O
-	O
aggregation	O
decreases	O
with	O
increasing	O
saliva	O
viscosity	O
.	O

Ethanol	O
,	O
human	O
papilloma	O
virus	O
(	O
HPV	O
)	O
,	O
and	O
poor	O
oral	O
hygiene	O
are	O
risk	O
factors	O
that	O
have	O
been	O
attributed	O
to	O
oral	O
carcinogenesis	O
.	O

Streptococci	B-bacteria
sp	I-bacteria
and	O
HPV	O
infections	O
are	O
common	O
in	O
the	O
head	O
and	O
neck	O
,	O
often	O
associated	O
with	O
sexual	O
activity	O
.	O

Although	O
HPV	O
is	O
linked	O
to	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
,	O
it	O
is	O
unclear	O
whether	O
there	O
is	O
a	O
similar	O
role	O
for	O
Streptococci	B-bacteria
sp	I-bacteria
.	O

This	O
cell	O
study	O
examines	O
whether	O
Streptococci	B-bacteria
sp	I-bacteria
and	O
HPV	O
-	O
16	O
with	O
exposure	O
to	O
ethyl	O
alcohol	O
(	O
ETOH	O
)	O
can	O
act	O
as	O
cofactors	O
in	O
the	O
malignant	O
transformation	O
of	O
oral	O
keratinocytes	O
.	O

ETOH	O
(	O
0	O
.	O
1	O
%	O
-	O
20	O
%	O
vol	O
/	O
vol	O
)	O
was	O
used	O
to	O
investigate	O
Streptococci	B-bacteria
sp	I-bacteria
attachment	O
with	O
immortalized	O
E6	O
-	O
expressing	O
HPV	O
/	O
HOK	O
-	O
16B	O
cells	O
,	O
human	O
oral	O
buccal	O
keratinocytes	O
,	O
and	O
foreskin	O
keratinocytes	O
.	O

Streptococci	B-bacteria
sp	I-bacteria
(	O
Streptococci	B-bacteria
mutans	I-bacteria
[	I-bacteria
LT11	I-bacteria
]	I-bacteria
)	O
and	O
various	O
strains	O
of	O
acetaldehyde	O
(	O
AA	O
)	O
producer	O
and	O
nonproducer	O
Streptococcus	B-bacteria
salivarius	I-bacteria
(	O
110	O
-	O
1	O
,	O
109	O
-	O
2	O
,	O
101	O
-	O
7	O
,	O
and	O
107	O
-	O
1	O
)	O
and	O
a	O
lactic	O
acid	O
producer	O
bacterium	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
(	O
24	O
-	O
1	O
and	O
25	O
-	O
2	O
)	O
,	O
were	O
examined	O
for	O
interactions	O
with	O
keratinocytes	O
by	O
use	O
of	O
a	O
green	O
dye	O
(	O
percent	O
of	O
cells	O
with	O
colonies	O
after	O
24	O
hours	O
)	O
.	O

Carcinogens	O
,	O
AA	O
,	O
malondialdehyde	O
,	O
DNA	O
damage	O
,	O
and	O
proliferation	O
(	O
5	O
'	O
-	O
bromo	O
-	O
2	O
-	O
deoxyuridine	O
)	O
among	O
keratinocytes	O
were	O
also	O
quantified	O
.	O

AA	O
and	O
malondialdehyde	O
production	O
from	O
permissible	O
Streptococci	B-bacteria
sp	I-bacteria
significantly	O
increased	O
with	O
attachment	O
to	O
keratinocytes	O
,	O
whereas	O
L	B-bacteria
rhamnosus	I-bacteria
did	O
not	O
significantly	O
attach	O
to	O
keratinocytes	O
.	O

This	O
attachment	O
was	O
associated	O
with	O
enhanced	O
levels	O
of	O
AA	O
adduct	O
formation	O
,	O
proliferation	O
(	O
5	O
'	O
-	O
bromo	O
-	O
2	O
-	O
deoxyuridine	O
incorporation	O
)	O
,	O
and	O
enhanced	O
migration	O
through	O
integrin	O
-	O
coated	O
basement	O
membrane	O
by	O
HPV	O
oral	O
keratinocytes	O
,	O
which	O
are	O
characteristics	O
of	O
a	O
malignant	O
phenotype	O
.	O

These	O
cell	O
studies	O
suggest	O
that	O
oral	O
Streptococci	B-bacteria
sp	I-bacteria
and	O
HPV	O
(	O
HPV	O
-	O
16	O
)	O
cooperate	O
to	O
transform	O
oral	O
keratinocytes	O
after	O
low	O
-	O
level	O
ETOH	O
(	O
1	O
%	O
)	O
exposure	O
.	O

These	O
results	O
appear	O
to	O
suggest	O
a	O
significant	O
clinical	O
interaction	O
,	O
but	O
further	O
validation	O
is	O
warranted	O
.	O

To	O
investigate	O
the	O
hypothesis	O
that	O
the	O
rectum	O
may	O
be	O
an	O
important	O
reservoir	O
for	O
vaginal	O
colonisation	O
by	O
Lactobacillus	B-bacteria
species	I-bacteria
.	O

We	O
included	O
60	O
pregnant	O
women	O
aged	O
18	O
-	O
35	O
years	O
and	O
80	O
postmenopausal	O
women	O
aged	O
55	O
-	O
65	O
years	O
in	O
this	O
cross	O
-	O
sectional	O
observational	O

.	O

Participants	O
had	O
to	O
be	O
without	O
clinical	O
signs	O
of	O
vaginal	O
infection	O
and	O
without	O
hormone	O
replacement	O
therapy	O
.	O

Only	O
women	O
with	O
normal	O
vaginal	O
microflora	O
(	O
Nugent	O
scores	O
0	O
-	O
3	O
)	O
were	O
included	O
in	O
the	O
evaluation	O
.	O

The	O
first	O
oral	O
,	O
vaginal	O
,	O
and	O
rectal	O
smears	O
were	O
taken	O
for	O
the	O
enumeration	O
of	O
lactobacilli	B-bacteria
by	O
cultural	O
methods	O
and	O
identification	O
of	O
dominating	O
lactobacilli	B-bacteria
based	O
on	O
multiplex	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

The	O
second	O
oral	O
,	O
vaginal	O
,	O
and	O
rectal	O
smears	O
were	O
taken	O
for	O
molecular	O
lactobacilli	B-bacteria
profiling	O
using	O
PCR	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
.	O

30	O
pregnant	O
and	O
30	O
postmenopausal	O
women	O
were	O
evaluated	O
.	O

On	O
multiplex	O
PCR	O
,	O
99	O
colonies	O
isolated	O
from	O
30	O
pregnant	O
women	O
and	O
37	O
colonies	O
isolated	O
from	O
30	O
postmenopausal	O
women	O
were	O
identified	O
as	O
being	O
members	O
of	O
the	O
genus	O
Lactobacillus	B-bacteria
:	O
50	O
%	O
of	O
pregnant	O
and	O
33	O
%	O
of	O
postmenopausal	O
women	O
had	O
one	O
or	O
more	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
recovered	O
from	O
their	O
oral	O
specimens	O
.	O

Around	O
80	O
%	O
of	O
pregnant	O
and	O
40	O
%	O
of	O
postmenopausal	O
women	O
harboured	O
one	O
or	O
more	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
vagina	O
and	O
rectum	O
.	O

On	O
PCR	O
-	O
DGGE	O
,	O
80	O
%	O
of	O
pregnant	O
and	O
40	O
%	O
of	O
postmenopausal	O
women	O
harboured	O
the	O
same	O
lactobacilli	B-bacteria
isolates	I-bacteria
in	O
both	O
the	O
vagina	O
and	O
rectum	O
.	O

This	O
supports	O
the	O
hypothesis	O
that	O
the	O
rectum	O
may	O
play	O
an	O
important	O
role	O
as	O
a	O
reservoir	O
for	O
some	O
strains	O
of	O
lactobacilli	B-bacteria
that	O
colonise	O
the	O
vagina	O
.	O

Molecular	O
method	O
of	O
16S	O
rRNA	O
sequencing	O
is	O
reported	O
to	O
be	O
helpful	O
in	O
the	O
accurate	O
identification	O
of	O
organisms	O
with	O
ambiguous	O
phenotypic	O
profiles	O
.	O

We	O
analyzed	O
the	O
use	O
of	O
16S	O
rRNA	O
sequencing	O
method	O
to	O
identify	O
clinically	O
significant	O
,	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
bacteria	O
recovered	O
from	O
clinical	O
specimens	O
,	O
and	O
evaluated	O
its	O
role	O
in	O
patient	O
management	O
and	O
consequent	O
clinical	O
outcome	O
.	O

Among	O
the	O
172	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
bacteria	O
recovered	O
over	O
a	O
4	O
-	O
year	O
period	O
,	O
140	O
were	O
gram	O
-	O
positive	O
cocci	O
or	O
gram	O
-	O
negative	O
bacilli	O
;	O
identification	O
by	O
16S	O
rRNA	O
did	O
not	O
play	O
a	O
role	O
in	O
the	O
management	O
of	O
patients	O
infected	O
with	O
these	O
bacteria	O
.	O

From	O
32	O
patients	O
,	O
33	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
gram	O
-	O
positive	O
bacilli	O
were	O
identified	O
;	O
the	O
organisms	O
were	O
mycobacteria	B-bacteria
,	O
Nocardia	B-bacteria
,	O
Tsukamurella	B-bacteria
,	O
Rhodococcus	B-bacteria
,	O
and	O
Gordonia	B-bacteria
.	O

In	O
24	O
patients	O
for	O
whom	O
clinical	O
data	O
were	O
available	O
,	O
results	O
from	O
the	O
16S	O
rRNA	O
sequencing	O
method	O
led	O
to	O
treatment	O
change	O
in	O
14	O
immunocompromised	O
patients	O
(	O
including	O
7	O
hematopoietic	O
stem	O
cell	O
recipients	O
and	O
1	O
liver	O
transplant	O
recipient	O
)	O
.	O

Therapy	O
was	O
modified	O
in	O
9	O
patients	O
,	O
initiated	O
in	O
3	O
patients	O
,	O
and	O
discontinued	O
in	O
2	O
patients	O
.	O

Most	O
patients	O
'	O
therapy	O
was	O
switched	O
to	O
oral	O
antibiotics	O
with	O
discontinuation	O
of	O
intravascular	O
catheters	O
,	O
facilitating	O
early	O
hospital	O
discharge	O
.	O

All	O
14	O
patients	O
were	O
alive	O
30	O
days	O
after	O
infection	O
onset	O
.	O

The	O
present	O
study	O
demonstrates	O
the	O
clinical	O
application	O
of	O
16S	O
rRNA	O
sequencing	O
method	O
to	O
identify	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
mycobacteria	B-bacteria
and	O
other	O
gram	O
-	O
positive	O
bacilli	O
in	O
clinical	O
specimens	O
,	O
particularly	O
in	O
immunocompromised	O
hosts	O
.	O

Denture	O
adhesives	O
increase	O
the	O
retention	O
and	O
stability	O
of	O
dentures	O
in	O
edentulous	O
patients	O
,	O
especially	O
in	O
cases	O
where	O
salivary	O
flow	O
is	O
impaired	O
or	O
in	O
the	O
management	O
of	O
traumatised	O
oral	O
mucosa	O
.	O

The	O
effect	O
of	O
a	O
denture	O
adhesive	O
on	O
the	O
oral	O
flora	O
at	O
different	O
time	O
intervals	O
.	O

Thirty	O
denture	O
-	O
wearing	O
patients	O
were	O
involved	O
in	O
this	O
study	O
.	O

While	O
half	O
of	O
the	O
group	O
received	O
a	O
denture	O
adhesive	O
,	O
the	O
other	O
half	O
did	O
not	O
.	O

At	O
baseline	O
,	O
1	O
and	O
2	O
months	O
after	O
delivering	O
the	O
dentures	O
,	O
smear	O
samples	O
were	O
obtained	O
from	O
the	O
saliva	O
,	O
palate	O
and	O
the	O
dentures	O
.	O

Candida	O
albicans	O
,	O
Candida	O
krusei	O
,	O
Candida	O
glabrata	O
,	O
Candida	O
spp	O
.	O
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Moraxella	B-bacteria
catarrhalis	I-bacteria
,	O
alpha	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
,	O
beta	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
,	O
Pneumococcus	B-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
constellatus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
and	O
yeasts	O
were	O
investigated	O
.	O

The	O
data	O
were	O
statistically	O
analysed	O
using	O
anova	O
and	O
repeated	O
measures	O
.	O

Most	O
types	O
of	O
the	O
micro	O
-	O
organisms	O
were	O
not	O
seen	O
and	O
could	O
not	O
be	O
analysed	O
statistically	O
except	O
alpha	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
and	O
C	O
.	O
albicans	O
.	O

No	O
statistically	O
significant	O
difference	O
was	O
found	O
for	O
alpha	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
and	O
C	O
.	O
albicans	O
in	O
saliva	O
,	O
palate	O
and	O
the	O
denture	O
at	O
all	O
time	O
intervals	O
.	O

Prolonged	O
use	O
of	O
the	O
denture	O
adhesive	O
tested	O
up	O
to	O
2	O
months	O
did	O
not	O
yield	O
to	O
increase	O
in	O
micro	O
-	O
organisms	O
of	O
the	O
oral	O
flora	O
.	O

The	O
antimicrobial	O
activity	O
of	O
four	O
labdane	O
-	O
type	O
diterpenes	O
isolated	O
from	O
the	O
oleoresin	O
of	O
Copaifera	O
langsdorffii	O
as	O
well	O
as	O
of	O
two	O
commercially	O
available	O
diterpenes	O
(	O
sclareol	O
and	O
manool	O
)	O
was	O
investigated	O
against	O
a	O
representative	O
panel	O
of	O
microorganisms	O
responsible	O
for	O
periodontitis	O
.	O

Among	O
all	O
the	O
evaluated	O
compounds	O
,	O
(	O
-	O
)	O
-	O
copalic	O
acid	O
(	O
CA	O
)	O
was	O
the	O
most	O
active	O
,	O
displaying	O
a	O
very	O
promising	O
MIC	O
value	O
(	O
3	O
.	O
1	O
microg	O
mL	O
-	O
1	O
;	O
10	O
.	O
2	O
microM	O
)	O
against	O
the	O
key	O
pathogen	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
involved	O
in	O
this	O
infectious	O
disease	O
.	O

Moreover	O
,	O
CA	O
did	O
not	O
exhibit	O
cytotoxicity	O
when	O
tested	O
in	O
human	O
fibroblasts	O
.	O

Time	O
-	O
kill	O
curve	O
assays	O
performed	O
with	O
CA	O
against	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
revealed	O
that	O
this	O
compound	O
only	O
inhibited	O
the	O
growth	O
of	O
the	O
inoculums	O
in	O
the	O
first	O
12	O
h	O
(	O
bacteriostatic	O
effect	O
)	O
.	O

However	O
,	O
its	O
bactericidal	O
effect	O
was	O
clearly	O
noted	O
thereafter	O
(	O
between	O
12	O
and	O
24	O
h	O
)	O
.	O

It	O
was	O
also	O
possible	O
to	O
verify	O
an	O
additive	O
effect	O
when	O
CA	O
and	O
chlorhexidine	O
dihydrochloride	O
(	O
CHD	O
,	O
positive	O
control	O
)	O
were	O
associated	O
at	O
their	O
MBC	O
values	O
.	O

The	O
time	O
curve	O
profile	O
resulting	O
from	O
this	O
combination	O
showed	O
that	O
this	O
association	O
needed	O
only	O
six	O
hours	O
for	O
the	O
bactericidal	O
effect	O
to	O
be	O
noted	O
.	O

In	O
summary	O
,	O
CA	O
has	O
shown	O
to	O
be	O
an	O
important	O
metabolite	O
for	O
the	O
control	O
of	O
periodontal	O
diseases	O
.	O

Moreover	O
,	O
the	O
use	O
of	O
standardized	O
extracts	O
based	O
on	O
copaiba	O
oleoresin	O
with	O
high	O
CA	O
contents	O
can	O
be	O
an	O
important	O
strategy	O
in	O
the	O
development	O
of	O
novel	O
oral	O
care	O
products	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
investigate	O
the	O
antimicrobial	O
activity	O
of	O
thyme	O
essential	O
oil	O
against	O
clinical	O
multidrug	O
resistant	O
strains	O
of	O
Staphylococcus	B-bacteria
,	O
Enterococcus	B-bacteria
,	O
Escherichia	B-bacteria
,	O
and	O
Pseudomonas	B-bacteria
genus	I-bacteria
.	O

The	O
antibacterial	O
activity	O
of	O
oil	O
was	O
tested	O
against	O
standard	O
strains	O
of	O
bacteria	O
and	O
120	O
clinical	O
strains	O
isolated	O
from	O
patients	O
with	O
infections	O
of	O
the	O
oral	O
cavity	O
,	O
abdominal	O
cavity	O
,	O
respiratory	O
and	O
genitourinary	O
tracts	O
,	O
skin	O
,	O
and	O
from	O
the	O
hospital	O
environment	O
.	O

Agar	O
diffusion	O
was	O
used	O
to	O
determine	O
the	O
microbial	O
growth	O
inhibition	O
of	O
bacterial	O
growth	O
at	O
various	O
concentrations	O
of	O
oil	O
from	O
Thymus	O
vulgaris	O
.	O

Susceptibility	O
testing	O
to	O
antibiotics	O
was	O
carried	O
out	O
using	O
disk	O
diffusion	O
.	O

Thyme	O
essential	O
oil	O
strongly	O
inhibited	O
the	O
growth	O
of	O
the	O
clinical	O
strains	O
of	O
bacteria	O
tested	O
.	O

The	O
use	O
of	O
phytopharmaceuticals	O
based	O
on	O
an	O
investigated	O
essential	O
oil	O
from	O
thyme	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
various	O
human	O
infections	O
may	O
be	O
reasonable	O
.	O

Candida	O
albicans	O
is	O
a	O
commensal	O
colonizer	O
of	O
the	O
gastrointestinal	O
tract	O
of	O
humans	O
,	O
where	O
it	O
coexists	O
with	O
highly	O
diverse	O
bacterial	O
communities	O
.	O

It	O
is	O
not	O
clear	O
whether	O
this	O
interaction	O
limits	O
or	O
promotes	O
the	O
potential	O
of	O
C	O
.	O
albicans	O
to	O
become	O
an	O
opportunistic	O
pathogen	O
.	O

Here	O
we	O
investigate	O
the	O
interaction	O
between	O
C	O
.	O
albicans	O
and	O
three	O
species	O
of	O
streptococci	B-bacteria
from	O
the	O
viridans	O
group	O
,	O
which	O
are	O
ubiquitous	O
and	O
abundant	O
oral	O
commensal	O
bacteria	O
.	O

The	O
ability	O
of	O
C	O
.	O
albicans	O
to	O
form	O
biofilm	O
with	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
or	O
Streptococcus	B-bacteria
gordonii	I-bacteria
was	O
investigated	O
using	O
flow	O
cell	O
devices	O
that	O
allow	O
abiotic	O
biofilm	O
formation	O
under	O
salivary	O
flow	O
.	O

In	O
addition	O
,	O
we	O
designed	O
a	O
novel	O
flow	O
cell	O
system	O
that	O
allows	O
mucosal	O
biofilm	O
formation	O
under	O
conditions	O
that	O
mimic	O
the	O
environment	O
in	O
the	O
oral	O
and	O
esophageal	O
mucosae	O
.	O

It	O
was	O
observed	O
that	O
C	O
.	O
albicans	O
and	O
streptococci	B-bacteria
formed	O
a	O
synergistic	O
partnership	O
where	O
C	O
.	O
albicans	O
promoted	O
the	O
ability	O
of	O
streptococci	B-bacteria
to	O
form	O
biofilm	O
on	O
abiotic	O
surfaces	O
or	O
on	O
the	O
surface	O
of	O
an	O
oral	O
mucosa	O
analogue	O
.	O

The	O
increased	O
ability	O
of	O
streptococci	B-bacteria
to	O
form	O
biofilm	O
in	O
the	O
presence	O
of	O
C	O
.	O
albicans	O
could	O
not	O
be	O
explained	O
by	O
a	O
growth	O
-	O
stimulatory	O
effect	O
since	O
the	O
streptococci	B-bacteria
were	O
unaffected	O
in	O
their	O
growth	O
in	O
planktonic	O
coculture	O
with	O
C	O
.	O
albicans	O
.	O

Conversely	O
,	O
the	O
presence	O
of	O
streptococci	B-bacteria
increased	O
the	O
ability	O
of	O
C	O
.	O
albicans	O
to	O
invade	O
organotypic	O
models	O
of	O
the	O
oral	O
and	O
esophageal	O
mucosae	O
under	O
conditions	O
of	O
salivary	O
flow	O
.	O

Moreover	O
,	O
characterization	O
of	O
mucosal	O
invasion	O
by	O
the	O
biofilm	O
microorganisms	O
suggested	O
that	O
the	O
esophageal	O
mucosa	O
is	O
more	O
permissive	O
to	O
invasion	O
than	O
the	O
oral	O
mucosa	O
.	O

In	O
summary	O
,	O
C	O
.	O
albicans	O
and	O
commensal	O
oral	O
streptococci	B-bacteria
display	O
a	O
synergistic	O
interaction	O
with	O
implications	O
for	O
the	O
pathogenic	O
potential	O
of	O
C	O
.	O
albicans	O
in	O
the	O
upper	O
gastrointestinal	O
tract	O
.	O

Propionibacterium	B-bacteria
acnes	I-bacteria
is	O
a	O
Gram	O
-	O
positive	O
bacterium	O
that	O
forms	O
part	O
of	O
the	O
normal	O
flora	O
of	O
the	O
skin	O
,	O
oral	O
cavity	O
,	O
large	O
intestine	O
,	O
the	O
conjunctiva	O
and	O
the	O
external	O
ear	O
canal	O
.	O

Although	O
primarily	O
recognized	O
for	O
its	O
role	O
in	O
acne	O
,	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
is	O
an	O
opportunistic	O
pathogen	O
,	O
causing	O
a	O
range	O
of	O
postoperative	O
and	O
device	O
-	O
related	O
infections	O
.	O

These	O
include	O
infections	O
of	O
the	O
bones	O
and	O
joints	O
,	O
mouth	O
,	O
eye	O
and	O
brain	O
.	O

Device	O
-	O
related	O
infections	O
include	O
those	O
of	O
joint	O
prostheses	O
,	O
shunts	O
and	O
prosthetic	O
heart	O
valves	O
.	O

P	B-bacteria
.	I-bacteria
acnes	I-bacteria
may	O
play	O
a	O
role	O
in	O
other	O
conditions	O
,	O
including	O
inflammation	O
of	O
the	O
prostate	O
leading	O
to	O
cancer	O
,	O
SAPHO	O
(	O
synovitis	O
,	O
acne	O
,	O
pustulosis	O
,	O
hyperostosis	O
,	O
osteitis	O
)	O
syndrome	O
,	O
sarcoidosis	O
and	O
sciatica	O
.	O

If	O
an	O
active	O
role	O
in	O
these	O
conditions	O
is	O
established	O
there	O
are	O
major	O
implications	O
for	O
diagnosis	O
,	O
treatment	O
and	O
protection	O
.	O

Genome	O
sequencing	O
of	O
the	O
organism	O
has	O
provided	O
an	O
insight	O
into	O
the	O
pathogenic	O
potential	O
and	O
virulence	O
of	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
.	O

The	O
antibacterial	O
activity	O
of	O
Casbane	O
Diterpene	O
(	O
CD	O
)	O
was	O
evaluated	O
in	O
vitro	O
against	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

The	O
viability	O
of	O
planktonic	O
cells	O
was	O
analysed	O
by	O
susceptibility	O
tests	O
(	O
MIC	O
and	O
MBC	O
)	O
and	O
antibiofilm	O
action	O
was	O
assayed	O
.	O

The	O
minimal	O
inhibitory	O
and	O
bactericidal	O
concentrations	O
(	O
MIC	O
and	O
MBC	O
)	O
of	O
oral	O
Streptococcus	B-bacteria
were	O
evaluated	O
through	O
microdilution	O
tests	O
.	O

To	O
assay	O
antibiofilm	O
activity	O
,	O
biofilms	O
were	O
generated	O
on	O
96	O
-	O
wells	O
polystyrene	O
plates	O
under	O
the	O
presence	O
of	O
CD	O
and	O
quantified	O
by	O
a	O
crystal	O
violet	O
technique	O
and	O
colonies	O
forming	O
units	O
counting	O
.	O

The	O
CD	O
isolated	O
from	O
Croton	O
nepetaefolius	O
showed	O
antimicrobial	O
effect	O
on	O
planktonic	O
forms	O
and	O
biofilms	O
of	O
oral	O
pathogens	O
,	O
with	O
MIC	O
values	O
of	O
62	O
.	O
5	O
mug	O
/	O
mL	O
against	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
values	O
between	O
125	O
and	O
500	O
mug	O
/	O
mL	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

CD	O
showed	O
an	O
inhibitory	O
effect	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
formation	O
at	O
250	O
mug	O
/	O
mL	O
,	O
and	O
a	O
decrease	O
on	O
viable	O
cell	O
of	O
94	O
.	O
28	O
%	O
compared	O
to	O
the	O
normal	O
biofilm	O
growth	O
.	O

The	O
compound	O
CD	O
can	O
be	O
considered	O
as	O
a	O
promising	O
molecule	O
for	O
the	O
treatment	O
against	O
oral	O
pathogens	O
responsible	O
for	O
dental	O
biofilm	O
.	O

The	O
study	O
of	O
initial	O
microbial	O
colonization	O
on	O
dental	O
surfaces	O
is	O
a	O
field	O
of	O
intensive	O
research	O
because	O
of	O
the	O
aetiological	O
role	O
of	O
biofilms	O
in	O
oral	O
diseases	O
.	O

Most	O
previous	O
studies	O
of	O
de	O
novo	O
accumulation	O
and	O
composition	O
of	O
dental	O
biofilms	O
in	O
vivo	O
do	O
not	O
differentiate	O
between	O
biofilms	O
formed	O
during	O
day	O
and	O
night	O
.	O

This	O
study	O
hypothesized	O
that	O
there	O
is	O
a	O
diurnal	O
variation	O
in	O
the	O
rate	O
of	O
accumulation	O
of	O
bacteria	O
on	O
solid	O
surfaces	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
situ	O
biofilm	O
from	O
healthy	O
individuals	O
was	O
collected	O
for	O
12	O
h	O
during	O
day	O
and	O
night	O
,	O
respectively	O
,	O
subjected	O
to	O
fluorescent	O
in	O
situ	O
hybridization	O
and	O
visualized	O
using	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Analysis	O
of	O
the	O
biofilms	O
using	O
stereological	O
methods	O
and	O
digital	O
image	O
analysis	O
revealed	O
a	O
consistent	O
statistically	O
significant	O
difference	O
between	O
both	O
the	O
total	O
number	O
of	O
bacteria	O
and	O
the	O
biovolume	O
in	O
the	O
two	O
12	O
-	O
h	O
groups	O
(	O
p	O
=	O
0	O
.	O
012	O
)	O
,	O
with	O
the	O
highest	O
accumulation	O
of	O
bacteria	O
during	O
daytime	O
(	O
a	O
factor	O
of	O
8	O
.	O
8	O
and	O
6	O
.	O
1	O
higher	O
,	O
respectively	O
)	O
.	O

Hybridization	O
with	O
probes	O
specific	O
for	O
streptococci	B-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
indicated	O
a	O
higher	O
proportion	O
of	O
streptococci	B-bacteria
in	O
biofilms	O
grown	O
during	O
daytime	O
as	O
compared	O
to	O
night	O
-	O
time	O
.	O

No	O
differences	O
could	O
be	O
observed	O
for	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
.	O

The	O
degree	O
of	O
microbial	O
coverage	O
and	O
the	O
bacterial	O
composition	O
varied	O
considerably	O
between	O
different	O
individuals	O
.	O

The	O
data	O
provide	O
firm	O
evidence	O
that	O
initial	O
biofilm	O
formation	O
decreases	O
during	O
the	O
night	O
,	O
which	O
may	O
reflect	O
differences	O
in	O
the	O
availability	O
of	O
salivary	O
nutrients	O
.	O

This	O
finding	O
is	O
of	O
significant	O
importance	O
when	O
studying	O
population	O
dynamics	O
during	O
experimental	O
dental	O
biofilm	O
formation	O
.	O

The	O
oral	O
cavity	O
serves	O
as	O
a	O
reservoir	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
for	O
infection	O
of	O
the	O
lower	O
respiratory	O
tract	O
and	O
cross	O
-	O
infection	O
to	O
other	O
patients	O
.	O

This	O
systematic	O
review	O
was	O
designed	O
to	O
examine	O
the	O
effectiveness	O
of	O
oral	O
health	O
promotion	O
interventions	O
on	O
this	O
pathogen	O
.	O

The	O
PubMed	O
,	O
ISI	O
Web	O
of	O
Science	O
,	O
and	O
Cochrane	O
Library	O
databases	O
were	O
searched	O
for	O
clinical	O
trials	O
assessing	O
the	O
effect	O
of	O
oral	O
health	O
promotion	O
interventions	O
on	O
oral	O
and	O
oropharyngeal	O
carriage	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
.	O

Oral	O
health	O
promotion	O
interventions	O
on	O
oral	O
reservoirs	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
both	O
systemically	O
healthy	O
and	O
medically	O
compromised	O
groups	O
consisted	O
of	O
oral	O
hygiene	O
interventions	O
only	O
.	O

There	O
was	O
a	O
lack	O
of	O
evidence	O
pertaining	O
to	O
the	O
effectiveness	O
of	O
mechanical	O
oral	O
hygiene	O
interventions	O
against	O
this	O
pathogen	O
.	O

Chlorhexidine	O
delivered	O
in	O
oral	O
hygiene	O
products	O
such	O
as	O
mouthrinses	O
,	O
gels	O
,	O
and	O
sprays	O
appeared	O
to	O
have	O
some	O
utility	O
against	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
although	O
some	O
studies	O
found	O
equivocal	O
effects	O
.	O

There	O
was	O
a	O
dearth	O
of	O
studies	O
investigating	O
the	O
efficacy	O
of	O
other	O
chemical	O
agents	O
.	O

Although	O
many	O
chemical	O
agents	O
contained	O
in	O
oral	O
hygiene	O
products	O
have	O
proven	O
in	O
vitro	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
their	O
clinical	O
effectiveness	O
and	O
potential	O
role	O
as	O
adjuncts	O
or	O
alternative	O
therapies	O
to	O
conventional	O
treatment	O
remain	O
to	O
be	O
confirmed	O
by	O
further	O
high	O
-	O
quality	O
randomized	O
controlled	O
trials	O
.	O

There	O
is	O
little	O
information	O
about	O
the	O
microbiologic	O
profiles	O
of	O
periodontal	O
lesions	O
in	O
Papillon	O
-	O
Lefevre	O
syndrome	O
(	O
PLS	O
)	O
and	O
the	O
significance	O
of	O
bacteria	O
in	O
the	O
pathogenesis	O
of	O
periodontitis	O
in	O
these	O
patients	O
.	O

This	O
comprehensive	O
analysis	O
of	O
the	O
subgingival	O
microbiota	O
in	O
patients	O
with	O
PLS	O
used	O
16S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
clonal	O
analysis	O
and	O
the	O
16S	O
rRNA	O
-	O
based	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
.	O

Thirteen	O
patients	O
with	O
PLS	O
from	O
seven	O
unrelated	O
families	O
volunteered	O
for	O
this	O
microbiologic	O
study	O
.	O

Subgingival	O
plaque	O
was	O
collected	O
with	O
sterile	O
paper	O
points	O
from	O
multiple	O
sites	O
with	O
>	O
/	O
=	O
5	O
mm	O
probing	O
depth	O
,	O
and	O
whole	O
genomic	O
DNA	O
was	O
extracted	O
.	O

The	O
16S	O
rRNA	O
genes	O
were	O
amplified	O
,	O
cloned	O
,	O
and	O
sequenced	O
.	O

The	O
samples	O
were	O
then	O
probed	O
for	O
approximately	O
300	O
predominant	O
oral	O
bacterial	O
species	O
using	O
the	O
HOMIM	O
.	O

The	O
most	O
commonly	O
detected	O
phylotypes	O
in	O
the	O
clonal	O
analysis	O
were	O
Gemella	B-bacteria
morbillorum	I-bacteria
,	O
Gemella	B-bacteria
haemolysans	I-bacteria
,	O
Granulicatella	B-bacteria
adiacens	I-bacteria
,	O
Lachnospiraceae	B-bacteria
OT	I-bacteria
100	I-bacteria
(	O
EI074	B-bacteria
)	O
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Selenomonas	B-bacteria
noxia	I-bacteria
,	O
and	O
Veillonella	B-bacteria
parvula	I-bacteria
.	O

As	O
a	O
group	O
,	O
streptococci	B-bacteria
were	O
commonly	O
detected	O
in	O
these	O
individuals	O
.	O

In	O
the	O
HOMIM	O
analysis	O
,	O
a	O
total	O
of	O
170	O
bacterial	O
species	O
/	O
phylotypes	O
were	O
detected	O
,	O
with	O
a	O
range	O
of	O
40	O
to	O
80	O
species	O
per	O
patient	O
with	O
PLS	O
.	O

Of	O
these	O
,	O
12	O
bacterial	O
species	O
were	O
detected	O
in	O
medium	O
to	O
high	O
levels	O
in	O
>	O
/	O
=	O
50	O
%	O
of	O
the	O
individuals	O
.	O

The	O
high	O
-	O
frequency	O
strains	O
were	O
clustered	O
into	O
eight	O
groups	O
:	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Campylobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Capnocytophaga	B-bacteria
granulosa	I-bacteria
,	O
G	B-bacteria
.	I-bacteria
morbillorum	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
,	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
,	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
.	O

The	O
subgingival	O
microbiota	O
in	O
PLS	O
is	O
diverse	O
.	O

Periodontal	O
pathogens	O
commonly	O
associated	O
with	O
chronic	O
and	O
aggressive	O
periodontitis	O
and	O
opportunistic	O
pathogens	O
may	O
be	O
associated	O
with	O
the	O
development	O
of	O
severe	O
periodontitis	O
in	O
patients	O
with	O
PLS	O
.	O

In	O
this	O
study	O
,	O
the	O
association	O
of	O
red	O
complex	O
(	O
RC	O
)	O
bacteria	O
that	O
include	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
with	O
acute	O
,	O
exacerbated	O
or	O
chronic	O
apical	O
periodontitis	O
was	O
evaluated	O
.	O

Seventy	O
-	O
one	O
patients	O
with	O
periapical	O
disease	O
were	O
evaluated	O
by	O
clinical	O
examination	O
and	O
microbiological	O
samples	O
obtained	O
from	O
the	O
root	O
canals	O
were	O
analyzed	O
by	O
a	O
polymerase	O
chain	O
reaction	O
assay	O
.	O

Twenty	O
-	O
one	O
(	O
29	O
.	O
6	O
%	O
)	O
samples	O
were	O
positive	O
for	O
RC	O
bacteria	O
,	O
with	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
being	O
detected	O
in	O
14	O
(	O
19	O
.	O
7	O
%	O
)	O
,	O
10	O
(	O
14	O
.	O
1	O
%	O
)	O
and	O
6	O
(	O
8	O
.	O
5	O
%	O
)	O
samples	O
,	O
respectively	O
.	O

RC	O
bacteria	O
were	O
mainly	O
associated	O
with	O
acute	O
apical	O
periodontitis	O
(	O
29	O
.	O
2	O
%	O
)	O
and	O
phoenix	O
abscess	O
(	O
63	O
.	O
2	O
%	O
)	O
,	O
while	O
they	O
were	O
only	O
sporadically	O
detected	O
(	O
7	O
.	O
1	O
%	O
)	O
in	O
patients	O
with	O
chronic	O
apical	O
periodontitis	O
.	O

Generally	O
,	O
RC	O
bacteria	O
were	O
associated	O
with	O
pain	O
and	O
a	O
higher	O
frequency	O
of	O
intracanalar	O
/	O
intrasulcular	O
pus	O
drainage	O
.	O

Involvement	O
of	O
RC	O
bacteria	O
in	O
symptomatic	O
periapical	O
disease	O
should	O
be	O
suspected	O
in	O
the	O
presence	O
of	O
particularly	O
severe	O
clinical	O
pain	O
and	O
pus	O
drainage	O
.	O

Enteromorpha	O
linza	O
,	O
a	O
green	O
alga	O
,	O
has	O
been	O
recognized	O
as	O
a	O
potential	O
source	O
of	O
natural	O
antimicrobial	O
and	O
antifungal	O
compounds	O
.	O

We	O
previously	O
reported	O
that	O
an	O
E	O
.	O
linza	O
extract	O
strongly	O
inhibited	O
the	O
growth	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
principal	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
clinical	O
effect	O
of	O
a	O
mouth	O
rinse	O
containing	O
the	O
E	O
.	O
linza	O
extract	O
on	O
gingivitis	O
disease	O
,	O
as	O
measured	O
by	O
the	O
plaque	O
index	O
(	O
PI	O
)	O
,	O
gingival	O
index	O
(	O
GI	O
)	O
,	O
and	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
,	O
and	O
on	O
two	O
bacterial	O
strains	O
(	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
,	O
in	O
comparison	O
with	O
Listerine	O
(	O
(	O
R	O
)	O
)	O
(	O
Listerine	O
-	O
Korea	O
,	O
Seoul	O
,	O
Korea	O
)	O
,	O
which	O
was	O
used	O
as	O
a	O
positive	O
control	O
.	O

In	O
total	O
,	O
55	O
subjects	O
were	O
recruited	O
into	O
active	O
participation	O
in	O
this	O
clinical	O
study	O
.	O

The	O
PI	O
,	O
GI	O
,	O
BOP	O
,	O
and	O
bacterial	O
strains	O
were	O
then	O
evaluated	O
over	O
a	O
test	O
period	O
of	O
6	O
weeks	O
.	O

After	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
6	O
weeks	O
,	O
the	O
same	O
clinical	O
indices	O
were	O
recorded	O
,	O
and	O
the	O
levels	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
quantified	O
via	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
.	O

At	O
the	O
end	O
of	O
the	O
study	O
,	O
the	O
group	O
using	O
the	O
mouth	O
rinse	O
containing	O
the	O
E	O
.	O
linza	O
extract	O
evidenced	O
significant	O
reductions	O
in	O
the	O
clinical	O
indices	O
(	O
PI	O
,	O
GI	O
,	O
and	O
BOP	O
)	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
compared	O
with	O
baseline	O
values	O
.	O

Moreover	O
,	O
E	O
.	O
linza	O
extract	O
containing	O
mouth	O
rinse	O
produced	O
effects	O
similar	O
to	O
those	O
of	O
Listerine	O
.	O

Overall	O
,	O
these	O
results	O
indicate	O
that	O
a	O
mouth	O
rinse	O
containing	O
E	O
.	O
linza	O
extract	O
significantly	O
reduces	O
plaque	O
,	O
improves	O
the	O
condition	O
of	O
gingival	O
tissues	O
,	O
and	O
reduces	O
bleeding	O
.	O

Additionally	O
,	O
E	O
.	O
linza	O
extract	O
mouth	O
rinse	O
significantly	O
inhibits	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
.	O

Thus	O
,	O
this	O
clinical	O
study	O
demonstrated	O
that	O
the	O
twice	O
-	O
daily	O
use	O
of	O
an	O
E	O
.	O
linza	O
extract	O
mouth	O
rinse	O
can	O
inhibit	O
and	O
prevent	O
gingivitis	O
.	O

Modifications	O
of	O
titanium	O
(	O
Ti	O
)	O
implant	O
surfaces	O
have	O
a	O
significant	O
effect	O
on	O
early	O
biofilm	O
formation	O
and	O
the	O
outcome	O
of	O
implant	O
procedures	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
role	O
of	O
plasma	O
proteins	O
and	O
electrostatic	O
forces	O
in	O
the	O
adhesion	O
mechanism	O
of	O
oral	O
bacteria	O
to	O
modified	O
Ti	O
surfaces	O
.	O

Ti	O
discs	O
with	O
three	O
different	O
types	O
of	O
surface	O
modifications	O
,	O
machined	O
,	O
acid	O
-	O
etched	O
,	O
and	O
acid	O
-	O
etched	O
and	O
blasted	O
,	O
were	O
examined	O
for	O
adhesion	O
of	O
oral	O
bacteria	O
:	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Following	O
pretreatment	O
of	O
the	O
Ti	O
with	O
ion	O
rich	O
solutions	O
or	O
coating	O
by	O
human	O
serum	O
albumin	O
or	O
fibronectin	O
,	O
bacterial	O
adhesion	O
was	O
examined	O
by	O
scanning	O
electron	O
microscopy	O
and	O
assessed	O
quantitatively	O
by	O
DNA	O
analysis	O
.	O

Ti	O
coating	O
by	O
proteins	O
as	O
well	O
as	O
bacterial	O
adhesion	O
and	O
their	O
interrelationships	O
were	O
further	O
investigated	O
through	O
confocal	O
scanning	O
laser	O
microscopy	O
.	O

Acid	O
-	O
etched	O
and	O
blasted	O
Ti	O
surfaces	O
exhibited	O
significantly	O
higher	O
amounts	O
of	O
bacteria	O
adhesion	O
than	O
the	O
other	O
two	O
surfaces	O
.	O

Calcium	O
was	O
found	O
to	O
serve	O
as	O
a	O
bridging	O
agent	O
in	O
the	O
adhesion	O
process	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
Ti	O
surfaces	O
.	O

Although	O
albumin	O
coating	O
of	O
the	O
Ti	O
reduced	O
the	O
adhesion	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
all	O
surfaces	O
,	O
it	O
had	O
no	O
influence	O
on	O
the	O
adhesion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Coating	O
the	O
Ti	O
with	O
fibronectin	O
enhanced	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adhesion	O
.	O

Bacterial	O
adhesion	O
to	O
Ti	O
surfaces	O
is	O
roughness	O
-	O
dependent	O
,	O
and	O
the	O
adhesion	O
mechanism	O
is	O
influenced	O
by	O
ions	O
and	O
proteins	O
of	O
the	O
initial	O
coating	O
derived	O
from	O
the	O
blood	O
.	O

Microbial	O
communities	O
inhabiting	O
human	O
mouth	O
are	O
associated	O
with	O
oral	O
health	O
and	O
disease	O
.	O

Previous	O
studies	O
have	O
indicated	O
the	O
general	O
prevalence	O
of	O
adult	O
gingivitis	O
in	O
China	O
to	O
be	O
high	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
characterize	O
in	O
depth	O
the	O
oral	O
microbiota	O
of	O
Chinese	O
adults	O
with	O
or	O
without	O
gingivitis	O
,	O
by	O
defining	O
the	O
microbial	O
phylogenetic	O
diversity	O
and	O
community	O
-	O
structure	O
using	O
highly	O
paralleled	O
pyrosequencing	O
.	O

Six	O
non	O
-	O
smoking	O
Chinese	O
,	O
three	O
with	O
and	O
three	O
without	O
gingivitis	O
(	O
age	O
range	O
21	O
-	O
39	O
years	O
,	O
4	O
females	O
and	O
2	O
males	O
)	O
were	O
enrolled	O
in	O
the	O
present	O
cross	O
-	O
sectional	O
study	O
.	O

Gingival	O
parameters	O
of	O
inflammation	O
and	O
bleeding	O
on	O
probing	O
were	O
characterized	O
by	O
a	O
clinician	O
using	O
the	O
Mazza	O
Gingival	O
Index	O
(	O
MGI	O
)	O
.	O

Plaque	O
(	O
sampled	O
separately	O
from	O
four	O
different	O
oral	O
sites	O
)	O
and	O
salivary	O
samples	O
were	O
obtained	O
from	O
each	O
subject	O
.	O

Sequences	O
and	O
relative	O
abundance	O
of	O
the	O
bacterial	O
16	O
S	O
rDNA	O
PCR	O
-	O
amplicons	O
were	O
determined	O
via	O
pyrosequencing	O
that	O
produced	O
400	O
bp	O
-	O
long	O
reads	O
.	O

The	O
sequence	O
data	O
were	O
analyzed	O
via	O
a	O
computational	O
pipeline	O
customized	O
for	O
human	O
oral	O
microbiome	O
analyses	O
.	O

Furthermore	O
,	O
the	O
relative	O
abundances	O
of	O
selected	O
microbial	O
groups	O
were	O
validated	O
using	O
quantitative	O
PCR	O
.	O

The	O
oral	O
microbiomes	O
from	O
gingivitis	O
and	O
healthy	O
subjects	O
could	O
be	O
distinguished	O
based	O
on	O
the	O
distinct	O
community	O
structures	O
of	O
plaque	O
microbiomes	O
,	O
but	O
not	O
the	O
salivary	O
microbiomes	O
.	O

Contributions	O
of	O
community	O
members	O
to	O
community	O
structure	O
divergence	O
were	O
statistically	O
accessed	O
at	O
the	O
phylum	O
,	O
genus	O
and	O
species	O
-	O
like	O
levels	O
.	O

Eight	O
predominant	O
taxa	O
were	O
found	O
associated	O
with	O
gingivitis	O
:	O
TM7	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
Selenomonas	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Lautropia	B-bacteria
,	O
and	O
Haemophilus	B-bacteria
.	O

Furthermore	O
,	O
98	O
species	O
-	O
level	O
OTUs	O
were	O
identified	O
to	O
be	O
gingivitis	O
-	O
associated	O
,	O
which	O
provided	O
microbial	O
features	O
of	O
gingivitis	O
at	O
a	O
species	O
resolution	O
.	O

Finally	O
,	O
for	O
the	O
two	O
selected	O
genera	O
Streptococcus	B-bacteria
and	O
Fusobacterium	B-bacteria
,	O
Real	O
-	O
Time	O
PCR	O
based	O
quantification	O
of	O
relative	O
bacterial	O
abundance	O
validated	O
the	O
pyrosequencing	O
-	O
based	O
results	O
.	O

This	O
methods	O
study	O
suggests	O
that	O
oral	O
samples	O
from	O
this	O
patient	O
population	O
of	O
gingivitis	O
can	O
be	O
characterized	O
via	O
plaque	O
microbiome	O
by	O
pyrosequencing	O
the	O
16	O
S	O
rDNA	O
genes	O
.	O

Further	O
studies	O
that	O
characterize	O
serial	O
samples	O
from	O
subjects	O
(	O
longitudinal	O
study	O
design	O
)	O
with	O
a	O
larger	O
population	O
size	O
may	O
provide	O
insight	O
into	O
the	O
temporal	O
and	O
ecological	O
features	O
of	O
oral	O
microbial	O
communities	O
in	O
clinically	O
-	O
defined	O
states	O
of	O
gingivitis	O
.	O

There	O
is	O
growing	O
evidence	O
that	O
the	O
role	O
of	O
lipids	O
in	O
innate	O
immunity	O
is	O
more	O
important	O
than	O
previously	O
realized	O
.	O

How	O
lipids	O
interact	O
with	O
bacteria	O
to	O
achieve	O
a	O
level	O
of	O
protection	O
,	O
however	O
,	O
is	O
still	O
poorly	O
understood	O
.	O

To	O
begin	O
to	O
address	O
the	O
mechanisms	O
of	O
antibacterial	O
activity	O
,	O
we	O
determined	O
MICs	O
and	O
minimum	O
bactericidal	O
concentrations	O
(	O
MBCs	O
)	O
of	O
lipids	O
common	O
to	O
the	O
skin	O
and	O
oral	O
cavity	O
-	O
-	O
the	O
sphingoid	O
bases	O
D	O
-	O
sphingosine	O
,	O
phytosphingosine	O
,	O
and	O
dihydrosphingosine	O
and	O
the	O
fatty	O
acids	O
sapienic	O
acid	O
and	O
lauric	O
acid	O
-	O
-	O
against	O
four	O
Gram	O
-	O
negative	O
bacteria	O
and	O
seven	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Exact	O
Kruskal	O
-	O
Wallis	O
tests	O
of	O
these	O
values	O
showed	O
differences	O
among	O
lipid	O
treatments	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
for	O
each	O
bacterial	O
species	O
except	O
Serratia	B-bacteria
marcescens	I-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

D	O
-	O
sphingosine	O
(	O
MBC	O
range	O
,	O
0	O
.	O
3	O
to	O
19	O
.	O
6	O
mug	O
/	O
ml	O
)	O
,	O
dihydrosphingosine	O
(	O
MBC	O
range	O
,	O
0	O
.	O
6	O
to	O
39	O
.	O
1	O
mug	O
/	O
ml	O
)	O
,	O
and	O
phytosphingosine	O
(	O
MBC	O
range	O
,	O
3	O
.	O
3	O
to	O
62	O
.	O
5	O
mug	O
/	O
ml	O
)	O
were	O
active	O
against	O
all	O
bacteria	O
except	O
S	B-bacteria
.	I-bacteria
marcescens	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
MBC	O
>	O
500	O
mug	O
/	O
ml	O
)	O
.	O

Sapienic	O
acid	O
(	O
MBC	O
range	O
,	O
31	O
.	O
3	O
to	O
375	O
.	O
0	O
mug	O
/	O
ml	O
)	O
was	O
active	O
against	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
but	O
not	O
active	O
against	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
marcescens	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
,	O
Corynebacterium	B-bacteria
bovis	I-bacteria
,	O
Corynebacterium	B-bacteria
striatum	I-bacteria
,	O
and	O
Corynebacterium	B-bacteria
jeikeium	I-bacteria
(	O
MBC	O
>	O
500	O
mug	O
/	O
ml	O
)	O
.	O

Lauric	O
acid	O
(	O
MBC	O
range	O
,	O
6	O
.	O
8	O
to	O
375	O
.	O
0	O
mug	O
/	O
ml	O
)	O
was	O
active	O
against	O
all	O
bacteria	O
except	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
marcescens	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
MBC	O
>	O
500	O
mug	O
/	O
ml	O
)	O
.	O

Complete	O
killing	O
was	O
achieved	O
as	O
early	O
as	O
0	O
.	O
5	O
h	O
for	O
some	O
lipids	O
but	O
took	O
as	O
long	O
as	O
24	O
h	O
for	O
others	O
.	O

Hence	O
,	O
sphingoid	O
bases	O
and	O
fatty	O
acids	O
have	O
different	O
antibacterial	O
activities	O
and	O
may	O
have	O
potential	O
for	O
prophylactic	O
or	O
therapeutic	O
intervention	O
in	O
infection	O
.	O

Viruses	O
are	O
the	O
most	O
abundant	O
known	O
infectious	O
agents	O
on	O
the	O
planet	O
and	O
are	O
significant	O
drivers	O
of	O
diversity	O
in	O
a	O
variety	O
of	O
ecosystems	O
.	O

Although	O
there	O
have	O
been	O
numerous	O
studies	O
of	O
viral	O
communities	O
,	O
few	O
have	O
focused	O
on	O
viruses	O
within	O
the	O
indigenous	O
human	O
microbiota	O
.	O

We	O
analyzed	O
2	O
267	O
695	O
virome	O
reads	O
from	O
viral	O
particles	O
and	O
compared	O
them	O
with	O
263	O
516	O
bacterial	O
16S	O
rRNA	O
gene	O
sequences	O
from	O
the	O
saliva	O
of	O
five	O
healthy	O
human	O
subjects	O
over	O
a	O
2	O
-	O
to	O
3	O
-	O
month	O
period	O
,	O
in	O
order	O
to	O
improve	O
our	O
understanding	O
of	O
the	O
role	O
viruses	O
have	O
in	O
the	O
complex	O
oral	O
ecosystem	O
.	O

Our	O
data	O
reveal	O
viral	O
communities	O
in	O
human	O
saliva	O
dominated	O
by	O
bacteriophages	O
whose	O
constituents	O
are	O
temporally	O
distinct	O
.	O

The	O
preponderance	O
of	O
shared	O
homologs	O
between	O
the	O
salivary	O
viral	O
communities	O
in	O
two	O
unrelated	O
subjects	O
in	O
the	O
same	O
household	O
suggests	O
that	O
environmental	O
factors	O
are	O
determinants	O
of	O
community	O
membership	O
.	O

When	O
comparing	O
salivary	O
viromes	O
to	O
those	O
from	O
human	O
stool	O
and	O
the	O
respiratory	O
tract	O
,	O
each	O
group	O
was	O
distinct	O
,	O
further	O
indicating	O
that	O
habitat	O
is	O
of	O
substantial	O
importance	O
in	O
shaping	O
human	O
viromes	O
.	O

Compared	O
with	O
coexisting	O
bacteria	O
,	O
there	O
was	O
concordance	O
among	O
certain	O
predicted	O
host	O
-	O
virus	O
pairings	O
such	O
as	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
,	O
whereas	O
there	O
was	O
discordance	O
among	O
others	O
such	O
as	O
Actinomyces	B-bacteria
.	O

We	O
identified	O
122	O
728	O
virulence	O
factor	O
homologs	O
,	O
suggesting	O
that	O
salivary	O
viruses	O
may	O
serve	O
as	O
reservoirs	O
for	O
pathogenic	O
gene	O
function	O
in	O
the	O
oral	O
environment	O
.	O

That	O
the	O
vast	O
majority	O
of	O
human	O
oral	O
viruses	O
are	O
bacteriophages	O
whose	O
putative	O
gene	O
function	O
signifies	O
some	O
have	O
a	O
prominent	O
role	O
in	O
lysogeny	O
,	O
suggests	O
these	O
viruses	O
may	O
have	O
an	O
important	O
role	O
in	O
helping	O
shape	O
the	O
microbial	O
diversity	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Implants	O
can	O
be	O
colonized	O
by	O
microorganisms	O
from	O
oral	O
biofilms	O
and	O
may	O
affect	O
peri	O
-	O
implant	O
tissues	O
health	O
.	O

Among	O
these	O
bacteria	O
,	O
pathogens	O
typically	O
associated	O
with	O
periodontitis	O
can	O
be	O
found	O
,	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
as	O
well	O
as	O
Gram	O
negative	O
enteric	O
bacilli	O
not	O
typically	O
associated	O
with	O
periodontal	O
diseases	O
.	O

Superinfecting	O
bacteria	O
were	O
characterized	O
from	O
peri	O
-	O
implant	O
lesions	O
in	O
patients	O
with	O
history	O
of	O
periodontitis	O
.	O

Sixty	O
-	O
eight	O
implants	O
were	O
studied	O
in	O
55	O
patients	O
;	O
the	O
average	O
patient	O
age	O
was	O
56	O
years	O
.	O

Forty	O
-	O
nine	O
implants	O
had	O
peri	O
-	O
implant	O
lesions	O
and	O
19	O
were	O
considered	O
stable	O
.	O

Subgingival	O
samples	O
were	O
obtained	O
in	O
affected	O
and	O
stable	O
implants	O
.	O

The	O
samples	O
were	O
streaked	O
on	O
Mac	O
-	O
Conkey	O
agar	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
24	O
hours	O
.	O

The	O
colonies	O
were	O
identified	O
with	O
the	O
kit	O
-	O
BD	O
BBL	O
Crystal	O
E	O
/	O
NF	O
(	O
R	O
)	O
.	O

Superinfecting	O
organisms	O
were	O
detected	O
in	O
20	O
patients	O
-	O
-	O
they	O
were	O
seen	O
more	O
frequently	O
at	O
diseased	O
implants	O
(	O
n	O
=	O
15	O
)	O
than	O
at	O
healthy	O
implants	O
(	O
n	O
=	O
5	O
)	O
.	O

The	O
prevalence	O
of	O
superinfecting	O
bacteria	O
on	O
the	O
selected	O
implants	O
was	O
33	O
.	O
8	O
%	O
(	O
n	O
=	O
23	O
/	O
68	O
)	O
.	O

These	O
bacteria	O
were	O
more	O
prevalent	O
among	O
affected	O
implants	O
(	O
n	O
=	O
17	O
or	O
25	O
%	O
)	O
than	O
those	O
with	O
stable	O
implants	O
n	O
=	O
6	O
(	O
8	O
.	O
8	O
%	O
)	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
was	O
the	O
most	O
frequent	O
Gram	O
negative	O
rod	O
detected	O
(	O
n	O
=	O
12	O
)	O
.	O

One	O
-	O
third	O
of	O
the	O
implants	O
had	O
superinfecting	O
organisms	O
.	O

Implants	O
with	O
a	O
peri	O
-	O
implant	O
lesion	O
had	O
a	O
higher	O
frequency	O
of	O
superinfecting	O
bacteria	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
was	O
the	O
most	O
common	O
superinfecting	O
organism	O
isolated	O
.	O

A	O
multiple	O
infection	O
caused	O
by	O
superinfecting	O
bacteria	O
was	O
present	O
only	O
at	O
diseased	O
implants	O
.	O

These	O
microbial	O
agents	O
potentially	O
affect	O
implant	O
stability	O
.	O

To	O
profile	O
plaque	O
microflora	O
on	O
root	O
-	O
caries	O
lesions	O
,	O
and	O
to	O
examine	O
the	O
protein	O
-	O
denaturing	O
activity	O
as	O
a	O
pilot	O

.	O

Six	O
subjects	O
with	O
root	O
-	O
caries	O
were	O
investigated	O
.	O

Plaque	O
samples	O
on	O
root	O
caries	O
lesions	O
(	O
R	O
)	O
,	O
as	O
well	O
as	O
from	O
healthy	O
supragingival	O
sites	O
(	O
S	O
)	O
and	O
periodontal	O
pockets	O
(	O
>	O
or	O
=	O
5	O
mm	O
)	O
(	O
P	O
)	O
were	O
collected	O
and	O
cultured	O
anaerobically	O
on	O
blood	O
agar	O
plates	O
.	O

The	O
isolated	O
bacteria	O
were	O
identified	O
by	O
16S	O
rRNA	O
sequencing	O
analysis	O
,	O
and	O
examined	O
for	O
the	O
protein	O
-	O
denaturing	O
activity	O
using	O
the	O
skim	O
-	O
milk	O
plates	O
and	O
the	O
SDS	O
-	O
PAGE	O
,	O
and	O
for	O
the	O
acidogenicity	O
using	O
the	O
FAB	O
broth	O
containing	O
1	O
%	O
glucose	O
.	O

Propionibacterium	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Lactobacillus	B-bacteria
and	O
Bifidobacterium	B-bacteria
were	O
predominant	O
in	O
R	O
,	O
while	O
Actinomyces	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Capnocytophaga	B-bacteria
in	O
S	O
,	O
and	O
Actinomyces	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Actinobaculum	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Olsenella	B-bacteria
and	O
Eubacterium	B-bacteria
were	O
predominant	O
in	O
P	B-bacteria
.	I-bacteria
Proteolytic	I-bacteria
bacteria	O
comprised	O
40	O
%	O
,	O
26	O
%	O
and	O
57	O
%	O
of	O
microflora	O
in	O
R	O
,	O
S	O
and	O
P	O
,	O
respectively	O
.	O

The	O
skim	O
-	O
milk	O
plates	O
distinguished	O
between	O
protein	O
-	O
degrading	O
and	O
protein	O
-	O
coagulating	O
bacteria	O
,	O
which	O
comprised	O
7	O
and	O
33	O
%	O
,	O
0	O
and	O
26	O
%	O
,	O
and	O
17	O
and	O
40	O
%	O
of	O
microflora	O
,	O
in	O
R	O
,	O
S	O
and	O
P	O
,	O
respectively	O
.	O

The	O
SDS	O
-	O
PAGE	O
analysis	O
revealed	O
that	O
protein	O
-	O
degrading	O
isolates	O
were	O
capable	O
of	O
degrading	O
collagen	O
molecules	O
.	O

Furthermore	O
,	O
the	O
final	O
culture	O
pHs	O
of	O
protein	O
-	O
degrading	O
and	O
-	O
coagulating	O
bacteria	O
were	O
5	O
.	O
0	O
-	O
5	O
.	O
4	O
and	O
3	O
.	O
8	O
-	O
3	O
.	O
9	O
,	O
respectively	O
.	O

The	O
latter	O
pH	O
was	O
low	O
enough	O
to	O
denature	O
proteins	O
in	O
skim	O
milk	O
.	O

The	O
microbial	O
composition	O
of	O
R	O
was	O
distinct	O
from	O
those	O
of	O
S	O
and	O
P	O
.	O

Deoxyribonucleic	O
acids	O
(	O
DNA	O
)	O
of	O
periodontal	O
pathogens	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
stimulate	O
cytokine	O
production	O
in	O
human	O
monocytic	O
cells	O
(	O
THP	O
-	O
1	O
)	O
through	O
Toll	O
-	O
like	O
receptor	O
9	O
(	O
TLR	O
-	O
9	O
)	O
and	O
nuclear	O
factor	O
-	O
kappaB	O
signaling	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
Fn	B-bacteria
)	O
is	O
one	O
of	O
the	O
most	O
frequently	O
isolated	O
bacteria	O
in	O
periodontally	O
diseased	O
tissues	O
and	O
is	O
reported	O
to	O
synergize	O
with	O
Pg	B-bacteria
,	O
enhancing	O
the	O
pathogenicity	O
.	O

We	O
investigate	O
inflammatory	O
mediator	O
production	O
in	O
THP	O
-	O
1	O
cells	O
challenged	O
with	O
Fn	B-bacteria
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
(	O
Ss	B-bacteria
)	O
DNA	O
,	O
a	O
non	O
-	O
pathogenic	O
oral	O
bacteria	O
,	O
and	O
further	O
assess	O
whether	O
cytokines	O
triggered	O
by	O
whole	O
pathogens	O
or	O
Pg	O
lipopolysaccharide	O
(	O
LPS	O
)	O
are	O
affected	O
by	O
TLR	O
-	O
9	O
signaling	O
inhibitors	O
(	O
chloroquine	O
)	O
.	O

THP	O
-	O
1	O
cells	O
were	O
stimulated	O
with	O
Pg	O
-	O
DNA	O
(	O
100	O
ng	O
/	O
muL	O
)	O
,	O
Fn	O
-	O
DNA	O
(	O
100	O
ng	O
/	O
muL	O
)	O
,	O
Ss	O
-	O
DNA	O
(	O
100	O
ng	O
/	O
muL	O
)	O
,	O
Pg	O
-	O
LPS	O
(	O
10	O
ng	O
/	O
muL	O
)	O
,	O
and	O
heat	O
-	O
killed	O
whole	O
bacteria	O
(	O
multiplicity	O
of	O
infection	O
,	O
1	O
:	O
100	O
)	O
for	O
16	O
hours	O
with	O
or	O
without	O
chloroquine	O
pretreatment	O
(	O
10	O
mug	O
/	O
mL	O
)	O
.	O

Interleukin	O
(	O
IL	O
)	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
levels	O
were	O
determined	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Statistical	O
analyses	O
included	O
analysis	O
of	O
variance	O
with	O
multiple	O
comparisons	O
using	O
Dunnett	O
or	O
Tukey	O
methods	O
and	O
paired	O
t	O
test	O
.	O

A	O
value	O
of	O
P	O
<	O
0	O
.	O
05	O
was	O
significant	O
.	O

Inflammatory	O
mediator	O
levels	O
were	O
increased	O
in	O
response	O
to	O
all	O
the	O
stimuli	O
with	O
the	O
exception	O
of	O
Ss	O
-	O
DNA	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Chloroquine	O
pretreatment	O
significantly	O
decreased	O
cytokine	O
production	O
from	O
THP	O
-	O
1	O
cells	O
with	O
the	O
exception	O
of	O
IL	O
-	O
6	O
production	O
triggered	O
by	O
whole	O
Fn	B-bacteria
and	O
Ss	B-bacteria
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Differences	O
exist	O
among	O
oral	O
bacterial	O
DNA	O
in	O
inducing	O
immune	O
responses	O
.	O

By	O
altering	O
the	O
conditions	O
in	O
cytosolic	O
compartments	O
,	O
we	O
can	O
interfere	O
with	O
cellular	O
responses	O
triggered	O
by	O
extracellular	O
receptor	O
activation	O
.	O

Thus	O
,	O
alternative	O
treatment	O
approaches	O
targeted	O
to	O
intracellular	O
receptors	O
might	O
be	O
of	O
benefit	O
in	O
controlling	O
periodontal	O
inflammation	O
.	O

The	O
fimbriae	O
-	O
associated	O
protein	O
1	O
(	O
Fap1	O
)	O
is	O
a	O
major	O
adhesin	O
of	O
Streptococcus	B-bacteria
parasanguinis	I-bacteria
,	O
a	O
primary	O
colonizer	O
of	O
the	O
oral	O
cavity	O
that	O
plays	O
an	O
important	O
role	O
in	O
the	O
formation	O
of	O
dental	O
plaque	O
.	O

Fap1	O
is	O
an	O
extracellular	O
adhesive	O
surface	O
fibre	O
belonging	O
to	O
the	O
serine	O
-	O
rich	O
repeat	O
protein	O
(	O
SRRP	O
)	O
family	O
,	O
which	O
plays	O
a	O
central	O
role	O
in	O
the	O
pathogenesis	O
of	O
streptococci	B-bacteria
and	O
staphylococci	B-bacteria
.	O

The	O
N	O
-	O
terminal	O
adhesive	O
region	O
of	O
Fap1	O
(	O
Fap1	O
-	O
NR	O
)	O
is	O
composed	O
of	O
two	O
domains	O
(	O
Fap1	O
-	O
NR	O
(	O
alpha	O
)	O
and	O
Fap1	O
-	O
NR	O
(	O
beta	O
)	O
)	O
and	O
is	O
projected	O
away	O
from	O
the	O
bacterial	O
surface	O
via	O
the	O
extensive	O
serine	O
-	O
rich	O
repeat	O
region	O
,	O
for	O
adhesion	O
to	O
the	O
salivary	O
pellicle	O
.	O

The	O
adhesive	O
properties	O
of	O
Fap1	O
are	O
modulated	O
through	O
a	O
pH	O
switch	O
in	O
which	O
a	O
reduction	O
in	O
pH	O
results	O
in	O
a	O
rearrangement	O
between	O
the	O
Fap1	O
-	O
NR	O
(	O
alpha	O
)	O
and	O
Fap1	O
-	O
NR	O
(	O
beta	O
)	O
domains	O
,	O
which	O
assists	O
in	O
the	O
survival	O
of	O
S	B-bacteria
.	I-bacteria
parasanguinis	I-bacteria
in	O
acidic	O
environments	O
.	O

We	O
have	O
solved	O
the	O
structure	O
of	O
Fap1	O
-	O
NR	O
(	O
alpha	O
)	O
at	O
pH	O
5	O
.	O
0	O
at	O
3	O
.	O
0A	O
resolution	O
and	O
reveal	O
how	O
subtle	O
rearrangements	O
of	O
the	O
3	O
-	O
helix	O
bundle	O
combined	O
with	O
a	O
change	O
in	O
electrostatic	O
potential	O
mediates	O
'	O
opening	O
'	O
and	O
activation	O
of	O
the	O
adhesive	O
region	O
.	O

Further	O
,	O
we	O
show	O
that	O
pH	O
-	O
dependent	O
changes	O
are	O
critical	O
for	O
biofilm	O
formation	O
and	O
present	O
an	O
atomic	O
model	O
for	O
the	O
inter	O
-	O
Fap1	O
-	O
NR	O
interactions	O
which	O
have	O
been	O
assigned	O
an	O
important	O
role	O
in	O
the	O
biofilm	O
formation	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
identify	O
a	O
group	O
of	O
patients	O
at	O
high	O
risk	O
of	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
infection	O
following	O
surgical	O
procedures	O
involving	O
oral	O
cavity	O
,	O
head	O
and	O
neck	O
.	O

A	O
retrospective	O
analysis	O
of	O
demographic	O
,	O
clinical	O
and	O
laboratory	O
data	O
was	O
performed	O
.	O

A	O
manual	O
search	O
of	O
laboratory	O
records	O
for	O
a	O
five	O
years	O
period	O
(	O
2005	O
-	O
2009	O
)	O
was	O
performed	O
for	O
specimens	O
submitted	O
to	O
the	O
diagnostic	O
microbiology	O
laboratory	O
from	O
patients	O
admitted	O
to	O
the	O
Cranio	O
-	O
Maxillofacial	O
and	O
Oncologic	O
Surgery	O
Department	O
.	O

Methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
was	O
identified	O
in	O
26	O
cases	O
.	O

Most	O
commonly	O
it	O
was	O
isolated	O
from	O
tongue	O
swabs	O
in	O
patients	O
following	O
extensive	O
oncological	O
surgical	O
procedures	O
involving	O
oral	O
cavity	O
.	O

Most	O
common	O
risk	O
factors	O
were	O
:	O
age	O
above	O
65	O
years	O
,	O
neoplasms	O
,	O
multisite	O
trauma	O
with	O
loss	O
of	O
consciousness	O
,	O
cigarette	O
smoking	O
,	O
alcohol	O
abuse	O
,	O
tobacco	O
addiction	O
,	O
antibiotic	O
therapy	O
immediately	O
before	O
hospitalization	O
.	O

More	O
than	O
half	O
of	O
patients	O
with	O
MRSA	B-bacteria
infection	O
required	O
surgical	O
treatment	O
except	O
for	O
pharmacological	O
treatment	O
.	O

Monitoring	O
of	O
postoperative	O
wounds	O
is	O
of	O
great	O
importance	O
with	O
regard	O
to	O
he	O
risk	O
of	O
MRSA	B-bacteria
infection	O
.	O

The	O
intensities	O
and	O
specificities	O
of	O
salivary	O
IgA	O
antibody	O
responses	O
to	O
antigens	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
main	O
pathogen	O
of	O
dental	O
caries	O
,	O
may	O
influence	O
colonization	O
by	O
these	O
organisms	O
during	O
the	O
first	O
1	O
.	O
5	O
year	O
of	O
life	O
.	O

Thus	O
,	O
the	O
ontogeny	O
of	O
salivary	O
IgA	O
responses	O
to	O
oral	O
colonizers	O
continues	O
to	O
warrant	O
investigation	O
,	O
especially	O
with	O
regard	O
to	O
the	O
influence	O
of	O
birth	O
conditions	O
,	O
e	O
.	O
g	O
.	O
prematurity	O
,	O
on	O
the	O
ability	O
of	O
children	O
to	O
efficiently	O
respond	O
to	O
oral	O
microorganisms	O
.	O

In	O
this	O
study	O
,	O
we	O
characterised	O
the	O
salivary	O
antibody	O
responses	O
to	O
two	O
bacterial	O
species	O
which	O
are	O
prototypes	O
of	O
pioneer	O
and	O
pathogenic	O
microorganisms	O
of	O
the	O
oral	O
cavity	O
(	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
respectively	O
)	O
in	O
fullterm	O
(	O
FT	O
)	O
and	O
preterm	O
(	O
PT	O
)	O
newborn	O
children	O
.	O

Salivas	O
from	O
123	O
infants	O
(	O
70	O
FT	O
and	O
53	O
PT	O
)	O
were	O
collected	O
during	O
the	O
first	O
10h	O
after	O
birth	O
and	O
levels	O
of	O
IgA	O
and	O
IgM	O
antibodies	O
and	O
the	O
presence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
were	O
analysed	O
respectively	O
by	O
ELISA	O
and	O
by	O
chequerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Two	O
subgroups	O
of	O
24	O
FT	O
and	O
24	O
PT	O
children	O
were	O
compared	O
with	O
respect	O
to	O
patterns	O
of	O
antibody	O
specificities	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
antigens	O
,	O
using	O
Western	O
blot	O
assays	O
.	O

Cross	O
-	O
adsorption	O
of	O
10	O
infant	O
'	O
s	O
saliva	O
was	O
tested	O
to	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
antigens	O
.	O

Salivary	O
levels	O
of	O
IgA	O
at	O
birth	O
were	O
2	O
.	O
5	O
-	O
fold	O
higher	O
in	O
FT	O
than	O
in	O
PT	O
children	O
(	O
Mann	O
-	O
Whitney	O
;	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Salivary	O
IgA	O
antibodies	O
reactive	O
with	O
several	O
antigens	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
detected	O
at	O
birth	O
in	O
children	O
with	O
undetectable	O
levels	O
of	O
those	O
bacteria	O
.	O

Adsorption	O
of	O
infant	O
saliva	O
with	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
produced	O
a	O
reduction	O
of	O
antibodies	O
recognizing	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
antigens	O
in	O
half	O
of	O
the	O
neonates	O
.	O

The	O
diversity	O
and	O
intensity	O
of	O
IgA	O
responses	O
were	O
lower	O
in	O
PT	O
compared	O
to	O
FT	O
children	O
,	O
although	O
those	O
differences	O
were	O
not	O
significant	O
.	O

These	O
data	O
provide	O
evidence	O
that	O
children	O
have	O
salivary	O
IgA	O
antibodies	O
shortly	O
after	O
birth	O
,	O
which	O
might	O
influence	O
the	O
establishment	O
of	O
the	O
oral	O
microbiota	O
,	O
and	O
that	O
the	O
levels	O
of	O
salivary	O
antibody	O
might	O
be	O
related	O
to	O
prematurity	O
.	O

Periodontitis	O
has	O
a	O
polymicrobial	O
etiology	O
within	O
the	O
framework	O
of	O
a	O
complex	O
microbial	O
ecosystem	O
.	O

With	O
advances	O
in	O
sequencing	O
technologies	O
,	O
comprehensive	O
studies	O
to	O
elucidate	O
bacterial	O
community	O
differences	O
have	O
recently	O
become	O
possible	O
.	O

We	O
used	O
454	O
sequencing	O
of	O
16S	O
rRNA	O
genes	O
to	O
compare	O
subgingival	O
bacterial	O
communities	O
from	O
29	O
periodontally	O
healthy	O
controls	O
and	O
29	O
subjects	O
with	O
chronic	O
periodontitis	O
.	O

Amplicons	O
from	O
both	O
the	O
V1	O
-	O
2	O
and	O
V4	O
regions	O
of	O
the	O
16S	O
gene	O
were	O
sequenced	O
,	O
yielding	O
1	O
,	O
393	O
,	O
579	O
sequences	O
.	O

They	O
were	O
identified	O
by	O
BLAST	O
against	O
a	O
curated	O
oral	O
16S	O
database	O
,	O
and	O
mapped	O
to	O
16	O
phyla	O
,	O
106	O
genera	O
,	O
and	O
596	O
species	O
.	O

81	O
%	O
of	O
sequences	O
could	O
be	O
mapped	O
to	O
cultivated	O
species	O
.	O

Differences	O
between	O
health	O
-	O
and	O
periodontitis	O
-	O
associated	O
bacterial	O
communities	O
were	O
observed	O
at	O
all	O
phylogenetic	O
levels	O
,	O
and	O
UniFrac	O
and	O
principal	O
coordinates	O
analysis	O
showed	O
distinct	O
community	O
profiles	O
in	O
health	O
and	O
disease	O
.	O

Community	O
diversity	O
was	O
higher	O
in	O
disease	O
,	O
and	O
123	O
species	O
were	O
identified	O
that	O
were	O
significantly	O
more	O
abundant	O
in	O
disease	O
,	O
and	O
53	O
in	O
health	O
.	O

Spirochaetes	B-bacteria
,	O
Synergistetes	B-bacteria
and	O
Bacteroidetes	B-bacteria
were	O
more	O
abundant	O
in	O
disease	O
,	O
whereas	O
the	O
Proteobacteria	B-bacteria
were	O
found	O
at	O
higher	O
levels	O
in	O
healthy	O
controls	O
.	O

Within	O
the	O
phylum	O
Firmicutes	B-bacteria
,	O
the	O
class	O
Bacilli	B-bacteria
was	O
health	O
-	O
associated	O
,	O
whereas	O
the	O
Clostridia	B-bacteria
,	O
Negativicutes	B-bacteria
and	O
Erysipelotrichia	B-bacteria
were	O
associated	O
with	O
disease	O
.	O

These	O
results	O
implicate	O
a	O
number	O
of	O
taxa	O
that	O
will	O
be	O
targets	O
for	O
future	O
research	O
.	O

Some	O
,	O
such	O
as	O
Filifactor	B-bacteria
alocis	I-bacteria
and	O
many	O
Spirochetes	B-bacteria
were	O
represented	O
by	O
a	O
large	O
fraction	O
of	O
sequences	O
as	O
compared	O
with	O
previously	O
identified	O
targets	O
.	O

Elucidation	O
of	O
these	O
differences	O
in	O
community	O
composition	O
provides	O
a	O
basis	O
for	O
further	O
understanding	O
the	O
pathogenesis	O
of	O
periodontitis	O
.	O

Salivary	O
host	O
-	O
defence	O
peptides	O
include	O
defensins	O
,	O
histatins	O
and	O
cathelicidin	O
.	O

We	O
have	O
investigated	O
the	O
effects	O
of	O
these	O
peptides	O
on	O
the	O
microbial	O
composition	O
of	O
dental	O
plaques	O
.	O

Salivary	O
consortia	O
,	O
established	O
within	O
hydroxyapatite	O
disc	O
models	O
,	O
were	O
exposed	O
during	O
development	O
to	O
physiological	O
levels	O
of	O
human	O
neutrophil	O
proteins	O
(	O
HNP	O
)	O
1	O
and	O
2	O
;	O
human	O
beta	O
defensins	O
(	O
hbetaD	O
)	O
1	O
,	O
2	O
and	O
3	O
;	O
histatins	O
(	O
His	O
)	O
5	O
and	O
8	O
;	O
and	O
cathelicidin	O
(	O
LL37	O
)	O
.	O

Effects	O
on	O
aggregation	O
and	O
microbial	O
composition	O
were	O
determined	O
using	O
fluorescence	O
microscopy	O
;	O
and	O
differential	O
culture	O
with	O
PCR	O
-	O
DGGE	O
,	O
respectively	O
.	O

LIVE	O
/	O
DEAD	O
microscopic	O
analysis	O
indicated	O
that	O
HDPs	O
decreased	O
total	O
bacterial	O
viability	O
,	O
whilst	O
beta	O
defensins	O
,	O
paired	O
HNPs	O
,	O
His	O
5	O
,	O
His	O
8	O
and	O
the	O
HDPs	O
combined	O
inhibited	O
bacterial	O
aggregation	O
.	O

According	O
to	O
differential	O
culture	O
,	O
all	O
test	O
HDPs	O
(	O
except	O
His	O
5	O
)	O
significantly	O
decreased	O
the	O
abundance	O
of	O
Gram	O
-	O
negative	O
anaerobes	O
and	O
lactobacilli	B-bacteria
(	O
except	O
HNP	O
2	O
,	O
hbetaD	O
1	O
,	O
paired	O
HNPs	O
and	O
His	O
5	O
)	O
.	O

Combined	O
HNPs	O
and	O
paired	O
hbetaD	O
1	O
and	O
3	O
inhibited	O
streptococci	B-bacteria
,	O
whereas	O
HNP	O
1	O
,	O
hbetaD	O
1	O
,	O
hbetaD	O
3	O
,	O
His	O
5	O
and	O
LL37	O
increased	O
streptococcal	B-bacteria
numbers	O
.	O

According	O
to	O
cluster	O
analyses	O
of	O
DGGE	O
profiles	O
,	O
HDP	O
-	O
exposed	O
plaques	O
were	O
compositionally	O
distinct	O
from	O
undosed	O
controls	O
.	O

Thus	O
,	O
whilst	O
HDPs	O
reportedly	O
exhibit	O
variable	O
potency	O
against	O
oral	O
bacteria	O
in	O
endpoint	O
susceptibly	O
tests	O
,	O
exposure	O
of	O
nascent	O
plaques	O
can	O
markedly	O
influence	O
bacterial	O
viability	O
,	O
composition	O
and	O
microbial	O
aggregation	O
.	O

To	O
assess	O
the	O
effectiveness	O
of	O
selective	O
digestive	O
decontamination	O
(	O
SDD	O
)	O
for	O
eradicating	O
carbapenem	B-bacteria
-	I-bacteria
resistant	I-bacteria
Klebsiella	I-bacteria
pneumoniae	I-bacteria
(	O
CRKP	B-bacteria	O
)	O
oropharyngeal	O
and	O
gastrointestinal	O
carriage	O
.	O

A	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
with	O
7	O
weeks	O
of	O
follow	O
-	O
up	O
per	O
patient	O
.	O

A	O
1	O
,	O
000	O
-	O
bed	O
tertiary	O
-	O
care	O
university	O
hospital	O
.	O

Adults	O
with	O
CRKP	O
-	O
positive	O
rectal	O
swab	O
cultures	O
.	O

Patients	O
were	O
blindly	O
randomized	O
(	O
1	O
:	O
1	O
)	O
over	O
a	O
20	O
-	O
month	O
period	O
.	O

The	O
SDD	O
arm	O
received	O
oral	O
gentamicin	O
and	O
polymyxin	O
E	O
gel	O
(	O
0	O
.	O
5	O
g	O
4	O
times	O
per	O
day	O
)	O
and	O
oral	O
solutions	O
of	O
gentamicin	O
(	O
80	O
mg	O
4	O
times	O
per	O
day	O
)	O
and	O
polymyxin	O
E	O
(	O
1	O
x	O
10	O
(	O
6	O
)	O
units	O
4	O
times	O
per	O
day	O
for	O
7	O
days	O
)	O
.	O

The	O
placebo	O
arm	O
received	O
oral	O
placebo	O
gel	O
4	O
times	O
per	O
day	O
and	O
2	O
placebo	O
oral	O
solutions	O
4	O
times	O
per	O
day	O
for	O
7	O
days	O
.	O

Strict	O
contact	O
precautions	O
were	O
applied	O
.	O

Samples	O
obtained	O
from	O
the	O
throat	O
,	O
groin	O
,	O
and	O
urine	O
were	O
also	O
cultured	O
.	O

Forty	O
patients	O
(	O
mean	O
age	O
+	O
/	O
-	O
standard	O
deviation	O
,	O
71	O
+	O
/	O
-	O
16	O
years	O
;	O
65	O
%	O
male	O
)	O
were	O
included	O
.	O

At	O
screening	O
,	O
greater	O
than	O
or	O
equal	O
to	O
30	O
%	O
of	O
oropharyngeal	O
,	O
greater	O
than	O
or	O
equal	O
to	O
60	O
%	O
of	O
skin	O
,	O
and	O
greater	O
than	O
or	O
equal	O
to	O
35	O
%	O
of	O
urine	O
cultures	O
yielded	O
CRKP	O
isolates	O
.	O

All	O
throat	O
cultures	O
became	O
negative	O
in	O
the	O
SDD	O
arm	O
after	O
3	O
days	O
(	O
P	O
<	O
.	O
0001	O
)	O
.	O

The	O
percentages	O
of	O
rectal	O
cultures	O
that	O
were	O
positive	O
for	O
CRKP	O
were	O
significantly	O
reduced	O
at	O
2	O
weeks	O
.	O

At	O
that	O
time	O
,	O
16	O
.	O
1	O
%	O
of	O
rectal	O
cultures	O
in	O
the	O
placebo	O
arm	O
and	O
61	O
.	O
1	O
%	O
in	O
the	O
SDD	O
arm	O
were	O
negative	O
(	O
odds	O
ratio	O
,	O
0	O
.	O
13	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
02	O
-	O
0	O
.	O
74	O
;	O
P	O
<	O
.	O
0016	O
)	O
.	O

A	O
difference	O
between	O
the	O
percentages	O
in	O
the	O
2	O
arms	O
was	O
still	O
maintained	O
at	O
6	O
weeks	O
(	O
33	O
.	O
3	O
%	O
vs	O
58	O
.	O
5	O
%	O
)	O
.	O

Groin	O
colonization	O
prevalence	O
did	O
not	O
change	O
in	O
either	O
arm	O
,	O
and	O
the	O
prevalence	O
of	O
urine	O
colonization	O
increased	O
in	O
the	O
placebo	O
arm	O
.	O

This	O
SDD	O
regimen	O
could	O
be	O
a	O
suitable	O
decolonization	O
therapy	O
for	O
selected	O
patients	O
colonized	O
with	O
CRKP	B-bacteria
,	O
such	O
as	O
transplant	O
recipients	O
or	O
immunocompromised	O
patients	O
pending	O
chemotherapy	O
and	O
patients	O
who	O
require	O
major	O
intestinal	O
or	O
oropharyngeal	O
surgery	O
.	O

Moreover	O
,	O
in	O
outbreaks	O
caused	O
by	O
CRKP	B-bacteria
infections	O
that	O
are	O
uncontrolled	O
by	O
routine	O
infection	O
control	O
measures	O
,	O
SDD	O
could	O
provide	O
additional	O
infection	O
containment	O
.	O

Clinical	O
observations	O
and	O
epidemiologic	O
studies	O
suggest	O
that	O
the	O
incidence	O
of	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
(	O
HNSCC	O
)	O
correlates	O
with	O
dental	O
hygiene	O
,	O
implying	O
a	O
role	O
for	O
bacteria	O
-	O
induced	O
inflammation	O
in	O
its	O
pathogenesis	O
.	O

Here	O
we	O
begin	O
to	O
explore	O
the	O
pilot	O
hypothesis	O
that	O
specific	O
microbial	O
populations	O
may	O
contribute	O
to	O
HNSCC	O
pathogenesis	O
via	O
epigenetic	O
modifications	O
in	O
inflammatory	O
-	O
and	O
HNSCC	O
-	O
associated	O
genes	O
.	O

Microbiomic	O
profiling	O
by	O
16S	O
rRNA	O
sequencing	O
of	O
matched	O
tumor	O
and	O
adjacent	O
normal	O
tissue	O
specimens	O
in	O
42	O
individuals	O
with	O
HNSCC	O
demonstrate	O
a	O
significant	O
association	O
of	O
specific	O
bacterial	O
subpopulations	O
with	O
HNSCC	O
over	O
normal	O
tissue	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Furthermore	O
,	O
microbial	O
populations	O
can	O
separate	O
tumors	O
by	O
tobacco	O
status	O
(	O
P	O
<	O
0	O
.	O
008	O
)	O
,	O
but	O
not	O
by	O
alcohol	O
status	O
(	O
P	O
=	O
0	O
.	O
41	O
)	O
.	O

If	O
our	O
subhypothesis	O
regarding	O
a	O
mechanistic	O
link	O
from	O
microorganism	O
to	O
carcinogenesis	O
via	O
inflammation	O
and	O
consequent	O
aberrant	O
DNA	O
methylation	O
is	O
correct	O
,	O
then	O
we	O
should	O
see	O
hypermethylation	O
of	O
relevant	O
genes	O
associate	O
with	O
specific	O
microbiomic	O
profiles	O
.	O

Methylation	O
analysis	O
in	O
four	O
genes	O
(	O
MDR1	O
,	O
IL8	O
,	O
RARB	O
,	O
TGFBR2	O
)	O
previously	O
linked	O
to	O
HNSCC	O
or	O
inflammation	O
shows	O
significantly	O
increased	O
methylation	O
in	O
tumor	O
samples	O
compared	O
with	O
normal	O
oral	O
mucosa	O
.	O

Of	O
these	O
,	O
MDR1	O
promoter	O
methylation	O
associates	O
with	O
specific	O
microbiomic	O
profiles	O
in	O
tumor	O
over	O
normal	O
mucosa	O
.	O

Additionally	O
,	O
we	O
report	O
that	O
MDR1	O
methylation	O
correlates	O
with	O
regional	O
nodal	O
metastases	O
in	O
the	O
context	O
of	O
two	O
specific	O
bacterial	O
subpopulations	O
,	O
Enterobacteriaceae	B-bacteria
and	O
Tenericutes	B-bacteria
(	O
P	O
<	O
0	O
.	O
001	O
for	O
each	O
)	O
.	O

These	O
associations	O
may	O
lead	O
to	O
a	O
different	O
,	O
and	O
potentially	O
more	O
comprehensive	O
,	O
perspective	O
on	O
the	O
pathogenesis	O
of	O
HNSCC	O
,	O
and	O
support	O
further	O
exploration	O
of	O
mechanistic	O
linkage	O
and	O
,	O
if	O
so	O
,	O
novel	O
therapeutic	O
strategies	O
such	O
as	O
demethylating	O
agents	O
and	O
probiotic	O
adjuncts	O
,	O
particularly	O
for	O
patients	O
with	O
advanced	O
or	O
refractory	O
disease	O
.	O

The	O
dog	O
has	O
been	O
used	O
extensively	O
for	O
experimental	O
and	O
microbiological	O
studies	O
on	O
periodontitis	O
and	O
peri	O
-	O
implantitis	O
without	O
detailed	O
knowledge	O
about	O
the	O
predominant	O
flora	O
of	O
the	O
subgingival	O
plaque	O
.	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
predominant	O
cultivable	O
bacterial	O
species	O
in	O
dogs	O
and	O
compare	O
them	O
phenotypically	O
and	O
genotypically	O
with	O
corresponding	O
human	O
species	O
.	O

Four	O
subgingival	O
samples	O
were	O
taken	O
from	O
two	O
upper	O
premolars	O
in	O
each	O
of	O
six	O
Labrador	O
retrievers	O
.	O

The	O
samples	O
from	O
each	O
dog	O
were	O
processed	O
for	O
anaerobic	O
culture	O
.	O

From	O
the	O
samples	O
of	O
each	O
dog	O
,	O
the	O
five	O
or	O
six	O
predominating	O
bacteria	O
based	O
on	O
colony	O
morphology	O
were	O
selected	O
and	O
pure	O
cultured	O
.	O

Each	O
of	O
the	O
strains	O
was	O
characterized	O
by	O
Gram	O
stain	O
,	O
anaerobic	O
/	O
aerobic	O
growth	O
and	O
API	O
-	O
ZYM	O
test	O
.	O

Eighteen	O
strains	O
showing	O
clear	O
-	O
cut	O
phenotypic	O
differences	O
were	O
further	O
classified	O
based	O
on	O
DNA	O
sequencing	O
technology	O
.	O

Cross	O
-	O
reactions	O
of	O
DNA	O
probes	O
from	O
human	O
and	O
dog	O
strains	O
were	O
also	O
tested	O
against	O
a	O
panel	O
of	O
both	O
human	O
and	O
dog	O
bacterial	O
species	O
.	O

Thirty	O
-	O
one	O
strains	O
in	O
the	O
dogs	O
were	O
isolated	O
and	O
characterized	O
.	O

They	O
represented	O
21	O
different	O
species	O
,	O
of	O
which	O
six	O
belonged	O
to	O
the	O
genus	O
Porphyromonas	B-bacteria
.	O

No	O
species	O
was	O
found	O
consistently	O
in	O
the	O
predominant	O
flora	O
of	O
all	O
six	O
dogs	O
.	O

Porphyromonas	B-bacteria
crevioricanis	I-bacteria
and	O
Fusobacterium	B-bacteria
canifelinum	I-bacteria
were	O
the	O
two	O
most	O
prevalent	O
species	O
in	O
predominant	O
flora	O
in	O
dogs	O
.	O

DNA	O
probes	O
from	O
human	O
and	O
dog	O
species	O
cross	O
-	O
reacted	O
to	O
some	O
extent	O
with	O
related	O
strains	O
from	O
humans	O
and	O
dogs	O
;	O
however	O
,	O
distinct	O
exceptions	O
were	O
found	O
.	O

The	O
predominant	O
cultural	O
subgingival	O
flora	O
in	O
dogs	O
shows	O
great	O
similarities	O
with	O
the	O
subgingival	O
bacteria	O
from	O
humans	O
at	O
the	O
genus	O
level	O
,	O
but	O
distinct	O
differences	O
at	O
the	O
species	O
level	O
;	O
however	O
,	O
a	O
genetic	O
relatedness	O
could	O
be	O
disclosed	O
for	O
most	O
strains	O
investigated	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
chewing	O
gums	O
containing	O
probiotic	O
bacteria	O
on	O
oral	O
malodour	O
.	O

The	O
null	O
hypothesis	O
was	O
that	O
no	O
difference	O
would	O
be	O
displayed	O
compared	O
with	O
placebo	O
gums	O
.	O

Twenty	O
-	O
five	O
healthy	O
young	O
adults	O
with	O
self	O
-	O
reported	O
malodorous	O
morning	O
breath	O
completed	O
this	O
randomized	O
double	O
-	O
blind	O
placebo	O
-	O
controlled	O
cross	O
-	O
over	O
trial	O
.	O

The	O
design	O
included	O
run	O
-	O
in	O
and	O
wash	O
-	O
out	O
periods	O
interspersed	O
by	O
two	O
intervention	O
periods	O
of	O
14	O
days	O
each	O
.	O

The	O
subjects	O
were	O
instructed	O
to	O
chew	O
one	O
gum	O
in	O
the	O
morning	O
and	O
one	O
in	O
the	O
evening	O
containing	O
either	O
two	O
strains	O
of	O
probiotic	O
lactobacilli	B-bacteria
(	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
DSM	I-bacteria
17938	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
ATCC	I-bacteria
PTA	I-bacteria
5289	I-bacteria
)	O
or	O
placebo	O
.	O

The	O
outcome	O
measures	O
were	O
(	O
i	O
)	O
organoleptic	O
scores	O
(	O
0	O
-	O
5	O
)	O
by	O
a	O
certified	O
test	O
panel	O
,	O
(	O
ii	O
)	O
concentration	O
of	O
volatile	O
sulphur	O
compounds	O
(	O
VSC	O
)	O
measured	O
with	O
a	O
Halimeter	O
and	O
(	O
iii	O
)	O
concentration	O
of	O
VSC	O
after	O
a	O
cysteine	O
rinse	O
.	O

Registrations	O
were	O
made	O
at	O
baseline	O
and	O
after	O
each	O
intervention	O
period	O
.	O

Differences	O
between	O
the	O
groups	O
were	O
assessed	O
by	O
non	O
-	O
parametric	O
paired	O
statistics	O
and	O
chi	O
-	O
square	O
test	O
.	O

The	O
median	O
organoleptic	O
score	O
was	O
similar	O
(	O
score	O
2	O
)	O
in	O
both	O
groups	O
at	O
baseline	O
.	O

After	O
14	O
days	O
of	O
treatment	O
,	O
the	O
organoleptic	O
scores	O
were	O
significantly	O
lower	O
in	O
the	O
probiotic	O
group	O
compared	O
with	O
the	O
placebo	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Assessments	O
of	O
the	O
VSC	O
levels	O
displayed	O
no	O
significant	O
differences	O
between	O
the	O
groups	O
,	O
either	O
before	O
or	O
after	O
rinsing	O
with	O
L	O
-	O
cysteine	O
.	O

No	O
adverse	O
effects	O
were	O
registered	O
.	O

The	O
results	O
demonstrated	O
that	O
probiotic	O
chewing	O
gums	O
may	O
have	O
some	O
beneficial	O
effect	O
on	O
oral	O
malodour	O
assessed	O
by	O
organoleptic	O
scores	O
.	O

The	O
results	O
indicate	O
that	O
the	O
probiotic	O
gum	O
may	O
affect	O
bacteria	O
that	O
produce	O
malodourous	O
compounds	O
other	O
than	O
VSCs	O
.	O

Oral	O
streptococci	B-bacteria
have	O
been	O
associated	O
with	O
systemic	O
diseases	O
,	O
including	O
infective	O
endocarditis	O
and	O
neutropenic	O
bacteremia	O
.	O

We	O
analyzed	O
58	O
recent	O
oral	O
streptococcal	B-bacteria
bloodstream	I-bacteria
isolates	I-bacteria
,	O
and	O
we	O
obtained	O
clinical	O
and	O
demographic	O
data	O
for	O
source	O
patients	O
.	O

The	O
sodA	O
gene	O
was	O
found	O
to	O
be	O
a	O
better	O
target	O
than	O
the	O
16S	O
-	O
23S	O
rRNA	O
internal	O
transcribed	O
spacer	O
for	O
DNA	O
sequence	O
-	O
based	O
species	O
identification	O
.	O

Together	O
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
were	O
significantly	O
more	O
likely	O
than	O
the	O
12	O
combined	O
remaining	O
species	O
to	O
be	O
isolated	O
from	O
neutropenic	O
patients	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
specific	O
parameters	O
of	O
low	O
-	O
level	O
laser	O
therapy	O
(	O
LLLT	O
)	O
on	O
biofilms	O
formed	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Candida	O
albicans	O
or	O
an	O
association	O
of	O
both	O
species	O
.	O

Single	O
and	O
dual	O
-	O
species	O
biofilms	O
-	O
-	O
SSB	O
and	O
DSB	O
-	O
-	O
were	O
exposed	O
to	O
laser	O
doses	O
of	O
5	O
,	O
10	O
or	O
20	O
J	O
/	O
cm	O
(	O
2	O
)	O
from	O
a	O
near	O
infrared	O
InGaAsP	O
diode	O
laser	O
prototype	O
(	O
LASERTable	O
;	O
780	O
+	O
/	O
-	O
3	O
nm	O
,	O
0	O
.	O
04	O
W	O
)	O
.	O

After	O
irradiation	O
,	O
the	O
analysis	O
of	O
biobilm	O
viability	O
(	O
MTT	O
assay	O
)	O
,	O
biofilm	O
growth	O
(	O
cfu	O
/	O
mL	O
)	O
and	O
cell	O
morphology	O
(	O
SEM	O
)	O
showed	O
that	O
LLLT	O
reduced	O
cell	O
viability	O
as	O
well	O
as	O
the	O
growth	O
of	O
biofilms	O
.	O

The	O
response	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
SSB	O
)	O
to	O
irradiation	O
was	O
similar	O
for	O
all	O
laser	O
doses	O
and	O
the	O
biofilm	O
growth	O
was	O
dose	O
dependent	O
.	O

However	O
,	O
when	O
associated	O
with	O
C	O
.	O
albicans	O
(	O
DSB	O
)	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
resistant	O
to	O
LLLT	O
.	O

For	O
C	O
.	O
albicans	O
,	O
the	O
association	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
DSB	O
)	O
caused	O
a	O
significant	O
decrease	O
in	O
biofilm	O
growth	O
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
.	O

The	O
morphology	O
of	O
the	O
microorganisms	O
in	O
the	O
SSB	O
was	O
not	O
altered	O
by	O
LLLT	O
,	O
while	O
the	O
association	O
of	O
microbial	O
species	O
(	O
DSB	O
)	O
promoted	O
a	O
reduction	O
in	O
the	O
formation	O
of	O
C	O
.	O
albicans	O
hyphae	O
.	O

LLLT	O
had	O
an	O
inhibitory	O
effect	O
on	O
the	O
microorganisms	O
,	O
and	O
this	O
capacity	O
can	O
be	O
altered	O
according	O
to	O
the	O
interactions	O
between	O
different	O
microbial	O
species	O
.	O

Oral	O
polymicrobial	O
interactions	O
and	O
biofilm	O
formation	O
are	O
associated	O
with	O
initiation	O
and	O
progression	O
of	O
caries	O
,	O
gingivitis	O
,	O
and	O
periodontitis	O
.	O

Transcriptome	O
studies	O
of	O
such	O
interactions	O
,	O
allowing	O
a	O
first	O
mechanistic	O
insight	O
,	O
are	O
hampered	O
by	O
current	O
single	O
-	O
species	O
array	O
designs	O
.	O

In	O
this	O
study	O
we	O
used	O
385	O
K	O
NimbleGene	O
technology	O
for	O
design	O
and	O
evaluation	O
of	O
an	O
array	O
covering	O
the	O
full	O
genomes	O
of	O
5	O
important	O
physiological	O
-	O
,	O
cariogenic	O
-	O
,	O
and	O
periodontitis	O
-	O
associated	O
microorganisms	O
(	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
.	O

Array	O
hybridization	O
was	O
done	O
with	O
cDNA	O
from	O
cultures	O
grown	O
for	O
24	O
h	O
anaerobically	O
.	O

Single	O
species	O
experiments	O
identified	O
cross	O
-	O
species	O
hybridizing	O
array	O
probes	O
.	O

These	O
probes	O
could	O
be	O
neglected	O
in	O
a	O
mixed	O
-	O
species	O
experimental	O
setting	O
without	O
the	O
need	O
to	O
exclude	O
the	O
whole	O
genes	O
from	O
the	O
analysis	O
.	O

Between	O
69	O
%	O
and	O
almost	O
99	O
%	O
of	O
the	O
genomes	O
were	O
actively	O
transcribed	O
under	O
the	O
mono	O
-	O
species	O
planktonic	O
,	O
monolayer	O
,	O
and	O
biofilm	O
conditions	O
.	O

The	O
influence	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
(	O
not	O
represented	O
on	O
the	O
array	O
)	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
gene	O
transcription	O
was	O
determined	O
as	O
a	O
test	O
for	O
a	O
dual	O
-	O
species	O
mixed	O
biofilm	O
setup	O
.	O

Phenotypically	O
,	O
under	O
the	O
influence	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
an	O
increase	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
mass	O
and	O
a	O
decrease	O
in	O
media	O
pH	O
-	O
value	O
were	O
noticed	O
,	O
thereby	O
confirming	O
previously	O
published	O
data	O
.	O

Employing	O
a	O
stringent	O
cut	O
-	O
off	O
(	O
2	O
-	O
fold	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
19	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
transcripts	O
were	O
identified	O
with	O
increased	O
abundance	O
,	O
and	O
11	O
with	O
decreased	O
abundance	O
compared	O
to	O
a	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
mono	O
-	O
species	O
biofilm	O
.	O

Several	O
of	O
these	O
genes	O
have	O
previously	O
been	O
found	O
differentially	O
regulated	O
under	O
general	O
and	O
acid	O
stress	O
,	O
thereby	O
confirming	O
the	O
value	O
of	O
this	O
array	O
.	O

This	O
new	O
array	O
allows	O
transcriptome	O
studies	O
on	O
multi	O
-	O
species	O
oral	O
biofilm	O
interactions	O
.	O

It	O
may	O
become	O
an	O
important	O
asset	O
in	O
future	O
oral	O
biofilm	O
and	O
inhibitor	O
/	O
therapy	O
studies	O
.	O

The	O
development	O
of	O
multispecies	O
oral	O
microbial	O
communities	O
involves	O
complex	O
intra	O
-	O
and	O
interspecies	O
interactions	O
at	O
various	O
levels	O
.	O

The	O
ability	O
to	O
adhere	O
to	O
the	O
resident	O
bacteria	O
or	O
the	O
biofilm	O
matrix	O
and	O
overcome	O
community	O
resistance	O
are	O
among	O
the	O
key	O
factors	O
that	O
determine	O
whether	O
a	O
bacterium	O
can	O
integrate	O
into	O
a	O
community	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
a	O
prevalent	O
Gram	O
-	O
negative	O
oral	O
bacterial	O
species	O
that	O
is	O
able	O
to	O
adhere	O
to	O
a	O
variety	O
of	O
oral	O
microbes	O
and	O
has	O
been	O
implicated	O
in	O
playing	O
an	O
important	O
role	O
in	O
the	O
establishment	O
of	O
multispecies	O
oral	O
microbial	O
community	O
.	O

However	O
,	O
the	O
majority	O
of	O
experiments	O
thus	O
far	O
has	O
focused	O
on	O
the	O
physical	O
adherence	O
between	O
two	O
species	O
as	O
measured	O
by	O
in	O
vitro	O
co	O
-	O
aggregation	O
assays	O
,	O
while	O
the	O
community	O
-	O
based	O
effects	O
on	O
the	O
integration	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
into	O
multispecies	O
microbial	O
community	O
remains	O
to	O
be	O
investigated	O
.	O

In	O
this	O
,	O
we	O
focus	O
on	O
community	O
integration	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

We	O
demonstrated	O
using	O
an	O
established	O
in	O
vitro	O
mice	O
oral	O
microbiota	O
(	O
O	O
-	O
mix	O
)	O
that	O
the	O
viability	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
significantly	O
reduced	O
upon	O
addition	O
to	O
the	O
O	O
-	O
mix	O
due	O
to	O
cell	O
contact	O
-	O
dependent	O
induction	O
of	O
hydrogen	O
peroxide	O
(	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
production	O
by	O
oral	O
community	O
.	O

Interestingly	O
,	O
this	O
inhibitory	O
effect	O
was	O
significantly	O
alleviated	O
when	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
allowed	O
to	O
adhere	O
to	O
its	O
known	O
interacting	O
partner	O
species	O
(	O
such	O
as	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
)	O
prior	O
to	O
addition	O
.	O

Furthermore	O
,	O
this	O
aggregate	O
formation	O
-	O
dependent	O
protection	O
was	O
absent	O
in	O
the	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
mutant	I-bacteria
strain	I-bacteria
DeltaFn1526	I-bacteria
that	O
is	O
unable	O
to	O
bind	O
to	O
a	O
number	O
of	O
Gram	O
-	O
positive	O
species	O
.	O

More	O
importantly	O
,	O
this	O
protective	O
effect	O
was	O
also	O
observed	O
during	O
integration	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
into	O
a	O
human	O
salivary	O
microbial	O
community	O
(	O
S	O
-	O
mix	O
)	O
.	O

These	O
results	O
suggest	O
that	O
by	O
adhering	O
to	O
other	O
oral	O
microbes	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
is	O
able	O
to	O
mask	O
the	O
surface	O
components	O
that	O
are	O
recognized	O
by	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
producing	O
oral	O
community	O
members	O
.	O

This	O
evasion	O
strategy	O
prevents	O
detection	O
by	O
antagonistic	O
oral	O
bacteria	O
and	O
allows	O
integration	O
into	O
the	O
developing	O
oral	O
microbial	O
community	O
.	O

Salmonella	B-bacteria
enterica	I-bacteria
serovar	I-bacteria
Choleraesuis	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
)	O
is	O
a	O
highly	O
invasive	O
zoonotic	O
pathogen	O
that	O
causes	O
bacteremia	O
in	O
humans	O
and	O
pigs	O
.	O

The	O
prevalence	O
of	O
S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
in	O
man	O
has	O
gradually	O
decreased	O
since	O
the	O
outbreak	O
of	O
foot	O
and	O
mouth	O
disease	O
in	O
pigs	O
in	O
1997	O
in	O
southern	O
Taiwan	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
change	O
in	O
prevalence	O
of	O
S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
carrying	O
the	O
virulence	O
plasmid	O
(	O
pSCV	O
)	O
in	O
human	O
and	O
swine	O
isolates	O
collected	O
in	O
1995	O
-	O
2005	O
and	O
characterize	O
these	O
.	O

380	O
isolates	O
were	O
collected	O
from	O
human	O
and	O
swine	O
blood	O
samples	O
.	O

Large	O
pSCVs	O
were	O
determined	O
by	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
.	O

Antimicrobial	O
susceptibility	O
and	O
resistance	O
genes	O
,	O
and	O
the	O
phylogenetic	O
association	O
of	O
these	O
large	O
pSCV	O
were	O
analyzed	O
.	O

The	O
number	O
of	O
isolates	O
harboring	O
the	O
large	O
pSCV	O
was	O
significantly	O
reduced	O
,	O
and	O
their	O
prevalence	O
differed	O
between	O
human	O
and	O
swine	O
isolates	O
.	O

These	O
large	O
pSCVs	O
were	O
a	O
recombinant	O
of	O
original	O
50	O
-	O
kb	O
pSCV	O
and	O
R	O
plasmid	O
.	O

In	O
addition	O
,	O
some	O
large	O
pSCVs	O
lacked	O
two	O
pSCV	O
-	O
specific	O
deletion	O
regions	O
from	O
pef	O
to	O
repC	O
and	O
from	O
traT	O
to	O
samA	O
.	O

These	O
large	O
pSCVs	O
carried	O
the	O
resistance	O
genes	O
bla	O
(	O
TEM	O
,	O
)	O
aadA2	O
,	O
and	O
sulI	O
,	O
as	O
well	O
as	O
class	O
I	O
integrons	O
of	O
0	O
.	O
65	O
and	O
/	O
or	O
1	O
.	O
9	O
kb	O
in	O
size	O
,	O
but	O
were	O
inconjugatible	O
.	O

Phylogenetic	O
analysis	O
demonstrated	O
that	O
the	O
large	O
pSCV	O
evolves	O
independently	O
in	O
human	O
and	O
swine	O
isolates	O
.	O

S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
with	O
large	O
pSCV	O
was	O
significantly	O
reduced	O
after	O
the	O
foot	O
and	O
mouth	O
disease	O
outbreak	O
and	O
may	O
evolve	O
in	O
human	O
and	O
swine	O
specific	O
isolates	O
.	O

White	O
Sponge	O
Nevus	O
(	O
WSN	O
)	O
is	O
a	O
rare	O
pathology	O
with	O
a	O
pathogenesis	O
on	O
genetic	O
basis	O
,	O
a	O
benign	O
course	O
and	O
a	O
localization	O
affecting	O
the	O
mucosal	O
keratin	O
.	O

WSN	O
is	O
usually	O
a	O
symptomless	O
pathology	O
:	O
when	O
pain	O
is	O
present	O
,	O
some	O
authors	O
reported	O
reduction	O
of	O
symptoms	O
by	O
taking	O
penicillin	O
or	O
oral	O
tetracycline	O
rinses	O
,	O
suggesting	O
that	O
a	O
bacterial	O
overinfection	O
could	O
be	O
at	O
the	O
base	O
of	O
possible	O
painful	O
symptoms	O
.	O

We	O
describe	O
2	O
patients	O
affected	O
by	O
WSN	O
,	O
father	O
and	O
son	O
:	O
they	O
presented	O
two	O
different	O
oral	O
diseases	O
associated	O
with	O
an	O
infection	O
by	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

So	O
,	O
we	O
have	O
performed	O
a	O
careful	O
oral	O
hygiene	O
to	O
reduce	O
infection	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
the	O
following	O
days	O
we	O
prescribed	O
2	O
rinses	O
a	O
day	O
with	O
a	O
mouthwash	O
containing	O
chlorhexidine	O
digluconate	O
at	O
two	O
different	O
percentages	O
.	O

Early	O
diagnosis	O
of	O
this	O
lesion	O
is	O
important	O
,	O
because	O
it	O
allows	O
us	O
to	O
exclude	O
other	O
more	O
serious	O
diseases	O
.	O

In	O
the	O
most	O
part	O
of	O
cases	O
,	O
WSN	O
requires	O
no	O
treatment	O
because	O
of	O
its	O
benign	O
and	O
asymptomatic	O
behaviour	O
:	O
up	O
to	O
now	O
,	O
no	O
protocol	O
of	O
treatment	O
for	O
this	O
condition	O
was	O
standardized	O
.	O

Even	O
if	O
WSN	O
is	O
a	O
painless	O
condition	O
,	O
sometime	O
a	O
correlated	O
painful	O
symptomatology	O
was	O
reported	O
.	O

In	O
our	O
experience	O
,	O
we	O
have	O
achieved	O
excellent	O
results	O
even	O
with	O
chlorhexidine	O
digluconate	O
rinses	O
,	O
considering	O
that	O
our	O
treated	O
cases	O
were	O
both	O
infected	O
by	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

We	O
hypothesize	O
that	O
the	O
corrugated	O
plaques	O
and	O
the	O
altered	O
texture	O
of	O
the	O
mucosa	O
create	O
the	O
right	O
conditions	O
for	O
the	O
colonization	O
and	O
the	O
development	O
of	O
microbial	O
species	O
such	O
as	O
saprophytic	O
bacteria	O
or	O
fungal	O
species	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
metabolize	O
carbohydrates	O
,	O
such	O
as	O
glucose	O
and	O
sucrose	O
,	O
to	O
produce	O
acid	O
and	O
enhance	O
biofilm	O
formation	O
with	O
the	O
early	O
colonizing	O
bacteria	O
to	O
induce	O
dental	O
caries	O
.	O

Xylitol	O
has	O
been	O
used	O
as	O
a	O
reliable	O
substitute	O
for	O
carbohydrate	O
to	O
inhibit	O
the	O
acid	O
production	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

However	O
,	O
long	O
-	O
term	O
xylitol	O
consumption	O
leads	O
to	O
the	O
emergence	O
of	O
xylitol	O
-	O
resistance	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
cariogenic	O
trait	O
of	O
Xylitol	O
-	O
resistant	O
(	O
X	O
(	O
R	O
)	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
using	O
biofilm	O
formation	O
and	O
coaggregation	O
of	O
xylitol	O
-	O
sensitive	O
(	O
X	O
(	O
S	O
)	O
)	O
and	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
with	O
salivary	O
bacteria	O
and	O
their	O
glucosyltransferases	O
expression	O
.	O

When	O
X	O
(	O
S	O
)	O
or	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
incubated	O
in	O
brain	O
heart	O
infusion	O
broth	O
with	O
bacteria	O
from	O
human	O
saliva	O
,	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
exhibited	O
reduction	O
in	O
biofilm	O
formation	O
in	O
comparison	O
to	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
coaggregation	O
between	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
,	I-bacteria
gordonii	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
was	O
less	O
pronounced	O
than	O
that	O
of	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
presence	O
of	O
sucrose	O
.	O

However	O
,	O
there	O
was	O
no	O
difference	O
in	O
the	O
coaggregation	O
between	O
X	O
(	O
R	O
)	O
and	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
sucrose	O
-	O
free	O
condition	O
.	O

The	O
level	O
of	O
gtfB	O
and	O
gtfC	O
mRNA	O
expression	O
of	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
lower	O
than	O
that	O
of	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
whilst	O
the	O
level	O
of	O
gtfD	O
mRNA	O
expression	O
did	O
not	O
differ	O
between	O
the	O
two	O
strains	O
.	O

The	O
reduction	O
of	O
biofilm	O
formation	O
in	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
due	O
to	O
decrease	O
in	O
glucosyltransferases	O
expression	O
suggests	O
that	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
may	O
be	O
less	O
cariogenic	O
than	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
present	O
investigation	O
aimed	O
to	O
analyse	O
clinical	O
and	O
microbiological	O
effects	O
of	O
systemic	O
administration	O
of	O
metronidazole	O
and	O
amoxicillin	O
combined	O
with	O
the	O
One	O
-	O
Stage	O
-	O
Full	O
-	O
Mouth	O
-	O
Disinfection	O
protocol	O
(	O
OSFMD	O
)	O
in	O
generalized	O
aggressive	O
periodontitis	O
patients	O
(	O
G	O
-	O
AgP	O
)	O
.	O

Thirty	O
-	O
nine	O
systemically	O
healthy	O
patients	O
with	O
G	O
-	O
AgP	O
were	O
consecutively	O
included	O
.	O

The	O
test	O
group	O
(	O
n	O
=	O
19	O
)	O
received	O
amoxicillin	O
-	O
metronidazole	O
combination	O
(	O
500	O
mg	O
of	O
each	O
,	O
three	O
times	O
a	O
day	O
for	O
7	O
days	O
)	O
and	O
the	O
OSFMD	O
,	O
the	O
control	O
group	O
(	O
n	O
=	O
20	O
)	O
received	O
the	O
OSFMD	O
and	O
a	O
placebo	O
.	O

In	O
addition	O
to	O
clinical	O
parameters	O
subgingival	O
plaque	O
samples	O
from	O
moderate	O
(	O
4	O
-	O
5	O
mm	O
)	O
and	O
deep	O
(	O
>	O
/	O
=	O
6	O
mm	O
)	O
pocket	O
sites	O
were	O
analysed	O
for	O
the	O
presence	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
using	O
polymerase	O
chain	O
reaction	O
.	O

Both	O
therapies	O
led	O
to	O
a	O
statistically	O
significant	O
decrease	O
in	O
clinical	O
and	O
microbiological	O
parameters	O
compared	O
to	O
baseline	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
most	O
beneficial	O
changes	O
were	O
observed	O
in	O
the	O
test	O
group	O
which	O
showed	O
significantly	O
greater	O
improvements	O
in	O
probing	O
depth	O
and	O
clinical	O
attachment	O
level	O
and	O
a	O
lower	O
prevalence	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
compared	O
to	O
the	O
control	O
one	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Systemic	O
administration	O
of	O
metronidazole	O
and	O
amoxicillin	O
as	O
an	O
adjunct	O
to	O
OSFMD	O
therapy	O
significantly	O
improved	O
clinical	O
and	O
microbiological	O
outcomes	O
in	O
patients	O
with	O
G	O
-	O
AgP	O
over	O
a	O
6	O
-	O
month	O
period	O
.	O

As	O
the	O
oral	O
cavity	O
is	O
regarded	O
as	O
a	O
relevant	O
site	O
for	O
Staphylococcus	B-bacteria
aureus	I-bacteria
colonization	O
and	O
interhuman	O
transmission	O
,	O
this	O
study	O
aimed	O
to	O
investigate	O
whether	O
different	O
oral	O
conditions	O
influence	O
the	O
rates	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
oral	O
carriage	O
and	O
genetic	O
characters	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
isolates	I-bacteria
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
searched	O
in	O
samples	O
collected	O
from	O
cheek	O
,	O
gingival	O
margin	O
,	O
and	O
anterior	O
nares	O
of	O
45	O
healthy	O
subjects	O
,	O
27	O
periodontitis	O
affected	O
subjects	O
,	O
and	O
29	O
subjects	O
with	O
fixed	O
prosthetic	O
restorations	O
.	O

Isolates	O
were	O
screened	O
for	O
17	O
genetic	O
determinants	O
,	O
and	O
Partial	O
Least	O
Square	O
Discriminant	O
Analysis	O
was	O
performed	O
to	O
evaluate	O
whether	O
specific	O
characters	O
correlated	O
with	O
oral	O
condition	O
or	O
site	O
of	O
isolation	O
.	O

The	O
three	O
subject	O
groups	O
showed	O
comparable	O
nasal	O
carriage	O
rates	O
but	O
,	O
both	O
the	O
periodontitis	O
and	O
prosthetic	O
restoration	O
groups	O
showed	O
significantly	O
higher	O
oral	O
carriage	O
rates	O
,	O
as	O
compared	O
to	O
healthy	O
subjects	O
(	O
P	O
=	O
0	O
.	O
01	O
and	O
0	O
.	O
02	O
,	O
respectively	O
)	O
.	O

Moreover	O
,	O
periodontitis	O
affected	O
subjects	O
hosted	O
strains	O
possessing	O
a	O
distinct	O
genotypic	O
and	O
phenotypic	O
background	O
,	O
characterized	O
by	O
the	O
presence	O
of	O
a	O
larger	O
number	O
of	O
exotoxins	O
encoding	O
genes	O
.	O

These	O
data	O
confirm	O
that	O
the	O
oral	O
cavity	O
is	O
an	O
important	O
site	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
colonization	O
and	O
demonstrate	O
that	O
conditions	O
modifying	O
the	O
oral	O
environment	O
,	O
as	O
the	O
presence	O
of	O
periodontitis	O
and	O
of	O
fixed	O
prosthetic	O
restorations	O
,	O
promote	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
carriage	O
and	O
may	O
favor	O
the	O
spread	O
of	O
more	O
pathogenic	O
strains	O
.	O

A	O
low	O
pH	O
environment	O
is	O
created	O
by	O
cariogenic	O
bacteria	O
.	O

This	O
study	O
was	O
aimed	O
to	O
measure	O
pH	O
of	O
carious	O
lesions	O
intraorally	O
using	O
a	O
micro	O
-	O
pH	O
sensor	O
,	O
and	O
assess	O
predominant	O
acid	O
-	O
producing	O
cariogens	O
by	O
qPCR	O
to	O
differentiate	O
caries	O
activities	O
.	O

103	O
dentine	O
lesions	O
classified	O
as	O
active	O
or	O
arrested	O
caries	O
based	O
on	O
the	O
clinical	O
and	O
radiological	O
examinations	O
were	O
collected	O
from	O
patients	O
after	O
intraoral	O
measurement	O
of	O
the	O
lesion	O
surface	O
pH	O
using	O
a	O
micro	O
-	O
pH	O
sensor	O
.	O

Quantitative	O
detection	O
of	O
genomic	O
DNA	O
copies	O
of	O
target	O
cariogenic	O
bacteria	O
(	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
in	O
each	O
lesion	O
was	O
performed	O
using	O
real	O
-	O
time	O
PCR	O
.	O

Correlation	O
between	O
the	O
pH	O
ranges	O
and	O
the	O
number	O
of	O
bacterial	O
species	O
was	O
examined	O
by	O
Spearman	O
test	O
.	O

50	O
samples	O
were	O
diagnosed	O
as	O
active	O
and	O
53	O
as	O
arrested	O
lesions	O
.	O

Statistically	O
significant	O
difference	O
was	O
observed	O
on	O
average	O
surface	O
pH	O
value	O
between	O
active	O
and	O
arrested	O
lesions	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Prevalence	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
higher	O
in	O
active	O
lesions	O
than	O
in	O
arrested	O
lesions	O
(	O
76	O
%	O
vs	O
.	O
58	O
%	O
of	O
samples	O
,	O
respectively	O
)	O
.	O

When	O
the	O
carious	O
lesions	O
were	O
categorised	O
into	O
four	O
different	O
pH	O
ranges	O
(	O
up	O
to	O
5	O
.	O
5	O
,	O
from	O
5	O
.	O
6	O
to	O
5	O
.	O
8	O
,	O
from	O
5	O
.	O
9	O
to	O
6	O
.	O
1	O
and	O
6	O
.	O
2	O
or	O
above	O
)	O
,	O
increased	O
prevalence	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
observed	O
with	O
decrease	O
of	O
pH	O
levels	O
.	O

A	O
significant	O
negative	O
relationship	O
was	O
found	O
between	O
pH	O
value	O
and	O
number	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
209	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
but	O
no	O
such	O
correlation	O
was	O
found	O
for	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Intraoral	O
pH	O
measurement	O
might	O
be	O
clinically	O
useful	O
to	O
determine	O
acidity	O
of	O
the	O
local	O
environment	O
of	O
carious	O
lesions	O
as	O
one	O
aspect	O
of	O
the	O
caries	O
activity	O
assessment	O
.	O

The	O
population	O
of	O
certain	O
bacteria	O
may	O
indicate	O
activity	O
of	O
carious	O
lesions	O
.	O

Intraoral	O
pH	O
measurement	O
of	O
the	O
carious	O
lesions	O
using	O
a	O
micro	O
-	O
pH	O
sensor	O
may	O
be	O
a	O
clinically	O
feasible	O
method	O
for	O
assessment	O
of	O
lesion	O
acidity	O
.	O

One	O
of	O
the	O
major	O
components	O
of	O
dental	O
polymerized	O
resin	O
-	O
based	O
restorative	O
materials	O
is	O
2	O
-	O
hydroxyethyl	O
methacrylate	O
(	O
HEMA	O
)	O
and	O
its	O
release	O
in	O
monomeric	O
form	O
interferes	O
with	O
the	O
oral	O
cavity	O
environment	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
HEMA	O
monomeric	O
effects	O
on	O
the	O
co	O
-	O
culture	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
human	O
gingival	O
fibroblasts	O
(	O
HGFs	O
)	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
DS12	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
6249	I-bacteria
were	O
co	O
-	O
cultivated	O
with	O
HGF	O
in	O
the	O
presence	O
of	O
HEMA	O
(	O
3	O
mM	O
)	O
,	O
for	O
48	O
and	O
72	O
h	O
;	O
the	O
amount	O
of	O
sessile	O
and	O
planktonic	O
cells	O
,	O
as	O
well	O
as	O
the	O
prokaryotic	O
and	O
eukaryotic	O
cell	O
viability	O
were	O
analyzed	O
in	O
treated	O
and	O
untreated	O
samples	O
.	O

The	O
treatment	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
/	O
HGFs	O
with	O
HEMA	O
did	O
not	O
produce	O
significant	O
effects	O
on	O
the	O
bacterial	O
adhesion	O
and	O
induced	O
an	O
increase	O
in	O
planktonic	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
6249	I-bacteria
population	O
after	O
48	O
and	O
72	O
h	O
.	O

HEMA	O
increased	O
significantly	O
the	O
planktonic	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
6249	I-bacteria
viability	O
when	O
co	O
-	O
cultured	O
with	O
HGFs	O
,	O
while	O
a	O
cytotoxic	O
effect	O
on	O
HGFs	O
,	O
without	O
bacteria	O
,	O
was	O
recorded	O
.	O

An	O
increase	O
of	O
bacterial	O
aggregation	O
on	O
HGFs	O
was	O
also	O
detected	O
with	O
HEMA	O
.	O

Data	O
obtained	O
in	O
this	O
study	O
suggest	O
that	O
HEMA	O
exhibits	O
a	O
toxic	O
effect	O
mainly	O
on	O
eukaryotic	O
cells	O
and	O
this	O
effect	O
can	O
be	O
modulated	O
by	O
co	O
-	O
cultivation	O
with	O
the	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
cells	O
which	O
,	O
in	O
the	O
presence	O
of	O
the	O
monomer	O
,	O
enhance	O
their	O
aggregation	O
rate	O
on	O
HGFs	O
.	O

A	O
well	O
-	O
known	O
indication	O
for	O
the	O
cytologic	O
examination	O
of	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
is	O
the	O
identification	O
of	O
infectious	O
organisms	O
.	O

However	O
,	O
an	O
important	O
distinction	O
must	O
be	O
made	O
as	O
to	O
whether	O
the	O
organisms	O
seen	O
represent	O
a	O
true	O
opportunistic	O
lower	O
respiratory	O
tract	O
infection	O
or	O
a	O
non	O
-	O
pathologic	O
contamination	O
.	O

We	O
describe	O
herein	O
the	O
case	O
of	O
a	O
13	O
-	O
month	O
-	O
old	O
male	O
infant	O
who	O
presented	O
with	O
persistent	O
chest	O
congestion	O
and	O
tracheobronchitis	O
and	O
who	O
underwent	O
BAL	O
as	O
part	O
of	O
his	O
clinical	O
work	O
-	O
up	O
.	O

On	O
cytological	O
examination	O
of	O
the	O
BAL	O
fluid	O
,	O
the	O
Romanowsky	O
-	O
stained	O
cytospin	O
slides	O
contained	O
numerous	O
squamous	O
epithelial	O
cells	O
with	O
some	O
showing	O
rare	O
striated	O
rod	O
-	O
like	O
structures	O
on	O
their	O
surfaces	O
.	O

The	O
peculiar	O
structures	O
also	O
had	O
rounded	O
ends	O
and	O
were	O
very	O
large	O
when	O
compared	O
to	O
adjacent	O
known	O
bacterial	O
cocci	O
.	O

We	O
have	O
determined	O
that	O
the	O
striated	O
rod	O
-	O
like	O
structures	O
in	O
the	O
infant	O
'	O
s	O
BAL	O
fluid	O
were	O
indeed	O
bacteria	O
,	O
Simonsiella	B-bacteria
sp	I-bacteria
.	O

Simonsiella	B-bacteria
has	O
reportedly	O
been	O
found	O
in	O
up	O
to	O
32	O
%	O
of	O
oral	O
swabs	O
in	O
normal	O
humans	O
and	O
it	O
is	O
considered	O
a	O
commensal	O
and	O
non	O
-	O
pathogenic	O
organism	O
.	O

The	O
characteristically	O
large	O
size	O
,	O
the	O
association	O
with	O
normal	O
oral	O
-	O
derived	O
squamous	O
cells	O
and	O
the	O
striated	O
appearance	O
is	O
diagnostic	O
and	O
will	O
hopefully	O
eliminate	O
any	O
possibility	O
of	O
confusion	O
with	O
a	O
truly	O
pathogenic	O
organism	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
gingival	O
fluid	O
(	O
GCF	O
)	O
cytokine	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
levels	O
,	O
subgingival	O
bacteria	O
,	O
and	O
clinical	O
periodontal	O
conditions	O
during	O
a	O
normal	O
pregnancy	O
to	O
postpartum	O
.	O

Subgingival	O
bacterial	O
samples	O
were	O
analyzed	O
with	O
the	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
method	O
.	O

GCF	O
samples	O
were	O
assessed	O
with	O
real	O
-	O
time	O
PCR	O
including	O
five	O
proinflammatory	O
cytokines	O
and	O
secretory	O
leukocyte	O
protease	O
inhibitor	O
.	O

Nineteen	O
pregnant	O
women	O
with	O
a	O
mean	O
age	O
of	O
32	O
years	O
(	O
S	O
.	O
D	O
.	O
+	O
/	O
-	O
4	O
years	O
,	O
range	O
26	O
-	O
42	O
)	O
participated	O
in	O
the	O
study	O
.	O

Full	O
-	O
mouth	O
bleeding	O
scores	O
(	O
BOP	O
)	O
decreased	O
from	O
an	O
average	O
of	O
41	O
.	O
2	O
%	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
18	O
.	O
6	O
%	O
)	O
at	O
the	O
12th	O
week	O
of	O
pregnancy	O
to	O
26	O
.	O
6	O
%	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
14	O
.	O
4	O
%	O
)	O
at	O
the	O
4	O
-	O
6	O
weeks	O
postpartum	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Between	O
week	O
12	O
and	O
4	O
-	O
6	O
weeks	O
postpartum	O
,	O
the	O
mean	O
probing	O
pocket	O
depth	O
changed	O
from	O
2	O
.	O
4	O
mm	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
0	O
.	O
4	O
)	O
to	O
2	O
.	O
3	O
mm	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
0	O
.	O
3	O
)	O
(	O
p	O
=	O
0	O
.	O
34	O
)	O
.	O

Higher	O
counts	O
of	O
Eubacterium	B-bacteria
saburreum	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Selenomonas	B-bacteria
noxia	I-bacteria
,	O
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
were	O
found	O
at	O
week	O
12	O
of	O
pregnancy	O
than	O
at	O
the	O
4	O
-	O
6	O
weeks	O
postpartum	O
examinations	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

During	O
and	O
after	O
pregnancy	O
,	O
statistically	O
significant	O
correlations	O
between	O
BOP	O
scores	O
and	O
bacterial	O
counts	O
were	O
observed	O
.	O

BOP	O
scores	O
and	O
GCF	O
levels	O
of	O
selected	O
cytokines	O
were	O
not	O
related	O
to	O
each	O
other	O
and	O
no	O
differences	O
in	O
GCF	O
levels	O
of	O
the	O
cytokines	O
were	O
observed	O
between	O
samples	O
from	O
the	O
12th	O
week	O
of	O
pregnancy	O
to	O
4	O
-	O
6	O
weeks	O
postpartum	O
.	O

Decreasing	O
postpartum	O
counts	O
of	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
were	O
associated	O
with	O
decreasing	O
levels	O
of	O
Il	O
-	O
8	O
and	O
Il	O
-	O
1beta	O
.	O

BOP	O
decreased	O
after	O
pregnancy	O
without	O
any	O
active	O
periodontal	O
therapy	O
.	O

Associations	O
between	O
bacterial	O
counts	O
and	O
cytokine	O
levels	O
varied	O
greatly	O
in	O
pregnant	O
women	O
with	O
gingivitis	O
and	O
a	O
normal	O
pregnancy	O
outcome	O
.	O

Postpartum	O
associations	O
between	O
GCF	O
cytokines	O
and	O
bacterial	O
counts	O
were	O
more	O
consistent	O
.	O

Combined	O
assessments	O
of	O
gingival	O
fluid	O
cytokines	O
and	O
subgingival	O
bacteria	O
may	O
provide	O
important	O
information	O
on	O
host	O
response	O
.	O

Oral	O
bacterial	O
biofilms	O
trigger	O
chronic	O
inflammatory	O
responses	O
in	O
the	O
host	O
that	O
can	O
result	O
in	O
the	O
tissue	O
destructive	O
events	O
of	O
periodontitis	O
.	O

However	O
,	O
the	O
characteristics	O
of	O
the	O
capacity	O
of	O
specific	O
host	O
cell	O
types	O
to	O
respond	O
to	O
these	O
biofilms	O
remain	O
ill	O
-	O
defined	O
.	O

This	O
report	O
describes	O
the	O
use	O
of	O
a	O
novel	O
model	O
of	O
bacterial	O
biofilms	O
to	O
stimulate	O
oral	O
epithelial	O
cells	O
and	O
profile	O
select	O
cytokines	O
and	O
chemokines	O
that	O
contribute	O
to	O
the	O
local	O
inflammatory	O
environment	O
in	O
the	O
periodontium	O
.	O

Monoinfection	O
biofilms	O
were	O
developed	O
with	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
on	O
rigid	O
gas	O
-	O
permeable	O
contact	O
lenses	O
.	O

Biofilms	O
,	O
as	O
well	O
as	O
planktonic	O
cultures	O
of	O
these	O
same	O
bacterial	O
species	O
,	O
were	O
incubated	O
under	O
anaerobic	O
conditions	O
with	O
a	O
human	O
oral	O
epithelial	O
cell	O
line	O
,	O
OKF4	O
,	O
for	O
up	O
to	O
24h	O
.	O

Gro	O
-	O
1alpha	O
,	O
IL1alpha	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
TGFalpha	O
,	O
Fractalkine	O
,	O
MIP	O
-	O
1alpha	O
,	O
and	O
IP	O
-	O
10	O
were	O
shown	O
to	O
be	O
produced	O
in	O
response	O
to	O
a	O
range	O
of	O
the	O
planktonic	O
or	O
biofilm	O
forms	O
of	O
these	O
species	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
significantly	O
inhibited	O
the	O
production	O
of	O
all	O
of	O
these	O
cytokines	O
and	O
chemokines	O
,	O
except	O
MIP	O
-	O
1alpha	O
.	O

Generally	O
,	O
the	O
biofilms	O
of	O
all	O
species	O
inhibited	O
Gro	O
-	O
1alpha	O
,	O
TGFalpha	O
,	O
and	O
Fractalkine	O
production	O
,	O
while	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
biofilms	O
stimulated	O
significant	O
increases	O
in	O
IL	O
-	O
1alpha	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
IP	O
-	O
10	O
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
biofilms	O
induced	O
elevated	O
levels	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
IP	O
-	O
10	O
.	O

The	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
in	O
biofilms	O
or	O
planktonic	O
forms	O
were	O
poor	O
stimulants	O
for	O
any	O
of	O
these	O
mediators	O
from	O
the	O
epithelial	O
cells	O
.	O

The	O
results	O
of	O
these	O
studies	O
demonstrate	O
that	O
oral	O
bacteria	O
in	O
biofilms	O
elicit	O
a	O
substantially	O
different	O
profile	O
of	O
responses	O
compared	O
to	O
planktonic	O
bacteria	O
of	O
the	O
same	O
species	O
.	O

Moreover	O
,	O
certain	O
oral	O
species	O
are	O
highly	O
stimulatory	O
when	O
in	O
biofilms	O
and	O
interact	O
with	O
host	O
cell	O
receptors	O
to	O
trigger	O
pathways	O
of	O
responses	O
that	O
appear	O
quite	O
divergent	O
from	O
individual	O
bacteria	O
.	O

Oral	O
candidiasis	O
is	O
often	O
accompanied	O
by	O
severe	O
inflammation	O
,	O
resulting	O
in	O
a	O
decline	O
in	O
the	O
quality	O
of	O
life	O
of	O
immunosuppressed	O
individuals	O
and	O
elderly	O
people	O
.	O

To	O
develop	O
a	O
new	O
oral	O
therapeutic	O
option	O
for	O
candidiasis	O
,	O
a	O
nonpathogenic	O
commensal	O
oral	O
probiotic	O
microorganism	O
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
,	O
was	O
evaluated	O
for	O
its	O
ability	O
to	O
modulate	O
Candida	O
albicans	O
growth	O
in	O
vitro	O
,	O
and	O
its	O
therapeutic	O
activity	O
in	O
an	O
experimental	O
oral	O
candidiasis	O
model	O
was	O
tested	O
.	O

In	O
vitro	O
inhibition	O
of	O
mycelial	O
growth	O
of	O
C	O
.	O
albicans	O
was	O
determined	O
by	O
plate	O
assay	O
and	O
fluorescence	O
microscopy	O
.	O

Addition	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
to	O
modified	O
RPMI	O
1640	O
culture	O
medium	O
inhibited	O
the	O
adherence	O
of	O
C	O
.	O
albicans	O
to	O
the	O
plastic	O
petri	O
dish	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Preculture	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
potentiated	O
its	O
inhibitory	O
activity	O
for	O
adherence	O
of	O
C	O
.	O
albicans	O
.	O

Interestingly	O
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
was	O
not	O
directly	O
fungicidal	O
but	O
appeared	O
to	O
inhibit	O
Candida	O
adhesion	O
to	O
the	O
substratum	O
by	O
preferentially	O
binding	O
to	O
hyphae	O
rather	O
than	O
yeast	O
.	O

To	O
determine	O
the	O
potentially	O
anti	O
-	O
infective	O
attributes	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
in	O
oral	O
candidiasis	O
,	O
the	O
probiotic	O
was	O
administered	O
to	O
mice	O
with	O
orally	O
induced	O
candidiasis	O
.	O

Oral	O
treatment	O
with	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
significantly	O
protected	O
the	O
mice	O
from	O
severe	O
candidiasis	O
.	O

These	O
findings	O
suggest	O
that	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
may	O
inhibit	O
the	O
process	O
of	O
invasion	O
of	O
C	O
.	O
albicans	O
into	O
mucous	O
surfaces	O
or	O
its	O
adhesion	O
to	O
denture	O
acrylic	O
resins	O
by	O
mechanisms	O
not	O
associated	O
with	O
the	O
antimicrobial	O
activity	O
of	O
the	O
bacteriocin	O
.	O

S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
may	O
be	O
useful	O
as	O
a	O
probiotic	O
as	O
a	O
protective	O
tool	O
for	O
oral	O
care	O
,	O
especially	O
with	O
regard	O
to	O
candidiasis	O
.	O

A	O
total	O
of	O
three	O
intensive	O
care	O
units	O
(	O
ICU	O
)	O
at	O
a	O
German	O
university	O
hospital	O
were	O
involved	O
in	O
an	O
outbreak	O
of	O
Burkholderia	B-bacteria
cepacia	I-bacteria
complex	I-bacteria
(	O
Bcc	B-bacteria
)	O
.	O

Patients	O
with	O
microbiological	O
detection	O
of	O
Bcc	B-bacteria
were	O
evaluated	O
.	O

Products	O
used	O
for	O
mouth	O
hygiene	O
were	O
microbiologically	O
tested	O
.	O

The	O
clonal	O
identity	O
of	O
Bcc	B-bacteria
was	O
proven	O
by	O
pulse	O
-	O
field	O
gel	O
electrophoresis	O
(	O
PFGE	O
)	O
.	O

On	O
3	O
ICUs	O
12	O
cases	O
were	O
identified	O
whereby	O
the	O
first	O
detection	O
of	O
Bcc	B-bacteria
was	O
in	O
respiratory	O
specimens	O
of	O
11	O
patients	O
and	O
1	O
in	O
a	O
wound	O
swab	O
from	O
the	O
oral	O
cavity	O
.	O

Of	O
these	O
patients	O
six	O
developed	O
ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
.	O

Investigations	O
revealed	O
that	O
five	O
different	O
batches	O
of	O
an	O
alcohol	O
-	O
free	O
mouthwash	O
containing	O
hexetidine	O
were	O
highly	O
contaminated	O
.	O

Isolates	O
of	O
Bcc	B-bacteria
from	O
patients	O
and	O
mouthwashes	O
were	O
genetically	O
indistinguishable	O
.	O

A	O
recall	O
of	O
the	O
product	O
was	O
initiated	O
.	O

After	O
elimination	O
of	O
the	O
product	O
from	O
the	O
ICUs	O
no	O
more	O
cases	O
were	O
identified	O
.	O

The	O
source	O
of	O
the	O
outbreak	O
was	O
an	O
intrinsically	O
contaminated	O
alcohol	O
-	O
free	O
mouthwash	O
.	O

Detection	O
of	O
Bcc	B-bacteria
in	O
specimens	O
from	O
ICU	O
patients	O
should	O
lead	O
to	O
further	O
investigations	O
.	O

Antiseptic	O
oral	O
care	O
products	O
are	O
recommended	O
for	O
reducing	O
the	O
risk	O
of	O
VAP	O
but	O
they	O
may	O
be	O
microbiologically	O
contaminated	O
and	O
,	O
in	O
consequence	O
,	O
increase	O
the	O
risk	O
.	O

The	O
safety	O
of	O
patient	O
care	O
products	O
should	O
be	O
increased	O
by	O
stricter	O
regulations	O
.	O

Dental	O
caries	O
and	O
pulpal	O
diseases	O
are	O
common	O
oral	O
bacterial	O
infectious	O
diseases	O
.	O

Controlling	O
and	O
reducing	O
the	O
causative	O
pathogens	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
is	O
a	O
key	O
step	O
toward	O
prevention	O
and	O
treatment	O
of	O
the	O
two	O
diseases	O
.	O

Chrysophsin	O
-	O
1	O
is	O
a	O
cationic	O
antimicrobial	O
peptide	O
having	O
broad	O
-	O
spectrum	O
bactericidal	O
activity	O
against	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
antibacterial	O
activity	O
of	O
chrysophsin	O
-	O
1	O
against	O
several	O
oral	O
pathogens	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
and	O
performed	O
a	O
preliminary	O
study	O
of	O
the	O
antimicrobial	O
mechanism	O
.	O

Cytotoxic	O
activity	O
of	O
chrysophsin	O
-	O
1	O
against	O
human	O
gingival	O
fibroblasts	O
(	O
HGFs	O
)	O
was	O
investigated	O
.	O

Minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
,	O
minimal	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
and	O
time	O
-	O
kill	O
assay	O
were	O
used	O
to	O
evaluate	O
the	O
killing	O
effect	O
of	O
chrysophsin	O
-	O
1	O
.	O

Scanning	O
electron	O
microscopy	O
(	O
SEM	O
)	O
was	O
used	O
to	O
analyze	O
morphological	O
and	O
membrane	O
change	O
in	O
oral	O
pathogens	O
.	O

Live	O
/	O
Dead	O
staining	O
,	O
in	O
conjunction	O
with	O
confocal	O
scanning	O
laser	O
microscopy	O
(	O
CSLM	O
)	O
,	O
was	O
used	O
to	O
observe	O
and	O
analyze	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

MIC	O
and	O
MBC	O
results	O
demonstrated	O
that	O
chrysophsin	O
-	O
1	O
had	O
different	O
antimicrobial	O
activities	O
against	O
the	O
tested	O
oral	O
microbes	O
.	O

Lysis	O
and	O
pore	O
formation	O
of	O
the	O
cytomembrane	O
were	O
observed	O
following	O
treatment	O
of	O
the	O
bacteria	O
with	O
chrysophsin	O
-	O
1	O
for	O
4h	O
or	O
24h	O
by	O
SEM	O
.	O

Furthermore	O
,	O
CLSM	O
images	O
showed	O
that	O
chrysophsin	O
-	O
1	O
remarkably	O
reduced	O
the	O
viability	O
of	O
cells	O
within	O
biofilms	O
and	O
had	O
a	O
significantly	O
lethal	O
effect	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

Toxicity	O
studies	O
showed	O
that	O
chrysophsin	O
-	O
1	O
at	O
concentration	O
between	O
8	O
mug	O
/	O
ml	O
and	O
32	O
mug	O
/	O
ml	O
had	O
little	O
effect	O
on	O
viability	O
of	O
HGFs	O
in	O
5	O
min	O
.	O

Our	O
findings	O
suggest	O
that	O
chrysophsin	O
-	O
1	O
may	O
have	O
potential	O
clinical	O
applications	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
dental	O
caries	O
and	O
pulpal	O
diseases	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
is	O
a	O
Gram	O
-	O
negative	O
anaerobe	O
that	O
resides	O
exclusively	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Long	O
-	O
term	O
colonization	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
requires	O
the	O
bacteria	O
to	O
evade	O
host	O
immune	O
responses	O
while	O
adapting	O
to	O
the	O
changing	O
host	O
physiology	O
and	O
alterations	O
in	O
the	O
composition	O
of	O
the	O
oral	O
microflora	O
.	O

The	O
genetic	O
diversity	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
appears	O
to	O
reflect	O
the	O
variability	O
of	O
its	O
habitat	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
molecular	O
mechanisms	O
generating	O
this	O
diversity	O
.	O

Previously	O
,	O
our	O
research	O
group	O
established	O
that	O
chromosomal	O
DNA	O
transfer	O
occurs	O
between	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
.	O

In	O
this	O
study	O
,	O
we	O
examine	O
the	O
role	O
of	O
putative	O
DNA	O
transfer	O
genes	O
in	O
conjugation	O
and	O
transformation	O
and	O
demonstrate	O
that	O
natural	O
competence	O
mediated	O
by	O
comF	O
is	O
the	O
dominant	O
form	O
of	O
chromosomal	O
DNA	O
transfer	O
,	O
with	O
transfer	O
by	O
a	O
conjugation	O
-	O
like	O
mechanism	O
playing	O
a	O
minor	O
role	O
.	O

Our	O
results	O
reveal	O
that	O
natural	O
competence	O
mechanisms	O
are	O
present	O
in	O
multiple	O
strains	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
DNA	O
uptake	O
is	O
not	O
sensitive	O
to	O
DNA	O
source	O
or	O
modification	O
status	O
.	O

Furthermore	O
,	O
extracellular	O
DNA	O
was	O
observed	O
for	O
the	O
first	O
time	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
and	O
is	O
predicted	O
to	O
be	O
the	O
major	O
DNA	O
source	O
for	O
horizontal	O
transfer	O
and	O
allelic	O
exchange	O
between	O
strains	O
.	O

We	O
propose	O
that	O
exchange	O
of	O
DNA	O
in	O
plaque	O
biofilms	O
by	O
a	O
transformation	O
-	O
like	O
process	O
is	O
of	O
major	O
ecological	O
importance	O
in	O
the	O
survival	O
and	O
persistence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
the	O
challenging	O
oral	O
environment	O
.	O

:	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
colonizes	O
the	O
oral	O
cavities	O
of	O
humans	O
worldwide	O
.	O

The	O
long	O
-	O
term	O
persistence	O
of	O
these	O
bacteria	O
can	O
lead	O
to	O
the	O
development	O
of	O
chronic	O
periodontitis	O
and	O
host	O
morbidity	O
associated	O
with	O
tooth	O
loss	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
is	O
a	O
genetically	O
diverse	O
species	O
,	O
and	O
this	O
variability	O
is	O
believed	O
to	O
contribute	O
to	O
its	O
successful	O
colonization	O
and	O
survival	O
in	O
diverse	O
human	O
hosts	O
,	O
as	O
well	O
as	O
evasion	O
of	O
host	O
immune	O
defenses	O
and	O
immunization	O
strategies	O
.	O

We	O
establish	O
here	O
that	O
natural	O
competence	O
is	O
the	O
major	O
driving	O
force	O
behind	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
DNA	O
exchange	O
and	O
that	O
conjugative	O
DNA	O
transfer	O
plays	O
a	O
minor	O
role	O
.	O

Furthermore	O
,	O
we	O
reveal	O
for	O
the	O
first	O
time	O
the	O
presence	O
of	O
extracellular	O
DNA	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
,	O
which	O
is	O
most	O
likely	O
the	O
source	O
of	O
DNA	O
exchanged	O
between	O
strains	O
within	O
dental	O
plaque	O
.	O

These	O
studies	O
expand	O
our	O
understanding	O
of	O
the	O
mechanisms	O
used	O
by	O
this	O
important	O
member	O
of	O
the	O
human	O
oral	O
flora	O
to	O
transition	O
its	O
relationship	O
with	O
the	O
host	O
from	O
a	O
commensal	O
to	O
a	O
pathogenic	O
relationship	O
.	O

The	O
ability	O
to	O
track	O
microbes	O
in	O
real	O
time	O
in	O
vivo	O
is	O
of	O
enormous	O
value	O
for	O
preclinical	O
investigations	O
in	O
infectious	O
disease	O
or	O
gene	O
therapy	O
research	O
.	O

Bacteria	O
present	O
an	O
attractive	O
class	O
of	O
vector	O
for	O
cancer	O
therapy	O
,	O
possessing	O
a	O
natural	O
ability	O
to	O
grow	O
preferentially	O
within	O
tumours	O
following	O
systemic	O
administration	O
.	O

Bioluminescent	O
Imaging	O
(	O
BLI	O
)	O
represents	O
a	O
powerful	O
tool	O
for	O
use	O
with	O
bacteria	O
engineered	O
to	O
express	O
reporter	O
genes	O
such	O
as	O
lux	O
.	O

BLI	O
is	O
traditionally	O
used	O
as	O
a	O
2D	O
modality	O
resulting	O
in	O
images	O
that	O
are	O
limited	O
in	O
their	O
ability	O
to	O
anatomically	O
locate	O
cell	O
populations	O
.	O

Use	O
of	O
3D	O
diffuse	O
optical	O
tomography	O
can	O
localize	O
the	O
signals	O
but	O
still	O
need	O
to	O
be	O
combined	O
with	O
an	O
anatomical	O
imaging	O
modality	O
like	O
micro	O
-	O
Computed	O
Tomography	O
(	O
muCT	O
)	O
for	O
interpretation	O
.	O
In	O
this	O
study	O
,	O
the	O
non	O
-	O
pathogenic	O
commensal	O
bacteria	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
K	I-bacteria
-	I-bacteria
12	I-bacteria
MG1655	I-bacteria
and	O
Bifidobacterium	B-bacteria
breve	I-bacteria
UCC2003	I-bacteria
,	O
or	O
Salmonella	B-bacteria
Typhimurium	I-bacteria
SL7207	I-bacteria
each	O
expressing	O
the	O
luxABCDE	O
operon	O
were	O
intravenously	O
(	O
i	O
.	O
v	O
.	O
)	O
administered	O
to	O
mice	O
bearing	O
subcutaneous	O
(	O
s	O
.	O
c	O
)	O
FLuc	O
-	O
expressing	O
xenograft	O
tumours	O
.	O

Bacterial	O
lux	O
signal	O
was	O
detected	O
specifically	O
in	O
tumours	O
of	O
mice	O
post	O
i	O
.	O
v	O
.	O
-	O
administration	O
and	O
bioluminescence	O
correlated	O
with	O
the	O
numbers	O
of	O
bacteria	O
recovered	O
from	O
tissue	O
.	O

Through	O
whole	O
body	O
imaging	O
for	O
both	O
lux	O
and	O
FLuc	O
,	O
bacteria	O
and	O
tumour	O
cells	O
were	O
co	O
-	O
localised	O
.	O

3D	O
BLI	O
and	O
muCT	O
image	O
analysis	O
revealed	O
a	O
pattern	O
of	O
multiple	O
clusters	O
of	O
bacteria	O
within	O
tumours	O
.	O

Investigation	O
of	O
spatial	O
resolution	O
of	O
3D	O
optical	O
imaging	O
was	O
supported	O
by	O
ex	O
vivo	O
histological	O
analyses	O
.	O

In	O
vivo	O
imaging	O
of	O
orally	O
-	O
administered	O
commensal	O
bacteria	O
in	O
the	O
gastrointestinal	O
tract	O
(	O
GIT	O
)	O
was	O
also	O
achieved	O
using	O
3D	O
BLI	O
.	O

This	O
study	O
demonstrates	O
for	O
the	O
first	O
time	O
the	O
potential	O
to	O
simultaneously	O
image	O
multiple	O
BLI	O
reporter	O
genes	O
three	O
dimensionally	O
in	O
vivo	O
using	O
approaches	O
that	O
provide	O
unique	O
information	O
on	O
spatial	O
locations	O
.	O

Contaminated	O
hands	O
play	O
a	O
major	O
role	O
in	O
fecal	O
-	O
oral	O
transmission	O
of	O
diseases	O
.	O

In	O
1847	O
,	O
Dr	O
Semmelweis	O
Ignac	O
pointed	O
to	O
the	O
link	O
between	O
infection	O
and	O
unclean	O
hands	O
,	O
and	O
demonstrated	O
that	O
washing	O
hands	O
could	O
reduce	O
transmission	O
of	O
puerperal	O
fever	O
(	O
child	O
birth	O
fever	O
)	O
,	O
a	O
dreaded	O
disease	O
with	O
high	O
mortality	O
in	O
those	O
days	O
.	O

A	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
to	O
find	O
out	O
the	O
extent	O
of	O
germs	O
present	O
in	O
hand	O
,	O
and	O
also	O
the	O
students	O
'	O
perception	O
on	O
hand	O
washing	O
.	O

This	O
was	O
assessed	O
by	O
questionnaire	O
as	O
well	O
as	O
by	O
collection	O
of	O
swab	O
from	O
hand	O
and	O
performing	O
bacteriological	O
culture	O
in	O
the	O
laboratory	O
.	O

In	O
regard	O
to	O
students	O
'	O
perception	O
about	O
the	O
dirty	O
areas	O
of	O
the	O
hands	O
,	O
it	O
was	O
observed	O
that	O
majority	O
(	O
78	O
%	O
)	O
felt	O
palm	O
was	O
likely	O
to	O
be	O
more	O
dirty	O
while	O
less	O
than	O
70	O
%	O
felt	O
that	O
web	O
spaces	O
could	O
harbor	O
dirt	O
.	O

Almost	O
86	O
%	O
reported	O
that	O
they	O
washed	O
hands	O
before	O
eating	O
lunch	O
,	O
but	O
only	O
21	O
.	O
3	O
%	O
said	O
they	O
always	O
used	O
soap	O
while	O
47	O
.	O
3	O
%	O
never	O
used	O
it	O
.	O

Availability	O
of	O
soap	O
all	O
the	O
time	O
in	O
the	O
school	O
was	O
reported	O
by	O
only	O
18	O
.	O
4	O
%	O
students	O
.	O

The	O
swabs	O
of	O
61	O
%	O
children	O
showed	O
potential	O
pathogens	O
.	O

The	O
commonest	O
of	O
these	O
was	O
Staphylococcus	B-bacteria
aureus	I-bacteria
which	O
was	O
seen	O
in	O
44	O
%	O
samples	O
.	O

The	O
students	O
'	O
hands	O
were	O
contaminated	O
before	O
taking	O
food	O
.	O

Although	O
they	O
washed	O
hands	O
before	O
meals	O
,	O
they	O
hardly	O
used	O
soap	O
due	O
to	O
non	O
-	O
availability	O
of	O
soap	O
.	O

The	O
school	O
authority	O
should	O
be	O
asked	O
to	O
keep	O
soaps	O
in	O
the	O
toilets	O
for	O
hand	O
washing	O
.	O

Previous	O
studies	O
demonstrated	O
that	O
a	O
cranberry	O
high	O
-	O
molecular	O
-	O
mass	O
,	O
nondialyzable	O
material	O
(	O
NDM	O
)	O
can	O
inhibit	O
adhesion	O
of	O
numerous	O
species	O
of	O
bacteria	O
and	O
prevents	O
bacterial	O
coaggregation	O
of	O
bacterial	O
pairs	O
.	O

Bacterial	O
coaggregation	O
leads	O
to	O
plaque	O
formation	O
leading	O
to	O
biofilm	O
development	O
on	O
surfaces	O
of	O
oral	O
cavity	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
low	O
concentrations	O
of	O
NDM	O
on	O
Streptococcus	B-bacteria
gordonii	I-bacteria
metabolic	O
activity	O
and	O
biofilm	O
formation	O
on	O
restorative	O
dental	O
surfaces	O
.	O

We	O
found	O
that	O
the	O
NDM	O
selectively	O
inhibited	O
metabolic	O
activity	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
without	O
affecting	O
bacterial	O
viability	O
.	O

Inhibiting	O
the	O
metabolic	O
activity	O
of	O
bacteria	O
in	O
biofilm	O
may	O
benefit	O
the	O
health	O
of	O
the	O
oral	O
cavity	O
.	O

To	O
investigate	O
whether	O
a	O
standard	O
dental	O
prophylaxis	O
followed	O
by	O
tooth	O
brushing	O
with	O
an	O
antibacterial	O
dentifrice	O
will	O
affect	O
the	O
oral	O
bacterial	O
community	O
,	O
as	O
determined	O
by	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
combined	O
with	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
.	O

Twenty	O
-	O
four	O
healthy	O
adults	O
were	O
instructed	O
to	O
brush	O
their	O
teeth	O
using	O
commercial	O
dentifrice	O
for	O
1	O
week	O
during	O
a	O
washout	O
period	O
.	O

An	O
initial	O
set	O
of	O
pooled	O
supragingival	O
plaque	O
samples	O
was	O
collected	O
from	O
each	O
participant	O
at	O
baseline	O
(	O
0	O
h	O
)	O
before	O
prophylaxis	O
treatment	O
.	O

The	O
subjects	O
were	O
given	O
a	O
clinical	O
examination	O
and	O
dental	O
prophylaxis	O
and	O
asked	O
to	O
brush	O
for	O
1	O
min	O
with	O
a	O
dentifrice	O
containing	O
0	O
.	O
3	O
%	O
triclosan	O
,	O
2	O
.	O
0	O
%	O
PVM	O
/	O
MA	O
copolymer	O
and	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
(	O
Colgate	O
Total	O
)	O
.	O

On	O
the	O
following	O
day	O
,	O
a	O
second	O
set	O
of	O
pooled	O
supragingival	O
plaque	O
samples	O
(	O
24	O
h	O
)	O
was	O
collected	O
.	O

Total	O
bacterial	O
genomic	O
DNA	O
was	O
isolated	O
from	O
the	O
samples	O
.	O

Differences	O
in	O
the	O
microbial	O
composition	O
before	O
and	O
after	O
the	O
prophylactic	O
procedure	O
and	O
tooth	O
brushing	O
were	O
assessed	O
by	O
comparing	O
the	O
DGGE	O
profiles	O
and	O
16S	O
rRNA	O
gene	O
segments	O
sequence	O
analysis	O
.	O

Two	O
distinct	O
clusters	O
of	O
DGGE	O
profiles	O
were	O
found	O
,	O
suggesting	O
that	O
a	O
shift	O
in	O
the	O
microbial	O
composition	O
had	O
occurred	O
24	O
h	O
after	O
the	O
prophylaxis	O
and	O
brushing	O
.	O

A	O
detailed	O
sequencing	O
analysis	O
of	O
16S	O
rRNA	O
gene	O
segments	O
further	O
identified	O
6	O
phyla	O
and	O
29	O
genera	O
,	O
including	O
known	O
and	O
unknown	O
bacterial	O
species	O
.	O

Importantly	O
,	O
an	O
increase	O
in	O
bacterial	O
diversity	O
was	O
observed	O
after	O
24	O
h	O
,	O
including	O
members	O
of	O
the	O
Streptococcaceae	B-bacteria
family	I-bacteria
,	O
Prevotella	B-bacteria
,	O
Corynebacterium	B-bacteria
,	O
TM7	B-bacteria
and	O
other	O
commensal	O
bacteria	O
.	O

The	O
results	O
suggest	O
that	O
the	O
use	O
of	O
a	O
standard	O
prophylaxis	O
followed	O
by	O
the	O
use	O
of	O
the	O
dentifrice	O
containing	O
0	O
.	O
3	O
%	O
triclosan	O
,	O
2	O
.	O
0	O
%	O
PVM	O
/	O
MA	O
copolymer	O
and	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
may	O
promote	O
a	O
healthier	O
composition	O
within	O
the	O
oral	O
bacterial	O
community	O
.	O

To	O
investigate	O
the	O
effects	O
of	O
chlorhexidine	O
(	O
CHX	O
)	O
,	O
Listerine	O
and	O
Fluoride	O
Listerine	O
on	O
putative	O
root	O
-	O
caries	O
pathogens	O
in	O
the	O
biofilm	O
in	O
the	O
artificial	O
mouth	O
model	O
.	O

A	O
total	O
of	O
24	O
human	O
dentine	O
discs	O
were	O
prepared	O
.	O

A	O
biofilm	O
composed	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
was	O
cultured	O
on	O
the	O
surfaces	O
of	O
human	O
dentine	O
discs	O
in	O
an	O
artificial	O
-	O
mouth	O
model	O
.	O

Sucrose	O
was	O
supplied	O
by	O
computer	O
-	O
controlled	O
release	O
on	O
a	O
daily	O
basis	O
to	O
simulate	O
the	O
real	O
-	O
life	O
situation	O
.	O

Three	O
treatment	O
reagents	O
,	O
CHX	O
,	O
Listerine	O
and	O
Fluoride	O
Listerine	O
,	O
were	O
supplied	O
at	O
a	O
flow	O
rate	O
of	O
15	O
ml	O
/	O
h	O
for	O
6	O
min	O
twice	O
a	O
day	O
.	O

The	O
dentine	O
discs	O
with	O
biofilm	O
were	O
removed	O
from	O
the	O
artificial	O
mouth	O
after	O
being	O
cultured	O
for	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
and	O
6	O
days	O
.	O

The	O
bacteria	O
in	O
the	O
biofilm	O
were	O
analysed	O
by	O
plating	O
on	O
BHIS	O
agar	O
and	O
the	O
colony	O
-	O
forming	O
units	O
of	O
each	O
species	O
were	O
counted	O
.	O

The	O
total	O
number	O
of	O
bacteria	O
in	O
the	O
CHX	O
group	O
was	O
significantly	O
lower	O
than	O
in	O
the	O
other	O
three	O
groups	O
(	O
including	O
control	O
)	O
.	O

There	O
was	O
no	O
decline	O
in	O
the	O
number	O
of	O
bacteria	O
in	O
the	O
Listerine	O
group	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
reduced	O
significantly	O
in	O
the	O
CHX	O
group	O
compared	O
with	O
the	O
control	O
group	O
.	O

The	O
number	O
and	O
proportion	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
in	O
the	O
CHX	O
group	O
were	O
significantly	O
lower	O
than	O
in	O
the	O
other	O
three	O
groups	O
.	O

The	O
proportion	O
of	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
in	O
the	O
CHX	O
group	O
was	O
significantly	O
higher	O
than	O
in	O
the	O
other	O
three	O
groups	O
.	O

CHX	O
has	O
the	O
most	O
significant	O
effect	O
on	O
inhibition	O
of	O
the	O
putative	O
root	O
-	O
caries	O
bacteria	O
,	O
with	O
the	O
exception	O
of	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
.	O

Both	O
Listerine	O
and	O
a	O
combination	O
of	O
fluoride	O
and	O
Listerine	O
could	O
not	O
effectively	O
reduce	O
the	O
numbers	O
of	O
bacteria	O
in	O
the	O
biofilm	O
.	O

The	O
effects	O
of	O
CHX	O
,	O
Listerine	O
and	O
Fluoride	O
Listerine	O
on	O
root	O
caries	O
prevention	O
need	O
further	O
investigation	O
.	O

A	O
randomized	O
clinical	O
trial	O
studied	O
the	O
effects	O
of	O
early	O
administration	O
of	O
Bifidobacterium	B-bacteria
animalis	I-bacteria
subsp	I-bacteria
.	I-bacteria
lactis	I-bacteria
BB	I-bacteria
-	I-bacteria
12	I-bacteria
(	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
)	O
on	O
oral	O
colonization	O
of	O
(	O
1	O
)	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
,	O
and	O
(	O
2	O
)	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
.	O

In	O
this	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
study	O
,	O
infants	O
(	O
n	O
=	O
106	O
)	O
received	O
probiotic	O
bacteria	O
(	O
BB	O
-	O
12	O
group	O
)	O
,	O
xylitol	O
(	O
X	O
group	O
)	O
,	O
or	O
sorbitol	O
(	O
S	O
group	O
)	O
.	O

Test	O
tablets	O
were	O
administered	O
twice	O
a	O
day	O
(	O
from	O
the	O
age	O
of	O
1	O
-	O
2	O
months	O
)	O
with	O
a	O
novel	O
slow	O
-	O
release	O
pacifier	O
or	O
a	O
spoon	O
(	O
daily	O
dose	O
of	O
BB	O
-	O
12	O
10	O
(	O
10	O
)	O
CFU	O
,	O
polyol	O
200	O
-	O
600	O
mg	O
)	O
.	O

Samples	O
were	O
collected	O
from	O
mucosa	O
/	O
teeth	O
at	O
the	O
age	O
of	O
8	O
months	O
and	O
2	O
years	O
for	O
BB	O
-	O
12	O
determination	O
(	O
qPCR	O
)	O
and	O
plate	O
culturing	O
of	O
MS	B-bacteria
(	O
MSB	B-bacteria
,	O
TYCSB	B-bacteria
)	O
,	O
lactobacilli	B-bacteria
(	O
Rogosa	B-bacteria
)	O
and	O
yeasts	O
(	O
Sabouraud	O
)	O
.	O

The	O
MS	B-bacteria
levels	O
of	O
the	O
mothers	O
were	O
determined	O
(	O
Dentocult	O
SM	O
Strip	O
Mutans	O
)	O
.	O

The	O
baseline	O
characteristics	O
of	O
the	O
three	O
groups	O
were	O
similar	O
.	O

Mean	O
duration	O
of	O
tablet	O
delivery	O
was	O
14	O
.	O
9	O
+	O
/	O
-	O
6	O
.	O
7	O
months	O
.	O

In	O
all	O
groups	O
,	O
>	O
90	O
%	O
of	O
the	O
mothers	O
showed	O
high	O
MS	B-bacteria
counts	O
(	O
log	O
CFU	O
>	O
/	O
=	O
5	O
)	O
.	O

MS	B-bacteria
colonization	O
percentages	O
of	O
the	O
children	O
at	O
the	O
age	O
of	O
2	O
years	O
were	O
rather	O
low	O
(	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
group	O
:	O
6	O
%	O
;	O
X	O
group	O
:	O
31	O
%	O
;	O
S	O
group	O
:	O
10	O
%	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
levels	O
of	O
lactobacilli	B-bacteria
and	O
yeasts	O
did	O
not	O
differ	O
between	O
the	O
groups	O
.	O

BB	B-bacteria
-	I-bacteria
12	I-bacteria
cell	O
counts	O
barely	O
exceeding	O
the	O
detection	O
limit	O
were	O
found	O
in	O
three	O
of	O
the	O
oral	O
samples	O
of	O
the	O
8	O
-	O
month	O
-	O
old	O
children	O
;	O
however	O
,	O
the	O
2	O
-	O
year	O
samples	O
did	O
not	O
contain	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
.	O

The	O
early	O
administration	O
of	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
did	O
not	O
result	O
in	O
permanent	O
oral	O
colonization	O
of	O
this	O
probiotic	O
or	O
significantly	O
affect	O
MS	B-bacteria
colonization	O
in	O
the	O
children	O
.	O

In	O
this	O
protocol	O
,	O
we	O
describe	O
the	O
application	O
of	O
commercially	O
available	O
three	O
-	O
dimensional	O
organotypic	O
tissues	O
of	O
human	O
oral	O
mucosa	O
to	O
study	O
the	O
interaction	O
between	O
Candida	O
albicans	O
and	O
epithelial	O
cells	O
.	O

Infection	O
experiments	O
show	O
high	O
reproducibility	O
and	O
can	O
be	O
used	O
to	O
analyse	O
directly	O
pathogen	O
/	O
epithelial	O
cell	O
interactions	O
.	O

However	O
,	O
the	O
system	O
is	O
also	O
very	O
flexible	O
.	O

Using	O
histological	O
,	O
biochemical	O
,	O
immunological	O
,	O
and	O
molecular	O
methods	O
,	O
it	O
is	O
possible	O
to	O
analyse	O
several	O
stages	O
of	O
infection	O
by	O
C	O
.	O
albicans	O
wild	O
type	O
or	O
mutant	O
strains	O
and	O
demonstrate	O
the	O
consequence	O
of	O
disrupting	O
genes	O
encoding	O
putative	O
virulence	O
factors	O
required	O
for	O
host	O
cell	O
invasion	O
and	O
immune	O
defence	O
induction	O
.	O

This	O
model	O
provides	O
information	O
about	O
host	O
and	O
pathogen	O
protein	O
and	O
gene	O
expression	O
during	O
direct	O
interactions	O
with	O
each	O
other	O
.	O

It	O
can	O
additionally	O
be	O
supplemented	O
with	O
other	O
host	O
factors	O
,	O
such	O
as	O
immune	O
cells	O
,	O
saliva	O
,	O
and	O
probiotic	O
bacteria	O
,	O
which	O
are	O
relevant	O
for	O
host	O
immune	O
defence	O
in	O
the	O
oral	O
cavity	O
.	O

Granulicatella	B-bacteria
species	I-bacteria
are	O
facultative	O
anaerobic	O
,	O
catalase	O
-	O
negative	O
Gram	O
-	O
positive	O
cocci	O
,	O
oral	O
microbiome	O
researches	O
find	O
out	O
Granulicatella	B-bacteria
species	I-bacteria
are	O
dominant	O
bacteria	O
in	O
oral	O
cavity	O
which	O
may	O
cause	O
opportunistic	O
infection	O
like	O
periodontal	O
disease	O
,	O
endodontic	O
infection	O
.	O

This	O
review	O
summarized	O
research	O
progress	O
of	O
Granulicatella	B-bacteria
species	I-bacteria
.	O

The	O
development	O
of	O
multispecies	O
biofilm	O
models	O
are	O
needed	O
to	O
explain	O
the	O
interactions	O
that	O
take	O
place	O
in	O
root	O
canal	O
biofilms	O
during	O
apical	O
periodontitis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
ability	O
of	O
4	O
root	O
canal	O
bacteria	O
to	O
establish	O
a	O
multispecies	O
biofilm	O
community	O
and	O
to	O
characterize	O
the	O
main	O
structural	O
,	O
compositional	O
,	O
and	O
physiological	O
features	O
of	O
this	O
community	O
.	O

Four	O
clinical	O
isolates	O
isolated	O
from	O
infected	O
root	O
canals	O
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
were	O
grown	O
together	O
in	O
a	O
miniflow	O
cell	O
system	O
.	O

Simultaneous	O
detection	O
of	O
the	O
4	O
species	O
in	O
the	O
biofilm	O
communities	O
was	O
achieved	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
in	O
combination	O
with	O
confocal	O
microscopy	O
at	O
different	O
time	O
points	O
.	O

The	O
LIVE	O
/	O
DEAD	O
BacLight	O
technique	O
(	O
Molecular	O
Probes	O
,	O
Carlsbad	O
,	O
CA	O
)	O
was	O
used	O
to	O
assess	O
cell	O
viability	O
and	O
to	O
calculate	O
3	O
-	O
dimensional	O
architectural	O
parameters	O
such	O
as	O
biovolume	O
(	O
mum	O
(	O
3	O
)	O
)	O
.	O

Redox	O
fluorescence	O
dye	O
5	O
-	O
cyano	O
-	O
2	O
,	O
3	O
-	O
ditolyl	O
tetrazolium	O
chloride	O
was	O
used	O
to	O
assess	O
the	O
metabolic	O
activity	O
of	O
biofilm	O
bacteria	O
.	O

The	O
4	O
species	O
tested	O
were	O
able	O
to	O
form	O
stable	O
and	O
reproducible	O
biofilm	O
communities	O
.	O

The	O
biofilms	O
formed	O
in	O
rich	O
medium	O
generally	O
showed	O
continuous	O
growth	O
over	O
time	O
,	O
however	O
,	O
in	O
the	O
absence	O
of	O
glucose	O
biofilms	O
showed	O
significantly	O
smaller	O
biovolumes	O
.	O

A	O
high	O
proportion	O
of	O
viable	O
cells	O
(	O
>	O
90	O
%	O
)	O
were	O
generally	O
observed	O
,	O
and	O
biofilm	O
growth	O
was	O
correlated	O
with	O
high	O
metabolic	O
activity	O
of	O
cells	O
.	O

The	O
community	O
structure	O
of	O
biofilms	O
formed	O
in	O
rich	O
medium	O
did	O
not	O
change	O
considerably	O
over	O
the	O
120	O
-	O
hour	O
period	O
,	O
during	O
which	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
were	O
most	O
abundant	O
.	O

The	O
ability	O
of	O
4	O
root	O
canal	O
bacteria	O
to	O
form	O
multispecies	O
biofilm	O
communities	O
shown	O
in	O
this	O
study	O
give	O
insights	O
into	O
assessing	O
the	O
community	O
lifestyle	O
of	O
these	O
microorganisms	O
in	O
vivo	O
.	O

This	O
multispecies	O
model	O
could	O
be	O
useful	O
for	O
further	O
research	O
simulating	O
stresses	O
representative	O
of	O
in	O
vivo	O
conditions	O
.	O

Both	O
hydrogen	O
sulfide	O
(	O
H2S	O
)	O
and	O
methyl	O
mercaptan	O
(	O
CH	O
(	O
3	O
)	O
SH	O
)	O
are	O
frequently	O
detected	O
in	O
large	O
amounts	O
in	O
malodorous	O
mouth	O
air	O
.	O

We	O
investigated	O
the	O
bacterial	O
composition	O
of	O
saliva	O
of	O
30	O
subjects	O
with	O
severe	O
oral	O
malodor	O
exhibiting	O
extreme	O
CH	O
(	O
3	O
)	O
SH	O
/	O
H	O
(	O
2	O
)	O
S	O
ratios	O
(	O
high	O
H	O
(	O
2	O
)	O
S	O
but	O
low	O
CH	O
(	O
3	O
)	O
SH	O
concentrations	O
,	O
n	O
5	O
14	O
;	O
high	O
CH	O
(	O
3	O
)	O
SH	O
but	O
low	O
H2S	O
concentrations	O
,	O
n	O
5	O
16	O
)	O
and	O
13	O
subjects	O
without	O
malodor	O
,	O
using	O
barcoded	O
pyrosequencing	O
analysis	O
of	O
the	O
16S	O
rRNA	O
gene	O
.	O

Phylogenetic	O
community	O
analysis	O
with	O
the	O
UniFrac	O
distance	O
metric	O
revealed	O
a	O
distinct	O
bacterial	O
community	O
structure	O
in	O
each	O
malodor	O
group	O
.	O

The	O
H2S	O
group	O
showed	O
higher	O
proportions	O
of	O
the	O
genera	O
Neisseria	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Porphyromonas	B-bacteria
and	O
SR1	B-bacteria
than	O
the	O
other	O
two	O
groups	O
,	O
whereas	O
the	O
CH	O
(	O
3	O
)	O
SH	O
group	O
had	O
higher	O
proportions	O
of	O
the	O
genera	O
Prevotella	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Atopobium	B-bacteria
,	O
Megasphaera	B-bacteria
,	O
and	O
Selenomonas	B-bacteria
.	O

Our	O
results	O
suggested	O
that	O
distinct	O
bacterial	O
populations	O
in	O
the	O
oral	O
microbiota	O
are	O
involved	O
in	O
production	O
of	O
high	O
levels	O
of	O
H2S	O
and	O
CH3SH	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
1986	O
,	O
oral	O
microbiology	O
,	O
and	O
especially	O
the	O
microbiology	O
of	O
periodontal	O
infections	O
,	O
was	O
of	O
central	O
importance	O
.	O

Interest	O
in	O
periodontology	O
was	O
growing	O
rapidly	O
and	O
with	O
it	O
,	O
interest	O
in	O
developments	O
in	O
microbiology	O
and	O
the	O
immunology	O
of	O
infectious	O
diseases	O
of	O
the	O
periodontium	O
.	O

At	O
national	O
and	O
international	O
meetings	O
discussions	O
took	O
place	O
concerning	O
the	O
role	O
of	O
the	O
newly	O
discovered	O
bacterial	O
species	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
the	O
role	O
of	O
antibiotics	O
in	O
the	O
treatment	O
of	O
severe	O
periodontitis	O
.	O

Since	O
the	O
1980s	O
,	O
much	O
has	O
changed	O
in	O
periodontology	O
,	O
not	O
least	O
of	O
all	O
as	O
a	O
result	O
of	O
a	O
new	O
specialism	O
:	O
oral	O
implantology	O
.	O

With	O
it	O
,	O
a	O
new	O
disease	O
also	O
came	O
into	O
existence	O
:	O
peri	O
-	O
implantitis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
dependence	O
of	O
the	O
condition	O
of	O
the	O
microflora	O
of	O
the	O
oral	O
cavity	O
on	O
the	O
etiology	O
of	O
xerostomia	O
,	O
patients	O
'	O
sex	O
,	O
age	O
,	O
degree	O
of	O
hyposalivation	O
,	O
and	O
duration	O
of	O
the	O
sense	O
of	O
dryness	O
.	O

A	O
total	O
of	O
64	O
patients	O
with	O
complaints	O
of	O
oral	O
dryness	O
referred	O
to	O
the	O
Clinic	O
of	O
Oral	O
and	O
Dental	O
Diseases	O
,	O
Hospital	O
of	O
Lithuanian	O
University	O
of	O
Health	O
Sciences	O
,	O
for	O
consultation	O
during	O
the	O
period	O
from	O
2003	O
to	O
2005	O
were	O
selected	O
for	O
the	O
study	O
.	O

The	O
etiological	O
factors	O
of	O
xerostomia	O
were	O
as	O
follows	O
:	O
radiotherapy	O
(	O
PRT	O
)	O
to	O
the	O
maxillofacial	O
area	O
,	O
Sjogren	O
'	O
s	O
syndrome	O
(	O
SS	O
)	O
,	O
and	O
xerogenic	O
medications	O
,	O
tricyclic	O
antidepressants	O
(	O
TCAs	O
)	O
.	O

There	O
were	O
50	O
women	O
and	O
14	O
men	O
.	O

Their	O
mean	O
age	O
was	O
60	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
6	O
years	O
.	O

All	O
the	O
patients	O
in	O
the	O
PRT	O
group	O
had	O
high	O
counts	O
of	O
Candida	O
spp	O
.	O
as	O
compared	O
with	O
percentages	O
of	O
patients	O
in	O
the	O
TCA	O
and	O
SS	O
groups	O
(	O
100	O
%	O
vs	O
.	O
66	O
.	O
7	O
%	O
and	O
56	O
.	O
2	O
%	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Patients	O
'	O
age	O
and	O
sex	O
in	O
different	O
etiology	O
groups	O
had	O
no	O
significant	O
impact	O
on	O
the	O
condition	O
of	O
their	O
oral	O
microflora	O
.	O

There	O
were	O
equal	O
percentages	O
of	O
patients	O
with	O
deficient	O
and	O
normal	O
salivation	O
in	O
the	O
TCA	O
group	O
(	O
44	O
%	O
in	O
both	O
the	O
groups	O
;	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

All	O
the	O
patients	O
in	O
the	O
PRT	O
group	O
had	O
pronounced	O
hyposalivation	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
.	O

A	O
significantly	O
greater	O
percentage	O
of	O
patients	O
with	O
severely	O
reduced	O
salivation	O
had	O
high	O
counts	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Significantly	O
greater	O
percentages	O
of	O
patients	O
with	O
the	O
clinical	O
duration	O
of	O
xerostomia	O
of	O
up	O
to	O
6	O
months	O
had	O
high	O
counts	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Candida	O
spp	O
.	O
colonies	O
.	O

In	O
patients	O
with	O
xerostomia	O
,	O
the	O
condition	O
of	O
the	O
microflora	O
of	O
the	O
oral	O
cavity	O
and	O
impairment	O
of	O
major	O
salivary	O
gland	O
function	O
varied	O
according	O
to	O
the	O
etiology	O
of	O
the	O
disease	O
.	O

The	O
level	O
of	O
hyposalivation	O
and	O
the	O
duration	O
of	O
xerostomia	O
were	O
found	O
to	O
have	O
a	O
significant	O
impact	O
on	O
the	O
microflora	O
of	O
the	O
oral	O
cavity	O
.	O

Oral	O
dryness	O
can	O
contribute	O
to	O
several	O
diseases	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
the	O
subjective	O
oral	O
dryness	O
,	O
salivary	O
flow	O
rates	O
,	O
the	O
number	O
of	O
oral	O
microbiota	O
,	O
and	O
the	O
dental	O
status	O
between	O
medicated	O
hypertensive	O
patients	O
and	O
control	O
subjects	O
.	O

Four	O
hundred	O
subjects	O
including	O
200	O
ambulatory	O
hypertensive	O
patients	O
who	O
were	O
taking	O
antihypertensive	O
medications	O
and	O
200	O
control	O
subjects	O
were	O
included	O
.	O

Each	O
subject	O
'	O
s	O
medical	O
history	O
was	O
reviewed	O
.	O

The	O
subject	O
'	O
s	O
oral	O
health	O
status	O
,	O
salivary	O
flow	O
rate	O
,	O
and	O
the	O
number	O
of	O
oral	O
microbiota	O
were	O
also	O
evaluated	O
.	O

The	O
prevalence	O
rate	O
of	O
xerostomia	O
in	O
the	O
medicated	O
hypertensive	O
group	O
was	O
50	O
%	O
whereas	O
only	O
25	O
.	O
5	O
%	O
of	O
the	O
control	O
group	O
had	O
xerostomia	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Using	O
modified	O
Schirmer	O
test	O
(	O
MST	O
)	O
,	O
the	O
mean	O
unstimulated	O
salivary	O
flow	O
rate	O
of	O
the	O
medicated	O
hypertensive	O
group	O
(	O
23	O
.	O
11	O
+	O
/	O
-	O
6	O
.	O
08	O
mm	O
/	O
3	O
min	O
)	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
31	O
.	O
30	O
+	O
/	O
-	O
3	O
.	O
36	O
mm	O
/	O
3	O
min	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
addition	O
,	O
the	O
mean	O
stimulated	O
salivary	O
flow	O
rate	O
of	O
the	O
medicated	O
hypertensive	O
group	O
(	O
0	O
.	O
73	O
+	O
/	O
-	O
0	O
.	O
30	O
ml	O
/	O
min	O
)	O
was	O
also	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
1	O
.	O
31	O
+	O
/	O
-	O
0	O
.	O
34	O
mi	O
/	O
min	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
strongest	O
associated	O
factor	O
for	O
dry	O
mouth	O
was	O
the	O
use	O
of	O
antihypertensive	O
medications	O
(	O
OR	O
=	O
6	O
.	O
28	O
)	O
.	O

The	O
mean	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
Lactobacilli	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Candida	O
spp	O
.	O
in	O
the	O
medicated	O
hypertensive	O
group	O
were	O
significantly	O
higher	O
than	O
in	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Furthermore	O
,	O
medicated	O
hypertensive	O
patients	O
were	O
more	O
likely	O
to	O
have	O
missing	O
teeth	O
compared	O
to	O
control	O
subjects	O
.	O

Xerostomia	O
,	O
hyposalivation	O
,	O
and	O
increasing	O
number	O
of	O
oral	O
microbiota	O
were	O
more	O
prevalent	O
in	O
hypertensive	O
patients	O
taking	O
antihypertensive	O
medications	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
if	O
three	O
probiotic	O
bacteria	O
present	O
in	O
the	O
milk	O
product	O
Cultura	O
Dofilus	O
(	O
R	O
)	O
naturell	O
could	O
be	O
detected	O
in	O
saliva	O
and	O
on	O
oral	O
mucosal	O
surfaces	O
,	O
and	O
if	O
they	O
colonized	O
dental	O
surfaces	O
in	O
situ	O
in	O
8	O
caries	O
-	O
inactive	O
individuals	O
after	O
8	O
daily	O
exposures	O
to	O
the	O
milk	O
product	O
for	O
up	O
to	O
3	O
days	O
.	O

Bacteria	O
were	O
identified	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
and	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

While	O
probiotic	O
bacteria	O
were	O
present	O
sporadically	O
in	O
the	O
oral	O
cavity	O
on	O
mucosal	O
surfaces	O
and	O
in	O
saliva	O
after	O
3	O
days	O
of	O
frequent	O
use	O
of	O
the	O
probiotic	O
milk	O
,	O
they	O
were	O
not	O
detected	O
on	O
dental	O
surfaces	O
.	O

Probiotic	O
bacteria	O
may	O
thus	O
contribute	O
to	O
general	O
oral	O
health	O
,	O
but	O
their	O
potential	O
role	O
in	O
biofilm	O
-	O
induced	O
dental	O
diseases	O
remains	O
unclear	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
is	O
a	O
gram	O
-	O
negative	O
periodontopathogen	O
found	O
within	O
the	O
subgingival	O
plaque	O
on	O
the	O
tooth	O
surface	O
.	O

It	O
is	O
associated	O
with	O
localized	O
aggressive	O
periodontitis	O
,	O
a	O
severe	O
form	O
of	O
periodontitis	O
in	O
adolescents	O
,	O
and	O
is	O
the	O
cause	O
various	O
extra	O
-	O
oral	O
infections	O
.	O

The	O
ability	O
of	O
this	O
organism	O
to	O
tenaciously	O
adhere	O
to	O
abiotic	O
surfaces	O
has	O
been	O
attributed	O
to	O
bundle	O
-	O
forming	O
type	O
IVb	O
-	O
like	O
fimbriae	O
whose	O
major	O
component	O
is	O
the	O
fimbrial	O
lower	O
molecular	O
weight	O
protein	O
(	O
Flp	O
)	O
.	O

In	O
this	O
study	O
the	O
adhesion	O
of	O
purified	O
Flp	O
fimbriae	O
isolated	O
from	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
to	O
materials	O
with	O
different	O
surface	O
chemistries	O
was	O
measured	O
using	O
atomic	O
force	O
microscopy	O
(	O
AFM	O
)	O
.	O

The	O
adhesion	O
of	O
Flp	O
fimbriae	O
to	O
uncoated	O
and	O
saliva	O
-	O
coated	O
tooth	O
,	O
hydroxylapatite	O
,	O
and	O
glass	O
surfaces	O
was	O
compared	O
.	O

Force	O
data	O
were	O
used	O
to	O
quantify	O
the	O
magnitude	O
of	O
adhesion	O
of	O
the	O
fimbriae	O
and	O
force	O
-	O
distance	O
profiles	O
were	O
used	O
to	O
predict	O
the	O
mechanisms	O
of	O
adhesion	O
.	O

The	O
results	O
of	O
this	O
study	O
confirm	O
that	O
non	O
-	O
specific	O
interactions	O
likely	O
dominate	O
the	O
adhesion	O
of	O
these	O
fimbriae	O
to	O
the	O
surfaces	O
used	O
in	O
this	O
study	O
.	O

However	O
,	O
force	O
data	O
indicate	O
that	O
non	O
-	O
specific	O
electrostatic	O
interactions	O
may	O
be	O
more	O
significant	O
under	O
the	O
conditions	O
used	O
in	O
this	O
study	O
.	O

Salivary	O
coatings	O
did	O
affect	O
both	O
the	O
hydrophobicity	O
and	O
adhesion	O
of	O
these	O
fimbriae	O
to	O
the	O
surfaces	O
used	O
in	O
this	O
study	O
.	O

Additionally	O
,	O
these	O
data	O
demonstrate	O
the	O
affect	O
of	O
salivary	O
proteins	O
on	O
bacterial	O
adhesion	O
in	O
the	O
oral	O
cavity	O
.	O

Many	O
human	O
microbial	O
infectious	O
diseases	O
including	O
dental	O
caries	O
are	O
polymicrobial	O
in	O
nature	O
.	O

How	O
these	O
complex	O
multi	O
-	O
species	O
communities	O
evolve	O
from	O
a	O
healthy	O
to	O
a	O
diseased	O
state	O
is	O
not	O
well	O
understood	O
.	O

Although	O
many	O
health	O
-	O
or	O
disease	O
-	O
associated	O
oral	O
bacteria	O
have	O
been	O
characterized	O
in	O
vitro	O
,	O
their	O
physiology	O
within	O
the	O
complex	O
oral	O
microbiome	O
is	O
difficult	O
to	O
determine	O
with	O
current	O
approaches	O
.	O

In	O
addition	O
,	O
about	O
half	O
of	O
these	O
species	O
remain	O
uncultivated	O
to	O
date	O
with	O
little	O
known	O
besides	O
their	O
16S	O
rRNA	O
sequence	O
.	O

Lacking	O
culture	O
-	O
based	O
physiological	O
analyses	O
,	O
the	O
functional	O
roles	O
of	O
uncultivated	O
species	O
will	O
remain	O
enigmatic	O
despite	O
their	O
apparent	O
disease	O
correlation	O
.	O

To	O
start	O
addressing	O
these	O
knowledge	O
gaps	O
,	O
we	O
applied	O
a	O
combination	O
of	O
Magnetic	O
Resonance	O
Spectroscopy	O
(	O
MRS	O
)	O
with	O
RNA	O
and	O
DNA	O
based	O
Stable	O
Isotope	O
Probing	O
(	O
SIP	O
)	O
to	O
oral	O
plaque	O
communities	O
from	O
healthy	O
children	O
for	O
in	O
vitro	O
temporal	O
monitoring	O
of	O
metabolites	O
and	O
identification	O
of	O
metabolically	O
active	O
and	O
inactive	O
bacterial	O
species	O
.	O

Supragingival	O
plaque	O
samples	O
from	O
caries	O
-	O
free	O
children	O
incubated	O
with	O
(	O
13	O
)	O
C	O
-	O
substrates	O
under	O
imposed	O
healthy	O
(	O
buffered	O
,	O
pH	O
7	O
)	O
and	O
diseased	O
states	O
(	O
pH	O
5	O
.	O
5	O
and	O
pH	O
4	O
.	O
5	O
)	O
produced	O
lactate	O
as	O
the	O
dominant	O
organic	O
acid	O
from	O
glucose	O
metabolism	O
.	O

Rapid	O
lactate	O
utilization	O
upon	O
glucose	O
depletion	O
was	O
observed	O
under	O
pH	O
7	O
conditions	O
.	O

SIP	O
analyses	O
revealed	O
a	O
number	O
of	O
genera	O
containing	O
cultured	O
and	O
uncultivated	O
taxa	O
with	O
metabolic	O
capabilities	O
at	O
pH	O
5	O
.	O
5	O
.	O

The	O
diversity	O
of	O
active	O
species	O
decreased	O
significantly	O
at	O
pH	O
4	O
.	O
5	O
and	O
was	O
dominated	O
by	O
Lactobacillus	B-bacteria
and	O
Propionibacterium	B-bacteria
species	I-bacteria
,	O
both	O
of	O
which	O
have	O
been	O
previously	O
found	O
within	O
carious	O
lesions	O
from	O
children	O
.	O

Our	O
approach	O
allowed	O
for	O
identification	O
of	O
species	O
that	O
metabolize	O
carbohydrates	O
under	O
different	O
pH	O
conditions	O
and	O
supports	O
the	O
importance	O
of	O
Lactobacilli	B-bacteria
and	O
Propionibacterium	B-bacteria
in	O
the	O
development	O
of	O
childhood	O
caries	O
.	O

Identification	O
of	O
species	O
within	O
healthy	O
subjects	O
that	O
are	O
active	O
at	O
low	O
pH	O
can	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
oral	O
caries	O
onset	O
and	O
generate	O
appropriate	O
targets	O
for	O
preventative	O
measures	O
in	O
the	O
early	O
stages	O
.	O

This	O
randomized	O
double	O
-	O
blind	O
clinical	O
study	O
evaluated	O
the	O
antimicrobial	O
efficacy	O
of	O
two	O
mouthwashes	O
containing	O
(	O
1	O
)	O
0	O
.	O
075	O
%	O
cetylpyridinium	O
chloride	O
(	O
CPC	O
)	O
+	O
0	O
.	O
05	O
%	O
sodium	O
fluoride	O
(	O
NaF	O
)	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
and	O
(	O
2	O
)	O
0	O
.	O
075	O
%	O
CPC	O
+	O
0	O
.	O
05	O
%	O
NaF	O
in	O
a	O
6	O
%	O
alcohol	O
base	O
,	O
versus	O
a	O
negative	O
control	O
mouthwash	O
containing	O
0	O
.	O
05	O
%	O
NaF	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
on	O
numbers	O
of	O
bacteria	O
in	O
supragingival	O
plaque	O
12	O
hours	O
after	O
a	O
single	O
use	O
and	O
12	O
hours	O
after	O
14	O
days	O
'	O
use	O
.	O

Enrolled	O
subjects	O
completed	O
a	O
one	O
-	O
week	O
washout	O
phase	O
prior	O
to	O
providing	O
baseline	O
samples	O
of	O
supragingival	O
plaque	O
that	O
were	O
analyzed	O
for	O
numbers	O
of	O
anaerobic	O
microorganisms	O
.	O

Subjects	O
were	O
randomized	O
to	O
a	O
treatment	O
group	O
and	O
instructed	O
to	O
rinse	O
with	O
20	O
mL	O
of	O
the	O
assigned	O
mouthwash	O
for	O
30	O
seconds	O
.	O

Post	O
-	O
treatment	O
microbiological	O
analyses	O
were	O
conducted	O
on	O
plaque	O
samples	O
collected	O
12	O
hours	O
after	O
the	O
first	O
use	O
of	O
each	O
assigned	O
mouthwash	O
and	O
after	O
completing	O
14	O
days	O
of	O
twice	O
-	O
daily	O
use	O
of	O
each	O
assigned	O
mouthwash	O
.	O

Oral	O
examinations	O
were	O
completed	O
by	O
a	O
dentist	O
at	O
each	O
sample	O
collection	O
to	O
assess	O
soft	O
and	O
hard	O
tissue	O
oral	O
health	O
over	O
the	O
course	O
of	O
the	O
study	O
.	O

The	O
study	O
enrolled	O
188	O
adults	O
(	O
mean	O
age	O
45	O
.	O
78	O
years	O
;	O
age	O
range	O
23	O
-	O
69	O
)	O
.	O

Subjects	O
rinsing	O
with	O
the	O
CPC	O
-	O
containing	O
mouthwash	O
realized	O
a	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduction	O
in	O
numbers	O
of	O
supragingival	O
anaerobic	O
bacteria	O
at	O
the	O
12	O
-	O
hour	O
evaluation	O
after	O
a	O
single	O
use	O
.	O

In	O
comparison	O
to	O
the	O
control	O
mouthwash	O
,	O
use	O
of	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
base	O
resulted	O
in	O
a	O
35	O
.	O
3	O
%	O
reduction	O
in	O
numbers	O
of	O
anaerobic	O
plaque	O
bacteria	O
,	O
while	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
demonstrated	O
a	O
34	O
.	O
5	O
%	O
reduction	O
.	O

Further	O
,	O
the	O
analysis	O
after	O
twice	O
-	O
daily	O
use	O
for	O
14	O
days	O
indicated	O
that	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
base	O
demonstrated	O
a	O
73	O
.	O
8	O
%	O
reduction	O
in	O
anaerobic	O
plaque	O
bacteria	O
,	O
while	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
demonstrated	O
a	O
70	O
.	O
9	O
%	O
reduction	O
in	O
anaerobic	O
plaque	O
bacteria	O
versus	O
the	O
control	O
mouthwash	O
.	O

The	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
reduced	O
supragingival	O
plaque	O
bacteria	O
by	O
34	O
.	O
5	O
%	O
and	O
70	O
.	O
9	O
%	O
compared	O
to	O
the	O
control	O
mouthwash	O
12	O
hours	O
after	O
a	O
single	O
use	O
and	O
after	O
14	O
days	O
of	O
use	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
base	O
reduced	O
supragingival	O
bacteria	O
by	O
35	O
.	O
3	O
%	O
and	O
73	O
.	O
8	O
%	O
compared	O
to	O
the	O
control	O
mouthwash	O
12	O
hours	O
after	O
a	O
single	O
use	O
and	O
after	O
14	O
days	O
of	O
use	O
,	O
respectively	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
the	O
CPC	O
-	O
containing	O
mouthwashes	O
at	O
either	O
of	O
the	O
post	O
-	O
treatment	O
time	O
points	O
.	O

This	O
study	O
is	O
a	O
proof	O
of	O
concept	O
to	O
determine	O
the	O
efficacy	O
of	O
a	O
custom	O
-	O
fabricated	O
tray	O
in	O
placing	O
antimicrobial	O
and	O
debriding	O
agents	O
in	O
the	O
periodontal	O
pockets	O
of	O
persons	O
with	O
active	O
gingival	O
infections	O
.	O

Localized	O
subgingival	O
delivery	O
of	O
antimicrobial	O
and	O
antibiotic	O
agents	O
is	O
routinely	O
employed	O
as	O
adjunctive	O
therapy	O
for	O
the	O
treatment	O
and	O
management	O
of	O
periopathogens	O
associated	O
with	O
periodontal	O
disease	O
.	O

Because	O
these	O
delivery	O
techniques	O
often	O
face	O
time	O
constraints	O
and	O
impose	O
temporary	O
restrictions	O
on	O
patient	O
brushing	O
and	O
flossing	O
,	O
a	O
custom	O
-	O
formed	O
prescription	O
dental	O
tray	O
can	O
be	O
used	O
to	O
deliver	O
and	O
maintain	O
medications	O
in	O
periodontal	O
pockets	O
between	O
office	O
visits	O
and	O
without	O
brushing	O
or	O
flossing	O
restrictions	O
.	O

The	O
ability	O
of	O
this	O
tray	O
to	O
maintain	O
sufficient	O
concentrations	O
of	O
medication	O
in	O
the	O
periodontal	O
pockets	O
to	O
have	O
a	O
therapeutic	O
effect	O
is	O
evaluated	O
here	O
with	O
theoretical	O
modeling	O
and	O
practical	O
application	O
.	O

Hydrogen	O
peroxide	O
is	O
an	O
oral	O
debriding	O
agent	O
and	O
oral	O
wound	O
cleanser	O
with	O
antimicrobial	O
properties	O
.	O

The	O
debriding	O
effect	O
of	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
gel	O
was	O
tested	O
in	O
vitro	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
biofilm	O
using	O
glass	O
carriers	O
for	O
collection	O
.	O

Diffusion	O
modeling	O
tested	O
the	O
potential	O
of	O
the	O
customized	O
tray	O
to	O
place	O
hydrogen	O
peroxide	O
gel	O
into	O
the	O
sulcus	O
in	O
the	O
presence	O
of	O
crevicular	O
fluid	O
flow	O
.	O

Changes	O
in	O
periodontal	O
microflora	O
with	O
scanning	O
electron	O
microscopy	O
analysis	O
of	O
in	O
vivo	O
paper	O
point	O
site	O
sampling	O
were	O
analyzed	O
before	O
and	O
after	O
a	O
thin	O
ribbon	O
of	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
gel	O
(	O
approximately	O
0	O
.	O
7	O
gm	O
)	O
and	O
a	O
subtherapeutic	O
dose	O
(	O
three	O
drops	O
)	O
of	O
Vibramycin	O
(	O
50	O
mg	O
/	O
5	O
ml	O
)	O
were	O
placed	O
via	O
Perio	O
Trays	O
into	O
periodontal	O
pockets	O
,	O
ranging	O
from	O
4	O
-	O
8	O
mm	O
at	O
daily	O
prescribed	O
intervals	O
for	O
two	O
to	O
five	O
weeks	O
.	O

In	O
vitro	O
results	O
indicate	O
that	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
gel	O
breaks	O
down	O
the	O
exopolysaccharide	O
slime	O
and	O
cell	O
walls	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
begins	O
to	O
debride	O
the	O
cells	O
from	O
glass	O
carriers	O
within	O
10	O
minutes	O
.	O

Diffusion	O
modeling	O
indicates	O
that	O
hydrogen	O
peroxide	O
can	O
penetrate	O
into	O
the	O
deeper	O
pockets	O
(	O
9	O
mm	O
)	O
,	O
but	O
also	O
its	O
concentration	O
in	O
these	O
deep	O
pockets	O
will	O
increase	O
over	O
wearing	O
time	O
in	O
the	O
absence	O
of	O
degradation	O
by	O
peroxidases	O
and	O
catalase	O
.	O

Site	O
sampling	O
data	O
confirm	O
diffusion	O
modeling	O
results	O
,	O
with	O
evidence	O
that	O
medication	O
delivered	O
with	O
the	O
prescription	O
tray	O
reduced	O
subgingival	O
bacterial	O
loads	O
and	O
enhanced	O
healing	O
of	O
corresponding	O
oral	O
tissues	O
.	O

The	O
prescription	O
Perio	O
Tray	O
effectively	O
placed	O
medication	O
in	O
the	O
gingival	O
sulcus	O
.	O

Mathematical	O
modeling	O
indicated	O
Perio	O
Tray	O
placement	O
of	O
hydrogen	O
peroxide	O
gel	O
in	O
periodontal	O
pockets	O
with	O
depths	O
up	O
to	O
9	O
mm	O
over	O
15	O
minutes	O
treatment	O
time	O
was	O
theoretically	O
possible	O
.	O

Pathology	O
reports	O
reveal	O
reductions	O
in	O
subgingival	O
bacterial	O
loads	O
and	O
improvements	O
in	O
pretreatment	O
pocket	O
depths	O
of	O
up	O
to	O
8	O
mm	O
after	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
and	O
Vibramycin	O
Syrup	O
were	O
prescribed	O
for	O
use	O
with	O
the	O
Perio	O
Tray	O
.	O

The	O
in	O
vitro	O
analysis	O
indicating	O
that	O
hydrogen	O
peroxide	O
is	O
the	O
active	O
and	O
effective	O
oral	O
debriding	O
agent	O
needs	O
to	O
be	O
confirmed	O
with	O
additional	O
studies	O
.	O

Noma	O
is	O
a	O
gangrenous	O
disease	O
that	O
leads	O
to	O
severe	O
disfigurement	O
of	O
the	O
face	O
with	O
high	O
morbidity	O
and	O
mortality	O
,	O
but	O
its	O
etiology	O
remains	O
unknown	O
.	O

Young	O
children	O
in	O
developing	O
countries	O
are	O
almost	O
exclusively	O
affected	O
.	O

The	O
purpose	O
of	O
the	O
study	O
was	O
to	O
record	O
and	O
compare	O
bacterial	O
diversity	O
in	O
oral	O
samples	O
from	O
children	O
with	O
or	O
without	O
acute	O
noma	O
or	O
acute	O
necrotizing	O
gingivitis	O
from	O
a	O
defined	O
geographical	O
region	O
in	O
Niger	O
by	O
culture	O
-	O
independent	O
molecular	O
methods	O
.	O

Gingival	O
samples	O
from	O
23	O
healthy	O
children	O
,	O
nine	O
children	O
with	O
acute	O
necrotizing	O
gingivitis	O
,	O
and	O
23	O
children	O
with	O
acute	O
noma	O
(	O
both	O
healthy	O
and	O
diseased	O
oral	O
sites	O
)	O
were	O
amplified	O
using	O
`	O
`	O
universal	O
'	O
'	O
PCR	O
primers	O
for	O
the	O
16	O
S	O
rRNA	O
gene	O
and	O
pooled	O
according	O
to	O
category	O
(	O
noma	O
,	O
healthy	O
,	O
or	O
acute	O
necrotizing	O
gingivitis	O
)	O
,	O
gender	O
,	O
and	O
site	O
status	O
(	O
diseased	O
or	O
control	O
site	O
)	O
.	O

Seven	O
libraries	O
were	O
generated	O
.	O

A	O
total	O
of	O
1237	O
partial	O
16	O
S	O
rRNA	O
sequences	O
representing	O
339	O
bacterial	O
species	O
or	O
phylotypes	O
at	O
a	O
98	O
-	O
99	O
%	O
identity	O
level	O
were	O
obtained	O
.	O

Analysis	O
of	O
bacterial	O
composition	O
and	O
frequency	O
showed	O
that	O
diseased	O
(	O
noma	O
or	O
acute	O
necrotizing	O
gingivitis	O
)	O
and	O
healthy	O
site	O
bacterial	O
communities	O
are	O
composed	O
of	O
similar	O
bacteria	O
,	O
but	O
differ	O
in	O
the	O
prevalence	O
of	O
a	O
limited	O
group	O
of	O
phylotypes	O
.	O

Large	O
increases	O
in	O
counts	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
members	O
of	O
the	O
Peptostreptococcus	B-bacteria
genus	I-bacteria
are	O
associated	O
with	O
disease	O
.	O

In	O
contrast	O
,	O
no	O
clear	O
-	O
cut	O
differences	O
were	O
found	O
between	O
noma	O
and	O
non	O
-	O
noma	O
libraries	O
.	O

Similarities	O
between	O
acute	O
necrotizing	O
gingivitis	O
and	O
noma	O
samples	O
support	O
the	O
hypothesis	O
that	O
the	O
disease	O
could	O
evolve	O
from	O
acute	O
necrotizing	O
gingivitis	O
in	O
certain	O
children	O
for	O
reasons	O
still	O
to	O
be	O
elucidated	O
.	O

This	O
study	O
revealed	O
oral	O
microbiological	O
patterns	O
associated	O
with	O
noma	O
and	O
acute	O
necrotizing	O
gingivitis	O
,	O
but	O
no	O
evidence	O
was	O
found	O
for	O
a	O
specific	O
infection	O
-	O
triggering	O
agent	O
.	O

Although	O
oral	O
bacteria	O
-	O
associated	O
systemic	O
diseases	O
have	O
been	O
reported	O
,	O
association	O
between	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
pathogen	O
of	O
dental	O
caries	O
,	O
and	O
ulcerative	O
colitis	O
(	O
UC	O
)	O
has	O
not	O
been	O
reported	O
.	O

We	O
investigated	O
the	O
effect	O
of	O
various	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
on	O
dextran	O
sodium	O
sulfate	O
(	O
DSS	O
)	O
-	O
induced	O
mouse	O
colitis	O
.	O

Administration	O
of	O
TW295	B-bacteria
,	O
the	O
specific	O
strain	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
caused	O
aggravation	O
of	O
colitis	O
;	O
the	O
standard	O
strain	O
,	O
MT8148	B-bacteria
did	O
not	O
.	O

Localization	O
of	O
TW295	O
in	O
hepatocytes	O
in	O
liver	O
was	O
observed	O
.	O

Increased	O
expression	O
of	O
interferon	O
-	O
gamma	O
in	O
liver	O
was	O
also	O
noted	O
,	O
indicating	O
that	O
the	O
liver	O
is	O
target	O
organ	O
for	O
the	O
specific	O
strain	O
of	O
S	O
.	O
mutans	O
-	O
mediated	O
aggravation	O
of	O
colitis	O
.	O

The	O
detection	O
frequency	O
of	O
the	O
specific	O
strains	O
in	O
UC	O
patients	O
was	O
significantly	O
higher	O
than	O
in	O
healthy	O
subjects	O
.	O

Administration	O
of	O
the	O
specific	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
isolated	O
from	O
patients	O
caused	O
aggravation	O
of	O
colitis	O
.	O

Infection	O
with	O
highly	O
-	O
virulent	O
specific	O
types	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
might	O
be	O
a	O
potential	O
risk	O
factor	O
in	O
the	O
aggravation	O
of	O
UC	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effectiveness	O
of	O
tablets	O
containing	O
two	O
probiotic	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
strains	I-bacteria
in	O
inhibiting	O
regrowth	O
of	O
salivary	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
after	O
full	O
-	O
mouth	O
disinfection	O
(	O
FMD	O
)	O
with	O
chlorhexidine	O
.	O

The	O
null	O
hypothesis	O
was	O
that	O
the	O
levels	O
of	O
MS	B-bacteria
would	O
not	O
differ	O
in	O
comparison	O
with	O
a	O
placebo	O
protocol	O
.	O

The	O
study	O
population	O
was	O
comprised	O
of	O
62	O
young	O
adults	O
(	O
mean	O
age	O
23	O
years	O
)	O
with	O
moderate	O
or	O
high	O
counts	O
of	O
salivary	O
MS	B-bacteria
who	O
volunteered	O
after	O
informed	O
consent	O
.	O

The	O
study	O
was	O
a	O
double	O
-	O
blinded	O
randomized	O
controlled	O
trial	O
with	O
two	O
parallel	O
groups	O
.	O

After	O
a	O
3	O
-	O
day	O
chlorhexidine	O
regimen	O
,	O
the	O
subjects	O
were	O
randomly	O
assigned	O
to	O
a	O
test	O
group	O
(	O
n	O
=	O
32	O
)	O
with	O
probiotic	O
lozenges	O
(	O
2	O
/	O
day	O
)	O
or	O
a	O
placebo	O
group	O
(	O
n	O
=	O
30	O
)	O
.	O

The	O
intervention	O
period	O
was	O
6	O
weeks	O
,	O
and	O
stimulated	O
whole	O
saliva	O
was	O
collected	O
at	O
baseline	O
and	O
after	O
1	O
,	O
6	O
,	O
and	O
12	O
weeks	O
.	O

The	O
samples	O
were	O
processed	O
for	O
MS	B-bacteria
by	O
a	O
chair	O
-	O
side	O
test	O
and	O
DNA	O
-	O
DNA	O
hybridization	O
as	O
an	O
estimate	O
of	O
19	O
bacterial	O
strains	O
associated	O
with	O
oral	O
health	O
and	O
disease	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
groups	O
at	O
inclusion	O
,	O
and	O
FMD	O
reduced	O
the	O
salivary	O
MS	B-bacteria
levels	O
significantly	O
in	O
both	O
groups	O
.	O

The	O
MS	B-bacteria
suppression	O
lasted	O
less	O
than	O
6	O
weeks	O
and	O
there	O
were	O
no	O
statistical	O
differences	O
in	O
salivary	O
MS	B-bacteria
regrowth	O
between	O
the	O
test	O
and	O
control	O
groups	O
at	O
any	O
of	O
the	O
follow	O
-	O
ups	O
.	O

Likewise	O
,	O
there	O
were	O
no	O
major	O
differences	O
in	O
the	O
regrowth	O
patterns	O
of	O
the	O
checkerboard	O
panel	O
between	O
the	O
two	O
groups	O
.	O

We	O
conclude	O
that	O
daily	O
oral	O
administration	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
did	O
not	O
seem	O
to	O
affect	O
or	O
delay	O
the	O
regrowth	O
of	O
salivary	O
MS	B-bacteria
after	O
FMD	O
with	O
chlorhexidine	O
.	O

Wingless	O
proteins	O
,	O
termed	O
Wnt	O
,	O
are	O
involved	O
in	O
embryonic	O
development	O
,	O
blood	O
cell	O
differentiation	O
,	O
and	O
tumorigenesis	O
.	O

In	O
mammalian	O
hematopoiesis	O
,	O
Wnt	O
signaling	O
is	O
essential	O
for	O
stem	O
-	O
cell	O
homeostasis	O
and	O
lymphocyte	O
differentiation	O
.	O

Recent	O
studies	O
have	O
suggested	O
that	O
these	O
molecules	O
are	O
associated	O
with	O
cardiovascular	O
diseases	O
,	O
rheumatoid	O
arthritis	O
,	O
and	O
osteoarthritis	O
.	O

Furthermore	O
,	O
Wnt5a	O
signaling	O
is	O
essential	O
for	O
the	O
general	O
inflammatory	O
response	O
of	O
human	O
macrophages	O
.	O

Periodontitis	O
is	O
a	O
chronic	O
inflammatory	O
disease	O
caused	O
by	O
gram	O
-	O
negative	O
periodontopathic	O
bacteria	O
and	O
the	O
resultant	O
host	O
immune	O
response	O
.	O

Periodontitis	O
is	O
characterized	O
by	O
loss	O
of	O
tooth	O
-	O
supporting	O
structures	O
and	O
alveolar	O
bone	O
resorption	O
.	O

There	O
have	O
been	O
no	O
previous	O
reports	O
on	O
Wnt5a	O
expression	O
in	O
periodontitis	O
tissue	O
,	O
and	O
only	O
few	O
study	O
reported	O
the	O
molecular	O
mechanisms	O
of	O
Wnt5a	O
expression	O
in	O
LPS	O
-	O
stimulated	O
monocytic	O
cells	O
.	O

Using	O
RT	O
-	O
PCR	O
,	O
we	O
demonstrated	O
that	O
Wnt5a	O
mRNA	O
expression	O
was	O
up	O
-	O
regulated	O
in	O
chronic	O
periodontitis	O
tissue	O
as	O
compared	O
to	O
healthy	O
control	O
tissue	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
induced	O
Wnt5a	O
mRNA	O
in	O
the	O
human	O
monocytic	O
cell	O
line	O
THP	O
-	O
1	O
with	O
a	O
peak	O
at	O
4	O
hrs	O
after	O
stimulation	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
induced	O
higher	O
up	O
-	O
regulation	O
of	O
Wnt5a	O
mRNA	O
than	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
LPS	O
.	O

The	O
LPS	O
receptors	O
TLR2	O
and	O
TLR4	O
were	O
equally	O
expressed	O
on	O
the	O
surface	O
of	O
THP	O
-	O
1	O
cells	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
induced	O
IkappaBalpha	O
degradation	O
and	O
was	O
able	O
to	O
increase	O
the	O
NF	O
-	O
kappaB	O
binding	O
activity	O
to	O
DNA	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
Wnt5a	O
expression	O
was	O
inhibited	O
by	O
NF	O
-	O
kappaB	O
inhibitors	O
,	O
suggesting	O
NF	O
-	O
kappaB	O
involvement	O
.	O

Furthermore	O
,	O
IFN	O
-	O
gamma	O
synergistically	O
enhanced	O
the	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
production	O
of	O
Wnt5a	O
.	O

Pharmacological	O
investigation	O
and	O
siRNA	O
experiments	O
showed	O
that	O
STAT1	O
was	O
important	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
Wnt5a	O
expression	O
.	O

These	O
results	O
suggest	O
that	O
the	O
modulation	O
of	O
Wnt5a	O
expression	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
may	O
play	O
an	O
important	O
role	O
in	O
the	O
periodontal	O
inflammatory	O
process	O
and	O
serve	O
a	O
target	O
for	O
the	O
development	O
of	O
new	O
therapies	O
.	O

Virulent	O
biofilms	O
are	O
responsible	O
for	O
a	O
range	O
of	O
infections	O
,	O
including	O
oral	O
diseases	O
.	O

All	O
biofilms	O
harbor	O
a	O
microbial	O
-	O
derived	O
extracellular	O
-	O
matrix	O
.	O

The	O
exopolysaccharides	O
(	O
EPS	O
)	O
formed	O
on	O
tooth	O
-	O
pellicle	O
and	O
bacterial	O
surfaces	O
provide	O
binding	O
sites	O
for	O
microorganisms	O
;	O
eventually	O
the	O
accumulated	O
EPS	O
enmeshes	O
microbial	O
cells	O
.	O

The	O
metabolic	O
activity	O
of	O
the	O
bacteria	O
within	O
this	O
matrix	O
leads	O
to	O
acidification	O
of	O
the	O
milieu	O
.	O

We	O
explored	O
the	O
mechanisms	O
through	O
which	O
the	O
Streptococcus	B-bacteria
mutans	I-bacteria
-	O
produced	O
EPS	O
-	O
matrix	O
modulates	O
the	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
architecture	O
and	O
the	O
population	O
shifts	O
during	O
morphogenesis	O
of	O
biofilms	O
on	O
a	O
saliva	O
-	O
coated	O
-	O
apatitic	O
surface	O
using	O
a	O
mixed	O
-	O
bacterial	O
species	O
system	O
.	O

Concomitantly	O
,	O
we	O
examined	O
whether	O
the	O
matrix	O
influences	O
the	O
development	O
of	O
pH	O
-	O
microenvironments	O
within	O
intact	O
-	O
biofilms	O
using	O
a	O
novel	O
3D	O
in	O
situ	O
pH	O
-	O
mapping	O
technique	O
.	O

Data	O
reveal	O
that	O
the	O
production	O
of	O
the	O
EPS	O
-	O
matrix	O
helps	O
to	O
create	O
spatial	O
heterogeneities	O
by	O
forming	O
an	O
intricate	O
network	O
of	O
exopolysaccharide	O
-	O
enmeshed	O
bacterial	O
-	O
islets	O
(	O
microcolonies	O
)	O
through	O
localized	O
cell	O
-	O
to	O
-	O
matrix	O
interactions	O
.	O

This	O
complex	O
3D	O
architecture	O
creates	O
compartmentalized	O
acidic	O
and	O
EPS	O
-	O
rich	O
microenvironments	O
throughout	O
the	O
biofilm	O
,	O
which	O
triggers	O
the	O
dominance	O
of	O
pathogenic	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
within	O
a	O
mixed	O
-	O
species	O
system	O
.	O

The	O
establishment	O
of	O
a	O
3D	O
-	O
matrix	O
and	O
EPS	O
-	O
enmeshed	O
microcolonies	O
were	O
largely	O
mediated	O
by	O
the	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
gtfB	O
/	O
gtfC	O
genes	O
,	O
expression	O
of	O
which	O
was	O
enhanced	O
in	O
the	O
presence	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
.	O

Acidic	O
pockets	O
were	O
found	O
only	O
in	O
the	O
interiors	O
of	O
bacterial	O
-	O
islets	O
that	O
are	O
protected	O
by	O
EPS	O
,	O
which	O
impedes	O
rapid	O
neutralization	O
by	O
buffer	O
(	O
pH	O
7	O
.	O
0	O
)	O
.	O

As	O
a	O
result	O
,	O
regions	O
of	O
low	O
pH	O
(	O
<	O
5	O
.	O
5	O
)	O
were	O
detected	O
at	O
specific	O
locations	O
along	O
the	O
surface	O
of	O
attachment	O
.	O

Resistance	O
to	O
chlorhexidine	O
was	O
enhanced	O
in	O
cells	O
within	O
EPS	O
-	O
microcolony	O
complexes	O
compared	O
to	O
those	O
outside	O
such	O
structures	O
within	O
the	O
biofilm	O
.	O

Our	O
results	O
illustrate	O
the	O
critical	O
interaction	O
between	O
matrix	O
architecture	O
and	O
pH	O
heterogeneity	O
in	O
the	O
3D	O
environment	O
.	O

The	O
formation	O
of	O
structured	O
acidic	O
-	O
microenvironments	O
in	O
close	O
proximity	O
to	O
the	O
apatite	O
-	O
surface	O
is	O
an	O
essential	O
factor	O
associated	O
with	O
virulence	O
in	O
cariogenic	O
-	O
biofilms	O
.	O

These	O
observations	O
may	O
have	O
relevance	O
beyond	O
the	O
mouth	O
,	O
as	O
matrix	O
is	O
inherent	O
to	O
all	O
biofilms	O
.	O

Determining	O
the	O
bacterial	O
composition	O
of	O
the	O
canine	O
oral	O
microbiome	O
is	O
of	O
interest	O
for	O
two	O
primary	O
reasons	O
.	O

First	O
,	O
while	O
the	O
human	O
oral	O
microbiome	O
has	O
been	O
well	O
studied	O
using	O
molecular	O
techniques	O
,	O
the	O
oral	O
microbiomes	O
of	O
other	O
mammals	O
have	O
not	O
been	O
studied	O
in	O
equal	O
depth	O
using	O
culture	O
independent	O
methods	O
.	O

This	O
study	O
allows	O
a	O
comparison	O
of	O
the	O
number	O
of	O
bacterial	O
taxa	O
,	O
based	O
on	O
16S	O
rRNA	O
-	O
gene	O
sequence	O
comparison	O
,	O
shared	O
between	O
humans	O
and	O
dogs	O
,	O
two	O
divergent	O
mammalian	O
species	O
.	O

Second	O
,	O
canine	O
oral	O
bacteria	O
are	O
of	O
interest	O
to	O
veterinary	O
and	O
human	O
medical	O
communities	O
for	O
understanding	O
their	O
roles	O
in	O
health	O
and	O
infectious	O
diseases	O
.	O

The	O
bacteria	O
involved	O
are	O
mostly	O
unnamed	O
and	O
not	O
linked	O
by	O
16S	O
rRNA	O
-	O
gene	O
sequence	O
identity	O
to	O
a	O
taxonomic	O
scheme	O
.	O

This	O
manuscript	O
describes	O
the	O
analysis	O
of	O
5	O
,	O
958	O
16S	O
rRNA	O
-	O
gene	O
sequences	O
from	O
65	O
clone	O
libraries	O
.	O

Full	O
length	O
16S	O
rRNA	O
reference	O
sequences	O
have	O
been	O
obtained	O
for	O
353	O
canine	O
bacterial	O
taxa	O
,	O
which	O
were	O
placed	O
in	O
14	O
bacterial	O
phyla	O
,	O
23	O
classes	O
,	O
37	O
orders	O
,	O
66	O
families	O
,	O
and	O
148	O
genera	O
.	O

Eighty	O
percent	O
of	O
the	O
taxa	O
are	O
currently	O
unnamed	O
.	O

The	O
bacterial	O
taxa	O
identified	O
in	O
dogs	O
are	O
markedly	O
different	O
from	O
those	O
of	O
humans	O
with	O
only	O
16	O
.	O
4	O
%	O
of	O
oral	O
taxa	O
are	O
shared	O
between	O
dogs	O
and	O
humans	O
based	O
on	O
a	O
98	O
.	O
5	O
%	O
16S	O
rRNA	O
sequence	O
similarity	O
cutoff	O
.	O

This	O
indicates	O
that	O
there	O
is	O
a	O
large	O
divergence	O
in	O
the	O
bacteria	O
comprising	O
the	O
oral	O
microbiomes	O
of	O
divergent	O
mammalian	O
species	O
.	O

The	O
historic	O
practice	O
of	O
identifying	O
animal	O
associated	O
bacteria	O
based	O
on	O
phenotypic	O
similarities	O
to	O
human	O
bacteria	O
is	O
generally	O
invalid	O
.	O

This	O
report	O
describes	O
the	O
diversity	O
of	O
the	O
canine	O
oral	O
microbiome	O
and	O
provides	O
a	O
provisional	O
16S	O
rRNA	O
based	O
taxonomic	O
scheme	O
for	O
naming	O
and	O
identifying	O
unnamed	O
canine	O
bacterial	O
taxa	O
.	O

Objective	O
of	O
this	O
study	O
is	O
to	O
evaluate	O
the	O
changes	O
of	O
the	O
oral	O
microbial	O
flora	O
,	O
concentrating	O
on	O
the	O
oral	O
streptococci	B-bacteria
,	O
after	O
the	O
first	O
3	O
and	O
6	O
months	O
of	O
orthodontic	O
treatment	O
.	O

40	O
patients	O
,	O
aged	O
7	O
-	O
17	O
,	O
that	O
presented	O
for	O
orthodontic	O
treatment	O
between	O
April	O
and	O
September	O
2010	O
in	O
the	O
Department	O
of	O
Orthodontics	O
and	O
Dento	O
-	O
Facial	O
Orthopedics	O
of	O
`	O
`	O
Carol	O
Davila	O
'	O
'	O
University	O
of	O
Medicine	O
and	O
Pharmacy	O
,	O
Bucharest	O
have	O
been	O
selected	O
.	O

According	O
to	O
the	O
protocol	O
,	O
coronary	O
and	O
subgingival	O
plaque	O
was	O
collected	O
from	O
the	O
dental	O
surface	O
before	O
starting	O
any	O
orthodontic	O
treatment	O
(	O
T0	O
)	O
,	O
3	O
months	O
after	O
wearing	O
orthodontic	O
appliances	O
(	O
T1	O
)	O
and	O
6	O
months	O
after	O
wearing	O
orthodontic	O
appliances	O
(	O
T2	O
)	O
.	O

The	O
samples	O
were	O
studied	O
in	O
Cantacuzino	O
National	O
Institute	O
of	O
Research	O
-	O
Development	O
for	O
Microbiology	O
and	O
Immunology	O
[	O
isolation	O
on	O
Columbia	O
agar	O
with	O
5	O
%	O
sheep	O
blood	O
,	O
identification	O
on	O
morphotinctorial	O
,	O
growth	O
and	O
biochemical	O
characteristics	O
using	O
API	O
20	O
STREP	O
(	O
BioMerieux	O
)	O
]	O
.	O

Bacterial	O
concentration	O
(	O
colony	O
-	O
forming	O
units	O
/	O
sample	O
=	O
CFU	O
/	O
sample	O
)	O
for	O
the	O
aerobic	O
and	O
anaerobic	O
flora	O
was	O
calculated	O
by	O
the	O
serial	O
dilution	O
method	O
of	O
counting	O
bacteria	O
.	O

106	O
strains	O
of	O
oral	O
streptococci	B-bacteria
were	O
isolated	O
from	O
dental	O
plaque	O
,	O
belonging	O
to	O
6	O
species	O
(	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
and	O
Streptococcus	B-bacteria
acidominimus	I-bacteria
)	O
,	O
37	O
strains	O
of	O
oral	O
streptococci	B-bacteria
in	O
patients	O
from	O
group	O
I	O
(	O
T0	O
)	O
,	O
40	O
strains	O
from	O
group	O
II	O
(	O
T1	O
)	O
and	O
29	O
strains	O
of	O
oral	O
streptococci	B-bacteria
from	O
group	O
III	O
(	O
T2	O
)	O
.	O

After	O
3	O
months	O
(	O
T1	O
)	O
the	O
aerobic	O
bacteria	O
percentage	O
,	O
detected	O
at	O
a	O
concentration	O
between	O
10	O
(	O
5	O
)	O
and	O
10	O
(	O
6	O
)	O
,	O
increased	O
from	O
30	O
to	O
38	O
.	O
2	O
%	O
.	O

The	O
percentage	O
of	O
patients	O
with	O
a	O
bacterial	O
concentration	O
higher	O
than	O
10	O
(	O
6	O
)	O
CFU	O
/	O
sample	O
increased	O
from	O
5	O
%	O
to	O
8	O
.	O
8	O
%	O
.	O

The	O
samples	O
colected	O
at	O
T2	O
(	O
patients	O
examined	O
after	O
6	O
months	O
of	O
orthodonic	O
treatment	O
)	O
presented	O
a	O
lower	O
bacterial	O
concentration	O
,	O
as	O
compared	O
to	O
group	O
II	O
(	O
T1	O
)	O
.	O

The	O
most	O
common	O
isolated	O
species	O
of	O
streptococci	B-bacteria
were	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
37	O
.	O
5	O
%	O
,	O
22	O
.	O
5	O
%	O
and	O
10	O
%	O
)	O
,	O
whose	O
frequency	O
increased	O
after	O
3	O
months	O
of	O
treatment	O
to	O
41	O
.	O
14	O
%	O
,	O
32	O
.	O
3	O
%	O
and	O
respectively	O
14	O
.	O
4	O
%	O
,	O
returning	O
after	O
6	O
months	O
of	O
treatment	O
at	O
values	O
similar	O
to	O
those	O
recorded	O
before	O
beginning	O
the	O
orthodontic	O
treatment	O
.	O

Presence	O
of	O
orthodontic	O
appliances	O
may	O
produce	O
a	O
transitory	O
increase	O
of	O
bacterial	O
concentration	O
(	O
CFU	O
/	O
sample	O
)	O
and	O
isolation	O
rate	O
of	O
oral	O
streptococci	B-bacteria
,	O
returning	O
to	O
the	O
level	O
prior	O
to	O
the	O
application	O
of	O
these	O
devices	O
after	O
a	O
time	O
interval	O
of	O
several	O
months	O
.	O

In	O
this	O
study	O
hypothesing	O
the	O
translocation	O
of	O
oral	O
bacteria	O
from	O
oropharynx	O
into	O
the	O
middle	O
ear	O
cavity	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
otitis	O
media	O
with	O
effusion	O
(	O
OME	O
)	O
,	O
we	O
aimed	O
to	O
investigate	O
the	O
presence	O
and	O
similarity	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
in	O
saliva	O
,	O
nasopharyngeal	O
secretion	O
and	O
the	O
middle	O
ear	O
effusion	O
samples	O
from	O
the	O
children	O
with	O
OME	O
.	O

Totally	O
20	O
children	O
with	O
OME	O
undergoing	O
myringotomy	O
and	O
ventilation	O
tube	O
placement	O
were	O
attended	O
.	O

Stimulated	O
saliva	O
samples	O
were	O
collected	O
after	O
otorhinolaryngological	O
and	O
oral	O
examinations	O
were	O
done	O
.	O

The	O
middle	O
ear	O
effusion	O
and	O
nasopharyngeal	O
secretions	O
were	O
collected	O
during	O
the	O
operations	O
.	O

The	O
presence	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
detected	O
using	O
16SrRNA	O
-	O
based	O
PCR	O
.	O

The	O
clonal	O
similarities	O
of	O
the	O
bacteria	O
were	O
detected	O
in	O
the	O
samples	O
which	O
the	O
same	O
bacteria	O
had	O
been	O
detected	O
in	O
each	O
samples	O
of	O
the	O
same	O
child	O
.	O

After	O
DNA	O
sequencing	O
,	O
clonal	O
similarity	O
was	O
determined	O
by	O
16SrRNA	O
gene	O
clone	O
library	O
analysis	O
.	O

The	O
sequences	O
from	O
each	O
clone	O
were	O
compared	O
with	O
similar	O
sequences	O
of	O
reference	O
organisms	O
by	O
FASTA	O
search	O
.	O

T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
detected	O
only	O
in	O
four	O
(	O
20	O
%	O
)	O
saliva	O
and	O
in	O
one	O
(	O
5	O
%	O
)	O
nasopharyngeal	O
sample	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
detected	O
in	O
11	O
(	O
55	O
%	O
)	O
saliva	O
,	O
eight	O
(	O
40	O
%	O
)	O
nasopharyngeal	O
and	O
six	O
(	O
30	O
%	O
)	O
middle	O
ear	O
effusion	O
samples	O
.	O

Sequences	O
from	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
clones	O
derived	O
from	O
three	O
different	O
anatomic	O
sites	O
within	O
patients	O
were	O
similar	O
in	O
33	O
%	O
of	O
OME	O
patients	O
,	O
indicating	O
their	O
genetic	O
relatedness	O
.	O

Bacteria	O
involved	O
in	O
this	O
process	O
most	O
likely	O
originate	O
from	O
the	O
oropharynx	O
since	O
they	O
show	O
a	O
close	O
genetic	O
relatedness	O
with	O
their	O
oropharyngeal	O
counterparts	O
.	O

Candida	O
albicans	O
frequently	O
causes	O
superficial	O
infections	O
by	O
invading	O
and	O
damaging	O
epithelial	O
cells	O
,	O
but	O
may	O
also	O
cause	O
systemic	O
infections	O
by	O
penetrating	O
through	O
epithelial	O
barriers	O
.	O

C	O
.	O
albicans	O
is	O
a	O
remarkable	O
pathogen	O
because	O
it	O
can	O
invade	O
epithelial	O
cells	O
via	O
two	O
distinct	O
mechanisms	O
:	O
induced	O
endocytosis	O
,	O
analogous	O
to	O
facultative	O
intracellular	O
enteropathogenic	O
bacteria	O
,	O
and	O
active	O
penetration	O
,	O
similar	O
to	O
plant	O
pathogenic	O
fungi	O
.	O

Here	O
we	O
investigated	O
the	O
contributions	O
of	O
the	O
two	O
invasion	O
routes	O
of	O
C	O
.	O
albicans	O
to	O
epithelial	O
invasion	O
.	O

Using	O
selective	O
cellular	O
inhibition	O
approaches	O
and	O
differential	O
fluorescence	O
microscopy	O
,	O
we	O
demonstrate	O
that	O
induced	O
endocytosis	O
contributes	O
considerably	O
to	O
the	O
early	O
time	O
points	O
of	O
invasion	O
,	O
while	O
active	O
penetration	O
represents	O
the	O
dominant	O
epithelial	O
invasion	O
route	O
.	O

Although	O
induced	O
endocytosis	O
depends	O
mainly	O
on	O
Als3	O
-	O
E	O
-	O
cadherin	O
interactions	O
,	O
we	O
observed	O
E	O
-	O
cadherin	O
independent	O
induced	O
endocytosis	O
.	O

Finally	O
,	O
we	O
provide	O
evidence	O
of	O
a	O
protective	O
role	O
for	O
serum	O
factors	O
in	O
oral	O
infection	O
:	O
human	O
serum	O
strongly	O
inhibited	O
C	O
.	O
albicans	O
adhesion	O
to	O
,	O
invasion	O
and	O
damage	O
of	O
oral	O
epithelial	O
cells	O
.	O

Probiotics	O
are	O
living	O
microorganisms	O
(	O
e	O
.	O
g	O
.	O
,	O
bacteria	O
)	O
that	O
are	O
either	O
the	O
same	O
as	O
or	O
similar	O
to	O
organisms	O
found	O
naturally	O
in	O
the	O
human	O
body	O
and	O
may	O
be	O
beneficial	O
to	O
health	O
.	O

Current	O
researches	O
have	O
shown	O
that	O
the	O
balance	O
between	O
beneficial	O
and	O
pathogenic	O
bacteria	O
is	O
essential	O
in	O
order	O
to	O
maintain	O
the	O
oral	O
health	O
.	O

Therefore	O
,	O
oral	O
cavity	O
has	O
recently	O
been	O
suggested	O
as	O
a	O
relevant	O
target	O
for	O
probiotic	O
applications	O
.	O

Dental	O
caries	O
can	O
be	O
seen	O
as	O
a	O
microbial	O
imbalance	O
where	O
the	O
oral	O
microbiota	O
shift	O
towards	O
community	O
dominance	O
which	O
produces	O
acidogenic	O
and	O
acid	O
-	O
tolerant	O
gram	O
positive	O
bacteria	O
.	O

Similarly	O
,	O
the	O
accumulation	O
of	O
bacteria	O
within	O
the	O
biofilm	O
,	O
facilitated	O
by	O
poor	O
oral	O
hygiene	O
,	O
predisposes	O
to	O
allogenic	O
shifts	O
in	O
the	O
microbial	O
community	O
,	O
leading	O
to	O
the	O
onset	O
of	O
periodontal	O
inflammation	O
.	O

probiotic	O
bacteria	O
belonging	O
to	O
the	O
genus	O
of	O
Lactobacillus	B-bacteria
,	O
Bifidobacterium	B-bacteria
and	O
Streptococcus	B-bacteria
have	O
been	O
proven	O
effective	O
for	O
preventing	O
caries	O
by	O
reducing	O
the	O
number	O
of	O
cariogenic	O
bacteria	O
in	O
saliva	O
after	O
a	O
short	O
period	O
of	O
consuming	O
the	O
probiotic	O
.	O

In	O
contrast	O
,	O
the	O
effect	O
of	O
probiotics	O
on	O
improving	O
gingivitis	O
and	O
periodontitis	O
has	O
been	O
less	O
investigated	O
.	O

The	O
currently	O
available	O
studies	O
on	O
the	O
effect	O
of	O
probiotics	O
on	O
periodontal	O
pathogens	O
and	O
clinical	O
periodontal	O
parameters	O
showed	O
differing	O
results	O
depending	O
on	O
the	O
strains	O
used	O
and	O
the	O
endpoints	O
analyzed	O
.	O

Many	O
of	O
the	O
clinical	O
studies	O
are	O
pilot	O
in	O
nature	O
and	O
with	O
low	O
quality	O
,	O
therefore	O
,	O
properly	O
conducted	O
clinical	O
trials	O
,	O
using	O
probiotic	O
strains	O
with	O
in	O
vitro	O
proven	O
periodontal	O
probiotic	O
effects	O
,	O
are	O
needed	O
.	O

The	O
putative	O
beneficial	O
effects	O
of	O
probiotics	O
on	O
oral	O
malodour	O
have	O
also	O
been	O
evaluated	O
,	O
but	O
further	O
evidence	O
is	O
needed	O
to	O
fully	O
explore	O
the	O
potential	O
of	O
probiotics	O
for	O
preventing	O
malodour	O
.	O

Campylobacter	B-bacteria
concisus	I-bacteria
,	O
a	O
bacterium	O
colonizing	O
the	O
human	O
oral	O
cavity	O
,	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
.	O

This	O
study	O
investigated	O
if	O
patients	O
with	O
IBD	O
are	O
colonized	O
with	O
specific	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
that	O
have	O
potential	O
to	O
cause	O
enteric	O
diseases	O
.	O

:	O
Seventy	O
oral	O
and	O
enteric	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
isolates	I-bacteria
obtained	O
from	O
eight	O
patients	O
with	O
IBD	O
and	O
six	O
controls	O
were	O
examined	O
for	O
housekeeping	O
genes	O
by	O
multilocus	O
sequence	O
typing	O
(	O
MLST	O
)	O
,	O
Caco2	O
cell	O
invasion	O
by	O
gentamicin	O
-	O
protection	O
-	O
assay	O
,	O
protein	O
analysis	O
by	O
mass	O
spectrometry	O
and	O
SDS	O
-	O
PAGE	O
,	O
and	O
morphology	O
by	O
scanning	O
electron	O
microscopy	O
.	O

The	O
whole	O
genome	O
sequenced	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strain	I-bacteria
13826	I-bacteria
which	O
was	O
isolated	O
from	O
an	O
individual	O
with	O
bloody	O
diarrhea	O
was	O
included	O
in	O
MLST	O
analysis	O
.	O

:	O
MLST	O
analysis	O
showed	O
that	O
87	O
.	O
5	O
%	O
of	O
individuals	O
whose	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
belonged	O
to	O
Cluster	O
I	O
had	O
inflammatory	O
enteric	O
diseases	O
(	O
six	O
IBD	O
and	O
one	O
with	O
bloody	O
diarrhea	O
)	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
remaining	O
individuals	O
(	O
28	O
.	O
6	O
%	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Enteric	B-bacteria
invasive	I-bacteria
C	I-bacteria
.	I-bacteria
concisus	I-bacteria
(	O
EICC	B-bacteria
)	O
oral	O
strain	O
was	O
detected	O
in	O
50	O
%	O
of	O
patients	O
with	O
IBD	O
and	O
none	O
of	O
the	O
controls	O
.	O

All	O
EICC	O
strains	O
were	O
in	O
Cluster	O
1	O
.	O

The	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strain	I-bacteria
colonizing	O
intestinal	O
tissues	O
of	O
patient	O
No	O
.	O
1	O
was	O
closely	O
related	O
to	O
the	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strain	I-bacteria
from	O
patient	O
No	O
.	O
6	O
and	O
had	O
gene	O
recombination	O
with	O
the	O
patient	O
'	O
s	O
own	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
.	O

The	O
oral	O
and	O
intestinal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	O
of	O
patient	O
No	O
.	O
3	O
were	O
the	O
same	O
strain	O
.	O

Some	O
individuals	O
were	O
colonized	O
with	O
multiple	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	O
that	O
have	O
undergone	O
natural	O
recombination	O
.	O

This	O
study	O
provides	O
the	O
first	O
evidence	O
that	O
patients	O
with	O
IBD	O
are	O
colonized	O
with	O
specific	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
,	O
with	O
some	O
being	O
EICC	B-bacteria
strains	I-bacteria
.	O

C	B-bacteria
.	I-bacteria
concisus	I-bacteria
colonizing	O
intestinal	O
tissues	O
of	O
patients	O
with	O
IBD	O
at	O
least	O
in	O
some	O
instances	O
results	O
from	O
an	O
endogenous	O
colonization	O
of	O
the	O
patient	O
'	O
s	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
and	O
that	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
undergo	O
natural	O
recombination	O
.	O

Highantagonistic	O
strains	O
of	O
lactobacillus	B-bacteria
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
healthy	O
people	O
,	O
genetically	O
identified	O
as	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
39	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
50	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
24	I-bacteria
,	O
showed	O
high	O
degree	O
of	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
,	O
adhesion	O
,	O
and	O
the	O
ability	O
to	O
form	O
biofilms	O
.	O

These	O
strains	O
can	O
be	O
used	O
to	O
create	O
new	O
probiotic	O
drugs	O
for	O
the	O
prevention	O
and	O
correction	O
the	O
dysbiosis	O
of	O
the	O
oral	O
cavity	O
.	O

The	O
phylogenetic	O
significance	O
of	O
the	O
diversity	O
of	O
key	O
enzymes	O
of	O
methylotrophic	O
and	O
autotrophic	O
metabolism	O
is	O
discussed	O
.	O

Primers	O
for	O
these	O
key	O
enzymes	O
were	O
designed	O
using	O
gene	O
sequences	O
encoding	O
methanol	O
dehydrogenase	O
(	O
mxaF	O
;	O
using	O
subsets	O
from	O
database	O
sequences	O
for	O
22	O
Bacteria	O
)	O
,	O
hydroxypyruvate	O
reductase	O
(	O
hpr	O
;	O
36	O
sequences	O
)	O
,	O
methylamine	O
dehydrogenase	O
(	O
mauA	O
;	O
12	O
sequences	O
)	O
,	O
methanesulfonate	O
monooxygenase	O
(	O
msmA	O
;	O
four	O
sequences	O
)	O
,	O
and	O
the	O
ccbL	O
and	O
cbbM	O
genes	O
of	O
ribulose	O
bisphosphate	O
carboxylase	O
(	O
26	O
and	O
23	O
sequences	O
)	O
.	O

These	O
were	O
effective	O
in	O
amplifying	O
the	O
correct	O
gene	O
products	O
for	O
the	O
target	O
genes	O
in	O
reference	O
organisms	O
and	O
in	O
test	O
organisms	O
not	O
previously	O
shown	O
to	O
contain	O
the	O
genes	O
,	O
as	O
well	O
as	O
in	O
some	O
methylotrophic	O
Proteobacteria	B-bacteria
isolated	O
from	O
the	O
human	O
mouth	O
.	O

The	O
availability	O
of	O
the	O
new	O
primers	O
increases	O
the	O
probability	O
of	O
detecting	O
diverse	O
examples	O
of	O
the	O
genes	O
encoding	O
these	O
key	O
enzymes	O
both	O
in	O
natural	O
populations	O
and	O
in	O
isolated	O
bacterial	O
strains	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
identify	O
the	O
bacteria	O
involved	O
in	O
delayed	O
-	O
onset	O
infections	O
after	O
lower	O
third	O
molar	O
removal	O
and	O
to	O
determine	O
the	O
most	O
suitable	O
antibiotic	O
for	O
such	O
complication	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
13	O
patients	O
who	O
developed	O
delayed	O
-	O
onset	O
infections	O
after	O
lower	O
third	O
molar	O
extraction	O
.	O

After	O
the	O
identification	O
of	O
the	O
bacterial	O
isolates	O
,	O
the	O
in	O
vitro	O
antimicrobial	O
susceptibility	O
of	O
the	O
isolated	O
strains	O
was	O
determined	O
.	O

A	O
total	O
of	O
11	O
patients	O
(	O
12	O
samples	O
)	O
were	O
finally	O
included	O
in	O
the	O
study	O
.	O

Up	O
to	O
7	O
bacteria	O
genera	O
were	O
identified	O
.	O

Fusobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
was	O
present	O
in	O
11	O
patients	O
,	O
Prevotella	B-bacteria
sp	I-bacteria
.	I-bacteria
in	O
8	O
cases	O
,	O
and	O
Peptostreptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
in	O
7	O
.	O

Some	O
strains	O
of	O
these	O
bacteria	O
were	O
not	O
susceptible	O
to	O
amoxicillin	O
,	O
amoxicillin	O
/	O
clavulanate	O
,	O
and	O
metronidazol	O
,	O
whereas	O
no	O
resistances	O
were	O
found	O
to	O
clindamycin	O
.	O

Fusobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Prevotella	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
and	O
Peptostreptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
are	O
frequently	O
present	O
in	O
delayed	O
-	O
onset	O
infections	O
after	O
lower	O
third	O
molar	O
removal	O
.	O

Based	O
on	O
the	O
results	O
of	O
the	O
microbial	O
susceptibility	O
tests	O
,	O
clindamycin	O
seems	O
to	O
be	O
the	O
most	O
adequate	O
antibiotic	O
for	O
the	O
treatment	O
of	O
this	O
complication	O
.	O

Bacteria	O
communicate	O
by	O
producing	O
quorum	O
sensing	O
molecules	O
called	O
autoinducers	O
,	O
which	O
include	O
autoinducer	O
-	O
1	O
,	O
an	O
N	O
-	O
hexanoyl	O
homoserine	O
lactone	O
(	O
AHL	O
)	O
,	O
and	O
autoinducer	O
-	O
2	O
.	O

Bacteria	O
present	O
in	O
the	O
human	O
oral	O
cavity	O
have	O
been	O
shown	O
to	O
produce	O
autoinducer	O
-	O
2	O
,	O
but	O
not	O
AHL	O
.	O

Here	O
,	O
we	O
report	O
the	O
isolation	O
of	O
two	O
AHL	O
-	O
producing	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
strains	I-bacteria
from	O
the	O
posterior	O
dorsal	O
surface	O
of	O
the	O
tongue	O
of	O
a	O
healthy	O
individual	O
.	O

Spent	O
culture	O
supernatant	O
extracts	O
from	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
activated	O
the	O
biosensors	O
Agrobacterium	B-bacteria
tumefaciens	I-bacteria
NTL4	I-bacteria
(	O
pZLR4	O
)	O
and	O
Escherichia	B-bacteria
coli	I-bacteria
[	O
O	O
pSB401	B-bacteria
]	O
O	O
,	O
suggesting	O
the	O
presence	O
of	O
both	O
long	O
and	O
short	O
chain	O
AHLs	O
.	O

High	O
resolution	O
mass	O
spectrometry	O
analyses	O
of	O
these	O
extracts	O
confirmed	O
that	O
both	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
isolates	O
produced	O
N	O
-	O
octanoylhomoserine	O
lactone	O
and	O
N	O
-	O
3	O
-	O
dodecanoyl	O
-	O
L	O
-	O
homoserine	O
lactone	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
the	O
isolation	O
of	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
from	O
the	O
posterior	O
dorsal	O
surface	O
of	O
the	O
human	O
tongue	O
and	O
the	O
production	O
of	O
these	O
AHLs	O
by	O
this	O
bacterium	O
.	O

To	O
determine	O
whether	O
variation	O
in	O
glucan	O
synthesis	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
isolates	I-bacteria
is	O
associated	O
with	O
caries	O
development	O
in	O
children	O
receiving	O
a	O
fluoride	O
mouth	O
rinse	O
(	O
FMR	O
)	O
.	O

Of	O
122	O
children	O
(	O
aged	O
9	O
to	O
10	O
years	O
)	O
,	O
64	O
had	O
received	O
FMR	O
(	O
FMR	O
(	O
+	O
)	O
group	O
)	O
and	O
the	O
remaining	O
58	O
children	O
had	O
not	O
(	O
FMR	O
(	O
-	O
)	O
group	O
)	O
.	O

The	O
number	O
of	O
decayed	O
and	O
filled	O
teeth	O
(	O
DFT	O
)	O
and	O
increases	O
in	O
the	O
number	O
of	O
DFT	O
in	O
1	O
year	O
(	O
dDFT	O
)	O
were	O
recorded	O
.	O

Saliva	O
samples	O
were	O
collected	O
to	O
isolate	O
the	O
clinical	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
.	O

The	O
isolates	O
were	O
incubated	O
in	O
heart	O
infusion	O
broth	O
supplemented	O
with	O
1	O
%	O
sucrose	O
,	O
then	O
the	O
amount	O
of	O
water	O
-	O
insoluble	O
glucan	O
(	O
WIG	O
)	O
formed	O
on	O
a	O
glass	O
tube	O
surface	O
was	O
evaluated	O
.	O

In	O
the	O
FMR	O
(	O
-	O
)	O
group	O
,	O
children	O
carrying	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
had	O
a	O
higher	O
DFT	O
(	O
P	O
=	O
0	O
.	O
039	O
)	O
and	O
tended	O
to	O
have	O
a	O
higher	O
dDFT	O
(	O
P	O
=	O
0	O
.	O
080	O
)	O
than	O
the	O
others	O
.	O

In	O
the	O
FMR	O
(	O
+	O
)	O
group	O
,	O
although	O
the	O
differences	O
between	O
children	O
with	O
and	O
without	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
not	O
significant	O
,	O
children	O
carrying	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
that	O
produced	O
a	O
high	O
amount	O
of	O
WIG	O
had	O
higher	O
dDFT	O
than	O
the	O
other	O
S	O
.	O
mutans	O
-	O
positive	O
children	O
(	O
P	O
=	O
0	O
.	O
034	O
)	O
.	O

This	O
study	O
revealed	O
that	O
the	O
variation	O
in	O
glucan	O
synthesis	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
is	O
associated	O
with	O
caries	O
development	O
in	O
children	O
receiving	O
a	O
FMR	O
.	O

Nickel	O
chromium	O
brackets	O
are	O
the	O
most	O
common	O
type	O
of	O
fixed	O
orthodontic	O
appliance	O
used	O
in	O
our	O
environment	O
and	O
may	O
alter	O
the	O
oral	O
microflora	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
nickel	O
chromium	O
brackets	O
in	O
orthodontic	O
treatment	O
on	O
the	O
oral	O
microflora	O
and	O
to	O
compare	O
with	O
a	O
control	O
group	O
of	O
dental	O
students	O
.	O

Thirty	O
-	O
eight	O
randomly	O
selected	O
participants	O
were	O
divided	O
into	O
two	O
groups	O
.	O

Group	O
1	O
was	O
19	O
orthodontic	O
patients	O
(	O
OS	O
)	O
with	O
anterior	O
segment	O
crowding	O
.	O

Group	O
2	O
were	O
19	O
normal	O
dental	O
students	O
(	O
DS	O
)	O
who	O
served	O
as	O
a	O
control	O
group	O
.	O

Two	O
samples	O
of	O
stimulated	O
saliva	O
were	O
collected	O
.	O

The	O
initial	O
sample	O
was	O
collected	O
before	O
the	O
placement	O
of	O
nickel	O
chromium	O
brackets	O
(	O
OS1	O
)	O
and	O
the	O
other	O
6	O
months	O
after	O
wearing	O
the	O
appliance	O
in	O
both	O
arches	O
(	O
OS2	O
)	O
for	O
group	O
1	O
.	O

Group	O
2	O
also	O
had	O
the	O
initial	O
(	O
DS1	O
)	O
and	O
second	O
samples	O
(	O
DS2	O
)	O
collected	O
after	O
a	O
6	O
month	O
interval	O
.	O

The	O
saliva	O
was	O
analysed	O
after	O
being	O
inoculated	O
onto	O
blood	O
,	O
chocolate	O
and	O
MacConkey	O
agar	O
plates	O
which	O
were	O
incubated	O
for	O
24	O
hours	O
at	O
37	O
degrees	O
C	O
aerobically	O
except	O
chocolate	O
agar	O
,	O
which	O
was	O
incubated	O
in	O
a	O
candle	O
extinction	O
jar	O
.	O

The	O
results	O
showed	O
that	O
Streptococcus	B-bacteria
viridans	I-bacteria
was	O
the	O
most	O
prevalent	O
microorganism	O
and	O
was	O
isolated	O
in	O
15	O
(	O
79	O
%	O
)	O
,	O
and	O
11	O
(	O
57	O
.	O
9	O
%	O
)	O
,	O
of	O
groups	O
OS1	O
and	O
DS1	O
respectively	O
.	O

There	O
was	O
no	O
statistical	O
difference	O
between	O
both	O
control	O
groups	O
OS1	O
and	O
DS1	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
,	O
and	O
treatment	O
groups	O
OS2	O
and	O
DS2	O
for	O
Streptococcus	B-bacteria
viridans	I-bacteria
.	O

There	O
was	O
a	O
significant	O
difference	O
between	O
DS1	O
with	O
7	O
(	O
36	O
.	O
8	O
%	O
)	O
and	O
OS1	O
with	O
2	O
(	O
10	O
.	O
5	O
%	O
)	O
for	O
Staphylococcus	B-bacteria
aureus	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
was	O
cultured	O
in	O
all	O
groups	O
except	O
OS2	O
.	O

There	O
was	O
also	O
no	O
statistically	O
significant	O
difference	O
between	O
groups	O
OS1	O
and	O
OS2	O
and	O
the	O
control	O
groups	O
DS1	O
and	O
DS2	O
for	O
all	O
the	O
organisms	O
cultured	O
.	O

There	O
was	O
no	O
change	O
in	O
composition	O
of	O
bacteria	O
between	O
groups	O
OS1	O
,	O
OS2	O
and	O
DS1	O
.	O

There	O
is	O
no	O
difference	O
in	O
the	O
oral	O
microflora	O
between	O
orthodontic	O
patients	O
and	O
normal	O
subjects	O
and	O
wearing	O
nickel	O
chromium	O
brackets	O
does	O
not	O
significantly	O
alter	O
the	O
composition	O
of	O
the	O
oral	O
microflora	O
.	O

A	O
comparative	O
study	O
was	O
carried	O
out	O
between	O
cinnamon	O
oil	O
and	O
clove	O
oil	O
on	O
the	O
oral	O
micro	O
-	O
biota	O
causing	O
dental	O
caries	O
.	O

Cinnamon	O
oil	O
was	O
found	O
to	O
be	O
more	O
effective	O
than	O
clove	O
oil	O
exhibiting	O
broad	O
spectrum	O
of	O
antibacterial	O
activity	O
inhibiting	O
all	O
the	O
ten	O
test	O
bacterial	O
species	O
involved	O
in	O
dental	O
caries	O
.	O

Cinnamon	O
oil	O
produced	O
maximum	O
inhibition	O
zone	O
of	O
diameter	O
(	O
IZD	O
)	O
of	O
24	O
.	O
0	O
mm	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
major	O
causative	O
bacteria	O
of	O
dental	O
plaque	O
)	O
as	O
compared	O
to	O
clove	O
oil	O
(	O
IZD	O
=	O
13	O
.	O
0mm	O
)	O
.	O

This	O
is	O
contrary	O
to	O
the	O
popular	O
belief	O
that	O
clove	O
oil	O
is	O
effective	O
in	O
tooth	O
decay	O
and	O
dental	O
plaque	O
.	O

This	O
study	O
shows	O
the	O
potential	O
of	O
cinnamon	O
oil	O
over	O
clove	O
oil	O
in	O
the	O
treatment	O
of	O
dental	O
caries	O
.	O

Empirically	O
prescribed	O
antibiotics	O
are	O
widely	O
employed	O
in	O
the	O
management	O
of	O
odontogenic	O
infections	O
.	O

To	O
characterise	O
the	O
infections	O
associated	O
with	O
extracted	O
teeth	O
and	O
assess	O
effectiveness	O
of	O
the	O
antibiotics	O
prescribed	O
empirically	O
following	O
tooth	O
extraction	O
.	O

The	O
study	O
was	O
cross	O
-	O
sectional	O
and	O
consisted	O
of	O
41	O
consecutively	O
recruited	O
subjects	O
who	O
required	O
extraction	O
for	O
infections	O
associated	O
with	O
the	O
tooth	O
.	O

Appropriate	O
clinical	O
specimens	O
were	O
collected	O
aseptically	O
from	O
each	O
patient	O
and	O
transported	O
in	O
Stuart	O
'	O
s	O
transport	O
medium	O
for	O
processing	O
in	O
the	O
laboratory	O
.	O

Isolation	O
,	O
identification	O
,	O
and	O
susceptibility	O
pattern	O
of	O
anaerobic	O
and	O
facultative	O
organisms	O
were	O
done	O
employing	O
standard	O
bacteriologic	O
techniques	O
.	O

Antimicrobial	O
susceptibility	O
testing	O
was	O
performed	O
by	O
the	O
disc	O
diffusion	O
technique	O
.	O

There	O
were	O
positive	O
cultures	O
for	O
37	O
patients	O
.	O

Twenty	O
-	O
eight	O
aerobic	O
(	O
45	O
.	O
9	O
%	O
)	O
bacteria	O
and	O
32	O
anaerobic	O
(	O
54	O
.	O
1	O
%	O
)	O
bacteria	O
were	O
isolated	O
,	O
an	O
approximation	O
of	O
two	O
microorganisms	O
per	O
patient	O
.	O

Staphylococcus	B-bacteria
was	O
the	O
most	O
predominant	O
aerobe	O
(	O
25	O
.	O
0	O
%	O
)	O
whereas	O
Bacteroides	B-bacteria
fragilis	I-bacteria
was	O
the	O
most	O
predominant	O
anaerobe	O
(	O
34	O
.	O
2	O
%	O
)	O
.	O

All	O
the	O
bacteria	O
isolated	O
showed	O
in	O
vitro	O
resistance	O
to	O
cephalexin	O
,	O
cloxacillin	O
and	O
metronidazole	O
.	O

Eighteen	O
(	O
64	O
.	O
3	O
%	O
)	O
different	O
aerobic	O
bacteria	O
and	O
13	O
(	O
40	O
.	O
6	O
%	O
)	O
different	O
anaerobic	O
bacteria	O
were	O
sensitive	O
to	O
ciprofloxacillin	O
and	O
these	O
included	O
staphylococcus	B-bacteria
and	O
Bacteroides	B-bacteria
fragilis	I-bacteria
.	O

Sensitivity	O
pattern	O
for	O
amoxycillin	O
was	O
very	O
poor	O
with	O
3	O
.	O
6	O
%	O
and	O
6	O
.	O
3	O
%	O
for	O
aerobes	O
and	O
anaerobes	O
respectively	O
.	O

Odontogenic	O
infections	O
from	O
our	O
centre	O
are	O
polymicrobial	O
in	O
nature	O
with	O
anaerobes	O
predominating	O
.	O

High	O
resistance	O
to	O
most	O
of	O
the	O
antibiotics	O
routinely	O
prescribed	O
in	O
our	O
centre	O
is	O
common	O
.	O

Ciprofloxacillin	O
demonstrated	O
the	O
highest	O
sensitivity	O
pattern	O
.	O

The	O
efficacy	O
of	O
early	O
maternal	O
caries	O
prevention	O
was	O
evaluated	O
.	O

Furthermore	O
,	O
the	O
difference	O
between	O
children	O
colonised	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
at	O
an	O
early	O
or	O
late	O
stage	O
with	O
regard	O
to	O
the	O
prevalence	O
of	O
carious	O
lesions	O
was	O
determined	O
.	O

The	O
children	O
of	O
first	O
-	O
time	O
mothers	O
selected	O
on	O
the	O
basis	O
of	O
high	O
salivary	O
levels	O
of	O
MS	B-bacteria
for	O
participation	O
in	O
a	O
caries	O
prevention	O
programme	O
were	O
recalled	O
at	O
the	O
age	O
of	O
19	O
years	O
.	O

They	O
were	O
examined	O
for	O
salivary	O
MS	B-bacteria
,	O
lesion	O
prevalence	O
(	O
decayed	O
and	O
filled	O
surfaces	O
,	O
DFS	O
)	O
and	O
MS	B-bacteria
in	O
plaque	O
from	O
12	O
selected	O
proximal	O
surfaces	O
.	O

The	O
recall	O
rate	O
was	O
70	O
%	O
for	O
the	O
children	O
of	O
both	O
the	O
high	O
-	O
control	O
and	O
interventional	O
groups	O
.	O

All	O
high	O
-	O
control	O
children	O
and	O
67	O
%	O
of	O
the	O
interventional	O
children	O
were	O
colonised	O
by	O
MS	B-bacteria
.	O

All	O
the	O
children	O
with	O
non	O
-	O
detectable	O
MS	B-bacteria
in	O
saliva	O
were	O
also	O
negative	O
in	O
all	O
plaque	O
samples	O
.	O

No	O
statistically	O
significant	O
difference	O
was	O
found	O
between	O
the	O
groups	O
in	O
terms	O
of	O
DFS	O
,	O
although	O
more	O
interventional	O
children	O
were	O
caries	O
free	O
than	O
in	O
the	O
control	O
group	O
.	O

Early	O
-	O
colonised	O
children	O
,	O
irrespective	O
of	O
group	O
identity	O
,	O
had	O
higher	O
salivary	O
MS	B-bacteria
levels	O
and	O
DFS	O
than	O
later	O
MS	O
-	O
colonised	O
children	O
.	O

The	O
results	O
indicate	O
that	O
it	O
is	O
possible	O
to	O
remain	O
negative	O
for	O
MS	B-bacteria
into	O
adulthood	O
if	O
non	O
-	O
colonised	O
at	O
an	O
early	O
age	O
and	O
this	O
affects	O
the	O
development	O
of	O
carious	O
lesions	O
.	O

Strategies	O
for	O
the	O
prevention	O
of	O
dental	O
caries	O
in	O
early	O
childhood	O
should	O
,	O
therefore	O
,	O
include	O
measures	O
to	O
prevent	O
or	O
delay	O
early	O
colonisation	O
by	O
cariogenic	O
bacteria	O
.	O

Oral	O
streptococci	B-bacteria
are	O
able	O
to	O
produce	O
growth	O
-	O
inhibiting	O
amounts	O
of	O
hydrogen	O
peroxide	O
(	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
as	O
byproduct	O
of	O
aerobic	O
metabolism	O
.	O

Several	O
recent	O
studies	O
showed	O
that	O
the	O
produced	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
is	O
not	O
a	O
simple	O
byproduct	O
of	O
metabolism	O
but	O
functions	O
in	O
several	O
aspects	O
of	O
oral	O
bacterial	O
biofilm	O
ecology	O
.	O

First	O
,	O
the	O
release	O
of	O
DNA	O
from	O
cells	O
is	O
closely	O
associated	O
to	O
the	O
production	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
in	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

Extracellular	O
DNA	O
is	O
crucial	O
for	O
biofilm	O
development	O
and	O
stabilization	O
and	O
can	O
also	O
serve	O
as	O
source	O
for	O
horizontal	O
gene	O
transfer	O
between	O
oral	O
streptococci	B-bacteria
.	O

Second	O
,	O
due	O
to	O
the	O
growth	O
inhibiting	O
nature	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
,	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
compatible	O
species	O
associate	O
with	O
the	O
producers	O
.	O

H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
production	O
therefore	O
might	O
help	O
in	O
structuring	O
the	O
initial	O
biofilm	O
development	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
oral	O
environment	O
harbors	O
salivary	O
peroxidases	O
that	O
are	O
potent	O
in	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
scavenging	O
.	O

Therefore	O
,	O
the	O
effects	O
of	O
biofilm	O
intrinsic	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
production	O
might	O
be	O
locally	O
confined	O
.	O

However	O
,	O
taking	O
into	O
account	O
that	O
80	O
%	O
of	O
initial	O
oral	O
biofilm	O
constituents	O
are	O
streptococci	B-bacteria
,	O
the	O
influence	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
on	O
biofilm	O
development	O
and	O
environmental	O
adaptation	O
might	O
be	O
under	O
appreciated	O
in	O
current	O
research	O
.	O

Currently	O
there	O
are	O
no	O
evidence	O
-	O
based	O
ecological	O
measures	O
for	O
prevention	O
of	O
overgrowth	O
and	O
subsequent	O
infection	O
by	O
fungi	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
increase	O
our	O
knowledge	O
on	O
fungal	O
-	O
bacterial	O
ecological	O
interactions	O
.	O

Salivary	O
Candida	O
abundance	O
of	O
82	O
Dutch	O
adults	O
aged	O
58	O
-	O
80	O
years	O
was	O
established	O
relative	O
to	O
the	O
bacterial	O
load	O
by	O
quantitative	O
PCR	O
analysis	O
of	O
the	O
Internal	O
Transcribed	O
(	O
ITS	O
)	O
region	O
(	O
Candida	O
)	O
and	O
16S	O
rDNA	O
gene	O
(	O
bacteria	O
)	O
.	O

The	O
salivary	O
microbiome	O
was	O
assessed	O
using	O
barcoded	O
pyrosequencing	O
of	O
the	O
bacterial	O
hypervariable	O
regions	O
V5	O
-	O
V7	O
of	O
16S	O
rDNA	O
.	O

Sequencing	O
data	O
was	O
preprocessed	O
by	O
denoising	O
and	O
chimera	O
removal	O
,	O
clustered	O
in	O
Operational	O
Taxonomic	O
Units	O
(	O
OTUs	O
)	O
and	O
assigned	O
to	O
taxonomy	O
.	O

Both	O
OTU	O
-	O
based	O
(	O
PCA	O
,	O
diversity	O
statistics	O
)	O
and	O
phylogeny	O
-	O
based	O
analyses	O
(	O
UniFrac	O
,	O
PCoA	O
)	O
were	O
performed	O
.	O

Saliva	O
of	O
Dutch	O
older	O
adults	O
contained	O
0	O
-	O
4	O
x	O
10	O
(	O
8	O
)	O
CFU	O
/	O
mL	O
Candida	O
with	O
a	O
median	O
Candida	O
load	O
of	O
0	O
.	O
06	O
%	O
.	O

With	O
increased	O
Candida	O
load	O
the	O
diversity	O
of	O
the	O
salivary	O
microbiome	O
decreased	O
significantly	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Increase	O
in	O
the	O
Candida	O
load	O
correlated	O
positively	O
with	O
class	B-bacteria
Bacilli	I-bacteria
,	O
and	O
negatively	O
with	O
class	O
Fusobacteria	B-bacteria
,	O
Flavobacteria	B-bacteria
,	O
and	O
Bacteroidia	B-bacteria
.	O

Microbiomes	O
with	O
high	O
Candida	O
load	O
were	O
less	O
diverse	O
and	O
had	O
a	O
distinct	O
microbial	O
composition	O
towards	O
dominance	O
by	O
saccharolytic	O
and	O
acidogenic	O
bacteria	O
-	O
-	O
streptococci	B-bacteria
.	O

The	O
control	O
of	O
the	O
acidification	O
of	O
the	O
oral	O
environment	O
may	O
be	O
a	O
potential	O
preventive	O
measure	O
for	O
Candida	O
outgrowth	O
that	O
should	O
be	O
evaluated	O
in	O
longitudinal	O
clinical	O
intervention	O
trials	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
relationship	O
between	O
infection	O
with	O
cariogenic	O
bacteria	O
or	O
periodontal	O
pathogens	O
and	O
the	O
oral	O
condition	O
of	O
children	O
in	O
the	O
primary	O
and	O
mixed	O
dentition	O
stages	O
.	O

Children	O
aged	O
3	O
to	O
11	O
years	O
were	O
selected	O
Detection	O
of	O
cariogenic	O
and	O
periodontopathic	O
bacteria	O
and	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
analyses	O
were	O
performed	O
,	O
and	O
the	O
prevalence	O
of	O
infection	O
with	O
cariogenic	O
bacteria	O
or	O
periodontal	O
pathogens	O
based	O
on	O
caries	O
experience	O
and	O
dental	O
stage	O
was	O
compared	O
.	O

The	O
prevalence	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
in	O
both	O
stages	O
was	O
significantly	O
higher	O
in	O
the	O
caries	O
group	O
than	O
in	O
the	O
caries	O
-	O
free	O
group	O
.	O

The	O
prevalence	O
of	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
was	O
significantly	O
higher	O
in	O
the	O
caries	O
group	O
only	O
in	O
the	O
mixed	O
dentition	O
stage	O
.	O

The	O
prevalence	O
ofperiodontal	O
pathogens	O
was	O
significantly	O
higher	O
in	O
the	O
mixed	O
dentition	O
stage	O
than	O
in	O
the	O
primary	O
dentition	O
stage	O
,	O
regardless	O
of	O
caries	O
experience	O
.	O

However	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
prevalence	O
of	O
the	O
periodontal	O
pathogens	O
between	O
the	O
primary	O
dentition	O
and	O
mixed	O
dentition	O
stages	O
,	O
based	O
on	O
caries	O
experience	O
.	O

Our	O
data	O
suggested	O
that	O
cariogenic	O
and	O
periodontopathic	O
bacteria	O
have	O
different	O
infection	O
patterns	O
,	O
and	O
that	O
the	O
period	O
of	O
infection	O
with	O
these	O
bacteria	O
also	O
differs	O
.	O

Congenital	O
heart	O
disease	O
(	O
CHD	O
)	O
,	O
abnormalities	O
in	O
the	O
structural	O
development	O
of	O
the	O
heart	O
,	O
occurs	O
in	O
approximately	O
8	O
:	O
1000	O
live	O
births	O
.	O

The	O
causative	O
microorganism	O
for	O
infective	O
endocarditis	O
in	O
more	O
than	O
60	O
%	O
of	O
the	O
patients	O
with	O
positive	O
hemoculture	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
(	O
s	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
s	B-bacteria
.	I-bacteria
mitior	I-bacteria
)	O
thus	O
making	O
it	O
mandatory	O
for	O
these	O
children	O
to	O
maintain	O
their	O
oral	O
health	O
.	O

The	O
present	O
study	O
assessed	O
the	O
oral	O
health	O
of	O
children	O
with	O
congenital	O
heart	O
disease	O
following	O
preventive	O
treatment	O
.	O

A	O
total	O
of	O
74	O
children	O
with	O
congenital	O
heart	O
disease	O
were	O
selected	O
for	O
the	O
study	O
with	O
30	O
healthy	O
controls	O
between	O
the	O
ages	O
5	O
-	O
16	O
.	O

The	O
oral	O
health	O
was	O
assessed	O
by	O
measuring	O
the	O
microbial	O
counts	O
,	O
the	O
OHI	O
-	O
S	O
and	O
the	O
gingival	O
indices	O
.	O

The	O
data	O
thus	O
obtained	O
were	O
subjected	O
to	O
paired	O
and	O
unpaired	O
t	O
-	O
test	O
.	O

Poor	O
oral	O
health	O
was	O
prevalent	O
among	O
these	O
children	O
of	O
the	O
study	O
group	O
as	O
compared	O
to	O
the	O
controls	O
indicating	O
a	O
lack	O
of	O
sound	O
knowledge	O
of	O
the	O
maintenance	O
of	O
oral	O
hygiene	O
.	O

Following	O
preventive	O
treatment	O
the	O
oral	O
health	O
improved	O
considerably	O
.	O

Interaction	O
of	O
oral	O
streptococci	B-bacteria
biofilm	O
is	O
the	O
main	O
etiological	O
factor	O
for	O
dental	O
caries	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
compare	O
oral	B-bacteria
streptococci	I-bacteria
(	O
OS	B-bacteria
)	O
distribution	O
in	O
the	O
biofilm	O
of	O
primary	O
dentition	O
from	O
caries	O
-	O
free	O
and	O
caries	O
-	O
affected	O
preschool	O
Mexican	O
children	O
.	O

This	O
cross	O
-	O
sectional	O
study	O
involved	O
40	O
caries	O
-	O
free	O
and	O
40	O
caries	O
-	O
affected	O
children	O
with	O
primary	O
dentition	O
.	O

Each	O
child	O
was	O
examined	O
using	O
the	O
dmfs	O
index	O
,	O
DNA	O
was	O
extracted	O
from	O
saliva	O
and	O
presence	O
of	O
OS	B-bacteria
was	O
determined	O
by	O
PCR	O
.	O

Data	O
obtained	O
showed	O
no	O
statistical	O
difference	O
regarding	O
age	O
and	O
gender	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
(	O
Smut	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
(	O
Ssob	B-bacteria
)	O
and	O
their	O
combination	O
showed	O
significant	O
statistical	O
differences	O
between	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Smut	B-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
had	O
an	O
inverse	O
relation	O
with	O
dmfs	O
index	O
and	O
Ssob	O
had	O
a	O
direct	O
relation	O
similar	O
to	O
combined	O
with	O
Smut	O
.	O

Smut	B-bacteria
-	O
Ssob	B-bacteria
combined	O
with	O
other	O
OS	B-bacteria
showed	O
statistical	O
differences	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
free	O
-	O
caries	O
group	O
Streptococcus	B-bacteria
gordonii	I-bacteria
was	O
more	O
frequently	O
identified	O
than	O
Smut	B-bacteria
.	O

The	O
ratio	O
Smut	B-bacteria
/	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
could	O
represent	O
a	O
high	O
risk	O
of	O
dental	O
caries	O
development	O
;	O
this	O
ratio	O
was	O
higher	O
in	O
the	O
caries	O
-	O
affected	O
(	O
1	O
.	O
18	O
)	O
than	O
in	O
the	O
caries	O
-	O
free	O
group	O
(	O
0	O
.	O
32	O
)	O
.	O

In	O
conclusion	O
,	O
OS	B-bacteria
play	O
an	O
important	O
role	O
in	O
dental	O
caries	O
predisposition	O
and	O
severity	O
,	O
not	O
only	O
the	O
presence	O
of	O
Smut	B-bacteria
and	O
Srob	B-bacteria
,	O
but	O
also	O
the	O
complexity	O
and	O
distribution	O
of	O
OS	B-bacteria
in	O
the	O
biofilm	O
.	O

Mouthwashes	O
decrease	O
the	O
risk	O
of	O
VAP	O
by	O
reducing	O
the	O
number	O
of	O
microorganisms	O
and	O
their	O
transmission	O
and	O
colonization	O
in	O
the	O
lung	O
.	O

Among	O
the	O
oral	O
rinses	O
,	O
chlorhexidine	O
is	O
considered	O
as	O
the	O
gold	O
standard	O
but	O
it	O
has	O
a	O
variety	O
of	O
complications	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
and	O
compare	O
anti	O
-	O
bacterial	O
effects	O
of	O
the	O
chlorhexidine	O
gluconate	O
and	O
herbal	O
mouthwashes	O
in	O
intensive	O
care	O
unit	O
patients	O
.	O

In	O
this	O
double	O
blind	O
randomized	O
clinical	O
trial	O
,	O
60	O
patients	O
who	O
were	O
admitted	O
in	O
ICU	O
were	O
divided	O
into	O
two	O
equal	O
30	O
persons	O
groups	O
.	O

In	O
the	O
first	O
group	O
Chlorhexidine	O
gluconate	O
2	O
%	O
mouthwash	O
and	O
in	O
the	O
second	O
group	O
herbal	O
mouth	O
wash	O
was	O
used	O
.	O

Just	O
before	O
and	O
again	O
after	O
6	O
min	O
of	O
oral	O
rinsing	O
,	O
salivary	O
samples	O
were	O
obtained	O
without	O
any	O
stimulation	O
in	O
order	O
to	O
culture	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
.	O

The	O
data	O
were	O
processed	O
in	O
SPSS16	O
software	O
and	O
were	O
analyzed	O
by	O
appropriate	O
statistical	O
tests	O
.	O

Matrica	O
(	O
R	O
)	O
and	O
chlorhexidine	O
mouthwashes	O
have	O
significant	O
antibacterial	O
effects	O
against	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

Decreasing	O
of	O
the	O
number	O
of	O
bacteria	O
in	O
samples	O
after	O
oral	O
rinsing	O
was	O
significant	O
in	O
both	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
but	O
chlorhexidine	O
was	O
significantly	O
more	O
effective	O
than	O
herbal	O
mouth	O
wash	O
in	O
reducing	O
the	O
number	O
of	O
colonies	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
herbal	O
mouth	O
wash	O
has	O
significant	O
antibacterial	O
effects	O
against	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
but	O
its	O
efficacy	O
is	O
less	O
than	O
chlorhexidine	O
,	O
so	O
after	O
further	O
investigation	O
,	O
it	O
would	O
be	O
considered	O
as	O
an	O
alternative	O
to	O
chlorhexidine	O
in	O
ICUs	O
(	O
Tab	O
.	O
3	O
,	O
Ref	O
.	O
33	O
)	O
.	O

Outbreaks	O
of	O
antibiotic	O
-	O
resistant	O
bacterial	O
infections	O
emphasize	O
the	O
importance	O
of	O
surveillance	O
of	O
potentially	O
pathogenic	O
bacteria	O
.	O

Genomic	O
sequencing	O
of	O
clinical	O
microbiological	O
specimens	O
expands	O
our	O
capacity	O
to	O
cultivable	O
,	O
fastidious	O
and	O
uncultivable	O
members	O
of	O
the	O
bacterial	O
community	O
.	O

Herein	O
,	O
we	O
compared	O
the	O
primary	O
data	O
collected	O
by	O
the	O
NIH	O
'	O
s	O
Human	O
Microbiome	O
Project	O
(	O
HMP	O
)	O
with	O
published	O
epidemiological	O
surveillance	O
data	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

The	O
HMP	O
'	O
s	O
initial	O
dataset	O
contained	O
microbial	O
survey	O
data	O
from	O
five	O
body	O
regions	O
(	O
skin	O
,	O
nares	O
,	O
oral	O
cavity	O
,	O
gut	O
and	O
vagina	O
)	O
of	O
242	O
healthy	O
volunteers	O
.	O

A	O
significant	O
component	O
of	O
the	O
HMP	O
dataset	O
was	O
deep	O
sequencing	O
of	O
the	O
16S	O
ribosomal	O
RNA	O
gene	O
,	O
which	O
contains	O
variable	O
regions	O
enabling	O
taxonomic	O
classification	O
.	O

Since	O
species	O
-	O
level	O
identification	O
is	O
essential	O
in	O
clinical	O
microbiology	O
,	O
we	O
built	O
a	O
reference	O
database	O
and	O
used	O
phylogenetic	O
placement	O
followed	O
by	O
most	O
recent	O
common	O
ancestor	O
classification	O
to	O
look	O
at	O
the	O
species	O
distribution	O
for	O
Staphylococcus	B-bacteria
,	O
Klebsiella	B-bacteria
and	O
Enterococcus	B-bacteria
.	O

We	O
show	O
that	O
selecting	O
the	O
accurate	O
region	O
of	O
the	O
16S	O
rRNA	O
gene	O
to	O
sequence	O
is	O
analogous	O
to	O
carefully	O
selecting	O
culture	O
conditions	O
to	O
distinguish	O
closely	O
related	O
bacterial	O
species	O
.	O

Analysis	O
of	O
the	O
HMP	O
data	O
showed	O
that	O
Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
present	O
in	O
the	O
nares	O
of	O
36	O
%	O
of	O
healthy	O
volunteers	O
,	O
consistent	O
with	O
culture	O
-	O
based	O
epidemiological	O
data	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
were	O
found	O
less	O
frequently	O
,	O
but	O
across	O
many	O
habitats	O
.	O

This	O
work	O
demonstrates	O
that	O
large	O
16S	O
rRNA	O
survey	O
studies	O
can	O
be	O
used	O
to	O
support	O
epidemiological	O
goals	O
in	O
the	O
context	O
of	O
an	O
increasing	O
awareness	O
that	O
microbes	O
flourish	O
and	O
compete	O
within	O
a	O
larger	O
bacterial	O
community	O
.	O

This	O
demonstrates	O
how	O
genomic	O
techniques	O
and	O
information	O
could	O
be	O
critically	O
important	O
to	O
trace	O
microbial	O
evolution	O
and	O
implement	O
hospital	O
infection	O
control	O
.	O

The	O
mouth	O
is	O
a	O
complex	O
biological	O
structure	O
inhabited	O
by	O
diverse	O
bacterial	O
communities	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
describe	O
the	O
effects	O
of	O
allogeneic	O
stem	O
cell	O
transplantation	O
on	O
the	O
oral	O
microbiota	O
and	O
to	O
examine	O
differences	O
among	O
those	O
patients	O
who	O
acquired	O
respiratory	O
complications	O
after	O
transplantation	O
.	O

All	O
patients	O
were	O
consented	O
at	O
the	O
National	O
Institutes	O
of	O
Health	O
,	O
Clinical	O
Center	O
.	O

Bacterial	O
DNA	O
was	O
analyzed	O
from	O
patients	O
'	O
oral	O
specimens	O
using	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
.	O

The	O
specimens	O
were	O
collected	O
from	O
four	O
oral	O
sites	O
in	O
45	O
allogeneic	O
transplantation	O
patients	O
.	O

Specimens	O
were	O
collected	O
at	O
baseline	O
prior	O
to	O
transplantation	O
,	O
after	O
transplantation	O
at	O
the	O
nadir	O
of	O
the	O
neutrophil	O
count	O
and	O
after	O
myeloid	O
engraftment	O
.	O

If	O
respiratory	O
signs	O
and	O
symptoms	O
developed	O
,	O
additional	O
specimens	O
were	O
obtained	O
.	O

Patients	O
were	O
followed	O
for	O
100	O
days	O
post	O
transplantation	O
.	O

Eleven	O
patients	O
'	O
specimens	O
were	O
subjected	O
to	O
further	O
statistical	O
analysis	O
.	O

Many	O
common	O
bacterial	O
genera	O
,	O
such	O
as	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Gemella	B-bacteria
,	O
Granulicatella	B-bacteria
and	O
Camplyobacter	B-bacteria
were	O
identified	O
as	O
being	O
present	O
before	O
and	O
after	O
transplantation	O
.	O

Five	O
of	O
11	O
patients	O
developed	O
respiratory	O
complications	O
following	O
transplantation	O
and	O
there	O
was	O
preliminary	O
evidence	O
that	O
the	O
oral	O
microbiome	O
changed	O
in	O
their	O
oral	O
specimens	O
.	O

Cluster	O
analysis	O
and	O
principal	O
component	O
analysis	O
revealed	O
this	O
change	O
in	O
the	O
oral	O
microbiota	O
.	O

After	O
allogeneic	O
transplantation	O
,	O
the	O
oral	O
bacterial	O
community	O
'	O
s	O
response	O
to	O
a	O
new	O
immune	O
system	O
was	O
not	O
apparent	O
and	O
many	O
of	O
the	O
most	O
common	O
core	O
oral	O
taxa	O
remained	O
unaffected	O
.	O

However	O
,	O
the	O
oral	O
microbiome	O
was	O
affected	O
in	O
patients	O
who	O
developed	O
respiratory	O
signs	O
and	O
symptoms	O
after	O
transplantation	O
.	O

The	O
association	O
related	O
to	O
the	O
change	O
in	O
the	O
oral	O
microbiota	O
and	O
respiratory	O
complications	O
after	O
transplantation	O
will	O
be	O
validated	O
by	O
future	O
studies	O
using	O
high	O
throughput	O
molecular	O
methods	O
.	O

Antimicrobial	O
resistance	O
is	O
on	O
the	O
increase	O
in	O
'	O
medical	O
and	O
dental	O
fields	O
.	O

Beta	O
-	O
lactam	O
antibiotics	O
are	O
the	O
most	O
widely	O
used	O
antimicrobials	O
in	O
dental	O
patients	O
.	O

This	O
study	O
investigated	O
the	O
prevalence	O
of	O
beta	O
-	O
lactamase	O
-	O
producing	O
anaerobic	O
oral	O
bacteria	O
in	O
patients	O
with	O
chronic	O
periodontitis	O
.	O

Pooled	O
subgingival	O
samples	O
from	O
two	O
sites	O
in	O
42	O
patients	O
with	O
chronic	O
periodontitis	O
were	O
cultured	O
anaerobically	O
on	O
blood	O
agar	O
plates	O
containing	O
amoxycillin	O
or	O
/	O
and	O
Augmentin	O
.	O

Colonies	O
that	O
grew	O
on	O
amoxycillin	O
but	O
not	O
Augmentin	O
were	O
identified	O
and	O
tested	O
for	O
beta	O
-	O
lactamase	O
production	O
.	O

Sixty	O
-	O
nine	O
percent	O
of	O
patients	O
carried	O
beta	O
-	O
lactamase	O
-	O
producing	O
anaerobes	O
,	O
with	O
a	O
mean	O
of	O
one	O
to	O
two	O
strains	O
per	O
patient	O
.	O

Seventy	O
isolates	O
of	O
the	O
beta	O
-	O
lactamase	O
-	O
producing	O
strains	O
formed	O
4	O
%	O
of	O
the	O
total	O
cultivable	O
anaerobic	O
flora	O
.	O

Prevotella	B-bacteria
was	O
the	O
most	O
prevalent	O
beta	O
-	O
lactamase	O
-	O
producing	O
species	O
,	O
followed	O
by	O
Capnocytophaga	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Bacteroides	B-bacteria
.	O

A	O
high	O
prevalence	O
of	O
beta	O
-	O
lactamase	O
-	O
producing	O
oral	O
anaerobes	O
was	O
detected	O
in	O
this	O
preliminary	O
study	O
.	O

However	O
,	O
the	O
percentage	O
of	O
beta	O
-	O
lactamase	O
producers	O
in	O
the	O
total	O
number	O
of	O
bacteria	O
per	O
patient	O
was	O
low	O
.	O

Therefore	O
,	O
beta	O
-	O
lactam	O
antibiotics	O
still	O
remain	O
the	O
drug	O
of	O
choice	O
in	O
infections	O
with	O
odontogenic	O
origin	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
bacterial	O
diversity	O
in	O
the	O
saliva	O
of	O
patients	O
with	O
different	O
oral	O
hygiene	O
indexes	O
using	O
of	O
two	O
16S	O
rRNA	O
gene	O
libraries	O
.	O

Each	O
library	O
was	O
composed	O
of	O
samples	O
from	O
patients	O
with	O
different	O
averages	O
of	O
the	O
differentiated	O
Silness	O
-	O
Loe	O
biofilm	O
index	O
:	O
the	O
first	O
library	O
(	O
A	O
)	O
with	O
an	O
index	O
between	O
1	O
.	O
0	O
and	O
3	O
.	O
0	O
(	O
considered	O
a	O
high	O
index	O
)	O
and	O
the	O
second	O
library	O
(	O
B	O
)	O
between	O
0	O
and	O
0	O
.	O
5	O
(	O
considered	O
a	O
low	O
index	O
)	O
.	O

Saliva	O
DNA	O
was	O
extracted	O
and	O
the	O
16S	O
rRNA	O
gene	O
was	O
amplified	O
and	O
cloned	O
.	O

The	O
obtained	O
sequences	O
were	O
compared	O
with	O
those	O
stored	O
at	O
NCBI	O
and	O
RDP	O
GenBank	O
.	O

The	O
saliva	O
of	O
patients	O
with	O
high	O
index	O
presented	O
five	O
known	O
genera	O
-	O
Streptococcus	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Gemella	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Peptostreptococcus	B-bacteria
-	O
and	O
33	O
.	O
3	O
%	O
of	O
nonculturable	O
bacteria	O
grouped	O
into	O
23	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
.	O

The	O
saliva	O
of	O
patients	O
with	O
low	O
index	O
differed	O
significantly	O
from	O
the	O
first	O
library	O
(	O
p	O
=	O
0	O
.	O
000	O
)	O
and	O
was	O
composed	O
of	O
42	O
OTUs	O
distributed	O
into	O
11	O
known	O
genera	O
-	O
Streptococcus	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Gemella	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Oribacterium	B-bacteria
,	O
Haemophilus	B-bacteria
,	O
Escherichia	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Capnocytophaga	B-bacteria
,	O
Actinomyces	B-bacteria
-	O
including	O
24	O
.	O
87	O
%	O
of	O
nonculturable	O
bacteria	O
.	O

It	O
was	O
possible	O
to	O
conclude	O
that	O
there	O
is	O
greater	O
bacterial	O
diversity	O
in	O
the	O
saliva	O
of	O
patients	O
with	O
low	O
dental	O
plaque	O
in	O
relation	O
to	O
patients	O
with	O
high	O
dental	O
plaque	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
possible	O
modifications	O
due	O
to	O
amoxicillin	O
-	O
clavulanic	O
acid	O
(	O
AMC	O
)	O
treatment	O
on	O
total	O
bacteria	O
and	O
on	O
Bifidobacterium	B-bacteria
species	I-bacteria
balance	O
in	O
human	O
colonic	O
microbiota	O
.	O

Eighteen	O
healthy	O
volunteers	O
(	O
19	O
to	O
36	O
years	O
old	O
)	O
were	O
given	O
a	O
875	O
/	O
125	O
mg	O
dose	O
of	O
AMC	O
twice	O
a	O
day	O
for	O
5	O
days	O
.	O

Fecal	O
samples	O
were	O
obtained	O
before	O
and	O
after	O
antibiotic	O
exposure	O
.	O

After	O
total	O
DNA	O
extraction	O
,	O
total	O
bacteria	O
and	O
bifidobacteria	B-bacteria
were	O
specifically	O
quantified	O
using	O
real	O
-	O
time	O
PCR	O
.	O

Dominant	O
species	O
were	O
monitored	O
over	O
time	O
using	O
bacterial	O
and	O
bifidobacterial	O
Temporal	O
Temperature	O
Gradient	O
gel	O
Electrophoresis	O
(	O
TTGE	O
)	O
.	O

At	O
the	O
end	O
of	O
AMC	O
exposure	O
,	O
total	O
bacterial	O
concentrations	O
as	O
well	O
as	O
bifidobacteria	B-bacteria
concentrations	O
were	O
significantly	O
reduced	O
compared	O
to	O
before	O
AMC	O
exposure	O
:	O
10	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
1	O
log	O
(	O
10	O
)	O
16S	O
rRNA	O
gene	O
copies	O
/	O
g	O
vs	O
11	O
.	O
1	O
+	O
/	O
-	O
0	O
.	O
1	O
log	O
(	O
10	O
)	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
8	O
.	O
1	O
+	O
/	O
-	O
0	O
.	O
5	O
log	O
(	O
10	O
)	O
16S	O
rRNA	O
gene	O
copies	O
/	O
g	O
vs	O
9	O
.	O
4	O
+	O
/	O
-	O
0	O
.	O
3	O
log	O
(	O
10	O
)	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
,	O
respectively	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
mean	O
similarity	O
percentages	O
of	O
TTGE	O
bacteria	O
and	O
TTGE	O
bifidobacteria	B-bacteria
profiles	O
were	O
significantly	O
reduced	O
compared	O
to	O
before	O
AMC	O
exposure	O
:	O
51	O
.	O
6	O
%	O
+	O
/	O
-	O
3	O
.	O
5	O
%	O
vs	O
81	O
.	O
4	O
%	O
+	O
/	O
-	O
2	O
.	O
1	O
%	O
and	O
55	O
.	O
8	O
%	O
+	O
/	O
-	O
7	O
.	O
6	O
%	O
vs	O
84	O
.	O
5	O
%	O
+	O
/	O
-	O
4	O
.	O
1	O
%	O
,	O
respectively	O
.	O

Occurrence	O
of	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
,	O
B	B-bacteria
.	I-bacteria
bifidum	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
pseudocatenulatum	I-bacteria
/	O
B	B-bacteria
.	I-bacteria
catenulatum	I-bacteria
species	I-bacteria
significantly	O
decreased	O
.	O

Occurrence	O
of	O
B	B-bacteria
.	I-bacteria
longum	I-bacteria
remained	O
stable	O
.	O

Moreover	O
,	O
the	O
number	O
of	O
distinct	O
Bifidobacterium	B-bacteria
species	I-bacteria
per	O
sample	O
significantly	O
decreased	O
(	O
1	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
3	O
vs	O
2	O
.	O
3	O
+	O
/	O
-	O
0	O
.	O
3	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O

Two	O
months	O
after	O
AMC	O
exposure	O
,	O
the	O
mean	O
similarity	O
percentage	O
of	O
TTGE	O
profiles	O
was	O
55	O
.	O
6	O
%	O
for	O
bacteria	O
and	O
62	O
.	O
3	O
%	O
for	O
bifidobacteria	B-bacteria
.	O

These	O
results	O
clearly	O
demonstrated	O
that	O
a	O
common	O
antibiotic	O
treatment	O
may	O
qualitatively	O
alter	O
the	O
colonic	O
microbiota	O
.	O

Such	O
modifications	O
may	O
have	O
potential	O
long	O
-	O
term	O
physiological	O
consequences	O
.	O

Periodontal	O
(	O
gum	O
)	O
disease	O
is	O
one	O
of	O
the	O
main	O
global	O
oral	O
health	O
burdens	O
and	O
severe	O
periodontal	O
disease	O
(	O
periodontitis	O
)	O
is	O
a	O
leading	O
cause	O
of	O
tooth	O
loss	O
in	O
adults	O
globally	O
.	O

It	O
also	O
increases	O
the	O
risk	O
of	O
cardiovascular	O
disease	O
and	O
diabetes	O
mellitus	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
key	O
virulent	O
attribute	O
that	O
significantly	O
contributes	O
to	O
periodontal	O
pathogenesis	O
.	O

Baicalin	O
is	O
a	O
flavonoid	O
from	O
Scutellaria	O
radix	O
,	O
an	O
herb	O
commonly	O
used	O
in	O
traditional	O
Chinese	O
medicine	O
for	O
treating	O
inflammatory	O
diseases	O
.	O

The	O
present	O
study	O
examined	O
the	O
modulatory	O
effect	O
of	O
baicalin	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
expression	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
in	O
human	O
oral	O
keratinocytes	O
(	O
HOKs	O
)	O
.	O

Cells	O
were	O
pre	O
-	O
treated	O
with	O
baicalin	O
(	O
0	O
-	O
80	O
microM	O
)	O
for	O
24	O
h	O
,	O
and	O
subsequently	O
treated	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
at	O
10	O
microg	O
/	O
ml	O
with	O
or	O
without	O
baicalin	O
for	O
3	O
h	O
.	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
transcripts	O
and	O
proteins	O
were	O
detected	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
respectively	O
.	O

The	O
expression	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
,	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
proteins	O
was	O
analyzed	O
by	O
western	O
blot	O
.	O

A	O
panel	O
of	O
genes	O
related	O
to	O
toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
signaling	O
was	O
examined	O
by	O
PCR	O
array	O
.	O

We	O
found	O
that	O
baicalin	O
significantly	O
downregulated	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
stimulated	O
expression	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
,	O
and	O
inhibited	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
activated	O
NF	O
-	O
kappaB	O
,	O
p38	O
MAPK	O
and	O
JNK	O
.	O

Furthermore	O
,	O
baicalin	O
markedly	O
downregulated	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
expression	O
of	O
genes	O
associated	O
with	O
TLR	O
signaling	O
.	O

In	O
conclusion	O
,	O
the	O
present	O
study	O
shows	O
that	O
baicalin	O
may	O
significantly	O
downregulate	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
upregulated	O
expression	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
in	O
HOKs	O
via	O
negative	O
regulation	O
of	O
TLR	O
signaling	O
.	O

In	O
the	O
aging	O
population	O
,	O
the	O
prevalence	O
of	O
root	O
caries	O
has	O
been	O
observed	O
,	O
which	O
is	O
a	O
characteristic	O
feature	O
of	O
the	O
elderly	O
people	O
.	O

The	O
most	O
important	O
element	O
used	O
in	O
caries	O
prevention	O
is	O
fluoride	O
,	O
which	O
is	O
derived	O
from	O
the	O
air	O
,	O
diet	O
or	O
fluoride	O
-	O
containing	O
preparations	O
and	O
materials	O
,	O
e	O
.	O
g	O
.	O
glass	O
-	O
ionomer	O
restorations	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
Ketac	O
Molar	O
Aplicap	O
glass	O
-	O
ionomer	O
on	O
the	O
growth	O
of	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
bacteria	I-bacteria
,	O
one	O
of	O
the	O
species	O
most	O
frequently	O
found	O
in	O
the	O
carietic	O
focus	O
of	O
the	O
tooth	O
root	O
.	O

The	O
study	O
was	O
carried	O
out	O
in	O
15	O
patients	O
with	O
good	O
oral	O
hygiene	O
,	O
in	O
whom	O
35	O
fillings	O
from	O
Ketac	O
Molar	O
Aplicap	O
conventional	O
glass	O
-	O
ionomer	O
material	O
were	O
performed	O
.	O

After	O
6	O
months	O
,	O
three	O
-	O
day	O
dental	O
plaque	O
from	O
these	O
fillings	O
and	O
from	O
the	O
tooth	O
enamel	O
of	O
the	O
control	O
group	O
was	O
examined	O
.	O

No	O
statistically	O
significant	O
differences	O
(	O
p	O
=	O
0	O
.	O
554	O
)	O
in	O
the	O
amounts	O
of	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
between	O
the	O
study	O
and	O
control	O
group	O
were	O
revealed	O
.	O

Lack	O
of	O
inhibiting	O
effect	O
of	O
glass	O
-	O
ionomer	O
material	O
on	O
the	O
growth	O
of	O
the	O
dental	O
plaque	O
with	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
after	O
the	O
time	O
of	O
observation	O
is	O
implied	O
.	O

Imbalance	O
in	O
the	O
resident	O
microbiota	O
may	O
promote	O
the	O
growth	O
of	O
opportunistic	O
microorganisms	O
,	O
such	O
as	O
yeasts	O
of	O
Candida	O
genus	O
and	O
the	O
development	O
of	O
diseases	O
,	O
especially	O
in	O
aged	O
people	O
.	O

This	O
study	O
evaluated	O
whether	O
the	O
consumption	O
of	O
the	O
probiotic	O
Yakult	O
LBz	O
(	O
(	O
R	O
)	O
)	O
(	O
Lactobacillus	B-bacteria
casei	I-bacteria
and	O
Bifidobacterium	B-bacteria
breve	I-bacteria
)	O
was	O
able	O
to	O
influence	O
on	O
the	O
specific	O
immunological	O
response	O
against	O
Candida	O
and	O
on	O
the	O
presence	O
of	O
these	O
yeasts	O
in	O
the	O
oral	O
cavity	O
of	O
42	O
healthy	O
aged	O
individuals	O
.	O

Saliva	O
samples	O
were	O
collected	O
before	O
and	O
after	O
the	O
probiotic	O
use	O
for	O
30	O
days	O
,	O
3	O
times	O
a	O
week	O
.	O

The	O
samples	O
were	O
plated	O
in	O
Dextrose	O
Saboraud	O
Agar	O
with	O
chloramphenicol	O
,	O
the	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
/	O
mL	O
)	O
were	O
counted	O
and	O
the	O
Candida	O
species	O
were	O
identified	O
.	O

Anti	O
-	O
Candida	O
IgA	O
analysis	O
was	O
conducted	O
using	O
the	O
ELISA	O
technique	O
.	O

ANOVA	O
and	O
Student	O
'	O
s	O
t	O
-	O
test	O
were	O
used	O
for	O
normally	O
distributed	O
data	O
and	O
the	O
Wilcoxon	O
test	O
was	O
used	O
for	O
data	O
with	O
non	O
-	O
normal	O
distribution	O
(	O
alpha	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
results	O
showed	O
a	O
statistically	O
significant	O
reduction	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
Candida	O
prevalence	O
(	O
from	O
92	O
.	O
9	O
%	O
to	O
85	O
.	O
7	O
%	O
)	O
,	O
in	O
CFU	O
/	O
mL	O
counts	O
of	O
Candida	O
and	O
in	O
the	O
number	O
of	O
non	O
-	O
albicans	O
species	O
after	O
consumption	O
of	O
the	O
probiotic	O
.	O

Immunological	O
analysis	O
demonstrated	O
a	O
significant	O
increase	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
anti	O
-	O
Candida	O
IgA	O
levels	O
.	O

In	O
conclusion	O
,	O
probiotic	O
bacteria	O
reduced	O
Candida	O
numbers	O
in	O
the	O
oral	O
cavity	O
of	O
the	O
elderly	O
and	O
increased	O
specific	O
secretory	O
immune	O
response	O
against	O
these	O
yeasts	O
,	O
suggesting	O
its	O
possible	O
use	O
in	O
controlling	O
oral	O
candidosis	O
.	O

Recent	O
insights	O
in	O
medical	O
science	O
indicate	O
that	O
human	O
biofilms	O
play	O
an	O
important	O
role	O
in	O
health	O
and	O
well	O
-	O
being	O
,	O
and	O
have	O
put	O
microbiota	O
modulation	O
through	O
bacteriotherapy	O
into	O
focus	O
.	O

In	O
dentistry	O
,	O
bacterial	O
interference	O
with	O
probiotic	O
bacteria	O
to	O
support	O
the	O
stability	O
and	O
diversity	O
of	O
oral	O
biofilms	O
has	O
gained	O
similar	O
interest	O
.	O

Investigations	O
in	O
vitro	O
into	O
metabolic	O
activity	O
,	O
co	O
-	O
aggregation	O
,	O
growth	O
inhibition	O
,	O
bacteriocin	O
production	O
,	O
and	O
adhesion	O
have	O
collectively	O
suggested	O
a	O
potential	O
role	O
for	O
probiotic	O
lactobacilli	B-bacteria
and	O
bifidobacteria	B-bacteria
to	O
modulate	O
the	O
oral	O
microbial	O
ecology	O
.	O

Likewise	O
,	O
short	O
-	O
term	O
clinical	O
studies	O
with	O
intermediate	O
microbial	O
endpoints	O
indicate	O
that	O
interference	O
with	O
caries	O
-	O
associated	O
bacteria	O
seems	O
possible	O
through	O
probiotic	O
dairy	O
products	O
,	O
tablets	O
,	O
lozenges	O
and	O
chewing	O
gum	O
in	O
various	O
dose	O
regimens	O
.	O

Few	O
randomized	O
controlled	O
clinical	O
trials	O
with	O
caries	O
outcomes	O
are	O
available	O
,	O
but	O
three	O
studies	O
with	O
preschool	O
children	O
and	O
the	O
elderly	O
have	O
demonstrated	O
preventive	O
fractions	O
between	O
21	O
%	O
and	O
75	O
%	O
,	O
following	O
regular	O
intake	O
of	O
milk	O
supplemented	O
with	O
probiotic	O
lactobacilli	B-bacteria
.	O

However	O
,	O
further	O
large	O
-	O
scale	O
trials	O
with	O
orally	O
derived	O
anti	O
-	O
caries	O
candidates	O
are	O
needed	O
before	O
we	O
can	O
say	O
that	O
we	O
are	O
ready	O
for	O
bacteriotherapy	O
as	O
an	O
adjunct	O
to	O
complement	O
the	O
existing	O
evidence	O
-	O
based	O
methods	O
for	O
preventing	O
and	O
controlling	O
caries	O
in	O
daily	O
practice	O
.	O

Dental	O
caries	O
is	O
the	O
destruction	O
of	O
enamel	O
,	O
dentin	O
,	O
or	O
cementum	O
of	O
teeth	O
due	O
to	O
bacterial	O
activities	O
,	O
which	O
if	O
left	O
untreated	O
can	O
cause	O
considerable	O
pain	O
,	O
discomfort	O
,	O

treatment	O
costs	O
are	O
very	O
high	O
.	O

Of	O
the	O
oral	O
bacteria	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
is	O
considered	O
to	O
be	O
causative	O
agent	O
of	O
dental	O
caries	O
in	O
humans	O
.	O

This	O

aims	O
at	O
screening	O
the	O
antibacterial	O
potential	O
of	O
available	O
oral	O
hygiene	O
products	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
the	O
primary	O
etiological	O
agent	O
.	O

selective	O
number	O
of	O
toothpaste	O
mouth	O
rinse	O
available	O
in	O
the	O
nearby	O
local	O
market	O
was	O
subjected	O
to	O
the	O
.	O

The	O
experiments	O
were	O
designed	O
in	O
a	O
way	O
to	O
determine	O
which	O
one	O
of	O
these	O
products	O
had	O
the	O
greatest	O
anti	O
-	O
S	O
.	O
mutans	O
activity	O
.	O

Antibiotic	O
sensitivity	O
tests	O
against	O
the	O
pathogenic	O
strains	O
were	O
also	O
conducted	O
.	O

Pathogenic	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
isolated	O
from	O
clinical	O
dental	O
specimen	O

identified	O
using	O
MTCC	O
standard	O
strain	O
No	O
.	O
890	O
.	O

Of	O
the	O
86	O
.	O
66	O
%	O
samples	O
which	O
showed	O
positive	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
growth	O
,	O
almost	O
96	O
%	O
conferred	O
sensitivity	O
to	O
0	O
.	O
08	O
mg	O
/	O
ml	O
of	O
penicillin	O
.	O

Among	O
the	O
toothpastes	O
used	O
,	O
A	O
showed	O
the	O
maximum	O
inhibitory	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
inhibiting	O
its	O
growth	O
even	O
at	O
a	O
very	O
low	O
concentration	O
of	O
0	O
.	O
0156	O
g	O
/	O
ml	O
.	O

Similar	O
results	O
were	O
seen	O
in	O
the	O
case	O
of	O
the	O
mouth	O
rinses	O
used	O
for	O
the	O

,	O
which	O
showed	O
that	O
N	O
had	O
the	O
most	O
effective	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
even	O
at	O
1	O
:	O
8	O
dilution	O
.	O

The	O
oral	O
hygiene	O
products	O
containing	O
triclosan	O
proved	O
to	O
be	O
the	O
most	O
effective	O
followed	O
by	O
those	O
containing	O
fluoride	O
.	O

Herbal	O
products	O
showed	O
comparatively	O
lesser	O
activity	O
in	O
inhibiting	O
the	O
growth	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Even	O
though	O
there	O
are	O
so	O
many	O
products	O
available	O
to	O
curb	O
the	O
progression	O
of	O
dental	O
caries	O
in	O
the	O
population	O
targeted	O
,	O
there	O
is	O
still	O
an	O
undoubted	O
prevalence	O

incidence	O
of	O
caries	O
among	O
the	O
general	O
public	O
.	O

The	O
need	O
for	O
a	O
better	O
alternative	O
to	O
help	O
control	O
dental	O
caries	O
is	O
on	O
the	O
rise	O
even	O
today	O
.	O

We	O
have	O
isolated	O
4	O
antibacterial	O
substances	O
that	O
were	O
active	O
against	O
the	O
oral	O
bacteria	O
that	O
cause	O
dental	O
caries	O
and	O
periodontitis	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
from	O
lemon	O
peel	O
,	O
a	O
waste	O
product	O
in	O
the	O
citrus	O
industry	O
.	O

The	O
isolated	O
substances	O
were	O
identified	O
as	O
8	O
-	O
geranyloxypsolaren	O
,	O
5	O
-	O
geranyloxypsolaren	O
,	O
5	O
-	O
geranyloxy	O
-	O
7	O
-	O
methoxycoumarin	O
,	O
and	O
phloroglucinol	O
1	O
-	O
beta	O
-	O
D	O
-	O
glucopyranoside	O
(	O
phlorin	O
)	O
upon	O
structural	O
analyses	O
.	O

Among	O
these	O
,	O
8	O
-	O
Geranyloxypsolaren	O
,	O
5	O
-	O
geranyloxypsolaren	O
,	O
and	O
5	O
-	O
geranyloxy	O
-	O
7	O
-	O
methoxycoumarin	O
exhibited	O
high	O
antibacterial	O
activity	O
.	O

These	O
3	O
compounds	O
were	O
effectively	O
extracted	O
using	O
ethanol	O
and	O
n	O
-	O
hexane	O
,	O
whereas	O
phlorin	O
was	O
extracted	O
with	O
water	O
.	O

Further	O
,	O
the	O
above	O
3	O
compounds	O
were	O
present	O
in	O
lemon	O
essential	O
oil	O
and	O
abundantly	O
present	O
in	O
the	O
residue	O
produced	O
upon	O
the	O
cooling	O
treatment	O
of	O
concentrated	O
lemon	O
essential	O
oil	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
find	O
the	O
oral	O
isolate	O
of	O
lactobacilli	B-bacteria
,	O
which	O
has	O
the	O
potential	O
to	O
inhibit	O
either	O
periodontal	O
,	O
cariogenic	O
,	O
or	O
fungal	O
pathogens	O
in	O
vitro	O
,	O
and	O
to	O
examine	O
the	O
effects	O
of	O
bovine	O
milk	O
fermented	O
with	O
the	O
isolate	O
on	O
the	O
oral	O
carriage	O
of	O
cariogenic	O
and	O
periodontal	O
pathogens	O
.	O

The	O
inhibitory	O
effects	O
of	O
the	O
supernatant	O
of	O
Man	O
-	O
Rogosa	O
-	O
Sharpe	O
broth	O
,	O
in	O
which	O
each	O
of	O
42	O
oral	O
isolates	O
of	O
lactobacilli	B-bacteria
grown	O
,	O
was	O
examined	O
.	O

One	O
isolate	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
L8020	I-bacteria
,	O
that	O
showed	O
the	O
potential	O
to	O
inhibit	O
either	O
periodontal	O
,	O
cariogenic	O
,	O
or	O
fungal	O
pathogens	O
in	O
vitro	O
,	O
was	O
used	O
to	O
examine	O
the	O
effects	O
of	O
fermented	O
milk	O
on	O
the	O
oral	O
carriage	O
of	O
cariogenic	O
and	O
periodontal	O
pathogens	O
,	O
which	O
was	O
examined	O
by	O
a	O
placebo	O
-	O
controlled	O
and	O
cohort	O
trial	O
using	O
50	O
participants	O
.	O

Edible	O
yogurt	O
containing	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
L8020	I-bacteria
significantly	O
reduced	O
the	O
oral	O
carriage	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
four	O
periodontal	O
pathogens	O
examined	O
:	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
but	O
the	O
phenomenon	O
were	O
not	O
observed	O
with	O
the	O
placebo	O
yogurt	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

These	O
results	O
suggest	O
that	O
yogurt	O
with	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
L8020	I-bacteria
could	O
reduce	O
the	O
risk	O
of	O
dental	O
caries	O
and	O
periodontal	O
disease	O
.	O

The	O
polysaccharide	O
gel	O
(	O
PG	O
)	O
extract	O
from	O
durian	O
fruit	O
rinds	O
(	O
Durio	O
zibethinus	O
Murr	O
.	O
`	O
`	O
Monthong	O
'	O
'	O
)	O
is	O
a	O
pectic	O
polysaccharide	O
with	O
antibacterial	O
activity	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
the	O
in	O
vitro	O
antibacterial	O
activity	O
of	O
PG	O
against	O
oral	O
pathogens	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
)	O
.	O

The	O
inhibitory	O
activity	O
of	O
PG	O
at	O
50	O
,	O
100	O
,	O
and	O
150	O
mg	O
/	O
mL	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
American	O
Tissue	O
Culture	O
Collection	O
25175	O
)	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
American	O
Tissue	O
Culture	O
Collection	O
43718	O
)	O
was	O
determined	O
after	O
1	O
-	O
and	O
5	O
-	O
min	O
exposure	O
by	O
broth	O
macrodilution	O
susceptibility	O
test	O
and	O
scanning	O
electron	O
microscopy	O
.	O

Normal	O
saline	O
or	O
culture	O
broth	O
medium	O
and	O
0	O
.	O
1	O
%	O
chlorhexidine	O
were	O
used	O
as	O
negative	O
and	O
positive	O
controls	O
,	O
respectively	O
.	O

For	O
1	O
-	O
min	O
exposure	O
,	O
150	O
mg	O
/	O
mL	O
PG	O
or	O
0	O
.	O
1	O
%	O
chlorhexidine	O
significantly	O
possessed	O
bactericidal	O
activity	O
against	O
both	O
tested	O
bacteria	O
(	O
P	O
=	O
0	O
.	O
037	O
)	O
,	O
while	O
PG	O
at	O
100	O
mg	O
/	O
mL	O
possessed	O
significant	O
bactericidal	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
P	O
=	O
0	O
.	O
037	O
)	O
and	O
inhibitory	O
activity	O
against	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

Blebs	O
,	O
irregular	O
-	O
shaped	O
cells	O
,	O
and	O
disrupted	O
cells	O
were	O
found	O
in	O
bacteria	O
treated	O
with	O
either	O
0	O
.	O
1	O
%	O
chlorhexidine	O
or	O
50	O
-	O
150mg	O
/	O
mL	O
PG	O
under	O
scanning	O
electron	O
microscopy	O
.	O

The	O
bactericidal	O
activity	O
of	O
PG	O
at	O
150	O
mg	O
/	O
mL	O
against	O
oral	O
bacteria	O
at	O
1	O
-	O
min	O
exposure	O
suggests	O
its	O
possibility	O
to	O
be	O
used	O
as	O
a	O
natural	O
antibacterial	O
ingredient	O
in	O
oral	O
hygiene	O
products	O
.	O

